PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lederle, FA; Cushman, WC; Ferguson, RE; Brophy, MT; Fiore, LD				Lederle, Frank A.; Cushman, William C.; Ferguson, Ryan E.; Brophy, Mary T.; Fiore, Louis D.			Chlorthalidone Versus Hydrochlorothiazide: A New Kind of Veterans Affairs Cooperative Study	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							TRIAL		[Lederle, Frank A.] Minneapolis Vet Affairs Hlth Care Syst, One Vet Dr, Minneapolis, MN 55417 USA; Vet Affairs Med Ctr, Memphis, TN USA; Vet Affairs Boston Healthcare Syst, Boston, MA USA; [Cushman, William C.] Memphis Vet Affairs Med Ctr, 1030 Jefferson Ave, Memphis, TN 38104 USA; [Ferguson, Ryan E.; Brophy, Mary T.; Fiore, Louis D.] Vet Affairs Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, 150 South Huntington Ave, Boston, MA 02130 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Lederle, FA (corresponding author), Minneapolis Vet Affairs Hlth Care Syst, One Vet Dr, Minneapolis, MN 55417 USA.	frank.lederle@va.gov						[Anonymous], 2011, LEARN WHAT WORKS INF; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; D'Avolio L, 2012, J AM MED INFORM ASSN, V19, pE170, DOI 10.1136/amiajnl-2011-000623; Ernst ME, 2006, HYPERTENSION, V47, P352, DOI 10.1161/01.HYP.0000203309.07140.d3; Ernst ME, 2010, J CLIN HYPERTENS, V12, P927, DOI 10.1111/j.1751-7176.2010.00373.x; Hernandez AF, 2015, ANN INTERN MED, V163, P635, DOI 10.7326/M15-1460; Pletcher MJ, 2014, JAMA INTERN MED, V174, P668, DOI 10.1001/jamainternmed.2013.13297; Roush GC, 2012, HYPERTENSION, V59, P1110, DOI 10.1161/HYPERTENSIONAHA.112.191106; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Woodman R, 2010, HYPERTENSION, V56, P463, DOI 10.1161/HYPERTENSIONAHA.110.154476	10	23	23	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2016	165	9					663	+		10.7326/M16-1208	http://dx.doi.org/10.7326/M16-1208			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8SJ	27538129				2022-12-28	WOS:000386908600008
J	Fried, LF; Palevsky, PM				Fried, Linda F.; Palevsky, Paul M.			Decreasing Prevalence of Chronic Kidney Disease in the United States: A Cause for Optimism	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Fried, Linda F.; Palevsky, Paul M.] VA Pittsburgh Healthcare Syst, Renal Sect 111F-U,Univ Dr, Pittsburgh, PA 15240 USA; Univ Pittsburgh, Pittsburgh, PA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Palevsky, PM (corresponding author), VA Pittsburgh Healthcare Syst, Renal Sect 111F-U,Univ Dr, Pittsburgh, PA 15240 USA.	palevsky@pitt.edu	Palevsky, Paul M./Q-1491-2019	Palevsky, Paul M./0000-0002-7334-5400				Boutten A, 2013, CLIN CHIM ACTA, V419, P132, DOI 10.1016/j.cca.2013.01.021; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Glassock RJ, 2010, CURR OPIN NEPHROL HY, V19, P123, DOI 10.1097/MNH.0b013e328335f951; Murphy D, 2016, ANN INTERN MED, V165, P473, DOI 10.7326/M16-0273; Myers GL, 2006, CLIN CHEM, V52, P5, DOI 10.1373/clinchem.2005.0525144; National Center for Helath Statistics, 2012, STATUS TURTLES QATAR; Plantinga LC, 2008, ARCH INTERN MED, V168, P2268, DOI 10.1001/archinte.168.20.2268; Schmidt RL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143205; United States Renal Data System, 2015, 2015 USRDS ANN DAT R; Westland R, 2013, CLIN J AM SOC NEPHRO, V8, P764, DOI 10.2215/CJN.07870812	10	3	4	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 4	2016	165	7					521	+		10.7326/M16-1649	http://dx.doi.org/10.7326/M16-1649			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DY0EY	27479750				2022-12-28	WOS:000384771300012
J	Goicoechea, JR; Pety, J; Cuadrado, S; Cernicharo, J; Chapillon, E; Fuente, A; Gerin, M; Joblin, C; Marcelino, N; Pilleri, P				Goicoechea, Javier R.; Pety, Jerome; Cuadrado, Sara; Cernicharo, Jose; Chapillon, Edwige; Fuente, Asuncion; Gerin, Maryvonne; Joblin, Christine; Marcelino, Nuria; Pilleri, Paolo			Compression and ablation of the photo-irradiated molecular cloud the Orion Bar	NATURE			English	Article							NONEQUILIBRIUM PHOTODISSOCIATION REGIONS; VIBRATIONALLY EXCITED H-2; H-II REGIONS; MASSIVE STAR; DENSE GAS; CHEMISTRY; IONIZATION; EMISSION; NEBULA; I.	The Orion Bar is the archetypal edge-on molecular cloud surface illuminated by strong ultraviolet radiation from nearby massive stars. Our relative closeness to the Orion nebula (about 1,350 light years away from Earth) means that we can study the effects of stellar feedback on the parental cloud in detail. Visible-light observations of the Orion Bar(1) show that the transition between the hot ionized gas and the warm neutral atomic gas (the ionization front) is spatially well separated from the transition between atomic and molecular gas (the dissociation front), by about 15 arcseconds or 6,200 astronomical units (one astronomical unit is the Earth-Sun distance). Static equilibrium models(2,3) used to interpret previous far-infrared and radio observations of the neutral gas in the Orion Bar(4-6) (typically at 10-20 arcsecond resolution) predict an inhomogeneous cloud structure comprised of dense clumps embedded in a lower-density extended gas component. Here we report one-arcsecond-resolution millimetre-wave images that allow us to resolve the molecular cloud surface. In contrast to stationary model predictions(7-9), there is no appreciable offset between the peak of the H-2 vibrational emission (delineating the H/H-2 transition) and the edge of the observed CO and HCO+ emission. This implies that the H/H-2 and C+/C/CO transition zones are very close. We find a fragmented ridge of high-density substructures, photoablative gas flows and instabilities at the molecular cloud surface. The results suggest that the cloud edge has been compressed by a high-pressure wave that is moving into the molecular cloud, demonstrating that dynamical and non-equilibrium effects are important for the cloud evolution.	[Goicoechea, Javier R.; Cuadrado, Sara; Cernicharo, Jose; Marcelino, Nuria] Inst Ciencia Mat Madrid CSIC, Grp Astrofis Mol, Calle Sor Juana Ines de la Cruz 3, E-28049 Madrid, Spain; [Pety, Jerome; Chapillon, Edwige] Inst Radioastron Millimetr IRAM, 300 Rue Piscine, F-38406 St Martin Dheres, France; [Pety, Jerome; Gerin, Maryvonne] PSL Res Univ, Ecole Normale Super, CNRS,UMR 8112,Observ Paris, Lab Etud Rayonnement & Mat Astrophy & Atomspheres, 24 Rue Lhomond, F-75231 Paris 05, France; [Chapillon, Edwige] Univ Bordeaux, LAB, UMR 5804, F-33270 Floirac, France; [Chapillon, Edwige] CNRS, LAB, UMR 5804, F-33270 Floirac, France; [Fuente, Asuncion] Observ Astron Nacl OAN IGN, Apartado 112, Alcala De Henares 28803, Spain; [Gerin, Maryvonne] Univ Paris 06, Sorbonne Univ, F-75000 Paris, France; [Joblin, Christine; Pilleri, Paolo] Univ Toulouse, UPS OMP, IRAP, F-31028 Toulouse, France; [Joblin, Christine; Pilleri, Paolo] CNRS, IRAP, 9 Ave Colonel Roche,BP 44346, F-31028 Toulouse, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Sorbonne Universite; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Goicoechea, JR (corresponding author), Inst Ciencia Mat Madrid CSIC, Grp Astrofis Mol, Calle Sor Juana Ines de la Cruz 3, E-28049 Madrid, Spain.	jr.goicoechea@icmm.csic.es	Joblin, Christine/ABD-5154-2020; Marcelino, Nuria/H-4400-2017; Goicoechea, Javier R./AAB-4788-2019; Cuadrado, Sara/AAA-9577-2020; Cernicharo, Jose/G-3059-2015; Fuente, Asuncion/G-1468-2016	Joblin, Christine/0000-0003-1561-6118; Marcelino, Nuria/0000-0001-7236-4047; Goicoechea, Javier R./0000-0001-7046-4319; Cuadrado, Sara/0000-0002-7393-1813; Cernicharo, Jose/0000-0002-3518-2524; Pilleri, Paolo/0000-0003-4861-0476; Fuente, Asuncion/0000-0001-6317-6343	ERC [ERC-2013-Syg-610256-NANOCOSMOS]; MINECO, Spain [CSD2009-00038, AYA2012-32032]; French CNRS programme 'Physique et Chimie du Milieu Interstellaire'; INSU/CNRS (France); MPG (Germany); IGN (Spain)	ERC(European Research Council (ERC)European Commission); MINECO, Spain(Spanish Government); French CNRS programme 'Physique et Chimie du Milieu Interstellaire'; INSU/CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); MPG (Germany)(Max Planck Society); IGN (Spain)	We thank the ERC for support under grant ERC-2013-Syg-610256-NANOCOSMOS. We also thank MINECO, Spain, for funding support under grants CSD2009-00038 and AYA2012-32032. This work was in part supported by the French CNRS programme 'Physique et Chimie du Milieu Interstellaire'. We thank P. Schilke and D. Lis for sharing their IRAM-PdBI observations of the H<SUP>13</SUP>CN J = 1-0 condensations inside the Orion Bar, and M. Walmsley for sharing his H<INF>2</INF> v = 1-0 S(1) and O i 1.3 mu m infrared images. ALMA is a partnership of the ESO (representing its member states), the NSF (USA) and NINS (Japan), together with the NRC (Canada), the NSC and ASIAA (Taiwan) and KASI (Republic of Korea) in cooperation with the Republic of Chile. The Joint ALMA Observatory is operated by the ESO, the AUI/NRAO and the NAOJ. This Letter makes use of observations obtained with the IRAM 30 m telescope. IRAM is supported by the INSU/CNRS (France), the MPG (Germany), and the IGN (Spain).	Aghanim N, 2016, ASTRON ASTROPHYS, V586, DOI 10.1051/0004-6361/201525616; Agundez M, 2010, ASTROPHYS J, V713, P662, DOI 10.1088/0004-637X/713/1/662; Allers KN, 2005, ASTROPHYS J, V630, P368, DOI 10.1086/431919; Andree-Labsch S., 2014, PREPRINT; Arab H, 2012, ASTRON ASTROPHYS, V541, DOI 10.1051/0004-6361/201118537; Berne O, 2010, NATURE, V466, P947, DOI 10.1038/nature09289; Bertoldi F, 1996, ASTROPHYS J, V458, P222, DOI 10.1086/176805; Bertoldi F, 1997, ESA SPEC PUBL, V419, P67; Brogan CL, 2005, ASTR SOC P, V343, P183; BURTON MG, 1990, ASTROPHYS J, V365, P620, DOI 10.1086/169516; CARDELLI JA, 1989, ASTROPHYS J, V345, P245, DOI 10.1086/167900; Cuadrado S, 2015, ASTRON ASTROPHYS, V575, DOI 10.1051/0004-6361/201424568; Draine B.T., 2011, PHYS INTERSTELLAR IN; ELMEGREEN BG, 1977, ASTROPHYS J, V214, P725, DOI 10.1086/155302; Federrath C, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/1/51; GarciaSegura G, 1996, ASTROPHYS J, V469, P171, DOI 10.1086/177769; GENZEL R, 1989, ANNU REV ASTRON ASTR, V27, P41, DOI 10.1146/annurev.aa.27.090189.000353; Goicoechea JR, 2006, ASTRON ASTROPHYS, V456, P565, DOI 10.1051/0004-6361:20065260; Goicoechea JR, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201116977; Goicoechea JR, 2015, ASTROPHYS J, V812, DOI 10.1088/0004-637X/812/1/75; Gorti U, 2002, ASTROPHYS J, V573, P215, DOI 10.1086/340556; Guzman V, 2012, ASTRON ASTROPHYS, V543, DOI 10.1051/0004-6361/201219449; Hennebelle P, 2012, ASTRON ASTROPHYS REV, V20, DOI 10.1007/s00159-012-0055-y; HILL JK, 1978, ASTROPHYS J, V225, P390, DOI 10.1086/156501; HOGERHEIJDE MR, 1995, ASTRON ASTROPHYS, V294, P792; HOLLENBACH D, 1995, ASTROPHYS J, V455, P133, DOI 10.1086/176562; Hollenbach DJ, 1999, REV MOD PHYS, V71, P173, DOI 10.1103/RevModPhys.71.173; Hosokawa T, 2006, ASTROPHYS J, V646, P240, DOI 10.1086/504789; Inutsuka S, 1997, ASTROPHYS J, V480, P681, DOI 10.1086/303982; LANGER WD, 1990, ASTROPHYS J, V357, P477, DOI 10.1086/168935; Le Petit F, 2006, ASTROPHYS J SUPPL S, V164, P506, DOI 10.1086/503252; LEFLOCH B, 1994, ASTRON ASTROPHYS, V289, P559; Lis DC, 2003, ASTROPHYS J, V597, pL145, DOI 10.1086/379868; Nagy Z, 2013, ASTRON ASTROPHYS, V550, DOI 10.1051/0004-6361/201220519; Neufeld DA, 2006, ASTRON ASTROPHYS, V454, pL37, DOI 10.1051/0004-6361:200600015; Neufeld DA, 2009, ASTROPHYS J, V706, P1594, DOI 10.1088/0004-637X/706/2/1594; Noel B, 2005, ASTRON ASTROPHYS, V436, P569, DOI 10.1051/0004-6361:20041760; O'Dell CR, 2000, ASTRON J, V120, P382, DOI 10.1086/301429; O'Dell CR, 2001, ANNU REV ASTRON ASTR, V39, P99, DOI 10.1146/annurev.astro.39.1.99; Owl RCY, 2000, ASTROPHYS J, V540, P886, DOI 10.1086/309342; Pety J, 2010, ASTRON ASTROPHYS, V517, DOI 10.1051/0004-6361/200912873; Raga AC, 2012, MON NOT R ASTRON SOC, V419, pL39, DOI 10.1111/j.1745-3933.2011.01173.x; ROBERGE WG, 1990, ASTROPHYS J, V350, P700, DOI 10.1086/168421; Spitzer L., 1978, PHYS PROCESSES INTER; STERNBERG A, 1995, ASTROPHYS J SUPPL S, V99, P565, DOI 10.1086/192198; Storzer H, 1998, ASTROPHYS J, V495, P853, DOI 10.1086/305315; STORZER H, 1995, ASTRON ASTROPHYS, V296, pL9; TIELENS AGGM, 1993, SCIENCE, V262, P86, DOI 10.1126/science.262.5130.86; TIELENS AGGM, 1985, ASTROPHYS J, V291, P722, DOI 10.1086/163111; Tremblin P, 2014, ASTRON ASTROPHYS, V564, DOI 10.1051/0004-6361/201322700; van der Werf PP, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/2/101; vanderWerf PP, 1996, ASTRON ASTROPHYS, V313, P633; Walmsley CM, 2000, ASTRON ASTROPHYS, V364, P301; Weilbacher PM, 2015, ASTRON ASTROPHYS, V582, DOI 10.1051/0004-6361/201526529; Wyrowski F, 1997, ASTROPHYS J, V487, pL171, DOI 10.1086/310893	57	71	71	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					207	+		10.1038/nature18957	http://dx.doi.org/10.1038/nature18957			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9LQ	27509859	Green Accepted, Green Submitted			2022-12-28	WOS:000382539100042
J	Habib, N; Li, YQ; Heidenreich, M; Swiech, L; Avraham-Davidi, I; Trombetta, JJ; Hession, C; Zhang, F; Regev, A				Habib, Naomi; Li, Yinqing; Heidenreich, Matthias; Swiech, Lukasz; Avraham-Davidi, Inbal; Trombetta, John J.; Hession, Cynthia; Zhang, Feng; Regev, Aviv			Div-Seq: Single-nucleus RNA-Seq reveals dynamics of rare adult newborn neurons	SCIENCE			English	Article							NEURAL STEM-CELLS; SPINAL-CORD; TRANSCRIPTOME	Single-cell RNA sequencing (RNA-Seq) provides rich information about cell types and states. However, it is difficult to capture rare dynamic processes, such as adult neurogenesis, because isolation of rare neurons from adult tissue is challenging and markers for each phase are limited. Here, we develop Div-Seq, which combines scalable single-nucleus RNA-Seq (sNuc-Seq) with pulse labeling of proliferating cells by 5-ethynyl-2'-deoxyuridine (EdU) to profile individual dividing cells. sNuc-Seq and Div-Seq can sensitively identify closely related hippocampal cell types and track transcriptional dynamics of newborn neurons within the adult hippocampal neurogenic niche, respectively. We also apply Div-Seq to identify and profile rare newborn neurons in the adult spinal cord, a noncanonical neurogenic region. sNuc-Seq and Div-Seq open the way for unbiased analysis of diverse complex tissues.	[Habib, Naomi; Li, Yinqing; Heidenreich, Matthias; Swiech, Lukasz; Avraham-Davidi, Inbal; Trombetta, John J.; Hession, Cynthia; Zhang, Feng; Regev, Aviv] Broad Inst MIT & Harvard, 415 Main St, Cambridge, MA 02142 USA; [Habib, Naomi; Li, Yinqing; Heidenreich, Matthias; Swiech, Lukasz; Zhang, Feng] Stanley Ctr Psychiat Res, 75 Ames St, Cambridge, MA 02142 USA; [Habib, Naomi; Li, Yinqing; Heidenreich, Matthias; Swiech, Lukasz; Zhang, Feng] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Li, Yinqing] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Zhang, Feng] MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA; [Zhang, Feng] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Regev, Aviv] MIT, Dept Biol, Howard Hughes Med Inst, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Zhang, F; Regev, A (corresponding author), Broad Inst MIT & Harvard, 415 Main St, Cambridge, MA 02142 USA.; Zhang, F (corresponding author), Stanley Ctr Psychiat Res, 75 Ames St, Cambridge, MA 02142 USA.; Zhang, F (corresponding author), MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Zhang, F (corresponding author), MIT, Dept Brain & Cognit Sci, E25-618, Cambridge, MA 02139 USA.; Zhang, F (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Regev, A (corresponding author), MIT, Dept Biol, Howard Hughes Med Inst, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	zhang@broadinstitute.org; aregev@broadinstitute.org	Macrae, Rhiannon/AAX-1536-2020; Habib, Naomi/AAA-8937-2020	Li, Yinqing/0000-0002-9096-8482	Human Frontier Science Program; Klarman Cell Observatory at the Broad Institute and National Institute of Mental Health (NIMH) [U01MH105960]; NIH through NIMH [5DP1-MH100706, 1R01-MH110049]; NSF; New York Stem Cell Foundation; Simons Foundation; Paul G. Allen Family Foundation; NATIONAL EYE INSTITUTE [R21EY026412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH100706, R01MH110049, U01MH105960] Funding Source: NIH RePORTER	Human Frontier Science Program(Human Frontier Science Program); Klarman Cell Observatory at the Broad Institute and National Institute of Mental Health (NIMH); NIH through NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NSF(National Science Foundation (NSF)); New York Stem Cell Foundation; Simons Foundation; Paul G. Allen Family Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Raw data are deposited to the Gene Expression Omnibus with accession no. GSE84371; annotated data are available at https://portals.broadinstitute.org/single_cell, and software tools are available at https://github.com/yinqingl/nucseq_analysis. We thank N. Friedman, A. Shalek, D. Gennert, T. Blosser, S. Kadosch, O. Rosen, Z. Wang, P. Rogers, and L. Gaffeny for support and J. Campbell for dissociated neurons image. N.H. is a Howard Hughes Medical Institute Fellow of the Helen Hay Whitney Foundation. M.H. is supported by the Human Frontier Science Program. This work was supported by the Klarman Cell Observatory at the Broad Institute and National Institute of Mental Health (NIMH) grant U01MH105960 (F.Z., A.R.). F.Z. is supported by the NIH through NIMH (5DP1-MH100706 and 1R01-MH110049), NSF, the New York Stem Cell, Simons, Paul G. Allen Family, and Vallee Foundations; and James and Patricia Poitras, Robert Metcalfe, and David Cheng. A.R. is a Howard Hughes Medical Institute Investigator on the scientific advisory board of Syros Pharmaceuticals and Thermo Fisher and a consultant for Driver group. N.H., Y.L., A.R., and F.Z. are inventors on provisional patent application 62/311,129, applied for by the Broad Institute and MIT, that covers the methods described in this paper. All DNA constructs are available from Addgene subject to a material transfer agreement with Addgene.	Agoston Z, 2014, DEVELOPMENT, V141, P28, DOI 10.1242/dev.097295; Cembrowski MS, 2016, NEURON, V89, P351, DOI 10.1016/j.neuron.2015.12.013; Feliciano DM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a018846; Horner PJ, 2000, J NEUROSCI, V20, P2218; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Lacar B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11022; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Llorens-Bobadilla E, 2015, CELL STEM CELL, V17, P329, DOI 10.1016/j.stem.2015.07.002; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Moore DL, 2015, SCIENCE, V349, P1334, DOI 10.1126/science.aac9868; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Roques BP, 2012, NAT REV DRUG DISCOV, V11, P292, DOI 10.1038/nrd3673; Rottkamp CA, 2008, DEV BIOL, V314, P23, DOI 10.1016/j.ydbio.2007.10.046; Schouten M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00025; Shechter R, 2007, STEM CELLS, V25, P2277, DOI 10.1634/stemcells.2006-0705; Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013; Swiech L, 2015, NAT BIOTECHNOL, V33, P102, DOI 10.1038/nbt.3055; Tasic B, 2016, NAT NEUROSCI, V19, P335, DOI 10.1038/nn.4216; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	20	275	288	5	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					925	928		10.1126/science.aad7038	http://dx.doi.org/10.1126/science.aad7038			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27471252	Green Accepted, Green Published			2022-12-28	WOS:000381867700038
J	Wellbrock, C				Wellbrock, Claudia			Melanoma and the Microenvironment - Age Matters	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							METASTASIS		[Wellbrock, Claudia] Univ Manchester, Manchester, Lancs, England	University of Manchester	Wellbrock, C (corresponding author), Univ Manchester, Manchester, Lancs, England.			Wellbrock, Claudia/0000-0002-3825-6381	Cancer Research UK [16416] Funding Source: researchfish	Cancer Research UK(Cancer Research UK)		Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Kaur A, 2016, NATURE, V532, P250, DOI 10.1038/nature17392; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726	4	3	3	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2016	375	7					696	698		10.1056/NEJMcibr1606907	http://dx.doi.org/10.1056/NEJMcibr1606907			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4VF	27532838	Green Submitted			2022-12-28	WOS:000381478600015
J	Setty, SG; Kong, MF				Setty, S. Gururaj; Kong, Marie-France			CASE REVIEW Intractable nausea and vomiting associated with poor glycaemic control in a patient with type 1 diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GASTROPARESIS; ERYTHROMYCIN; STIMULATION; SYMPTOMS; MOTILITY; MELLITUS; MEAL		[Setty, S. Gururaj] Northampton Gen Hosp, Dept Endocrinol & Diabet, Northampton, England; [Kong, Marie-France] Univ Hosp Leicester NHS Trust, Dept Endocrinol & Diabet, Leicester, Leics, England	University Hospitals of Leicester NHS Trust; University of Leicester	Setty, SG (corresponding author), Northampton Gen Hosp, Dept Endocrinol & Diabet, Northampton, England.	sowmyagururaj@doctors.org.uk						Abell TL, 2008, AM J GASTROENTEROL, V103, P753, DOI 10.1111/j.1572-0241.2007.01636.x; Abell TL, 2006, NEUROGASTROENT MOTIL, V18, P263, DOI 10.1111/j.1365-2982.2006.00760.x; Abell TL, 2002, DIGESTION, V66, P204, DOI 10.1159/000068359; Bai Y, 2010, DIGESTION, V81, P27, DOI 10.1159/000235917; Camilleri M, 2013, AM J GASTROENTEROL, V108, P18, DOI 10.1038/ajg.2012.373; Chang J, 2011, J GASTROEN HEPATOL, V26, P46, DOI 10.1111/j.1440-1746.2010.06573.x; Eckhauser FE, 1998, AM SURGEON, V64, P711; Ehrenpreis ED, 1998, ALIMENT PHARM THER, V12, P373; European Medicines Agency, DOMP CONT MED; FRASER RJ, 1990, DIABETOLOGIA, V33, P675, DOI 10.1007/BF00400569; HOROWITZ M, 1986, J GASTROEN HEPATOL, V1, P97, DOI 10.1111/j.1440-1746.1986.tb00104.x; HOROWITZ M, 1989, DIABETOLOGIA, V32, P151, DOI 10.1007/BF00265086; IBER FL, 1993, DIGEST DIS SCI, V38, P45, DOI 10.1007/BF01296772; Jones KL, 1999, DIABETES CARE, V22, P339, DOI 10.2337/diacare.22.2.339; Kashyap P, 2010, GUT, V59, P1716, DOI 10.1136/gut.2009.199703; Kim SW, 2006, PSYCHOSOMATICS, V47, P440, DOI 10.1176/appi.psy.47.5.440; Kong MF, 2015, BRIT J DIABETES VASC, V15, P34, DOI 10.15277/bjdvd.2015.001; Kuo B, 2008, ALIMENT PHARM THER, V27, P186, DOI 10.1111/j.1365-2036.2007.03564.x; Lipp RW, 1996, DIABETES CARE, V19, P1306, DOI 10.2337/diacare.19.11.1306a; Medicines and Healthcare products Regulatory Agency, 2014, DRUG SAFETY UPDATE, V7; Medicines and Healthcare products Regulatory Agency, 2012, DRUG SAFETY UPDATE, V5; Medicines and Healthcare products Regulatory Agency, 2013, DRUG SAFETY UPDATE, V7; Meier M, 2002, CLIN AUTON RES, V12, P197, DOI 10.1007/s10286-002-0023-0; National Institute for Health and Care Excellence, GASTR STIM GASTR, V489; Parrish CR, 2007, DIABETES SPECTRUM, V20, P231, DOI DOI 10.2337/DIASPECT.20.4.231; Quan C, 2008, AM J GASTROENTEROL, V103, P2023, DOI 10.1111/j.1572-0241.2008.01943.x; Sharma D, 2011, DIABETOLOGIA, V54, P2768, DOI 10.1007/s00125-011-2282-6; Soykan I, 1998, DIGEST DIS SCI, V43, P2398, DOI 10.1023/A:1026665728213; Szarka LA, 2008, CLIN GASTROENTEROL H, V6, P635, DOI 10.1016/j.cgh.2008.01.009; van Can J, 2014, INT J OBESITY, V38, P784, DOI 10.1038/ijo.2013.162	30	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2016	354								i4197	10.1136/bmj.i4197	http://dx.doi.org/10.1136/bmj.i4197			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GZ	27534973				2022-12-28	WOS:000381806400004
J	Korhonen, P; Heintjes, EM; Williams, R; Hoti, F; Christopher, S; Majak, M; Kool-Houweling, L; Strongman, H; Linder, M; Dolin, P; Bahmanyar, S				Korhonen, Pasi; Heintjes, Edith M.; Williams, Rachael; Hoti, Fabian; Christopher, Solomon; Majak, Maila; Kool-Houweling, Leanne; Strongman, Helen; Linder, Marie; Dolin, Paul; Bahmanyar, Shahram			Pioglitazone use and risk of bladder cancer in patients with type 2 diabetes: retrospective cohort study using datasets from four European countries	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOLLOW-UP; THIAZOLIDINEDIONES; DATABASE; TRIAL	OBJECTIVE To evaluate the association between pioglitazone use and bladder cancer risk in patients with type 2 diabetes. Design Retrospective cohort study using propensity score matched cohorts. Settings Healthcare databases from Finland, the Netherlands, Sweden, and the United Kingdom. Data comprised country specific datasets of linked records on prescriptions, hospitals, general practitioners, cancer, and deaths. Participants Patients with type 2 diabetes who initiated pioglitazone (n=56 337) matched with patients with type 2 diabetes in the same country exposed to diabetes drug treatments other than pioglitazone (n=317 109). Two matched cohorts were created, using a 1: 1 fixed ratio (nearest match cohort) and a 1: 10 variable ratio (multiple match cohort). Patients were matched on treatment history and propensity scores accounting for several variables associated with pioglitazone initiation. Main outcome measures Hazard ratios and 95% confidence intervals were estimated by Cox's proportional hazards model with adjustments for relevant confounders. To assess the robustness of the findings, several sensitivity and stratified analyses were performed. Results In the cohort exposed to pioglitazone treatment, 130 bladder cancers occurred over a mean follow-up time of 2.9 years. In the nearest match and multiple match cohorts not exposed to pioglitazone treatment, 153 and 970 bladder cancers were recorded, with a mean follow-up time of 2.8 and 2.9 years, respectively. With regards to bladder cancer risk, the adjusted hazard ratio for patients ever exposed versus never exposed to pioglitazone was 0.99 (95% confidence interval 0.75 to 1.30) and 1.00 (0.83 to 1.21) in the nearest and multiple match cohorts, respectively. Increasing duration of pioglitazone use and increasing cumulative dose were not associated with risk of bladder cancer (>48 months of pioglitazone use, adjusted hazard ratio 0.86 (0.44 to 1.66); >40 000 mg cumulative dose, 0.65 (0.33 to 1.26) in the nearest match cohort). Conclusions This study shows no evidence of an association between ever use of pioglitzone and risk of bladder cancer compared with never use, which is consistent with results from other recent studies that also included a long follow-up period.	[Korhonen, Pasi; Hoti, Fabian; Christopher, Solomon; Majak, Maila] EPID Res, FI-02130 Espoo, Finland; [Heintjes, Edith M.; Kool-Houweling, Leanne] PHARMO Inst, Utrecht, Netherlands; [Williams, Rachael; Strongman, Helen] Clin Practice Res Datalink, London, England; [Linder, Marie; Bahmanyar, Shahram] Karolinska Inst, Ctr Pharmacoepidemiol, Stockholm, Sweden; [Dolin, Paul] Takeda Dev Ctr Europe, London, England	Karolinska Institutet; Takeda Pharmaceutical Company Ltd; Takeda Development Centre Europe Ltd.	Korhonen, P (corresponding author), EPID Res, FI-02130 Espoo, Finland.	pasi.korhonen@epidresearch.com		Strongman, Helen/0000-0001-8739-4601; Linder, Marie/0000-0003-2619-2189; Bahmanyar, Shahram/0000-0002-9205-6540; Hoti, Fabian/0000-0002-7464-3549	Takeda Development Centre Europe	Takeda Development Centre Europe(Takeda Pharmaceutical Company Ltd)	The European Medicines Agency (EMA) mandated the marketing authorisation holder of Actos (pioglitazone) to conduct this study. The study protocol was reviewed and approved by the EMA, and the study was granted the ENCePP Seal, reflecting transparency and quality in research. The study was fully funded by Takeda Development Centre Europe.	Barlow L, 2009, ACTA ONCOL, V48, P27, DOI 10.1080/02841860802247664; Boggon R, 2013, PHARMACOEPIDEM DR S, V22, P168, DOI 10.1002/pds.3374; Bosetti C, 2013, ONCOLOGIST, V18, P148, DOI 10.1634/theoncologist.2012-0302; Colmers IN, 2012, CAN MED ASSOC J, V184, pE675, DOI 10.1503/cmaj.112102; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Dregan A, 2012, CANCER EPIDEMIOL, V36, P425, DOI 10.1016/j.canep.2012.05.013; Erdmann E, 2014, DIABETES OBES METAB, V16, P63, DOI 10.1111/dom.12180; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hillaire-Buys D, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3500; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; International Agency for Research on Cancer, 2015, SOME DRUGS AND HERBA, V108; Korhonen P, 2002, ACTA ONCOL, V41, P381, DOI 10.1080/028418602760169442; Levin D, 2015, DIABETOLOGIA, V58, P493, DOI 10.1007/s00125-014-3456-9; Lewis JD, 2015, JAMA-J AM MED ASSOC, V314, P265, DOI 10.1001/jama.2015.7996; Lewis JD, 2011, DIABETES CARE, V34, P916, DOI 10.2337/dc10-1068; Ryder REJ, 2015, BRIT J DIABETES VASC, V15, P46, DOI 10.15277/bjdvd.2015.021; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Tuccori M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1541; Turner RM, 2014, BRIT J CLIN PHARMACO, V78, P258, DOI 10.1111/bcp.12306; Wei L, 2013, BRIT J CLIN PHARMACO, V75, P254, DOI 10.1111/j.1365-2125.2012.04325.x	20	36	37	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2016	354								i3903	10.1136/bmj.i3903	http://dx.doi.org/10.1136/bmj.i3903			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GX	27530399	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000381806200001
J	Song, ZR; Fisher, ES				Song, Zirui; Fisher, Elliott S.			The ACO Experiment in Infancy-Looking Back and Looking Forward	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACCOUNTABLE CARE ORGANIZATIONS; MEDICARE		Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Fisher, Elliott S.] Dartmouth Inst Hlth Policy & Clin Practice, Williamson Bldg,One Med Ctr Dr, Lebanon, NH 03766 USA	Harvard University; Massachusetts General Hospital; Dartmouth College	Fisher, ES (corresponding author), Dartmouth Inst Hlth Policy & Clin Practice, Williamson Bldg,One Med Ctr Dr, Lebanon, NH 03766 USA.	elliott.s.fisher@dartmouth.edu						Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; McWilliams JM, 2016, NEW ENGL J MED, V374, P2357, DOI 10.1056/NEJMsa1600142; McWilliams JM, 2015, NEW ENGL J MED, V372, P1927, DOI 10.1056/NEJMsa1414929; McWilliams JM, 2014, NEW ENGL J MED, V371, P1715, DOI 10.1056/NEJMsa1406552; Muhlestein D, HLTH AFFAIRS BLOG; Nyweide DJ, 2015, JAMA-J AM MED ASSOC, V313, P2152, DOI 10.1001/jama.2015.4930; Skinner J, 1997, NATL TAX J, V50, P413; Song ZR, 2014, NEW ENGL J MED, V371, P1704, DOI 10.1056/NEJMsa1404026	8	18	18	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2016	316	7					705	706		10.1001/jama.2016.9958	http://dx.doi.org/10.1001/jama.2016.9958			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT5IA	27533150				2022-12-28	WOS:000381514800010
J	Kermode-Scott, B				Kermode-Scott, Barbara			Canadians authorised to use cannabis for medical purposes to be allowed to grow their own again	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Government of Canada, 2016, INF B SAF SEC CONS P; Health Canada, DRUGS HLTH PROD MARK; Health Canada, 2016, MED US CANN INF NEW; Spurgeon D, 2001, BMJ-BRIT MED J, DOI [10.1136/bmj.323.7304.68/b, DOI 10.1136/BMJ.323.7304.68/B]	4	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 15	2016	354								i4480	10.1136/bmj.i4480	http://dx.doi.org/10.1136/bmj.i4480			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GR	27527731				2022-12-28	WOS:000381805400017
J	Sawyer, AH; David, CH; Famiglietti, JS				Sawyer, Audrey H.; David, Cedric H.; Famiglietti, James S.			Continental patterns of submarine groundwater discharge reveal coastal vulnerabilities	SCIENCE			English	Article							VOLCANIC ISLANDS; INTRUSION; AQUIFERS; FLUXES; WATERS; INPUTS; OCEAN	Submarine groundwater discharge (SGD) delivers water and dissolved chemicals from continents to oceans, and its spatial distribution affects coastal water quality. Unlike rivers, SGD is broadly distributed and relatively difficult to measure, especially at continental scales. We present spatially resolved estimates of fresh (land-derived) SGD for the contiguous United States, based on historical climate records and high-resolution hydrographic data. Climate controls regional patterns in fresh SGD, while coastal drainage geometry imparts strong local variability. Because the recharge zones that contribute fresh SGD are densely populated, the quality and quantity of fresh SGD are both vulnerable to anthropogenic disturbance. Our analysis unveils hot spots for contaminant discharge to marine waters and saltwater intrusion into coastal aquifers.	[Sawyer, Audrey H.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [David, Cedric H.; Famiglietti, James S.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	University System of Ohio; Ohio State University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Sawyer, AH (corresponding author), Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA.	sawyer.143@osu.edu	Sawyer, Audrey H/W-3729-2017; Famiglietti, James S/G-7383-2017	Sawyer, Audrey H/0000-0001-8174-0542; Famiglietti, James S/0000-0002-6053-5379; David, Cedric/0000-0002-0924-5907	Jet Propulsion Laboratory, California Institute of Technology; NASA; NASA SWOT and Sea Level Science Teams; NSF [EAR-1446724]; Ohio State University School of Earth Sciences; Directorate For Geosciences [1446763] Funding Source: National Science Foundation; Division Of Earth Sciences [1446724] Funding Source: National Science Foundation	Jet Propulsion Laboratory, California Institute of Technology; NASA(National Aeronautics & Space Administration (NASA)); NASA SWOT and Sea Level Science Teams; NSF(National Science Foundation (NSF)); Ohio State University School of Earth Sciences; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank three anonymous reviewers for their suggestions, and M. Durand, H. Michael, C. Russoniello, and J. Heiss for discussions. Supported by the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA, and grants from the NASA SWOT and Sea Level Science Teams (C.H.D. and J.S.F.); NSF grant EAR-1446724; and the Ohio State University School of Earth Sciences. The authors declare no competing interests. Fresh SGD rates and associated data are freely available at http://dx.doi.org/10.5281/zenodo.58871.	Barlow PM, 2010, HYDROGEOL J, V18, P247, DOI 10.1007/s10040-009-0514-3; Barlow PM, 2003, GROUND WATER FRESHWA, V1262, DOI [10.3133/cir1262, DOI 10.3133/CIR1262]; Beusen AHW, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034035; Burnett WC, 2006, SCI TOTAL ENVIRON, V367, P498, DOI 10.1016/j.scitotenv.2006.05.009; Burnett WC, 2003, BIOGEOCHEMISTRY, V66, P3, DOI 10.1023/B:BIOG.0000006066.21240.53; Cyronak T, 2013, BIOGEOSCIENCES, V10, P2467, DOI 10.5194/bg-10-2467-2013; Destouni G, 2003, BIOGEOCHEMISTRY, V66, P171, DOI 10.1023/B:BIOG.0000006101.12076.10; Destouni G, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2008GB003287; Destouni G, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035064; Ferguson G, 2012, NAT CLIM CHANGE, V2, P342, DOI [10.1038/NCLIMATE1413, 10.1038/nclimate1413]; Gebert W. A., 1987, AVERAGE ANN RUNOFF U; Gleeson T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045565; Hu CM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025449; Kwon EY, 2014, GEOPHYS RES LETT, V41, P8438, DOI 10.1002/2014GL061574; Mazi K, 2014, HYDROL EARTH SYST SC, V18, P1663, DOI 10.5194/hess-18-1663-2014; Mazi K, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/014001; Michael HA, 2011, MAR CHEM, V127, P100, DOI 10.1016/j.marchem.2011.08.001; Moore WS, 2010, ANNU REV MAR SCI, V2, P59, DOI 10.1146/annurev-marine-120308-081019; Moore WS, 1996, NATURE, V380, P612, DOI 10.1038/380612a0; Paerl HW, 1997, LIMNOL OCEANOGR, V42, P1154, DOI 10.4319/lo.1997.42.5_part_2.1154; Prieto C, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045621; Rad SD, 2007, EARTH PLANET SC LETT, V262, P109, DOI 10.1016/j.epsl.2007.07.019; Schaller MF, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD010636; Schopka HH, 2012, EARTH PLANET SC LETT, V339, P67, DOI 10.1016/j.epsl.2012.05.028; Slomp CP, 2004, J HYDROL, V295, P64, DOI 10.1016/j.jhydrol.2004.02.018; VALIELA I, 1990, BIOGEOCHEMISTRY, V10, P177; Younger PL, 1996, NATURE, V382, P121, DOI 10.1038/382121a0; ZEKTSER IS, 1993, J HYDROL, V144, P405, DOI 10.1016/0022-1694(93)90182-9; Zektzer I. S., 1973, J HYDROL, V20, P1, DOI DOI 10.1016/0022-1694(73)90042-5	29	64	65	9	94	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					705	707		10.1126/science.aag1058	http://dx.doi.org/10.1126/science.aag1058			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZC	27492476				2022-12-28	WOS:000381561200042
J	Chen, JC; Alvarez, MJ; Talos, F; Dhruv, H; Rieckhof, GE; Iyer, A; Diefes, KL; Aldape, K; Berens, M; Shen, MM; Califano, A				Chen, James C.; Alvarez, Mariano J.; Talos, Flaminia; Dhruv, Harshil; Rieckhof, Gabrielle E.; Iyer, Archana; Diefes, Kristin L.; Aldape, Kenneth; Berens, Michael; Shen, Michael M.; Califano, Andrea			Identification of Causal Genetic Drivers of Human Disease through Systems-Level Analysis of Regulatory Networks (vol 159, pg 402, 2014)	CELL			English	Correction												califano@c2b2.columbia.edu	; Shen, Michael/C-7546-2009	Califano, Andrea/0000-0003-4742-3679; Shen, Michael/0000-0002-4042-1657; Alfaro, Kristin/0000-0002-9870-8415; Shen, Mouquan/0000-0001-6448-4866				Chen JC, 2014, CELL, V159, P402, DOI 10.1016/j.cell.2014.09.021	1	6	6	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					1055	1055		10.1016/j.cell.2016.07.036	http://dx.doi.org/10.1016/j.cell.2016.07.036			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27518566	Bronze			2022-12-28	WOS:000382258700025
J	Lee, TH				Lee, Thomas H.			Coming Back from the Dead	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lee, Thomas H.] Press Ganey, Wakefield, MA 01880 USA; [Lee, Thomas H.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Lee, TH (corresponding author), Press Ganey, Wakefield, MA 01880 USA.; Lee, TH (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.								0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2016	375	6					507	509		10.1056/NEJMp1606163	http://dx.doi.org/10.1056/NEJMp1606163			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU4OT	27509099				2022-12-28	WOS:000382193100003
J	Mathis, D				Mathis, Diane			IL-33, Imprimatur of Adipocyte Thermogenesis	CELL			English	Editorial Material							REGULATORY T-CELLS; MICE; ACCUMULATION; TISSUE	Chawla and colleagues find that interleukin-33 is a critical controller of brown and beige adipocyte thermogenesis. Its primary impact is on the splicing of transcripts encoding uncoupling protein-1, resulting in uncoupled respiration and effective heat generation. Interleukin-33 acts perinatally to ensure adaptive thermogenesis lifelong.	[Mathis, Diane] Harvard Med Sch, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Mathis, D (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Div Immunol, Boston, MA 02115 USA.	dm@hms.harvard.edu			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092541] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK092541] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Kolodin D, 2015, CELL METAB, V21, P543, DOI 10.1016/j.cmet.2015.03.005; Kuswanto W, 2016, IMMUNITY, V44, P355, DOI 10.1016/j.immuni.2016.01.009; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; MOLOFSKY AB, 2015, IMMUNITY, V42, P1005, DOI [DOI 10.1016/j.immuni.2015.06.006, DOI 10.1016/J.IMMUNI.2015.06.006]; Odegaard JI, 2016, CELL, V166, P841, DOI 10.1016/j.cell.2016.06.040; Vishvanath L, 2016, CELL METAB, V23, P350, DOI 10.1016/j.cmet.2015.10.018	7	4	4	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					794	795		10.1016/j.cell.2016.07.051	http://dx.doi.org/10.1016/j.cell.2016.07.051			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27518556	Bronze			2022-12-28	WOS:000382258700003
J	Nilges, T				Nilges, Tom			Fast track for silver	NATURE			English	Editorial Material							TRANSPORT; LI6PS5X		[Nilges, Tom] Tech Univ Munich, Dept Chem, D-85748 Garching, Germany	Technical University of Munich	Nilges, T (corresponding author), Tech Univ Munich, Dept Chem, D-85748 Garching, Germany.	tom.nilges@lrz.tum.de	Nilges, Tom/Q-3035-2019	Nilges, Tom/0000-0003-1415-4265				Bernal JD, 1924, P R SOC LOND A-CONTA, V106, P749, DOI 10.1098/rspa.1924.0101; Chen CC, 2016, NATURE, V536, P159, DOI 10.1038/nature19078; Deiseroth HJ, 2008, ANGEW CHEM INT EDIT, V47, P755, DOI 10.1002/anie.200703900; Deiseroth HJ, 2011, Z ANORG ALLG CHEM, V637, P1287, DOI 10.1002/zaac.201100158; GELLER S, 1967, SCIENCE, V157, P310, DOI 10.1126/science.157.3786.310; Hu S, 2014, NATURE, V516, P227, DOI 10.1038/nature14015; Maier J, 2006, ANN PHYS-BERLIN, V15, P469, DOI 10.1002/andp.200510201; Riess I, 2003, SOLID STATE IONICS, V157, P1, DOI 10.1016/S0167-2738(02)00182-0; Rivnay J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11287	9	0	0	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					150	151		10.1038/536150a	http://dx.doi.org/10.1038/536150a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27510215				2022-12-28	WOS:000381472100020
J	Plumb, LA; van't Hoff, W; Kleta, R; Reid, C; Ashton, E; Samuels, M; Bockenhauer, D				Plumb, Lucy Anne; van't Hoff, William; Kleta, Robert; Reid, Chris; Ashton, Emma; Samuels, Martin; Bockenhauer, Detlef			Renal apnoea: extreme disturbance of homoeostasis in a child with Bartter syndrome type IV	LANCET			English	Editorial Material							ALKALOSIS		[Plumb, Lucy Anne; van't Hoff, William; Kleta, Robert; Ashton, Emma; Samuels, Martin; Bockenhauer, Detlef] Great Ormond St Hosp Children NHS Fdn Trust, London, England; [Kleta, Robert; Bockenhauer, Detlef] UCL Ctr Nephrol, London, England; [Reid, Chris] Evelina Childrens Hosp, London, England	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London	Bockenhauer, D (corresponding author), Great Ormond St Hosp Children NHS Fdn Trust, UCL Ctr Nephrol, Renal Unit, London WC1N 3JH, England.	d.bockenhauer@ucl.ac.uk	Bockenhauer, Detlef/AAF-6495-2020	Bockenhauer, Detlef/0000-0001-5878-941X; Plumb, Lucy/0000-0002-3873-8567				ANDERSON LE, 1987, SOUTHERN MED J, V80, P729, DOI 10.1097/00007611-198706000-00016; JAVAHERI S, 1982, CHEST, V81, P296, DOI 10.1378/chest.81.3.296; Jeck N, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.1.e5; Kleta R, 2006, NEPHRON PHYSIOL, V104, P73, DOI 10.1159/000094001; MOSTELLAR ME, 1964, J CLIN INVEST, V43, P138, DOI 10.1172/JCI104888	5	12	13	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2016	388	10044					631	632		10.1016/S0140-6736(16)00087-8	http://dx.doi.org/10.1016/S0140-6736(16)00087-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS4NA	27511787	Green Submitted			2022-12-28	WOS:000380756600036
J	Debnath, S; Linke, NM; Figgatt, C; Landsman, KA; Wright, K; Monroe, C				Debnath, S.; Linke, N. M.; Figgatt, C.; Landsman, K. A.; Wright, K.; Monroe, C.			Demonstration of a small programmable quantum computer with atomic qubits	NATURE			English	Article							DEUTSCH-JOZSA ALGORITHM; EXPERIMENTAL REALIZATION; IMPLEMENTATION; ENTANGLEMENT; COMPUTATION	Quantum computers can solve certain problems more efficiently than any possible conventional computer. Small quantum algorithms have been demonstrated on multiple quantum computing platforms, many specifically tailored in hardware to implement a particular algorithm or execute a limited number of computational paths(1-10). Here we demonstrate a five-qubit trapped-ion quantum computer that can be programmed in software to implement arbitrary quantum algorithms by executing any sequence of universal quantum logic gates. We compile algorithms into a fully connected set of gate operations that are native to the hardware and have a mean fidelity of 98 per cent. Reconfiguring these gate sequences provides the flexibility to implement a variety of algorithms without altering the hardware. As examples, we implement the Deutsch-Jozsa(11) and Bernstein-Vazirani(12) algorithms with average success rates of 95 and 90 per cent, respectively. We also perform a coherent quantum Fourier transform(13,14) on five trapped-ion qubits for phase estimation and period finding with average fidelities of 62 and 84 per cent, respectively. This small quantum computer can be scaled to larger numbers of qubits within a single register, and can be further expanded by connecting several such modules through ion shuttling(15) or photonic quantum channels(16).	[Debnath, S.; Linke, N. M.; Figgatt, C.; Landsman, K. A.; Wright, K.; Monroe, C.] Univ Maryland, Dept Phys, Joint Quantum Inst, College Pk, MD 20742 USA; [Monroe, C.] Univ Maryland, Joint Ctr Quantum Informat & Comp Sci, College Pk, MD 20742 USA; [Monroe, C.] IonQ Inc, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Debnath, S (corresponding author), Univ Maryland, Dept Phys, Joint Quantum Inst, College Pk, MD 20742 USA.	sdebnath@umd.edu	Monroe, Christopher R/G-8105-2011; Debnath, Shantanu/J-6185-2019	Debnath, Shantanu/0000-0003-4659-9138; Wright, Kenneth/0000-0002-5098-6723; Landsman, Kevin/0000-0001-7048-7182; Linke, Norbert/0000-0001-5655-9258	US Army Research Office; IARPA MQCO Program; IARPA LogiQ Program; Air Force Office of Scientific Research MURI on Quantum Measurement and Verification; National Science Foundation Physics Frontier Center at JQI; Direct For Mathematical & Physical Scien [1430094] Funding Source: National Science Foundation	US Army Research Office; IARPA MQCO Program; IARPA LogiQ Program; Air Force Office of Scientific Research MURI on Quantum Measurement and Verification; National Science Foundation Physics Frontier Center at JQI; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank K. R. Brown, J. Kim, T. Choi, Z.-X. Gong, T. A. Manning, D. Maslov and C. Volin for discussions. This work was supported by the US Army Research Office with funds from the IARPA MQCO and LogiQ Programs, the Air Force Office of Scientific Research MURI on Quantum Measurement and Verification, and the National Science Foundation Physics Frontier Center at JQI.	Ballance C. J., 2016, PREPRINT; Bernstein E, 1997, SIAM J COMPUT, V26, P1411, DOI 10.1137/S0097539796300921; Brainis E, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.157902; Brickman KA, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.050306; Chiaverini J, 2005, SCIENCE, V308, P997, DOI 10.1126/science.1110335; Choi T, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.190502; CIRAC JI, 1995, PHYS REV LETT, V74, P4091, DOI 10.1103/PhysRevLett.74.4091; Crain S, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4900754; DEUTSCH D, 1992, P ROY SOC LOND A MAT, V439, P553, DOI 10.1098/rspa.1992.0167; DiCarlo L, 2009, NATURE, V460, P240, DOI 10.1038/nature08121; Fisk PTH, 1997, IEEE T ULTRASON FERR, V44, P344, DOI 10.1109/58.585119; Gaebler J, 2016, PREPRINT; Gottesman D, 2000, J MOD OPTIC, V47, P333, DOI 10.1080/095003400148240; Green TJ, 2015, PHYS REV LETT, V114, DOI 10.1103/PhysRevLett.114.120502; Gulde S, 2003, NATURE, V421, P48, DOI 10.1038/nature01336; Hayes D, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.140501; Higgins BL, 2007, NATURE, V450, P393, DOI 10.1038/nature06257; Hill CD, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500707; Johnson KG, 2016, REV SCI INSTRUM, V87, DOI 10.1063/1.4948734; Kielpinski D, 2002, NATURE, V417, P709, DOI 10.1038/nature00784; Linden N, 1998, CHEM PHYS LETT, V296, P61, DOI 10.1016/S0009-2614(98)01015-X; Martin-Lopez E, 2012, NAT PHOTONICS, V6, P773, DOI [10.1038/NPHOTON.2012.259, 10.1038/nphoton.2012.259]; Merrill JT, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/10/103005; Milburn GJ, 2000, FORTSCHR PHYS, V48, P801, DOI 10.1002/1521-3978(200009)48:9/11<801::AID-PROP801>3.0.CO;2-1; Molmer K, 1999, PHYS REV LETT, V82, P1835, DOI 10.1103/PhysRevLett.82.1835; Monroe C, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.022317; Nielsen MA., 2002, QUANTUM COMPUTATION; Olmschenk S, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.052314; SCHIFFER JP, 1993, PHYS REV LETT, V70, P818, DOI 10.1103/PhysRevLett.70.818; Shi FZ, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.040504; Shor PW, 1997, SIAM J COMPUT, V26, P1484, DOI [10.1137/S0097539795293172, 10.1137/S0036144598347011]; Solano E, 1999, PHYS REV A, V59, pR2539, DOI 10.1103/PhysRevA.59.R2539; Vandersypen LMK, 2001, NATURE, V414, P883, DOI 10.1038/414883a; Zhu SL, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.050505	36	418	431	12	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2016	536	7614					63	+		10.1038/nature18648	http://dx.doi.org/10.1038/nature18648			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS7YM	27488798	Green Submitted			2022-12-28	WOS:000380999200030
J	Siu, AL				Siu, Albert L.			Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Siu, Albert L.] US Prevent Serv Task Force, Rockville, MD 20857 USA		Siu, AL (corresponding author), US Prevent Serv Task Force, Rockville, MD 20857 USA.								0	4	4	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2016	165	3					225	225		10.7326/L16-0102	http://dx.doi.org/10.7326/L16-0102			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2HA	27479225				2022-12-28	WOS:000380583300014
J	Chingcuanco, F; Segal, JB; Kim, SC; Alexander, GC				Chingcuanco, Francine; Segal, Jodi B.; Kim, Seoyoung C.; Alexander, G. Caleb			Bioequivalence of Biosimilar Tumor Necrosis Factor-alpha Inhibitors Compared With Their Reference Biologics A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							INFLAMMATORY-BOWEL-DISEASE; PARALLEL-GROUP; DOUBLE-BLIND; COMPARATIVE PHARMACOKINETICS; ANKYLOSING-SPONDYLITIS; INNOVATOR INFLIXIMAB; CLINICAL-EXPERIENCE; SAFETY; CT-P13; EFFICACY	Background: Biosimilars are of growing clinical, regulatory, and commercial importance. Purpose: To summarize evidence about the bioequivalence between biosimilar and reference tumor necrosis factor-alpha (TNF-alpha) inhibitors. Data Sources: PubMed, EMBASE, Cochrane Central Register of Controlled Trials, and LILACS from inception through 13 April 2016 and ClinicalTrials. gov, World Health Organization International Clinical Trials Registry Platform, EU Clinical Trials Register, U.S. Food and Drug Administration, and European Medicines Agency from inception through 30 April 2016. Study Selection: Published English-language studies of any size or design that compared the pharmacokinetics, clinical efficacy, adverse events, or immunogenicity of a biosimilar TNF-alpha inhibitor with a reference biologic in humans. Data Extraction: Two reviewers independently screened titles and abstracts, extracted data from selected studies, and assessed study quality. Data Synthesis: Of 19 eligible studies, 8 were phase 1 randomized trials, 5 were phase 3 randomized trials, and 6 were observational studies. Most phase 1 trials (n = 7) involved healthy vol-unteers, phase 3 trials involved patients with rheumatoid arthritis, and observational studies involved those with rheumatoid arthritis or inflammatory bowel disease. All phase 1 trials showed that pharmacokinetic parameters of the biosimilar and respective biologic were within the prespecified equivalence margin of 80% to 125%. Phase 3 trials suggested similar clinical responses and adverse events. Adverse events were usually of mild to moderate severity. Two cross-sectional observational studies showed cross-reactivity between products, whereas 4 cohort studies of patients switched from reference to biosimilar products suggested similar efficacy and safety outcomes. Limitation: Possible publication bias, small sample sizes of many studies, and lack of published studies for several biosimilars. Conclusion: Preliminary evidence supports the biosimilarity and interchangeability of biosimilar and reference TNF-alpha inhibitors.	[Chingcuanco, Francine; Alexander, G. Caleb] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 North Wolfe St,W6035, Baltimore, MD USA; [Segal, Jodi B.] Johns Hopkins Bloomberg Sch Publ Hlth, Hampton House,624 North Broadway,Room 644, Baltimore, MD 21205 USA; [Kim, Seoyoung C.] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 1620 Tremont St,Suite 3030, Boston, MA 02115 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Harvard University; Brigham & Women's Hospital	Alexander, GC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 North Wolfe St,W6035, Baltimore, MD USA.	galexand@jhsph.edu	Kim, Seoyoung/L-6561-2019	Kim, Seoyoung/0000-0002-2517-3579	Johns Hopkins Center of Excellence in Regulatory Science and Innovation [U01 FD004977-01]	Johns Hopkins Center of Excellence in Regulatory Science and Innovation	In part by the Johns Hopkins Center of Excellence in Regulatory Science and Innovation (grant U01 FD004977-01).	American College of Rheumatology, 2016, ACR END CRIT RHEUM D; [Anonymous], 2016, PROSPERO INT PROSPEC; [Anonymous], J GASTROENTEROLOGY H, DOI DOI 10.14735/AMGH201627; [Anonymous], INF CONS BIOS; Bae SC, 2017, ANN RHEUM DIS, V76, P65, DOI 10.1136/annrheumdis-2015-207613; Ruiz-Arguello MB, 2016, ANN RHEUM DIS, V75, P1693, DOI 10.1136/annrheumdis-2015-208684; Ben-Horin S, 2016, GUT, V65, P1132, DOI 10.1136/gutjnl-2015-309290; Bond S., COMP MSD ELECTROCHEM; Cadila Healthcare, 2016, AD; Celltrion Healthcare, 2016, REMS; Choe JY, 2017, ANN RHEUM DIS, V76, P58, DOI 10.1136/annrheumdis-2015-207764; CiplaMed, 2013, ETACEPT INJ; Coherus Biosciences, 2016, CHS 0214 ET BIOS; Derbyshire M, 2014, GENERICS BIOSIMILARS, V3, P154; Dorner T, 2015, NAT REV RHEUMATOL, V11, P713, DOI 10.1038/nrrheum.2015.110; Emery P, 2017, ANN RHEUM DIS, V76, P51, DOI 10.1136/annrheumdis-2015-207588; Epirus Biopharmaceuticals, 2015, BOW015 INFL; European Medicines Agency, 2014, GUID SIM BIOL MED PR; European Medicines Agency, 2013, ASS REP REMS; Furst DE, 2005, ANN RHEUM DIS, V64, P2, DOI 10.1136/ard.2005.044941; Generics and Biosimilars Initiative, 2015, EXTR IND BIOS INFL; Gu N, 2011, CLIN THER, V33, P2029, DOI 10.1016/j.clinthera.2011.10.022; Hanwha Chemical, 2016, BIOPH; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; IMS Institute for Healthcare Informatics, 2013, GLOB US MED OUTL 201; Isaacs JD, 2016, J INTERN MED, V279, P41, DOI 10.1111/joim.12432; Jani RH, 2016, INT J RHEUM DIS, V19, P1157, DOI 10.1111/1756-185X.12711; Janssen Biotech, 2015, ANK SPOND REM INFL E; Janssen Biotech, 2015, RHEUM ARTHR REM INFL; Jung YS, 2015, J GASTROEN HEPATOL, V30, P1705, DOI 10.1111/jgh.12997; Kang YS, 2015, DIGEST DIS SCI, V60, P951, DOI 10.1007/s10620-014-3392-z; Kuhlmann M, 2006, NEPHROL DIAL TRANSPL, V21, P4, DOI 10.1093/ndt/gfl474; Lambert J, 2016, INT J CLIN PHARM TH, V54, P315, DOI 10.5414/CP202530; Lee YJ, 2016, BRIT J CLIN PHARMACO, V82, P64, DOI 10.1111/bcp.12929; Matsushima S, 2015, EXPERT OPIN DRUG MET, V11, P179, DOI 10.1517/17425255.2015.990438; Mellstedt H, 2008, ANN ONCOL, V19, P411, DOI 10.1093/annonc/mdm345; Nikiphorou E, 2015, EXPERT OPIN BIOL TH, V15, P1677, DOI 10.1517/14712598.2015.1103733; OConnell D, 2019, NEWCASTLE OTTAWA SCA; Papamichael K, 2015, ALIMENT PHARM THER, V42, P1158, DOI 10.1111/apt.13402; Park W, 2017, ANN RHEUM DIS, V76, P346, DOI 10.1136/annrheumdis-2015-208783; Park W, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0930-4; Park W, 2015, EXPERT REV CLIN IMMU, V11, pS25, DOI 10.1586/1744666X.2015.1090311; Park W, 2013, ANN RHEUM DIS, V72, P1605, DOI 10.1136/annrheumdis-2012-203091; Philippidis A., 2015, TOP 25 BEST SELLING; Quantia, 2015, READ SIGNS ROADM ENG; Samsung Bioepis, 2015, NEWS ROOM; Shin D, 2015, BIODRUGS, V29, P381, DOI 10.1007/s40259-015-0150-5; Sieper J, 2009, ANN RHEUM DIS, V68, P1, DOI 10.1136/ard.2008.104018; Takeuchi T, 2015, MOD RHEUMATOL, V25, P817, DOI 10.3109/14397595.2015.1022297; U.S. Food and Drug Administration, 2016, REP SER PROBL FDA; U.S. Food and Drug Administration, 2015, INF TUM NECR FACT TN; US Food and Drug Administration, 2016, FDA BRIEF DOC ARTHR; Wadhwa M, 2015, BIOLOGICALS, V43, P298, DOI 10.1016/j.biologicals.2015.06.004; Wire Business, 2015, SAMS BIOEP RENFLEXIS; Yi S, 2012, BIODRUGS, V26, P177, DOI 10.2165/11631860-000000000-00000; Yoo DH, 2017, ANN RHEUM DIS, V76, P355, DOI 10.1136/annrheumdis-2015-208786; Yoo DH, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0981-6; Yoo DH, 2013, ANN RHEUM DIS, V72, P1613, DOI 10.1136/annrheumdis-2012-203090; Zelenetz AD, 2011, J NATL COMPR CANC NE, V9, pS1	59	37	40	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2016	165	8					565	+		10.7326/M16-0428	http://dx.doi.org/10.7326/M16-0428			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ6BM	27479870				2022-12-28	WOS:000385946600017
J	Meeske, AJ; Riley, EP; Robins, WP; Uehara, T; Mekalanos, JJ; Kahne, D; Walker, S; Kruse, AC; Bernhardt, TG; Rudner, DZ				Meeske, Alexander J.; Riley, Eammon P.; Robins, William P.; Uehara, Tsuyoshi; Mekalanos, John J.; Kahne, Daniel; Walker, Suzanne; Kruse, Andrew C.; Bernhardt, Thomas G.; Rudner, David Z.			SEDS proteins are a widespread family of bacterial cell wall polymerases	NATURE			English	Article							PENICILLIN-BINDING PROTEINS; BETA-LACTAM RESISTANCE; BACILLUS-SUBTILIS; PEPTIDOGLYCAN SYNTHESIS; DIVISION; GENE; BIOSYNTHESIS; PRECURSORS; DYNAMICS; FLIPPASE	Elongation of rod-shaped bacteria is mediated by a dynamic peptidoglycan-synthetizing machinery called the Rod complex. Here we report that, in Bacillus subtilis, this complex is functional in the absence of all known peptidoglycan polymerases. Cells lacking these enzymes survive by inducing an envelope stress response that increases the expression of RodA, a widely conserved core component of the Rod complex. RodA is a member of the SEDS (shape, elongation, division and sporulation) family of proteins, which have essential but ill-defined roles in cell wall biogenesis during growth, division and sporulation. Our genetic and biochemical analyses indicate that SEDS proteins constitute a family of peptidoglycan polymerases. Thus, B. subtilis and probably most bacteria use two distinct classes of polymerase to synthesize their exoskeleton. Our findings indicate that SEDS family proteins are core cell wall synthases of the cell elongation and division machinery, and represent attractive targets for antibiotic development.	[Meeske, Alexander J.; Riley, Eammon P.; Robins, William P.; Uehara, Tsuyoshi; Mekalanos, John J.; Walker, Suzanne; Bernhardt, Thomas G.; Rudner, David Z.] Harvard Med Sch, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA; [Kahne, Daniel; Walker, Suzanne; Kruse, Andrew C.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, 250 Longwood Ave, Boston, MA 02115 USA; [Kahne, Daniel; Walker, Suzanne] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Bernhardt, TG; Rudner, DZ (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	thomas@hms.harvard.edu; rudner@hms.harvard.edu		Riley, Eammon/0000-0003-4960-7578; Meeske, Alexander/0000-0003-3878-531X; Uehara, Tsuyoshi/0000-0001-6994-4286	National Institute of Health [GM073831, RC2 GM092616, AI083365, AI099144]; Center for Excellence in Translational Research [U19 AI109764]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007061, R01AI099144, R37AI018045, R01AI018045, R01AI083365, U19AI109764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073831, RC2GM092616, R01GM076710] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Excellence in Translational Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank past and present members of the Rudner and Bernhardt super group for advice and encouragement, members of the Walker and Kahne labs for help with PGT assays, D. Perlstein for initial characterization of a PGT activity in the aPBP quadruple mutant, and X. Wang for plasmids. Support for this work comes from the National Institute of Health Grants GM073831 (D.Z.R.), RC2 GM092616 (D.Z.R.), AI083365 (T.G.B.), AI099144 (T.G.B. and S.W.), and Center for Excellence in Translational Research (U19 AI109764) (D.Z.R., T.G.B., A.C.K., S.W., D.K., J.J.M.).	Adachi M, 2006, J AM CHEM SOC, V128, P14012, DOI 10.1021/ja065905c; Arbeloa A, 2004, J BACTERIOL, V186, P1221, DOI 10.1128/JB.186.5.1221-1228.2004; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Daniel RA, 1996, J BACTERIOL, V178, P2343, DOI 10.1128/jb.178.8.2343-2350.1996; Dominguez-Escobar J, 2011, SCIENCE, V333, P225, DOI 10.1126/science.1203466; Eiamphungporn W, 2008, MOL MICROBIOL, V67, P830, DOI 10.1111/j.1365-2958.2007.06090.x; Fay A, 2010, J MOL BIOL, V399, P547, DOI 10.1016/j.jmb.2010.04.036; Fraipont C, 2011, MICROBIOL-SGM, V157, P251, DOI 10.1099/mic.0.040071-0; Fujita M, 2000, GENES CELLS, V5, P79, DOI 10.1046/j.1365-2443.2000.00307.x; Gamba P, 2009, J BACTERIOL, V191, P4186, DOI 10.1128/JB.01758-08; Gampe CM, 2011, TETRAHEDRON, V67, P9771, DOI 10.1016/j.tet.2011.09.114; Garner EC, 2011, SCIENCE, V333, P222, DOI 10.1126/science.1203285; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goehring NW, 2006, MOL MICROBIOL, V61, P33, DOI 10.1111/j.1365-2958.2006.05206.x; Goffin C, 1998, MICROBIOL MOL BIOL R, V62, P1079, DOI 10.1128/MMBR.62.4.1079-1093.1998; Henriques AO, 1998, MOL MICROBIOL, V28, P235, DOI 10.1046/j.1365-2958.1998.00766.x; ISHINO F, 1986, J BIOL CHEM, V261, P7024; Jeske O, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8116; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; Kus JV, 2008, J BACTERIOL, V190, P7464, DOI 10.1128/JB.01075-08; Liechti GW, 2014, NATURE, V506, P507, DOI 10.1038/nature12892; Lin DCH, 1997, P NATL ACAD SCI USA, V94, P4721, DOI 10.1073/pnas.94.9.4721; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mascher T, 2007, J BACTERIOL, V189, P6919, DOI 10.1128/JB.00904-07; Mattei PJ, 2010, CURR OPIN STRUC BIOL, V20, P749, DOI 10.1016/j.sbi.2010.09.014; McPherson DC, 2003, J BACTERIOL, V185, P1423, DOI 10.1128/JB.185.4.1423-1431.2003; Meeske AJ, 2015, P NATL ACAD SCI USA, V112, P6437, DOI 10.1073/pnas.1504967112; Mercer KLN, 2002, J BACTERIOL, V184, P904, DOI 10.1128/jb.184.4.904-912.2002; Packiam M, 2015, P NATL ACAD SCI USA, V112, P11660, DOI 10.1073/pnas.1514026112; Pilhofer M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3856; Rice LB, 2009, J BACTERIOL, V191, P3649, DOI 10.1128/JB.01834-08; Robins WP, 2013, P NATL ACAD SCI USA, V110, pE848, DOI 10.1073/pnas.1222538110; Ruiz Natividad, 2015, Lipid Insights, V8, P21, DOI 10.4137/LPI.S31783; Salzberg LI, 2011, J BACTERIOL, V193, P5793, DOI 10.1128/JB.05862-11; SCHMIDT G, 1976, J BACTERIOL, V126, P579, DOI 10.1128/JB.126.2.579-586.1976; Sham LT, 2014, SCIENCE, V345, P220, DOI 10.1126/science.1254522; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Telenti A, 1997, NAT MED, V3, P567, DOI 10.1038/nm0597-567; van Teeffelen S, 2011, P NATL ACAD SCI USA, V108, P15822, DOI 10.1073/pnas.1108999108; van Teeseling MCF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7878; Vasudevan P, 2007, MOL MICROBIOL, V65, P1582, DOI 10.1111/j.1365-2958.2007.05896.x; Vasudevan P, 2009, J BACTERIOL, V191, P6012, DOI 10.1128/JB.00604-09; Vollmer J, 2013, INT J MED MICROBIOL, V303, P140, DOI 10.1016/j.ijmm.2013.01.002; Wei YP, 2003, J BACTERIOL, V185, P4717, DOI 10.1128/JB.185.16.4717-4726.2003; WILKINSON RG, 1972, J GEN MICROBIOL, V70, P527, DOI 10.1099/00221287-70-3-527; Ye XY, 2001, J AM CHEM SOC, V123, P3155, DOI 10.1021/ja010028q	47	275	278	3	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2016	537	7622					634	+		10.1038/nature19331	http://dx.doi.org/10.1038/nature19331			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4DR	27525505	Green Submitted, Green Accepted			2022-12-28	WOS:000384331700040
J	Zimmerman, CA; Lin, YC; Leib, DE; Guo, L; Huey, EL; Daly, GE; Chen, YM; Knight, ZA				Zimmerman, Christopher A.; Lin, Yen-Chu; Leib, David E.; Guo, Ling; Huey, Erica L.; Daly, Gwendolyn E.; Chen, Yiming; Knight, Zachary A.			Thirst neurons anticipate the homeostatic consequences of eating and drinking	NATURE			English	Article							SUBFORNICAL ORGAN; WATER-INTAKE; VASOPRESSIN SECRETION; ANGIOTENSIN-II; BODY-FLUID; RATS; FOOD; CONSCIOUSNESS; POPULATIONS; MECHANISMS	Thirst motivates animals to drink in order to maintain fluid balance. Thirst has conventionally been viewed as a homeostatic response to changes in blood volume or tonicity(1-3). However, most drinking behaviour is regulated too rapidly to be controlled by blood composition directly, and instead seems to anticipate homeostatic imbalances before they arise(4-11). How this is achieved remains unknown. Here we reveal an unexpected role for the subfornical organ (SFO) in the anticipatory regulation of thirst in mice. By monitoring deep-brain calcium dynamics, we show that thirst-promoting SFO neurons respond to inputs from the oral cavity during eating and drinking and then integrate these inputs with information about the composition of the blood. This integration allows SFO neurons to predict how ongoing food and water consumption will alter fluid balance in the future and then to adjust behaviour pre-emptively. Complementary optogenetic manipulations show that this anticipatory modulation is necessary for drinking in several contexts. These findings provide a neural mechanism to explain longstanding behavioural observations, including the prevalence of drinking during meals(10,11), the rapid satiation of thirst(7-9), and the fact that oral cooling is thirst-quenching(12-14).	[Zimmerman, Christopher A.; Lin, Yen-Chu; Leib, David E.; Guo, Ling; Huey, Erica L.; Daly, Gwendolyn E.; Chen, Yiming; Knight, Zachary A.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Zimmerman, Christopher A.; Lin, Yen-Chu; Leib, David E.; Guo, Ling; Huey, Erica L.; Daly, Gwendolyn E.; Chen, Yiming; Knight, Zachary A.] Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94158 USA; [Zimmerman, Christopher A.; Leib, David E.; Guo, Ling; Chen, Yiming; Knight, Zachary A.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Knight, ZA (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.; Knight, ZA (corresponding author), Univ Calif San Francisco, Kavli Inst Fundamental Neurosci, San Francisco, CA 94158 USA.; Knight, ZA (corresponding author), Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA.	zachary.knight@ucsf.edu	Core, Vector/CAF-4832-2022	Knight, Zachary/0000-0001-7621-1478; Guo, Ling/0000-0001-8394-4338; Huey, Erica/0000-0002-6055-8095; Zimmerman, Christopher/0000-0002-6286-1485	NSF Graduate Research Fellowship [1144247]; UCSF Discovery Fellowship; New York Stem Cell Foundation; American Diabetes Association; Rita Allen Foundation; McKnight Foundation; Sloan Foundation; Brain and Behavior Research Foundation; Klingenstein Foundation; Program for Breakthrough Biological Research Foundation; NIH [DP2-DK109533, R01-DK106399, R01-NS094781]; UCSF Diabetes and Obesity Centers [U01 DK089541]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL131463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK098722, DP2DK109533, R01DK106399, U01DK089541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094781] Funding Source: NIH RePORTER	NSF Graduate Research Fellowship(National Science Foundation (NSF)); UCSF Discovery Fellowship; New York Stem Cell Foundation; American Diabetes Association(American Diabetes Association); Rita Allen Foundation; McKnight Foundation; Sloan Foundation(Alfred P. Sloan Foundation); Brain and Behavior Research Foundation; Klingenstein Foundation(Klingenstein Philanthropies); Program for Breakthrough Biological Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF Diabetes and Obesity Centers; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	C.A.Z. is supported by an NSF Graduate Research Fellowship (grant no. 1144247) and a UCSF Discovery Fellowship. Z.A.K. is a New York Stem Cell Foundation-Robertson Investigator and acknowledges support from the New York Stem Cell Foundation, American Diabetes Association, Rita Allen, McKnight, Sloan, Brain and Behavior Research, Klingenstein, and Program for Breakthrough Biological Research Foundations. This work was supported by an NIH New Innovator Award (DP2-DK109533), R01-DK106399, and R01-NS094781, as well as the UCSF Diabetes and Obesity Centers (U01 DK089541).	ADOLPH EF, 1954, AM J PHYSIOL, V178, P538, DOI 10.1152/ajplegacy.1954.178.3.538; Bellows RT, 1939, AM J PHYSIOL, V125, P87, DOI 10.1152/ajplegacy.1938.125.1.87; Berridge KC, 2004, PHYSIOL BEHAV, V81, P179, DOI 10.1016/j.physbeh.2004.02.004; Betley JN, 2015, NATURE, V521, P180, DOI 10.1038/nature14416; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; Chen YM, 2015, CELL, V160, P829, DOI 10.1016/j.cell.2015.01.033; DEAUX E, 1973, SCIENCE, V181, P1166, DOI 10.1126/science.181.4105.1166; Eccles R, 2013, APPETITE, V71, P357, DOI 10.1016/j.appet.2013.09.011; Egan G, 2003, P NATL ACAD SCI USA, V100, P15241, DOI 10.1073/pnas.2136650100; Farrell MJ, 2011, AM J PHYSIOL-REG I, V301, pR623, DOI 10.1152/ajpregu.00817.2010; FITZSIMO.JT, 1969, J COMP PHYSIOL PSYCH, V67, P273, DOI 10.1037/h0026772; FITZSIMONS J, 1961, J PHYSIOL-LONDON, V159, P297, DOI 10.1113/jphysiol.1961.sp006809; Grob M, 2003, NEUROSCIENCE, V122, P247, DOI 10.1016/j.neuroscience.2003.07.005; Gunaydin LA, 2014, CELL, V157, P1535, DOI 10.1016/j.cell.2014.05.017; HSIAO S, 1969, J COMP PHYSIOL PSYCH, V69, P448, DOI 10.1037/h0028192; KAPATOS G, 1972, SCIENCE, V176, P685, DOI 10.1126/science.176.4035.685; LIND RW, 1984, PHYSIOL BEHAV, V32, P69; Mandelblat-Cerf Y, 2015, ELIFE, V4, DOI 10.7554/eLife.07122; McKinley MJ, 2006, SEMIN NEPHROL, V26, P249, DOI 10.1016/j.semnephrol.2006.02.001; McKinley MJ, 2004, NEWS PHYSIOL SCI, V19, P1, DOI 10.1152/nips.01470.2003; MENDELSON J, 1970, SCIENCE, V170, P1418, DOI 10.1126/science.170.3965.1418; MISELIS RR, 1979, SCIENCE, V205, P1022, DOI 10.1126/science.472723; OATLEY K, 1969, PSYCHON SCI, V16, P225; Oka Y, 2015, NATURE, V520, P349, DOI 10.1038/nature14108; ONDETTI MA, 1977, SCIENCE, V196, P441, DOI 10.1126/science.191908; Rowland NE, 1998, NEUROSCI BIOBEHAV R, V23, P49, DOI 10.1016/S0149-7634(97)00068-7; Shizgal P. B., 2013, PRINCIPLES NEURAL SC, P1095; SIMPSON JB, 1973, SCIENCE, V181, P1172, DOI 10.1126/science.181.4105.1172; SMITH RD, 1992, ANNU REV PHARMACOL, V32, P135; Stricker EM, 2007, PHYSIOL BEHAV, V91, P404, DOI 10.1016/j.physbeh.2007.04.007; SZCZEPANSKASADOWSKA E, 1975, PFLUG ARCH EUR J PHY, V358, P259, DOI 10.1007/BF00587222; THRASHER TN, 1981, AM J PHYSIOL, V240, pE394, DOI 10.1152/ajpendo.1981.240.4.E394; Woods SC, 2007, APPETITE, V49, P388, DOI 10.1016/j.appet.2006.09.015	33	149	151	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2016	537	7622					680	+		10.1038/nature18950	http://dx.doi.org/10.1038/nature18950			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4DR	27487211	Green Accepted, Green Submitted			2022-12-28	WOS:000384331700050
J	Nakamura, T; Gehrke, AR; Lemberg, J; Zymaszek, JS; Shubin, NH				Nakamura, Tetsuya; Gehrke, Andrew R.; Lemberg, Justin; Zymaszek, Julie S.; Shubin, Neil H.			Digits and fin rays share common developmental histories	NATURE			English	Article							TRUNK NEURAL CREST; GENE-EXPRESSION; LIMB TRANSITION; PAIRED FINS; HOX-GENES; ZEBRAFISH; ORIGIN; EVOLUTION; FISH; APPENDAGES	Understanding the evolutionary transformation of fish fins into tetrapod limbs is a fundamental problem in biology(1). The search for antecedents of tetrapod digits in fish has remained controversial because the distal skeletons of limbs and fins differ structurally, developmentally, and histologically(2,3). Moreover, comparisons of fins with limbs have been limited by a relative paucity of data on the cellular and molecular processes underlying the development of the fin skeleton. Here, we provide a functional analysis, using CRISPR/Cas9 and fate mapping, of 5' hox genes and enhancers in zebrafish that are indispensable for the development of the wrists and digits of tetrapods(4,5). We show that cells marked by the activity of an autopodial hoxa13 enhancer exclusively form elements of the fin fold, including the osteoblasts of the dermal rays. In hox13 knockout fish, we find that a marked reduction and loss of fin rays is associated with an increased number of endochondral distal radials. These discoveries reveal a cellular and genetic connection between the fin rays of fish and the digits of tetrapods and suggest that digits originated via the transition of distal cellular fates.	[Nakamura, Tetsuya; Gehrke, Andrew R.; Lemberg, Justin; Zymaszek, Julie S.; Shubin, Neil H.] Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA	University of Chicago	Shubin, NH (corresponding author), Univ Chicago, Dept Organismal Biol & Anat, 1025 E 57Th St, Chicago, IL 60637 USA.	nshubin@uchicago.edu		Nakamura, Tetsuya/0000-0003-0183-1685	Uehara Memorial Foundation; Japan Society for the Promotion of Science; Marine Biological Laboratory Research Award; National Institutes of Health [T32 HD055164]; National Science Foundation [1311436]; Brinson Foundation; University of Chicago Biological Sciences Division; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD055164] Funding Source: NIH RePORTER	Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Marine Biological Laboratory Research Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Brinson Foundation; University of Chicago Biological Sciences Division(University of Chicago); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank J. Westlund for figure preparation and construction, as well as maintenance of zebrafish facilities. M. Coates, M. Davis, R. Ho, I. Ruvinsky, J-L. Gomez Skarmeta, and C. Tabin provided comments and advice. We thank L. I. Zon, C. Mosimann, and C. Lawrence for Tg(ubi:Switch) fish, M. L. Suster for the pCR8GW-Cre-pA-FRT-kan-FRT plasmid, R. Ho and S. Briscoe for insights regarding lineage-tracing experiments, V. Bindokas and the University of Chicago Integrated Light Microscopy Core Facility for assistance with imaging, L. Zhexi for use of the high-energy CT scanning facility of University of Chicago, M. E. Horb and M. C. Salanga of the National Xenopus Resource (RRID:SCR-013731) of the Marine Biological Laboratories for tutelage in applying CRISPR/Cas9, J. Gitlin, A. Latimer and R. Thomason for providing space for zebrafish CRISPR/Cas9 experiments and also maintaining juveniles, and the Marine Resource Center of the Marine Biological Laboratories for assistance with the transfer of mutant zebrafish between University of Chicago and the MBL. This study was supported by the Uehara Memorial Foundation Research Fellowship 2013, Japan Society for the Promotion of Science Postdoctoral Research Fellowship 2012-127, and Marine Biological Laboratory Research Award 2014 (to T.N.); National Institutes of Health Grant T32 HD055164 and National Science Foundation Doctoral Dissertation Improvement Grant 1311436 (to A.R.G.); and the Brinson Foundation and the University of Chicago Biological Sciences Division (to N.H.S.).	Ahn D, 2008, DEV BIOL, V322, P220, DOI 10.1016/j.ydbio.2008.06.032; Asharani PV, 2012, AM J HUM GENET, V90, P661, DOI 10.1016/j.ajhg.2012.02.026; Berlivet S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004018; Braasch I, 2016, NAT GENET, V48, P427, DOI 10.1038/ng.3526; Clack J. A., 2012, GAINING GROUND ORIGI; Clack JA, 2009, ANNU REV EARTH PL SC, V37, P163, DOI 10.1146/annurev.earth.36.031207.124146; Coates MI, 2008, ANNU REV ECOL EVOL S, V39, P571, DOI 10.1146/annurev.ecolsys.38.091206.095546; Davis MC, 2007, NATURE, V447, P473, DOI 10.1038/nature05838; Fernandez-Teran M, 2008, INT J DEV BIOL, V52, P857, DOI 10.1387/ijdb.072416mf; Freitas R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000754; Freitas R, 2012, DEV CELL, V23, P1219, DOI 10.1016/j.devcel.2012.10.015; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Gehrke A. R., 2016, SEMIN CELL DEV BIOL; Gehrke AR, 2015, P NATL ACAD SCI USA, V112, P803, DOI 10.1073/pnas.1420208112; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; Jao LE, 2013, P NATL ACAD SCI USA, V110, P13904, DOI 10.1073/pnas.1308335110; Lee RTH, 2013, DEVELOPMENT, V140, P2923, DOI 10.1242/dev.093534; Lee RTH, 2013, CURR BIOL, V23, pR336, DOI 10.1016/j.cub.2013.02.055; Mosimann C, 2011, DEVELOPMENT, V138, P169, DOI 10.1242/dev.059345; Nakayama T, 2013, GENESIS, V51, P835, DOI 10.1002/dvg.22720; Schneider I, 2013, TRENDS GENET, V29, P419, DOI 10.1016/j.tig.2013.01.012; Scotti M, 2015, GENESIS, V53, P366, DOI 10.1002/dvg.22859; SMITH M, 1994, P ROY SOC B-BIOL SCI, V256, P137, DOI 10.1098/rspb.1994.0061; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; THISSE C, 1995, DEV BIOL, V172, P86, DOI 10.1006/dbio.1995.0007; Thorogood P., 1991, DEV TELEOST FIN IMPL; Tulenko FJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep22720; Westerfield M., 2000, ZFIN ZEBRAFISH BOOK; Woltering JM, 2010, DEV CELL, V18, P526, DOI 10.1016/j.devcel.2010.04.002; Yano T, 2012, DEVELOPMENT, V139, P2916, DOI 10.1242/dev.075572; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhang J, 2010, NATURE, V466, P234, DOI 10.1038/nature09137	33	79	80	3	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					225	+		10.1038/nature19322	http://dx.doi.org/10.1038/nature19322			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9LQ	27533041	Green Accepted			2022-12-28	WOS:000382539100046
J	Oh, WC; Lutzu, S; Castillo, PE; Kwon, HB				Oh, Won Chan; Lutzu, Stefano; Castillo, Pablo E.; Kwon, Hyung-Bae			De novo synaptogenesis induced by GABA in the developing mouse cortex	SCIENCE			English	Article							DENDRITIC SPINES; INHIBITORY SYNAPSES; PYRAMIDAL NEURONS; IN-VIVO; HIPPOCAMPAL-NEURONS; ADULT NEOCORTEX; PLASTICITY; GROWTH; MATURATION	Dendrites of cortical pyramidal neurons contain intermingled excitatory and inhibitory synapses. We studied the local mechanisms that regulate the formation and distribution of synapses. We found that local gamma-aminobutyric acid (GABA) release on dendrites of mouse cortical layer 2/3 pyramidal neurons could induce gephyrin puncta and dendritic spine formation via GABA type A receptor activation and voltage-gated calcium channels during early postnatal development. Furthermore, the newly formed inhibitory and excitatory synaptic structures rapidly gained functions. Bidirectional manipulation of GABA release from somatostatin-positive interneurons increased and decreased the number of gephyrin puncta and dendritic spines, respectively. These results highlight a noncanonical function of GABA as a local synaptogenic element shaping the early establishment of neuronal circuitry in mouse cortex.	[Oh, Won Chan; Kwon, Hyung-Bae] Max Planck Florida Inst Neurosci MPFI, Jupiter, FL 33458 USA; [Lutzu, Stefano; Castillo, Pablo E.] Albert Einstein Coll Med, Dominick P Purpura Dept Neurosci, Bronx, NY 10461 USA; [Kwon, Hyung-Bae] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany	Yeshiva University; Albert Einstein College of Medicine; Max Planck Society	Kwon, HB (corresponding author), Max Planck Florida Inst Neurosci MPFI, Jupiter, FL 33458 USA.; Kwon, HB (corresponding author), Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.	hyungbae.kwon@mpfi.org		Castillo, Pablo/0000-0002-9834-1801	MPFI; NARSAD; NIH [MH107460, MH081935, DA017392]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081935, R01MH107460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017392] Funding Source: NIH RePORTER	MPFI; NARSAD(NARSAD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the Kwon laboratory for discussion, E. Nedivi for Teal-gephyrin, and H. Taniguchi for Flex-TeTxLC. Supported by the MPFI, a NARSAD Young Investigator grant, and NIH grants MH107460 (H.-B.K.) and MH081935 and DA017392 (P.E.C.). Supplementary materials contain additional data. Author contributions: W.C.O. and H.-B.K. conceived and designed the study; W.C.O. performed and analyzed all experiments except perforated patch-clamp recordings, which were performed and analyzed by S.L. and P.E.C.; W.C.O. prepared the figures; W.C.O. and H.-B.K. wrote the manuscript; and all authors revised the manuscript.	Batista-Brito R, 2008, CEREB CORTEX, V18, P2306, DOI 10.1093/cercor/bhm258; Ben-Ari Y, 2014, NEUROSCIENCE, V279, P187, DOI 10.1016/j.neuroscience.2014.08.001; Branco T, 2010, SCIENCE, V329, P1671, DOI 10.1126/science.1189664; Cane M, 2014, J NEUROSCI, V34, P2075, DOI 10.1523/JNEUROSCI.3353-13.2014; Caroni P, 2012, NAT REV NEUROSCI, V13, P478, DOI 10.1038/nrn3258; Chen JL, 2012, NEURON, V74, P361, DOI 10.1016/j.neuron.2012.02.030; Chen SX, 2015, NAT NEUROSCI, V18, P1109, DOI 10.1038/nn.4049; Chiu CQ, 2013, SCIENCE, V340, P759, DOI 10.1126/science.1234274; Cichon J, 2015, NATURE, V520, P180, DOI 10.1038/nature14251; Dejanovic B, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001908; Flores CE, 2015, P NATL ACAD SCI USA, V112, pE65, DOI 10.1073/pnas.1411170112; Hage TA, 2015, J NEUROSCI, V35, P5823, DOI 10.1523/JNEUROSCI.3904-14.2015; Hamilton AM, 2012, NEURON, V74, P1023, DOI 10.1016/j.neuron.2012.04.031; Hayama T, 2013, NAT NEUROSCI, V16, P1409, DOI 10.1038/nn.3496; Huang ZJ, 2009, J PHYSIOL-LONDON, V587, P1881, DOI 10.1113/jphysiol.2008.168211; Kim T, 2016, P NATL ACAD SCI USA, V113, pE1372, DOI 10.1073/pnas.1513410113; Kirsch J, 1998, NATURE, V392, P717, DOI 10.1038/33694; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Kozorovitskiy Y, 2012, NATURE, V485, P646, DOI 10.1038/nature11052; Kwon HB, 2011, NATURE, V474, P100, DOI 10.1038/nature09986; Losonczy A, 2006, NEURON, V50, P291, DOI 10.1016/j.neuron.2006.03.016; Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5; Matsuzaki M, 2010, NAT CHEM BIOL, V6, P255, DOI [10.1038/nchembio.321, 10.1038/NCHEMBIO.321]; MILLER M, 1981, J COMP NEUROL, V203, P555, DOI 10.1002/cne.902030402; Murray AJ, 2011, NAT NEUROSCI, V14, P297, DOI 10.1038/nn.2751; Nagerl UV, 2007, J NEUROSCI, V27, P8149, DOI 10.1523/JNEUROSCI.0511-07.2007; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; van Versendaal D, 2012, NEURON, V74, P374, DOI 10.1016/j.neuron.2012.03.015; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054	29	112	116	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2016	353	6303					1037	1040		10.1126/science.aaf5206	http://dx.doi.org/10.1126/science.aaf5206			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9SU	27516412	hybrid, Green Accepted			2022-12-28	WOS:000382558900041
J	Chung, JH; Granja, I; Taylor, MG; Mpourmpakis, G; Asplin, JR; Rimer, JD				Chung, Jihae; Granja, Ignacio; Taylor, Michael G.; Mpourmpakis, Giannis; Asplin, John R.; Rimer, Jeffrey D.			Molecular modifiers reveal a mechanism of pathological crystal growth inhibition	NATURE			English	Article							CALCIUM-OXALATE MONOHYDRATE; SODIUM-CHLORATE CRYSTALS; KIDNEY-STONES; CRYSTALLIZATION; BIOMINERALIZATION; ENERGY; SHAPE; APPROXIMATION; EQUILIBRIUM; MAGNESIUM	Crystalline materials are crucial to the function of living organisms, in the shells of molluscs(1-3), the matrix of bone(4), the teeth of sea urchins5, and the exoskeletons of coccoliths(6). However, pathological biomineralization can be an undesirable crystallization process associated with human diseases(7-9). The crystal growth of biogenic, natural and synthetic materials may be regulated by the action of modifiers, most commonly inhibitors, which range from small ions and molecules(10,11) to large macromolecules(12). Inhibitors adsorb on crystal surfaces and impede the addition of solute, thereby reducing the rate of growth(13,14). Complex inhibitor-crystal interactions in biomineralization are often not well elucidated(15). Here we show that two molecular inhibitors of calcium oxalate monohydrate crystallization-citrate and hydroxycitrate-exhibit a mechanism that differs from classical theory in that inhibitor adsorption on crystal surfaces induces dissolution of the crystal under specific conditions rather than a reduced rate of crystal growth. This phenomenon occurs even in supersaturated solutions where inhibitor concentration is three orders of magnitude less than that of the solute. The results of bulk crystallization, in situ atomic force microscopy, and density functional theory studies are qualitatively consistent with a hypothesis that inhibitor-crystal interactions impart localized strain to the crystal lattice and that oxalate and calcium ions are released into solution to alleviate this strain. Calcium oxalate monohydrate is the principal component of human kidney stones(16-19) and citrate is an often-used therapy(20), but hydroxycitrate is not. For hydroxycitrate to function as a kidney stone treatment, it must be excreted in urine. We report that hydroxycitrate ingested by non-stone-forming humans at an often-recommended dose leads to substantial urinary excretion. In vitro assays using human urine reveal that the molecular modifier hydroxycitrate is as effective an inhibitor of nucleation of calcium oxalate monohydrate nucleation as is citrate. Our findings support exploration of the clinical potential of hydroxycitrate as an alternative treatment to citrate for kidney stones.	[Chung, Jihae; Rimer, Jeffrey D.] Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA; [Granja, Ignacio; Asplin, John R.] Litholink Corp, Lab Corp Amer Holdings, Chicago, IL 60612 USA; [Taylor, Michael G.; Mpourmpakis, Giannis] Univ Pittsburgh, Dept Chem Engn, Pittsburgh, PA 15261 USA	University of Houston System; University of Houston; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rimer, JD (corresponding author), Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA.; Asplin, JR (corresponding author), Litholink Corp, Lab Corp Amer Holdings, Chicago, IL 60612 USA.	asplinj@labcorp.com; jrimer@central.uh.edu	Mpourmpakis, Giannis/H-2048-2013	Mpourmpakis, Giannis/0000-0002-3063-0607; Taylor, Michael/0000-0003-4327-2746	National Science Foundation [1207441, ACI-1053575]; Welch Foundation [E-1794]; University of Pittsburgh; Direct For Mathematical & Physical Scien [1207441] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Welch Foundation(The Welch Foundation); University of Pittsburgh(University of Pittsburgh); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	J.D.R. acknowledges support from the National Science Foundation (grant 1207441) and the Welch Foundation (grant E-1794). G.M. acknowledges start-up funds from the University of Pittsburgh and computational support from the Center for Simulation and Modeling, and the Extreme Science and Engineering Discovery Environment, which is supported by the National Science Foundation (grant ACI-1053575).	AHLRICHS R, 1989, CHEM PHYS LETT, V162, P165, DOI 10.1016/0009-2614(89)85118-8; Asplin JR, 2008, SEMIN NEPHROL, V28, P99, DOI 10.1016/j.semnephrol.2008.01.001; Asplin JR, 1999, KIDNEY INT, V56, P1505, DOI 10.1046/j.1523-1755.1999.00682.x; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; BOLL M, 1969, ACTA CHEM SCAND, V23, P286; BURTON WK, 1951, PHILOS T R SOC S-A, V243, P299, DOI 10.1098/rsta.1951.0006; Cabrera N., 1958, GROWTH PERFECTION CR, V393-425; CAHN JW, 1982, ACTA METALL MATER, V30, P51, DOI 10.1016/0001-6160(82)90043-8; ChemAxon, 2016, HYDR AC; CHERNOV AA, 1989, CONTEMP PHYS, V30, P251, DOI 10.1080/00107518908225517; COE FL, 1992, NEW ENGL J MED, V327, P1141, DOI 10.1056/NEJM199210153271607; Davis KJ, 2000, SCIENCE, V290, P1134, DOI 10.1126/science.290.5494.1134; De Yoreo JJ, 2003, REV MINERAL GEOCHEM, V54, P57, DOI 10.2113/0540057; Dey A, 2010, CHEM SOC REV, V39, P397, DOI 10.1039/b811842f; Dunlop JWC, 2010, ANNU REV MATER RES, V40, P1, DOI 10.1146/annurev-matsci-070909-104421; Ettinger B, 1997, J UROLOGY, V158, P2069, DOI 10.1016/S0022-5347(01)68155-2; Evans JS, 2008, CHEM REV, V108, P4455, DOI 10.1021/cr078251e; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Farmanesh S, 2015, CHEM COMMUN, V51, P13964, DOI 10.1039/c5cc04361a; Farmanesh S, 2014, J AM CHEM SOC, V136, P12648, DOI 10.1021/ja505402r; Farmanesh S, 2014, J AM CHEM SOC, V136, P367, DOI 10.1021/ja410623q; Farmanesh S, 2013, J CRYST GROWTH, V373, P13, DOI 10.1016/j.jcrysgro.2012.09.018; FEYEREISEN M, 1993, CHEM PHYS LETT, V208, P359, DOI 10.1016/0009-2614(93)87156-W; FRANK FC, 1949, DISCUSS FARADAY SOC, P48, DOI 10.1039/df9490500048; Graether SP, 2000, NATURE, V406, P325, DOI 10.1038/35018610; Grimme S, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3382344; Jung T, 2004, LANGMUIR, V20, P8587, DOI 10.1021/la0488755; Killian CE, 2009, J AM CHEM SOC, V131, P18404, DOI 10.1021/ja907063z; KLAMT A, 1993, J CHEM SOC PERK T 2, P799, DOI 10.1039/p29930000799; Linnikov OD, 2000, DESALINATION, V128, P47, DOI 10.1016/S0011-9164(00)00022-9; Loe YCC, 2001, ANAL BIOCHEM, V292, P148, DOI 10.1006/abio.2001.5046; Lovette MA, 2008, IND ENG CHEM RES, V47, P9812, DOI 10.1021/ie800900f; Lupulescu AI, 2014, SCIENCE, V344, P729, DOI 10.1126/science.1250984; Lutsko JF, 2014, CRYST GROWTH DES, V14, P6129, DOI 10.1021/cg501307y; Malivuk DA, 2013, J CRYST GROWTH, V377, P164, DOI 10.1016/j.jcrysgro.2013.05.018; Meldrum FC, 2003, INT MATER REV, V48, P187, DOI 10.1179/095066003225005836; Millan A, 2001, CRYST GROWTH DES, V1, P245, DOI 10.1021/cg0055530; Mpourmpakis G, 2010, NANO LETT, V10, P3408, DOI 10.1021/nl101421q; NANCOLLA.GH, 1974, J CRYST GROWTH, V21, P267, DOI 10.1016/0022-0248(74)90014-1; Olafson KN, 2015, P NATL ACAD SCI USA, V112, P4946, DOI 10.1073/pnas.1501023112; Orme CA, 2001, NATURE, V411, P775, DOI 10.1038/35081034; Parks JH, 2004, KIDNEY INT, V66, P777, DOI 10.1111/j.1523-1755.2004.00803.x; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Phillips R, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010057.pub2; Qiu SR, 2004, P NATL ACAD SCI USA, V101, P1811, DOI 10.1073/pnas.0307900100; Rimer JD, 2010, SCIENCE, V330, P337, DOI 10.1126/science.1191968; RISTIC RI, 1988, J CRYST GROWTH, V91, P163, DOI 10.1016/0022-0248(88)90382-X; RYALL RL, 1981, CLIN CHIM ACTA, V112, P349, DOI 10.1016/0009-8981(81)90458-7; Scales CD, 2012, EUR UROL, V62, P160, DOI 10.1016/j.eururo.2012.03.052; Sizemore JP, 2009, CRYST GROWTH DES, V9, P2637, DOI 10.1021/cg8011124; Smith R. M., 1982, CRITICAL STABILITY S, V5, P329; Snyder RC, 2009, P ROY SOC A-MATH PHY, V465, P1145, DOI 10.1098/rspa.2008.0234; TOMAZIC BB, 1979, INVEST UROL, V16, P329; van Loon LJC, 2000, AM J CLIN NUTR, V72, P1445; VANDERHEIJDEN AEDM, 1992, J CRYST GROWTH, V118, P14, DOI 10.1016/0022-0248(92)90044-J; VORONKOV VV, 1994, J CRYST GROWTH, V144, P107, DOI 10.1016/0022-0248(94)90018-3; Wang LJ, 2008, CHEM REV, V108, P4628, DOI 10.1021/cr0782574; Wang LJ, 2006, CRYST GROWTH DES, V6, P1769, DOI 10.1021/cg050679o; Weigend F, 1998, CHEM PHYS LETT, V294, P143, DOI 10.1016/S0009-2614(98)00862-8; Weigend F, 1997, THEOR CHEM ACC, V97, P331, DOI 10.1007/s002140050269; WEISSBUCH I, 1991, SCIENCE, V253, P637, DOI 10.1126/science.253.5020.637; Weissbuch I, 2008, CHEM REV, V108, P4899, DOI 10.1021/cr078274t; Wesson JA, 2007, ELEMENTS, V3, P415, DOI 10.2113/GSELEMENTS.3.6.415; Winn D, 2000, AICHE J, V46, P1348, DOI 10.1002/aic.690460709; YOUNG JR, 1992, NATURE, V356, P516, DOI 10.1038/356516a0	65	114	121	7	213	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					446	+		10.1038/nature19062	http://dx.doi.org/10.1038/nature19062			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27501150				2022-12-28	WOS:000382646600039
J	Soliveres, S; van der Plas, F; Manning, P; Prati, D; Gossner, MM; Renner, SC; Alt, F; Arndt, H; Baumgartner, V; Binkenstein, J; Birkhofer, K; Blaser, S; Bluthgen, N; Boch, S; Bohm, S; Borschig, C; Buscot, F; Diekotter, T; Heinze, J; Holzel, N; Jung, K; Klaus, VH; Kleinebecker, T; Klemmer, S; Krauss, J; Lange, M; Morris, EK; Muller, J; Oelmann, Y; Overmann, J; Pasalic, E; Rillig, MC; Schaefer, HM; Schloter, M; Schmitt, B; Schoning, I; Schrumpf, M; Sikorski, J; Socher, SA; Solly, EF; Sonnemann, I; Sorkau, E; Steckel, J; Steffan-Dewenter, I; Stempfhuber, B; Tschapka, M; Turke, M; Venter, PC; Weiner, CN; Weisser, WW; Werner, M; Westphal, C; Wilcke, W; Wolters, V; Wubet, T; Wurst, S; Fischer, M; Allan, E				Soliveres, Santiago; van der Plas, Fons; Manning, Peter; Prati, Daniel; Gossner, Martin M.; Renner, Swen C.; Alt, Fabian; Arndt, Hartmut; Baumgartner, Vanessa; Binkenstein, Julia; Birkhofer, Klaus; Blaser, Stefan; Bluethgen, Nico; Boch, Steffen; Boehm, Stefan; Boerschig, Carmen; Buscot, Francois; Diekoetter, Tim; Heinze, Johannes; Hoelzel, Norbert; Jung, Kirsten; Klaus, Valentin H.; Kleinebecker, Till; Klemmer, Sandra; Krauss, Jochen; Lange, Markus; Morris, E. Kathryn; Mueller, Joerg; Oelmann, Yvonne; Overmann, Joerg; Pasalic, Esther; Rillig, Matthias C.; Schaefer, H. Martin; Schloter, Michael; Schmitt, Barbara; Schoening, Ingo; Schrumpf, Marion; Sikorski, Johannes; Socher, Stephanie A.; Solly, Emily F.; Sonnemann, Ilja; Sorkau, Elisabeth; Steckel, Juliane; Steffan-Dewenter, Ingolf; Stempfhuber, Barbara; Tschapka, Marco; Tuerke, Manfred; Venter, Paul C.; Weiner, Christiane N.; Weisser, Wolfgang W.; Werner, Michael; Westphal, Catrin; Wilcke, Wolfgang; Wolters, Volkmar; Wubet, Tesfaye; Wurst, Susanne; Fischer, Markus; Allan, Eric			Biodiversity at multiple trophic levels is needed for ecosystem multifunctionality	NATURE			English	Article							LAND-USE INTENSITY; PLANT; DIVERSITY; PRODUCTIVITY; CONSEQUENCES; HERBIVORE; RICHNESS; SERVICES; WEAKENS; IMPACT	Many experiments have shown that loss of biodiversity reduces the capacity of ecosystems to provide the multiple services on which humans depend(1,2). However, experiments necessarily simplify the complexity of natural ecosystems and will normally control for other important drivers of ecosystem functioning, such as the environment or land use. In addition, existing studies typically focus on the diversity of single trophic groups, neglecting the fact that biodiversity loss occurs across many taxa(3,4) and that the functional effects of any trophic group may depend on the abundance and diversity of others(5,6). Here we report analysis of the relationships between the species richness and abundance of nine trophic groups, including 4,600 above-and below-ground taxa, and 14 ecosystem services and functions and with their simultaneous provision (or multifunctionality) in 150 grasslands. We show that high species richness in multiple trophic groups (multitrophic richness) had stronger positive effects on ecosystem services than richness in any individual trophic group; this includes plant species richness, the most widely used measure of biodiversity. On average, three trophic groups influenced each ecosystem service, with each trophic group influencing at least one service. Multitrophic richness was particularly beneficial for 'regulating' and 'cultural' services, and for multifunctionality, whereas a change in the total abundance of species or biomass in multiple trophic groups (the multitrophic abundance) positively affected supporting services. Multitrophic richness and abundance drove ecosystem functioning as strongly as abiotic conditions and land-use intensity, extending previous experimental results(7,8) to real-world ecosystems. Primary producers, herbivorous insects and microbial decomposers seem to be particularly important drivers of ecosystem functioning, as shown by the strong and frequent positive associations of their richness or abundance with multiple ecosystem services. Our results show that multitrophic richness and abundance support ecosystem functioning, and demonstrate that a focus on single groups has led to researchers to greatly underestimate the functional importance of biodiversity.	[Soliveres, Santiago; van der Plas, Fons; Manning, Peter; Prati, Daniel; Blaser, Stefan; Boch, Steffen; Schmitt, Barbara; Fischer, Markus; Allan, Eric] Univ Bern, Inst Plant Sci, Altenbergrain 21, CH-3013 Bern, Switzerland; [van der Plas, Fons; Manning, Peter; Fischer, Markus] Senckenberg Gesell Nat Forsch Biodivers & Climate, Senckenberganlage 25, D-60325 Frankfurt, Germany; [Gossner, Martin M.; Lange, Markus; Pasalic, Esther; Schoening, Ingo; Tuerke, Manfred; Weisser, Wolfgang W.] Univ Jena, Inst Ecol, Dornburger Str 159, D-07743 Jena, Germany; [Gossner, Martin M.; Lange, Markus; Pasalic, Esther; Tuerke, Manfred; Weisser, Wolfgang W.] Tech Univ Munich, Terr Ecol Res Grp, Dept Ecol & Ecosyst Management, Sch Life Sci Weihenstephan, Hans Carl von Carlowitz Pl 2, D-85354 Freising Weihenstephan, Germany; [Renner, Swen C.; Boehm, Stefan] Univ Nat Resources & Life Sci, Inst Zool, Gregor Mendel Str 33, A-1180 Vienna, Austria; [Renner, Swen C.] Natl Zool Pk, Smithsonian Conservat Biol Inst, 1500 Remount Rd, Front Royal, VA 22630 USA; [Alt, Fabian; Oelmann, Yvonne; Sorkau, Elisabeth] Univ Tubingen, Geocol, Ruemelinstr 19-23, Tubingen, Germany; [Arndt, Hartmut; Venter, Paul C.] Univ Cologne, Inst Zool, Zulpicher Str 47b, D-50674 Cologne, Germany; [Baumgartner, Vanessa; Overmann, Joerg; Sikorski, Johannes] Leibniz Inst DSMZ German Collect Microorganisms &, Inhoffenstr 7B, D-38124 Braunschweig, Germany; [Binkenstein, Julia] Univ Freiburg, Fac Environm & Nat Resources, Chair Nat Conservat & Landscape Ecol, Tennenbacher Str 4, D-79106 Freiburg, Germany; [Birkhofer, Klaus] Lund Univ, Dept Biol, Solvegatan 35, D-22362 Lund, Germany; [Bluethgen, Nico; Weiner, Christiane N.] Tech Univ Darmstadt, Biol, Ecol Networks, Schnittspahnstr 3, D-64287 Darmstadt, Germany; [Boch, Steffen; Fischer, Markus] Univ Bern, Bot Gardens, Altenbergrain 21, CH-3013 Bern, Switzerland; [Boerschig, Carmen; Westphal, Catrin] Univ Gottingen, Dept Crop Sci, Agroecol, Grisebachstr 6, D-37077 Gottingen, Germany; [Buscot, Francois; Klemmer, Sandra; Wubet, Tesfaye] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Theodor Lieser Str 4, D-06120 Halle, Saale, Germany; [Buscot, Francois; Tuerke, Manfred; Wubet, Tesfaye] German Ctr Integrat Biodivers Res iDiv, Deutsch Pl 5e, D-04103 Leipzig, Germany; [Diekoetter, Tim] Univ Kiel, Dept Landscape Ecol, Olshausenstr 75, D-24118 Kiel, Germany; [Heinze, Johannes; Mueller, Joerg] Univ Potsdam, Biodivers Res Systemat Bot, Maulbeerallee 1, D-14469 Potsdam, Germany; [Heinze, Johannes; Rillig, Matthias C.] Berlin Brandenburg Inst Adv Biodivers Res BBIB, D-14195 Berlin, Germany; [Hoelzel, Norbert; Klaus, Valentin H.; Kleinebecker, Till] Univ Munster, Inst Landscape Ecol, D-48149 Munster, Germany; [Jung, Kirsten; Tschapka, Marco] Univ Ulm, Inst Evolutionary Ecol & Conservat Genom, Albert Einstein Allee 11, D-89069 Ulm, Germany; [Krauss, Jochen; Steckel, Juliane; Steffan-Dewenter, Ingolf; Werner, Michael] Univ Wurzburg, Bioctr, Dept Anim Ecol & Trop Biol, Hubland, D-97074 Wurzburg, Germany; [Lange, Markus; Schoening, Ingo; Schrumpf, Marion; Solly, Emily F.] Max Planck Inst Biogeochem, Hans Knoell Str 10, D-07745 Jena, Germany; [Morris, E. Kathryn] Xavier Univ, Dept Biol, 3800 Victory Pkwy, Cincinnati, OH 45207 USA; [Morris, E. Kathryn; Rillig, Matthias C.] Free Univ Berlin, Inst Biol, Plant Ecol, Altensteinstr 6, D-14195 Berlin, Germany; [Schaefer, H. Martin] Univ Freiburg, Fac Biol, Dept Ecol & Evolutionary Biol, D-79104 Freiburg, Germany; [Schloter, Michael; Stempfhuber, Barbara] Helmholtz Zentrum Munchen, Res Unit Environm Genom, Ingolstadter Landstr 1, D-85758 Oberschleissheim, Germany; [Socher, Stephanie A.] Salzburg Univ, Dept Ecol & Evolut, Hellbrunnerstr 34, A-5020 Salzburg, Austria; [Solly, Emily F.] Swiss Fed Inst Forest Snow & Landscape Res WSL, Zurcherstr 111, CH-8903 Birmensdorf, Switzerland; [Sonnemann, Ilja; Wurst, Susanne] Free Univ Berlin, Inst Biol, Funct Biodivers, Konigin Luise Str 1-3, D-14195 Berlin, Germany; [Tschapka, Marco] Smithsonian Trop Res Inst, Balboa, Panama; [Tuerke, Manfred] Univ Leipzig, Inst Biol, Johannisallee 21, D-04103 Leipzig, Germany; [Wilcke, Wolfgang] KIT, Inst Geog & Geoecol, Reinhard Baumeister Pl 1, D-76131 Karlsruhe, Germany; [Wolters, Volkmar] Univ Giessen, Dept Anim Ecol, Heinrich Buff Ring 26-32, D-35392 Giessen, Germany; [Allan, Eric] Univ Bern, Ctr Dev & Environm, Hallerstr 10, CH-3012 Bern, Switzerland	University of Bern; Senckenberg Gesellschaft fur Naturforschung (SGN); Friedrich Schiller University of Jena; Technical University of Munich; University of Natural Resources & Life Sciences, Vienna; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; Eberhard Karls University of Tubingen; University of Cologne; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); University of Freiburg; Technical University of Darmstadt; University of Bern; University of Gottingen; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Kiel; University of Potsdam; University of Munster; Ulm University; University of Wurzburg; Max Planck Society; Xavier University; Free University of Berlin; University of Freiburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Salzburg University; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Free University of Berlin; Smithsonian Institution; Smithsonian Tropical Research Institute; Leipzig University; Helmholtz Association; Karlsruhe Institute of Technology; Justus Liebig University Giessen; University of Bern	Soliveres, S (corresponding author), Univ Bern, Inst Plant Sci, Altenbergrain 21, CH-3013 Bern, Switzerland.	santiago.soliveres@ips.unibe.ch	Buscot, Francois/A-4125-2016; Sikorski, Johannes/AAD-9775-2019; Fischer, Markus/C-6411-2008; Wubet, Tesfaye/C-6241-2012; Gossner, Martin M./J-2730-2015; Schrumpf, Marion/C-1671-2013; Rillig, Matthias C./B-3675-2009; Westphal, Catrin/F-9560-2015; Weisser, Wolfgang W/B-9718-2014; Rillig, Matthias C./AAE-6980-2019; Allan, Eric/AAR-9566-2020; Birkhofer, Klaus/AAA-2374-2021; Arndt, Hartmut/K-9364-2017; Oelmann, Yvonne/J-8730-2016; Heinze, Johannes/AAH-9895-2020; Wilcke, Wolfgang/P-4620-2016; Morris, Kathryn/I-4701-2014; Schloter, 1Michael/H-9151-2013; Krauss, Jochen/C-6216-2014; Sikorski, Johannes/AAX-1960-2020; van der Plas, Fons/A-2242-2017; Hölzel, Norbert/H-8753-2013; Manning, Peter/I-6523-2012; Codina, Santiago Soliveres/A-2291-2016; Wolters, Volkmar/B-4635-2010; Schöning, Ingo/D-3341-2009; Blüthgen, Nico/F-5983-2010; Türke, Manfred/AFE-8308-2022	Buscot, Francois/0000-0002-2364-0006; Fischer, Markus/0000-0002-5589-5900; Wubet, Tesfaye/0000-0001-8572-4486; Gossner, Martin M./0000-0003-1516-6364; Rillig, Matthias C./0000-0003-3541-7853; Westphal, Catrin/0000-0002-2615-1339; Weisser, Wolfgang W/0000-0002-2757-8959; Rillig, Matthias C./0000-0003-3541-7853; Allan, Eric/0000-0001-9641-9436; Birkhofer, Klaus/0000-0002-9301-2443; Arndt, Hartmut/0000-0003-2811-3595; Oelmann, Yvonne/0000-0003-3513-6568; Heinze, Johannes/0000-0002-3556-5883; Wilcke, Wolfgang/0000-0002-6031-4613; Morris, Kathryn/0000-0003-3548-444X; Krauss, Jochen/0000-0003-2304-9117; Sikorski, Johannes/0000-0002-1890-5540; van der Plas, Fons/0000-0003-4680-543X; Hölzel, Norbert/0000-0002-6367-3400; Manning, Peter/0000-0002-7940-2023; Codina, Santiago Soliveres/0000-0001-9661-7192; Wolters, Volkmar/0000-0002-7556-4578; Schöning, Ingo/0000-0002-9830-5026; Türke, Manfred/0000-0002-8957-5454; Overmann, Jorg/0000-0003-3909-7201; Schrumpf, Marion/0000-0003-4219-4125; Socher, Stephanie/0000-0002-0090-4005; Kleinebecker, Till/0000-0003-1121-2861; /0000-0002-6893-4219; Klaus, Valentin H./0000-0002-7469-6800; Solly, Emily/0000-0002-3157-1805	Deutsche Forschungsgemeinschaft [1374]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank B. Schmid, F. T. Maestre and S. Kefi for comments that helped improve this manuscript. W. Ulrich and N. J. Gotelli provided statistical advice. We thank the people who maintain the Biodiversity Exploratories program: A. Hemp, K. Wells, S. Gockel, K. Wiesner and M. Gorke (local management team); S. Pfeiffer and C. Fischer (central office), B. Konig-Ries and M. Owonibi (central database management); and E. Linsenmair, D. Hessenmoller, J. Nieschulze, E.-D. Schulze and the late E. Kalko for their role in setting up the project. This work was funded by the Deutsche Forschungsgemeinschaft Priority Program 1374 'Infrastructure-Biodiversity Exploratories'. Fieldwork permits were given by the responsible state environmental offices of Baden-Wurttemberg, Thuringen and Brandenburg (according to 72 BbgNatSchG). Figure icons were created by R. D. Manzanedo.	Allan E, 2015, ECOL LETT, V18, P834, DOI 10.1111/ele.12469; Allan E, 2014, P NATL ACAD SCI USA, V111, P308, DOI 10.1073/pnas.1312213111; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; Balvanera P, 2014, BIOSCIENCE, V64, P49, DOI 10.1093/biosci/bit003; Bluthgen N, 2012, BASIC APPL ECOL, V13, P207, DOI 10.1016/j.baae.2012.04.001; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Bruno JF, 2008, ECOLOGY, V89, P2518, DOI 10.1890/07-1345.1; Byrnes JEK, 2014, METHODS ECOL EVOL, V5, P111, DOI 10.1111/2041-210X.12143; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Delgado-Baquerizo M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10541; Deraison H, 2015, ECOL LETT, V18, P1346, DOI 10.1111/ele.12529; Douglass JG, 2008, ECOL LETT, V11, P598, DOI 10.1111/j.1461-0248.2008.01175.x; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Gamfeldt L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2328; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Grace JB, 2016, NATURE, V529, P390, DOI 10.1038/nature16524; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Handa IT, 2014, NATURE, V509, P218, DOI 10.1038/nature13247; Hautier Y, 2014, NATURE, V508, P521, DOI 10.1038/nature13014; Hector A, 2007, NATURE, V448, P188, DOI 10.1038/nature05947; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Jing X, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9159; Lefcheck JS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7936; MA (Millennium Ecosystem Assessment), 2005, ECOSYSTEMS HUMAN WEL, P1; Maestre FT, 2012, SCIENCE, V335, P214, DOI 10.1126/science.1215442; Manning P, 2015, ECOLOGY, V96, P1492, DOI 10.1890/14-1307.1; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; Micallef L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101717; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Naeem S, 2000, NATURE, V403, P762, DOI 10.1038/35001568; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Naeem S, 2012, SCIENCE, V336, P1401, DOI 10.1126/science.1215855; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Petchey OL, 1999, NATURE, V402, P69, DOI 10.1038/47023; R Development Core Team, 2014, R LANG ENV STAT COMP; Soliveres S, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0269; Tilman D, 2012, P NATL ACAD SCI USA, V109, P10394, DOI 10.1073/pnas.1208240109; Tylianakis JM, 2008, PLOS BIOL, V6, P947, DOI 10.1371/journal.pbio.0060122; Worm B, 2003, TRENDS ECOL EVOL, V18, P628, DOI 10.1016/j.tree.2003.09.003; Zavaleta ES, 2010, P NATL ACAD SCI USA, V107, P1443, DOI 10.1073/pnas.0906829107	45	346	362	78	971	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					456	+		10.1038/nature19092	http://dx.doi.org/10.1038/nature19092			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27533038	Green Accepted			2022-12-28	WOS:000382646600041
J	Labinger, JA				Labinger, Jay A.			Elusive active site in focus	NATURE			English	Editorial Material							METHANE MONOOXYGENASE; OXIDATION; ZEOLITES		[Labinger, Jay A.] CALTECH, Beckman Inst, Pasadena, CA 91125 USA	California Institute of Technology	Labinger, JA (corresponding author), CALTECH, Beckman Inst, Pasadena, CA 91125 USA.	jal@caltech.edu	Nanozymes, Nanozymes/D-8197-2019					Dubkov KA, 2002, J CATAL, V207, P341, DOI 10.1006/jcat.2002.3552; Labinger JA, 2004, J MOL CATAL A-CHEM, V220, P27, DOI 10.1016/j.molcata.2004.03.051; Panov GI, 1997, REACT KINET CATAL L, V61, P251, DOI 10.1007/BF02478380; Parfenov MV, 2014, J CATAL, V318, P14, DOI 10.1016/j.jcat.2014.07.009; Shu LJ, 1997, SCIENCE, V275, P515, DOI 10.1126/science.275.5299.515; Snyder BER, 2016, NATURE, V536, P317, DOI 10.1038/nature19059; VALLEE BL, 1968, P NATL ACAD SCI USA, V59, P498, DOI 10.1073/pnas.59.2.498; Xia HA, 2008, J PHYS CHEM C, V112, P9001, DOI 10.1021/jp800455x	8	2	2	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					280	281		10.1038/536280a	http://dx.doi.org/10.1038/536280a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27535531				2022-12-28	WOS:000381804900023
J	McDonnell, JJ				McDonnell, Jeffrey J.			The 1-hour workday	SCIENCE			English	Editorial Material									[McDonnell, Jeffrey J.] Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK, Canada	University of Saskatchewan	McDonnell, JJ (corresponding author), Univ Saskatchewan, Sch Environm & Sustainabil, Saskatoon, SK, Canada.		McDonnell, Jeffrey J/I-6400-2013	McDonnell, Jeffrey J/0000-0002-3880-3162					0	3	3	3	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					718	718		10.1126/science.353.6300.718	http://dx.doi.org/10.1126/science.353.6300.718			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5ZC	27516604				2022-12-28	WOS:000381561200044
J	Nielsen, J; Hedeholm, RB; Heinemeier, J; Bushnell, PG; Christiansen, JS; Olsen, J; Ramsey, CB; Brill, RW; Simon, M; Steffensen, KF; Steffensen, JF				Nielsen, Julius; Hedeholm, Rasmus B.; Heinemeier, Jan; Bushnell, Peter G.; Christiansen, Jorgen S.; Olsen, Jesper; Ramsey, Christopher Bronk; Brill, Richard W.; Simon, Malene; Steffensen, Kirstine F.; Steffensen, John F.			Eye lens radiocarbon reveals centuries of longevity in the Greenland shark (Somniosus microcephalus)	SCIENCE			English	Article							POST-BOMB RADIOCARBON; FEEDING ECOLOGY; NORTHWEST ATLANTIC; AGE VALIDATION; LAMNA-NASUS; PRE-BOMB; FOOD-WEB; CALIBRATION; OTOLITHS; DELTA-N-15	The Greenland shark (Somniosus microcephalus), an iconic species of the Arctic Seas, grows slowly and reaches >500 centimeters (cm) in total length, suggesting a life span well beyond those of other vertebrates. Radiocarbon dating of eye lens nuclei from 28 female Greenland sharks (81 to 502 cm in total length) revealed a life span of at least 272 years. Only the smallest sharks (220 cm or less) showed signs of the radiocarbon bomb pulse, a time marker of the early 1960s. The age ranges of prebomb sharks (reported as midpoint and extent of the 95.4% probability range) revealed the age at sexual maturity to be at least 156 +/- 22 years, and the largest animal (502 cm) to be 392 +/- 120 years old. Our results show that the Greenland shark is the longest-lived vertebrate known, and they raise concerns about species conservation.	[Nielsen, Julius; Steffensen, Kirstine F.; Steffensen, John F.] Univ Copenhagen, Marine Biol Sect, Strandpromenaden 5, DK-3000 Helsingor, Denmark; [Nielsen, Julius; Hedeholm, Rasmus B.] Greenland Inst Nat Resources, POB 570,Kivioq 2, Nuuk 3900, Greenland; [Nielsen, Julius] Natl Aquarium Denmark, Den Bla Planet, Jacob Fortlingsvej 1, DK-2770 Kastrup, Denmark; [Nielsen, Julius; Christiansen, Jorgen S.] UiT Arctic Univ Norway, Dept Arctic & Marine Biol, N-9037 Tromso, Norway; [Heinemeier, Jan; Olsen, Jesper] Aarhus Univ, Aarhus AMS Ctr, Dept Phys & Astron, Ny Munkegade 120, DK-8000 Aarhus, Denmark; [Bushnell, Peter G.] Indiana Univ South Bend, Dept Biol Sci, 1700 Mishawaka Ave, South Bend, IN USA; [Ramsey, Christopher Bronk] Univ Oxford, Oxford Radiocarbon Accelerator Unit, Dyson Perrins Bldg,South Parks Rd, Oxford OX1 3QY, England; [Brill, Richard W.] NOAA, Natl Marine Fisheries Serv, Northeast Fisheries Sci Ctr, James J Howard Marine Sci Lab, 74 Magruder Rd, Highlands, NJ 07732 USA; [Brill, Richard W.] Virginia Inst Marine Sci, POB 1346, Gloucester Point, VA 23062 USA; [Simon, Malene] Greenland Inst Nat Resources, Greenland Climate Res Ctr, POB 570,Kivioq 2, Nuuk 3900, Greenland	University of Copenhagen; Greenland Institute of Natural Resources; UiT The Arctic University of Tromso; Aarhus University; Indiana University System; Indiana University South Bend; University of Oxford; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; William & Mary; Virginia Institute of Marine Science; Greenland Institute of Natural Resources	Nielsen, J (corresponding author), Univ Copenhagen, Marine Biol Sect, Strandpromenaden 5, DK-3000 Helsingor, Denmark.; Nielsen, J (corresponding author), Greenland Inst Nat Resources, POB 570,Kivioq 2, Nuuk 3900, Greenland.; Nielsen, J (corresponding author), Natl Aquarium Denmark, Den Bla Planet, Jacob Fortlingsvej 1, DK-2770 Kastrup, Denmark.; Nielsen, J (corresponding author), UiT Arctic Univ Norway, Dept Arctic & Marine Biol, N-9037 Tromso, Norway.	julius.nielsen@bio.ku.dk	Ramsey, Christopher Bronk/AAQ-2227-2021; Steffensen, John F/F-6778-2010; Ramsey, Christopher Bronk/A-3277-2012; Olsen, Jesper/F-1656-2013	Ramsey, Christopher Bronk/0000-0002-8641-9309; Steffensen, John F/0000-0002-4477-8039; Ramsey, Christopher Bronk/0000-0002-8641-9309; Olsen, Jesper/0000-0002-4445-5520; Steffensen, Kirstine Fleng/0000-0001-8404-6425	Commission of Scientific Investigations in Greenland (KVUG); Save Our Seas Foundation; National Geographic Foundation; Carlsberg Foundation; Danish Centre for Marine Research; Den Bla Planet-National Aquarium of Denmark; Greenland Institute of Natural Resources (GINR); Danish Council for Independent Research; Natural Environment Research Council [NRCF010002] Funding Source: researchfish; NERC [NRCF010002] Funding Source: UKRI	Commission of Scientific Investigations in Greenland (KVUG); Save Our Seas Foundation; National Geographic Foundation(National Geographic Society); Carlsberg Foundation(Carlsberg Foundation); Danish Centre for Marine Research; Den Bla Planet-National Aquarium of Denmark; Greenland Institute of Natural Resources (GINR); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We are grateful for the contributions from M. B. Backe throughout the manuscript. We thank the Commission of Scientific Investigations in Greenland (KVUG), Save Our Seas Foundation, National Geographic Foundation, Carlsberg Foundation, Danish Centre for Marine Research, Den Bla Planet-National Aquarium of Denmark, Greenland Institute of Natural Resources (GINR), and the Danish Council for Independent Research for financial support. We thank GINR, the University of Copenhagen and the TUNU Programme (UIT, The Arctic University of Norway) for ship time. We are grateful for the collaboration with K.P. Lange. We thank the crews of the RV Pamiut, RV Dana, RV Helmer Hanssen, RV Sanna, and RV Porsild. Three anonymous reviewers provided helpful comments and discussion that improved earlier versions of the manuscript.	BADA JL, 1987, GEOPHYS RES LETT, V14, P1065, DOI 10.1029/GL014i010p01065; Bassnett S, 2011, PHILOS T R SOC B, V366, P1250, DOI 10.1098/rstb.2010.0302; Bigelow H. B., 1948, FISHES W N ATLANTIC, P516; Butler PG, 2013, PALAEOGEOGR PALAEOCL, V373, P141, DOI 10.1016/j.palaeo.2012.01.016; Butler PG, 2009, EARTH PLANET SC LETT, V279, P230, DOI 10.1016/j.epsl.2008.12.043; Campana SE, 2002, CAN J FISH AQUAT SCI, V59, P450, DOI 10.1139/F02-027; Campana SE, 1997, MAR ECOL PROG SER, V150, P49, DOI 10.3354/meps150049; Campana SE, 2006, ENVIRON BIOL FISH, V77, P327, DOI 10.1007/s10641-006-9107-3; Campana SE, 2015, DEEP-SEA RES PT II, V115, P109, DOI 10.1016/j.dsr2.2013.11.001; Christensen JT, 2008, MAR ECOL PROG SER, V368, P1, DOI 10.3354/meps07635; Compagno L, 1984, FAO SPECIES CATALO 1, V4; DEVRIES H, 1958, SCIENCE, V128, P1550, DOI 10.1126/science.128.3338.1550; Estrada JA, 2006, ECOLOGY, V87, P829, DOI 10.1890/0012-9658(2006)87[829:UOIAOV]2.0.CO;2; Fisk AT, 2002, ECOLOGY, V83, P2162, DOI 10.1890/0012-9658(2002)083[2162:UACASI]2.0.CO;2; Francis MP, 2007, MAR FRESHWATER RES, V58, P10, DOI 10.1071/MF06069; George JC, 1999, CAN J ZOOL, V77, P571, DOI 10.1139/cjz-77-4-571; Hamady LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084006; Hansen JH, 2012, MAR ECOL PROG SER, V467, P47, DOI 10.3354/meps09945; Hansen P.M., 1963, INT COMMISSION NW AT, P172; Heide-Jorgensen M. P., 1994, BIOSCIENCE, V39, P195; Henriksen S., 2015, NORSK RODLISTE ARTER; Joyce WN, 2002, ICES J MAR SCI, V59, P1263, DOI 10.1006/jmsc.2002.1286; KALISH JM, 1993, EARTH PLANET SC LETT, V114, P549, DOI 10.1016/0012-821X(93)90082-K; Kalish JM, 2001, RADIOCARBON, V43, P843; Kyne PM, 2010, CRC MAR BIOL SER, P37; Lynnerup N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001529; McMeans BC, 2010, CAN J FISH AQUAT SCI, V67, P1428, DOI 10.1139/F10-072; Nielsen J, 2014, POLAR BIOL, V37, P37, DOI 10.1007/s00300-013-1408-3; Ramsey CB, 1995, RADIOCARBON, V37, P425, DOI 10.1017/S0033822200030903; Ramsey CB, 2008, QUATERNARY SCI REV, V27, P42, DOI 10.1016/j.quascirev.2007.01.019; Ramsey CB, 2013, RADIOCARBON, V55, P720, DOI 10.1017/S0033822200057878; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Scourse JD, 2012, RADIOCARBON, V54, P165, DOI 10.2458/azu_js_rc.v54i2.16026; Stewart REA, 2006, CAN J ZOOL, V84, P1840, DOI 10.1139/Z06-182; Stouby R. B., 2011, EKSPORTKRONER SKIDTF, V2; Treble MA, 2008, CAN J FISH AQUAT SCI, V65, P1047, DOI 10.1139/F08-030; Yano K, 2007, J FISH BIOL, V70, P374, DOI 10.1111/j.1095-8649.2007.01308.x	38	158	170	4	271	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					702	704		10.1126/science.aaf1703	http://dx.doi.org/10.1126/science.aaf1703			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZC	27516602	Green Submitted			2022-12-28	WOS:000381561200041
J	Stern, PC; Perkins, JH; Sparks, RE; Knox, RA				Stern, Paul C.; Perkins, John H.; Sparks, Richard E.; Knox, Robert A.			The challenge of climate-change neoskepticism Decision science and risk management are underutilized	SCIENCE			English	Editorial Material									[Stern, Paul C.] CNR, Washington, DC 20001 USA; [Stern, Paul C.] Norwegian Univ Sci & Technol, N-7491 Trondheim, Norway; [Perkins, John H.] Evergreen State Coll, Olympia, WA USA; [Perkins, John H.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Sparks, Richard E.] Univ Illinois, Champaign, IL 61801 USA; [Knox, Robert A.] Univ Calif San Diego, La Jolla, CA 92093 USA	Norwegian University of Science & Technology (NTNU); University of California System; University of California Berkeley; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California San Diego	Stern, PC (corresponding author), CNR, Washington, DC 20001 USA.; Stern, PC (corresponding author), Norwegian Univ Sci & Technol, N-7491 Trondheim, Norway.	pstern@nas.edu						[Anonymous], 2013, ABR IMP CLIM CHANG A; Boussalis C, 2016, GLOBAL ENVIRON CHANG, V36, P89, DOI 10.1016/j.gloenvcha.2015.12.001; Carraro C, 2015, SCIENCE, V350, P34, DOI 10.1126/science.aac4419; Curry J., 2014, WALL STREET J; EPA, 1975, EPA540175022; Farrell J, 2016, P NATL ACAD SCI USA, V113, P92, DOI 10.1073/pnas.1509433112; IPCC, 2013, CLIMATE CHANGE 2022; Koonin S., 2014, WALL STREET J; Monckton C, 2015, SCI BULL, V60, P122, DOI 10.1007/s11434-014-0699-2; National Research Council (NRC), 2009, INF DEC CHANG CLIM; NRC, 2012, REV US GLOB CHANG RE; NRC, 2011, ADV SCI CLIMATE CHAN; Perkins JH, 2015, NATURE, V522, P287, DOI 10.1038/522287c; Pidgeon N, 2011, NAT CLIM CHANGE, V1, P35, DOI [10.1038/NCLIMATE1080, 10.1038/nclimate1080]; Stern PC, 2016, NAT CLIM CHANGE, V6, P547, DOI 10.1038/NCLIMATE3027; Stern PC, 2015, SOC RES, V82, P581; Vallentyne J. R., 1974, MISC SPECIAL PUBL, V22; Whorton J., 1974, SILENT SPRING PESTIC, P20	18	20	20	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					653	654		10.1126/science.aaf6675	http://dx.doi.org/10.1126/science.aaf6675			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZC	27516588				2022-12-28	WOS:000381561200023
J	Brown, R; Kaganovich, D				Brown, Rachel; Kaganovich, Daniel			Look Out Autophagy, Ubiquilin UPS Its Game	CELL			English	Editorial Material							ALS; INCLUSIONS; MUTATIONS; UBQLN2	Mutations in Ubiquilin-2 are linked to the onset of amyotrophic lateral sclerosis, but its connection to disease processes has remained unknown. Hjerpe et. al now report that Ubiquilin-2 enables the ubiquitin proteasome system (UPS) to single-handedly clear aggregated proteins, a cellular function previously thought to rely at least partially on autophagy.	[Brown, Rachel; Kaganovich, Daniel] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Cell & Dev Biol, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Kaganovich, D (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Cell & Dev Biol, IL-91904 Jerusalem, Israel.	dan@cc.huji.ac.il		Kaganovich, Daniel/0000-0003-2398-1596				Amen T, 2015, CELL MOL LIFE SCI, V72, P401, DOI 10.1007/s00018-014-1740-y; Chesi A, 2013, NAT NEUROSCI, V16, P851, DOI 10.1038/nn.3412; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Hjerpe R, 2016, CELL, V166, P935, DOI 10.1016/j.cell.2016.07.001; Kaye FJ, 2000, FEBS LETT, V467, P348, DOI 10.1016/S0014-5793(00)01135-2; Matiuhin Y, 2008, MOL CELL, V32, P415, DOI 10.1016/j.molcel.2008.10.011; Peters OM, 2015, J CLIN INVEST, V125, P1767, DOI 10.1172/JCI71601; Zeng L, 2015, NEUROBIOL DIS, V82, P281, DOI 10.1016/j.nbd.2015.06.017; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017	9	10	10	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4								10.1016/j.cell.2016.07.048	http://dx.doi.org/10.1016/j.cell.2016.07.048			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27518558	Bronze			2022-12-28	WOS:000382258700005
J	Wolfe, GI; Kaminski, HJ; Aban, IB; Minisman, G; Kuo, HC; Marx, A; Strobel, P; Mazia, C; Oger, J; Cea, JG; Heckmann, JM; Evoli, A; Nix, W; Ciafaloni, E; Antonini, G; Witoonpanich, R; King, JO; Beydoun, SR; Chalk, CH; Barboi, AC; Amato, AA; Shaibani, AI; Katirji, B; Lecky, BRF; Buckley, C; Vincent, A; Dias-Tosta, E; Yoshikawa, H; Waddington-Cruz, M; Pulley, MT; Rivner, MH; Kostera-Pruszczyk, A; Pascuzzi, RM; Jackson, CE; Ramos, GSG; Verschuuren, JJGM; Massey, JM; Kissel, JT; Werneck, LC; Benatar, M; Barohn, RJ; Tandan, R; Mozaffar, T; Conwit, R; Odenkirchen, J; Sonett, JR; Jaretzki, A; Newsom-Davis, J; Cutter, GR				Wolfe, G. I.; Kaminski, H. J.; Aban, I. B.; Minisman, G.; Kuo, H-C; Marx, A.; Strobel, P.; Mazia, C.; Oger, J.; Cea, J. G.; Heckmann, J. M.; Evoli, A.; Nix, W.; Ciafaloni, E.; Antonini, G.; Witoonpanich, R.; King, J. O.; Beydoun, S. R.; Chalk, C. H.; Barboi, A. C.; Amato, A. A.; Shaibani, A. I.; Katirji, B.; Lecky, B. R. F.; Buckley, C.; Vincent, A.; Dias-Tosta, E.; Yoshikawa, H.; Waddington-Cruz, M.; Pulley, M. T.; Rivner, M. H.; Kostera-Pruszczyk, A.; Pascuzzi, R. M.; Jackson, C. E.; Ramos, G. S. Garcia; Verschuuren, J. J. G. M.; Massey, J. M.; Kissel, J. T.; Werneck, L. C.; Benatar, M.; Barohn, R. J.; Tandan, R.; Mozaffar, T.; Conwit, R.; Odenkirchen, J.; Sonett, J. R.; Jaretzki, A., III; Newsom-Davis, J.; Cutter, G. R.		MGTX Study Grp	Randomized Trial of Thymectomy in Myasthenia Gravis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EXTENDED THYMECTOMY; THORACOSCOPIC THYMECTOMY	BACKGROUND Thymectomy has been a mainstay in the treatment of myasthenia gravis, but there is no conclusive evidence of its benefit. We conducted a multicenter, randomized trial comparing thymectomy plus prednisone with prednisone alone. METHODS We compared extended transsternal thymectomy plus alternate-day prednisone with alternate-day prednisone alone. Patients 18 to 65 years of age who had generalized nonthymomatous myasthenia gravis with a disease duration of less than 5 years were included if they had Myasthenia Gravis Foundation of America clinical class II to IV disease (on a scale from I to V, with higher classes indicating more severe disease) and elevated circulating concentrations of acetylcholine-receptor antibody. The primary outcomes were the time-weighted average Quantitative Myasthenia Gravis score (on a scale from 0 to 39, with higher scores indicating more severe disease) over a 3-year period, as assessed by means of blinded rating, and the time-weighted average required dose of prednisone over a 3-year period. RESULTS A total of 126 patients underwent randomization between 2006 and 2012 at 36 sites. Patients who underwent thymectomy had a lower time-weighted average Quantitative Myasthenia Gravis score over a 3-year period than those who received prednisone alone (6.15 vs. 8.99, P < 0.001); patients in the thymectomy group also had a lower average requirement for alternate-day prednisone (44 mg vs. 60 mg, P < 0.001). Fewer patients in the thymectomy group than in the prednisone-only group required immunosuppression with azathioprine (17% vs. 48%, P < 0.001) or were hospitalized for exacerbations (9% vs. 37%, P < 0.001). The number of patients with treatment-associated complications did not differ significantly between groups (P = 0.73), but patients in the thymectomy group had fewer treatment-associated symptoms related to immunosuppressive medications (P < 0.001) and lower distress levels related to symptoms (P = 0.003). CONCLUSIONS Thymectomy improved clinical outcomes over a 3-year period in patients with nonthymomatous myasthenia gravis. (Funded by the National Institute of Neurological Disorders and Stroke and others; MGTX ClinicalTrials.gov number, NCT00294658.)	[Wolfe, G. I.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurol, 100 High St, Buffalo, NY 14203 USA; [Ciafaloni, E.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14627 USA; [Sonett, J. R.; Jaretzki, A., III] Columbia Univ, Sect Gen Thorac Surg, Med Ctr, New York, NY USA; [Kaminski, H. J.] George Washington Univ, Dept Neurol, Sch Med & Hlth Sci, Washington, DC USA; [Aban, I. B.; Minisman, G.; Kuo, H-C; Cutter, G. R.] Univ Alabama Birmingham, Dept Biostat, Birmingham, AL 35294 USA; [Marx, A.] Heidelberg Univ, Inst Pathol, Univ Med Ctr Mannheim, Mannheim, Germany; [Strobel, P.] Univ Gottingen, Inst Pathol, Gottingen, Germany; [Nix, W.] Johannes Gutenberg Univ Mainz, Dept Neurol, Mainz, Germany; [Mazia, C.] Univ Buenos Aires, Dept Neurol, Buenos Aires, DF, Argentina; [Oger, J.] Univ British Columbia, Div Neurol, Vancouver, BC, Canada; [Chalk, C. H.] McGill Univ, Dept Neurol, Montreal, PQ, Canada; [Cea, J. G.] Univ Chile, Dept Neurol, Santiago, Chile; [Heckmann, J. M.] Univ Cape Town, Div Neurol, Dept Med, Cape Town, South Africa; [Evoli, A.] Catholic Univ, Dept Neurol, Rome, Italy; [Antonini, G.] Sapienza Univ Rome, Dept Neurosci Mental Hlth & Sensory Organs, Rome, Italy; [Witoonpanich, R.] Mahidol Univ, Div Neurol, Ramathibodi Hosp, Bangkok, Thailand; [King, J. O.] Univ Melbourne, Dept Neurol, Melbourne, Vic, Australia; [Beydoun, S. R.] Univ Southern Calif, Dept Neurol, Los Angeles, CA USA; [Mozaffar, T.] Univ Calif Irvine, Dept Neurol, Med Ctr, Orange, CA 92668 USA; [Barboi, A. C.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Amato, A. A.] Harvard Med Sch, Dept Neurol, Boston, MA USA; [Shaibani, A. I.] Nerve & Muscle Ctr Texas, Houston, TX USA; [Jackson, C. E.] Univ Texas Hlth Sci Ctr San Antonio, Dept Neurol, San Antonio, TX 78229 USA; [Katirji, B.] Case Western Reserve Univ, Dept Neurol, Cleveland, OH 44106 USA; [Kissel, J. T.] Ohio State Univ, Dept Neurol, Wexner Med Ctr, Columbus, OH 43210 USA; [Lecky, B. R. F.] Walton Ctr Neurol & Neurosurg, Liverpool, Merseyside, England; [Buckley, C.; Vincent, A.; Newsom-Davis, J.] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford, England; [Dias-Tosta, E.] Univ Brasilia, Neurol Unit, Brasilia, DF, Brazil; [Waddington-Cruz, M.] Fed Univ, Dept Neurol, Rio De Janeiro, Brazil; [Werneck, L. C.] Univ Fed Parana, Dept Neurol, Curitiba, Parana, Brazil; [Yoshikawa, H.] Kanazawa Univ, Dept Neurol, Kanazawa, Ishikawa, Japan; [Pulley, M. T.] Univ Florida, Dept Neurol, Jacksonville, FL USA; [Benatar, M.] Univ Miami, Dept Neurol, Miami, FL USA; [Rivner, M. H.] Georgia Regents Univ, Dept Neurol, Augusta, GA USA; [Kostera-Pruszczyk, A.] Med Univ Warsaw, Dept Neurol, Warsaw, Poland; [Pascuzzi, R. M.] Indiana Sch Med, Dept Neurol, Indianapolis, IN USA; [Ramos, G. S. Garcia] Inst Nacl Nutr, Dept Neurol & Psychiat, Tlalpan, Mexico; [Verschuuren, J. J. G. M.] Leiden Univ Med Ctr, Dept Neurol, Leiden, Netherlands; [Massey, J. M.] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA; [Barohn, R. J.] Univ Kansas, Med Ctr, Dept Neurol, Kansas City, KS 66103 USA; [Tandan, R.] Univ Vermont, Coll Med, Dept Neurol Sci, Burlington, VT USA; [Conwit, R.; Odenkirchen, J.] NINDS, Div Extramural Res, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Rochester; Columbia University; George Washington University; University of Alabama System; University of Alabama Birmingham; Ruprecht Karls University Heidelberg; University of Gottingen; Johannes Gutenberg University of Mainz; University of Buenos Aires; University of British Columbia; McGill University; Universidad de Chile; University of Cape Town; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Sapienza University Rome; Mahidol University; University of Melbourne; University of Southern California; University of California System; University of California Irvine; Medical College of Wisconsin; Harvard University; Harvard Medical School; University of Texas System; University of Texas Health San Antonio; Case Western Reserve University; University System of Ohio; Ohio State University; Walton Centre; University of Oxford; Universidade de Brasilia; Universidade Federal do Parana; Kanazawa University; State University System of Florida; University of Florida; University of Miami; University System of Georgia; Augusta University; Medical University of Warsaw; Indiana University System; Indiana University Bloomington; Leiden University; Leiden University Medical Center (LUMC); Duke University; University of Kansas; University of Kansas Medical Center; University of Vermont; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Wolfe, GI (corresponding author), Univ Buffalo, Jacobs Sch Med & Biomed Sci, Dept Neurol, 100 High St, Buffalo, NY 14203 USA.	gilwolfe@buffalo.edu	Mozaffar, Tahseen/AAE-6971-2020; Evoli, Amelia/AAD-6807-2022; Werneck, Lineu/Y-4038-2019; Yoshikawa, Hiroaki/G-5015-2012; Cutter, Gary/AAY-5392-2021; Heckmann, Jeannine M/K-3972-2019; Katirji, Bashar/AAM-8409-2021; Yoshikawa, Hiroaki/AFH-2169-2022; Cea, Gabriel/AAJ-7086-2020; Vincent, Angela/AAE-7310-2019; Rivner, Michael/AAK-6479-2020; Shaibani, Aziz/AAE-1755-2022; Cea, Gabriel/K-2387-2019; Yoshikawa, Hiroaki/AAF-2368-2022; Benatar, Michael/AAF-6605-2019; Pulley, Michael/T-8381-2019; Wolfe, Gil/AAO-2786-2020; Antonini, Giovanni/AAC-6698-2022	Yoshikawa, Hiroaki/0000-0002-6350-5183; Cutter, Gary/0000-0002-8455-980X; Heckmann, Jeannine M/0000-0002-8999-718X; Cea, Gabriel/0000-0002-6388-7783; Rivner, Michael/0000-0002-6135-035X; Benatar, Michael/0000-0003-4241-5135; Pulley, Michael/0000-0003-1879-725X; Verschuuren, Jan/0000-0002-4572-1501; Kaminski, Henry/0000-0002-8195-0141; Butzkueven, Helmut/0000-0003-3940-8727; Venuta, Federico/0000-0001-9296-877X; Zickler, Philipp/0000-0002-2852-7360; Gutmann, Laurie/0000-0003-3926-4209; Titulaer, Maarten/0000-0002-1033-3840; Cacho-Diaz, Bernardo/0000-0001-9289-5312; ANTONINI, Giovanni/0000-0002-7519-7739	National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS042685] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funded by the National Institute of Neurological Disorders and Stroke and others; MGTX ClinicalTrials.gov number, NCT00294658.	Alshekhlee A, 2009, NEUROLOGY, V72, P1548, DOI 10.1212/WNL.0b013e3181a41211; Barohn RJ, 1998, ANN NY ACAD SCI, V841, P769, DOI 10.1111/j.1749-6632.1998.tb11015.x; Bedlack RS, 2005, NEUROLOGY, V64, P1968, DOI 10.1212/01.WNL.0000163988.28892.79; Berrih-Aknin S, 2014, J AUTOIMMUN, V52, P90, DOI 10.1016/j.jaut.2013.12.011; Blalock A, 1941, J AMER MED ASSOC, V117, P1529, DOI 10.1001/jama.1941.02820440037009; Cea G, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008111.pub2; Conti-Fine BM, 2009, MYASTHENIA GRAVIS RE, P43; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; Grob D, 2008, MUSCLE NERVE, V37, P141, DOI 10.1002/mus.20950; Gronseth GS, 2000, NEUROLOGY, V55, P7, DOI 10.1212/WNL.55.1.7; Jaretzki A, 2000, NEUROLOGY, V55, P16, DOI 10.1212/WNL.55.1.16; JARETZKI A, 1988, J THORAC CARDIOV SUR, V95, P747; Jaretzki III A, 1997, NEUROLOGY S5, V48, P52; LANSKA DJ, 1990, NEUROLOGY, V40, P1828, DOI 10.1212/WNL.40.12.1828; Lee CY, 2011, SURG ENDOSC, V25, P849, DOI 10.1007/s00464-010-1280-y; Mack MJ, 1996, J THORAC CARDIOV SUR, V112, P1352, DOI 10.1016/S0022-5223(96)70151-4; Mantegazza R, 2003, J NEUROL SCI, V212, P31, DOI 10.1016/S0022-510X(03)00087-X; MASAOKA A, 1982, NEUROLOGY, V32, P83, DOI 10.1212/WNL.32.1.83; MCQUILLEN MP, 1977, NEUROLOGY, V27, P1103, DOI 10.1212/WNL.27.12.1103; MILLER RG, 1991, NEUROLOGY, V41, P923, DOI 10.1212/WNL.41.6.923; Moons P, 1998, HEART LUNG, V27, P315, DOI 10.1016/S0147-9563(98)90052-8; Muppidi S, 2011, MUSCLE NERVE, V44, P727, DOI 10.1002/mus.22140; Newsom-Davis J, 2008, ANN NY ACAD SCI, V1132, P344, DOI 10.1196/annals.1405.014; OOSTERHUIS HJ, 1981, ANN NY ACAD SCI, V377, P678, DOI 10.1111/j.1749-6632.1981.tb33766.x; PASCUZZI RM, 1984, ANN NEUROL, V15, P291, DOI 10.1002/ana.410150316; Ponseti JM, 2008, EUR J CARDIO-THORAC, V34, P1062, DOI 10.1016/j.ejcts.2008.07.049; RODRIGUEZ M, 1983, ANN NEUROL, V13, P504, DOI 10.1002/ana.410130506; Ruckert JC, 2011, J THORAC CARDIOV SUR, V141, P673, DOI 10.1016/j.jtcvs.2010.11.042; Sanders DB, 2008, NEUROLOGY, V71, P400, DOI 10.1212/01.wnl.0000312374.95186.cc; Sanders DB, 2008, NEUROLOGY, V71, P394, DOI 10.1212/01.wnl.0000312373.67493.7f; Shrager JB, 2002, ANN THORAC SURG, V74, P320, DOI 10.1016/S0003-4975(02)03722-0; Wolfe GI, 1999, NEUROLOGY, V52, P1487, DOI 10.1212/WNL.52.7.1487	32	413	439	5	61	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2016	375	6					511	522		10.1056/NEJMoa1602489	http://dx.doi.org/10.1056/NEJMoa1602489			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU4OT	27509100	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000382193100004
J	Bibbins-Domingo, K; Grossman, DC; Curry, SJ; Davidson, KW; Epling, JW; Garcia, FAR; Gillman, MW; Kemper, AR; Krist, AH; Kurth, AE; Landefeld, CS; LeFevre, M; Mangione, CM; Phillips, WR; Phipps, MG; Pignone, MP; Siu, AL				Bibbins-Domingo, Kirsten; Grossman, David C.; Curry, Susan J.; Davidson, Karina W.; Epling, John W., Jr.; Garcia, Francisco A. R.; Gillman, Matthew W.; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Landefeld, C. Seth; LeFevre, Michael; Mangione, Carol M.; Phillips, William R.; Phipps, Maureen G.; Pignone, Michael P.; Siu, Albert L.		US Preventive Serv Task Force	Screening for Lipid Disorders in Children and Adolescents US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							FAMILIAL HYPERCHOLESTEROLEMIA; DYSLIPIDEMIA; THERAPY; DISEASE; TRENDS; RISK	IMPORTANCE Elevations in levels of total, low-density lipoprotein, and non-high-density lipoprotein cholesterol; lower levels of high-density lipoprotein cholesterol; and, to a lesser extent, elevated triglyceride levels are associated with risk of cardiovascular disease in adults. OBJECTIVE To update the 2007 US Preventive Services Task Force (USPSTF) recommendation on screening for lipid disorders in children, adolescents, and young adults. EVIDENCE REVIEW The USPSTF reviewed the evidence on screening for lipid disorders in children and adolescents 20 years or younger-1 review focused on screening for heterozygous familial hypercholesterolemia, and 1 review focused on screening for multifactorial dyslipidemia. FINDINGS Evidence on the quantitative difference in diagnostic yield between universal and selective screening approaches, the effectiveness and harms of long-term treatment and the harms of screening, and the association between changes in intermediate outcomes and improvements in adult cardiovascular health outcomes are limited. Therefore, the USPSTF concludes that the balance of benefits and harms cannot be determined. CONCLUSIONS AND RECOMMENDATION The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for lipid disorders in children and adolescents 20 years or younger. (I statement)	[Bibbins-Domingo, Kirsten] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Grossman, David C.] Grp Hlth Res Inst, Seattle, WA USA; [Curry, Susan J.] Univ Iowa, Iowa City, IA USA; [Davidson, Karina W.] Columbia Univ, New York, NY USA; [Epling, John W., Jr.] SUNY Upstate Med Univ, Syracuse, NY 13210 USA; [Garcia, Francisco A. R.] Pima Cty Dept Hlth, Tucson, AZ USA; [Gillman, Matthew W.] Harvard Med Sch, Boston, MA USA; [Gillman, Matthew W.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Kemper, Alex R.] Duke Univ, Durham, NC USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA 23284 USA; [Kurth, Ann E.] Yale Univ, New Haven, CT USA; [Landefeld, C. Seth] Univ Alabama Birmingham, Birmingham, AL USA; [LeFevre, Michael] Univ Missouri, Columbia, MO 65211 USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA USA; [Phillips, William R.] Univ Washington, Seattle, WA 98195 USA; [Phipps, Maureen G.] Brown Univ, Providence, RI 02912 USA; [Pignone, Michael P.] Univ Texas Austin, Austin, TX 78712 USA; [Siu, Albert L.] Mt Sinai Sch Med, New York, NY USA; [Siu, Albert L.] James J Peters Vet Affairs Med Ctr, Bronx, NY USA	University of California System; University of California San Francisco; University of Iowa; Columbia University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; Duke University; Virginia Commonwealth University; Yale University; University of Alabama System; University of Alabama Birmingham; University of Missouri System; University of Missouri Columbia; University of California System; University of California Los Angeles; University of Washington; University of Washington Seattle; Brown University; University of Texas System; University of Texas Austin; Icahn School of Medicine at Mount Sinai; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.		Epling, John W/J-1097-2019; Davidson, Karina/GWC-0996-2022; Davidson, Karina/AAG-2388-2019; Phillips, William R./V-1065-2017	Epling, John W/0000-0001-9445-8669; Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Phillips, William R./0000-0003-2802-4349; Kemper, Alex/0000-0001-5491-3997	Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	American Academy of Family Physicians (AAFP), 2007, CLIN PREV SERV REC L; American Academy of Pediatrics (AAP), 2015, REC PREV PED HLTH CA; Barton M, 2010, PEDIATRICS, V125, P361, DOI 10.1542/peds.2009-2037; Calonge N, 2007, PEDIATRICS, V120, pE215, DOI 10.1542/peds.2006-1812; CLARKE WR, 1978, CIRCULATION, V58, P626, DOI 10.1161/01.CIR.58.4.626; Cook Stephen, 2009, J Pediatr, V155, DOI 10.1016/j.jpeds.2009.04.051; Cottrell L, 2013, J OBES, V2013, DOI 10.1155/2013/732579; Eiland Lea S, 2010, J Pediatr Pharmacol Ther, V15, P160; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; GARCIA RE, 1989, PEDIATRICS, V84, P751; Haney EM, 2007, PEDIATRICS, V120, pE189, DOI 10.1542/peds.2006-1801; Joyce N, 2015, J PEDIATR-US, V167, P113, DOI 10.1016/j.jpeds.2015.04.004; Kit BK, 2015, JAMA PEDIATR, V169, P272, DOI 10.1001/jamapediatrics.2014.3216; Kit BK, 2012, JAMA-J AM MED ASSOC, V308, P591, DOI 10.1001/jama.2012.9136; Kusters DM, 2014, JAMA-J AM MED ASSOC, V312, P1055, DOI 10.1001/jama.2014.8892; LAUER RM, 1992, PEDIATRICS, V89, P495; Lozano P, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2016.6423, DOI 10.1001/JAMA.2016]; Lozano P, 2016, AHRQ PUBLICATION, V141; Lozano P, 2016, JAMA-J AM MED ASSOC, V316, P645, DOI 10.1001/jama.2016.6176; Magnussen CG, 2008, CIRCULATION, V117, P32, DOI 10.1161/CIRCULATIONAHA.107.718981; Moyer VA, 2013, PEDIATRICS, V132, P907, DOI 10.1542/peds.2013-2864; Obarzanek E, 1997, PEDIATRICS, V100, P51, DOI 10.1542/peds.100.1.51; Saydah S, 2013, PEDIATRICS, V131, pE679, DOI 10.1542/peds.2012-2583; Setia N, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/658526; SKOVBY F, 1991, ARCH DIS CHILD, V66, P844, DOI 10.1136/adc.66.7.844; SLACK J, 1969, LANCET, V2, P1380; STONE NJ, 1974, CIRCULATION, V49, P476, DOI 10.1161/01.CIR.49.3.476; TAMIR I, 1981, J CHRON DIS, V34, P27, DOI 10.1016/0021-9681(81)90079-5; UK National Screening Committee (UK NSC), 2015, UK NSC REC FAM HYP S; Vinci SR, 2014, JAMA-J AM MED ASSOC, V311, P1804, DOI 10.1001/jama.2014.2410; Vuorio A, 2013, ATHEROSCLEROSIS, V226, P315, DOI 10.1016/j.atherosclerosis.2012.10.032; Wong H, 2013, JAMA PEDIATR, V167, P708, DOI 10.1001/jamapediatrics.2013.1442	32	107	107	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2016	316	6					625	633		10.1001/jama.2016.9852	http://dx.doi.org/10.1001/jama.2016.9852			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7TK	27532917	Bronze			2022-12-28	WOS:000380985600015
J	[Anonymous]				[Anonymous]			The Lipoids ("Fats") of Human Blood (Reprinted from JAMA, vol 67, pg 956, 1916)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Bloor WR, 1916, J BIOL CHEM, V25, P577; Bloor WR, 1916, J BIOL CHEM, V24, P447; 1916, J A M A         0205, P433; 1916, J A M A         0401, P1029; 1916, JAMA, V67, P956	5	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2016	316	6					669	669		10.1001/jama.2015.17097	http://dx.doi.org/10.1001/jama.2015.17097			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7TK	27532933				2022-12-28	WOS:000380985600030
J	Sheridan, RL				Sheridan, Robert L.			Fire-Related Inhalation Injury	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							LOW-TIDAL-VOLUME; SMOKE-INHALATION; BURN PATIENTS; LUNG INJURY; PNEUMONIA; SEVERITY; OUTCOMES		[Sheridan, Robert L.] Shriners Hosp Children, Burn Serv, 51 Blossom St, Boston, MA 02114 USA; [Sheridan, Robert L.] Massachusetts Gen Hosp, Div Burns, Boston, MA 02114 USA; [Sheridan, Robert L.] Harvard Med Sch, Dept Surg, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Sheridan, RL (corresponding author), Shriners Hosp Children, Burn Serv, 51 Blossom St, Boston, MA 02114 USA.	rsheridan@mgh.harvard.edu						Al Ashry HS, 2016, BURNS; Albright JM, 2012, CRIT CARE MED, V40, P1113, DOI 10.1097/CCM.0b013e3182374a67; Anseeuw K, 2013, EUR J EMERG MED, V20, P2, DOI 10.1097/MEJ.0b013e328357170b; Aub JC, 1943, ANN SURG, V117, P834, DOI 10.1097/00000658-194311760-00006; Barillo David J., 1994, Journal of Burn Care and Rehabilitation, V15, P46, DOI 10.1097/00004630-199401000-00010; Bourbeau J, 1996, EUR RESPIR J, V9, P1470, DOI 10.1183/09031936.96.09071470; Buckley NA, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002041.pub3; Carr JA, 2013, EUR J TRAUMA EMERG S, V39, P177, DOI 10.1007/s00068-013-0254-x; Dumestre D, 2014, J BURN CARE RES, V35, pE112, DOI 10.1097/BCR.0b013e31829b3868; Endorf FW, 2007, J BURN CARE RES, V28, P80, DOI 10.1097/BCR.0B013E31802C889F; GAISSERT HA, 1993, ANN SURG, V218, P672, DOI 10.1097/00000658-199321850-00014; Guzman JA, 2012, CRIT CARE CLIN, V28, P537, DOI 10.1016/j.ccc.2012.07.007; Hassan Z, 2010, BURNS, V36, P212, DOI 10.1016/j.burns.2009.06.205; Kashefi NS, 2014, PRS-GLOB OPEN, V2, DOI 10.1097/GOX.0000000000000121; Miller AC, 2014, CRIT CARE MED, V42, P413, DOI 10.1097/CCM.0b013e3182a645e5; Palmieri TL, 2009, J BURN CARE RES, V30, P201, DOI 10.1097/BCR.0b013e3181923e93; Peck MD, 2009, J BURN CARE RES, V30, P172, DOI 10.1097/BCR.0b013e3181923c32; PUTMAN CE, 1977, AM J ROENTGENOL, V129, P865, DOI 10.2214/ajr.129.5.865; Roderique JD, 2015, TOXICOLOGY, V334, P45, DOI 10.1016/j.tox.2015.05.004; Rosenberg M, 2015, BURNS, V41, P721, DOI 10.1016/j.burns.2015.01.013; Ryan CM, 1998, NEW ENGL J MED, V338, P362, DOI 10.1056/NEJM199802053380604; Ryan CM, 2012, CRIT CARE MED, V40, P1345, DOI 10.1097/CCM.0b013e31823c8b2f; Sheridan RL, 1999, J TRAUMA, V47, P426, DOI 10.1097/00005373-199908000-00045; Shiau YC, 2003, ANN NUCL MED, V17, P435, DOI 10.1007/BF03006430; SHIRANI KZ, 1987, ANN SURG, V205, P82, DOI 10.1097/00000658-198701000-00015; Sousse LE, 2015, J AM COLL SURGEONS, V220, P570, DOI 10.1016/j.jamcollsurg.2014.12.028; Spano S, 2016, J BURN CARE RES, V37, P1, DOI 10.1097/BCR.0000000000000320; Veeravagu A, 2015, J BURN CARE RES, V36, P258, DOI 10.1097/BCR.0000000000000064; Yamamura H, 2015, BURNS, V41, P1428, DOI 10.1016/j.burns.2015.06.008	29	42	50	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2016	375	5					464	469		10.1056/NEJMra1601128	http://dx.doi.org/10.1056/NEJMra1601128			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7AN	27518664				2022-12-28	WOS:000380934900010
J	Hey, SP; Kesselheim, AS				Hey, Spencer Phillips; Kesselheim, Aaron S.			Countering imprecision in precision medicine	SCIENCE			English	Editorial Material									[Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, PORTAL, Boston, MA 02120 USA; Harvard Med Sch, Boston, MA 02120 USA; Harvard Med Sch, Ctr Bioeth, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kesselheim, AS (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, PORTAL, Boston, MA 02120 USA.	akesselheim@partners.org	Kesselheim, Aaron/R-6793-2017	Kesselheim, Aaron/0000-0002-8867-2666				Andre F, 2011, NAT REV CLIN ONCOL, V8, P171, DOI 10.1038/nrclinonc.2011.4; Ballman KV, 2015, J CLIN ONCOL, V33, P3968, DOI 10.1200/JCO.2015.63.3651; de Gramont A, 2015, NAT REV CLIN ONCOL, V12, P197, DOI 10.1038/nrclinonc.2014.202; FDA, 2012, GUID IND ENR STRAT C; Febbo PG, 2011, J NATL COMPR CANC NE, V9, pS1, DOI 10.6004/jnccn.2011.0137; Hayes DF, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005950; Hey S. P., 2015, THEORIA, V30; Mallett S, 2010, BRIT J CANCER, V102, P173, DOI 10.1038/sj.bjc.6605462; National Academies of Sciences, 2016, BIOM TESTS MOL TARG; Office of Public Health Strategy and Analysis FDA, 2015, PUBL HLTH EV FDA OV; Sargent DJ, 2005, J CLIN ONCOL, V23, P2020, DOI 10.1200/JCO.2005.01.112; Schmidt Charlie, 2011, J Natl Cancer Inst, V103, P87, DOI 10.1093/jnci/djq557	12	24	24	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					448	449		10.1126/science.aaf5101	http://dx.doi.org/10.1126/science.aaf5101			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS2HC	27471295				2022-12-28	WOS:000380583600023
J	Ntoukakis, V; Gimenez-Ibanez, S				Ntoukakis, Vardis; Gimenez-Ibanez, Selena			Parasitic plants-A CuRe for what ails thee	SCIENCE			English	Editorial Material									[Ntoukakis, Vardis] Univ Warwick, Sch Life Sci, Warwick Integrat Synthet Biol Ctr, Coventry CV4 7AL, W Midlands, England; [Gimenez-Ibanez, Selena] CSIC, Ctr Nacl Biotecnol, Plant Mol Genet Dept, E-28049 Madrid, Spain	University of Warwick; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Ntoukakis, V (corresponding author), Univ Warwick, Sch Life Sci, Warwick Integrat Synthet Biol Ctr, Coventry CV4 7AL, W Midlands, England.	v.ntoukakis@warwick.ac.uk; selena.gimenez@cnb.csic.es	Gimenez-Ibanez, Selena/B-1172-2017; Ntoukakis, Vardis/C-6296-2012	Gimenez-Ibanez, Selena/0000-0002-5453-8565; Ntoukakis, Vardis/0000-0003-0069-6004	Biotechnology and Biological Sciences Research Council [BB/L019345/1] Funding Source: researchfish; BBSRC [BB/L019345/1, BB/M017982/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/M017982/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Gust AA, 2014, CURR OPIN PLANT BIOL, V21, P104, DOI 10.1016/j.pbi.2014.07.007; Hegenauer V, 2016, SCIENCE, V353, P478, DOI 10.1126/science.aaf3919; Huang PY, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00624; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaiser B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00045; Li JX, 2009, SCIENCE, V325, P1094, DOI 10.1126/science.1174754; Patron N, 2015, NEW PHYTOL, V208, P13, DOI 10.1111/nph.13532; Runyon J. B., 2009, AGR REV, V1, P13; Thomma BPHJ, 2011, PLANT CELL, V23, P4, DOI 10.1105/tpc.110.082602; Woo JW, 2015, NAT BIOTECHNOL, V33, P1162, DOI 10.1038/nbt.3389; Yoshida S, 2016, ANNU REV PLANT BIOL, V67, P643, DOI 10.1146/annurev-arplant-043015-111702; Yoshida S, 2009, NEW PHYTOL, V183, P180, DOI 10.1111/j.1469-8137.2009.02840.x; Zipfel C, 2014, TRENDS IMMUNOL, V35, P345, DOI 10.1016/j.it.2014.05.004	13	6	6	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					442	443		10.1126/science.aag3111	http://dx.doi.org/10.1126/science.aag3111			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27471291	Green Submitted			2022-12-28	WOS:000380583600019
J	Pandya, B; Cullen, S; Walker, F				Pandya, Bejal; Cullen, Shay; Walker, Fiona			CLINICAL UPDATES Congenital heart disease in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CARDIOVASCULAR MAGNETIC-RESONANCE; REPAIR; ENDOCARDITIS; PROPHYLAXIS; TETRALOGY		[Pandya, Bejal; Cullen, Shay; Walker, Fiona] St Bartholomews Hosp, Barts Heart Ctr, Grown Up Congenital Heart Dis GUCH Clin, London, England	University of London; Queen Mary University London	Walker, F (corresponding author), St Bartholomews Hosp, Barts Heart Ctr, Grown Up Congenital Heart Dis GUCH Clin, London, England.	fiona.walker@bartshealth.nhs.uk						Chambers JB, 2016, LANCET INFECT DIS, V16, P275, DOI 10.1016/S1473-3099(16)00048-7; Diller GP, 2005, CIRCULATION, V112, P828, DOI 10.1161/CIRCULATIONAHA.104.529800; Gatzoulis MA, 2000, AM J CARDIOL, V86, P1352, DOI 10.1016/S0002-9149(00)01241-8; Gatzoulis MA, 2000, LANCET, V356, P975, DOI 10.1016/S0140-6736(00)02714-8; HANLEY FL, 1993, J THORAC CARDIOV SUR, V106, P387; Kilner PJ, 2010, EUR HEART J, V31, P794, DOI 10.1093/eurheartj/ehp586; Kutty S, 2012, AM J CARDIOL, V109, P1348, DOI 10.1016/j.amjcard.2011.12.031; Oechslin E, 2010, CURR CARDIOL REV, V6, P363, DOI 10.2174/157340310793566127; Owen Andrew R., 2000, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V3, P216; Pennell DJ, 2004, EUR HEART J, V25, P1940, DOI 10.1016/j.ehj.2004.06.040; Public Health England, 2016, MED RAD US DOS MEAS; Regitz-Zagrosek V, 2011, EUR HEART J, V32, P3147, DOI 10.1093/eurheartj/ehr218; Stokes T, 2008, HEART, V94, P930, DOI 10.1136/hrt.2008.147090; Thorne S, 2006, HEART, V92, P1520, DOI 10.1136/hrt.2006.095240; Thornhill Martin H, 2011, BMJ, V342, pd2392, DOI 10.1136/bmj.d2392	15	6	6	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2016	354								i3905	10.1136/bmj.i3905	http://dx.doi.org/10.1136/bmj.i3905			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS6ZO	27470314				2022-12-28	WOS:000380932300003
J	Chen, CK; Blanco, M; Jackson, C; Aznauryan, E; Ollikainen, N; Surka, C; Chow, A; Cerase, A; McDonel, P; Guttman, M				Chen, Chun-Kan; Blanco, Mario; Jackson, Constanza; Aznauryan, Erik; Ollikainen, Noah; Surka, Christine; Chow, Amy; Cerase, Andrea; McDonel, Patrick; Guttman, Mitchell			Xist recruits the X chromosome to the nuclear lamina to enable chromosome-wide silencing	SCIENCE			English	Article							FACULTATIVE HETEROCHROMATIN; RNA; INACTIVATION; GENOME; CELLS; LOCALIZATION; MOTION; GENES	The Xist long noncoding RNA orchestrates X chromosome inactivation, a process that entails chromosome-wide silencing and remodeling of the three-dimensional (3D) structure of the X chromosome. Yet, it remains unclear whether these changes in nuclear structure are mediated by Xist and whether they are required for silencing. Here, we show that Xist directly interacts with the Lamin B receptor, an integral component of the nuclear lamina, and that this interaction is required for Xist-mediated silencing by recruiting the inactive X to the nuclear lamina and by doing so enables Xist to spread to actively transcribed genes across the X. Our results demonstrate that lamina recruitment changes the 3D structure of DNA, enabling Xist and its silencing proteins to spread across the X to silence transcription.	[Chen, Chun-Kan; Blanco, Mario; Jackson, Constanza; Aznauryan, Erik; Ollikainen, Noah; Surka, Christine; Chow, Amy; Guttman, Mitchell] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Cerase, Andrea] European Mol Biol Lab Monterotondo, Via Ramarini 32, I-00015 Monterotondo, RM, Italy; [McDonel, Patrick] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01655 USA	California Institute of Technology; European Molecular Biology Laboratory (EMBL); University of Massachusetts System; University of Massachusetts Worcester	Guttman, M (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	mguttman@caltech.edu	Cerase, Andrea/P-4741-2016	Cerase, Andrea/0000-0002-1985-2049	NIH National Research Service Award [T32GM07616]; New York Stem Cell Foundation; NIH Director's Early Independence Award [DP5OD012190]; Edward Mallinckrodt Foundation; Sontag Foundation; Searle Scholars Program; Pew-Steward Scholars program; California Institute of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER	NIH National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York Stem Cell Foundation; NIH Director's Early Independence Award; Edward Mallinckrodt Foundation; Sontag Foundation; Searle Scholars Program; Pew-Steward Scholars program; California Institute of Technology; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. Plath for extensive discussions; A. Collazo for microscopy help; A. Shur, P. Quintero, and V. Grishkevich for technical help; M. Lai for analytical help; J. Engreitz, S. Quinodoz, M. Garber, I. Amit, and J. Rinn for comments on the manuscript; and S. Knemeyer for illustrations. Imaging was performed in the Biological Imaging Facility, and sequencing was performed in the Millard and Muriel Jacobs Genetics and Genomics Laboratory at the California Institute of Technology. C.-K.C. is supported by a NIH National Research Service Award training grant (T32GM07616). This research was funded by the New York Stem Cell Foundation, a NIH Director's Early Independence Award (DP5OD012190), the Edward Mallinckrodt Foundation, Sontag Foundation, Searle Scholars Program, Pew-Steward Scholars program, and funds from the California Institute of Technology. M.G. is a New York Stem Cell Foundation-Robertson Investigator. Sequencing data are available online from the National Center for Biotechnology Information Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo) accession no. GSE80510 (RAP data) and GSE86250 (CLIP data), and additional data and information are available at www.lncRNA.caltech.edu/data.php.	Baron-Benhamou Julie, 2004, Methods Mol Biol, V257, P135, DOI 10.1385/1-59259-750-5:135; Buxbaum AR, 2015, NAT REV MOL CELL BIO, V16, P95, DOI 10.1038/nrm3918; Chaumeil J, 2006, GENE DEV, V20, P2223, DOI 10.1101/gad.380906; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Clemson CM, 2006, P NATL ACAD SCI USA, V103, P7688, DOI 10.1073/pnas.0601069103; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Galupa R, 2015, CURR OPIN GENET DEV, V31, P57, DOI 10.1016/j.gde.2015.04.002; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Kind J, 2010, CURR OPIN CELL BIOL, V22, P320, DOI 10.1016/j.ceb.2010.04.002; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; Minajigi A, 2015, SCIENCE, V349, DOI [10.1126/science.aab2276, 10.1126/science.aab2276 aab2276]; Moindrot B, 2015, CELL REP, V12, P562, DOI 10.1016/j.celrep.2015.06.053; Monfort A, 2015, CELL REP, V12, P554, DOI 10.1016/j.celrep.2015.06.067; Pombo A, 2015, NAT REV MOL CELL BIO, V16, P245, DOI 10.1038/nrm3965; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Rego A, 2008, J CELL SCI, V121, P1119, DOI 10.1242/jcs.026104; Simon MD, 2013, NATURE, V504, P465, DOI 10.1038/nature12719; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Wutz A, 2002, NAT GENET, V30, P167, DOI 10.1038/ng820; Wutz A, 2011, NAT REV GENET, V12, P542, DOI 10.1038/nrg3035	24	159	168	1	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 28	2016	354	6311					468	472		10.1126/science.aae0047	http://dx.doi.org/10.1126/science.aae0047			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB9AT	27492478				2022-12-28	WOS:000387684400042
J	Gunderman, R				Gunderman, Richard			Hospitalists and the Decline of Comprehensive Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gunderman, Richard] Indiana Univ Sch Med, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Gunderman, R (corresponding author), Indiana Univ Sch Med, Indianapolis, IN 46202 USA.							Bryant DC, 1999, J GEN INTERN MED, V14, P182, DOI 10.1046/j.1525-1497.1999.00310.x; Meltzer D, 2001, J LEGAL STUD, V30, P589, DOI 10.1086/339294; Pham HH, 2008, HEALTH AFFAIR, V27, P1315, DOI 10.1377/hlthaff.27.5.1315; Taub Ben, 2016, NEW YORKER	4	13	14	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2016	375	11					1011	1013		10.1056/NEJMp1608289	http://dx.doi.org/10.1056/NEJMp1608289			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DV6ZG	27509007	Green Published			2022-12-28	WOS:000383085000002
J	He, R; Hou, SY; Liu, C; Zhang, AL; Bai, Q; Han, M; Yang, Y; Wei, G; Shen, T; Yang, XX; Xu, LF; Chen, XY; Hao, YX; Wang, PC; Zhu, CH; Ou, JJ; Liang, HJ; Ni, T; Zhang, XY; Zhou, XY; Deng, K; Chen, YK; Luo, YD; Xu, JQ; Qi, H; Wu, YZ; Ye, LL				He, Ran; Hou, Shiyue; Liu, Cheng; Zhang, Anli; Bai, Qiang; Han, Miao; Yang, Yu; Wei, Gang; Shen, Ting; Yang, Xinxin; Xu, Lifan; Chen, Xiangyu; Hao, Yaxing; Wang, Pengcheng; Zhu, Chuhong; Ou, Juanjuan; Liang, Houjie; Ni, Ting; Zhang, Xiaoyan; Zhou, Xinyuan; Deng, Kai; Chen, Yaokai; Luo, Yadong; Xu, Jianqing; Qi, Hai; Wu, Yuzhang; Ye, Lilin			Follicular CXCR5-expressing CD8(+) T cells curtail chronic viral infection	NATURE			English	Article							IN-VIVO; DIFFERENTIATION; TRANSCRIPTION; EXHAUSTION; HIV-1; REPLICATION; TOLERANCE; ROLES; FH	During chronic viral infection, virus-specific CD8(+) T cells become exhausted, exhibit poor effector function and lose memory potential(1-4). However, exhausted CD8(+) T cells can still contain viral replication in chronic infections(5-9), although the mechanism of this containment is largely unknown. Here we show that a subset of exhausted CD8(+) T cells expressing the chemokine receptor CXCR5 has a critical role in the control of viral replication in mice that were chronically infected with lymphocytic choriomeningitis virus (LCMV). These CXCR5(+) CD8(+) T cells were able to migrate into B-cell follicles, expressed lower levels of inhibitory receptors and exhibited more potent cytotoxicity than the CXCR5(+) subset. Furthermore, we identified the Id2-E2A signalling axis as an important regulator of the generation of this subset. In patients with HIV, we also identified a virus-specific CXCR5(+) CD8(+) T-cell subset, and its number was inversely correlated with viral load. The CXCR5(+) subset showed greater therapeutic potential than the CXCR5(+) subset when adoptively transferred to chronically infected mice, and exhibited synergistic reduction of viral load when combined with anti-PD-L1 treatment. This study defines a unique subset of exhausted CD8(+) T cells that has a pivotal role in the control of viral replication during chronic viral infection.	[He, Ran; Liu, Cheng; Bai, Qiang; Yang, Xinxin; Xu, Lifan; Chen, Xiangyu; Hao, Yaxing; Wang, Pengcheng; Zhou, Xinyuan; Wu, Yuzhang; Ye, Lilin] Third Mil Med Univ, Inst Immunol, Chongqing 400038, Peoples R China; [Hou, Shiyue; Qi, Hai] Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Lab Dynam Immunobiol, Beijing 100084, Peoples R China; [Zhang, Anli; Yang, Yu; Zhang, Xiaoyan; Xu, Jianqing] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 201508, Peoples R China; [Zhang, Anli; Yang, Yu; Zhang, Xiaoyan; Xu, Jianqing] Fudan Univ, Inst Biomed Sci, Shanghai 201508, Peoples R China; [Han, Miao; Wei, Gang; Shen, Ting; Ni, Ting] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, State Key Lab Genet Engn, Shanghai 200438, Peoples R China; [Han, Miao; Wei, Gang; Shen, Ting; Ni, Ting] Fudan Univ, Sch Life Sci, Collaborat Innovat Ctr Genet & Dev, MOE Key Lab Contemporary Anthropol, Shanghai 200438, Peoples R China; [Zhu, Chuhong] Third Mil Med Univ, Sch Basic Med, Dept Anat, Chongqing 400038, Peoples R China; [Ou, Juanjuan; Liang, Houjie] Third Mil Med Univ, Southwestern Hosp, Dept Oncol, Chongqing 400038, Peoples R China; [Deng, Kai] Sun Yat Sen Univ, Inst Human Virol, Zhongshan Sch Med, Guangzhou 510080, Guangdong, Peoples R China; [Chen, Yaokai; Luo, Yadong] Chongqing Publ Hlth Med Ctr, Chongqing 400000, Peoples R China	Army Medical University; Tsinghua University; Fudan University; Fudan University; Fudan University; Fudan University; Army Medical University; Army Medical University; Sun Yat Sen University	Wu, YZ; Ye, LL (corresponding author), Third Mil Med Univ, Inst Immunol, Chongqing 400038, Peoples R China.; Qi, H (corresponding author), Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Lab Dynam Immunobiol, Beijing 100084, Peoples R China.	qihai@mail.tsinghua.edu.cn; wuyuzhang@tmmu.edu.cn; yelilinlcmv@tmmu.edu.cn	Luo, Yadong/ABE-6518-2020; Zhou, Xinyuan/AFS-9817-2022; Deng, Kai/AAK-4404-2020; BAI, Qiang/O-1069-2019	Deng, Kai/0000-0002-9973-8130; BAI, Qiang/0000-0001-7423-0712; Chen, Xiangyu/0000-0001-7947-3211; Zhou, Xinyuan/0000-0002-1374-8240; Ye, Lilin/0000-0003-0778-3311; Qi, Hai/0000-0001-5475-3989; Wu, Yuzhang/0000-0002-4049-0214; ZHANG, ANLI/0000-0001-7847-6541; Xu, Jianqing/0000-0003-0896-9273	National Basic Research Program of China (973 program) [2013CB531500, 2014CB542501]; National Natural Science Foundation of China [81220108024, 81471624, U1202228, 81425011, 81330070, 31500733]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank R. Ahmed (Emory University) for providing the P14 TCR transgenic mice, retroviral vectors and LCMV Armstrong and Cl13 viruses; Y. Zhuang (Duke University) for providing the Id2<SUP>fl/fl</SUP> mice; the core facility centre of Third Military Medical University for helping us with cell sorting; T. Wu (NIH) for insightful discussion. The work was supported by National Basic Research Program of China (973 program, 2013CB531500, to L.Y.; 2014CB542501 to H.Q.), the National Natural Science Foundation of China (81220108024 to Y.W.; 81471624 to L.Y.; U1202228 to J.X.; No. 81425011, 81330070 to H.Q.; No. 31500733 to Q.B).	Banga R, 2016, NAT MED, V22, P754, DOI 10.1038/nm.4113; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Belle I, 2014, CURR TOP DEV BIOL, V110, P153, DOI [10.1016/B978-0-12-405943-6.00003-4-X, 10.1016/B978-0-12-405943-6.00004-X]; Connick E, 2007, J IMMUNOL, V178, P6975, DOI 10.4049/jimmunol.178.11.6975; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Cyster JG, 2000, IMMUNOL REV, V176, P181; Deng K, 2015, NATURE, V517, P381, DOI 10.1038/nature14053; Freeman GJ, 2006, J EXP MED, V203, P2223, DOI 10.1084/jem.20061800; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; Fuller MJ, 2013, P NATL ACAD SCI USA, V110, P15001, DOI 10.1073/pnas.1312772110; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Jones RB, 2016, J CLIN INVEST, V126, P455, DOI 10.1172/JCI80566; Kim HJ, 2011, SEMIN IMMUNOL, V23, P446, DOI 10.1016/j.smim.2011.06.001; Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370; Kim PS, 2010, CURR OPIN IMMUNOL, V22, P223, DOI 10.1016/j.coi.2010.02.005; McCausland MM, 2008, J VIROL METHODS, V147, P167, DOI 10.1016/j.jviromet.2007.08.025; Miles B, 2016, TRENDS MICROBIOL, V24, P338, DOI 10.1016/j.tim.2016.02.006; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Quigley MF, 2007, EUR J IMMUNOL, V37, P3352, DOI 10.1002/eji.200636746; Rasheed MAU, 2013, J VIROL, V87, P7737, DOI 10.1128/JVI.00063-13; Schietinger A, 2014, TRENDS IMMUNOL, V35, P51, DOI 10.1016/j.it.2013.10.001; Shaw LA, 2016, NAT IMMUNOL, V17, P834, DOI 10.1038/ni.3461; Speiser DE, 2014, NAT REV IMMUNOL, V14, P768, DOI 10.1038/nri3740; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Verdeil G., 2015, BIOCH BIOPHYS ACTA; Vezys V, 2006, J EXP MED, V203, P2263, DOI 10.1084/jem.20060995; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Xu LF, 2015, NAT IMMUNOL, V16, P991, DOI 10.1038/ni.3229; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zehn D, 2016, CURR OPIN VIROL, V16, P49, DOI 10.1016/j.coviro.2016.01.002; Zhong Silin, 2011, Cold Spring Harb Protoc, V2011, P940, DOI 10.1101/pdb.prot5652; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	37	360	370	5	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2016	537	7620					412	+		10.1038/nature19317	http://dx.doi.org/10.1038/nature19317			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV7EC	27501245				2022-12-28	WOS:000383098000056
J	Gunderson, EP				Gunderson, Erica P.		Women Infant Feeding Type 2 Diabet	Lactation and Progression to Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter							SWIFT; WOMEN; GDM		[Gunderson, Erica P.] Kaiser Permanente Northern Calif, Oakland, CA 94611 USA	Kaiser Permanente	Gunderson, EP (corresponding author), Kaiser Permanente Northern Calif, Oakland, CA 94611 USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050625] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD050625] Funding Source: Medline; NIDDK NIH HHS [R01 DK106201] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Food and Agriculture Organization of the United Nations World Health Organization & UNU, 2001, FOOD NUTR TECHN REP; Gunderson EP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-952; Gunderson EP, 2012, DIABETES CARE, V35, P50, DOI 10.2337/dc11-1409; Otten J.J., 2006, DIETARY REFERENCE IN, DOI DOI 10.17226/11537; Piper S, 2001, J Hum Lact, V17, P227, DOI 10.1177/089033440101700306	5	4	4	1	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					299	300		10.7326/L16-0106	http://dx.doi.org/10.7326/L16-0106			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UI	27538169	Green Accepted			2022-12-28	WOS:000381267200028
J	Hankey, GJ				Hankey, Graeme J.			The ability of the ABCD(2) score to predict stroke 1 year after TIA or minor stroke was assessed	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Hankey, Graeme J.] Univ Western Australia, Perth, WA, Australia	University of Western Australia	Hankey, GJ (corresponding author), Univ Western Australia, Perth, WA, Australia.		Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328				Wardlaw JM, 2015, NEUROLOGY, V85, P373, DOI 10.1212/WNL.0000000000001780	1	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					JC23	JC23		10.7326/ACPJC-2016-165-4-023	http://dx.doi.org/10.7326/ACPJC-2016-165-4-023			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UI	27538184				2022-12-28	WOS:000381267200010
J	Smith, KR; Woodward, A; Lemke, B; Otto, M; Chang, CJ; Mance, AA; Balmes, J; Kjellstrom, T				Smith, Kirk R.; Woodward, Alistair; Lemke, Bruno; Otto, Matthias; Chang, Cindy J.; Mance, Anna A.; Balmes, John; Kjellstrom, Tord			The last Summer Olympics? Climate change, health, and work outdoors	LANCET			English	Editorial Material									[Smith, Kirk R.; Mance, Anna A.; Balmes, John] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Woodward, Alistair] Univ Auckland, Sch Populat Hlth, Auckland, New Zealand; [Lemke, Bruno; Otto, Matthias] Nelson Marlborough Inst Technol, Digital Technol, Nelson, New Zealand; [Chang, Cindy J.] Univ Calif San Francisco, Dept Orthopaed, San Francisco, CA 94143 USA; [Chang, Cindy J.] Univ Calif San Francisco, Dept Family & Community Med, San Francisco, CA 94143 USA; [Kjellstrom, Tord] Ctr Technol Res & Innovat, Limassol, Cyprus	University of California System; University of California Berkeley; University of Auckland; Nelson Marlborough Institute of Technology; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Smith, KR (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	krksmith@berkeley.edu	Balmes, John/L-6281-2019	Mance, Anna/0000-0001-8658-7866				[Anonymous], 2014, HUMAN THERMAL ENV EF; [Anonymous], 2016, CLIM CHANG LAB IMP H; [Anonymous], 2016, TS3 23 CLIM RES UN T; Baxter K., 2016, LOS ANGELES TIMES; Brinkoff T., 2010, CITY POPULATION STAT; Butler SL, 2016, RUNNERS WORLD; Davey M., 2007, NY TIMES, pA1; Dunne JP, 2013, J CLIMATE, V26, P2247, DOI 10.1175/JCLI-D-12-00150.1; Jones CD, 2011, GEOSCI MODEL DEV, V4, P543, DOI 10.5194/gmd-4-543-2011; King D., 2015, CLIMATE CHANGE RISK; Kjellstrom T, 2016, ASIA-PAC J PUBLIC HE, V28, p28S, DOI 10.1177/1010539514568711; Kjellstrom T, 2009, GLOBAL HEALTH ACTION, V2, DOI [10.3402/gha.v2i0.1958, 10.3402/gha.v2i0.2047]; Meade RD, 2016, MED SCI SPORT EXER, V48, P1187, DOI 10.1249/MSS.0000000000000886; Roberts WO, 2010, MED SCI SPORT EXER, V42, P226, DOI 10.1249/MSS.0b013e3181b1cdcf; Scott D, 2014, FUTURE WINTER OLYMPI; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Virgin C, 2016, VIRGIN RUNNING US MA; Woodward A, 2014, LANCET, V383, P1185, DOI 10.1016/S0140-6736(14)60576-6	18	38	38	1	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 13	2016	388	10045					642	644		10.1016/S0140-6736(16)31335-6	http://dx.doi.org/10.1016/S0140-6736(16)31335-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT1UX	27533426				2022-12-28	WOS:000381268700008
J	Fan, J; Leroux-Coyau, M; Avery, NJS; Strick, TR				Fan, Jun; Leroux-Coyau, Mathieu; Avery, Nigel J. S.; Strick, Terence R.			Reconstruction of bacterial transcription-coupled repair at single-molecule resolution	NATURE			English	Article							RNA-POLYMERASE; DNA-REPAIR; ESCHERICHIA-COLI; STRUCTURAL BASIS; NANOMANIPULATION; INITIATION; COMPLEXES; EXCINUCLEASE; MECHANISM; DAMAGE	Escherichia coli Mfd translocase enables transcription-coupled repair by displacing RNA polymerase (RNAP) stalled on a DNA lesion and then coordinating assembly of the UvrAB(C) components at the damage site(1-4.) Recent studies have shown that after binding to and dislodging stalled RNAP, Mfd remains on the DNA in the form of a stable, slowly translocating complex with evicted RNAP attached(5,6). Here we find, using a series of single-molecule assays, that recruitment of UvrA and UvrAB to Mfd-RNAP arrests the translocating complex and causes its dissolution. Correlative single-molecule nanomanipulation and fluorescence measurements show that dissolution of the complex leads to loss of both RNAP and Mfd. Subsequent DNA incision by UvrC is faster than when only UvrAB(C) are available, in part because UvrAB binds 20-200 times more strongly to Mfd-RNAP than to DNA damage. These observations provide a quantitative framework for comparing complementary DNA repair pathways in vivo.	[Fan, Jun; Leroux-Coyau, Mathieu; Strick, Terence R.] Univ Paris Diderot, CNRS, Inst Jacques Monod, Sorbonne Paris Cite,UMR7592, F-75205 Paris, France; [Avery, Nigel J. S.] Univ Bristol, Sch Biochem, DNA Prot Interact Unit, Bristol BS8 1TD, Avon, England; [Strick, Terence R.] PSL Res Univ, Ecole Normale Super, INSERM, CNRS,IBENS, F-75005 Paris, France; [Strick, Terence R.] Programme Equipe Labellisees Ligue Contre Canc, F-75013 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University of Bristol; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Strick, TR (corresponding author), Univ Paris Diderot, CNRS, Inst Jacques Monod, Sorbonne Paris Cite,UMR7592, F-75205 Paris, France.; Strick, TR (corresponding author), PSL Res Univ, Ecole Normale Super, INSERM, CNRS,IBENS, F-75005 Paris, France.; Strick, TR (corresponding author), Programme Equipe Labellisees Ligue Contre Canc, F-75013 Paris, France.	strick@biologie.ens.fr		Strick, Terence/0000-0003-1744-3679; Savery, Nigel/0000-0002-0803-4075; FAN, Jun/0000-0002-1433-7283; Leroux-Coyau, Mathieu/0000-0002-8299-7961	China Scholarship Council; French Agence Nationale pour la Recherche (RepOne); European Science Foundation (EURYI); CNRS; University of Paris Diderot	China Scholarship Council(China Scholarship Council); French Agence Nationale pour la Recherche (RepOne)(French National Research Agency (ANR)); European Science Foundation (EURYI)(European Science Foundation (ESF)); CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Paris Diderot	This work was made possible by a China Scholarship Council award to J.F., as well as grants from the French Agence Nationale pour la Recherche (RepOne) and the European Science Foundation (EURYI) to T.R.S., as well as core funding from the CNRS and the University of Paris Diderot. The Strick laboratory is also part of the Programme Equipe Labellisees of the Ligue Contre le Cancer. We thank N. Joly for assistance with protein purification and the Strick laboratory for feedback.	Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; Duboc C, 2016, METHODS, V105, P56, DOI 10.1016/j.ymeth.2016.03.028; Graves ET, 2015, NAT STRUCT MOL BIOL, V22, P452, DOI 10.1038/nsmb.3019; Haines NM, 2014, P NATL ACAD SCI USA, V111, P4037, DOI 10.1073/pnas.1322350111; Howan K, 2012, NATURE, V490, P431, DOI 10.1038/nature11430; Kou SC, 2005, J PHYS CHEM B, V109, P19068, DOI 10.1021/jp051490q; Manelyte L, 2010, MOL CELL, V40, P714, DOI 10.1016/j.molcel.2010.11.012; Manelyte L, 2009, DNA REPAIR, V8, P1300, DOI 10.1016/j.dnarep.2009.08.005; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Revyakin A, 2005, NAT METHODS, V2, P127, DOI 10.1038/nmeth0205-127; Revyakin A, 2004, P NATL ACAD SCI USA, V101, P4776, DOI 10.1073/pnas.0307241101; Revyakin A, 2003, METHOD ENZYMOL, V370, P577; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Savery NJ, 2007, TRENDS MICROBIOL, V15, P326, DOI 10.1016/j.tim.2007.05.005; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELBY CP, 1990, MUTAT RES, V236, P203, DOI 10.1016/0921-8777(90)90005-P; Smith AJ, 2007, NUCLEIC ACIDS RES, V35, P1802, DOI 10.1093/nar/gkm019; Smith AJ, 2005, NUCLEIC ACIDS RES, V33, P755, DOI 10.1093/nar/gki225; Srivastava DB, 2011, J MOL BIOL, V406, P275, DOI 10.1016/j.jmb.2010.12.004; Strick TR, 1996, SCIENCE, V271, P1835, DOI 10.1126/science.271.5257.1835; Taniguchi Y, 2010, SCIENCE, V329, P533, DOI 10.1126/science.1188308; van den Broek B, 2005, NUCLEIC ACIDS RES, V33, P2676, DOI 10.1093/nar/gki565; VANHOUTEN B, 1987, J BIOL CHEM, V262, P13180; Verhoeven EEA, 2001, EMBO J, V20, P601, DOI 10.1093/emboj/20.3.601; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902; Westblade LF, 2010, NUCLEIC ACIDS RES, V38, P8357, DOI 10.1093/nar/gkq692; WITKIN EM, 1966, SCIENCE, V152, P1345, DOI 10.1126/science.152.3727.1345	28	59	59	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					234	+		10.1038/nature19080	http://dx.doi.org/10.1038/nature19080			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27487215	Green Submitted			2022-12-28	WOS:000381472100041
J	Germain, DP; Hughes, DA; Nicholls, K; Bichet, DG; Giugliani, R; Wilcox, WR; Feliciani, C; Shankar, SP; Ezgu, F; Amartino, H; Bratkovic, D; Feldt-Rasmussen, U; Nedd, K; El Din, US; Lourenco, CM; Banikazemi, M; Charrow, J; Dasouki, M; Finegold, D; Giraldo, P; Goker-Alpan, O; Longo, N; Scott, CR; Torra, R; Tuffaha, A; Jovanovic, A; Waldek, S; Packman, S; Ludington, E; Viereck, C; Kirk, J; Yu, J; Benjamin, ER; Johnson, F; Lockhart, DJ; Skuban, N; Castelli, J; Barth, J; Barlow, C; Schiffmann, R				Germain, D. P.; Hughes, D. A.; Nicholls, K.; Bichet, D. G.; Giugliani, R.; Wilcox, W. R.; Feliciani, C.; Shankar, S. P.; Ezgu, F.; Amartino, H.; Bratkovic, D.; Feldt-Rasmussen, U.; Nedd, K.; El Din, U. Sharaf; Lourenco, C. M.; Banikazemi, M.; Charrow, J.; Dasouki, M.; Finegold, D.; Giraldo, P.; Goker-Alpan, O.; Longo, N.; Scott, C. R.; Torra, R.; Tuffaha, A.; Jovanovic, A.; Waldek, S.; Packman, S.; Ludington, E.; Viereck, C.; Kirk, J.; Yu, J.; Benjamin, E. R.; Johnson, F.; Lockhart, D. J.; Skuban, N.; Castelli, J.; Barth, J.; Barlow, C.; Schiffmann, R.			Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ENZYME REPLACEMENT THERAPY; AGALSIDASE BETA TREATMENT; NATURAL-HISTORY DATA; ALPHA-GALACTOSIDASE; GASTROINTESTINAL SYMPTOMS; NEPHROPATHY; PROGRESSION; PREVALENCE; EVENTS; SAFETY	BACKGROUND Fabry's disease, an X-linked disorder of lysosomal alpha-galactosidase deficiency, leads to substrate accumulation in multiple organs. Migalastat, an oral pharmacologic chaperone, stabilizes specific mutant forms of alpha-galactosidase, increasing enzyme trafficking to lysosomes. METHODS The initial assay of mutant alpha-galactosidase forms that we used to categorize 67 patients with Fabry's disease for randomization to 6 months of double-blind migalastat or placebo (stage 1), followed by open-label migalastat from 6 to 12 months (stage 2) plus an additional year, had certain limitations. Before unblinding, a new, validated assay showed that 50 of the 67 participants had mutant alpha-galactosidase forms suitable for targeting by migalastat. The primary end point was the percentage of patients who had a response (>= 50% reduction in the number of globotriaosylceramide inclusions per kidney interstitial capillary) at 6 months. We assessed safety along with disease substrates and renal, cardiovascular, and patient-reported outcomes. RESULTS The primary end-point analysis, involving patients with mutant alpha-galactosidase forms that were suitable or not suitable for migalastat therapy, did not show a significant treatment effect: 13 of 32 patients (41%) who received migalastat and 9 of 32 patients (28%) who received placebo had a response at 6 months (P = 0.30). Among patients with suitable mutant alpha-galactosidase who received migalastat for up to 24 months, the annualized changes from baseline in the estimated glomerular filtration rate (GFR) and measured GFR were -0.30 +/- 0.66 and -1.51 +/- 1.33 ml per minute per 1.73 m(2) of body-surface area, respectively. The left-ventricular-mass index decreased significantly from baseline (-7.7 g per square meter; 95% confidence interval [CI], -15.4 to -0.01), particularly when left ventricular hypertrophy was present (-18.6 g per square meter; 95% CI, -38.2 to 1.0). The severity of diarrhea, reflux, and indigestion decreased. CONCLUSIONS Among all randomly assigned patients (with mutant alpha-galactosidase forms that were suitable or not suitable for migalastat therapy), the percentage of patients who had a response at 6 months did not differ significantly between the migalastat group and the placebo group. (Funded by Amicus Therapeutics; ClinicalTrials.gov numbers, NCT00925301 [study AT1001-011] and NCT01458119 [study AT1001-041].)	[Germain, D. P.] Paris Saclay Univ, Univ Versailles, Div Med Genet, Versailles, France; [Germain, D. P.] AP HP, Paris, France; [Hughes, D. A.] Royal Free & Univ Coll, Sch Med, Dept Acad Haematol, London, England; [Jovanovic, A.] Salford Royal NHS Fdn Trust, Salford, Lancs, England; [Waldek, S.] Univ Sunderland, Sunderland, England; [Nicholls, K.] Royal Melbourne Hosp, Dept Nephrol, Parkville, Vic, Australia; [Bratkovic, D.] Womens & Childrens Hosp, Metab Clin, Adelaide, SA, Australia; [Bichet, D. G.] Hop Sacre Coeur, Div Clin Res, Montreal, PQ H4J 1C5, Canada; [Giugliani, R.] Clin Hosp Porto Alegre, Med Genet Serv, Porto Alegre, RS, Brazil; [Lourenco, C. M.] Univ Sao Paulo, Fac Med, Hosp Clin, Ribeirao Preto, Brazil; [Wilcox, W. R.; Shankar, S. P.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA USA; [Shankar, S. P.] Emory Univ, Sch Med, Dept Ophthalmol, Atlanta, GA 30322 USA; [Feliciani, C.] Univ Parma, Dermatol Unit, Parma, Italy; [Ezgu, F.] Gazi Univ, Dept & Lab Pediat Metab Disorders, Fac Med, Ankara, Turkey; [Amartino, H.] Hosp Aleman, Dept Pediat, Buenos Aires, DF, Argentina; [Feldt-Rasmussen, U.] Copenhagen Univ Hosp, Rigshosp, Dept Med Endocrinol, Copenhagen, Denmark; [Nedd, K.] Infus Associates, Grand Rapids, MI USA; [El Din, U. Sharaf] Kasr El Ainy Hosp, Fac Med, Cairo, Egypt; [Banikazemi, M.] New York Presbyterian Hosp, New York, NY USA; [Charrow, J.] Ann & Robert H Lurie Childrens Hosp Chicago, Div Genet, Chicago, IL 60611 USA; [Charrow, J.] Northwestern Univ, Sch Med, Chicago, IL USA; [Dasouki, M.; Tuffaha, A.] Univ Kansas, Med Ctr, Dept Urol, Kansas City, KS 66103 USA; [Finegold, D.] Childrens Hosp Pittsburgh, Pittsburgh, PA 15213 USA; [Giraldo, P.] Hosp Miguel Servet, Zaragoza, Spain; [Torra, R.] Univ Autonoma Barcelona, Fundacio Puigvert, E-08193 Barcelona, Spain; [Goker-Alpan, O.] O&O Alpan, Springfield, VA USA; [Longo, N.] Univ Utah Hosp & Clin, Dept Pediat Genet, Salt Lake City, UT USA; [Scott, C. R.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Packman, S.; Schiffmann, R.] Univ Calif San Francisco, Div Pediat, San Francisco, CA 94143 USA; [Ludington, E.] Agil Clin, Carlsbad, CA USA; [Lockhart, D. J.] TranscripTx, Sunnyvale, CA USA; [Barlow, C.] Parkinsons Inst & Clin Ctr, Sunnyvale, CA USA; [Viereck, C.; Kirk, J.; Yu, J.; Benjamin, E. R.; Johnson, F.; Skuban, N.; Castelli, J.; Barth, J.] Amicus Therapeut, Cranbury, NJ USA; [Schiffmann, R.] Baylor Res Inst, Inst Metab Dis, Dallas, TX USA	UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); University of London; University College London; UCL Medical School; Salford Royal NHS Foundation Trust; University of Sunderland; Royal Melbourne Hospital; Universite de Montreal; Universidade de Sao Paulo; Emory University; Emory University; University of Parma; Gazi University; Hospital Aleman; University of Buenos Aires; Rigshospitalet; University of Copenhagen; NewYork-Presbyterian Hospital; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; University of Kansas; University of Kansas Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Miguel Servet University Hospital; Autonomous University of Barcelona; Fundacio Puigvert; Utah System of Higher Education; University of Utah; University of Utah Hospital; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; Baylor Scott & White Health; Baylor University Medical Center	Germain, DP (corresponding author), Paris Saclay Univ, Univ Versailles, UMR U1179, Div Med Genet, 2 Ave Source Bievre, F-78180 Montigny, France.	dominique.germain@uvsq.fr	GERMAIN, Dominique P./AAD-6747-2020; Nicholls, Kathleen/N-5002-2017; Torra, Roser/A-9983-2008; hughes, derralynn/J-8012-2013	BICHET, DANIEL-G/0000-0003-2856-6850; Nicholls, Kathleen/0000-0002-1297-8722; Torra, Roser/0000-0001-8714-2332; hughes, derralynn/0000-0003-4531-9173; GERMAIN, Dominique/0000-0002-8355-007X; feliciani, claudio/0000-0003-0883-3210	Amicus Therapeutics; Novo Nordisk Fonden [NNF15OC0014622] Funding Source: researchfish	Amicus Therapeutics; Novo Nordisk Fonden(Novo Nordisk Foundation)	Funded by Amicus Therapeutics; ClinicalTrials.gov numbers, NCT00925301 [study AT1001-011] and NCT01458119 [study AT1001-041].)	Banikazemi M, 2005, MOL GENET METAB, V85, P255, DOI 10.1016/j.ymgme.2005.04.009; Banikazemi M, 2007, ANN INTERN MED, V146, P77, DOI 10.7326/0003-4819-146-2-200701160-00148; Barisoni L, 2012, ARCH PATHOL LAB MED, V136, P816, DOI 10.5858/arpa.2011-0350-OA; Benichou B, 2009, MOL GENET METAB, V96, P4, DOI 10.1016/j.ymgme.2008.10.004; Benjamin ER, 2009, J INHERIT METAB DIS, V32, P424, DOI 10.1007/s10545-009-1077-0; Benjamin ER, 2014, J INHERIT METAB DIS, V37, pS161; Boutin M, 2014, ANAL CHEM, V86, P3476, DOI 10.1021/ac404000d; BRADY RO, 1967, NEW ENGL J MED, V276, P1163, DOI 10.1056/NEJM196705252762101; Cleeland C. S., 1994, Annals Academy of Medicine Singapore, V23, P129; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Genzyme Therapeutics, 2014, SUMM PROD CHAR FABR; Germain DP, 2009, INT J CLIN PHARM TH, V47, pS111; Germain DP, 2013, GENET MED, V15, P958, DOI 10.1038/gim.2013.53; Germain DP, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-91; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; Hoffmann B, 2007, CLIN GASTROENTEROL H, V5, P1447, DOI 10.1016/j.cgh.2007.08.012; Johnson FK, 2013, CLIN PHARM DRUG DEV, V2, P120, DOI 10.1002/cpdd.1; Khanna R, 2010, MOL THER, V18, P23, DOI 10.1038/mt.2009.220; Lenders M, 2016, J AM SOC NEPHROL, V27, P256, DOI 10.1681/ASN.2014121226; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Nilsson-Ehle P., 2001, EJIFCC, V13, P1; Patel MR, 2011, J AM COLL CARDIOL, V57, P1093, DOI 10.1016/j.jacc.2010.11.018; Pisani A, 2014, CLIN GENET, V86, P301, DOI 10.1111/cge.12386; Rombach SM, 2010, BBA-MOL BASIS DIS, V1802, P741, DOI 10.1016/j.bbadis.2010.05.003; Schiffmann R, 2009, NEPHROL DIAL TRANSPL, V24, P2102, DOI 10.1093/ndt/gfp031; Shire Human Genetic Therapies, 2014, SUMM PROD CHAR REPL; SVEDLUND J, 1988, DIGEST DIS SCI, V33, P129, DOI 10.1007/BF01535722; van Breemen MJ, 2011, BBA-MOL BASIS DIS, V1812, P70, DOI 10.1016/j.bbadis.2010.09.007; Waldek S, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-72; Waldek S, 2009, GENET MED, V11, P790, DOI 10.1097/GIM.0b013e3181bb05bb; Wanner C, 2010, CLIN J AM SOC NEPHRO, V5, P2220, DOI 10.2215/CJN.04340510; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Warnock DG, 2012, NEPHROL DIAL TRANSPL, V27, P1042, DOI 10.1093/ndt/gfr420; Weidemann F, 2011, ANNU REV MED, V62, P59, DOI 10.1146/annurev-med-090910-085119; Weidemann F, 2009, CIRCULATION, V119, P524, DOI 10.1161/CIRCULATIONAHA.108.794529; Wilcox WR, 2012, MOL GENET METAB, V105, P443, DOI 10.1016/j.ymgme.2011.12.006; Wu XY, 2011, HUM MUTAT, V32, P965, DOI 10.1002/humu.21530; Yam GHF, 2005, FASEB J, V19, P12, DOI 10.1096/fj.04-2375com	38	269	297	0	37	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2016	375	6					545	555		10.1056/NEJMoa1510198	http://dx.doi.org/10.1056/NEJMoa1510198			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU4OT	27509102	Green Published, Bronze			2022-12-28	WOS:000382193100007
J	Tsementzi, D; Wu, JY; Deutsch, S; Nath, S; Rodriguez, LM; Burns, AS; Ranjan, P; Sarode, N; Malmstrom, RR; Padilla, CC; Stone, BK; Bristow, LA; Larsen, M; Glass, JB; Thamdrup, B; Woyke, T; Konstantinidis, KT; Stewart, FJ				Tsementzi, Despina; Wu, Jieying; Deutsch, Samuel; Nath, Sangeeta; Rodriguez-R, Luis M.; Burns, Andrew S.; Ranjan, Piyush; Sarode, Neha; Malmstrom, Rex R.; Padilla, Cory C.; Stone, Benjamin K.; Bristow, Laura A.; Larsen, Morten; Glass, Jennifer B.; Thamdrup, Bo; Woyke, Tanja; Konstantinidis, Konstantinos T.; Stewart, Frank J.			SAR11 bacteria linked to ocean anoxia and nitrogen loss	NATURE			English	Article							NITRITE-OXIDIZING BACTERIUM; 2ND NITRATE REDUCTASE; METAGENOMIC ANALYSIS; SEASONAL DYNAMICS; SINGLE-CELL; SEQUENCE; GENOME; IDENTIFICATION; QUALITY; GENES	Bacteria of the SAR11 clade constitute up to one half of all microbial cells in the oxygen-rich surface ocean. SAR11 bacteria are also abundant in oxygen minimum zones (OMZs), where oxygen falls below detection and anaerobic microbes have vital roles in converting bioavailable nitrogen to N-2 gas. Anaerobic metabolism has not yet been observed in SAR11, and it remains unknown how these bacteria contribute to OMZ biogeochemical cycling. Here, genomic analysis of single cells from the world's largest OMZ revealed previously uncharacterized SAR11 lineages with adaptations for life without oxygen, including genes for respiratory nitrate reductases (Nar). SAR11 nar genes were experimentally verified to encode proteins catalysing the nitrite-producing first step of denitrification and constituted similar to 40% of OMZ nar transcripts, with transcription peaking in the anoxic zone of maximum nitrate reduction activity. These results link SAR11 to pathways of ocean nitrogen loss, redefining the ecological niche of Earth's most abundant organismal group.	[Tsementzi, Despina; Konstantinidis, Konstantinos T.] Georgia Inst Technol, Sch Civil & Environm Engn, Ford Environm Sci & Technol Bldg,311 Ferst Dr, Atlanta, GA 30332 USA; [Wu, Jieying; Rodriguez-R, Luis M.; Burns, Andrew S.; Ranjan, Piyush; Sarode, Neha; Padilla, Cory C.; Konstantinidis, Konstantinos T.; Stewart, Frank J.] Georgia Inst Technol, Sch Biol Sci, Ford Environm Sci & Technol Bldg,311 Ferst Dr, Atlanta, GA 30332 USA; [Deutsch, Samuel; Nath, Sangeeta; Malmstrom, Rex R.; Woyke, Tanja] Dept Energy Joint Genome Inst, 2800 Mitchell Dr, Walnut Creek, CA 94598 USA; [Stone, Benjamin K.] Bowdoin Coll, Dept Biol, 255 Maine St, Brunswick, ME 04011 USA; [Bristow, Laura A.] Max Planck Inst Marine Microbiol, Biochem Grp, D-28359 Bremen, Germany; [Larsen, Morten; Thamdrup, Bo] Univ Southern Denmark, Dept Biol, Campusvej 55, DK-5230 Odense M, Denmark; [Larsen, Morten; Thamdrup, Bo] Univ Southern Denmark, Nord Ctr Earth Evolut NordCEE, Campusvej 55, DK-5230 Odense M, Denmark; [Glass, Jennifer B.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Ford Environm Sci & Technol Bldg,311 Ferst Dr, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Bowdoin College; Max Planck Society; University of Southern Denmark; University of Southern Denmark; University System of Georgia; Georgia Institute of Technology	Stewart, FJ (corresponding author), Georgia Inst Technol, Sch Biol Sci, Ford Environm Sci & Technol Bldg,311 Ferst Dr, Atlanta, GA 30332 USA.	frank.stewart@biology.gatech.edu	Glass, Jennifer/H-5363-2018; Konstantinidis, Kostas/ABE-7113-2020; ranjan, piyush/AAI-8587-2020; Rodriguez-R, Luis M./S-6996-2018	Glass, Jennifer/0000-0003-0775-2486; Konstantinidis, Kostas/0000-0002-0954-4755; Rodriguez-R, Luis M./0000-0001-7603-3093; Stone, Benjamin/0000-0003-3430-6756; Ranjan, Piyush/0000-0001-8293-6889; Malmstrom, Rex/0000-0002-4758-7369; Bristow, Laura/0000-0003-4865-070X; Tsementzi, Despina/0000-0002-4578-1918; Deutsch, Samuel/0000-0001-9456-7101	National Science Foundation [1151698, 1416673]; NASA Exobiology Program [NNX14AJ87G]; Sloan Foundation [RC944]; Community Science Program grant from the Department of Energy (DOE); European Research Council [267233]; Danish National Research Foundation [DNRF53]; Onassis Foundation Fellowship;  [DE-AC02-05CH11231]; Directorate For Geosciences [1151698] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); NASA Exobiology Program(National Aeronautics & Space Administration (NASA)); Sloan Foundation(Alfred P. Sloan Foundation); Community Science Program grant from the Department of Energy (DOE)(United States Department of Energy (DOE)); European Research Council(European Research Council (ERC)European Commission); Danish National Research Foundation(Danmarks Grundforskningsfond); Onassis Foundation Fellowship; ; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the National Science Foundation (1151698 to F.J.S. and 1416673 to K.T.K.), the NASA Exobiology Program (NNX14AJ87G to J.B.G. and F.J.S.), the Sloan Foundation (RC944 to F.J.S.), and a Community Science Program grant from the Department of Energy (DOE; to F.J.S. and K.T.K.). The work conducted by the US DOE Joint Genome Institute, a DOE Office of Science User Facility, is supported under contract no. DE-AC02-05CH11231. L.A.B., M.L. and B.T. were supported by a European Research Council Advanced Grant (OXYGEN, 267233) and by the Danish National Research Foundation (DNRF53). D.T. acknowledges the support of Onassis Foundation Fellowship. We are grateful for the generosity of J. Cole, A. Magalon, C. Sohaskey and F. Sargent for providing E. coli mutant strains, S. Pavlostathis for the ion chromatography methods and J. Spain for his suggestions on the heterologous expression experiment.	Alberge F, 2015, ELIFE, V4, DOI 10.7554/eLife.05357; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bender KS, 2005, J BACTERIOL, V187, P5090, DOI 10.1128/JB.187.15.5090-5096.2005; Berger SA, 2011, SYST BIOL, V60, P291, DOI 10.1093/sysbio/syr010; Brown MV, 2005, ENVIRON MICROBIOL, V7, P1466, DOI 10.1111/j.1462-2920.2005.00835.x; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Carlson CA, 2009, ISME J, V3, P283, DOI 10.1038/ismej.2008.117; Castelle CJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3120; Codispoti LA, 2001, SCI MAR, V65, P85, DOI 10.3989/scimar.2001.65s285; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Dalsgaard T, 2014, MBIO, V5, DOI 10.1128/mBio.01966-14; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dupont CL, 2012, ISME J, V6, P1186, DOI 10.1038/ismej.2011.189; Eiler A, 2009, ENVIRON MICROBIOL, V11, P2291, DOI 10.1111/j.1462-2920.2009.01954.x; Ganesh S, 2015, ISME J, V9, P2682, DOI 10.1038/ismej.2015.44; Ganesh S, 2014, ISME J, V8, P187, DOI 10.1038/ismej.2013.144; Giovannoni SJ, 2005, SCIENCE, V309, P1242, DOI 10.1126/science.1114057; Glass JB, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00998; Grote J, 2012, MBIO, V3, DOI 10.1128/mBio.00252-12; Gruber N., 2004, OCEAN CARBON CYCLE C, VIV, P97, DOI [10.1007/978-1-4020-2087-2_4, DOI 10.1007/978-1-4020-2087-2_4]; Hajaya MG, 2012, BIORESOURCE TECHNOL, V118, P73, DOI 10.1016/j.biortech.2012.05.050; IOBBI C, 1987, EUR J BIOCHEM, V168, P451, DOI 10.1111/j.1432-1033.1987.tb13438.x; IOBBINIVOL C, 1990, EUR J BIOCHEM, V188, P679, DOI 10.1111/j.1432-1033.1990.tb15450.x; Jormakka M, 2004, STRUCTURE, V12, P95, DOI 10.1016/j.str.2003.11.020; Kalvelage T, 2013, NAT GEOSCI, V6, P228, DOI [10.1038/ngeo1739, 10.1038/NGEO1739]; Kalvelage T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029299; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Khlebnikov A, 2002, BIOTECHNOL PROGR, V18, P672, DOI 10.1021/bp010141k; King GM, 2013, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00438; Konstantinidis KT, 2008, ISME J, V2, P1052, DOI 10.1038/ismej.2008.62; Konstantinidis KT, 2007, CURR OPIN MICROBIOL, V10, P504, DOI 10.1016/j.mib.2007.08.006; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kuwahara H, 2007, CURR BIOL, V17, P881, DOI 10.1016/j.cub.2007.04.039; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lucker S, 2010, P NATL ACAD SCI USA, V107, P13479, DOI 10.1073/pnas.1003860107; Luke C, 2016, PEERJ, V4, DOI 10.7717/peerj.1924; Luo CW, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku169; Luo HW, 2015, ISME J, V9, P1423, DOI 10.1038/ismej.2014.227; Martinez-Espinosa RM, 2007, FEMS MICROBIOL LETT, V276, P129, DOI 10.1111/j.1574-6968.2007.00887.x; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Parks DH, 2015, GENOME RES, V25, P1043, DOI 10.1101/gr.186072.114; Paulmier A, 2009, PROG OCEANOGR, V80, P113, DOI 10.1016/j.pocean.2008.08.001; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Philippot L, 2002, BBA-GENE STRUCT EXPR, V1577, P355, DOI 10.1016/S0167-4781(02)00420-7; Potter LC, 1999, BIOCHEM J, V344, P77, DOI 10.1042/0264-6021:3440077; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Reddy TBK, 2015, NUCLEIC ACIDS RES, V43, pD1099, DOI 10.1093/nar/gku950; Revsbech NP, 2009, LIMNOL OCEANOGR-METH, V7, P371, DOI 10.4319/lom.2009.7.371; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; Rinke C, 2013, NATURE, V499, P431, DOI 10.1038/nature12352; Rodriguez-Ezpeleta N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030520; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; Salter I, 2015, ISME J, V9, P347, DOI 10.1038/ismej.2014.129; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sorokin DY, 2012, ISME J, V6, P2245, DOI 10.1038/ismej.2012.70; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Starkenburg SR, 2006, APPL ENVIRON MICROB, V72, P2050, DOI 10.1128/AEM.72.3.2050-2063.2006; Stewart FJ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r26; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739; Swan BK, 2011, SCIENCE, V333, P1296, DOI 10.1126/science.1203690; Takami H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030559; Thrash JC, 2014, ISME J, V8, P1440, DOI 10.1038/ismej.2013.243; Thrash JC, 2011, SCI REP-UK, V1, DOI 10.1038/srep00013; Tiano L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105399; Tripp HJ, 2013, J MICROBIOL, V51, P147, DOI 10.1007/s12275-013-2671-2; Ulloa O, 2012, P NATL ACAD SCI USA, V109, P15996, DOI 10.1073/pnas.1205009109; Vergin KL, 2013, ISME J, V7, P1322, DOI 10.1038/ismej.2013.32; Viklund J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078858; Yoshimatsu K, 2002, FEBS LETT, V516, P145, DOI 10.1016/S0014-5793(02)02524-3; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhu Wenhan, 2010, Nucleic Acids Res, V38, pe132, DOI 10.1093/nar/gkq275	76	92	94	4	139	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					179	+		10.1038/nature19068	http://dx.doi.org/10.1038/nature19068			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27487207	Green Accepted, Green Submitted			2022-12-28	WOS:000381472100029
J	Ganeshan, RM; Bakr, AI				Ganeshan, Raghavendra Marappa; Bakr, Ahmed Ibrahim			Not "just" a shoulder dislocation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ganeshan, Raghavendra Marappa] Pennine Acute Hosp NHS Trust, Manchester, Lancs, England; [Bakr, Ahmed Ibrahim] North Manchester Gen Hosp, Manchester, Lancs, England		Ganeshan, RM (corresponding author), Pennine Acute Hosp NHS Trust, Manchester, Lancs, England.	raghu.mg@gmail.com						Kralinger FS, 2002, AM J SPORT MED, V30, P116, DOI 10.1177/03635465020300010501; Olds M, 2015, BRIT J SPORT MED, V49, P913, DOI 10.1136/bjsports-2014-094342	2	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 10	2016	354								i4062	10.1136/bmj.i4062	http://dx.doi.org/10.1136/bmj.i4062			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4TW	27510714				2022-12-28	WOS:000381475000001
J	Hamersley, C				Hamersley, Catherine			John McKessar Duncan OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2016	354								i4261	10.1136/bmj.i4261	http://dx.doi.org/10.1136/bmj.i4261			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9DD	27494937				2022-12-28	WOS:000381081800006
J	Mohanraju, P; Makarova, KS; Zetsche, B; Zhang, F; Koonin, EV; van der Oost, J				Mohanraju, Prarthana; Makarova, Kira S.; Zetsche, Bernd; Zhang, Feng; Koonin, Eugene V.; van der Oost, John			Diverse evolutionary roots and mechanistic variations of the CRISPR-Cas systems	SCIENCE			English	Review							GUIDED SURVEILLANCE COMPLEX; ADAPTIVE IMMUNE-SYSTEMS; GENOME-EDITING SPECIFICITY; RNA-SILENCING COMPLEX; HUMAN-CELLS; SPACER ACQUISITION; CRYSTAL-STRUCTURE; FOREIGN DNA; ESCHERICHIA-COLI; STRUCTURAL BASIS	Adaptive immunity had been long thought of as an exclusive feature of animals. However, the discovery of the CRISPR-Cas defense system, present in almost half of prokaryotic genomes, proves otherwise. Because of the everlasting parasite-host arms race, CRISPR-Cas has rapidly evolved through horizontal transfer of complete loci or individual modules, resulting in extreme structural and functional diversity. CRISPR-Cas systems are divided into two distinct classes that each consist of three types and multiple subtypes. We discuss recent advances in CRISPR-Cas research that reveal elaborate molecular mechanisms and provide for a plausible scenario of CRISPR-Cas evolution. We also briefly describe the latest developments of a wide range of CRISPR-based applications.	[Mohanraju, Prarthana; van der Oost, John] Wageningen Univ, Dept Agrotechnol & Food Sci, Microbiol Lab, NL-6703 HB Wageningen, Netherlands; [Makarova, Kira S.; Koonin, Eugene V.] Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; [Zetsche, Bernd; Zhang, Feng] Broad Inst & Harvard, Cambridge, MA 02142 USA	Wageningen University & Research; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	van der Oost, J (corresponding author), Wageningen Univ, Dept Agrotechnol & Food Sci, Microbiol Lab, NL-6703 HB Wageningen, Netherlands.	john.vanderoost@wur.nl	Mohanraju, Prarthana/AFK-4376-2022; van+der+Oost, John/Y-2548-2019; Mohanraju, Prarthana/AAG-3127-2022; Macrae, Rhiannon/AAX-1536-2020	Mohanraju, Prarthana/0000-0002-4766-8660; Mohanraju, Prarthana/0000-0002-4766-8660; 	U.S. Department of Health and Human Services; NWO/TOP [714.015.001]; NIH through NIMH [5DP1-MH100706, 1R01-MH110049]; NIH through NIDDK [5R01DK097768-03]; New York Stem Cell Foundation; Paul G. Allen Family Foundation; Vallee Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK097768] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH110049] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000061, ZIALM000073] Funding Source: NIH RePORTER	U.S. Department of Health and Human Services; NWO/TOP(Netherlands Organization for Scientific Research (NWO)); NIH through NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH through NIDDK; New York Stem Cell Foundation; Paul G. Allen Family Foundation; Vallee Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	E.V.K. and K.S.M. are supported by the intramural program of the U.S. Department of Health and Human Services (to the National Library of Medicine). J.v.d.O. and P.M. are supported by the NWO/TOP grant 714.015.001. F.Z. is a New York Stem Cell Foundation-Robertson Investigator. F.Z. is supported by the NIH through NIMH (5DP1-MH100706 and 1R01-MH110049) and NIDDK (5R01DK097768-03), the New York Stem Cell, Simons, Paul G. Allen Family, and Vallee Foundations, and D. R. Cheng, T. Harriman, and R. Metcalfe. F.Z. is a founder of Editas Medicine and scientific advisor for Editas Medicine and Horizon Discovery.	Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573; Amitai G, 2016, NAT REV MICROBIOL, V14, P67, DOI 10.1038/nrmicro.2015.14; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Arslan Z, 2014, NUCLEIC ACIDS RES, V42, P7884, DOI 10.1093/nar/gku510; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Barrangou R, 2014, MOL CELL, V54, P234, DOI 10.1016/j.molcel.2014.03.011; Benda C, 2014, MOL CELL, V56, P43, DOI 10.1016/j.molcel.2014.09.002; Bikard D, 2014, NAT BIOTECHNOL, V32, P1146, DOI 10.1038/nbt.3043; Bikard D, 2013, NUCLEIC ACIDS RES, V41, P7429, DOI 10.1093/nar/gkt520; Blosser TR, 2015, MOL CELL, V58, P60, DOI 10.1016/j.molcel.2015.01.028; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Bondy-Denomy J, 2015, NATURE, V526, P136, DOI 10.1038/nature15254; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Charpentier E, 2015, FEMS MICROBIOL REV, V39, P428, DOI 10.1093/femsre/fuv023; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cho SW, 2013, NAT BIOTECHNOL, V31, P230, DOI 10.1038/nbt.2507; Chopin MC, 2005, CURR OPIN MICROBIOL, V8, P473, DOI 10.1016/j.mib.2005.06.006; Chylinski K, 2014, NUCLEIC ACIDS RES, V42, P6091, DOI 10.1093/nar/gku241; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; D'Astolfo DS, 2015, CELL, V161, P674, DOI 10.1016/j.cell.2015.03.028; Datsenko KA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1937; Davis KM, 2015, NAT CHEM BIOL, V11, P316, DOI [10.1038/NCHEMBIO.1793, 10.1038/nchembio.1793]; Deltcheva E, 2011, NATURE, V471, P602, DOI 10.1038/nature09886; Deng L, 2013, MOL MICROBIOL, V87, P1088, DOI 10.1111/mmi.12152; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Diez-Villasenor C, 2013, RNA BIOL, V10, P792, DOI 10.4161/rna.24023; Dupuis ME, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3087; Ebina H, 2013, SCI REP-UK, V3, DOI 10.1038/srep02510; Elmore JR, 2016, GENE DEV, V30, P447, DOI 10.1101/gad.272153.115; Erdmann S, 2014, MOL MICROBIOL, V91, P900, DOI 10.1111/mmi.12503; Estrella MA, 2016, GENE DEV, V30, P460, DOI 10.1101/gad.273722.115; Esvelt KM, 2014, ELIFE, V3, DOI 10.7554/eLife.03401; Fineran PC, 2014, P NATL ACAD SCI USA, V111, pE1629, DOI 10.1073/pnas.1400071111; Fineran PC, 2012, VIROLOGY, V434, P202, DOI 10.1016/j.virol.2012.10.003; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; Garneau JE, 2010, NATURE, V468, P67, DOI 10.1038/nature09523; Garrett Roger A., 2015, Life-Basel, V5, P783, DOI 10.3390/life5010783; Gasiunas G, 2014, CELL MOL LIFE SCI, V71, P449, DOI 10.1007/s00018-013-1438-6; Gasiunas G, 2012, P NATL ACAD SCI USA, V109, pE2579, DOI 10.1073/pnas.1208507109; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Goldberg GW, 2014, NATURE, V514, P633, DOI 10.1038/nature13637; Goldfarb T, 2015, EMBO J, V34, P169, DOI 10.15252/embj.201489455; Hale CR, 2014, GENE DEV, V28, P2432, DOI 10.1101/gad.250712.114; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Hatoum-Aslan A, 2013, J BIOL CHEM, V288, P27888, DOI 10.1074/jbc.M113.499244; Haurwitz RE, 2010, SCIENCE, V329, P1355, DOI 10.1126/science.1192272; Heler R, 2015, NATURE, V519, P199, DOI 10.1038/nature14245; Hickman AB, 2015, NUCLEIC ACIDS RES, V43, P10576, DOI 10.1093/nar/gkv1180; Hilton IB, 2015, NAT BIOTECHNOL, V33, P510, DOI 10.1038/nbt.3199; Hooton SPT, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00744; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Hu WH, 2014, P NATL ACAD SCI USA, V111, P11461, DOI 10.1073/pnas.1405186111; Ivancic-Bace I, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1213; Jackson RN, 2015, MOL CELL, V58, P722, DOI 10.1016/j.molcel.2015.05.023; Jackson RN, 2014, SCIENCE, V345, P1473, DOI 10.1126/science.1256328; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Jiang WY, 2016, CELL, V164, P710, DOI 10.1016/j.cell.2015.12.053; Jinek M, 2014, SCIENCE, V343, P1215, DOI 10.1126/science.1247997; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Jore MM, 2011, NAT STRUCT MOL BIOL, V18, P529, DOI 10.1038/nsmb.2019; Kapitonov VV, 2016, J BACTERIOL, V198, P797, DOI 10.1128/JB.00783-15; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kiani S, 2014, NAT METHODS, V11, P723, DOI [10.1038/nmeth.2969, 10.1038/NMETH.2969]; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Kleinstiver BP, 2016, NAT BIOTECHNOL, V34, P869, DOI 10.1038/nbt.3620; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Konermann S, 2013, NATURE, V500, P472, DOI 10.1038/nature12466; Koonin EV, 2015, NAT REV GENET, V16, P184, DOI 10.1038/nrg3859; Koonin EV, 2015, MOL BIOSYST, V11, P20, DOI 10.1039/c4mb00438h; Koonin EV, 2013, CURR OPIN VIROL, V3, P546, DOI 10.1016/j.coviro.2013.06.008; Krupovic M, 2016, GENOME BIOL EVOL, V8, P375, DOI 10.1093/gbe/evw006; Krupovic M, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-36; Levasseur A, 2016, NATURE, V531, P249, DOI 10.1038/nature17146; Levy A, 2015, NATURE, V520, P505, DOI 10.1038/nature14302; Li M, 2014, NUCLEIC ACIDS RES, V42, P2483, DOI 10.1093/nar/gkt1154; Liu YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6393; Louwen R, 2014, MICROBIOL MOL BIOL R, V78, P74, DOI 10.1128/MMBR.00039-13; Magadan AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040913; Majumdar S, 2015, RNA, V21, P1147, DOI 10.1261/rna.049130.114; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2013, BIOCHEM SOC T, V41, P1392, DOI 10.1042/BST20130038; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Makarova KS, 2011, J BACTERIOL, V193, P6039, DOI 10.1128/JB.05535-11; Makarova KS, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-38; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marraffini LA, 2015, NATURE, V526, P55, DOI 10.1038/nature15386; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Marraffini LA, 2010, NATURE, V463, P568, DOI 10.1038/nature08703; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Mulepati S, 2014, SCIENCE, V345, P1479, DOI 10.1126/science.1256996; Nam KH, 2012, STRUCTURE, V20, P1574, DOI 10.1016/j.str.2012.06.016; Niewoehner O, 2016, RNA, V22, P318, DOI 10.1261/rna.054098.115; Niewoehner O, 2014, NUCLEIC ACIDS RES, V42, P1341, DOI 10.1093/nar/gkt922; Nishimasu H, 2014, CELL, V156, P935, DOI 10.1016/j.cell.2014.02.001; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Nunez JK, 2015, NATURE, V519, P193, DOI 10.1038/nature14237; Nunez JK, 2014, NAT STRUCT MOL BIOL, V21, P528, DOI 10.1038/nsmb.2820; Osawa T, 2015, MOL CELL, V58, P418, DOI 10.1016/j.molcel.2015.03.018; Peng WF, 2015, NUCLEIC ACIDS RES, V43, P406, DOI 10.1093/nar/gku1302; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Qin WN, 2015, GENETICS, V200, P423, DOI 10.1534/genetics.115.176594; Ramanan V, 2015, SCI REP-UK, V5, DOI 10.1038/srep10833; Ramia NF, 2014, CELL REP, V9, P1610, DOI 10.1016/j.celrep.2014.11.007; Ramia NF, 2014, NUCLEIC ACIDS RES, V42, P1129, DOI 10.1093/nar/gkt914; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Redding S, 2015, CELL, V163, P854, DOI 10.1016/j.cell.2015.10.003; Reeks J, 2013, BIOCHEM J, V453, P155, DOI 10.1042/BJ20130316; Richter C, 2014, NUCLEIC ACIDS RES, V42, P8516, DOI 10.1093/nar/gku527; Rollins MF, 2015, NUCLEIC ACIDS RES, V43, P2216, DOI 10.1093/nar/gkv094; Rouillon C, 2013, MOL CELL, V52, P124, DOI 10.1016/j.molcel.2013.08.020; Rutkauskas M, 2015, CELL REP, V10, P1534, DOI 10.1016/j.celrep.2015.01.067; Samai P, 2015, CELL, V161, P1164, DOI 10.1016/j.cell.2015.04.027; Sampson TR, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00037; Samson JE, 2013, NAT REV MICROBIOL, V11, P675, DOI 10.1038/nrmicro3096; Seed KD, 2013, NATURE, V494, P489, DOI 10.1038/nature11927; Semenova E, 2011, P NATL ACAD SCI USA, V108, P10098, DOI 10.1073/pnas.1104144108; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sheppard NF, 2016, RNA, V22, P216, DOI 10.1261/rna.039842.113; Shmakov S, 2015, MOL CELL, V60, P385, DOI 10.1016/j.molcel.2015.10.008; Silas S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4234; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Spilman M, 2013, MOL CELL, V52, P146, DOI 10.1016/j.molcel.2013.09.008; Staals RHJ, 2014, MOL CELL, V56, P518, DOI 10.1016/j.molcel.2014.10.005; Staals RHJ, 2013, MOL CELL, V52, P135, DOI 10.1016/j.molcel.2013.09.013; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Sternberg SH, 2015, NATURE, V527, P110, DOI 10.1038/nature15544; Sternberg SH, 2014, NATURE, V507, P62, DOI 10.1038/nature13011; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; Swarts DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035888; Takeuchi N, 2012, J BACTERIOL, V194, P1216, DOI 10.1128/JB.06521-11; Tamulaitis G, 2014, MOL CELL, V56, P506, DOI 10.1016/j.molcel.2014.09.027; Taylor DW, 2015, SCIENCE, V348, P581, DOI 10.1126/science.aaa4535; Terns MP, 2011, CURR OPIN MICROBIOL, V14, P321, DOI 10.1016/j.mib.2011.03.005; Tock MR, 2005, CURR OPIN MICROBIOL, V8, P466, DOI 10.1016/j.mib.2005.06.003; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; Vorontsova D, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1261; Wang JY, 2015, CELL, V163, P840, DOI 10.1016/j.cell.2015.10.008; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wei YZ, 2015, GENE DEV, V29, P356, DOI 10.1101/gad.257550.114; Westra ER, 2014, NAT REV MICROBIOL, V12, P317, DOI 10.1038/nrmicro3241; Wiedenheft B, 2012, NATURE, V482, P331, DOI 10.1038/nature10886; Wiedenheft B, 2011, NATURE, V477, P486, DOI 10.1038/nature10402; Wiedenheft B, 2011, P NATL ACAD SCI USA, V108, P10092, DOI 10.1073/pnas.1102716108; Wigley DB, 2007, CELL, V131, P651, DOI 10.1016/j.cell.2007.11.004; Xue CY, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1259; Yamano T, 2016, CELL, V165, P949, DOI 10.1016/j.cell.2016.04.003; Yosef I, 2012, NUCLEIC ACIDS RES, V40, P5569, DOI 10.1093/nar/gks216; Zebec Z, 2014, NUCLEIC ACIDS RES, V42, P5280, DOI 10.1093/nar/gku161; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zetsche B, 2015, NAT BIOTECHNOL, V33, P139, DOI 10.1038/nbt.3149; Zhang J, 2012, MOL CELL, V45, P303, DOI 10.1016/j.molcel.2011.12.013; Zhang Y, 2015, MOL CELL, V60, P242, DOI 10.1016/j.molcel.2015.09.020; Zhang Y, 2013, MOL CELL, V50, P488, DOI 10.1016/j.molcel.2013.05.001	166	361	390	22	254	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299							aad5147	10.1126/science.aad5147	http://dx.doi.org/10.1126/science.aad5147			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27493190	Green Published			2022-12-28	WOS:000381560900031
J	Adamsson Eryd, S; Gudbjornsdottir, S; Manhem, K; Rosengren, A; Svensson, AM; Miftaraj, M; Franzen, S; Bjorck, S				Adamsson Eryd, Samuel; Gudbjornsdottir, Soffia; Manhem, Karin; Rosengren, Annika; Svensson, Ann-Marie; Miftaraj, Mervete; Franzen, Stefan; Bjorck, Staffan			Blood pressure and complications in individuals with type 2 diabetes and no previous cardiovascular disease: national population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MORTALITY; REGISTER; OUTCOMES	OBJECTIVES To compare the risk associated with systolic blood pressure that meets current recommendations (that is, below 140 mm Hg) with the risk associated with lower levels in patients who have type 2 diabetes and no previous cardiovascular disease. DESIGN Population based cohort study with nationwide clinical registries, 2006-12. The mean follow-up was 5.0 years. SETTING 861 Swedish primary care units and hospital outpatient clinics. PARTICIPANTS 187 106 patients registered in the Swedish national diabetes register who had had type 2 diabetes for at least a year, age 75 or younger, and with no previous cardiovascular or other major disease. MAIN OUTCOME MEASURES Clinical events were obtained from the hospital discharge and death registers with respect to acute myocardial infarction, stroke, a composite of acute myocardial infarction and stroke (cardiovascular disease), coronary heart disease, heart failure, and total mortality. Hazard ratios were estimated for different levels of baseline systolic blood pressure with clinical characteristics and drug prescription data as covariates. RESULTS The group with the lowest systolic blood pressure (110-119 mm Hg) had a significantly lower risk of non-fatal acute myocardial infarction (adjusted hazard ratio 0.76, 95% confidence interval 0.64 to 0.91; P=0.003), total acute myocardial infarction (0.85, 0.72 to 0.99; P=0.04), non-fatal cardiovascular disease (0.82, 0.72 to 0.93; P=0.002), total cardiovascular disease (0.88, 0.79 to 0.99; P=0.04), and non-fatal coronary heart disease (0.88, 0.78 to 0.99; P=0.03) compared with the reference group (130-139 mm Hg). There was no indication of a J shaped relation between systolic blood pressure and the endpoints, with the exception of heart failure and total mortality. CONCLUSIONS Lower systolic blood pressure than currently recommended is associated with significantly lower risk of cardiovascular events in patients with type 2 diabetes. The association between low blood pressure and increased mortality could be due to concomitant disease rather than antihypertensive treatment.	[Adamsson Eryd, Samuel; Gudbjornsdottir, Soffia; Svensson, Ann-Marie; Miftaraj, Mervete; Franzen, Stefan; Bjorck, Staffan] Ctr Registers Vastra Gotaland, Gothenburg, Sweden; [Adamsson Eryd, Samuel; Gudbjornsdottir, Soffia; Manhem, Karin; Rosengren, Annika] Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden; [Adamsson Eryd, Samuel; Rosengren, Annika] Ostra Hosp, Sahlgrenska Univ Hosp, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital	Adamsson Eryd, S (corresponding author), Ctr Registers Vastra Gotaland, Gothenburg, Sweden.; Adamsson Eryd, S (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Dept Mol & Clin Med, Gothenburg, Sweden.; Adamsson Eryd, S (corresponding author), Ostra Hosp, Sahlgrenska Univ Hosp, Gothenburg, Sweden.	samuel.adamssoneryd@registercentrum.se		Bjorck, Staffan/0000-0003-4652-5593	Region Vastra Gotaland in Sweden; Swedish Heart and Lung Foundation; Diabetes Wellness; Swedish Diabetes Foundation; Swedish Council for Working Life and Social Research (Epilife); Swedish Research Council	Region Vastra Gotaland in Sweden; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Diabetes Wellness; Swedish Diabetes Foundation; Swedish Council for Working Life and Social Research (Epilife)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by grants from the Region Vastra Gotaland in Sweden, the Swedish Heart and Lung Foundation, Diabetes Wellness, the Swedish Diabetes Foundation, the Swedish Council for Working Life and Social Research (Epilife), and the Swedish Research Council.	American Diabetes Association, 2016, Clin Diabetes, V34, P3, DOI 10.2337/diaclin.34.1.3; Bangalore S, 2011, CIRCULATION, V123, P2799, DOI 10.1161/CIRCULATIONAHA.110.016337; Brunstrom M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i717; Cederholm J, 2012, J HYPERTENS, V30, P2020, DOI 10.1097/HJH.0b013e3283577bdf; Cooper-DeHoff RM, 2010, JAMA-J AM MED ASSOC, V304, P61, DOI 10.1001/jama.2010.884; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Emdin CA, 2015, JAMA-J AM MED ASSOC, V313, P603, DOI 10.1001/jama.2014.18574; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gudbjornsdottir S, 2003, DIABETES CARE, V26, P1270, DOI 10.2337/diacare.26.4.1270; James PA, 2014, JAMA-J AM MED ASSOC, V311, P507, DOI 10.1001/jama.2013.284427; Johansson LA, 2000, INT J EPIDEMIOL, V29, P495, DOI 10.1093/ije/29.3.495; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Perkovic V, 2015, NEW ENGL J MED, V373, P2175, DOI 10.1056/NEJMe1513301; Redon J, 2012, J AM COLL CARDIOL, V59, P74, DOI 10.1016/j.jacc.2011.09.040; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Swedish National Diabetes Register, 2016, 20 YEARS SUCC IMPR; Tancredi M, 2015, NEW ENGL J MED, V373, P1720, DOI 10.1056/NEJMoa1504347; Wettermark B, 2007, PHARMACOEPIDEM DR S, V16, P726, DOI 10.1002/pds.1294; Xie XF, 2016, LANCET, V387, P435, DOI 10.1016/S0140-6736(15)00805-3	23	33	33	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2016	354								i4070	10.1136/bmj.i4070	http://dx.doi.org/10.1136/bmj.i4070			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9CY	27492939	Green Published, hybrid			2022-12-28	WOS:000381081300003
J	Warren, E				Warren, Elizabeth			Strengthening Research through Data Sharing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Anderson ML, 2015, NEW ENGL J MED, V372, P1031, DOI 10.1056/NEJMsa1409364; Miller JE, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009758; Piller C, 2015, FAILURE REPORT STAT; Taichman DB, 2016, NEW ENGL J MED, V374, P384, DOI 10.1056/NEJMe1515172; Unger JM, 2016, JAMA ONCOL	5	53	53	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2016	375	5					401	403		10.1056/NEJMp1607282	http://dx.doi.org/10.1056/NEJMp1607282			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS7AN	27518656	Bronze, Green Published			2022-12-28	WOS:000380934900001
J	Barkoudah, E; Weinrauch, LA				Barkoudah, Ebrahim; Weinrauch, Larry A.			Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus	ANNALS OF INTERNAL MEDICINE			English	Letter									[Barkoudah, Ebrahim; Weinrauch, Larry A.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Barkoudah, Ebrahim] Harvard Med Sch, Boston, MA USA; [Weinrauch, Larry A.] EP Joslin Res Lab, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Joslin Diabetes Center, Inc.	Barkoudah, E (corresponding author), Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA.		Barkoudah, Ebrahim/AAS-3053-2020; Barkoudah, Ebrahim/GQP-1197-2022	Barkoudah, Ebrahim/0000-0001-8224-5121				Barkoudah E, 2012, J AM HEART ASSOC, V1, P8, DOI 10.1161/JAHA.111.000059; CENTERS FOR DISEASE CONTROL AND PREVENTION, 2015, DIAB PUBL HLTH RES; Hillier TA, 2003, DIABETES CARE, V26, P2999, DOI 10.2337/diacare.26.11.2999; Kahn R, 2010, LANCET, V375, P1365, DOI 10.1016/S0140-6736(09)62162-0; Siu AL, 2015, ANN INTERN MED, V163, P861, DOI 10.7326/M15-2345	5	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2016	165	3					225	225		10.7326/L16-0100	http://dx.doi.org/10.7326/L16-0100			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2HA	27479224				2022-12-28	WOS:000380583300013
J	Levine, DM; Lipsitz, SR; Linder, JA				Levine, David M.; Lipsitz, Stuart R.; Linder, Jeffrey A.			Trends in Seniors' Use of Digital Health Technology in the United States, 2011-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Levine, David M.; Lipsitz, Stuart R.; Linder, Jeffrey A.] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Levine, DM (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 1620 Tremont St,Third Floor, Boston, MA 02120 USA.	dmlevine@partners.org	Linder, Jeffrey/AAF-3424-2021	Linder, Jeffrey/0000-0003-2217-184X	PHS HHS [T32HP10251] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Care Innovations, OLD POP HAV AD TECHN; Centers for Medicare & Medicaid Services, NAT HLTH EXP FACT SH; Fox Susannah, 2013, INFORM TRIAGE; Gordon NP, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5105; Greysen SR, 2014, JAMA INTERN MED, V174, P1188, DOI 10.1001/jamainternmed.2014.1864; National Health and Aging Trends Study, NHATS DAT COLL PROC	6	112	112	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2016	316	5					538	540		10.1001/jama.2016.9124	http://dx.doi.org/10.1001/jama.2016.9124			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9AU	27483069	Bronze			2022-12-28	WOS:000381075000022
J	Lane, R				Lane, Richard			Pedro Hallal: putting physical activity at the heart of better health	LANCET			English	Editorial Material																			0	2	2	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2016	388	10051					1271	1271		10.1016/S0140-6736(16)31148-5	http://dx.doi.org/10.1016/S0140-6736(16)31148-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW5RH	27475267				2022-12-28	WOS:000383704000018
J	Reis, RS; Salvo, D; Ogilvie, D; Lambert, EV; Goenka, S; Brownson, RC				Reis, Rodrigo S.; Salvo, Deborah; Ogilvie, David; Lambert, Estelle V.; Goenka, Shifalika; Brownson, Ross C.		Lancet Phys Act Series 2 Executive	Scaling up physical activity interventions worldwide: stepping up to larger and smarter approaches to get people moving	LANCET			English	Article							PUBLIC-HEALTH IMPACT; RAPID-TRANSIT SYSTEM; RE-AIM FRAMEWORK; COORDINATED APPROACH; BUILT ENVIRONMENT; LATIN-AMERICA; CHILD; REACH; IMPLEMENTATION; PROGRAMS	The global pandemic of physical inactivity requires a multisectoral, multidisciplinary public-health response. Scaling up interventions that are capable of increasing levels of physical activity in populations across the varying cultural, geographic, social, and economic contexts worldwide is challenging, but feasible. In this paper, we review the factors that could help to achieve this. We use a mixed-methods approach to comprehensively examine these factors, drawing on the best available evidence from both evidence-to-practice and practice-to-evidence methods. Policies to support active living across society are needed, particularly outside the health-care sector, as demonstrated by some of the successful examples of scale up identified in this paper. Researchers, research funders, and practitioners and policymakers in culture, education, health, leisure, planning, and transport, and civil society as a whole, all have a role. We should embrace the challenge of taking action to a higher level, aligning physical activity and health objectives with broader social, environmental, and sustainable development goals.	[Reis, Rodrigo S.; Brownson, Ross C.] Washington Univ, Brown Sch, Prevent Res Ctr St Louis, St Louis, MO 63130 USA; [Reis, Rodrigo S.] Univ Fed Parana, Phys Educ Grad Program, Curitiba, Parana, Brazil; [Salvo, Deborah] Univ Texas Hlth Sci Ctr Houston, Michael & Susan Dell Ctr Hlth Living, Austin Reg Campus, Austin, TX USA; [Salvo, Deborah] Natl Inst Publ Hlth Mexico, Ctr Nutr & Hlth Res, Cuernavaca, Morelos, Mexico; [Ogilvie, David] Univ Cambridge, Sch Clin Med, MRC Epidemiol Unit, Cambridge Biomed Campus, Cambridge, England; [Ogilvie, David] Univ Cambridge, Sch Clin Med, UKCRC Ctr Diet & Act Res CEDAR, Cambridge Biomed Campus, Cambridge, England; [Lambert, Estelle V.] Univ Cape Town, Div Exercise Sci & Sports Med, Dept Human Biol, Fac Hlth Sci, Cape Town, South Africa; [Goenka, Shifalika] Indian Inst Publ Hlth, Delhi, India; [Goenka, Shifalika] Publ Hlth Fdn India, Delhi, India; [Brownson, Ross C.] Washington Univ, Sch Med, Div Publ Hlth Sci, St Louis, MO USA; [Brownson, Ross C.] Washington Univ, Sch Med, Alvin J Siteman Canc Ctr, St Louis, MO USA	Washington University (WUSTL); Universidade Federal do Parana; University of Texas System; University of Texas Health Science Center Houston; Instituto Nacional de Salud Publica; University of Cambridge; University of Cambridge; University of Cape Town; Public Health Foundation of India; Washington University (WUSTL); Siteman Cancer Center; Washington University (WUSTL)	Reis, RS (corresponding author), Washington Univ, Brown Sch, Prevent Res Ctr St Louis, St Louis, MO 63130 USA.	reis.rodrigo@wustl.edu	Reis, Rodrigo/F-7447-2012; Lambert, Estelle/ABF-1268-2020	Reis, Rodrigo/0000-0002-9872-9865; Lambert, Estelle/0000-0003-4315-9153; Goenka, Shifalika/0000-0001-6993-2883; Ogilvie, David/0000-0002-0270-4672; Salvo, Deborah/0000-0002-9726-0882	ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_UP_1001/1, MR/K023187/1, MC_UU_12015/6] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA124404, P30CA091842] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448, KL2TR000450] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101593, P30DK092950] Funding Source: NIH RePORTER; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MR/K023187/1, MC_UU_12015/6, MC_UP_1001/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Anderson YC, 2015, J PRIM HEALTH CARE, V7, P192, DOI 10.1071/HC15192; [Anonymous], 2016, PUBLIC HLTH RES; [Anonymous], 2020, WORLD DEV IND; [Anonymous], 2012, LANCET, DOI DOI 10.1016/S0140-6736(12)60646-1; Arbour-Nicitopoulos KP, 2014, PM&R, V6, P1088, DOI 10.1016/j.pmrj.2014.05.018; Babalik-Sutcliffe E, 2015, TRANSPORT REV, V35, P792, DOI 10.1080/01441647.2015.1059381; Beutler I, 2008, SPORT SOC, V11, P359, DOI 10.1080/17430430802019227; Bhandari N, 2008, MATERN CHILD NUTR, V4, P5, DOI 10.1111/j.1740-8709.2007.00126.x; Brady TJ, 2012, TRANSL BEHAV MED, V2, P3, DOI 10.1007/s13142-011-0105-4; Brown HS, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-47; Brownson R. C., 2011, EVIDENCE BASED PUBLI; Brownson RC, 2007, AM J PUBLIC HEALTH, V97, P1900, DOI 10.2105/AJPH.2006.090399; Brownson RC, 2009, AM J PUBLIC HEALTH, V99, P1576, DOI 10.2105/AJPH.2008.156224; Brownson RC, 2008, J PHYS ACT HEALTH, V5, P488, DOI 10.1123/jpah.5.4.488; Buis LR, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2928; CATCH Global Foundation, 2014, COORD APPR CHILD HLT; Cervero R., 2013, 201301 IURD; Cervero R, 2009, INT J SUSTAIN TRANSP, V3, P203, DOI 10.1080/15568310802178314; Conroy JL, 2011, EVALUATION HLTH U YE; Conroy JL, 2013, EVALUATION HLTH U NE; Conroy JL, 2012, EVALUATION HLTH U AF; de Silva-Sanigorski AM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-65; Delmelle EC, 2012, TRANSPORT POLICY, V20, P36, DOI 10.1016/j.tranpol.2011.12.001; Dzewaltowski DA, 2004, HEALTH PROMOT INT, V19, P235, DOI 10.1093/heapro/dah211; Farrell L, 2014, PUBLIC HEALTH RES PR, V25, DOI 10.17061/phrp2511408; Fernald D, 2012, PREV CHRONIC DIS, V9, DOI 10.5888/pcd9.120004; Giulianotti R, 2011, ETHNIC RACIAL STUD, V34, P207, DOI 10.1080/01419870.2010.522245; Glanz K, 2010, ANNU REV PUBL HEALTH, V31, P399, DOI 10.1146/annurev.publhealth.012809.103604; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Green LW, 2008, FAM PRACT, V25, pI20, DOI 10.1093/fampra/cmn055; Green LW, 2006, AM J PUBLIC HEALTH, V96, P406, DOI 10.2105/AJPH.2005.066035; Guest AM, 2009, SPORT SOC, V12, P1336, DOI 10.1080/17430430903204868; Gyurcsik NC, 2006, PUBLIC HEALTH NURS, V23, P516, DOI 10.1111/j.1525-1446.2006.00591.x; Hardy LL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2031-8; Heath EM, 2002, HEALTH EDUC BEHAV, V29, P444, DOI 10.1177/109019810202900405; Heath GW, 2012, LANCET, V380, P272, DOI 10.1016/S0140-6736(12)60816-2; Hino AAF, 2014, J URBAN HEALTH, V91, P446, DOI 10.1007/s11524-013-9831-x; Hoehner CM, 2013, AM J PREV MED, V44, pE31, DOI 10.1016/j.amepre.2012.10.026; Hoelscher D M, 2001, J Public Health Manag Pract, V7, P90; Hoelscher DM, 2011, J PHYS ACT HEALTH, V8, pS5, DOI 10.1123/jpah.8.s1.s5; Hoelscher DM, 2004, PREV MED, V38, P594, DOI 10.1016/j.ypmed.2003.11.017; Hoffman SJ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2041-6; Hsu CC, 2007, PARE, V12, P1; JANUS ED, 2012, TRIALS, V13, pNIL_0001, DOI DOI 10.1186/1745-6215-13-152; Jauregui E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1474-2; Jilcott S, 2007, ANN BEHAV MED, V34, P105, DOI 10.1007/BF02872666; Kidd B, 2008, SPORT SOC, V11, P370, DOI 10.1080/17430430802019268; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Landeta J, 2011, TECHNOL FORECAST SOC, V78, P1629, DOI 10.1016/j.techfore.2011.03.009; Lemoine PD, 2016, J URBAN HEALTH, V93, P256, DOI 10.1007/s11524-015-0019-4; Lewallen TC, 2015, J SCHOOL HEALTH, V85, P729, DOI 10.1111/josh.12310; Luepker RV, 1996, JAMA-J AM MED ASSOC, V275, P768, DOI 10.1001/jama.275.10.768; McKay HA, 2015, BRIT J SPORT MED, V49, P210, DOI 10.1136/bjsports-2013-093361; Milat A., 2014, EVIDENCE EVALUATION; Milat AJ, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0301-6; Milat AJ, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-18; Milat AJ, 2013, HEALTH PROMOT INT, V28, P285, DOI 10.1093/heapro/dar097; Nader PR, 1999, ARCH PEDIAT ADOL MED, V153, P695, DOI 10.1001/archpedi.153.7.695; Niebylski ML, 2015, NUTRITION, V31, P787, DOI 10.1016/j.nut.2014.12.010; Nilsen P, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0242-0; Parra DC, 2013, GLOB HEALTH PROMOT, V20, P5, DOI 10.1177/1757975913502368; Perez-Escamilla R, 2012, ADV NUTR, V3, P790, DOI 10.3945/an.112.002873; Phelan EA, 2002, J AM GERIATR SOC, V50, P1519, DOI 10.1046/j.1532-5415.2002.50407.x; Pratt M, 2016, ENVIRON BEHAV, V48, P37, DOI 10.1177/0013916515609668; Pratt M, 2010, J PHYS ACT HEALTH, V7, pS131, DOI 10.1123/jpah.7.s2.s131; Reis RS, 2012, REV PANAM SALUD PUBL, V32, P93, DOI 10.1590/S1020-49892012000800002; Richards J, 2013, J PHYS ACT HEALTH, V10, P929, DOI 10.1123/jpah.10.7.929; Rowe G, 2011, TECHNOL FORECAST SOC, V78, P1487, DOI 10.1016/j.techfore.2011.09.002; Rychetnik L, 2002, J EPIDEMIOL COMMUN H, V56, P119, DOI 10.1136/jech.56.2.119; Sallis J. F., 2016, LANCET; Salvo D, 2014, PREV MED, V69, pS86, DOI 10.1016/j.ypmed.2014.10.014; Schulenkorf N., 2014, GLOBAL SPORT FOR DEV, P3; Seguin Rebecca A, 2008, Prev Chronic Dis, V5, pA25; Suzuki H, 2013, TRANSFORMING CITIES; Tabak RG, 2012, AM J PREV MED, V43, P337, DOI 10.1016/j.amepre.2012.05.024; Tiwari G, 2012, J TRANSP GEOGR, V22, P87, DOI 10.1016/j.jtrangeo.2011.11.020; Trost SG, 2014, BRIT J SPORT MED, V48, P169, DOI 10.1136/bjsports-2013-093372; van Dongen Johanna M, 2012, BMC Res Notes, V5, P514, DOI 10.1186/1756-0500-5-514; Wilson PM, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-91; World Health Organization, 2009, PRACT GUID SCAL HLTH; Yamey G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001049; [No title captured]	82	366	379	8	146	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2016	388	10051					1337	1348		10.1016/S0140-6736(16)30728-0	http://dx.doi.org/10.1016/S0140-6736(16)30728-0			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DW5RH	27475273	Green Accepted			2022-12-28	WOS:000383704000036
J	Nishida, K; Arazoe, T; Yachie, N; Banno, S; Kakimoto, M; Tabata, M; Mochizuki, M; Miyabe, A; Araki, M; Hara, KY; Shimatani, Z; Kondo, A				Nishida, Keiji; Arazoe, Takayuki; Yachie, Nozomu; Banno, Satomi; Kakimoto, Mika; Tabata, Mayura; Mochizuki, Masao; Miyabe, Aya; Araki, Michihiro; Hara, Kiyotaka Y.; Shimatani, Zenpei; Kondo, Akihiko			Targeted nucleotide editing using hybrid prokaryotic and vertebrate adaptive immune systems	SCIENCE			English	Article							CRISPR-CAS SYSTEMS; STRANDED-DNA; CHO-CELLS; NUCLEASES; DEAMINASE; AID; DIVERSIFICATION; CLEAVAGE; ENZYME	The generation of genetic variation (somatic hypermutation) is an essential process for the adaptive immune system in vertebrates. We demonstrate the targeted single-nucleotide substitution of DNA using hybrid vertebrate and bacterial immune systems components. Nuclease-deficient type II CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated) and the activation-induced cytidine deaminase (AID) ortholog PmCDA1 were engineered to form a synthetic complex (Target-AID) that performs highly efficient target-specific mutagenesis. Specific point mutation was induced primarily at cytidines within the target range of five bases. The toxicity associated with the nuclease-based CRISPR/Cas9 system was greatly reduced. Although combination of nickase Cas9(D10A) and the deaminase was highly effective in yeasts, it also induced insertion and deletion (indel) in mammalian cells. Use of uracil DNA glycosylase inhibitor suppressed the indel formation and improved the efficiency.	[Nishida, Keiji; Arazoe, Takayuki; Banno, Satomi; Kakimoto, Mika; Tabata, Mayura; Mochizuki, Masao; Miyabe, Aya; Araki, Michihiro; Shimatani, Zenpei; Kondo, Akihiko] Kobe Univ, Grad Sch Sci Technol & Innovat, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan; [Yachie, Nozomu] Univ Tokyo, Synthet Biol Div, Res Ctr Adv Sci & Technol, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan; [Yachie, Nozomu] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Yachie, Nozomu] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Tokyo, Japan; [Hara, Kiyotaka Y.] Univ Shizuoka, Grad Sch Nutr & Environm Sci, Dept Environm Sci, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan; [Kondo, Akihiko] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan	Kobe University; University of Tokyo; Keio University; Japan Science & Technology Agency (JST); University of Shizuoka; Kobe University	Kondo, A (corresponding author), Kobe Univ, Grad Sch Sci Technol & Innovat, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.; Kondo, A (corresponding author), Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	akondo@kobe-u.ac.jp	Kondo, Akihiko/A-2130-2015	Banno, Satomi/0000-0002-5853-5003	Ministry of Education, Culture, Sports and Technology (MEXT) of Japan; commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan; JSPS [26119710, 16K14654]; Cross-ministerial Strategic Innovation Promotion Program (SIP); Grants-in-Aid for Scientific Research [16K14654, 26430198] Funding Source: KAKEN	Ministry of Education, Culture, Sports and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Cross-ministerial Strategic Innovation Promotion Program (SIP); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Yajima for helpful discussion. This work was supported by a Special Coordination Fund for Promoting Science and Technology, Creation of Innovative Centers for Advanced Interdisciplinary Research Areas (Innovative Bioproduction Kobe) from the Ministry of Education, Culture, Sports and Technology (MEXT) of Japan. This work was also partly supported by the commission for Development of Artificial Gene Synthesis Technology for Creating Innovative Biomaterial from the Ministry of Economy, Trade and Industry (METI), Japan, by JSPS KAKENHI grant numbers 26119710 and 16K14654, and by Cross-ministerial Strategic Innovation Promotion Program (SIP); 'Technologies for creating next-generation agriculture, forestry and fisheries.' Patents have been filed related to this work.	Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007; Bransteitter R, 2003, P NATL ACAD SCI USA, V100, P4102, DOI 10.1073/pnas.0730835100; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; DiCarlo JE, 2013, NUCLEIC ACIDS RES, V41, P4336, DOI 10.1093/nar/gkt135; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Knisbacher BA, 2016, TRENDS GENET, V32, P16, DOI 10.1016/j.tig.2015.10.005; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Lada AG, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003736; Lee JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep08572; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Rada C, 2002, CURR BIOL, V12, P1748, DOI 10.1016/S0960-9822(02)01215-0; Rattray AJ, 2003, ANNU REV GENET, V37, P31, DOI 10.1146/annurev.genet.37.042203.132748; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463; Shin J, 2015, BIOTECHNOL BIOPROC E, V20, P825, DOI 10.1007/s12257-015-0233-7; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Stemmer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124633; Tsai SQ, 2015, NAT BIOTECHNOL, V33, P187, DOI 10.1038/nbt.3117; Tsai SQ, 2014, NAT BIOTECHNOL, V32, P569, DOI 10.1038/nbt.2908; van der Oost J, 2014, NAT REV MICROBIOL, V12, P479, DOI 10.1038/nrmicro3279; Vercoe RB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003454; WANG ZG, 1991, GENE, V99, P31; Zhao B, 2004, NUCLEIC ACIDS RES, V32, P3984, DOI 10.1093/nar/gkh710	27	690	797	23	256	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 16	2016	353	6305							aaf8729	10.1126/science.aaf8729	http://dx.doi.org/10.1126/science.aaf8729			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW2AD	27492474				2022-12-28	WOS:000383444400036
J	Laxminarayan, R; Sridhar, D; Blaser, M; Wang, MG; Woolhouse, M				Laxminarayan, Ramanan; Sridhar, Devi; Blaser, Martin; Wang, Minggui; Woolhouse, Mark			Achieving global targets for antimicrobial resistance	SCIENCE			English	Editorial Material							ANTIBIOTICS; ACCESS		[Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC 20005 USA; [Sridhar, Devi; Woolhouse, Mark] Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland; [Blaser, Martin] NYU, Sch Med, New York, NY 10016 USA; [Wang, Minggui] Fudan Univ, Shanghai 200433, Peoples R China	University of Edinburgh; New York University; Fudan University	Woolhouse, M (corresponding author), Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland.	mark.woolhouse@ed.ac.uk	Laxminarayan, Ramanan/ABD-5050-2021; Wang, Minggui/AAR-8281-2020	Wang, Minggui/0000-0001-7682-5859				Ardal C, 2016, LANCET, V387, P296, DOI 10.1016/S0140-6736(15)00470-5; Baym M, 2016, SCIENCE, V351, DOI 10.1126/science.aad3292; Center for Disease Dynamics Economics and Policy, 2015, STAT WORLDS ANT 2015; Clinton C., 2016, GOVERNING GLOBAL HLT; Czaplewski L, 2016, LANCET INFECT DIS, V16, P239, DOI 10.1016/S1473-3099(15)00466-1; Huttner B, 2010, LANCET INFECT DIS, V10, P17, DOI 10.1016/S1473-3099(09)70305-6; Laxminarayan R., 2015, OECD FOOD AGR FISH P, V78; Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2; Laxminarayan R, 2014, SCIENCE, V345, P1299, DOI 10.1126/science.1254163; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Laxminarayan R, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000135; Laxminarayan R, 2012, SCIENCE, V338, P615, DOI 10.1126/science.1231010; SRIDHAR D, 2011, GETTING POLITICS RIG; Tougher S., 2012, LANCET, V6736, P1; Van Boeckel TP, 2014, LANCET INFECT DIS, V14, P742, DOI 10.1016/S1473-3099(14)70780-7; Woolhouse M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0083; Woolhouse M, 2014, NATURE, V509, P555, DOI 10.1038/509555a; World Health Organization, 2016, ANTIMICROBIAL RESIST	18	161	166	5	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					874	875		10.1126/science.aaf9286	http://dx.doi.org/10.1126/science.aaf9286			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU0CA	27540009	Green Accepted			2022-12-28	WOS:000381867700021
J	Dissel, S; Shaw, PJ				Dissel, Stephane; Shaw, Paul J.			Flipping the sleep switch	NATURE			English	Editorial Material							DROSOPHILA		[Dissel, Stephane; Shaw, Paul J.] Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63130 USA	Washington University (WUSTL)	Dissel, S (corresponding author), Washington Univ, Sch Med, Dept Neurosci, St Louis, MO 63130 USA.	dissels@wustl.edu; shawp@wustl.edu		Dissel, Stephane/0000-0002-4486-5052				Donlea JM, 2011, SCIENCE, V332, P1571, DOI 10.1126/science.1202249; Jones Barbara E, 2011, Handb Clin Neurol, V98, P131, DOI 10.1016/B978-0-444-52006-7.00009-5; Kahsai L, 2011, J COMP NEUROL, V519, P290, DOI 10.1002/cne.22520; Liu QL, 2012, CURR BIOL, V22, P2114, DOI 10.1016/j.cub.2012.09.008; Pimentel D, 2016, NATURE, V536, P333, DOI 10.1038/nature19055; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; Sorooshyari S, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00032; Ueno T, 2012, NAT NEUROSCI, V15, P1516, DOI 10.1038/nn.3238	8	2	2	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					278	280		10.1038/nature18918	http://dx.doi.org/10.1038/nature18918			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27487223				2022-12-28	WOS:000381804900022
J	Mayor, S				Mayor, Susan			Targeted case finding improves treatment of patients at high risk for CVD, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Hemming K, 2016, BRIT J GEN PRACT, V66, pE758, DOI 10.3399/bjgp16X686629	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2016	354								i4535	10.1136/bmj.i4535	http://dx.doi.org/10.1136/bmj.i4535			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GZ	27535997				2022-12-28	WOS:000381806400013
J	Carter, RE; Hodge, DO; Lopez-Jimenez, F				Carter, Rickey E.; Hodge, David O.; Lopez-Jimenez, Francisco			Normal-Weight Central Obesity and Mortality Risk RESPONSE	ANNALS OF INTERNAL MEDICINE			English	Letter									[Carter, Rickey E.; Hodge, David O.; Lopez-Jimenez, Francisco] Mayo Clin, Rochester, MN 55902 USA	Mayo Clinic	Carter, RE (corresponding author), Mayo Clin, Rochester, MN 55902 USA.								0	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					298	299		10.7326/L16-0073	http://dx.doi.org/10.7326/L16-0073			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UI	27538166				2022-12-28	WOS:000381267200026
J	McDonald, A				McDonald, Andrew			What doctors say and what patients hear	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[McDonald, Andrew] Scope, 6 Market Rd, London N7 9PW, England		McDonald, A (corresponding author), Scope, 6 Market Rd, London N7 9PW, England.	info@nationalvoices.org.uk							0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2016	354								i4453	10.1136/bmj.i4453	http://dx.doi.org/10.1136/bmj.i4453			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GX	27530907				2022-12-28	WOS:000381806200005
J	Evans, WN; Sullivan, JX; Wallskog, M				Evans, William N.; Sullivan, James X.; Wallskog, Melanie			The impact of homelessness prevention programs on homelessness	SCIENCE			English	Article							SERVICES	Despite the prevalence of temporary financial assistance programs for those facing imminent homelessness, there is little evidence of their impact. Using data from Chicago from 2010 to 2012 (n = 4448), we demonstrate that the volatile nature of funding availability leads to good-as-random variation in the allocation of resources to individuals seeking assistance. To estimate impacts, we compare families that call when funds are available with those who call when they are not. We find that those calling when funding is available are 76% less likely to enter a homeless shelter. The per-person cost of averting homelessness through financial assistance is estimated as $10,300 and would be much less with better targeting of benefits to lower-income callers. The estimated benefits, not including many health benefits, exceed $20,000.	[Evans, William N.; Sullivan, James X.] Univ Notre Dame, Dept Econ, Notre Dame, IN 46556 USA; [Evans, William N.] Natl Bur Econ Res, Cambridge, MA 02138 USA; [Evans, William N.; Sullivan, James X.] Wilson Sheehan Lab Econ Opportun, Notre Dame, IN 46556 USA; [Wallskog, Melanie] Stanford Univ, Dept Econ, Stanford, CA 94305 USA	University of Notre Dame; National Bureau of Economic Research; Stanford University	Sullivan, JX (corresponding author), Univ Notre Dame, Dept Econ, Notre Dame, IN 46556 USA.; Sullivan, JX (corresponding author), Wilson Sheehan Lab Econ Opportun, Notre Dame, IN 46556 USA.	jsulliv4@nd.edu			Wilson Sheehan Lab for Economic Opportunities at the University of Notre Dame	Wilson Sheehan Lab for Economic Opportunities at the University of Notre Dame	This project is supported by the Wilson Sheehan Lab for Economic Opportunities at the University of Notre Dame. The study received approval from the University of Notre Dame's Institutional Review Board (protocol 14-10-2111). We have benefited from the research assistance of A. Kroeger, J. Macke, and C. Palmer, as well as from the help and cooperation of Catholic Charities of the Archdiocese of Chicago and its HPCC, with special thanks to K. Donahue, B. Haennicke, S. Murray, and N. Russo. We also thank N. Brennan, P. Thangaraj, and the data team at All Chicago, who provided the HMIS data. We thank K. Corinth, S. Heller, and seminar participants at the University of Wisconsin Institute for Research on Poverty, the University of Chicago, the University of Maryland, the University of Utah, and the University of Notre Dame for helpful comments. Data and code to replicate the results of this study are available at the University of Michigan's Interuniversity Consortium for Political and Social Research (www.openicpsr.org/repoEntity/show/83434).	[Anonymous], 2012, RAP REH SUCC END FAM; Barrow SM, 1999, AM J PUBLIC HEALTH, V89, P529, DOI 10.2105/AJPH.89.4.529; Burt M., 2005, STRATEGIES PREVENTIN; Culhane D. P., 2010, HOUS POLICY DEBATE, V21, P2; Flaming D., 2015, HOME NOT FDN COST HO; Friedman D. H., 2007, PREVENTING HOMELESSN; George C., 2011, EVALUATION HOMELESSN; Greer AL, 2016, SOC SERV REV, V90, P130, DOI 10.1086/686466; org, 2015, FIND YOUR LOC 2 1 1; Shinn M., 2001, ANAL SOC ISS PUB POL, V1, P95, DOI DOI 10.1111/1530-2415.00006; Shinn M, 2013, AM J PUBLIC HEALTH, V103, pS324, DOI 10.2105/AJPH.2013.301468; Spellman B., 2010, COSTS ASSOCIATED 1 T; U. S. Department of Housing and Urban Development (HUD), 2014, 2014 ANN HOM ASS R 1	13	45	45	3	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					694	699		10.1126/science.aag0833	http://dx.doi.org/10.1126/science.aag0833			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5ZC	27516600				2022-12-28	WOS:000381561200039
J	Mizielinska, S; Isaacs, AM				Mizielinska, Sarah; Isaacs, Adrian M.			One target for amyotrophic lateral sclerosis therapy? Targeting a single protein reduces both toxic repeat RNAs and proteins	SCIENCE			English	Editorial Material							HEXANUCLEOTIDE REPEAT; C9ORF72; TRANSCRIPTION; EXPANSIONS; FTD; ALS		[Mizielinska, Sarah; Isaacs, Adrian M.] UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England	University of London; University College London	Isaacs, AM (corresponding author), UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1N 3BG, England.	a.isaacs@ucl.ac.uk		Mizielinska, Sarah/0000-0001-8052-600X	Motor Neurone Disease Association [Isaacs/Apr13/818-791] Funding Source: researchfish	Motor Neurone Disease Association		Batra R, 2010, HUM MOL GENET, V19, pR77, DOI 10.1093/hmg/ddq132; Cheng HM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005043; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Kramer NJ, 2016, SCIENCE, V353, P708, DOI 10.1126/science.aaf7791; Liu CR, 2012, CELL, V148, P690, DOI 10.1016/j.cell.2011.12.032; Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Wojciechowska M, 2011, HUM MOL GENET, V20, P3811, DOI 10.1093/hmg/ddr299; Zu T, 2011, P NATL ACAD SCI USA, V108, P260, DOI 10.1073/pnas.1013343108	9	0	0	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					647	648		10.1126/science.aah5408	http://dx.doi.org/10.1126/science.aah5408			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZC	27516584	Green Submitted			2022-12-28	WOS:000381561200019
J	Whicher, JR; MacKinnon, R				Whicher, Jonathan R.; MacKinnon, Roderick			Structure of the voltage-gated K+ channel Eag1 reveals an alternative voltage sensing mechanism	SCIENCE			English	Article							GO POTASSIUM CHANNEL; HUMAN-ETHER; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; GATING CHARGE; KCNH-CHANNEL; S4 SEGMENT; ACTIVATION; EXPRESSION; PORE	Voltage-gated potassium (K-v) channels are gated by the movement of the transmembrane voltage sensor, which is coupled, through the helical S4-S5 linker, to the potassium pore. We determined the single-particle cryo-electron microscopy structure of mammalian K(v)10.1, or Eag1, bound to the channel inhibitor calmodulin, at 3.78 angstrom resolution. Unlike previous K-v structures, the S4-S5 linker of Eag1 is a five-residue loop and the transmembrane segments are not domain swapped, which suggest an alternative mechanism of voltage-dependent gating. Additionally, the structure and position of the S4-S5 linker allow calmodulin to bind to the intracellular domains and to close the potassium pore, independent of voltage-sensor position. The structure reveals an alternative gating mechanism for K-v channels and provides a template to further understand the gating properties of Eag1 and related channels.	[Whicher, Jonathan R.; MacKinnon, Roderick] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu			NIH [GM43949]; Damon Runyon Cancer Research Foundation [DRG-2212-15]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Ebrahim at the Rockefeller University cryo-EM resource center for help with data collection and J. Chen and members of the MacKinnon laboratory for helpful discussions. This work was supported in part by NIH grant GM43949. J.R.W. is a Damon Runyon Fellow supported by the Damon Runyon Cancer Research Foundation (DRG-2212-15) and R.M. is an investigator in the Howard Hughes Medical Institute. The low-pass filtered and amplitude-modified three-dimensional cryo-EM density maps for rEag1 have been deposited in the EM Data Bank with accession code EMD-8215. Atomic coordinates for rEag1 have been deposited in the Protein Data Bank under accession code 5K7L. J.R.W. performed functional experiments and expressed, purified, and determined single-particle cryo-EM structure of rEag1. J.R.W. and R.M. designed experiments, analyzed and interpreted results, and wrote the manuscript.	Agarwal JR, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-18; Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Bijlenga P, 1998, J PHYSIOL-LONDON, V512, P317, DOI 10.1111/j.1469-7793.1998.317be.x; Brelidze TI, 2012, NATURE, V481, P530, DOI 10.1038/nature10735; Brelidze TI, 2009, J BIOL CHEM, V284, P27989, DOI 10.1074/jbc.M109.016337; Cabral JHM, 1998, CELL, V95, P649, DOI 10.1016/S0092-8674(00)81635-9; de Queiroz FM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-42; del Camino D, 2000, NATURE, V403, P321, DOI 10.1038/35002099; Downie BR, 2008, J BIOL CHEM, V283, P36234, DOI 10.1074/jbc.M801830200; Garcia-Quiroz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045063; Gomez-Varela D, 2007, CANCER RES, V67, P7343, DOI 10.1158/0008-5472.CAN-07-0107; GUY HR, 1991, SCIENCE, V254, P730, DOI 10.1126/science.1658932; Haitin Y, 2013, NATURE, V501, P444, DOI 10.1038/nature12487; Hardman RM, 2007, J BIOL CHEM, V282, P31972, DOI 10.1074/jbc.M705835200; Hemmerlein B, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-41; Hsu PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041203; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Ju M, 2006, BIOCHEM BIOPH RES CO, V342, P1088, DOI 10.1016/j.bbrc.2006.02.062; Ju M, 2002, FEBS LETT, V524, P204, DOI 10.1016/S0014-5793(02)03055-7; Lorinczi E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7672; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lu Z, 2001, NATURE, V413, P809, DOI 10.1038/35101535; Ludwig J, 1997, EMBO J, V16, P6337, DOI 10.1093/emboj/16.21.6337; LUDWIG J, 1994, EMBO J, V13, P4451, DOI 10.1002/j.1460-2075.1994.tb06767.x; Marques-Carvalho MJ, 2012, J MOL BIOL, V423, P34, DOI 10.1016/j.jmb.2012.06.025; Mortensen L. S., 2014, J PHYSL, V593, P181; Muskett FW, 2011, J BIOL CHEM, V286, P6184, DOI 10.1074/jbc.M110.199364; Pardo LA, 1999, EMBO J, V18, P5540, DOI 10.1093/emboj/18.20.5540; Pardo LA, 1998, J CELL BIOL, V143, P767, DOI 10.1083/jcb.143.3.767; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Schonherr R, 2000, EMBO J, V19, P3263, DOI 10.1093/emboj/19.13.3263; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Terlau H, 1997, J PHYSIOL-LONDON, V502, P537, DOI 10.1111/j.1469-7793.1997.537bj.x; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922; Zhang M, 2004, J GEN PHYSIOL, V124, P703, DOI 10.1085/jgp.200409119; Ziechner U, 2006, FEBS J, V273, P1074, DOI 10.1111/j.1742-4658.2006.05134.x	42	193	199	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					664	669		10.1126/science.aaf8070	http://dx.doi.org/10.1126/science.aaf8070			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZC	27516594	Green Accepted			2022-12-28	WOS:000381561200032
J	Alarcon, CR; Tavazoie, SF				Alarcon, Claudio R.; Tavazoie, Sohail F.			Endothelial-cell killing promotes metastasis	NATURE			English	Editorial Material							LUNG		[Alarcon, Claudio R.; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA	Rockefeller University	Alarcon, CR (corresponding author), Rockefeller Univ, Lab Syst Canc Biol, New York, NY 10065 USA.	calarcon@rockefeller.edu; stavazoie@rockefeller.edu						Ding BS, 2014, NATURE, V505, P97, DOI 10.1038/nature12681; Dvorak HF, 2015, CANCER J, V21, P237, DOI 10.1097/PPO.0000000000000124; Ferrara N, 2009, ARTERIOSCL THROM VAS, V29, P789, DOI 10.1161/ATVBAHA.108.179663; FOLKMAN J, 1986, CANCER RES, V46, P467; Furlow PW, 2015, NAT CELL BIOL, V17, P943, DOI 10.1038/ncb3194; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Headley MB, 2016, NATURE, V531, P513, DOI 10.1038/nature16985; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Schumacher D, 2013, CANCER CELL, V24, P130, DOI 10.1016/j.ccr.2013.05.008; Strilic B, 2016, NATURE, V536, P215, DOI 10.1038/nature19076	11	7	8	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					154	155		10.1038/nature19465	http://dx.doi.org/10.1038/nature19465			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27487224				2022-12-28	WOS:000381472100023
J	Park, IY; Powell, RT; Tripathi, DN; Dere, R; Ho, TH; Blasius, TL; Chiang, YC; Davis, IJ; Fahey, CC; Hacker, KE; Verhey, KJ; Bedford, MT; Jonasch, E; Rathmell, WK; Walker, CL				Park, In Young; Powell, Reid T.; Tripathi, Durga Nand; Dere, Ruhee; Ho, Thai H.; Blasius, T. Lynne; Chiang, Yun-Chen; Davis, Ian J.; Fahey, Catherine C.; Hacker, Kathryn E.; Verhey, Kristen J.; Bedford, Mark T.; Jonasch, Eric; Rathmell, W. Kimryn; Walker, Cheryl Lyn			Dual Chromatin and Cytoskeletal Remodeling by SETD2	CELL			English	Article							RENAL-CELL CARCINOMA; ACUTE LYMPHOBLASTIC-LEUKEMIA; HISTONE H3K36 METHYLATION; RNA-POLYMERASE-II; EPIGENETIC REGULATORS; POSTTRANSLATIONAL MODIFICATIONS; HOMOLOGOUS RECOMBINATION; BRANCHED EVOLUTION; CANCER GENOMICS; TUBULIN CODE	Posttranslational modifications (PTMs) of tubulin specify microtubules for specialized cellular functions and comprise what is termed a "tubulin code.'' PTMs of histones comprise an analogous "histone code,'' although the "readers, writers, and erasers'' of the cytoskeleton and epigenome have heretofore been distinct. We show that methylation is a PTM of dynamic microtubules and that the histone methyltransferase SET-domain-containing 2 (SETD2), which is responsible for H3 lysine 36 trimethylation (H3K36me3) of histones, also methylates a-tubulin at lysine 40, the same lysine that is marked by acetylation on microtubules. Methylation of microtubules occurs during mitosis and cytokinesis and can be ablated by SETD2 deletion, which causes mitotic spindle and cytokinesis defects, micronuclei, and polyploidy. These data now identify SETD2 as a dual-function methyltransferase for both chromatin and the cytoskeleton and show a requirement for methylation in maintenance of genomic stability and the integrity of both the tubulin and histone codes.	[Park, In Young; Powell, Reid T.; Tripathi, Durga Nand; Dere, Ruhee; Walker, Cheryl Lyn] Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Translat Canc Res, Houston, TX 77030 USA; [Ho, Thai H.] Mayo Clin Arizona, Div Hematol Oncol, Scottsdale, AZ 85259 USA; [Blasius, T. Lynne; Verhey, Kristen J.] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Chiang, Yun-Chen; Davis, Ian J.; Fahey, Catherine C.; Hacker, Kathryn E.; Rathmell, W. Kimryn] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Chiang, Yun-Chen; Davis, Ian J.; Fahey, Catherine C.; Hacker, Kathryn E.; Rathmell, W. Kimryn] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Davis, Ian J.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; [Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA; [Jonasch, Eric] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Rathmell, W. Kimryn] Vanderbilt Univ, Div Hematol Oncol, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Park, In Young; Powell, Reid T.; Tripathi, Durga Nand; Dere, Ruhee; Walker, Cheryl Lyn] Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Mayo Clinic; Mayo Clinic Phoenix; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Vanderbilt University; Baylor College of Medicine	Walker, CL (corresponding author), Texas A&M Hlth Sci Ctr, Inst Biosci & Technol, Ctr Translat Canc Res, Houston, TX 77030 USA.; Walker, CL (corresponding author), Baylor Coll Med, Dept Mol & Cell Biol, Houston, TX 77030 USA.	cherylw@bcm.edu	Tripathi, Durga Nand/H-3247-2019; Park, In Young/AAN-7901-2020; Chiang, Yun/GRJ-5251-2022	Tripathi, Durga Nand/0000-0001-8736-4808; Park, In Young/0000-0002-0082-1189; Ho, Thai/0000-0003-0023-2939; Fahey, Catherine/0000-0003-4347-361X; Davis, Ian/0000-0002-1552-0960; Powell, Reid T./0000-0002-6242-8315	Robert E. Welch Foundation [BE-0023]; NIH [RC2ES018789, R01ES008263, R01ES023206, R01CA214052, P30ES023512]; Cancer Prevention and Research Institute of Texas (CPRIT) [DP150086]; V Foundation for Cancer Research award [T2012-008, R01CA166447, T32 GM008719]; NRSA [F30 CA192643-02]; CPRIT [RP110471, K12CA90628]; Gerstner Family Career Development Award; NIH/NCI [P30CA016672];  [R01GM070862];  [R01CA198482]; NATIONAL CANCER INSTITUTE [K12CA090628, P30CA016672, R01CA203012, F30CA192643, R01CA198482, T32CA009156, R01CA166447, R01CA121052] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES008263, R01ES023206, P30ES023512, RC2ES018789] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719, R01GM070862] Funding Source: NIH RePORTER	Robert E. Welch Foundation(The Welch Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas (CPRIT); V Foundation for Cancer Research award; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; Gerstner Family Career Development Award; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Claire Walczak (University of Indiana) for valuable discussions concerning mitotic defects, Tia Berry and Xuefei Tong for technical assistance, Austin Hepperla (UNC Chapel Hill) for designing the pipeline used to align the RNA-sequencing data, and Dr. Sung Yun Jung (Baylor College of Medicine) for mass spectrometry analysis. This work was supported in part by grants from the Robert E. Welch Foundation (BE-0023), the NIH (RC2ES018789, R01ES008263, R01ES023206, R01CA214052, and P30ES023512) and the Cancer Prevention and Research Institute of Texas (CPRIT, DP150086) to C.L.W.; grant R01GM070862 to K.J.V.; grant R01CA198482 and R01CA214052 to W.K.R. and I.J.D.; a V Foundation for Cancer Research award (T2012-008) to W.K.R.; grant R01CA166447 to I.J.D.; grant T32 GM008719 and NRSA award F30 CA192643-02 to C.C.F.; grant CPRIT RP110471 to M.T.B.; grant K12CA90628 and a Gerstner Family Career Development Award to T.H.H.; and NIH/NCI grant P30CA016672 to E.J.	Agromayor M, 2013, TRENDS CELL BIOL, V23, P433, DOI 10.1016/j.tcb.2013.04.006; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; [Anonymous], 2013, NATURE, V499, P43, DOI [10.1038/nature12222, DOI 10.1038/NATURE12222, DOI 10.1038/nature12222]; Aymard F, 2014, NAT STRUCT MOL BIOL, V21, P366, DOI 10.1038/nsmb.2796; Barisic M, 2015, SCIENCE, V348, P799, DOI 10.1126/science.aaa5175; Bi M, 2016, P NATL ACAD SCI USA, V113, P2170, DOI 10.1073/pnas.1525735113; Carvalho S, 2014, ELIFE, V3, DOI 10.7554/eLife.02482; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen ZZ, 2007, P NATL ACAD SCI USA, V104, P10818, DOI 10.1073/pnas.0704525104; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; Ganem NJ, 2007, CELL, V131, P437, DOI 10.1016/j.cell.2007.10.024; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Green RA, 2012, ANNU REV CELL DEV BI, V28, P29, DOI 10.1146/annurev-cellbio-101011-155718; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Hakimi AA, 2013, CLIN CANCER RES, V19, P3259, DOI 10.1158/1078-0432.CCR-12-3886; Ho TH, 2016, ONCOGENE, V35, P1565, DOI 10.1038/onc.2015.221; Ho TH, 2016, MODERN PATHOL, V29, P34, DOI 10.1038/modpathol.2015.123; Hu M, 2010, P NATL ACAD SCI USA, V107, P2956, DOI 10.1073/pnas.0915033107; Huang K.K., 2015, GUT; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630; Janke C, 2014, J CELL BIOL, V206, P461, DOI 10.1083/jcb.201406055; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kanu N, 2015, ONCOGENE, V34, P5699, DOI 10.1038/onc.2015.24; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Kovac M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7336; Kwok BH, 2007, CURR OPIN CELL BIOL, V19, P36, DOI 10.1016/j.ceb.2006.12.003; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Lee JS, 2010, CELL, V142, P682, DOI 10.1016/j.cell.2010.08.011; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Liao LL, 2015, CANCER GENET-NY, V208, P206, DOI 10.1016/j.cancergen.2015.02.008; Liu WS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002004; Magiera MM, 2013, METHOD CELL BIOL, V115, P247, DOI 10.1016/B978-0-12-407757-7.00016-5; Mar BG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4469; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Motulsky H. J., 2016, GRAPHPAD STAT GUIDE; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Perdiz D, 2011, CELL SIGNAL, V23, P763, DOI 10.1016/j.cellsig.2010.10.014; Pfister SX, 2014, CELL REP, V7, P2006, DOI 10.1016/j.celrep.2014.05.026; Rebehmed J, 2014, FEBS LETT, V588, P4431, DOI 10.1016/j.febslet.2014.10.014; Simon JM, 2014, GENOME RES, V24, P241, DOI 10.1101/gr.158253.113; Song YY, 2015, TRENDS CELL BIOL, V25, P125, DOI 10.1016/j.tcb.2014.10.004; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Walczak CE, 2008, INT REV CYTOL, V265, P111, DOI 10.1016/S0074-7696(07)65003-7; Yuan W, 2009, J BIOL CHEM, V284, P15701, DOI 10.1074/jbc.M808431200; Zhang JH, 2012, NATURE, V481, P157, DOI 10.1038/nature10725	49	134	142	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					950	962		10.1016/j.cell.2016.07.005	http://dx.doi.org/10.1016/j.cell.2016.07.005			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27518565	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000382258700017
J	Haussig, S; Mangner, N; Dwyer, MG; Lehmkuhl, L; Lucke, C; Woitek, F; Holzhey, DM; Mohr, FW; Gutberlet, M; Zivadinov, R; Schuler, G; Linke, A				Haussig, Stephan; Mangner, Norman; Dwyer, Michael G.; Lehmkuhl, Lukas; Luecke, Christian; Woitek, Felix; Holzhey, David M.; Mohr, Friedrich W.; Gutberlet, Matthias; Zivadinov, Robert; Schuler, Gerhard; Linke, Axel			Effect of a Cerebral Protection Device on Brain Lesions Following Transcatheter Aortic Valve Implantation in Patients With Severe Aortic Stenosis The CLEAN-TAVI Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK-FACTORS; REPLACEMENT; SURGERY; EVENTS; SILENT; IMAGES; MRI	IMPORTANCE Stroke remains a major predictor of mortality after transcatheter aortic valve implantation (TAVI). Cerebral protection devices might reduce brain injury as determined by diffusion-weighted magnetic resonance imaging (DWMRI). OBJECTIVE To determine the effect of a cerebral protection device on the number and volume of cerebral lesions in patients undergoing TAVI. DESIGN, SETTING, AND PARTICIPANTS Investigator-initiated, single center, blinded, randomized clinical trial in higher-risk patients with severe aortic stenosis undergoing TAVI at the University of Leipzig Heart Center. Brain MRI was performed at baseline, 2 days, and 7 days after TAVI. Between April 2013 and June 2014, patients were randomly assigned to undergo TAVI with a cerebral protection device (filter group) or without a cerebral protection device (control group). The last 1-month follow-up occurred in July 2014. INTERVENTIONS TAVI with or without a cerebral protection device (filter system). MAIN OUTCOMES AND MEASURES The primary end point was the numerical difference in new positive postprocedure DWMRI brain lesions at 2 days after TAVI in potentially protected territories. The first hierarchical secondary outcome was the difference in volume of new lesions after TAVI in potentially protected territories. RESULTS Among the 100 enrolled patients, mean (SD) age was 80.0 (5.1) years in the filter group (n=50) and 79.1 (4.1) years in the control group (n=50), and the mean (SD) procedural risk scores (logistic EuroScores) were 16.4%(10.0%) in the filter group and 14.5% (8.7%) in the control group. For the primary end point, the number of new lesions was lower in the filter group, 4.00 (interquartile range [IQR], 3.00-7.25) vs 10.00 (IQR, 6.75-17.00) in the control group (difference, 5.00 [IQR, 2.00-8.00]; P<.001). For the first hierarchical secondary end point, new lesion volume after TAVI was lower in the filter group (242 mm(3) [95% CI, 159-353]) vs in the control group (527 mm(3) [95% CI, 364-830]) (difference, 234 mm(3) [95% CI, 91-406]; P=.001). Considering adverse events, 1 patient in the control group died prior to the 30-day visit. Life-threatening hemorrhages occurred in 1 patient in the filter group and 1 in the control group. Major vascular complications occurred in 5 patients in the filter group and 6 patients in the control group. One patient in the filter group and 5 in the control group had acute kidney injury, and 3 patients in the filter group had a thoracotomy. CONCLUSIONS AND RELEVANCE Among patients with severe aortic stenosis undergoing TAVI, the use of a cerebral protection device reduced the frequency of ischemic cerebral lesions in potentially protected regions. Larger studies are needed to assess the effect of cerebral protection device use on neurological and cognitive function after TAVI and to devise methods that will provide more complete coverage of the brain to prevent new lesions.	[Haussig, Stephan; Mangner, Norman; Lehmkuhl, Lukas; Luecke, Christian; Woitek, Felix; Holzhey, David M.; Mohr, Friedrich W.; Gutberlet, Matthias; Schuler, Gerhard; Linke, Axel] Univ Leipzig, Ctr Heart, Leipzig, Germany; [Dwyer, Michael G.; Zivadinov, Robert] Univ Buffalo, Dept Neurol, Buffalo Neuroimaging Anal Ctr, Buffalo, NY USA; [Mohr, Friedrich W.; Linke, Axel] Leipzig Heart Inst, Leipzig, Germany	Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Heart Center Leipzig GMBH	Linke, A (corresponding author), Univ Leipzig, Dept Internal Med Cardiol, Ctr Heart, Struempellstr 39, D-04289 Leipzig, Germany.	axel.linke@medizin.uni-leipzig.de	Zivadinov, Robert/Q-2054-2019; Gutberlet, Matthias/AAL-2699-2021; Mangner, Norman/AAN-4673-2020	Zivadinov, Robert/0000-0002-7799-1485; Mangner, Norman/0000-0003-0793-7923; Gutberlet, Matthias/0000-0003-4879-0438; Holzhey, David/0000-0002-0613-4419	Claret Medical; Medtronic	Claret Medical; Medtronic(Medtronic)	The Leipzig Heart Center received a grant from Claret Medical and Medtronic.	Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; Amat-Santos IJ, 2012, J AM COLL CARDIOL, V59, P178, DOI 10.1016/j.jacc.2011.09.061; Astarci P, 2011, EUR J CARDIO-THORAC, V40, P475, DOI 10.1016/j.ejcts.2010.11.070; Fairbairn TA, 2012, HEART, V98, P18, DOI 10.1136/heartjnl-2011-300065; Genereux P, 2012, J AM COLL CARDIOL, V59, P2317, DOI 10.1016/j.jacc.2012.02.022; Ghanem A, 2010, J AM COLL CARDIOL, V55, P1427, DOI 10.1016/j.jacc.2009.12.026; Goldberg I, 2012, J NEUROL SCI, V322, P250, DOI 10.1016/j.jns.2012.02.021; Hartkamp NS, 2013, NEUROIMAGE, V83, P58, DOI 10.1016/j.neuroimage.2013.06.070; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; JEZZARD P, 1995, MAGNET RESON MED, V34, P65, DOI 10.1002/mrm.1910340111; Kahlert P, 2010, CIRCULATION, V121, P870, DOI 10.1161/CIRCULATIONAHA.109.855866; Lansky AJ, 2015, EUR HEART J, V36, P2070, DOI 10.1093/eurheartj/ehv191; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Linke A, 2014, EUR HEART J, V35, P2672, DOI 10.1093/eurheartj/ehu162; Ludman PF, 2015, CIRCULATION, V131, P1181, DOI 10.1161/CIRCULATIONAHA.114.013947; Messe SR, 2014, CIRCULATION, V129, P2253, DOI 10.1161/CIRCULATIONAHA.113.005084; Miller DC, 2012, J THORAC CARDIOV SUR, V143, P832, DOI 10.1016/j.jtcvs.2012.01.055; Miller DC, 2012, J THORAC CARDIOVASC, V143, pe13; Naber CK, 2012, EUROINTERVENTION, V8, P43, DOI 10.4244/EIJV8I1A8; Rodes-Cabau J, 2014, JACC-CARDIOVASC INTE, V7, P1146, DOI 10.1016/j.jcin.2014.04.019; Tay ELW, 2011, JACC-CARDIOVASC INTE, V4, P1290, DOI 10.1016/j.jcin.2011.08.012; Van Mieghem NM, 2013, CIRCULATION, V127, P2194, DOI 10.1161/CIRCULATIONAHA.112.001091; van Rooij FG, 2014, STROKE, V45, P2270, DOI 10.1161/STROKEAHA.114.005205	23	198	201	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2016	316	6					592	601		10.1001/jama.2016.10302	http://dx.doi.org/10.1001/jama.2016.10302			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7TK	27532914	Bronze			2022-12-28	WOS:000380985600012
J	Stillman, MD; Williams, SR				Stillman, Michael D.; Williams, Steve R.			It's Rough Out There for Us	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACCESSIBILITY		[Stillman, Michael D.] Univ Washington, Sch Med, Dept Internal Med, Seattle, WA 98195 USA; [Williams, Steve R.] Univ Washington, Sch Med, Dept Rehabil Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stillman, MD (corresponding author), Univ Washington, Sch Med, Dept Internal Med, Seattle, WA 98195 USA.	michael.stillman1972@gmail.com	Williams, Steve C/D-6979-2011	Williams, Steve C/0000-0003-4299-1941				Frost KL, 2015, J REHABIL RES DEV, V52, P653, DOI 10.1682/JRRD.2015.01.0002; Graham CL, 2008, DISABIL HEALTH J, V1, P209, DOI 10.1016/j.dhjo.2008.06.001; McNeal MAL., 2002, PROVIDING PRIMARY HL; Stillman MD, 2014, ARCH PHYS MED REHAB, V95, P1114, DOI 10.1016/j.apmr.2014.02.005	4	2	2	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2016	316	6					585	586		10.1001/jama.2016.4460	http://dx.doi.org/10.1001/jama.2016.4460			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7TK	27532911				2022-12-28	WOS:000380985600009
J	Briggs, WR				Briggs, Winslow R.			How do sunflowers follow the Sun-and to what end?	SCIENCE			English	Editorial Material							AUXIN		[Briggs, Winslow R.] Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA	Carnegie Institution for Science	Briggs, WR (corresponding author), Carnegie Inst Sci, Dept Plant Biol, Stanford, CA 94305 USA.	briggs@stanford.edu						Atamian HS, 2016, SCIENCE, V353, P587, DOI 10.1126/science.aaf9793; BRIGGS WR, 1957, SCIENCE, V126, P210, DOI 10.1126/science.126.3266.210; Esmon CA, 2006, P NATL ACAD SCI USA, V103, P236, DOI 10.1073/pnas.0507127103; IINO M, 1984, PLANT CELL ENVIRON, V7, P97, DOI 10.1111/j.1365-3040.1984.tb01562.x; Koller D., 2011, THE RESTLESS PLANT; Kutschera U, 2016, ANN BOT-LONDON, V117, P1, DOI 10.1093/aob/mcv141; Merrow M, 1999, NATURE, V399, P584, DOI 10.1038/21190; Vandenbrink J. P., 2014, PLANT BIOLOGY, V224, P26; WENT F. W., 1928, REC TRAV BOT NEERL, V25, P1	9	7	7	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					541	542		10.1126/science.aah4439	http://dx.doi.org/10.1126/science.aah4439			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27493168				2022-12-28	WOS:000381560900017
J	Campbell, IS; Howell, JD; Evans, HH				Campbell, Ian S.; Howell, Joel D.; Evans, H. Hughes			Visceral Vistas: Basil Hirschowitz and the Birth of Fiberoptic Endoscopy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							GASTROINTESTINAL ENDOSCOPY; FIBERSCOPE; GASTROSCOPY; GASTROENTEROLOGY; ESOPHAGOSCOPY; PERFORATION; EXPERIENCE; DIAGNOSIS; STOMACH; HISTORY	Fiberoptic endoscopy was developed at the University of Michigan in the 1950s by gastroenterology fellow Basil Hirschowitz and 2 physicists. Previous methods to visualize the gastrointestinal lumen used rigid instruments that relied on rudimentary optical systems. They were limited in reach and caused patients considerable discomfort. Fiberoptic technology dramatically changed endoscopic practice. The fiberoptic endoscope, or fiberscope, was a flexible instrument that allowed direct inspection of the gastrointestinal lumen. Although many practicing endoscopists initially resisted its adoption, the fiberscope ultimately held sway. Studying the period from the fiberscope's first introduction in the late 1950s to its more widespread acceptance in the late 1960s may help us understand how a new technology makes its way into routine clinical practice.	Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Howell, Joel D.] Univ Michigan, North Campus Res Complex,2800 Plymouth Rd,Bldg 16, Ann Arbor, MI 48109 USA; [Evans, H. Hughes] Emory Univ, 1760 Haygood Dr,Suite W417, Atlanta, GA 30322 USA; [Campbell, Ian S.] Vanderbilt Univ, Med Ctr, NT, 1215 21st Ave South,Suite 6000 MCE, Nashville, TN 37232 USA	Vanderbilt University; University of Michigan System; University of Michigan; Emory University; Vanderbilt University	Campbell, IS (corresponding author), Vanderbilt Univ, Med Ctr, Sect Hosp Med, Div Gen Internal Med,NT, 1215 21st Ave South,Suite 6000 MCE, Nashville, TN 37232 USA.	ian.s.campbell@vanderbilt.edu						[Anonymous], 1956, U.S. Patent, Patent No. [3,010,357, 3010357]; BENEDICT EB, 1962, GASTROENTEROLOGY, V42, P171; BIRD EW, 1962, MED BIOL ILLUS, V12, P167; BRAUCHER R E, 1965, Gastrointest Endosc, V12, P20; Christensen CM, 2015, HARVARD BUS REV, V93, P44; COHEN N N, 1964, Bull Gastrointest Endosc, V11, P19; COHEN NN, 1966, AM J DIG DIS, V11, P943, DOI 10.1007/BF02233083; CONN HO, 1967, GASTROENTEROLOGY, V52, P810; CURTISS LE, 1957, J OPT SOC AM, V47, P117; DAGRADI A E, 1968, Gastrointestinal Endoscopy, V15, P93; Dagradi A E, 1971, Gastrointest Endosc, V17, P101; DEUTSCH E, 1962, GASTROENTEROLOGY, V43, P617; EDMONSON JM, 1991, GASTROINTEST ENDOSC, V37, pS27, DOI 10.1016/S0016-5107(91)70910-3; FALKENSTEIN DB, 1977, NEW ENGL J MED, V297, P116; FONTANA ROBERT S., 1963, BULL GASTROINTESTINAL ENDOSCOPY, V9, P9; FULTON WF, 1962, AM J GASTROENTEROL, V38, P290; GALEN EH, 1963, GASTROENTEROLOGY, V44, P391; GOLDMAN JA, 1965, NEW ENGL J MED, V273, P1425, DOI 10.1056/NEJM196512232732607; HIRSCHOWITZ B, 1961, LANCET, V1, P1074; HIRSCHOWITZ B I, 1957, Med Bull (Ann Arbor), V23, P178; HIRSCHOWITZ BASIL I., 1962, BULL GASTROINTESTINAL ENDOSCOPY, V8, P15; HIRSCHOWITZ BI, 1962, SURG CLIN N AM, V42, P1081; HIRSCHOWITZ BI, 1979, GASTROENTEROLOGY, V76, P864; HIRSCHOWITZ BI, 1988, CANCER, V61, P1935, DOI 10.1002/1097-0142(19880515)61:10<1935::AID-CNCR2820611002>3.0.CO;2-E; HIRSCHOWITZ BI, 1958, GASTROENTEROLOGY, V35, P50; HIRSCHOWITZ BI, 1989, ITAL J GASTROENTEROL, V21, P247; HOPKINS HH, 1954, NATURE, V173, P39, DOI 10.1038/173039b0; Howell JD, 1995, TECHNOLOGY HOSP TRAN; JONES FA, 1961, LANCET, V1, P1285; KATZ D, 1965, Bull Gastrointest Endosc, V11, P25; KATZ D, 1967, AM J DIG DIS, V12, P1185, DOI 10.1007/BF02233889; KEMP R, 1962, LANCET, V2, P88; Lemire S, 1966, Gastrointest Endosc, V13, P29; LERNER BH, 1993, B HIST MED, V67, P439; LOPRESTI PA, 1964, AM J DIG DIS, V9, P690, DOI 10.1007/BF02237727; MORRISSEY JF, 1972, GASTROENTEROLOGY, V62, P1241; MORRISSEY JF, 1983, GASTROINTEST ENDOSC, V29, P53, DOI 10.1016/S0016-5107(83)72506-X; MORRISSEY JF, 1967, GASTROENTEROLOGY, V53, P456; OLSEN ARTHUR M., 1962, IN BULL GASTROINTESTINAL ENDOSCOPY, V9, P4; POWELL DW, 1992, GASTROENTEROLOGY, V103, P1720, DOI 10.1016/0016-5085(92)91426-5; RAYL JE, 1976, ANN OTO RHINOL LARYN, V85, P627, DOI 10.1177/000348947608500511; SCHEELE GA, 1969, GASTROENTEROLOGY, V57, P203; STANFORD B, 1961, LANCET, V1, P1285; STRUB IH, 1963, AM J GASTROENTEROL, V40, P75; Tobin J, 2009, MED MICHIGAN, V2, P14; WEISIGER BB, 1963, GASTROENTEROLOGY, V44, P858; Wilcox CM, 2009, AM J MED SCI, V338, P84, DOI 10.1097/MAJ.0b013e3181ad587c; Zimmon D S, 1968, Gastrointest Endosc, V14, P220	48	4	4	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2016	165	3					214	+		10.7326/M16-0025	http://dx.doi.org/10.7326/M16-0025			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2HA	27479222				2022-12-28	WOS:000380583300010
J	Honigsbaum, M				Honigsbaum, Mark			Legionnaires' disease: revisiting the puzzle of the century	LANCET			English	Editorial Material														honigsbaum, mark/0000-0002-1891-8763					0	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2016	388	10043					456	457						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS2EK	27529093				2022-12-28	WOS:000380559400014
J	Mao, LB; Gao, HL; Yao, HB; Liu, L; Colfen, H; Liu, G; Chen, SM; Li, SK; Yan, YX; Liu, YY; Yu, SH				Mao, Li-Bo; Gao, Huai-Ling; Yao, Hong-Bin; Liu, Lei; Colfen, Helmut; Liu, Gang; Chen, Si-Ming; Li, Shi-Kuo; Yan, You-Xian; Liu, Yang-Yi; Yu, Shu-Hong			Synthetic nacre by predesigned matrix-directed mineralization	SCIENCE			English	Article							MECHANICAL-PROPERTIES; CERAMICS; MIMETICS; DESIGN; TOUGH	Although biomimetic designs are expected to play a key role in exploring future structural materials, facile fabrication of bulk biomimetic materials under ambient conditions remains a major challenge. Here, we describe a mesoscale "assembly-and-mineralization" approach inspired by the natural process in mollusks to fabricate bulk synthetic nacre that highly resembles both the chemical composition and the hierarchical structure of natural nacre. The millimeter-thick synthetic nacre consists of alternating organic layers and aragonite platelet layers (91 weight percent) and exhibits good ultimate strength and fracture toughness. This predesigned matrix-directed mineralization method represents a rational strategy for the preparation of robust composite materials with hierarchically ordered structures, where various constituents are adaptable, including brittle and heat-labile materials.	[Mao, Li-Bo; Gao, Huai-Ling; Yao, Hong-Bin; Liu, Lei; Chen, Si-Ming; Li, Shi-Kuo; Yan, You-Xian; Liu, Yang-Yi; Yu, Shu-Hong] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Div Nanomat & Chem, Hefei 230026, Peoples R China; [Mao, Li-Bo; Gao, Huai-Ling; Yao, Hong-Bin; Liu, Lei; Chen, Si-Ming; Li, Shi-Kuo; Yan, You-Xian; Liu, Yang-Yi; Yu, Shu-Hong] Chinese Acad Sci, Univ Sci & Technol China, Collaborat Innovat Ctr Suzhou Nano Sci & Technol, Hefei Sci Ctr,Dept Chem,Ctr Excellence Nanosci, Hefei 230026, Peoples R China; [Liu, Lei; Colfen, Helmut] Univ Konstanz, Phys Chem, Univ Str 10, D-78457 Constance, Germany; [Liu, Gang; Yu, Shu-Hong] Univ Sci & Technol China, Natl Synchrotron Radiat Lab, Hefei 230029, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Konstanz; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Yu, SH (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Div Nanomat & Chem, Hefei 230026, Peoples R China.; Yu, SH (corresponding author), Chinese Acad Sci, Univ Sci & Technol China, Collaborat Innovat Ctr Suzhou Nano Sci & Technol, Hefei Sci Ctr,Dept Chem,Ctr Excellence Nanosci, Hefei 230026, Peoples R China.; Yu, SH (corresponding author), Univ Sci & Technol China, Natl Synchrotron Radiat Lab, Hefei 230029, Peoples R China.	shyu@ustc.edu.cn	Gao, Huai-Ling/P-9709-2019; Yu, Shu-Hong/A-1903-2010; Yao, Hong-Bin/AAF-9517-2019; Gao, Huai-Ling/J-6295-2012; Mao, Li-bo/W-3794-2019; Liu, Yang-Yi/F-4350-2019; Yao, Hongbin/B-8347-2011	Gao, Huai-Ling/0000-0001-8908-1967; Yu, Shu-Hong/0000-0003-3732-1011; Gao, Huai-Ling/0000-0001-8908-1967; Liu, Yang-Yi/0000-0001-5823-828X; Mao, Li-Bo/0000-0002-9249-2449	National Natural Science Foundation of China [21431006]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [21521001]; National Basic Research Program of China [2014CB931800, 2013CB931800]; Users with Excellence and Scientific Research Grant of Hefei Science Center of CAS [2015HSC-UE007, 2015SRG-HSC038]; Key Research Program of Frontier Sciences, CAS [QYZDJ-SSW-SLH036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Users with Excellence and Scientific Research Grant of Hefei Science Center of CAS; Key Research Program of Frontier Sciences, CAS	The authors thank Y. Tian, L. Chen, and Y. Guan for computed tomography imaging, and L. Wang for sample preparation. The authors also thank Y. Ni and Z. Song for discussion about mechanical models. This work was supported by the National Natural Science Foundation of China (grant 21431006), the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (grant 21521001), the National Basic Research Program of China (grants 2014CB931800 and 2013CB931800), the Users with Excellence and Scientific Research Grant of Hefei Science Center of CAS (2015HSC-UE007 and 2015SRG-HSC038), and Key Research Program of Frontier Sciences, CAS (Grant QYZDJ-SSW-SLH036). Data are available in the supplementary materials.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Bai H, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500849; Barthelat F, 2007, J MECH PHYS SOLIDS, V55, P306, DOI 10.1016/j.jmps.2006.07.007; Bonderer LJ, 2008, SCIENCE, V319, P1069, DOI 10.1126/science.1148726; Bouville F, 2014, NAT MATER, V13, P508, DOI [10.1038/nmat3915, 10.1038/NMAT3915]; Chec AG, 2009, P NATL ACAD SCI USA, V106, P38, DOI 10.1073/pnas.0808796106; Chen PY, 2008, J MECH BEHAV BIOMED, V1, P208, DOI 10.1016/j.jmbbm.2008.02.003; Colfen H., 2008, MESOCRYSTALS NONCLAS, DOI DOI 10.1002/9780470994603; Das P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6967; Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937; Deville S, 2008, ADV ENG MATER, V10, P155, DOI 10.1002/adem.200700270; Finnemore A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1970; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Fratzl P, 2016, CHEM SOC REV, V45, P252, DOI 10.1039/c5cs00598a; Gebauer D, 2009, ADV MATER, V21, P435, DOI 10.1002/adma.200801614; Huang ZW, 2013, SCI REP-UK, V3, DOI 10.1038/srep01693; Jager I, 2000, BIOPHYS J, V79, P1737, DOI 10.1016/S0006-3495(00)76426-5; Ji BH, 2010, ANNU REV MATER RES, V40, P77, DOI 10.1146/annurev-matsci-070909-104424; Kato T, 2000, CHEM LETT, P186, DOI 10.1246/cl.2000.186; Kim Y, 2013, NATURE, V500, P59, DOI 10.1038/nature12401; Laaksonen P, 2011, ANGEW CHEM INT EDIT, V50, P8688, DOI 10.1002/anie.201102973; Le Ferrand H, 2015, NAT MATER, V14, P1172, DOI [10.1038/NMAT4419, 10.1038/nmat4419]; Meyers MA, 2013, SCIENCE, V339, P773, DOI 10.1126/science.1220854; Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865; Niederberger M, 2006, PHYS CHEM CHEM PHYS, V8, P3271, DOI 10.1039/b604589h; Rabiei R, 2010, ACTA BIOMATER, V6, P4081, DOI 10.1016/j.actbio.2010.04.008; Ritchie RO, 2011, NAT MATER, V10, P817, DOI [10.1038/nmat3115, 10.1038/NMAT3115]; Seto J, 2012, P NATL ACAD SCI USA, V109, P3699, DOI 10.1073/pnas.1109243109; Shao Y, 2012, J MECH PHYS SOLIDS, V60, P1400, DOI 10.1016/j.jmps.2012.04.011; Tang ZY, 2003, NAT MATER, V2, P413, DOI 10.1038/nmat906; Wang JF, 2012, CHEM SOC REV, V41, P1111, DOI 10.1039/c1cs15106a; Wang Jiwen, 2009, Biomaterials, V30, P6565, DOI 10.1016/j.biomaterials.2009.08.048; Wang RZ, 2001, J MATER RES, V16, P2485, DOI 10.1557/JMR.2001.0340; Wegst UGK, 2015, NAT MATER, V14, P23, DOI [10.1038/NMAT4089, 10.1038/nmat4089]; Weiner S, 2000, MAT SCI ENG C-BIO S, V11, P1, DOI 10.1016/S0928-4931(00)00141-7; Yao HB, 2014, ADV MATER, V26, P163, DOI 10.1002/adma.201303470; Zhu BL, 2015, ANGEW CHEM INT EDIT, V54, P8653, DOI 10.1002/anie.201502323; Zhu FJ, 2013, CHEM-ASIAN J, V8, P3002, DOI 10.1002/asia.201300745	38	524	542	111	1338	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	OCT 7	2016	354	6308			SI		107	110		10.1126/science.aaf8991	http://dx.doi.org/10.1126/science.aaf8991			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC0GT	27540008	Green Submitted			2022-12-28	WOS:000387777900040
J	Sheehan, WJ; Mauger, DT; Paul, IM; Moy, JN; Boehmer, SJ; Szefler, SJ; Fitzpatrick, AM; Jackson, DJ; Bacharier, LB; Cabana, MD; Covar, R; Holguin, F; Lemanske, RF; Martinez, FD; Pongracic, JA; Beigelman, A; Baxi, SN; Benson, M; Blake, K; Chmiel, JF; Daines, CL; Daines, MO; Gaffin, JM; Gentile, DA; Gower, WA; Israel, E; Kumar, HV; Lang, JE; Lazarus, SC; Lima, JJ; Ly, N; Marbin, J; Morgan, WJ; Myers, RE; Olin, JT; Peters, SP; Raissy, HH; Robison, RG; Ross, K; Sorkness, CA; Thyne, SM; Wechsler, ME; Phipatanakul, W				Sheehan, W. J.; Mauger, D. T.; Paul, I. M.; Moy, J. N.; Boehmer, S. J.; Szefler, S. J.; Fitzpatrick, A. M.; Jackson, D. J.; Bacharier, L. B.; Cabana, M. D.; Covar, R.; Holguin, F.; Lemanske, R. F., Jr.; Martinez, F. D.; Pongracic, J. A.; Beigelman, A.; Baxi, S. N.; Benson, M.; Blake, K.; Chmiel, J. F.; Daines, C. L.; Daines, M. O.; Gaffin, J. M.; Gentile, D. A.; Gower, W. A.; Israel, E.; Kumar, H. V.; Lang, J. E.; Lazarus, S. C.; Lima, J. J.; Ly, N.; Marbin, J.; Morgan, W. J.; Myers, R. E.; Olin, J. T.; Peters, S. P.; Raissy, H. H.; Robison, R. G.; Ross, K.; Sorkness, C. A.; Thyne, S. M.; Wechsler, M. E.; Phipatanakul, W.		NIH	Acetaminophen versus Ibuprofen in Young Children with Mild Persistent Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PARACETAMOL EXPOSURE; RISK; ASSOCIATION; RHINOCONJUNCTIVITIS; MEDICATION; CHILDHOOD; INFANCY; WHEEZE; ECZEMA; AGE	BACKGROUND Studies have suggested an association between frequent acetaminophen use and asthma-related complications among children, leading some physicians to recommend that acetaminophen be avoided in children with asthma; however, appropriately designed trials evaluating this association in children are lacking. METHODS In a multicenter, prospective, randomized, double-blind, parallel-group trial, we enrolled 300 children ( age range, 12 to 59 months) with mild persistent asthma and assigned them to receive either acetaminophen or ibuprofen when needed for the alleviation of fever or pain over the course of 48 weeks. The primary outcome was the number of asthma exacerbations that led to treatment with systemic glucocorticoids. Children in both treatment groups received standardized asthma-controller therapies that were used in a simultaneous, factorially linked trial. RESULTS Participants received a median of 5.5 doses ( interquartile range, 1.0 to 15.0) of trial medication; there was no significant between-group difference in the median number of doses received ( P = 0.47). The number of asthma exacerbations did not differ significantly between the two groups, with a mean of 0.81 per participant with acetaminophen and 0.87 per participant with ibuprofen over 46 weeks of follow-up ( relative rate of asthma exacerbations in the acetaminophen group vs. the ibuprofen group, 0.94; 95% confidence interval, 0.69 to 1.28; P = 0.67). In the acetaminophen group, 49% of participants had at least one asthma exacerbation and 21% had at least two, as compared with 47% and 24%, respectively, in the ibuprofen group. Similarly, no significant differences were detected between acetaminophen and ibuprofen with respect to the percentage of asthma-control days ( 85.8% and 86.8%, respectively; P = 0.50), use of an albuterol rescue inhaler ( 2.8 and 3.0 inhalations per week, respectively; P = 0.69), unscheduled health care utilization for asthma ( 0.75 and 0.76 episodes per participant, respectively; P = 0.94), or adverse events. CONCLUSIONS Among young children with mild persistent asthma, as-needed use of acetaminophen was not shown to be associated with a higher incidence of asthma exacerbations or worse asthma control than was as-needed use of ibuprofen. (Funded by the National Institutes of Health; AVICA ClinicalTrials.gov number, NCT01606319.)	[Sheehan, W. J.; Baxi, S. N.; Phipatanakul, W.] Boston Childrens Hosp, Div Allergy & Immunol, Boston, MA USA; [Gaffin, J. M.] Boston Childrens Hosp, Div Resp Dis, Boston, MA USA; [Israel, E.] Harvard Med Sch, Boston, MA USA; [Israel, E.] Brigham & Womens Hosp, Div Allergy & Pulm Med, 75 Francis St, Boston, MA 02115 USA; [Mauger, D. T.; Boehmer, S. J.] Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Paul, I. M.] Penn State Coll Med, Dept Pediat, Hershey, PA USA; [Holguin, F.] Univ Pittsburgh, Med Ctr, Asthma Inst, Pittsburgh, PA USA; [Gentile, D. A.] Allegheny Gen Hosp, Dept Pediat, Pittsburgh, PA 15212 USA; [Moy, J. N.] Rush Univ, Med Ctr, Stroger Hosp Cook Cty, Chicago, IL 60612 USA; [Moy, J. N.] Rush Univ, Med Ctr, Dept Pediat, Chicago, IL 60612 USA; [Pongracic, J. A.; Robison, R. G.] Ann & Robert H Lurie Childrens Hosp Chicago, Chicago, IL 60611 USA; [Kumar, H. V.] Univ Illinois, Chicago, IL USA; [Szefler, S. J.] Childrens Hosp Colorado, Breathing Inst, Aurora, CO USA; [Szefler, S. J.] Univ Colorado, Dept Pediat, Sch Med, Aurora, CO USA; [Wechsler, M. E.] Univ Colorado, Dept Med, Sch Med, Aurora, CO USA; [Covar, R.; Olin, J. T.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Wechsler, M. E.] Natl Jewish Hlth, Div Pulm Crit Care & Sleep Med, Dept Med, Denver, CO USA; Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Jackson, D. J.; Lemanske, R. F., Jr.] Univ Wisconsin, Sect Allergy Immunol & Rheumatol, Dept Pediat, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Sorkness, C. A.] Univ Wisconsin, Sch Pharm, Madison, WI 53706 USA; [Bacharier, L. B.; Beigelman, A.] Washington Univ, Sch Med, St Louis, MO USA; [Bacharier, L. B.; Beigelman, A.] St Louis Childrens Hosp, Dept Pediat, St Louis, MO 63110 USA; [Cabana, M. D.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA USA; [Lazarus, S. C.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Ly, N.] Univ Calif San Francisco, Airway Clin Res Ctr, San Francisco, CA 94143 USA; [Benson, M.; Gaffin, J. M.] Benioff Childrens Hosp Oakland, Oakland, CA USA; [Thyne, S. M.] Univ Calif Los Angeles, David Geffen Sch Med, Olive View UCLA Med Ctr, Los Angeles, CA 90095 USA; [Thyne, S. M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Martinez, F. D.; Daines, C. L.; Daines, M. O.; Morgan, W. J.] Univ Arizona, Arizona Resp Ctr, Tucson, AZ USA; [Blake, K.; Lima, J. J.] Nemours Childrens Hlth Syst, Jacksonville, FL USA; [Lang, J. E.] Univ Cent Florida, Coll Med, Nemours Childrens Hosp, Orlando, FL 32816 USA; [Chmiel, J. F.; Myers, R. E.; Ross, K.] Case Western Reserve Univ, Rainbow Babies & Childrens Hosp, Sch Med, Cleveland, OH 44106 USA; [Chmiel, J. F.; Myers, R. E.; Ross, K.] Case Western Reserve Univ, Dept Pediat, Sch Med, Cleveland, OH 44106 USA; [Gower, W. A.; Peters, S. P.] Wake Forest Sch Med, Winston Salem, NC USA; [Raissy, H. H.] Univ New Mexico, Dept Pediat, Div Pulmonol, Albuquerque, NM 87131 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Allegheny General Hospital; John H Stroger Junior Hospital Cook County; Rush University; Rush University; Ann & Robert H. Lurie Children's Hospital of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; National Jewish Health; National Jewish Health; Emory University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL); St. Louis Children's Hospital; Washington University (WUSTL); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Arizona; State University System of Florida; University of Central Florida; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Case Western Reserve University; Wake Forest University; University of New Mexico	Phipatanakul, W (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Allergy & Immunol, 300 Longwood Ave, Boston, MA 02115 USA.	wanda.phipatanakul@childrens.harvard.edu	Wechsler, Michael/AAC-5506-2019; Paul, Ian/AAD-9813-2020	Robison, Rachel/0000-0003-0160-0529; GAFFIN, JONATHAN/0000-0003-2213-4504; Fitzpatrick, Anne/0000-0002-2933-5926; Bacharier, Leonard/0000-0003-0432-2704; Szefler, Stanley/0000-0002-6911-3199; Paul, Ian/0000-0002-6344-8609; Myers, Ross/0000-0002-9494-3653; Gower, William Adam/0000-0001-5863-7379	National Institutes of Health; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454, UL1TR000439, UL1TR001082, UL1TR001102, UL1TR000448] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL098107, U10HL098096, U10HL098177, U10HL098115, U10HL098103, U10HL098075, U10HL098098, U10HL098090, U10HL098102, U10HL098112] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI104780, K24AI106822, K23AI106945] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the National Institutes of Health; AVICA ClinicalTrials.gov number, NCT01606319.	Beasley R, 2008, LANCET, V372, P1039, DOI 10.1016/S0140-6736(08)61445-2; Beasley RW, 2011, AM J RESP CRIT CARE, V183, P171, DOI 10.1164/rccm.201005-0757OC; Davey G, 2005, J ALLERGY CLIN IMMUN, V116, P863, DOI 10.1016/j.jaci.2005.05.045; Hilbe JM, 2007, NEGATIVE BINOMIAL RE; Ioannides SJ, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004324; Lesko SM, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.2.e20; McBride JT, 2011, PEDIATRICS, V128, P1181, DOI 10.1542/peds.2011-1106; McKeever TM, 2005, AM J RESP CRIT CARE, V171, P966, DOI 10.1164/rccm.200409-1269OC; National Asthma Education and Prevention Program, 2007, J Allergy Clin Immunol, V120, pS94; Perzanowski MS, 2010, THORAX, V65, P118, DOI 10.1136/thx.2009.121459; Schnabel E, 2010, J ALLERGY CLIN IMMUN, V126, P1071, DOI 10.1016/j.jaci.2010.08.023; Shaheen SO, 2005, CLIN EXP ALLERGY, V35, P18, DOI 10.1111/j.1365-2222.2005.02151.x; Soferman R, 2013, CLIN PEDIATR, V52, P42, DOI 10.1177/0009922812462764; Sordillo JE, 2015, J ALLERGY CLIN IMMUN, V135, P441, DOI 10.1016/j.jaci.2014.07.065; Sullivan JE, 2011, PEDIATRICS, V127, P580, DOI 10.1542/peds.2010-3852; Vernacchio L, 2009, PEDIATRICS, V124, P446, DOI 10.1542/peds.2008-2869; Wickens K, 2011, CLIN EXP ALLERGY, V41, P399, DOI 10.1111/j.1365-2222.2010.03610.x	17	47	49	0	18	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2016	375	7					619	630		10.1056/NEJMoa1515990	http://dx.doi.org/10.1056/NEJMoa1515990			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4VF	27532828	Bronze, Green Accepted			2022-12-28	WOS:000381478600004
J	Warner, JC; Ludwig, JK				Warner, John C.; Ludwig, Jennifer K.			Rethink how chemical hazards are tested	NATURE			English	Editorial Material									[Warner, John C.; Ludwig, Jennifer K.] Warner Babcock Inst Green Chem, Wilmington, MA 01887 USA		Warner, JC (corresponding author), Warner Babcock Inst Green Chem, Wilmington, MA 01887 USA.	john.warner@warnerbabcock.com; jennifer.ludwig@warnerbabcock.com		Warner, John/0000-0001-9426-4952				Anastas P. T., 1998, GREEN CHEM THEORY PR; Bengtstrom L, 2016, FOOD ADDIT CONTAM A, V33, P1080, DOI 10.1080/19440049.2016.1184941; Guyton KZ, 2015, LANCET ONCOL, V16, P490, DOI 10.1016/S1470-2045(15)70134-8; Rochester JR, 2015, ENVIRON HEALTH PERSP, V123, P643, DOI 10.1289/ehp.1408989; Schug TT, 2013, GREEN CHEM, V15, P181, DOI 10.1039/c2gc35055f; UNEP, 2011, HFCS CRIT LINK PROT	6	3	3	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					269	270		10.1038/536269a	http://dx.doi.org/10.1038/536269a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27535519	Bronze			2022-12-28	WOS:000381804900011
J	Bates, ER				Bates, Eric R.			In CAD with LV dysfunction, adding CABG to medical therapy reduced all-cause and CV mortality at 10 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ARTERY-BYPASS-SURGERY; HEART-FAILURE; SURVIVAL; TRIAL		[Bates, Eric R.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bates, ER (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.							Cleland JGF, 2011, EUR J HEART FAIL, V13, P227, DOI 10.1093/eurjhf/hfq230; Guyton RA, 2016, NEW ENGL J MED, V374, P1576, DOI 10.1056/NEJMe1603615; PASSAMANI E, 1985, NEW ENGL J MED, V312, P1665, DOI 10.1056/NEJM198506273122603; Velazquez EJ, 2011, NEW ENGL J MED, V364, P1607, DOI 10.1056/NEJMoa1100356; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019	5	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					JC15	JC15		10.7326/ACPJC-2016-165-4-015	http://dx.doi.org/10.7326/ACPJC-2016-165-4-015			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UI	27538176				2022-12-28	WOS:000381267200002
J	Czeisler, CA				Czeisler, Charles A.			Measuring the passage of brain time Many brain areas are under both circadian and homeostatic control	SCIENCE			English	Editorial Material							SLEEP; HUMANS; MODEL		[Czeisler, Charles A.] Brigham & Womens Hosp, Sleep Hlth Inst, Dept Med, Div Sleep & Circadian Disorders, Boston, MA 02115 USA; [Czeisler, Charles A.] Brigham & Womens Hosp, Sleep Hlth Inst, Dept Neurol, Div Sleep & Circadian Disorders, Boston, MA 02115 USA; [Czeisler, Charles A.] Harvard Med Sch, Div Sleep Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Czeisler, CA (corresponding author), Brigham & Womens Hosp, Sleep Hlth Inst, Dept Med, Div Sleep & Circadian Disorders, Boston, MA 02115 USA.; Czeisler, CA (corresponding author), Brigham & Womens Hosp, Sleep Hlth Inst, Dept Neurol, Div Sleep & Circadian Disorders, Boston, MA 02115 USA.; Czeisler, CA (corresponding author), Harvard Med Sch, Div Sleep Med, Boston, MA 02115 USA.	charles_czeisler@hms.harvard.edu		Czeisler, Charles Andrew/0000-0002-7408-1849				Basheer R, 2004, PROG NEUROBIOL, V73, P379, DOI 10.1016/j.pneurobio.2004.06.004; Brown EN, 1997, AM J PHYSIOL-ENDOC M, V272, pE506, DOI 10.1152/ajpendo.1997.272.3.E506; Cohen DA, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000458; CZEISLER CA, 1980, SCIENCE, V210, P1264, DOI 10.1126/science.7434029; Czeisler C, 2013, NATURE, V497, pS13, DOI 10.1038/497S13a; DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9; Ding FF, 2016, SCIENCE, V352, P550, DOI 10.1126/science.aad4821; Duffy Jeanne F, 2015, Rev Hum Factors Ergon, V10, P29; FEINBERG I, 1990, J THEOR BIOL, V142, P149, DOI 10.1016/S0022-5193(05)80218-8; Hoel EP, 2016, J NEUROPHYSIOL, V115, P2199, DOI 10.1152/jn.00812.2015; Muto V, 2016, SCIENCE, V353, P687, DOI 10.1126/science.aad2993; Shekleton JA, 2013, J CLIN SLEEP MED, V9, P353, DOI 10.5664/jcsm.2588; STROGATZ SH, 1986, SLEEP, V9, P353, DOI 10.1093/sleep/9.2.353; STROGATZ SH, 1987, AM J PHYSIOL, V253, pR172, DOI 10.1152/ajpregu.1987.253.1.R172; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224	15	8	8	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					648	649		10.1126/science.aah5402	http://dx.doi.org/10.1126/science.aah5402			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZC	27516585				2022-12-28	WOS:000381561200020
J	Burns, JP; Truog, RD				Burns, Jeffrey P.; Truog, Robert D.			HISTORY OF MEDICINE The DNR Order after 40 Years	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RESUSCITATE		[Burns, Jeffrey P.] Harvard Med Sch, Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Div Crit Care Med, Boston, MA 02115 USA; Harvard Med Sch, Dept Anaesthesia, Boston, MA 02115 USA; Harvard Med Sch, Ctr Bioeth, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Burns, JP (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Div Crit Care Med, Boston, MA 02115 USA.		Burns, Jeffrey P/AAW-8474-2021					*AM MED ASS, 1974, JAMA-J AM MED ASSOC, V227, P864; Bosslet GT, 2015, AM J RESP CRIT CARE, V191, P1318, DOI 10.1164/rccm.201505-0924ST; Burns JP, 2003, CRIT CARE MED, V31, P1543, DOI 10.1097/01.CCM.0000064743.44696.49; KOUWENHOVEN WB, 1960, JAMA-J AM MED ASSOC, V173, P1064, DOI 10.1001/jama.1960.03020280004002; RABKIN MT, 1976, NEW ENGL J MED, V295, P364, DOI 10.1056/NEJM197608122950705	5	31	31	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2016	375	6					504	506		10.1056/NEJMp1605597	http://dx.doi.org/10.1056/NEJMp1605597			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU4OT	27509098				2022-12-28	WOS:000382193100002
J	Rosen, J				Rosen, Julia			RESEARCH PROTOCOLS A forest of hypotheses	NATURE			English	Editorial Material							MULTIPLE WORKING HYPOTHESES; EARTHS CONTINENTS											Branch TA, 2015, FISHERIES, V40, P373, DOI 10.1080/03632415.2015.1059825; Chamberlin T. C., 1890, SCIENCE, V15, P92, DOI DOI 10.1126/SCIENCE.NS-15.366.92; Elliott LP, 2007, BIOSCIENCE, V57, P608, DOI 10.1641/B570708; MacCoun R, 2015, NATURE, V526, P187, DOI 10.1038/526187a; McElreath R., 2016, PREPRINT; Pardon LG, 2003, J ANIM ECOL, V72, P106, DOI 10.1046/j.1365-2656.2003.00686.x; Symes L.B., 2015, B ECOL SOC AM, V96, P352; Wegener A, 1912, PETERMANNS MITT, V58, P185; Wegener A, 1912, PETERMANNS MITT, V58, P253; Wegener A, 1912, PETERMANNS MITT, V58, P305	10	12	14	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					239	241		10.1038/nj7615-239a	http://dx.doi.org/10.1038/nj7615-239a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4SV	27529104				2022-12-28	WOS:000381472100043
J	Tenaillon, O; Barrick, JE; Ribeck, N; Deatherage, DE; Blanchard, JL; Dasgupta, A; Wu, GC; Wielgoss, S; Cruveiller, S; Medigue, C; Schneider, D; Lenski, RE				Tenaillon, Olivier; Barrick, Jeffrey E.; Ribeck, Noah; Deatherage, Daniel E.; Blanchard, Jeffrey L.; Dasgupta, Aurko; Wu, Gabriel C.; Wielgoss, Sebastien; Cruveiller, Stephane; Medigue, Claudine; Schneider, Dominique; Lenski, Richard E.			Tempo and mode of genome evolution in a 50,000-generation experiment	NATURE			English	Article							TERM EXPERIMENTAL EVOLUTION; ESCHERICHIA-COLI; BENEFICIAL MUTATIONS; BACTERIAL POPULATION; ADAPTING POPULATIONS; MOLECULAR EVOLUTION; CLONAL INTERFERENCE; POSITIVE SELECTION; GENETIC DRAFT; CODON BIAS	Adaptation by natural selection depends on the rates, effects and interactions of many mutations, making it difficult to determine what proportion of mutations in an evolving lineage are beneficial. Here we analysed 264 complete genomes from 12 Escherichia coli populations to characterize their dynamics over 50,000 generations. The populations that retained the ancestral mutation rate support a model in which most fixed mutations are beneficial, the fraction of beneficial mutations declines as fitness rises, and neutral mutations accumulate at a constant rate. We also compared these populations to mutation-accumulation lines evolved under a bottlenecking regime that minimizes selection. Nonsynonymous mutations, intergenic mutations, insertions and deletions are overrepresented in the long-term populations, further supporting the inference that most mutations that reached high frequency were favoured by selection. These results illuminate the shifting balance of forces that govern genome evolution in populations adapting to a new environment.	[Tenaillon, Olivier] Univ Paris Diderot, Sorbonne Paris Cite, INSERM, IAME,UMR 1137, F-75018 Paris, France; [Barrick, Jeffrey E.; Deatherage, Daniel E.; Dasgupta, Aurko; Wu, Gabriel C.] Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Syst & Synthet Biol, Dept Mol Biosci,Ctr Computat Biol & Bioinformat, Austin, TX 78712 USA; [Barrick, Jeffrey E.; Ribeck, Noah; Lenski, Richard E.] Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA; [Ribeck, Noah; Lenski, Richard E.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA; [Blanchard, Jeffrey L.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Wielgoss, Sebastien] ETH, Inst Integrat Biol, Univ Str 16, CH-8092 Zurich, Switzerland; [Wielgoss, Sebastien; Schneider, Dominique] Univ Grenoble Alpes, Lab Technol Ingn Med & Complexite Informat Math &, F-38000 Grenoble, France; [Cruveiller, Stephane; Medigue, Claudine] Univ Evry Val dEssonne, CEA, Lab Anal Bioinformat Genom & Metabol, Inst Genom,CNRS,UMR 8030, F-91000 Evry, France; [Schneider, Dominique] CNRS, TIMC IMAG, F-38000 Grenoble, France; [Dasgupta, Aurko] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of Texas System; University of Texas Austin; Michigan State University; Michigan State University; University of Massachusetts System; University of Massachusetts Amherst; Swiss Federal Institutes of Technology Domain; ETH Zurich; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Institut National Polytechnique de Grenoble; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Washington University (WUSTL)	Lenski, RE (corresponding author), Michigan State Univ, BEACON Ctr Study Evolut Act, E Lansing, MI 48824 USA.; Lenski, RE (corresponding author), Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI 48824 USA.	lenski@msu.edu	Blanchard, Jeffrey/AAA-5173-2020; Tenaillon, Olivier/L-9857-2017; Wielgoss, Sébastien/X-3788-2019	Blanchard, Jeffrey/0000-0002-7310-9678; Wielgoss, Sébastien/0000-0002-0127-3380; Lenski, Richard/0000-0002-1064-8375; Tenaillon, Olivier/0000-0002-3796-1601	US National Science Foundation [DEB-1451740]; BEACON Center for the Study of Evolution in Action [DBI-0939454]; European Research Council [310944]; European Union [610427]; French National Funding Agency [ANR-08-GENM-023-001]; French CNRS International Associated Laboratory; US National Institutes of Health [R00-GM087550]; Cancer Prevention and Research Institute of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM087550] Funding Source: NIH RePORTER; Division Of Environmental Biology [1451740] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); BEACON Center for the Study of Evolution in Action; European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); French National Funding Agency; French CNRS International Associated Laboratory; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank N. Hajela for assistance, R. Maddamsetti and Z. Blount for discussions, and M. Lynch for starting the MAE lines. This research was supported by the US National Science Foundation (DEB-1451740 to R.E.L.), BEACON Center for the Study of Evolution in Action (DBI-0939454), European Research Council (FP7 grant 310944 to O.T.), European Union (FP7 grant 610427 to D.S.), French National Funding Agency (ANR-08-GENM-023-001 to D.S., O.T. and C.M.), French CNRS International Associated Laboratory (to D.S. and R.E.L.), and US National Institutes of Health (R00-GM087550 to J.E.B.). D.E.D. was supported by a traineeship from the Cancer Prevention and Research Institute of Texas. We acknowledge the use of high-performance computing resources at the Texas Advanced Computing Center.	Barrick JE, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1039; Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Blount ZD, 2012, NATURE, V489, P513, DOI 10.1038/nature11514; Burke MK, 2010, NATURE, V467, P587, DOI 10.1038/nature09352; Bustamante CD, 2005, NATURE, V437, P1153, DOI 10.1038/nature04240; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; CHAO L, 1983, NATURE, V303, P633, DOI 10.1038/303633a0; Charlesworth J, 2006, MOL BIOL EVOL, V23, P1348, DOI 10.1093/molbev/msk025; Cooper TF, 2007, PLOS BIOL, V5, P1899, DOI 10.1371/journal.pbio.0050225; Cooper VS, 2001, J BACTERIOL, V183, P2834, DOI 10.1128/JB.183.9.2834-2841.2001; Deatherage DE, 2014, METHODS MOL BIOL, V1151, P165, DOI 10.1007/978-1-4939-0554-6_12; Gerrish PJ, 1998, GENETICA, V102-3, P127, DOI 10.1023/A:1017067816551; Gillespie JH, 2000, GENETICS, V155, P909; Good BH, 2014, GENETICS, V198, P1183, DOI 10.1534/genetics.114.170233; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Khan AI, 2011, SCIENCE, V332, P1193, DOI 10.1126/science.1203801; Kibota TT, 1996, NATURE, V381, P694, DOI 10.1038/381694a0; Kimura M., 1983, NEUTRAL THEORY MOL E; Kosheleva K, 2013, GENETICS, V195, P1007, DOI 10.1534/genetics.113.156430; Kvitek DJ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003972; Lang GI, 2013, NATURE, V500, P571, DOI 10.1038/nature12344; LENSKI RE, 1991, AM NAT, V138, P1315, DOI 10.1086/285289; Levy SF, 2015, NATURE, V519, P181, DOI 10.1038/nature14279; Lieberman TD, 2011, NAT GENET, V43, P1275, DOI 10.1038/ng.997; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Maddamsetti R, 2015, GENETICS, V200, P619, DOI 10.1534/genetics.115.176677; Miskinyte M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003802; Neher RA, 2011, GENETICS, V188, P975, DOI 10.1534/genetics.111.128876; Oren Y, 2014, P NATL ACAD SCI USA, V111, P16112, DOI 10.1073/pnas.1413272111; Paterson S, 2010, NATURE, V464, P275, DOI 10.1038/nature08798; Plotkin JB, 2011, NAT REV GENET, V12, P32, DOI 10.1038/nrg2899; Plucain J, 2014, SCIENCE, V343, P1366, DOI 10.1126/science.1248688; Rozen DE, 2000, AM NAT, V155, P24, DOI 10.1086/303299; Satterwhite RS, 2015, EVOLUTION, V69, P2067, DOI 10.1111/evo.12710; Sawyer SA, 2003, J MOL EVOL, V57, pS154, DOI 10.1007/s00239-003-0022-3; Sharp PM, 2010, PHILOS T R SOC B, V365, P1203, DOI 10.1098/rstb.2009.0305; Sniegowski PD, 1997, NATURE, V387, P703, DOI 10.1038/42701; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Tenaillon O, 2001, RES MICROBIOL, V152, P11, DOI 10.1016/S0923-2508(00)01163-3; Tenaillon O, 2012, SCIENCE, V335, P457, DOI 10.1126/science.1212986; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; Whitney KD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001080; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; Wielgoss S, 2016, MOL BIOL EVOL, V33, P770, DOI 10.1093/molbev/msv270; Wielgoss S, 2013, P NATL ACAD SCI USA, V110, P222, DOI 10.1073/pnas.1219574110; Wiser MJ, 2013, SCIENCE, V342, P1364, DOI 10.1126/science.1243357; Woods R, 2006, P NATL ACAD SCI USA, V103, P9107, DOI 10.1073/pnas.0602917103; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	50	230	233	6	135	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					165	+		10.1038/nature18959	http://dx.doi.org/10.1038/nature18959			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27479321	Green Submitted, Green Accepted			2022-12-28	WOS:000381472100027
J	Thomsen, ARB; Plouffe, B; Cahill, TJ; Shukla, AK; Tarrasch, JT; Dosey, AM; Kahsai, AW; Strachan, RT; Pani, B; Mahoney, JP; Huang, LY; Breton, B; Heydenreich, FM; Sunahara, RK; Skiniotis, G; Bouvier, M; Lefkowitz, RJ				Thomsen, Alex R. B.; Plouffe, Bianca; Cahill, Thomas J., III; Shukla, Arun K.; Tarrasch, Jeffrey T.; Dosey, Annie M.; Kahsai, Alem W.; Strachan, Ryan T.; Pani, Biswaranjan; Mahoney, Jacob P.; Huang, Liyin; Breton, Billy; Heydenreich, Franziska M.; Sunahara, Roger K.; Skiniotis, Georgios; Bouvier, Michel; Lefkowitz, Robert J.			GPCR-G Protein-beta-Arrestin Super-Complex Mediates Sustained G Protein Signaling	CELL			English	Article							COUPLED RECEPTOR; VASOPRESSIN RECEPTOR; CRYSTAL-STRUCTURE; BETA(2)-ADRENERGIC RECEPTOR; CLATHRIN ADAPTER; ENDOCYTOSIS; BETA-ARRESTIN2; ASSOCIATION; INTERNALIZATION; DETERMINANTS	Classically, G protein-coupled receptor (GPCR) stimulation promotes G protein signaling at the plasma membrane, followed by rapid beta-arrestin-mediated desensitization and receptor internalization into endosomes. However, it has been demonstrated that some GPCRs activate G proteins from within internalized cellular compartments, resulting in sustained signaling. We have used a variety of biochemical, biophysical, and cell-based methods to demonstrate the existence, functionality, and architecture of internalized receptor complexes composed of a single GPCR, beta-arrestin, and G protein. These super-complexes or "megaplexes'' more readily form at receptors that interact strongly with beta-arrestins via a C-terminal tail containing clusters of serine/threonine phosphorylation sites. Single-particle electron microscopy analysis of negative-stained purified megaplexes reveals that a single receptor simultaneously binds through its core region with G protein and through its phosphorylated C-terminal tail with b-arrestin. The formation of such megaplexes provides a potential physicalbasis for thenewlyappreciated sustained G protein signaling from internalized GPCRs.	[Thomsen, Alex R. B.; Cahill, Thomas J., III; Shukla, Arun K.; Kahsai, Alem W.; Strachan, Ryan T.; Pani, Biswaranjan; Huang, Liyin; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Plouffe, Bianca; Breton, Billy; Heydenreich, Franziska M.; Bouvier, Michel] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Plouffe, Bianca; Breton, Billy; Heydenreich, Franziska M.; Bouvier, Michel] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Cahill, Thomas J., III; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Tarrasch, Jeffrey T.; Dosey, Annie M.; Skiniotis, Georgios] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA; [Mahoney, Jacob P.; Sunahara, Roger K.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Sunahara, Roger K.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Shukla, Arun K.] Indian Inst Technol, Dept Biol Sci & Bioengn, Kanpur 208016, Uttar Pradesh, India; [Breton, Billy] Domain Therapeut NA, Montreal, PQ H4S 1Z9, Canada; [Heydenreich, Franziska M.] Paul Scherrer Inst, Lab Biomol Res, CH-5232 Villigen, Switzerland	Duke University; Universite de Montreal; Universite de Montreal; Duke University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California San Diego; Duke University; Howard Hughes Medical Institute; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kanpur; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.; Bouvier, M (corresponding author), Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada.; Bouvier, M (corresponding author), Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada.; Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA.; Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA.	michel.bouvier@umontreal.ca; lefko001@receptor-biol.duke.edu	Sunahara, Roger/AAJ-8667-2020; Bouvier, Michel/H-2758-2014; Pani, Biswaranjan/GLT-9217-2022; Lefkowitz, Robert/AAW-2649-2021; Heydenreich, Franziska M/N-6314-2015	Bouvier, Michel/0000-0003-1128-0100; Heydenreich, Franziska M/0000-0002-8049-4383; Skiniotis, Georgios/0000-0003-0238-7846; Plouffe, Bianca/0000-0002-8321-0796; shukla, arun/0000-0003-2910-8288; Thomsen, Alex/0000-0003-1638-8911	Danish Council for Independent Research & Lundbeck Foundation; NIH [F30HL129803, RO1GM083118, T32GM007767, DK090165, HL16037]; CIHR [SNSF P1EZP3_165219, MOP10501]; Lundbeck Foundation [R172-2014-1468] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F30HL129803, R01HL016037, T32HL007101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171, R01GM083118, T32GM007767] Funding Source: NIH RePORTER	Danish Council for Independent Research & Lundbeck Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIHR(Canadian Institutes of Health Research (CIHR)); Lundbeck Foundation(Lundbeckfonden); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to L. Barak and B. Kobilka for generous gifts of plasmids encoding mStrawberry-beta arr2 and Nb35, respectively. We thank C.-R. Liang, L.-L. Gu, J.-M. Shan, and X. Chen for synthesizing BI-167107. We thank S. Johnson, C. Le Gouill, A. Laperriere, M. Walters, M. DeLong, M. Plue, T. Milledge, D. Capel, X. Jiang, R. Irannejad, and M. von Zastrow for support and discussion. This work received supported from the Danish Council for Independent Research & Lundbeck Foundation (to A.R.B.T.), NIH grants (F30HL129803 to T.J.C.; RO1GM083118 to R.K.S.; T32GM007767 to J.P.M.; DK090165 to G.S.; and HL16037 to R.J.L.); CIHR grants (post-doctoral fellowship to B. Plouffe; SNSF P1EZP3_165219 to F.M.H.; and MOP10501 to M.B.). R.J.L. is a HHMI Investigator. R.J.L. is a co-founder and shareholder of Trevena. M.B. holds a Canada Research Chair in Signal Transduction and Molecular Pharmacology.	Audet N, 2012, J NEUROSCI, V32, P4827, DOI 10.1523/JNEUROSCI.3734-11.2012; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Feinstein TN, 2013, J BIOL CHEM, V288, P27849, DOI 10.1074/jbc.M112.445098; Feinstein TN, 2011, NAT CHEM BIOL, V7, P278, DOI 10.1038/nchembio.545; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gilliland CT, 2013, J BIOL CHEM, V288, P32194, DOI 10.1074/jbc.M113.503797; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Goodman OB, 1996, NATURE, V383, P447, DOI 10.1038/383447a0; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; JARD S, 1986, MOL PHARMACOL, V30, P171; Kang YY, 2015, NATURE, V523, P561, DOI 10.1038/nature14656; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lee MH, 2016, NATURE, V531, P665, DOI 10.1038/nature17154; Marullo S, 2007, TRENDS PHARMACOL SCI, V28, P362, DOI 10.1016/j.tips.2007.06.007; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Mullershausen F, 2009, NAT CHEM BIOL, V5, P428, DOI 10.1038/nchembio.173; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; ODONNELL SR, 1980, LIFE SCI, V27, P671, DOI 10.1016/0024-3205(80)90008-9; Peisley Alys, 2015, Methods Mol Biol, V1335, P29, DOI 10.1007/978-1-4939-2914-6_3; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Shukla AK, 2013, NATURE, V497, P137, DOI 10.1038/nature12120; STAEHELIN M, 1983, J BIOL CHEM, V258, P3496; Szczepek M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5801; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Vilardaga JP, 2002, J BIOL CHEM, V277, P8121, DOI 10.1074/jbc.M110433200; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Wehbi VL, 2013, P NATL ACAD SCI USA, V110, P1530, DOI 10.1073/pnas.1205756110; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108	34	319	325	7	106	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					907	919		10.1016/j.cell.2016.07.004	http://dx.doi.org/10.1016/j.cell.2016.07.004			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27499021	Green Accepted, Bronze			2022-12-28	WOS:000382258700014
J	Olie, E; Courtet, P				Olie, Emilie; Courtet, Philippe			The Controversial Issue of Euthanasia in Patients With Psychiatric Illness	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIAN-ASSISTED SUICIDE; DISORDERS; ATTITUDES	IMPORTANCE Euthanasia or assisted suicide (EAS) of psychiatric patients is increasing in some jurisdictions such as Belgium and the Netherlands. However, little is known about the practice, and it remains controversial. OBJECTIVES To describe the characteristics of patients receiving EAS for psychiatric conditions and how the practice is regulated in the Netherlands. DESIGN, SETTING, AND PARTICIPANTS This investigation reviewed psychiatric EAS case summaries made available online by the Dutch regional euthanasia review committees as of June 1, 2015. Two senior psychiatrists used directed content analysis to review and code the reports. In total, 66 cases from 2011 to 2014 were reviewed. MAIN OUTCOMES AND MEASURES Clinical and social characteristics of patients, physician review process of the patients' requests, and the euthanasia review committees' assessments of the physicians' actions. RESULTS Of the 66 cases reviewed, 70%(n = 46) werewomen. In total, 32%(n = 21) were 70 years or older, 44%(n = 29) were 50 to 70 years old, and 24%(n = 16) were 30 to 50 years old. Most had chronic, severe conditions, with histories of attempted suicides and psychiatric hospitalizations. Most had personality disorders andwere described as socially isolated or lonely. Depressive disorderswere the primary psychiatric issue in 55% (n = 36) of cases. Other conditions representedwere psychotic, posttraumatic stress or anxiety, somatoform, neurocognitive, and eating disorders, aswell as prolonged grief and autism. Comorbidities with functional impairmentswere common. Forty-one percent (n = 27) of physicians performing EASwere psychiatrists. Twenty-seven percent (n = 18) of patients received the procedure from physicians new to them, 14 of whomwere physicians from the End-of-Life Clinic, a mobile euthanasia clinic. Consultation with other physicianswas extensive, but 11% (n = 7) of cases had no independent psychiatric input, and 24% (n = 16) of cases involved disagreement among consultants. The euthanasia review committees found that one case failed to meet legal due care criteria. CONCLUSIONS AND RELEVANCE Persons receiving EAS for psychiatric disorders in the Netherlands are mostly women and of diverse ages, with complex and chronic psychiatric, medical, and psychosocial histories. The granting of their EAS requests appears to involve considerable physician judgment, usually involving multiple physicians who do not always agree (sometimes without independent psychiatric input), but the euthanasia review committees generally defer to the judgments of the physicians performing the EAS.	[Olie, Emilie; Courtet, Philippe] Univ Montpellier, CHU Montpellier, Lapeyronie Hosp, Dept Psychiat Emergency & Acute Care,INSERM U1061, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier	Courtet, P (corresponding author), CHU Montpellier, Lapeyronie Hosp, Dept Psychiat Emergency & Acute Care, 191 Ave Doyen Gaston Giraud, F-34295 Montpellier 5, France.	p-courtet@chu-montpellier.fr						Blank K, 2001, GEN HOSP PSYCHIAT, V23, P326, DOI 10.1016/S0163-8343(01)00160-8; Ducasse D, 2014, PSYCHOTHER PSYCHOSOM, V83, P374, DOI 10.1159/000365974; Emanuel EJ, 2016, JAMA-J AM MED ASSOC, V316, P79, DOI 10.1001/jama.2016.8499; Insel TR, 2006, MOL PSYCHIATR, V11, P11, DOI 10.1038/sj.mp.4001777; Kim SYH, 2016, JAMA PSYCHIAT, V73, P362, DOI 10.1001/jamapsychiatry.2015.2887; Olie E, 2010, J AFFECT DISORDERS, V120, P226, DOI 10.1016/j.jad.2009.03.013; Richard-Devantoy S, 2014, PSYCHOL MED, V44, P1663, DOI 10.1017/S0033291713002304; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Thienpont L, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007454; Yovell Y, 2016, AM J PSYCHIAT, V173, P491, DOI 10.1176/appi.ajp.2015.15040535	10	25	25	1	54	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2016	316	6					656	+		10.1001/jama.2016.9883	http://dx.doi.org/10.1001/jama.2016.9883			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS7TK	27532920				2022-12-28	WOS:000380985600018
J	van der Linden, V; Rolim, EL; Lins, OG; van der Linden, A; Aragao, MDVV; Brainer-Lima, AM; Cruz, DDS; Rocha, MAW; da Silva, PFS; Carvalho, MDCG; do Amaral, FJ; Gomes, JA; de Medeiros, ICR; Ventura, CV; Ramos, RC				van der Linden, Vanessa; Rolim Filho, Epitacio Leite; Lins, Otavio Gomes; van der Linden, Ana; Viana Vasco Aragao, Maria de Fatima; Brainer-Lima, Alessandra Mertens; Sousa Cruz, Danielle Di Cavalcanti; Wanderley Rocha, Maria Angela; Sobral da Silva, Paula Fabiana; Costa Gomes Carvalho, Maria Durce; do Amaral, Fernando Jose; Gomes, Joelma Arruda; Ribeiro de Medeiros, Igor Colaco; Ventura, Camila V.; Ramos, Regina Coeli			Congenital Zika syndrome with arthrogryposis: retrospective case series study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MULTIPLEX-CONGENITA; VIRUS OUTBREAK	OBJECTIVE To describe the clinical, radiological, and electromyographic features in a series of children with joint contractures (arthrogryposis) associated with congenital infection presumably caused by Zika virus. DESIGN Retrospective case series study. SETTING Association for Assistance of Disabled Children, Pernambuco state, Brazil. PARTICIPANTS Seven children with arthrogryposis and a diagnosis of congenital infection presumably caused by Zika virus during the Brazilian microcephaly epidemic. MAIN OUTCOME MEASURES Main clinical, radiological, and electromyographic findings, and likely correlation between clinical and primary neurological abnormalities. RESULTS The brain images of all seven children were characteristic of congenital infection and arthrogryposis. Two children tested positive for IgM to Zika virus in the cerebrospinal fluid. Arthrogryposis was present in the arms and legs of six children (86%) and the legs of one child (14%). Hip radiographs showed bilateral dislocation in seven children, subluxation of the knee associated with genu valgus in three children (43%), which was bilateral in two (29%). All the children underwent high definition ultrasonography of the joints, and there was no evidence of abnormalities. Moderate signs of remodeling of the motor units and a reduced recruitment pattern were found on needle electromyography (monopolar). Five of the children underwent brain computed tomography (CT) and magnetic resonance imaging (MRI) and the remaining two CT only. All presented malformations of cortical development, calcifications predominantly in the cortex and subcortical white matter (especially in the junction between the cortex and white matter), reduction in brain volume, ventriculomegaly, and hypoplasia of the brainstem and cerebellum. MRI of the spine in four children showed apparent thinning of the cord and reduced ventral roots. CONCLUSIONS Congenital Zika syndrome should be added to the differential diagnosis of congenital infections and arthrogryposis. The arthrogryposis was unrelated to the abnormalities of the joints themselves, but was possibly of neurogenic origin, with chronic involvement of central and peripheral motor neurones leading to deformities as a result of fixed postures in utero. Based on the neurophysiological observations, we suggest two possible mechanisms: tropism of neurones, with involvement of peripheral and central motor neurones, or a relation with vascular disorders.	[van der Linden, Vanessa; Rolim Filho, Epitacio Leite] AACD, Recife, PE, Brazil; [van der Linden, Vanessa; do Amaral, Fernando Jose; Gomes, Joelma Arruda] HBL, Recife, PE, Brazil; [Rolim Filho, Epitacio Leite; Lins, Otavio Gomes] Univ Fed Pernambuco, Recife, PE, Brazil; [van der Linden, Ana; Sousa Cruz, Danielle Di Cavalcanti] Inst Materno Infantil Pernambuco, Prof Fernando Figueira Integral Med Inst, Recife, PE, Brazil; [Viana Vasco Aragao, Maria de Fatima] Ctr Diagnost Multimagem, Recife, PE, Brazil; [Viana Vasco Aragao, Maria de Fatima; Brainer-Lima, Alessandra Mertens] Mauricio de Nassau Univ, Recife, PE, Brazil; [Brainer-Lima, Alessandra Mertens] Univ Pernambuco, Recife, PE, Brazil; [Wanderley Rocha, Maria Angela; Sobral da Silva, Paula Fabiana; Costa Gomes Carvalho, Maria Durce; Ramos, Regina Coeli] HUOC, Recife, PE, Brazil; [Ribeiro de Medeiros, Igor Colaco] Hosp Infantil Jorge de Medeiros, Recife, PE, Brazil; [Ventura, Camila V.] FAV, Recife, PE, Brazil; [Ventura, Camila V.] Pernambucos Eye Hosp, Recife, PE, Brazil	Universidade Federal de Pernambuco; Instituto de Medicina Integral Professor Fernando Figueira (IMIP); Universidade de Pernambuco (UPE)	van der Linden, V (corresponding author), AACD, Recife, PE, Brazil.; van der Linden, V (corresponding author), HBL, Recife, PE, Brazil.	vanessavdlinden@hotmail.com	Ventura, Camila V/N-2654-2018	Ventura, Camila V/0000-0002-2927-4684; Silva, Paula/0000-0001-9475-4732				Bamshad M, 2009, J BONE JOINT SURG AM, V91A, P40, DOI 10.2106/JBJS.I.00281; Besnard M, 2014, Euro Surveill, V19; *BRAS MIN SAUD, PROT VIG RESP OC MIC; Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6; Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715; FEDRIZZI E, 1993, PEDIATR NEUROL, V9, P343, DOI 10.1016/0887-8994(93)90102-I; Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217; Kalampokas Emmanouil, 2012, ISRN Obstet Gynecol, V2012, P264918, DOI 10.5402/2012/264918; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Moller-Madsen B, 2015, THESIS, V9, P425; Moller-Madsen B, 2015, J CHILD ORTHOP, V9, P425, DOI 10.1007/s11832-015-0688-2; Mussi-Pinhata M, 1999, J PEDIAT RIO J, V75, P15; Poduri A, 2010, BRAIN DEV-JPN, V32, P550, DOI 10.1016/j.braindev.2009.08.005; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; RUSSELL LJ, 1984, AM J MED GENET, V17, P509, DOI 10.1002/ajmg.1320170213; Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2; Tavernise S, 2016, ZIKA VIRUS GLOBAL HL; Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5; Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6; Volpe J.J., 2008, NEUROLOGY NEWBORN; World Health Organization, 2016, ASS INF MICR CONT ZI; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192	28	130	133	1	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2016	354								i3899	10.1136/bmj.i3899	http://dx.doi.org/10.1136/bmj.i3899			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4TU	27509902	Green Published, hybrid			2022-12-28	WOS:000381474800002
J	Roberts, R				Roberts, Rebecca			Geoffrey James Roberts OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		ROBERTS GJ, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2016	354								i4273	10.1136/bmj.i4273	http://dx.doi.org/10.1136/bmj.i4273			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9DD	27495239				2022-12-28	WOS:000381081800011
J	Santiago-Gonzalez, B; Monguzzi, A; Azpiroz, JM; Prato, M; Erratico, S; Campione, M; Lorenzi, R; Pedrini, J; Santambrogio, C; Torrente, Y; De Angelis, F; Meinardi, F; Brovelli, S				Santiago-Gonzalez, Beatriz; Monguzzi, Angelo; Mikel Azpiroz, Jon; Prato, Mirko; Erratico, Silvia; Campione, Marcello; Lorenzi, Roberto; Pedrini, Jacopo; Santambrogio, Carlo; Torrente, Yvan; De Angelis, Filippo; Meinardi, Francesco; Brovelli, Sergio			Permanent excimer superstructures by supramolecular networking of metal quantum clusters	SCIENCE			English	Article							FLUORESCENT GOLD NANOCLUSTERS; HIGHLY FLUORESCENT; ATOMIC CLUSTERS; AU CLUSTERS; NANOPARTICLES; LUMINESCENCE; APOPTOSIS; PROBES; DOTS	Excimers are evanescent quasi-particles that typically form during collisional intermolecular interactions and exist exclusively for their excited-state lifetime. We exploited the distinctive structure of metal quantum clusters to fabricate permanent excimer-like colloidal superstructures made of ground-state noninteracting gold cores, held together by a network of hydrogen bonds between their capping ligands. This previously unknown aggregation state of matter, studied through spectroscopic experiments and ab initio calculations, conveys the photophysics of excimers into stable nanoparticles, which overcome the intrinsic limitation of excimers in single-particle applications-that is, their nearly zero formation probability in ultra-diluted solutions. In vitro experiments demonstrate the suitability of the superstructures as nonresonant intracellular probes and further reveal their ability to scavenge reactive oxygen species, which enhances their potential as anticytotoxic agents for biomedical applications.	[Santiago-Gonzalez, Beatriz; Monguzzi, Angelo; Lorenzi, Roberto; Pedrini, Jacopo; Meinardi, Francesco; Brovelli, Sergio] Univ Studi Milano Bicocca, Dipartimento Sci Mat, Via R Cozzi 55, I-20125 Milan, Italy; [Mikel Azpiroz, Jon; De Angelis, Filippo] CNR, Inst Mol Sci & Technol CNR ISTM, Computat Lab Hybrid & Organ Photovolta, Via Elce Sotto 8, I-06123 Perugia, Italy; [Mikel Azpiroz, Jon] Euskal Herriko Unibertsitatea UPV EHU, Kimika Fak, Donostia San Sebastian 20080, Euskadi, Spain; [Mikel Azpiroz, Jon] Donostia Int Phys Ctr, Donostia San Sebastian 20080, Euskadi, Spain; [Prato, Mirko; De Angelis, Filippo] Ist Italiano Tecnol, Via Morego 30, I-16163 Genoa, Italy; [Erratico, Silvia; Torrente, Yvan] Univ Milan, Dipartimento Fisiopatol Medicochirurg & Trapianti, Fdn IRCCS Ist Ricovero & Cura Carattere Sci Ca Gr, Ctr Dino Ferrari, Via Francesco Sforza 35, I-20122 Milan, Italy; [Campione, Marcello] Univ Milano Bicocca, Dipartimento Sci Ambiente & Terr & Sci Terra, Piazza Sci, I-20125 Milan, Italy; [Santambrogio, Carlo] Univ Milano Bicocca, Dipartimento Biotecnol & Biosci, Piazza Sci 2, I-20126 Milan, Italy	University of Milano-Bicocca; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie Molecolari (ISTM-CNR); University of Basque Country; Istituto Italiano di Tecnologia - IIT; University of Milan; University of Milano-Bicocca; University of Milano-Bicocca	Monguzzi, A; Meinardi, F; Brovelli, S (corresponding author), Univ Studi Milano Bicocca, Dipartimento Sci Mat, Via R Cozzi 55, I-20125 Milan, Italy.	angelo.monguzzi@mater.unimib.it; meinardi@mater.unimib.it; sergio.brovelli@unimib.it	Lorenzi, Roberto/D-1916-2014; De Angelis, Filippo/N-4341-2015; Santambrogio, Carlo/W-6070-2019; Prato, Mirko/AAD-9075-2019; Prato, Mirko/D-8531-2012	Lorenzi, Roberto/0000-0002-6199-0971; De Angelis, Filippo/0000-0003-3833-1975; Santambrogio, Carlo/0000-0003-3986-6971; Prato, Mirko/0000-0002-2188-8059; Prato, Mirko/0000-0002-2188-8059; Brovelli, Sergio/0000-0002-5993-855X; CAMPIONE, MARCELLO/0000-0001-5627-6186; Santiago Gonzalez, Beatriz/0000-0001-8908-6434	Cariplo Foundation [2012-0844, 2012-0920]; European Commission [324603]	Cariplo Foundation(Fondazione Cariplo); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work is dedicated to the loving memory of Jon Mikel Azpiroz, colleague and friend. B.S.-G., F.M., R.L., and S.B. acknowledge support from the Cariplo Foundation (grants 2012-0844 and 2012-0920). S.B. thanks the European Commission's Seventh Framework Programme (FP7) for financial support under grant agreement no. 324603 (EDONHIST project). The data presented in this report are available upon request to S.B.	Aldeek F, 2013, ACS NANO, V7, P2509, DOI 10.1021/nn305856t; Birks J., 1970, PHOTOPHYSICS AROMATI, DOI DOI 10.1002/BBPC.19700741223; Chen J, 2014, J AM CHEM SOC, V136, P92, DOI 10.1021/ja411061e; Duan HW, 2007, J AM CHEM SOC, V129, P2412, DOI 10.1021/ja067727t; Fernando A, 2015, CHEM REV, V115, P6112, DOI 10.1021/cr500506r; Fiers W, 1999, ONCOGENE, V18, P7719, DOI 10.1038/sj.onc.1203249; Gao Y, 2011, ACS NANO, V5, P7818, DOI 10.1021/nn201817b; Guo WW, 2012, CHEM COMMUN, V48, P3076, DOI 10.1039/c2cc17155d; Huang CC, 2007, ANGEW CHEM INT EDIT, V46, P6824, DOI 10.1002/anie.200700803; Huang J, 2011, ANGEW CHEM INT EDIT, V50, P401, DOI 10.1002/anie.201005375; Huang X, 2012, J PHYS CHEM C, V116, P448, DOI 10.1021/jp209662n; Jiang ZQ, 2007, J PHYS CHEM C, V111, P12434, DOI 10.1021/jp073446b; Jin RC, 2004, J AM CHEM SOC, V126, P9900, DOI 10.1021/ja0482482; Kennedy TAC, 2012, CHEM COMMUN, V48, P6845, DOI 10.1039/c2cc32841k; Lakowicz J.R., 2010, PRINCIPLES FLUORESCE, VThird; Lin CAJ, 2009, ACS NANO, V3, P395, DOI 10.1021/nn800632j; Mates JM, 2008, ARCH TOXICOL, V82, P273, DOI 10.1007/s00204-008-0304-z; Mei J, 2014, ADV MATER, V26, P5429, DOI 10.1002/adma.201401356; Meinardi F, 2015, NAT NANOTECHNOL, V10, P878, DOI [10.1038/nnano.2015.178, 10.1038/NNANO.2015.178]; Pyo K, 2015, J AM CHEM SOC, V137, P8244, DOI 10.1021/jacs.5b04210; Qin W, 2014, ANGEW CHEM INT EDIT, V53, P7316, DOI 10.1002/anie.201402685; Gonzalez BS, 2010, NANO LETT, V10, P4217, DOI 10.1021/nl1026716; Shang L, 2011, NANO TODAY, V6, P401, DOI 10.1016/j.nantod.2011.06.004; Stamplecoskie KG, 2014, J AM CHEM SOC, V136, P11093, DOI 10.1021/ja505361n; Venkatesh V, 2014, ACS APPL MATER INTER, V6, P2185, DOI 10.1021/am405345h; Wang ZJ, 2009, CHEMPHYSCHEM, V10, P2012, DOI 10.1002/cphc.200900067; Yang X, 2011, NANOSCALE, V3, P2596, DOI 10.1039/c1nr10287g; Zhang LB, 2014, NANO TODAY, V9, P132, DOI 10.1016/j.nantod.2014.02.010; Zheng J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.077402	29	37	37	2	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					571	575		10.1126/science.aaf4924	http://dx.doi.org/10.1126/science.aaf4924			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27493181	Green Submitted			2022-12-28	WOS:000381560900037
J	Krumholz, HM; Waldstreicher, J				Krumholz, Harlan M.; Waldstreicher, Joanne			The Yale Open Data Access (YODA) Project - A Mechanism for Data Sharing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Krumholz, Harlan M.] Yale Sch Med, Sect Cardiovasc Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Sch Med, Robert Wood Johnson Fdn, Clin Scholars Program, Dept Internal Med, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA; [Krumholz, Harlan M.] Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA; [Waldstreicher, Joanne] Johnson & Johnson, New Brunswick, NJ USA	Yale University; Robert Wood Johnson Foundation (RWJF); Yale University; Yale University; Johnson & Johnson; Johnson & Johnson USA	Krumholz, HM (corresponding author), Yale Sch Med, Sect Cardiovasc Med, New Haven, CT 06510 USA.; Krumholz, HM (corresponding author), Yale Sch Med, Robert Wood Johnson Fdn, Clin Scholars Program, Dept Internal Med, New Haven, CT 06510 USA.; Krumholz, HM (corresponding author), Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, 20 York St, New Haven, CT 06504 USA.; Krumholz, HM (corresponding author), Yale Sch Publ Hlth, Dept Hlth Policy & Management, New Haven, CT 06510 USA.		, Harlan/AAI-2875-2020					[Anonymous], 2016, COMMENTS ICMJES PROP; Institute of Medicine, 2015, SHAR CLIN TRIAL DAT; Krumholz HM, 2011, JAMA-J AM MED ASSOC, V306, P1593, DOI 10.1001/jama.2011.1459; Taichman DB, 2016, ANN INTERN MED, V164, P505, DOI 10.7326/M15-2928	4	76	79	1	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2016	375	5					403	405		10.1056/NEJMp1607342	http://dx.doi.org/10.1056/NEJMp1607342			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS7AN	27518657				2022-12-28	WOS:000380934900002
J	Warren, P				Warren, Penny			Thomas Boulton OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												penny.warren@btinternet.com						BOULTON T, PUBLICATION LIST, P67093	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2016	354								i4285	10.1136/bmj.i4285	http://dx.doi.org/10.1136/bmj.i4285			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9CS	27488646				2022-12-28	WOS:000381080600005
J	Tan, JY				Tan, Jiaying			Targeting Resistance	CELL			English	Editorial Material																		Abraham SA, 2016, NATURE, V534, P341, DOI 10.1038/nature18288; Cerezo M, 2016, CANCER CELL, V29, P805, DOI 10.1016/j.ccell.2016.04.013; Fox RG, 2016, NATURE, V534, P407, DOI 10.1038/nature17988; Manchado E, 2016, NATURE, V534, P647, DOI 10.1038/nature18600; Restifo NP, 2016, NAT REV CANCER, V16, P121, DOI 10.1038/nrc.2016.2	5	7	7	0	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					523	523		10.1016/j.cell.2016.07.017	http://dx.doi.org/10.1016/j.cell.2016.07.017			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27471957	Bronze			2022-12-28	WOS:000380546500001
J	Downs, JA; Fitzgerald, DW				Downs, Jennifer A.; Fitzgerald, Daniel W.			No more neglect of helminths and HIV	LANCET			English	Editorial Material							GENITAL SCHISTOSOMIASIS; TANZANIA; ASSOCIATION; INFECTIONS		[Downs, Jennifer A.; Fitzgerald, Daniel W.] Weill Cornell Med, Dept Med, Ctr Global Hlth, New York, NY 10065 USA; [Downs, Jennifer A.] Bugando Med Ctr, Dept Med, Mwanza, Tanzania	Cornell University	Downs, JA (corresponding author), Weill Cornell Med, Dept Med, Ctr Global Hlth, New York, NY 10065 USA.	jna2002@med.cornell.edu		Downs, Jennifer/0000-0001-9537-204X	NIAID NIH HHS [K23 AI110238] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI110238] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BENTWICH Z, 1995, IMMUNOL TODAY, V16, P187, DOI 10.1016/0167-5699(95)80119-7; Downs JA, 2012, AM J TROP MED HYG, V87, P868, DOI 10.4269/ajtmh.2012.12-0395; FELDMEIER H, 1994, INT J STD AIDS, V5, P368, DOI 10.1177/095646249400500517; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Hotez PJ, 2006, DIS CONTROL PRIORITI, V2nd; Kjetland EF, 2006, AIDS, V20, P593, DOI 10.1097/01.aids.0000210614.45212.0a; Knopp S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003752; Kroidl I, 2016, LANCET; Nielsen NO, 2006, T ROY SOC TROP MED H, V100, P543, DOI 10.1016/j.trstmh.2005.08.016; PEARCE EJ, 1991, J EXP MED, V173, P159, DOI 10.1084/jem.173.1.159; Riess H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002408; Schule SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092032; WHO, 2016, NEGLECTED TROPICAL D	13	1	1	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 15	2016	388	10054					1857	+		10.1016/S0140-6736(16)31253-3	http://dx.doi.org/10.1016/S0140-6736(16)31253-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DZ0AM	27495353				2022-12-28	WOS:000385499000007
J	Saxena, A; Cooper, KL				Saxena, Aditya; Cooper, Kimberly L.			EVOLUTIONARY BIOLOGY Fin to limb within our grasp	NATURE			English	Editorial Material							HOX GENE-EXPRESSION; DIGITS; ORIGIN		[Saxena, Aditya; Cooper, Kimberly L.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Saxena, A (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	adsaxena@ucsd.edu; kcooper@ucsd.edu	Saxena, Aditya/AAJ-8168-2021	Saxena, Aditya/0000-0002-7908-1565				Ahn D, 2008, DEV BIOL, V322, P220, DOI 10.1016/j.ydbio.2008.06.032; Boisvert CA, 2008, NATURE, V456, P636, DOI 10.1038/nature07339; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; FromentalRamain C, 1996, DEVELOPMENT, V122, P2997; Gehrke AR, 2015, P NATL ACAD SCI USA, V112, P803, DOI 10.1073/pnas.1420208112; Nakamura T, 2016, NATURE, V537, P225, DOI 10.1038/nature19322; Nelson CE, 1996, DEVELOPMENT, V122, P1449; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; Woltering JM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001773; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011	10	5	6	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					176	177		10.1038/nature19425	http://dx.doi.org/10.1038/nature19425			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU9LQ	27533039				2022-12-28	WOS:000382539100036
J	Paez-Espino, D; Eloe-Fadrosh, EA; Pavlopoulos, GA; Thomas, AD; Huntemann, M; Mikhailova, N; Rubin, E; Ivanova, NN; Kyrpides, NC				Paez-Espino, David; Eloe-Fadrosh, Emiley A.; Pavlopoulos, Georgios A.; Thomas, Alex D.; Huntemann, Marcel; Mikhailova, Natalia; Rubin, Edward; Ivanova, Natalia N.; Kyrpides, Nikos C.			Uncovering Earth's virome	NATURE			English	Article							MARINE VIRUSES; PHAGE; BACTERIOPHAGE; PROTEIN; SEQUENCES; GENE; ENVIRONMENT; RESISTANCE; ALGORITHM; DATABASE	Viruses are the most abundant biological entities on Earth, but challenges in detecting, isolating, and classifying unknown viruses have prevented exhaustive surveys of the global virome. Here we analysed over 5 Tb of metagenomic sequence data from 3,042 geographically diverse samples to assess the global distribution, phylogenetic diversity, and host specificity of viruses. We discovered over 125,000 partial DNA viral genomes, including the largest phage yet identified, and increased the number of known viral genes by 16-fold. Half of the predicted partial viral genomes were clustered into genetically distinct groups, most of which included genes unrelated to those in known viruses. Using CRISPR spacers and transfer RNA matches to link viral groups to microbial host(s), we doubled the number of microbial phyla known to be infected by viruses, and identified viruses that can infect organisms from different phyla. Analysis of viral distribution across diverse ecosystems revealed strong habitat-type specificity for the vast majority of viruses, but also identified some cosmopolitan groups. Our results highlight an extensive global viral diversity and provide detailed insight into viral habitat distribution and host-virus interactions.	[Paez-Espino, David; Eloe-Fadrosh, Emiley A.; Pavlopoulos, Georgios A.; Thomas, Alex D.; Huntemann, Marcel; Mikhailova, Natalia; Rubin, Edward; Ivanova, Natalia N.; Kyrpides, Nikos C.] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; [Rubin, Edward] Lawrence Berkeley Natl Lab, Berkeley, CA 94720 USA; [Rubin, Edward] Metabiota Inc, San Francisco, CA 94104 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Kyrpides, NC (corresponding author), Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA.	nckyrpides@lbl.gov	Eloe-Fadrosh, Emiley/AAP-8019-2021; Pavlopoulos, Georgios A./L-7544-2017; Paez-Espino, David/I-8297-2019; Kyrpides, Nikos C./A-6305-2014; Huntemann, Marcel/HCH-8928-2022	Pavlopoulos, Georgios A./0000-0002-4577-8276; Paez-Espino, David/0000-0002-2939-5398; Kyrpides, Nikos C./0000-0002-6131-0462; Huntemann, Marcel/0000-0002-1284-3748; Ivanova, Natalia/0000-0002-5802-9485; Eloe-Fadrosh, Emiley/0000-0002-8162-1276	US Department of Energy Joint Genome Institute, a DOE Office of Science User Facility [DE-AC02-05CH11231]; Office of Science of US Department of Energy	US Department of Energy Joint Genome Institute, a DOE Office of Science User Facility(United States Department of Energy (DOE)); Office of Science of US Department of Energy(United States Department of Energy (DOE))	We thank A. Visel and H. Maughan for critical reading and feedback, A. Pati for help in earlier versions, and the IMG and GOLD teams for their support. This work was conducted by the US Department of Energy Joint Genome Institute, a DOE Office of Science User Facility, under contract number DE-AC02-05CH11231 and used resources of the National Energy Research Scientific Computing Center, supported by the Office of Science of the US Department of Energy.	Abeles SR, 2014, J MOL BIOL, V426, P3892, DOI 10.1016/j.jmb.2014.07.002; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Aziz RK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00381; Bailly-Bechet M, 2007, GENOME RES, V17, P1486, DOI 10.1101/gr.6649807; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Bondy-Denomy J, 2014, J MICROBIOL, V52, P235, DOI 10.1007/s12275-014-4083-3; Breitbart M, 2005, TRENDS MICROBIOL, V13, P278, DOI 10.1016/j.tim.2005.04.003; Breitbart M, 2004, FEMS MICROBIOL LETT, V236, P249, DOI 10.1016/j.femsle.2004.05.042; Brum JR, 2015, SCIENCE, V348, DOI 10.1126/science.1261498; Brum JR, 2015, NAT REV MICROBIOL, V13, P147, DOI 10.1038/nrmicro3404; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chow CET, 2015, ANNU REV VIROL, V2, P41, DOI 10.1146/annurev-virology-031413-085540; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dutilh BE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5498; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Edwards RA, 2016, FEMS MICROBIOL REV, V40, P258, DOI 10.1093/femsre/fuv048; Emerson JB, 2013, ARCHAEA, V2013, DOI 10.1155/2013/370871; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Fuhrman JA, 1999, NATURE, V399, P541, DOI 10.1038/21119; Goren MG, 2015, TRENDS MICROBIOL, V23, P744, DOI 10.1016/j.tim.2015.10.006; Holmfeldt K, 2007, APPL ENVIRON MICROB, V73, P6730, DOI 10.1128/AEM.01399-07; Huntemann M, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/s40793-015-0077-y; Hurwitz BL, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw077; Hurwitz BL, 2015, ISME J, V9, P472, DOI 10.1038/ismej.2014.143; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Ignacio-Espinoza J Cesar, 2013, Curr Opin Virol, V3, P566, DOI 10.1016/j.coviro.2013.07.004; Ivanova N, 2010, ENVIRON MICROBIOL, V12, P1803, DOI 10.1111/j.1462-2920.2010.02270.x; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kyrpides NC, 2016, TRENDS MICROBIOL, V24, P425, DOI 10.1016/j.tim.2016.02.011; Laslett D, 2004, NUCLEIC ACIDS RES, V32, P11, DOI 10.1093/nar/gkh152; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lu HJ, 2016, WATER RES, V88, P337, DOI 10.1016/j.watres.2015.10.013; Lum AG, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1615-0; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD568, DOI 10.1093/nar/gkt919; Merchant N, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002342; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mukherjee S, 2015, STAND GENOMIC SCI, V10, DOI 10.1186/1944-3277-10-18; Peters DL, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1848-y; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Reddy TBK, 2015, NUCLEIC ACIDS RES, V43, pD1099, DOI 10.1093/nar/gku950; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robles-Sikisaka R, 2013, ISME J, V7, P1710, DOI 10.1038/ismej.2013.63; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; Roux S, 2015, ELIFE, V4, DOI 10.7554/eLife.08490; Roux S, 2015, PEERJ, V3, DOI 10.7717/peerj.985; Salazar G, 2016, ISME J, V10, P596, DOI 10.1038/ismej.2015.137; Salmond GPC, 2015, NAT REV MICROBIOL, V13, P777, DOI 10.1038/nrmicro3564; Serwer P, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-21; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Short CM, 2005, APPL ENVIRON MICROB, V71, P480, DOI 10.1128/AEM.71.1.480-486.2005; Simmonds P, 2015, J GEN VIROL, V96, P1193, DOI 10.1099/jgv.0.000016; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Tschitschko B, 2015, ISME J, V9, P2094, DOI 10.1038/ismej.2015.110; Varghese NJ, 2015, NUCLEIC ACIDS RES, V43, P6761, DOI 10.1093/nar/gkv657; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wylie KM, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0071-7	65	507	523	13	274	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					425	+		10.1038/nature19094	http://dx.doi.org/10.1038/nature19094			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27533034	Green Published			2022-12-28	WOS:000382646600035
J	Schmidt, JC; Zaug, AJ; Cech, TR				Schmidt, Jens C.; Zaug, Arthur J.; Cech, Thomas R.			Live Cell Imaging Reveals the Dynamics of Telomerase Recruitment to Telomeres	CELL			English	Article							TERT PROMOTER MUTATIONS; CHROMOSOME ENDS; LIVING CELLS; DNA-DAMAGE; TEL-PATCH; CANCER; EXPRESSION; SHELTERIN; TPP1; TRAFFICKING	Telomerase maintains genome integrity by adding repetitive DNA sequences to the chromosome ends in actively dividing cells, including 90% of all cancer cells. Recruitment of human telomerase to telomeres occurs during S-phase of the cell cycle, but the molecular mechanism of the process is only partially understood. Here, we use CRISPR genome editing and single-molecule imaging to track telomerase trafficking in nuclei of living human cells. We demonstrate that telomerase uses three-dimensional diffusion to search for telomeres, probing each telomere thousands of times each S-phase but only rarely forming a stable association. Both the transient and stable association events depend on the direct interaction of the telomerase protein TERT with the telomeric protein TPP1. Our results reveal that telomerase recruitment to telomeres is driven by dynamic interactions between the rapidly diffusing telomerase and the chromosome end.	[Schmidt, Jens C.; Zaug, Arthur J.; Cech, Thomas R.] Univ Colorado Boulder, Howard Hughes Med Inst, BioFrontiers Inst, Dept Chem & Biochem, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Cech, TR (corresponding author), Univ Colorado Boulder, Howard Hughes Med Inst, BioFrontiers Inst, Dept Chem & Biochem, Boulder, CO 80309 USA.	thomas.cech@colorado.edu	Core, BioFrontiers Advanced Light Microscopy/O-6175-2019		NIH [R01 GM099705]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R00GM120386, R01GM099705, K99GM120386] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Cech lab members for assistance with experiments and useful discussions, Joe Dragavon and the BioFrontiers Advanced Light Microscopy Core for assistance with imaging, and Luke Lavis and Zhe Liu (HHMI Janelia Research Campus) for providing HaloTag dyes and assistance with data analysis. This work was supported in part by NIH grant R01 GM099705 to T.R.C. J.C.S. is a Merck Fellow of the Damon Runyon Cancer Research Foundation (DRG-2169-13). T.R.C. is an investigator of the Howard Hughes Medical Institute and is on the board of directors of Merck.	Arnoult N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000920; Bandaria JN, 2016, CELL, V164, P735, DOI 10.1016/j.cell.2016.01.036; Bell RJA, 2015, SCIENCE, V348, P1036, DOI 10.1126/science.aab0015; Borah S, 2015, SCIENCE, V347, P1006, DOI 10.1126/science.1260200; Cheeseman Iain M, 2005, Sci STKE, V2005, ppl1, DOI 10.1126/stke.2662005pl1; Cohen SB, 2008, NAT METHODS, V5, P355, DOI 10.1038/NMETH.F.209; Cohen SB, 2007, SCIENCE, V315, P1850, DOI 10.1126/science.1138596; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dalby AB, 2015, J MOL BIOL, V427, P1291, DOI 10.1016/j.jmb.2015.01.008; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Doksani Y, 2013, CELL, V155, P345, DOI 10.1016/j.cell.2013.09.048; Egan ED, 2010, MOL CELL BIOL, V30, P2775, DOI 10.1128/MCB.00151-10; Gallardo F, 2011, MOL CELL, V44, P819, DOI 10.1016/j.molcel.2011.09.020; Grimm JB, 2015, NAT METHODS, V12, P244, DOI [10.1038/NMETH.3256, 10.1038/nmeth.3256]; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Jady BE, 2006, MOL BIOL CELL, V17, P944, DOI 10.1091/mbc.E05-09-0904; Jiang JS, 2015, SCIENCE, V350, DOI 10.1126/science.aab4070; Knight SC, 2015, SCIENCE, V350, P823, DOI 10.1126/science.aac6572; Lee SS, 2015, CELL REP, V13, DOI 10.1016/j.celrep.2015.10.035; Liu Z, 2014, ELIFE, V3, DOI 10.7554/eLife.04236; Mattern KA, 2004, MOL CELL BIOL, V24, P5587, DOI 10.1128/MCB.24.12.5587-5594.2004; Nandakumar J, 2013, NAT REV MOL CELL BIO, V14, P71, DOI 10.1038/nrm3505; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Normanno D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8357; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Sauerwald A, 2013, NAT STRUCT MOL BIOL, V20, P454, DOI 10.1038/nsmb.2530; Schmidt JC, 2014, ELIFE, V3, DOI 10.7554/eLife.03563; Schmidt JC, 2015, GENE DEV, V29, P1095, DOI 10.1101/gad.263863.115; Serge A, 2008, NAT METHODS, V5, P687, DOI 10.1038/nmeth.1233; Stern JL, 2015, GENE DEV, V29, P2219, DOI 10.1101/gad.269498.115; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Takagi M, 2005, CELL, V123, P49, DOI 10.1016/j.cell.2005.07.034; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Tong AS, 2015, CELL REP, V13, P1633, DOI 10.1016/j.celrep.2015.10.041; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Wang XY, 2008, EPIGENET CHROMATIN, V1, DOI 10.1186/1756-8935-1-4; Weidenfeld I, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp108; Wong JMY, 2002, NAT CELL BIOL, V4, P731, DOI 10.1038/ncb846; Wu RA, 2015, ELIFE, V4, DOI 10.7554/eLife.08363; Xi LH, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0791-1; Xi LH, 2014, NUCLEIC ACIDS RES, V42, P8565, DOI 10.1093/nar/gku560; Zhang MS, 2012, NAT METHODS, V9, P727, DOI [10.1038/NMETH.2021, 10.1038/nmeth.2021]; Zhao Y, 2011, MOL CELL, V42, P297, DOI 10.1016/j.molcel.2011.03.020; Zhao Y, 2009, CELL, V138, P463, DOI 10.1016/j.cell.2009.05.026; Zhong FL, 2012, CELL, V150, P481, DOI 10.1016/j.cell.2012.07.012	51	102	104	0	102	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1188	+		10.1016/j.cell.2016.07.033	http://dx.doi.org/10.1016/j.cell.2016.07.033			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27523609	Green Accepted, Bronze			2022-12-28	WOS:000382259500016
J	Fuchizaki, U; Nishikawa, M				Fuchizaki, Uichiro; Nishikawa, Masahi			Gastric Anisakiasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fuchizaki, Uichiro; Nishikawa, Masahi] Keiju Med Ctr, Nanao, Japan		Fuchizaki, U (corresponding author), Keiju Med Ctr, Nanao, Japan.	ufuchizaki@ybb.ne.jp							0	4	4	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2016	375	7					E11	E11		10.1056/NEJMicm1509451	http://dx.doi.org/10.1056/NEJMicm1509451			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4VF	27532850				2022-12-28	WOS:000381478600010
J	Stewart, ZA; Wilinska, ME; Hartnell, S; Temple, RC; Rayman, G; Stanley, KP; Simmons, D; Law, GR; Scott, EM; Hovorka, R; Murphy, HR				Stewart, Zoe A.; Wilinska, Malgorzata E.; Hartnell, Sara; Temple, Rosemary C.; Rayman, Gerry; Stanley, Katharine P.; Simmons, David; Law, Graham R.; Scott, Eleanor M.; Hovorka, Roman; Murphy, Helen R.			Closed-Loop Insulin Delivery during Pregnancy in Women with Type 1 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ARTIFICIAL PANCREAS; RANDOMIZED CROSSOVER; GLYCEMIC CONTROL; GLUCOSE CONTROL; HOME-USE; HYPOGLYCEMIA; ADULTS; TRIAL; 1ST	BACKGROUND In patients with type 1 diabetes who are not pregnant, closed-loop (automated) insulin delivery can provide better glycemic control than sensor-augmented pump therapy, but data are lacking on the efficacy, safety, and feasibility of closed-loop therapy during pregnancy. METHODS We performed an open-label, randomized, crossover study comparing overnight closed-loop therapy with sensor-augmented pump therapy, followed by a continuation phase in which the closed-loop system was used day and night. Sixteen pregnant women with type 1 diabetes completed 4 weeks of closed-loop pump therapy (intervention) and sensor-augmented pump therapy (control) in random order. During the continuation phase, 14 of the participants used the closed-loop system day and night until delivery. The primary outcome was the percentage of time that overnight glucose levels were within the target range (63 to 140 mg per deciliter [3.5 to 7.8 mmol per liter]). RESULTS The percentage of time that overnight glucose levels were in the target range was higher during closed-loop therapy than during control therapy (74.7% vs. 59.5%; absolute difference, 15.2 percentage points; 95% confidence interval, 6.1 to 24.2; P = 0.002). The overnight mean glucose level was lower during closed-loop therapy than during control therapy (119 vs. 133 mg per deciliter [6.6 vs. 7.4 mmol per liter], P = 0.009). There were no significant differences between closed-loop and control therapy in the percentage of time in which glucose levels were below the target range (1.3% and 1.9%, respectively; P = 0.28), in insulin doses, or in adverse-event rates. During the continuation phase (up to 14.6 additional weeks, including antenatal hospitalizations, labor, and delivery), glucose levels were in the target range 68.7% of the time; the mean glucose level was 126 mg per deciliter (7.0 mmol per liter). No episodes of severe hypoglycemia requiring third-party assistance occurred during either phase. CONCLUSIONS Overnight closed-loop therapy resulted in better glucose control than sensor-augmented pump therapy in pregnant women with type 1 diabetes. Women receiving day-and-night closed-loop therapy maintained glycemic control during a high proportion of the time in a period that encompassed antenatal hospital admission, labor, and delivery. (Funded by the National Institute for Health Research and others; Current Controlled Trials number, ISRCTN71510001.)	[Stewart, Zoe A.; Wilinska, Malgorzata E.; Hovorka, Roman; Murphy, Helen R.] Univ Cambridge, Wellcome Trust Med Res Council, Inst Metab Sci, Cambridge, England; [Hartnell, Sara; Simmons, David; Murphy, Helen R.] Cambridge Univ Hosp NHS Fdn Trust, Wolfson Diabet & Endocrine Clin, Cambridge, England; [Temple, Rosemary C.; Murphy, Helen R.] Norfolk & Norwich Univ Hosp NHS Fdn Trust, Elsie Bertram Diabet Ctr, Norwich, Norfolk, England; [Stanley, Katharine P.] Norfolk & Norwich Univ Hosp NHS Fdn Trust, Dept Obstet & Gynaecol, Norwich, Norfolk, England; [Murphy, Helen R.] Univ East Anglia, Norwich Med Sch, Fl 2,Bob Champ Res & Educ Bldg, Norwich NR4 7UQ, Norfolk, England; [Rayman, Gerry] Ipswich Hosp NHS Trust, Ipswich Diabet Ctr, Ipswich, Suffolk, England; [Law, Graham R.; Scott, Eleanor M.] Univ Leeds, Div Epidemiol & Biostat, Leeds Inst Cardiovasc & Metab Med, Leeds, W Yorkshire, England	University of Cambridge; University of Cambridge; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospitals NHS Foundation Trust; University of East Anglia; Ipswich Hospital NHS Trust; Ipswich Hospital; University of Leeds	Murphy, HR (corresponding author), Univ East Anglia, Norwich Med Sch, Fl 2,Bob Champ Res & Educ Bldg, Norwich NR4 7UQ, Norfolk, England.	hm386@medschl.cam.-ac.-uk	Hovorka, Roman/J-4123-2016; Hovorka, Roman/O-1116-2019; Law, Graham R/B-9654-2008	Hovorka, Roman/0000-0003-2901-461X; Hovorka, Roman/0000-0003-2901-461X; Law, Graham R/0000-0001-7904-0264; Murphy, Helen/0000-0002-5489-0614	National Institute for Health Research; National Institute for Health Research [CDF-2013-06-035, ACF-2016-14-009, PDF/01/036] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by the National Institute for Health Research and others; Current Controlled Trials number, ISRCTN71510001.	[Anonymous], 2015, NAT PREGN DIAB NIPD; [Anonymous], 2007, WE LIVE BEST ALL TIM; Breton M, 2012, DIABETES, V61, P2230, DOI 10.2337/db11-1445; Casson IF, 1997, BRIT MED J, V315, P275, DOI 10.1136/bmj.315.7103.275; Combs CA, 2012, J MATERN-FETAL NEO M, V25, P2025, DOI 10.3109/14767058.2012.670409; Dassau E, 2013, DIABETES CARE, V36, P801, DOI 10.2337/dc12-0948; Desoye G, 2016, DIABETOLOGIA, V59, P1089, DOI 10.1007/s00125-016-3931-6; Evers IM, 2002, DIABETES CARE, V25, P554, DOI 10.2337/diacare.25.3.554; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Garcia-Patterson A, 2010, DIABETOLOGIA, V53, P446, DOI 10.1007/s00125-009-1633-z; Goudie RJB, 2014, DIABETES CARE, V37, pE121, DOI 10.2337/dc13-2535; Hovorka R, 2014, DIABETES CARE, V37, P1204, DOI 10.2337/dc13-2644; Hovorka R, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1855; Hovorka R, 2010, LANCET, V375, P743, DOI 10.1016/S0140-6736(09)61998-X; Kerssen A, 2003, J Matern Fetal Neonatal Med, V13, P309, DOI 10.1080/jmf.13.5.309.313; KITZMILLER JL, 1991, JAMA-J AM MED ASSOC, V265, P731, DOI 10.1001/jama.265.6.731; Kovatchev BP, 2013, DIABETES CARE, V36, P1851, DOI 10.2337/dc12-1965; Kropff J, 2016, DIABETES TECHNOL THE, V18, P53, DOI 10.1089/dia.2015.0345; Law GR, 2015, DIABETES CARE, V38, P1319, DOI 10.2337/dc15-0070; Ly TT, 2015, DIABETES CARE, V38, P1205, DOI 10.2337/dc14-3073; Middleton P, 2012, COCHRANE DB SYST REV, V8, DOI [10.1002/14651858.1, DOI 10.1002/14651858.1.PUBMED:2289597620824880]; Murphy HR, 2012, DIABETOLOGIA, V55, P282, DOI 10.1007/s00125-011-2363-6; Murphy HR, 2007, DIABETES CARE, V30, P2785, DOI 10.2337/dc07-0500; Murphy HR, 2011, DIABETES CARE, V34, P2527, DOI 10.2337/dc11-1430; Murphy HR, 2011, DIABETES CARE, V34, P406, DOI 10.2337/dc10-1796; Nimri R, 2014, DIABETES CARE, V37, P3025, DOI 10.2337/dc14-0835; Ramsay JO, 2009, USE R, P1, DOI 10.1007/978-0-387-98185-7_1; Ringholm L, 2012, DIABETIC MED, V29, P558, DOI 10.1111/j.1464-5491.2012.03604.x; Russell SJ, 2014, NEW ENGL J MED, V371, P313, DOI 10.1056/NEJMoa1314474; ter Braak EWMT, 2002, DIABETES-METAB RES, V18, P96, DOI 10.1002/dmrr.271; Thabit H, 2015, NEW ENGL J MED, V373, P2129, DOI 10.1056/NEJMoa1509351; Thabit H, 2014, LANCET DIABETES ENDO, V2, P701, DOI 10.1016/S2213-8587(14)70114-7	32	118	125	1	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2016	375	7					644	654		10.1056/NEJMoa1602494	http://dx.doi.org/10.1056/NEJMoa1602494			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4VF	27532830	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000381478600006
J	Nagahori, W; Takenoshita, H; Yuki, K; Kimachi, M				Nagahori, Wataru; Takenoshita, Hiromasa; Yuki, Kataoka; Kimachi, Miho			Lactation and Progression to Type 2 Diabetes Mellitus After Gestational Diabetes Mellitus	ANNALS OF INTERNAL MEDICINE			English	Letter									[Nagahori, Wataru] Hokkaido Ohno Hosp, Sapporo, Hokkaido, Japan; [Takenoshita, Hiromasa] Karatsu Red Cross Hosp, Karatsu, Japan; [Yuki, Kataoka; Kimachi, Miho] Kyoto Univ, Grad Sch Med & Publ Hlth, Kyoto, Japan	Kyoto University	Nagahori, W (corresponding author), Hokkaido Ohno Hosp, Sapporo, Hokkaido, Japan.							Gunderson EP, 2015, ANN INTERN MED, V163, P889, DOI 10.7326/M15-0807; Gunderson EP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-952; Kraemer HC, 2001, AM J PSYCHIAT, V158, P848, DOI 10.1176/appi.ajp.158.6.848; Nommsen-Rivers LA, 2009, MATERN CHILD HLTH J, V13, P334, DOI 10.1007/s10995-008-0356-y	4	2	2	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					299	299		10.7326/L16-0105	http://dx.doi.org/10.7326/L16-0105			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UI	27538168				2022-12-28	WOS:000381267200027
J	Oliver, D				Oliver, David			David Oliver: Consultant contracts and seven day services	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						[Anonymous], 2016, BBC, VBBC1; Campbell D, 2016, GUARDIAN; Campbell D., 2016, 7 DAY NHS UNACHIEVAB; Gulland A., 2016, BMJ CAREERS; Hunt J, 2016, ORAL STATEMENT PARLI; Hunt J., 2015, MAKING HEALTHCARE MO; Kirkland F, 2015, GUARDIAN; National Audit Office, 2016, HC18 SESS 2016 17; *NHS ENGL, 2013, NHS SERV 7 DAYS WEEK; Royal College of Physicians, 2016, YOUR STOR INTR 7 DAY; Royal College of Physicians, 2015, 2 3 PHYS SUPP 7 DAY; The Commissioning Review, 2016, STEPS JIM MACK REV I	12	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2016	354								i4357	10.1136/bmj.i4357	http://dx.doi.org/10.1136/bmj.i4357			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4UY	27520473	Green Published, Bronze			2022-12-28	WOS:000381477800001
J	Rossignol, S; Tinel, L; Bianco, A; Passananti, M; Brigante, M; Donaldson, DJ; George, C				Rossignol, Stephanie; Tinel, Liselotte; Bianco, Angelica; Passananti, Monica; Brigante, Marcello; Donaldson, D. James; George, Christian			Atmospheric photochemistry at a fatty acid-coated air-water interface	SCIENCE			English	Article							ORGANIC-COMPOUNDS; PHOTOSENSITIZED PRODUCTION; SURFACE; REACTIVITY; SOLVATION	Although fatty acids are believed to be photochemically inert in the actinic region, complex volatile organic compounds are produced during illumination of an air-water interface coated solely with a monolayer of carboxylic acid. When aqueous solutions containing nonanoic acid (NA) at bulk concentrations that give rise to just over a monolayer of NA coverage are illuminated with actinic radiation, saturated and unsaturated aldehydes are seen in the gas phase, and more highly oxygenated products appear in the aqueous phase. This chemistry is probably initiated by triplet-state NA molecules excited by direct absorption of actinic light at the water surface. Because fatty acids-covered interfaces are ubiquitous in the environment, such photochemical processing will have a substantial impact on local ozone and particle formation.	[Rossignol, Stephanie; Tinel, Liselotte; Passananti, Monica; George, Christian] Univ Lyon 1, CNRS, Inst Rech Catalyze & Environm Lyon IRCELYON, F-69626 Villeurbanne, France; [Bianco, Angelica; Brigante, Marcello] Univ Clermont Ferrand, Clermont Univ, Inst Chim Clermont Ferrand, BP 10448, F-63000 Clermont Ferrand, France; [Donaldson, D. James] Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada; [Donaldson, D. James] Univ Toronto, Dept Phys & Environm Sci, Toronto, ON M5S 3H6, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of Toronto; University of Toronto	George, C (corresponding author), Univ Lyon 1, CNRS, Inst Rech Catalyze & Environm Lyon IRCELYON, F-69626 Villeurbanne, France.; Donaldson, DJ (corresponding author), Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada.; Donaldson, DJ (corresponding author), Univ Toronto, Dept Phys & Environm Sci, Toronto, ON M5S 3H6, Canada.	jdonalds@chem.utoronto.ca; christian.george@ircelyon.univ-lyon1.fr	Brigante, Marcello/I-5212-2012; Brigante, Marcello/AAQ-3898-2020; Tinel, Liselotte/ABE-1893-2021; Bianco, Angelica/AAA-8241-2021; Passananti, Monica/N-7013-2016; Passananti, Monica/AAY-1479-2020; Tinel, Liselotte/I-8755-2018; Donaldson, James/G-7120-2012; George, Christian/F-5220-2018	Brigante, Marcello/0000-0003-2150-9888; Bianco, Angelica/0000-0002-6297-2062; Passananti, Monica/0000-0003-4053-1191; Passananti, Monica/0000-0003-4053-1191; Tinel, Liselotte/0000-0003-1742-2755; Donaldson, James/0000-0002-5090-3318; George, Christian/0000-0003-1578-7056	European Research Council (ERC) under the European Union [290852-AIRSEA]	European Research Council (ERC) under the European Union(European Research Council (ERC))	This study was supported by the European Research Council (ERC) under the European Union's Seventh Framework Program (FP/2007-2013)/ERC Grant Agreement 290852-AIRSEA. D.J.D. acknowledges ongoing support from the Natural Sciences and Engineering Research Council of Canada. The authors are grateful to P. Mascunan and N. Cristin for the ICP-MS analysis and N. Charbonnel and S. Perrier for the technical support provided by IRCELYON. All the data presented here can be downloaded from the supplementary materials.	Baergen AM, 2013, ENVIRON SCI TECHNOL, V47, P815, DOI 10.1021/es3037862; Calvert J. G., 1966, PHOTOCHEMISTRY; CASWELL LR, 1976, J ORG CHEM, V41, P3312, DOI 10.1021/jo00882a023; Ciuraru R, 2015, ENVIRON SCI TECHNOL, V49, P13199, DOI 10.1021/acs.est.5b02388; Ciuraru R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12741; COYLE JD, 1978, CHEM REV, V78, P97, DOI 10.1021/cr60312a002; Dupart Y, 2012, P NATL ACAD SCI USA, V109, P20842, DOI 10.1073/pnas.1212297109; Enami S, 2015, J PHYS CHEM LETT, V6, P527, DOI 10.1021/jz502432j; Fu HB, 2015, J AM CHEM SOC, V137, P8348, DOI 10.1021/jacs.5b04051; George C, 2015, CHEM REV, V115, P4218, DOI 10.1021/cr500648z; Griffith EC, 2014, J AM CHEM SOC, V136, P3784, DOI 10.1021/ja5006256; Kanicky JR, 2000, LANGMUIR, V16, P172, DOI 10.1021/la990719o; Martins-Costa MTC, 2015, ORG BIOMOL CHEM, V13, P1673, DOI 10.1039/c4ob02029d; Martins-Costa MTC, 2012, J AM CHEM SOC, V134, P11821, DOI 10.1021/ja304971e; Mozgawa K, 2014, J PHYS CHEM C, V118, P4715, DOI 10.1021/jp4117276; Parsons AF, 2000, INTRO FREE RADICAL C; Plane J. M. C., 1997, SEA SURFACE GLOBAL C, P71; Rossignol S, 2014, ENVIRON SCI TECHNOL, V48, P3218, DOI 10.1021/es405581g; Vacha R, 2004, J PHYS CHEM A, V108, P11573, DOI 10.1021/jp046268k; Zhu CZ, 2008, CHEM PHYS LETT, V458, P373, DOI 10.1016/j.cplett.2008.04.125	20	96	98	10	314	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					699	702		10.1126/science.aaf3617	http://dx.doi.org/10.1126/science.aaf3617			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZC	27516601	Green Submitted			2022-12-28	WOS:000381561200040
J	Scotson, J				Scotson, John			Charles Desmond Ross Pengelly OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		PENGELLY CDR, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2016	354								i4271	10.1136/bmj.i4271	http://dx.doi.org/10.1136/bmj.i4271			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9DD	27496391				2022-12-28	WOS:000381081800010
J	Kotlyar, S				Kotlyar, Simon			Urticaria Multiforme	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Kotlyar, Simon] Telluride Med Ctr, Telluride, CO 81435 USA		Kotlyar, S (corresponding author), Telluride Med Ctr, Telluride, CO 81435 USA.	simonkotlyar@mac.com							0	1	2	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2016	375	5					470	470		10.1056/NEJMicm1508654	http://dx.doi.org/10.1056/NEJMicm1508654			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7AN	27518665				2022-12-28	WOS:000380934900011
J	Stein, MM; Hrusch, CL; Gozdz, J; Igartua, C; Pivniouk, V; Murray, SE; Ledford, JG; dos Santos, MM; Anderson, RL; Metwali, N; Neilson, JW; Maier, RM; Gilbert, JA; Holbreich, M; Thorne, PS; Martinez, FD; von Mutius, E; Vercelli, D; Ober, C; Sperling, AI				Stein, Michelle M.; Hrusch, Cara L.; Gozdz, Justyna; Igartua, Catherine; Pivniouk, Vadim; Murray, Sean E.; Ledford, Julie G.; dos Santos, Mauricius Marques; Anderson, Rebecca L.; Metwali, Nervana; Neilson, Julia W.; Maier, Raina M.; Gilbert, Jack A.; Holbreich, Mark; Thorne, Peter S.; Martinez, Fernando D.; von Mutius, Erika; Vercelli, Donata; Ober, Carole; Sperling, Anne I.			Innate Immunity and Asthma Risk in Amish and Hutterite Farm Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHILDHOOD ASTHMA; DISEASE; EXPOSURE; SUSCEPTIBILITY; ENDOTOXIN; CELLS; SENSITIZATION; NEUTROPHILS; PREVALENCE; ACTIVATION	BACKGROUND The Amish and Hutterites are U.S. agricultural populations whose lifestyles are remarkably similar in many respects but whose farming practices, in particular, are distinct; the former follow traditional farming practices whereas the latter use industrialized farming practices. The populations also show striking disparities in the prevalence of asthma, and little is known about the immune responses underlying these disparities. METHODS We studied environmental exposures, genetic ancestry, and immune profiles among 60 Amish and Hutterite children, measuring levels of allergens and endotoxins and assessing the microbiome composition of indoor dust samples. Whole blood was collected to measure serum IgE levels, cytokine responses, and gene expression, and peripheral-blood leukocytes were phenotyped with flow cytometry. The effects of dust extracts obtained from Amish and Hutterite homes on immune and airway responses were assessed in a murine model of experimental allergic asthma. RESULTS Despite the similar genetic ancestries and lifestyles of Amish and Hutterite children, the prevalence of asthma and allergic sensitization was 4 and 6 times as low in the Amish, whereas median endotoxin levels in Amish house dust was 6.8 times as high. Differences in microbial composition were also observed in dust samples from Amish and Hutterite homes. Profound differences in the proportions, phenotypes, and functions of innate immune cells were also found between the two groups of children. In a mouse model of experimental allergic asthma, the intranasal instillation of dust extracts from Amish but not Hutterite homes significantly inhibited airway hyperreactivity and eosinophilia. These protective effects were abrogated in mice that were deficient in MyD88 and Trif, molecules that are critical in innate immune signaling. CONCLUSIONS The results of our studies in humans and mice indicate that the Amish environment provides protection against asthma by engaging and shaping the innate immune response.	[Stein, Michelle M.; Igartua, Catherine; Anderson, Rebecca L.; Ober, Carole] Univ Chicago, Dept Human Genet, 920 E 58th St,CLSC 425, Chicago, IL 60637 USA; [Hrusch, Cara L.; Sperling, Anne I.] Univ Chicago, Dept Med, Sect Pulm & Crit Care Med, Chicago, IL 60637 USA; [Hrusch, Cara L.; Sperling, Anne I.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Gilbert, Jack A.] Univ Chicago, Dept Surg, Chicago, IL 60637 USA; [Gilbert, Jack A.] Argonne Natl Lab, Inst Genom & Syst Biol, 9700 S Cass Ave, Argonne, IL 60439 USA; [Gozdz, Justyna] Univ Arizona, NIEHS Training Program Environm Toxicol, Tucson, AZ 85721 USA; [Gozdz, Justyna] Univ Arizona, Grad Program Cellular & Mol Med, Tucson, AZ 85721 USA; [Pivniouk, Vadim; Vercelli, Donata] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85721 USA; [Ledford, Julie G.] Univ Arizona, Dept Med, Tucson, AZ 85721 USA; [dos Santos, Mauricius Marques] Univ Arizona, Dept Chem & Environm Engn, Tucson, AZ 85721 USA; [Neilson, Julia W.; Maier, Raina M.] Univ Arizona, Dept Soil Water & Environm Sci, Tucson, AZ 85721 USA; [Gozdz, Justyna; Pivniouk, Vadim; Murray, Sean E.; Ledford, Julie G.; Martinez, Fernando D.; Vercelli, Donata] Arizona Resp Ctr, Tucson, AZ USA; [Gozdz, Justyna; Pivniouk, Vadim; Murray, Sean E.; Ledford, Julie G.; Martinez, Fernando D.; Vercelli, Donata] Bio5 Inst, Tucson, AZ USA; [Metwali, Nervana; Thorne, Peter S.] Univ Iowa, Dept Occupat & Environm Hlth, Iowa City, IA USA; [Holbreich, Mark] Allergy & Asthma Consultants, Indianapolis, IN USA; [von Mutius, Erika] Univ Munich, Dr von Hauner Childrens Hosp, Munich, Germany	University of Chicago; University of Chicago; University of Chicago; University of Chicago; University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Arizona; University of Iowa; University of Munich	Vercelli, D (corresponding author), Univ Arizona, Arizona Resp Ctr, Inst Bio5, Rm 339,1657 E Helen St, Tucson, AZ 85721 USA.; Ober, C (corresponding author), Univ Chicago, Dept Human Genet, 920 E 58th St,CLSC 425, Chicago, IL 60637 USA.; Sperling, AI (corresponding author), Univ Chicago, Dept Med, 924 E 57th St,JFK R316, Chicago, IL 60637 USA.	donata@email.arizona.edu; c-ober@genetics.uchicago.edu; asperlin@uchicago.edu	Gilbert, Jack/AAF-3270-2019; Sperling, Anne/ACZ-2351-2022	Stein, Michelle/0000-0002-7680-9012; Gozdz, Justyna/0000-0003-2273-0533; Sperling, Anne I./0000-0002-4265-9212; Thorne, Peter/0000-0002-5045-0929; Ober, Carole/0000-0003-4626-9809; Maier, Raina/0000-0002-0421-4677; von Mutius, Erika/0000-0002-8893-4515	National Institutes of Health; NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007605, R00HL111151, R01HL125602] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095230] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006694, P30ES005605] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funded by the National Institutes of Health and others.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bosco A, 2012, J ALLERGY CLIN IMMUN, V129, P88, DOI 10.1016/j.jaci.2011.10.038; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Caliskan M, 2013, NEW ENGL J MED, V368, P1398, DOI 10.1056/NEJMoa1211592; Cann HM, 2002, SCIENCE, V296, P261; Devi S, 2013, J EXP MED, V210, P2321, DOI 10.1084/jem.20130056; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Ege MJ, 2011, J ALLERGY CLIN IMMUN, V127, P138, DOI 10.1016/j.jaci.2010.09.041; Ege MJ, 2007, J ALLERGY CLIN IMMUN, V119, P1140, DOI 10.1016/j.jaci.2007.01.037; Fortunati E, 2009, CLIN EXP IMMUNOL, V155, P559, DOI 10.1111/j.1365-2249.2008.03791.x; Gomez HG, 2014, CRIT CARE MED, V42, P771, DOI 10.1097/CCM.0000000000000100; Holbreich M, 2012, J ALLERGY CLIN IMMUN, V129, P1671, DOI 10.1016/j.jaci.2012.03.016; Hostetler J, 1974, HUTTERITE SOC; Hostetler John, 1993, AMISH SOC, DOI 10.2307/539066; Kim-Schulze S, 2006, J IMMUNOL, V176, P2790, DOI 10.4049/jimmunol.176.5.2790; Li Q, 2011, P NATL ACAD SCI USA, V108, P19341, DOI 10.1073/pnas.1110946108; Lluis A, 2014, J ALLERGY CLIN IMMUN, V133, P551, DOI 10.1016/j.jaci.2013.06.034; Loss GJ, 2016, AM J RESP CRIT CARE, V193, P889, DOI 10.1164/rccm.201507-1493OC; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Meyers DA, 2014, LANCET RESP MED, V2, P405, DOI 10.1016/S2213-2600(14)70012-8; Motika CA, 2011, J ALLERGY CLIN IMMUN, V128, P774, DOI 10.1016/j.jaci.2011.06.046; Netea MG, 2012, NAT IMMUNOL, V13, P535, DOI 10.1038/ni.2284; Ober C, 2011, IMMUNOL REV, V242, P10, DOI 10.1111/j.1600-065X.2011.01029.x; Orden S, 2014, J ANTIMICROB CHEMOTH, V69, P995, DOI 10.1093/jac/dkt468; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Velten FW, 2004, EUR J IMMUNOL, V34, P2800, DOI 10.1002/eji.200324732; Yamada M, 2011, CELL MOL IMMUNOL, V8, P305, DOI 10.1038/cmi.2011.8; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262	32	540	551	3	94	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2016	375	5					411	421		10.1056/NEJMoa1508749	http://dx.doi.org/10.1056/NEJMoa1508749			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7AN	27518660	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000380934900005
J	Reisman, A				Reisman, Anna			How Many Have You Done?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Reisman, Anna] Yale Sch Med, Dept Internal Med, New Haven, CT USA	Yale University	Reisman, A (corresponding author), Yale Sch Med, Dept Internal Med, New Haven, CT USA.	anna.reisman@yale.edu							0	7	7	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2016	316	5					491	491		10.1001/jama.2016.1996	http://dx.doi.org/10.1001/jama.2016.1996			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9AU	27483063				2022-12-28	WOS:000381075000011
J	Davis, MM				Davis, Mark M.			In Praise of Descriptive Science: A Breath of Fresh AIRE	CELL			English	Editorial Material							CELLS	Meyer et al. find that subjects lacking the AIRE gene, critical for self-tolerance in T lymphocytes, show a broad range of autoantibody specificities, which can have extremely high affinities. The data also suggest that some of these autoantibodies can, surprisingly, prevent some types of auto-immunity, particularly type I diabetes.	[Davis, Mark M.] Stanford Univ, Howard Hughes Med Inst, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Davis, MM (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA.	mmdavis@stanford.edu		Davis, Mark/0000-0001-6868-657X	NIAID NIH HHS [U19 AI057229] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Anderson MS, 2005, IMMUNITY, V23, P227, DOI 10.1016/j.immuni.2005.07.005; Davis MM, 2015, IMMUNITY, V43, P833, DOI 10.1016/j.immuni.2015.11.002; Gardner JM, 2013, IMMUNITY, V39, P560, DOI 10.1016/j.immuni.2013.08.005; Kisand K, 2010, J EXP MED, V207, P299, DOI 10.1084/jem.20091669; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Meyer S, 2016, CELL, V166, P582, DOI 10.1016/j.cell.2016.06.024; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Sabouri Z, 2014, P NATL ACAD SCI USA, V111, pE2567, DOI 10.1073/pnas.1406974111	9	1	1	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					530	531		10.1016/j.cell.2016.07.018	http://dx.doi.org/10.1016/j.cell.2016.07.018			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27471960	Green Accepted, Bronze			2022-12-28	WOS:000380546500004
J	Chou, R; Dana, T; Blazina, I; Daeges, M; Bougatsos, C; Jeanne, TL				Chou, Roger; Dana, Tracy; Blazina, Ian; Daeges, Monica; Bougatsos, Christina; Jeanne, Thomas L.			Screening for Dyslipidemia in Younger Adults: A Systematic Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Review							NATIONAL-HEALTH; HEART-DISEASE; PROGRESSION; PREVALENCE; MANAGEMENT	Background: Dyslipidemia may occur in younger adults (defined as persons aged 21 to 39 years) and is an important risk factor for cardiovascular disease. Screening might identify younger adults with asymptomatic dyslipidemia who may benefit from lipid-lowering therapies. Purpose: To update the 2008 U.S. Preventive Services Task Force review on dyslipidemia screening in younger adults. Data Sources: The Cochrane Central Register of Controlled Trials, the Cochrane Database of Systematic Reviews, and MEDLINE through May 2016, and reference lists. Study Selection: Randomized, controlled trials; cohort studies; and case-control studies on screening for or treatment of asymptomatic dyslipidemia in adults aged 21 to 39 years. Data Extraction: The plan was for 1 investigator to abstract data and a second to check their accuracy, and for 2 investigators to independently assess study quality; however, no studies met the inclusion criteria. Data Synthesis: No study evaluated the effects of lipid screening versus no screening, treatment versus no treatment, or delayed versus earlier treatment on clinical outcomes in younger adults. In addition, no study evaluated the diagnostic yield of alternative screening strategies (such as targeted screening of persons with a family history of hyperlipidemia vs. general screening) in younger adults. Limitation: No direct relevant evidence. Conclusion: Direct evidence on the benefits and harms of screening for or treatment of dyslipidemia in younger adults remains unavailable. Estimating the potential effects of screening for dyslipidemia in this population requires extrapolation from studies performed in older adults.	[Chou, Roger; Dana, Tracy; Blazina, Ian; Bougatsos, Christina] Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, 3181 Southwest Sam Jackson Pk Rd, Portland, OR 97239 USA; [Daeges, Monica] 1505 Duke Univ Rd,Unit 7D, Durham, NC 27701 USA; [Jeanne, Thomas L.] 2841 Southeast Tibbetts St,Apartment B, Portland, OR 97202 USA	Oregon Health & Science University	Chou, R (corresponding author), Oregon Hlth & Sci Univ, Pacific Northwest Evidence Based Practice Ctr, 3181 Southwest Sam Jackson Pk Rd, Portland, OR 97239 USA.	chour@ohsu.edu		Jeanne, Thomas/0000-0002-1021-2475; Blazina, Ian/0000-0003-0164-6674; Chou, Roger/0000-0001-9889-8610				Asselbergs FW, 2004, CIRCULATION, V110, P2809, DOI 10.1161/01.CIR.0000146378.65439.7A; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bakx JC, 2000, PREV MED, V30, P138, DOI 10.1006/pmed.1999.0608; Beishuizen ED, 2004, DIABETES CARE, V27, P2887, DOI 10.2337/diacare.27.12.2887; Chan KL, 2010, CIRCULATION, V121, P306, DOI 10.1161/CIRCULATIONAHA.109.900027; Chou R, 2016, SCREENING DYSLIPIDEM, V138; Chou R, 2016, STATINS PREVENTION C, V139; Fang Jing, 2011, Morbidity and Mortality Weekly Report, V60, P1377; Genest J, 2003, CAN MED ASSOC J, V169, P921; Ghandehari H, 2008, AM HEART J, V156, P112, DOI 10.1016/j.ahj.2008.03.005; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Helfand M, 2008, AHRQ PUBLICATION; KREGER BE, 1994, AM HEART J, V127, P1607, DOI 10.1016/0002-8703(94)90393-X; Lozano P, 2015, EVIDENCE RE IN PRESS; Muldoon MF, 2004, AM J MED, V117, P823, DOI 10.1016/j.amjmed.2004.07.041; National Diabetes Education Initiative, 2013, DIAB MAN GUID AM DIA; Pignone MP, 2001, AM J PREV MED, V20, P77, DOI 10.1016/S0749-3797(01)00255-0; Pignone MP, 2001, AHRQ PUBLICATION, VAHRQ 01-S004; Reiner Z, 2011, EUR HEART J, V32, P1769, DOI [10.1093/eurheartj/ehr158, 10.1016/j.atherosclerosis.2011.06.012]; SLACK J, 1969, LANCET, V2, P1380; STONE NJ, 1974, CIRCULATION, V49, P476, DOI 10.1161/01.CIR.49.3.476; Toth PP, 2012, J CLIN LIPIDOL, V6, P325, DOI 10.1016/j.jacl.2012.05.002; U.S. Preventive Services Task Force, 2016, PROC MAN; U.S. Preventive Services Task Force, 2008, LIP DIS AD CHOL DYSL; Versmissen J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2423	27	25	25	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2016	165	8					560	+		10.7326/M16-0946	http://dx.doi.org/10.7326/M16-0946			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ6BM	27538032				2022-12-28	WOS:000385946600016
J	Zineh, I; Christl, LA				Zineh, Issam; Christl, Leah A.			The Biosimilarity Concept: Toward an Integrated Framework for Evidence Assessment	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Zineh, Issam; Christl, Leah A.] US FDA, Silver Spring, MD 20993 USA; [Zineh, Issam] US FDA, Off Clin Pharmacol, Ctr Drug Evaluat & Res, White Oak Bldg 51,Room 3177, Silver Spring, MD 20993 USA; [Christl, Leah A.] US FDA, Off New Drugs, Ctr Drug Evaluat & Res, White Oak Bldg 22,Room 6426,New Hampshire Ave, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Zineh, I (corresponding author), US FDA, Off Translat Sci, Ctr Drug Evaluat & Res, White Oak Bldg 51,Room 3177, Silver Spring, MD 20993 USA.	issam.zineh@fda.hhs.gov						[Anonymous], 2016, J MANAG CARE SPEC PH, V22, P434, DOI 10.18553/jmcp.2016.22.4.434; Chingcuanco F, 2016, ANN INTERN MED, V165, P565, DOI 10.7326/M16-0428; European Medicines Agency, 2016, SCI GUID MULT BIOS; Khraishi M, 2016, CLIN THER, V38, P1238, DOI 10.1016/j.clinthera.2016.02.023; US Food and Drug Administration, BIOSIMILARS	5	2	2	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2016	165	8					595	+		10.7326/M16-1559	http://dx.doi.org/10.7326/M16-1559			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ6BM	27478907				2022-12-28	WOS:000385946600023
J	Ekelund, U; Steene-Johannessen, J; Brown, WJ; Fagerland, MW; Owen, N; Powell, KE; Bauman, A; Lee, IM				Ekelund, Ulf; Steene-Johannessen, Jostein; Brown, Wendy J.; Fagerland, Morten Wang; Owen, Neville; Powell, Kenneth E.; Bauman, Adrian; Lee, I-Min		Lancet Phys Activity Series; Lancet Sedentary Behaviour Working	Does physical activity attenuate, or even eliminate, the detrimental association of sitting time with mortality? A harmonised meta-analysis of data from more than 1 million men and women	LANCET			English	Article							ALL-CAUSE MORTALITY; TELEVISION VIEWING TIME; SEDENTARY BEHAVIORS; PROSPECTIVE COHORT; CARDIOVASCULAR-DISEASE; INTENSITY EXERCISE; ACTIVITY LEVEL; LIFE-STYLE; ADULTS; RISK	Background High amounts of sedentary behaviour have been associated with increased risks of several chronic conditions and mortality. However, it is unclear whether physical activity attenuates or even eliminates the detrimental effects of prolonged sitting. We examined the associations of sedentary behaviour and physical activity with all-cause mortality. Methods We did a systematic review, searching six databases (PubMed, PsycINFO, Embase, Web of Science, Sport Discus, and Scopus) from database inception until October, 2015, for prospective cohort studies that had individual level exposure and outcome data, provided data on both daily sitting or TV-viewing time and physical activity, and reported effect estimates for all-cause mortality, cardiovascular disease mortality, or breast, colon, and colorectal cancer mortality. We included data from 16 studies, of which 14 were identified through a systematic review and two were additional unpublished studies where pertinent data were available. All study data were analysed according to a harmonised protocol, which categorised reported daily sitting time and TV-viewing time into four standardised groups each, and physical activity into quartiles (in metabolic equivalent of task [MET]-hours per week). We then combined data across all studies to analyse the association of daily sitting time and physical activity with all-cause mortality, and estimated summary hazard ratios using Cox regression. We repeated these analyses using TV-viewing time instead of daily sitting time. Findings Of the 16 studies included in the meta-analysis, 13 studies provided data on sitting time and all-cause mortality. These studies included 1 005 791 individuals who were followed up for 2-18.1 years, during which 84 609 (8.4%) died. Compared with the referent group (ie, those sitting <4 h/day and in the most active quartile [> 35.5 MET-h per week]), mortality rates during follow-up were 12-59% higher in the two lowest quartiles of physical activity (from HR=1.12, 95% CI 1.08-1.16, for the second lowest quartile of physical activity [<16 MET-h per week] and sitting <4 h/day; to HR=1.59, 1.52-1.66, for the lowest quartile of physical activity [<2.5 MET-h per week] and sitting > 8 h/day). Daily sitting time was not associated with increased all-cause mortality in those in the most active quartile of physical activity. Compared with the referent (<4 h of sitting per day and highest quartile of physical activity [> 35.5 MET-h per week]), there was no increased risk of mortality during follow-up in those who sat for more than 8 h/day but who also reported > 35.5 MET-h per week of activity (HR=1.04; 95% CI 0.99-1.10). By contrast, those who sat the least (<4 h/day) and were in the lowest activity quartile (<2.5 MET-h per week) had a significantly increased risk of dying during follow-up (HR=1.27, 95% CI 1.22-1.31). Six studies had data on TV-viewing time (N=465 450; 43 740 deaths). Watching TV for 3 h or more per day was associated with increased mortality regardless of physical activity, except in the most active quartile, where mortality was significantly increased only in people who watched TV for 5 h/day or more (HR=1.16, 1.05-1.28). Interpretation High levels of moderate intensity physical activity (ie, about 60-75 min per day) seem to eliminate the increased risk of death associated with high sitting time. However, this high activity level attenuates, but does not eliminate the increased risk associated with high TV-viewing time. These results provide further evidence on the benefits of physical activity, particularly in societies where increasing numbers of people have to sit for long hours for work and may also inform future public health recommendations.	[Ekelund, Ulf; Steene-Johannessen, Jostein; Fagerland, Morten Wang] Norwegian Sch Sport Sci, Dept Sport Med, Oslo, Norway; [Ekelund, Ulf] Univ Cambridge, MRC, Epidemiol Unit, Cambridge, England; [Brown, Wendy J.] Univ Queensland, Ctr Res Exercise Phys Act & Hlth, Sch Human Movement & Nutr Sci, Brisbane, Qld, Australia; [Fagerland, Morten Wang] Oslo Univ Hosp, Oslo Ctr Biostat & Epidemiol, Res Support Serv, Oslo, Norway; [Owen, Neville] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Owen, Neville] Swinburne Univ Technol, Melbourne, Vic, Australia; [Bauman, Adrian] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Lee, I-Min] Harvard Med Sch, Brigham & Womens Hosp, Div Prevent Med, Boston, MA USA; [Lee, I-Min] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Norwegian School of Sport Sciences; University of Cambridge; University of Queensland; University of Oslo; Baker Heart and Diabetes Institute; Swinburne University of Technology; University of Sydney; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Ekelund, U (corresponding author), Norwegian Sch Sports Sci, Dept Sports Med, N-0806 Oslo, Norway.	ulf.ekelund@nih.no	Lee, I-Min/ABD-5409-2021; Brown, Wendy J/A-1553-2016; Ding, Ding/AAF-9985-2021; van der Ploeg, Hidde P/B-2599-2013; Ekelund, Ulf/AAE-8471-2019; Sallis, James F/D-3001-2014; Pavey, Toby/G-1299-2012; Katzmarzyk, Peter/N-1974-2017	Brown, Wendy J/0000-0001-9093-4509; Ding, Ding/0000-0001-9850-9224; van der Ploeg, Hidde P/0000-0002-3719-5249; Ekelund, Ulf/0000-0003-2115-9267; Rangul, Vegar/0000-0001-8863-0557; Sallis, James F/0000-0003-2555-9452; Pavey, Toby/0000-0002-4946-6683; Petersen, Christina Bjork/0000-0003-2605-0850; Katzmarzyk, Peter/0000-0002-9280-6022; Keadle, Sarah/0000-0002-9569-9306	UK Medical Research Council programme grant [MC_UU_12015/3]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [G11HD080232] Funding Source: NIH RePORTER; Medical Research Council [MC_UU_12015/3, MC_U106179473] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0009875] Funding Source: researchfish; MRC [MC_UU_12015/3, MC_U106179473] Funding Source: UKRI	UK Medical Research Council programme grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	UE was partly funded by the UK Medical Research Council programme grant MC_UU_12015/3 Members of The Lancet Physical Activity Series II steering group are: Adrian Bauman (School of Public Health, Sydney University, Sydney, NSW, Australia), Ding Ding (Sydney School of Public Health University of Sydney, Sydney, NSW, Australia), Ulf Ekelund (Norwegian School of Sports Sciences, Oslo, Norway and Medical Research Council Epidemiology Unit, University of Cambridge, Cambridge, UK), Gregory Heath (Department of Health & Human Performance, University of Tennessee, Chattanooga, USA), Pedro C Hallal (Postgraduate Programme in Epidemiology, Federal University of Pelotas, Pelotas, Brazil), Harold W Kohl III (University of Texas School of Public Health, Austin, USA), I-Min Lee (Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA, and Department of Epidemiology, Harvard T H Chan School of Public Health, Boston, MA, USA), Kenneth E Powell (Atlanta, GA, USA), Michael Pratt (National Center for Chronic Disease Prevention and Health Promotion, Emory University, Atlanta, GA, USA), Rodrigo Reis (Prevention Research Center in St Louis, Brown School, Washington University in St Louis, USA; Urban Management Graduate Program, Pontifical Catholic University of Parana, Curitiba, Brazil), and Jim Sallis (Division of Behavioural Medicine, University of California, San Diego, CA, USA).; Members of The Lancet Sedentary Working Group are: Mette Aadahl (Department of Public Health, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark), William J Blot (Department of Medicine, Vanderbilt University Medical Center and Vanderbilt-Ingram Cancer Center, Nashville, TN, USA), Tien Chey (Sydney School of Public Health, University of Sydney, Sydney NSW, Australia), Anusila Deka (Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA), David Dunstan (Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia), Earl S Ford (Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, GA, USA), Kristine Faerch (Steno Diabetes Center, Gentofte, Denmark), Manami Inoue (Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, Tokyo, Japan), Peter T Katzmarzyk (Pennington Biomedical Research Center, Baton Rouge, LA, USA), Sarah Kozey Keadle (Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, USA), Charles E Matthews (Nutritional Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA), David Martinez (Preventive Medicine and Public Health School of Medicine Universidad Autonoma de Madrid, Madrid, Spain), Alpa V Patel (Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA), Toby Pavey (School of Human Movement and Nutrition Sciences, The University of Queensland, Brisbane, QLD, Australia), Christina Bjork Petersen (National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark), Hidde Van Der Ploeg (Department of Public & Occupational Health, VU University Medical Center Amsterdam, Amsterdam, Netherlands), Vegar Rangul (HUNT Research Centre, Faculty of Health Science Nord-Troendelag University College Levanger, Namsos, Norway), Parneet Sethi (Baker IDI Heart and Diabetes Institute, Melbourne, VIC, Australia), Erik R Sund (HUNT Research Centre, Faculty of Health Science Nord-Troendelag University College Levanger, Namsos, Norway), Kate Westgate (MRC Epidemiology Unit, University of Cambridge, Cambridge, UK), Katrien Wijndaele (MRC Epidemiology Unit, University of Cambridge, Cambridge, UK), Song Yi-Park (Cancer Epidemiology Program, University of Hawaii Cancer Center, Honululu, HI, USA). In addition to data from all the contributing studies, this manuscript was prepared using WHIOS Research Materials obtained from the NHLBI Biologic Specimen and Data Repository Information Coordinating Center and does not necessarily reflect the opinions or views of the WHIOS or the NHLBI.	Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Arem H, 2015, JAMA INTERN MED, V175, P959, DOI 10.1001/jamainternmed.2015.0533; Benatti FB, 2015, MED SCI SPORT EXER, V47, P2053, DOI 10.1249/MSS.0000000000000654; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Brown WJ, 2012, DEV EVIDENCE BASED P; Carlsson S, 2006, SCAND J PUBLIC HEALT, V34, P480, DOI 10.1080/14034940600551293; Chau JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080000; Dunstan DW, 2010, CIRCULATION, V121, P384, DOI 10.1161/CIRCULATIONAHA.109.894824; Ensrud KE, 2014, J AM GERIATR SOC, V62, P2079, DOI 10.1111/jgs.13101; Ford ES, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-70; Frydenlund G, 2012, EUR J PREV CARDIOL, V19, P1111, DOI 10.1177/1741826711419999; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Hansen BH, 2012, MED SCI SPORT EXER, V44, P266, DOI 10.1249/MSS.0b013e31822cb354; Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399; Inoue M, 2008, ANN EPIDEMIOL, V18, P522, DOI 10.1016/j.annepidem.2008.03.008; Jorgensen Torben, 2003, Eur J Cardiovasc Prev Rehabil, V10, P377; Katzmarzyk PT, 2014, MED SCI SPORT EXER, V46, P940, DOI 10.1249/MSS.0000000000000198; Kim IY, 2014, MED SCI SPORT EXER, V46, P1882, DOI 10.1249/MSS.0000000000000324; Kim Y, 2013, INT J EPIDEMIOL, V42, P1040, DOI 10.1093/ije/dyt108; Kmet L.M., 2004, STANDARD QUALITY ASS; Krokstad S, 2013, INT J EPIDEMIOL, V42, P968, DOI 10.1093/ije/dys095; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Leon-Munoz LM, 2013, MED SCI SPORT EXER, V45, P1501, DOI 10.1249/MSS.0b013e3182897e87; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Matthews CE, 2014, AM J EPIDEMIOL, V180, P394, DOI 10.1093/aje/kwu142; Matthews CE, 2012, AM J CLIN NUTR, V95, P437, DOI 10.3945/ajcn.111.019620; MORRIS JN, 1953, LANCET, V265, P1053; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Patel AV, 2010, AM J EPIDEMIOL, V172, P419, DOI 10.1093/aje/kwq155; Pavey TG, 2015, BRIT J SPORT MED, V49, P95, DOI 10.1136/bjsports-2012-091676; Petersen CB, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-13; Schumacher M, 2014, NEW ENGL J MED, V370, P186, DOI 10.1056/NEJMc1315315; Seguin R, 2014, AM J PREV MED, V46, P122, DOI 10.1016/j.amepre.2013.10.021; Sterne JAC, 2001, J CLIN EPIDEMIOL, V54, P1046, DOI 10.1016/S0895-4356(01)00377-8; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; van Dijk JW, 2013, DIABETES CARE, V36, P3448, DOI 10.2337/dc12-2620; Wen CP, 2011, LANCET, V378, P1244, DOI 10.1016/S0140-6736(11)60749-6; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wijndaele K, 2011, INT J EPIDEMIOL, V40, P150, DOI 10.1093/ije/dyq105; World Health Organisation (WHO), 2010, GLOBAL RECOMMENDATIO, P23	41	1313	1356	24	387	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2016	388	10051					1302	1310		10.1016/S0140-6736(16)30370-1	http://dx.doi.org/10.1016/S0140-6736(16)30370-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW5RH	27475271	Green Submitted, Green Accepted			2022-12-28	WOS:000383704000033
J	Cho, SH; Raybuck, AL; Stengel, K; Wei, M; Beck, TC; Volanakis, E; Thomas, JW; Hiebert, S; Haase, VH; Boothby, MR				Cho, Sung Hoon; Raybuck, Ariel L.; Stengel, Kristy; Wei, Mei; Beck, Thomas C.; Volanakis, Emmanuel; Thomas, James W.; Hiebert, Scott; Haase, Volker H.; Boothby, Mark R.			Germinal centre hypoxia and regulation of antibody qualities by a hypoxia response system	NATURE			English	Article							CLASS SWITCH RECOMBINATION; INDUCIBLE FACTOR-I; FLOW-CYTOMETRY; MTOR; INFLAMMATION; DISEASE; CELLS; ACTIVATION; EXPRESSION; SELECTION	Germinal centres (GCs) promote humoral immunity and vaccine efficacy. In GCs, antigen-activated B cells proliferate, express high-affinity antibodies, promote antibody class switching, and yield B cell memory(1,2). Whereas the cytokine milieu has long been known to regulate effector functions that include the choice of immunoglobulin class(3,4), both cell-autonomous5 and extrinsic(6,7) metabolic programming have emerged as modulators of T-cell-mediated immunity(8). Here we show in mice that GC light zones are hypoxic, and that low oxygen tension (p(O2)) alters B cell physiology and function. In addition to reduced proliferation and increased B cell death, low p(O2) impairs antibody class switching to the pro-inflammatory IgG2c antibody isotype by limiting the expression of activation-induced cytosine deaminase (AID). Hypoxia induces HIF transcription factors by restricting the activity of prolyl hydroxyl dioxygenase enzymes, which hydroxylate HIF-1 alpha and HIF-2 alpha to destabilize HIF by binding the von Hippel-Landau tumour suppressor protein (pVHL)(7). B-cell-specific depletion of pVHL leads to constitutive HIF stabilization, decreases antigen-specific GC B cells and undermines the generation of high-affinity IgG, switching to IgG2c, early memory B cells, and recall antibody responses. HIF induction can reprogram metabolic and growth factor gene expression. Sustained hypoxia or HIF induction by pVHL deficiency inhibits mTOR complex 1 (mTORC1) activity in B lymphoblasts, and mTORC1-haploinsufficient B cells have reduced clonal expansion, AID expression, and capacities to yield IgG2c and high-affinity antibodies. Thus, the normal physiology of GCs involves regional variegation of hypoxia, and HIF-dependent oxygen sensing regulates vital functions of B cells. We propose that the restriction of oxygen in lymphoid organs, which can be altered in pathophysiological states, modulates humoral immunity.	[Cho, Sung Hoon; Raybuck, Ariel L.; Wei, Mei; Beck, Thomas C.; Thomas, James W.; Boothby, Mark R.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Stengel, Kristy; Hiebert, Scott] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Volanakis, Emmanuel] Vanderbilt Univ, Dept Pediat, Nashville, TN 37232 USA; [Thomas, James W.; Haase, Volker H.; Boothby, Mark R.] Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA; [Hiebert, Scott; Haase, Volker H.; Boothby, Mark R.] Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA; [Hiebert, Scott; Haase, Volker H.; Boothby, Mark R.] Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA; [Haase, Volker H.] Tennessee Valley Healthcare Syst, Dept Vet Affairs, Med & Res Serv, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Boothby, MR (corresponding author), Vanderbilt Univ, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA.; Boothby, MR (corresponding author), Vanderbilt Univ, Dept Med, Nashville, TN 37232 USA.; Boothby, MR (corresponding author), Vanderbilt Univ, Dept Canc Biol, Nashville, TN 37232 USA.; Boothby, MR (corresponding author), Vanderbilt Univ, Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA.	mark.boothby@vanderbilt.edu	Haase, Volker Hans/A-6758-2013; Haase, Volker Hans/AAJ-5061-2021	Haase, Volker Hans/0000-0002-7051-8994; Stengel, Kristy/0000-0002-8330-5744; Thomas, James/0000-0002-2098-6458; Raybuck, Ariel/0000-0003-3445-2112; Beck, Thomas/0000-0002-8860-5850	National Institutes of Health (NIH) [R01 AI113292, HL106812, CA164605]; Veterans Affairs Merit award [I01 BX002348]; American Cancer Society [PF-13-303-01-DMC]; Cancer Center Support Grant [CA068485]; Diabetes Research Center [DK0205930];  [T32 DK007563]; NATIONAL CANCER INSTITUTE [P30CA068485, T32CA009582, R01CA164605] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113292, R01AI051448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101791, T32DK007563, R01DK081646] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002348] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit award(US Department of Veterans Affairs); American Cancer Society(American Cancer Society); Cancer Center Support Grant; Diabetes Research Center; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	Research funding via National Institutes of Health (NIH) grants R01 AI113292, HL106812 to M.R.B., CA164605 to S.H.; Veterans Affairs Merit award I01 BX002348 to V.H.H., along with support of K.S. by American Cancer Society postdoctoral fellowship PF-13-303-01-DMC, and T.C.B. by T32 DK007563 are gratefully acknowledged, as are O. Davidoff and Q. Liu for expert help with mouse management and with hypoxia chamber usage, respectively, K. Rathmell for critically reading and suggesting manuscript text, P. Young for use of an additional hypoxia chamber, H. Simkins and T. Laufer for guidance on making NP-conjugated fluors, N. Papavasiliou for the AID retrovector, C. Koch for hypoxia detection reagents, and scholarships via the Cancer Center Support Grant (CA068485) and Diabetes Research Center (DK0205930) to help pay for Vanderbilt University cores.	Bannard O, 2013, IMMUNITY, V39, P912, DOI 10.1016/j.immuni.2013.08.038; Cho SH, 2013, J IMMUNOL, V191, P3169, DOI 10.4049/jimmunol.1301106; Cho SH, 2011, P NATL ACAD SCI USA, V108, P15972, DOI 10.1073/pnas.1017082108; Colgan SP, 2010, NAT REV GASTRO HEPAT, V7, P281, DOI 10.1038/nrgastro.2010.39; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Eustace A, 2013, CLIN CANCER RES, V19, P4879, DOI 10.1158/1078-0432.CCR-13-0542; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Hatfield SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1260; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Keating R, 2013, NAT IMMUNOL, V14, P1266, DOI 10.1038/ni.2741; Koch CJ, 2008, RADIAT RES, V169, P677, DOI 10.1667/RR1305.1; Konisti S, 2012, NAT REV RHEUMATOL, V8, P153, DOI 10.1038/nrrheum.2011.205; Krymskaya VP, 2011, FASEB J, V25, P1922, DOI 10.1096/fj.10-175018; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liu QD, 2012, J CLIN INVEST, V122, P4635, DOI 10.1172/JCI63924; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; OKEEFFE S, 1991, EUR RESPIR J, V4, P932; Patten DA, 2010, MOL BIOL CELL, V21, P3247, DOI 10.1091/mbc.E10-01-0025; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Rush JS, 2005, P NATL ACAD SCI USA, V102, P13242, DOI 10.1073/pnas.0502779102; Shlomchik MJ, 2012, IMMUNOL REV, V247, P52, DOI 10.1111/j.1600-065X.2012.01124.x; Spencer JA, 2014, NATURE, V508, P269, DOI 10.1038/nature13034; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Woods ML, 1996, INT J RADIAT ONCOL, V34, P93, DOI 10.1016/0360-3016(95)02006-3; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Xu ZM, 2012, NAT REV IMMUNOL, V12, P517, DOI 10.1038/nri3216; Zhang SL, 2013, J IMMUNOL, V191, P1692, DOI 10.4049/jimmunol.1201767	35	151	151	0	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					234	+		10.1038/nature19334	http://dx.doi.org/10.1038/nature19334			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9LQ	27501247	Green Accepted			2022-12-28	WOS:000382539100048
J	Huang, CD; Rossi, P; Saio, T; Kalodimos, CG				Huang, Chengdong; Rossi, Paolo; Saio, Tomohide; Kalodimos, Charalampos G.			Structural basis for the antifolding activity of a molecular chaperone	NATURE			English	Article							MALTOSE-BINDING PROTEIN; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; CHEMICAL-SHIFTS; QUALITY-CONTROL; SECB CHAPERONE; NMR; SYSTEM; DISAGGREGATION; RECOGNITION	Molecular chaperones act on non-native proteins in the cell to prevent their aggregation, premature folding or misfolding. Different chaperones often exert distinct effects, such as acceleration or delay of folding, on client proteins via mechanisms that are poorly understood. Here we report the solution structure of SecB, a chaperone that exhibits strong antifolding activity, in complex with alkaline phosphatase and maltose-binding protein captured in their unfolded states. SecB uses long hydrophobic grooves that run around its disk-like shape to recognize and bind to multiple hydrophobic segments across the length of non-native proteins. The multivalent binding mode results in proteins wrapping around SecB. This unique complex architecture alters the kinetics of protein binding to SecB and confers strong antifolding activity on the chaperone. The data show how the different architectures of chaperones result in distinct binding modes with non-native proteins that ultimately define the activity of the chaperone.	[Huang, Chengdong; Rossi, Paolo; Saio, Tomohide; Kalodimos, Charalampos G.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Kalodimos, CG (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	ckalodim@umn.edu	Huang, Chengdong/G-8454-2018; Kalodimos, Charalampos/Q-9846-2018	Kalodimos, Charalampos/0000-0001-6354-2796; Huang, Chengdong/0000-0002-8997-9459; Saio, Tomohide/0000-0003-3639-7399	National Institutes of Health [GM073854]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073854] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by National Institutes of Health grant GM073854 to C.G.K.	Baars L, 2006, J BIOL CHEM, V281, P10024, DOI 10.1074/jbc.M509929200; Bechtluft P, 2007, SCIENCE, V318, P1458, DOI 10.1126/science.1144972; Betton JM, 1996, J BIOL CHEM, V271, P8046, DOI 10.1074/jbc.271.14.8046; Betton JM, 1998, J BIOL CHEM, V273, P8897, DOI 10.1074/jbc.273.15.8897; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Burmann BM, 2013, NAT STRUCT MOL BIOL, V20, P1265, DOI 10.1038/nsmb.2677; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Camilloni C, 2012, BIOCHEMISTRY-US, V51, P2224, DOI 10.1021/bi3001825; Castanie-Cornet MP, 2014, BBA-MOL CELL RES, V1843, P1442, DOI 10.1016/j.bbamcr.2013.11.007; CHUN SY, 1993, J BIOL CHEM, V268, P20855; Clare DK, 2009, NATURE, V457, P107, DOI 10.1038/nature07479; Dekker C, 2003, J STRUCT BIOL, V144, P313, DOI 10.1016/j.jsb.2003.09.012; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Gelis I, 2007, CELL, V131, P756, DOI 10.1016/j.cell.2007.09.039; Guntert Peter, 2004, Methods Mol Biol, V278, P353; HARDY SJS, 1991, SCIENCE, V251, P439, DOI 10.1126/science.1989077; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Horwich AL, 2014, CELL, V157, P285, DOI 10.1016/j.cell.2014.03.029; Kerfah R, 2015, CURR OPIN STRUC BIOL, V32, P113, DOI 10.1016/j.sbi.2015.03.009; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Knoblauch NTM, 1999, J BIOL CHEM, V274, P34219, DOI 10.1074/jbc.274.48.34219; Krishnamurthy VM, 2007, J AM CHEM SOC, V129, P1312, DOI 10.1021/ja066780e; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Mattoo RUH, 2014, CELL MOL LIFE SCI, V71, P3311, DOI 10.1007/s00018-014-1627-y; Milbradt AG, 2015, J BIOMOL NMR, V62, P291, DOI 10.1007/s10858-015-9944-5; Muren EM, 1999, J BIOL CHEM, V274, P19397, DOI 10.1074/jbc.274.27.19397; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Rosenzweig R, 2013, SCIENCE, V339, P1080, DOI 10.1126/science.1233066; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Saio T, 2014, SCIENCE, V344, P597, DOI 10.1126/science.1250494; Sakr S, 2010, J BIOL CHEM, V285, P23504, DOI 10.1074/jbc.M110.133058; Sala A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00666; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Tang Y, 2010, BIOCHEM BIOPH RES CO, V393, P698, DOI 10.1016/j.bbrc.2010.02.062; Tejero R, 2013, J BIOMOL NMR, V56, P337, DOI 10.1007/s10858-013-9753-7; Ullers RS, 2007, P NATL ACAD SCI USA, V104, P3101, DOI 10.1073/pnas.0608232104; Ullers RS, 2004, P NATL ACAD SCI USA, V101, P7583, DOI 10.1073/pnas.0402398101; Wolff N, 2003, J BIOL CHEM, V278, P38247, DOI 10.1074/jbc.M302322200; Xu ZH, 2000, NAT STRUCT BIOL, V7, P1172, DOI 10.1038/82040; Zhou JH, 2003, NAT STRUCT BIOL, V10, P942, DOI 10.1038/nsb980; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002	42	100	101	3	84	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					202	+		10.1038/nature18965	http://dx.doi.org/10.1038/nature18965			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9LQ	27501151	Green Accepted			2022-12-28	WOS:000382539100041
J	Patel, S				Patel, Salma			WHAT YOUR PATIENT IS THINKING "It's just a bit of colic," they said	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material														Patel, Salma/0000-0002-6058-8382					0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2016	354								i4195	10.1136/bmj.i4195	http://dx.doi.org/10.1136/bmj.i4195			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GZ	27534873	Green Published, Bronze			2022-12-28	WOS:000381806400003
J	Torjesen, I				Torjesen, Ingrid			Growing gaps in paediatric rotas threaten children's healthcare, says royal college	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		O'Dowd A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3308; Royal College of Paediatrics and Child Health, 2016, ROT VAC COMPL SURV	2	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2016	354								i4495	10.1136/bmj.i4495	http://dx.doi.org/10.1136/bmj.i4495			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GX	27530122				2022-12-28	WOS:000381806200013
J	McCarthy, M				McCarthy, Michael			Incidence of neonatal abstinence syndrome triples in US	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Ko JY, 2016, MMWR-MORBID MORTAL W, V65, P799, DOI 10.15585/mmwr.mm6531a2	1	0	0	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 15	2016	354								i4476	10.1136/bmj.i4476	http://dx.doi.org/10.1136/bmj.i4476			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GR	27528262				2022-12-28	WOS:000381805400015
J	Milne, RM				Milne, Robert Marshall			Robert Marshall Milne OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2016	354								i4397	10.1136/bmj.i4397	http://dx.doi.org/10.1136/bmj.i4397			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4UY	27521151				2022-12-28	WOS:000381477800005
J	Oppenheimer, R				Oppenheimer, Rebecca			Making sense of the exoplanet zoo The diversity of substellar objects may call for a rethinking of our labeling conventions	SCIENCE			English	Editorial Material							PLANET		[Oppenheimer, Rebecca] Amer Museum Nat Hist, Dept Astrophys, Cent Pk West 79th St, New York, NY 10024 USA	American Museum of Natural History (AMNH)	Oppenheimer, R (corresponding author), Amer Museum Nat Hist, Dept Astrophys, Cent Pk West 79th St, New York, NY 10024 USA.	roppenheimer@amnh.org						Chauvin G, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201015433; Dupuy TJ, 2016, ASTROPHYS J, V817, DOI 10.3847/0004-637X/817/1/80; Ma SZ, 2016, MON NOT R ASTRON SOC, V461, pL107, DOI 10.1093/mnrasl/slw110; Macintosh B, 2015, SCIENCE, V350, P64, DOI 10.1126/science.aac5891; Oppenheimer B. R., 2014, 50 YEARS BROWN DWARF, P81; Vogt H., 1925, ASTRON NACHR, V226, P301; Wagner K, 2016, SCIENCE, V353, P673, DOI 10.1126/science.aaf9671; Zucker S, 2004, ASTRON ASTROPHYS, V426, P695, DOI 10.1051/0004-6361:20040384	8	0	0	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					644	645		10.1126/science.aah4097	http://dx.doi.org/10.1126/science.aah4097			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5ZC	27516582				2022-12-28	WOS:000381561200017
J	Ashton, J				Ashton, John			Slobodan Lang Obituary	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		LANG S, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2016	354								i4383	10.1136/bmj.i4383	http://dx.doi.org/10.1136/bmj.i4383			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4TU	27506818				2022-12-28	WOS:000381474800011
J	Chochinov, HM; Frazee, C				Chochinov, Harvey Max; Frazee, Catherine			Finding a balance: Canada's law on medical assistance in dying	LANCET			English	Editorial Material									[Chochinov, Harvey Max] Univ Manitoba, Dept Psychiat, Winnipeg, MB, Canada; [Chochinov, Harvey Max] CancerCare Manitoba, Manitoba Palliat Care Res Unit, Winnipeg, MB R3E 0V9, Canada; Ryerson Univ, Sch Disabil Studies, Toronto, ON, Canada	University of Manitoba; CancerCare Manitoba Foundation; Toronto Metropolitan University	Chochinov, HM (corresponding author), Univ Manitoba, Dept Psychiat, Winnipeg, MB, Canada.; Chochinov, HM (corresponding author), CancerCare Manitoba, Manitoba Palliat Care Res Unit, Winnipeg, MB R3E 0V9, Canada.	hchochinov@cancercare.mb.ca		Chochinov, Harvey/0000-0003-2656-4704				[Anonymous], 2016, RT QUESTION MOR 0618; Department of Justice Government of Canada., 2015, CONS PHYS ASS DYING; Parliament of Canada, 2016, MED ASS DYING PAT CT; Provincial Territorial Expert Advisory Group on Physician Assisted Dying, 2015, FIN REP NOV 30 PROV; Stone L, 2016, GLOBE MAIL	5	13	13	0	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2016	388	10044					543	545		10.1016/S0140-6736(16)31254-5	http://dx.doi.org/10.1016/S0140-6736(16)31254-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS4NA	27511771				2022-12-28	WOS:000380756600009
J	Roland, M; Guthrie, B				Roland, Martin; Guthrie, Bruce			Quality and Outcomes Framework: what have we learnt?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PAY-FOR-PERFORMANCE; PRIMARY-CARE; FINANCIAL INCENTIVES		[Roland, Martin] Inst Publ Hlth, Cambridge CB2 0SR, England; [Guthrie, Bruce] Univ Dundee, Populat Hlth Sci, Dundee, Scotland	University of Cambridge; University of Dundee	Roland, M (corresponding author), Inst Publ Hlth, Cambridge CB2 0SR, England.	mr108@cam.ac.uk	Guthrie, Bruce/HHM-9696-2022	Guthrie, Bruce/0000-0003-4191-4880; Roland, Martin/0000-0002-8533-3060				Calvert M, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1870; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Doran T, 2008, NEW ENGL J MED, V359, P274, DOI 10.1056/NEJMsa0800310; Doran T, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d3590; Dreischulte T, 2016, NEW ENGL J MED, V374, P1053, DOI 10.1056/NEJMsa1508955; Gibson J, 2015, 8 NATL GP WORKLIFE S; Guthrie B, 2006, BRIT J GEN PRACT, V56, P836; Harrison MJ, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6423; Health and Social Care Information Centre, 2015, GP EARN EXP TIM SER; Lester H, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1898; McDonald R, 2007, BMJ-BRIT MED J, V334, P1357, DOI 10.1136/bmj.39238.890810.BE; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Roland M, 2016, BMJ QUAL SAF, V25, P653, DOI 10.1136/bmjqs-2015-005003; Roland M, 2016, LANCET, V388, P217, DOI 10.1016/S0140-6736(16)00550-X; Roland M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3851; Ryan AM, 2016, LANCET, V388, P268, DOI 10.1016/S0140-6736(16)00276-2	17	46	47	1	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2016	354								i4060	10.1136/bmj.i4060	http://dx.doi.org/10.1136/bmj.i4060			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9CY	27492602	Green Published, hybrid			2022-12-28	WOS:000381081300002
J	Hegenauer, V; Furst, U; Kaiser, B; Smoker, M; Zipfel, C; Felix, G; Stahl, M; Albert, M				Hegenauer, Volker; Fuerst, Ursula; Kaiser, Bettina; Smoker, Matthew; Zipfel, Cyril; Felix, Georg; Stahl, Mark; Albert, Markus			Detection of the plant parasite Cuscuta reflexa by a tomato cell surface receptor	SCIENCE			English	Article							MESSENGER-RNA; GENUS CUSCUTA; HOST PLANTS; IMMUNITY; PROTEIN; KINASE; CONVOLVULACEAE; IDENTIFICATION; LOCALIZATION; ASSOCIATION	Parasitic plants are a constraint on agriculture worldwide. Cuscuta reflexa is a stem holoparasite that infests most dicotyledonous plants. One exception is tomato, which is resistant to C. reflexa. We discovered that tomato responds to a small peptide factor occurring in Cuscuta spp. with immune responses typically activated after perception of microbe-associated molecular patterns. We identified the cell surface receptor-like protein CUSCUTA RECEPTOR 1 ( CuRe1) as essential for the perception of this parasite-associated molecular pattern. CuRe1 is sufficient to confer responsiveness to the Cuscuta factor and increased resistance to parasitic C. reflexa when heterologously expressed in otherwise susceptible host plants. Our findings reveal that plants recognize parasitic plants in a manner similar to perception of microbial pathogens.	[Hegenauer, Volker; Fuerst, Ursula; Kaiser, Bettina; Felix, Georg; Stahl, Mark; Albert, Markus] Univ Tubingen, Ctr Plant Mol Biol, D-72076 Tubingen, Germany; [Smoker, Matthew; Zipfel, Cyril] Norwich Res Pk, Sainsbury Lab, Norwich NR4 7UH, Norfolk, England	Eberhard Karls University of Tubingen; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Albert, M (corresponding author), Univ Tubingen, Ctr Plant Mol Biol, D-72076 Tubingen, Germany.	markus.albert@zmbp.uni-tuebingen.de	ZIPFEL, CYRIL B/D-7103-2011; ZIPFEL, CYRIL/ABD-5076-2021	ZIPFEL, CYRIL B/0000-0003-4935-8583; ZIPFEL, CYRIL/0000-0003-4935-8583; Albert, Markus/0000-0003-4729-2453; Kaiser, Bettina/0000-0003-2052-2642	Deutsche Forschungsgemeinschaft (DFG) [AL1426/1-1]; DFG [AL1426/1-2, CRC 1101]; German Federal Ministry of Education (BMBF-KBBE project) [031A328 36]; Gatsby Charitable Foundation	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); German Federal Ministry of Education (BMBF-KBBE project); Gatsby Charitable Foundation	We thank the Tomato Genetics Resource Center (University of California, Davis) for providing seeds of the tomato introgression lines; N. Sinha and M. Farhi for providing C. pentagona material and seeds; M. H. A. J. Joosten and S. Robatzek for SlSOBIR and SlSOBIR-like constructs; and P. Neumann and I. Bock for technical assistance; and N. Holton and I. Albert for critical reading of the manuscript before submission. Supported by Deutsche Forschungsgemeinschaft (DFG) grant AL1426/1-1 (M.A.), DFG grant AL1426/1-2 (V.H., U.F., and B.K.), the German Federal Ministry of Education (BMBF-KBBE project 031A328 36) (U.F.), and DFG grant CRC 1101 (M. S. and G.F.). Research at the C.Z. laboratory is funded by the Gatsby Charitable Foundation. The authors do not have any competing interests. Supplement contains additional data.	Alakonya A, 2012, PLANT CELL, V24, P3153, DOI 10.1105/tpc.112.099994; Albert I, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.140, 10.1038/nplants.2015.140]; Albert M, 2006, PLANT J, V48, P548, DOI 10.1111/j.1365-313X.2006.02897.x; Bleischwitz M, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-227; Chitwood DH, 2013, PLANT CELL, V25, P2465, DOI 10.1105/tpc.113.112391; David-Schwartz R, 2008, NEW PHYTOL, V179, P1133, DOI 10.1111/j.1469-8137.2008.02540.x; Davis CC, 2015, CURR OPIN PLANT BIOL, V26, P14, DOI 10.1016/j.pbi.2015.05.008; Dawson J. H. M., 1994, WEED SCI, V6, P265; Dodds PN, 2010, NAT REV GENET, V11, P539, DOI 10.1038/nrg2812; ESHED Y, 1995, GENETICS, V141, P1147; Funk HT, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-45; Garcia MA, 2014, AM J BOT, V101, P670, DOI 10.3732/ajb.1300449; Gust AA, 2014, CURR OPIN PLANT BIOL, V21, P104, DOI 10.1016/j.pbi.2014.07.007; Hanisch FG, 2001, ANAL BIOCHEM, V290, P47, DOI 10.1006/abio.2000.4955; Haupt S, 2001, J EXP BOT, V52, P173, DOI 10.1093/jexbot/52.354.173; Hibberd JM, 1998, PLANTA, V205, P506, DOI 10.1007/s004250050349; Hibberd JM, 1999, PLANT CELL ENVIRON, V22, P937, DOI 10.1046/j.1365-3040.1999.00462.x; IHL B, 1988, FLORA, V181, P383; Jehle AK, 2013, PLANT CELL, V25, P2330, DOI 10.1105/tpc.113.110833; Jeschke WD, 1997, PLANT CELL ENVIRON, V20, P47, DOI 10.1046/j.1365-3040.1997.d01-2.x; Johnsen HR, 2015, NEW PHYTOL, V207, P805, DOI 10.1111/nph.13378; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaiser B, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00045; Kim G, 2015, CURR OPIN PLANT BIOL, V26, P20, DOI 10.1016/j.pbi.2015.05.012; Kim G, 2014, SCIENCE, V345, P808, DOI 10.1126/science.1253122; Liebrand TWH, 2014, TRENDS PLANT SCI, V19, P123, DOI 10.1016/j.tplants.2013.10.003; Liebrand TWH, 2013, P NATL ACAD SCI USA, V110, P10010, DOI 10.1073/pnas.1220015110; McNeal JR, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-55; Postma J, 2016, NEW PHYTOL, V210, P627, DOI 10.1111/nph.13802; Roney JK, 2007, PLANT PHYSIOL, V143, P1037, DOI 10.1104/pp.106.088369; Runyon JB, 2006, SCIENCE, V313, P1964, DOI 10.1126/science.1131371; Spallek T, 2013, MOL PLANT PATHOL, V14, P861, DOI 10.1111/mpp.12058; Thuerig B, 2005, PHYSIOL MOL PLANT P, V67, P180, DOI 10.1016/j.pmpp.2006.01.002; Werner M, 2001, PLANTA, V213, P550, DOI 10.1007/s004250100533; Westwood JH, 2010, TRENDS PLANT SCI, V15, P227, DOI 10.1016/j.tplants.2010.01.004; Zhang WG, 2013, PLANT CELL, V25, P4227, DOI 10.1105/tpc.113.117010; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	37	78	81	7	108	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					478	481		10.1126/science.aaf3919	http://dx.doi.org/10.1126/science.aaf3919			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27471302	Green Accepted			2022-12-28	WOS:000380583600038
J	Novoselov, KS; Mishchenko, A; Carvalho, A; Neto, AHC				Novoselov, K. S.; Mishchenko, A.; Carvalho, A.; Castro Neto, A. H.			2D materials and van der Waals heterostructures	SCIENCE			English	Review							TRANSITION-METAL DICHALCOGENIDES; HEXAGONAL BORON-NITRIDE; EXCITON BINDING-ENERGY; CHARGE-DENSITY-WAVE; EPITAXIAL-GROWTH; BLACK PHOSPHORUS; LATERAL HETEROSTRUCTURES; 2-DIMENSIONAL MATERIALS; ELECTRONIC-PROPERTIES; VALLEY POLARIZATION	The physics of two-dimensional ( 2D) materials and heterostructures based on such crystals has been developing extremely fast. With these new materials, truly 2D physics has begun to appear ( for instance, the absence of long-range order, 2D excitons, commensurate-incommensurate transition, etc.). Novel heterostructure devices-such as tunneling transistors, resonant tunneling diodes, and light-emitting diodes-are also starting to emerge. Composed from individual 2D crystals, such devices use the properties of those materials to create functionalities that are not accessible in other heterostructures. Here we review the properties of novel 2D crystals and examine how their properties are used in new heterostructure devices.	[Novoselov, K. S.; Mishchenko, A.] Univ Manchester, Sch Phys & Astron, Oxford Rd, Manchester M13 9PL, Lancs, England; [Novoselov, K. S.; Mishchenko, A.] Univ Manchester, Natl Graphene Inst, Manchester M13 9PL, Lancs, England; [Carvalho, A.; Castro Neto, A. H.] Natl Univ Singapore, Ctr Adv Mat 2D, 2 Sci Dr 3, Singapore 117542, Singapore; [Carvalho, A.; Castro Neto, A. H.] Natl Univ Singapore, Graphene Res Ctr, 2 Sci Dr 3, Singapore 117542, Singapore	University of Manchester; University of Manchester; National University of Singapore; National University of Singapore	Novoselov, KS (corresponding author), Univ Manchester, Sch Phys & Astron, Oxford Rd, Manchester M13 9PL, Lancs, England.; Neto, AHC (corresponding author), Natl Univ Singapore, Ctr Adv Mat 2D, 2 Sci Dr 3, Singapore 117542, Singapore.; Neto, AHC (corresponding author), Natl Univ Singapore, Graphene Res Ctr, 2 Sci Dr 3, Singapore 117542, Singapore.	kostya@manchester.ac.uk; phycastr@nus.edu.sg	Novoselov, Kostya S/G-9581-2014; Carvalho, Alexandra/B-2771-2011; Mishchenko, Artem/C-7561-2011; Carvalho, Alexandra/AAC-6858-2019; Castro Neto, Antonio/C-8363-2014	Novoselov, Kostya S/0000-0003-4972-5371; Carvalho, Alexandra/0000-0002-2851-1887; Mishchenko, Artem/0000-0002-0427-5664; Carvalho, Alexandra/0000-0002-2851-1887; Castro Neto, Antonio/0000-0003-0613-4010; hai yan, he/0000-0003-0366-6185	European Union [604391]; European Research Council Synergy Grant; Hetero2D; Engineering and Physical Sciences Research Council (EPSRC) (Toward Engineering Grand Challenges); Royal Society; U.S. Army Research Office; U.S. Navy Research Office; U.S. Airforce Research Office; EPSRC Early Career Fellowship [EP/N007131/1]; National Research Foundation of Singapore under the Prime Minister's Office under the Mid Size Centre Grant; Engineering and Physical Sciences Research Council [EP/N007131/1, EP/K005014/1] Funding Source: researchfish; EPSRC [EP/N007131/1, EP/K005014/1] Funding Source: UKRI	European Union(European Commission); European Research Council Synergy Grant(European Research Council (ERC)); Hetero2D; Engineering and Physical Sciences Research Council (EPSRC) (Toward Engineering Grand Challenges)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); U.S. Army Research Office; U.S. Navy Research Office; U.S. Airforce Research Office; EPSRC Early Career Fellowship(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Research Foundation of Singapore under the Prime Minister's Office under the Mid Size Centre Grant; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the European Union FP7 Graphene Flagship Project 604391, European Research Council Synergy Grant, Hetero2D, Engineering and Physical Sciences Research Council (EPSRC) (Toward Engineering Grand Challenges), the Royal Society, U.S. Army Research Office, U.S. Navy Research Office, and U.S. Airforce Research Office. A.M. acknowledges support of EPSRC Early Career Fellowship EP/N007131/1. A.H.C.N. and A.C. acknowledge the National Research Foundation of Singapore under the Prime Minister's Office for Financial support under the Mid Size Centre Grant. We thank A. K. Geim, I. V. Grigorieva, V. I. Fal'ko, R. V. Gorbachev, F. Withers, A. V. Kretinin, C. Gesner, and S. J. Haigh.	Alemayehu MB, 2015, ANGEW CHEM INT EDIT, V54, P15468, DOI 10.1002/anie.201506152; Amet F, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.073405; Aretouli KE, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4917422; Avsar A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5875; Azizi A, 2015, ACS NANO, V9, P4882, DOI 10.1021/acsnano.5b01677; Baugher BWH, 2014, NAT NANOTECHNOL, V9, P262, DOI [10.1038/nnano.2014.25, 10.1038/NNANO.2014.25]; Bonaccorso F, 2010, NAT PHOTONICS, V4, P611, DOI [10.1038/NPHOTON.2010.186, 10.1038/nphoton.2010.186]; Brar VW, 2014, NANO LETT, V14, P3876, DOI 10.1021/nl501096s; Britnell L, 2013, SCIENCE, V340, P1311, DOI 10.1126/science.1235547; Britnell L, 2012, SCIENCE, V335, P947, DOI 10.1126/science.1218461; Buscema M, 2014, NANO LETT, V14, P3347, DOI 10.1021/nl5008085; Cai XK, 2015, J AM CHEM SOC, V137, P2844, DOI 10.1021/jacs.5b00317; Cao T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1882; Carvalho A, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.115205; Castro Neto AH, 2001, PHYS REV LETT, V86, P4382, DOI 10.1103/PhysRevLett.86.4382; Cattelan M, 2015, CHEM MATER, V27, P4105, DOI 10.1021/acs.chemmater.5b01170; CAVA RJ, 1988, NATURE, V336, P211, DOI 10.1038/336211a0; Chen H, 2015, RSC ADV, V5, P50883, DOI 10.1039/c5ra08329j; Cheng R, 2014, NANO LETT, V14, P5590, DOI 10.1021/nl502075n; Chernikov A, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.076802; Choi MS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2652; Coleman JN, 2011, SCIENCE, V331, P568, DOI 10.1126/science.1194975; Dai S, 2015, NAT NANOTECHNOL, V10, P682, DOI [10.1038/NNANO.2015.131, 10.1038/nnano.2015.131]; Dai S, 2014, SCIENCE, V343, P1125, DOI 10.1126/science.1246833; Dean CR, 2013, NATURE, V497, P598, DOI 10.1038/nature12186; Dean CR, 2010, NAT NANOTECHNOL, V5, P722, DOI 10.1038/nnano.2010.172; Deng DH, 2016, NAT NANOTECHNOL, V11, P218, DOI [10.1038/nnano.2015.340, 10.1038/NNANO.2015.340]; Deng YX, 2014, ACS NANO, V8, P8292, DOI 10.1021/nn5027388; Diaz HC, 2015, 2D MATER, V2, DOI 10.1088/2053-1583/2/4/044010; Fang H, 2014, P NATL ACAD SCI USA, V111, P6198, DOI 10.1073/pnas.1405435111; Fei RX, 2014, NANO LETT, V14, P6393, DOI 10.1021/nl502865s; Finn DJ, 2014, J MATER CHEM C, V2, P925, DOI 10.1039/c3tc31993h; Gannett W, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3599708; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; Georgiou T, 2013, NAT NANOTECHNOL, V8, P100, DOI [10.1038/NNANO.2012.224, 10.1038/nnano.2012.224]; Giovannetti G, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.073103; Gomes LC, 2013, J PHYS CHEM C, V117, P11770, DOI 10.1021/jp400420m; Gomes LC, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.214103; Gomes LC, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.085406; Gong YJ, 2014, NAT MATER, V13, P1135, DOI [10.1038/NMAT4091, 10.1038/nmat4091]; Gorbachev RV, 2012, NAT PHYS, V8, P896, DOI [10.1038/NPHYS2441, 10.1038/nphys2441]; Green MA, 2014, NAT PHOTONICS, V8, P506, DOI [10.1038/nphoton.2014.134, 10.1038/NPHOTON.2014.134]; Grigorenko AN, 2012, NAT PHOTONICS, V6, P749, DOI [10.1038/nphoton.2012.262, 10.1038/NPHOTON.2012.262]; Haigh SJ, 2012, NAT MATER, V11, P764, DOI [10.1038/nmat3386, 10.1038/NMAT3386]; HESS HF, 1991, PHYSICA B, V169, P422, DOI 10.1016/0921-4526(91)90262-D; HOHENBERG PC, 1967, PHYS REV, V158, P383, DOI 10.1103/PhysRev.158.383; Hu PA, 2013, NANO LETT, V13, P1649, DOI 10.1021/nl400107k; Hu PA, 2012, ACS NANO, V6, P5988, DOI 10.1021/nn300889c; Huang CM, 2014, NAT MATER, V13, P1096, DOI [10.1038/nmat4064, 10.1038/NMAT4064]; Hunt B, 2013, SCIENCE, V340, P1427, DOI 10.1126/science.1237240; Jones AM, 2013, NAT NANOTECHNOL, V8, P634, DOI [10.1038/NNANO.2013.151, 10.1038/nnano.2013.151]; Kang J, 2013, NANO LETT, V13, P5485, DOI 10.1021/nl4030648; KOMA A, 1985, J VAC SCI TECHNOL B, V3, P724, DOI 10.1116/1.583125; Koppens FHL, 2014, NAT NANOTECHNOL, V9, P780, DOI [10.1038/NNANO.2014.215, 10.1038/nnano.2014.215]; Kretinin AV, 2014, NANO LETT, V14, P3270, DOI 10.1021/nl5006542; Kuiri M, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/48/485704; Late DJ, 2012, ADV MATER, V24, P3549, DOI 10.1002/adma.201201361; Lee GH, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3662043; Levendorf MP, 2012, NATURE, V488, P627, DOI 10.1038/nature11408; Li LJ, 2016, NATURE, V529, P185, DOI 10.1038/nature16175; Li LK, 2014, NAT NANOTECHNOL, V9, P372, DOI [10.1038/NNANO.2014.35, 10.1038/nnano.2014.35]; Li LY, 2014, J PHYS CHEM C, V118, P19129, DOI 10.1021/jp5043359; Li MY, 2015, SCIENCE, V349, P524, DOI 10.1126/science.aab4097; Li XF, 2015, ACS NANO, V9, P8078, DOI 10.1021/acsnano.5b01943; Lin YC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8311; Lin YC, 2014, NANO LETT, V14, P6936, DOI 10.1021/nl503144a; Lin YC, 2014, ACS NANO, V8, P3715, DOI 10.1021/nn5003858; Liu H, 2014, ACS NANO, V8, P4033, DOI 10.1021/nn501226z; Liu XL, 2016, ACS NANO, V10, P1067, DOI 10.1021/acsnano.5b06398; Liu Z, 2011, NANO LETT, V11, P2032, DOI 10.1021/nl200464j; Lu JP, 2015, ACS NANO, V9, P10411, DOI 10.1021/acsnano.5b04623; Lui CH, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.165403; Ma L, 2015, J POWER SOURCES, V285, P274, DOI 10.1016/j.jpowsour.2015.03.120; Mak KF, 2014, SCIENCE, V344, P1489, DOI 10.1126/science.1250140; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Mak KF, 2013, NAT MATER, V12, P207, DOI [10.1038/NMAT3505, 10.1038/nmat3505]; Mak KF, 2012, NAT NANOTECHNOL, V7, P494, DOI [10.1038/nnano.2012.96, 10.1038/NNANO.2012.96]; MINNHAGEN P, 1987, REV MOD PHYS, V59, P1001, DOI 10.1103/RevModPhys.59.1001; Mishchenko A, 2014, NAT NANOTECHNOL, V9, P808, DOI [10.1038/NNANO.2014.187, 10.1038/nnano.2014.187]; Miwa JA, 2015, ACS NANO, V9, P6502, DOI 10.1021/acsnano.5b02345; Mudd GW, 2015, ADV MATER, V27, P3760, DOI 10.1002/adma.201500889; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; OHUCHI FS, 1990, J APPL PHYS, V68, P2168, DOI 10.1063/1.346574; Ponomarenko LA, 2013, NATURE, V497, P594, DOI 10.1038/nature12187; Qiao JS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5475; Rivera P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7242; Robinson JA, 2016, ACS NANO, V10, P42, DOI 10.1021/acsnano.5b08117; Rodin AS, 2016, PHYS REV B, V93, DOI 10.1103/PhysRevB.93.045431; Roy K, 2013, NAT NANOTECHNOL, V8, P826, DOI [10.1038/nnano.2013.206, 10.1038/NNANO.2013.206]; Rybkovskiy DV, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.235302; Secor EB, 2015, J PHYS CHEM LETT, V6, P620, DOI 10.1021/jz502431r; Shang JZ, 2015, ACS NANO, V9, P647, DOI 10.1021/nn5059908; Shi YM, 2012, NANO LETT, V12, P2784, DOI [10.1021/nl204562J, 10.1021/nl204562j]; Takada K, 2003, NATURE, V422, P53, DOI 10.1038/nature01450; Tamalampudi SR, 2014, NANO LETT, V14, P2800, DOI 10.1021/nl500817g; Terrones H, 2013, SCI REP-UK, V3, DOI 10.1038/srep01549; Tomadin A, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.161406; Tongay S, 2014, NANO LETT, V14, P3185, DOI 10.1021/nl500515q; Torrisi F, 2012, ACS NANO, V6, P2992, DOI 10.1021/nn2044609; UENO K, 1990, J VAC SCI TECHNOL A, V8, P68, DOI 10.1116/1.576983; Valla T, 2000, PHYS REV LETT, V85, P4759, DOI 10.1103/PhysRevLett.85.4759; Wallbank JR, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.245408; Wang F, 2015, NANO LETT, V15, P7558, DOI 10.1021/acs.nanolett.5b03291; Wang L, 2013, SCIENCE, V342, P614, DOI 10.1126/science.1244358; Wang LF, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/38/385701; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Wang SS, 2015, ACS NANO, V9, P5246, DOI 10.1021/acsnano.5b00655; Wang Z, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9339; WILSON JA, 1969, ADV PHYS, V18, P193, DOI 10.1080/00018736900101307; Withers F, 2015, NANO LETT, V15, P8223, DOI 10.1021/acs.nanolett.5b03740; Withers F, 2015, NAT MATER, V14, P301, DOI 10.1038/nmat4205; Withers F, 2014, NANO LETT, V14, P3987, DOI 10.1021/nl501355j; Woessner A, 2015, NAT MATER, V14, P421, DOI [10.1038/NMAT4169, 10.1038/nmat4169]; Woods CR, 2014, NAT PHYS, V10, P451, DOI [10.1038/NPHYS2954, 10.1038/nphys2954]; Wu Q, 2015, NANOSCALE, V7, P7574, DOI 10.1039/c5nr00889a; Xenogiannopoulou E, 2015, NANOSCALE, V7, P7896, DOI 10.1039/c4nr06874b; Xia FN, 2014, NAT PHOTONICS, V8, P899, DOI [10.1038/nphoton.2014.271, 10.1038/nphoton.2010.271]; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Xiao D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.236809; Xu ZG, 2015, APPL PHYS LETT, V107, DOI 10.1063/1.4936378; Yan AM, 2015, NANO LETT, V15, P6324, DOI 10.1021/acs.nanolett.5b01311; Yang H, 2012, SCIENCE, V336, P1140, DOI 10.1126/science.1220527; Yang W, 2013, NAT MATER, V12, P792, DOI [10.1038/NMAT3695, 10.1038/nmat3695]; Ye ZL, 2014, NATURE, V513, P214, DOI 10.1038/nature13734; Yu GL, 2014, NAT PHYS, V10, P525, DOI [10.1038/NPHYS2979, 10.1038/nphys2979]; Yu GL, 2013, P NATL ACAD SCI USA, V110, P3282, DOI 10.1073/pnas.1300599110; Yu LL, 2014, NANO LETT, V14, P3055, DOI 10.1021/nl404795z; Zeng HL, 2012, NAT NANOTECHNOL, V7, P490, DOI [10.1038/nnano.2012.95, 10.1038/NNANO.2012.95]; Zhang CH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7519; Zhang K, 2014, ADV FUNCT MATER, V24, P731, DOI 10.1002/adfm.201302009; Zhang XQ, 2015, NANO LETT, V15, P410, DOI 10.1021/nl503744f; Zhu BR, 2015, SCI REP-UK, V5, DOI 10.1038/srep09218; Zhu J, 2015, NANO LETT, V15, P7029, DOI 10.1021/acs.nanolett.5b03075; Ziletti A, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.085407; Zolyomi V, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.205416; Zolyomi V, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.195403	138	3830	3870	362	4014	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298							aac9439	10.1126/science.aac9439	http://dx.doi.org/10.1126/science.aac9439			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27471306	Green Submitted			2022-12-28	WOS:000380583600031
J	Reed, GW; Rossi, JE; Cannon, CP				Reed, Grant W.; Rossi, Jeffrey E.; Cannon, Christopher P.			Acute myocardial infarction	LANCET			English	Review							PERCUTANEOUS CORONARY INTERVENTION; DUAL-ANTIPLATELET THERAPY; ASSOCIATION TASK-FORCE; DRUG-ELUTING STENTS; BYPASS GRAFT-SURGERY; RANDOMIZED-TRIAL; AMERICAN-COLLEGE; UNFRACTIONATED HEPARIN; FIBRINOLYTIC THERAPY; PRIMARY ANGIOPLASTY	Acute myocardial infarction has traditionally been divided into ST elevation or non-ST elevation myocardial infarction; however, therapies are similar between the two, and the overall management of acute myocardial infarction can be reviewed for simplicity. Acute myocardial infarction remains a leading cause of morbidity and mortality worldwide, despite substantial improvements in prognosis over the past decade. The progress is a result of several major trends, including improvements in risk stratification, more widespread use of an invasive strategy, implementation of care delivery systems prioritising immediate revascularisation through percutaneous coronary intervention (or fibrinolysis), advances in antiplatelet agents and anticoagulants, and greater use of secondary prevention strategies such as statins. This seminar discusses the important topics of the pathophysiology, epidemiological trends, and modern management of acute myocardial infarction, focusing on the recent advances in reperfusion strategies and pharmacological treatment approaches.	[Reed, Grant W.; Rossi, Jeffrey E.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Cannon, Christopher P.] Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc, 930 W Commonwealth Ave,3rd Floor, Boston, MA 02215 USA; [Cannon, Christopher P.] Harvard Clin Res Inst, Cardiometab Trials, Boston, MA USA	Cleveland Clinic Foundation; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Cannon, CP (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc, 930 W Commonwealth Ave,3rd Floor, Boston, MA 02215 USA.	christopher.cannon@hcri.harvard.edu	Cannon, Christopher P/AAY-7644-2020	Cannon, Christopher P/0000-0003-4596-2791	Arisaph; AstraZeneca; Bristol-Myers Squibb; Boehringer-Ingelheim; GlaxoSmithKline; Merck; Takeda; Amgen; Kowa; Lipimedix; Pfizer; Regeneron; Sanofi	Arisaph; AstraZeneca(AstraZeneca); Bristol-Myers Squibb(Bristol-Myers Squibb); Boehringer-Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Takeda(Takeda Pharmaceutical Company Ltd); Amgen(Amgen); Kowa; Lipimedix; Pfizer(Pfizer); Regeneron(Regeneron); Sanofi	CPC has grants from Arisaph, AstraZeneca, Bristol-Myers Squibb, Boehringer-Ingelheim, GlaxoSmithKline, Merck, and Takeda; and consulting fees from Amgen, Boehringer-Ingelheim, Bristol-Myers Squibb, GlaxoSmithKline, Kowa, Merck, Takeda, Lipimedix, Pfizer, Regeneron, and Sanofi. GWR and JER declare no competing interests.	Amsterdam EA, 2014, J AM COLL CARDIOL, V64, P2713, DOI 10.1016/j.jacc.2014.10.011; Andersen HR, 2003, NEW ENGL J MED, V349, P733, DOI 10.1056/NEJMoa025142; Antman EM, 1999, CIRCULATION, V100, P1593, DOI 10.1161/01.CIR.100.15.1593; Armstrong PW, 2013, NEW ENGL J MED, V368, P1379, DOI 10.1056/NEJMoa1301092; Badheka AO, IMPACT ANN OPERATOR; Bardy GH, 2005, NEW ENGL J MED, V352, P2146; Bhatt DL, 2013, NEW ENGL J MED, V368, P1303, DOI 10.1056/NEJMoa1300815; Bhatt DL, 2010, NEW ENGL J MED, V363, P1909, DOI 10.1056/NEJMoa1007964; Bhatt DL, 2009, NEW ENGL J MED, V361, P2330, DOI 10.1056/NEJMoa0908629; Boersma E, 2006, EUR HEART J, V27, P779, DOI 10.1093/eurheartj/ehi810; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Busk M, 2008, EUR HEART J, V29, P1259, DOI 10.1093/eurheartj/ehm392; Buxton AE, 1999, NEW ENGL J MED, V341, P1882, DOI 10.1056/NEJM199912163412503; CAIRNS JA, 1985, NEW ENGL J MED, V313, P1369, DOI 10.1056/NEJM198511283132201; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Cannon CP, 2001, NEW ENGL J MED, V344, P1879, DOI 10.1056/NEJM200106213442501; Cannon CP, 2000, JAMA-J AM MED ASSOC, V283, P2941, DOI 10.1001/jama.283.22.2941; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Cantor WJ, 2009, NEW ENGL J MED, V360, P2705, DOI 10.1056/NEJMoa0808276; Cavender MA, 2014, LANCET, V384, P599, DOI 10.1016/S0140-6736(14)61216-2; Chen ZM, 2005, LANCET, V366, P1622; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; Collet JP, 2006, J AM COLL CARDIOL, V48, P1326, DOI 10.1016/j.jacc.2006.03.064; Collet JP, 2014, LANCET, V384, P1577, DOI 10.1016/S0140-6736(14)60612-7; Cutlip DE, 2015, JACC-CARDIOVASC INTE, V8, P404, DOI 10.1016/j.jcin.2014.10.017; de la Torre Hernandez JM, 2015, CATHETER CARDIOVASC; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; De Luca G, 2009, INT J CARDIOL; Dewilde WJM, 2013, LANCET, V381, P1107, DOI 10.1016/S0140-6736(12)62177-1; Di Mario C, 2008, LANCET, V371, P559, DOI 10.1016/S0140-6736(08)60268-8; Dzavik V, 2006, CIRCULATION, V114, P2449, DOI 10.1161/CIRCULATIONAHA.106.669432; Ellis SG, 2008, NEW ENGL J MED, V358, P2205, DOI 10.1056/NEJMoa0706816; Engstrom T, 2015, LANCET, V386, P665, DOI 10.1016/S0140-6736(15)60648-1; Epstein AE, 2008, CIRCULATION, V117, P2820, DOI 10.1161/CIRCUALTIONAHA.108.189741; Farkouh ME, 2012, NEW ENGL J MED, V367, P2375, DOI 10.1056/NEJMoa1211585; Feres F, 2013, JAMA-J AM MED ASSOC, V310, P2510, DOI 10.1001/jama.2013.282183; Fibrinolytic Therapy Trialists' (FTT) Collaborative Group, 1994, LANCET, V343, P311; Fox KM, 2003, LANCET, V362, P782; French JK, 1999, J AM COLL CARDIOL, V34, P62, DOI 10.1016/S0735-1097(99)00166-7; Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789; Gershlick AH, 2015, J AM COLL CARDIOL, V65, P963, DOI 10.1016/j.jacc.2014.12.038; Gibson CM, 2007, J AM COLL CARDIOL, V49, P2238, DOI 10.1016/j.jacc.2007.01.093; Goncalves PDA, 2005, EUR HEART J, V26, P865, DOI 10.1093/eurheartj/ehi187; Goodman SG, 2000, J AM COLL CARDIOL, V36, P693, DOI 10.1016/S0735-1097(00)00808-1; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Gurbel PA, 2012, JAMA-J AM MED ASSOC, V308, P1785, DOI 10.1001/jama.2012.17312; Han YL, 2015, JAMA-J AM MED ASSOC, V313, P1336, DOI 10.1001/jama.2015.2323; Hansson EC, 2016, EUR HEART J, V37, P189, DOI 10.1093/eurheartj/ehv381; Harrington RA, 2009, NEW ENGL J MED, V361, P2318, DOI 10.1056/NEJMoa0908628; Hillis LD, 2011, CIRCULATION, V124, P2610, DOI 10.1161/CIR.0b013e31823b5fee; Hochman JS, 2006, NEW ENGL J MED, V355, P2395, DOI 10.1056/NEJMoa066139; *INT JOINT EFF COM, 1995, LANCET, V346, P329; Jang JS, 2012, EUROINTERVENTION; Jneid H, 2012, J AM COLL CARDIOL, V60, P645, DOI 10.1016/j.jacc.2012.06.004; Jolly SS, 2015, NEW ENGL J MED, V372, P1389, DOI 10.1056/NEJMoa1415098; Joyal D, 2012, AM J CARDIOL, V109, P813, DOI 10.1016/j.amjcard.2011.11.007; Kastrati A, 2007, EUR HEART J, V28, P2706, DOI 10.1093/eurheartj/ehm402; Kastrati A, 2011, NEW ENGL J MED, V365, P1980, DOI 10.1056/NEJMoa1109596; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; Kumar A, 2009, MAYO CLIN PROC, V84, P917, DOI 10.1016/S0025-6196(11)60509-0; Kumbhani DJ, 2009, JAMA-J AM MED ASSOC, V302, P2207, DOI 10.1001/jama.2009.1715; Levine GN, 2016, CIRCULATION, V134, pE123, DOI 10.1161/CIR.0000000000000404; Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Lloyd-Jones DM, 2016, J AM COLL CARDIOL, V68, P92, DOI 10.1016/j.jacc.2016.03.519; Mamas MA, 2012, HEART; Mauri L, 2014, NEW ENGL J MED, V371, P2155, DOI 10.1056/NEJMoa1409312; McMurray JJV, 2014, NEW ENGL J MED, V371, P993, DOI 10.1056/NEJMoa1409077; Mega JL, 2012, NEW ENGL J MED, V366, P9, DOI 10.1056/NEJMoa1112277; Mehilli J, 2009, CIRCULATION, V119, P1933, DOI 10.1161/CIRCULATIONAHA.108.818617; Mehta SR, 2010, NEW ENGL J MED, V363, P930, DOI 10.1056/NEJMoa0909475; Mehta SR, 2009, NEW ENGL J MED, V360, P2165, DOI 10.1056/NEJMoa0807986; Menichelli M, 2007, J AM COLL CARDIOL; Menon V, 2013, AM J CARDIOL, V111, P930, DOI 10.1016/j.amjcard.2012.12.009; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Montalescot G, 2014, J AM COLL CARDIOL, V64, P2563, DOI 10.1016/j.jacc.2014.08.053; Montalescot G, 2014, NEW ENGL J MED, V371, P1016, DOI 10.1056/NEJMoa1407024; Montalescot G, 2013, NEW ENGL J MED, V369, P999, DOI 10.1056/NEJMoa1308075; Montalescot G, 2011, LANCET, V378, P693, DOI 10.1016/S0140-6736(11)60876-3; Montalescot G, 2009, JAMA-J AM MED ASSOC, V302, P947, DOI 10.1001/jama.2009.1267; Morrow DA, 2007, CLIN CHEM, V53, P552, DOI 10.1373/clinchem.2006.084194; Morrow DA, 2012, NEW ENGL J MED, V366, P1404, DOI 10.1056/NEJMoa1200933; Moses JW, 2003, N ENGL J MED; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Nichols M, 2014, EUR HEART J, V35, P2950, DOI 10.1093/eurheartj/ehu299; Nordmann AJ, 2004, AM J MED, V116, P253, DOI 10.1016/j.amjmed.2003.08.035; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Oler A, 1996, JAMA-J AM MED ASSOC, V276, P811, DOI 10.1001/jama.276.10.811; Park SJ, 2010, NEW ENGL J MED, V362, P1374, DOI 10.1056/NEJMoa1001266; Parodi G, 2015, J AM COLL CARDIOL, V65, P511, DOI 10.1016/j.jacc.2014.08.056; Pasceri V, 2007, AM HEART J, V153, P749, DOI 10.1016/j.ahj.2007.02.016; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; Patti G, 2005, CIRCULATION, V111, P2099, DOI 10.1161/01.CIR.0000161383.06692.D4; Perk Joep, 2012, Atherosclerosis, V223, P1, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1007/s12529-012-9242-5, 10.1093/eurheartj/ehs092]; PFEFFER MA, 1992, NEW ENGL J MED, V327, P669, DOI 10.1056/NEJM199209033271001; Pinto DS, 2006, CIRCULATION, V114, P2019, DOI 10.1161/CIRCULATIONAHA.106.638353; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Reiner Z, 2011, EUR HEART J; ROBERTS R, 1991, CIRCULATION, V83, P422, DOI 10.1161/01.CIR.83.2.422; Roe MT, 2012, NEW ENGL J MED, V367, P1297, DOI 10.1056/NEJMoa1205512; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Rollini F, 2016, J AM COLL CARDIOL, V67, P1994, DOI 10.1016/j.jacc.2016.02.045; Sabate M, 2012, LANCET, V380, P1482, DOI 10.1016/S0140-6736(12)61223-9; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Sarno G, 2014, J AM COLL CARDIOL, V64, P16, DOI 10.1016/j.jacc.2014.04.022; Schwartz GG, 2001, JAMA-J AM MED ASSOC, V285, P1711, DOI 10.1001/jama.285.13.1711; Shahzad A, 2014, LANCET, V384, P1849, DOI 10.1016/S0140-6736(14)60924-7; Spaulding C, 2006, NEW ENGL J MED, V355, P1093, DOI 10.1056/NEJMoa062006; Steg PG, 2004, EUR HEART J, V25, P2187, DOI 10.1016/j.ehj.2004.10.019; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Steg PG, 2013, NEW ENGL J MED, V369, P2207, DOI 10.1056/NEJMoa1311096; Steinhubl SR, 2002, JAMA-J AM MED ASSOC, V288, P2411, DOI 10.1001/jama.288.19.2411; Stone GW, 2006, NEW ENGL J MED, V355, P2203, DOI 10.1056/NEJMoa062437; Stone GW, 2015, J AM COLL CARDIOL, V65, P27, DOI 10.1016/j.jacc.2014.10.029; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Topol E, 1997, NEW ENGL J MED, V337, P1118; TOPOL E, 1993, NEW ENGL J MED, V329, P673, DOI 10.1056/nejm199309023291001; Valgimigli M, 2015, NEW ENGL J MED, V373, P997, DOI 10.1056/NEJMoa1507854; Valgimigli M, 2015, LANCET, V385, P2465, DOI 10.1016/S0140-6736(15)60292-6; Valgimigli M, 2012, CIRCULATION, V125, P2015, DOI 10.1161/CIRCULATIONAHA.111.071589; Van de Werf F, 1999, LANCET, V354, P716, DOI 10.1016/S0140-6736(99)07403-6; Van de Werf F, 2006, LANCET, V367, P569, DOI 10.1016/S0140-6736(06)68147-6; van't Hof AWJ, 2008, LANCET, V372, P537, DOI 10.1016/S0140-6736(08)61235-0; Wald DS, 2013, NEW ENGL J MED, V369, P1115, DOI 10.1056/NEJMoa1305520; WALLENTIN L, 1990, LANCET, V336, P827; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327; Weintraub WS, 2011, CIRCULATION, V124, P967, DOI 10.1161/CIR.0b013e3182285a81; Widimsky P, 2003, EUR HEART J, V24, P94, DOI 10.1016/S0195-668X(02)00468-2; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224, 10.1093/ejcts/ezu366]; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yeh RW, 2016, JAMA-J AM MED ASSOC, V315, P1735, DOI 10.1001/jama.2016.3775; Yeh RW, 2015, J AM COLL CARDIOL, V65, P2211, DOI 10.1016/j.jacc.2015.03.003; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; Yusuf S, 2006, JAMA-J AM MED ASSOC, V295, P1519; Yusuf S, 2006, NEW ENGL J MED, V354, P1464; Yusuf S, 2001, NEW ENGL J MED, V345, P494; Zalewski J, 2011, J AM COLL CARDIOL, V57, P1867, DOI 10.1016/j.jacc.2010.10.061; Zhu MM, 2001, AM J CARDIOL, V88, P297, DOI 10.1016/S0002-9149(01)01645-9	141	574	604	34	235	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 14	2017	389	10065					197	210		10.1016/S0140-6736(16)30677-8	http://dx.doi.org/10.1016/S0140-6736(16)30677-8			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH9UT	27502078				2022-12-28	WOS:000392117600032
J	Homan, T; Hiscox, A; Mweresa, CK; Masiga, D; Mukabana, WR; Oria, P; Maire, N; Di Pasquale, A; Silkey, M; Alaii, J; Bousema, T; Leeuwis, C; Smith, TA; Takken, W				Homan, Tobias; Hiscox, Alexandra; Mweresa, Collins K.; Masiga, Daniel; Mukabana, Wolfgang R.; Oria, Prisca; Maire, Nicolas; Di Pasquale, Aurelio; Silkey, Mariabeth; Alaii, Jane; Bousema, Teun; Leeuwis, Cees; Smith, Thomas A.; Takken, Willem			The effect of mass mosquito trapping on malaria transmission and disease burden (SolarMal): a stepped-wedge cluster-randomised trial	LANCET			English	Article							WESTERN KENYA; RUSINGA ISLAND; PLASMODIUM-FALCIPARUM; CARBON-DIOXIDE; PATHOGENS; SYSTEMS; AFRICA; BLEND	Background Odour baits can attract host-seeking Anopheles mosquitoes indoors and outdoors. We assessed the effects of mass deployment of odour-baited traps on malaria transmission and disease burden. Methods We installed solar-powered odour-baited mosquito trapping systems (SMoTS) to households on Rusinga Island, Lake Victoria, western Kenya (mean population 24 879), in a stepped-wedge cluster-randomised trial. All residents in the completed health and demographic surveillance system were eligible to participate. We used the travelling salesman algorithm to assign all households to a cluster (50 or 51 geographically contiguous households); nine contiguous clusters formed a metacluster. Initially, no cluster had SMoTS (non-intervened). During the course of the intervention roll-out SMoTS were gradually installed cluster by cluster until all clusters had SMoTS installed (intervened). We generated 27 cluster randomisations, with the cluster as unit of randomisation, to establish the order to install the traps in the clusters until all had a SMoTS installed. Field workers and participants were not masked to group allocation. The primary outcome of clinical malaria was monitored through repeated household visits covering the entire population, once before roll-out (baseline) and five times throughout the 2-year roll-out. We measured clinical malaria as fever plus a positive result with a rapid diagnostic test. The SolarMal project was registered on the Dutch Trial Register (NTR 3496). Findings We enrolled 34 041 participants between April 25, 2012, and March 23, 2015, to 81 clusters and nine metaclusters. 4358 households were provided with SMoTS during roll-out between June 3, 2013, and May 16, 2015. 23 clinical malaria episodes were recorded in intervened clusters and 33 episodes in non-intervened clusters (adjusted effectiveness 40.8% [95% CI -172.8 to 87.1], p=0.5) during the roll-out. Malaria prevalence measured by rapid diagnostic test was 29.8% (95% CI 20.9-38.0) lower in SMoTS clusters (prevalence 23.7%; 1552 of 6550 people) than in non-intervened clusters (prevalence 34.5%; 2002 of 5795 people). Interpretation The unexpectedly low clinical incidence of malaria during roll-out led to an imprecise estimate of effectiveness from the clinical incidence data. The substantial effect on malaria prevalence is explained by reduction in densities of Anopheles funestus. Odour-baited traps might be an effective malaria intervention.	[Homan, Tobias; Hiscox, Alexandra; Takken, Willem] Univ Wageningen & Res Ctr, Entomol Lab, NL-6700 AA Wageningen, Netherlands; [Oria, Prisca; Leeuwis, Cees] Univ Wageningen & Res Ctr, Knowledge Technol & Innovat Grp, Wageningen, Netherlands; [Mweresa, Collins K.; Masiga, Daniel] Int Ctr Insect Physiol & Ecol, Nairobi, Kenya; [Mukabana, Wolfgang R.] Univ Nairobi, Sch Biol Sci, Nairobi, Kenya; [Maire, Nicolas; Di Pasquale, Aurelio; Silkey, Mariabeth; Smith, Thomas A.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Alaii, Jane] Context Factor Solut, Nairobi, Kenya; [Bousema, Teun] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Hlth Sci, Nijmegen, Netherlands	Wageningen University & Research; Wageningen University & Research; International Centre of Insect Physiology & Ecology (ICIPE); University of Nairobi; University of Basel; Swiss Tropical & Public Health Institute; Radboud University Nijmegen	Takken, W (corresponding author), Univ Wageningen & Res Ctr, Entomol Lab, NL-6700 AA Wageningen, Netherlands.	willem.takken@wur.nl	Smith, Thomas/B-5569-2015; Bousema, Teun/N-3574-2014	Smith, Thomas/0000-0002-3650-9381; Bousema, Teun/0000-0003-2666-094X	COmON Foundation; COmON Foundation, through the University Fund Wageningen	COmON Foundation; COmON Foundation, through the University Fund Wageningen	COmON Foundation.; We thank the Mbita staff of International Centre of Insect Physiology and Ecology (icipe) and the members of the SolarMal field teams, in particular: Faith Kyengo, Ibrahim Kiche, Kelvin Onoka, Patrick Sawa, Bruno Otieno, Philemon Omusula, Andrew Abuya, Anthony Muthai Kibet, Margaret Ayugi, Francis Okomo, Maurine Santino, Kennedy Okoth, Elizabeth Okello, Winnie Ogonda, Violet Bolo, Pauline Okode, David Odhiambo, Kennedy Ojijo, Hilary Kennedy, Thomas Odhiambo, Lillian Awuor, Charles Otieno, Molly Ariko, Jared Odhiambo, Tom Gumba, Jackton Arija, and Charles Wambua. Siempre Verde (Netherlands) developed the solar home system, and Biogents AG (Germany) contributed to the development of the Suna traps. We thank Tropicare (Netherlands) for their donation of the Mosquito Magnet-X traps. We thank the people of Rusinga and their representatives in the Community Advisory Board SolarMal for Rusinga, who were supportive throughout. We thank Sander Koenraadt for their constructive comments on an earlier version of the manuscript. Financial support was provided by the COmON Foundation, through the University Fund Wageningen.	[Anonymous], 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD000363.PUB2; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bretscher MT, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0813-1; Das P, 2015, LANCET, V385, P1613, DOI 10.1016/S0140-6736(15)60783-8; Durnez L, 2013, ANOPHELES MOSQUITOES - NEW INSIGHTS INTO MALARIA VECTORS, P671, DOI 10.5772/55925; Guerra CA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-276; Hawley WA, 2003, AM J TROP MED HYG, V68, P121, DOI 10.4269/ajtmh.2003.68.121; Hemming K, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-102; Hiscox A, 2012, MALARIA J, V11, pO45; Hiscox A, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1469-z; Hiscox A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-257; Homan T, 2016, INT J EPIDEMIOL, V45, P718, DOI 10.1093/ije/dyw072; Homan Tobias, 2015, BMC Res Notes, V8, P397, DOI 10.1186/s13104-015-1373-8; Killeen GF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-330; Kirby MJ, 2009, LANCET, V374, P998, DOI 10.1016/S0140-6736(09)60871-0; Menger DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123415; Mukabana WR, 2012, J CHEM ECOL, V38, P235, DOI 10.1007/s10886-012-0088-8; Mweresa CK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-160; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011573; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008951; Oria PA, 2015, TROP MED INT HEALTH, V20, P1048, DOI 10.1111/tmi.12514; Oria PA, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0523-5; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Shah JA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0844-7; Silkey M, 2016, TRIALS, V17, DOI 10.1186/s13063-016-1378-1; van Loon JJA, 2015, J CHEM ECOL, V41, P567, DOI 10.1007/s10886-015-0587-5; WHO, 2013, WORLD MALARIA REPORT 2013, P1	28	70	70	2	20	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2016	388	10050					1193	1201		10.1016/S0140-6736(16)30445-7	http://dx.doi.org/10.1016/S0140-6736(16)30445-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW5RA	27520594				2022-12-28	WOS:000383703100033
J	Im, SJ; Hashimoto, M; Gerner, MY; Lee, J; Kissick, HT; Urger, MCB; Shan, Q; Hale, JS; Lee, J; Nasti, TH; Sharpe, AH; Freeman, GJ; Germain, RN; Nakaya, HI; Xue, HH; Ahmed, R				Im, Se Jin; Hashimoto, Masao; Gerner, Michael Y.; Lee, Junghwa; Kissick, Haydn T.; Urger, Matheus C. B.; Shan, Qiang; Hale, J. Scott; Lee, Judong; Nasti, Tahseen H.; Sharpe, Arlene H.; Freeman, Gordon J.; Germain, Ronald N.; Nakaya, Helder I.; Xue, Hai-Hui; Ahmed, Rafi			Defining CD8(+) T cells that provide the proliferative burst after PD-1 therapy	NATURE			English	Article							CHRONIC VIRAL-INFECTION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; TRANSCRIPTION FACTOR; LYMPHOID ORGANS; MEMORY; PERSISTENCE; EFFECTOR; FH; DIFFERENTIATION; EXHAUSTION	Chronic viral infections are characterized by a state of CD8(+) T-cell dysfunction that is associated with expression of the programmed cell death 1 (PD-1) inhibitory receptor(1-4). A better understanding of the mechanisms that regulate CD8(+) T-cell responses during chronic infection is required to improve immunotherapies that restore function in exhausted CD8(+) T cells. Here we identify a population of virus-specific CD8(+) T cells that proliferate after blockade of the PD-1 inhibitory pathway in mice chronically infected with lymphocytic choriomeningitis virus (LCMV). These LCMV-specific CD8(+) T cells expressed the PD-1 inhibitory receptor, but also expressed several costimulatory molecules such as ICOS and CD28. This CD8(+) T-cell subset was characterized by a unique gene signature that was related to that of CD4(+) T follicular helper (T-FH) cells, CD8(+) T cell memory precursors and haematopoietic stem cell progenitors, but that was distinct from that of CD4(+) T(H)1 cells and CD8(+) terminal effectors. This CD8(+) T-cell population was found only in lymphoid tissues and resided predominantly in the T-cell zones along with naive CD8(+) T cells. These PD-1(+) CD8(+) T cells resembled stem cells during chronic LCMV infection, undergoing self-renewal and also differentiating into the terminally exhausted CD8(+) T cells that were present in both lymphoid and non-lymphoid tissues. The proliferative burst after PD-1 blockade came almost exclusively from this CD8(+) T-cell subset. Notably, the transcription factor TCF1 had a cell-intrinsic and essential role in the generation of this CD8(+) T-cell subset. These findings provide a better understanding of T-cell exhaustion and have implications in the optimization of PD-1-directed immunotherapy in chronic infections and cancer.	[Im, Se Jin; Hashimoto, Masao; Lee, Junghwa; Kissick, Haydn T.; Hale, J. Scott; Lee, Judong; Nasti, Tahseen H.; Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA; [Im, Se Jin; Hashimoto, Masao; Lee, Junghwa; Kissick, Haydn T.; Hale, J. Scott; Lee, Judong; Nasti, Tahseen H.; Ahmed, Rafi] Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA; [Gerner, Michael Y.; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Gerner, Michael Y.] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98109 USA; [Kissick, Haydn T.] Emory Univ, Dept Urol, Sch Med, Atlanta, GA 30322 USA; [Urger, Matheus C. B.; Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, BR-05508 Sao Paulo, Brazil; [Shan, Qiang; Xue, Hai-Hui] Univ Iowa, Dept Microbiol, Carver Coll Med, Iowa City, IA 52242 USA; [Sharpe, Arlene H.] Harvard Med Sch, Dept Microbiol & Immunol, Boston, MA 02115 USA; [Sharpe, Arlene H.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Freeman, Gordon J.] Harvard Med Sch, Dana Farber Canc Inst, Dept Med Oncol, Dept Med, Boston, MA 02115 USA; [Xue, Hai-Hui] Univ Iowa, Carver Coll Med, Interdisciplinary Immunol Grad Program, Iowa City, IA 52242 USA	Emory University; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle; Emory University; Universidade de Sao Paulo; University of Iowa; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Iowa	Ahmed, R (corresponding author), Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA 30322 USA.; Ahmed, R (corresponding author), Emory Univ, Sch Med, Dept Microbiol & Immunol, Atlanta, GA 30322 USA.	rahmed@emory.edu	Freeman, Gordon/AAC-5380-2019; Nakaya, Helder I/A-1397-2010; Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020; Nakaya, Helder/AAF-1738-2020; Kissick, Haydn/AAS-6292-2021; Hashimoto, Masao/AAC-9225-2020	Freeman, Gordon/0000-0002-7210-5616; Nakaya, Helder I/0000-0001-5297-9108; Nakaya, Helder/0000-0001-5297-9108; Kissick, Haydn/0000-0001-7624-5598; Hashimoto, Masao/0000-0002-7120-1390; Shan, Qiang/0000-0002-7089-0278; Xue, Hai-Hui/0000-0002-9163-7669; Gerner, Michael/0000-0001-5406-8308	National Institutes of Health [R01 AI30048, P01 AI056299, R01 AI112579, R01 AI121080]; Intramural Research Program of NIAID, NIH; Prostate Cancer Foundation; Swim Across America; CNPq; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001034, R01AI030048, R01AI112579, P01AI080192, R01AI121080, P01AI056299] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research Program of NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Prostate Cancer Foundation; Swim Across America; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grants R01 AI30048 (R.A.), P01 AI056299 (R.A. and A.H.S.), R01 AI112579 (H.H.X.) and R01 AI121080 (H.-H.X.) and also by the Intramural Research Program of NIAID, NIH (R.N.G. and M.Y.G.). H.T.K. is supported by funding from the Prostate Cancer Foundation and Swim Across America. H.I.N. receives a CNPq research fellowship. The authors acknowledge technical support from R. Karaffa and S. Durham for cell sorting.	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Jung YW, 2010, J IMMUNOL, V185, P5315, DOI 10.4049/jimmunol.1001948; Kim HJ, 2010, NATURE, V467, P328, DOI 10.1038/nature09370; Masopust D, 2010, J EXP MED, V207, P553, DOI 10.1084/jem.20090858; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; MATLOUBIAN M, 1993, J VIROL, V67, P7340, DOI 10.1128/JVI.67.12.7340-7349.1993; Miyazaki M, 2015, GENE DEV, V29, P409, DOI 10.1101/gad.255331.114; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Mueller SN, 2007, P NATL ACAD SCI USA, V104, P15430, DOI 10.1073/pnas.0702579104; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Quigley MF, 2007, EUR J IMMUNOL, V37, P3352, DOI 10.1002/eji.200636746; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wu JQ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002565; Xu LF, 2015, NAT IMMUNOL, V16, P991, DOI 10.1038/ni.3229; Yamazaki C, 2013, J IMMUNOL, V190, P6071, DOI 10.4049/jimmunol.1202798; Yang CY, 2011, NAT IMMUNOL, V12, P1221, DOI 10.1038/ni.2158; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205	37	896	920	13	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2016	537	7620					417	+		10.1038/nature19330	http://dx.doi.org/10.1038/nature19330			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV7EC	27501248	Green Accepted			2022-12-28	WOS:000383098000057
J	Yaxley, JW; Coughlin, GD; Chambers, SK; Occhipinti, S; Samaratunga, H; Zajdlewicz, L; Dunglison, N; Carter, R; Williams, S; Payton, DJ; Perry-Keene, J; Lavin, MF; Gardiner, RA				Yaxley, John W.; Coughlin, Geoffrey D.; Chambers, Suzanne K.; Occhipinti, Stefano; Samaratunga, Hema; Zajdlewicz, Leah; Dunglison, Nigel; Carter, Rob; Williams, Scott; Payton, Diane J.; Perry-Keene, Joanna; Lavin, Martin F.; Gardiner, Robert A.			Robot-assisted laparoscopic prostatectomy versus open radical retropubic prostatectomy: early outcomes from a randomised controlled phase 3 study	LANCET			English	Article							POSITIVE SURGICAL MARGINS; QUALITY-OF-LIFE; LYMPH-NODE DISSECTION; ERECTILE DYSFUNCTION; CANCER; METAANALYSIS; TRIAL; SCALE; INDEX; COMPLICATIONS	Background The absence of trial data comparing robot-assisted laparoscopic prostatectomy and open radical retropubic prostatectomy is a crucial knowledge gap in uro-oncology. We aimed to compare these two approaches in terms of functional and oncological outcomes and report the early postoperative outcomes at 12 weeks. Method In this randomised controlled phase 3 study, men who had newly diagnosed clinically localised prostate cancer and who had chosen surgery as their treatment approach, were able to read and speak English, had no previous history of head injury, dementia, or psychiatric illness or no other concurrent cancer, had an estimated life expectancy of 10 years or more, and were aged between 35 years and 70 years were eligible and recruited from the Royal Brisbane and Women's Hospital (Brisbane, QLD). Participants were randomly assigned (1:1) to receive either robot-assisted laparoscopic prostatectomy or radical retropubic prostatectomy. Randomisation was computer generated and occurred in blocks of ten. This was an open trial; however, study investigators involved in data analysis were masked to each patient's condition. Further, a masked central pathologist reviewed the biopsy and radical prostatectomy specimens. Primary outcomes were urinary function (urinary domain of EPIC) and sexual function (sexual domain of EPIC and IIEF) at 6 weeks, 12 weeks, and 24 months and oncological outcome (positive surgical margin status and biochemical and imaging evidence of progression at 24 months). The trial was powered to assess health-related and domain-specific quality of life outcomes over 24 months. We report here the early outcomes at 6 weeks and 12 weeks. The per-protocol populations were included in the primary and safety analyses. This trial was registered with the Australian New Zealand Clinical Trials Registry (ANZCTR), number ACTRN12611000661976. Findings Between Aug 23, 2010, and Nov 25, 2014, 326 men were enrolled, of whom 163 were randomly assigned to radical retropubic prostatectomy and 163 to robot-assisted laparoscopic prostatectomy. 18 withdrew (12 assigned to radical retropubic prostatectomy and six assigned to robot-assisted laparoscopic prostatectomy); thus, 151 in the radical retropubic prostatectomy group proceeded to surgery and 157 in the robot-assisted laparoscopic prostatectomy group. 121 assigned to radical retropubic prostatectomy completed the 12 week questionnaire versus 131 assigned to robot-assisted laparoscopic prostatectomy. Urinary function scores did not differ significantly between the radical retropubic prostatectomy group and robot-assisted laparoscopic prostatectomy group at 6 weeks post-surgery (74.50 vs 71.10; p=0.09) or 12 weeks post-surgery (83.80 vs 82.50; p=0.48). Sexual function scores did not differ significantly between the radical retropubic prostatectomy group and robot-assisted laparoscopic prostatectomy group at 6 weeks post-surgery (30.70 vs 32.70; p=0.45) or 12 weeks post-surgery (35.00 vs 38.90; p=0.18). Equivalence testing on the difference between the proportion of positive surgical margins between the two groups (15 [10%] in the radical retropubic prostatectomy group vs 23 [15%] in the robot-assisted laparoscopic prostatectomy group) showed that equality between the two techniques could not be established based on a 90% CI with a Delta of 10%. However, a superiority test showed that the two proportions were not significantly different (p=0.21). 14 patients (9%) in the radical retropubic prostatectomy group versus six (4%) in the robot-assisted laparoscopic prostatectomy group had postoperative complications (p=0.052). 12 (8%) men receiving radical retropubic prostatectomy and three (2%) men receiving robot-assisted laparoscopic prostatectomy experienced intraoperative adverse events. Interpretation These two techniques yield similar functional outcomes at 12 weeks. Longer term follow-up is needed. In the interim, we encourage patients to choose an experienced surgeon they trust and with whom they have rapport, rather than a specific surgical approach.	[Yaxley, John W.; Coughlin, Geoffrey D.; Dunglison, Nigel; Gardiner, Robert A.] Royal Brisbane & Womens Hosp, Dept Urol, Brisbane, Qld, Australia; [Chambers, Suzanne K.; Occhipinti, Stefano] Griffith Univ, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia; [Chambers, Suzanne K.; Samaratunga, Hema; Lavin, Martin F.; Gardiner, Robert A.] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Chambers, Suzanne K.; Gardiner, Robert A.] Edith Cowan Univ, Perth, WA, Australia; [Chambers, Suzanne K.; Zajdlewicz, Leah] Canc Council Queensland, Brisbane, Qld, Australia; [Chambers, Suzanne K.] Prostate Canc Fdn Australia, Sydney, NSW, Australia; [Samaratunga, Hema] Aquesta Specialized Uropathol, Brisbane, Qld, Australia; [Samaratunga, Hema] Princess Alexandra Hosp, Brisbane, Qld, Australia; [Carter, Rob] Deakin Univ, Melbourne, Vic, Australia; [Williams, Scott] Peter Macallum Canc Ctr, Melbourne, Vic, Australia; [Payton, Diane J.; Perry-Keene, Joanna] Queensland Pathol, Brisbane, Qld, Australia	Royal Brisbane & Women's Hospital; Griffith University; Menzies Health Institute Queensland; University of Queensland; Edith Cowan University; Cancer Council Queensland; Deakin University	Gardiner, RA (corresponding author), Royal Brisbane & Womens Hosp, Dept Urol, Brisbane, Qld, Australia.; Gardiner, RA (corresponding author), Univ Queensland, Clin Res Ctr, Royal Brisbane & Womens Hosp, Brisbane, Qld 4029, Australia.	f.gardiner@uq.edu.au	Chambers, Suzanne K/H-5957-2012; Occhipinti, Stefano/G-3361-2015; Samaratunga, Hemamali M L/D-1559-2013; Lavin, Martin/F-5961-2014	Chambers, Suzanne K/0000-0003-2369-6111; Occhipinti, Stefano/0000-0002-2558-0609; Samaratunga, Hemamali M L/0000-0001-5796-1791; Carter, Rob/0000-0002-1586-5619; Nielsen, Lisa/0000-0002-0752-6115; Lavin, Martin/0000-0002-5940-4769	Cancer Council Queensland; Royal Brisbane & Women's Hospital	Cancer Council Queensland(Cancer Council Queensland); Royal Brisbane & Women's Hospital	Cancer Council Queensland.; We thank the Cancer Council Queensland for providing the grant for this research project; the patients for supporting this study; the medical administration at Royal Brisbane & Women's Hospital, in particular Judy Graves, Keith McNeill, and Barry O'Loughlin, for funding the robotic programme; the Independent Data Monitoring Committee (Joanne Aitken [Cancer Council Queensland; Menzies Health Institute Queensland, Griffith University; School of Public Health and Social Work, QUT], David Smith [Cancer Council New South Wales; Menzies Health Institute Queensland, Griffith University], and Mark Frydenberg AM [Department of Surgery, Monash University; Department of Urology, Monash Health]); and Robyn Medcraft and Nigel Bennett for assistance with data management.	Alonso J., 2003, VERSION ESPAOLA SF 3; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Atug F, 2006, EUR UROL, V49, P866, DOI 10.1016/j.eururo.2006.02.054; Ball AJ, 2006, J ENDOUROL, V20, P723, DOI 10.1089/end.2006.20.723; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; Binder J, 2001, BJU INT, V87, P408, DOI 10.1046/j.1464-410x.2001.00115.x; Chuang AY, 2008, AM J SURG PATHOL, V32, P1201, DOI 10.1097/PAS.0b013e318162a8bf; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Eastham JA, 2003, J UROLOGY, V170, P2292, DOI 10.1097/01.ju.0000091100.83725.51; Ferlay JSI, 2013, GLOBOCAN 2012 V1 0 C; Ficarra V, 2012, EUR UROL, V62, P405, DOI 10.1016/j.eururo.2012.05.045; Ficarra V, 2012, EUR UROL, V62, P418, DOI 10.1016/j.eururo.2012.05.046; Gandaglia G, 2014, J CLIN ONCOL, V32, P1419, DOI 10.1200/JCO.2013.53.5096; Gardiner RA, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-189; Haglind E, 2015, EUR UROL, V68, P216, DOI 10.1016/j.eururo.2015.02.029; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; Hu JC, 2014, EUR UROL, V66, P666, DOI 10.1016/j.eururo.2014.02.015; Isgoren Abidin Egemen, 2014, Sex Med Rev, V2, P10, DOI 10.1002/smrj.21; Jo B, 2002, PSYCHOL METHODS, V7, P178, DOI 10.1037//1082-989X.7.2.178; Jung JH, 2012, J LAPAROENDOSC ADV S, V22, P785, DOI 10.1089/lap.2011.0516; Liss MA, 2013, WORLD J UROL, V31, P481, DOI 10.1007/s00345-013-1056-9; McCarthy M, 2005, J AM COLL SURGEONS, V201, P245, DOI 10.1016/j.jamcollsurg.2005.03.034; Meeks JJ, 2013, UROL ONCOL-SEMIN ORI, V31, P974, DOI 10.1016/j.urolonc.2011.12.011; Novara G, 2012, EUR UROL, V62, P382, DOI 10.1016/j.eururo.2012.05.047; Perry-Keene J, 2014, HISTOPATHOLOGY, V64, P399, DOI 10.1111/his.12262; Richardson J, 2014, PATIENT, V7, P85, DOI 10.1007/s40271-013-0036-x; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Schover LR, 2012, CANCER-AM CANCER SOC, V118, P500, DOI 10.1002/cncr.26308; SCHUIRMANN DJ, 1987, J PHARMACOKINET BIOP, V15, P657, DOI 10.1007/BF01068419; Smith JA, 2008, WORLD J UROL, V26, P443, DOI 10.1007/s00345-008-0293-9; Suardi N, 2016, UROL ONCOL, V34, P57; Sundi D, 2014, J CLIN ONCOL, V32, P1394, DOI 10.1200/JCO.2013.54.9741; Wei JT, 2000, UROLOGY, V56, P899, DOI 10.1016/S0090-4295(00)00858-X; Wood DP, 2007, UROLOGY, V70, P945, DOI 10.1016/j.urology.2007.06.1120; Yossepowitch O, 2014, EUR UROL, V65, P303, DOI 10.1016/j.eururo.2013.07.039; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	36	394	403	6	87	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2016	388	10049					1057	1066		10.1016/S0140-6736(16)30592-X	http://dx.doi.org/10.1016/S0140-6736(16)30592-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV0OD	27474375				2022-12-28	WOS:000382616900027
J	Johnson, TC; Werne, JP; Brown, ET; Abbott, A; Berke, M; Steinman, BA; Halbur, J; Contreras, S; Grosshuesch, S; Deino, A; Lyons, RP; Scholz, CA; Schouten, S; Damste, JSS				Johnson, T. C.; Werne, J. P.; Brown, E. T.; Abbott, A.; Berke, M.; Steinman, B. A.; Halbur, J.; Contreras, S.; Grosshuesch, S.; Deino, A.; Lyons, R. P.; Scholz, C. A.; Schouten, S.; Damste, J. S. Sinninghe			A progressively wetter climate in southern East Africa over the past 1.3 million years	NATURE			English	Article							SEA-SURFACE TEMPERATURES; TETRAETHER LIPIDS; TEX86 PALEOTHERMOMETER; LAKE; RECORD; VARIABILITY; EQUATORIAL; MEGADROUGHTS; CALIBRATION; EVOLUTION	African climate is generally considered to have evolved towards progressively drier conditions over the past few million years, with increased variability as glacial-interglacial change intensified worldwide(1-3). Palaeoclimate records derived mainly from northern Africa exhibit a 100,000-year (eccentricity) cycle overprinted on a pronounced 20,000-year (precession) beat, driven by orbital forcing of summer insolation, global ice volume and long-lived atmospheric greenhouse gases(4). Here we present a 1.3-million-year-long climate history from the Lake Malawi basin (10 degrees-14 degrees S in eastern Africa), which displays strong 100,000-year (eccentricity) cycles of temperature and rainfall following the Mid-Pleistocene Transition around 900,000 years ago. Interglacial periods were relatively warm and moist, while ice ages were cool and dry. The Malawi record shows limited evidence for precessional variability, which we attribute to the opposing effects of austral summer insolation and the temporal/spatial pattern of sea surface temperature in the Indian Ocean. The temperature history of the Malawi basin, at least for the past 500,000 years, strongly resembles past changes in atmospheric carbon dioxide and terrigenous dust flux in the tropical Pacific Ocean, but not in global ice volume. Climate in this sector of eastern Africa (unlike northern Africa) evolved from a predominantly arid environment with high-frequency variability to generally wetter conditions with more prolonged wet and dry intervals.	[Johnson, T. C.; Brown, E. T.; Steinman, B. A.; Halbur, J.; Grosshuesch, S.] Univ Minnesota, Large Lakes Observ, Duluth, MN 55812 USA; [Johnson, T. C.; Brown, E. T.; Steinman, B. A.; Halbur, J.; Grosshuesch, S.] Univ Minnesota, Dept Earth & Environm Sci, Duluth, MN 55812 USA; [Johnson, T. C.] Univ Massachusetts, Dept Geosci, Amherst, MA 01003 USA; [Werne, J. P.] Univ Pittsburgh, Dept Geol & Planetary Sci, Pittsburgh, PA 15260 USA; [Abbott, A.] Macquarie Univ, Fac Sci & Engn, Dept Earth & Planetary Sci, Sydney, NSW 2109, Australia; [Berke, M.] Univ Notre Dame, Dept Civil & Environm Engn & Earth Sci, 257 Fitzpatrick Hall, Notre Dame, IN 46556 USA; [Contreras, S.] Univ Catolica Santisima Concepcion, Dept Quim Ambiental, Casilla 297, Concepcion, Chile; [Contreras, S.] Univ Catolica Santisima Concepcion, CIBAS, Casilla 297, Concepcion, Chile; [Deino, A.] Berkeley Geochronol Ctr, 2455 Ridge Rd, Berkeley, CA 94709 USA; [Lyons, R. P.; Scholz, C. A.] Syracuse Univ, Dept Earth Sci, Heroy Geol Lab 011a, Syracuse, NY 13244 USA; [Schouten, S.; Damste, J. S. Sinninghe] NIOZ Netherlands Inst Sea Res, Dept Marine Microbiol & Biogeochem, POB 59, NL-1790 AB Den Burg, Netherlands; [Schouten, S.; Damste, J. S. Sinninghe] Univ Utrecht, POB 59, NL-1790 AB Den Burg, Netherlands; [Schouten, S.; Damste, J. S. Sinninghe] Univ Utrecht, Dept Earth Sci, Fac Geosci, POB 80-021, NL-3508 TA Utrecht, Netherlands; [Lyons, R. P.] Chevron Corp, 1400 Smith St, Houston, TX 77002 USA	University of Minnesota System; University of Minnesota Duluth; University of Minnesota System; University of Minnesota Duluth; University of Massachusetts System; University of Massachusetts Amherst; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Macquarie University; University of Notre Dame; Universidad Catolica de la Santisima Concepcion; Universidad Catolica de la Santisima Concepcion; Berkeley Geochronolgy Center; Syracuse University; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Utrecht University; Utrecht University; Chevron	Johnson, TC (corresponding author), Univ Minnesota, Large Lakes Observ, Duluth, MN 55812 USA.; Johnson, TC (corresponding author), Univ Minnesota, Dept Earth & Environm Sci, Duluth, MN 55812 USA.	tcj@d.umn.edu	Contreras, Sergio/I-1858-2014; Berke, Melissa A/H-3819-2016; Damste, Jaap S Sinninghe/F-6128-2011	Contreras, Sergio/0000-0001-7192-6810; Damste, Jaap S Sinninghe/0000-0002-8683-1854; Abbott, April/0000-0001-6694-3675; Werne, Josef/0000-0002-7019-6024; Brown, Erik T/0000-0001-7154-2729; Berke, Melissa/0000-0003-4810-3773	US National Science Foundation EAR; US National Science Foundation P2C2; International Continental Scientific Drilling Program; Netherlands Earth System Science Centre (NESSC); Dutch Ministry of Education, Culture and Science (OCW)	US National Science Foundation EAR(National Science Foundation (NSF)); US National Science Foundation P2C2; International Continental Scientific Drilling Program; Netherlands Earth System Science Centre (NESSC); Dutch Ministry of Education, Culture and Science (OCW)	We thank the engineering and design team of the Lake Malawi Scientific Drilling Project for overcoming substantial technical challenges associated with drilling on Lake Malawi, especially the efforts of D. Schnurrenberger, M. Pardy and Lengeek Vessel Engineering. B. Otto-Bliesner and S. Albani provided advice on climate model results relevant to this study. J. King provided the palaeomagnetic reversal data that contributed substantially to the age model of the Malawi sediment record. We thank the scientists and technicians of LacCore, University of Minnesota, for their assistance in the splitting, initial analyses, sampling and archiving of the sediment cores obtained by the Lake Malawi Drilling Project. Financial support was provided by the US National Science Foundation EAR and P2C2 programmes and by the International Continental Scientific Drilling Program. S.S. and J.S.S.D. were supported by the Netherlands Earth System Science Centre (NESSC), which is financially supported by the Dutch Ministry of Education, Culture and Science (OCW).	Albani S, 2014, J ADV MODEL EARTH SY, V6, P541, DOI 10.1002/2013MS000279; Bard E, 1997, NATURE, V385, P707, DOI 10.1038/385707a0; Blaga CI, 2013, GEOPHYS RES LETT, V40, P948, DOI 10.1002/grl.50181; Blaga CI, 2011, GEOCHIM COSMOCHIM AC, V75, P6416, DOI 10.1016/j.gca.2011.08.016; Brown ET, 2011, PALAEOGEOGR PALAEOCL, V303, P120, DOI 10.1016/j.palaeo.2010.01.038; Burrough SL, 2009, QUATERNARY SCI REV, V28, P1392, DOI 10.1016/j.quascirev.2009.02.007; Cane MA, 2001, NATURE, V411, P157, DOI 10.1038/35075500; Castaneda IS, 2007, GEOLOGY, V35, P823, DOI 10.1130/G23916A.1; Castaneda IS, 2015, QUATERNARY SCI REV, V125, P174, DOI 10.1016/j.quascirev.2015.07.020; Castaneda IS, 2011, QUATERNARY SCI REV, V30, P2851, DOI 10.1016/j.quascirev.2011.07.009; Cerling TE, 1992, PALAEOGEOGR PALAEOCL, V97, P241, DOI 10.1016/0031-0182(92)90211-M; Cerling TE, 2011, NATURE, V476, P51, DOI 10.1038/nature10306; Cohen AS, 2007, P NATL ACAD SCI USA, V104, P16422, DOI 10.1073/pnas.0703873104; Damste JSS, 2012, QUATERNARY SCI REV, V50, P43, DOI 10.1016/j.quascirev.2012.07.001; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; FINNEY BP, 1991, PALAEOGEOGR PALAEOCL, V85, P351, DOI 10.1016/0031-0182(91)90167-P; FINNEY BP, 1996, LIMNOLOGY CLIMATOLOG, P495; Goddard L, 1999, J GEOPHYS RES-ATMOS, V104, P19099, DOI 10.1029/1999JD900326; Kim JH, 2008, GEOCHIM COSMOCHIM AC, V72, P1154, DOI 10.1016/j.gca.2007.12.010; Lane CS, 2013, P NATL ACAD SCI USA, V110, P8025, DOI 10.1073/pnas.1301474110; Levin NE, 2015, ANNU REV EARTH PL SC, V43, P405, DOI 10.1146/annurev-earth-060614-105310; Liesecki L. E., 2004, PALEOCEANOGRAPHY, V20; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Lyons RP, 2015, P NATL ACAD SCI USA, V112, P15568, DOI 10.1073/pnas.1512864112; Lyons RP, 2011, PALAEOGEOGR PALAEOCL, V303, P20, DOI 10.1016/j.palaeo.2009.04.014; Magill CR, 2013, P NATL ACAD SCI USA, V110, P1167, DOI 10.1073/pnas.1206276110; Mohtadi M., 2011, IGBP PAGES; Otto-Bliesner BL, 2014, SCIENCE, V346, P1223, DOI 10.1126/science.1259531; Pearson A, 2013, ANNU REV EARTH PL SC, V41, P359, DOI 10.1146/annurev-earth-050212-123947; Peterse F, 2012, ORG GEOCHEM, V51, P11, DOI [10.1016/j.orggeochem.2012.07.004, 10.1016/j.orggeochem.2012.09.006]; Potts R, 1996, SCIENCE, V273, P922, DOI 10.1126/science.273.5277.922; Powers L, 2010, ORG GEOCHEM, V41, P404, DOI 10.1016/j.orggeochem.2009.11.009; Ricketts R. D., 1996, CLIMATOLOGY PALEOCLI, P475; Schefuss E, 2003, NATURE, V422, P418, DOI 10.1038/nature01500; Scholz CA, 2007, P NATL ACAD SCI USA, V104, P16416, DOI 10.1073/pnas.0703874104; Schouten S, 2003, GEOLOGY, V31, P1069, DOI 10.1130/G19876.1; Schouten S, 2002, EARTH PLANET SC LETT, V204, P265, DOI 10.1016/S0012-821X(02)00979-2; Schouten S, 2007, ANAL CHEM, V79, P2940, DOI 10.1021/ac062339v; Thomas DSG, 2009, QUATERNARY SCI REV, V28, P526, DOI 10.1016/j.quascirev.2008.10.023; Tierney JE, 2013, NATURE, V493, P389, DOI 10.1038/nature11785; Trauth MH, 2007, J HUM EVOL, V53, P475, DOI 10.1016/j.jhevol.2006.12.009; Trauth MH, 2005, SCIENCE, V309, P2051, DOI 10.1126/science.1112964; Van Bocxlaer B, 2012, BIOGEOSCIENCES, V9, P4497, DOI 10.5194/bg-9-4497-2012; Winckler G, 2008, SCIENCE, V320, P93, DOI 10.1126/science.1150595; Woltering M. L., THESIS; Woltering M, 2012, GEOCHIM COSMOCHIM AC, V87, P136, DOI 10.1016/j.gca.2012.03.024	48	62	63	6	82	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					220	+		10.1038/nature19065	http://dx.doi.org/10.1038/nature19065			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9LQ	27509851				2022-12-28	WOS:000382539100045
J	Zhu, JP; Vinothkumar, KR; Hirst, J				Zhu, Jiapeng; Vinothkumar, Kutti R.; Hirst, Judy			Structure of mammalian respiratory complex I	NATURE			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; ACYL CARRIER PROTEIN; CRYSTAL-STRUCTURE; BINDING-SITE; SUBUNIT; FEATURES; DOMAIN; ND1; KDA	Complex I (NADH: ubiquinone oxidoreductase), one of the largest membrane-bound enzymes in the cell, powers ATP synthesis in mammalian mitochondria by using the reducing potential of NADH to drive protons across the inner mitochondrial membrane. Mammalian complex I (ref. 1) contains 45 subunits, comprising 14 core subunits that house the catalytic machinery (and are conserved from bacteria to humans) and a mammalian-specific cohort of 31 supernumerary subunits(1,2). Knowledge of the structures and functions of the supernumerary subunits is fragmentary. Here we describe a 4.2-angstrom resolution single-particle electron cryomicroscopy structure of complex I from Bos taurus. We have located and modelled all 45 subunits, including the 31 supernumerary subunits, to provide the entire structure of the mammalian complex. Computational sorting of the particles identified different structural classes, related by subtle domain movements, which reveal conformationally dynamic regions and match biochemical descriptions of the 'active-to-de-active' enzyme transition that occurs during hypoxia(3,4). Our structures therefore provide a foundation for understanding complex I assembly(5) and the effects of mutations that cause clinically relevant complex I dysfunctions(6), give insights into the structural and functional roles of the supernumerary subunits and reveal new information on the mechanism and regulation of catalysis.	[Zhu, Jiapeng; Hirst, Judy] MRC Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England; [Vinothkumar, Kutti R.] MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England; [Zhu, Jiapeng] Nanjing Univ Chinese Med, Nanjing 210023, Jiangsu, Peoples R China	MRC Laboratory Molecular Biology; Nanjing University of Chinese Medicine	Hirst, J (corresponding author), MRC Mitochondrial Biol Unit, Hills Rd, Cambridge CB2 0XY, England.; Vinothkumar, KR (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	vkumar@mrc-lmb.cam.ac.uk; jh@mrc-mbu.cam.ac.uk	Hirst, Judy/F-4803-2011	Hirst, Judy/0000-0001-8667-6797	Medical Research Council [U105184322, U105663141]; Medical Research Council [MC_U105663141] Funding Source: researchfish; MRC [MC_U105663141] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank R. Henderson and G. Murshudov for discussions, J. Grimmett and T. Darling for computational help, S. Chen and C. Savva for electron microscopy help, and J. N. Blaza for quantifying the ratio of de-active and active enzymes in our preparation. This work was supported by The Medical Research Council, grant numbers U105184322 (K.R.V., in R. Henderson's group) and U105663141 (J.H.).	Abdrakhmanova A, 2006, BBA-BIOENERGETICS, V1757, P1676, DOI 10.1016/j.bbabio.2006.09.003; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Angerer H, 2014, P NATL ACAD SCI USA, V111, P5207, DOI 10.1073/pnas.1322438111; Babot M, 2014, BBA-BIOENERGETICS, V1837, P929, DOI 10.1016/j.bbabio.2014.02.013; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balsa E, 2012, CELL METAB, V16, P378, DOI 10.1016/j.cmet.2012.07.015; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Brockmann C, 2004, STRUCTURE, V12, P1645, DOI 10.1016/j.str.2004.06.021; Brown A, 2015, ACTA CRYSTALLOGR D, V71, P136, DOI 10.1107/S1399004714021683; Carroll J, 2013, J BIOL CHEM, V288, P24799, DOI 10.1074/jbc.M113.488106; Chan DI, 2010, BIOCHEM J, V430, P1, DOI 10.1042/BJ20100462; Chovancova E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002708; Cooley RB, 2010, J MOL BIOL, V404, P232, DOI 10.1016/j.jmb.2010.09.034; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fassone E, 2012, J MED GENET, V49, P578, DOI 10.1136/jmedgenet-2012-101159; FEARNLEY IM, 1992, BIOCHIM BIOPHYS ACTA, V1140, P105, DOI 10.1016/0005-2728(92)90001-I; Feng DJ, 2009, J BIOL CHEM, V284, P11436, DOI 10.1074/jbc.M806991200; Galkin A, 2008, J BIOL CHEM, V283, P20907, DOI 10.1074/jbc.M803190200; Galkin A, 2009, J BIOL CHEM, V284, P36055, DOI 10.1074/jbc.M109.054346; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Hirst J, 2003, BBA-BIOENERGETICS, V1604, P135, DOI 10.1016/S0005-2728(03)00059-8; Hirst J, 2016, BBA-BIOENERGETICS, V1857, P872, DOI 10.1016/j.bbabio.2015.12.009; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Johansson K, 2001, NAT STRUCT BIOL, V8, P616, DOI 10.1038/89661; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kmita K, 2015, P NATL ACAD SCI USA, V112, P5685, DOI 10.1073/pnas.1424353112; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Murai M, 2016, BBA-BIOENERGETICS, V1857, P884, DOI 10.1016/j.bbabio.2015.11.009; Murai M, 2011, BIOCHEMISTRY-US, V50, P6901, DOI 10.1021/bi200883c; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; RUNSWICK MJ, 1991, FEBS LETT, V286, P121, DOI 10.1016/0014-5793(91)80955-3; Sanchez-Caballero L, 2016, BBA-BIOENERGETICS, V1857, P980, DOI 10.1016/j.bbabio.2016.03.031; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sharma V, 2015, P NATL ACAD SCI USA, V112, P11571, DOI 10.1073/pnas.1503761112; Sharpley MS, 2006, BIOCHEMISTRY-US, V45, P241, DOI 10.1021/bi051809x; Szklarczyk R, 2011, FEBS LETT, V585, P737, DOI 10.1016/j.febslet.2011.01.046; Tocilescu MA, 2007, J BIOL CHEM, V282, P29514, DOI 10.1074/jbc.M704519200; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Zhu JP, 2015, P NATL ACAD SCI USA, V112, P12087, DOI 10.1073/pnas.1510577112; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859	44	341	350	5	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					354	+		10.1038/nature19095	http://dx.doi.org/10.1038/nature19095			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27509854	Green Accepted, Green Submitted			2022-12-28	WOS:000381804900040
J	Clarke, R				Clarke, Rachel			Lessons for consultants from the junior doctor dispute	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rtsclarke@gmail.com						BBC Radio 4, 2015, BBC RADIO 4 TODAY PR	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2016	354								i4500	10.1136/bmj.i4500	http://dx.doi.org/10.1136/bmj.i4500			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GZ	27535806				2022-12-28	WOS:000381806400009
J	[Anonymous]				[Anonymous]			Seven days in medicine: 10-16 August 2016	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2016	354								i4498	10.1136/bmj.i4498	http://dx.doi.org/10.1136/bmj.i4498			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GZ	27534424				2022-12-28	WOS:000381806400008
J	Butt, CA				Butt, Carrie A.			Face Mask Bruce Nauman	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2016	316	7					694	695		10.1001/jama.2015.14434	http://dx.doi.org/10.1001/jama.2015.14434			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT5IA	27533141				2022-12-28	WOS:000381514800001
J	Chubak, J; Whitlock, EP; Williams, SB				Chubak, J.; Whitlock, E. P.; Williams, S. B.			Review: Aspirin reduces colorectal cancer incidence and mortality in patients at average risk	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chubak, J.] Grp Hlth Res Inst, Seattle, WA USA		Chubak, J (corresponding author), Grp Hlth Res Inst, Seattle, WA USA.	chubak.j@ghc.org							0	0	0	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					JC16	JC16		10.7326/ACPJC-2016-165-4-016	http://dx.doi.org/10.7326/ACPJC-2016-165-4-016			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UI	27538177				2022-12-28	WOS:000381267200003
J	Dzau, VJ; McClellan, M; McGinnis, JM				Dzau, Victor J.; McClellan, Mark; McGinnis, J. Michael			Vital Directions for Health and Health Care An Initiative of the National Academy of Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Dzau, Victor J.; McGinnis, J. Michael] Natl Acad Med, 500 Fifth St NW, Washington, DC 20001 USA; [McClellan, Mark] Duke Univ, Durham, NC USA	National Academies of Sciences, Engineering & Medicine; Duke University	Dzau, VJ (corresponding author), Natl Acad Med, 500 Fifth St NW, Washington, DC 20001 USA.	vdzau@nas.edu						Adams P, 2013, VITAL HLTH STAT, V10, P259; Anderson G, 2010, CHRONIC CARE MAKING; Davis K, 2014, MIRROR MIRROR WALL 2; Institute of Medicine, 2010, HEALTHC IMP LOW COST; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Moses H, 2015, JAMA-J AM MED ASSOC, V313, P174, DOI 10.1001/jama.2014.15939; Woolf SH, 2013, US HLTH INT PERSP SH	7	15	16	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2016	316	7					711	712		10.1001/jama.2016.10692	http://dx.doi.org/10.1001/jama.2016.10692			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT5IA	27533152				2022-12-28	WOS:000381514800013
J	Kazi, DS; Moran, AE; Coxson, PG; Penko, J; Ollendorf, DA; Pearson, SD; Tice, JA; Guzman, D; Bibbins-Domingo, K				Kazi, Dhruv S.; Moran, Andrew E.; Coxson, Pamela G.; Penko, Joanne; Ollendorf, Daniel A.; Pearson, Steven D.; Tice, Jeffrey A.; Guzman, David; Bibbins-Domingo, Kirsten			Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SUBTILISIN/KEXIN TYPE 9; ISCHEMIC-HEART-DISEASE; STATIN THERAPY; GLOBAL BURDEN; RISK PATIENTS; REDUCING LIPIDS; EFFICACY; SAFETY; ALIROCUMAB; EZETIMIBE	IMPORTANCE Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors were recently approved for lowering low-density lipoprotein cholesterol in heterozygous familial hypercholesterolemia (FH) or atherosclerotic cardiovascular disease (ASCVD) and have potential for broad ASCVD prevention. Their long-term cost-effectiveness and effect on total health care spending are uncertain. OBJECTIVE To estimate the cost-effectiveness of PCSK9 inhibitors and their potential effect on US health care spending. DESIGN, SETTING, AND PARTICIPANTS The Cardiovascular Disease Policy Model, a simulation model of US adults aged 35 to 94 years, was used to evaluate cost-effectiveness of PCSK9 inhibitors or ezetimibe in heterozygous FH or ASCVD. The model incorporated 2015 annual PCSK9 inhibitor costs of $14 350 (based on mean wholesale acquisition costs of evolocumab and alirocumab); adopted a health-system perspective, lifetime horizon; and included probabilistic sensitivity analyses to explore uncertainty. EXPOSURES Statin therapy compared with addition of ezetimibe or PCSK9 inhibitors. MAIN OUTCOMES AND MEASURES Lifetime major adverse cardiovascular events (MACE: cardiovascular death, nonfatalmyocardial infarction, or stroke), incremental cost per quality-adjusted life-year (QALY), and total effect on US health care spending over 5 years. RESULTS Adding PCSK9 inhibitors to statins in heterozygous FH was estimated to prevent 316 300 MACE at a cost of $503 000 per QALY gained compared with adding ezetimibe to statins (80% uncertainty interval [UI], $493 000-$1 737 000). In ASCVD, adding PCSK9 inhibitors to statins was estimated to prevent 4.3 million MACE compared with adding ezetimibe at $414 000 per QALY (80% UI, $277 000-$1 539 000). Reducing annual drug costs to $4536 per patient or less would be needed for PCSK9 inhibitors to be cost-effective at less than $100 000 per QALY. At 2015 prices, PCSK9 inhibitor use in all eligible patients was estimated to reduce cardiovascular care costs by $29 billion over 5 years, but drug costs increased by an estimated $592 billion (a 38% increase over 2015 prescription drug expenditures). In contrast, initiating statins in these high-risk populations in all statin-tolerant individuals who are not currently using statins was estimated to save $12 billion. CONCLUSIONS AND RELEVANCE Assuming 2015 prices, PCSK9 inhibitor use in patients with heterozygous FH or ASCVD did not meet generally acceptable incremental cost-effectiveness thresholds and was estimated to increase US health care costs substantially. Reducing annual drug prices from more than $14 000 to $4536 would be necessary to meet a $100 000 per QALY threshold.	[Kazi, Dhruv S.; Coxson, Pamela G.; Penko, Joanne; Guzman, David; Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Med, Ctr Vulnerable Populat, San Francisco, CA 94143 USA; [Kazi, Dhruv S.; Coxson, Pamela G.; Penko, Joanne; Tice, Jeffrey A.; Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Kazi, Dhruv S.; Bibbins-Domingo, Kirsten] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Kazi, Dhruv S.] Univ Calif San Francisco, Ctr Healthcare Value, San Francisco, CA 94143 USA; [Kazi, Dhruv S.] Zuckerberg San Francisco Gen Hosp, Div Cardiol, San Francisco, CA USA; [Moran, Andrew E.] Columbia Univ, Med Ctr, Div Gen Internal Med, New York, NY USA; [Moran, Andrew E.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Coxson, Pamela G.; Bibbins-Domingo, Kirsten] Zuckerberg San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA USA; [Ollendorf, Daniel A.; Pearson, Steven D.] Inst Clin & Econ Review, Boston, MA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Columbia University; Columbia University	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Div Gen Internal Med, POB 1364, San Francisco, CA 94143 USA.	kirsten.bibbins-domingo@ucsf.edu		Tice, Jeffrey/0000-0002-9857-2028	New England States Consortium Systems Organization; Laura and John Arnold Foundation	New England States Consortium Systems Organization; Laura and John Arnold Foundation	Portions of this work were presented to the New England Comparative Effectiveness Public Advisory Council, a program of the Institute for Clinical and Economic Review that is supported by grants from the New England States Consortium Systems Organization and the Laura and John Arnold Foundation.	Agency for Healthcare Research and Quality, MED EXP PAN SURV PUB; Akinboro O, 2014, ANN INTERN MED, V161, P531, DOI [10.7326/L14-5019-2, 10.7326/L14-5019]; Anderson JL, 2014, J AM COLL CARDIOL, V63, P2304, DOI 10.1016/j.jacc.2014.03.016; [Anonymous], 2003, HOSP FIN DAT 1999 20; [Anonymous], 2008, CAL PUBL PAT DISCH D; Ara R, 2008, HEALTH TECHNOL ASSES, V12, P1; Bays H, 2015, J CLIN ENDOCR METAB, V100, P3140, DOI 10.1210/jc.2015-1520; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Blackstone EA, 2013, AM HEALTH DRUG BENEF, V6, P469; Blom DJ, 2014, NEW ENGL J MED, V370, P1809, DOI 10.1056/NEJMoa1316222; Cannon CP, 2015, NEW ENGL J MED, V372, P2387, DOI 10.1056/NEJMoa1410489; Cannon CP, 2015, EUR HEART J, V36, P1186, DOI 10.1093/eurheartj/ehv028; Everett BM, 2015, NEW ENGL J MED, V373, P1588, DOI 10.1056/NEJMp1508120; Farnier M, 2016, ATHEROSCLEROSIS, V244, P138, DOI 10.1016/j.atherosclerosis.2015.11.010; Fulcher J, 2015, LANCET, V385, P1397, DOI 10.1016/S0140-6736(14)61368-4; Gidding SS, 2015, CIRCULATION, V132, P2167, DOI 10.1161/CIR.0000000000000297; Giugliano RP, 2015, J AM COLL CARDIOL, V65, P2638, DOI 10.1016/j.jacc.2015.05.001; Giugliano RP, 2012, LANCET, V380, P2007, DOI 10.1016/S0140-6736(12)61770-X; Gold MR, 1996, COST EFFECTIVENESS H; Grundy SM, 2013, ANN INTERN MED, V158, P562, DOI 10.7326/0003-4819-158-7-201304020-00010; Hunt SC, 2000, ARTERIOSCL THROM VAS, V20, P1089, DOI 10.1161/01.ATV.20.4.1089; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Kastelein JJP, 2015, EUR HEART J, V36, P2996, DOI 10.1093/eurheartj/ehv370; Kazi DS, 2014, ANN INTERN MED, V160, P221, DOI 10.7326/M13-1999; Kereiakes DJ, 2015, AM HEART J, V169, P906, DOI 10.1016/j.ahj.2015.03.004; Khazeni N, 2009, ANN INTERN MED, V151, P829, DOI [10.7326/0000605-200912150-00157, 10.7326/0003-4819-151-12-200912150-00157]; Khazeni N, 2009, ANN INTERN MED, V151, P840, DOI [10.7326/0000605-200912150-00156, 10.7326/0003-4819-151-12-200912150-00156]; Lazar LD, 2011, CIRCULATION, V124, P146, DOI 10.1161/CIRCULATIONAHA.110.986349; Mikhailidis DP, 2007, CURR MED RES OPIN, V23, P2009, DOI 10.1185/030079907X210507; Moran AE, 2015, NEW ENGL J MED, V372, P447, DOI 10.1056/NEJMsa1406751; Moran AE, 2014, CIRCULATION, V129, P1483, DOI 10.1161/CIRCULATIONAHA.113.004042; Moran AE, 2014, CIRCULATION, V129, P1493, DOI 10.1161/CIRCULATIONAHA.113.004046; Moriarty PM, 2015, J CLIN LIPIDOL, V9, P758, DOI 10.1016/j.jacl.2015.08.006; Mulcahy AW, COST SAVINGS POTENTI; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Navarese EP, 2015, ANN INTERN MED, V163, P40, DOI 10.7326/M14-2957; Newman CB, 2015, JAMA-J AM MED ASSOC, V313, P1011, DOI 10.1001/jama.2015.1335; Office of the Assistant Secretary for Planning and Evaluation Department of Health and Human Services, OBS TRENDS PRESCR DR; Raal FJ, 2015, LANCET, V385, P341, DOI 10.1016/S0140-6736(14)61374-X; Reinhardt U., PROBING OUR MORAL VA; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858; Singh S, 2015, CURR ATHEROSCLER REP, V17, DOI 10.1007/s11883-014-0482-5; Tice JA, 2015, PCSK9 INHIBITORS TRE; Truven Health Analytics, RED BOOK ONL; UK National Health Service Medicines Information, NEW DRUGS ONL REP EV; United States National Center for Health Statistics, 2005, NAT HLTH NUTR EX SUR; US Census Bureau, 1998, STAT ABSTR US AV COS, P136; USNational Library of Medicine, LAB PRAL AL INJ SOL; WEINSTEIN MC, 1987, AM J PUBLIC HEALTH, V77, P1417, DOI 10.2105/AJPH.77.11.1417; Zhang HB, 2013, ANN INTERN MED, V158, P526, DOI 10.7326/0003-4819-158-7-201304020-00004	51	247	252	4	43	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2016	316	7					743	753		10.1001/jama.2016.11004	http://dx.doi.org/10.1001/jama.2016.11004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT5IA	27533159	Bronze			2022-12-28	WOS:000381514800020
J	Wise, J				Wise, Jacqui			UK drug appraisal process is restricting access to cancer drugs, say charities	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Breast Cancer Now; Prostate Cancer UK, 2016, INT COMP HLTH TECHN; Hawkes N, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4216	2	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 15	2016	354								i4465	10.1136/bmj.i4465	http://dx.doi.org/10.1136/bmj.i4465			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GR	27528458				2022-12-28	WOS:000381805400014
J	van der Veeken, J; Gonzalez, AJ; Cho, H; Arvey, A; Hemmers, S; Leslie, CS; Rudensky, AY				van der Veeken, Joris; Gonzalez, Alvaro J.; Cho, Hyunwoo; Arvey, Aaron; Hemmers, Saskia; Leslie, Christina S.; Rudensky, Alexander Y.			Memory of Inflammation in Regulatory T Cells	CELL			English	Article							SELF; COMMITMENT; CHROMATIN; EFFECTOR	Eukaryotic cells can "remember'' transient encounters with a wide range of stimuli, inducing lasting states of altered responsiveness. Regulatory T (Treg) cells are a specialized lineage of suppressive CD4 T cells that act as critical negative regulators of inflammation in various biological contexts. Treg cells exposed to inflammatory conditions acquire strongly enhanced suppressive function. Using inducible genetic tracing, we analyzed the long-term stability of activation-induced transcriptional, epigenomic, and functional changes in Treg cells. We found that the inflammation-experienced Treg cell population reversed many activation-induced changes and lost its enhanced suppressive function over time. The "memory-less'' potentiation of Treg suppressor function may help avoid a state of generalized immunosuppression that could otherwise result from repeated activation.	[van der Veeken, Joris; Arvey, Aaron; Hemmers, Saskia; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [van der Veeken, Joris; Arvey, Aaron; Hemmers, Saskia; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Gonzalez, Alvaro J.; Cho, Hyunwoo; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA; [Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10065 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.; Leslie, CS (corresponding author), Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr, New York, NY 10065 USA.	cleslie@cbio.mskcc.org; rudenska@mskcc.org		van der Veeken, Joris/0000-0001-7299-2174; Arvey, Aaron/0000-0002-8789-0290	NIH [R37 AI034206, P30 CA008748, U01 HG007893]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG007893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Memorial Sloan Kettering Cancer Center (MSKCC) integrated genomics operation for sequencing RNA-, ChIP-, and ATAC-seq libraries and preprocessing data. CD4<SUP>CreERT2</SUP> mice were generated by S.H. in the laboratory of Thorsten Buch. We thank C. Campbell, S. Dikiy, A. Levine, S. Lee, K. Wu, and W. Hu for help with tissue lymphocyte isolations and all members of the A.Y.R. lab for helpful discussions and technical assistance. This study was supported by NIH grants R37 AI034206, P30 CA008748, and U01 HG007893. A.Y.R. is an investigator with the Howard Hughes Medical Institute.	Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Belkaid Y, 2009, ANNU REV IMMUNOL, V27, P551, DOI 10.1146/annurev.immunol.021908.132723; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burzyn D, 2013, NAT IMMUNOL, V14, P1007, DOI 10.1038/ni.2683; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Hale JS, 2013, IMMUNITY, V38, P805, DOI 10.1016/j.immuni.2013.02.020; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Legoux FP, 2015, IMMUNITY, V43, P896, DOI 10.1016/j.immuni.2015.10.011; Lertmemongkolchai G, 2001, J IMMUNOL, V166, P1097, DOI 10.4049/jimmunol.166.2.1097; Liu J, 2014, EUR J IMMUNOL, V44, P1058, DOI 10.1002/eji.201343766; Luo CT, 2016, NATURE, V529, P532, DOI 10.1038/nature16486; Monticelli S, 2013, NAT IMMUNOL, V14, P777, DOI 10.1038/ni.2636; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Quintin J, 2014, CURR OPIN IMMUNOL, V29, P1, DOI 10.1016/j.coi.2014.02.006; Rosenblum MD, 2011, NATURE, V480, P538, DOI 10.1038/nature10664; Rowe JH, 2012, NATURE, V490, P102, DOI 10.1038/nature11462; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Schietinger A, 2012, SCIENCE, V335, P723, DOI 10.1126/science.1214277; Shafiani S, 2013, IMMUNITY, V38, P1261, DOI 10.1016/j.immuni.2013.06.003; Sledzinska A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001674; Smigiel KS, 2014, J EXP MED, V211, P121, DOI 10.1084/jem.20131142; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wirth TC, 2010, IMMUNITY, V33, P128, DOI 10.1016/j.immuni.2010.06.014	35	91	91	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					977	990		10.1016/j.cell.2016.07.006	http://dx.doi.org/10.1016/j.cell.2016.07.006			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27499023	Bronze, Green Accepted			2022-12-28	WOS:000382258700019
J	McCartney, M				McCartney, Margaret			Margaret McCartney: Game on for Pokemon Go	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Griffin A., 2016, INDEPENDENT; Grohol J. M., 2016, POKEMON GO REPORTEDL; Khomami N., 2016, GUARDIAN; Morris S, 2016, GUARDIAN; Schilling D., 2016, GUARDIAN	5	47	47	0	53	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2016	354								i4306	10.1136/bmj.i4306	http://dx.doi.org/10.1136/bmj.i4306			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4TU	27510374	Green Published, Bronze			2022-12-28	WOS:000381474800005
J	Nelson, DA; Deuster, PA; Carter, R; Hill, OT; Wolcott, VL; Kurina, LM				Nelson, D. Alan; Deuster, Patricia A.; Carter, Robert, III; Hill, Owen T.; Wolcott, Vickee L.; Kurina, Lianne M.			Sickle Cell Trait, Rhabdomyolysis, and Mortality among US Army Soldiers	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE-RENAL-FAILURE; SUDDEN-DEATH; FATAL RHABDOMYOLYSIS; RISK-FACTOR; EXERTION; RECRUITS; FORCES	BACKGROUND Studies have suggested that sickle cell trait elevates the risks of exertional rhabdomyolysis and death. We conducted a study of sickle cell trait in relation to these outcomes, controlling for known risk factors for exertional rhabdomyolysis, in a large population of active persons who had undergone laboratory tests for hemoglobin AS (HbAS) and who were subject to exertional-injury precautions. METHODS We used Cox proportional-hazards models to test whether the risks of exertional rhabdomyolysis and death varied according to sickle cell trait status among 47,944 black soldiers who had undergone testing for HbAS and who were on active duty in the U.S. Army between January 2011 and December 2014. We used the Stanford Military Data Repository, which contains comprehensive medical and administrative data on all active-duty soldiers. RESULTS There was no significant difference in the risk of death among soldiers with sickle cell trait, as compared with those without the trait (hazard ratio, 0.99; 95% confidence interval [CI], 0.46 to 2.13; P = 0.97), but the trait was associated with a significantly higher adjusted risk of exertional rhabdomyolysis (hazard ratio, 1.54; 95% CI, 1.12 to 2.12; P = 0.008). This effect was similar in magnitude to that associated with tobacco use, as compared with no use (hazard ratio, 1.54; 95% CI, 1.23 to 1.94; P<0.001), and to that associated with having a body-mass index (BMI; the weight in kilograms divided by the square of the height in meters) of 30.0 or more, as compared with a BMI of less than 25.0 (hazard ratio, 1.39; 95% CI, 1.04 to 1.86; P = 0.03). The effect was less than that associated with recent use of a statin, as compared with no use (hazard ratio, 2.89; 95% CI, 1.51 to 5.55; P = 0.001), or an antipsychotic agent (hazard ratio, 3.02; 95% CI, 1.34 to 6.82; P = 0.008). CONCLUSIONS Sickle cell trait was not associated with a higher risk of death than absence of the trait, but it was associated with a significantly higher risk of exertional rhabdomyolysis.	[Nelson, D. Alan; Kurina, Lianne M.] Stanford Univ, Sch Med, Dept Med, 450 Serra Mall,Bldg 20, Stanford, CA 94305 USA; [Deuster, Patricia A.] Uniformed Serv Univ Hlth Sci, Consortium Hlth & Mil Performance, Dept Def Ctr Excellence, Bethesda, MD 20814 USA; [Deuster, Patricia A.] Uniformed Serv Univ Hlth Sci, Dept Mil & Emergency Med, Bethesda, MD 20814 USA; [Carter, Robert, III] US Army Inst Surg Res, Ft Sam Houston, TX USA; [Hill, Owen T.] Brooke Army Med Ctr, Extrem Trauma & Amputat Ctr Excellence, Ctr Intrepid, Ft Sam Houston, TX 78234 USA; [Wolcott, Vickee L.] Army Baylor Univ, Grad Program Hlth & Business Adm, Ft Sam Houston, TX USA; [Carter, Robert, III] Univ Texas Hlth Sci Ctr San Antonio, Dept Emergency Med, San Antonio, TX 78229 USA	Stanford University; Uniformed Services University of the Health Sciences - USA; Uniformed Services University of the Health Sciences - USA; United States Department of Defense; United States Army; San Antonio Military Medical Center; United States Department of Defense; United States Army; Baylor College of Medicine; University of Texas System; University of Texas Health San Antonio	Kurina, LM (corresponding author), Stanford Univ, Sch Med, Dept Med, 450 Serra Mall,Bldg 20, Stanford, CA 94305 USA.	lkurina@stanford.edu	Deuster, Patricia A/G-3838-2015	Deuster, Patricia A/0000-0002-7895-0888; Kurina, Lianne/0000-0002-2610-126X	National Heart, Lung, and Blood Institute; Uniformed Services University of the Health Sciences	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Uniformed Services University of the Health Sciences	Funded by the National Heart, Lung, and Blood Institute and the Uniformed Services University of the Health Sciences.	Abkowitz JL, 2014, CURR SPORT MED REP, V13, P192, DOI 10.1249/JSR.0000000000000054; [Anonymous], 2016, HEAT ILLN PREV; [Anonymous], 2015, MSMR, V22, P22; Anzalone ML, 2010, MED SCI SPORT EXER, V42, P3, DOI 10.1249/MSS.0b013e3181ae0700; Centers for Disease Control and Prevention (CDC), 2015, AB AD BMI; DAVIS AM, 1988, NEW ENGL J MED, V318, P787; Department of the Army, 2012, FIELD MAN 7 22 ARM P; DIGGS LW, 1984, AVIAT SPACE ENVIR MD, V55, P487; Dincer H Erhan, 2005, WMJ, V104, P67; Eckart RE, 2004, ANN INTERN MED, V141, P829, DOI 10.7326/0003-4819-141-11-200412070-00005; Eichner E Randy, 2007, Curr Sports Med Rep, V6, P134, DOI 10.1007/s11932-007-0016-9; Eichner ER, 2010, CURR SPORT MED REP, V9, P347, DOI 10.1249/JSR.0b013e3181fc73d7; Eichner ER, 2010, CURR SPORT MED REP, V9, P3, DOI 10.1249/JSR.0b013e3181caa9fa; Ferster K, 2012, MIL MED, V177, P56, DOI 10.7205/MILMED-D-11-00106; GARDNER JW, 1994, MIL MED, V159, P160, DOI 10.1093/milmed/159.2.160; GEORGE C, 1979, INTENS CARE MED, V5, P204, DOI 10.1007/BF01683941; Goldsmith JC, 2012, AM J HEMATOL, V87, P340, DOI 10.1002/ajh.22271; Grant AM, 2011, AM J PREV MED, V41, pS435, DOI 10.1016/j.amepre.2011.09.012; Harmon KG, 2012, BRIT J SPORT MED, V46, P325, DOI 10.1136/bjsports-2011-090896; Hill OT, 2012, MED SCI SPORT EXER, V44, P442, DOI 10.1249/MSS.0b013e3182312745; Incidence of sickle cell trait - United States, 2010, MMWR MORB MORTAL WKL, V63, P1155; Joy TR, 2009, ANN INTERN MED, V150, P858, DOI 10.7326/0003-4819-150-12-200906160-00009; KARK JA, 1994, SEMIN HEMATOL, V31, P181; KARK JA, 1987, NEW ENGL J MED, V317, P781, DOI 10.1056/NEJM198709243171301; Kark JA, 2010, 53 AM SOC HEM ANN M; Kerle KK, 1996, MIL MED, V161, P766, DOI 10.1093/milmed/161.12.766; KOPPES GM, 1977, AM J MED, V63, P313, DOI 10.1016/0002-9343(77)90247-9; Makaryus JN, 2007, HEMATOLOGY, V12, P349, DOI 10.1080/10245330701255254; Murray MJ, 1996, MIL MED, V161, P303, DOI 10.1093/milmed/161.5.303; O'Connor FG, 2012, MED SCI SPORT EXER, V44, P2045, DOI 10.1249/MSS.0b013e31826851c2; Packard Kathleen, 2014, J Pharm Pract, V27, P501, DOI 10.1177/0897190013516509; Pretzlaff Robert K., 2002, Pediatr Crit Care Med, V3, P308, DOI 10.1097/00130478-200207000-00023; Scheinin L, 2009, AM J FOREN MED PATH, V30, P204, DOI 10.1097/PAF.0b013e318187dfcd; Scoville SL, 2004, AM J PREV MED, V26, P205, DOI 10.1016/j.amepre.2003.12.003; Thogmartin JR, 2011, J FORENSIC SCI, V56, P1352, DOI 10.1111/j.1556-4029.2011.01774.x; Thompson AA, 2013, HEMATOL-AM SOC HEMAT, P632, DOI 10.1182/asheducation-2013.1.632; Wirthwein DP, 2001, J FORENSIC SCI, V46, P399	37	68	68	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2016	375	5					435	442		10.1056/NEJMoa1516257	http://dx.doi.org/10.1056/NEJMoa1516257			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7AN	27518662	Green Accepted, Bronze			2022-12-28	WOS:000380934900007
J	Wise, J				Wise, Jacqui			Prescription drug misuse in Europe is higher than previously thought	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Novak SP, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0909-3	1	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2016	354								i4304	10.1136/bmj.i4304	http://dx.doi.org/10.1136/bmj.i4304			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9CY	27492387				2022-12-28	WOS:000381081300006
J	Miao, P; Zhang, ZF; Sun, JB; Walasik, W; Longhi, S; Litchinitser, NM; Feng, L				Miao, Pei; Zhang, Zhifeng; Sun, Jingbo; Walasik, Wiktor; Longhi, Stefano; Litchinitser, Natalia M.; Feng, Liang			Orbital angular momentum microlaser	SCIENCE			English	Article							OPTICAL-ELEMENTS; LIGHT; LASER; BEAM; MODE	Structured light provides an additional degree of freedom for modern optics and practical applications. The effective generation of orbital angular momentum ( OAM) lasing, especially at a micro- and nanoscale, could address the growing demand for information capacity. By exploiting the emerging non-Hermitian photonics design at an exceptional point, we demonstrate a microring laser producing a single-mode OAM vortex lasing with the ability to precisely define the topological charge of the OAM mode. The polarization associated with OAM lasing can be further manipulated on demand, creating a radially polarized vortex emission. Our OAM microlaser could find applications in the next generation of integrated optoelectronic devices for optical communications in both quantum and classical regimes.	[Miao, Pei; Zhang, Zhifeng; Sun, Jingbo; Walasik, Wiktor; Litchinitser, Natalia M.; Feng, Liang] SUNY Buffalo, Dept Elect Engn, Buffalo, NY 14260 USA; [Longhi, Stefano] Politecn Milan, Dipartimento Fis, Piazza L da Vinci 32, I-20133 Milan, Italy; [Longhi, Stefano] CNR, Ist Foton & Nanotecnol, Piazza L da Vinci 32, I-20133 Milan, Italy	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Polytechnic University of Milan; Consiglio Nazionale delle Ricerche (CNR)	Litchinitser, NM; Feng, L (corresponding author), SUNY Buffalo, Dept Elect Engn, Buffalo, NY 14260 USA.	natashal@buffalo.edu; fengl@buffalo.edu	Longhi, Stefano/AAY-7537-2021; Zhang, Zhifeng/AAH-3875-2020; Longhi, Stefano/A-4215-2016; Walasik, Wiktor/AAD-5188-2022	Longhi, Stefano/0000-0002-8739-3542; Zhang, Zhifeng/0000-0001-6847-4876; Longhi, Stefano/0000-0002-8739-3542; Miao, Pei/0000-0002-3347-0389	U.S. Army Research Office Award [W911NF-15-1-0152]; Department of Energy Award [DE-SC0014485]; National Science Foundation Award [DMR-1506884]	U.S. Army Research Office Award; Department of Energy Award(United States Department of Energy (DOE)); National Science Foundation Award(National Science Foundation (NSF))	We acknowledge funding from the U.S. Army Research Office Award (W911NF-15-1-0152) that enabled the design, modeling, and topological charge characterization of the EP-based OAM laser, Department of Energy Award (DE-SC0014485) that was used to perform the analysis and characterization of the spectral properties of OAM lasing, and National Science Foundation Award (DMR-1506884) that facilitated the fabrication of the device and optimization of the EP modulation.	ALLEN L, 1992, PHYS REV A, V45, P8185, DOI 10.1103/PhysRevA.45.8185; Bomzon Z, 2002, OPT LETT, V27, P1141, DOI 10.1364/OL.27.001141; Bozinovic N, 2013, SCIENCE, V340, P1545, DOI 10.1126/science.1237861; Brandstetter M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5034; Cai XL, 2012, SCIENCE, V338, P363, DOI 10.1126/science.1226528; Chong KE, 2015, NANO LETT, V15, P5369, DOI 10.1021/acs.nanolett.5b01752; Courtial J, 1998, PHYS REV LETT, V81, P4828, DOI 10.1103/PhysRevLett.81.4828; Dorn R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.233901; Feng L, 2013, NAT MATER, V12, P108, DOI [10.1038/NMAT3495, 10.1038/nmat3495]; Franke-Arnold S, 2004, NEW J PHYS, V6, DOI 10.1088/1367-2630/6/1/103; Franke-Arnold S, 2011, SCIENCE, V333, P65, DOI 10.1126/science.1203984; Guo QH, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.067402; Heeres RW, 2014, NANO LETT, V14, P4598, DOI 10.1021/nl501647t; Karimi E, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3154549; Knoner G, 2007, OPT EXPRESS, V15, P5521, DOI 10.1364/OE.15.005521; Lin DM, 2014, SCIENCE, V345, P298, DOI 10.1126/science.1253213; Lin Z, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.213901; Makris KG, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.103904; Maurer C, 2011, LASER PHOTONICS REV, V5, P81, DOI 10.1002/lpor.200900047; Naidoo D, 2016, NAT PHOTONICS, V10, P327, DOI [10.1038/NPHOTON.2016.37, 10.1038/nphoton.2016.37]; Noginov MA, 2009, NATURE, V460, P1110, DOI 10.1038/nature08318; Peng B, 2014, NAT PHYS, V10, P394, DOI [10.1038/nphys2927, 10.1038/NPHYS2927]; Regensburger A, 2012, NATURE, V488, P167, DOI 10.1038/nature11298; Ruter CE, 2010, NAT PHYS, V6, P192, DOI 10.1038/NPHYS1515; Schomerus H, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.233601; Shalaev MI, 2015, NANO LETT, V15, P6261, DOI 10.1021/acs.nanolett.5b02926; Wiersig J, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.053809; Yao AM, 2011, ADV OPT PHOTONICS, V3, P161, DOI 10.1364/AOP.3.000161; Yu NF, 2011, SCIENCE, V334, P333, DOI 10.1126/science.1210713	29	364	375	28	328	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					464	467		10.1126/science.aaf8533	http://dx.doi.org/10.1126/science.aaf8533			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27471299	Green Submitted			2022-12-28	WOS:000380583600034
J	Mandeville, KL; Lagarde, M; Hanson, K; Mills, A				Mandeville, Kate L.; Lagarde, Mylene; Hanson, Kara; Mills, Anne			Human resources for health: time to move out of crisis mode	LANCET			English	Editorial Material									[Mandeville, Kate L.; Lagarde, Mylene; Hanson, Kara; Mills, Anne] London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1H 9SH, England	University of London; London School of Hygiene & Tropical Medicine	Mandeville, KL (corresponding author), London Sch Hyg & Trop Med, Dept Global Hlth & Dev, London WC1H 9SH, England.	kate.mandeville@lshtm.ac.uk	Lagarde, Mylene/GVS-9289-2022	Mandeville, Kate/0000-0002-5525-1574				Bossert TJ, 2010, HEALTH AFFAIR, V29, P1376, DOI 10.1377/hlthaff.2009.0443; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Donovan S, 2016, WHITE HOUSE BLOG; George A., 2007, HUMAN RESOURCES HLTH; Hernandez-Pena P, 2013, B WORLD HEALTH ORGAN, V91, P808, DOI 10.2471/BLT.13.120840; Lagarde M, 2012, SOC SCI MED, V75, P801, DOI 10.1016/j.socscimed.2012.05.005; Management Sciences for Health, 2010, EV MAL EM HUM RES PR; Mandeville K, 2016, LANCET GLOB HEALTH, V4, pE445, DOI 10.1016/S2214-109X(16)30079-1; McPake B, 2013, B WORLD HEALTH ORGAN, V91, P841, DOI 10.2471/BLT.13.118794; Morgan R, 2016, HLTH POLICY PLAN; WHO, 2016, 69 WORLD HL IN PRESS; World Health Organization (WHO), 2006, WORLD HLTH REP 2006	12	14	14	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2016	388	10041					220	222		10.1016/S0140-6736(16)30952-7	http://dx.doi.org/10.1016/S0140-6736(16)30952-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR2LN	27479555				2022-12-28	WOS:000379736100009
J	Larsen, TB; Nielsen, PB				Larsen, Torben Bjerregaard; Nielsen, Peter Bronnum			Stroke and mortality after atrial fibrillation-a global struggle	LANCET			English	Editorial Material							ORAL ANTICOAGULANTS; NATIONWIDE COHORT; WARFARIN; SAFETY		[Larsen, Torben Bjerregaard; Nielsen, Peter Bronnum] Aalborg Univ, Fac Hlth, Dept Clin Med, Aalborg Thrombosis Res Unit, DK-9100 Aalborg, Denmark; [Larsen, Torben Bjerregaard; Nielsen, Peter Bronnum] Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark	Aalborg University; Aalborg University; Aalborg University Hospital	Larsen, TB (corresponding author), Aalborg Univ, Fac Hlth, Dept Clin Med, Aalborg Thrombosis Res Unit, DK-9100 Aalborg, Denmark.; Larsen, TB (corresponding author), Aalborg Univ Hosp, Dept Cardiol, Aalborg, Denmark.	tobl@rn.dk		Nielsen, Peter Bronnum/0000-0003-2922-6970				Albertsen IE, 2014, CHEST, V145, P559, DOI 10.1378/chest.13-1740; [Anonymous], 2015, WHO REP GLOB TOB EP; Fauchier L, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000088; Healey JS, 2016, LANCET; Hobbs FDR, RANDOMISED CONTROLLE; Larsen TB, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3189; Lip GYH, 2015, JAMA-J AM MED ASSOC, V313, P1950, DOI 10.1001/jama.2015.4369; Lip GYH, 2015, EUROPACE, V17, P194, DOI 10.1093/europace/euu201; Nielsen PB, 2016, SCI REP-UK, V6, DOI 10.1038/srep27410; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Yeh RW, 2010, NEW ENGL J MED, V362, P2155, DOI 10.1056/NEJMoa0908610; 2005, HLTH TECHNOL ASSESS, V9, P1	12	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2016	388	10050					1131	1132		10.1016/S0140-6736(16)31274-0	http://dx.doi.org/10.1016/S0140-6736(16)31274-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW5RA	27515685				2022-12-28	WOS:000383703100005
J	Vaida, V				Vaida, Veronica			Atmospheric radical chemistry revisited Sunlight may directly drive previously unknown organic reactions at environmental surfaces	SCIENCE			English	Editorial Material							PHOTOSENSITIZED PRODUCTION; INTERFACE		[Vaida, Veronica] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Vaida, V (corresponding author), Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA.	vaida@colorado.edu	Vaida, Veronica/N-6069-2014	Vaida, Veronica/0000-0001-5863-8056				Ciuraru R, 2015, SCI REP-UK, V5, DOI 10.1038/srep12741; Donaldson DJ, 2006, CHEM REV, V106, P1445, DOI 10.1021/cr040367c; Fu HB, 2015, J AM CHEM SOC, V137, P8348, DOI 10.1021/jacs.5b04051; George C, 2015, CHEM REV, V115, P4218, DOI 10.1021/cr500648z; Griffith EC, 2014, J AM CHEM SOC, V136, P3784, DOI 10.1021/ja5006256; Griffith EC, 2012, ACCOUNTS CHEM RES, V45, P2106, DOI 10.1021/ar300027q; Martins-Costa MTC, 2012, J AM CHEM SOC, V134, P11821, DOI 10.1021/ja304971e; Reed Harris AE, 2014, J PHYS CHEM A, V118, P8505, DOI 10.1021/jp502186q; Renard P, 2014, J PHYS CHEM C, V118, P29421, DOI 10.1021/jp5065598; Rossignol S, 2016, SCIENCE, V353, P699, DOI 10.1126/science.aaf3617; Vacha R, 2004, J PHYS CHEM A, V108, P11573, DOI 10.1021/jp046268k; Wang XF, 2015, ACS CENTRAL SCI, V1, P124, DOI 10.1021/acscentsci.5b00148	12	31	31	6	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					650	650		10.1126/science.aah4111	http://dx.doi.org/10.1126/science.aah4111			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZC	27516586				2022-12-28	WOS:000381561200021
J	Wigley, FM; Flavahan, NA				Wigley, Fredrick M.; Flavahan, Nicholas A.			Raynaud's Phenomenon	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INDUCED CUTANEOUS VASOCONSTRICTION; CALCIUM-CHANNEL BLOCKERS; SYSTEMIC-SCLEROSIS; DOUBLE-BLIND; DIGITAL ULCERS; SECONDARY; CRITERIA; THERAPY; SCLERODERMA; PREVENTION		[Wigley, Fredrick M.] Johns Hopkins Univ, Sch Med, Div Rheumatol, 5200 Eastern Ave,Suite 4100,Mason E Lord Bldg Ctr, Baltimore, MD 21224 USA; [Flavahan, Nicholas A.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, 5200 Eastern Ave,Suite 4100,Mason E Lord Bldg Ctr, Baltimore, MD 21224 USA	Johns Hopkins University; Johns Hopkins University	Wigley, FM (corresponding author), Johns Hopkins Univ, Sch Med, Div Rheumatol, 5200 Eastern Ave,Suite 4100,Mason E Lord Bldg Ctr, Baltimore, MD 21224 USA.	fwig@jhmi.edu			CSL Behring; Cytori Therapeutics; Corbus; Boehringer Ingelheim; Allergan	CSL Behring; Cytori Therapeutics; Corbus; Boehringer Ingelheim(Boehringer Ingelheim); Allergan(AbbVieAllergan)	Dr. Wigley reports receiving research support from CSL Behring, Cytori Therapeutics, Corbus, Boehringer Ingelheim, and Allergan; and Dr. Flavahan, holding a patent (U.S. patent no. 6,444,681) related to the use of alpha<INF>2C</INF>-adrenergic inhibitors for the treatment of Raynaud's phenomenon and scleroderma. No other potential conflict of interest relevant to this article was reported.	Abou-Raya A, 2008, J RHEUMATOL, V35, P1801; [Anonymous], 2000, COCHRANE DATABASE SY; Bergersen TK, 2014, CLIN EXP RHEUMAT S86, V32; Bose N, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0558-9; Chikura B, 2010, J RHEUMATOL, V37, P783, DOI 10.3899/jrheum.091117; Coleiro B, 2001, RHEUMATOLOGY, V40, P1038, DOI 10.1093/rheumatology/40.9.1038; Denton CP, 2000, CLIN EXP RHEUMATOL, V18, P499; Duquene PP, 2015, INT ANGIOL, V34, P467; Dziadzio M, 1999, ARTHRITIS RHEUM-US, V42, P2646, DOI 10.1002/1529-0131(199912)42:12<2646::AID-ANR21>3.0.CO;2-T; Ennis H, 2014, COCHRANE DB SYST REV, V1; Fava A, 2012, ARTHRIT CARE RES, V64, P925, DOI 10.1002/acr.21622; Flavahan NA, 2015, RAYNAUDS PHENOMENON, P57; Flavahan NA, 2015, NAT REV RHEUMATOL, V11, P146, DOI 10.1038/nrrheum.2014.195; Freedman RR, 1996, ARTHRITIS RHEUM, V39, P1189, DOI 10.1002/art.1780390717; Furukawa S, 2006, ANN RHEUM DIS, V65, P1118, DOI 10.1136/ard.2005.046870; Garner R, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006389; Ghofrani HA, 2013, NEW ENGL J MED, V369, P319, DOI 10.1056/NEJMoa1209657; Gladue H, 2013, ARTHRIT CARE RES, V65, P630, DOI 10.1002/acr.21858; Guiducci S., 2015, RAYNAUDS PHENOMENON, V1, P13; Hashmonai M, 2016, SURG ENDOSC, V30, P1255, DOI 10.1007/s00464-015-4353-0; Herrick Ariane, 2014, BMJ Clin Evid, V2014; Herrick AL, 2014, RHEUMATOLOGY, V53, P948, DOI 10.1093/rheumatology/ket421; Hughes M, 2015, RHEUMATOLOGY, V54, P1443, DOI 10.1093/rheumatology/kev002; Huisstede BM, 2011, ARCH PHYS MED REHAB, V92, P1166, DOI 10.1016/j.apmr.2011.01.022; Hutchinson, 1901, PRESSE MED, V128, P403; Ingegnoli F, 2015, MICROVASC RES, V102, P19, DOI 10.1016/j.mvr.2015.07.007; Khanna D, 2016, JAMA-J AM MED ASSOC, V315, P1975, DOI 10.1001/jama.2016.5258; Khanna PP, 2010, ANN RHEUM DIS, V69, P588, DOI 10.1136/ard.2009.107706; Koenig M, 2008, ARTHRITIS RHEUM-US, V58, P3902, DOI 10.1002/art.24038; Korn JH, 2004, ARTHRITIS RHEUM-US, V50, P3985, DOI 10.1002/art.20676; Kuwana M, 2006, ARTHRITIS RHEUM-US, V54, P1946, DOI 10.1002/art.21899; Luks AM, 2009, HIGH ALT MED BIOL, V10, P321, DOI 10.1089/ham.2009.1051; Malenfant D, 2009, RHEUMATOLOGY, V48, P791, DOI 10.1093/rheumatology/kep039; Matucci-Cerinic M, 2011, ANN RHEUM DIS, V70, P32, DOI 10.1136/ard.2010.130658; Maverakis E, 2014, J AUTOIMMUN, V48-49, P60, DOI 10.1016/j.jaut.2014.01.020; Neumeister MW, 2015, HAND CLIN, V31, P23, DOI 10.1016/j.hcl.2014.09.003; Overbury R, 2015, CLIN RHEUMATOL, V34, P2135, DOI 10.1007/s10067-015-3062-3; Park JS, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0594-5; Pavlov-Dolijanovic SR, 2013, RHEUMATOL INT, V33, P2967, DOI 10.1007/s00296-013-2844-7; Pope Janet, 2013, BMJ Clin Evid, V2013, P1119; Raynaud M., 1888, LOCAL ASPHYXIA SYMME; Roquelaure Y, 2012, ARTHRIT CARE RES, V64, P898, DOI 10.1002/acr.21615; Roustit M, 2013, ANN RHEUM DIS, V72, P1696, DOI 10.1136/annrheumdis-2012-202836; Shah A.A., 2015, RAYNAUDS PHENOMENON, P129, DOI [10.1007/978-1-4939-1526-2, DOI 10.1007/978-1-4939-1526-2]; Shah AA, 2013, ANN RHEUM DIS, V72, P1136, DOI 10.1136/annrheumdis-2012-201861; Stewart M, 2012, COCHRANE DB SYST REV, V7; Suter LG, 2005, ARTHRITIS RHEUM, V52, P1259, DOI 10.1002/art.20988; Thompson AE, 2005, RHEUMATOLOGY, V44, P145, DOI 10.1093/rheumatology/keh390; Thompson AE, 2001, ARTHRITIS RHEUM-US, V44, P1841, DOI 10.1002/1529-0131(200108)44:8<1841::AID-ART322>3.0.CO;2-8; Thompson-Torgerson CS, 2007, AM J PHYSIOL-HEART C, V293, pH30, DOI 10.1152/ajpheart.00152.2007; Thompson-Torgerson CS, 2007, AM J PHYSIOL-HEART C, V292, pH1700, DOI 10.1152/ajpheart.01078.2006; Wigley FM, 1998, ARTHRITIS RHEUM-US, V41, P670, DOI 10.1002/1529-0131(199804)41:4<670::AID-ART14>3.0.CO;2-I; Wigley FM, 2002, NEW ENGL J MED, V347, P1001, DOI 10.1056/NEJMcp013013	53	145	151	2	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2016	375	6					556	565		10.1056/NEJMra1507638	http://dx.doi.org/10.1056/NEJMra1507638			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU4OT	27509103				2022-12-28	WOS:000382193100008
J	Steiger, N; Cifu, AS				Steiger, Nathaniel; Cifu, Adam S.			Primary Prevention of Stroke	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GUIDELINES; ASSOCIATION; STATEMENT; STATINS; DISEASE; UPDATE; RISK		[Steiger, Nathaniel; Cifu, Adam S.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA	University of Chicago	Cifu, AS (corresponding author), Univ Chicago, 5841 S Maryland Ave,MC 3051, Chicago, IL 60637 USA.	adamcifu@uchicago.edu						Amarenco P, 2004, STROKE, V35, P2902, DOI 10.1161/01.STR.0000147965.52712.fa; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; McKinney JS, 2012, STROKE, V43, P2149, DOI 10.1161/STROKEAHA.112.655894; Meschia JF, 2014, STROKE, V45, P3754, DOI 10.1161/STR.0000000000000046; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Ovbiagele B, 2013, STROKE, V44, P2361, DOI 10.1161/STR.0b013e31829734f2; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Ridker PM, 2013, LANCET, V382, P1762, DOI 10.1016/S0140-6736(13)62388-0; Stone NJ, 2014, CIRCULATION, V129, pS1, DOI 10.1161/01.cir.0000437738.63853.7a	10	9	9	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2016	316	6					658	659		10.1001/jama.2016.5529	http://dx.doi.org/10.1001/jama.2016.5529			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7TK	27532921				2022-12-28	WOS:000380985600019
J	Cantley, J				Cantley, Jason			Working my way out	SCIENCE			English	Editorial Material								Less than 24 hours after the mass murders that took place at a gay nightclub in Orlando, Florida, in June, I posted an emotionally raw message on social media. I usually avoid posting about potentially divisive issues, but I made an exception because, as a gay man, I wanted to reach out to the LGBTQ community to provide comfort, and to encourage us to come together in this time of pain. I was acutely aware that all of my "friends" would be able to see my post, including a few new co-workers whose positions on LGBTQ issues I was not certain about. But, after years of being hesitant to tell other scientists that I was gay, I no longer cared. Something changed for me that day. I decided that it was no longer useful for me to worry about how others judge me based on my sexual orientation.	[Cantley, Jason] Bucknell Univ, Lewisburg, PA 17837 USA	Bucknell University	Cantley, J (corresponding author), Bucknell Univ, Lewisburg, PA 17837 USA.	SciCareerEditor@aaas.org							0	1	1	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					618	618		10.1126/science.353.6299.618	http://dx.doi.org/10.1126/science.353.6299.618			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5YZ	27493189				2022-12-28	WOS:000381560900046
J	Gal, A; Wirth, R; Kopka, J; Fratzl, P; Faivre, D; Scheffel, A				Gal, Assaf; Wirth, Richard; Kopka, Joachim; Fratzl, Peter; Faivre, Damien; Scheffel, Andre			Macromolecular recognition directs calcium ions to coccolith mineralization sites	SCIENCE			English	Article							PLEUROCHRYSIS-CARTERAE; ACIDIC POLYSACCHARIDE; BIOMINERALIZATION; ALGA; CALCIFICATION; SCALES; CRYSTALLIZATION; HAPTONEMOFERA; NUCLEATION; CRYSTALS	Many organisms form elaborate mineralized structures, constituted of highly organized arrangements of crystals and organic macromolecules. The localization of crystals within these structures is presumably determined by the interaction of nucleating macromolecules with the mineral phase. Here we show that, preceding nucleation, a specific interaction between soluble organic molecules and an organic backbone structure directs mineral components to specific sites. This strategy underlies the formation of coccoliths, which are highly ordered arrangements of calcite crystals produced by marine microalgae. On combining the insoluble organic coccolith scaffold with coccolith-associated soluble macromolecules in vitro, we found a massive accretion of calcium ions at the sites where the crystals form in vivo. The in vitro process exhibits profound similarities to the initial stages of coccolith biogenesis in vivo.	[Gal, Assaf; Fratzl, Peter; Faivre, Damien] Max Planck Inst Colloids & Interfaces, D-14476 Potsdam, Germany; [Gal, Assaf; Kopka, Joachim; Scheffel, Andre] Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany; [Wirth, Richard] Geoforschungszentrum Potsdam, D-14473 Potsdam, Germany	Max Planck Society; Max Planck Society; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences	Scheffel, A (corresponding author), Max Planck Inst Mol Plant Physiol, D-14476 Potsdam, Germany.	scheffel@mpimp-golm.mpg.de	Fratzl, Peter/H-9095-2012; Gal, Assaf/L-6104-2019; faivre, damien/D-3713-2009	Fratzl, Peter/0000-0003-4437-7830; Gal, Assaf/0000-0003-1488-1227; faivre, damien/0000-0001-6191-3389; Kopka, Joachim/0000-0001-9675-4883	Max-Planck Society; Deutsche Forschungsgemeinschaft (DFG) [Sche1637/3-1, FA835/9-1]; Alexander von Humboldt postdoctoral fellowship; European Research Council [256915]; Gottfried Wilhelm Leibniz Preis of the DFG	Max-Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Alexander von Humboldt postdoctoral fellowship(Alexander von Humboldt Foundation); European Research Council(European Research Council (ERC)European Commission); Gottfried Wilhelm Leibniz Preis of the DFG(German Research Foundation (DFG))	We are grateful to A. Skeffington, N. Kroger, and U. Armbruster for critically reading the manuscript; M. Brzezinka for help with SDS-polyacrylamide gel electrophoresis; and A. Erban for gas chromatography-mass spectrometry analysis. This research was supported by the Max-Planck Society, Deutsche Forschungsgemeinschaft (DFG) grants Sche1637/3-1 to A.S., and FA835/9-1 to D.F. A.G. is supported by an Alexander von Humboldt postdoctoral fellowship. D.F. acknowledges financial support from the European Research Council (Starting Grant MB2 No. 256915). P.F. acknowledges financial support from the Gottfried Wilhelm Leibniz Preis of the DFG. All data used to support the conclusions in this manuscript are provided in the supplementary materials.	ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531; ADDADI L, 1985, P NATL ACAD SCI USA, V82, P4110, DOI 10.1073/pnas.82.12.4110; Bonucci E., 2007, BIOL CALCIFICATION; BROWN RM, 1969, SCIENCE, V166, P894, DOI 10.1126/science.166.3907.894; Falini G, 1996, SCIENCE, V271, P67, DOI 10.1126/science.271.5245.67; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Gilbert PUPA, 2005, REV MINERAL GEOCHEM, V59, P157, DOI 10.2138/rmg.2005.59.7; Giuffre AJ, 2013, P NATL ACAD SCI USA, V110, P9261, DOI 10.1073/pnas.1222162110; Gong YUT, 2012, P NATL ACAD SCI USA, V109, P6088, DOI 10.1073/pnas.1118085109; Henriksen K, 2004, AM MINERAL, V89, P1709, DOI 10.2138/am-2004-11-1217; Hirokawa Y, 2005, MAR BIOTECHNOL, V7, P634, DOI 10.1007/s10126-004-5148-9; ISENBERG HD, 1965, NATURE, V206, P1153, DOI 10.1038/2061153a0; Kayano K, 2011, MAR BIOTECHNOL, V13, P83, DOI 10.1007/s10126-010-9272-4; MANTON I, 1969, J MAR BIOL ASSOC UK, V49, P1, DOI 10.1017/S0025315400046385; MARSH ME, 1992, J BIOL CHEM, V267, P20507; Marsh ME, 1996, PROTOPLASMA, V190, P181, DOI 10.1007/BF01281317; Marsh ME, 1999, PROTOPLASMA, V207, P54, DOI 10.1007/BF01294713; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; Okazaki M, 1998, J MAR BIOTECHNOL, V6, P16; OUTKA DE, 1971, J PROTOZOOL, V18, P285, DOI 10.1111/j.1550-7408.1971.tb03319.x; Ozaki N, 2001, BIOSCI BIOTECH BIOCH, V65, P2330, DOI 10.1271/bbb.65.2330; Ozaki N, 2007, BIOCHEM BIOPH RES CO, V357, P1172, DOI 10.1016/j.bbrc.2007.04.078; Weiner S, 2011, ANNU REV MATER RES, V41, P21, DOI 10.1146/annurev-matsci-062910-095803; WILBUR KM, 1963, ANN NY ACAD SCI, V109, P82, DOI 10.1111/j.1749-6632.1963.tb13463.x; YOUNG JR, 1992, NATURE, V356, P516, DOI 10.1038/356516a0; Young JR, 2003, REV MINERAL GEOCHEM, V54, P189, DOI 10.2113/0540189; Young JR, 1999, J STRUCT BIOL, V126, P195, DOI 10.1006/jsbi.1999.4132	27	66	68	8	165	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					590	593		10.1126/science.aaf7889	http://dx.doi.org/10.1126/science.aaf7889			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27493186				2022-12-28	WOS:000381560900042
J	von Both, U; Alberer, M				von Both, Ulrich; Alberer, Martin			Borrelia recurrentis Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[von Both, Ulrich; Alberer, Martin] Univ Munich, Munich, Germany	University of Munich	von Both, U (corresponding author), Univ Munich, Munich, Germany.	ulrich.von.both@med.uni-muenchen.de	von Both, Ulrich/HCI-1318-2022	von Both, Ulrich/0000-0001-8411-1071					0	8	8	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2016	375	5					E5	E5		10.1056/NEJMicm1513366	http://dx.doi.org/10.1056/NEJMicm1513366			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7AN	27518689				2022-12-28	WOS:000380934900012
J	Bradley, SM; Rumsfeld, JS; Ho, PM				Bradley, Steven M.; Rumsfeld, John S.; Ho, P. Michael			Incorporating Health Status in Routine Care to Improve Health Care Value The VA Patient Reported Health Status Assessment (PROST) System	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Bradley, Steven M.; Rumsfeld, John S.; Ho, P. Michael] VA Eastern Colorado Hlth Care Syst, Denver, CO 80220 USA; [Bradley, Steven M.; Rumsfeld, John S.; Ho, P. Michael] Univ Colorado, Sch Med, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Bradley, SM (corresponding author), VA Eastern Colorado Hlth Care Syst, Dept Vet Affairs, 1055 Clermont St 111B, Denver, CO 80220 USA.	steven.bradley@va.gov	Bradley, Steven/AID-7839-2022					[Anonymous], 2013, OUTCOMES PROS PERFOR; Berwick DM, 2016, JAMA-J AM MED ASSOC, V315, P1329, DOI 10.1001/jama.2016.1509; Maddox TM, 2014, AM J CARDIOL, V114, P1750, DOI 10.1016/j.amjcard.2014.08.045; McNamara RL, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001767; Rumsfeld JS, 2013, CIRCULATION, V127, P2233, DOI 10.1161/CIR.0b013e3182949a2e; Schwartz AL, 2014, JAMA INTERN MED, V174, P1067, DOI 10.1001/jamainternmed.2014.1541	6	27	28	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2016	316	5					487	488		10.1001/jama.2016.6495	http://dx.doi.org/10.1001/jama.2016.6495			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9AU	27483062				2022-12-28	WOS:000381075000009
J	Cantillon, DJ; Loy, M; Burkle, A; Pengel, S; Brosovich, D; Hamilton, A; Khot, UN; Lindsay, BD				Cantillon, Daniel J.; Loy, Molly; Burkle, Alicia; Pengel, Shannon; Brosovich, Deborah; Hamilton, Aaron; Khot, Umesh N.; Lindsay, Bruce D.			Association Between Off-site Central Monitoring Using Standardized Cardiac Telemetry and Clinical Outcomes Among Non-Critically Ill Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTENSIVE-CARE-UNIT; SETTINGS	IMPORTANCE Telemetry alarms involving traditional on-site monitoring rarely alter management and often miss serious events, sometimes resulting in death. Poor patient selection contributes to a high alarm volume with low clinical yield. OBJECTIVE To evaluate outcomes associated with an off-site central monitoring unit (CMU) applying standardized cardiac telemetry indications using electronic order entry. DESIGN, SETTING, AND PARTICIPANTS All non-intensive care unit (ICU) patients at Cleveland Clinic and 3 regional hospitals over 13 months between March 4, 2014, and April 4, 2015. EXPOSURES An off-site CMU applied standardized cardiac telemetry when ordered for standard indications, such as for known or suspected tachyarrhythmias or bradyarrhythmias. MAIN OUTCOMES AND MEASURES CMU detection and notification of rhythm/rate alarms occurring 1 hour or less prior to emergency response team (ERT) activation, direct CMU-to-ERT notification outcomes, total telemetry census, and cardiopulmonary arrests in comparison with the previous 13 months. RESULTS The CMU received electronic telemetry orders for 99 048 patients (main campus, 72 199 [73%]) and provided 410 534 notifications (48% arrhythmia/hemodynamic) among 61 nursing units. ERT activation occurred among 3243 patients, including 979 patients (30%) with rhythm/rate changes occurring 1 hour or less prior to the ERT activation. The CMU detected and provided accurate notification for 772 (79%) of those events. In addition, the CMU provided discretionary direct ERT notification for 105 patients (ventricular tachycardia, n = 44; pause/asystole, n = 36; polymorphic ventricular tachycardia/ventricular fibrillation, n = 14; other, n = 11), including advance warning of 27 cardiopulmonary arrest events (26%) for which return of circulation was achieved in 25 patients (93%). Telemetry standardization was associated with a mean 15.5% weekly census reduction in the number of non-ICU monitored patients per week when compared with the prior 13-month period (580 vs 670 patients; mean difference, -90 patients [95% CI, -82 to -99]; P < .001). The number of cardiopulmonary arrests was 126 in the 13 months preintervention and 122 postintervention. CONCLUSIONS AND RELEVANCE Among non-critically ill patients, use of standardized cardiac telemetry with an off-site central monitoring unit was associated with detection and notification of cardiac rhythm and rate changes within 1 hour prior to the majority of ERT activations, and also with a reduction in the census of monitored patients, without an increase in cardiopulmonary arrest events.	[Cantillon, Daniel J.; Khot, Umesh N.; Lindsay, Bruce D.] Cleveland Clin, Inst Heart & Vasc, 9500 Euclid Ave,Desk J2-2, Cleveland, OH 44195 USA; [Loy, Molly; Burkle, Alicia; Pengel, Shannon; Brosovich, Deborah] Cleveland Clin, Nursing Inst, Cleveland, OH 44195 USA; [Hamilton, Aaron] Cleveland Clin, Qual & Patient Safety Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Cantillon, DJ (corresponding author), Cleveland Clin, Inst Heart & Vasc, 9500 Euclid Ave,Desk J2-2, Cleveland, OH 44195 USA.	cantild@ccf.org						Atzema C, 2006, AM J EMERG MED, V24, P62, DOI 10.1016/j.ajem.2005.05.015; Bulger J, 2013, J HOSP MED, V8, P486, DOI 10.1002/jhm.2063; Chambrin MC, 1999, INTENS CARE MED, V25, P1360, DOI 10.1007/s001340051082; Dressler R, 2014, JAMA INTERN MED, V174, P1852, DOI 10.1001/jamainternmed.2014.4491; Drew BJ, 2004, CIRCULATION, V110, P2721, DOI 10.1161/01.CIR.0000145144.56673.59; Emergency Care Research Institute, 2002, HLTH DEVICES, V31, P397; ESTRADA CA, 1995, AM J CARDIOL, V76, P960, DOI 10.1016/S0002-9149(99)80270-7; Funk M, 1997, Am J Crit Care, V6, P318; Knight BP, 1999, NEW ENGL J MED, V341, P1270, DOI 10.1056/NEJM199910213411704; Pennsylvania Patient Safety Authority, 2008, AL INT MED TEL MON S; Schull MJ, 2000, ACAD EMERG MED, V7, P647, DOI 10.1111/j.1553-2712.2000.tb02038.x; Sendelbach S, 2013, AACN ADV CRIT CARE, V24, P378, DOI 10.1097/NCI.0b013e3182a903f9; Stukshis I, 1997, Am J Crit Care, V6, P312	13	22	20	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2016	316	5					519	524		10.1001/jama.2016.10258	http://dx.doi.org/10.1001/jama.2016.10258			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9AU	27483066				2022-12-28	WOS:000381075000018
J	Breda, T; Hillion, M				Breda, Thomas; Hillion, Melina			Teaching accreditation exams reveal grading biases favor women in male-dominated disciplines in France	SCIENCE			English	Article							JOB APPLICANTS; GENDER STEREOTYPES; SCIENCE; FACULTY; FIELDS	Discrimination against women is seen as one of the possible causes behind their underrepresentation in certain STEM ( science, technology, engineering, and mathematics) subjects. We show that this is not the case for the competitive exams used to recruit almost all French secondary and postsecondary teachers and professors. Comparisons of oral non-gender-blind tests with written gender-blind tests for about 100,000 individuals observed in 11 different fields over the period 2006-2013 reveal a bias in favor of women that is strongly increasing with the extent of a field's male-domination. This bias turns from 3 to 5 percentile ranks for men in literature and foreign languages to about 10 percentile ranks for women in math, physics, or philosophy. These findings have implications for the debate over what interventions are appropriate to increase the representation of women in fields in which they are currently underrepresented.	[Breda, Thomas; Hillion, Melina] Paris Sch Econ, 48 Blvd Jourdan, F-75014 Paris, France; [Breda, Thomas] Paris Jourdan Sci Econom, UMR8545, CNRS, 48 Blvd Jourdan, F-75014 Paris, France; [Hillion, Melina] Ctr Res Econ & Stat CREST, 15 Blvd Gabriel Peri, F-92245 Malakoff, France	Paris School of Economics; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS)	Breda, T; Hillion, M (corresponding author), Paris Sch Econ, 48 Blvd Jourdan, F-75014 Paris, France.; Breda, T (corresponding author), Paris Jourdan Sci Econom, UMR8545, CNRS, 48 Blvd Jourdan, F-75014 Paris, France.; Hillion, M (corresponding author), Ctr Res Econ & Stat CREST, 15 Blvd Gabriel Peri, F-92245 Malakoff, France.	thomas.breda@ens.fr; melina.hillion@gmail.com						BAGUES M, 2015, 9199 IZA; Breda T, 2015, AM ECON J-APPL ECON, V7, P53, DOI 10.1257/app.20140022; Ceci SJ, 2014, PSYCHOL SCI PUBL INT, V15, P75, DOI 10.1177/1529100614541236; Ceci SJ, 2011, P NATL ACAD SCI USA, V108, P3157, DOI 10.1073/pnas.1014871108; EAGLY AH, 1995, AM PSYCHOL, V50, P145, DOI 10.1037/0003-066X.50.3.145; FOSCHI M, 1994, SOC PSYCHOL QUART, V57, P326, DOI 10.2307/2787159; Fryer RG, 2007, J PUBLIC ECON, V91, P1151, DOI 10.1016/j.jpubeco.2006.05.015; Glass C, 2010, J DIVERS HIGH EDUC, V3, P218, DOI 10.1037/a0020581; Halpern D., 2013, SEX DIFFERENCES COGN, V4th; HEILMAN ME, 1988, ORGAN BEHAV HUM DEC, V41, P98, DOI 10.1016/0749-5978(88)90049-0; Hill C., 2010, WOMEN SCI TECHNOLOGY, DOI [10.1002/sce.21007, DOI 10.1002/SCE.21007]; Hyde JS, 2005, AM PSYCHOL, V60, P581, DOI 10.1037/0003-066X.60.6.581; IRVINE AD, 1996, DIALOGUE-CAN PHILOS, V35, P255, DOI 10.1017/S0012217300008350; KIMURA D, 2002, U BRIT COLUMBIA REPO; Koch AJ, 2015, J APPL PSYCHOL, V100, P128, DOI 10.1037/a0036734; Leslie SJ, 2015, SCIENCE, V347, P262, DOI 10.1126/science.1261375; Moss-Racusin CA, 2012, P NATL ACAD SCI USA, V109, P16474, DOI 10.1073/pnas.1211286109; National Academy of Sciences National Academy of Engineering & Institute of Medicine, 2007, BIAS BARR FULF POT W; National Research Council, 2009, GEND DIFF CRIT TRANS; National Science Foundation [NSF], 2011, SURV EARN DOCT; Reuben E, 2014, P NATL ACAD SCI USA, V111, P4403, DOI 10.1073/pnas.1314788111; Seligman Clive, 2001, SUMMARY RECRUITMENT; Sheltzer JM, 2014, P NATL ACAD SCI USA, V111, P10107, DOI 10.1073/pnas.1403334111; Spelke ES, 2005, AM PSYCHOL, V60, P950, DOI 10.1037/0003-066X.60.9.950; Steinpreis RE, 1999, SEX ROLES, V41, P509, DOI 10.1023/A:1018839203698; SWIM J, 1989, PSYCHOL BULL, V105, P409, DOI 10.1037/0033-2909.105.3.409; WEST MS, 2006, AAUP GENDER EQUITY I; Williams WM, 2015, P NATL ACAD SCI USA, V112, P5360, DOI 10.1073/pnas.1418878112; Wolfinger NH, 2008, J HIGH EDUC-UK, V79, P388, DOI 10.1353/jhe.0.0015	29	14	14	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					474	478		10.1126/science.aaf4372	http://dx.doi.org/10.1126/science.aaf4372			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS2HC	27471301	Green Submitted			2022-12-28	WOS:000380583600037
J	Kvajo, M; Leonardo, A; Ulanovsky, N; Laurent, G				Kvajo, Mirna; Leonardo, Anthony; Ulanovsky, Nachum; Laurent, Gilles			Brain Exploration, Off the Beaten Path	CELL			English	Editorial Material									[Leonardo, Anthony] Janelia Res Campus, Ashburn, VA 20147 USA; [Ulanovsky, Nachum] Weizmann Inst Sci, IL-76100 Rehovot, Israel; [Laurent, Gilles] MPI Brain Res, Frankfurt, Germany	Weizmann Institute of Science	Leonardo, A (corresponding author), Janelia Res Campus, Ashburn, VA 20147 USA.								0	0	0	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					525	527		10.1016/j.cell.2016.07.009	http://dx.doi.org/10.1016/j.cell.2016.07.009			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27471958	Bronze			2022-12-28	WOS:000380546500002
J	Killeen, GF				Killeen, Gerry F.			Mass trapping of malaria vector mosquitoes	LANCET			English	Editorial Material							CARBON-DIOXIDE; INSECTICIDE		[Killeen, Gerry F.] Ifakara Hlth Inst, Ifakara, Tanzania; [Killeen, Gerry F.] Univ Liverpool Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	Ifakara Health Institute; Liverpool School of Tropical Medicine	Killeen, GF (corresponding author), Ifakara Hlth Inst, Ifakara, Tanzania.; Killeen, GF (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England.	gkilleen@ihi.or.tz						ALONSO PL, 1991, LANCET, V337, P1499, DOI 10.1016/0140-6736(91)93194-E; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Hiscox A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-257; Homan T, 2016, LANCET, V388, P1193, DOI 10.1016/S0140-6736(16)30445-7; Mmbando AS, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1013-8; Mweresa CK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-160; Okumu FO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011573; Rowland M, 2001, LANCET, V357, P1837, DOI 10.1016/S0140-6736(00)04955-2; Sinka ME, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1187-8; van Loon JJA, 2015, J CHEM ECOL, V41, P567, DOI 10.1007/s10886-015-0587-5; World Health Organization, 2015, ACHIEVING MALARIA MD; World Health Organization, 2014, GUID NOT CONTR RES M	12	2	2	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2016	388	10050					1136	1137		10.1016/S0140-6736(16)30674-2	http://dx.doi.org/10.1016/S0140-6736(16)30674-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW5RA	27520595				2022-12-28	WOS:000383703100008
J	Zulman, DM; Shah, NH; Verghese, A				Zulman, Donna M.; Shah, Nigam H.; Verghese, Abraham			Evolutionary Pressures on the Electronic Health Record Caring for Complexity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE; PATIENT		[Zulman, Donna M.] Stanford Univ, Sch Med, Div Gen Med Disciplines, 1265 Welch Rd, Stanford, CA 94305 USA; [Zulman, Donna M.] VA Palo Alto Hlth Care Syst, Ctr Innovat Implementat, Menlo Pk, CA USA; [Shah, Nigam H.] Stanford Univ, Sch Med, Ctr Biomed Informat Res, Stanford, CA 94305 USA; [Verghese, Abraham] Stanford Univ, Sch Med, Program Bedside Med, Stanford, CA 94305 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Stanford University	Zulman, DM (corresponding author), Stanford Univ, Sch Med, Div Gen Med Disciplines, 1265 Welch Rd, Stanford, CA 94305 USA.	dzulman@stanford.edu						Institute of Medicine, 2014, CAPT SOC BEH DOM MEA; Longhurst CA, 2014, HEALTH AFFAIR, V33, P1229, DOI 10.1377/hlthaff.2014.0099; Martin SA, 2016, LANCET, V388, P2053, DOI 10.1016/S0140-6736(16)00338-X; Parikh RB, 2016, JAMA-J AM MED ASSOC, V315, P651, DOI 10.1001/jama.2015.19417; Peabody FW, 1927, J AMER MED ASSOC, V88, P0877, DOI 10.1001/jama.1927.02680380001001; Silow-Carroll Sharon, 2012, Issue Brief (Commonw Fund), V17, P1; Verghese A, 2015, AM J MED, V128, P1322, DOI 10.1016/j.amjmed.2015.06.004	7	42	42	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	SEP 6	2016	316	9					923	924		10.1001/jama.2016.9538	http://dx.doi.org/10.1001/jama.2016.9538			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU8JV	27532804				2022-12-28	WOS:000382460200011
J	McGowan, S				McGowan, Suzanne			Muddy messages about American migration	NATURE			English	Editorial Material							ICE-FREE CORRIDOR; LATE PLEISTOCENE; NORTH-AMERICA; CANADA; PALEOENVIRONMENTS; DISPERSAL; DNA		[McGowan, Suzanne] Univ Nottingham, Sch Geog, Nottingham NG7 2RD, England	University of Nottingham	McGowan, S (corresponding author), Univ Nottingham, Sch Geog, Nottingham NG7 2RD, England.	suzanne.mcgowan@nottingham.ac.uk	McGowan, Suzanne/GZB-0118-2022					Birks HJB, 2016, NEW PHYTOL, V209, P499, DOI 10.1111/nph.13657; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; DRIVER JC, 1988, CAN J EARTH SCI, V25, P1545, DOI 10.1139/e88-147; Dyke AS, 2004, DEV QUA SCI, V2, P373, DOI 10.1016/S1571-0866(04)80209-4; Erlandson Jon M., 2014, PALEOAMERICAN ODYSSE, P127; Gilbert MTP, 2008, SCIENCE, V320, P786, DOI 10.1126/science.1154116; Goebel T, 2008, SCIENCE, V319, P1497, DOI 10.1126/science.1153569; Heintzman PD, 2016, P NATL ACAD SCI USA, V113, P8057, DOI 10.1073/pnas.1601077113; Ives JW., 2014, PALEOAMERICAN ODYSSE, P149; Mandryk CAS, 2001, QUATERNARY SCI REV, V20, P301, DOI 10.1016/S0277-3791(00)00115-3; Pedersen MW, 2016, NATURE, V537, P45, DOI 10.1038/nature19085; Pedersen MW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0383; Seddon AWR, 2014, J ECOL, V102, P256, DOI 10.1111/1365-2745.12195; Waters MR, 2015, P NATL ACAD SCI USA, V112, P4263, DOI 10.1073/pnas.1420650112	14	0	0	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					43	44		10.1038/nature19421	http://dx.doi.org/10.1038/nature19421			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU7XC	27509860				2022-12-28	WOS:000382426900034
J	Tan, CH; McNaughton, PA				Tan, Chun-Hsiang; McNaughton, Peter A.			The TRPM2 ion channel is required for sensitivity to warmth	NATURE			English	Article							2-AMINOETHOXYDIPHENYL BORATE; CAPSAICIN-RECEPTOR; MICE LACKING; CA2+ INFLUX; ADP-RIBOSE; HEAT; TRPV2; THERMOSENSATION; NEURONS; SENSOR	Thermally activated ion channels are known to detect the entire thermal range from extreme heat (TRPV2), painful heat (TRPV1, TRPM3 and ANO1), non-painful warmth (TRPV3 and TRPV4) and non-painful coolness (TRPM8) through to painful cold (TRPA1)(1-7). Genetic deletion of each of these ion channels, however, has only modest effects on thermal behaviour in mice(6-12), with the exception of TRPM8, the deletion of which has marked effects on the perception of moderate coolness in the range 10-25 degrees C-13. The molecular mechanism responsible for detecting non-painful warmth, in particular, is unresolved. Here we used calcium imaging to identify a population of thermally sensitive somatosensory neurons which do not express any of the known thermally activated TRP channels. We then used a combination of calcium imaging, electrophysiology and RNA sequencing to show that the ion channel generating heat sensitivity in these neurons is TRPM2. Autonomic neurons, usually thought of as exclusively motor, also express TRPM2 and respond directly to heat. Mice in which TRPM2 had been genetically deleted showed a striking deficit in their sensation of non-noxious warm temperatures, consistent with the idea that TRPM2 initiates a 'warm' signal which drives cool-seeking behaviour.	[Tan, Chun-Hsiang; McNaughton, Peter A.] Kings Coll London, Wolfson Ctr Age Related Dis, Guys Campus, London SE1 1UL, England; [Tan, Chun-Hsiang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Neurol, Kaohsiung, Taiwan	University of London; King's College London; Kaohsiung Medical University; Kaohsiung Medical University Hospital	McNaughton, PA (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, Guys Campus, London SE1 1UL, England.	peter.mcnaughton@kcl.ac.uk		Tan, Chun-Hsiang/0000-0001-6950-4678; McNaughton, Peter/0000-0003-1946-9610	BBSRC (UK); Raymond & Beverley Sackler studentship; BBSRC [BB/L002787/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L002787/1] Funding Source: researchfish	BBSRC (UK)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Raymond & Beverley Sackler studentship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank A. Tolkovsky for help and advice, R.-L. Yu for assistance with experiments, Y. Mori for Trpm2<SUP>-/-</SUP> mice and for the cDNA for mouse TRPM2, S. Birren for MAH cells, J. Wood for loan of the thermal-preference test apparatus, S. Skerratt for PF-4674114, and E. Smith, J. Btesh, D. Andersson, and T. Buijs for their comments on the manuscript. Initial experiments were performed in the Department of Pharmacology, University of Cambridge. Supported by a grant from the BBSRC (UK) to P.A.McN. and a Raymond & Beverley Sackler studentship to C.-H.T.	Ariza-McNaughton L, 2002, INT REV NEUROBIOL, V47, P239; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; BIRREN SJ, 1990, NEURON, V4, P189, DOI 10.1016/0896-6273(90)90094-V; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cesare P, 1996, P NATL ACAD SCI USA, V93, P15435, DOI 10.1073/pnas.93.26.15435; Cho H, 2012, NAT NEUROSCI, V15, P1015, DOI 10.1038/nn.3111; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Huang SM, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-37; Jang Y, 2014, PFLUG ARCH EUR J PHY, V466, P1987, DOI 10.1007/s00424-013-1436-4; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Lawson JJ, 2008, J PAIN, V9, P298, DOI 10.1016/j.jpain.2007.12.001; Miyamoto T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1371; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Nagy I, 1999, NEUROSCIENCE, V88, P995, DOI 10.1016/S0306-4522(98)00535-1; Naziroglu M, 2011, J MEMBRANE BIOL, V241, P69, DOI 10.1007/s00232-011-9363-9; Schmid D, 2011, NEUROSCI LETT, V488, P168, DOI 10.1016/j.neulet.2010.11.022; Togashi K, 2008, BRIT J PHARMACOL, V153, P1324, DOI 10.1038/sj.bjp.0707675; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Uchida K, 2011, DIABETES, V60, P119, DOI 10.2337/db10-0276; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Vennekens R., 2007, V179, P269; Vriens J, 2014, NAT REV NEUROSCI, V15, P573, DOI 10.1038/nrn3784; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Woodbury CJ, 2004, J NEUROSCI, V24, P6410, DOI 10.1523/JNEUROSCI.1421-04.2004; Wu LJ, 2010, PHARMACOL REV, V62, P381, DOI 10.1124/pr.110.002725; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758	31	150	153	1	110	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					460	+		10.1038/nature19074	http://dx.doi.org/10.1038/nature19074			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27533035	Green Submitted, Green Accepted			2022-12-28	WOS:000382646600042
J	Iacobucci, G				Iacobucci, Gareth			Syrian doctors appeal to President Obama for help	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Global Health Workforce Alliance, 2016, SUPP SYR HLTH CAR WO; Owen C., 1989, Thatcheria, V24, P1	2	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2016	354								i4458	10.1136/bmj.i4458	http://dx.doi.org/10.1136/bmj.i4458			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4UY	27520706				2022-12-28	WOS:000381477800013
J	Blouin, CM; Hamon, Y; Gonnord, P; Boularan, C; Kagan, J; de Lesegno, CV; Ruez, R; Mailfert, S; Bertaux, N; Loew, D; Wunder, C; Johannes, L; Vogt, G; Contreras, FX; Marguet, D; Casanova, JL; Gales, C; He, HT; Lamaze, C				Blouin, Cedric M.; Hamon, Yannick; Gonnord, Pauline; Boularan, Cedric; Kagan, Jeremy; de Lesegno, Christine Viaris; Ruez, Richard; Mailfert, Sebastien; Bertaux, Nicolas; Loew, Damarys; Wunder, Christian; Johannes, Ludger; Vogt, Guillaume; Contreras, Francesc-Xabier; Marguet, Didier; Casanova, Jean-Laurent; Gales, Celine; He, Hai-Tao; Lamaze, Christophe			Glycosylation-Dependent IFN-gamma R Partitioning in Lipid and Actin Nanodomains Is Critical for JAK Activation	CELL			English	Article							PLASMA-MEMBRANE; INTERFERON-GAMMA; SIGNAL-TRANSDUCTION; GLYCAN INTERACTIONS; PROTEIN COMPLEXES; RECEPTOR COMPLEX; LIVING CELLS; ORGANIZATION; SUSCEPTIBILITY; MECHANISMS	Understanding how membrane nanoscale organization controls transmembrane receptors signaling activity remains a challenge. We studied interferon-gamma receptor (IFN-gamma R) signaling in fibroblasts from homozygous patients with a T168N mutation in IFNGR2. By adding a neo-N-glycan on IFN-gamma R2 subunit, this mutation blocks IFN-gamma activity by unknown mechanisms. We show that the lateral diffusion of IFN-gamma R2 is confined by sphingolipid/cholesterol nanodomains. In contrast, the IFN-gamma R2 T168N mutant diffusion is confined by distinct actin nanodomains where conformational changes required for Janus-activated tyrosine kinase/signal transducer and activator of transcription (JAK/STAT) activation by IFN-gamma could not occur. Removing IFN-gamma R2 T168N-bound galectins restored lateral diffusion in lipid nanodomains and JAK/STAT signaling in patient cells, whereas adding galectins impaired these processes in control cells. These experiments prove the critical role of dynamic receptor interactions with actin and lipid nanodomains and reveal a new function for receptor glycosylation and galectins. Our study establishes the physiological relevance of membrane nanodomains in the control of transmembrane receptor signaling in vivo.	[Blouin, Cedric M.; Kagan, Jeremy; de Lesegno, Christine Viaris; Ruez, Richard; Wunder, Christian; Johannes, Ludger; Lamaze, Christophe] PSL Res Univ, Inst Curie, CNRS UMR3666, INSERM U1143, F-75005 Paris, France; [Hamon, Yannick; Mailfert, Sebastien; Marguet, Didier; He, Hai-Tao] Aix Marseille Univ, CNRS, Ctr Immunol Marseille Luminy, INSERM, Marseille, France; [Gonnord, Pauline] Ctr Physiol Toulouse Purpan CPTP, INSERM U1043, F-31300 Toulouse, France; [Boularan, Cedric; Gales, Celine] Univ Toulouse III Paul Sabatier, Inst Malad Metabol & Cardiovasc, INSERM U1048, F-31432 Toulouse, France; [Bertaux, Nicolas] Aix Marseille Univ, CNRS, Inst Fresnel, Cent Marseille, Marseille, France; [Loew, Damarys] PSL Res Univ, Inst Curie, Prote & Mass Spectrometry Lab, F-75005 Paris, France; [Vogt, Guillaume; Casanova, Jean-Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10065 USA; [Vogt, Guillaume; Casanova, Jean-Laurent] Imagine Inst, Necker Hosp Sick Children, Necker Branch, Lab Human Genet Infect Dis,INSERM UMR1163, F-75015 Paris, France; [Vogt, Guillaume; Casanova, Jean-Laurent] Univ Paris 05, F-75006 Paris, France; [Contreras, Francesc-Xabier] Univ Basque Country, CSIC, Inst Biofis, POB 644, E-48080 Bilbao, Spain; [Contreras, Francesc-Xabier] Univ Basque Country, Dept Bioquim & Biol Mol, POB 644, E-48080 Bilbao, Spain; [Contreras, Francesc-Xabier] IKERBASQUE Basque Fdn Sci, E-48011 Bilbao, Spain; [Casanova, Jean-Laurent] Howard Hughes Med Inst, New York, NY 10065 USA; [Casanova, Jean-Laurent] Necker Hosp Sick Children, Pediat Hematol Immunol Unit, F-75015 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Rockefeller University; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Consejo Superior de Investigaciones Cientificas (CSIC); University of Basque Country; CSIC - UPV EHU - Instituto Biofisika; University of Basque Country; Basque Foundation for Science; Howard Hughes Medical Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Lamaze, C (corresponding author), PSL Res Univ, Inst Curie, CNRS UMR3666, INSERM U1143, F-75005 Paris, France.; He, HT (corresponding author), Aix Marseille Univ, CNRS, Ctr Immunol Marseille Luminy, INSERM, Marseille, France.	he@ciml.univ-mrs.fr; christophe.lamaze@curie.fr	Johannes, Ludger/W-8593-2019; Marguet, Didier/B-9946-2008; HAMON, Yannick/S-3118-2019; Wunder, Christian/K-8542-2017; Ruez, Richard/A-3479-2013; Johannes, Ludger/M-9778-2017; HE, Hai-Tao/O-6551-2016; Blouin, Cedric M/A-8924-2018; Blouin, Cedric M./Y-7091-2019; Lamaze, Christophe/M-4912-2017; Mailfert, Sébastien/X-6986-2019; HAMON, Yannick YH/N-5372-2016; Contreras, Xabier/AAA-8885-2019; Casanova, Jean-Laurent/I-3418-2017; Marguet, Didier/AGO-5421-2022; VIARIS de LESEGNO, Christine/B-3663-2018	Johannes, Ludger/0000-0002-2168-0004; HAMON, Yannick/0000-0002-7636-2310; Wunder, Christian/0000-0001-9091-0080; Ruez, Richard/0000-0001-5187-2210; Johannes, Ludger/0000-0002-2168-0004; HE, Hai-Tao/0000-0002-6594-290X; Blouin, Cedric M/0000-0003-0800-0948; Blouin, Cedric M./0000-0003-0800-0948; Mailfert, Sébastien/0000-0002-0409-0432; HAMON, Yannick YH/0000-0002-7636-2310; Marguet, Didier/0000-0003-3198-5095; VIARIS de LESEGNO, Christine/0000-0002-2033-1128; Contreras, Xabier/0000-0003-0875-634X; Damarys, Loew/0000-0002-9111-8842; VOGT, Guillaume/0000-0001-8192-1247; LAMAZE, Christophe/0000-0001-5430-2707; Casanova, Jean-Laurent/0000-0002-7782-4169; GALES, Celine/0000-0002-4938-1583	Institut Curie; INSERM; CNRS; Agence Nationale de la Recherche (ANR) [NANOSTAT-15-CE11-0025-01, ANR-10-BLAN-1509, ANR-11-LABX-0054, ANR-10-BLAN-1214, ANR-10-INBS-04-01, ANR-11-IDEX-0001-02]; Institut National du Cancer (INCa) [PLBIO12-203]; Marie Curie Actions-Networks for Initial Training; Spanish Ministry of Economy [BFU2012-33103]; Ligue Nationale contre le Cancer; program "Investissements d'Avenir''	Institut Curie; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Marie Curie Actions-Networks for Initial Training; Spanish Ministry of Economy(Spanish Government); Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); program "Investissements d'Avenir''(French National Research Agency (ANR))	We would like to thank Scott Mark for help with the BRET experiments. We are especially thankful to Sandy Schmid for reading of the manuscript and helpful suggestions. The facilities, as well as scientific and technical assistance from staff in the PICT-IBiSA/Nikon Imaging Centre at Institut Curie-CNRS, Paris member of the France-BioImaging National Research Infrastructure, are acknowledged. This work was supported by institutional grants from the Institut Curie, INSERM, CNRS, and by specific grants from Agence Nationale de la Recherche (ANR NANOSTAT-15-CE11-0025-01 to C.L.; ANR-10-BLAN-1509 and ANR-11-LABX-0054 [Investissements d'Avenir-Labex INFORM] to H.-T.H.; ANR-10-BLAN-1214, ANR-10-INBS-04-01 France Bio Imaging and ANR-11-IDEX-0001-02 [Investissements d'Avenir-AMIDEX] to D.M.), Institut National du Cancer (INCa PLBIO12-203 to C.L.), and Marie Curie Actions-Networks for Initial Training (FP7-PEOPLE-2010-ITN to C.L.). This work was supported in part by a grant from the Spanish Ministry of Economy BFU2012-33103 to F.-X.C. C.M.B. was supported by a postdoctoral fellowship from Ligue Nationale contre le Cancer. The Johannes and Lamaze teams received support under the program "Investissements d'Avenir'' launched by the French Government and implemented by ANR with the references Labex Cel-TisPhyBio ANR-10-LBX-0038 part of the IDEX Idex PSL ANR-10-IDEX-0001-02 PSL.	Babon JJ, 2014, BIOCHEM J, V462, P1, DOI 10.1042/BJ20140712; Bacart Johan, 2008, Biotechnol J, V3, P311, DOI 10.1002/biot.200700222; Billaudeau C, 2013, METHOD ENZYMOL, V519, P277, DOI 10.1016/B978-0-12-405539-1.00010-5; Blouin CM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00267; Brooks AJ, 2014, SCIENCE, V344, P710, DOI 10.1126/science.1249783; Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; Chung AW, 2013, J INFECT DIS, V207, P947, DOI 10.1093/infdis/jis920; Claudinon J, 2009, J BIOL CHEM, V284, P24328, DOI 10.1074/jbc.M109.021915; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; Dennis JW, 2013, MOL CELL PROTEOMICS, V12, P913, DOI 10.1074/mcp.R112.026989; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; Dorman SE, 1998, J CLIN INVEST, V101, P2364, DOI 10.1172/JCI2901; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gowrishankar K, 2012, CELL, V149, P1353, DOI 10.1016/j.cell.2012.05.008; Hamdan FF, 2006, CURR PROTOC NEUROSCI, V5, P523, DOI DOI 10.1002/0471142301.NS0523S34; Krause CD, 2002, MOL CELL PROTEOMICS, V1, P805, DOI 10.1074/mcp.M200065-MCP200; Krause CD, 2006, CELL RES, V16, P55, DOI 10.1038/sj.cr.7310008; Kusumi A, 2012, ANNU REV CELL DEV BI, V28, P215, DOI 10.1146/annurev-cellbio-100809-151736; Kusumi A, 2012, SEMIN CELL DEV BIOL, V23, P126, DOI 10.1016/j.semcdb.2012.01.018; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lasserre R, 2008, NAT CHEM BIOL, V4, P538, DOI 10.1038/nchembio.103; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Marchetti M, 2006, MOL BIOL CELL, V17, P2896, DOI 10.1091/mbc.E06-01-0076; Nabi IR, 2015, J CELL SCI, V128, P2213, DOI 10.1242/jcs.151159; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Raghupathy R, 2015, CELL, V161, P581, DOI 10.1016/j.cell.2015.03.048; Rao MD, 2014, CURR OPIN CELL BIOL, V29, P126, DOI 10.1016/j.ceb.2014.05.007; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Thompson JE, 2002, BIOORG MED CHEM LETT, V12, P1219, DOI 10.1016/S0960-894X(02)00106-3; van Boxel-Dezaire AHH, 2007, CURR TOP MICROBIOL, V316, P119; Vogt G, 2008, J EXP MED, V205, P1729, DOI 10.1084/jem.20071987	37	71	73	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					920	934		10.1016/j.cell.2016.07.003	http://dx.doi.org/10.1016/j.cell.2016.07.003			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27499022	Bronze			2022-12-28	WOS:000382258700015
J	Lozano, P; Henrikson, NB; Morrison, CC; Dunn, J; Nguyen, M; Blasi, PR; Whitlock, EP				Lozano, Paula; Henrikson, Nora B.; Morrison, Caitlin C.; Dunn, John; Nguyen, Matt; Blasi, Paula R.; Whitlock, Evelyn P.			Lipid Screening in Childhood and Adolescence for Detection of Multifactorial Dyslipidemia Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							DENSITY-LIPOPROTEIN CHOLESTEROL; FAT-REDUCED DIET; BLOOD-PRESSURE; CARDIOVASCULAR RISK; LOWERING DIET; CHILDREN; INTERVENTION; HEALTH; METAANALYSIS; ADULTHOOD	IMPORTANCE Multifactorial dyslipidemia, characterized by elevated total cholesterol (TC) or low-density lipoprotein cholesterol (LDL-C), is associated with dyslipidemia and markers of atherosclerosis in young adulthood. Screening for dyslipidemia in childhood could delay or reduce cardiovascular events in adulthood. OBJECTIVE Tosystematically review the evidence on benefits and harms of screening adolescents and children for multifactorial dyslipidemia for the US Preventive Services Task Force (USPSTF). DATA SOURCES MEDLINE, Cochrane Central Register of Controlled Trials, and PubMed were searched for studies published between January 1, 2005, and June 2, 2015; studies included in a previous USPSTF evidence report and reference lists of relevant studies and ongoing trials were also searched. Surveillance was conducted through April 9, 2016. STUDY SELECTION Fair-and good-quality studies in English with participants 0 to 20 years of age. DATA EXTRACTION AND SYNTHESIS Two investigators independently reviewed abstracts and full-text articles and extracted data into evidence tables. Results were qualitatively summarized. MAIN OUTCOMES AND MEASURES Outcomes included dyslipidemia (TC >= 200mg/dL or LDL-C >= 130mg/dL) and atherosclerosis in childhood; myocardial infarction and ischemic stroke in adulthood; diagnostic yield (number of confirmed cases per children screened); and harms of screening or treatment. Simulated diagnostic yield was calculated as initial screening yield x positive predictive value from a study with confirmatory testing. RESULTS Screening of children for multifactorial dyslipidemia has not been evaluated in randomized clinical trials. Based on 1 observational study (n = 6500) and nationally representative prevalence estimates, the simulated diagnostic yield of screening for elevated TC varies between 4.8% and 12.3%(higher in obese children [12.3%] and at the ages when TC naturally peaks-7.2% at age 9-11 years and 7.2% at age 16-19 years). One good-quality randomized clinical trial (n = 663) found a modest effect of intensive dietary counseling for a low-fat, low-cholesterol diet on lipid levels at 1 year in children aged 8 to 10 years with mild to moderate dyslipidemia; mean between-group difference in TC change from baseline was -6.1mg/dL (95% CI, -9.1 to -3.2mg/ dL; P <.001). Between-group differences dissipated by year 5. The intervention did not adversely affect nutritional status, growth, or development over the 18-year study period. One observational study (n = 9245) found that TC concentration at age 12 to 39 years was not associated with death before age 55 years. CONCLUSIONS AND RELEVANCE The diagnostic yield of lipid screening varies by age and body mass index. No direct evidence was identified for benefits or harms of childhood screening or treatment on outcomes in adulthood. Intensive dietary interventions may be safe, with modest short-term benefit of uncertain clinical significance.	[Lozano, Paula; Henrikson, Nora B.; Morrison, Caitlin C.; Dunn, John; Nguyen, Matt; Blasi, Paula R.] Kaiser Permanente, Res Affiliates Evidence Based Practice Ctr, Grp Hlth Res Inst, Seattle, WA USA; [Whitlock, Evelyn P.] Kaiser Permanente, Res Affiliates Evidence Based Practice Ctr, Ctr Hlth Res, Portland, OR USA	Kaiser Permanente; Kaiser Permanente	Lozano, P (corresponding author), Grp Hlth Res Inst, 1730 Minor Ave,Ste 1600, Seattle, WA 98101 USA.	lozano.p@ghc.org	Lozano, Paula Maria/GPP-4090-2022	Blasi, Paula/0000-0002-7094-706X	AHRQ	AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This research was funded by AHRQ under a contract to support the USPSTF.	Calonge N, 2007, PEDIATRICS, V120, pE215, DOI 10.1542/peds.2006-1812; CLARKE WR, 1978, CIRCULATION, V58, P626, DOI 10.1161/01.CIR.58.4.626; Cook S, 2009, J PEDIAT S6, V155, p6e15; Daniels SR, 2008, PEDIATRICS, V122, P198, DOI 10.1542/peds.2008-1349; Daniels SR, 2008, NAT CLIN PRACT CARD, V5, P130, DOI 10.1038/ncpcardio1084; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Disc Collaborative Research Group, 1993, Annals of Epidemiology, V3, P393, DOI 10.1016/1047-2797(93)90067-E; Dorgan JF, 2011, J CLIN ENDOCR METAB, V96, pE1999, DOI 10.1210/jc.2010-2726; Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents, 2011, Pediatrics, V128 Suppl 5, pS213, DOI 10.1542/peds.2009-2107C; Ford ES, 2009, CIRCULATION, V119, P1108, DOI 10.1161/CIRCULATIONAHA.108.816769; GARCIA RE, 1989, PEDIATRICS, V84, P751; Gidding SS, 2006, PEDIATRICS, V118, P2388, DOI 10.1542/peds.2006-1785; Haney EM, 2007, PEDIATRICS, V120, pE189, DOI 10.1542/peds.2006-1801; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Helfand M, 2008, AHRQ PUBLICATION; Ice CL, 2011, INT J PEDIATR OBES, V6, P113, DOI 10.3109/17477161003792556; Joyce N, 2015, J PEDIATR-US, V167, P113, DOI 10.1016/j.jpeds.2015.04.004; Juhola J, 2011, J PEDIATR-US, V159, P584, DOI 10.1016/j.jpeds.2011.03.021; Kit BK, 2015, JAMA PEDIATR, V169, P272, DOI 10.1001/jamapediatrics.2014.3216; Kit BK, 2012, JAMA-J AM MED ASSOC, V308, P591, DOI 10.1001/jama.2012.9136; LAUER RM, 1992, PEDIATRICS, V89, P495; LAUER RM, 1995, JAMA-J AM MED ASSOC, V273, P1429, DOI 10.1001/jama.273.18.1429; Lavigne JV, 1999, HEALTH PSYCHOL, V18, P604, DOI 10.1037/0278-6133.18.6.604; Lozano P, 2016, LIPIC SCREENING CHIL; Lozano P, 2016, JAMA-J AM MED ASSOC, V316, P645, DOI 10.1001/jama.2016.6176; Magnussen CG, 2008, CIRCULATION, V117, P32, DOI 10.1161/CIRCULATIONAHA.107.718981; Margolis KL, 2014, CIRC-CARDIOVASC QUAL, V7, P718, DOI 10.1161/CIRCOUTCOMES.114.000842; Martinez-Gomez D, 2010, REV ESP CARDIOL, V63, P277, DOI 10.1016/S0300-8932(10)70086-5; May A. L., 2010, Morbidity and Mortality Weekly Report, V59, P29; National Center for Health Statistics, 1996, AN REP GUID 3 NAT HL; Obarzanek E, 1997, PEDIATRICS, V100, P51, DOI 10.1542/peds.100.1.51; Obarzanek E, 2001, PEDIATRICS, V107, P256, DOI 10.1542/peds.107.2.256; Raman A, 2010, ACTA PAEDIATR, V99, P912, DOI 10.1111/j.1651-2227.2009.01639.x; Ritchie SK, 2010, PEDIATRICS, V126, P260, DOI 10.1542/peds.2009-2546; Robinson JG, 2009, J AM COLL CARDIOL, V53, P316, DOI 10.1016/j.jacc.2008.10.024; Saydah S, 2013, PEDIATRICS, V131, pE679, DOI 10.1542/peds.2012-2583; Sniderman AD, 2011, CIRC-CARDIOVASC QUAL, V4, P337, DOI 10.1161/CIRCOUTCOMES.110.959247; US Preventive Services Task Force, 2015, US PREV SERV TASK FO; Van Horn L, 2005, PEDIATRICS, V115, P1723, DOI 10.1542/peds.2004-2392; Vinci SR, 2014, JAMA-J AM MED ASSOC, V311, P1804, DOI 10.1001/jama.2014.2410; Wells G., NEWCASTLE OTTAWA SCA; Wong H, 2013, JAMA PEDIATR, V167, P708, DOI 10.1001/jamapediatrics.2013.1442; WONG ND, 1992, PEDIATRICS, V90, P75	43	55	57	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2016	316	6					634	644		10.1001/jama.2016.6423	http://dx.doi.org/10.1001/jama.2016.6423			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7TK	27532918				2022-12-28	WOS:000380985600016
J	Ivers, NM; Grimshaw, JM				Ivers, Noah M.; Grimshaw, Jeremy M.			Reducing research waste with implementation laboratories	LANCET			English	Editorial Material							FEEDBACK INTERVENTIONS; AUDIT; BEHAVIOR; SCIENCE		[Ivers, Noah M.] Womens Coll Hosp, Womens Coll Res Inst, Family Practice Hlth Ctr, Toronto, ON, Canada; [Ivers, Noah M.] Womens Coll Hosp, Womens Coll Inst Hlth Syst Solut & Virtual Care, Toronto, ON, Canada; [Ivers, Noah M.] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Ivers, Noah M.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Grimshaw, Jeremy M.] Ottawa Hosp, Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Grimshaw, Jeremy M.] Univ Ottawa, Dept Med, Ottawa, ON K1H 8L6, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Grimshaw, JM (corresponding author), Ottawa Hosp, Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.; Grimshaw, JM (corresponding author), Univ Ottawa, Dept Med, Ottawa, ON K1H 8L6, Canada.	jgrimshaw@ohri.ca	Ivers, Noah/O-7643-2018	Ivers, Noah/0000-0003-2500-2435				Brehaut JC, 2016, ANN INTERN MED, V164, P435, DOI 10.7326/M15-2248; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Eccles MP, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-18; Emanuel EJ, 2016, ANN INTERN MED, V164, P114, DOI 10.7326/M15-1330; Fisher ES, 2016, JAMA-J AM MED ASSOC, V315, P339, DOI 10.1001/jama.2015.17949; Forsetlund L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003030.pub2; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Ivers NM, 2014, J GEN INTERN MED, V29, P1534, DOI 10.1007/s11606-014-2913-y; Ivers NM, 2014, IMPLEMENT SCI, V9, DOI [10.1186/1748-5908-9-14, 10.1186/1748-5908-9-51]; O'Brien MA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000409.pub2; Prior M, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-50; Shojania KG, 2010, CAN MED ASSOC J, V182, pE216, DOI 10.1503/cmaj.090578	12	51	51	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2016	388	10044					547	548		10.1016/S0140-6736(16)31256-9	http://dx.doi.org/10.1016/S0140-6736(16)31256-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS4NA	27511773				2022-12-28	WOS:000380756600011
J	Ding, D; Lawson, KD; Kolbe-Alexander, TL; Finkelstein, EA; Katzmarzyk, PT; van Mechelen, W; Pratt, M				Ding, Ding; Lawson, Kenny D.; Kolbe-Alexander, Tracy L.; Finkelstein, Eric A.; Katzmarzyk, Peter T.; van Mechelen, Willem; Pratt, Michael		Phys Activity Series 2 Executive	The economic burden of physical inactivity: a global analysis of major non-communicable diseases	LANCET			English	Article							COST; METAANALYSIS; HEALTH	Background The pandemic of physical inactivity is associated with a range of chronic diseases and early deaths. Despite the well documented disease burden, the economic burden of physical inactivity remains unquantified at the global level. A better understanding of the economic burden could help to inform resource prioritisation and motivate efforts to increase levels of physical activity worldwide. Methods Direct health-care costs, productivity losses, and disability-adjusted life-years (DALYs) attributable to physical inactivity were estimated with standardised methods and the best data available for 142 countries, representing 93.2% of the world's population. Direct health-care costs and DALYs were estimated for coronary heart disease, stroke, type 2 diabetes, breast cancer, and colon cancer attributable to physical inactivity. Productivity losses were estimated with a friction cost approach for physical inactivity related mortality. Analyses were based on national physical inactivity prevalence from available countries, and adjusted population attributable fractions (PAFs) associated with physical inactivity for each disease outcome and all-cause mortality. Findings Conservatively estimated, physical inactivity cost health-care systems international $(INT$) 53.8 billion worldwide in 2013, of which $31.2 billion was paid by the public sector, $12.9 billion by the private sector, and $9.7 billion by households. In addition, physical inactivity related deaths contribute to $13.7 billion in productivity losses, and physical inactivity was responsible for 13.4 million DALYs worldwide. High-income countries bear a larger proportion of economic burden (80.8% of health-care costs and 60.4% of indirect costs), whereas low-income and middle-income countries have a larger proportion of the disease burden (75.0% of DALYs). Sensitivity analyses based on less conservative assumptions led to much higher estimates. Interpretation In addition to morbidity and premature mortality, physical inactivity is responsible for a substantial economic burden. This paper provides further justification to prioritise promotion of regular physical activity worldwide as part of a comprehensive strategy to reduce non-communicable diseases.	[Ding, Ding] Univ Sydney, Sydney Sch Publ Hlth, Charles Perkins Ctr, Prevent Res Collaborat, Camperdown, NSW, Australia; [Ding, Ding; Lawson, Kenny D.] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Ctr Chron Dis Prevent, Cairns, Qld, Australia; [Lawson, Kenny D.] Univ Western Sydney, Sch Med, Ctr Hlth Res, Sydney, NSW, Australia; [Kolbe-Alexander, Tracy L.; van Mechelen, Willem] Univ Queensland, Ctr Res Exercise Phys Act & Hlth, Sch Human Movement & Nutr Sci, St Lucia, Qld, Australia; [Kolbe-Alexander, Tracy L.; van Mechelen, Willem] Univ Cape Town, Fac Hlth Sci, Dept Human Biol, Res Unit Exercise Sci & Sports Med ESSM, Cape Town, South Africa; [Finkelstein, Eric A.] Duke Univ Natl Univ Singapore, Singapore, Singapore; [Katzmarzyk, Peter T.] Louisiana State Univ, Pennington Biomed Res Ctr, Baton Rouge, LA 70808 USA; [van Mechelen, Willem] Vrije Univ Amsterdam, Dept Publ & Occupat Hlth, Med Ctr, Amsterdam, Netherlands; [van Mechelen, Willem] Vrije Univ Amsterdam, EMGO Inst, Med Ctr, Amsterdam, Netherlands; [van Mechelen, Willem] Univ Coll Dublin, Sch Publ Hlth Physiotherapy & Populat Sci, Dublin, Ireland; [Pratt, Michael] Emory Univ, Hubert Dept Global Hlth, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	University of Sydney; James Cook University; Western Sydney University; University of Queensland; University of Cape Town; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University College Dublin; Emory University; Rollins School Public Health	Ding, D (corresponding author), Univ Sydney, Prevent Res Collaborat, Sydney Sch Publ Hlth 6N55, Charles Perkins Ctr D17, Level 6, Camperdown, NSW 2006, Australia.	melody.ding@sydney.edu.au	Ding, Ding/AAF-9985-2021; Katzmarzyk, Peter T/N-1974-2017; Reis, Rodrigo/F-7447-2012; Kolbe-Alexander, Tracy/C-1333-2014	Ding, Ding/0000-0001-9850-9224; Katzmarzyk, Peter T/0000-0002-9280-6022; Reis, Rodrigo/0000-0002-9872-9865; Kolbe-Alexander, Tracy/0000-0002-5025-3204; van Mechelen, Willem/0000-0001-7136-6382				Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Bloom DE, 2011, GLOBAL EC BURDEN NON, DOI DOI 10.1192/BJP.184.5.393; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Daneman D, 2006, LANCET, V367, P847, DOI 10.1016/S0140-6736(06)68341-4; Davis JC, 2014, BRIT J SPORT MED, V48, P947, DOI 10.1136/bjsports-2014-093575; Economist Intelligence Unit, 2009, BREAK GLOB BURD CANC; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Kohl Harold W 3rd, 2012, Lancet, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; KOOPMANSCHAP MA, 1995, J HEALTH ECON, V14, P171, DOI 10.1016/0167-6296(94)00044-5; Leal J, EUROPEAN CARDIOVASCU; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Luengo-Fernandez R, 2013, LANCET ONCOL, V14, P1165, DOI 10.1016/S1470-2045(13)70442-X; Merkur S, 2013, PROMOTING HLTH PREVE; Murray CJL, 2015, LANCET, V386, P2145, DOI 10.1016/S0140-6736(15)61340-X; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Pratt M, 2014, BRIT J SPORT MED, V48, P171, DOI 10.1136/bjsports-2012-091810; Sallis JF, 2016, LANCET, V388, P1325, DOI 10.1016/S0140-6736(16)30581-5; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Scarborough P, 2011, J PUBLIC HEALTH-UK, V33, P527, DOI 10.1093/pubmed/fdr033; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wendel-Vos GCW, 2004, INT J EPIDEMIOL, V33, P787, DOI 10.1093/ije/dyh168; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; World Bank, 2015, GDP PER CAP PPP CURR; Zhang P, 2010, DIABETES RES CLIN PR, V87, P293, DOI 10.1016/j.diabres.2010.01.026	26	994	1014	12	208	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2016	388	10051					1311	1324		10.1016/S0140-6736(16)30383-X	http://dx.doi.org/10.1016/S0140-6736(16)30383-X			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW5RH	27475266				2022-12-28	WOS:000383704000034
J	Damgaard, RB; Walker, JA; Marco-Casanova, P; Morgan, NV; Titheradge, HL; Elliott, PR; McHale, D; Maher, ER; McKenzie, ANJ; Komander, D				Damgaard, Rune Busk; Walker, Jennifer A.; Marco-Casanova, Paola; Morgan, Neil V.; Titheradge, Hannah L.; Elliott, Paul R.; McHale, Duncan; Maher, Eamonn R.; McKenzie, Andrew N. J.; Komander, David			The Deubiquitinase OTULIN Is an Essential Negative Regulator of Inflammation and Autoimmunity	CELL			English	Article							NF-KAPPA-B; LINEAR UBIQUITIN; MET1-LINKED UBIQUITINATION; SHARPIN CONTROLS; LUBAC; INNATE; ACTIVATION; HOIP; IMMUNODEFICIENCY; AUTOINFLAMMATION	Methionine-1 (M1)-linked ubiquitin chains regulate the activity of NF-kappa B, immune homeostasis, and responses to infection. The importance of negative regulators of M1-linked chains in vivo remains poorly understood. Here, we show that the M1-specific deubiquitinase OTULIN is essential for preventing TNF-associated systemic inflammation in humans and mice. A homozygous hypomorphic mutation in human OTULIN causes a potentially fatal autoinflammatory condition termed OTULIN-related autoinflammatory syndrome (ORAS). Four independent OTULIN mouse models reveal that OTULIN deficiency in immune cells results in cell-type-specific effects, ranging from over-production of inflammatory cytokines and autoimmunity due to accumulation of M1-linked polyubiquitin and spontaneous NF-kB activation in myeloid cells to downregulation of M1-polyubiquitin signaling by degradation of LUBAC in B and T cells. Remarkably, treatment with anti-TNF neutralizing antibodies ameliorates inflammation in ORAS patients and rescues mouse phenotypes. Hence, OTULIN is critical for restraining life-threatening spontaneous inflammation and maintaining immune homeostasis.	[Damgaard, Rune Busk; Walker, Jennifer A.; Marco-Casanova, Paola; Elliott, Paul R.; McKenzie, Andrew N. J.; Komander, David] MRC, Mol Biol Lab, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England; [Morgan, Neil V.] Univ Birmingham, Coll Med & Dent Sci, Inst Cardiovasc Sci, Birmingham B15 2TT, W Midlands, England; [Titheradge, Hannah L.] Birmingham Womens NHS Fdn Trust, Dept Clin Genet, Birmingham B15 2TG, W Midlands, England; [Titheradge, Hannah L.] Univ Birmingham, Inst Canc & Genom Sci, Birmingham B15 2TT, W Midlands, England; [Maher, Eamonn R.] UCB Pharma, New Med, Slough SL1 3WE, Berks, England; [Maher, Eamonn R.] Univ Cambridge, Dept Med Genet, Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Maher, Eamonn R.] Cambridge NIHR Biomed Res Ctr, Cambridge Biomed Campus, Cambridge CB2 0QQ, England	MRC Laboratory Molecular Biology; University of Birmingham; University of Birmingham; UCB Pharma SA; University of Cambridge	McKenzie, ANJ; Komander, D (corresponding author), MRC, Mol Biol Lab, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England.; Maher, ER (corresponding author), Univ Cambridge, Dept Med Genet, Cambridge Biomed Campus, Cambridge CB2 0QQ, England.; Maher, ER (corresponding author), Cambridge NIHR Biomed Res Ctr, Cambridge Biomed Campus, Cambridge CB2 0QQ, England.	erm1000@medschl.cam.ac.uk; anm@mrc-lmb.cam.ac.uk; dk@mrc-lmb.cam.ac.uk	MAHER, EAMONN R/A-9507-2008; Morgan, Neil V/A-5475-2009; Damgaard, Rune/AAX-4661-2021	MAHER, EAMONN R/0000-0002-6226-6918; Morgan, Neil V/0000-0001-6433-5692; Damgaard, Rune Busk/0000-0002-1709-6534; Elliott, Paul/0000-0002-7641-2103	Medical Research Council [U105192732, U105178805]; European Research Council [309756]; Lister Institute for Preventive Medicine; EMBO Young Investigator Program; Marie-Sklodowska Curie Individual Fellowship from European Commission [MC-IF-654019]; Corpus Christi College Cambridge; Wellcome Trust [100963/Z/13/Z]; WellChild; UCB; Medical Research Council [MC_U105178805, MC_U105192732] Funding Source: researchfish; MRC [MC_U105192732, MC_U105178805] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); Lister Institute for Preventive Medicine; EMBO Young Investigator Program(European Molecular Biology Organization (EMBO)); Marie-Sklodowska Curie Individual Fellowship from European Commission; Corpus Christi College Cambridge; Wellcome Trust(Wellcome Trust); WellChild; UCB(UCB Pharma SA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank The Wellcome Trust Sanger Institute, the EUCOMM Consortium, and the Mutant Mouse and Resource & Research Centers (MMRRC) for Otulin-targeted ES cells. We would also like to thank Helen Jolin for help with mouse colony management and genotyping; Richard Pannell, Angela Middleton, Richard Berks, Xinping Gong, and Ares and Biomed staff for assistance with animal procedures and experiments; Kirstin Keusekotten for help with initial stages of the project; Flow Cytometry Core staff for technical assistance; Louise Tee for assistance with human genetic studies; the late Louise Brueton for clinical genetic assessments; Chris Johnson for assistance with biophysics techniques; Juan Garaycoechea for providing MEFs; Neil Grant for help with photographic images; and Menna Clatworthy for helpful discussions. This work was supported by the Medical Research Council (U105192732 and U105178805), the European Research Council (309756), the Lister Institute for Preventive Medicine, and the EMBO Young Investigator Program (to D.K.); a Marie-Sklodowska Curie Individual Fellowship from the European Commission (MC-IF-654019) and a Research Fellowship from Corpus Christi College Cambridge (to R.B.D.); and Wellcome Trust (to N.V.M., E.R.M., and A.N.J.M [100963/Z/13/Z]), WellChild (to N.V.M. and E.R.M.), and UCB (to H.L.T., D.M. and E.R.M.). Figures 1E, 2B, 3K, and 7H were produced using Servier Medical Art (www.servier.com). D.K. is part of the DUB Alliance that includes Cancer Research Technology and FORMA Therapeutics. D.M. is an employee of UCB.	Boisson B, 2015, J EXP MED, V212, P939, DOI 10.1084/jem.20141130; Boisson B, 2012, NAT IMMUNOL, V13, P1178, DOI 10.1038/ni.2457; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Clark GR, 2014, J CLIN ENDOCR METAB, V99, pE2046, DOI 10.1210/jc.2014-1659; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Damgaard RB, 2013, EMBO MOL MED, V5, P1278, DOI 10.1002/emmm.201303090; Damgaard RB, 2012, MOL CELL, V46, P746, DOI 10.1016/j.molcel.2012.04.014; Draber P, 2015, CELL REP, V13, P2258, DOI 10.1016/j.celrep.2015.11.009; Elliott PR, 2014, MOL CELL, V54, P335, DOI 10.1016/j.molcel.2014.03.018; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Fiil BK, 2014, FEBS J, V281, P4337, DOI 10.1111/febs.12944; Fiil BK, 2013, MOL CELL, V50, P818, DOI 10.1016/j.molcel.2013.06.004; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Groom JR, 2007, J EXP MED, V204, P1959, DOI 10.1084/jem.20062567; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Harhaj EW, 2012, IMMUNOL REV, V246, P107, DOI 10.1111/j.1600-065X.2012.01100.x; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hrdinka M, 2016, CELL REP, V14, P2846, DOI 10.1016/j.celrep.2016.02.062; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Iwai K, 2014, NAT REV MOL CELL BIO, V15, P503, DOI 10.1038/nrm3836; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Keusekotten K, 2013, CELL, V153, P1312, DOI 10.1016/j.cell.2013.05.014; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kumari S, 2014, ELIFE, V3, DOI 10.7554/eLife.03422; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MacDuff DA, 2015, ELIFE, V4, DOI 10.7554/eLife.04494; Morley JE, 2006, AM J CLIN NUTR, V83, P735, DOI 10.1093/ajcn/83.4.735; Morrison PJ, 2013, MUCOSAL IMMUNOL, V6, P1143, DOI 10.1038/mi.2013.11; Park Y, 2016, NAT IMMUNOL, V17, P286, DOI 10.1038/ni.3352; Peltzer N, 2014, CELL REP, V9, P153, DOI 10.1016/j.celrep.2014.08.066; Redecke V, 2016, IMMUNOLOGY, V148, P216, DOI 10.1111/imm.12604; Rickard JA, 2014, ELIFE, V3, DOI 10.7554/eLife.03464; Rivkin E, 2013, NATURE, V498, P318, DOI 10.1038/nature12296; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; Sasaki Y, 2013, EMBO J, V32, P2463, DOI 10.1038/emboj.2013.184; Satpathy S., 2015, MOL SYST BIOL, V11, P810, DOI [10.15252/msb.20145880, DOI 10.15252/MSB.20145880]; Schaeffer V, 2014, MOL CELL, V54, P349, DOI 10.1016/j.molcel.2014.03.016; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Yang H, 2015, NAT PROTOC, V10, P1556, DOI 10.1038/nprot.2015.105; Yang YB, 2016, CANCER CELL, V29, P494, DOI 10.1016/j.ccell.2016.03.006	43	178	182	1	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 25	2016	166	5					1215	+		10.1016/j.cell.2016.07.019	http://dx.doi.org/10.1016/j.cell.2016.07.019			36	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NW	27523608	Green Published, hybrid			2022-12-28	WOS:000382259500018
J	Borlongan, CV				Borlongan, Cesar V.			Age of PISCES: stem-cell clinical trials in stroke	LANCET			English	Editorial Material							ISCHEMIC-STROKE; TRANSPLANTATION; THERAPY		[Borlongan, Cesar V.] Univ S Florida, Dept Neurosurg & Brain Repair, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33612 USA	State University System of Florida; University of South Florida	Borlongan, CV (corresponding author), Univ S Florida, Dept Neurosurg & Brain Repair, Coll Med, Ctr Excellence Aging & Brain Repair, Tampa, FL 33612 USA.	cborlong@health.usf.edu						BORLONGAN CV, 1999, LANCET S1, V353, pS129, DOI DOI 10.1016/s0140-6736(99)90229-5; Diamandis T, 2015, STROKE, V46, P588, DOI 10.1161/STROKEAHA.114.007105; Hagell P, 2002, NAT NEUROSCI, V5, P627, DOI 10.1038/nn863; Hess DC, 2008, CELL PROLIFERAT, V41, P94, DOI 10.1111/j.1365-2184.2008.00486.x; Hess DC, 2014, INT J STROKE, V9, P381, DOI 10.1111/ijs.12065; Horie N, 2011, STEM CELLS, V29, P274, DOI 10.1002/stem.584; Kalladka D, 2016, LANCET; Kasahara Y, 2016, TRANSL RES, V176, P69, DOI 10.1016/j.trsl.2016.04.003; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; Muir KW, 2015, CELL THERAPY BRAIN I, P111; Prasad K, 2014, STROKE, V45, P3618, DOI 10.1161/STROKEAHA.114.007028; Reyes S, 2015, EXPERT REV NEUROTHER, V15, P381, DOI 10.1586/14737175.2015.1021787; Savitz SI, 2011, ANN NEUROL, V70, P59, DOI 10.1002/ana.22458; Steinberg GK, 2016, STROKE, V47, P1817, DOI 10.1161/STROKEAHA.116.012995; Stevanato L, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-86; Stroemer P, 2009, NEUROREHAB NEURAL RE, V23, P895, DOI 10.1177/1545968309335978; Sullivan R, 2015, EXPERT OPIN BIOL TH, V15, P949, DOI 10.1517/14712598.2015.1043264	17	33	34	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2016	388	10046					736	738		10.1016/S0140-6736(16)31259-4	http://dx.doi.org/10.1016/S0140-6736(16)31259-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT6UH	27497863				2022-12-28	WOS:000381619200006
J	Johnston, CP; Smith, RT; Allmendinger, S; MacMillan, DWC				Johnston, Craig P.; Smith, Russell T.; Allmendinger, Simon; MacMillan, David W. C.			Metallaphotoredox-catalysed sp(3)-sp(3) cross-coupling of carboxylic acids with alkyl halides	NATURE			English	Article							PHOTOREDOX CATALYSIS; VISIBLE-LIGHT; ROOM-TEMPERATURE; NICKEL CATALYSIS; ARYL HALIDES; REAGENTS; BROMIDES; IODIDES; COMPLEX; DESIGN	In the past 50 years, cross-coupling reactions mediated by transition metals have changed the way in which complex organic molecules are synthesized. The predictable and chemoselective nature of these transformations has led to their widespread adoption across many areas of chemical research(1). However, the construction of a bond between two sp(3)-hybridized carbon atoms, a fundamental unit of organic chemistry, remains an important yet elusive objective for engineering cross-coupling reactions(2). In comparison to related procedures with sp(2)-hybridized species, the development of methods for sp(3)-sp(3) bond formation via transition metal catalysis has been hampered historically by deleterious side-reactions, such as beta-hydride elimination with palladium catalysis or the reluctance of alkyl halides to undergo oxidative addition(3,4.) To address this issue, nickel-catalysed cross-coupling processes can be used to form sp(3)-sp(3) bonds that utilize organometallic nucleophiles and alkyl electrophiles(5-7). In particular, the coupling of alkyl halides with pre-generated organozinc(8,9), Grignard(10) and organoborane(11) species has been used to furnish diverse molecular structures. However, the manipulations required to produce these activated structures is inefficient, leading to poor step-and atom-economies. Moreover, the operational difficulties associated with making and using these reactive coupling partners, and preserving them through a synthetic sequence, has hindered their widespread adoption. A generically useful sp(3)-sp(3) coupling technology that uses bench-stable, native organic functional groups, without the need for pre-functionalization or substrate derivatization, would therefore be valuable. Here we demonstrate that the synergistic merger of photoredox and nickel catalysis enables the direct formation of sp(3)-sp(3) bonds using only simple carboxylic acids and alkyl halides as the nucleophilic and electrophilic coupling partners, respectively. This metallaphotoredox protocol is suitable for many primary and secondary carboxylic acids. The merit of this coupling strategy is illustrated by the synthesis of the pharmaceutical tirofiban in four steps from commercially available starting materials.	[Johnston, Craig P.; Smith, Russell T.; Allmendinger, Simon; MacMillan, David W. C.] Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA	Princeton University	MacMillan, DWC (corresponding author), Princeton Univ, Merck Ctr Catalysis, Princeton, NJ 08544 USA.	dmacmill@princeton.edu		Johnston, Craig P./0000-0003-2459-1872	NIHGMS [R01 GM093213-01]; Marie Curie Actions [PIOF-GA-2013-627695]; Deutsche Forschungsgemeinschaft (DFG) [AL 1860/2-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093213] Funding Source: NIH RePORTER	NIHGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Marie Curie Actions(European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support was provided by NIHGMS (R01 GM093213-01); we acknowledge gifts from Merck, AbbVie, and Bristol-Myers Squibb. C.P.J. thanks Marie Curie Actions for an international outgoing fellowship (PIOF-GA-2013-627695). S.A. thanks the Deutsche Forschungsgemeinschaft (DFG) for a postdoctoral fellowship (AL 1860/2-1).	de Meijere A., 2004, METAL CATALYZED CROS, V2nd, DOI 10.1002/9783527619535; Durandetti M, 1996, NEW J CHEM, V20, P659; Fabry DC, 2014, ANGEW CHEM INT EDIT, V53, P10228, DOI 10.1002/anie.201400560; Geist E, 2014, NAT PROD REP, V31, P441, DOI 10.1039/c3np70108e; Giovannini R, 1998, ANGEW CHEM INT EDIT, V37, P2387, DOI 10.1002/(SICI)1521-3773(19980918)37:17<2387::AID-ANIE2387>3.0.CO;2-M; Gutierrez O, 2015, J AM CHEM SOC, V137, P4896, DOI 10.1021/ja513079r; Haas D, 2016, ACS CATAL, V6, P1540, DOI 10.1021/acscatal.5b02718; HARTMAN GD, 1992, J MED CHEM, V35, P4640, DOI 10.1021/jm00102a020; Huihui KMM, 2016, J AM CHEM SOC, V138, P5016, DOI 10.1021/jacs.6b01533; Jana R, 2011, CHEM REV, V111, P1417, DOI 10.1021/cr100327p; Jeffrey JL, 2015, SCIENCE, V349, P1532, DOI 10.1126/science.aac8555; Kalyani D, 2011, J AM CHEM SOC, V133, P18566, DOI 10.1021/ja208068w; Lin XF, 2008, J ORG CHEM, V73, P3680, DOI 10.1021/jo702497p; Lovering F, 2009, J MED CHEM, V52, P6752, DOI 10.1021/jm901241e; Lowry MS, 2005, CHEM MATER, V17, P5712, DOI 10.1021/cm051312+; Meanwell NA, 2011, J MED CHEM, V54, P2529, DOI 10.1021/jm1013693; Narayanam JMR, 2011, CHEM SOC REV, V40, P102, DOI 10.1039/b913880n; Phapale VB, 2009, CHEM SOC REV, V38, P1598, DOI 10.1039/b805648j; Prier CK, 2013, CHEM REV, V113, P5322, DOI 10.1021/cr300503r; Qin T, 2016, SCIENCE, V352, P801, DOI 10.1126/science.aaf6123; Ren P, 2011, J AM CHEM SOC, V133, P7084, DOI 10.1021/ja200270k; Sahoo B, 2013, J AM CHEM SOC, V135, P5505, DOI 10.1021/ja400311h; Saito B, 2007, J AM CHEM SOC, V129, P9602, DOI 10.1021/ja074008l; Schley ND, 2014, J AM CHEM SOC, V136, P16588, DOI 10.1021/ja508718m; Tasker SZ, 2014, NATURE, V509, P299, DOI 10.1038/nature13274; Tellis JC, 2014, SCIENCE, V345, P433, DOI 10.1126/science.1253647; Terao J, 2002, J AM CHEM SOC, V124, P4222, DOI 10.1021/ja025828v; Terrett JA, 2015, NATURE, V524, P330, DOI 10.1038/nature14875; Zhou JR, 2003, J AM CHEM SOC, V125, P14726, DOI 10.1021/ja0389366; Zuo ZW, 2014, SCIENCE, V345, P437, DOI 10.1126/science.1255525	30	293	292	21	364	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					322	325		10.1038/nature19056	http://dx.doi.org/10.1038/nature19056			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27535536	Green Accepted			2022-12-28	WOS:000381804900033
J	Snyder, BER; Vanelderen, P; Bols, ML; Hallaert, SD; Bottger, LH; Ungur, L; Pierloot, K; Schoonheydt, RA; Sels, BF; Solomon, EI				Snyder, Benjamin E. R.; Vanelderen, Pieter; Bols, Max L.; Hallaert, Simon D.; Bottger, Lars H.; Ungur, Liviu; Pierloot, Kristine; Schoonheydt, Robert A.; Sels, Bert F.; Solomon, Edward I.			The active site of low-temperature methane hydroxylation in iron-containing zeolites	NATURE			English	Article							CIRCULAR-DICHROISM SPECTROSCOPY; DENSITY-FUNCTIONAL THEORY; ELECTRONIC-STRUCTURE; PERTURBATION-THEORY; FEZSM-5 ZEOLITE; FE-BEA; CATALYSTS; ENZYMES; COMPLEXES; OXIDATION	An efficient catalytic process for converting methane into methanol could have far-reaching economic implications. Iron-containing zeolites (microporous aluminosilicate minerals) are noteworthy in this regard, having an outstanding ability to hydroxylate methane rapidly at room temperature to form methanol(1-3). Reactivity occurs at an extra-lattice active site called alpha-Fe(ii), which is activated by nitrous oxide to form the reactive intermediate alpha-O-4,O-5; however, despite nearly three decades of research(5), the nature of the active site and the factors determining its exceptional reactivity are unclear. The main difficulty is that the reactive species-alpha-Fe(ii) and alpha-O-are challenging to probe spectroscopically: data from bulk techniques such as X-ray absorption spectroscopy and magnetic susceptibility are complicated by contributions from inactive 'spectator' iron. Here we show that a site-selective spectroscopic method regularly used in bioinorganic chemistry can overcome this problem. Magnetic circular dichroism reveals alpha-Fe(ii) to be a mononuclear, high-spin, square planar Fe(ii) site, while the reactive intermediate, alpha-O, is a mononuclear, high-spin Fe(IV)=O species, whose exceptional reactivity derives from a constrained coordination geometry enforced by the zeolite lattice. These findings illustrate the value of our approach to exploring active sites in heterogeneous systems. The results also suggest that using matrix constraints to activate metal sites for function-producing what is known in the context of metalloenzymes as an 'entatic' state(6)-might be a useful way to tune the activity of heterogeneous catalysts.	[Snyder, Benjamin E. R.; Vanelderen, Pieter; Bottger, Lars H.; Solomon, Edward I.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Vanelderen, Pieter; Bols, Max L.; Schoonheydt, Robert A.; Sels, Bert F.] Univ Leuven, KU Leuven, Ctr Surface Chem & Catalysis, Dept Microbial & Mol Syst, Celestijnenlaan 200F, B-3001 Leuven, Belgium; [Hallaert, Simon D.; Ungur, Liviu; Pierloot, Kristine] Katholieke Univ Leuven, Dept Chem, Celestijnenlaan 200F, B-3001 Leuven, Belgium; [Solomon, Edward I.] SLAC Natl Accelerator Lab, Photon Sci, 2575 Sand Hill Rd, Menlo Pk, CA 94025 USA; [Ungur, Liviu] Lund Univ, Div Theoret Chem, POB 124, S-22100 Lund, Sweden	Stanford University; KU Leuven; KU Leuven; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Lund University	Solomon, EI (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.; Schoonheydt, RA; Sels, BF (corresponding author), Univ Leuven, KU Leuven, Ctr Surface Chem & Catalysis, Dept Microbial & Mol Syst, Celestijnenlaan 200F, B-3001 Leuven, Belgium.; Solomon, EI (corresponding author), SLAC Natl Accelerator Lab, Photon Sci, 2575 Sand Hill Rd, Menlo Pk, CA 94025 USA.	robert.schoonheydt@biw.kuleuven.be; bert.sels@biw.kuleuven.be; edward.solomon@stanford.edu	Ungur, Liviu/G-2057-2012; Pierloot, Kristine/F-9479-2012; Nanozymes, Nanozymes/D-8197-2019	Ungur, Liviu/0000-0001-5015-4225; Pierloot, Kristine/0000-0002-3196-4940; Bols, Max/0000-0002-4576-5969; Snyder, Benjamin/0000-0002-7904-0341; Solomon, Edward/0000-0003-0291-3199	National Science Foundation [DGE-11474, CHE-1360046]; Munger; Pollock; Reynolds; Robinson, Smith & Yoedicke Stanford Graduate Fellowship; Research Foundation-Flanders (FWO) [12L0715N]; KU Leuven; FWO [G0A2216N, G.0865.13]; Hercules Foundation; Flemish Government department EWI; Division Of Chemistry [1360046] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Munger; Pollock; Reynolds; Robinson, Smith & Yoedicke Stanford Graduate Fellowship; Research Foundation-Flanders (FWO)(FWO); KU Leuven(KU Leuven); FWO(FWO); Hercules Foundation; Flemish Government department EWI; Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	B.E.R.S. acknowledges support from the National Science Foundation Graduate Research Fellowship Program under grant DGE-11474, and from the Munger, Pollock, Reynolds, Robinson, Smith & Yoedicke Stanford Graduate Fellowship. P.V. acknowledges Research Foundation-Flanders (FWO; grant 12L0715N) and KU Leuven for his postdoctoral fellowships and travel grants during his stay at Stanford University. S.D.H. acknowledges FWO for a PhD (aspirant) Fellowship. L.U. acknowledges FWO for a postdoctoral fellowship. Funding for this work was provided by the National Science Foundation (grant CHE-1360046 to E.I.S.), and within the framework of FWO (grants G0A2216N to B.F.S and G.0865.13 to K.P.). The computational resources and services used for the CASPT2 calculations were provided by the VSC (Flemish Supercomputer Center) and funded by the Hercules Foundation and the Flemish Government department EWI.	ANDERSSON K, 1992, J CHEM PHYS, V96, P1218, DOI 10.1063/1.462209; Aquilante F, 2016, J COMPUT CHEM, V37, P506, DOI 10.1002/jcc.24221; Baerlocher C., 2007, ATLAS ZEOLITE FRAMEW; BURNS RG, 1966, INORG CHEM, V5, P1268, DOI 10.1021/ic50041a043; CAMPOCHIARO C, 1995, INORG CHEM, V34, P4669, DOI 10.1021/ic00122a025; Cantalupo SA, 2012, ANGEW CHEM INT EDIT, V51, P1000, DOI 10.1002/anie.201106091; Centi G, 2004, CATAL TODAY, V91-2, P17, DOI 10.1016/j.cattod.2004.03.004; Chibotaru LF, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4739763; CLARK MG, 1967, J CHEM PHYS, V47, P4250, DOI 10.1063/1.1701608; Dedecek J, 2012, CATAL REV, V54, P135, DOI 10.1080/01614940.2012.632662; Dubkov KA, 1998, KINET CATAL+, V39, P72; Dubkov KA, 2002, J CATAL, V207, P341, DOI 10.1006/jcat.2002.3552; Dubkov KA, 1997, J MOL CATAL A-CHEM, V123, P155, DOI 10.1016/S1381-1169(97)00051-4; Forsberg N, 1997, CHEM PHYS LETT, V274, P196, DOI 10.1016/S0009-2614(97)00669-6; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Ghigo G, 2004, CHEM PHYS LETT, V396, P142, DOI 10.1016/j.cplett.2004.08.032; Hess BA, 1996, CHEM PHYS LETT, V251, P365, DOI 10.1016/0009-2614(96)00119-4; Jisa K, 2009, J CATAL, V262, P27, DOI 10.1016/j.jcat.2008.11.025; Kahn O., 1993, MOL MAGNETISM; LOEWENSTEIN W, 1954, AM MINERAL, V39, P92; Malmqvist PA, 2002, CHEM PHYS LETT, V357, P230, DOI 10.1016/S0009-2614(02)00498-0; McDonald AR, 2013, COORDIN CHEM REV, V257, P414, DOI 10.1016/j.ccr.2012.08.002; Neese F, 1999, INORG CHEM, V38, P1847, DOI 10.1021/ic981264d; Neese F, 2002, INORG CHIM ACTA, V337, P181, DOI 10.1016/S0020-1693(02)01031-9; Neidig ML, 2006, P NATL ACAD SCI USA, V103, P12966, DOI 10.1073/pnas.0605067103; NEWSAM JM, 1988, P ROY SOC LOND A MAT, V420, P375, DOI 10.1098/rspa.1988.0131; Ovanesyan NS, 1998, KINET CATAL+, V39, P792; Panov G. I., 2000, CATTECH, V4, P18, DOI DOI 10.1023/A:1011991110517; Pascualini ME, 2015, CHEM SCI, V6, P608, DOI 10.1039/c4sc02634a; Pinkert D, 2013, ANGEW CHEM INT EDIT, V52, P5155, DOI 10.1002/anie.201209650; Puri M, 2015, ACCOUNTS CHEM RES, V48, P2443, DOI 10.1021/acs.accounts.5b00244; Roos BO, 2004, J PHYS CHEM A, V108, P2851, DOI 10.1021/jp031064+; Roos BO, 2005, J PHYS CHEM A, V109, P6575, DOI 10.1021/jp0581126; Rosa A, 2010, INORG CHEM, V49, P3866, DOI 10.1021/ic1000073; ROSSI AR, 1975, INORG CHEM, V14, P365, DOI 10.1021/ic50144a032; Smeets PJ, 2010, INORG CHEM, V49, P3573, DOI 10.1021/ic901814f; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; SOLOMON EI, 1995, COORDIN CHEM REV, V144, P369, DOI 10.1016/0010-8545(95)01150-N; VALLEE BL, 1968, P NATL ACAD SCI USA, V59, P498, DOI 10.1073/pnas.59.2.498; Weckhuysen BM, 1999, CATAL TODAY, V49, P441, DOI 10.1016/S0920-5861(98)00458-1; Wurzenberger X, 2011, ANGEW CHEM INT EDIT, V50, P4974, DOI 10.1002/anie.201006898; Xia HA, 2008, J PHYS CHEM C, V112, P9001, DOI 10.1021/jp800455x; Zecchina A, 2007, PHYS CHEM CHEM PHYS, V9, P3483, DOI 10.1039/b703445h	43	227	233	32	539	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					317	+		10.1038/nature19059	http://dx.doi.org/10.1038/nature19059			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27535535				2022-12-28	WOS:000381804900032
J	Zeidman, JA; Shellito, PC; Davis, BT; Zukerberg, LR				Zeidman, Jessica A.; Shellito, Paul C.; Davis, Benjamin T.; Zukerberg, Lawrence R.			Case 25-2016: A 33-Year-Old Man with Rectal Pain and Bleeding	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; SECONDARY SYPHILIS; LYMPHOGRANULOMA-VENEREUM; PROCTITIS; DISEASE; MEN; SEX; PROCTOSIGMOIDITIS		[Zeidman, Jessica A.; Davis, Benjamin T.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Shellito, Paul C.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Zukerberg, Lawrence R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Zeidman, Jessica A.; Davis, Benjamin T.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Shellito, Paul C.] Harvard Med Sch, Dept Surg, Boston, MA 02115 USA; [Zukerberg, Lawrence R.] Harvard Med Sch, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Zeidman, JA (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.							Abraham P, 1914, A SYSTEM OF SYPHILIS, P150; Adachi E, 2011, J CLIN MICROBIOL, V49, P4394, DOI 10.1128/JCM.01240-11; Allingham W, 1879, FISTULA HAEMORRHOIDS; [Anonymous], 2016, COPYRIGHT; Assi R, 2014, WORLD J GASTROENTERO, V20, P15262, DOI 10.3748/wjg.v20.i41.15262; Begovac J, 2005, NEW ENGL J MED, V352, P708, DOI 10.1056/NEJMicm040514; Bharucha AE, 1996, AM J GASTROENTEROL, V91, P2305; *CDCP, 2015, 2014 SEX TRANSM DIS; CHAPEL TA, 1980, SEX TRANSM DIS, V7, P161, DOI 10.1097/00007435-198010000-00002; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; Davis TW, 2009, DIS COLON RECTUM, V52, P507, DOI 10.1007/DCR.0b013e31819ad537; de Vrieze NHN, 2013, SEX TRANSM INFECT, V89, P548, DOI 10.1136/sextrans-2012-050915; Febbraro I, 2008, DIGEST LIVER DIS, V40, P579, DOI 10.1016/j.dld.2007.09.004; Gallegos M, 2012, WORLD J GASTROENTERO, V18, P3317, DOI 10.3748/wjg.v18.i25.3317; Hamlyn E, 2006, POSTGRAD MED J, V82, P733, DOI 10.1136/pmj.2006.048488; Herzig DO, 2010, SURG CLIN N AM, V90, P33, DOI 10.1016/j.suc.2009.09.002; KEIGHLEY MRB, 1986, INT J COLORECTAL DIS, V1, P104, DOI 10.1007/BF01648416; Klausner JD, 2004, CLIN INFECT DIS, V38, P300, DOI 10.1086/380838; Mathew Soniya, 2008, Int J Surg, V6, pe36, DOI 10.1016/j.ijsu.2006.11.005; MINDEL A, 1989, GENITOURIN MED, V65, P1; Puri AS, 1996, DIS COLON RECTUM, V39, P1126, DOI 10.1007/BF02081413; Studemeister A, 2011, SEX TRANSM DIS, V38, P876, DOI 10.1097/OLQ.0b013e31821a5a90; Tas A, 2011, DIGEST LIVER DIS, V43, P331, DOI 10.1016/j.dld.2010.10.016; Ward H, 2007, CLIN INFECT DIS, V44, P26, DOI 10.1086/509922	24	2	2	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2016	375	7					676	682		10.1056/NEJMcpc1602815	http://dx.doi.org/10.1056/NEJMcpc1602815			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4VF	27532834				2022-12-28	WOS:000381478600011
J	Barer, D				Barer, David			In ICH associated with antiplatelet therapy, platelet transfusion increased death or dependence	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Barer, David] Sunderland Royal Hosp, Sunderland, Tyne & Wear, England	Sunderland Royal Hospital	Barer, D (corresponding author), Sunderland Royal Hosp, Sunderland, Tyne & Wear, England.							Bath PMW, 2012, STROKE, V43, P1171, DOI 10.1161/STROKEAHA.111.641456; Kumar A, 2015, TRANSFUSION, V55, P1116, DOI 10.1111/trf.12943	2	1	1	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					JC19	JC19		10.7326/ACPJC-2016-165-4-019	http://dx.doi.org/10.7326/ACPJC-2016-165-4-019			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UI	27538180				2022-12-28	WOS:000381267200006
J	Stafford, N				Stafford, Ned			Vitamin D supplements poison dozens of Danish children	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Mayor S, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4061; Miljo-og Fodevareministeriet, 2016, BEW DANG D DROPS	2	3	3	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2016	354								i4534	10.1136/bmj.i4534	http://dx.doi.org/10.1136/bmj.i4534			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GX	27530440				2022-12-28	WOS:000381806200016
J	Arkan, MC				Arkan, Melek Canan			Fat and the fate of pancreatic tumours	NATURE			English	Editorial Material									[Arkan, Melek Canan] Goethe Univ Frankfurt, Inst Biochem 2, D-60590 Frankfurt, Germany; [Arkan, Melek Canan] Inst Tumor Biol & Expt Therapy, Georg Speyer Haus, D-60596 Frankfurt, Germany	Goethe University Frankfurt	Arkan, MC (corresponding author), Goethe Univ Frankfurt, Inst Biochem 2, D-60590 Frankfurt, Germany.; Arkan, MC (corresponding author), Inst Tumor Biol & Expt Therapy, Georg Speyer Haus, D-60596 Frankfurt, Germany.	arkan@med.uni-frankfurt.de						DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Govannucci E, 2007, GASTROENTEROLOGY, V132, P2208, DOI 10.1053/j.gastro.2007.03.050; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Incio J., 2016, CANC DISCOV; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Provenzano PP, 2013, BRIT J CANCER, V108, P1, DOI 10.1038/bjc.2012.569; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Shook B., ANN REV CELL DEV BIO	8	9	11	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					157	158		10.1038/nature19419	http://dx.doi.org/10.1038/nature19419			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27487208	Bronze			2022-12-28	WOS:000381472100025
J	Lopez-Otin, C; Galluzzi, L; Freije, JMP; Madeo, F; Kroemer, G				Lopez-Otin, Carlos; Galluzzi, Lorenzo; Freije, Jose M. P.; Madeo, Frank; Kroemer, Guido			Metabolic Control of Longevity	CELL			English	Review							EXTENDS LIFE-SPAN; ADIPOSE-TISSUE; MOUSE MODEL; DNA-DAMAGE; MITOCHONDRIAL DYSFUNCTION; OXIDATIVE STRESS; CIRCADIAN CLOCK; OBESE MICE; PHARMACOLOGICAL INHIBITION; NORDIHYDROGUAIARETIC ACID	Several metabolic alterations accumulate over time along with a reduction in biological fitness, suggesting the existence of a "metabolic clock'' that controls aging. Multiple inborn defects in metabolic circuitries accelerate aging, whereas genetic loci linked to exceptional longevity influence metabolism. Each of the nine hallmarks of aging is connected to undesirable metabolic alterations. The main features of the "westernized'' lifestyle, including hypercaloric nutrition and sedentariness, can accelerate aging as they have detrimental metabolic consequences. Conversely, lifespan-extending maneuvers including caloric restriction impose beneficial pleiotropic effects on metabolism. The introduction of strategies that promote metabolic fitness may extend healthspan in humans.	[Lopez-Otin, Carlos; Freije, Jose M. P.] Univ Oviedo, Inst Univ Oncol IUOPA, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain; [Galluzzi, Lorenzo] Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY 10065 USA; [Galluzzi, Lorenzo; Kroemer, Guido] Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc 11, F-75006 Paris, France; [Galluzzi, Lorenzo; Kroemer, Guido] Inst Natl Sante & Rech Med, U1138, F-75006 Paris, France; [Galluzzi, Lorenzo; Kroemer, Guido] Univ Paris Descartes Paris V, Sorbonne Paris Cite, F-75006 Paris, France; [Galluzzi, Lorenzo; Kroemer, Guido] Univ Pierre & Marie Curie Paris VI, F-75006 Paris, France; [Galluzzi, Lorenzo] Gustave Roussy Canc Campus, F-94805 Villejuif, France; [Madeo, Frank] Graz Univ, NAWI Graz, Inst Mol Biosci, A-8010 Graz, Austria; [Madeo, Frank] BioTechMed Graz, A-8010 Graz, Austria; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Pole Biol, F-75015 Paris, France; [Kroemer, Guido] Karolinska Inst, Karolinska Univ Hosp, Dept Womens & Childrens Hlth, S-17176 Stockholm, Sweden; [Kroemer, Guido] Gustave Roussy Canc Campus, F-94805 Villejuif, France	University of Oviedo; Instituto Universitario de Oncologia de Asturias; Cornell University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; University of Graz; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; Karolinska University Hospital	Lopez-Otin, C (corresponding author), Univ Oviedo, Inst Univ Oncol IUOPA, Dept Bioquim & Biol Mol, E-33006 Oviedo, Spain.; Kroemer, G (corresponding author), Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc 11, F-75006 Paris, France.; Kroemer, G (corresponding author), Inst Natl Sante & Rech Med, U1138, F-75006 Paris, France.; Kroemer, G (corresponding author), Univ Paris Descartes Paris V, Sorbonne Paris Cite, F-75006 Paris, France.; Kroemer, G (corresponding author), Univ Pierre & Marie Curie Paris VI, F-75006 Paris, France.; Kroemer, G (corresponding author), Hop Europeen Georges Pompidou, AP HP, Pole Biol, F-75015 Paris, France.; Kroemer, G (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Womens & Childrens Hlth, S-17176 Stockholm, Sweden.; Kroemer, G (corresponding author), Gustave Roussy Canc Campus, F-94805 Villejuif, France.	clo@uniovi.es; kroemer@orange.fr	López-Otín, Carlos/AAB-2106-2020; KROEMER, Guido/B-4263-2013; Kroemer, Guido/AAY-9859-2020; Galluzzi, Lorenzo/AAG-6294-2019; Galluzzi, Lorenzo/AAH-3286-2021; Galluzzi, Lorenzo/AAG-6432-2019; Freije, José M.P./A-6535-2008	López-Otín, Carlos/0000-0001-6964-1904; KROEMER, Guido/0000-0002-9334-4405; Freije, José M.P./0000-0002-4688-8266; Madeo, Frank/0000-0002-5070-1329	Ministerio de Economia y Competitividad, Instituto de Salud Carlos III, and Botin Foundation (Spain); Ministerio de Economia y Competitividad and Gobierno del Principado de Asturias (Spain); Fundacion Bancaria Caja de Ahorros de Asturias; FWF grants LIPOTOX [I1000, P 27893, P24381-B20]; BMWFW grant "Unconventional research''; Ligue contre le Cancer (equipe labelisee); Agence National de la Recherche (ANR) - Projets blancs; ANR; ERA-Net for Research on Rare Diseases; Association pour la recherche sur le cancer (ARC); Canceropole Ile-de-France; Institut National du Cancer (INCa); Institut Universitaire de France; Fondation pour la Recherche Medicale (FRM); European Commission (ArtForce); European Research Council (ERC); LeDucq Foundation; LabEx Immuno-Oncology; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Paris Alliance of Cancer Research Institutes (PACRI)	Ministerio de Economia y Competitividad, Instituto de Salud Carlos III, and Botin Foundation (Spain); Ministerio de Economia y Competitividad and Gobierno del Principado de Asturias (Spain); Fundacion Bancaria Caja de Ahorros de Asturias; FWF grants LIPOTOX; BMWFW grant "Unconventional research''; Ligue contre le Cancer (equipe labelisee)(Ligue nationale contre le cancer); Agence National de la Recherche (ANR) - Projets blancs(French National Research Agency (ANR)); ANR(French National Research Agency (ANR)); ERA-Net for Research on Rare Diseases; Association pour la recherche sur le cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Canceropole Ile-de-France(Region Ile-de-France); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Institut Universitaire de France; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European Commission (ArtForce)(European CommissionEuropean Commission Joint Research Centre); European Research Council (ERC)(European Research Council (ERC)European Commission); LeDucq Foundation(Leducq Foundation); LabEx Immuno-Oncology; SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Paris Alliance of Cancer Research Institutes (PACRI)	We acknowledge all members of our laboratories for the support and constructive discussion during the elaboration of this manuscript, and we apologize for omission of relevant works and citations due to space constraints. C.L.-O. is supported by grants from Ministerio de Economia y Competitividad, Instituto de Salud Carlos III, and Botin Foundation (Spain). J.M.P.F. is supported by grants from Ministerio de Economia y Competitividad and Gobierno del Principado de Asturias (Spain). The Instituto Universitario de Oncologia is supported by Fundacion Bancaria Caja de Ahorros de Asturias. F.M. is supported by FWF grants LIPOTOX, I1000, P 27893, and P24381-B20, as well as by the BMWFW grant "Unconventional research.'' G.K. is supported by the Ligue contre le Cancer (equipe labelisee); Agence National de la Recherche (ANR) - Projets blancs; ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases; Association pour la recherche sur le cancer (ARC); Canceropole Ile-de-France; Institut National du Cancer (INCa); Institut Universitaire de France; Fondation pour la Recherche Medicale (FRM); the European Commission (ArtForce); the European Research Council (ERC); the LeDucq Foundation; the LabEx Immuno-Oncology; the SIRIC Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); the SIRIC Cancer Research and Personalized Medicine (CARPEM); and the Paris Alliance of Cancer Research Institutes (PACRI).	Arruda AP, 2014, NAT MED, V20, P1427, DOI 10.1038/nm.3735; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Benayoun BA, 2015, NAT REV MOL CELL BIO, V16, P593, DOI 10.1038/nrm4048; Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012; Brehme M, 2014, CELL REP, V9, P1135, DOI 10.1016/j.celrep.2014.09.042; Brestoff JR, 2015, CELL, V161, P146, DOI 10.1016/j.cell.2015.02.022; Broer L, 2015, ADV EXP MED BIOL, V847, P107, DOI 10.1007/978-1-4939-2404-2_5; Burke MF, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001188; Cabreiro F, 2013, CELL, V153, P228, DOI 10.1016/j.cell.2013.02.035; Cai WJ, 2014, P NATL ACAD SCI USA, V111, P4940, DOI 10.1073/pnas.1316013111; Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Cerutti R, 2014, CELL METAB, V19, P1042, DOI 10.1016/j.cmet.2014.04.001; Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x; Chaix A, 2014, CELL METAB, V20, P991, DOI 10.1016/j.cmet.2014.11.001; Chang HC, 2013, CELL, V153, P1448, DOI 10.1016/j.cell.2013.05.027; Chatterjee S, 2016, DIABETES CARE, V39, P300, DOI 10.2337/dc15-1588; Chen C, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000559; Chondrogianni N, 2015, AGEING RES REV, V23, P37, DOI 10.1016/j.arr.2014.12.003; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Clark-Matott J, 2015, NEUROBIOL AGING, V36, P2972, DOI 10.1016/j.neurobiolaging.2015.07.020; D'Antona G, 2010, CELL METAB, V12, P362, DOI 10.1016/j.cmet.2010.08.016; Denzel MS, 2014, CELL, V156, P1167, DOI 10.1016/j.cell.2014.01.061; Desai M, 2016, APPETITE, V99, P193, DOI 10.1016/j.appet.2016.01.023; Dietz WH, 2015, LANCET, V385, P2521, DOI 10.1016/S0140-6736(14)61748-7; Dou ZX, 2015, NATURE, V527, P105, DOI 10.1038/nature15548; Duca FA, 2015, NAT MED, V21, P506, DOI 10.1038/nm.3787; Eckel-Mahan KL, 2013, CELL, V155, P1464, DOI 10.1016/j.cell.2013.11.034; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Eisenberg T, 2014, CELL METAB, V19, P431, DOI 10.1016/j.cmet.2014.02.010; Escande C, 2014, AGING CELL, V13, P951, DOI 10.1111/acel.12235; Fang EF, 2014, CELL, V157, P882, DOI 10.1016/j.cell.2014.03.026; Fang YM, 2013, CELL METAB, V17, P456, DOI 10.1016/j.cmet.2013.02.008; Finkel T, 2015, NAT MED, V21, P1416, DOI 10.1038/nm.3998; Finley LWS, 2012, P NATL ACAD SCI USA, V109, P2931, DOI 10.1073/pnas.1115813109; Fontana L, 2016, AGING CELL, V15, P22, DOI 10.1111/acel.12400; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Fuku N, 2015, AGING CELL, V14, P921, DOI 10.1111/acel.12389; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; Galluzzi L, 2014, CELL, V159, P1263, DOI 10.1016/j.cell.2014.11.006; Garcia-Calzon S, 2015, AM J CLIN NUTR, V102, P897, DOI 10.3945/ajcn.115.116863; Garcia-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187; Gariani K, 2016, HEPATOLOGY, V63, P1190, DOI 10.1002/hep.28245; Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241; Gebauer SK, 2015, AM J CLIN NUTR, V102, P1339, DOI 10.3945/ajcn.115.116129; Goldberg EL, 2015, IMMUNOL REV, V265, P63, DOI 10.1111/imr.12295; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Gonzalez-Covarrubias V, 2013, AGING CELL, V12, P426, DOI 10.1111/acel.12064; Goodell MA, 2015, SCIENCE, V350, P1199, DOI 10.1126/science.aab3388; Harrison DE, 2014, AGING CELL, V13, P273, DOI 10.1111/acel.12170; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Heinonen S, 2015, DIABETES, V64, P3135, DOI 10.2337/db14-1937; Hertel J, 2016, J PROTEOME RES, V15, P400, DOI 10.1021/acs.jproteome.5b00561; Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048; Hofmann JW, 2015, CELL, V160, P477, DOI 10.1016/j.cell.2014.12.016; Hong SY, 2015, NAT MED, V21, P887, DOI 10.1038/nm.3882; Hood DA, 2015, PROG MOL BIOL TRANSL, V135, P99, DOI 10.1016/bs.pmbts.2015.07.007; Horvath S, 2014, P NATL ACAD SCI USA, V111, P15538, DOI 10.1073/pnas.1412759111; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Jahansouz C, 2015, OBES SURG, V25, P2376, DOI 10.1007/s11695-015-1708-5; Jamwal S, 2016, PHYSIOL BEHAV, V155, P180, DOI 10.1016/j.physbeh.2015.12.015; Jimenez-Gomez Y, 2013, CELL METAB, V18, P533, DOI 10.1016/j.cmet.2013.09.004; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; Jukarainen S, 2016, J CLIN ENDOCR METAB, V101, P274, DOI 10.1210/jc.2015-3095; Kaeberlein M, 2015, SCIENCE, V350, P1191, DOI 10.1126/science.aad3267; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Karakasilioti I, 2013, CELL METAB, V18, P403, DOI 10.1016/j.cmet.2013.08.011; Karamanlidis G, 2013, CELL METAB, V18, P239, DOI 10.1016/j.cmet.2013.07.002; Katewa SD, 2016, CELL METAB, V23, P143, DOI 10.1016/j.cmet.2015.10.014; Kibe R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04548; Kim KH, 2014, NAT REV ENDOCRINOL, V10, P322, DOI 10.1038/nrendo.2014.35; Koga H, 2010, FASEB J, V24, P3052, DOI 10.1096/fj.09-144519; Kraus D, 2014, NATURE, V508, P258, DOI 10.1038/nature13198; Krishnan V, 2011, P NATL ACAD SCI USA, V108, P12325, DOI 10.1073/pnas.1102789108; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Laimer M, 2016, INT J OBESITY, V40, P773, DOI 10.1038/ijo.2015.238; Lapierre LR, 2012, TRENDS ENDOCRIN MET, V23, P637, DOI 10.1016/j.tem.2012.07.007; LaRocca TJ, 2013, MECH AGEING DEV, V134, P314, DOI 10.1016/j.mad.2013.04.004; Lee C, 2015, CELL METAB, V21, P443, DOI 10.1016/j.cmet.2015.02.009; Lee JV, 2014, CELL METAB, V20, P306, DOI 10.1016/j.cmet.2014.06.004; Lee JH, 2013, CELL METAB, V18, P792, DOI 10.1016/j.cmet.2013.08.018; Leiser SF, 2015, SCIENCE, V350, P1375, DOI 10.1126/science.aac9257; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine ME, 2014, CELL METAB, V19, P407, DOI 10.1016/j.cmet.2014.02.006; Lewis GD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001006; Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001; Li JX, 2012, NAT CELL BIOL, V14, P999, DOI 10.1038/ncb2562; Lim YM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5934; Lin A.L., 2015, J CEREB BLOOD FLOW M; Liu BH, 2012, CELL METAB, V16, P738, DOI 10.1016/j.cmet.2012.11.007; Liu K, 2015, AUTOPHAGY, V11, P271, DOI 10.1080/15548627.2015.1009787; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Luo YB, 2015, CELL METAB, V22, P886, DOI 10.1016/j.cmet.2015.08.020; Ma SM, 2015, CELL METAB, V22, P332, DOI 10.1016/j.cmet.2015.07.005; Ma TH, 2015, NAT CELL BIOL, V17, P1379, DOI 10.1038/ncb3256; Madeo F, 2015, J CLIN INVEST, V125, P85, DOI 10.1172/JCI73946; Makino N, 2016, MOL CELL BIOCHEM, V412, P119, DOI 10.1007/s11010-015-2615-8; Malik VS, 2015, J AM COLL CARDIOL, V66, P1615, DOI 10.1016/j.jacc.2015.08.025; Mannick JB, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009892; Marino G, 2008, HUM MOL GENET, V17, P2196, DOI 10.1093/hmg/ddn120; Marino G, 2014, MOL CELL, V53, P710, DOI 10.1016/j.molcel.2014.01.016; Masri S, 2014, CELL, V158, P659, DOI 10.1016/j.cell.2014.06.050; Mattison JA, 2014, CELL METAB, V20, P183, DOI 10.1016/j.cmet.2014.04.018; Merkwirth C, 2016, CELL, V165, P1209, DOI 10.1016/j.cell.2016.04.012; Min SW, 2015, NAT MED, V21, P1154, DOI 10.1038/nm.3951; Missios P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5924; Mitchell SJ, 2014, CELL REP, V6, P836, DOI 10.1016/j.celrep.2014.01.031; Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Muezzinler A, 2016, EXP GERONTOL, V74, P1, DOI 10.1016/j.exger.2015.11.019; Muoio DM, 2014, CELL, V159, P1253, DOI 10.1016/j.cell.2014.11.034; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Neufer PD, 2015, CELL METAB, V22, P4, DOI 10.1016/j.cmet.2015.05.011; Obata F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9332; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Ortega-Molina A, 2015, CELL METAB, V21, P558, DOI 10.1016/j.cmet.2015.02.017; Ortega-Molina A, 2012, CELL METAB, V15, P382, DOI 10.1016/j.cmet.2012.02.001; Overmyer KA, 2015, CELL METAB, V21, P468, DOI 10.1016/j.cmet.2015.02.007; Peng Wei, 2012, Sci Transl Med, V4, p118ra11, DOI 10.1126/scitranslmed.3002629; Peters MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9570; Pietrocola F, 2016, CANCER CELL, V30, P147, DOI 10.1016/j.ccell.2016.05.016; Pirinen E, 2014, CELL METAB, V19, P1034, DOI 10.1016/j.cmet.2014.04.002; Platt TL, 2016, NEUROSCIENCE, V315, P162, DOI 10.1016/j.neuroscience.2015.12.011; Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300; Revesz D, 2015, J CLIN ENDOCR METAB, V100, P3050, DOI 10.1210/JC.2015-1995; Riera CE, 2014, CELL, V157, P1023, DOI 10.1016/j.cell.2014.03.051; Ryall JG, 2015, CELL STEM CELL, V17, P651, DOI 10.1016/j.stem.2015.11.012; Sahar S, 2014, J BIOL CHEM, V289, P6091, DOI 10.1074/jbc.M113.537191; Sahin E, 2011, NATURE, V470, P359, DOI 10.1038/nature09787; Sala ML, 2015, AGE AGEING, V44, P713, DOI 10.1093/ageing/afv063; Sanchez-Roman I, 2013, EXP GERONTOL, V48, P1030, DOI 10.1016/j.exger.2013.02.021; Sataranatarajan K, 2016, J GERONTOL A-BIOL, V71, P850, DOI 10.1093/gerona/glv170; Scarpato R, 2011, FASEB J, V25, P685, DOI 10.1096/fj.10-168427; Scheibye-Knudsen M, 2014, CELL METAB, V20, P840, DOI 10.1016/j.cmet.2014.10.005; Schneider JL, 2014, CELL METAB, V20, P417, DOI 10.1016/j.cmet.2014.06.009; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Shi M., 2015, J AM SOC NEPHROL; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Shimizu I, 2014, CELL METAB, V20, P967, DOI 10.1016/j.cmet.2014.10.008; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Shyh-Chang N, 2013, DEVELOPMENT, V140, P2535, DOI 10.1242/dev.091777; Slack C, 2015, CELL, V162, P72, DOI 10.1016/j.cell.2015.06.023; Solon-Biet SM, 2014, CELL METAB, V19, P418, DOI 10.1016/j.cmet.2014.02.009; Soria-Valles C, 2015, NAT CELL BIOL, V17, P1004, DOI 10.1038/ncb3207; Steptoe A, 2014, P NATL ACAD SCI USA, V111, P15693, DOI 10.1073/pnas.1410401111; Strong R, 2008, AGING CELL, V7, P641, DOI 10.1111/j.1474-9726.2008.00414.x; Su XY, 2016, CURR OPIN CHEM BIOL, V30, P52, DOI 10.1016/j.cbpa.2015.10.030; Suarez-Zamorano N, 2015, NAT MED, V21, P1497, DOI 10.1038/nm.3994; Sun N, 2015, MOL CELL, V60, P685, DOI 10.1016/j.molcel.2015.10.009; Sundaresan NR, 2016, MOL CELL BIOL, V36, P678, DOI 10.1128/MCB.00586-15; Tao RY, 2015, DIABETES, V64, P1211, DOI 10.2337/db14-0539; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; Traba J, 2015, J CLIN INVEST, V125, P4592, DOI 10.1172/JCI83260; Umemura A, 2014, CELL METAB, V20, P133, DOI 10.1016/j.cmet.2014.05.001; Ventura N, 2009, AGING CELL, V8, P380, DOI 10.1111/j.1474-9726.2009.00482.x; Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854; Vermeij WP, 2016, ANNU REV PHARMACOL, V56, P427, DOI 10.1146/annurev-pharmtox-010814-124316; Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659; Vogt MC, 2014, CELL, V156, P495, DOI 10.1016/j.cell.2014.01.008; Walsh ME, 2015, AGING CELL, V14, P957, DOI 10.1111/acel.12387; Wang QY, 2015, DIABETES CARE, V38, P1099, DOI 10.2337/dc14-2101; Wang Y, 2015, SCIENCE, V350, P1204, DOI 10.1126/science.aac4357; Weimer S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4563; Wiley CD, 2016, CELL METAB, V23, P303, DOI 10.1016/j.cmet.2015.11.011; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Xu M, 2015, ELIFE, V4, DOI 10.7554/eLife.12997; Yan JQ, 2014, NAT MED, V20, P1001, DOI 10.1038/nm.3616; Yang L, 2016, CELL REP, V14, P422, DOI 10.1016/j.celrep.2015.12.042; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yao YH, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004968; Yee C, 2014, CELL, V157, P897, DOI 10.1016/j.cell.2014.02.055; Yen K, 2013, J MOL ENDOCRINOL, V50, pR11, DOI 10.1530/JME-12-0203; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Yu QJ, 2015, CELL REP, V11, P785, DOI 10.1016/j.celrep.2015.03.069; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693; Zhang XJ, 2011, AUTOPHAGY, V7, P412, DOI 10.4161/auto.7.4.14541; Zhang YC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0044465, 10.1155/2012/583417]; Zierer J, 2016, AGING-US, V8, P77, DOI 10.18632/aging.100874; Zwighaft Z, 2015, CELL METAB, V22, P874, DOI 10.1016/j.cmet.2015.09.011	190	403	408	16	216	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					802	821		10.1016/j.cell.2016.07.031	http://dx.doi.org/10.1016/j.cell.2016.07.031			20	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27518560	Bronze			2022-12-28	WOS:000382258700007
J	Maxwell, S; Fuller, RA; Brooks, TM; Watson, JEM				Maxwell, Sean; Fuller, Richard A.; Brooks, Thomas M.; Watson, James E. M.			The ravages of guns, nets and bulldozers	NATURE			English	Editorial Material							IUCN RED LIST; CLIMATE-CHANGE		[Maxwell, Sean; Watson, James E. M.] Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia; [Fuller, Richard A.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Brooks, Thomas M.] Int Union Conservat Nat, Gland, Switzerland; [Watson, James E. M.] Wildlife Conservat Soc, Global Conservat Program, New York, NY USA	University of Queensland; University of Queensland; Wildlife Conservation Society	Maxwell, S (corresponding author), Univ Queensland, Sch Geog Planning & Environm Management, Brisbane, Qld, Australia.	smaxwell@uq.edu.au	Watson, James Edward Maxwell/D-8779-2013; Fuller, Richard/B-7971-2008	Watson, James Edward Maxwell/0000-0003-4942-1984; Fuller, Richard/0000-0001-9468-9678	Division Of Environmental Biology [1136586] Funding Source: National Science Foundation	Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Anderson BJ, 2009, J APPL ECOL, V46, P888, DOI 10.1111/j.1365-2664.2009.01666.x; Bellard C, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.0623; Brooks TM, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.7; Cote IM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2592; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Hayward MW, 2011, BIODIVERS CONSERV, V20, P2563, DOI 10.1007/s10531-011-0091-3; Keith DA, 2014, CONSERV BIOL, V28, P810, DOI 10.1111/cobi.12234; Laurance WF, 2009, TRENDS ECOL EVOL, V24, P659, DOI 10.1016/j.tree.2009.06.009; Martin TG, 2016, NAT CLIM CHANGE, V6, P122, DOI 10.1038/nclimate2918; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947	10	838	856	22	180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					143	145		10.1038/536143a	http://dx.doi.org/10.1038/536143a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4SV	27510207	Bronze			2022-12-28	WOS:000381472100010
J	Ito, Y; Ofengeim, D; Najafov, A; Das, S; Saberi, S; Li, Y; Hitomi, J; Zhu, H; Chen, HB; Mayo, L; Geng, JF; Amin, P; DeWitt, JP; Mookhtiar, AK; Florez, M; Ouchida, AT; Fan, JB; Pasparakis, M; Kelliher, MA; Ravits, J; Yuan, JY				Ito, Yasushi; Ofengeim, Dimitry; Najafov, Ayaz; Das, Sudeshna; Saberi, Shahram; Li, Ying; Hitomi, Junichi; Zhu, Hong; Chen, Hongbo; Mayo, Lior; Geng, Jiefei; Amin, Palak; DeWitt, Judy Park; Mookhtiar, Adnan Kasim; Florez, Marcus; Ouchida, Amanda Tomie; Fan, Jian-bing; Pasparakis, Manolis; Kelliher, Michelle A.; Ravits, John; Yuan, Junying			RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; KAPPA-B ACTIVATION; MOTOR-NEURON DEATH; CELL-DEATH; SELF-DESTRUCTION; OPTINEURIN; KINASE; IDENTIFICATION; MICE; REGENERATION	Mutations in the optineurin (OPTN) gene have been implicated in both familial and sporadic amyotrophic lateral sclerosis (ALS). However, the role of this protein in the central nervous system (CNS) and how it may contribute to ALS pathology are unclear. Here, we found that optineurin actively suppressed receptor-interacting kinase 1 (RIPK1)-dependent signaling by regulating its turnover. Loss of OPTN led to progressive dysmyelination and axonal degeneration through engagement of necroptotic machinery in the CNS, including RIPK1, RIPK3, and mixed lineage kinase domain-like protein (MLKL). Furthermore, RIPK1- and RIPK3-mediated axonal pathology was commonly observed in SOD1(G93A) transgenic mice and pathological samples from human ALS patients. Thus, RIPK1 and RIPK3 play a critical role in mediating progressive axonal degeneration. Furthermore, inhibiting RIPK1 kinase may provide an axonal protective strategy for the treatment of ALS and other human degenerative diseases characterized by axonal degeneration.	[Ito, Yasushi; Ofengeim, Dimitry; Najafov, Ayaz; Li, Ying; Hitomi, Junichi; Zhu, Hong; Chen, Hongbo; Geng, Jiefei; Amin, Palak; DeWitt, Judy Park; Mookhtiar, Adnan Kasim; Florez, Marcus; Ouchida, Amanda Tomie; Yuan, Junying] Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA; [Das, Sudeshna] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Dis, Cambridge, MA 02139 USA; [Saberi, Shahram; Ravits, John] Harvard Med Sch, Dept Neurol, Boston, MA 02115 USA; [Saberi, Shahram; Ravits, John] Univ Calif San Diego, Dept Neurosci, ALS Translat Res Program, La Jolla, CA 92093 USA; [Li, Ying; Yuan, Junying] Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, 26 QiuYue Rd, Shanghai 201210, Peoples R China; [Mayo, Lior] Harvard Med Sch, Brigham & Womens Hosp, Ann Romney Ctr Neurol Dis, Boston, MA 02115 USA; [Fan, Jian-bing] Illumina Inc, San Diego, CA 92122 USA; [Pasparakis, Manolis] Univ Cologne, Inst Genet, D-50674 Cologne, Germany; [Kelliher, Michelle A.] Univ Massachusetts, Dept Canc Biol, Sch Med, Worcester, MA 01605 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California San Diego; Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Illumina; University of Cologne; University of Massachusetts System; University of Massachusetts Worcester	Yuan, JY (corresponding author), Harvard Med Sch, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.; Yuan, JY (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, Interdisciplinary Res Ctr Biol & Chem, 26 QiuYue Rd, Shanghai 201210, Peoples R China.	jyuan@hms.harvard.edu	Najafov, Ayaz/AAY-9135-2021; Chen, Hongbo/P-5263-2019; Pasparakis, Manolis/N-4350-2019; Pasparakis, Manolis/H-9292-2017; m, Lior/AGK-3671-2022	Najafov, Ayaz/0000-0002-1350-2056; Chen, Hongbo/0000-0002-9084-7277; Pasparakis, Manolis/0000-0002-9870-0966; Pasparakis, Manolis/0000-0002-9870-0966; m, Lior/0000-0002-1296-6692; Zhu, Hong/0000-0002-2575-4031; Amin, Palak/0000-0001-5617-8703; Li, Ying/0000-0002-3506-1255; Das, Sudeshna/0000-0002-9486-6811	National Institute of Neurological Disorders and Stroke, NIH [1R01NS082257]; National Institute on Aging, NIH [1R01AG047231]; National Science and Technology Major Project of China [2014ZX09102001-002]; State Key Program of National Natural Science of China [31530041]; National Institute of Allergy and Infectious Diseases [2RO1AI075118]; European Research Council [323040]; Daiichi Sankyo Foundation of Life Science (Japan); Nakatomi Foundation (Japan); Mochida Memorial Foundation for Medical and Pharmaceutical Research (Japan); Japan Society for the Promotion of Science (Japan); National Multiple Sclerosis Society; National Multiple Sclerosis Society Career Transition Award; Huazhong University of Science and Technology, Wuhan, China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075118] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS082257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047231] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Science and Technology Major Project of China; State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Research Council(European Research Council (ERC)European Commission); Daiichi Sankyo Foundation of Life Science (Japan); Nakatomi Foundation (Japan); Mochida Memorial Foundation for Medical and Pharmaceutical Research (Japan); Japan Society for the Promotion of Science (Japan)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Multiple Sclerosis Society Career Transition Award(National Multiple Sclerosis Society); Huazhong University of Science and Technology, Wuhan, China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank B. Caldarone of the NeuroBehavior Laboratory, Harvard Institute of Medicine, for conducting mouse behavior analysis; J. Walters at the Harvard Medical School Nikon microscope facility for fluorescence microscopy; and M. Ericsson of the Electron Microscopy Facility at Harvard Medical School for analysis. This work was supported in part by grants from the National Institute of Neurological Disorders and Stroke (1R01NS082257) and the National Institute on Aging (1R01AG047231), NIH; and by the National Science and Technology Major Project of China (2014ZX09102001-002) and State Key Program of National Natural Science of China (no. 31530041) (to J.Y.); National Institute of Allergy and Infectious Diseases (2RO1AI075118) (to M.A.K.); European Research Council Advanced Grants (grant agreement no. 323040) (to M.P.) and Target ALS (to J.R.). Y.I. was supported in part by postdoctoral fellowships from Japan (Daiichi Sankyo Foundation of Life Science, The Nakatomi Foundation, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, and Japan Society for the Promotion of Science). D.O. was supported by a postdoctoral fellowship from the National Multiple Sclerosis Society and a National Multiple Sclerosis Society Career Transition Award. H.C. was supported by a grant from Huazhong University of Science and Technology, Wuhan, China. Ripk3<SUP>-/-</SUP> mice and K48 ubiquitin antibodies are available from V. Dixit under a material transfer agreement with Genentech. Ripk1<SUP>D138N</SUP> mice are available from M. Pasparakis of University of Cologne, Germany, under a material transfer agreement with University of Cologne. J.Y. is an inventor on U.S. patent 7,491,743 B2 held by Harvard University that covers 7-Cl-O-Nec-1.	Beeldman E, 2015, AMYOTROPH LAT SCL FR, V16, P410, DOI 10.3109/21678421.2015.1066821; Berger SI, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-372; Christofferson DE, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.64; Christofferson DE, 2010, CURR OPIN CELL BIOL, V22, P263, DOI 10.1016/j.ceb.2009.12.003; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT CHEM BIOL, V4, P313, DOI 10.1038/nchembio.83; Deng HX, 2011, ARCH NEUROL-CHICAGO, V68, P1057, DOI 10.1001/archneurol.2011.178; Gould TW, 2006, J NEUROSCI, V26, P8774, DOI 10.1523/JNEUROSCI.2315-06.2006; He SD, 2009, CELL, V137, P1100, DOI 10.1016/j.cell.2009.05.021; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Munitic I, 2013, J IMMUNOL, V191, P6231, DOI 10.4049/jimmunol.1301696; Ofengeim D, 2015, CELL REP, V10, P1836, DOI 10.1016/j.celrep.2015.02.051; Ofengeim D, 2013, NAT REV MOL CELL BIO, V14, P727, DOI 10.1038/nrm3683; Osawa T, 2011, NEUROPATHOLOGY, V31, P569, DOI 10.1111/j.1440-1789.2011.01199.x; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Peschon JJ, 1998, J IMMUNOL, V160, P943; Polykratis A, 2014, J IMMUNOL, V193, P1539, DOI 10.4049/jimmunol.1400590; Raff MC, 2002, SCIENCE, V296, P868, DOI 10.1126/science.1068613; Re DB, 2014, NEURON, V81, P1001, DOI 10.1016/j.neuron.2014.01.011; SASAKI S, 1992, J NEUROL SCI, V110, P114, DOI 10.1016/0022-510X(92)90017-F; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhu G, 2007, CURR BIOL, V17, P1438, DOI 10.1016/j.cub.2007.07.041; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	34	323	340	11	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					603	608		10.1126/science.aaf6803	http://dx.doi.org/10.1126/science.aaf6803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27493188	Green Accepted			2022-12-28	WOS:000381560900045
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: NHS continuing care is a mess	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Appleby J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1563; Barker K., 2014, NEW SETTLEMENT HLTH; *COMM FUND CAR SUP, 2011, SUMM RESP CALL EV; *DEP HLTH, 2007, FRAM ASS NHS CONT HE; *DEP HLTH, 2012, NAT FRAM NHS FUND CO; HAYWARD C, 2014, BBC NEWS; McNicoll A., 2013, COMMUNITY CARE; *NHS BENCHM, 2015, OLD PEOPL AC CAR SET; *NHS ENGL, 2015, MONTH DEL TRANS CAR; POWELL T, 2014, SOCIAL POLICY NOTE S; Thompson J., 2015, DELAYED TRANSFERS CA; 2015, INDEPENDENT AGE FACT	12	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2016	354								i4214	10.1136/bmj.i4214	http://dx.doi.org/10.1136/bmj.i4214			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9DD	27495806	Bronze, Green Published			2022-12-28	WOS:000381081800001
J	Butt, CA				Butt, Carrie A.			Cave Dwellings Deforrest Judd	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																		2016, THE ART OF JAMA 0616	1	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2016	316	5					480	481		10.1001/jama.2015.14408	http://dx.doi.org/10.1001/jama.2015.14408			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9AU	27483055				2022-12-28	WOS:000381075000001
J	Krakauer, EL; Rajagopal, MR				Krakauer, Eric L.; Rajagopal, M. R.			End-of-life care across the world: a global moral failing	LANCET			English	Editorial Material									[Krakauer, Eric L.] Harvard Med Sch, Ctr Palliat Care, Boston, MA 02115 USA; [Krakauer, Eric L.] Massachusetts Gen Hosp, Div Palliat Care, Boston, MA 02114 USA; [Rajagopal, M. R.] WHO Collaborating Ctr Training & Policy Access Pa, Pallium India, Thiruvananthapuram, Kerala, India	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Krakauer, EL (corresponding author), Harvard Med Sch, Ctr Palliat Care, Boston, MA 02115 USA.; Krakauer, EL (corresponding author), Massachusetts Gen Hosp, Div Palliat Care, Boston, MA 02114 USA.	eric_krakauer@hms.harvard.edu						Chalkidou K, 2014, LANCET ONCOL, V15, pE119, DOI 10.1016/S1470-2045(13)70547-3; DesRosiers T, 2014, J PAIN SYMPTOM MANAG, V47, P786, DOI 10.1016/j.jpainsymman.2013.05.021; Economist Intelligence Unit, 2015, 2015 QUAL DEATH IND; Economist Intelligence Unit, 2010, 2010 QUAL DEATH IND; Gomez-Batiste X, 2012, J PAIN SYMPTOM MANAG, V43, P783, DOI 10.1016/j.jpainsymman.2011.05.006; Krakauer EL, 2007, SUBJECTIVITY ETHNOGR; Krakauer EL, 2008, J PAIN SYMPTOM MANAG, V36, P505, DOI 10.1016/j.jpainsymman.2007.11.015; World Health Organization, 2014, GLOBAL ATLAS PALLIAT; World Health Organization (WHO), DEF PALL CAR	9	4	4	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2016	388	10043					444	446						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS2EK	27507744				2022-12-28	WOS:000380559400007
J	Cronk, Q				Cronk, Quentin			Plant extinctions take time	SCIENCE			English	Editorial Material							DEBT		[Cronk, Quentin] Univ British Columbia, Beaty Biodivers Res Ctr, Vancouver, BC, Canada	University of British Columbia	Cronk, Q (corresponding author), Univ British Columbia, Beaty Biodivers Res Ctr, Vancouver, BC, Canada.	quentin.cronk@ubc.ca		Cronk, Quentin/0000-0002-4027-7368				Cronk Q. C. B., 2000, ENDEMIC FLORA ST HEL; DIAMOND JM, 1972, P NATL ACAD SCI USA, V69, P3199, DOI 10.1073/pnas.69.11.3199; Downey PO, 2016, AOB PLANTS, V8, DOI 10.1093/aobpla/plw047; Gibson L, 2013, SCIENCE, V341, P1508, DOI 10.1126/science.1240495; Groombridge JJ, 2001, J ANIM ECOL, V70, P401, DOI 10.1046/j.1365-2656.2001.00502.x; Hanski I, 2000, ANN ZOOL FENN, V37, P271; He FL, 2013, ECOLOGY, V94, P1905, DOI 10.1890/12-1795.1; Hylander K, 2013, TRENDS ECOL EVOL, V28, P341, DOI 10.1016/j.tree.2013.01.010; Janzen DH, 2001, ENCY BIODIVERSITY, DOI [10.1016/B978-0-12-384719-5.00085-X, DOI 10.1016/B978-0-12-384719-5.00085-X]; JENKINS M, 1992, GLOBAL BIODIVERSITY; REID WV, 1992, TROPICAL DEFORESTATION AND SPECIES EXTINCTION, P55; Royal Botanic Gardens Kew, 2016, STAT WORLDS PLANTS; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Vellend M, 2006, ECOLOGY, V87, P542, DOI 10.1890/05-1182; Wearn OR, 2012, SCIENCE, V337, P228, DOI 10.1126/science.1219013	15	56	56	2	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					446	447		10.1126/science.aag1794	http://dx.doi.org/10.1126/science.aag1794			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27471294				2022-12-28	WOS:000380583600022
J	Vallery, TK				Vallery, Tenaya K.			Growth from failure	SCIENCE			English	Editorial Material									[Vallery, Tenaya K.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Vallery, TK (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))			0	1	1	1	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					514	514		10.1126/science.353.6298.514	http://dx.doi.org/10.1126/science.353.6298.514			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27471305				2022-12-28	WOS:000380583600047
J	Williams, JL; Kendall, BE; Levine, JM				Williams, Jennifer L.; Kendall, Bruce E.; Levine, Jonathan M.			Rapid evolution accelerates plant population spread in fragmented experimental landscapes	SCIENCE			English	Article							DISPERSAL; INVASIONS; STOCHASTICITY	Predicting the speed of biological invasions and native species migrations requires an understanding of the ecological and evolutionary dynamics of spreading populations. Theory predicts that evolution can accelerate species' spread velocity, but how landscape patchiness-an important control over traits under selection-influences this process is unknown. We manipulated the response to selection in populations of a model plant species spreading through replicated experimental landscapes of varying patchiness. After six generations of change, evolving populations spread 11% farther than nonevolving populations in continuously favorable landscapes and 200% farther in the most fragmented landscapes. The greater effect of evolution on spread in patchier landscapes was consistent with the evolution of dispersal and competitive ability. Accounting for evolutionary change may be critical when predicting the velocity of range expansions.	[Williams, Jennifer L.] Univ British Columbia, Dept Geog, 1984 West Mall, Vancouver, BC V6T 1Z2, Canada; [Williams, Jennifer L.] Univ British Columbia, Biodivers Res Ctr, 1984 West Mall, Vancouver, BC V6T 1Z2, Canada; [Kendall, Bruce E.] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Levine, Jonathan M.] Swiss Fed Inst Technol, Inst Integrat Biol, Univ Str 16, CH-8092 Zurich, Switzerland	University of British Columbia; University of British Columbia; University of California System; University of California Santa Barbara; Swiss Federal Institutes of Technology Domain; ETH Zurich	Williams, JL (corresponding author), Univ British Columbia, Dept Geog, 1984 West Mall, Vancouver, BC V6T 1Z2, Canada.; Williams, JL (corresponding author), Univ British Columbia, Biodivers Res Ctr, 1984 West Mall, Vancouver, BC V6T 1Z2, Canada.	jennifer.williams@geog.ubc.ca	Williams, Jennifer L/H-1717-2011; Levine, Jonathan/A-7167-2014; Williams, Jennifer/AAG-9660-2019; Kendall, Bruce/C-1871-2008	Williams, Jennifer L/0000-0002-4497-4961; Williams, Jennifer/0000-0002-4497-4961; Kendall, Bruce/0000-0003-1782-8106; Levine, Jonathan/0000-0003-2857-7904	Swiss National Science Foundation [31003A_141025, IZK0Z3_163497]; U.S. NSF [DEB-1120865]; Natural Sciences and Engineering Research Council of Canada	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); U.S. NSF(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank S. Giovanettina, R. Guidon, A. Bieger, M. Clerc, and other members of the ETH Zurich Plant Ecology group for help with performing the experiments and F. Altermatt, A. Angert, T. Miller, and the Plant Ecology group for providing comments on the manuscript. J.M.L., J.L.W., and B.E.K. acknowledge support from the Swiss National Science Foundation (grants 31003A_141025 and IZK0Z3_163497), B.E.K. from the U.S. NSF (grant DEB-1120865), and J.L.W. from the Natural Sciences and Engineering Research Council of Canada. Data described in the paper are available from the Dryad Digital Repository: http://dx.doi.org/10.5061/dryad.q7605.	ABBOTT RJ, 1989, HEREDITY, V62, P411, DOI 10.1038/hdy.1989.56; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; Chuang A, 2016, GLOBAL CHANGE BIOL, V22, P494, DOI 10.1111/gcb.13107; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Fakheran S, 2010, P NATL ACAD SCI USA, V107, P19120, DOI 10.1073/pnas.1010846107; Fronhofer EA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7844; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Hughes CL, 2007, ECOL ENTOMOL, V32, P437, DOI 10.1111/j.1365-2311.2007.00890.x; Kilkenny FF, 2013, EVOLUTION, V67, P722, DOI 10.1111/j.1558-5646.2012.01829.x; Kot M, 1996, ECOLOGY, V77, P2027, DOI 10.2307/2265698; Lindenmayer DB, 2013, HABITAT FRAGMENTATIO; Melbourne BA, 2009, SCIENCE, V325, P1536, DOI 10.1126/science.1176138; Miller TEX, 2013, ECOL LETT, V16, P354, DOI 10.1111/ele.12049; Pachepsky E, 2011, AM NAT, V177, P18, DOI 10.1086/657438; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Perkins TA, 2013, ECOL LETT, V16, P1079, DOI 10.1111/ele.12136; Phillips BL, 2010, J EVOLUTION BIOL, V23, P2595, DOI 10.1111/j.1420-9101.2010.02118.x; Phillips BL, 2015, BIOL INVASIONS, V17, P1949, DOI 10.1007/s10530-015-0849-8; Phillips BL, 2008, AM NAT, V172, pS34, DOI 10.1086/588255; Phillips BL, 2006, NATURE, V439, P803, DOI 10.1038/439803a; SHIGESADA N, 1986, THEOR POPUL BIOL, V30, P143, DOI 10.1016/0040-5809(86)90029-8; Shine R, 2011, P NATL ACAD SCI USA, V108, P5708, DOI 10.1073/pnas.1018989108; Simmons AD, 2004, AM NAT, V164, P378, DOI 10.1086/423430; Snyder RE, 2003, ECOLOGY, V84, P1333, DOI 10.1890/0012-9658(2003)084[1333:HDSCSB]2.0.CO;2; Thomas CD, 2001, NATURE, V411, P577, DOI 10.1038/35079066; Travis JMJ, 2010, DIVERS DISTRIB, V16, P690, DOI 10.1111/j.1472-4642.2010.00674.x; Williams JL, 2016, AM NAT, V188, P15, DOI 10.1086/686685; Williamson M., 1996, BIOL INVASIONS	28	80	80	2	115	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					482	485		10.1126/science.aaf6268	http://dx.doi.org/10.1126/science.aaf6268			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27471303	Green Submitted			2022-12-28	WOS:000380583600039
J	Sousa, CM; Biancur, DE; Wang, XX; Halbrook, CJ; Sherman, MH; Zhang, L; Kremer, D; Hwang, RF; Witkiewicz, AK; Ying, HQ; Asara, JM; Evans, RM; Cantley, LC; Lyssiotis, CA; Kimmelman, AC				Sousa, Cristovao M.; Biancur, Douglas E.; Wang, Xiaoxu; Halbrook, Christopher J.; Sherman, Mara H.; Zhang, Li; Kremer, Daniel; Hwang, Rosa F.; Witkiewicz, Agnes K.; Ying, Haoqiang; Asara, John M.; Evans, Ronald M.; Cantley, Lewis C.; Lyssiotis, Costas A.; Kimmelman, Alec C.			Pancreatic stellate cells support tumour metabolism through autophagic alanine secretion	NATURE			English	Article							CANCER; FIBROBLASTS; GROWTH; PROGRESSION; PROTEIN	Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease characterized by an intense fibrotic stromal response and deregulated metabolism(1-4). The role of the stroma in PDAC biology is complex and it has been shown to play critical roles that differ depending on the biological context(5-10). The stromal reaction also impairs the vasculature, leading to a highly hypoxic, nutrient-poor environment(4,11,12). As such, these tumours must alter how they capture and use nutrients to support their metabolic needs(11,13). Here we show that stroma-associated pancreatic stellate cells (PSCs) are critical for PDAC metabolism through the secretion of non-essential amino acids (NEAA). Specifically, we uncover a previously undescribed role for alanine, which outcompetes glucose and glutamine-derived carbon in PDAC to fuel the tricarboxylic acid (TCA) cycle, and thus NEAA and lipid biosynthesis. This shift in fuel source decreases the tumour's dependence on glucose and serum-derived nutrients, which are limited in the pancreatic tumour microenvironment(4,11). Moreover, we demonstrate that alanine secretion by PSCs is dependent on PSC autophagy, a process that is stimulated by cancer cells. Thus, our results demonstrate a novel metabolic interaction between PSCs and cancer cells, in which PSC-derived alanine acts as an alternative carbon source. This finding highlights a previously unappreciated metabolic network within pancreatic tumours in which diverse fuel sources are used to promote growth in an austere tumour microenvironment.	[Sousa, Cristovao M.; Biancur, Douglas E.; Wang, Xiaoxu; Kimmelman, Alec C.] Harvard Med Sch, Dana Farber Canc Inst, Dept Radiat Oncol, Div Genom Stabil & DNA Repair, Boston, MA 02215 USA; [Halbrook, Christopher J.; Zhang, Li; Kremer, Daniel; Lyssiotis, Costas A.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Sherman, Mara H.; Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA; [Hwang, Rosa F.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77230 USA; [Witkiewicz, Agnes K.] UT Southwestern, Dept Pathol, Dallas, TX 75390 USA; [Witkiewicz, Agnes K.] UT Southwestern, Simmons Canc Ctr, Dallas, TX 75390 USA; [Ying, Haoqiang] UT MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Dept Med, Div Signal Transduct, Boston, MA 02115 USA; [Asara, John M.] Harvard Med Sch, Boston, MA 02115 USA; [Cantley, Lewis C.] Weill Cornell Med Coll, Dept Med, Meyer Canc Ctr, New York, NY 10065 USA; [Lyssiotis, Costas A.] Univ Michigan, Sch Med, Div Gastroenterol, Dept Internal Med, Ann Arbor, MI 48109 USA; [Kimmelman, Alec C.] NYU, Langone Med Ctr, Perlmutter Canc Ctr, Dept Radiat Oncol, New York, NY 10016 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; Salk Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Cornell University; University of Michigan System; University of Michigan; New York University; NYU Langone Medical Center	Kimmelman, AC (corresponding author), Harvard Med Sch, Dana Farber Canc Inst, Dept Radiat Oncol, Div Genom Stabil & DNA Repair, Boston, MA 02215 USA.; Lyssiotis, CA (corresponding author), Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.; Lyssiotis, CA (corresponding author), Univ Michigan, Sch Med, Div Gastroenterol, Dept Internal Med, Ann Arbor, MI 48109 USA.; Kimmelman, AC (corresponding author), NYU, Langone Med Ctr, Perlmutter Canc Ctr, Dept Radiat Oncol, New York, NY 10016 USA.	clyssiot@med.umich.edu; alec.kimmelman@nyumc.org	Evans, Ronald/AAF-4001-2019; Ying, Haoqiang/AAK-4325-2020; Lyssiotis, Costas A/AAI-1923-2019	Evans, Ronald/0000-0002-9986-5965; Lyssiotis, Costas A/0000-0001-9309-6141	NIH [5P30CA06516, GM095567, DK097153]; NCI [R01CA157490, R01CA188048]; ACS [RSG-13-298-01-TBG]; Lustgarten Foundation; PanCAN-AACRPathway to Leadership award; Dale F. Frey award from Damon Runyon Cancer Research Foundation [DFS-09-14]; PanCAN-AACR; Stand Up to Cancer Dream Team Translational Cancer Research Grant, a Program of the Entertainment Industry Foundation [SU2C-AACR-DT0509];  [P01CA117969];  [P30CA006516];  [P01CA120964]; NATIONAL CANCER INSTITUTE [P01CA120964, P30CA006516, P01CA117969, R01CA157490, P30CA046592, P30CA014195, T32CA009370, R00CA188259, R01CA188048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK057978, U24DK097153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095567] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD010612] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ACS(American Cancer Society); Lustgarten Foundation; PanCAN-AACRPathway to Leadership award; Dale F. Frey award from Damon Runyon Cancer Research Foundation; PanCAN-AACR; Stand Up to Cancer Dream Team Translational Cancer Research Grant, a Program of the Entertainment Industry Foundation; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Kimmelman laboratory members for reading the manuscript, A. Yang for help with orthotopic injections, M. Yuan and S. Breitkopf for technical support with mass spectrometry, E. Sicinska for resected PDAC specimens, and the Dana-Farber/Harvard Cancer Center Rodent Histopathology Core for assistance with tissue processing. DFHCC is supported in part by NIH 5P30CA06516. A.C.K. is supported by NIH grant GM095567, NCI grants R01CA157490, R01CA188048, ACS Research Scholar Grant (RSG-13-298-01-TBG), and the Lustgarten Foundation. C.A.L. is supported by a PanCAN-AACRPathway to Leadership award and a Dale F. Frey award from the Damon Runyon Cancer Research Foundation (DFS-09-14). Metabolomics studies performed at the University of Michigan were supported by NIH grant DK097153. L.C.C. was supported by P01CA117969, PanCAN-AACR and the Lustgarten Foundation. J.M.A. was supported by P30CA006516 and P01CA120964. R.M.E. is an investigator of the Howard Hughes Medical Institute and March of Dimes Chair in Molecular and Developmental Biology at the Salk Institute, and is supported in part by grants from The Lustgarten Foundation and a Stand Up to Cancer Dream Team Translational Cancer Research Grant, a Program of the Entertainment Industry Foundation (SU2C-AACR-DT0509).	Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Erkan M, 2012, GUT, V61, P172, DOI 10.1136/gutjnl-2011-301220; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Fernandez CA, 1996, J MASS SPECTROM, V31, P255, DOI 10.1002/(SICI)1096-9888(199603)31:3<255::AID-JMS290>3.0.CO;2-3; Gore J, 2014, CANCER CELL, V25, P711, DOI 10.1016/j.ccr.2014.05.026; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Kamphorst JJ, 2015, CANCER RES, V75, P544, DOI 10.1158/0008-5472.CAN-14-2211; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Sastra Stephen A, 2013, Methods Mol Biol, V980, P249, DOI 10.1007/978-1-62703-287-2_13; Serrao EM, 2016, GUT, V65, P465, DOI 10.1136/gutjnl-2015-310114; Sherman MH, 2014, CELL, V159, P80, DOI 10.1016/j.cell.2014.08.007; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843; Sousa CM, 2014, CARCINOGENESIS, V35, P1441, DOI 10.1093/carcin/bgu097; Tape CJ, 2016, CELL, V165, P910, DOI 10.1016/j.cell.2016.03.029; Trinquier G, 1998, PROTEIN ENG, V11, P153, DOI 10.1093/protein/11.3.153; Whatcott CJ, 2015, CLIN CANCER RES, V21, P3561, DOI 10.1158/1078-0432.CCR-14-1051; Wilson J. S., J GASTROENTEROL H S2, V27, P69; Yang A, 2014, CANCER DISCOV, V4, P905, DOI 10.1158/2159-8290.CD-14-0362; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yuan M, 2012, NAT PROTOC, V7, P872, DOI 10.1038/nprot.2012.024; Zhao HY, 2016, ELIFE, V5, DOI 10.7554/eLife.10250	29	605	618	11	220	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					479	+		10.1038/nature19084	http://dx.doi.org/10.1038/nature19084			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27509858	Green Accepted			2022-12-28	WOS:000382646600046
J	Jacques, DA; McEwan, WA; Hilditch, L; Price, AJ; Towers, GJ; James, LC				Jacques, David A.; McEwan, William A.; Hilditch, Laura; Price, Amanda J.; Towers, Greg J.; James, Leo C.			HIV-1 uses dynamic capsid pores to import nucleotides and fuel encapsidated DNA synthesis	NATURE			English	Article							AMINO-TERMINAL DOMAIN; CRYSTAL-STRUCTURES; PROTEIN; RECOGNITION	During the early stages of infection, the HIV-1 capsid protects viral components from cytosolic sensors and nucleases such as cGAS and TREX, respectively, while allowing access to nucleotides for efficient reverse transcription1. Here we show that each capsid hexamer has a size-selective pore bound by a ring of six arginine residues and a 'molecular iris' formed by the amino-terminal beta-hairpin. The arginine ring creates a strongly positively charged channel that recruits the four nucleotides with on-rates that approach diffusion limits. Progressive removal of pore arginines results in a dose-dependent and concomitant decrease in nucleotide affinity, reverse transcription and infectivity. This positively charged channel is universally conserved in lentiviral capsids despite the fact that it is strongly destabilizing without nucleotides to counteract charge repulsion. We also describe a channel inhibitor, hexacarboxybenzene, which competes for nucleotide binding and efficiently blocks encapsidated reverse transcription, demonstrating the tractability of the pore as a novel drug target.	[Jacques, David A.; McEwan, William A.; Price, Amanda J.; James, Leo C.] MRC Lab Mol Biol, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England; [Hilditch, Laura; Towers, Greg J.] UCL, Infect & Immun, Cruciform Bldg 3-3,90 Gower St, London WC1E 6BT, England; [Price, Amanda J.] Astex Pharmaceut, 436 Cambridge Sci Pk,Milton Rd, Cambridge CB4 0QA, England	MRC Laboratory Molecular Biology; University of London; University College London; Astex Pharmaceuticals	James, LC (corresponding author), MRC Lab Mol Biol, Francis Crick Ave,Cambridge Biomed Campus, Cambridge CB2 0QH, England.; Towers, GJ (corresponding author), UCL, Infect & Immun, Cruciform Bldg 3-3,90 Gower St, London WC1E 6BT, England.	g.towers@ucl.ac.uk; lcj@mrc-lmb.cam.ac.uk		Jacques, David/0000-0002-6426-4510; Towers, Gregory/0000-0002-7707-0264	Medical Research Council (UK) [U105181010]; European Research Council [281627 -IAI]; European Research Council under the European Union; ERC [339223]; National Institute for Health Research University College London Hospitals Biomedical Research Centre; Wellcome Trust; NHMRC [GNT1036521]; Emmanuel College, Cambridge; MRC [G9721629, MC_U105181010, MC_PC_12024, G0801172] Funding Source: UKRI; Medical Research Council [MC_PC_12024, MC_U105181010] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council(European Research Council (ERC)European Commission); European Research Council under the European Union(European Research Council (ERC)); ERC(European Research Council (ERC)European Commission); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); Wellcome Trust(Wellcome TrustEuropean Commission); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Emmanuel College, Cambridge; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was funded by the Medical Research Council (UK; U105181010), the European Research Council (281627 -IAI), the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013), ERC grant agreement number 339223 and the National Institute for Health Research University College London Hospitals Biomedical Research Centre. G.J.T. was supported by a Wellcome Trust Senior Biomedical Research Fellowship, D.A.J. by an NHMRC Early Career Fellowship (CJ Martin) (GNT1036521) and AJP by a Research Fellowship from Emmanuel College, Cambridge. We thank L. McKeane for her help designing figures.	Arhel NJ, 2007, EMBO J, V26, P3025, DOI 10.1038/sj.emboj.7601740; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bar-Even A, 2015, BIOCHEMISTRY-US, V54, P4969, DOI 10.1021/acs.biochem.5b00621; Campbell EM, 2015, NAT REV MICROBIOL, V13, P471, DOI 10.1038/nrmicro3503; Cheley S, 2002, CHEM BIOL, V9, P829, DOI 10.1016/S1074-5521(02)00172-2; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chowdhury C, 2015, P NATL ACAD SCI USA, V112, P2990, DOI 10.1073/pnas.1423672112; Du SC, 2011, J MOL BIOL, V406, P371, DOI 10.1016/j.jmb.2010.11.027; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gamble TR, 1996, CELL, V87, P1285, DOI 10.1016/S0092-8674(00)81823-1; Gres AT, 2015, SCIENCE, V349, P99, DOI 10.1126/science.aaa5936; Julias JG, 2001, J VIROL, V75, P6537, DOI 10.1128/JVI.75.14.6537-6546.2001; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Kelly BN, 2006, BIOCHEMISTRY-US, V45, P11257, DOI 10.1021/bi060927x; Kennedy EM, 2012, J BIOL CHEM, V287, P14280, DOI 10.1074/jbc.M112.348482; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; MAGALHAES A, 1994, J PROTEIN CHEM, V13, P195, DOI 10.1007/BF01891978; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mortuza GB, 2008, J MOL BIOL, V376, P1493, DOI 10.1016/j.jmb.2007.12.043; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neves MAC, 2012, J PHYS CHEM B, V116, P7006, DOI 10.1021/jp3009699; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Price AJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004459; Price AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002896; Price AJ, 2009, NAT STRUCT MOL BIOL, V16, P1036, DOI 10.1038/nsmb.1667; Rasaiyaah J, 2013, NATURE, V503, P402, DOI 10.1038/nature12769; Rihn SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003461; Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427; Shah VB, 2011, JOVE-J VIS EXP, V57, P3384; Tanaka S, 2010, SCIENCE, V327, P81, DOI 10.1126/science.1179513; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; Warrilow D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013229; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Ylinen LMJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001062; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162	40	129	130	2	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					349	+		10.1038/nature19098	http://dx.doi.org/10.1038/nature19098			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27509857	Green Accepted, Green Submitted			2022-12-28	WOS:000381804900039
J	Plusa, B; Hadjantonakis, AK				Plusa, Berenika; Hadjantonakis, Anna-Katerina			Mechanics drives cell differentiation	NATURE			English	Editorial Material							PREIMPLANTATION MOUSE EMBRYO; POLARITY		[Plusa, Berenika] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Hadjantonakis, Anna-Katerina] Mem Sloan Kettering Canc Ctr, Dev Biol Program, Sloan Kettering Inst, New York, NY 10065 USA	University of Manchester; Memorial Sloan Kettering Cancer Center	Plusa, B (corresponding author), Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England.	berenika.plusa@manchester.ac.uk; hadj@mskcc.org		Hadjantonakis, Anna-Katerina/0000-0002-7580-5124; Plusa, Berenika/0000-0003-2214-5940				Anani S, 2014, DEVELOPMENT, V141, P2813, DOI 10.1242/dev.107276; Chazaud C, 2016, DEVELOPMENT, V143, P1063, DOI 10.1242/dev.128314; HILLMAN N, 1972, J EMBRYOL EXP MORPH, V28, P263; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; Johnson MH, 2004, SEMIN CELL DEV BIOL, V15, P583, DOI 10.1016/j.semcdb.2004.04.002; Maitre JL, 2016, NATURE, V536, P344, DOI 10.1038/nature18958; Piotrowska K, 2001, NATURE, V409, P517, DOI 10.1038/35054069; Plusa B, 2005, J CELL SCI, V118, P505, DOI 10.1242/jcs.01666; Samarage CR, 2015, DEV CELL, V34, P435, DOI 10.1016/j.devcel.2015.07.004; Sasaki H, 2015, SEMIN CELL DEV BIOL, V47-48, P80, DOI 10.1016/j.semcdb.2015.05.003; TARKOWSKI AK, 1967, J EMBRYOL EXP MORPH, V18, P155	11	8	8	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					281	282		10.1038/nature18920	http://dx.doi.org/10.1038/nature18920			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27487214				2022-12-28	WOS:000381804900024
J	Fletcher, RH				Fletcher, Robert H.			Review: Aspirin for CVD primary prevention increases gastrointestinal bleeding and hemorrhagic stroke	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							SERVICES TASK-FORCE		[Fletcher, Robert H.] Harvard Med Sch, Chapel Hill, NC 27514 USA		Fletcher, RH (corresponding author), Harvard Med Sch, Chapel Hill, NC 27514 USA.							Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Bibbins-Domingo K, 2016, ANN INTERN MED, V164, P836, DOI 10.7326/M16-0577; Guirguis-Blake JM, 2016, ANN INTERN MED, V164, P804, DOI 10.7326/M15-2113	3	8	8	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					JC17	JC17		10.7326/ACPJC-2016-165-4-017	http://dx.doi.org/10.7326/ACPJC-2016-165-4-017			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UI	27538178				2022-12-28	WOS:000381267200004
J	Govindan, S; Iwashyna, TJ				Govindan, Sushant; Iwashyna, Theodore J.			Inpatient Notes: Sepsis-3 for Hospitalists-Sepsis Without SIRS	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							INTERNATIONAL CONSENSUS DEFINITIONS; INFLAMMATORY RESPONSE SYNDROME; SEPTIC SHOCK SEPSIS-3; CRITERIA		[Govindan, Sushant] Univ Michigan Hlth Syst, 1500 East Med Ctr Dr,SPC 5376, Ann Arbor, MI 48109 USA; [Iwashyna, Theodore J.] Vet Affairs Ann Arbor Healthcare Syst, 300 North Ingalls Bldg, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Govindan, S (corresponding author), Univ Michigan Hlth Syst, 1500 East Med Ctr Dr,SPC 5376, Ann Arbor, MI 48109 USA.	sushantg@med.umich.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007749] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Churpek MM, 2015, AM J RESP CRIT CARE, V192, P958, DOI 10.1164/rccm.201502-0275OC; Kaukonen KM, 2015, NEW ENGL J MED, V372, P1629, DOI 10.1056/NEJMoa1415236; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Simpson SQ, 2016, CHEST, V149, P1117, DOI 10.1016/j.chest.2016.02.653; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287	5	2	2	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					HO2	HO3		10.7326/M16-1507	http://dx.doi.org/10.7326/M16-1507			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UI	27538174				2022-12-28	WOS:000381267200001
J	Schulman, KA; Richman, BD				Schulman, Kevin A.; Richman, Barak D.			Reassessing ACOs and Health Care Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ORGANIZATIONS; PATIENT		[Schulman, Kevin A.] Duke Univ, Sch Med, Durham, NC USA; [Schulman, Kevin A.] Harvard Sch Business, Boston, MA USA; [Richman, Barak D.] Duke Univ, Sch Law, Durham, NC 27706 USA	Duke University; Harvard University; Duke University	Schulman, KA (corresponding author), Duke Univ, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	kevin.schulman@duke.edu						Cooper Z, 2015, 21815 NBER; Hospital inpatient and outpatient services, 2016, REP C MED PAYM POL; McWilliams JM, 2016, NEW ENGL J MED, V374, P2357, DOI 10.1056/NEJMsa1600142; McWilliams JM, 2015, NEW ENGL J MED, V373, P777, DOI 10.1056/NEJMc1507320; Medicare Physician Group Practice Demonstration, 2011, PHYS GROUPS CONT IMP; Nyweide DJ, 2015, JAMA-J AM MED ASSOC, V313, P2152, DOI 10.1001/jama.2015.4930; Richman BD, 2011, JAMA-J AM MED ASSOC, V305, P602, DOI 10.1001/jama.2011.111; Robinson JC, 2014, JAMA-J AM MED ASSOC, V312, P1663, DOI 10.1001/jama.2014.14072	8	18	18	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2016	316	7					707	708		10.1001/jama.2016.10874	http://dx.doi.org/10.1001/jama.2016.10874			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT5IA	27533151				2022-12-28	WOS:000381514800011
J	Woodhead, M				Woodhead, Michael			Australian medical leaders call for urgent action on reports of abuse of immigrant detainees	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		[Anonymous], 2016, GUARDIAN	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2016	354								i4454	10.1136/bmj.i4454	http://dx.doi.org/10.1136/bmj.i4454			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT4UY	27519710				2022-12-28	WOS:000381477800011
J	Nuttle, X; Giannuzzi, G; Duyzend, MH; Schraiber, JG; Narvaiza, I; Sudmant, PH; Penn, O; Chiatante, G; Malig, M; Huddleston, J; Benner, C; Camponeschi, F; Ciofi-Baffoni, S; Stessman, HAF; Marchetto, MCN; Denman, L; Harshman, L; Baker, C; Raja, A; Penewit, K; Janke, N; Tang, WJ; Ventura, M; Banci, L; Antonacci, F; Akey, JM; Amemiya, CT; Gage, FH; Reymond, A; Eichler, EE				Nuttle, Xander; Giannuzzi, Giuliana; Duyzend, Michael H.; Schraiber, Joshua G.; Narvaiza, Inigo; Sudmant, Peter H.; Penn, Osnat; Chiatante, Giorgia; Malig, Maika; Huddleston, John; Benner, Chris; Camponeschi, Francesca; Ciofi-Baffoni, Simone; Stessman, Holly A. F.; Marchetto, Maria C. N.; Denman, Laura; Harshman, Lana; Baker, Carl; Raja, Archana; Penewit, Kelsi; Janke, Nicolette; Tang, W. Joyce; Ventura, Mario; Banci, Lucia; Antonacci, Francesca; Akey, Joshua M.; Amemiya, Chris T.; Gage, Fred H.; Reymond, Alexandre; Eichler, Evan E.			Emergence of a Homo sapiens-specific gene family and chromosome 16p11.2 CNV susceptibility	NATURE			English	Article							GENOME SEQUENCE; POSITIVE SELECTION; HUMAN BOLA2; HUMANS; AUTISM; IDENTIFICATION; MICRODELETION; NEANDERTHAL; CHIMPANZEES; POPULATION	Genetic differences that specify unique aspects of human evolution have typically been identified by comparative analyses between the genomes of humans and closely related primates(1), including more recently the genomes of archaic hominins(2,3). Not all regions of the genome, however, are equally amenable to such study. Recurrent copy number variation (CNV) at chromosome 16p11.2 accounts for approximately 1% of cases of autism(4,5) and is mediated by a complex set of segmental duplications, many of which arose recently during human evolution. Here we reconstruct the evolutionary history of the locus and identify bolA family member 2 (BOLA2) as a gene duplicated exclusively in Homo sapiens. We estimate that a 95-kilobase-pair segment containing BOLA2 duplicated across the critical region approximately 282 thousand years ago (ka), one of the latest among a series of genomic changes that dramatically restructured the locus during hominid evolution. All humans examined carried one or more copies of the duplication, which nearly fixed early in the human lineage-a pattern unlikely to have arisen so rapidly in the absence of selection (P < 0.0097). We show that the duplication of BOLA2 led to a novel, human-specific in-frame fusion transcript and that BOLA2 copy number correlates with both RNA expression (r = 0.36) and protein level (r = 0.65), with the greatest expression difference between human and chimpanzee in experimentally derived stem cells. Analyses of 152 patients carrying a chromosome 16p11.2 rearrangement show that more than 96% of breakpoints occur within the H. sapiens-specific duplication. In summary, the duplicative transposition of BOLA2 at the root of the H. sapiens lineage about 282 ka simultaneously increased copy number of a gene associated with iron homeostasis and predisposed our species to recurrent rearrangements associated with disease.	[Nuttle, Xander; Duyzend, Michael H.; Schraiber, Joshua G.; Sudmant, Peter H.; Penn, Osnat; Malig, Maika; Huddleston, John; Stessman, Holly A. F.; Denman, Laura; Harshman, Lana; Baker, Carl; Raja, Archana; Penewit, Kelsi; Janke, Nicolette; Akey, Joshua M.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Giannuzzi, Giuliana; Reymond, Alexandre] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Narvaiza, Inigo; Benner, Chris; Marchetto, Maria C. N.; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Chiatante, Giorgia; Ventura, Mario; Antonacci, Francesca] Univ Bari Aldo Moro, Dipartimento Biol, I-70125 Bari, Italy; [Huddleston, John; Raja, Archana; Eichler, Evan E.] Howard Hughes Med Inst, Seattle, WA 98195 USA; [Camponeschi, Francesca; Ciofi-Baffoni, Simone; Banci, Lucia] Univ Florence, Dept Chem, Via Lastruccia 3, I-50019 Florence, Italy; [Ciofi-Baffoni, Simone; Banci, Lucia] Univ Florence, Magnet Resonance Ctr CERM, Via Luigi Sacconi 6, I-50019 Florence, Italy; [Tang, W. Joyce; Amemiya, Chris T.] Benaroya Res Inst Virginia Mason, Seattle, WA 98101 USA; [Gage, Fred H.] Ctr Acad Res & Training Anthropogeny, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Sudmant, Peter H.] MIT, Program Computat & Syst Biol, Cambridge, MA 02142 USA	University of Washington; University of Washington Seattle; University of Lausanne; Salk Institute; Universita degli Studi di Bari Aldo Moro; Howard Hughes Medical Institute; University of Florence; University of Florence; Benaroya Research Institute; Virginia Mason Medical Center; Massachusetts Institute of Technology (MIT)	Eichler, EE (corresponding author), Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA.; Reymond, A (corresponding author), Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.; Eichler, EE (corresponding author), Howard Hughes Med Inst, Seattle, WA 98195 USA.	alexandre.reymond@unil.ch; eee@gs.washington.edu	Ciofi-Baffoni, Simone/AAH-9778-2021; Camponeschi, Francesca/GWU-8535-2022; Kutalik, Zoltan/HHZ-5697-2022; Ventura, Mario/E-6420-2011; Antonacci, Francesca/F-5457-2013; Giannuzzi, Giuliana/N-7117-2017	Kutalik, Zoltan/0000-0001-8285-7523; Ventura, Mario/0000-0001-7762-8777; Antonacci, Francesca/0000-0002-5833-6186; Reymond, Alexandre/0000-0003-1030-8327; Sudmant, Peter/0000-0002-9573-8248; Akey, Joshua/0000-0002-4411-1330; Stessman, Holly/0000-0002-0764-3493; Giannuzzi, Giuliana/0000-0002-4030-0601; Duyzend, Michael/0000-0002-3941-6447; BANCI, LUCIA/0000-0003-0562-5774; Chiatante, Giorgia/0000-0002-7505-4818; Benner, Christopher/0000-0002-4618-0719	Paul G. Allen Foundation [11631]; Simons Foundation Autism Research Initiative (SFARI) [303241, 274424]; US National Institutes of Health (NIH) [2R01HG002385]; Swiss National Science Foundation [31003A_160203, CRSII33-133044]; NIH [TR01 MH095741]; Helmsley Charitable Fund; Mathers Foundation; JPB Foundation; US National Science Foundation [DGE-1256082]; Faculty of Biology and Medicine, University of Lausanne; US National Institute of Mental Health [1F30MH105055-01]; Human Frontier Science Program postdoctoral fellowship; EC [N653706]; Ente Cassa di Risparmio grant [2013/7201]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002385] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095741, F30MH105055] Funding Source: NIH RePORTER	Paul G. Allen Foundation; Simons Foundation Autism Research Initiative (SFARI); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmsley Charitable Fund; Mathers Foundation; JPB Foundation; US National Science Foundation(National Science Foundation (NSF)); Faculty of Biology and Medicine, University of Lausanne; US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Human Frontier Science Program postdoctoral fellowship(Human Frontier Science Program); EC(European CommissionEuropean Commission Joint Research Centre); Ente Cassa di Risparmio grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank families at the participating Simons Variation in Individuals Project (Simons VIP) and Simons Simplex Collection sites, as well as the Simons VIP Consortium. Approved researchers can obtain the Simons VIP data set, the Simons Simplex Collection data set and/or biospecimens by applying at https://base.sfari.org. We thank M. Chaisson for single-molecule, real-time WGS data, B. Vernot for archaic introgression data, B.J. Nelson and K. Munson for technical assistance, M. L. Gage for editorial comments and T. Brown for assistance with manuscript preparation. This work was supported by the Paul G. Allen Foundation (grant 11631 to E.E.E.), the Simons Foundation Autism Research Initiative (SFARI 303241 to E.E.E. and 274424 to A.R.), the US National Institutes of Health (NIH grant 2R01HG002385 to E.E.E.), the Swiss National Science Foundation (31003A_160203 and CRSII33-133044 to A.R.) and funds from NIH TR01 MH095741, the Helmsley Charitable Fund, the Mathers Foundation and the JPB Foundation (to F.H.G.). X.N. was supported by a US National Science Foundation Graduate Research Fellowship under grant DGE-1256082. G. G. was awarded a Pro-Women Scholarship from the Faculty of Biology and Medicine, University of Lausanne. M.H.D. is supported by US National Institute of Mental Health grant 1F30MH105055-01. O.P. is a recipient of a Human Frontier Science Program postdoctoral fellowship. L. B. is supported by EC grant N653706, project iNEXT. S.C.B. and F.C. were supported by an Ente Cassa di Risparmio grant (2013/7201). E.E.E. is an investigator of the Howard Hughes Medical Institute. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Antonacci F, 2014, NAT GENET, V46, P1293, DOI 10.1038/ng.3120; Banci L, 2015, J AM CHEM SOC, V137, P16133, DOI 10.1021/jacs.5b10592; Bersaglieri T, 2004, AM J HUM GENET, V74, P1111, DOI 10.1086/421051; Brawand D, 2011, NATURE, V478, P343, DOI 10.1038/nature10532; Bray NPH, 2015, NEAR OPTIMAL RNA SEQ; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Ewing G, 2010, BIOINFORMATICS, V26, P2064, DOI 10.1093/bioinformatics/btq322; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Fu QM, 2014, NATURE, V514, P445, DOI 10.1038/nature13810; Haunhorst P, 2013, MOL BIOL CELL, V24, P1895, DOI 10.1091/mbc.E12-09-0648; Hiatt JB, 2013, GENOME RES, V23, P843, DOI 10.1101/gr.147686.112; Huddleston J, 2014, GENOME RES, V24, P688, DOI 10.1101/gr.168450.113; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kumanovics A, 2008, J BIOL CHEM, V283, P10276, DOI 10.1074/jbc.M801160200; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Li HR, 2012, BIOCHEMISTRY-US, V51, P4377, DOI 10.1021/bi300393z; Li HR, 2012, BIOCHEMISTRY-US, V51, P1687, DOI 10.1021/bi2019089; Marchetto MCN, 2013, NATURE, V503, P525, DOI 10.1038/nature12686; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Nuttle X, 2014, NAT PROTOC, V9, P1496, DOI 10.1038/nprot.2014.096; Nuttle X, 2013, NAT METHODS, V10, P903, DOI [10.1038/NMETH.2572, 10.1038/nmeth.2572]; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Prado-Martinez J, 2013, NATURE, V499, P471, DOI 10.1038/nature12228; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Simons VIP Consortium, 2012, NEURON, V73, P1063, DOI 10.1016/j.neuron.2012.02.014; Sudmant PH, 2015, SCIENCE, V349, DOI 10.1126/science.aab3761; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Tishkoff SA, 2009, SCIENCE, V324, P1035, DOI 10.1126/science.1172257; Vernot B, 2016, SCIENCE, V352, P235, DOI 10.1126/science.aad9416; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Yang MA, 2014, GENETICS, V198, P1655, DOI 10.1534/genetics.112.145359; Zufferey F, 2012, J MED GENET, V49, P660, DOI 10.1136/jmedgenet-2012-101203; 2012, NATURE, V491, P56, DOI DOI 10.1038/NATURE11632	39	67	68	1	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					205	+		10.1038/nature19075	http://dx.doi.org/10.1038/nature19075			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27487209	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000381472100035
J	Stamatiades, EG; Tremblay, ME; Bohm, M; Crozet, L; Bisht, K; Kao, D; Coelho, C; Fan, XY; Yewdell, WT; Davidson, A; Heeger, PS; Diebold, S; Nimmerjahn, F; Geissmann, F				Stamatiades, Efstathios G.; Tremblay, Marie-Eve; Bohm, Mathieu; Crozet, Lucile; Bisht, Kanchan; Kao, Daniela; Coelho, Carolina; Fan, Xiying; Yewdell, William T.; Davidson, Anne; Heeger, Peter S.; Diebold, Sandra; Nimmerjahn, Falk; Geissmann, Frederic			Immune Monitoring of Trans-endothelial Transport by Kidney-Resident Macrophages	CELL			English	Article							FC-GAMMA RECEPTORS; DENDRITIC CELLS; ARTHUS REACTION; BLOOD-VESSELS; ALBUMIN; IDENTIFICATION; COMPLEXES; MOUSE; MONOCYTES; SYSTEM	Small immune complexes cause type III hypersensitivity reactions that frequently result in tissue injury. The responsible mechanisms, however, remain unclear and differ depending on target organs. Here, we identify a kidney-specific anatomical and functional unit, formed by resident macrophages and peritubular capillary endothelial cells, which monitors the transport of proteins and particles ranging from 20 to 700 kDa or 10 to 200 nm into the kidney interstitium. Kidney-resident macrophages detect and scavenge circulating immune complexes "pumped'' into the interstitium via trans-endothelial transport and trigger a Fc gamma RIV-dependent inflammatory response and the recruitment of monocytes and neutrophils. In addition, Fc gamma RIV and TLR pathways synergistically "super-activate'' kidney macrophages when immune complexes contain a nucleic acid. These data identify a physiological function of tissue-resident kidney macrophages and a basic mechanism by which they initiate the inflammatory response to small immune complexes in the kidney.	[Stamatiades, Efstathios G.; Bohm, Mathieu; Crozet, Lucile; Coelho, Carolina; Fan, Xiying; Yewdell, William T.; Geissmann, Frederic] Mem Sloan Kettering Canc Ctr, Program Immunol, 417 East 68th St, New York, NY 10065 USA; [Stamatiades, Efstathios G.; Bohm, Mathieu; Crozet, Lucile; Coelho, Carolina; Fan, Xiying; Yewdell, William T.; Geissmann, Frederic] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, 417 East 68th St, New York, NY 10065 USA; [Tremblay, Marie-Eve; Bisht, Kanchan] Univ Laval, Dept Mol Med, Laval, PQ G1V 0A6, Canada; [Tremblay, Marie-Eve; Bisht, Kanchan] CHU Quebec, Ctr Rech, Axe Neurosci, Quebec City, PQ G1V 4G2, Canada; [Bohm, Mathieu; Geissmann, Frederic] Kings Coll London, Div Immunol, Infect, London SE1 1UL, England; [Bohm, Mathieu; Geissmann, Frederic] Kings Coll London, Ctr Mol & Cellular Biol Inflammat Inflammatory Di, London SE1 1UL, England; [Crozet, Lucile; Geissmann, Frederic] Weill Cornell Grad Sch Med Sci, 1300 York Ave, New York, NY 10065 USA; [Kao, Daniela; Nimmerjahn, Falk] Univ Erlangen Nurnberg, Dept Biol, Erwin Rommel Str 3, D-91058 Erlangen, Germany; [Fan, Xiying] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, 417 East 68th St, New York, NY 10065 USA; [Davidson, Anne] Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Heeger, Peter S.] Mt Sinai Sch Med, Recanati Miller Transplant Inst, Dept Med, New York, NY 10029 USA; [Heeger, Peter S.] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Diebold, Sandra] Natl Inst Biol Stand & Controls, Immunotoxicol Team Div, Potters Bar EN6 3QG, Herts, England	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Laval University; Laval University; University of London; King's College London; University of London; King's College London; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Erlangen Nuremberg; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Northwell Health; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; National Institute for Biological Standards & Control	Geissmann, F (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 417 East 68th St, New York, NY 10065 USA.; Geissmann, F (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr, 417 East 68th St, New York, NY 10065 USA.; Geissmann, F (corresponding author), Kings Coll London, Div Immunol, Infect, London SE1 1UL, England.; Geissmann, F (corresponding author), Kings Coll London, Ctr Mol & Cellular Biol Inflammat Inflammatory Di, London SE1 1UL, England.; Geissmann, F (corresponding author), Weill Cornell Grad Sch Med Sci, 1300 York Ave, New York, NY 10065 USA.	geissmaf@mskcc.org	Bisht, Kanchan/I-4798-2017	Bisht, Kanchan/0000-0002-2575-8913; Stamatiades, Efstathios/0000-0002-2785-9005; Fan, Xiying/0000-0003-3090-381X; Tremblay, Marie-Eve/0000-0003-2863-9626; Coelho, Carolina/0000-0002-7523-3031	National Cancer Institute of the NIH [P30CA008748]; Ludwig Center at the Memorial Sloan Kettering Cancer Center; Wellcome Trust [WT101853MA]; European Research Council [2010-StG-261299]; Oliver Bird Rheumatism Program; Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program [T32 GM07739]; Universite Laval; CHU de Quebec; NIH [R01 AI 071185]; German Research Foundation [GK1660, CRC1181-A07]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F30AI122721, R01AI071185] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK085241] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ludwig Center at the Memorial Sloan Kettering Cancer Center; Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Oliver Bird Rheumatism Program; Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program; Universite Laval; CHU de Quebec; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jayanta Chaudari and Doris Herzlinger for helpful discussion of the manuscript, Antonio Pires da Silva Baptista for help with immunofluorescence, and Neil Lipman and the Research Animal Resource Center at MSKCC. This work was supported by the National Cancer Institute of the NIH (P30CA008748), the Ludwig Center at the Memorial Sloan Kettering Cancer Center, a Wellcome Trust Senior Investigator award (WT101853MA), a European Research Council Investigator award (2010-StG-261299) to F.G., and a PhD fellowship from the Oliver Bird Rheumatism Program to E.G.S. X.F. is supported by T32 GM07739 to the Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program. M.-E.T. is supported by start-up funds from Universite Laval and CHU de Quebec. P.S.H. is supported by NIH grant R01 AI 071185. D.K. and F.N. are supported by grants from the German Research Foundation (GK1660 and CRC1181-A07).	Aird WC, 2007, CIRC RES, V100, P158, DOI 10.1161/01.RES.0000255691.76142.4a; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; BELL DR, 1978, J PHYSIOL-LONDON, V279, P621, DOI 10.1113/jphysiol.1978.sp012365; Binstadt BA, 2006, NAT IMMUNOL, V7, P284, DOI 10.1038/ni1306; Bournazos S, 2015, J EXP MED, V212, P1361, DOI 10.1084/jem.20151267; BRUNS RR, 1968, J CELL BIOL, V37, P277, DOI 10.1083/jcb.37.2.277; Cao Q, 2015, J AM SOC NEPHROL, V26, P349, DOI 10.1681/ASN.2013121336; Carlin LM, 2013, CELL, V153, P362, DOI 10.1016/j.cell.2013.03.010; Cheng LE, 2013, IMMUNITY, V38, P166, DOI 10.1016/j.immuni.2012.09.022; Clatworthy MR, 2014, NAT MED, V20, P1458, DOI 10.1038/nm.3709; Clynes R, 1998, SCIENCE, V279, P1052, DOI 10.1126/science.279.5353.1052; DAHA MR, 1988, EUR J IMMUNOL, V18, P783, DOI 10.1002/eji.1830180519; Davis RS, 2002, IMMUNOL REV, V190, P123, DOI 10.1034/j.1600-065X.2002.19009.x; Freinkel, 2001, BIOL SKIN; Froehlich H, 2001, CLIN INFECT DIS, V33, P906, DOI 10.1086/322585; Gottschalk C, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00435; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Hasenberg A, 2015, NAT METHODS, V12, P445, DOI [10.1038/nmeth.3322, 10.1038/NMETH.3322]; Hazenbos WLW, 1996, IMMUNITY, V5, P181, DOI 10.1016/S1074-7613(00)80494-X; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; HUME DA, 1983, J EXP MED, V157, P1704, DOI 10.1084/jem.157.5.1704; Jancar S, 2005, TRENDS IMMUNOL, V26, P48, DOI 10.1016/j.it.2004.11.007; Jonsson F, 2013, J LEUKOCYTE BIOL, V94, P643, DOI 10.1189/jlb.1212623; Kahn P, 2008, ARTHRITIS RHEUM, V58, P2824, DOI 10.1002/art.23764; KALLSKOG O, 1973, ACTA PHYSIOL SCAND, V89, P116, DOI 10.1111/j.1748-1716.1973.tb05502.x; Kaneko Y, 2006, J EXP MED, V203, P789, DOI 10.1084/jem.20051900; Kao D, 2015, CELL REP, V13, P2376, DOI 10.1016/j.celrep.2015.11.027; Kasperkiewicz M, 2012, J PATHOL, V228, P8, DOI 10.1002/path.4023; Kruger T, 2004, J AM SOC NEPHROL, V15, P613, DOI 10.1097/01.ASN.0000114553.36258.91; Lamprecht P, 1999, ARTHRITIS RHEUM, V42, P2507, DOI 10.1002/1529-0131(199912)42:12<2507::AID-ANR2>3.0.CO;2-#; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Mancardi DA, 2011, J IMMUNOL, V186, P1899, DOI 10.4049/jimmunol.1003642; Mayadas TN, 2009, CIRCULATION, V120, P2012, DOI 10.1161/CIRCULATIONAHA.108.771170; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Mechetina LV, 2002, IMMUNOGENETICS, V54, P463, DOI 10.1007/s00251-002-0486-0; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00262; MILICI AJ, 1985, CIRC RES, V56, P709, DOI 10.1161/01.RES.56.5.709; MILICI AJ, 1987, J CELL BIOL, V105, P2603, DOI 10.1083/jcb.105.6.2603; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Oh P, 2007, NAT BIOTECHNOL, V25, P327, DOI 10.1038/nbt1292; Pandey S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016246; Perdiguero EG, 2013, COLD SH Q B, V78, P91, DOI 10.1101/sqb.2013.78.020032; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; PINTER GG, 1967, J PHYSIOL-LONDON, V192, P761, DOI 10.1113/jphysiol.1967.sp008329; PINTER GG, 1970, EXPERIENTIA, V26, P265, DOI 10.1007/BF01900085; Poteser M, 2004, BRIT J PHARMACOL, V143, P143, DOI 10.1038/sj.bjp.0705897; PREDESCU D, 1993, AM J PHYSIOL, V265, pH725, DOI 10.1152/ajpheart.1993.265.2.H725; Rayner LE, 2013, J MOL BIOL, V425, P506, DOI 10.1016/j.jmb.2012.11.019; SCHIFFERLI JA, 1989, KIDNEY INT, V35, P993, DOI 10.1038/ki.1989.83; Schubert W, 2001, J BIOL CHEM, V276, P48619, DOI 10.1074/jbc.C100613200; Soos TJ, 2006, KIDNEY INT, V70, P591, DOI 10.1038/sj.ki.5001567; Stan RV, 2012, DEV CELL, V23, P1203, DOI 10.1016/j.devcel.2012.11.003; Stan RV, 1999, P NATL ACAD SCI USA, V96, P13203, DOI 10.1073/pnas.96.23.13203; Stokol T, 2004, J EXP MED, V200, P835, DOI 10.1084/jem.20040501; Sun WP, 2013, LAB INVEST, V93, P626, DOI 10.1038/labinvest.2013.61; Sutterwala FS, 1997, J EXP MED, V185, P1977, DOI 10.1084/jem.185.11.1977; Sylvestre DL, 1996, IMMUNITY, V5, P387, DOI 10.1016/S1074-7613(00)80264-2; SYLVESTRE DL, 1994, SCIENCE, V265, P1095, DOI 10.1126/science.8066448; van Nieuwenhuijze AEM, 2015, IMMUNOL CELL BIOL, V93, P841, DOI 10.1038/icb.2015.49; Vidarsson G, 1998, CURR OPIN INFECT DIS, V11, P271, DOI 10.1097/00001432-199806000-00002; Vogelpoel LTC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6444; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477	65	111	113	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					991	1003		10.1016/j.cell.2016.06.058	http://dx.doi.org/10.1016/j.cell.2016.06.058			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27477514	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000382258700020
J	Atamian, HS; Creux, NM; Brown, EA; Garner, AG; Blackman, BK; Harmer, SL				Atamian, Hagop S.; Creux, Nicky M.; Brown, Evan A.; Garner, Austin G.; Blackman, Benjamin K.; Harmer, Stacey L.			Circadian regulation of sunflower heliotropism, floral orientation, and pollinator visits	SCIENCE			English	Article							STEM ELONGATION; SOLAR TRACKING; GROWTH; ARABIDOPSIS; CLOCKS	Young sunflower plants track the Sun from east to west during the day and then reorient during the night to face east in anticipation of dawn. In contrast, mature plants cease movement with their flower heads facing east. We show that circadian regulation of directional growth pathways accounts for both phenomena and leads to increased vegetative biomass and enhanced pollinator visits to flowers. Solar tracking movements are driven by antiphasic patterns of elongation on the east and west sides of the stem. Genes implicated in control of phototropic growth, but not clock genes, are differentially expressed on the opposite sides of solar tracking stems. Thus, interactions between environmental response pathways and the internal circadian oscillator coordinate physiological processes with predictable changes in the environment to influence growth and reproduction.	[Atamian, Hagop S.; Creux, Nicky M.; Harmer, Stacey L.] Univ Calif Davis, Dept Plant Biol, One Shields Ave, Davis, CA 95616 USA; [Brown, Evan A.; Garner, Austin G.; Blackman, Benjamin K.] Univ Virginia, Dept Biol, POB 400328, Charlottesville, VA 22904 USA; [Blackman, Benjamin K.] Univ Calif Berkeley, Dept Plant & Microbial Biol, 111 Koshland Hall, Berkeley, CA 94720 USA	University of California System; University of California Davis; University of Virginia; University of California System; University of California Berkeley	Harmer, SL (corresponding author), Univ Calif Davis, Dept Plant Biol, One Shields Ave, Davis, CA 95616 USA.	slharmer@ucdavis.edu	Creux, Nicky/ABB-3215-2020; Atamian, Hagop S/H-5595-2019; Garner, Austin/O-6261-2016	Creux, Nicky/0000-0002-4179-6995; Blackman, Benjamin/0000-0003-4936-6153; Garner, Austin/0000-0001-8279-8260	NSF [IOS-1238040]; University of Virginia Harrison Undergraduate Research Award; Division Of Integrative Organismal Systems [1238040] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); University of Virginia Harrison Undergraduate Research Award; Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Agricultural Research Service, North Central Regional Plant Introduction Station) for providing germplasm; the Morven Farm staff, R. Karp, J. Vandenbrink, L. Henry, and N. Infantino for assistance in the field and with video scoring; and J. Maloof for helpful discussions. This work was supported by NSF grant IOS-1238040 (to S.L.H. and B.K.B.) and a University of Virginia Harrison Undergraduate Research Award (to E.A.B.). The supplementary materials contain additional data.	Briggs WR, 2014, PLANT PHYSIOL, V164, P13, DOI 10.1104/pp.113.230573; Covington MF, 2007, PLOS BIOL, V5, P1773, DOI 10.1371/journal.pbio.0050222; Darwin C, 1880, POWER MOVEMENT PLANT; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Fambrini M, 2011, PLANT MOL BIOL, V75, P431, DOI 10.1007/s11103-011-9740-x; FOSTER KR, 1995, PLANT PHYSIOL, V108, P337, DOI 10.1104/pp.108.1.337; Hagen G, 2002, PLANT MOL BIOL, V49, P373, DOI 10.1023/A:1015207114117; Jouve L, 1999, PLANTA, V209, P136, DOI 10.1007/s004250050615; KEVAN PG, 1975, SCIENCE, V189, P723, DOI 10.1126/science.189.4204.723; Koller D, 2001, PHOTOMOVEMENT, P833, DOI 10.1016/S1568-461X(01)80029-6; Kutschera U, 2016, ANN BOT-LONDON, V117, P1, DOI 10.1093/aob/mcv141; Merrow M, 1999, NATURE, V399, P584, DOI 10.1038/21190; Millar AJ, 1996, P NATL ACAD SCI USA, V93, P15491, DOI 10.1073/pnas.93.26.15491; Muller LM, 2014, J EXP BOT, V65, P2915, DOI 10.1093/jxb/eru117; Neily WG, 1997, J AM SOC HORTIC SCI, V122, P778, DOI 10.21273/JASHS.122.6.778; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Ren H, 2015, MOL PLANT, V8, P1153, DOI 10.1016/j.molp.2015.05.003; Schaffner JH, 1898, BOT GAZ, V25, P395, DOI 10.1086/327699; SHIBAOKA HIROH, 1959, SCI PAPERS COLL GEN EDUC UNIV TOKYO BIOL, V9, P105; Spartz AK, 2014, PLANT CELL, V26, P2129, DOI 10.1105/tpc.114.126037; STANTON ML, 1989, OECOLOGIA, V78, P477, DOI 10.1007/BF00378737; Stavang JA, 2005, PLANT PHYSIOL, V138, P2344, DOI 10.1104/pp.105.063149; Tatematsu K, 2004, PLANT CELL, V16, P379, DOI 10.1105/tpc.018630; Vandenbrink JP, 2014, PLANT SCI, V224, P20, DOI 10.1016/j.plantsci.2014.04.006; Arana MV, 2011, P NATL ACAD SCI USA, V108, P9292, DOI 10.1073/pnas.1101050108; Vinterhalter D, 2014, J PLANT GROWTH REGUL, V33, P539, DOI 10.1007/s00344-013-9403-z; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660	27	131	133	13	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					587	590		10.1126/science.aaf9793	http://dx.doi.org/10.1126/science.aaf9793			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27493185	Green Submitted			2022-12-28	WOS:000381560900041
J	Cronin, TW; Gagnon, YL; Johnsen, S; Marshall, NJ; Roberts, NW				Cronin, Thomas W.; Gagnon, Yakir Luc; Johnsen, Sonke; Marshall, N. Justin; Roberts, Nicholas W.			Comment on "Open-ocean fish reveal an omnidirectional solution to camouflage in polarized environments"	SCIENCE			English	Editorial Material							PSEUDOREPLICATION; FIELD	Brady et al. (Reports, 20 November 2015, p. 965) claimed that the silvery sides of certain fish are cryptic when viewed by animals with polarization sensitivity, which they termed "polarocrypsis." After examining their evidence, we find this claim to be unsupported due to (i) pseudoreplication, (ii) confounding polarization contrast with intensity contrast, and (iii) measurements taken at very shallow depths.	[Cronin, Thomas W.] Univ Maryland, Dept Biol Sci, Baltimore, MD 21250 USA; [Gagnon, Yakir Luc; Marshall, N. Justin] Univ Queensland, Queensland Brain Inst, St Lucia, Qld 4072, Australia; [Johnsen, Sonke] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Roberts, Nicholas W.] Univ Bristol, Sch Biol Sci, Bristol BS8 1TQ, Avon, England	University System of Maryland; University of Maryland Baltimore; University of Queensland; Duke University; University of Bristol	Cronin, TW (corresponding author), Univ Maryland, Dept Biol Sci, Baltimore, MD 21250 USA.	cronin@umbc.edu	Gagnon, Yakir/C-2665-2008	Gagnon, Yakir/0000-0003-2512-4520; Marshall, Justin/0000-0001-9006-6713; Roberts, Nicholas/0000-0002-4540-6683				Brady PC, 2015, SCIENCE, V350, P965, DOI 10.1126/science.aad5284; Cronin T. W., 2014, VISUAL ECOLOGY; Darecki M., 2011, J GEOPHYS RES, V116; DENTEN EJ, 1970, PHILOS T ROY SOC B, V258, P285, DOI 10.1098/rstb.1970.0037; DERA J, 1986, Oceanologia, V23, P15; Duntley S.Q., 1952, VISIBILITY SUBMERGED; HURLBERT SH, 1984, ECOL MONOGR, V54, P187, DOI 10.2307/1942661; Hurlbert SH, 2009, J COMP PSYCHOL, V123, P434, DOI 10.1037/a0016221; Johnsen S, 2014, LIMNOL OCEANOGR, V59, P1839, DOI 10.4319/lo.2014.59.6.1839; Sabbah S, 2012, LIMNOL OCEANOGR, V57, P1025, DOI 10.4319/lo.2012.57.4.1025	10	4	4	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299							aaf4481	10.1126/science.aaf4481	http://dx.doi.org/10.1126/science.aaf4481			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27493176	Green Submitted			2022-12-28	WOS:000381560900029
J	Heron, RJL				Heron, Richard J. L.			James Riddick Heron OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2016	354								i4267	10.1136/bmj.i4267	http://dx.doi.org/10.1136/bmj.i4267			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9DD	27496284				2022-12-28	WOS:000381081800008
J	Margulies, KB; Hernandez, AF; Redfield, MM; Givertz, MM; Oliveira, GH; Cole, R; Mann, DL; Whellan, DJ; Kiernan, MS; Felker, GM; McNulty, SE; Anstrom, KJ; Shah, MR; Braunwald, E; Cappola, TP				Margulies, Kenneth B.; Hernandez, Adrian F.; Redfield, Margaret M.; Givertz, Michael M.; Oliveira, Guilherme H.; Cole, Robert; Mann, Douglas L.; Whellan, David J.; Kiernan, Michael S.; Felker, G. Michael; McNulty, Steven E.; Anstrom, Kevin J.; Shah, Monica R.; Braunwald, Eugene; Cappola, Thomas P.		NHLBI Heart Failure Clinical Res	Effects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CARDIOVASCULAR OUTCOMES; INSULIN-RESISTANCE; MORTALITY; DESIGN	IMPORTANCE Abnormal cardiac metabolism contributes to the pathophysiology of advanced heart failure with reduced left ventricular ejection fraction (LVEF). Glucagon-like peptide 1 (GLP-1) agonists have shown cardioprotective effects in early clinical studies of patients with advanced heart failure, irrespective of type 2 diabetes status. OBJECTIVE To test whether therapy with a GLP-1 agonist improves clinical stability following hospitalization for acute heart failure. DESIGN, SETTING, AND PARTICIPANTS Phase 2, double-blind, placebo-controlled randomized clinical trial of patients with established heart failure and reduced LVEF who were recently hospitalized. Patients were enrolled between August 2013 and March 2015 at 24 US sites. INTERVENTIONS The GLP-1 agonist liraglutide (n = 154) or placebo (n = 146) via a daily subcutaneous injection; study drug was advanced to a dosage of 1.8 mg/d during the first 30 days as tolerated and continued for 180 days. MAIN OUTCOMES AND MEASURES The primary end point was a global rank score in which all patients, regardless of treatment assignment, were ranked across 3 hierarchical tiers: time to death, time to rehospitalization for heart failure, and time-averaged proportional change in N-terminal pro-B-type natriuretic peptide level from baseline to 180 days. Higher values indicate better health (stability). Exploratory secondary outcomes included primary end point components, cardiac structure and function, 6-minute walk distance, quality of life, and combined events. RESULTS Among the 300 patients who were randomized (median age, 61 years [interquartile range {IQR}, 52-68 years]; 64 [21%] women; 178 [59%] with type 2 diabetes; median LVEF of 25%[IQR, 19%-33%]; median N-terminal pro-B-type natriuretic peptide level of 2049 pg/mL [IQR, 1054-4235 pg/mL]), 271 completed the study. Compared with placebo, liraglutide had no significant effect on the primary end point (mean rank of 146 for the liraglutide group vs 156 for the placebo group, P = .31). There were no significant between-group differences in the number of deaths (19 [12%] in the liraglutide group vs 16 [11%] in the placebo group; hazard ratio, 1.10 [95% CI, 0.57-2.14]; P = .78) or rehospitalizations for heart failure (63 [41%] vs 50 [34%], respectively; hazard ratio, 1.30 [95% CI, 0.89-1.88]; P = .17) or for the exploratory secondary end points. Prespecified subgroup analyses in patients with diabetes did not reveal any significant between-group differences. The number of investigator-reported hyperglycemic events was 16 (10%) in the liraglutide group vs 27 (18%) in the placebo group and hypoglycemic events were infrequent (2 [1%] vs 4 [3%], respectively). CONCLUSIONS AND RELEVANCE Among patients recently hospitalized with heart failure and reduced LVEF, the use of liraglutide did not lead to greater posthospitalization clinical stability. These findings do not support the use of liraglutide in this clinical situation.	[Margulies, Kenneth B.; Cappola, Thomas P.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Hernandez, Adrian F.; McNulty, Steven E.; Anstrom, Kevin J.] Duke Clin Res Inst, Durham, NC USA; [Redfield, Margaret M.] Mayo Clin, Rochester, MN USA; [Givertz, Michael M.; Braunwald, Eugene] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Oliveira, Guilherme H.] Univ Hosp, Case Med Ctr, Cleveland, OH USA; [Cole, Robert] Emory Univ, Atlanta, GA 30322 USA; [Mann, Douglas L.] Washington Univ, Sch Med, St Louis, MO USA; [Whellan, David J.] Thomas Jefferson Univ, Philadelphia, PA 19107 USA; [Kiernan, Michael S.] Tufts Univ, Boston, MA 02111 USA; [Felker, G. Michael] Duke Univ, Sch Med, Durham, NC USA; [Felker, G. Michael] Duke Heart Ctr, Durham, NC USA; [Shah, Monica R.] NHLBI, Bldg 10, Bethesda, MD 20892 USA	University of Pennsylvania; Pennsylvania Medicine; Duke University; Mayo Clinic; Harvard University; Brigham & Women's Hospital; Case Western Reserve University; University Hospitals of Cleveland; Emory University; Washington University (WUSTL); Jefferson University; Tufts University; Duke University; Duke University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Margulies, KB (corresponding author), Smilow Ctr Translat Res, Perelman Sch Med, 3400 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	ken.margulies@uphs.upenn.edu	Oliveira, Guilherme H/ABC-8487-2021; Hernandez, Adrian F/A-7818-2016; Felker, Michael/AAX-2288-2021; Mann, Douglas Lowell/AAQ-3524-2021	Hernandez, Adrian F/0000-0003-3387-9616; Felker, Gary/0000-0002-5931-1239	National Heart, Lung, and Blood Institute (NHLBI) [U10 HL084904, U01 HL084861, U10 HL110312, U10 HL110337, U10 HL110342, U10 HL110262, U10 HL110297, U10 HL110302, U10 HL110309, U10 HL110336, U10 HL110338]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL110337, U10HL110342, U10HL110297, U10HL110312, U10HL110262, U10HL110309, U10HL110302, U10HL110336, U10HL110338, U01HL084861, U10HL084904] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by grants U10 HL084904 (awarded to the coordinating center) and U01 HL084861, U10 HL110312, U10 HL110337, U10 HL110342, U10 HL110262, U10 HL110297, U10 HL110302, U10 HL110309, U10 HL110336, and U10 HL110338 (awarded to the regional clinical centers) from the National Heart, Lung, and Blood Institute (NHLBI). The study drug (liraglutide) and matching placebo injections were supplied by NovoNordisk Inc.	Abel E. Dale, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P219, DOI 10.2174/1568008054064869; Anand IS, 2003, CIRCULATION, V107, P1278, DOI 10.1161/01.CIR.0000054164.99881.00; Blecker S, 2013, J AM COLL CARDIOL, V61, P1259, DOI 10.1016/j.jacc.2012.12.038; Clarke SJ, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-12; Davies MJ, 2016, DIABETES CARE, V39, P222, DOI 10.2337/dc14-2883; Green JB, 2015, NEW ENGL J MED, V373, P232, DOI 10.1056/NEJMoa1501352; Grigoropoulou P, 2013, CURR DIABETES REV, V9, P412, DOI 10.2174/15733998113099990070; Lachin JM, 1999, CONTROL CLIN TRIALS, V20, P408, DOI 10.1016/S0197-2456(99)00022-7; Margulies KB, 2014, CIRC-HEART FAIL, V7, P673, DOI 10.1161/CIRCHEARTFAILURE.114.000346; Marso SP, 2013, AM HEART J, V166, P823, DOI 10.1016/j.ahj.2013.07.012; Nikolaidis LA, 2004, CARDIOVASC RES, V61, P297, DOI 10.1016/j.cardiores.2003.11.027; Packer M, 2001, NEW ENGL J MED, V344, P1651, DOI 10.1056/NEJM200105313442201; Pfeffer MA, 2015, NEW ENGL J MED, V373, P2247, DOI 10.1056/NEJMoa1509225; Scirica BM, 2014, CIRCULATION, V130, P1579, DOI 10.1161/CIRCULATIONAHA.114.010389; Scirica BM, 2015, CIRCULATION, V132, pe198; Sokos GG, 2006, J CARD FAIL, V12, P694, DOI 10.1016/j.cardfail.2006.08.211; Swan JW, 1997, J AM COLL CARDIOL, V30, P527, DOI 10.1016/S0735-1097(97)00185-X; Ussher JR, 2014, CIRC RES, V114, P1788, DOI 10.1161/CIRCRESAHA.114.301958; Velez M, 2015, J CARD FAIL, V21, P2, DOI 10.1016/j.cardfail.2014.10.012; Wu SY, 2014, CARDIOVASC THER, V32, P147, DOI 10.1111/1755-5922.12075; Zannad F, 2015, LANCET, V385, P2067, DOI 10.1016/S0140-6736(14)62225-X; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	22	334	346	2	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2016	316	5					500	508		10.1001/jama.2016.10260	http://dx.doi.org/10.1001/jama.2016.10260			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9AU	27483064	Green Accepted, Bronze			2022-12-28	WOS:000381075000016
J	Snyder, A				Snyder, Alison			Philip Majerus Obituary	LANCET			English	Biographical-Item												amsnyder@alum.mit.edu						MAJERUS PW, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2016	388	10043					458	458						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2EK	27529094				2022-12-28	WOS:000380559400015
J	Borkowski, O; Gilbert, C; Ellis, T				Borkowski, Olivier; Gilbert, Charlie; Ellis, Tom			On the record with E. coli DNA	SCIENCE			English	Editorial Material									[Borkowski, Olivier; Gilbert, Charlie; Ellis, Tom] Imperial Coll London, Ctr Synthet Biol & Innovat, London SW7 2AZ, England; [Borkowski, Olivier; Gilbert, Charlie; Ellis, Tom] Imperial Coll London, Dept Bioengn, London SW7 2AZ, England	Imperial College London; Imperial College London	Ellis, T (corresponding author), Imperial Coll London, Ctr Synthet Biol & Innovat, London SW7 2AZ, England.; Ellis, T (corresponding author), Imperial Coll London, Dept Bioengn, London SW7 2AZ, England.	t.ellis@imperial.ac.uk		Gilbert, Charlie/0000-0001-6231-9584; Borkowski, Olivier/0000-0001-8467-8975	EPSRC [EP/M002306/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/M002306/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Kotula JW, 2014, P NATL ACAD SCI USA, V111, P4838, DOI 10.1073/pnas.1321321111; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Nielsen AAK, 2016, SCIENCE, V352, DOI 10.1126/science.aac7341; Roquet N, 2016, SCIENCE, V353, P363, DOI 10.1126/science.aad8559; Shipman SL, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1175; Yang L, 2014, NAT METHODS, V11, P1261, DOI [10.1038/nmeth.3147, 10.1038/NMETH.3147]	7	1	1	2	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					444	445		10.1126/science.aah4438	http://dx.doi.org/10.1126/science.aah4438			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27471292				2022-12-28	WOS:000380583600020
J	Sharma, V; Ahuja, A				Sharma, Vishal; Ahuja, Arvind			Nodular Lymphoid Hyperplasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sharma, Vishal] Postgrad Inst Med Educ & Res, Chandigarh, India; [Ahuja, Arvind] Dr Ram Manohar Lohia Hosp, New Delhi, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Sharma, V (corresponding author), Postgrad Inst Med Educ & Res, Chandigarh, India.	docvishalsharma@gmail.com	Ahuja, Arvind/F-3531-2015; Sharma, Vishal/B-9729-2011	Ahuja, Arvind/0000-0001-7003-5952; Sharma, Vishal/0000-0003-2472-3409					0	2	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2016	375	3					E3	E3		10.1056/NEJMicm1514403	http://dx.doi.org/10.1056/NEJMicm1514403			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS0ZL	27468084				2022-12-28	WOS:000380325400010
J	Wachter, RM; Goldman, L				Wachter, Robert M.; Goldman, Lee			Zero to 50,000-The 20th Anniversary of the Hospitalist	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SERVICE		[Wachter, Robert M.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Goldman, Lee] Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA	University of California System; University of California San Francisco; Columbia University	Wachter, RM (corresponding author), Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA.							[Anonymous], 2006, J HOSP MED S1, V1, P2; Auerbach AD, 2002, ANN INTERN MED, V137, P859, DOI 10.7326/0003-4819-137-11-200212030-00006; Auerbach AD, 2010, ARCH INTERN MED, V170, P2004, DOI 10.1001/archinternmed.2010.432; Wachter RM, 1998, JAMA-J AM MED ASSOC, V279, P1560, DOI 10.1001/jama.279.19.1560; Wachter RM, 1996, NEW ENGL J MED, V335, P514, DOI 10.1056/NEJM199608153350713	5	137	138	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 15	2016	375	11					1009	1011		10.1056/NEJMp1607958	http://dx.doi.org/10.1056/NEJMp1607958			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DV6ZG	27508924				2022-12-28	WOS:000383085000001
J	Orchard, RC; Wilen, CB; Doench, JG; Baldridge, MT; McCune, BT; Lee, YCJ; Lee, S; Pruett-Miller, SM; Nelson, CA; Fremont, DH; Virgin, HW				Orchard, Robert C.; Wilen, Craig B.; Doench, John G.; Baldridge, Megan T.; McCune, Broc T.; Lee, Ying-Chiang J.; Lee, Sanghyun; Pruett-Miller, Shondra M.; Nelson, Christopher A.; Fremont, Daved H.; Virgin, Herbert W.			Discovery of a proteinaceous cellular receptor for a norovirus	SCIENCE			English	Article							NORWALK VIRUS-INFECTION; CMRF-35-LIKE MOLECULE-1; SUSCEPTIBILITY; CELLS; PHOSPHATIDYLSERINE; PERSISTENCE; SUFFICIENT; BACTERIA; DISEASE; BINDING	Noroviruses (NoVs) are a leading cause of gastroenteritis globally, yet the host factors required for NoV infection are poorly understood. We identified host molecules that are essential for murine NoV (MNoV)-induced cell death, including CD300lf as a proteinaceous receptor. We found that CD300lf is essential for MNoV binding and replication in cell lines and primary cells. Additionally, Cd300lf(-/-) mice are resistant to MNoV infection. Expression of CD300lf in human cells breaks the species barrier that would otherwise restrict MNoV replication. The crystal structure of the CD300lf ectodomain reveals a potential ligand-binding cleft composed of residues that are critical for MNoV infection. Therefore, the presence of a proteinaceous receptor is the primary determinant of MNoV species tropism, whereas other components of cellular machinery required for NoV replication are conserved between humans and mice.	[Orchard, Robert C.; Wilen, Craig B.; Baldridge, Megan T.; McCune, Broc T.; Lee, Ying-Chiang J.; Lee, Sanghyun; Nelson, Christopher A.; Fremont, Daved H.; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Doench, John G.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Pruett-Miller, Shondra M.] Washington Univ, Sch Med, Dept Genet, Genome Engn & iPSC Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Washington University (WUSTL)	Virgin, HW (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	virgin@wustl.edu	Doench, John G/HCI-9570-2022; Baldridge, Megan/T-7274-2019; Pruett-Miller, Shondra M./M-9414-2018; Doench, John/ABE-6251-2020	Doench, John G/0000-0002-3707-9889; Baldridge, Megan/0000-0002-7030-6131; Pruett-Miller, Shondra M./0000-0002-3793-585X; Doench, John/0000-0002-3707-9889; Fremont, Daved/0000-0002-8544-2689; Virgin, Herbert/0000-0001-8580-7628; Lee, Ying-Chiang/0000-0002-0319-1493	National Cancer Institute Cancer Center [P30 CA091842]; NIH [U19 AI109725, 1F31CA177194, 5T32CA009547]; NATIONAL CANCER INSTITUTE [P30CA091842, T32CA009547, F31CA177194] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007163, K08AI128043, U19AI109725] Funding Source: NIH RePORTER	National Cancer Institute Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank S. Karst and M. Diamond for providing valuable reagents and S. Handley and C. Desai for their helpful discussion and figure generation. We thank the Alvin J. Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, Missouri, for the use of the Genome Engineering and iPSC Center. CD300 constructs, cell lines, and mice are available from H.W.V. under a material transfer agreement with Washington University. The data from this study are tabulated in the main paper and in the supplementary materials. H.W.V., D.H.F., R.C.O., C.B.W., and C.A.N. are inventors on a patent application submitted by Washington University entitled "Receptor for norovirus and uses thereof" (U.S. Provisional Application 62/301,965). The atomic coordinates are deposited in the Protein Data Bank under accession code 5FFL. The Siteman Cancer Center is supported in part by National Cancer Institute Cancer Center Support Grant P30 CA091842. This work was supported by NIH grants U19 AI109725 (H.W.V.), 1F31CA177194 (B.T.M.), and 5T32CA009547 (M.T.B.).	Baldridge MT, 2015, SCIENCE, V347, P266, DOI 10.1126/science.1258025; Borrego F, 2013, BLOOD, V121, P1951, DOI 10.1182/blood-2012-09-435057; Cannon JP, 2012, IMMUNOGENETICS, V64, P39, DOI 10.1007/s00251-011-0562-4; Choi SC, 2011, J IMMUNOL, V187, P3483, DOI 10.4049/jimmunol.1101549; Chung DH, 2003, J IMMUNOL, V171, P6541, DOI 10.4049/jimmunol.171.12.6541; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Glass RI, 2009, NEW ENGL J MED, V361, P1776, DOI 10.1056/NEJMra0804575; Hutson AM, 2004, TRENDS MICROBIOL, V12, P279, DOI 10.1016/j.tim.2004.04.005; Hutson AM, 2002, J INFECT DIS, V185, P1335, DOI 10.1086/339883; Izawa K, 2012, IMMUNITY, V37, P827, DOI 10.1016/j.immuni.2012.08.018; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Kambhampati A, 2016, CLIN INFECT DIS, V62, P11, DOI 10.1093/cid/civ873; Karst SM, 2014, CELL HOST MICROBE, V15, P668, DOI 10.1016/j.chom.2014.05.015; Kernbauer E, 2014, NATURE, V516, P94, DOI 10.1038/nature13960; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Lindesmith L, 2003, NAT MED, V9, P548, DOI 10.1038/nm860; Marquez JA, 2007, J MOL BIOL, V367, P310, DOI 10.1016/j.jmb.2007.01.011; Newman KL, 2015, EUR J IMMUNOL, V45, P2742, DOI 10.1002/eji.201545512; Nice TJ, 2015, SCIENCE, V347, P269, DOI 10.1126/science.1258100; Nice TJ, 2013, J VIROL, V87, P327, DOI 10.1128/JVI.01864-12; Ossiboff RJ, 2007, J VIROL, V81, P13608, DOI 10.1128/JVI.01509-07; Ossiboff RJ, 2010, J VIROL, V84, P5550, DOI 10.1128/JVI.02371-09; Strong DW, 2012, J VIROL, V86, P2950, DOI 10.1128/JVI.07038-11; Taube S, 2013, MBIO, V4, DOI 10.1128/mBio.00450-13; Taube S, 2012, J VIROL, V86, P5584, DOI 10.1128/JVI.06854-11; Tian LJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4146; Ward VK, 2007, P NATL ACAD SCI USA, V104, P11050, DOI 10.1073/pnas.0700336104; Wobus CE, 2004, PLOS BIOL, V2, P2076, DOI 10.1371/journal.pbio.0020432	28	163	174	4	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 26	2016	353	6302					933	936		10.1126/science.aaf1220	http://dx.doi.org/10.1126/science.aaf1220			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU0CA	27540007	Green Accepted			2022-12-28	WOS:000381867700040
J	Alfieri, C; Chang, LF; Zhang, ZG; Yang, J; Maslen, S; Skehel, M; Barford, D				Alfieri, Claudio; Chang, Leifu; Zhang, Ziguo; Yang, Jing; Maslen, Sarah; Skehel, Mark; Barford, David			Molecular basis of APC/C regulation by the spindle assembly checkpoint	NATURE			English	Article							ANAPHASE-PROMOTING COMPLEX; MITOTIC CHECKPOINT; PROTEIN BUBR1; SACCHAROMYCES-CEREVISIAE; RECOMBINANT EXPRESSION; CDC20 BINDING; UCSF CHIMERA; PHOSPHORYLATION; MECHANISM; MAD2	In the dividing eukaryotic cell, the spindle assembly checkpoint (SAC) ensures that each daughter cell inherits an identical set of chromosomes. The SAC coordinates the correct attachment of sister chromatid kinetochores to the mitotic spindle with activation of the anaphase-promoting complex (APC/C), the E3 ubiquitin ligase responsible for initiating chromosome separation. In response to unattached kinetochores, the SAC generates the mitotic checkpoint complex (MCC), which inhibits the APC/C and delays chromosome segregation. By cryo-electron microscopy, here we determine the near-atomic resolution structure of a human APC/C-MCC complex (APC/C-MCC). Degron-like sequences of the MCC subunit BubR1 block degron recognition sites on Cdc20, the APC/C coactivator subunit responsible for substrate interactions. BubR1 also obstructs binding of the initiating E2 enzyme UbcH10 to repress APC/C ubiquitination activity. Conformational variability of the complex enables UbcH10 association, and structural analysis shows how the Cdc20 subunit intrinsic to the MCC (Cdc20M(CC)) is ubiquitinated, a process that results in APC/C reactivation when the SAC is silenced.	[Alfieri, Claudio; Chang, Leifu; Zhang, Ziguo; Yang, Jing; Maslen, Sarah; Skehel, Mark; Barford, David] MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Barford, D (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.	dbarford@mrc-lmb.cam.ac.uk		Zhang, Ziguo/0000-0002-7268-9631; Yang, Jing/0000-0002-8984-4503; Barford, David/0000-0001-8810-950X; Alfieri, Claudio/0000-0003-3215-1607	Cancer Research UK [C576/A14109]; Medical Research Council [MRC_UP_1201/6]; Long Term EMBO Fellowship; Cancer Research UK [14109] Funding Source: researchfish; Medical Research Council [MC_UP_1201/6] Funding Source: researchfish; MRC [MC_UP_1201/6] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Long Term EMBO Fellowship(European Molecular Biology Organization (EMBO)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Cancer Research UK grant (C576/A14109) and the Medical Research Council (MRC_UP_1201/6) to D.B. and a Long Term EMBO Fellowship to C.A. We thank members of the Barford group for discussions, X. Bai and S. Scheres for their help with RELION; C. Savva and S. Chen for EM facilities; J. Grimmett and T. Darling for computing and W. Zachariae and J. Pines for their invaluable advice and J. Pines for communicating data before publication.	Bai XC, 2013, ELIFE, V2, DOI 10.7554/eLife.00461; Bolanos-Garcia VM, 2011, STRUCTURE, V19, P1691, DOI 10.1016/j.str.2011.09.017; Brown NG, 2015, P NATL ACAD SCI USA, V112, P5272, DOI 10.1073/pnas.1504161112; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Chang LF, 2015, NATURE, V522, P450, DOI 10.1038/nature14471; Chang LF, 2014, NATURE, V513, P388, DOI 10.1038/nature13543; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Di Fiore B, 2015, DEV CELL, V32, P358, DOI 10.1016/j.devcel.2015.01.003; Diaz-Martinez LA, 2015, J BIOL CHEM, V290, P2431, DOI 10.1074/jbc.M114.616490; Elowe S, 2010, J CELL SCI, V123, P84, DOI 10.1242/jcs.056507; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Fernandez IS, 2014, CELL, V157, P823, DOI 10.1016/j.cell.2014.04.015; Foster SA, 2012, MOL CELL, V47, P921, DOI 10.1016/j.molcel.2012.07.031; Garnett MJ, 2009, NAT CELL BIOL, V11, P1363, DOI 10.1038/ncb1983; Ge S, 2009, CELL CYCLE, V8, P167, DOI 10.4161/cc.8.1.7606; Han JS, 2013, MOL CELL, V51, P92, DOI 10.1016/j.molcel.2013.05.019; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; He J, 2013, MOL CELL, V50, P649, DOI 10.1016/j.molcel.2013.04.024; Hegemann B, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001993; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Izawa D, 2015, NATURE, V517, P631, DOI 10.1038/nature13911; Izawa D, 2011, NAT CELL BIOL, V13, P223, DOI 10.1038/ncb2165; Kaisari S, 2016, P NATL ACAD SCI USA, V113, P966, DOI 10.1073/pnas.1524551113; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kelly A, 2014, MOL CELL, V56, P232, DOI 10.1016/j.molcel.2014.09.010; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005; Labit H, 2012, EMBO J, V31, P3351, DOI 10.1038/emboj.2012.168; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lara-Gonzalez P, 2012, CURR BIOL, V22, pR966, DOI 10.1016/j.cub.2012.10.006; Lara-Gonzalez P, 2011, J CELL SCI, V124, P4332, DOI 10.1242/jcs.094763; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Lischetti T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6563; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Luo XL, 2002, MOL CELL, V9, P59, DOI 10.1016/S1097-2765(01)00435-X; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Mansfeld J, 2011, NAT CELL BIOL, V13, P1234, DOI 10.1038/ncb2347; Mapelli M, 2007, CELL, V131, P730, DOI 10.1016/j.cell.2007.08.049; Meyer HJ, 2011, SEMIN CELL DEV BIOL, V22, P544, DOI 10.1016/j.semcdb.2011.03.009; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799; Pan J, 2004, GENE DEV, V18, P1439, DOI 10.1101/gad.1184204; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Primorac I, 2013, J CELL BIOL, V201, P177, DOI 10.1083/jcb.201301130; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Reis A, 2006, EMBO REP, V7, P1040, DOI 10.1038/sj.embor.7400772; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sironi L, 2002, EMBO J, V21, P2496, DOI 10.1093/emboj/21.10.2496; Steen JAJ, 2008, P NATL ACAD SCI USA, V105, P6069, DOI 10.1073/pnas.0709807104; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Suijkerbuijk SJE, 2012, DEV CELL, V22, P1321, DOI 10.1016/j.devcel.2012.03.009; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Tian W, 2012, P NATL ACAD SCI USA, V109, P18419, DOI 10.1073/pnas.1213438109; Uzunova K, 2012, NAT STRUCT MOL BIOL, V19, P1116, DOI 10.1038/nsmb.2412; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Varetti G, 2011, MOL CELL, V44, P710, DOI 10.1016/j.molcel.2011.11.014; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; Yudkovsky Y, 2000, BIOCHEM BIOPH RES CO, V271, P299, DOI 10.1006/bbrc.2000.2622; Zhang SY, 2016, NATURE, V533, P260, DOI 10.1038/nature17973; Zhang ZG, 2016, METHODS, V95, P13, DOI 10.1016/j.ymeth.2015.10.003; Zhang ZG, 2013, BIOCHEM J, V449, P365, DOI 10.1042/BJ20121374	74	123	126	2	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					431	+		10.1038/nature19083	http://dx.doi.org/10.1038/nature19083			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27509861	Green Accepted			2022-12-28	WOS:000382646600036
J	Miller, PD; Hattersley, G; Riis, BJ; Williams, GC; Lau, E; Russo, LA; Alexandersen, P; Zerbini, CAF; Hu, MY; Harris, AG; Fitzpatrick, LA; Cosman, F; Christiansen, C				Miller, Paul D.; Hattersley, Gary; Riis, Bente Juel; Williams, Gregory C.; Lau, Edith; Russo, Luis Augusto; Alexandersen, Peter; Zerbini, Cristiano A. F.; Hu, Ming-yi; Harris, Alan G.; Fitzpatrick, Lorraine A.; Cosman, Felicia; Christiansen, Claus		ACTIVE Study Investigators	Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PARATHYROID-HORMONE RECEPTOR; SUBSEQUENT FRACTURES; PREVENTION; RISK; DENSITY; BONE; MEN; SUPPLEMENTATION; METAANALYSIS; MORTALITY	IMPORTANCE Additional therapies are needed for prevention of osteoporotic fractures. Abaloparatide is a selective activator of the parathyroid hormone type 1 receptor. OBJECTIVE To determine the efficacy and safety of abaloparatide, 80 mu g, vs placebo for prevention of new vertebral fracture in postmenopausal women at risk of osteoporotic fracture. DESIGN, SETTING, AND PARTICIPANTS The Abaloparatide Comparator Trial In Vertebral Endpoints (ACTIVE) was a phase 3, double-blind, RCT (March 2011-October 2014) at 28 sites in 10 countries. Postmenopausal women with bone mineral density (BMD) T score <=-2.5 and >-5.0 at the lumbar spine or femoral neck and radiological evidence >= 2 mild or >= 1 moderate lumbar or thoracic vertebral fracture or history of low-trauma nonvertebral fracture within the past 5 years were eligible. Postmenopausal women (>65 y) with fracture criteria and a T score >-2.0 and >-5.0 or without fracture criteria and a T score <=-3.0 and >-5.0 could enroll. INTERVENTIONS Blinded, daily subcutaneous injections of placebo (n = 821); abaloparatide, 80 mu g (n = 824); or open-label teriparatide, 20 mu g (n = 818) for 18 months. MAIN OUTCOMES AND MEASURES Primary end point was percentage of participants with new vertebral fracture in the abaloparatide vs placebo groups. Sample size was set to detect a 4% difference (57% risk reduction) between treatment groups. Secondary end points included change in BMD at total hip, femoral neck, and lumbar spine in abaloparatide-treated vs placebo participants and time to first incident nonvertebral fracture. Hypercalcemia was a prespecified safety end point in abaloparatide-treated vs teriparatide participants. RESULTS Among 2463 women (mean age, 69 years [range, 49-86]), 1901 completed the study. New morphometric vertebral fractures occurred less frequently in the active treatment groups vs placebo. The Kaplan-Meier estimated event rate for nonvertebral fracture was lower with abaloparatide vs placebo. BMD increases were greater with abaloparatide than placebo (all P < .001). Incidence of hypercalcemia was lower with abaloparatide (3.4%) vs teriparatide (6.4%) (risk difference [RD], -2.96 [95% CI, -5.12 to -0.87]; P = .006). [GRAPHICS] CONCLUSIONS AND RELEVANCE Among postmenopausal women with osteoporosis, the use of subcutaneous abaloparatide, compared with placebo, reduced the risk of new vertebral and nonvertebral fractures over 18 months. Further research is needed to understand the clinical importance of RD, the risks and benefits of abaloparatide treatment, and the efficacy of abaloparatide vs other osteoporosis treatments.	[Miller, Paul D.] Colorado Ctr Bone Res, Lakewood, CO USA; [Hattersley, Gary; Williams, Gregory C.; Hu, Ming-yi; Harris, Alan G.; Fitzpatrick, Lorraine A.] Radius Hlth, Waltham, MA USA; [Riis, Bente Juel; Christiansen, Claus] Nord Biosci, Copenhagen, Denmark; [Lau, Edith] Ctr Hlth & Med Res, Hong Kong, Hong Kong, Peoples R China; [Russo, Luis Augusto] Ctr Clin & Basic Res, Rio De Janeiro, Brazil; [Alexandersen, Peter] Ctr Clin & Basic Res, Vejle, Denmark; [Zerbini, Cristiano A. F.] Ctr Paulista Invest Clin, Sao Paulo, Brazil; [Cosman, Felicia] Helen Hayes Hosp, Clin Res Ctr, W Haverstraw, NY USA	Colorado Center For Bone Research; Nordic Bioscience; Center Clinical & Basic Research; Center Clinical & Basic Research	Miller, PD (corresponding author), Colorado Ctr Bone Res PC, 3190 S Wadsworth Blvd,Ste 250, Lakewood, CO 80227 USA.	millerccbr@aol.com		Harris, Alan/0000-0002-6618-2092; Glogowska-Szelag, Joanna/0000-0003-0949-322X	Radius Health	Radius Health	This study was funded by Radius Health.	Akesson K, 2013, OSTEOPOROSIS INT, V24, P2135, DOI 10.1007/s00198-013-2348-z; Bilezikian John P, 2008, Curr Osteoporos Rep, V6, P24, DOI 10.1007/s11914-008-0005-9; Bliuc D, 2015, J BONE MINER RES, V30, P637, DOI 10.1002/jbmr.2393; Calonge N, 2011, ANN INTERN MED, V154, P356, DOI 10.7326/0003-4819-154-5-201103010-00307; Cawthon PM, 2011, CLIN ORTHOP RELAT R, V469, P1900, DOI 10.1007/s11999-011-1780-7; Center JR, 2007, JAMA-J AM MED ASSOC, V297, P387, DOI 10.1001/jama.297.4.387; Cosman F, 2014, OSTEOPOROSIS INT, V25, P2359, DOI 10.1007/s00198-014-2794-2; Cummings SR, 2009, NEW ENGL J MED, V361, P756, DOI 10.1056/NEJMoa0809493; DawsonHughes B, 1997, NEW ENGL J MED, V337, P670, DOI 10.1056/NEJM199709043371003; Eisman JA, 2012, J BONE MINER RES, V27, P2039, DOI 10.1002/jbmr.1698; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; FLEISS JL, 1976, ARCH GEN PSYCHIAT, V33, P107; Gehlbach S, 2012, J BONE MINER RES, V27, P645, DOI 10.1002/jbmr.1476; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Hattersley G, 2016, ENDOCRINOLOGY, V157, P141, DOI 10.1210/en.2015-1726; Horwitz MJ, 2003, J CLIN ENDOCR METAB, V88, P569, DOI 10.1210/jc.2002-021122; Kanis JA, 2007, ASSESSMENT OSTEOPORO; Lindsay R, 2001, JAMA-J AM MED ASSOC, V285, P320, DOI 10.1001/jama.285.3.320; Marrinan S, 2015, AGE AGEING, V44, P258, DOI 10.1093/ageing/afu123; Maurer W., 1995, BIOMETRIE CHEM PHARM, V6; National Committee for Quality Assurance, 2014, PROP CHANG EX MEAS H; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Okazaki M, 2008, P NATL ACAD SCI USA, V105, P16525, DOI 10.1073/pnas.0808750105; Papadimitropoulos E, 2002, ENDOCR REV, V23, P560, DOI 10.1210/er.2001-8002; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.1093/biomet/63.3.581; Ryg P, 2009, J BONE MINER RES, V24, P1299, DOI [10.1359/JBMR.090207, 10.1359/jbmr.090207]; Shea B, 2002, ENDOCR REV, V23, P552, DOI 10.1210/er.2001-7002; Watts NB, 2014, NAT REV ENDOCRINOL, V10, P412, DOI 10.1038/nrendo.2014.55; Wright NC, 2014, J BONE MINER RES, V29, P2520, DOI 10.1002/jbmr.2269	30	427	447	3	51	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2016	316	7					722	733		10.1001/jama.2016.11136	http://dx.doi.org/10.1001/jama.2016.11136			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT5IA	27533157	Bronze			2022-12-28	WOS:000381514800018
J	McCarthy, M				McCarthy, Michael			Medicaid expansion is associated with improved access to care and self reported health, US study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Sommers BD, 2016, JAMA INTERN MED, V176, P1501, DOI 10.1001/jamainternmed.2016.4419	1	1	1	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2016	354								i4455	10.1136/bmj.i4455	http://dx.doi.org/10.1136/bmj.i4455			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4UY	27520579				2022-12-28	WOS:000381477800012
J	Pearson, B; Pearson, A				Pearson, Bryony; Pearson, Arthur			Anne Marion Pearson OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2016	354								i4401	10.1136/bmj.i4401	http://dx.doi.org/10.1136/bmj.i4401			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4UY	27519535				2022-12-28	WOS:000381477800007
J	Berry, M; Clatworthy, MR				Berry, Miriam; Clatworthy, Menna R.			Kidney Macrophages: Unique Position Solves a Complex Problem	CELL			English	Editorial Material							MYELOID CELLS; NEPHRITIS	Immune complex-mediated diseases, such as systemic lupus erythematosus, commonly affect the kidney and determine disease prognosis. Stamatiades et al. now propose a kidney-specific mechanism for trans-endothelial transport of small immune complexes that activate strategically positioned tissue resident macrophages.	[Berry, Miriam; Clatworthy, Menna R.] Univ Cambridge, Dept Med, Mol Immun Unit, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology; University of Cambridge	Clatworthy, MR (corresponding author), Univ Cambridge, Dept Med, Mol Immun Unit, Mol Biol Lab, Cambridge CB2 0QH, England.	mrc38@medschl.cam.ac.uk			MRC [MR/K023934/1] Funding Source: UKRI; Medical Research Council [MR/K023934/1] Funding Source: Medline; Kidney Research UK [JF1/2013] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Kidney Research UK(Kidney Research UK (KRUK))		Chalmers SA, 2015, J AUTOIMMUN, V57, P42, DOI 10.1016/j.jaut.2014.11.007; Lenda DM, 2003, J IMMUNOL, V170, P3254, DOI 10.4049/jimmunol.170.6.3254; Rogers NM, 2014, NAT REV NEPHROL, V10, P625, DOI 10.1038/nrneph.2014.170; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Sharp PEH, 2013, J IMMUNOL, V190, P340, DOI 10.4049/jimmunol.1202250; Willcocks LC, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001161	6	3	3	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					799	801		10.1016/j.cell.2016.07.047	http://dx.doi.org/10.1016/j.cell.2016.07.047			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27518559	Bronze			2022-12-28	WOS:000382258700006
J	Carter, M				Carter, Meg			MEDICINE AND THE MEDIA The Brexit broadcast that stoked fears over the NHS's future	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												meg@megcarter.com						*ADV STAND AUTH, 2016, POL ADV COMPL; *BBC, 2016, BBC             0614; Dilnot A, 2016, UK CONTRIBUTIONS EUR; ESKANDER A, 2016, NEW STATESMAN	4	0	0	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2016	354								i4342	10.1136/bmj.i4342	http://dx.doi.org/10.1136/bmj.i4342			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9DD	27495305				2022-12-28	WOS:000381081800022
J	Devereaux, PJ; Guyatt, G; Gerstein, H; Connolly, S; Yusuf, S				Devereaux, P. J.; Guyatt, Gordon; Gerstein, Hertzel; Connolly, Stuart; Yusuf, Salim		Int Consortium Investigators Fairn	Toward Fairness in Data Sharing	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Devereaux, P. J.; Guyatt, Gordon; Gerstein, Hertzel; Connolly, Stuart; Yusuf, Salim] McMaster Univ, Hamilton, ON, Canada	McMaster University	Devereaux, PJ (corresponding author), McMaster Univ, Hamilton, ON, Canada.		Gerstein, Hertzel C/B-1235-2013; Cooper, D. James/G-7961-2013; Gerstein, Hertzel/ABB-8781-2020; Devereaux, PJ/AAF-2862-2019; Devereaux, PJ/AAY-1757-2021	Gerstein, Hertzel C/0000-0001-8072-2836; Cooper, D. James/0000-0002-5872-9051; Gerstein, Hertzel/0000-0001-8072-2836; Yusuf, Salim/0000-0003-4776-5601; Mendoza, Gabriela/0000-0002-1479-1494; Meyhoff, Christian/0000-0002-4885-4609; Jasinski, Marek/0000-0002-9989-7748				Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Gordon D, 2013, NEW ENGL J MED, V369, P1926, DOI 10.1056/NEJMsa1300237; Taichman DB, 2016, JAMA-J AM MED ASSOC, V315, P467, DOI 10.1001/jama.2015.18164	3	47	49	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2016	375	5					405	407		10.1056/NEJMp1605654	http://dx.doi.org/10.1056/NEJMp1605654			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS7AN	27518658	Bronze			2022-12-28	WOS:000380934900003
J	Mahony, C				Mahony, Chris			John Garrow OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												chris.mahony@cjmedia.biz						GARROW J, PUBLICATION LIST, P67093	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2016	354								i4290	10.1136/bmj.i4290	http://dx.doi.org/10.1136/bmj.i4290			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9CY	27491311				2022-12-28	WOS:000381081300005
J	Hannah-Shmouni, F; Demidowich, A; Stratakis, CA				Hannah-Shmouni, Fady; Demidowich, Andrew; Stratakis, Constantine A.			Cortisol in the Evaluation of Adrenal Insufficiency	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DIAGNOSIS		[Hannah-Shmouni, Fady; Demidowich, Andrew; Stratakis, Constantine A.] NICHHD, Sect Endocrinol & Genet, Program Dev Endocrinol & Genet, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Stratakis, CA (corresponding author), NICHD, SEGEN, PDEGEN, NIH, 9000 Rockville Pk,Bldg 10,CRC,Room 1-3330,MSC1103, Bethesda, MD 20892 USA.	stratakc@mail.nih.gov	Stratakis, Constantine/AAP-4745-2020; Fady Hannah-Shmouni, FRCPC/AAF-5159-2019	Fady Hannah-Shmouni, FRCPC/0000-0001-6829-6205	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008920] Funding Source: NIH RePORTER	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bornstein SR, 2016, J CLIN ENDOCR METAB, V101, P364, DOI 10.1210/jc.2015-1710; Charmandari E, 2014, LANCET, V383, P2152, DOI 10.1016/S0140-6736(13)61684-0; Dorin RI, 2003, ANN INTERN MED, V139, P194, DOI 10.7326/0003-4819-139-3-200308050-00009; HAGG E, 1987, CLIN ENDOCRINOL, V26, P221, DOI 10.1111/j.1365-2265.1987.tb00780.x; Kazlauskaite R, 2008, J CLIN ENDOCR METAB, V93, P4245, DOI 10.1210/jc.2008-0710; Ospina NS, 2016, J CLIN ENDOCR METAB, V101, P427, DOI 10.1210/jc.2015-1700	6	3	3	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2016	316	5					535	536		10.1001/jama.2016.8360	http://dx.doi.org/10.1001/jama.2016.8360			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9AU	27483068				2022-12-28	WOS:000381075000021
J	Khan, NA				Khan, Nadia A.			Getting to Lower Systolic Blood Pressure: Beyond Antihypertensive Therapy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Khan, Nadia A.] Univ British Columbia, Ctr Hlth Evaluat & Outcome Sci, Vancouver, BC V6Z 1Y6, Canada	University of British Columbia	Khan, NA (corresponding author), Univ British Columbia, Ctr Hlth Evaluat & Outcome Sci, 570 4B,1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada.	nakhanubc@gmail.com						BRUCKERT E, 2011, ARCH CARDIOVASC DIS, V381, P104; Fahey T, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005182.pub3; Feldman RD, 2009, HYPERTENSION, V53, P646, DOI 10.1161/HYPERTENSIONAHA.108.123455; Leung AA, 2016, CAN J CARDIOL, V32, P569, DOI 10.1016/j.cjca.2016.02.066; Lonn EM, 2016, NEW ENGL J MED, V374, P2009, DOI 10.1056/NEJMoa1600175; Myers MG, 2012, CAN J CARDIOL, V28, P341, DOI 10.1016/j.cjca.2011.09.004; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; TURCHIN A, 2009, HYPERTENSION, V53, P646; Williamson JD, 2016, JAMA-J AM MED ASSOC, V315, P2673, DOI 10.1001/jama.2016.7050	9	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2016	165	9					661	662		10.7326/M16-1421	http://dx.doi.org/10.7326/M16-1421			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8SJ	27537098				2022-12-28	WOS:000386908600025
J	Kosmyna, B; Query, CC				Kosmyna, Brian; Query, Charles C.			STRUCTURAL BIOLOGY Catalytic spliceosome captured	NATURE			English	Editorial Material							U4/U6.U5 TRI-SNRNP; CRYO-EM; RESOLUTION		[Kosmyna, Brian; Query, Charles C.] Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA	Yeshiva University	Kosmyna, B (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA.	brian.kosmyna@phd.einstein.yu.edu; charles.query@einstein.yu.edu			NIGMS NIH HHS [R01 GM057829] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057829] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Agafonov DE, 2016, SCIENCE, V351, P1416, DOI 10.1126/science.aad2085; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Galej WP, 2016, NATURE, V537, P197, DOI 10.1038/nature19316; Newby MI, 2002, NAT STRUCT BIOL, V9, P958, DOI 10.1038/nsb873; Nogales E, 2016, NAT METHODS, V13, P24, DOI 10.1038/nmeth.3694; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Nguyen THD, 2016, NATURE, V530, P298, DOI 10.1038/nature16940; Wan R., 2016, SCIENCE; Wan RX, 2016, SCIENCE, V351, P466, DOI 10.1126/science.aad6466; Yan C., 2016, SCIENCE; Yan CY, 2015, SCIENCE, V349, P1182, DOI 10.1126/science.aac7629; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496	12	1	1	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					175	176		10.1038/nature19422	http://dx.doi.org/10.1038/nature19422			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU9LQ	27509853				2022-12-28	WOS:000382539100035
J	Venkatakrishnan, AJ; Deupi, X; Lebon, G; Heydenreich, FM; Flock, T; Miljus, T; Balaji, S; Bouvier, M; Veprintsev, DB; Tate, CG; Schertler, GFX; Babu, MM				Venkatakrishnan, A. J.; Deupi, Xavier; Lebon, Guillaume; Heydenreich, Franziska M.; Flock, Tilman; Miljus, Tamara; Balaji, Santhanam; Bouvier, Michel; Veprintsev, Dmitry B.; Tate, Christopher G.; Schertler, Gebhard F. X.; Babu, M. Madan			Diverse activation pathways in class A GPCRs converge near the G-protein-coupling region	NATURE			English	Article							RECEPTOR ACTIVATION; BETA(2)-ADRENERGIC RECEPTOR; STRUCTURAL INSIGHTS; MECHANISM	Class A G-protein-coupled receptors (GPCRs) are a large family of membrane proteins that mediate a wide variety of physiological functions, including vision, neurotransmission and immune responses(1-4). They are the targets of nearly one-third of all prescribed medicinal drugs(5) such as beta blockers and antipsychotics. GPCR activation is facilitated by extracellular ligands and leads to the recruitment of intracellular G proteins(3,6). Structural rearrangements of residue contacts in the transmembrane domain serve as 'activation pathways' that connect the ligand-binding pocket to the G-protein-coupling region within the receptor. In order to investigate the similarities in activation pathways across class A GPCRs, we analysed 27 GPCRs from diverse subgroups for which structures of active, inactive or both states were available. Here we show that, despite the diversity in activation pathways between receptors, the pathways converge near the G-protein-coupling region. This convergence is mediated by a highly conserved structural rearrangement of residue contacts between transmembrane helices 3, 6 and 7 that releases G-protein-contacting residues. The convergence of activation pathways may explain how the activation steps initiated by diverse ligands enable GPCRs to bind a common repertoire of G proteins.	[Venkatakrishnan, A. J.; Flock, Tilman; Balaji, Santhanam; Tate, Christopher G.; Babu, M. Madan] MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England; [Venkatakrishnan, A. J.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA; [Venkatakrishnan, A. J.] Stanford Univ, Dept Comp Sci, 318 Campus Dr, Stanford, CA 94305 USA; [Venkatakrishnan, A. J.] Stanford Univ, Inst Computat & Math Engn, 475 Via Ortega, Stanford, CA 94305 USA; [Deupi, Xavier; Heydenreich, Franziska M.; Miljus, Tamara; Veprintsev, Dmitry B.; Schertler, Gebhard F. X.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Lebon, Guillaume] CNRS, UMR 5203, Inst Genom Fonct, 141 Rue Cardonille, F-34094 Montpellier 05, France; [Lebon, Guillaume] INSERM, U1191, F-34094 Montpellier, France; [Lebon, Guillaume] Univ Montpellier, F-34094 Montpellier, France; [Heydenreich, Franziska M.; Miljus, Tamara; Veprintsev, Dmitry B.; Schertler, Gebhard F. X.] ETH, Dept Biol, Wolfgang Pauli Str 27, CH-8093 Zurich, Switzerland; [Heydenreich, Franziska M.; Bouvier, Michel] Univ Montreal, Dept Biochem, Montreal, PQ H3C 3J7, Canada; [Heydenreich, Franziska M.; Bouvier, Michel] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada	MRC Laboratory Molecular Biology; Stanford University; Stanford University; Stanford University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Swiss Federal Institutes of Technology Domain; ETH Zurich; Universite de Montreal; Universite de Montreal	Venkatakrishnan, AJ; Babu, MM (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge CB2 0QH, England.; Venkatakrishnan, AJ (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, 279 Campus Dr, Stanford, CA 94305 USA.; Venkatakrishnan, AJ (corresponding author), Stanford Univ, Dept Comp Sci, 318 Campus Dr, Stanford, CA 94305 USA.; Venkatakrishnan, AJ (corresponding author), Stanford Univ, Inst Computat & Math Engn, 475 Via Ortega, Stanford, CA 94305 USA.	ajvenkat@stanford.edu; madanm@mrc-lmb.cam.ac.uk	Heydenreich, Franziska M/N-6314-2015; Lebon, Guillaume/AAZ-4486-2020; Veprintsev, Dmitry B/H-2228-2012; Bouvier, Michel/H-2758-2014; Mohan, Babu P./I-7362-2019; Deupi, Xavier/B-2424-2009	Heydenreich, Franziska M/0000-0002-8049-4383; Veprintsev, Dmitry B/0000-0002-3583-5409; Bouvier, Michel/0000-0003-1128-0100; Deupi, Xavier/0000-0003-4572-9316; Guillaume, Lebon/0000-0003-1162-5148; Schertler, Gebhard F.X./0000-0002-5846-6810; Miljus, Tamara/0000-0003-0462-7866; /0000-0003-3398-0968	LMB International Scholarship; St. John's College Benefactor Scholarship; MRC Centenary Early Career Award; Medical Research Council [MC_U105185859, MC_U105197215]; Boehringer Ingelheim Fonds; Heptares Therapeutics Ltd; ATIP-Avenir program; Swiss National Science Foundation [310030_153145, 31003A_146520, 31003A_159748, P1EZP3_165219]; Human Frontiers Science Program [RGP0034/2014]; Canadian Institute for Health Research [MOP-10501]; COST Action [CM1207]; MRC [MC_U105185859, MC_U105197215] Funding Source: UKRI	LMB International Scholarship; St. John's College Benefactor Scholarship; MRC Centenary Early Career Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Heptares Therapeutics Ltd; ATIP-Avenir program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Human Frontiers Science Program(Human Frontier Science Program); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); COST Action(European Cooperation in Science and Technology (COST)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Chothia, G. Chalancon, N. Latysheva, R. Henderson, A. Sente, K. Kruse, A. Singhal and S. Chavali for their comments on this manuscript. We acknowledge LMB International Scholarship (in support of A.J.V.), St. John's College Benefactor Scholarship (A.J.V.), MRC Centenary Early Career Award (A. J. V.), the Medical Research Council (MC_U105185859) (M.M.B., S.B., T.F.); (MC_U105197215) (C.G.T., G.L.), Boehringer Ingelheim Fonds (T.F.), Heptares Therapeutics Ltd (G.L.), ATIP-Avenir program (G.L.), Swiss National Science Foundation (grant number 310030_153145) (G.F.X.S.); (31003A_146520) (X.D.); (31003A_159748) (D.B.V.), Swiss National Science Foundation Doc. Mobility fellowship P1EZP3_165219 (F.M.H.), the Human Frontiers Science Program (RGP0034/2014) (G.F.X.S.), the Canadian Institute for Health Research (MOP-10501) (M.B.) and the COST Action CM1207 (GLISTEN) (X.D., G.F.X.S., C.G.T., G.L.). M.M.B. is a Lister Institute Research Prize Fellow. M. B. holds a Canada Research Chair.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Bohm SK, 1997, J BIOL CHEM, V272, P2363; Breton B, 2010, BIOPHYS J, V99, P4037, DOI 10.1016/j.bpj.2010.10.025; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Dror RO, 2015, SCIENCE, V348, P1361, DOI 10.1126/science.aaa5264; Flock T, 2015, NATURE, V524, P173, DOI 10.1038/nature14663; Gabilondo AM, 1996, EUR J PHARMACOL, V307, P243, DOI 10.1016/0014-2999(96)00247-6; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gonzalez A, 2012, CHEMBIOCHEM, V13, P1393, DOI 10.1002/cbic.201200189; Greasley PJ, 2002, MOL PHARMACOL, V61, P1025, DOI 10.1124/mol.61.5.1025; Huang WJ, 2015, NATURE, V524, P315, DOI 10.1038/nature14886; Isberg V, 2016, NUCLEIC ACIDS RES, V44, pD356, DOI 10.1093/nar/gkv1178; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Isom DG, 2015, P NATL ACAD SCI USA, V112, P5702, DOI 10.1073/pnas.1417888112; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kruse AC, 2013, NATURE, V504, P101, DOI 10.1038/nature12735; Lagerstrom MC, 2008, NAT REV DRUG DISCOV, V7, P339, DOI 10.1038/nrd2518; Lans I, 2015, J STRUCT BIOL, V192, P545, DOI 10.1016/j.jsb.2015.10.019; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Manglik A, 2015, CELL, V161, P1101, DOI 10.1016/j.cell.2015.04.043; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Sun DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078878; Tello JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038456; Venkatakrishnan AJ, 2014, CURR OPIN STRUC BIOL, V27, P129, DOI 10.1016/j.sbi.2014.08.002; Venkatakrishnan AJ, 2013, NATURE, V494, P185, DOI 10.1038/nature11896; Yuan SG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5733	32	176	181	5	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					484	+		10.1038/nature19107	http://dx.doi.org/10.1038/nature19107			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27525504	Green Accepted			2022-12-28	WOS:000382646600047
J	Manrai, AK; Funke, BH; Rehm, HL; Olesen, MS; Maron, BA; Szolovits, P; Margulies, DM; Loscalzo, J; Kohane, IS				Manrai, Arjun K.; Funke, Birgit H.; Rehm, Heidi L.; Olesen, Morten S.; Maron, Bradley A.; Szolovits, Peter; Margulies, David M.; Loscalzo, Joseph; Kohane, Isaac S.			Genetic Misdiagnoses and the Potential for Health Disparities	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPERTROPHIC CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; MUTATIONS; VARIANTS; PATHOGENICITY; POPULATION; STANDARDS; GENOMICS; DATABASE; RISK	BACKGROUND For more than a decade, risk stratification for hypertrophic cardiomyopathy has been enhanced by targeted genetic testing. Using sequencing results, clinicians routinely assess the risk of hypertrophic cardiomyopathy in a patient's relatives and diagnose the condition in patients who have ambiguous clinical presentations. However, the benefits of genetic testing come with the risk that variants may be misclassified. METHODS Using publicly accessible exome data, we identified variants that have previously been considered causal in hypertrophic cardiomyopathy and that are overrepresented in the general population. We studied these variants in diverse populations and reevaluated their initial ascertainments in the medical literature. We reviewed patient records at a leading genetic-testing laboratory for occurrences of these variants during the near-decade-long history of the laboratory. RESULTS Multiple patients, all of whom were of African or unspecified ancestry, received positive reports, with variants misclassified as pathogenic on the basis of the understanding at the time of testing. Subsequently, all reported variants were recategorized as benign. The mutations that were most common in the general population were significantly more common among black Americans than among white Americans ( P<0.001). Simulations showed that the inclusion of even small numbers of black Americans in control cohorts probably would have prevented these misclassifications. We identified methodologic shortcomings that contributed to these errors in the medical literature. CONCLUSIONS The misclassification of benign variants as pathogenic that we found in our study shows the need for sequencing the genomes of diverse populations, both in asymptomatic controls and the tested patient population. These results expand on current guidelines, which recommend the use of ancestry-matched controls to interpret variants. As additional populations of different ancestry backgrounds are sequenced, we expect variant reclassifications to increase, particularly for ancestry groups that have historically been less well studied. ( Funded by the National Institutes of Health.)	[Manrai, Arjun K.; Margulies, David M.; Kohane, Isaac S.] Harvard Med Sch, Dept Biomed Informat, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Funke, Birgit H.] Harvard Med Sch, Dept Pathol, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Maron, Bradley A.; Loscalzo, Joseph] Harvard Med Sch, Dept Pathol, Massachusetts Gen Hosp, Dept Med, Boston, MA 02115 USA; [Rehm, Heidi L.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Maron, Bradley A.] Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA; [Maron, Bradley A.; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Manrai, Arjun K.; Kohane, Isaac S.] Harvard Massachusetts Inst Technol MIT, Div Hlth Sci & Technol, Cambridge, MA USA; [Funke, Birgit H.; Rehm, Heidi L.] Partners HealthCare Personalized Med, Mol Med Lab, Cambridge, MA USA; [Szolovits, Peter] MIT, Comp Sci & Artificial Intelligence Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Olesen, Morten S.] Univ Copenhagen Hosp, Rigshosp, Lab Mol Cardiol, Dept Cardiol,Heart Ctr, Copenhagen, Denmark; [Olesen, Morten S.] Univ Copenhagen, Dept Biomed Sci, Fac Hlth & Med Sci, Copenhagen, Denmark	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Partners Healthcare System; Massachusetts Institute of Technology (MIT); Rigshospitalet; University of Copenhagen; University of Copenhagen	Kohane, IS (corresponding author), 10 Shattuck St, Boston, MA 02115 USA.	isaac_kohane@harvard.edu	olesen, morten/AAC-5752-2021; Loscalzo, Joseph/ABD-8980-2021	Rehm, Heidi L./0000-0002-6025-0015; Manrai, Arjun/0000-0001-9657-9800; Olesen, Morten Salling/0000-0001-9477-5322; Margulies, David/0000-0002-1294-3386	National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295, U01HG007690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH094267] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [U54LM008748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Funded by the National Institutes of Health.	Alfares AA, 2015, GENET MED, V17, P880, DOI [10.1038/gim.2014.205, 10.1038/gim.2015.16]; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Andreasen C, 2013, EUR J HUM GENET, V21, P918, DOI 10.1038/ejhg.2012.283; [Anonymous], 2011, PRECISION MED BUILDI; Arimura T, 2007, BIOCHEM BIOPH RES CO, V362, P281, DOI 10.1016/j.bbrc.2007.07.183; Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; Bick AG, 2012, AM J HUM GENET, V91, P513, DOI 10.1016/j.ajhg.2012.07.017; Drazen JM, 2015, NEW ENGL J MED, V372, P201, DOI 10.1056/NEJMp1415160; Duzkale H, 2013, CLIN GENET, V84, P453, DOI 10.1111/cge.12257; Exome Aggregation Consortium (ExAC), 2016, EXAC BROWS BET; Garcia-Castro M, 2003, CLIN CHEM, V49, P1279, DOI 10.1373/49.8.1279; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Ioannidis JPA, 2004, NAT GENET, V36, P1312, DOI 10.1038/ng1474; Keinan A, 2012, SCIENCE, V336, P740, DOI 10.1126/science.1217283; Klitzman R, 2013, J GENET COUNS, V22, P90, DOI 10.1007/s10897-012-9504-z; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lo B, 2015, JAMA-J AM MED ASSOC, V313, P793, DOI 10.1001/jama.2015.292; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Manrai AK, 2016, JAMA-J AM MED ASSOC, V315, P1233, DOI 10.1001/jama.2016.1519; Maron BJ, 2012, J AM COLL CARDIOL, V60, P705, DOI 10.1016/j.jacc.2012.02.068; Maron BJ, 2011, AM J CARDIOL, V107, P604, DOI 10.1016/j.amjcard.2010.10.022; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Matsushita Y, 2007, J HUM GENET, V52, P543, DOI 10.1007/s10038-007-0149-y; Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463; Niimura H, 2002, CIRCULATION, V105, P446, DOI 10.1161/hc0402.102990; Norton N, 2012, CIRC-CARDIOVASC GENE, V5, P167, DOI 10.1161/CIRCGENETICS.111.961805; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Pugh TJ, 2014, GENET MED, V16, P601, DOI 10.1038/gim.2013.204; Rehm HL, 2013, NAT REV GENET, V14, P295, DOI 10.1038/nrg3463; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Richards CS, 2008, GENET MED, V10, P294, DOI 10.1097/GIM.0b013e31816b5cae; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Seldin MF, 2011, NAT REV GENET, V12, P523, DOI 10.1038/nrg3002; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Stenson PD, 2009, GENOME MED, V1, DOI 10.1186/gm13; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Weidemann F, 2009, CIRCULATION, V119, P524, DOI 10.1161/CIRCULATIONAHA.108.794529; Wilcox AR, 2014, J AM MED INFORM ASSN, V21, pE117, DOI 10.1136/amiajnl-2013-001965	40	409	409	1	27	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2016	375	7					655	665		10.1056/NEJMsa1507092	http://dx.doi.org/10.1056/NEJMsa1507092			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4VF	27532831	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000381478600007
J	Torjesen, I				Torjesen, Ingrid			"Weekend effect" for emergency general surgery has almost disappeared, study shows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		McCallum IJD, 2016, BRIT J SURG, V103, P1557, DOI 10.1002/bjs.10261	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2016	354								i4513	10.1136/bmj.i4513	http://dx.doi.org/10.1136/bmj.i4513			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GX	27531004				2022-12-28	WOS:000381806200014
J	Carrillo-Reid, L; Yang, WJ; Bando, Y; Peterka, DS; Yuste, R				Carrillo-Reid, Luis; Yang, Weijian; Bando, Yuki; Peterka, Darcy S.; Yuste, Rafael			Imprinting and recalling cortical ensembles	SCIENCE			English	Article							NEURAL-NETWORKS; VISUAL-STIMULI; MOTOR CORTEX; MEMORY; REPRESENTATION; POPULATIONS; ATTRIBUTES	Neuronal ensembles are coactive groups of neurons that may represent building blocks of cortical circuits. These ensembles could be formed by Hebbian plasticity, whereby synapses between coactive neurons are strengthened. Here we report that repetitive activation with two-photon optogenetics of neuronal populations from the visual cortex of awake mice builds neuronal ensembles that recur spontaneously after being imprinted and do not disrupt preexisting ones. Moreover, imprinted ensembles can be recalled by single-cell stimulation and remain coactive on consecutive days. Our results demonstrate the persistent reconfiguration of cortical circuits by two-photon optogenetics into neuronal ensembles that can perform pattern completion.	[Carrillo-Reid, Luis; Yang, Weijian; Bando, Yuki; Peterka, Darcy S.; Yuste, Rafael] Columbia Univ, NeuroTechnol Ctr, Dept Biol Sci, New York, NY 10027 USA	Columbia University	Carrillo-Reid, L (corresponding author), Columbia Univ, NeuroTechnol Ctr, Dept Biol Sci, New York, NY 10027 USA.	lc2998@columbia.edu		Bando, Yuki/0000-0003-3050-4982; Peterka, Darcy/0000-0001-7351-5820; Carrillo-Reid, Luis/0000-0002-0511-2533	National Eye Institute [DP1EY024503, R01EY011787]; National Institute of Mental Health [R01MH101218, R01MH100561, R41MH100895, R44MH109187]; Defense Advanced Research Projects Agency [SIMPLEX N66001-15-C-4032]; Uehara Memorial Foundation; Burroughs Wellcome Fund; U.S. Army Research Laboratory; U.S. Army Research Office [W911NF-12-1-0594]; NATIONAL EYE INSTITUTE [R01EY011787, DP1EY024503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100561, R01MH101218, R41MH100895, R44MH109187] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Uehara Memorial Foundation(Uehara Memorial Foundation); Burroughs Wellcome Fund(Burroughs Wellcome Fund); U.S. Army Research Laboratory(United States Department of DefenseUS Army Research Laboratory (ARL)); U.S. Army Research Office; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank our laboratory members for help and virus injections, A. Fairhall for comments, and the Stanford Neuroscience Gene Vector and Virus Core for AAVdj virus. This work was supported by the National Eye Institute (grants DP1EY024503 and R01EY011787), National Institute of Mental Health (grants R01MH101218, R01MH100561, R41MH100895, and R44MH109187), and Defense Advanced Research Projects Agency (grant SIMPLEX N66001-15-C-4032). Y.B. holds a fellowship from Uehara Memorial Foundation. W.Y. holds a Career Award at the Scientific Interface from Burroughs Wellcome Fund. This material is based on work supported by, or in part by, the U.S. Army Research Laboratory and the U.S. Army Research Office (contract W911NF-12-1-0594, Multidisciplinary University Research Initiative). We declare no competing financial interests. Author contributions: L.C.-R. and R.Y. came up with the concept for this work. L.C.-R., D.S.P., W.Y., and R.Y. designed the methodology. L.C.-R., W.Y., and Y.B. carried out the investigation. L.C.-R. wrote the original draft. L.C.-R. and R.Y. reviewed and edited the paper. D.S.P., W.Y., and L.C.-R. provided the resources for this work. R.Y. acquired funding. All of the data are archived in the NeuroTechnology Center at Columbia University.	Brown SL, 2005, NAT NEUROSCI, V8, P1568, DOI 10.1038/nn1559; Cao VY, 2015, NEURON, V86, P1385, DOI 10.1016/j.neuron.2015.05.022; Carrillo-Reid L, 2008, J NEUROPHYSIOL, V99, P1435, DOI 10.1152/jn.01131.2007; Carrillo-Reid L, 2015, J NEUROSCI, V35, P8813, DOI 10.1523/JNEUROSCI.5214-14.2015; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Drew PJ, 2010, NAT METHODS, V7, P981, DOI 10.1038/NMETH.1530; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Hunsaker MR, 2013, NEUROSCI BIOBEHAV R, V37, P36, DOI 10.1016/j.neubiorev.2012.09.014; Jackson A, 2006, NATURE, V444, P56, DOI 10.1038/nature05226; Johansen JP, 2010, P NATL ACAD SCI USA, V107, P12692, DOI 10.1073/pnas.1002418107; Kampa BM, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00018; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Liu X, 2012, NATURE, V484, P381, DOI 10.1038/nature11028; Luczak A, 2009, NEURON, V62, P413, DOI 10.1016/j.neuron.2009.03.014; Miller JEK, 2014, P NATL ACAD SCI USA, V111, pE4053, DOI 10.1073/pnas.1406077111; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; Ohki K, 2005, NATURE, V433, P597, DOI 10.1038/nature03274; OREILLY RC, 1994, HIPPOCAMPUS, V4, P661, DOI 10.1002/hipo.450040605; Packer AM, 2015, NAT METHODS, V12, P140, DOI 10.1038/nmeth.3217; Peters AJ, 2014, NATURE, V510, P263, DOI 10.1038/nature13235; Rickgauer JP, 2014, NAT NEUROSCI, V17, P1816, DOI 10.1038/nn.3866; Rolls ET, 2006, PROG NEUROBIOL, V79, P1, DOI 10.1016/j.pneurobio.2006.04.005; ROLLS ET, 1994, PROG BRAIN RES, V102, P335; Sawinski J, 2009, P NATL ACAD SCI USA, V106, P19557, DOI 10.1073/pnas.0903680106; Yuste R, 2015, NAT REV NEUROSCI, V16, P487, DOI 10.1038/nrn3962	27	137	138	7	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					691	694		10.1126/science.aaf7560	http://dx.doi.org/10.1126/science.aaf7560			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZC	27516599	Green Accepted			2022-12-28	WOS:000381561200038
J	Rambaut, A; Dudas, G; de Carvalho, LM; Park, DJ; Yozwiak, NL; Holmes, EC; Andersen, KG				Rambaut, Andrew; Dudas, Gytis; de Carvalho, Luiz Max; Park, Daniel J.; Yozwiak, Nathan L.; Holmes, Edward C.; Andersen, Kristian G.			Comment on "Mutation rate and genotype variation of Ebola virus from Mali case sequences"	SCIENCE			English	Editorial Material							SIERRA-LEONE; TRANSMISSION; OUTBREAK	Hoenen et al. (Reports, 3 April 2015, p. 117; published online 26 March) suggested that the Ebola virus Makona responsible for the West African epidemic evolved more slowly than previously reported. We show that this was based on corrupted data. An erratum provided a rate compatible with the initial and later, more precise, estimates but did not correctly state the nature of the error.	[Rambaut, Andrew; Dudas, Gytis; de Carvalho, Luiz Max] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3FL, Midlothian, Scotland; [Rambaut, Andrew] Univ Edinburgh, Ctr Immunol Infect & Evolut, Edinburgh EH9 3FL, Midlothian, Scotland; [Park, Daniel J.; Yozwiak, Nathan L.; Andersen, Kristian G.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Yozwiak, Nathan L.] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Holmes, Edward C.] Univ Sydney, Sydney Med Sch, Charles Perkins Ctr, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW 2006, Australia; [Holmes, Edward C.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia; [Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Andersen, Kristian G.] Scripps Translat Sci Inst, La Jolla, CA 92037 USA	University of Edinburgh; University of Edinburgh; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; University of Sydney; University of Sydney; Scripps Research Institute; Scripps Research Institute	Rambaut, A (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH9 3FL, Midlothian, Scotland.; Rambaut, A (corresponding author), Univ Edinburgh, Ctr Immunol Infect & Evolut, Edinburgh EH9 3FL, Midlothian, Scotland.; Andersen, KG (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; Andersen, KG (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.; Andersen, KG (corresponding author), Scripps Translat Sci Inst, La Jolla, CA 92037 USA.	a.rambaut@ed.ac.uk; kga1978@gmail.com	Dudas, Gytis/H-5968-2019; Holmes, Edward/Y-2789-2019; Carvalho, Luiz Max/AAC-8266-2020; Rambaut, Andrew/B-2481-2009; Holmes, Edward/GVR-9499-2022; Carvalho, Luiz Max F/J-6446-2014	Dudas, Gytis/0000-0002-0227-4158; Holmes, Edward/0000-0001-9596-3552; Carvalho, Luiz Max/0000-0001-5736-5578; Rambaut, Andrew/0000-0003-4337-3707; Carvalho, Luiz Max F/0000-0001-5736-5578; Rambaut FRSE, Professor Andrew/0000-0002-1278-598X				Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Hoenen T, 2015, SCIENCE, V348, P117, DOI 10.1126/science.aaa5646; Katzelnick LC, 2015, SCIENCE, V349, P1338, DOI 10.1126/science.aac5017; Kugelman JR, 2015, CELL REP, V12, P2111, DOI 10.1016/j.celrep.2015.08.038; Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007; Sanjuan R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002685; Tong YG, 2015, NATURE, V524, P93, DOI 10.1038/nature14490	10	5	5	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300								10.1126/science.aaf3823	http://dx.doi.org/10.1126/science.aaf3823			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZC	27516592				2022-12-28	WOS:000381561200029
J	Bothwell, LE; Podolsky, SH				Bothwell, Laura E.; Podolsky, Scott H.			HISTORY OF CLINICAL TRIALS The Emergence of the Randomized, Controlled Trial	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bothwell, Laura E.] Harvard Med Sch, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL,Dept Med, Boston, MA 02115 USA; [Bothwell, Laura E.] Harvard Med Sch, Boston, MA 02115 USA; [Podolsky, Scott H.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Bothwell, LE (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL,Dept Med, Boston, MA 02115 USA.; Bothwell, LE (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.							Bothwell L., 2014, THESIS; Chalmers I., 2005, BODY COUNTS MED QUAN, P309; Chalmers I, 2012, J ROY SOC MED, V105, P221, DOI 10.1258/jrsm.2012.12k029; Marks H., 1997, PROGR EXPT SCI THERA; Podolsky SH, 2016, BLINDING SOLUTION BI, P45	5	85	84	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2016	375	6					501	504		10.1056/NEJMp1604635	http://dx.doi.org/10.1056/NEJMp1604635			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU4OT	27509097				2022-12-28	WOS:000382193100001
J	Hjerpe, R; Bett, JS; Keuss, MJ; Solovyova, A; McWilliams, TG; Johnson, C; Sahu, I; Varghese, J; Wood, N; Wightman, M; Osborne, G; Bates, GP; Glickman, MH; Trost, M; Knebel, A; Marchesi, F; Kurz, T				Hjerpe, Roland; Bett, John S.; Keuss, Matthew J.; Solovyova, Alexandra; McWilliams, Thomas G.; Johnson, Clare; Sahu, Indrajit; Varghese, Joby; Wood, Nicola; Wightman, Melanie; Osborne, Georgina; Bates, Gillian P.; Glickman, Michael H.; Trost, Matthias; Knebel, Axel; Marchesi, Francesco; Kurz, Thimo			UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome	CELL			English	Article							POLYUBIQUITIN-BINDING PROTEIN; INTERACTION NETWORK; NUCLEAR; RAD23; HSP70; UBIQUITINATION; IDENTIFICATION; DEGRADATION; RECEPTORS; PROMOTES	Clearance of misfolded and aggregated proteins is central to cell survival. Here, we describe a new pathway for maintaining protein homeostasis mediated by the proteasome shuttle factor UBQLN2. The 26S proteasome degrades polyubiquitylated substrates by recognizing them through stoichiometrically bound ubiquitin receptors, but substrates are also delivered by reversibly bound shuttles. We aimed to determine why these parallel delivery mechanisms exist and found that UBQLN2 acts with the HSP70-HSP110 disaggregase machinery to clear protein aggregates via the 26S proteasome. UBQLN2 recognizes client-bound HSP70 and links it to the proteasome to allow for the degradation of aggregated and misfolded proteins. We further show that this process is active in the cell nucleus, where another system for aggregate clearance, autophagy, does not act. Finally, we found that mutations in UBQLN2, which lead to neurodegeneration in humans, are defective in chaperone binding, impair aggregate clearance, and cause cognitive deficits in mice.	[Hjerpe, Roland; Bett, John S.; Kurz, Thimo] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Henry Wellcome Lab Cell Biol, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland; [Hjerpe, Roland; Bett, John S.; Keuss, Matthew J.; McWilliams, Thomas G.; Johnson, Clare; Varghese, Joby; Wood, Nicola; Wightman, Melanie; Trost, Matthias; Knebel, Axel; Kurz, Thimo] Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat & Ubiquitylat Unit, Sir James Black Ctr, Dow St, Dundee DD1 5EH, Scotland; [Solovyova, Alexandra] Newcastle Univ Prot & Proteome Anal, Devonshire Bldg,Devonshire Terrace, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Sahu, Indrajit; Glickman, Michael H.] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Osborne, Georgina; Bates, Gillian P.] Kings Coll London, Guys Hosp, Dept Med & Mol Genet, 8th Floor Tower Wing, London SE1 9RT, England; [Marchesi, Francesco] Univ Glasgow, Coll Med Vet & Life Sci, Sch Vet Med, 464 Bearsden Rd, Glasgow G61 1QH, Lanark, Scotland	University of Glasgow; University of Dundee; Technion Israel Institute of Technology; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Glasgow	Bett, JS; Kurz, T (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Henry Wellcome Lab Cell Biol, Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.; Bett, JS; Kurz, T (corresponding author), Univ Dundee, Coll Life Sci, MRC Prot Phosphorylat & Ubiquitylat Unit, Sir James Black Ctr, Dow St, Dundee DD1 5EH, Scotland.	johnsbett@yahoo.co.uk; thimo.kurz@glasgow.ac.uk	Marchesi, Francesco/ABF-9255-2021; Trost, Matthias/A-9999-2009; Bates, Gillian/E-1146-2012	Marchesi, Francesco/0000-0003-1179-5788; Trost, Matthias/0000-0002-5732-700X; Bates, Gillian/0000-0002-4041-6305; Sahu, Indrajit/0000-0002-4143-0600; Glickman, Michael/0000-0002-1222-8104; Kurz, Thimo/0000-0003-0700-6993; Osborne, Georgina/0000-0001-8308-3179; McWilliams, Thomas/0000-0002-9570-4152; Wood, Nicola/0000-0002-3347-6625; Knebel, Axel/0000-0002-9197-6054; Solovyova, Alexandra/0000-0002-5682-7037	Medical Research Council [MRC_MC_UU_12016/7]; ERC [ERC_243019]; University of Glasgow Leadership Fellowship and Tenovus Scotland grant; CDHI foundation; Israel Science Foundation [ISF 909.14]; Division of Signal Transduction Therapy Unit; Medical Research Council [MC_UU_12016/5, MC_UP_A500_1020, MC_UU_12016/7] Funding Source: researchfish; MRC [MC_UP_A500_1020, MC_UU_12016/7, MC_UU_12016/5] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERC(European Research Council (ERC)European Commission); University of Glasgow Leadership Fellowship and Tenovus Scotland grant; CDHI foundation; Israel Science Foundation(Israel Science Foundation); Division of Signal Transduction Therapy Unit; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge technical support of the MRC Protein Phosphorylation and Ubiquitylation Unit, Elaine Forsyth for assistance with mouse work, the DNA Sequencing Service (coordinated by Nicholas Helps), Thomas Macartney and other members of the cloning team (coordinated by Rachel Toth and Mark Peggie), and the Protein Purification Team and Antibody Production Team (coordinated by Hilary McLauchlan and James Hastie). We thank Prof. Mike Cheetham (UCL) for providing HTT constructs and Prof. Ron Kopito (Stanford University) for providing GFPu-NLS cells. Special thanks to Dr. Katsuaki Inoue (beamline B21, Diamond Light Source, Didcot, UK) for help with SAXS data collection and primary data treatment and the Diamond Light Source for beamtime granted (proposal SM-5025-1). We thank Prof. Jeremy H. Lakey and Dr. Helen Waller for help in carrying out CD experiments, Mrs. Lynn Stevenson and Ms. Lynn Oxford (Veterinary Diagnostic Services, School of Veterinary Medicine, University of Glasgow) for their technical assistance with immunohistochemistry, and Dr. Ian Ganley and Dr. Michael Munson for advice on autophagy-related experiments and for providing ATG5 KO cells and LC3 antibodies. We thank Professor Kazuhiro Nagata (Kyoto Sangyo University) for providing HSP105 KO cells. We thank John MacLeod for his assistance in anaesthetizing mice and Amnon Golan for aiding in purification and characterization of 26S proteasome from human cells. This work was supported by the Medical Research Council (MRC_MC_UU_12016/7), an ERC Starting Investigator Grant to T.K. (ERC_243019), a University of Glasgow Leadership Fellowship and Tenovus Scotland grant (to J.S.B.), the CDHI foundation (to G.B.), an Israel Science Foundation (ISF 909.14) grant (to M.H.G.), as well as the pharmaceutical companies supporting the Division of Signal Transduction Therapy Unit (AstraZeneca, Boehringer-Ingelheim, GlaxoSmithKline, Merck, Janssen Pharmaceutica, and Pfizer).	Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Eggers DK, 1997, MOL BIOL CELL, V8, P1559, DOI 10.1091/mbc.8.8.1559; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Fahed AC, 2014, ANN NEUROL, V75, P793, DOI 10.1002/ana.24164; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Ganguly A, 2008, HUM MOL GENET, V17, P293, DOI 10.1093/hmg/ddm305; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hjerpe R, 2009, EMBO REP, V10, P1250, DOI 10.1038/embor.2009.192; Kaye FJ, 2000, FEBS LETT, V467, P348, DOI 10.1016/S0014-5793(00)01135-2; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lin CH, 2001, HUM MOL GENET, V10, P137, DOI 10.1093/hmg/10.2.137; Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048; Lu Y, 2015, SCIENCE, V348, DOI 10.1126/science.1250834; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Marin I, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-63; Matiuhin Y, 2008, MOL CELL, V32, P415, DOI 10.1016/j.molcel.2008.10.011; Mori F, 2012, ACTA NEUROPATHOL, V124, P149, DOI 10.1007/s00401-012-0999-z; Nakamura J, 2008, STROKE, V39, P2853, DOI 10.1161/STROKEAHA.107.506188; Nillegoda NB, 2015, NATURE, V524, P247, DOI 10.1038/nature14884; Osaka M, 2015, HUM MOL GENET, V24, P1617, DOI 10.1093/hmg/ddu575; Park SH, 2013, CELL, V154, P134, DOI 10.1016/j.cell.2013.06.003; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Rutherford NJ, 2013, BRAIN RES, V1524, P62, DOI 10.1016/j.brainres.2013.06.006; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V296, P813, DOI 10.1016/S0006-291X(02)02002-8; Shabek N, 2012, MOL CELL, V48, P87, DOI 10.1016/j.molcel.2012.07.011; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; VELAZQUEZ JM, 1984, CELL, V36, P655, DOI 10.1016/0092-8674(84)90345-3; Vengoechea J, 2013, AMYOTROPH LAT SCL FR, V14, P615, DOI 10.3109/21678421.2013.824001; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Wang J, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.67; Williams K. L., 2012, NEUROBIOL AGING, V33, pe3, DOI [DOI 10.1016/J.NEUR0BI0LAGING.2012.05.008, 10.1016/j.neurobiolaging.2012.05.008]; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Zhang HQ, 2015, STRUCTURE, V23, P472, DOI 10.1016/j.str.2015.01.003	40	183	184	1	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					935	949		10.1016/j.cell.2016.07.001	http://dx.doi.org/10.1016/j.cell.2016.07.001			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27477512	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000382258700016
J	Mayor, S				Mayor, Susan			Curative hepatitis C treatment is effective in drug users, trial shows	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Dore GJ, 2016, ANN INTERN MED, V165, P625, DOI 10.7326/M16-0816	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2016	354								i4346	10.1136/bmj.i4346	http://dx.doi.org/10.1136/bmj.i4346			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4TU	27506612				2022-12-28	WOS:000381474800006
J	Stevens, SL; Wood, S; Koshiaris, C; Law, K; Glasziou, P; Stevens, RJ; McManus, RJ				Stevens, Sarah L.; Wood, Sally; Koshiaris, Constantinos; Law, Kathryn; Glasziou, Paul; Stevens, Richard J.; McManus, Richard J.			Blood pressure variability and cardiovascular disease: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							VISIT-TO-VISIT; ALL-CAUSE MORTALITY; PROGNOSTIC VALUE; RISK-FACTOR; HEART-RATE; HYPERTENSIVE PATIENTS; STROKE; ASSOCIATION; HOME; POPULATION	OBJECTIVE To systematically review studies quantifying the associations of long term (clinic), mid-term (home), and short term (ambulatory) variability in blood pressure, independent of mean blood pressure, with cardiovascular disease events and mortality. DATA SOURCES Medline, Embase, Cinahl, and Web of Science, searched to 15 February 2016 for full text articles in English. ELIGIBILITY CRITERIA FOR STUDY SELECTION Prospective cohort studies or clinical trials in adults, except those in patients receiving haemodialysis, where the condition may directly impact blood pressure variability. Standardised hazard ratios were extracted and, if there was little risk of confounding, combined using random effects meta-analysis in main analyses. Outcomes included all cause and cardiovascular disease mortality and cardiovascular disease events. Measures of variability included standard deviation, coefficient of variation, variation independent of mean, and average real variability, but not night dipping or day-night variation. RESULTS 41 papers representing 19 observational cohort studies and 17 clinical trial cohorts, comprising 46 separate analyses were identified. Long term variability in blood pressure was studied in 24 papers, mid-term in four, and short-term in 15 (two studied both long term and short term variability). Results from 23 analyses were excluded from main analyses owing to high risks of confounding. Increased long term variability in systolic blood pressure was associated with risk of all cause mortality (hazard ratio 1.15, 95% confidence interval 1.09 to 1.22), cardiovascular disease mortality (1.18, 1.09 to 1.28), cardiovascular disease events (1.18, 1.07 to 1.30), coronary heart disease (1.10, 1.04 to 1.16), and stroke (1.15, 1.04 to 1.27). Increased mid-term and short term variability in daytime systolic blood pressure were also associated with all cause mortality (1.15, 1.06 to 1.26 and 1.10, 1.04 to 1.16, respectively). CONCLUSIONS Long term variability in blood pressure is associated with cardiovascular and mortality outcomes, over and above the effect of mean blood pressure. Associations are similar in magnitude to those of cholesterol measures with cardiovascular disease. Limited data for mid-term and short term variability showed similar associations. Future work should focus on the clinical implications of assessment of variability in blood pressure and avoid the common confounding pitfalls observed to date.	[Stevens, Sarah L.; Wood, Sally; Koshiaris, Constantinos; Law, Kathryn; Stevens, Richard J.; McManus, Richard J.] Univ Oxford, Radcliffe Observ Quarter, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England; [Glasziou, Paul] Bond Univ, Fac Hlth Sci & Med, Southport, Qld 4229, Australia	University of Oxford; Bond University	Stevens, RJ (corresponding author), Univ Oxford, Radcliffe Observ Quarter, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.	richard.stevens@phc.ox.ac.uk	Koshiaris, Constantinos/R-1263-2019; Glasziou, Paul/A-7832-2008	Glasziou, Paul/0000-0001-7564-073X; Lay-Flurrie, Sarah/0000-0003-1094-8455; Stevens, Richard/0000-0002-9258-4060	NIHR [RP-PG-1209-10051]; National Institute for Health Research [NIHR-RP-02-12-015, RP-PG-1209-10051, CDF/01/017, SPCR-077] Funding Source: researchfish	NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	This manuscript presents independent research commissioned by the NIHR under its programme grants for applied research funding scheme (grant No RP-PG-1209-10051).	Arashi H, 2015, AM J CARDIOL, V116, P236, DOI 10.1016/j.amjcard.2015.04.011; Asayama K, 2013, HYPERTENSION, V61, P61, DOI 10.1161/HYPERTENSIONAHA.111.00138; Bjorklund K, 2004, J HYPERTENS, V22, P1691; Blacher J, 2015, J HUM HYPERTENS, V29, P122, DOI 10.1038/jhh.2014.44; BRING J, 1994, AM STAT, V48, P209, DOI 10.2307/2684719; Carr MJ, 2012, J HYPERTENS, V30, P1725, DOI 10.1097/HJH.0b013e3283568a73; Conen D, 2008, J HYPERTENS, V26, P1290, DOI 10.1097/HJH.0b013e3282f97854; Daugirdas JT, 2001, AM J KIDNEY DIS, V38, pS11, DOI 10.1053/ajkd.2001.28090; Diaz KM, 2014, HYPERTENSION, V64, P965, DOI 10.1161/HYPERTENSIONAHA.114.03903; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eguchi K, 2012, AM J HYPERTENS, V25, P962, DOI 10.1038/ajh.2012.75; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; FRATTOLA A, 1993, J HYPERTENS, V11, P1133, DOI 10.1097/00004872-199310000-00019; Gao SJ, 2014, HYPERTENSION, V64, P45, DOI 10.1161/HYPERTENSIONAHA.114.03576; Garcia-Garcia A, 2013, BLOOD PRESS MONIT, V18, P101, DOI 10.1097/MBP.0b013e32835ebc58; Gavish B, 2015, J HYPERTENS, V33, P491, DOI 10.1097/HJH.0000000000000459; Gavish B, 2009, HYPERTENS RES, V32, P488, DOI 10.1038/hr.2009.39; Grassi G, 2012, CURR HYPERTENS REP, V14, P333, DOI 10.1007/s11906-012-0273-8; Grove JS, 1997, AM J EPIDEMIOL, V145, P771, DOI 10.1093/oxfordjournals.aje.a009169; Hansen TW, 2010, HYPERTENSION, V55, P1049, DOI [10.1161/HYPERTENSIONAHA.109.140798, 10.1161/HYP.0b013e3181dfc0ad]; Hara A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103169; Hashimoto T, 2012, AM J HYPERTENS, V25, P883, DOI 10.1038/ajh.2012.62; Hata J, 2013, CIRCULATION, V128, P1325, DOI 10.1161/CIRCULATIONAHA.113.002717; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; Hsieh YT, 2012, EUR J CLIN INVEST, V42, P245, DOI 10.1111/j.1365-2362.2011.02574.x; Inrig JK, 2007, KIDNEY INT, V71, P454, DOI 10.1038/sj.ki.5002077; Inrig JK, 2010, AM J KIDNEY DIS, V55, P580, DOI 10.1053/j.ajkd.2009.08.013; Inrig JK, 2009, AM J KIDNEY DIS, V54, P881, DOI 10.1053/j.ajkd.2009.05.012; Johansson JK, 2012, HYPERTENSION, V59, P212, DOI 10.1161/HYPERTENSIONAHA.111.178657; Kawai T, 2013, J HYPERTENS, V31, P1387, DOI 10.1097/HJH.0b013e328360f796; Kikuya M, 2000, HYPERTENSION, V36, P901, DOI 10.1161/01.HYP.36.5.901; Kikuya M, 2008, HYPERTENSION, V52, P1045, DOI 10.1161/HYPERTENSIONAHA.107.104620; Kostis JB, 2014, J CLIN HYPERTENS, V16, P34, DOI 10.1111/jch.12230; Lane D, 2002, J HYPERTENS, V20, P1089, DOI 10.1097/00004872-200206000-00019; Lau KK, 2014, ATHEROSCLEROSIS, V235, P230, DOI 10.1016/j.atherosclerosis.2014.04.015; Lau KK, 2014, AM J HYPERTENS, V27, P1486, DOI 10.1093/ajh/hpu070; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Levesque LE, 2010, BMJ, V340, pb5087, DOI DOI 10.1136/BMJ.B5087; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; LINFORS EW, 1984, ARCH INTERN MED, V144, P1482, DOI 10.1001/archinte.144.7.1482; Mallamaci F, 2013, KIDNEY INT, V84, P381, DOI 10.1038/ki.2013.132; Mancia G, 2007, HYPERTENSION, V49, P1265, DOI 10.1161/HYPERTENSIONAHA.107.088708; Mancia G, 2012, HYPERTENSION, V60, P512, DOI 10.1161/HYPERTENSIONAHA.112.194340; Mancia G, 2012, J HYPERTENS, V30, P1241, DOI 10.1097/HJH.0b013e32835339ac; Manning LS, 2015, STROKE, V46, P2482, DOI 10.1161/STROKEAHA.115.010075; McMullan CJ, 2013, CLIN J AM SOC NEPHRO, V8, P731, DOI 10.2215/CJN.10131012; Mena LJ, 2014, AM J HYPERTENS, V27, P46, DOI 10.1093/ajh/hpt142; Modesti PA, 2006, HYPERTENSION, V47, P155, DOI 10.1161/01.HYP.0000199192.17126.d4; Muntner P, 2015, ANN INTERN MED, V163, P329, DOI 10.7326/M14-2803; Muntner P, 2013, J CLIN HYPERTENS, V15, P112, DOI 10.1111/jch.12037; Nagai M, 2011, J AM SOC HYPERTENS, V5, P184, DOI 10.1016/j.jash.2011.03.001; National Institute for Health and Care Excellence, 2011, NICE CG127; Okada H, 2012, ATHEROSCLEROSIS, V220, P155, DOI 10.1016/j.atherosclerosis.2011.10.033; Palatini P, 2014, HYPERTENSION, V64, P487, DOI 10.1161/HYPERTENSIONAHA.114.03694; Parati G, 2013, NAT REV CARDIOL, V10, P143, DOI 10.1038/nrcardio.2013.1; Perera R, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta191000; PICKERING TG, 1982, JAMA-J AM MED ASSOC, V247, P992, DOI 10.1001/jama.247.7.992; Pierdomenico SD, 2006, AM J HYPERTENS, V19, P991, DOI 10.1016/j.amjhyper.2006.03.009; Pierdomenico SD, 2009, AM J HYPERTENS, V22, P842, DOI 10.1038/ajh.2009.103; Pierdomenico SD, 2005, AM HEART J, V149, P934, DOI 10.1016/j.ahj.2004.06.029; Poortvliet RKE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052438; Pringle E, 2003, J HYPERTENS, V21, P2251, DOI 10.1097/00004872-200312000-00012; Rakugi H, 2015, J HYPERTENS, V33, P2165, DOI 10.1097/HJH.0000000000000668; Rosenberg MS, 2005, EVOLUTION, V59, P464, DOI 10.1554/04-602; Rossignol P, 2015, INT J CARDIOL, V187, P183, DOI 10.1016/j.ijcard.2015.03.169; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Schillaci G, 2012, HYPERTENSION, V60, P369, DOI 10.1161/HYPERTENSIONAHA.112.197491; Shimbo D, 2012, HYPERTENSION, V60, P625, DOI 10.1161/HYPERTENSIONAHA.112.193094; Stergiou GS, 2014, HYPERTENS RES, V37, P565, DOI 10.1038/hr.2014.2; Suchy-Dicey AM, 2013, AM J HYPERTENS, V26, P1210, DOI 10.1093/ajh/hpt092; Tai CH, 2015, J CLIN HYPERTENS, V17, P107, DOI 10.1111/jch.12484; Takahashi O, 2012, J HUM HYPERTENS, V26, P540, DOI 10.1038/jhh.2011.72; Taylor KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126375; Verdecchia P, 2007, AM J HYPERTENS, V20, P154, DOI 10.1016/j.amjhyper.2006.07.017; Ward AM, 2012, J HYPERTENS, V30, P449, DOI 10.1097/HJH.0b013e32834e4aed; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Wei Y, 2013, J CLIN HYPERTENS, V15, P420, DOI 10.1111/jch.12094; Yu JM, 2014, INT J CARDIOL, V177, P995, DOI 10.1016/j.ijcard.2014.09.149; Yudkin PL, 1996, LANCET, V347, P241, DOI 10.1016/S0140-6736(96)90410-9	80	409	424	7	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2016	354								i4098	10.1136/bmj.i4098	http://dx.doi.org/10.1136/bmj.i4098			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4TU	27511067	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000381474800003
J	Samarasinghe, N; Seneviratne, K				Samarasinghe, Nihal; Seneviratne, Knightly			Neelika Karunaratne OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2016	354								i4269	10.1136/bmj.i4269	http://dx.doi.org/10.1136/bmj.i4269			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9DD	27495152				2022-12-28	WOS:000381081800009
J	Aday, AW; Saavedra, AP; Levy, BD; Loscalzo, J				Aday, Aaron W.; Saavedra, Arturo P.; Levy, Bruce D.; Loscalzo, Joseph			Prevention as Precipitant	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							GENERALIZED EXANTHEMATOUS PUSTULOSIS; T-CELLS; INVOLVEMENT; AGEP		[Aday, Aaron W.; Levy, Bruce D.; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Saavedra, Arturo P.] Brigham & Womens Hosp, Dept Dermatol, 75 Francis St, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Levy, BD (corresponding author), Brigham & Womens Hosp, Harvard Inst Med Bldg,77 Ave Louis Pasteur, Boston, MA 02115 USA.	blevy@partners.org	Loscalzo, Joseph/ABD-8980-2021	Aday, Aaron/0000-0001-6243-3432				Batya BD, 2006, J AM ACAD DERMATOL, V55, P525, DOI 10.1016/j.jaad.2006.05.010; Britschgi M, 2001, J CLIN INVEST, V107, P1433, DOI 10.1172/JCI12118; BURROWS NP, 1993, HISTOPATHOLOGY, V22, P569, DOI 10.1111/j.1365-2559.1993.tb00178.x; Eeckhout I, 1997, DERMATOLOGY, V194, P408, DOI 10.1159/000246163; Hotz C, 2013, BRIT J DERMATOL, V169, P1223, DOI 10.1111/bjd.12502; Lerch M, 2004, CONTACT DERMATITIS, V50, P349, DOI 10.1111/j.0105-1873.2004.00366.x; Schaerli P, 2004, J IMMUNOL, V173, P2151, DOI 10.4049/jimmunol.173.3.2151; Schmid S, 2002, AM J PATHOL, V161, P2079, DOI 10.1016/S0002-9440(10)64486-0; Sidoroff A, 2001, J CUTAN PATHOL, V28, P113, DOI 10.1034/j.1600-0560.2001.028003113.x; Sim HS, 2011, ANN DERMATOL, V23, pS368, DOI 10.5021/ad.2011.23.S3.S368; Speeckaert MM, 2010, EUR J DERMATOL, V20, P425, DOI 10.1684/ejd.2010.0932; van Hattem S, 2014, BRIT J DERMATOL, V171, P1539, DOI 10.1111/bjd.13152	12	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2016	375	5					471	475		10.1056/NEJMcps1301580	http://dx.doi.org/10.1056/NEJMcps1301580			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7AN	27518666				2022-12-28	WOS:000380934900013
J	Tolles, J; Meurer, WJ				Tolles, Juliana; Meurer, William J.			Logistic Regression Relating Patient Characteristics to Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Tolles, Juliana] Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA; [Tolles, Juliana] Los Angeles Biomed Res Inst, Torrance, CA USA; [Tolles, Juliana] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Meurer, William J.] Univ Michigan, Dept Emergency Med, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA; [Meurer, William J.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Meurer, WJ (corresponding author), Univ Michigan, Dept Emergency Med, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	wmeurer@med.umich.edu	Meurer, William/A-7547-2010	Meurer, William/0000-0002-1158-5302				Hosmer D. W., 2013, APPL LOGISTIC REGRES; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288	2	180	182	1	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2016	316	5					533	534		10.1001/jama.2016.7653	http://dx.doi.org/10.1001/jama.2016.7653			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9AU	27483067				2022-12-28	WOS:000381075000020
J	Barnett, ML; Mehrotra, A; Jena, AB				Barnett, Michael L.; Mehrotra, Ateev; Jena, Anupam B.			Adverse inpatient outcomes during the transition to a new electronic health record system: observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHYSICIAN ORDER ENTRY; INFORMATION-TECHNOLOGY; INCREASED MORTALITY; MEDICAL-RECORD; US HOSPITALS; IMPLEMENTATION; IMPACT; WEEKEND; RATES; CPOE	OBJECTIVE To assess the short term association of inpatient implementation of electronic health records (EHRs) with patient outcomes of mortality, readmissions, and adverse safety events. Design Observational study with difference-in-differences analysis. Setting Medicare, 2011-12. Participants Patients admitted to 17 study hospitals with a verifiable "go live" date for implementation of inpatient EHRs during 2011-12, and 399 control hospitals in the same hospital referral region. Main outcome measures All cause readmission within 30 days of discharge, all cause mortality within 30 days of admission, and adverse safety events as defined by the patient safety for selected indicators (PSI)-90 composite measure among Medicare beneficiaries admitted to one of these hospitals 90 days before and 90 days after implementation of the EHRs (n=28 235 and 26 453 admissions), compared with the control group of all contemporaneous admissions to hospitals in the same hospital referral region (n=284 632 and 276 513 admissions). Analyses were adjusted for beneficiaries' sociodemographic and clinical characteristics. Results Before and after implementation, characteristics of admissions were similar in both study and control hospitals. Among study hospitals, unadjusted 30 day mortality (6.74% to 7.15%, P=0.06) and adverse safety event rates (10.5 to 11.4 events per 1000 admissions, P=0.34) did not significantly change after implementation of EHRs. There was an unadjusted decrease in 30 day readmission rates, from 19.9% to 19.0% post-implementation (P=0.02). In difference-indifferences analysis, however, there was no significant change in any outcome between pre-implementation and post-implementation periods (all P >= 0.13). Conclusions Despite concerns that implementation of EHRs might adversely impact patient care during the acute transition period, we found no overall negative association of such implementation on short term inpatient mortality, adverse safety events, or readmissions in the Medicare population across 17 US hospitals.	[Barnett, Michael L.] Harvard TH Chan Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Barnett, Michael L.] Brigham & Womens Hosp, Dept Med, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA; [Mehrotra, Ateev; Jena, Anupam B.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA; [Mehrotra, Ateev] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA; [Jena, Anupam B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Massachusetts General Hospital	Jena, AB (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA.; Jena, AB (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.	jena@hcp.med.harvard.edu	Mehrotra, Ateev/AAO-8454-2021; Barnett, Michael/AAF-4017-2019; Barnett, Michael/ABA-4159-2021	Mehrotra, Ateev/0000-0003-2223-1582; Barnett, Michael/0000-0002-4884-6609; Barnett, Michael/0000-0002-4884-6609	Office of the Director, National Institutes of Health (NIH early independence award) [1DP5OD017897-01]; Health Resources and Services Administration [T32-HP10251]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD017897] Funding Source: NIH RePORTER	Office of the Director, National Institutes of Health (NIH early independence award)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from the Office of the Director, National Institutes of Health (ABJ, NIH early independence award, grant 1DP5OD017897-01) and Health Resources and Services Administration (MLB, T32-HP10251).	Adler-Milstein J, 2014, HEALTH AFFAIR, V33, P1664, DOI 10.1377/hlthaff.2014.0453; Ammenwerth E, 2006, METHOD INFORM MED, V45, P586; Attenello FJ, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1460; Bell CM, 2001, NEW ENGL J MED, V345, P663, DOI 10.1056/NEJMsa003376; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; Boonstra A, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-370; Buntin MB, 2011, HEALTH AFFAIR, V30, P464, DOI 10.1377/hlthaff.2011.0178; Campbell EM, 2006, J AM MED INFORM ASSN, V13, P547, DOI 10.1197/jamia.M2042; *CTR MED MED SERV, 2014, CHRON COND DAT WAR; Del Beccaro MA, 2006, PEDIATRICS, V118, P290, DOI 10.1542/peds.2006-0367; Dimick JB, 2014, JAMA-J AM MED ASSOC, V312, P2401, DOI 10.1001/jama.2014.16153; Gettinger A, 2012, APPL CLIN INFORM, V3, P367, DOI 10.4338/ACI-2012-04-R-0014; GRAHAM N, 2014, MULTIWAYVCOV MULTIWA; HALL SD, WILL 2013 YEAR GREAT; Han YY, 2005, PEDIATRICS, V116, P1506, DOI 10.1542/peds.2005-1287; Himmelstein DU, 2010, AM J MED, V123, P40, DOI 10.1016/j.amjmed.2009.09.004; Jena AB, 2013, CIRCULATION, V128, P2754, DOI 10.1161/CIRCULATIONAHA.113.004074; Jha AK, 2009, NEW ENGL J MED, V360, P1628, DOI 10.1056/NEJMsa0900592; Jones SS, 2014, ANN INTERN MED, V160, P48, DOI 10.7326/M13-1531; Jones Spencer S, 2011, AMIA Annu Symp Proc, V2011, P644; Jones SS, 2011, HEALTH AFFAIR, V30, P2005, DOI 10.1377/hlthaff.2011.0245; Kostis WJ, 2007, NEW ENGL J MED, V356, P1099, DOI 10.1056/NEJMoa063355; Lee J, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-39; Lilford RJ, 2015, BMJ QUAL SAF, V24, P480, DOI 10.1136/bmjqs-2015-004360; MASSARO TA, 1993, ACAD MED, V68, P20, DOI 10.1097/00001888-199301000-00003; McCullough JS, 2010, HEALTH AFFAIR, V29, P647, DOI 10.1377/hlthaff.2010.0155; Meeks DW, 2014, J AM MED INFORM ASSN, V21, P1053, DOI 10.1136/amiajnl-2013-002578; Muller CJ, 2014, INT J EPIDEMIOL, V43, P962, DOI 10.1093/ije/dyu029; Poon EG, 2004, HEALTH AFFAIR, V23, P184, DOI 10.1377/hlthaff.23.4.184; Prasad V, 2013, JAMA-J AM MED ASSOC, V309, P241, DOI 10.1001/jama.2012.96867; R Development Core Team, 2009, R LANG ENV STAT COMP; Rajaram R, 2015, JAMA-J AM MED ASSOC, V313, P897, DOI 10.1001/jama.2015.52; Ryan AM, 2015, HEALTH SERV RES, V50, P1211, DOI 10.1111/1475-6773.12270; SCHECTMAN J, 2012, KANSAS HOSP FAILED E; Simon SR, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-67; Singh H, 2009, ARCH INTERN MED, V169, P982, DOI 10.1001/archinternmed.2009.102; Spetz J, 2014, HEALTHCARE-J DEL SCI, V2, P40, DOI 10.1016/j.hjdsi.2013.12.009; Spetz J, 2012, AM J MANAG CARE, V18, P157; Thompson G, 2015, CRIT CARE MED, V43, P1276, DOI 10.1097/CCM.0000000000000948; *US NAT HLTH STAT, 2012, HLTH US 2011 SPEC FE; Weiner JP, 2007, J AM MED INFORM ASSN, V14, P387, DOI 10.1197/jamia.M2338; *YNHHSC CORE, 2014, 2014 MEAS UPD SPEC R; Young JQ, 2011, ANN INTERN MED, V155, P309, DOI 10.7326/0003-4819-155-5-201109060-00354; Zaslavsky AM, 2012, HEALTH SERV RES, V47, P1300, DOI 10.1111/j.1475-6773.2012.01411.x	44	24	24	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2016	354								i3835	10.1136/bmj.i3835	http://dx.doi.org/10.1136/bmj.i3835			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS6ZO	27471242	Green Published, hybrid			2022-12-28	WOS:000380932300002
J	Kyrgiou, M; Athanasiou, A; Paraskevaidi, M; Mitra, A; Kalliala, I; Martin-Hirsch, P; Arbyn, M; Bennett, P; Paraskevaidis, E				Kyrgiou, Maria; Athanasiou, Antonios; Paraskevaidi, Maria; Mitra, Anita; Kalliala, Ilkka; Martin-Hirsch, Pierre; Arbyn, Marc; Bennett, Phillip; Paraskevaidis, Evangelos			Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LOOP ELECTROSURGICAL EXCISION; COLD-KNIFE CONIZATION; LONG-TERM OUTCOMES; INTRAEPITHELIAL NEOPLASIA CIN; SPONTANEOUS PRETERM DELIVERY; DIOXIDE LASER CONIZATION; CARCINOMA IN-SITU; TRANSFORMATION ZONE; PREGNANCY OUTCOMES; PRECANCEROUS CHANGES	OBJECTIVE To assess the effect of treatment for cervical intraepithelial neoplasia (CIN) on obstetric outcomes and to correlate this with cone depth and comparison group used. Design Systematic review and meta-analysis. Data sources CENTRAL, Medline, Embase from 1948 to April 2016 were searched for studies assessing obstetric outcomes in women with or without previous local cervical treatment. DATA EXTRACTION AND SYNTHESIS Independent reviewers extracted the data and performed quality assessment using the Newcastle-Ottawa criteria. Studies were classified according to method and obstetric endpoint. Pooled risk ratios were calculated with a random effect model and inverse variance. Heterogeneity between studies was assessed with I-2 statistics. Main outcome measures Obstetric outcomes comprised preterm birth (including spontaneous and threatened), premature rupture of the membranes, chorioamnionitis, mode of delivery, length of labour, induction of delivery, oxytocin use, haemorrhage, analgesia, cervical cerclage, and cervical stenosis. Neonatal outcomes comprised low birth weight, admission to neonatal intensive care, stillbirth, APGAR scores, and perinatal mortality. Results 71 studies were included (6 338 982 participants: 65 082 treated/6 292 563 untreated). Treatment significantly increased the risk of overall (<37 weeks; 10.7% v 5.4%; relative risk 1.78, 95% confidence interval 1.60 to 1.98), severe (<32-34 weeks; 3.5% v 1.4%; 2.40, 1.92 to 2.99), and extreme (<28-30 weeks; 1.0% v 0.3%; 2.54, 1.77 to 3.63) preterm birth. Techniques removing or ablating more tissue were associated with worse outcomes. Relative risks for delivery at <37 weeks were 2.70 (2.14 to 3.40) for cold knife conisation, 2.11 (1.26 to 3.54) for laser conisation, 2.02 (1.60 to 2.55) for excision not otherwise specified, 1.56 (1.36 to 1.79) for large loop excision of the transformation zone, and 1.46 (1.27 to 1.66) for ablation not otherwise specified. Compared with no treatment, the risk of preterm birth was higher in women who had undergone more than one treatment (13.2% v 4.1%; 3.78, 2.65 to 5.39) and with increasing cone depth (<= 10-12 mm; 7.1% v 3.4%; 1.54, 1.09 to 2.18; >= 10-12 mm: 9.8% v 3.4%, 1.93, 1.62 to 2.31; <= 15-17 mm: 10.1% v 3.4%; 2.77, 1.95 to 3.93; >= 20 mm: 10.2% v 3.4%; 4.91, 2.06 to 11.68). The choice of comparison group affected the magnitude of effect. This was higher for external comparators, followed by internal comparators, and ultimately women with disease who did not undergo treatment. In women with untreated CIN and in pregnancies before treatment, the risk of preterm birth was higher than the risk in the general population (5.9% v 5.6%; 1.24, 1.14 to 1.35). Spontaneous preterm birth, premature rupture of the membranes, chorioamnionitis, low birth weight, admission to neonatal intensive care, and perinatal mortality were also significantly increased after treatment. Conclusions Women with CIN have a higher baseline risk for prematurity. Excisional and ablative treatment further increases that risk. The frequency and severity of adverse sequelae increases with increasing cone depth and is higher for excision than for ablation.	[Kyrgiou, Maria; Paraskevaidi, Maria; Mitra, Anita; Kalliala, Ilkka; Bennett, Phillip] Imperial Coll, Inst Reprod & Dev Biol, Dept Surg & Canc, Fac Med, London, England; [Kyrgiou, Maria; Mitra, Anita; Bennett, Phillip] Imperial Healthcare NHS Trust, Queen Charlottes & Chelsea Hammersmith Hosp, London, England; [Athanasiou, Antonios; Paraskevaidis, Evangelos] Univ Hosp Ioannina, Ioannina, Greece; [Martin-Hirsch, Pierre] Lancashire Teaching Hosp, Dept Gynaecol Oncol, Preston, Lancs, England; [Martin-Hirsch, Pierre] Univ Lancaster, Dept Biophoton, Lancaster, England; [Arbyn, Marc] Sci Inst Publ Hlth, Unit Canc Epidemiol, Brussels, Belgium	Imperial College London; University Hospital Ioannina; Lancaster University	Kyrgiou, M (corresponding author), Imperial Coll, Inst Reprod & Dev Biol, Dept Surg & Canc, Fac Med, London, England.	m.kyrgiou@imperial.ac.uk	Athanasiou, Antonios/GZM-3553-2022; Kalliala, Ilkka/ABC-9253-2021; Paraskevaidis, Evangelos/ABH-4990-2020	Kalliala, Ilkka/0000-0002-7664-0587; Athanasiou, Antonios/0000-0002-9442-3703; Bennett, Phillip/0000-0002-6253-4919	British Society of Colposcopy Cervical Pathology Jordan/Singer Award [P47773]; Imperial College Healthcare Charity [P47907]; Genesis Research Trust [P55549]; Sigrid Juselius Fellowship [P52483]; Imperial Healthcare NHS Trust NIHR Biomedical Research Centre [P45272]; COHEAHR Network - Seventh Framework Programme of DG Research of the European Commission (Brussels) [603019]; Institut National du Cancer (Paris) through the COSPCC study (Consequences obstetricales du (sur) traitement des precurseurs du cancer du col); European Federation of Colposcopy (Birmingham); Joint Action CANCON; National Institute for Health Research [ACF-2014-21-012] Funding Source: researchfish	British Society of Colposcopy Cervical Pathology Jordan/Singer Award; Imperial College Healthcare Charity; Genesis Research Trust; Sigrid Juselius Fellowship(Sigrid Juselius Foundation); Imperial Healthcare NHS Trust NIHR Biomedical Research Centre; COHEAHR Network - Seventh Framework Programme of DG Research of the European Commission (Brussels); Institut National du Cancer (Paris) through the COSPCC study (Consequences obstetricales du (sur) traitement des precurseurs du cancer du col); European Federation of Colposcopy (Birmingham); Joint Action CANCON; National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the British Society of Colposcopy Cervical Pathology Jordan/Singer Award (P47773) (MK); the Imperial College Healthcare Charity (P47907) (AM and MK); Genesis Research Trust (P55549) (MK); Sigrid Juselius Fellowship (P52483 to IK and MK), and the Imperial Healthcare NHS Trust NIHR Biomedical Research Centre (P45272) (MK, PRB). MA received support from the COHEAHR Network (grant No 603019), funded by Seventh Framework Programme of DG Research of the European Commission (Brussels); Institut National du Cancer (Paris) through the COSPCC study (Consequences obstetricales du (sur) traitement des precurseurs du cancer du col); the European Federation of Colposcopy (Birmingham); and the Joint Action CANCON. None of the funders has any influence on the study design; in the collection, analysis, and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Acharya Ganesh, 2005, Archives of Gynecology and Obstetrics, V272, P109, DOI 10.1007/s00404-005-0727-1; Al-Halal H, 2013, ARCH GYNECOL OBSTET, V287, P245, DOI 10.1007/s00404-012-2475-3; Albrechtsen S, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1343; Althuisius SM, 2001, INT J GYNECOL OBSTET, V72, P31, DOI 10.1016/S0020-7292(00)00326-X; Andersen ES, 1999, J GYNECOL SURG, V15, P7, DOI 10.1089/gyn.1999.15.7; Anderson MC, 1984, J GYNECOLOGIC SURG, V1, P35, DOI DOI 10.1089/GYN.1984.1.35; Andia D, 2011, INT J GYNECOL OBSTET, V112, P225, DOI 10.1016/j.ijgo.2010.10.015; Anwar A, 2016, J MATERN-FETAL NEO M, V29, P477, DOI 10.3109/14767058.2015.1006619; Arbyn M, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7700; Arbyn M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1284; Armarnik S, 2011, ARCH GYNECOL OBSTET, V283, P765, DOI 10.1007/s00404-011-1848-3; Bekassy Z, 1996, ARCH GYNECOL OBSTET, V258, P75, DOI 10.1007/BF00626027; Berghella V, 2004, AM J OBSTET GYNECOL, V191, P1393, DOI 10.1016/j.ajog.2004.06.087; Berretta R, 2013, DIS MARKERS, V2013, DOI 10.1155/2013/686027; BLOMFIELD PI, 1993, AM J OBSTET GYNECOL, V169, P620, DOI 10.1016/0002-9378(93)90633-T; Braet P. G., 1994, Journal of Obstetrics and Gynaecology (Abingdon), V14, P79, DOI 10.3109/01443619409030016; Bruinsma F, 2007, BJOG-INT J OBSTET GY, V114, P70, DOI 10.1111/j.1471-0528.2006.01107.x; Bruinsma FJ, 2011, BJOG-INT J OBSTET GY, V118, P1031, DOI 10.1111/j.1471-0528.2011.02944.x; BULLER RE, 1982, AM J OBSTET GYNECOL, V142, P506, DOI 10.1016/0002-9378(82)90752-9; Castanon A, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6223; Castanon A, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5174; Ciavattini A, 2015, FERTIL STERIL, V103, P1043, DOI 10.1016/j.fertnstert.2014.12.112; Ciavattini A, 2014, J MATERN-FETAL NEO M, V27, P1169, DOI 10.3109/14767058.2013.850483; COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616; Conner SN, 2014, OBSTET GYNECOL, V123, P752, DOI 10.1097/AOG.0000000000000174; Conner SN, 2013, OBSTET GYNECOL, V122, P1154, DOI 10.1097/01.AOG.0000435454.31850.79; Crane JMG, 2006, OBSTET GYNECOL, V107, P37, DOI 10.1097/01.AOG.0000192169.44775.76; Crane JMG, 2003, OBSTET GYNECOL, V102, P1058, DOI 10.1016/S0029-7844(03)00741-5; CRUICKSHANK ME, 1995, BRIT J OBSTET GYNAEC, V102, P467, DOI 10.1111/j.1471-0528.1995.tb11319.x; Danhof NA, 2015, EUR J OBSTET GYN R B, V188, P24, DOI 10.1016/j.ejogrb.2015.02.033; Deeks J.J., 2001, SYSTEMATIC REV HLTH, P285, DOI DOI 10.1002/9780470693926.CH15; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ehsanipoor RM, 2014, J MATERN-FETAL NEO M, V27, P821, DOI 10.3109/14767058.2013.836178; El-Bastawissi AY, 1999, OBSTET GYNECOL, V93, P207, DOI 10.1016/S0029-7844(98)00386-X; Fischer RL, 2010, ULTRASOUND OBST GYN, V36, P613, DOI 10.1002/uog.7682; Forsmo S, 1996, ACTA OBSTET GYN SCAN, V75, P139, DOI 10.3109/00016349609033306; Founta C, 2010, BJOG-INT J OBSTET GY, V117, P1468, DOI 10.1111/j.1471-0528.2010.02709.x; Frega A, 2013, INT J GYNECOL OBSTET, V122, P145, DOI 10.1016/j.ijgo.2013.03.013; Frey HA, 2013, OBSTET GYNECOL, V121, P39, DOI [10.1097/AOG.0b013e318278f904, http://10.1097/AOG.0b013e318278f904]; Gentry DJ, 2000, AM J OBSTET GYNECOL, V182, P516, DOI 10.1067/mob.2000.104209; Gong J, 2014, ARCH GYNECOL OBSTET, V289, P85, DOI 10.1007/s00404-013-2955-0; GRONROOS M, 1979, ACTA OBSTET GYN SCAN, V58, P477; Gunasekera P. C., 1992, Journal of Obstetrics and Gynaecology (Abingdon), V12, P291, DOI 10.3109/01443619209015508; Guo HJ, 2013, EUR J GYNAECOL ONCOL, V34, P79; HAFFENDEN DK, 1993, BRIT J OBSTET GYNAEC, V100, P1059, DOI 10.1111/j.1471-0528.1993.tb15153.x; HAGEN B, 1993, BRIT J OBSTET GYNAEC, V100, P717, DOI 10.1111/j.1471-0528.1993.tb14261.x; Heinonen A, 2013, OBSTET GYNECOL, V121, P1063, DOI 10.1097/AOG.0b013e31828caa31; HEMMINGSSON E, 1982, BRIT J OBSTET GYNAEC, V89, P675, DOI 10.1111/j.1471-0528.1982.tb04725.x; Henk HJ, 2010, J LOW GENIT TRACT DI, V14, P29, DOI 10.1097/LGT.0b013e3181ac05e9; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Himes KP, 2007, OBSTET GYNECOL, V109, P314, DOI 10.1097/01.AOG.0000251497.55065.74; Jakobsson M, 2007, OBSTET GYNECOL, V109, P309, DOI 10.1097/01.AOG.0000253239.87040.23; Jakobsson M, 2009, OBSTET GYNECOL, V114, P504, DOI 10.1097/AOG.0b013e3181b052de; JONES JM, 1979, BRIT J OBSTET GYNAEC, V86, P913, DOI 10.1111/j.1471-0528.1979.tb11237.x; Kalliala I, 2012, BJOG-INT J OBSTET GY, V119, P227, DOI 10.1111/j.1471-0528.2011.03042.x; Khalid S, 2012, BJOG-INT J OBSTET GY, V119, P685, DOI 10.1111/j.1471-0528.2011.03252.x; Kim M, 2016, ARCH GYNECOL OBSTET, V293, P651, DOI 10.1007/s00404-015-3860-5; Kindinger L, 2013, BJOG-INT J OBSTET GY, V120, P50; Kindinger L, PLOS ONE IN PRESS; Kirn V, 2015, ARCH GYNECOL OBSTET, V291, P599, DOI 10.1007/s00404-014-3463-6; Kitson SJ, 2014, EUR J OBSTET GYN R B, V180, P51, DOI 10.1016/j.ejogrb.2014.06.011; Klaritsch P, 2006, GYNECOL ONCOL, V103, P604, DOI 10.1016/j.ygyno.2006.04.003; KRISTENSEN GB, 1985, ARCH GYNECOL, V236, P127, DOI 10.1007/BF02133954; KRISTENSEN J, 1993, OBSTET GYNECOL, V81, P1005; KULLANDER S, 1971, ACTA OBSTET GYN SCAN, V50, P153, DOI 10.3109/00016347109157302; KUOPPALA T, 1986, ARCH GYNECOL OBSTET, V237, P149, DOI 10.1007/BF02133858; Kyrgiou M, 2006, LANCET, V367, P489, DOI 10.1016/S0140-6736(06)68181-6; Kyrgiou M, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5847; Kyrgiou M, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6192; Kyrgiou M, 2015, INT J GYNECOL OBSTET, V128, P141, DOI 10.1016/j.ijgo.2014.07.038; LARSSON G, 1982, ACTA OBSTET GYN SCAN, V61, P461, DOI 10.3109/00016348209156591; LEIMAN G, 1980, AM J OBSTET GYNECOL, V136, P14, DOI 10.1016/0002-9378(80)90556-6; Lima AF, 2011, J LOW GENIT TRACT DI, V15, P276, DOI 10.1097/LGT.0b013e31821a6823; Liu Y, 2014, GYNECOL OBSTET INVES, V77, P240, DOI 10.1159/000360538; LUDVIKSSON K, 1982, EUR J OBSTET GYN R B, V14, P135, DOI 10.1016/0028-2243(82)90088-0; Macvicar J, 1968, J Obstet Gynaecol Br Commonw, V75, P355; Martin-Hirsch PPL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001318.pub3; Martyn FM, 2015, EUR J OBSTET GYN R B, V185, P114, DOI 10.1016/j.ejogrb.2014.12.004; Masamoto H, 2008, J OBSTET GYNAECOL RE, V34, P838, DOI 10.1111/j.1447-0756.2008.00852.x; Michelin MA, 2009, CLIN EXP OBSTET GYN, V36, P17; Miller ES, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.025; Mitsuhashi A, 2000, INT J GYNECOL OBSTET, V71, P237, DOI 10.1016/S0020-7292(99)00173-3; Moher David, 2009, Open Med, V3, pe123; MOINIAN M, 1982, ACTA OBSTET GYN SCAN, V61, P101, DOI 10.3109/00016348209156537; MONAGHAN JM, 1982, BRIT J OBSTET GYNAEC, V89, P387, DOI 10.1111/j.1471-0528.1982.tb05082.x; Naleway AL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117525; Nam KH, 2010, J GYNECOL ONCOL, V21, P225, DOI 10.3802/jgo.2010.21.4.225; Noehr B, 2009, OBSTET GYNECOL, V114, P1232, DOI 10.1097/AOG.0b013e3181bf1ef2; Noehr B, 2009, OBSTET GYNECOL, V114, P511, DOI 10.1097/AOG.0b013e3181b1377b; Noehr B, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.02.004; Novikova EG, 1994, AKUSH GINEKOL MOSK, V2, P44; Ortoft G, 2010, BJOG-INT J OBSTET GY, V117, P258, DOI 10.1111/j.1471-0528.2009.02438.x; Paraskevaidis E, 2007, BJOG-INT J OBSTET GY, V114, P3, DOI 10.1111/j.1471-0528.2006.01178.x; Paraskevaidis E, 2002, GYNECOL ONCOL, V86, P10, DOI 10.1006/gyno.2002.6650; Parikh R, 2008, J REPROD MED, V53, P909; Patrelli T S, 2008, Minerva Ginecol, V60, P295; Petry KU, 2008, EUR J GYNAECOL ONCOL, V29, P345; Phadnis SV, 2011, BJOG-INT J OBSTET GY, V118, P1585, DOI 10.1111/j.1471-0528.2011.03085.x; Pils S, 2014, BJOG-INT J OBSTET GY, V121, P457, DOI 10.1111/1471-0528.12390; Pinborg A, 2015, HUM REPROD, V30, P197, DOI 10.1093/humrep/deu260; Poon LCY, 2012, BJOG-INT J OBSTET GY, V119, P692, DOI 10.1111/j.1471-0528.2011.03203.x; Prabhu TRB, 2010, J OBSTET GYN INDIA, V60, P149; Rafaeli-Yehudai T, 2014, J MATERN-FETAL NEO M, V27, P1594, DOI 10.3109/14767058.2013.871254; Raio L, 1997, OBSTET GYNECOL, V90, P978, DOI 10.1016/S0029-7844(97)00489-4; Reilly R, 2012, BJOG-INT J OBSTET GY, V119, P236, DOI 10.1111/j.1471-0528.2011.03052.x; RICCIOTTI HA, 1995, INT J GYNECOL OBSTET, V50, P175, DOI 10.1016/0020-7292(95)02432-C; ROSEN A, 1991, GEBURTSH FRAUENHEILK, V51, P208, DOI 10.1055/s-2007-1023705; Sadler L, 2004, JAMA-J AM MED ASSOC, V291, P2100, DOI 10.1001/jama.291.17.2100; SAGOT P, 1995, EUR J OBSTET GYN R B, V58, P53, DOI 10.1016/0028-2243(94)01986-H; Samson SLA, 2005, OBSTET GYNECOL, V105, P325, DOI 10.1097/01.AOG.0000151991.09124.bb; Sangkarat S, 2014, ASIAN PAC J CANCER P, V15, P1035, DOI 10.7314/APJCP.2014.15.2.1035; Saunders N, 1986, GYNAECOLOGICAL LASER, P121; Seki N, 2010, EUR J GYNAECOL ONCOL, V31, P399; Shanbhag S, 2009, OBSTET GYNECOL, V114, P727, DOI 10.1097/AOG.0b013e3181b5cba3; Shin MY, 2010, J GYNECOL ONCOL, V21, P230, DOI 10.3802/jgo.2010.21.4.230; Simoens C, 2012, BJOG-INT J OBSTET GY, V119, P1247, DOI 10.1111/j.1471-0528.2012.03429.x; Sjoborg KD, 2007, ACTA OBSTET GYN SCAN, V86, P423, DOI 10.1080/11038120701208158; Sljivancanin D, 2013, SRP ARK CELOK LEK, V141, P192, DOI 10.2298/SARH1304192S; Smaldone GMM, 2010, J WOMENS HEALTH, V19, P969, DOI 10.1089/jwh.2009.1574; Sozen H, 2014, J REPROD MED, V59, P81; SPITZER M, 1995, OBSTET GYNECOL, V86, P504, DOI 10.1016/0029-7844(95)00237-L; Spracklen CN, 2013, BJOG-INT J OBSTET GY, V120, P960, DOI 10.1111/1471-0528.12209; Stout MJ, 2015, BJOG-INT J OBSTET GY, V122, P545, DOI 10.1111/1471-0528.13252; Strander B, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.f7361; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tan Linda, 2004, J Obstet Gynaecol, V24, P25; Turlington WT, 1996, J REPROD MED, V41, P815; van de Vijver A, 2010, BJOG-INT J OBSTET GY, V117, P268, DOI 10.1111/j.1471-0528.2009.02437.x; Van Hentenryck M, 2012, EUR J OBSTET GYN R B, V162, P16, DOI 10.1016/j.ejogrb.2012.01.019; van Rooijen M, 1999, ACTA OBSTET GYN SCAN, V78, P346; Wakita K, 1990, J Clin Laser Med Surg, V8, P71; WEBER T, 1979, ACTA OBSTET GYN SCAN, V58, P347, DOI 10.3109/00016347909154594; Wells G., NEWCASTLE OTTAWA SCA; Werner CL, 2010, OBSTET GYNECOL, V115, P605, DOI 10.1097/AOG.0b013e3181d068a3; Wongtiraporn W, 2014, ASIAN PAC J CANCER P, V15, P7757, DOI 10.7314/APJCP.2014.15.18.7757; Wuntakal R, 2013, INT J GYNECOL CANCER, V23, P710, DOI 10.1097/IGC.0b013e3182885496; Zuo Z, 2011, AM J CLIN PATHOL, V136, P260, DOI 10.1309/AJCP93JMIUEKRPIW	137	217	239	3	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 28	2016	354								i3633	10.1136/bmj.i3633	http://dx.doi.org/10.1136/bmj.i3633			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS6ZO	27469988	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000380932300001
J	Green, J				Green, Jamison			Transgender: why should we care?	LANCET			English	Editorial Material									[Green, Jamison] Calif Inst Integral Studies San Francisco, San Francisco, CA 94103 USA		Green, J (corresponding author), Calif Inst Integral Studies San Francisco, San Francisco, CA 94103 USA.	jgreenphd1@gmail.com						Coleman E, 2012, STANDARDS CARE TRANS; Deutsch MB, 2013, J AM MED INFORM ASSN, V20, P700, DOI 10.1136/amiajnl-2012-001472; Grant J.M., 2011, INJUSTICE EVERY TURN; Green J, 2014, LGBT HEALTH, V1, P256, DOI 10.1089/lgbt.2014.0076; Green Jamison, 2004, BECOMING VISIBLE MAN	5	5	5	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2016	388	10042					334	335		10.1016/S0140-6736(16)30840-6	http://dx.doi.org/10.1016/S0140-6736(16)30840-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DR6MV	27482590				2022-12-28	WOS:000380016900024
J	Freedman, DO; Chen, LH; Kozarsky, PE				Freedman, David O.; Chen, Lin H.; Kozarsky, Phyllis E.			Medical Considerations before International Travel	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							JAPANESE ENCEPHALITIS VACCINE; RABIES IMMUNE GLOBULIN; ADVISORY-COMMITTEE; IMMUNIZATION PRACTICES; UNITED-STATES; ANTIBODY PERSISTENCE; GEOSENTINEL SURVEILLANCE; GLOBAL AVAILABILITY; RETURNED TRAVELERS; TROPICAL DISEASES	In 2015, international tourist arrivals in all countries exceeded 1.2 billion persons. In 2014, the total number of arrivals in countries with emerging markets nearly surpassed the number in developed countries (www.-e-unwto.-org/-doi/-book/-10.-18111/-9789284416899). Depending on the destination, 22 to 64% of travelers report some illness; most of these illnesses are mild and self-limited, such as diarrhea, respiratory infections, and skin disorders.(1-4) Some travelers return to their own countries with preventable life-threatening infections. 5 Yet 20 to 80% of travelers do not seek pretravel health consultation.(6) Data about the effect of pretravel advice are limited, although such advice has had a positive effect on the prevention of malaria.(7) Travelers visiting friends and relatives in their country of origin constitute the group with the highest morbidity, especially from malaria and typhoid; this group requires special approaches to illness prevention and education.(8,9) Persons who are planning to travel to other countries often ask their health care providers for information about preventive interventions. Nonspecialists can provide information and care to healthy adults traveling to common destinations by following protocols such as those offered in this review. Advice from a specialist(10) is of benefit for persons who are planning high-risk or adventure travel, those who are immunocompromised(11-13) or have underlying chronic disease, those who are planning to live abroad for a long time, women who are pregnant(14) or plan to become pregnant soon, young children, and travelers with complicated itineraries.	[Freedman, David O.] Univ Alabama Birmingham, William C Gorgas Ctr Geog Med, Div Infect Dis, 1720 2nd Ave S,BBRB 203, Birmingham, AL 35294 USA; [Chen, Lin H.] Mt Auburn Hosp, Div Infect Dis, Cambridge, MA USA; [Chen, Lin H.] Harvard Med Sch, Dept Med, Boston, MA USA; [Kozarsky, Phyllis E.] Emory Univ, Div Infect Dis, Atlanta, GA 30322 USA	University of Alabama System; University of Alabama Birmingham; Harvard University; Mount Auburn Hospital; Harvard University; Harvard Medical School; Emory University	Freedman, DO (corresponding author), Univ Alabama Birmingham, William C Gorgas Ctr Geog Med, Div Infect Dis, 1720 2nd Ave S,BBRB 203, Birmingham, AL 35294 USA.	freedman@uab.edu	amsalu, ribka/G-8780-2019; Chen, Lin/ADS-6751-2022; Freedman, David O./AAV-2999-2020	Freedman, David O./0000-0002-5642-5257; Chen, Lin/0000-0002-5684-8436				[Anonymous], 2013, Wkly Epidemiol Rec, V88, P269; [Anonymous], 2011, Wkly Epidemiol Rec, V86, P241; Anonymous, 2011, Morbidity and Mortality Weekly Report, V60, P13; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P117; [Anonymous], 2016, CDC HLTH INFORM INT, P622; Baumgartner EA, 2012, J INFECT DIS, V206, P838, DOI 10.1093/infdis/jis467; Bavishi C, 2011, ALIMENT PHARM THER, V34, P1269, DOI 10.1111/j.1365-2036.2011.04874.x; Baxter R, 2015, PEDIATR INFECT DIS J, V34, P1236, DOI 10.1097/INF.0000000000000866; Caldas IR, 2014, VACCINE, V32, P4977, DOI 10.1016/j.vaccine.2014.07.021; Chen LH, 2006, JAMA-J AM MED ASSOC, V296, P2234, DOI 10.1001/jama.296.18.2234; Chiappini E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-151; Cohn AC, 2013, MMWR RECOMM REP, V62, P1; Coltart CEM, 2015, T ROY SOC TROP MED H, V109, P214, DOI 10.1093/trstmh/tru195; Connor BA, 2013, J TRAVEL MED, V20, P303, DOI 10.1111/jtm.12049; Delord M, 2014, TRAVEL MED INFECT DI, V12, P443, DOI 10.1016/j.tmaid.2014.08.006; Fischer Marc, 2010, Morbidity and Mortality Weekly Report, V59, P1; FitzSimons D, 2013, VACCINE, V31, P584, DOI 10.1016/j.vaccine.2012.10.101; Freedman DO, 2008, NEW ENGL J MED, V359, P603, DOI 10.1056/NEJMcp0803572; Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331; Gautret P, 2012, VACCINE, V30, P126, DOI 10.1016/j.vaccine.2011.11.007; Gershman MD, 2016, CDC HLTH INFORM INT, P346; Grohskopf LA, 2015, AM J TRANSPLANT, V15, P2767, DOI [10.15585/mmwr.mm6430a3, 10.1111/ajt.13505]; Hassing RJ, 2015, EURO SURVEILL, V20; Hochberg NS, 2006, MMWR RECOMM REP, V55, P1; Jackson BR, 2015, MMWR-MORBID MORTAL W, V64, P305; Jackson SS, 2015, FUTURE MICROBIOL, V10, P1271, DOI 10.2217/FMB.15.51; Jelinek T, 2015, J TRAVEL MED, V22, P225, DOI 10.1111/jtm.12210; Jensenius M, 2013, AM J TROP MED HYG, V88, P397, DOI 10.4269/ajtmh.12-0551; Jentes ES, 2014, J TRAVEL MED, V21, P62, DOI 10.1111/jtm.12085; Jentes ES, 2013, J TRAVEL MED, V20, P148, DOI 10.1111/jtm.12024; Jost M, 2015, TRAVEL MED INFECT DI, V13, P10, DOI 10.1016/j.tmaid.2014.10.022; Kahn SR, 2012, CHEST, V141, pE195S, DOI 10.1378/chest.11-2296; Kantele A, 2016, EMERG INFECT DIS, V22, P117, DOI 10.3201/eid2201.151272; Kantele A, 2015, CLIN INFECT DIS, V60, P837, DOI 10.1093/cid/ciu957; Keller-Stanislawski B, 2014, VACCINE, V32, P7057, DOI 10.1016/j.vaccine.2014.09.052; Lapostolle F, 2001, NEW ENGL J MED, V345, P779, DOI 10.1056/NEJMoa010378; LaRocque RC, 2013, AM J TROP MED HYG, V88, P376, DOI 10.4269/ajtmh.2012.12-0460; LaRocque RC, 2012, CLIN INFECT DIS, V54, P455, DOI 10.1093/cid/cir839; LaRocque RC, 2010, J TRAVEL MED, V17, P387, DOI 10.1111/j.1708-8305.2010.00457.x; Leder K, 2012, VACCINE, V30, P2600, DOI 10.1016/j.vaccine.2011.12.133; Leder K, 2006, CLIN INFECT DIS, V43, P1185, DOI 10.1086/507893; Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005; Leshem E, 2010, AM J TROP MED HYG, V82, P459, DOI 10.4269/ajtmh.2010.09-0239; Lindsey NP, 2008, VACCINE, V26, P6077, DOI 10.1016/j.vaccine.2008.09.009; Luks AM, 2014, WILD ENVIRON MED, V25, pS4, DOI 10.1016/j.wem.2014.06.017; Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005; Mahon BE, 2014, VACCINE, V32, P3577, DOI 10.1016/j.vaccine.2014.04.055; Manning Susan E., 2008, Morbidity and Mortality Weekly Report, V57, P1; Mast Eric E., 2006, Morbidity and Mortality Weekly Report, V55, P1; McLean HQ, 2013, MMWR RECOMM REP, V62, P1; Mendelson M, 2014, EMERG INFECT DIS, V20, P532, DOI 10.3201/eid2004.131128; Mogasale V, 2014, LANCET GLOB HEALTH, V2, pE570, DOI 10.1016/S2214-109X(14)70301-8; Monsel G, 2015, J TRAVEL MED, V22, P221, DOI 10.1111/jtm.12224; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Nielsen US, 2009, J INFECTION, V59, P353, DOI 10.1016/j.jinf.2009.08.018; Pages F, 2014, VECTOR-BORNE ZOONOT, V14, P85, DOI 10.1089/vbz.2013.1410; Paulke-Korinek M, 2015, VACCINE, V33, P3600, DOI 10.1016/j.vaccine.2015.05.037; Rabe IB, 2015, VACCINE, V33, P708, DOI 10.1016/j.vaccine.2014.11.046; Ruppe E, 2015, CLIN INFECT DIS, V61, P593, DOI 10.1093/cid/civ333; Schlagenhauf P, 2015, TRAVEL MED INFECT DI, V13, P192, DOI 10.1016/j.tmaid.2015.03.010; Schlagenhauf P, 2015, LANCET INFECT DIS, V15, P55, DOI 10.1016/S1473-3099(14)71000-X; Schlagenhauf P, 2012, EXPERT REV ANTI-INFE, V10, P537, DOI [10.1586/ERI.12.42, 10.1586/eri.12.42]; Schwartz E, 2008, EMERG INFECT DIS, V14, P1081, DOI 10.3201/eid1407.071412; Staples JE, 2015, MMWR-MORBID MORTAL W, V64, P647; Steffen R, 2015, JAMA-J AM MED ASSOC, V313, P71, DOI 10.1001/jama.2014.17006; Steffen R, 2015, J TRAVEL MED, V22, P1, DOI 10.1111/jtm.12171; Theeten H, 2015, VACCINE, V33, P5723, DOI 10.1016/j.vaccine.2015.07.008; Van Damme P, 2012, J MED VIROL, V84, P11, DOI 10.1002/jmv.22264; Vannice KS, 2015, VACCINE, V33, P7091, DOI 10.1016/j.vaccine.2015.09.053; Visser LG, 2012, INFECT DIS CLIN N AM, V26, P609, DOI 10.1016/j.idc.2012.06.003; Wallace GS, 2014, MMWR-MORBID MORTAL W, V63, P591; Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035; Wieten RW, 2013, CLIN INFECT DIS, V56, P414, DOI 10.1093/cid/cis853; Wilder-Smith A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0363-y	74	66	68	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2016	375	3					247	260		10.1056/NEJMra1508815	http://dx.doi.org/10.1056/NEJMra1508815			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS0ZL	27468061				2022-12-28	WOS:000380325400008
J	Watts, G				Watts, Geoff			Irene Tracey: seeing pain for what it is	LANCET			English	Editorial Material															Medical Research Council [G0700399] Funding Source: Medline; MRC [G0700399] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2016	388	10041					229	229		10.1016/S0140-6736(16)31032-7	http://dx.doi.org/10.1016/S0140-6736(16)31032-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR2LN	27479560				2022-12-28	WOS:000379736100015
J	Schillinger, D; Jacobson, MF				Schillinger, Dean; Jacobson, Michael F.			Science and Public Health on Trial Warning Notices on Advertisements for Sugary Drinks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Schillinger, Dean] Univ Calif San Francisco, Div Gen Internal Med, 1001 Potrero Ave,Ward 13, San Francisco, CA 94110 USA; [Schillinger, Dean] Zuckerberg San Francisco Gen Hosp, Hlth Commun Res Program, UCSF Ctr Vulnerable Populat, San Francisco, CA USA; [Jacobson, Michael F.] Ctr Sci Publ Interest, Washington, DC USA	University of California System; University of California San Francisco	Schillinger, D (corresponding author), Univ Calif San Francisco, Div Gen Internal Med, 1001 Potrero Ave,Ward 13, San Francisco, CA 94110 USA.	dean.schillinger@ucsf.edu						Bes-Rastrollo M, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001578; Grummon AH, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150306; Roberto CA, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3185; Stanhope KL, 2016, CRIT REV CL LAB SCI, V53, P52, DOI 10.3109/10408363.2015.1084990; Zoellner J, 2011, J AM DIET ASSOC, V111, P1012, DOI 10.1016/j.jada.2011.04.010	5	17	18	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 18	2016	316	15					1545	1546		10.1001/jama.2016.10516	http://dx.doi.org/10.1001/jama.2016.10516			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ0KM	27479332				2022-12-28	WOS:000385527600013
J	Frieden, TR; Schuchat, A; Petersen, LR				Frieden, Thomas R.; Schuchat, Anne; Petersen, Lyle R.			Zika Virus 6 Months Later	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Frieden, Thomas R.; Schuchat, Anne; Petersen, Lyle R.] Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS D-14, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Frieden, TR (corresponding author), Ctr Dis Control & Prevent, 1600 Clifton Rd NE,MS D-14, Atlanta, GA 30333 USA.	tfrieden@cdc.gov		Frieden, Thomas/0000-0002-4759-2256				Adams L, 2016, MMWR-MORBID MORTAL W, V65, P774, DOI 10.15585/mmwr.mm6530e1; Centers for Disease Control and Prevention, 2016, ZIK VIR; Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3; Lorenzi OD, 2016, MMWR-MORBID MORTAL W, V65, P479, DOI 10.15585/mmwr.mm6518e3; Pacheco O, 2016, NEW ENGL J MED, DOI [DOI 10.1056/NEJM0A1604037, 10.1056/NEJMoa1604037]; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338	6	30	30	0	18	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 11	2016	316	14					1443	1444		10.1001/jama.2016.11941	http://dx.doi.org/10.1001/jama.2016.11941			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DY1TC	27532277	Bronze			2022-12-28	WOS:000384876300011
J	Mayer, E; Darzi, A				Mayer, Erik; Darzi, Ara			Innovation and surgical clinical trials	LANCET			English	Editorial Material							RADICAL PROSTATECTOMY; RANDOMIZED-TRIAL; CANCER		[Mayer, Erik; Darzi, Ara] Imperial Coll London, St Marys Hosp Campus, Dept Surg & Canc, London W2 1NY, England	Imperial College London	Darzi, A (corresponding author), Imperial Coll London, St Marys Hosp Campus, Dept Surg & Canc, London W2 1NY, England.	a.darzi@imperial.ac.uk	Mayer, Erik K/A-6207-2013	Mayer, Erik K/0000-0002-5509-4580	National Institute for Health Research [CL-2008-21-502, NF-SI-0510-10186] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Avery KNL, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-200; Binder J, 2001, BJU INT, V87, P408, DOI 10.1046/j.1464-410x.2001.00115.x; Collinson FJ, 2012, INT J COLORECTAL DIS, V27, P233, DOI 10.1007/s00384-011-1313-6; Cook JA, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-9; Gardiner RA, 2014, EUR UROL, V65, P512, DOI 10.1016/j.eururo.2013.10.031; Gardiner RA, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-189; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; Trinh QD, 2012, EUR UROL, V61, P679, DOI 10.1016/j.eururo.2011.12.027; Thompson JE, 2014, EUR UROL, V65, P521, DOI 10.1016/j.eururo.2013.10.030; Yaxley JW, 2016, LANCET	10	6	6	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2016	388	10049					1027	1028		10.1016/S0140-6736(16)30588-8	http://dx.doi.org/10.1016/S0140-6736(16)30588-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DV0OD	27474377	Green Submitted			2022-12-28	WOS:000382616900005
J	Haavardsholm, EA; Aga, AB; Olsen, IC; Lillegraven, S; Hammer, HB; Uhlig, T; Fremstad, H; Madland, TM; Lexberg, AS; Haukeland, H; Rodevand, E; Hoili, C; Stray, H; Noraas, A; Hansen, IJW; Bakland, G; Nordberg, LB; van der Heijde, D; Kvien, TK				Haavardsholm, Espen A.; Aga, Anna-Birgitte; Olsen, Inge Christoffer; Lillegraven, Siri; Hammer, Hilde B.; Uhlig, Till; Fremstad, Hallvard; Madland, Tor Magne; Lexberg, Ase Stavland; Haukeland, Hilde; Rodevand, Erik; Hoili, Christian; Stray, Hilde; Noraas, Anne; Hansen, Inger Johanne Widding; Bakland, Gunnstein; Nordberg, Lena Bugge; van der Heijde, Desiree; Kvien, Tore K.			Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TREAT-TO-TARGET; MODIFYING ANTIRHEUMATIC DRUGS; ADALIMUMAB PLUS METHOTREXATE; CLINICAL REMISSION; AMERICAN-COLLEGE; RHEUMATOLOGY/EUROPEAN LEAGUE; EULAR RECOMMENDATIONS; COMBINATION THERAPY; SCORING SYSTEMS; DOUBLE-BLIND	OBJECTIVE To determine whether a treatment strategy based on structured ultrasound assessment would lead to improved outcomes in rheumatoid arthritis, compared with a conventional strategy. Design Multicentre, open label, two arm, parallel group, randomised controlled strategy trial. Setting Ten rheumatology departments and one specialist centre in Norway, from September 2010 to September 2015. Participants 238 patients were recruited between September 2010 and April 2013, of which 230 (141 (61%) female) received the allocated intervention and were analysed for the primary outcome. The main inclusion criteria were age 18-75 years, fulfilment of the 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis, disease modifying anti-rheumatic drug naivety with indication for disease modifying drug therapy, and time from first patient reported swollen joint less than two years. Patients with abnormal kidney or liver function or major comorbidities were excluded. Interventions 122 patients were randomised to an ultrasound tight control strategy targeting clinical and imaging remission, and 116 patients were randomised to a conventional tight control strategy targeting clinical remission. Patients in both arms were treated according to the same disease modifying anti-rheumatic drug escalation strategy, with 13 visits over two years. Main outcome measures The primary endpoint was the proportion of patients with a combination between 16 and 24 months of clinical remission, no swollen joints, and non-progression of radiographic joint damage. Secondary outcomes included measures of disease activity, radiographic progression, functioning, quality of life, and adverse events. All participants who attended at least one follow-up visit were included in the full analysis set. Results 26 (22%) of the 118 analysed patients in the ultrasound tight control arm and 21 (19%) of the 112 analysed patients in the clinical tight control arm reached the primary endpoint (mean difference 3.3%, 95% confidence interval -7.1% to 13.7%). Secondary endpoints (disease activity, physical function, and joint damage) were similar between the two groups. Six (5%) patients in the ultrasound tight control arm and seven (6%) patients in the conventional arm had serious adverse events. Conclusions The systematic use of ultrasound in the follow-up of patients with early rheumatoid arthritis treated according to current recommendations is not justified on the basis of the ARCTIC results. The findings highlight the need for randomised trials assessing the clinical application of medical technology.	[Haavardsholm, Espen A.; Aga, Anna-Birgitte; Olsen, Inge Christoffer; Lillegraven, Siri; Hammer, Hilde B.; Uhlig, Till; Nordberg, Lena Bugge; van der Heijde, Desiree; Kvien, Tore K.] Diakonhjemmet Hosp, Dept Rheumatol, Box 23 Vinderen, N-0319 Oslo, Norway; [Fremstad, Hallvard] Alesund Hosp, Dept Rheumatol, Alesund, Norway; [Madland, Tor Magne] Haukeland Hosp, Dept Rheumatol, Bergen, Norway; [Lexberg, Ase Stavland] Drammen Hosp, Dept Rheumatol, Drammen, Norway; [Haukeland, Hilde] Martina Hansens Hosp AS, Dept Rheumatol, Sandvika, Norway; [Rodevand, Erik] Univ Trondheim Hosp, St Olavs Hosp, Dept Rheumatol, Trondheim, Norway; [Hoili, Christian] Hosp Ostfold HF Moss, Dept Rheumatol, Gralum, Norway; [Stray, Hilde] Haugesund Rheumatism Hosp AS, Haugesund, Norway; [Noraas, Anne] Rheumatol Clin Dovland Bendvold, Kristiansand, Norway; [Hansen, Inger Johanne Widding] Sorlandet Hosp HF, Dept Rheumatol, Kristiansand, Norway; [Bakland, Gunnstein] Univ Hosp North Norway, Dept Rheumatol, Tromso, Norway; [Bakland, Gunnstein] Univ Tromso, Inst Clin Med, Tromso, Norway; [van der Heijde, Desiree] Leiden Univ, Med Ctr, Dept Rheumatol, Leiden, Netherlands	Diakonhjemmet Hospital; University of Bergen; Haukeland University Hospital; Norwegian University of Science & Technology (NTNU); UiT The Arctic University of Tromso; University Hospital of North Norway; UiT The Arctic University of Tromso; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Haavardsholm, EA (corresponding author), Diakonhjemmet Hosp, Dept Rheumatol, Box 23 Vinderen, N-0319 Oslo, Norway.	e.a.haavardsholm@medisin.uio.no	emery, paul/B-3560-2013; van der Heijde, Désirée/I-6774-2019; Olsen, Inge Christoffer/R-9128-2019; Haavardsholm, Espen Andre/C-3895-2011	van der Heijde, Désirée/0000-0002-5781-158X; Olsen, Inge Christoffer/0000-0001-6889-5873; Haavardsholm, Espen Andre/0000-0002-1427-4745; Aga, Anna-Birgitte/0000-0003-0234-4993	Norwegian Research Council; Norwegian South-Eastern Health Region; Norwegian Women's Public Health Association; Norwegian Rheumatism Association; AbbVie; UCB Pharma; Pfizer Inc; MSD Norway; Roche Norway	Norwegian Research Council(Research Council of NorwayEuropean Commission); Norwegian South-Eastern Health Region; Norwegian Women's Public Health Association; Norwegian Rheumatism Association; AbbVie(AbbVie); UCB Pharma(UCB Pharma SA); Pfizer Inc(Pfizer); MSD Norway; Roche Norway	This trial was supported by the Norwegian Research Council, Norwegian South-Eastern Health Region, Norwegian Women's Public Health Association, Norwegian Rheumatism Association, investigator initiated research grants from AbbVie, UCB Pharma, Pfizer Inc, MSD Norway, and Roche Norway. Siemens Healthcare and GE Healthcare provided technical support regarding standardisation of ultrasound equipment. The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Aga AB, 2015, ANN RHEUM DIS, V74, P381, DOI 10.1136/annrheumdis-2013-204020; Agrawal S, 2009, MOD RHEUMATOL, V19, P53, DOI 10.1007/s10165-008-0122-4; Aletaha D, 2011, ANN RHEUM DIS, V70, P733, DOI 10.1136/ard.2010.138693; Breedveld FC, 2006, ARTHRITIS RHEUM-US, V54, P26, DOI 10.1002/art.21519; Brown AK, 2008, ARTHRITIS RHEUM-US, V58, P2958, DOI 10.1002/art.23945; Brown AK, 2006, ARTHRITIS RHEUM, V54, P3761, DOI 10.1002/art.22190; Bruynesteyn K, 2002, J RHEUMATOL, V29, P2306; Clair EWS, 2004, ARTHRITIS RHEUM-US, V50, P3432, DOI 10.1002/art.20568; Colebatch AN, 2013, ANN RHEUM DIS, V72, P804, DOI 10.1136/annrheumdis-2012-203158; Dale J, 2016, ANN RHEUM DIS, V75, P1043, DOI 10.1136/annrheumdis-2015-208941; Detert J, 2013, ANN RHEUM DIS, V72, P844, DOI 10.1136/annrheumdis-2012-201612; Dougados M, 2010, ANN RHEUM DIS, V69, P828, DOI 10.1136/ard.2009.115493; Felson DT, 2011, ANN RHEUM DIS, V70, P404, DOI 10.1002/art.30129; Filer A, 2011, ANN RHEUM DIS, V70, P500, DOI 10.1136/ard.2010.131573; Gartner M, 2015, ANN RHEUM DIS, V74, P2050, DOI 10.1136/annrheumdis-2014-207212; Genovese MC, 2002, ARTHRITIS RHEUM, V46, P1443, DOI 10.1002/art.10308; Grigor C, 2004, LANCET, V364, P263, DOI 10.1016/S0140-6736(04)16676-2; Haavardsholm EA, 2012, BEST PRACT RES CL RH, V26, P767, DOI 10.1016/j.berh.2012.10.004; Hammer HB, 2012, CURR RHEUMATOL REP, V14, P438, DOI 10.1007/s11926-012-0266-2; Hammer HB, 2011, ANN RHEUM DIS, V70, P1995, DOI 10.1136/ard.2011.152926; Hetland ML, 2008, ANN RHEUM DIS, V67, P815, DOI 10.1136/ard.2007.076307; Horslev-Petersen K, 2014, ANN RHEUM DIS, V73, P654, DOI 10.1136/annrheumdis-2012-202735; Nguyen H, 2014, RHEUMATOLOGY, V53, P2110, DOI 10.1093/rheumatology/keu217; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Lillegraven S, 2012, ANN RHEUM DIS, V71, P681, DOI 10.1136/ard.2011.154625; Mandl P, 2011, J RHEUMATOL, V38, P2055, DOI 10.3899/jrheum.110424; Markusse IM, 2016, ARTHRIT CARE RES, V68, P446, DOI 10.1002/acr.22681; Matsos M, 2009, SKELETAL RADIOL, V38, P1049, DOI 10.1007/s00256-009-0738-2; Moller-Bisgaard S, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0693-2; O'Dell JR, 2013, NEW ENGL J MED, V369, P307, DOI 10.1056/NEJMoa1303006; Odegard S, 2006, ARTHRITIS RHEUM, V54, P68, DOI 10.1002/art.21548; Ostergaard M, 2014, NAT REV RHEUMATOL, V10, P326, DOI 10.1038/nrrheum.2014.63; Peluso G, 2011, ANN RHEUM DIS, V70, P172, DOI 10.1136/ard.2010.129924; Saleem B, 2012, ANN RHEUM DIS, V71, P1316, DOI 10.1136/annrheumdis-2011-200548; Scire CA, 2009, RHEUMATOLOGY, V48, P1092, DOI 10.1093/rheumatology/kep171; Scott DL, 2000, EULAR HDB CLIN ASSES; Sibbitt WL, 2009, J RHEUMATOL, V36, P1892, DOI 10.3899/jrheum.090013; Singh JA, 2016, ARTHRIT CARE RES, V68, P1, DOI 10.1002/acr.22783; Smolen JS, 2016, ANN RHEUM DIS, V75, P3, DOI 10.1136/annrheumdis-2015-207524; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Stoffer MA, 2016, ANN RHEUM DIS, V75, P16, DOI 10.1136/annrheumdis-2015-207526; Szkudlarek M, 2012, RHEUMATOLOGY, V51, P6, DOI 10.1093/rheumatology/kes334; Torp-Pedersen ST, 2008, ANN RHEUM DIS, V67, P143, DOI 10.1136/ard.2007.078451; van der Heijde D, 2012, ANN RHEUM DIS, V71, P89, DOI 10.1136/annrheumdis-2011-200797; VANDERHEIJDE DMFM, 1990, ANN RHEUM DIS, V49, P916, DOI 10.1136/ard.49.11.916; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Verstappen SMM, 2007, ANN RHEUM DIS, V66, P1443, DOI 10.1136/ard.2007.071092; Wakefield RJ, 2012, POSTGRAD MED J, V88, P482, DOI 10.1136/postgradmedj-2011-201048rep; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697	51	113	120	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2016	354								i4205	10.1136/bmj.i4205	http://dx.doi.org/10.1136/bmj.i4205			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GX	27530741	Green Published, hybrid			2022-12-28	WOS:000381806200002
J	Tanner, M				Tanner, Michael			Review: In type 2 diabetes, adding dipeptidyl peptidase-4 inhibitors to sulphonylureas increases hypoglycemia	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Tanner, Michael] NYU, Sch Med, New York, NY 10016 USA	New York University	Tanner, M (corresponding author), NYU, Sch Med, New York, NY 10016 USA.			Tanner, Michael/0000-0002-3012-8641; Salvo, Francesco/0000-0003-3210-7171				Hampp C, 2014, DIABETES CARE, V37, P1367, DOI 10.2337/dc13-2289; Karagiannis T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1369	2	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					JC20	JC20		10.7326/ACPJC-2016-165-4-020	http://dx.doi.org/10.7326/ACPJC-2016-165-4-020			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UI	27538181				2022-12-28	WOS:000381267200007
J	Baruch, J				Baruch, John			Steer driverless cars towards full automation	NATURE			English	Editorial Material									[Baruch, John] Univ Bradford, Bradford, W Yorkshire, England; [Baruch, John] S China Univ Technol, Guangzhou, Guangdong, Peoples R China	University of Bradford; South China University of Technology	Baruch, J (corresponding author), Univ Bradford, Bradford, W Yorkshire, England.; Baruch, J (corresponding author), S China Univ Technol, Guangzhou, Guangdong, Peoples R China.	j.e.f.baruch@bradford.ac.uk		Baruch, John/0000-0001-8177-9914					0	9	9	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					127	127		10.1038/536127a	http://dx.doi.org/10.1038/536127a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT4SV	27510189	Bronze, Green Accepted			2022-12-28	WOS:000381472100003
J	Bazari, H; Palmer, WE; Baron, JM; Armstrong, K				Bazari, Hasan; Palmer, William E.; Baron, Jason M.; Armstrong, Katrina			Case 24-2016: A 66-Year-Old Man with Malaise, Weakness, and Hypercalcemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALKALI SYNDROME; MANAGEMENT		[Bazari, Hasan; Armstrong, Katrina] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Palmer, William E.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02115 USA; [Baron, Jason M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Bazari, Hasan; Armstrong, Katrina] Harvard Med Sch, Dept Med, Boston, MA USA; [Palmer, William E.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Baron, Jason M.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Bazari, H (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.				International Business Machines; GlaxoSmithKline	International Business Machines(International Business Machines (IBM)); GlaxoSmithKline(GlaxoSmithKline)	Dr. Bazari reports holding stock in Pfizer; Dr. Baron, receiving grant support to his institution from International Business Machines; and Dr. Armstrong, receiving consulting fees from GlaxoSmithKline. No other potential conflict of interest relevant to this article was reported.	Baron JM, 2014, CLIN CHIM ACTA, V427, P196, DOI 10.1016/j.cca.2013.09.027; Berend K, 2014, NEW ENGL J MED, V371, P1434, DOI 10.1056/NEJMra1003327; BLACK WC, 1990, MED DECIS MAKING, V10, P212, DOI 10.1177/0272989X9001000308; Bowen JL, 2006, NEW ENGL J MED, V355, P2217, DOI 10.1056/NEJMra054782; BURNETT CH, 1949, NEW ENGL J MED, V240, P787, DOI 10.1056/NEJM194905192402001; Desai HV, 2010, AM J THER, V17, pE234, DOI 10.1097/MJT.0b013e3181c6c21b; Jacobs TP, 2005, J CLIN ENDOCR METAB, V90, P6316, DOI 10.1210/jc.2005-0675; Jha AK, 2009, HEALTH AFFAIR, V28, P1475, DOI 10.1377/hlthaff.28.5.1475; Khanna A, 2006, SEMIN NEPHROL, V26, P244, DOI 10.1016/j.semnephrol.2006.03.004; Lindner G, 2013, AM J EMERG MED, V31, P657, DOI 10.1016/j.ajem.2012.11.010; Neilson EG, 2004, ANN INTERN MED, V141, P196, DOI 10.7326/0003-4819-141-3-200408030-00008; Patel AM, 2010, J AM SOC NEPHROL, V21, P1440, DOI 10.1681/ASN.2010030255; Picolos MK, 2005, CLIN ENDOCRINOL, V63, P566, DOI 10.1111/j.1365-2265.2005.02383.x; Porter ME, 2009, NEW ENGL J MED, V361, P109, DOI 10.1056/NEJMp0904131	14	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2016	375	6					567	577		10.1056/NEJMcpc1503829	http://dx.doi.org/10.1056/NEJMcpc1503829			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU4OT	27509105				2022-12-28	WOS:000382193100011
J	Limb, M				Limb, Matthew			Website aims to help people understand health research	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 10	2016	354								i4403	10.1136/bmj.i4403	http://dx.doi.org/10.1136/bmj.i4403			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4TW	27510722				2022-12-28	WOS:000381475000009
J	Watts, G				Watts, Geoff			Allen Richard Selzer Obituary	LANCET			English	Biographical-Item																		SELZER AR, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2016	388	10044					558	558		10.1016/S0140-6736(16)31226-0	http://dx.doi.org/10.1016/S0140-6736(16)31226-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS4NA	27529103	Bronze			2022-12-28	WOS:000380756600017
J							Drug Therapeutics Bulletin	QT interval and drug therapy (Clinical review from Drug and Therapeutics Bulletin) (vol 353, i2732, 2016)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction																		Drug & Therapeutics Bulletin, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2732	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2016	354								i4331	10.1136/bmj.i4331	http://dx.doi.org/10.1136/bmj.i4331			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9CY	27492970	Bronze, Green Published			2022-12-28	WOS:000381081300011
J	Jezouin, S; Iftikhar, Z; Anthore, A; Parmentier, FD; Gennser, U; Cavanna, A; Ouerghi, A; Levkivskyi, IP; Idrisov, E; Sukhorukov, EV; Glazman, LI; Pierre, F				Jezouin, S.; Iftikhar, Z.; Anthore, A.; Parmentier, F. D.; Gennser, U.; Cavanna, A.; Ouerghi, A.; Levkivskyi, I. P.; Idrisov, E.; Sukhorukov, E. V.; Glazman, L. I.; Pierre, F.			Controlling charge quantization with quantum fluctuations	NATURE			English	Article							COULOMB-BLOCKADE; OSCILLATIONS; CONDUCTANCE; DOT; COHERENT; FLOW	In 1909, Millikan showed that the charge of electrically isolated systems is quantized in units of the elementary electron charge e. Today, the persistence of charge quantization in small, weakly connected conductors allows for circuits in which single electrons are manipulated, with applications in, for example, metrology, detectors and thermometry(1-5). However, as the connection strength is increased, the discreteness of charge is progressively reduced by quantum fluctuations. Here we report the full quantum control and characterization of charge quantization. By using semiconductor-based tunable elemental conduction channels to connect a micrometre-scale metallic island to a circuit, we explore the complete evolution of charge quantization while scanning the entire range of connection strengths, from a very weak (tunnel) to a perfect (ballistic) contact. We observe, when approaching the ballistic limit, that charge quantization is destroyed by quantum fluctuations, and scales as the square root of the residual probability for an electron to be reflected across the quantum channel; this scaling also applies beyond the different regimes of connection strength currently accessible to theory(6-8). At increased temperatures, the thermal fluctuations result in an exponential suppression of charge quantization and in a universal square-root scaling, valid for all connection strengths, in agreement with expectations(8). Besides being pertinent for the improvement of single-electron circuits and their applications, and for the metal-semiconductor hybrids relevant to topological quantum computing(9), knowledge of the quantum laws of electricity will be essential for the quantum engineering of future nanoelectronic devices.	[Jezouin, S.; Iftikhar, Z.; Anthore, A.; Parmentier, F. D.; Gennser, U.; Cavanna, A.; Ouerghi, A.; Pierre, F.] Univ Paris Diderot, Univ Paris Saclay, Univ Paris Sud,CNR, Ctr NanoSci & Nanotechnol C2N,Sorbonne Paris Cite, F-91120 Palaiseau, France; [Levkivskyi, I. P.] ETH, Inst Theoret Phys, CH-8093 Zurich, Switzerland; [Idrisov, E.; Sukhorukov, E. V.] Univ Geneva, Dept Phys Theor, CH-1211 Geneva, Switzerland; [Glazman, L. I.] Yale Univ, Dept Phys, New Haven, CT 06520 USA	UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva; Yale University	Pierre, F (corresponding author), Univ Paris Diderot, Univ Paris Saclay, Univ Paris Sud,CNR, Ctr NanoSci & Nanotechnol C2N,Sorbonne Paris Cite, F-91120 Palaiseau, France.	frederic.pierre@lpn.cnrs.fr	Pierre, Frederic/J-3119-2016; Gennser, Ulf/F-2728-2019; Parmentier, François/GZG-3568-2022; Iftikhar, Zubair/I-8317-2016	Pierre, Frederic/0000-0003-1243-6808; Parmentier, François/0000-0003-1301-3305; Iftikhar, Zubair/0000-0001-6487-1620; Gennser, Ulf/0000-0003-2423-2140; Parmentier, Francois/0000-0001-9319-565X; Anthore, Anne/0000-0002-5870-3513	European Research Council [ERC-2010-StG-20091028, 259033]; French RENATECH network; national French programme 'Investissements d'Avenir' (Labex NanoSaclay) [ANR-10-LABX-0035]; US Department of Energy [DE-FG02-08ER46482]; Swiss National Science Foundation	European Research Council(European Research Council (ERC)European Commission); French RENATECH network; national French programme 'Investissements d'Avenir' (Labex NanoSaclay)(French National Research Agency (ANR)); US Department of Energy(United States Department of Energy (DOE)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the European Research Council (ERC-2010-StG-20091028, no. 259033), the French RENATECH network, the national French programme 'Investissements d'Avenir' (Labex NanoSaclay, ANR-10-LABX-0035), the US Department of Energy (DE-FG02-08ER46482) and the Swiss National Science Foundation.	Albrecht SM, 2016, NATURE, V531, P206, DOI 10.1038/nature17162; Aleiner IL, 1998, PHYS REV B, V57, P9608, DOI 10.1103/PhysRevB.57.9608; Amasha S, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.216804; Berman D, 1999, PHYS REV LETT, V82, P161, DOI 10.1103/PhysRevLett.82.161; Chouvaev D, 1999, PHYS REV B, V59, P10599, DOI 10.1103/PhysRevB.59.10599; Cronenwett SM, 1998, PHYS REV LETT, V81, P5904, DOI 10.1103/PhysRevLett.81.5904; Crouch CH, 1996, SUPERLATTICE MICROST, V20, P377, DOI 10.1006/spmi.1996.0092; Duncan DS, 1999, APPL PHYS LETT, V74, P1045, DOI 10.1063/1.123450; FLENSBERG K, 1993, PHYS REV B, V48, P11156, DOI 10.1103/PhysRevB.48.11156; FROHLICH J, 1991, NUCL PHYS B, V364, P517, DOI 10.1016/0550-3213(91)90275-3; Furusaki A, 1995, PHYS REV B, V52, P16676, DOI 10.1103/PhysRevB.52.16676; GLAZMAN LI, 1989, J PHYS-CONDENS MAT, V1, P5811, DOI 10.1088/0953-8984/1/33/027; Goktas O, 2008, PHYSICA E, V40, P1579, DOI 10.1016/j.physe.2007.09.115; GRABERT H, 1992, SINGLE CHARGE TUNNEL; HALPERIN BI, 1982, PHYS REV B, V25, P2185, DOI 10.1103/PhysRevB.25.2185; Iftikhar Z, 2015, NATURE, V526, P233, DOI 10.1038/nature15384; Jezouin S, 2013, SCIENCE, V342, P601, DOI 10.1126/science.1241912; Joyez P, 1997, PHYS REV LETT, V79, P1349, DOI 10.1103/PhysRevLett.79.1349; KORSHUNOV SE, 1987, JETP LETT+, V45, P434; KOUWENHOVEN LP, 1991, Z PHYS B CON MAT, V85, P367, DOI 10.1007/BF01307632; Le Hur K, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165338; Liang CT, 1998, PHYS REV LETT, V81, P3507, DOI 10.1103/PhysRevLett.81.3507; Likharev KK, 1999, P IEEE, V87, P606, DOI 10.1109/5.752518; Lukyanov SL, 2007, NUCL PHYS B, V784, P151, DOI 10.1016/j.nuclphysb.2007.04.034; Matveev KA, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.045301; MATVEEV KA, 1995, PHYS REV B, V51, P1743, DOI 10.1103/PhysRevB.51.1743; Meschke M, 2011, INT J THERMOPHYS, V32, P1378, DOI 10.1007/s10765-011-1033-8; Mitchell AK, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.157202; MOLENKAMP LW, 1995, PHYS REV LETT, V75, P4282, DOI 10.1103/PhysRevLett.75.4282; Nazarov YV, 1999, PHYS REV LETT, V82, P1245, DOI 10.1103/PhysRevLett.82.1245; PANYUKOV SV, 1991, PHYS REV LETT, V67, P3168, DOI 10.1103/PhysRevLett.67.3168; PASQUIER C, 1993, PHYS REV LETT, V70, P69, DOI 10.1103/PhysRevLett.70.69; Pekola JP, 2013, REV MOD PHYS, V85, P1421, DOI 10.1103/RevModPhys.85.1421; SCHON G, 1990, PHYS REP, V198, P237, DOI 10.1016/0370-1573(90)90156-V; Slobodeniuk AO, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.165307; Spietz L, 2003, SCIENCE, V300, P1929, DOI 10.1126/science.1084647; STARING AAM, 1991, PHYSICA B, V175, P226, DOI 10.1016/0921-4526(91)90717-S; Sukhorukov EV, 2016, PHYSICA E, V77, P191, DOI 10.1016/j.physe.2015.11.018; Tkachenko OA, 2001, J PHYS-CONDENS MAT, V13, P9515, DOI 10.1088/0953-8984/13/42/312; VANDERVAART NC, 1993, PHYSICA B, V189, P99, DOI 10.1016/0921-4526(93)90150-5; Wang XH, 1996, PHYS REV B, V53, P12621, DOI 10.1103/PhysRevB.53.12621; WEN XG, 1990, PHYS REV B, V41, P12838, DOI 10.1103/PhysRevB.41.12838; Yi HM, 1996, PHYS REV B, V53, P12956, DOI 10.1103/PhysRevB.53.12956	43	31	31	4	57	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 4	2016	536	7614					58	+		10.1038/nature19072	http://dx.doi.org/10.1038/nature19072			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS7YM	27488797	Green Submitted, Green Published			2022-12-28	WOS:000380999200029
J	Kimball, AB; Okun, MM; Williams, DA; Gottlieb, AB; Papp, KA; Zouboulis, CC; Armstrong, AW; Kerdel, F; Gold, MH; Forman, SB; Korman, NJ; Giamarellos-Bourboulis, EJ; Crowley, JJ; Lynde, C; Reguiai, Z; Prens, EP; Alwawi, E; Mostafa, NM; Pinsky, B; Sundaram, M; Gu, YH; Carlson, DM; Jemec, GBE				Kimball, Alexa B.; Okun, Martin M.; Williams, David A.; Gottlieb, Alice B.; Papp, Kim A.; Zouboulis, Christos C.; Armstrong, April W.; Kerdel, Francisco; Gold, Michael H.; Forman, Seth B.; Korman, Neil J.; Giamarellos-Bourboulis, Evangelos J.; Crowley, Jeffrey J.; Lynde, Charles; Reguiai, Ziad; Prens, Errol-Prospero; Alwawi, Eihab; Mostafa, Nael M.; Pinsky, Brett; Sundaram, Murali; Gu, Yihua; Carlson, Dawn M.; Jemec, Gregor B. E.			Two Phase 3 Trials of Adalimumab for Hidradenitis Suppurativa	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MODERATE; PREVALENCE; PSORIASIS; THERAPY; INVERSA; DISEASE; ALPHA	BACKGROUND Hidradenitis suppurativa is a painful, chronic inflammatory skin disease with few options for effective treatment. In a phase 2 trial, adalimumab, an antibody against tumor necrosis factor a, showed efficacy against hidradenitis suppurativa. METHODS PIONEER I and II were similarly designed, phase 3 multicenter trials of adalimumab for hidradenitis suppurativa, with two double-blind, placebo-controlled periods. In period 1, patients were randomly assigned in a 1: 1 ratio to 40 mg of adalimumab weekly or matching placebo for 12 weeks. In period 2, patients were reassigned to adalimumab at a weekly or every-other-week dose or to placebo for 24 weeks. The primary end point was a clinical response, defined as at least a 50% reduction from baseline in the abscess and inflammatory-nodule count, with no increase in abscess or draining-fistula counts, at week 12. RESULTS We enrolled 307 patients in PIONEER I and 326 in PIONEER II. Clinical response rates at week 12 were significantly higher for the groups receiving adalimumab weekly than for the placebo groups: 41.8% versus 26.0% in PIONEER I (P=0.003) and 58.9% versus 27.6% in PIONEER II (P<0.001). Patients receiving adalimumab had significantly greater improvement than the placebo groups in rank-ordered secondary outcomes (lesions, pain, and the modified Sartorius score for disease severity) at week 12 in PIONEER II only. Serious adverse events in period 1 (excluding worsening of underlying disease) occurred in 1.3% of patients receiving adalimumab and 1.3% of those receiving placebo in PIONEER I and in 1.8% and 3.7% of patients, respectively, in PIONEER II. In period 2, the rates of serious adverse events were 4.6% or less in all the groups in both studies, with no significant between-group differences. CONCLUSIONS Treatment with adalimumab (40 mg weekly), as compared with placebo, resulted in significantly higher clinical response rates in both trials at 12 weeks; rates of serious adverse events were similar in the study groups.	[Kimball, Alexa B.] Harvard Med Sch, Boston, MA USA; [Kimball, Alexa B.] Massachusetts Gen Hosp, Boston, MA USA; [Gottlieb, Alice B.] Tufts Med Ctr, Boston, MA USA; [Okun, Martin M.; Williams, David A.; Alwawi, Eihab; Mostafa, Nael M.; Pinsky, Brett; Sundaram, Murali; Gu, Yihua; Carlson, Dawn M.] AbbVie, N Chicago, IL USA; [Papp, Kim A.] Prob Med Res, Waterloo, ON, Canada; [Papp, Kim A.] K Papp Clin Res, Waterloo, ON, Canada; [Lynde, Charles] Lynde Ctr Dermatol, Markham, ON, Canada; [Lynde, Charles] Prob Med Res, Markham, ON, Canada; [Zouboulis, Christos C.] Dessau Med Ctr, Dept Dermatol, Dessau, Germany; [Zouboulis, Christos C.] Dessau Med Ctr, Dept Venereol, Dessau, Germany; [Zouboulis, Christos C.] Dessau Med Ctr, Dept Allergol, Dessau, Germany; [Zouboulis, Christos C.] Dessau Med Ctr, Dept Immunol, Dessau, Germany; [Armstrong, April W.] Univ So Calif, Los Angeles, CA USA; [Crowley, Jeffrey J.] Bakersfield Dermatol, Bakersfield, CA USA; [Kerdel, Francisco] Florida Acad Dermatol Ctr, Miami, FL USA; [Forman, Seth B.] Forward Clin Trials, Tampa, FL USA; [Gold, Michael H.] Tennessee Clin Res Ctr, Nashville, TN USA; [Korman, Neil J.] Univ Hosp Case Med Ctr, Cleveland, OH USA; [Giamarellos-Bourboulis, Evangelos J.] Univ Athens, Sch Med, Dept Internal Med 4, Athens, Greece; [Reguiai, Ziad] CHU Reims, Hop Robert Debre, Serv Dermatol, Reims, France; [Prens, Errol-Prospero] Erasmus Univ, Med Ctr, Rotterdam, Netherlands; [Jemec, Gregor B. E.] Univ Copenhagen, Roskilde Hosp, Dept Dermatol, Copenhagen, Denmark; [Jemec, Gregor B. E.] Univ Copenhagen, Fac Hlth Sci, Copenhagen, Denmark	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Tufts Medical Center; AbbVie; Dessau Medical Center; Dessau Medical Center; Dessau Medical Center; Dessau Medical Center; University of Southern California; Case Western Reserve University; Case Western Reserve University Hospital; Athens Medical School; National & Kapodistrian University of Athens; CHU de Reims; Universite de Reims Champagne-Ardenne; Erasmus University Rotterdam; Erasmus MC; University of Copenhagen; University of Copenhagen	Kimball, AB (corresponding author), 375 Longwood Ave,3rd Fl, Boston, MA 02215 USA.	harvardskinstudies@gmail.com	Kimball, Alexandra B./M-6347-2019; Jemec, Gregor/H-6702-2019; Giamarellos-Bourboulis, Evangelos/AAD-7155-2019; Zouboulis, Christos C./I-4493-2013	Kimball, Alexandra B./0000-0001-9405-0479; Jemec, Gregor/0000-0002-0712-2540; Zouboulis, Christos C./0000-0003-1646-2608; Papp, Kim A./0000-0001-9557-3642	AbbVie	AbbVie(AbbVie)	Funded by AbbVie; ClinicalTrials.gov numbers, NCT01468207 and NCT01468233 for PIONEER I and PIONEER II, respectively.	Adams DR, 2010, ARCH DERMATOL, V146, P501, DOI 10.1001/archdermatol.2010.72; Fimmel S, 2010, DERM-ENDOCRINOL, V2, P9, DOI 10.4161/derm.2.1.12490; Grant A, 2010, J AM ACAD DERMATOL, V62, P205, DOI 10.1016/j.jaad.2009.06.050; Hongbo Y, 2005, J INVEST DERMATOL, V125, P659, DOI 10.1111/j.0022-202X.2005.23621.x; Hurley HJ, 1996, ROENIGK ROENIGKS DER, V2nd, P623; Jemec GBE, 1996, J AM ACAD DERMATOL, V35, P191, DOI 10.1016/S0190-9622(96)90321-7; Jemec GBE, 1996, CLIN EXP DERMATOL, V21, P419, DOI 10.1111/j.1365-2230.1996.tb00145.x; Jemec GBE, 2012, NEW ENGL J MED, V366, P158, DOI 10.1056/NEJMcp1014163; Kimball AB, 2016, J EUR ACAD DERMATOL, V30, P989, DOI 10.1111/jdv.13216; Kimball AB, 2014, BRIT J DERMATOL, V171, P1434, DOI 10.1111/bjd.13270; Kimball AB, 2012, ANN INTERN MED, V157, P846, DOI 10.7326/0003-4819-157-12-201212180-00004; Kurzen H, 2008, EXP DERMATOL, V17, P455, DOI [10.1111/j.1600-0625.2008.00712.x, 10.1111/j.1600-0625.2008.00712_1.x]; Menter A, 2008, J AM ACAD DERMATOL, V58, P106, DOI 10.1016/j.jaad.2007.09.010; Naldi L., 2006, HIDRADENITIS SUPPURA, V1, P58; Revuz JE, 2008, J AM ACAD DERMATOL, V59, P596, DOI 10.1016/j.jaad.2008.06.020; Sartorius K, 2003, BRIT J DERMATOL, V149, P211, DOI 10.1046/j.1365-2133.2003.05390.x; Saunte DM, 2015, BRIT J DERMATOL, V173, P1546, DOI 10.1111/bjd.14038; Semble AL, 2014, AM J CLIN DERMATOL, V15, P37, DOI 10.1007/s40257-013-0053-5; Shlyankevich J, 2014, J AM ACAD DERMATOL, V71, P1144, DOI 10.1016/j.jaad.2014.09.012; van de Putte BA, 2004, ANN RHEUM DIS, V63, P508, DOI 10.1136/ard.2003.013052; van der Zee HH, 2011, BRIT J DERMATOL, V164, P1292, DOI 10.1111/j.1365-2133.2011.10254.x; van Rappard DC, 2013, J DERMATOL TREAT, V24, P392, DOI 10.3109/09546634.2012.674193; Von der Werth JM, 2001, BRIT J DERMATOL, V144, P809, DOI 10.1046/j.1365-2133.2001.04137.x; Zouboulis CC, 2015, J EUR ACAD DERMATOL, V29, P619, DOI 10.1111/jdv.12966; Zouboulis CC, 2015, DERMATOLOGY, V231, P184, DOI 10.1159/000431175	25	352	361	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2016	375	5					422	434		10.1056/NEJMoa1504370	http://dx.doi.org/10.1056/NEJMoa1504370			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7AN	27518661	Bronze			2022-12-28	WOS:000380934900006
J	Perkel, J				Perkel, Jeffrey			THE PAPER PROMOTERS	NATURE			English	Editorial Material														Perkel, Jeffrey/0000-0001-5699-1008					0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2016	536	7614					113	114		10.1038/536113a	http://dx.doi.org/10.1038/536113a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS7YM	27488800	Bronze			2022-12-28	WOS:000380999200042
J	Schmittner, A				Schmittner, Andreas			The smoking gun for Atlantic circulation changes	SCIENCE			English	Editorial Material							DELTA-C-13		[Schmittner, Andreas] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA	Oregon State University	Schmittner, A (corresponding author), Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA.	aschmitt@coas.oregonstate.edu	Schmittner, Andreas/O-9647-2015	Schmittner, Andreas/0000-0002-8376-0843				Buizert C, 2015, NATURE, V520, P661, DOI 10.1038/nature14401; Cheng W, 2013, J CLIMATE, V26, P7187, DOI 10.1175/JCLI-D-12-00496.1; Crowley TJ, 1992, PALEOCEANOGRAPHY, V7, P489, DOI 10.1029/92PA01058; Hayes CT, 2015, DEEP-SEA RES PT II, V116, P29, DOI 10.1016/j.dsr2.2014.07.007; Henry LG, 2016, SCIENCE, V353, P470, DOI 10.1126/science.aaf5529; Kuhlbrodt T, 2007, REV GEOPHYS, V45, DOI 10.1029/2004RG000166; Schmittner A, 2015, CLIM PAST, V11, P135, DOI 10.5194/cp-11-135-2015; Schmittner A, 2013, BIOGEOSCIENCES, V10, P5793, DOI 10.5194/bg-10-5793-2013; Stocker TF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2003PA000920	9	1	1	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					445	446		10.1126/science.aag3156	http://dx.doi.org/10.1126/science.aag3156			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27471293				2022-12-28	WOS:000380583600021
J	Teesdale, E				Teesdale, Ellen			The wisdom of crowds	LANCET			English	Editorial Material									[Teesdale, Ellen] The Lancet, London EC2Y 5AS, England		Teesdale, E (corresponding author), The Lancet, London EC2Y 5AS, England.								0	0	0	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2016	388	10042					321	321		10.1016/S0140-6736(16)31130-8	http://dx.doi.org/10.1016/S0140-6736(16)31130-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DR6MV	27477150				2022-12-28	WOS:000380016900010
J	Watts, G				Watts, Geoff			Evert Joost Dorhout Mees Obituary	LANCET			English	Biographical-Item																		MEES EJD, PUBLICATION LIST	1	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2016	388	10041					232	232		10.1016/S0140-6736(16)31034-0	http://dx.doi.org/10.1016/S0140-6736(16)31034-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR2LN	27489914	Bronze			2022-12-28	WOS:000379736100016
J	Park, RS; Konopliv, AS; Bills, BG; Rambaux, N; Castillo-Rogez, JC; Raymond, CA; Vaughan, AT; Ermakov, AI; Zuber, MT; Fu, RR; Toplis, MJ; Russell, CT; Nathues, A; Preusker, F				Park, R. S.; Konopliv, A. S.; Bills, B. G.; Rambaux, N.; Castillo-Rogez, J. C.; Raymond, C. A.; Vaughan, A. T.; Ermakov, A. I.; Zuber, M. T.; Fu, R. R.; Toplis, M. J.; Russell, C. T.; Nathues, A.; Preusker, F.			A partially differentiated interior for (1) Ceres deduced from its gravity field and shape	NATURE			English	Article							MOMENT; INERTIA; ORIGIN	Remote observations of the asteroid (1) Ceres from ground-and space-based telescopes have provided its approximate density and shape, leading to a range of models for the interior of Ceres, from homogeneous to fully differentiated(1-6). A previously missing parameter that can place a strong constraint on the interior of Ceres is its moment of inertia, which requires the measurement of its gravitational variation(1,7) together with either precession rate(8,9) or a validated assumption of hydrostatic equilibrium(10). However, Earthbased remote observations cannot measure gravity variations and the magnitude of the precession rate is too small to be detected(9). Here we report gravity and shape measurements of Ceres obtained from the Dawn spacecraft, showing that it is in hydrostatic equilibrium with its inferred normalized mean moment of inertia of 0.37. These data show that Ceres is a partially differentiated body, with a rocky core overlaid by a volatile-rich shell, as predicted in some studies(1,4,6). Furthermore, we show that the gravity signal is strongly suppressed compared to that predicted by the topographic variation. This indicates that Ceres is isostatically compensated(11), such that topographic highs are supported by displacement of a denser interior. In contrast to the asteroid (4) Vesta(8,12), this strong compensation points to the presence of a lower-viscosity layer at depth, probably reflecting a thermal rather than compositional gradient(1,4). To further investigate the interior structure, we assume a two-layer model for the interior of Ceres with a core density of 2,460-2,900 kilograms per cubic metre (that is, composed of CI and CM chondrites(13)), which yields an outer-shell thickness of 70-190 kilometres. The density of this outer shell is 1,6801,950 kilograms per cubic metre, indicating a mixture of volatiles and denser materials such as silicates and salts(14). Although the gravity and shape data confirm that the interior of Ceres evolved thermally(1,4,6,) its partially differentiated interior indicates an evolution more complex than has been envisioned for mid-sized (less than 1,000 kilometres across) ice-rich rocky bodies.	[Park, R. S.; Konopliv, A. S.; Bills, B. G.; Castillo-Rogez, J. C.; Raymond, C. A.; Vaughan, A. T.] CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA; [Rambaux, N.] Sorbonne Univ, Univ Paris 06, Univ Lille 1, IMCCE,Observ Paris,PSL Res Univ,CNRS, 77 Ave Denfert Rochereau, F-75014 Paris, France; [Ermakov, A. I.; Zuber, M. T.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Fu, R. R.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Toplis, M. J.] Univ Toulouse, UPS, CNRS, Inst Rech Astrophys & Planetol, Toulouse, France; [Russell, C. T.] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Los Angeles, CA 90095 USA; [Nathues, A.] Max Planck Inst Solar Syst Res, Gottingen, Germany; [Preusker, F.] DLR, Inst Planetary Res, Dept Planetary Geodesy, Rutherfordstr 2, D-12489 Berlin, Germany	California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Sorbonne Universite; Universite de Lille - ISITE; Universite de Lille; Massachusetts Institute of Technology (MIT); Columbia University; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of California System; University of California Los Angeles; Max Planck Society; Helmholtz Association; German Aerospace Centre (DLR)	Park, RS (corresponding author), CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA.	Ryan.S.Park@jpl.nasa.gov	Russell, Christopher T/E-7745-2012; Nathues, Andreas/AAW-4340-2020	Russell, Christopher T/0000-0003-1639-8298; Ermakov, Anton/0000-0002-7020-7061; /0000-0003-3635-2676	National Aeronautics and Space Administration; MESR; French National Programme of Planetology (PNP); CNES	National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); MESR(Ministry of Research, France); French National Programme of Planetology (PNP); CNES(Centre National D'etudes Spatiales)	This research was carried out in part at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration. We thank the Dawn operations team for the development, cruise, orbital insertion and operations of the Dawn spacecraft at Ceres. R.S.P. thanks W. M. Folkner, E. M. Mazarico, and M. D. Rayman for comments and suggestions. N.R. is grateful to the CNU, Section 34, for supporting a six-month full-time research project through CRCT-2015 funding delivered by the MESR and acknowledges funding from the French National Programme of Planetology (PNP). M.J.T. acknowledges funding by the CNES. Government sponsorship acknowledged. All rights reserved.	Anderson JD, 1996, NATURE, V384, P541, DOI 10.1038/384541a0; Bills BG, 2014, ICARUS, V240, P161, DOI 10.1016/j.icarus.2014.05.033; Buczkowski D., SCIENCE; Castillo-Rogez J. C., PLANETESIMA IN PRESS; Castillo-Rogez JC, 2011, ICARUS, V215, P599, DOI 10.1016/j.icarus.2011.08.007; Castillo-Rogez JC, 2010, ICARUS, V205, P443, DOI 10.1016/j.icarus.2009.04.008; Consolmagno GJ, 2008, CHEM ERDE-GEOCHEM, V68, P1, DOI 10.1016/j.chemer.2008.01.003; Darwin GH., 1899, MNRAS, V60, P82; Gao P, 2013, ICARUS, V226, P1185, DOI 10.1016/j.icarus.2013.07.034; Gaskell RW, 2008, METEORIT PLANET SCI, V43, P1049, DOI 10.1111/j.1945-5100.2008.tb00692.x; Heiskanen W.A., 1967, PHYS GEODESY; Hiesinger H., SCIENCE; Iess L, 2010, SCIENCE, V327, P1367, DOI 10.1126/science.1182583; Kargel JS, 2000, ICARUS, V148, P226, DOI 10.1006/icar.2000.6471; Konopliv AS, 2014, ICARUS, V240, P103, DOI 10.1016/j.icarus.2013.09.005; KUCINSKAS AB, 1994, ICARUS, V112, P104, DOI 10.1006/icar.1994.1172; McCord TB, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002244; Nathues A, 2015, NATURE, V528, P237, DOI 10.1038/nature15754; Neveu M, 2015, GEOPHYS RES LETT, V42, P10197, DOI 10.1002/2015GL066375; PEALE SJ, 1976, J GEOPHYS RES, V81, P1813, DOI 10.1029/JB081i011p01813; Preusker F, 2015, ASTRON ASTROPHYS, V583, DOI 10.1051/0004-6361/201526349; Radau R., 1885, CR HEBD ACAD SCI, V100, P972; Rambaux N, 2015, ASTRON ASTROPHYS, V584, DOI 10.1051/0004-6361/201527005; Rambaux N, 2011, ASTRON ASTROPHYS, V535, DOI 10.1051/0004-6361/201116563; Ruesch O., SCIENCE; RUSSELL CT, SCIENCE; Showman AP, 1999, SCIENCE, V286, P77, DOI 10.1126/science.286.5437.77; Thomas PC, 2005, NATURE, V437, P224, DOI 10.1038/nature03938; Zolotov MY, 2009, ICARUS, V204, P183, DOI 10.1016/j.icarus.2009.06.011	30	138	140	2	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 22	2016	537	7621					515	+		10.1038/nature18955	http://dx.doi.org/10.1038/nature18955			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW3MO	27487219				2022-12-28	WOS:000383545900048
J	Ye, D; Xiong, Y				Ye, Dan; Xiong, Yue			Suffocation of gene expression	NATURE			English	Editorial Material							ONCOMETABOLITE 2-HYDROXYGLUTARATE; MAMMALIAN DNA; HYPOXIA; L-2-HYDROXYGLUTARATE; 5-CARBOXYLCYTOSINE; 5-METHYLCYTOSINE; DEMETHYLASES; SUCCINATE; CANCERS; HISTONE		[Ye, Dan] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Ye, Dan] Fudan Univ, Huashan Hosp, Shanghai 200032, Peoples R China; [Xiong, Yue] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Fudan University; Fudan University; University of North Carolina; University of North Carolina Chapel Hill	Ye, D (corresponding author), Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China.; Ye, D (corresponding author), Fudan Univ, Huashan Hosp, Shanghai 200032, Peoples R China.	yedan@fudan.edu.cn; yxiong@email.unc.edu						Buffa FM, 2010, BRIT J CANCER, V102, P428, DOI 10.1038/sj.bjc.6605450; Chowdhury R, 2011, EMBO REP, V12, P463, DOI 10.1038/embor.2011.43; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; He YF, 2011, SCIENCE, V333, P1303, DOI 10.1126/science.1210944; Intlekofer AM, 2015, CELL METAB, V22, P304, DOI 10.1016/j.cmet.2015.06.023; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Jain RK, 2014, CANCER CELL, V26, P605, DOI 10.1016/j.ccell.2014.10.006; Jeschke J, 2016, CURR OPIN GENET DEV, V36, P16, DOI 10.1016/j.gde.2016.01.004; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Loenarz C, 2011, TRENDS BIOCHEM SCI, V36, P7, DOI 10.1016/j.tibs.2010.07.002; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Oldham WM, 2015, CELL METAB, V22, P291, DOI 10.1016/j.cmet.2015.06.021; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Thienpont B, 2016, NATURE, V537, P63, DOI 10.1038/nature19081; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014	18	4	5	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					42	43		10.1038/nature19426	http://dx.doi.org/10.1038/nature19426			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU7XC	27533033				2022-12-28	WOS:000382426900033
J	Kuffer, A; Lakkaraju, AKK; Mogha, A; Petersen, SC; Airich, K; Doucerain, C; Marpakwar, R; Bakirci, P; Senatore, A; Monnard, A; Schiavi, C; Nuvolone, M; Grosshans, B; Hornemann, S; Bassilana, F; Monk, KR; Aguzzi, A				Kuffer, Alexander; Lakkaraju, Asvin K. K.; Mogha, Amit; Petersen, Sarah C.; Airich, Kristina; Doucerain, Cedric; Marpakwar, Rajlakshmi; Bakirci, Pamela; Senatore, Assunta; Monnard, Arnaud; Schiavi, Carmen; Nuvolone, Mario; Grosshans, Bianka; Hornemann, Simone; Bassilana, Frederic; Monk, Kelly R.; Aguzzi, Adriano			The prion protein is an agonistic ligand of the G protein-coupled receptor Adgrg6	NATURE			English	Article							PERIPHERAL MYELIN MAINTENANCE; SCHWANN-CELL DEVELOPMENT; GPR126; ZEBRAFISH; APOPTOSIS; NEURONS; DOMAIN; MICE; RNA	Ablation of the cellular prion protein PrPC leads to a chronic demyelinating polyneuropathy affecting Schwann cells. Neuron-restricted expression of PrPC prevents the disease(1), suggesting that PrPC acts in trans through an unidentified Schwann cell receptor. Here we show that the cAMP concentration in sciatic nerves from PrPC-deficient mice is reduced, suggesting that PrPC acts via a G protein-coupled receptor (GPCR). The amino-terminal flexible tail (residues 23-120) of PrPC triggered a concentration-dependent increase in cAMP in primary Schwann cells, in the Schwann cell line SW10, and in HEK293T cells overexpressing the GPCR Adgrg6 (also known as Gpr126). By contrast, naive HEK293T cells and HEK293T cells expressing several other GPCRs did not react to the flexible tail, and ablation of Gpr126 from SW10 cells abolished the flexible tail-induced cAMP response. The flexible tail contains a polycationic cluster (KKRPKPG) similar to the GPRGKPG motif of the Gpr126 agonist type-IV collagen(2). A KKRPKPG-containing PrPC-derived peptide (FT23-50) sufficed to induce a Gpr126-dependent cAMP response in cells and mice, and improved myelination in hypomorphic gpr126 mutant zebrafish (Danio rerio). Substitution of the cationic residues with alanines abolished the biological activity of both FT23-50 and the equivalent type-IV collagen peptide. We conclude that PrPC promotes myelin homeostasis through flexible tail-mediated Gpr126 agonism. As well as clarifying the physiological role of PrPC, these observations are relevant to the pathogenesis of demyelinating polyneuropathies-common debilitating diseases for which there are limited therapeutic options.	[Kuffer, Alexander; Lakkaraju, Asvin K. K.; Airich, Kristina; Doucerain, Cedric; Marpakwar, Rajlakshmi; Bakirci, Pamela; Senatore, Assunta; Monnard, Arnaud; Schiavi, Carmen; Nuvolone, Mario; Hornemann, Simone; Aguzzi, Adriano] Univ Zurich, Inst Neuropathol, CH-8091 Zurich, Switzerland; [Mogha, Amit; Petersen, Sarah C.; Monk, Kelly R.] Washington Univ, Sch Med, Dept Dev Biol, 660 South Euclid Ave,Campus Box 8103, St Louis, MO 63110 USA; [Mogha, Amit; Petersen, Sarah C.; Monk, Kelly R.] Hope Ctr Neurol Disorders, 660 South Euclid Ave,Campus Box 8103, St Louis, MO 63110 USA; [Grosshans, Bianka; Bassilana, Frederic] Novartis Inst Biomed Res, CH-4056 Basel, Switzerland	University of Zurich; Washington University (WUSTL); Novartis	Aguzzi, A (corresponding author), Univ Zurich, Inst Neuropathol, CH-8091 Zurich, Switzerland.	adriano.aguzzi@usz.ch	Nuvolone, Mario/K-4763-2018	Nuvolone, Mario/0000-0001-8334-1684; Marpakwar, Rajlakshmi/0000-0002-6683-0571; Bassilana, Frederic/0000-0003-2063-8450; Petersen, Sarah/0000-0003-4540-4909; Aguzzi, Adriano/0000-0002-0344-6708; Lakkaraju, Asvin/0000-0001-8752-148X	European Research Council; European Union; Swiss National Research Foundation; Sinergia grant [147660]; Clinical Research Priority Program 'Small RNAs'; Clinical Research Priority Program 'Human Hemato-Lymphatic Diseases'; SystemsX.ch; EU Joint Programme on Neurodegenerative Disease Research (JPND) CureALS and REfrAME; Novartis Research Foundation; MD/PhD fellowship from the Swiss National Science Foundation; Synapsis Foundation; NIH [F32 NS087786, NS079445]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS087786, R01NS079445] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); European Union(European Commission); Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Sinergia grant; Clinical Research Priority Program 'Small RNAs'; Clinical Research Priority Program 'Human Hemato-Lymphatic Diseases'; SystemsX.ch; EU Joint Programme on Neurodegenerative Disease Research (JPND) CureALS and REfrAME; Novartis Research Foundation; MD/PhD fellowship from the Swiss National Science Foundation; Synapsis Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Moos, P. Schwarz, C. Tiberi, C. Sturzenegger, V. Escalante, M. Delic, C. Johnson and Z. Spence for technical help; J. Bremer for discussions; V. Beck, M.-A. Wulf, K. Frontzek, T. Johnson, T. O'Connor, A. Lau and C. Rehwald for help in performing experiments; and X. Piao for antibodies against Gpr126. A. A. is the recipient of support from an Advanced Grant of the European Research Council (Prion2020), a European Union Framework 7 Grant (NEURINOX), the Swiss National Research Foundation, Sinergia grant #147660, the Clinical Research Priority Programs 'Small RNAs' and 'Human Hemato-Lymphatic Diseases', SystemsX.ch, the EU Joint Programme on Neurodegenerative Disease Research (JPND) CureALS and REfrAME, and the Novartis Research Foundation. A.K. was supported by an MD/PhD fellowship from the Swiss National Science Foundation. A.K.K.L. is supported by a grant from the Synapsis Foundation. S.H. is a recipient of a SystemsX. ch grant. This work was supported by NIH grants F32 NS087786 to S.C.P. and NS079445 to K.R.M.	Altmeppen HC, 2015, ELIFE, V4, DOI 10.7554/eLife.04260; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Dametto P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117412; Decker L, 2006, J NEUROSCI, V26, P9771, DOI 10.1523/JNEUROSCI.0716-06.2006; Guillot-Sestier MV, 2009, J BIOL CHEM, V284, P35973, DOI 10.1074/jbc.M109.051086; Hornemann S, 2009, FEBS J, V276, P2359, DOI 10.1111/j.1742-4658.2009.06968.x; Ishida C, 2005, J NEUROL NEUROSUR PS, V76, P325, DOI 10.1136/jnnp.2003.035154; Jaegle M, 2003, GENE DEV, V17, P1380, DOI 10.1101/gad.258203; Kasof GM, 2001, J BIOL CHEM, V276, P3238, DOI 10.1074/jbc.M003670200; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kou I, 2013, NAT GENET, V45, P676, DOI 10.1038/ng.2639; Kuwahara C, 1999, NATURE, V400, P225, DOI 10.1038/22241; Liebscher I, 2014, CELL REP, V9, P2018, DOI 10.1016/j.celrep.2014.11.036; Lyons DA, 2005, CURR BIOL, V15, P513, DOI 10.1016/j.cub.2005.02.030; Lysek DA, 2004, BIOCHEMISTRY-US, V43, P10393, DOI 10.1021/bi0494828; Mogha A, 2013, J NEUROSCI, V33, P17976, DOI 10.1523/JNEUROSCI.1809-13.2013; Monk KR, 2009, SCIENCE, V325, P1402, DOI 10.1126/science.1173474; Nuvolone M, 2016, J EXP MED, V213, P313, DOI 10.1084/jem.20151610; Paavola KJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005347; Petersen SC, 2015, NEURON, V85, P755, DOI 10.1016/j.neuron.2014.12.057; Pogoda HM, 2006, DEV BIOL, V298, P118, DOI 10.1016/j.ydbio.2006.06.021; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Radovanovic I, 2005, J NEUROSCI, V25, P4879, DOI 10.1523/JNEUROSCI.0328-05.2005; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schulz JB, 1996, J NEUROSCI, V16, P4696; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	29	129	129	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					464	+		10.1038/nature19312	http://dx.doi.org/10.1038/nature19312			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27501152	Green Published, Green Accepted			2022-12-28	WOS:000382646600043
J	Yao, RF; Ming, ZH; Yan, LM; Li, SH; Wang, F; Ma, S; Yu, CT; Yang, M; Chen, L; Chen, LH; Li, YW; Yan, C; Miao, D; Sun, ZY; Yan, JB; Sun, YN; Wang, L; Chu, JF; Fan, SL; He, W; Deng, HT; Nan, FJ; Li, JY; Rao, ZH; Lou, ZY; Xie, DX				Yao, Ruifeng; Ming, Zhenhua; Yan, Liming; Li, Suhua; Wang, Fei; Ma, Sui; Yu, Caiting; Yang, Mai; Chen, Li; Chen, Linhai; Li, Yuwen; Yan, Chun; Miao, Di; Sun, Zhongyuan; Yan, Jianbin; Sun, Yuna; Wang, Lei; Chu, Jinfang; Fan, Shilong; He, Wei; Deng, Haiteng; Nan, Fajun; Li, Jiayang; Rao, Zihe; Lou, Zhiyong; Xie, Daoxin			DWARF14 is a non-canonical hormone receptor for strigolactone	NATURE			English	Article							ARABIDOPSIS-THALIANA; STRUCTURAL BASIS; PERCEPTION; RICE; DEGRADATION; INHIBITION; KARRIKIN; RECOGNITION; MECHANISM; REPRESSOR	Classical hormone receptors reversibly and non-covalently bind active hormone molecules, which are generated by biosynthetic enzymes, to trigger signal transduction. The alpha/beta hydrolase DWARF14 (D14), which hydrolyses the plant branching hormone strigolactone and interacts with the F-box protein D3/MAX2, is probably involved in strigolactone detection(1-3). However, the active form of strigolactone has yet to be identified and it is unclear which protein directly binds the active form of strigolactone, and in which manner, to act as the genuine strigolactone receptor. Here we report the crystal structure of the strigolactone-induced AtD14-D3-ASK1 complex, reveal that Arabidopsis thaliana (At) D14 undergoes an open-to-closed state transition to trigger strigolactone signalling, and demonstrate that strigolactone is hydrolysed into a covalently linked intermediate molecule (CLIM) to initiate a conformational change of AtD14 to facilitate interaction with D3. Notably, analyses of a highly branched Arabidopsis mutant d14-5 show that the AtD14(G158E) mutant maintains enzyme activity to hydrolyse strigolactone, but fails to efficiently interact with D3/MAX2 and loses the ability to act as a receptor that triggers strigolactone signalling in planta. These findings uncover a mechanism underlying the allosteric activation of AtD14 by strigolactone hydrolysis into CLIM, and define AtD14 as a non-canonical hormone receptor with dual functions to generate and sense the active form of strigolactone.	[Yao, Ruifeng; Li, Suhua; Wang, Fei; Ma, Sui; Yu, Caiting; Yang, Mai; Chen, Li; Li, Yuwen; Yan, Chun; Miao, Di; Sun, Zhongyuan; Yan, Jianbin; Fan, Shilong; Deng, Haiteng; Xie, Daoxin] Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China; [Yao, Ruifeng; Li, Suhua; Wang, Fei; Ma, Sui; Yu, Caiting; Yang, Mai; Chen, Li; Li, Yuwen; Yan, Chun; Miao, Di; Sun, Zhongyuan; Yan, Jianbin; Fan, Shilong; Deng, Haiteng; Xie, Daoxin] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China; [Ming, Zhenhua; Yan, Liming; Rao, Zihe; Lou, Zhiyong] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Ming, Zhenhua; Yan, Liming; Rao, Zihe; Lou, Zhiyong] Tsinghua Univ, Collaborat Innovat Ctr Biotherapy, Beijing 100084, Peoples R China; [Chen, Linhai; Nan, Fajun] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China; [Sun, Yuna; Rao, Zihe] Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China; [Wang, Lei; Chu, Jinfang; Li, Jiayang] Chinese Acad Sci, State Key Lab Plant Genom, Beijing 100101, Peoples R China; [Wang, Lei; Chu, Jinfang; Li, Jiayang] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res Beijing, Beijing 100101, Peoples R China; [He, Wei] Tsinghua Univ, Sch Pharmaceut Sci, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Tsinghua University	Xie, DX (corresponding author), Tsinghua Univ, Tsinghua Peking Joint Ctr Life Sci, Beijing 100084, Peoples R China.; Xie, DX (corresponding author), Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.; Rao, ZH; Lou, ZY (corresponding author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.; Rao, ZH; Lou, ZY (corresponding author), Tsinghua Univ, Collaborat Innovat Ctr Biotherapy, Beijing 100084, Peoples R China.; Rao, ZH (corresponding author), Chinese Acad Sci, Inst Biophys, Beijing 100101, Peoples R China.	raozh@mail.tsinghua.edu.cn; louzy@mail.tsinghua.edu.cn; daoxinlab@mail.tsinghua.edu.cn	Chen, Linhai/AAW-9332-2020; Rao, Zihe/HCH-6944-2022; Yan, JianBin/AAE-3494-2022; Yan, Jianbin/GLT-7566-2022; Yan, Liming/AAE-6898-2019; li, yuwen/HGU-6435-2022; xie, daoxin d/C-8646-2017; Yao, Ruifeng/C-9177-2017; Li, Jiayang/AAG-4377-2020; Li, yu/HHZ-5236-2022; Chen, Linhai/S-8485-2016	Yan, Jianbin/0000-0001-7934-8808; Yao, Ruifeng/0000-0002-0367-6423; Chen, Linhai/0000-0002-7152-3533; CHEN, LI/0000-0002-1108-7645; Fan, Shilong/0000-0001-9272-2438; Deng, Haiteng/0000-0001-9496-1280; yan, li ming/0000-0003-0648-9604; Li, Suhua/0000-0001-6825-6203	National Natural Science Foundation of China [91417302, 81322023, 31421001, 91335204]; Ministry of Science and Technology [2013CB911100, 2016YFA0500500]; Ministry of Agriculture [2014ZX08011006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi)	We thank the staff (J. He, Q. Wang and F. Yu) at the Shanghai Synchrotron Radiation Facility (SSRF) beamline BL17U and the staff at Tsukuba Photon Factory beamline NE3A for help with data collection. We also thank G. Liu (School of Pharmaceutical Sciences), Z. Yin and H. Fu (Department of Chemistry) at Tsinghua University, B. Xia and P. Ding (School of Life Sciences), T. Luo (College of Chemistry and Molecular Engineering) at Peking University for valuable suggestions on chemistry analysis; Y. Ding, W. Wang and Y. Tian (Drug Facility, School of Pharmaceutical Sciences) at Tsinghua University for help with D-OH quantitation. This work was supported by the National Natural Science Foundation of China (Grant no. 91417302, 81322023, 31421001 and 91335204), the Ministry of Science and Technology (grant number 2013CB911100 and 2016YFA0500500), and the Ministry of Agriculture (grant number 2014ZX08011006).	Akiyama K, 2005, NATURE, V435, P824, DOI 10.1038/nature03608; Arite T, 2009, PLANT CELL PHYSIOL, V50, P1416, DOI 10.1093/pcp/pcp091; Chevalier F, 2014, PLANT CELL, V26, P1134, DOI 10.1105/tpc.114.122903; Conn CE, 2015, SCIENCE, V349, P540, DOI 10.1126/science.aab1140; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Hothorn M, 2011, NAT CHEM BIOL, V7, P766, DOI 10.1038/nchembio.667; Hothorn M, 2011, NATURE, V474, P467, DOI 10.1038/nature10153; Ishikawa S, 2005, PLANT CELL PHYSIOL, V46, P79, DOI 10.1093/pcp/pci022; Jiang L, 2013, NATURE, V504, P401, DOI 10.1038/nature12870; Johnson X, 2006, PLANT PHYSIOL, V142, P1014, DOI 10.1104/pp.106.087676; Kagiyama M, 2013, GENES CELLS, V18, P147, DOI 10.1111/gtc.12025; Kretzschmar T, 2012, NATURE, V483, P341, DOI 10.1038/nature10873; Murase K, 2008, NATURE, V456, P459, DOI 10.1038/nature07519; Nakamura H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3613; Nelson DC, 2011, P NATL ACAD SCI USA, V108, P8897, DOI 10.1073/pnas.1100987108; Norman A.W., 2014, HORMONES; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Stirnberg P, 2002, DEVELOPMENT, V129, P1131; Tan X, 2007, NATURE, V446, P640, DOI 10.1038/nature05731; Toh S, 2015, SCIENCE, V350, P203, DOI 10.1126/science.aac9476; Tsuchiya Y, 2015, SCIENCE, V349, P864, DOI 10.1126/science.aab3831; Umehara M, 2008, NATURE, V455, P195, DOI 10.1038/nature07272; Umehara M, 2015, PLANT CELL PHYSIOL, V56, P1059, DOI 10.1093/pcp/pcv028; Wang L, 2015, PLANT CELL, V27, P3128, DOI 10.1105/tpc.15.00605; Waters MT, 2012, DEVELOPMENT, V139, P1285, DOI 10.1242/dev.074567; Zhao LH, 2015, CELL RES, V25, P1219, DOI 10.1038/cr.2015.122; Zhao LH, 2013, CELL RES, V23, P436, DOI 10.1038/cr.2013.19; Zhou F, 2013, NATURE, V504, P406, DOI 10.1038/nature12878	30	277	301	32	356	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					469	+		10.1038/nature19073	http://dx.doi.org/10.1038/nature19073			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0YL	27479325				2022-12-28	WOS:000382646600044
J	Fleischman, W; Agrawal, S; King, M; Venkatesh, AK; Krumholz, HM; McKee, D; Brown, D; Ross, JS				Fleischman, William; Agrawal, Shantanu; King, Marissa; Venkatesh, Arjun K.; Krumholz, Harlan M.; McKee, Douglas; Brown, Douglas; Ross, Joseph S.			Association between payments from manufacturers of pharmaceuticals to physicians and regional prescribing: cross sectional ecological study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INDUSTRY PAYMENTS; RADIATION ONCOLOGISTS; DRUG COMPANIES; POPULATION; DISCLOSURE; MEDICARE; INSIGHTS; TIES	OBJECTIVE To examine the association between payments made by the manufacturers of pharmaceuticals to physicians and prescribing by physicians within hospital referral regions. DESIGN Cross sectional analysis of 2013 and 2014 Open Payments and Medicare Part D prescribing data for two classes of commonly prescribed, commonly marketed drugs: oral anticoagulants and non-insulin diabetes drugs, overall and stratified by physician and payment type. Setting 306 hospital referral regions, United States. Participants 45 949 454 Medicare Part D prescriptions written by 623 886 physicians to 10 513 173 patients for two drug classes: oral anticoagulants and non-insulin diabetes drugs. Main outcome measures Proportion, or market share, of marketed oral anticoagulants and non-insulin diabetes drugs prescribed by physicians among all drugs in each class and within hospital referral regions. Results Among 306 hospital referral regions, there were 977 407 payments to physicians totaling $61 026 140 (46 pound 174 600; (sic)54 632 500) related to oral anticoagulants, and 1 787 884 payments totaling $108 417 616 related to non-insulin diabetes drugs. The median market share of the hospital referral regions was 21.6% for marketed oral anticoagulants and 12.6% for marketed non-insulin diabetes drugs. Among hospital referral regions, one additional payment (median value $13, interquartile range, $10-$18) was associated with 94 (95% confidence interval 76 to 112) additional days filled of marketed oral anticoagulants and 107 (89 to 125) additional days filled of marketed non-insulin diabetes drugs (P<0.001). Payments to specialists were associated with greater prescribing of marketed drugs than payments to non-specialists (212 v 100 additional days filled per payment of marketed oral anticoagulants, 331 v 114 for marketed non-insulin diabetes drugs, P<0.001). Payments for speaker and consulting fees for non-insulin diabetes drugs were associated with greater prescribing of marketed drugs than payments for food and beverages or educational materials (484 v 110, P<0.001). Conclusions and study limitations Payments by the manufacturers of pharmaceuticals to physicians were associated with greater regional prescribing of marketed drugs among Medicare Part D beneficiaries. Payments to specialists and payments for speaker and consulting fees were predominantly associated with greater regional prescribing of marketed drugs than payments to non-specialists or payments for food and beverages, gifts, or educational materials. As a cross sectional, ecological study, we cannot prove causation between payments to physicians and increased prescribing. Furthermore, our findings should be interpreted only at the regional level. Our study is limited to prescribing by physicians and the two drug classes studied.	[Fleischman, William] Yale Sch Med, Robert Wood Johnson Fdn, Clin Scholars Program, SHM IE61, New Haven, CT 06510 USA; [Agrawal, Shantanu; Brown, Douglas] US Dept HHS, Ctr Medicare & Medicaid Serv, Washington, DC USA; [King, Marissa] Yale Sch Management, New Haven, CT USA; [Venkatesh, Arjun K.] Yale Sch Med, Dept Emergency Med, SHM IE61, New Haven, CT 06510 USA; [Krumholz, Harlan M.] Yale Sch Med, Sect Cardiovasc Med, Dept Med, SHM IE61, New Haven, CT 06510 USA; [McKee, Douglas] Yale Univ, Dept Econ, New Haven, CT 06520 USA; [Ross, Joseph S.] Yale Sch Med, Dept Med, Sect Gen Internal Med, SHM IE61, New Haven, CT USA	Robert Wood Johnson Foundation (RWJF); Yale University; Centers for Medicare & Medicaid Services; Yale University; Yale University; Yale University; Yale University; Yale University	Fleischman, W (corresponding author), Yale Sch Med, Robert Wood Johnson Fdn, Clin Scholars Program, SHM IE61, New Haven, CT 06510 USA.	WFleischmanwf3@buffalo.edu	Fleischman, William/Q-8686-2019; , Harlan/AAI-2875-2020	Ross, Joseph/0000-0002-9218-3320	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001862, UL1TR001863] Funding Source: NIH RePORTER	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Ahmed R, 2016, AM J TRANSPLANT, V16, P292, DOI 10.1111/ajt.13427; [Anonymous], 2014, 2014 PHYSICIAN SPECI; Austad KE, 2013, J GEN INTERN MED, V28, P1064, DOI 10.1007/s11606-013-2361-0; Bowman M A, 1988, J Contin Educ Health Prof, V8, P13, DOI 10.1002/chp.4750080104; Campbell D, 2015, READY OR NOT FULL SP; Campbell EG, 2007, NEW ENGL J MED, V357, P1796, DOI 10.1056/NEJMp078141; Centers for Medicare & Medicaid Services, MONTHLY CONTRACT AND; Centers for Medicare & Medicaid Services, OPEN PAYMENTS DATA S; Chang JS, 2015, OPHTHALMOLOGY, V122, P656, DOI 10.1016/j.ophtha.2014.11.003; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; Cvetanovich GL, 2015, J BONE JOINT SURG AM, V97A, P1288, DOI 10.2106/JBJS.N.01093; Dailey G, 2001, CLIN THER, V23, P1311, DOI 10.1016/S0149-2918(01)80110-7; Donohue JM, 2012, NEW ENGL J MED, V366, P530, DOI 10.1056/NEJMsa1104816; Fleischman W, 2016, ANN EMERG MED, V68, P153, DOI 10.1016/j.annemergmed.2016.01.014; Halperin EC, 2004, INT J RADIAT ONCOL, V59, P1477, DOI 10.1016/j.ijrobp.2004.01.052; Hoadley J, 2014, MEDICARE PART D IN I; Huskamp HA, 2003, NEW ENGL J MED, V349, P2224, DOI 10.1056/NEJMsa030954; Jairam V, 2016, INT J RADIAT ONCOL, V94, P19, DOI 10.1016/j.ijrobp.2015.09.004; Kassirer JP, 2000, JAMA-J AM MED ASSOC, V284, P2156, DOI 10.1001/jama.284.17.2156; King M, 2013, HEALTH PLACE, V20, P32, DOI 10.1016/j.healthplace.2012.11.007; Marshall DC, 2016, MAYO CLIN PROC, V91, P84, DOI 10.1016/j.mayocp.2015.10.016; Moynihan R, 2008, BRIT MED J, V336, P1402, DOI 10.1136/bmj.39575.675787.651; Narayanan S, 2005, J MARKETING RES, V42, P278, DOI 10.1509/jmkr.2005.42.3.278; National Center for Health Statistics (US), 2014, HLTH US; ORLOWSKI JP, 1992, CHEST, V102, P270, DOI 10.1378/chest.102.1.270; Ornstein C, 2015, VYING FOR MARKET SHA; Ornstein C, 2014, AS FULL DISCLOSURE N; Rathi VK, 2015, OTOLARYNG HEAD NECK, V152, P993, DOI 10.1177/0194599815573718; Robinson WS, 2011, INT J EPIDEMIOL, V40, P1134, DOI [10.1093/ije/dyn357, 10.1093/ije/dyr082]; Ross JS, 2007, JAMA-J AM MED ASSOC, V297, P1216, DOI 10.1001/jama.297.11.1216; Spurling GK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000352; Steensma DP, 2015, J CLIN ONCOL, V33, P3213, DOI 10.1200/JCO.2015.63.1275; Steinman MA, 2001, AM J MED, V110, P551, DOI 10.1016/S0002-9343(01)00660-X; WAUD DR, 1992, NEW ENGL J MED, V327, P351, DOI 10.1056/NEJM199207303270511; Wazana A, 2000, JAMA-J AM MED ASSOC, V283, P373, DOI 10.1001/jama.283.3.373; Yeh JS, 2016, JAMA INTERN MED, V176, P763, DOI 10.1001/jamainternmed.2016.1709	36	63	63	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 18	2016	354								i4189	10.1136/bmj.i4189	http://dx.doi.org/10.1136/bmj.i4189			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9HB	27540015	Green Published, hybrid			2022-12-28	WOS:000381806600002
J	Hamilton, C				Hamilton, Clive			Define the Anthropocene in terms of the whole Earth	NATURE			English	Editorial Material									[Hamilton, Clive] Charles Sturt Univ, Publ Eth, Canberra, ACT, Australia	Charles Sturt University	Hamilton, C (corresponding author), Charles Sturt Univ, Publ Eth, Canberra, ACT, Australia.	mail@clivehamilton.com						Steffen W, 2011, PHILOS T R SOC A, V369, P842, DOI 10.1098/rsta.2010.0327	1	22	23	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					251	251		10.1038/536251a	http://dx.doi.org/10.1038/536251a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27535500	Bronze			2022-12-28	WOS:000381804900003
J	Eagle, KA; Weinberg, RL				Eagle, Kim A.; Weinberg, Richard L.			In severe aortic stenosis, TAVR was noninferior to conventional surgery for death or disabling stroke at 2 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							VALVE-REPLACEMENT; TRANSCATHETER		[Eagle, Kim A.; Weinberg, Richard L.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Eagle, KA (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.			Weinberg, Richard/0000-0001-8563-1554				Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; Mack MJ, 2015, LANCET, V385, P2477, DOI 10.1016/S0140-6736(15)60308-7; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510	3	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					JC21	JC21		10.7326/ACPJC-2016-165-4-021	http://dx.doi.org/10.7326/ACPJC-2016-165-4-021			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UI	27538182				2022-12-28	WOS:000381267200008
J	Hawkes, N				Hawkes, Nigel			German body calls for pause in European plan for fast track drug approval	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		European Medicines Agency, 2016, FIN REP AD PATHW PIL; Hawkes N, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3060	2	6	6	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2016	354								i4479	10.1136/bmj.i4479	http://dx.doi.org/10.1136/bmj.i4479			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GX	27530526				2022-12-28	WOS:000381806200008
J	Shekelle, P				Shekelle, Paul			In adults = 75 years of age with hypertension, intensive vs standard BP-lowering treatment reduced CV events	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Greater Los Angeles VA Healthcare Syst, Los Angeles, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Shekelle, P (corresponding author), Greater Los Angeles VA Healthcare Syst, Los Angeles, CA USA.								0	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					JC14	JC14		10.7326/ACPJC-2016-165-4-014	http://dx.doi.org/10.7326/ACPJC-2016-165-4-014			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UI	27538175				2022-12-28	WOS:000381267200032
J	Kramer, NJ; Carlomagno, Y; Zhang, YJ; Almeida, S; Cook, CN; Gendron, TF; Prudencio, M; Van Blitterswijk, M; Belzil, V; Couthouis, J; Paul, JW; Goodman, LD; Daughrity, L; Chew, J; Garrett, A; Pregent, L; Jansen-West, K; Tabassian, LJ; Rademakers, R; Boylan, K; Graff-Radford, NR; Josephs, KA; Parisi, JE; Knopman, DS; Petersen, RC; Boeve, BF; Deng, N; Feng, Y; Cheng, TH; Dickson, DW; Cohen, SN; Bonini, NM; Link, CD; Gao, FB; Petrucelli, L; Gitler, AD				Kramer, Nicholas J.; Carlomagno, Yari; Zhang, Yong-Jie; Almeida, Sandra; Cook, Casey N.; Gendron, Tania F.; Prudencio, Mercedes; Van Blitterswijk, Marka; Belzil, Veronique; Couthouis, Julien; Paul, Joseph West, III; Goodman, Lindsey D.; Daughrity, Lillian; Chew, Jeannie; Garrett, Aliesha; Pregent, Luc; Jansen-West, Karen; Tabassian, Lilia J.; Rademakers, Rosa; Boylan, Kevin; Graff-Radford, Neill R.; Josephs, Keith A.; Parisi, Joseph E.; Knopman, David S.; Petersen, Ronald C.; Boeve, Bradley F.; Deng, Ning; Feng, Yanan; Cheng, Tzu-Hao; Dickson, Dennis W.; Cohen, Stanley N.; Bonini, Nancy M.; Link, Christopher D.; Gao, Fen-Biao; Petrucelli, Leonard; Gitler, Aaron D.			Spt4 selectively regulates the expression of C9orf72 sense and antisense mutant transcripts	SCIENCE			English	Article							DIPEPTIDE-REPEAT PROTEINS; NUCLEAR-RNA FOCI; HEXANUCLEOTIDE REPEAT; FRONTOTEMPORAL DEMENTIA; GGGGCC REPEAT; EXPANSION; ALS; ELONGATION; TOXICITY; FTD	An expanded hexanucleotide repeat in C9orf72 causes amyotrophic lateral sclerosis and frontotemporal dementia (c9FTD/ALS). Therapeutics are being developed to target RNAs containing the expanded repeat sequence (GGGGCC); however, this approach is complicated by the presence of antisense strand transcription of expanded GGCCCC repeats. We found that targeting the transcription elongation factor Spt4 selectively decreased production of both sense and antisense expanded transcripts, as well as their translated dipeptide repeat (DPR) products, and also mitigated degeneration in animal models. Knockdown of SUPT4H1, the human Spt4 ortholog, similarly decreased production of sense and antisense RNA foci, as well as DPR proteins, in patient cells. Therapeutic targeting of a single factor to eliminate c9FTD/ALS pathological features offers advantages over approaches that require targeting sense and antisense repeats separately.	[Kramer, Nicholas J.; Couthouis, Julien; Paul, Joseph West, III; Deng, Ning; Feng, Yanan; Cohen, Stanley N.; Gitler, Aaron D.] Stanford Univ, Sch Med, Dept Geriatr, Stanford, CA 94305 USA; [Kramer, Nicholas J.] Stanford Univ, Sch Med, Neurosci Grad Program, Stanford, CA USA; [Carlomagno, Yari; Zhang, Yong-Jie; Cook, Casey N.; Gendron, Tania F.; Prudencio, Mercedes; Van Blitterswijk, Marka; Belzil, Veronique; Daughrity, Lillian; Chew, Jeannie; Garrett, Aliesha; Pregent, Luc; Jansen-West, Karen; Tabassian, Lilia J.; Rademakers, Rosa; Dickson, Dennis W.; Petrucelli, Leonard] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Almeida, Sandra; Gao, Fen-Biao] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA; [Goodman, Lindsey D.] Univ Penn, Dept Biol, Philadelphia, PA USA; [Goodman, Lindsey D.] Univ Penn, Neurosci Grad Program, Philadelphia, PA USA; [Boylan, Kevin; Graff-Radford, Neill R.; Petersen, Ronald C.; Boeve, Bradley F.] Mayo Clin, Dept Neurol, Jacksonville, FL USA; [Josephs, Keith A.; Parisi, Joseph E.; Knopman, David S.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Cheng, Tzu-Hao] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei, Taiwan; [Link, Christopher D.] Univ Colorado, Dept Integrat Physiol, Boulder, CO USA	Stanford University; Stanford University; Mayo Clinic; University of Massachusetts System; University of Massachusetts Worcester; University of Pennsylvania; University of Pennsylvania; Mayo Clinic; Mayo Clinic; National Yang Ming Chiao Tung University; University of Colorado System; University of Colorado Boulder	Gitler, AD (corresponding author), Stanford Univ, Sch Med, Dept Geriatr, Stanford, CA 94305 USA.; Petrucelli, L (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	petrucelli.leonard@mayo.edu; agitler@stanford.edu	van Blitterswijk, Marka/AAL-4126-2021; COUTHOUIS, Julien/G-3895-2012; van Blitterswijk, Marka/H-7274-2012	van Blitterswijk, Marka/0000-0002-3054-7053; COUTHOUIS, Julien/0000-0002-2378-4595; van Blitterswijk, Marka/0000-0002-3054-7053; Prudencio, Mercedes/0000-0002-4894-4858; Goodman, Lindsey/0000-0002-9255-3811; O'Raw, Aliesha/0000-0002-6618-3036; DENG, NING/0000-0002-1321-5508; Gitler, Aaron/0000-0001-8603-1526	NIH [R01NS065317, R01NS09386501, R01NS073660, R01AG026251, R21NS079807, R21NS094489, R01NS063964, R01NS077402, R21NS084528, P01NS084974, R01NS088689, R01ES20395, R01NS085812, R01NS079725]; Mayo Clinic Foundation; Alzheimer's Association [NIRP-14-304425]; Amyotrophic Lateral Sclerosis Association; National Science Foundation Graduate Research Fellowship; Robert Packard Center for ALS Research at Johns Hopkins; Target ALS; Association for Frontotemporal Degeneration; Stanford University; Glenn Foundation; Hoffmann-La Roche, Inc.; Merck, Inc.; Genentech, Inc.; Biogen, Inc.; Eli Lilly Co.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020395] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS094489, R01NS088689, R01NS093865, P01NS084974, R35NS097263, R01NS063964, R01NS077402, R21NS079807, R01NS085812, R01NS079725, R01NS065317, R21NS084528, R01NS073660] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026251] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021580] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Foundation; Alzheimer's Association(Alzheimer's Association); Amyotrophic Lateral Sclerosis Association; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Robert Packard Center for ALS Research at Johns Hopkins; Target ALS; Association for Frontotemporal Degeneration; Stanford University(Stanford University); Glenn Foundation; Hoffmann-La Roche, Inc.(Hoffmann-La Roche); Merck, Inc.(Merck & Company); Genentech, Inc.(Roche HoldingGenentech); Biogen, Inc.(Biogen); Eli Lilly Co.(Eli Lilly); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Cerza and Y. Zu for technical support. This work was supported by NIH grants R01NS065317 (A.D.G.), R01NS09386501 (A.D.G., L.P.), R01NS073660 (A.D.G., N.M.B.), R01AG026251 (L.P.), R21NS079807 (Y.-J.Z.), R21NS094489 (C.N.C.), R01NS063964 (L.P.), R01NS077402 (L.P.), R21NS084528 (L.P.), P01NS084974 (L.P.), R01NS088689 (L.P.), R01ES20395 (L.P.), R01NS085812 (S.N.C. and T.-H.C.), R01NS079725 (F.-B.G.), Mayo Clinic Foundation (L.P.), Alzheimer's Association [NIRP-14-304425 (Y.-J.Z.)], Amyotrophic Lateral Sclerosis Association (Y.-J.Z, T.F.G., M.P., L.P., F.-B.G.), the National Science Foundation Graduate Research Fellowship (N.J.K.), the Robert Packard Center for ALS Research at Johns Hopkins (L.P., A.D.G., F.-B.G.), Target ALS (L.P., A.D.G., N.B., F.-B.G.), Association for Frontotemporal Degeneration (S.A.), Stanford University (S.N.C.), and the Glenn Foundation (A.D.G., N.M.B). The induced pluripotent stem cell (iPSC) lines are available from the Gao laboratory under a material transfer agreement with the University of Massachusetts Medical School. R.C.P. has paid consulting relationships with Hoffmann-La Roche, Inc.; Merck, Inc.; Genentech, Inc.; Biogen, Inc.; and Eli Lilly & Co. RNA sequencing data are deposited with the National Center for Biotechnology Information Gene Expression Omnibus (GSE83484).	Almeida S, 2013, ACTA NEUROPATHOL, V126, P385, DOI 10.1007/s00401-013-1149-y; Ash PEA, 2013, NEURON, V77, P639, DOI 10.1016/j.neuron.2013.02.004; Cheng HM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005043; Chew J, 2015, SCIENCE, V348, P1151, DOI 10.1126/science.aaa9344; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Freibaum BD, 2015, NATURE, V525, P129, DOI 10.1038/nature14974; Gendron TF, 2015, ACTA NEUROPATHOL, V130, P559, DOI 10.1007/s00401-015-1474-4; Gendron TF, 2014, ACTA NEUROPATHOL, V127, P359, DOI 10.1007/s00401-013-1237-z; Gendron TF, 2013, ACTA NEUROPATHOL, V126, P829, DOI 10.1007/s00401-013-1192-8; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Hirtreiter A, 2010, NUCLEIC ACIDS RES, V38, P4040, DOI 10.1093/nar/gkq135; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Lee YB, 2013, CELL REP, V5, P1178, DOI 10.1016/j.celrep.2013.10.049; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liu CR, 2012, CELL, V148, P690, DOI 10.1016/j.cell.2011.12.032; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mizielinska S, 2014, SCIENCE, V345, P1192, DOI 10.1126/science.1256800; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rondon AG, 2003, EMBO J, V22, P612, DOI 10.1093/emboj/cdg047; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Tran H, 2015, NEURON, V87, P1207, DOI 10.1016/j.neuron.2015.09.015; van Blitterswijk M, 2015, ACTA NEUROPATHOL, V130, P863, DOI 10.1007/s00401-015-1480-6; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Xue YC, 2013, CELL, V152, P82, DOI 10.1016/j.cell.2012.11.045; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110	27	92	95	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					708	712		10.1126/science.aaf7791	http://dx.doi.org/10.1126/science.aaf7791			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZC	27516603	Green Accepted			2022-12-28	WOS:000381561200043
J	Garcia-Caceres, C; Quarta, C; Varela, L; Gao, YQ; Gruber, T; Legutko, B; Jastroch, M; Johansson, P; Ninkovic, J; Yi, CX; Thuc, OL; Szigeti-Buck, K; Cai, WK; Meyer, CW; Pfluger, PT; Fernandez, AM; Luquet, S; Woods, SC; Torres-Aleman, I; Kahn, CR; Gotz, M; Horvath, TL; Tschop, MH				Garcia-Caceres, Cristina; Quarta, Carmelo; Varela, Luis; Gao, Yuanqing; Gruber, Tim; Legutko, Beata; Jastroch, Martin; Johansson, Pia; Ninkovic, Jovica; Yi, Chun-Xia; Thuc, Ophelia Le; Szigeti-Buck, Klara; Cai, Weikang; Meyer, Carola W.; Pfluger, Paul T.; Fernandez, Ana M.; Luquet, Serge; Woods, Stephen C.; Torres-Aleman, Ignacio; Kahn, C. Ronald; Goetz, Magdalena; Horvath, Tamas L.; Tschoep, Matthias H.			Astrocytic Insulin Signaling Couples Brain Glucose Uptake with Nutrient Availability	CELL			English	Article							BODY-WEIGHT; NEURONAL DYSFUNCTION; ALZHEIMERS-DISEASE; ENERGY-METABOLISM; BARRIER; LEPTIN; CELLS; TRANSPORTER; CIRCUITS; MICE	We report that astrocytic insulin signaling co-regulates hypothalamic glucose sensing and systemic glucose metabolism. Postnatal ablation of insulin receptors (IRs) in glial fibrillary acidic protein (GFAP)-expressing cells affects hypothalamic astrocyte morphology, mitochondrial function, and circuit connectivity. Accordingly, astrocytic IR ablation reduces glucose-induced activation of hypothalamic proopio-melanocortin (POMC) neurons and impairs physiological responses to changes in glucose availability. Hypothalamus-specific knockout of astrocytic IRs, as well as postnatal ablation by targeting glutamate aspartate transporter (GLAST)-expressing cells, replicates such alterations. A normal response to altering directly CNS glucose levels in mice lacking astrocytic IRs indicates a role in glucose transport across the blood-brain barrier (BBB). This was confirmed in vivo in GFAP-IR KO mice by using positron emission tomography and glucose monitoring in cerebral spinal fluid. We conclude that insulin signaling in hypothalamic astrocytes co-controls CNS glucose sensing and systemic glucose metabolism via regulation of glucose uptake across the BBB.	[Garcia-Caceres, Cristina; Quarta, Carmelo; Gao, Yuanqing; Gruber, Tim; Legutko, Beata; Jastroch, Martin; Yi, Chun-Xia; Thuc, Ophelia Le; Meyer, Carola W.; Pfluger, Paul T.; Tschoep, Matthias H.] Helmholtz Zentrum Munchen, Helmholtz Diabet Ctr HDC, D-85764 Neuherberg, Germany; [Garcia-Caceres, Cristina; Quarta, Carmelo; Gao, Yuanqing; Gruber, Tim; Legutko, Beata; Jastroch, Martin; Yi, Chun-Xia; Thuc, Ophelia Le; Meyer, Carola W.; Pfluger, Paul T.; Tschoep, Matthias H.] Helmholtz Zentrum Munchen, German Ctr Diabet Res DZD, D-85764 Neuherberg, Germany; [Garcia-Caceres, Cristina; Quarta, Carmelo; Gao, Yuanqing; Gruber, Tim; Legutko, Beata; Jastroch, Martin; Yi, Chun-Xia; Thuc, Ophelia Le; Meyer, Carola W.; Pfluger, Paul T.; Tschoep, Matthias H.] Tech Univ Munich, Div Metab Dis, D-80333 Munich, Germany; [Varela, Luis; Szigeti-Buck, Klara; Horvath, Tamas L.] Yale Univ, Sch Med, Comparat Med Sect, Program Integrat Cell Signaling & Neurobiol Metab, New Haven, CT 06520 USA; [Johansson, Pia; Ninkovic, Jovica; Goetz, Magdalena] Helmholtz Zentrum Munchen, Inst Stem Cell Res Ctr, D-85764 Neuherberg, Germany; [Johansson, Pia; Ninkovic, Jovica; Goetz, Magdalena] Ludwigs Maximilians Univ, Biomed Ctr, Physiol Genom, D-80336 Munich, Germany; [Johansson, Pia; Ninkovic, Jovica; Goetz, Magdalena] Ludwigs Maximilians Univ, Biomed Ctr, 7SYNERGY, Excellence Cluster Syst Neurol, D-80336 Munich, Germany; [Cai, Weikang; Kahn, C. Ronald] Brigham & Womens Hosp, Joslin Diabet Ctr, Sect Integrat Physiol & Metab, Boston, MA 02115 USA; [Cai, Weikang; Kahn, C. Ronald] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Cai, Weikang; Kahn, C. Ronald] Harvard Med Sch, Boston, MA 02115 USA; [Fernandez, Ana M.; Torres-Aleman, Ignacio] CSIC, Inst Cajal, E-28002 Madrid, Spain; [Luquet, Serge] Univ Paris Diderot, Sorbonne Paris Cite, Unite Biol Fonct & Adaptat, CNRS UMR 8251, F-75205 Paris, France; [Woods, Stephen C.] Univ Cincinnati, Dept Psychiat & Behav Neurosci, 2170 Galbraith Ave, Cincinnati, OH 45237 USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Yale University; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Munich; Harvard University; Brigham & Women's Hospital; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Cajal (IC); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; University System of Ohio; University of Cincinnati	Tschop, MH (corresponding author), Helmholtz Zentrum Munchen, Helmholtz Diabet Ctr HDC, D-85764 Neuherberg, Germany.; Tschop, MH (corresponding author), Helmholtz Zentrum Munchen, German Ctr Diabet Res DZD, D-85764 Neuherberg, Germany.; Tschop, MH (corresponding author), Tech Univ Munich, Div Metab Dis, D-80333 Munich, Germany.	tschoep@helmholtz-muenchen.de	Ninkovic, Jovica/AAH-5220-2019; Yi, Chun-Xia/J-4068-2016; Varela, Luis/ABG-7581-2020; Quarta, Carmelo/AAC-1629-2020; Pfluger, Paul T/A-3770-2019; Torres-Aleman, Ignacio/A-1613-2008; García-Cáceres, Cristina/O-6601-2016; Kahn, Ronald/AAY-2435-2021; Jastroch, Martin/I-7494-2017; Cai, Weikang/K-2394-2019; Luquet, serge/AAT-1809-2021	Ninkovic, Jovica/0000-0002-4381-0041; Yi, Chun-Xia/0000-0003-1184-4615; Varela, Luis/0000-0001-7794-7241; Pfluger, Paul T/0000-0002-8118-7588; Torres-Aleman, Ignacio/0000-0001-8107-7947; García-Cáceres, Cristina/0000-0001-6376-9448; Kahn, Ronald/0000-0002-7583-9228; Luquet, serge/0000-0001-8668-6645; Quarta, Carmelo/0000-0002-1352-4239; Cai, Weikang/0000-0001-5638-0805; Le Thuc, Ophelia/0000-0001-8154-9916; Fernandez, Ana M./0000-0001-5160-3854	Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases; Humboldt Foundation; Initiative and Networking Fund of the Helmholtz Association; Deutsches Zentrum fur DiabetesForschung (DZD); Institute of Advanced Studies of Technische Universitat Munchen (IAS-TUM Hans-Fischer); DFG [SFB 1123, SFB 870, SFB 1757]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836, R01DK031036, R01DK033201] Funding Source: NIH RePORTER	Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases; Humboldt Foundation(Alexander von Humboldt Foundation); Initiative and Networking Fund of the Helmholtz Association; Deutsches Zentrum fur DiabetesForschung (DZD); Institute of Advanced Studies of Technische Universitat Munchen (IAS-TUM Hans-Fischer); DFG(German Research Foundation (DFG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Heicko Lickert and Silke Morin for helpful discussion and support and Lewis Norris, Clarita Mergen, Veronica Casquero Garcia, Olavi Jarvinen, and Nicole Wiegert for excellent technical assistance. This work was funded, in part, by the Helmholtz Alliance ICEMED - Imaging and Curing Environmental Metabolic Diseases, the Humboldt Foundation (to M.H.T.), through the Initiative and Networking Fund of the Helmholtz Association and Deutsches Zentrum fur DiabetesForschung (DZD). This work also received funding from the Institute of Advanced Studies of Technische Universitat Munchen (IAS-TUM Hans-Fischer Senior Fellowship to T.L.H.) and from DFG funding (SFB 1123 to M.H.T; SFB 870 and SPP 1757 to M.G.).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Alvarez JI, 2013, GLIA, V61, P1939, DOI 10.1002/glia.22575; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Baltzer C, 2010, MITOCHONDRION, V10, P589, DOI 10.1016/j.mito.2010.07.009; Barros LF, 2007, GLIA, V55, P1222, DOI 10.1002/glia.20375; Brown AM, 2007, GLIA, V55, P1263, DOI 10.1002/glia.20557; Bruning JC, 2000, SCIENCE, V289, P2122, DOI 10.1126/science.289.5487.2122; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Cranston I, 1998, J CEREBR BLOOD F MET, V18, P130, DOI 10.1097/00004647-199802000-00002; De Felice FG, 2014, DIABETES, V63, P2262, DOI 10.2337/db13-1954; Dietrich MO, 2013, CELL, V155, P188, DOI 10.1016/j.cell.2013.09.004; Ferreira ST, 2014, ALZHEIMERS DEMENT, V10, pS76, DOI 10.1016/j.jalz.2013.12.010; FRANK HJL, 1986, DIABETES, V35, P654, DOI 10.2337/diabetes.35.6.654; Fuente-Martin E, 2012, J CLIN INVEST, V122, P3900, DOI 10.1172/JCI64102; Ganat YM, 2006, J NEUROSCI, V26, P8609, DOI 10.1523/JNEUROSCI.2532-06.2006; Garcia-Caceres C, 2012, MOL METAB, V1, P37, DOI 10.1016/j.molmet.2012.07.001; Goldman S, 2003, TRENDS NEUROSCI, V26, P590, DOI 10.1016/j.tins.2003.09.011; Hasselbalch SG, 1999, DIABETES, V48, P1915, DOI 10.2337/diabetes.48.10.1915; HAVRANKOVA J, 1978, NATURE, V272, P827, DOI 10.1038/272827a0; Kim JG, 2014, NAT NEUROSCI, V17, P908, DOI 10.1038/nn.3725; Kleinridders A, 2014, DIABETES, V63, P2232, DOI 10.2337/db14-0568; Klepper J, 2002, EUR J PEDIATR, V161, P295, DOI 10.1007/s00431-002-0939-3; Koch L, 2008, J CLIN INVEST, V118, P2132, DOI 10.1172/JCI31073; Magistretti PJ, 1999, PHILOS T R SOC B, V354, P1155, DOI 10.1098/rstb.1999.0471; Mandl J, 2009, TRENDS ENDOCRIN MET, V20, P194, DOI 10.1016/j.tem.2009.01.003; McMinn JE, 2005, AM J PHYSIOL-ENDOC M, V289, pE403, DOI 10.1152/ajpendo.00535.2004; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Nedergaard M, 2003, TRENDS NEUROSCI, V26, P523, DOI 10.1016/j.tins.2003.08.008; Nolte C, 2001, GLIA, V33, P72; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Schneeberger M, 2013, CELL, V155, P172, DOI 10.1016/j.cell.2013.09.003; Simpson IA, 2001, J BIOL CHEM, V276, P12725, DOI 10.1074/jbc.M010897200; Simpson IA, 1999, J NEUROCHEM, V72, P238, DOI 10.1046/j.1471-4159.1999.0720238.x; SMITH GP, 1969, AM J PHYSIOL, V217, P1083, DOI 10.1152/ajplegacy.1969.217.4.1083; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; TORANALLERAND CD, 1991, BRAIN RES, V558, P296; Tubbs E, 2014, DIABETES, V63, P3279, DOI 10.2337/db13-1751; Winkler EA, 2015, NAT NEUROSCI, V18, P521, DOI 10.1038/nn.3966; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Zeltser LM, 2012, NAT NEUROSCI, V15, P1336, DOI 10.1038/nn.3219	40	269	272	2	65	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					867	880		10.1016/j.cell.2016.07.028	http://dx.doi.org/10.1016/j.cell.2016.07.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27518562	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000382258700011
J	Rimmer, A				Rimmer, Abi			Avoiding unconscious bias	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												arimmer@bmj.com						Royal College of Surgeons, 2016, AV UNC BIAS GUID SUR	1	0	0	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 10	2016	354								i4366	10.1136/bmj.i4366	http://dx.doi.org/10.1136/bmj.i4366			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4TW	27511864				2022-12-28	WOS:000381475000006
J	Frankl, FEK				Frankl, Fiona E. Karet			The importance of being rare	LANCET			English	Editorial Material							ALKALOSIS		[Frankl, Fiona E. Karet] Cambridge Inst Med Res, Cambridge Biomed Campus,Box 139, Cambridge CB2 OXY, England		Frankl, FEK (corresponding author), Cambridge Inst Med Res, Cambridge Biomed Campus,Box 139, Cambridge CB2 OXY, England.	fek1000@cam.ac.uk		Karet, Fiona/0000-0002-2457-2869				Karet Frankl FE, 2016, UK NATL RENAL RES ST; Luke RG, 2012, J AM SOC NEPHROL, V23, P204, DOI 10.1681/ASN.2011070720; Plumb LA, 2016, LANCET, V388, P631, DOI 10.1016/S0140-6736(16)00087-8; Taylor CM, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e2417; Webster NR, 1999, CRIT REV CL LAB SCI, V36, P497, DOI 10.1080/10408369991239286	5	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2016	388	10044					632	632		10.1016/S0140-6736(16)30667-5	http://dx.doi.org/10.1016/S0140-6736(16)30667-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS4NA	27511788				2022-12-28	WOS:000380756600037
J	Asadi, M; Kim, K; Liu, C; Addepalli, AV; Abbasi, P; Yasaei, P; Phillips, P; Behranginia, A; Cerrato, JM; Haasch, R; Zapol, P; Kumar, B; Klie, RF; Abiade, J; Curtiss, LA; Salehi-Khojin, A				Asadi, Mohammad; Kim, Kibum; Liu, Cong; Addepalli, Aditya Venkata; Abbasi, Pedram; Yasaei, Poya; Phillips, Patrick; Behranginia, Amirhossein; Cerrato, Jose M.; Haasch, Richard; Zapol, Peter; Kumar, Bijandra; Klie, Robert F.; Abiade, Jeremiah; Curtiss, Larry A.; Salehi-Khojin, Amin			Nanostructured transition metal dichalcogenide electrocatalysts for CO2 reduction in ionic liquid	SCIENCE			English	Article							HYDROGEN EVOLUTION REACTION; OXYGEN-EVOLVING CATALYST; CARBON-DIOXIDE REDUCTION; ACTIVE EDGE SITES; AU NANOPARTICLES; SELECTIVE CONVERSION; AQUEOUS CO2; IN-SITU; FILMS; WATER	Conversion of carbon dioxide ( CO2) into fuels is an attractive solution to many energy and environmental challenges. However, the chemical inertness of CO2 renders many electrochemical and photochemical conversion processes inefficient. We report a transition metal dichalcogenide nanoarchitecture for catalytic electrochemical CO2 conversion to carbon monoxide ( CO) in an ionic liquid. We found that tungsten diselenide nanoflakes show a current density of 18.95 milliamperes per square centimeter, CO faradaic efficiency of 24%, and CO formation turnover frequency of 0.28 per second at a low overpotential of 54 millivolts. We also applied this catalyst in a light-harvesting artificial leaf platform that concurrently oxidized water in the absence of any external potential.	[Asadi, Mohammad; Kim, Kibum; Addepalli, Aditya Venkata; Abbasi, Pedram; Yasaei, Poya; Behranginia, Amirhossein; Kumar, Bijandra; Abiade, Jeremiah; Salehi-Khojin, Amin] Univ Illinois, Dept Mech & Ind Engn, Chicago, IL 60607 USA; [Kim, Kibum] Chungbuk Natl Univ, Dept Mech Engn, Cheongju 361763, South Korea; [Liu, Cong; Zapol, Peter; Curtiss, Larry A.] Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA; [Phillips, Patrick; Klie, Robert F.] Univ Illinois, Dept Phys, Chicago, IL 60607 USA; [Cerrato, Jose M.] Univ New Mexico, Dept Civil Engn, Albuquerque, NM 87131 USA; [Haasch, Richard] Univ Illinois, Mat Res Lab, Urbana, IL 61801 USA; [Kumar, Bijandra] Univ Louisville, Conn Ctr Renewable Energy Res, Louisville, KY 40292 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Chungbuk National University; United States Department of Energy (DOE); Argonne National Laboratory; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of New Mexico; University of Illinois System; University of Illinois Urbana-Champaign; University of Louisville	Salehi-Khojin, A (corresponding author), Univ Illinois, Dept Mech & Ind Engn, Chicago, IL 60607 USA.; Curtiss, LA (corresponding author), Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA.	curtiss@anl.gov; salehikh@uic.edu	Asadi, Mohammad/AAF-6564-2020; Zapol, Peter/G-1810-2012; Abbasi, Pedram/K-2669-2019; Asadi, Mohammad/ABA-9701-2021; Liu, Cong/A-6297-2014	Zapol, Peter/0000-0003-0570-9169; Cerrato, Jose/0000-0002-2473-6376; Klie, Robert/0000-0003-4773-6667; Kumar, Bijandra/0000-0002-7985-5903; Liu, Cong/0000-0002-2145-5034; Haasch, Richard/0000-0001-9479-2595	NSF [CBET-1512647]; MRSEC Materials Preparation and Measurement Laboratory shared user facility at the University of Chicago [NSF-DMR-1420709]; EPIC facility (NUANCE Center-Northwestern University); MRSEC program at the Materials Research Center [NSF-DMR-1121262]; Nanoscale Science and Engineering Center at the International Institute for Nanotechnology [NSF EEC-0647560]; State of Illinois through the International Institute for Nanotechnology; U.S. Department of Energy from the Division of Materials Science and Engineering, Basic Energy Science [DE-AC0206CH11357]	NSF(National Science Foundation (NSF)); MRSEC Materials Preparation and Measurement Laboratory shared user facility at the University of Chicago; EPIC facility (NUANCE Center-Northwestern University); MRSEC program at the Materials Research Center; Nanoscale Science and Engineering Center at the International Institute for Nanotechnology; State of Illinois through the International Institute for Nanotechnology; U.S. Department of Energy from the Division of Materials Science and Engineering, Basic Energy Science	Supported by NSF grant CBET-1512647 (A.S.-K.); the MRSEC Materials Preparation and Measurement Laboratory shared user facility at the University of Chicago (grant NSF-DMR-1420709); the EPIC facility (NUANCE Center-Northwestern University), which has received support from the MRSEC program (grant NSF-DMR-1121262) at the Materials Research Center; the Nanoscale Science and Engineering Center (NSF EEC-0647560) at the International Institute for Nanotechnology; and the State of Illinois through the International Institute for Nanotechnology. The work at Argonne National Laboratory was supported by the U.S. Department of Energy under contract DE-AC0206CH11357 from the Division of Materials Science and Engineering, Basic Energy Science (P.Z., C.L., and L.A.C.). The authors also acknowledge Analytical Chemistry Laboratory of the Earth and Planetary Sciences Department, University of New Mexico.	Angamuthu R, 2010, SCIENCE, V327, P313, DOI 10.1126/science.1177981; Asadi M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5470; Chen YH, 2012, J AM CHEM SOC, V134, P19969, DOI 10.1021/ja309317u; DiMeglio JL, 2013, J AM CHEM SOC, V135, P8798, DOI 10.1021/ja4033549; FISHMAN G, 1989, PHYS REV LETT, V62, P1302, DOI 10.1103/PhysRevLett.62.1302; Fujita T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.166601; Gao DF, 2015, J AM CHEM SOC, V137, P4288, DOI 10.1021/jacs.5b00046; Gong C, 2013, ACS NANO, V7, P11350, DOI 10.1021/nn4052138; HAMMER B, 1995, NATURE, V376, P238, DOI 10.1038/376238a0; Hammer B, 2000, ADV CATAL, V45, P71; Hansen HA, 2013, J PHYS CHEM LETT, V4, P388, DOI 10.1021/jz3021155; HAWECKER J, 1986, HELV CHIM ACTA, V69, P1990, DOI 10.1002/hlca.19860690824; Kanan MW, 2008, SCIENCE, V321, P1072, DOI 10.1126/science.1162018; Kibsgaard J, 2012, NAT MATER, V11, P963, DOI [10.1038/NMAT3439, 10.1038/nmat3439]; Kumar B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3819; Li CW, 2012, J AM CHEM SOC, V134, P7231, DOI 10.1021/ja3010978; Li DJ, 2014, NANO LETT, V14, P1228, DOI 10.1021/nl404108a; Lutterman DA, 2009, J AM CHEM SOC, V131, P3838, DOI 10.1021/ja900023k; Medina-Ramos J, 2014, J AM CHEM SOC, V136, P8361, DOI 10.1021/ja501923g; Mistry H, 2014, J AM CHEM SOC, V136, P16473, DOI 10.1021/ja508879j; Norskov JK, 2004, J PHYS CHEM B, V108, P17886, DOI 10.1021/jp047349j; Peterson AA, 2010, ENERG ENVIRON SCI, V3, P1311, DOI 10.1039/c0ee00071j; Reece SY, 2011, SCIENCE, V334, P645, DOI 10.1126/science.1209816; Reske R, 2014, J AM CHEM SOC, V136, P6978, DOI 10.1021/ja500328k; Richardson RD, 2011, NAT CHEM, V3, P301, DOI 10.1038/NCHEM.1000; Rosen BA, 2013, J ELECTROCHEM SOC, V160, pH138, DOI 10.1149/2.004303jes; Rosen BA, 2011, SCIENCE, V334, P643, DOI 10.1126/science.1209786; Salehi-Khojin A, 2013, J PHYS CHEM C, V117, P1627, DOI 10.1021/jp310509z; Tan YW, 2014, ADV MATER, V26, P8023, DOI 10.1002/adma.201403808; Tsai C, 2014, PHYS CHEM CHEM PHYS, V16, P13156, DOI 10.1039/c4cp01237b; Tsai C, 2014, NANO LETT, V14, P1381, DOI 10.1021/nl404444k; Zhang LH, 2014, ANGEW CHEM INT EDIT, V53, P9746, DOI 10.1002/anie.201404328; Zhu WL, 2013, J AM CHEM SOC, V135, P16833, DOI 10.1021/ja409445p	33	597	606	45	1172	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					467	470		10.1126/science.aaf4767	http://dx.doi.org/10.1126/science.aaf4767			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27471300				2022-12-28	WOS:000380583600035
J	Kuhnen, P; Clement, K; Wiegand, S; Blankenstein, O; Gottesdiener, K; Martini, LL; Mai, K; Blume-Peytavi, U; Gruters, A; Krude, H				Kuehnen, Peter; Clement, Karine; Wiegand, Susanna; Blankenstein, Oliver; Gottesdiener, Keith; Martini, Lea L.; Mai, Knut; Blume-Peytavi, Ulrike; Grueters, Annette; Krude, Heiko			Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGENITAL LEPTIN DEFICIENCY; EARLY-ONSET OBESITY; MUTATION; HUMANS; PIGMENTATION; DYSFUNCTION; GENE	Patients with rare defects in the gene encoding proopiomelanocortin ( POMC) have extreme early-onset obesity, hyperphagia, hypopigmentation, and hypocortisolism, resulting from the lack of the proopiomelanocortin-derived peptides melanocyte-stimulating hormone and corticotropin. In such patients, adrenal insufficiency must be treated with hydrocortisone early in life. No effective pharmacologic treatments have been available for the hyperphagia and obesity that characterize the condition. In this investigator-initiated, open-label study, two patients with proopiomelanocortin deficiency were treated with setmelanotide, a new melanocortin-4 receptor agonist. The patients had a sustainable reduction in hunger and substantial weight loss ( 51.0 kg after 42 weeks in Patient 1 and 20.5 kg after 12 weeks in Patient 2).	[Kuehnen, Peter; Blankenstein, Oliver; Krude, Heiko] Charite, Inst Expt Pediat Endocrinol, Augustenburger Pl 1, D-13353 Berlin, Germany; [Wiegand, Susanna; Grueters, Annette] Charite, Dept Pediat Endocrinol & Diabet, Berlin, Germany; [Mai, Knut] Charite, Dept Endocrinol Diabet & Nutr, Berlin, Germany; [Mai, Knut] Charite, Charite Ctr Cardiovasc Res, Berlin, Germany; [Blume-Peytavi, Ulrike] Charite, Dept Dermatol & Allergy, Clin Res Ctr Hair & Skin Sci, Berlin, Germany; [Mai, Knut] Berlin Inst Hlth, Clin Res Unit, Berlin, Germany; [Clement, Karine; Martini, Lea L.] Univ Paris 06, Pitie Salpetriere Hosp, AP HP,Unite Mixte Rech Sci 1166, Inst Cardiometab & Nutr,Nutr Dept,INSERM,Sorbonne, Paris, France; [Gottesdiener, Keith] Rhythm Pharmaceut, Boston, MA USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Kuhnen, P (corresponding author), Charite, Inst Expt Pediat Endocrinol, Augustenburger Pl 1, D-13353 Berlin, Germany.	peter.kuehnen@charite.de	Mai, Knut/W-9904-2019; Blankenstein, Oliver/AAS-7611-2020; Clément, karine/R-1120-2017	Mai, Knut/0000-0003-0126-3155; Blankenstein, Oliver/0000-0003-1803-5589; Kuhnen, Peter/0000-0003-0211-176X; Blume-Peytavi, Ulrike/0000-0003-3528-3752; Wiegand, Susanna/0000-0001-8341-9533				Chen KY, 2015, J CLIN ENDOCR METAB, V100, P1639, DOI 10.1210/jc.2014-4024; Clement K, 1998, NATURE, V392, P398, DOI 10.1038/32911; Clement K, 2008, J CLIN ENDOCR METAB, V93, P4955, DOI 10.1210/jc.2008-1164; Farooqi IS, 2008, NAT CLIN PRACT ENDOC, V4, P569, DOI 10.1038/ncpendmet0966; Farooqi IS, 2006, ENDOCR REV, V27, P710, DOI 10.1210/er.2006-0040; Farooqi IS, 2006, DIABETES, V55, P2549, DOI 10.2337/db06-0214; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Gottesdiener KHC, 2015, OBESITYWEEK 2015 LOS; Greenfield JR, 2009, NEW ENGL J MED, V360, P44, DOI 10.1056/NEJMoa0803085; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Kuehnen P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002543; Kuo JJ, 2004, HYPERTENSION, V43, P370, DOI 10.1161/01.HYP.0000111836.54204.93; Mendiratta MS, 2011, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2011-5; Mercer RE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003207; Molinoff PB, 2003, ANN NY ACAD SCI, V994, P96, DOI 10.1111/j.1749-6632.2003.tb03167.x; Montague CT, 1997, NATURE, V387, P903, DOI 10.1038/43185; Ni XP, 2006, J HYPERTENS, V24, P2239, DOI 10.1097/01.hjh.0000249702.49854.fa; Samuels ME, 2013, J CLIN ENDOCR METAB, V98, P736, DOI 10.1210/jc.2012-3199	19	246	252	5	31	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2016	375	3					240	246		10.1056/NEJMoa1512693	http://dx.doi.org/10.1056/NEJMoa1512693			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS0ZL	27468060	Bronze			2022-12-28	WOS:000380325400007
J	Das, P; Horton, R				Das, Pamela; Horton, Richard			Physical activity-time to take it seriously and regularly	LANCET			English	Editorial Material							PUBLIC-HEALTH; INACTIVITY; DISEASE		[Das, Pamela; Horton, Richard] The Lancet, London EC2Y 5AS, England		Das, P (corresponding author), The Lancet, London EC2Y 5AS, England.				welcome trust Funding Source: Medline	welcome trust(Wellcome Trust)		Ding D, 2016, LANCET, V388, P1311, DOI 10.1016/S0140-6736(16)30383-X; Ekelund U., 2016, LANCET; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; MORRIS JN, 1994, MED SCI SPORT EXER, V26, P807; Reis R. S., 2016, LANCET; Sallis J. F., 2016, LANCET; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1	8	76	78	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2016	388	10051					1254	+		10.1016/S0140-6736(16)31070-4	http://dx.doi.org/10.1016/S0140-6736(16)31070-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DW5RH	27475269				2022-12-28	WOS:000383704000007
J	Sallis, JF; Bull, F; Guthold, R; Heath, GW; Inoue, S; Kelly, P; Oyeyemi, AL; Perez, LG; Richards, J; Hallal, PC				Sallis, James F.; Bull, Fiona; Guthold, Regina; Heath, Gregory W.; Inoue, Shigeru; Kelly, Paul; Oyeyemi, Adewale L.; Perez, Lilian G.; Richards, Justin; Hallal, Pedro C.		Lancet Phys Activity Series 2	Progress in physical activity over the Olympic quadrennium	LANCET			English	Article							ACTIVITY QUESTIONNAIRE; ACTIVITY INTERVENTION; SHORT-FORM; HEALTH; PREVENTION; VALIDITY; INACTIVITY; DISEASE; OBESITY; TRIAL	On the eve of the 2012 summer Olympic Games, the first Lancet Series on physical activity established that physical inactivity was a global pandemic, and global public health action was urgently needed. The present paper summarises progress on the topics covered in the first Series. In the past 4 years, more countries have been monitoring the prevalence of physical inactivity, although evidence of any improvements in prevalence is still scarce. According to emerging evidence on brain health, physical inactivity accounts for about 3.8% of cases of dementia worldwide. An increase in research on the correlates of physical activity in low-income and middle-income countries (LMICs) is providing a better evidence base for development of context-relevant interventions. A finding specific to LMICs was that physical inactivity was higher in urban (vs rural) residents, which is a cause for concern because of the global trends toward urbanisation. A small but increasing number of intervention studies from LMICs provide initial evidence that community-based interventions can be effective. Although about 80% of countries reported having national physical activity policies or plans, such policies were operational in only about 56% of countries. There are important barriers to policy implementation that must be overcome before progress in increasing physical activity can be expected. Despite signs of progress, efforts to improve physical activity surveillance, research, capacity for intervention, and policy implementation are needed, especially among LMICs.	[Sallis, James F.] Univ Calif San Diego, Dept Family Med & Publ Hlth, 3900 Fifth Ave,Suite 310, San Diego, CA 92103 USA; [Bull, Fiona] Univ Western Australia, Ctr Built Environm & Hlth, Perth, WA, Australia; [Guthold, Regina] WHO, Prevent Noncommunicable Dis Dept, Geneva, Switzerland; [Heath, Gregory W.] Univ Tennessee, Dept Hlth & Human Performance & Med, Chattanooga, TN USA; [Inoue, Shigeru] Tokyo Med Univ, Dept Prevent Med & Publ Hlth, Tokyo, Japan; [Kelly, Paul] Univ Edinburgh, Phys Act Hlth Res Ctr, Edinburgh, Midlothian, Scotland; [Oyeyemi, Adewale L.] Univ Maiduguri, Dept Physiotherapy, Coll Med Sci, Maiduguri, Nigeria; [Oyeyemi, Adewale L.] North West Univ, Fac Hlth Sci, Phys Act Sport & Recreat Res Focus Area, Potchefstroom, South Africa; [Perez, Lilian G.] UCSD SDSU Joint Doctoral Program Publ Hlth Global, San Diego, CA USA; [Richards, Justin] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Richards, Justin] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia; [Hallal, Pedro C.] Univ Fed Pelotas, Pelotas, Brazil	University of California System; University of California San Diego; University of Western Australia; World Health Organization; University of Tennessee System; University of Tennessee at Chattanooga; Tokyo Medical University; University of Edinburgh; North West University - South Africa; University of Sydney; University of Sydney; Universidade Federal de Pelotas	Sallis, JF (corresponding author), Univ Calif San Diego, Dept Family Med & Publ Hlth, 3900 Fifth Ave,Suite 310, San Diego, CA 92103 USA.	jsallis@ucsd.edu	Oyeyemi, Adewale/AAA-2792-2019; Reis, Rodrigo/F-7447-2012; Guthold, Regina/AAD-9998-2021; Sallis, James F/D-3001-2014; Heath, Gregory Wayne/AAE-2464-2020	Reis, Rodrigo/0000-0002-9872-9865; Guthold, Regina/0000-0003-3073-6468; Sallis, James F/0000-0003-2555-9452; Heath, Gregory Wayne/0000-0003-2864-5225; Oyeyemi, Adewale/0000-0002-3737-2911	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Ainsworth BE, 2006, MED SCI SPORT EXER, V38, P1584, DOI 10.1249/01.mss.0000229457.73333.9a; Almas A, 2013, ARCH DIS CHILD, V98, P515, DOI 10.1136/archdischild-2012-303242; [Anonymous], 2001, ASSESSMENT NATL CAPA; Ardoy DN, 2014, SCAND J MED SCI SPOR, V24, pe52, DOI 10.1111/sms.12093; Assah FK, 2011, DIABETES CARE, V34, P491, DOI 10.2337/dc10-0990; Balagopal P, 2012, DIABETES EDUCATOR, V38, P822, DOI 10.1177/0145721712459890; Baptista F, 2012, MED SCI SPORT EXER, V44, P466, DOI 10.1249/MSS.0b013e318230e441; Bauman AE, 2013, J PHYS ACT HEALTH, V10, P1, DOI 10.1123/jpah.10.1.1; Bauman AE, 2012, LANCET, V380, P31; Belcher BR, 2010, MED SCI SPORT EXER, V42, P2211, DOI 10.1249/MSS.0b013e3181e1fba9; Blondell SJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-510; Bornstein DB, 2009, J PHYS ACT HEALTH, V6, pS245, DOI 10.1123/jpah.6.s2.s245; Bull Fiona C, 2006, Promot Educ, V13, P127, DOI 10.1177/10253823060130020107; Bull FC, 2014, J PHYS ACT HEALTH, V11, P233, DOI 10.1123/jpah.2012-0083; Colley Rachel C, 2011, Health Rep, V22, P7; Craig R, 2009, HLTH SURVEY ENGLAND; Ekelund U, 2006, PUBLIC HEALTH NUTR, V9, P258, DOI 10.1079/PHN2005840; Elhakeem A, 2015, INT J BEHAV NUTR PHY, V12, DOI [10.1186/s12966-015-0250-0, 10.1186/s12966-015-0274-5]; European Union Sport and Health Working Group, 2008, EUR UN PHYS ACT GUID; Hagstromer M, 2007, MED SCI SPORT EXER, V39, P1502, DOI 10.1249/mss.0b013e3180a76de5; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Hallal PC, 2014, LANCET, V384, P471, DOI 10.1016/S0140-6736(14)61321-0; Hallal PC, 2012, LANCET, V380, P190, DOI 10.1016/S0140-6736(12)61027-7; Hansen BH, 2012, MED SCI SPORT EXER, V44, P266, DOI 10.1249/MSS.0b013e31822cb354; Heath Gregory W, 2006, J Phys Act Health, V3, pS55, DOI 10.1123/jpah.3.s1.s55; Heath GW, 2012, LANCET, V380, P272, DOI 10.1016/S0140-6736(12)60816-2; Hillman CH, 2014, RELATION CHILDHOOD P; Husu P, 2014, SUOM LAAKARILEHTI, V69, P1861; International Society of Physical Activity and Health, 2014, CAP BUILD PROM PHYS; Jemmott JB, 2014, PREV MED, V64, P114, DOI 10.1016/j.ypmed.2014.04.012; Kahn EB, 2002, AM J PREV MED, V22, P73, DOI 10.1016/S0749-3797(02)00434-8; Kahn EB, 2005, GUIDE COMMUNITY PREV, P80; Kain J, 2014, J OBES, V2014, DOI 10.1155/2014/618293; Kalman M, 2015, EUR J PUBLIC HEALTH, V25, P37, DOI 10.1093/eurpub/ckv024; Khan NA, 2014, PEDIATR EXERC SCI, V26, P138, DOI 10.1123/pes.2013-0125; Krishnan A, 2011, HEALTH PROMOT INT, V26, P276, DOI 10.1093/heapro/daq067; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Lee PH, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-115; Li YP, 2010, BIOMED ENVIRON SCI, V23, P180, DOI 10.1016/S0895-3988(10)60050-5; Lv J, 2014, J EPIDEMIOL COMMUN H, V68, P333, DOI 10.1136/jech-2013-203356; Martin Sarah Levin, 2006, Prev Chronic Dis, V3, pA24; Mendonca BC, 2010, J PHYS ACT HEALTH, V7, pS223, DOI 10.1123/jpah.7.s2.s223; Monda KL, 2007, SOC SCI MED, V64, P858, DOI 10.1016/j.socscimed.2006.10.019; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Parra DC, 2010, AM J PUBLIC HEALTH, V100, P1420, DOI 10.2105/AJPH.2009.181230; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Pratt M, 2012, LANCET, V380, P282, DOI 10.1016/S0140-6736(12)60736-3; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Nguyen QN, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-56; Rabiei K, 2010, ARCH MED SCI, V6, P32, DOI 10.5114/aoms.2010.13504; Richards J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-619; Rzewnicki R, 2003, PUBLIC HEALTH NUTR, V6, P299, DOI 10.1079/PHN2002427; Sallis JF, 2012, CIRCULATION, V125, P729, DOI 10.1161/CIRCULATIONAHA.110.969022; Scholes S, 2014, AM J EPIDEMIOL, V179, P1493, DOI 10.1093/aje/kwu087; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Siefken K, 2015, GLOB HEALTH PROMOT, V22, P53, DOI 10.1177/1757975914539179; Singh A, 2012, ARCH PEDIAT ADOL MED, V166, P49, DOI 10.1001/archpediatrics.2011.716; Skaal L, 2012, TRANSL BEHAV MED, V2, P384, DOI 10.1007/s13142-012-0136-5; Sullivan R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024898; Tammelin T, 2013, OPPILAIDEN FYYSINEN, V272; Torres Andrea, 2013, Am J Public Health, V103, pe23, DOI 10.2105/AJPH.2012.301142; Tremblay MS, 2014, J PHYS ACT HEALTH, V11, pS113, DOI 10.1123/jpah.2014-0177; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Troiano RP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2014-093546; Trost SG, 2002, MED SCI SPORT EXER, V34, P350, DOI 10.1097/00005768-200202000-00025; Tudor-Locke C, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-60; UN Department of Economic and Social Affairs Population Division, WORLD URB PROSP 2014; United Nations General Assembly, 2011, POL DECL HIGH LEV M; Vio F, 2011, ARCH LATINOAM NUTR, V61, P406; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; WHO, MON IMPL EUR STRAT N; WHO, 2012, DISC PAP COMPR GLOB; WHO Global Health Observatory, 2015, INS PHYS ACT; Wijndaele K, 2015, MED SCI SPORT EXER, V47, P2129, DOI 10.1249/MSS.0000000000000661; World Health Organization, 2004, GLOB STRAT DIET PHYS; World Health Organization, GLOB SCH BAS STUD HL; World Health Organization Rotary International Centers for Disease Control and Prevention and UNICEF, 2013, GLOBAL ACTION PLAN P	80	516	538	4	78	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2016	388	10051					1325	1336		10.1016/S0140-6736(16)30581-5	http://dx.doi.org/10.1016/S0140-6736(16)30581-5			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DW5RH	27475270				2022-12-28	WOS:000383704000035
J	Zaanen, J				Zaanen, Jan			Superconducting electrons go missing	NATURE			English	Editorial Material							COPPER OXIDES; TEMPERATURE; DENSITY; SYSTEM; TC		[Zaanen, Jan] Leiden Univ, Inst Lorentz Theoret Phys, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Zaanen, J (corresponding author), Leiden Univ, Inst Lorentz Theoret Phys, NL-2300 RA Leiden, Netherlands.	jan@lorentz.leidenuniv.nl						BARDEEN J, 1957, PHYS REV, V106, P162, DOI 10.1103/PhysRev.106.162; BEDNORZ JG, 1986, Z PHYS B CON MAT, V64, P189, DOI 10.1007/BF01303701; Bozovic I, 2016, NATURE, V536, P309, DOI 10.1038/nature19061; Chatterjee U, 2011, P NATL ACAD SCI USA, V108, P9346, DOI 10.1073/pnas.1101008108; Keimer B, 2015, NATURE, V518, P179, DOI 10.1038/nature14165; Leggett AJ, 1998, J STAT PHYS, V93, P927, DOI 10.1023/B:JOSS.0000033170.38619.6c; MOTT NF, 1949, P PHYS SOC LOND A, V62, P416, DOI 10.1088/0370-1298/62/7/303; Tinkham M., 2004, INTRO SUPERCONDUCTIV, V2nd; UEMURA YJ, 1989, PHYS REV LETT, V62, P2317, DOI 10.1103/PhysRevLett.62.2317; Vignolle B, 2008, NATURE, V455, P952, DOI 10.1038/nature07323; Zaanen J, 2007, SCIENCE, V315, P1372, DOI 10.1126/science.1139805	11	26	28	1	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					282	283		10.1038/536282a	http://dx.doi.org/10.1038/536282a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27535532	Green Submitted			2022-12-28	WOS:000381804900025
J	Priglinger, ML				Priglinger, Miriam L.			In acute stroke or TIA, ticagrelor did not differ from aspirin for a composite of stroke, MI, or death at 90 days	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CLOPIDOGREL		[Priglinger, Miriam L.] Univ Hosp Berlin, Berlin, Germany		Priglinger, ML (corresponding author), Univ Hosp Berlin, Berlin, Germany.							Rothwell PM, 2016, LANCET; Sharma M, 2013, NEW ENGL J MED, V369, P1375, DOI 10.1056/NEJMc1309713; Wallentin L, 2009, NEW ENGL J MED, V361, P1045, DOI 10.1056/NEJMoa0904327	3	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					JC18	JC18		10.7326/ACPJC-2016-165-4-018	http://dx.doi.org/10.7326/ACPJC-2016-165-4-018			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UI	27538179				2022-12-28	WOS:000381267200005
J	Wise, J				Wise, Jacqui			MEDICINE AND THE MEDIA No "breakthrough" in Alzheimer's disease	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												jacquiyoung1@gmail.com						Bodkin Henry, 2016, TELEGRAPH; Herber M., 2016, FORBES; Pollack Andrew, 2016, NY TIMES; Smyth C, 2016, TIMES; Spencer B., 2016, DAILY MAIL; Whalen J, 2016, WALL STREET J	6	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2016	354								i4474	10.1136/bmj.i4474	http://dx.doi.org/10.1136/bmj.i4474			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GX	27531826				2022-12-28	WOS:000381806200007
J	Gulland, A				Gulland, Anne			CCG ditches plan to suspend non-urgent referrals	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Gulland A, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4384	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2016	354								i4444	10.1136/bmj.i4444	http://dx.doi.org/10.1136/bmj.i4444			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4UY	27519603				2022-12-28	WOS:000381477800010
J	Torjesen, I				Torjesen, Ingrid			History of depression in grandparent and parent may raise risk of the condition	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Weissman MM, 2016, JAMA PSYCHIAT, V73, P970, DOI 10.1001/jamapsychiatry.2016.1586	1	0	0	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2016	354								i4431	10.1136/bmj.i4431	http://dx.doi.org/10.1136/bmj.i4431			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4UY	27520393				2022-12-28	WOS:000381477800008
J	Drake, JM; Paull, EO; Graham, NA; Lee, JK; Smith, BA; Titz, B; Stoyanova, T; Faltermeier, CM; Uzunangelov, V; Carlin, DE; Fleming, DT; Wong, CK; Newton, Y; Sudha, S; Vashisht, AA; Huang, JT; Wohlschlegel, JA; Graeber, TG; Witte, ON; Stuart, JM				Drake, Justin M.; Paull, Evan O.; Graham, Nicholas A.; Lee, John K.; Smith, Bryan A.; Titz, Bjoern; Stoyanova, Tanya; Faltermeier, Claire M.; Uzunangelov, Vladislav; Carlin, Daniel E.; Fleming, Daniel Teo; Wong, Christopher K.; Newton, Yulia; Sudha, Sud; Vashisht, Ajay A.; Huang, Jiaoti; Wohlschlegel, James A.; Graeber, Thomas G.; Witte, Owen N.; Stuart, Joshua M.			Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer	CELL			English	Article							MUTATIONAL LANDSCAPE; ENRICHMENT ANALYSIS; INCREASED SURVIVAL; BETA-CATENIN; CELL-GROWTH; ACTIVATION; IDENTIFICATION; EZH2; HETEROGENEITY; PROGRESSION	We used clinical tissue from lethal metastatic castration-resistant prostate cancer (CRPC) patients obtained at rapid autopsy to evaluate diverse genomic, transcriptomic, and phosphoproteomic datasets for pathway analysis. Using Tied Diffusion through Interacting Events (TieDIE), we integrated differentially expressed master transcriptional regulators, functionally mutated genes, and differentially activated kinases in CRPC tissues to synthesize a robust signaling network consisting of druggable kinase pathways. Using MSigDB hallmark gene sets, six major signaling pathways with phosphorylation of several key residues were significantly enriched in CRPC tumors after incorporation of phosphoproteomic data. Individual autopsy profiles developed using these hallmarks revealed clinically relevant pathway information potentially suitable for patient stratification and targeted therapies in late stage prostate cancer. Here, we describe phosphorylation-based cancer hallmarks using integrated personalized signatures (pCHIPS) that shed light on the diversity of activated signaling pathways in metastatic CRPC while providing an integrative, pathway-based reference for drug prioritization in individual patients.	[Drake, Justin M.; Smith, Bryan A.; Stoyanova, Tanya; Witte, Owen N.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Graham, Nicholas A.; Titz, Bjoern; Graeber, Thomas G.] Univ Calif Los Angeles, David Geffen Sch Med, Crump Inst Mol Imaging, Los Angeles, CA 90095 USA; [Graham, Nicholas A.; Titz, Bjoern; Graeber, Thomas G.; Witte, Owen N.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Lee, John K.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Hematol & Oncol, Los Angeles, CA 90095 USA; [Lee, John K.; Faltermeier, Claire M.] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Biol, Los Angeles, CA 90095 USA; [Vashisht, Ajay A.; Wohlschlegel, James A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Huang, Jiaoti; Graeber, Thomas G.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Huang, Jiaoti] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Graeber, Thomas G.] Univ Calif Los Angeles, David Geffen Sch Med, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Witte, Owen N.] Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Huang, Jiaoti; Witte, Owen N.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Sudha, Sud] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Paull, Evan O.; Uzunangelov, Vladislav; Carlin, Daniel E.; Fleming, Daniel Teo; Wong, Christopher K.; Newton, Yulia; Stuart, Joshua M.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Drake, Justin M.] Rutgers Robert Wood Johnson Med Sch, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA; [Drake, Justin M.] Rutgers Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08903 USA; [Graham, Nicholas A.] Univ Southern Calif, Mork Family Dept Chem Engn & Mat Sci, Los Angeles, CA 90089 USA; [Stoyanova, Tanya] Stanford Univ, Canary Ctr Stanford Canc Early Detect, Dept Radiol, Palo Alto, CA 94304 USA; [Carlin, Daniel E.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Huang, Jiaoti] Duke Univ, Sch Med, Dept Pathol, Durham, NC 27710 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of Michigan System; University of Michigan; University of California System; University of California Santa Cruz; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Southern California; Stanford University; University of California System; University of California San Diego; Duke University	Drake, JM; Witte, ON (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Witte, ON (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.; Witte, ON (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.; Witte, ON (corresponding author), Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA.; Stuart, JM (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA.; Drake, JM (corresponding author), Rutgers Robert Wood Johnson Med Sch, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08903 USA.; Drake, JM (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ 08903 USA.	justin.drake@cinj.rutgers.edu; owenwitte@mednet.ucla.edu; jstuart@ucsc.edu	Titz, Bjoern/G-6317-2017; Graham, Nicholas A./X-2738-2019; Graham, Nicholas/GYD-5066-2022	Titz, Bjoern/0000-0003-4414-4105; Graham, Nicholas A./0000-0002-6811-1941; Graham, Nicholas/0000-0002-6811-1941; Drake, Justin/0000-0002-8329-7748; Huang, Jiaoti/0000-0003-1195-1998; Lee, John/0000-0002-6570-2180; Stuart, Joshua/0000-0002-2171-565X; Graeber, Thomas/0000-0001-8574-9181	Department of Defense Prostate Cancer Research Program [W81XWH-14-1-0148, W81XWH-12-1-0206]; Prostate Cancer Foundation Young Investigator Award; New Jersey Health Foundation Research grant; UCLA Scholars in Oncologic Molecular Imaging (SOMI) program, NIH [R25T CA098010]; Specialty Training and Advanced Research (STAR) Program at UCLA; Tower Cancer Research Foundation Career Development Award; UCLA Tumor Immunology Training grant [T32 CA009120]; American Cancer Society [PF-16-082-01-TBE]; NIH/National Cancer Institute [4R00CA184397]; UCLA Medical Scientist Training Program; NIH [5R01CA172603-02, 2P30CA016042-39, 1R01CA181242-01A1, 1R01CA195505, GM089778]; UCLA SPORE in prostate cancer; Prostate Cancer Foundation Honorable A. David Mazzone Special Challenge Award; UCLA Jonsson Comprehensive Cancer Center Impact Grant; NCI/NIH [P01 CA168585, U24CA143858, 1R01CA180778]; American Cancer Society Research Scholar Award [RSG-12-257-01-TBE]; Cal-Tech-UCLA Joint Center for Translational Medicine; UCLA Jonsson Cancer Center Foundation; National Center for Advancing Translational Sciences UCLA CTSI grant [UL1TR000124]; Concern Foundation CONquer CanCER Now Award; NHGRI/NIH [5U54HG006097]; NIGMS/NIH [5R01GM109031]; Zimmerman Family; Concern Foundation; Prostate Cancer Foundation Challenge Award; NATIONAL CANCER INSTITUTE [P01CA168585, R25CA098010, P30CA016042, R01CA180778, R01CA195505, R01CA172603, R03CA230819, T32CA009120, R00CA184397, R01CA181242, U24CA143858, P50CA092131] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG006097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109031, R01GM089778] Funding Source: NIH RePORTER	Department of Defense Prostate Cancer Research Program(United States Department of Defense); Prostate Cancer Foundation Young Investigator Award; New Jersey Health Foundation Research grant; UCLA Scholars in Oncologic Molecular Imaging (SOMI) program, NIH; Specialty Training and Advanced Research (STAR) Program at UCLA; Tower Cancer Research Foundation Career Development Award; UCLA Tumor Immunology Training grant; American Cancer Society(American Cancer Society); NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UCLA Medical Scientist Training Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCLA SPORE in prostate cancer; Prostate Cancer Foundation Honorable A. David Mazzone Special Challenge Award; UCLA Jonsson Comprehensive Cancer Center Impact Grant; NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society Research Scholar Award(American Cancer Society); Cal-Tech-UCLA Joint Center for Translational Medicine; UCLA Jonsson Cancer Center Foundation; National Center for Advancing Translational Sciences UCLA CTSI grant; Concern Foundation CONquer CanCER Now Award; NHGRI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Zimmerman Family; Concern Foundation; Prostate Cancer Foundation Challenge Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the O.N.W. and J.M.S. labs for helpful comments and discussion on the manuscript and the University of Michigan for supplying material from their rapid autopsy program. J.M.D. is supported by the Department of Defense Prostate Cancer Research Program W81XWH-14-1-0148, Prostate Cancer Foundation Young Investigator Award, and a New Jersey Health Foundation Research grant. N.A.G. is supported by UCLA Scholars in Oncologic Molecular Imaging (SOMI) program, NIH grant R25T CA098010. J.K.L. is supported by Specialty Training and Advanced Research (STAR) Program at UCLA, Prostate Cancer Foundation Young Investigator Award, and Tower Cancer Research Foundation Career Development Award. B.A.S. is supported by the UCLA Tumor Immunology Training grant T32 CA009120, American Cancer Society Postdoctoral Fellowship PF-16-082-01-TBE, and Prostate Cancer Foundation Young Investigator Award. T.S. is supported by Prostate Cancer Foundation Young Investigator Award and NIH/National Cancer Institute K99 Pathway to Independence Award 4R00CA184397. C.M.F. is supported by the UCLA Medical Scientist Training Program. J.H. is supported by NIH grants 5R01CA172603-02, 2P30CA016042-39, 1R01CA181242-01A1, 1R01CA195505, the Department of Defense Prostate Cancer Research Program W81XWH-12-1-0206, UCLA SPORE in prostate cancer, Prostate Cancer Foundation Honorable A. David Mazzone Special Challenge Award, and UCLA Jonsson Comprehensive Cancer Center Impact Grant. J.A.W. is supported by NIH GM089778. T.G.G. is supported by the NCI/NIH P01 CA168585, an American Cancer Society Research Scholar Award RSG-12-257-01-TBE, the Cal-Tech-UCLA Joint Center for Translational Medicine, the UCLA Jonsson Cancer Center Foundation, the National Center for Advancing Translational Sciences UCLA CTSI grant UL1TR000124, and a Concern Foundation CONquer CanCER Now Award. J.M.S. is supported by NCI/NIH U24CA143858, NCI/NIH 1R01CA180778, NHGRI/NIH 5U54HG006097, and NIGMS/NIH 5R01GM109031 grants. O.N.W. is an Investigator of the Howard Hughes Medical Institute and is supported by the Zimmerman Family, the Concern Foundation, and by a Prostate Cancer Foundation Challenge Award.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Alvarez M.J., 2015, USING VIPER PACKAGE; [Anonymous], 2013, NATURE, V499, P43, DOI [10.1038/nature12222, DOI 10.1038/NATURE12222, DOI 10.1038/nature12222]; Aytes A, 2014, CANCER CELL, V25, P638, DOI 10.1016/j.ccr.2014.03.017; Beltran H, 2011, CANCER DISCOV, V1, P487, DOI 10.1158/2159-8290.CD-11-0130; Casado P, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003573; Chang CJ, 2011, CANCER CELL, V19, P86, DOI 10.1016/j.ccr.2010.10.035; Chen JC, 2014, CELL, V159, P402, DOI 10.1016/j.cell.2014.09.021; Cheng ASL, 2011, CANCER RES, V71, P4028, DOI 10.1158/0008-5472.CAN-10-3342; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Deeb SJ, 2012, MOL CELL PROTEOMICS, V11, P77, DOI 10.1074/mcp.M111.015362; Drake JM, 2013, P NATL ACAD SCI USA, V110, pE4762, DOI 10.1073/pnas.1319948110; Drake JM, 2012, P NATL ACAD SCI USA, V109, P1643, DOI 10.1073/pnas.1120985109; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gioeli D, 1999, CANCER RES, V59, P279; Gonzalez ME, 2011, CANCER RES, V71, P2360, DOI 10.1158/0008-5472.CAN-10-1933; Goodwin JF, 2015, CANCER CELL, V28, P97, DOI 10.1016/j.ccell.2015.06.004; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hagberg A.A., 2008, 7 PYTH SCI C SCIPY20, P11; Huang SSC, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002887; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Kandoth C, 2013, NATURE, V502, P333, DOI 10.1038/nature12634; Kelstrup CD, 2012, J PROTEOME RES, V11, P3487, DOI 10.1021/pr3000249; Khurana E, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002886; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lee JK, 2016, CANCER CELL, V29, P536, DOI 10.1016/j.ccell.2016.03.001; Lia WL, 2014, P NATL ACAD SCI USA, V111, P1521, DOI 10.1073/pnas.1320638111; Lu S, 1997, CANCER RES, V57, P4511; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Michalski A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.011015; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Newman RH, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.12; Ning XH, 2015, CANCER LETT, V359, P198, DOI 10.1016/j.canlet.2015.01.005; Pandey M, 2014, TOXICOL APPL PHARM, V280, P296, DOI 10.1016/j.taap.2014.08.015; Park HU, 2009, MOL CANCER THER, V8, P733, DOI 10.1158/1535-7163.MCT-08-0631; Paull EO, 2013, BIOINFORMATICS, V29, P2757, DOI 10.1093/bioinformatics/btt471; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Robinson D, 2015, CELL, V161, P1215, DOI 10.1016/j.cell.2015.05.001; Rubin MA, 2000, CLIN CANCER RES, V6, P1038; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Smith BA, 2015, P NATL ACAD SCI USA, V112, pE6544, DOI 10.1073/pnas.1518007112; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Vaske CJ, 2010, BIOINFORMATICS, V26, pi237, DOI 10.1093/bioinformatics/btq182; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wang GX, 2006, J CELL BIOCHEM, V99, P382, DOI 10.1002/jcb.20847; Weinstein JN, 2014, NATURE, V507, P315, DOI 10.1038/nature12965; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yu G, 2015, MOL CANCER RES, V13, P348, DOI 10.1158/1541-7786.MCR-14-0384-T; Zimman A, 2010, J PROTEOME RES, V9, P2812, DOI 10.1021/pr901194x	54	135	136	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					1041	1054		10.1016/j.cell.2016.07.007	http://dx.doi.org/10.1016/j.cell.2016.07.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27499020	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000382258700024
J	Morejudo, SH; Zanon, R; Escolastico, S; Yuste-Tirados, I; Malerod-Fjeld, H; Vestre, PK; Coors, WG; Martinez, A; Norby, T; Serra, JM; Kjolseth, C				Morejudo, S. H.; Zanon, R.; Escolastico, S.; Yuste-Tirados, I.; Malerod-Fjeld, H.; Vestre, P. K.; Coors, W. G.; Martinez, A.; Norby, T.; Serra, J. M.; Kjolseth, C.			Direct conversion of methane to aromatics in a catalytic co-ionic membrane reactor	SCIENCE			English	Article							NATURAL-GAS CONVERSION; DEHYDROAROMATIZATION REACTION; FUEL-CELLS; HYDROGEN; AROMATIZATION; ENHANCEMENT; PERFORMANCE; MO/HZSM-5; CHEMICALS; MO/ZSM-5	Nonoxidative methane dehydroaromatization (MDA: 6CH(4) <-> C6H6 + 9H(2)) using shape-selective Mo/zeolite catalysts is a key technology for exploitation of stranded natural gas reserves by direct conversion into transportable liquids. However, this reaction faces two major issues: The one-pass conversion is limited by thermodynamics, and the catalyst deactivates quickly through kinetically favored formation of coke. We show that integration of an electrochemical BaZrO3-based membrane exhibiting both proton and oxide ion conductivity into an MDA reactor gives rise to high aromatic yields and improved catalyst stability. These effects originate from the simultaneous extraction of hydrogen and distributed injection of oxide ions along the reactor length. Further, we demonstrate that the electrochemical co-ionic membrane reactor enables high carbon efficiencies (up to 80%) that improve the technoeconomic process viability.	[Morejudo, S. H.; Yuste-Tirados, I.; Malerod-Fjeld, H.; Vestre, P. K.; Coors, W. G.; Kjolseth, C.] CoorsTek Membrane Sci, Forskningspk,Gaustadalleen 21, NO-0349 Oslo, Norway; [Morejudo, S. H.; Norby, T.] Univ Oslo, Dept Chem, FERMiO, Gaustadalleen 21, NO-0349 Oslo, Norway; [Zanon, R.; Escolastico, S.; Martinez, A.; Serra, J. M.] Univ Politecn Valencia, CSIC, Inst Tecnol Quim, Ave los Naranjos S-N, E-46022 Valencia, Spain	University of Oslo; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; CSIC-UPV - Instituto de Tecnologia Quimica (ITQ)	Kjolseth, C (corresponding author), CoorsTek Membrane Sci, Forskningspk,Gaustadalleen 21, NO-0349 Oslo, Norway.; Serra, JM (corresponding author), Univ Politecn Valencia, CSIC, Inst Tecnol Quim, Ave los Naranjos S-N, E-46022 Valencia, Spain.	jmserra@itq.upv.es; ckjolseth@coorstek.com	Serra, Jose M/K-7646-2014; Martinez, Agustin/D-2644-2012; Yakovlev, Vladislav V/P-4668-2015	Serra, Jose M/0000-0002-1515-1106; Martinez, Agustin/0000-0002-9974-1567; Malerod-Fjeld, Harald/0000-0001-7035-7687; Kjolseth, Christian/0000-0003-4927-9412; Yuste-Tirados, Irene/0000-0002-8700-7664	Research Council of Norway [195912, 210418, 210765, 219194]; Spanish government [SEV-2012-0267, ENE2014-57651]	Research Council of Norway(Research Council of Norway); Spanish government(Spanish GovernmentEuropean Commission)	This work was supported by the Research Council of Norway (grants 195912, 210418, 210765, and 219194) and the Spanish government (grants SEV-2012-0267 and ENE2014-57651). We thank the ALBA Synchrotron Light Laboratory for beam time provision. C.K. and P.K.V. have applied for a patent based on this work (PCT/EP2014/071697). Experimental data are available online at ftp://itqrepositorio.itq.upv.es/pub/.	Atkinson A, 2004, NAT MATER, V3, P17, DOI 10.1038/nmat1040; Bijani PM, 2012, CHEM ENG TECHNOL, V35, P1825, DOI 10.1002/ceat.201100436; Cao ZW, 2013, ANGEW CHEM INT EDIT, V52, P13794, DOI 10.1002/anie.201307935; Chen Y, 2014, NANO ENERGY, V10, P1, DOI 10.1016/j.nanoen.2014.08.016; Duan CC, 2015, SCIENCE, V349, P1321, DOI 10.1126/science.aab3987; Gao J, 2015, SCIENCE, V348, P686, DOI 10.1126/science.aaa7048; Guo XG, 2014, SCIENCE, V344, P616, DOI 10.1126/science.1253150; Ismagilov ZR, 2008, ENERG ENVIRON SCI, V1, P526, DOI 10.1039/b810981h; Kinage AK, 2003, CATAL LETT, V88, P199, DOI 10.1023/A:1024022124804; Kreuer KD, 1999, SOLID STATE IONICS, V125, P285, DOI 10.1016/S0167-2738(99)00188-5; Kyriakou V., APPL CATAL B, V186, P1; Liu SL, 2003, J CATAL, V220, P57, DOI 10.1016/S0021-9517(03)00236-7; Liu Z, 2002, CATAL LETT, V82, P175, DOI 10.1023/A:1020510810548; Natesakhawat S, 2015, CATAL SCI TECHNOL, V5, P5023, DOI 10.1039/c5cy00934k; National Energy Technology Laboratory, 2013, DOENETL20131597; Shudo Y, 2009, INT J HYDROGEN ENERG, V34, P4500, DOI 10.1016/j.ijhydene.2008.06.043; Spivey JJ, 2014, CHEM SOC REV, V43, P792, DOI 10.1039/c3cs60259a; Tempelman CHL, 2015, APPL CATAL B-ENVIRON, V176, P731, DOI 10.1016/j.apcatb.2015.04.052; Vasileiou E, 2015, TOP CATAL, V58, P1193, DOI 10.1007/s11244-015-0491-9; Xu YD, 2003, J CATAL, V216, P386, DOI 10.1016/S0021-9517(02)00124-0; Xue J, 2016, ACS CATAL, V6, P2448, DOI 10.1021/acscatal.6b00004	21	251	258	37	628	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					563	566		10.1126/science.aag0274	http://dx.doi.org/10.1126/science.aag0274			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27493179	Green Published			2022-12-28	WOS:000381560900035
J	Shaw, AJ; Lam, FH; Hamilton, M; Consiglio, A; MacEwen, K; Brevnova, EE; Greenhagen, E; LaTouf, WG; South, CR; van Dijken, H; Stephanopoulos, G				Shaw, A. Joe; Lam, Felix H.; Hamilton, Maureen; Consiglio, Andrew; MacEwen, Kyle; Brevnova, Elena E.; Greenhagen, Emily; LaTouf, W. Greg; South, Colin R.; van Dijken, Hans; Stephanopoulos, Gregory			Metabolic engineering of microbial competitive advantage for industrial fermentation processes	SCIENCE			English	Article							ETHANOL; CLONING	Microbial contamination is an obstacle to widespread production of advanced biofuels and chemicals. Current practices such as process sterilization or antibiotic dosage carry excess costs or encourage the development of antibiotic resistance. We engineered Escherichia coli to assimilate melamine, a xenobiotic compound containing nitrogen. After adaptive laboratory evolution to improve pathway efficiency, the engineered strain rapidly outcompeted a control strain when melamine was supplied as the nitrogen source. We additionally engineered the yeasts Saccharomyces cerevisiae and Yarrowia lipolytica to assimilate nitrogen from cyanamide and phosphorus from potassium phosphite, and they outcompeted contaminating strains in several low-cost feedstocks. Supplying essential growth nutrients through xenobiotic or ecologically rare chemicals provides microbial competitive advantage with minimal external risks, given that engineered biocatalysts only have improved fitness within the customized fermentation environment.	[Shaw, A. Joe; Hamilton, Maureen; Consiglio, Andrew; MacEwen, Kyle; Brevnova, Elena E.; Greenhagen, Emily; LaTouf, W. Greg; South, Colin R.; van Dijken, Hans; Stephanopoulos, Gregory] Novogy, 85 Bolton St, Cambridge, MA 02140 USA; [Lam, Felix H.; Stephanopoulos, Gregory] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Brevnova, Elena E.] Total New Energies USA, 5858 Horton St, Emeryville, CA 94608 USA; [Brevnova, Elena E.] Evelo Therapeut, 620 Mem Dr, Cambridge, MA 02139 USA; [Greenhagen, Emily] Ginkgo Bioworks, 27 Drydock Ave, Boston, MA 02210 USA; [South, Colin R.] Proterro, 66 Palmer Ave, Bronxville, NY 10708 USA	Massachusetts Institute of Technology (MIT)	Shaw, AJ (corresponding author), Novogy, 85 Bolton St, Cambridge, MA 02140 USA.	jshaw@novogyinc.com		Lam, Felix/0000-0001-6585-3360	Novogy; Total New Energies; U.S. Department of Energy [DE-SC0008744]	Novogy; Total New Energies(Total SA); U.S. Department of Energy(United States Department of Energy (DOE))	We thank O. Vidalin and V. Rajgarhia for managerial support, D. Crabtree and J. Afshar for analytical support, H. Blitzblau and V. Tsakraklides for helpful comments, Cereal Process Technologies and the National Corn to Ethanol Research Center for materials and insight into corn fractionation processes, Beta Renewables for wheat straw hydrolysate, and Phibro for the yeast Ethanol Red. This work was supported by Novogy and Total New Energies. F.H.L. and G.S. were supported in part by the U.S. Department of Energy (grant DE-SC0008744). A.J.S., C.R.S., H.v.D., E.G., M.H., W.G.L., A.C., K.M., and Novogy have filed patent applications [WO2014107660 (A3), WO2015031441 (A3), and WO2015157431 (A3)] that relate to the use of ROBUST pathways for fermentation selective advantage. PROESA wheat straw hydrolysate is available from Biochemtex under a material transfer agreement. Data are available in the supplementary materials, and strains are available by request. A.J.S., F.H.L., E.E.B., E.G., W.G.L., C.R.S., H.v.D., and G.S. participated in the design of the experiments and/or the interpretation of the results. A.J.S., F.H.L., M.H., A.C., K.M., E.E.B., and E.G. participated in the acquisition and/or analysis of data. A.J.S., F.H.L., and G.S. participated in drafting and/or revising the manuscript.	Bischoff KM, 2007, J IND MICROBIOL BIOT, V34, P739, DOI 10.1007/s10295-007-0250-4; Bush K, 2011, NAT REV MICROBIOL, V9, P894, DOI 10.1038/nrmicro2693; Costas AMG, 2001, J BIOL CHEM, V276, P17429, DOI 10.1074/jbc.M011764200; Dashko S, 2014, FEMS YEAST RES, V14, P826, DOI 10.1111/1567-1364.12161; de Jong B, 2012, CURR OPIN BIOTECH, V23, P624, DOI 10.1016/j.copbio.2011.11.021; EATON RW, 1991, J BACTERIOL, V173, P1215, DOI 10.1128/jb.173.3.1215-1222.1991; Friedlander J, 2016, BIOTECHNOL BIOFUELS, V9, DOI 10.1186/s13068-016-0492-3; Fulton LM, 2015, BIOFUEL BIOPROD BIOR, V9, P476, DOI 10.1002/bbb.1559; Giguere R. J., U. S. Patent, Patent No. [US8113447 B1, 8113447]; Grayson Michelle, 2011, Nature, V474, pS1, DOI 10.1038/474S01a; Gronenberg LS, 2013, CURR OPIN CHEM BIOL, V17, P462, DOI 10.1016/j.cbpa.2013.03.037; Hede K, 2014, NATURE, V509, pS2, DOI 10.1038/509S2a; Hynes SH, 1997, J IND MICROBIOL BIOT, V18, P284, DOI 10.1038/sj.jim.2900381; Ingledew WM, 2009, ENCY IND BIOTECHNOLO, P1; Lane Melanie M., 2010, Fungal Biology Reviews, V24, P17, DOI 10.1016/j.fbr.2010.01.001; MAIERGREINER UH, 1991, P NATL ACAD SCI USA, V88, P4260, DOI 10.1073/pnas.88.10.4260; Martinez B, 2001, J BACTERIOL, V183, P5684, DOI 10.1128/JB.183.19.5684-5697.2001; Narendranath N. V., 2009, ALCOHOL TXB, P337; Peralta-Yahya PP, 2012, NATURE, V488, P320, DOI 10.1038/nature11478; Rajagopalan S, 2005, APPL BIOCHEM BIOTECH, V120, P37, DOI 10.1385/ABAB:120:1:37; Seffernick JL, 2010, J BACTERIOL, V192, P1106, DOI 10.1128/JB.01243-09; Shapir N, 2007, J BACTERIOL, V189, P674, DOI 10.1128/JB.01257-06; Walker GM, 2011, J I BREWING, V117, P3, DOI 10.1002/j.2050-0416.2011.tb00438.x; Westfall PJ, 2011, CURR OPIN BIOTECH, V22, P344, DOI 10.1016/j.copbio.2011.04.023	24	85	91	4	161	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					583	586		10.1126/science.aaf6159	http://dx.doi.org/10.1126/science.aaf6159			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27493184				2022-12-28	WOS:000381560900040
J	Questa, JI; Song, J; Geraldo, N; An, HL; Dean, C				Questa, Julia I.; Song, Jie; Geraldo, Nuno; An, Hailong; Dean, Caroline			Arabidopsis transcriptional repressor VAL1 triggers Polycomb silencing at FLC during vernalization	SCIENCE			English	Article							EPIGENETIC REGULATION; PROTEIN; COLD; SWITCH; MATURATION; PROMOTERS; MOTIF	The determinants that specify the genomic targets of Polycomb silencing complexes are still unclear. Polycomb silencing of Arabidopsis FLOWERING LOCUS C ( FLC) accelerates flowering and involves a cold-dependent epigenetic switch. Here we identify a single point mutation at an intragenic nucleation site within FLC that prevents this epigenetic switch from taking place. The mutation blocks nucleation of plant homeodomain-Polycomb repressive complex 2 ( PHD-PRC2) and indicates a role for the transcriptional repressor VAL1 in the silencing mechanism. VAL1 localizes to the nucleation region in vivo, promoting histone deacetylation and FLC transcriptional silencing, and interacts with components of the conserved apoptosis-and splicing-associated protein ( ASAP) complex. Sequence-specific targeting of transcriptional repressors thus recruits the machinery for PHD-PRC2 nucleation and epigenetic silencing.	[Questa, Julia I.; Song, Jie; Geraldo, Nuno; An, Hailong; Dean, Caroline] Norwich Res Pk, Dept Cell & Dev Biol, John Innes Ctr, Norwich NR4 7UH, Norfolk, England; [Song, Jie] Imperial Coll London, Dept Life Sci, London SW7 2AZ, England; [An, Hailong] Shandong Agr Univ, State Key Lab Crop Biol, Tai An 271018, Shandong, Peoples R China	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; Imperial College London; Shandong Agricultural University	Dean, C (corresponding author), Norwich Res Pk, Dept Cell & Dev Biol, John Innes Ctr, Norwich NR4 7UH, Norfolk, England.	caroline.dean@jic.ac.uk	Qüesta, Julia I/B-5333-2019	Qüesta, Julia I/0000-0002-0462-8423; Dean, Caroline/0000-0002-6555-3525	UK Biotechnology and Biological Sciences Research Council; European Research Council; BBSRC [BBS/E/J/000CA537] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA537] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Council(European Research Council (ERC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank all members of the Dean and Howard research groups for discussions. We are grateful to G. Saalbach for assistance with mass spectrometry, M. Suzuki for providing val1 and val2 lines, J. Irwin for the Brassica FLC sequences, J. Long for the hda19-1 line, and A. Pendle for the 35S::GFP-AtSAP18 plasmid. We thank V. Coustham, B. Rutjens, and J. Mylne for contributions at the early phase of this project. The Dean laboratory is supported by the UK Biotechnology and Biological Sciences Research Council and a European Research Council Advanced Investigator grant. The and a European Research Council Advanced Investigator grant. The supplementary materials contain additional data.	Angel A, 2015, P NATL ACAD SCI USA, V112, P4146, DOI 10.1073/pnas.1503100112; Angel A, 2011, NATURE, V476, P105, DOI 10.1038/nature10241; Blackledge NP, 2015, NAT REV MOL CELL BIO, V16, P643, DOI 10.1038/nrm4067; Braybrook SA, 2006, P NATL ACAD SCI USA, V103, P3468, DOI 10.1073/pnas.0511331103; Csorba T, 2014, P NATL ACAD SCI USA, V111, P16160, DOI 10.1073/pnas.1419030111; Derkacheva M, 2014, J EXP BOT, V65, P2769, DOI 10.1093/jxb/ert410; Finnegan EJ, 2015, PLANT J, V84, P875, DOI 10.1111/tpj.13044; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Gendall AR, 2001, CELL, V107, P525, DOI 10.1016/S0092-8674(01)00573-6; Hill K, 2008, PLANT J, V53, P172, DOI 10.1111/j.1365-313X.2007.03336.x; Kagaya Y, 1999, NUCLEIC ACIDS RES, V27, P470, DOI 10.1093/nar/27.2.470; Michaels SD, 1999, PLANT CELL, V11, P949, DOI 10.1105/tpc.11.5.949; Mylne J, 2004, COLD SPRING HARB SYM, V69, P457, DOI 10.1101/sqb.2004.69.457; Nag R, 2005, PLANT MOL BIOL, V59, P821, DOI 10.1007/s11103-005-1387-z; Pengelly AR, 2015, GENE DEV, V29, P1487, DOI 10.1101/gad.265439.115; Reidt W, 2000, PLANT J, V21, P401, DOI 10.1046/j.1365-313x.2000.00686.x; Boer DR, 2014, CELL, V156, P577, DOI 10.1016/j.cell.2013.12.027; Schwerk C, 2003, MOL CELL BIOL, V23, P2981, DOI 10.1128/MCB.23.8.2981-2990.2003; Sheldon CC, 2000, P NATL ACAD SCI USA, V97, P3753, DOI 10.1073/pnas.060023597; Singh KK, 2010, RNA, V16, P2442, DOI 10.1261/rna.2304410; Steffen PA, 2014, NAT REV MOL CELL BIO, V15, P340, DOI 10.1038/nrm3789; Sun B, 2014, SCIENCE, V343, P505, DOI 10.1126/science.1248559; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Suzuki M, 2007, PLANT PHYSIOL, V143, P902, DOI 10.1104/pp.106.092320; Swaminathan K, 2008, TRENDS PLANT SCI, V13, P647, DOI 10.1016/j.tplants.2008.09.006; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Yang C, 2013, CURR BIOL, V23, P1324, DOI 10.1016/j.cub.2013.05.050; Yang HC, 2014, CURR BIOL, V24, P1793, DOI 10.1016/j.cub.2014.06.047; Zhang Y, 1997, CELL, V89, P357, DOI 10.1016/S0092-8674(00)80216-0	29	145	151	2	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298					485	488		10.1126/science.aaf7354	http://dx.doi.org/10.1126/science.aaf7354			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27471304	Green Submitted			2022-12-28	WOS:000380583600040
J	Loeb, M; Russell, ML; Manning, V; Fonseca, K; Earn, DJD; Horsman, G; Chokani, K; Vooght, M; Babiuk, L; Schwartz, L; Neupane, B; Singh, P; Walter, SD; Pullenayegum, E				Loeb, Mark; Russell, Margaret L.; Manning, Vanessa; Fonseca, Kevin; Earn, David J. D.; Horsman, Gregory; Chokani, Khami; Vooght, Mark; Babiuk, Lorne; Schwartz, Lisa; Neupane, Binod; Singh, Pardeep; Walter, Stephen D.; Pullenayegum, Eleanor			Live Attenuated Versus Inactivated Influenza Vaccine in Hutterite Children A Cluster Randomized Blinded Trial	ANNALS OF INTERNAL MEDICINE			English	Article							YOUNG-CHILDREN; UNITED-STATES; SEASONAL INFLUENZA; SCHOOLCHILDREN; EFFICACY; INFECTIONS; FAMILIES; VIRUS; METAANALYSIS; TRIVALENT	Background: Whether vaccinating children with intranasal live attenuated influenza vaccine (LAIV) is more effective than inactivated influenza vaccine (IIV) in providing both direct protection in vaccinated persons and herd protection in unvaccinated persons is uncertain. Hutterite colonies, where members live in close-knit, small rural communities in which influenza virus infection regularly occurs, offer an opportunity to address this question. Objective: To determine whether vaccinating children and adolescents with LAIV provides better community protection than IIV. Design: A cluster randomized blinded trial conducted between October 2012 and May 2015 over 3 influenza seasons. (ClinicalTrials.gov: NCT01653015) Setting: 52 Hutterite colonies in Alberta and Saskatchewan, Canada. Participants: 1186 Canadian children and adolescents aged 36 months to 15 years who received the study vaccine and 3425 community members who did not. Intervention: Children were randomly assigned according to community in a blinded manner to receive standard dosing of either trivalent LAIV or trivalent IIV. Measurements: The primary outcome was reverse transcriptase polymerase chain reaction-confirmed influenza A or B virus in all participants (vaccinated children and persons who did not receive the study vaccine). Results: Mean vaccine coverage among children in the LAIV group was 76.9% versus 72.3% in the IIV group. Influenza virus infection occurred at a rate of 5.3% (295 of 5560 person-years) in the LAIV group versus 5.2% (304 of 5810 person-years) in the IIV group. The hazard ratio comparing LAIV with IIV for influenza A or B virus was 1.03 (95% CI, 0.85 to 1.24). Limitation: The study was conducted in Hutterite communities, which may limit generalizability. Conclusion: Immunizing children with LAIV does not provide better community protection against influenza than IIV.	McMaster Univ, Hamilton, ON, Canada; Univ Calgary, Calgary, AB, Canada; Saskatchewan Dis Control Lab, Regina, SK, Canada; [Chokani, Khami] Prince Albert Parkland Hlth Reg, 1521 6th Ave West, Prince Albert, SK S6V 5K1, Canada; [Vooght, Mark] Five Hills Hlth Reg, 107-110 Ominica St West, Moose Jaw, SK S6H 6V2, Canada; Hosp Sick Children, Toronto, ON, Canada; [Loeb, Mark; Manning, Vanessa; Singh, Pardeep] McMaster Univ, Michael G DeGroote Ctr Learning, Room 3200,1280 Main St West, Hamilton, ON L8S 4K1, Canada; [Russell, Margaret L.] Univ Calgary, Cumming Sch Med, Dept Community Hlth Sci, 3280 Hosp Dr Northwest, Calgary, AB T2N 4Z6, Canada; [Fonseca, Kevin] Prov Lab Publ Hlth, 3030 Hosp Dr Northwest, Calgary, AB T2N 4W4, Canada; [Earn, David J. D.] McMaster Univ, Dept Math & Stat, 1280 Main St West, Hamilton, ON L8S 4K1, Canada; [Horsman, Gregory] Saskatchewan Dis Control Lab, 5 Res Dr, Regina, SK S4S 0A4, Canada; [Babiuk, Lorne] Univ Alberta, 2-51 South Acad Bldg, Edmonton, AB T6G 2G7, Canada; [Schwartz, Lisa] McMaster Univ, Dept Clin Epidemiol & Biostat, 1280 Main St W,CRL 224, Hamilton, ON L8S 4K1, Canada; [Neupane, Binod] McMaster Univ, Dept Clin Epidemiol & Biostat, Michael G DeGroote Ctr Learning, Room 3202,1280 Main St West, Hamilton, ON L8S 4K1, Canada; [Walter, Stephen D.] McMaster Univ, Dept Clin Epidemiol & Biostat, Commun Res Lab, Room 233,1280 Main St West, Hamilton, ON L8S 4K1, Canada; [Pullenayegum, Eleanor] Hosp Sick Children, 555 Univ Ave, Toronto, ON M5G IX8, Canada	McMaster University; University of Calgary; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; University of Calgary; McMaster University; University of Alberta; McMaster University; McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Loeb, M (corresponding author), McMaster Univ, Michael G DeGroote Ctr Learning, Room 3200,1280 Main St West, Hamilton, ON L8S 4K1, Canada.	loebm@mcmaster.ca	Walter, Stephen/AAB-5548-2022; Pullenayegum, Eleanor/AAT-1712-2020	Walter, Stephen/0000-0003-4157-8928; Pullenayegum, Eleanor/0000-0003-4265-1330; kumbara, arya/0000-0002-0395-1245; Earn, David/0000-0002-7562-1341; Schwartz, Lisa/0000-0002-4959-225X	Canadian Institutes of Health Research [123266]; Public Health Agency of Canada; Canadian Institutes of Health Research Influenza Research Network	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Public Health Agency of Canada; Canadian Institutes of Health Research Influenza Research Network	By the Canadian Institutes of Health Research (grant 123266), Public Health Agency of Canada, and Canadian Institutes of Health Research Influenza Research Network.	Ashkenazi S, 2006, PEDIATR INFECT DIS J, V25, P870, DOI 10.1097/01.inf.0000237829.66310.85; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Centers for Disease Control and Prevention, 2016, VACC CHILDR PROGR; Cowling BJ, 2012, CLIN INFECT DIS, V55, P695, DOI 10.1093/cid/cis518; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Dushoff J, 2006, AM J EPIDEMIOL, V163, P181, DOI 10.1093/aje/kwj024; Dushoff J, 2007, PLOS MED, V4, P921, DOI 10.1371/journal.pmed.0040174; Fleming DM, 2006, PEDIATR INFECT DIS J, V25, P860, DOI 10.1097/01.inf.0000237797.14283.cf; FOX JP, 1982, AM J EPIDEMIOL, V116, P212, DOI 10.1093/oxfordjournals.aje.a113407; FOY HM, 1976, J INFECT DIS, V134, P362, DOI 10.1093/infdis/134.4.362; Grohskopf LA, 2015, AM J TRANSPLANT, V15, P2767, DOI [10.15585/mmwr.mm6430a3, 10.1111/ajt.13505]; Hoft DF, 2011, J INFECT DIS, V204, P845, DOI 10.1093/infdis/jir436; Hurwitz ES, 2000, JAMA-J AM MED ASSOC, V284, P1677, DOI 10.1001/jama.284.13.1677; King JC, 2006, NEW ENGL J MED, V355, P2523, DOI 10.1056/NEJMoa055414; Kwong JC, 2015, VACCINE, V33, P535, DOI 10.1016/j.vaccine.2014.11.044; Loeb M, 2010, JAMA-J AM MED ASSOC, V303, P943, DOI 10.1001/jama.2010.250; Long CE, 1997, ARCH FAM MED, V6, P459, DOI 10.1001/archfami.6.5.459; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; MONTO AS, 1985, AM J EPIDEMIOL, V121, P811, DOI 10.1093/oxfordjournals.aje.a114052; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Neuzil KM, 2002, ARCH PEDIAT ADOL MED, V156, P986, DOI 10.1001/archpedi.156.10.986; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Piedra PA, 2005, VACCINE, V23, P1540, DOI 10.1016/j.vaccine.2004.09.025; Public Health Agency of Canada, 2015, CAN IMM GUID CHAPT I; Public Health England, 2013, CHILDHOOD FLU PROGRA; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; RUDENKO LG, 1993, J INFECT DIS, V168, P881, DOI 10.1093/infdis/168.4.881; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Xie TL, 2003, STAT MED, V22, P2835, DOI 10.1002/sim.1536	30	25	25	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2016	165	9					617	+		10.7326/M16-0513	http://dx.doi.org/10.7326/M16-0513			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8SJ	27538259				2022-12-28	WOS:000386908600004
J	Morgan, DO				Morgan, David O.			CELL DIVISION Mitotic regulation comes into focus	NATURE			English	Editorial Material							APC/C; PHOSPHORYLATION; ACTIVATION; MECHANISM		[Morgan, David O.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Morgan, DO (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.	david.morgan@ucsf.edu		Morgan, David/0000-0001-8753-4416				Alfieri C, 2016, NATURE, V536, P431, DOI 10.1038/nature19083; Fujimitsu K, 2016, SCIENCE, V352, P1121, DOI 10.1126/science.aad3925; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; Izawa D, 2015, NATURE, V517, P631, DOI 10.1038/nature13911; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Musacchio A, 2015, CURR BIOL, V25, pR1002, DOI 10.1016/j.cub.2015.08.051; Primorac I, 2013, J CELL BIOL, V201, P177, DOI 10.1083/jcb.201301130; Qiao RP, 2016, P NATL ACAD SCI USA, V113, pE2570, DOI 10.1073/pnas.1604929113; Valk E, 2014, MOL BIOL CELL, V25, P3456, DOI 10.1091/mbc.E14-02-0774; Yamaguchi M., 2016, MOL CELL; Yang Q, 2013, NAT CELL BIOL, V15, P519, DOI 10.1038/ncb2737; Zhang SY, 2016, NATURE, V533, P260, DOI 10.1038/nature17973	12	3	3	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					407	408		10.1038/nature19423	http://dx.doi.org/10.1038/nature19423			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV0YL	27509855				2022-12-28	WOS:000382646600031
J	Nevens, F; Andreone, P; Mazzella, G; Strasser, SI; Bowlus, C; Invernizzi, P; Drenth, JPH; Pockros, PJ; Regula, J; Beuers, U; Trauner, M; Jones, DE; Floreani, A; Hohenester, S; Luketic, V; Shiffman, M; van Erpecum, KJ; Vargas, V; Vincent, C; Hirschfield, GM; Shah, H; Hansen, B; Lindor, KD; Marschall, HU; Kowdley, KV; Hooshmand-Rad, R; Marmon, T; Sheeron, S; Pencek, R; MacConell, L; Pruzanski, M; Shapiro, D				Nevens, F.; Andreone, P.; Mazzella, G.; Strasser, S. I.; Bowlus, C.; Invernizzi, P.; Drenth, J. P. H.; Pockros, P. J.; Regula, J.; Beuers, U.; Trauner, M.; Jones, D. E.; Floreani, A.; Hohenester, S.; Luketic, V.; Shiffman, M.; van Erpecum, K. J.; Vargas, V.; Vincent, C.; Hirschfield, G. M.; Shah, H.; Hansen, B.; Lindor, K. D.; Marschall, H-U; Kowdley, K. V.; Hooshmand-Rad, R.; Marmon, T.; Sheeron, S.; Pencek, R.; MacConell, L.; Pruzanski, M.; Shapiro, D.		POISE Study Grp	A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHANGING NOMENCLATURE; BIOCHEMICAL RESPONSE; CIRRHOSIS; PBC; PROGNOSIS; SCALE; FXR	BACKGROUND Primary biliary cholangitis ( formerly called primary biliary cirrhosis) can progress to cirrhosis and death despite ursodiol therapy. Alkaline phosphatase and bilirubin levels correlate with the risk of liver transplantation or death. Obeticholic acid, a farnesoid X receptor agonist, has shown potential benefit in patients with this disease. METHODS In this 12-month, double-blind, placebo-controlled, phase 3 trial, we randomly assigned 217 patients who had an inadequate response to ursodiol or who found the side effects of ursodiol unacceptable to receive obeticholic acid at a dose of 10 mg ( the 10-mg group), obeticholic acid at a dose of 5 mg with adjustment to 10 mg if applicable ( the 5-10-mg group), or placebo. The primary end point was an alkaline phosphatase level of less than 1.67 times the upper limit of the normal range, with a reduction of at least 15% from baseline, and a normal total bilirubin level. RESULTS Of 216 patients who underwent randomization and received at least one dose of obeticholic acid or placebo, 93% received ursodiol as background therapy. The primary end point occurred in more patients in the 5-10-mg group ( 46%) and the 10-mg group ( 47%) than in the placebo group ( 10%; P<0.001 for both comparisons). Patients in the 5-10-mg group and those in the 10-mg group had greater decreases than those in the placebo group in the alkaline phosphatase level ( least-squares mean, -113 and -130 U per liter, respectively, vs. -14 U per liter; P<0.001 for both comparisons) and total bilirubin level (-0.02 and -0.05 mg per deciliter [-0.3 and -0.9 mu mol per liter], respectively, vs. 0.12 mg per deciliter [ 2.0 mu mol per liter]; P<0.001 for both comparisons). Changes in noninvasive measures of liver fibrosis did not differ significantly between either treatment group and the placebo group at 12 months. Pruritus was more common with obeticholic acid than with placebo ( 56% of patients in the 5-10-mg group and 68% of those in the 10-mg group vs. 38% in the placebo group). The rate of serious adverse events was 16% in the 5-10-mg group, 11% in the 10-mg group, and 4% in the placebo group. CONCLUSIONS Obeticholic acid administered with ursodiol or as monotherapy for 12 months in patients with primary biliary cholangitis resulted in decreases from baseline in alkaline phosphatase and total bilirubin levels that differed significantly from the changes observed with placebo. There were more serious adverse events with obeticholic acid. (Funded by Intercept Pharmaceuticals; POISE ClinicalTrials.gov number, NCT01473524; Current Controlled Trials number, ISRCTN89514817.)	[Nevens, F.] Univ Hosp KU Leuven, Leuven, Belgium; [Andreone, P.; Mazzella, G.] Univ Bologna, Bologna, Italy; [Invernizzi, P.] Univ Milano Bicocca, Dept Med & Surg, Int Ctr Digest Hlth, Program Autoimmune Liver Dis, Milan, Italy; [Invernizzi, P.] Humanitas Clin & Res Ctr, Rozzano, Italy; [Floreani, A.] Univ Padua, Padua, Italy; [Strasser, S. I.] Royal Prince Alfred Hosp, Camperdown, NSW, Australia; [Bowlus, C.] Univ Calif Davis, Med Ctr, Sacramento, CA 95817 USA; [Pockros, P. J.] Scripps Clin, La Jolla, CA 92037 USA; [Hooshmand-Rad, R.; Marmon, T.; Sheeron, S.; Pencek, R.; MacConell, L.; Pruzanski, M.; Shapiro, D.] Intercept Pharmaceut, San Diego, CA USA; [Drenth, J. P. H.] Radboud Univ Nijmegen, Med Ctr, Nijmegen, Netherlands; [Beuers, U.] Univ Amsterdam, Amsterdam, Netherlands; [van Erpecum, K. J.] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Hansen, B.] Univ Med Ctr Rotterdam, Rotterdam, Netherlands; [Regula, J.] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland; [Trauner, M.] Med Univ Vienna, Vienna, Austria; [Jones, D. E.] Newcastle Univ, Sch Med, Newcastle Upon Tyne, Tyne & Wear, England; [Hirschfield, G. M.] Univ Birmingham, NIHR Biomed Res Unit, Liver Res Ctr, Birmingham, W Midlands, England; [Hohenester, S.] Univ Munich, Dept Med 2, Liver Ctr Munich, Munich, Germany; [Luketic, V.] Virginia Commonwealth Univ, Div Gastroenterol Hepatol & Nutr, Richmond, VA USA; [Luketic, V.] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Shiffman, M.] Liver Inst Virginia, Newport News, VA USA; [Vargas, V.] Univ Autonoma Barcelona, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Inst Salud Carlos III, Liver Unit,Hosp Vall dHebron, Barcelona, Spain; [Vincent, C.] Ctr Hosp Univ Montreal St Luc, Montreal, PQ, Canada; [Shah, H.] Univ Hlth Network Toronto Western Hosp, Toronto, ON, Canada; [Lindor, K. D.] Arizona State Univ, Tempe, AZ USA; [Marschall, H-U] Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden; [Kowdley, K. V.] Swedish Med Ctr, Seattle, WA USA	KU Leuven; University Hospital Leuven; University of Bologna; University of Milano-Bicocca; IRCCS Humanitas Research Hospital; University of Padua; University of Sydney; University of California System; University of California Davis; Scripps Research Institute; Intercept Pharmaceuticals; Radboud University Nijmegen; University of Amsterdam; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Maria Sklodowska-Curie National Research Institute of Oncology; Medical University of Vienna; Newcastle University - UK; University of Birmingham; University of Munich; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Hospital Universitari Vall d'Hebron; Instituto de Salud Carlos III; Universite de Montreal; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Arizona State University; Arizona State University-Tempe; University of Gothenburg; Swedish Medical Center	Nevens, F (corresponding author), Univ Hosp KU Leuven, Div Liver & Biliopancreat Disorders, Herestr 49, B-3000 Leuven, Belgium.	frederik.nevens@uzleuven.be	Vargas, Victor/AAD-3303-2020; mazzella, giuseppe/A-1865-2016; Drenth, Joost/V-7436-2019; Drenth, J.P.H./H-8025-2014; Andreone, Pietro/K-8050-2016; Marschall, Hanns-Ulrich/K-8842-2017; Bowlus, Christopher/N-9276-2016; Invernizzi, Pietro/AAB-8367-2022; Kowdley, Kris/AAF-5202-2019; Hirschfield, Gideon/M-2143-2015; Vargas Blasco, Victor Manuel/C-9711-2018	Andreone, Pietro/0000-0002-4794-9809; Marschall, Hanns-Ulrich/0000-0001-7347-3085; Bowlus, Christopher/0000-0002-3906-6811; Invernizzi, Pietro/0000-0003-3262-1998; Hirschfield, Gideon/0000-0002-6736-2255; Regula, Jaroslaw/0000-0001-7071-3151; Vargas Blasco, Victor Manuel/0000-0002-7190-6948; Mookerjee, Rajeshwar/0000-0002-6275-9384; Mazzella, Giuseppe/0000-0001-8656-8112; Ryder, Stephen David/0000-0001-9649-4444; Hohenester, Simon/0000-0002-9982-6317; Kremer, Andreas/0000-0002-9263-948X; Trauner, Michael/0000-0002-1275-6425	Intercept Pharmaceuticals; MRC [MR/L001489/1] Funding Source: UKRI; Medical Research Council [MR/L001489/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10091] Funding Source: researchfish	Intercept Pharmaceuticals; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	Funded by Intercept Pharmaceuticals; POISE ClinicalTrials.gov number, NCT01473524; Current Controlled Trials number, ISRCTN89514817.	Adorini L, 2012, DRUG DISCOV TODAY, V17, P988, DOI 10.1016/j.drudis.2012.05.012; Beuers U, 2015, GASTROENTEROLOGY, V149, P1627, DOI 10.1053/j.gastro.2015.08.031; Beuers U, 2015, DIGEST LIVER DIS, V47, P924, DOI 10.1016/j.dld.2015.08.007; Beuers U, 2015, HEPATOLOGY, V62, P1620, DOI 10.1002/hep.28140; Beuers U, 2015, J HEPATOL, V63, P1285, DOI 10.1016/j.jhep.2015.06.031; Beuers U, 2015, GUT, V64, P1671, DOI 10.1136/gutjnl-2015-310593; Beuers U, 2015, J HEPATOL, V62, pS25, DOI 10.1016/j.jhep.2015.02.023; Beuers U, 2009, J HEPATOL, V51, P237, DOI 10.1016/j.jhep.2009.04.009; Bolier AR, 2012, ACTA GASTRO-ENT BELG, V75, P399; Carbone M, 2013, GASTROENTEROLOGY, V144, P560, DOI 10.1053/j.gastro.2012.12.005; Corpechot C, 2008, HEPATOLOGY, V48, P871, DOI 10.1002/hep.22428; Corpechot C, 2012, HEPATOLOGY, V56, P198, DOI 10.1002/hep.25599; Elman S, 2010, BRIT J DERMATOL, V162, P587, DOI 10.1111/j.1365-2133.2009.09586.x; Hirschfield GM, 2015, GASTROENTEROLOGY, V148, P751, DOI 10.1053/j.gastro.2014.12.005; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Jacoby A, 2005, GUT, V54, P1622, DOI 10.1136/gut.2005.065862; Jones EA, 1999, HEPATOLOGY, V29, P1003, DOI 10.1002/hep.510290450; Kim WR, 2000, GASTROENTEROLOGY, V119, P1631, DOI 10.1053/gast.2000.20197; Kremer AE, 2010, GASTROENTEROLOGY, V139, P1008, DOI 10.1053/j.gastro.2010.05.009; Kuiper EMM, 2009, GASTROENTEROLOGY, V136, P1281, DOI 10.1053/j.gastro.2009.01.003; Lammers WJ, 2014, GASTROENTEROLOGY, V147, P1338, DOI 10.1053/j.gastro.2014.08.029; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Lichtinghagen R, 2013, J HEPATOL, V59, P236, DOI 10.1016/j.jhep.2013.03.016; Lindor KD, 2009, HEPATOLOGY, V50, P291, DOI 10.1002/hep.22906; Longo M, 2002, GUT, V51, P265, DOI 10.1136/gut.51.2.265; Neuman M, 2002, J GASTROEN HEPATOL, V17, P196, DOI 10.1046/j.1440-1746.2002.02672.x; Neuschwander-Tetri BA, 2015, LANCET, V385, P956, DOI 10.1016/S0140-6736(14)61933-4; Pellicciari R, 2002, J MED CHEM, V45, P3569, DOI 10.1021/jm025529g; Reich A, 2012, ACTA DERM-VENEREOL, V92, P497, DOI 10.2340/00015555-1265; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Zhang YQ, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.083899	31	574	600	8	59	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2016	375	7					631	643		10.1056/NEJMoa1509840	http://dx.doi.org/10.1056/NEJMoa1509840			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4VF	27532829	Green Published, Bronze			2022-12-28	WOS:000381478600005
J	Patterson, G				Patterson, Gary			Sixty years of living polymers	NATURE			English	Editorial Material							POLYMERIZATION		[Patterson, Gary] Carnegie Mellon Univ, Dept Chem, 4400 5th Ave, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Patterson, G (corresponding author), Carnegie Mellon Univ, Dept Chem, 4400 5th Ave, Pittsburgh, PA 15213 USA.	gp9a@andrew.cmu.edu						[Anonymous], 1980, VISCOELASTIC PROPERT; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Flory PJ, 1940, J AM CHEM SOC, V62, P1561, DOI 10.1021/ja01863a066; FOX TG, 1951, J PHYS COLLOID CHEM, V55, P221, DOI 10.1021/j150485a010; FOX TG, 1950, J APPL PHYS, V21, P581, DOI 10.1063/1.1699711; Franta E, 2007, J POLYM SCI POL CHEM, V45, P2576, DOI 10.1002/pola.22006; Matyjaszewski K, 2006, PROG POLYM SCI, V31, P1039, DOI 10.1016/j.progpolymsci.2006.09.002; Matyjaszewski K, 2012, MACROMOLECULES, V45, P4015, DOI 10.1021/ma3001719; Patterson G, 2007, PHYS CHEM MACROMOLEC; SZWARC M, 1983, ADV POLYM SCI, V49, P1; SZWARC M, 1956, NATURE, V178, P1168, DOI 10.1038/1781168a0	11	5	6	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					276	277		10.1038/536276a	http://dx.doi.org/10.1038/536276a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27535529				2022-12-28	WOS:000381804900020
J	Bryniarska, E				Bryniarska, Ela			Andrzej Maciejewski OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2016	354								i4396	10.1136/bmj.i4396	http://dx.doi.org/10.1136/bmj.i4396			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4UY	27520980				2022-12-28	WOS:000381477800004
J	Guarnerio, J; Bezzi, M; Jeong, JC; Paffenholz, SV; Berry, K; Naldini, MM; Lo-Coco, F; Tay, Y; Beck, AH; Pandolfi, PP				Guarnerio, Jlenia; Bezzi, Marco; Jeong, Jong Cheol; Paffenholz, Stella V.; Berry, Kelsey; Naldini, Matteo M.; Lo-Coco, Francesco; Tay, Yvonne; Beck, Andrew H.; Pandolfi, Pier Paolo			Oncogenic Role of Fusion-circRNAs Derived from Cancer-Associated Chromosomal Translocations (vol 165, pg 289, 2016)	CELL			English	Correction												ppandolf@bidmc.harvard.edu						Guarnerio J, 2016, CELL, V165, P289, DOI 10.1016/j.cell.2016.03.020	1	102	112	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					1055	1056		10.1016/j.cell.2016.07.035	http://dx.doi.org/10.1016/j.cell.2016.07.035			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27518567	Bronze			2022-12-28	WOS:000382258700026
J	Jourjine, N; Mullaney, BC; Mann, K; Scott, K				Jourjine, Nicholas; Mullaney, Brendan C.; Mann, Kevin; Scott, Kristin			Coupled Sensing of Hunger and Thirst Signals Balances Sugar and Water Consumption	CELL			English	Article							DROSOPHILA-MELANOGASTER; CAENORHABDITIS-ELEGANS; OSMOTIC REGULATION; ADULT DROSOPHILA; NUTRIENT SENSOR; HOMEOSTASIS; DOPAMINE; NANCHUNG; CHANNELS; NEURONS	Hunger and thirst are ancient homeostatic drives for food and water consumption. Although molecular and neural mechanisms underlying these drives are currently being uncovered, less is known about how hunger and thirst interact. Here, we use molecular genetic, behavioral, and anatomical studies in Drosophila to identify four neurons that modulate food and water consumption. Activation of these neurons promotes sugar consumption and restricts water consumption, whereas inactivation promotes water consumption and restricts sugar consumption. By calciumimaging studies, we show that these neurons are directly regulated by a hormone signal of nutrient levels and by osmolality. Finally, we identify a hormone receptor and an osmolality-sensitive ion channel that underlie this regulation. Thus, a small population of neurons senses internal signals of nutrient and water availability to balance sugar and water consumption. Our results suggest an elegant mechanism by which interoceptive neurons oppositely regulate homeostatic drives to eat and drink.	[Jourjine, Nicholas; Mullaney, Brendan C.; Mann, Kevin; Scott, Kristin] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Jourjine, Nicholas; Mullaney, Brendan C.; Mann, Kevin; Scott, Kristin] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Mann, Kevin] Stanford Univ, Dept Neurobiol, Stanford, CA 94305 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Stanford University	Scott, K (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.; Scott, K (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	kscott@berkeley.edu			NIH [R01 DK098747]; NSF; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098747, F32DK009874] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The K.S. lab provided comments on the manuscript. Dr. B. Rubinksy provided materials for osmolality measurements. This work was supported by a grant from the NIH (R01 DK098747 to K.S.) and an NSF predoctoral fellowship (to N.J.).	Akerboom J, 2012, J NEUROSCI, V32, P13819, DOI 10.1523/JNEUROSCI.2601-12.2012; Albers MA, 2004, J EXP BIOL, V207, P2313, DOI 10.1242/jeb.01024; ARAV A, 1994, AM J PHYSIOL-REG I, V267, pR1646, DOI 10.1152/ajpregu.1994.267.6.R1646; Bharucha KN, 2008, J EXP BIOL, V211, P3103, DOI 10.1242/jeb.016451; Bjordal M, 2014, CELL, V156, P510, DOI 10.1016/j.cell.2013.12.024; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; Burke CJ, 2012, NATURE, V492, P433, DOI 10.1038/nature11614; Cameron P, 2010, NATURE, V465, P91, DOI 10.1038/nature09011; Candy DJ, 2002, INSECT BIOCHEM MOLEC, V32, P1361, DOI 10.1016/S0965-1748(02)00056-5; Cao G, 2013, CELL, V154, P904, DOI 10.1016/j.cell.2013.07.027; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Chen ZJ, 2010, J NEUROSCI, V30, P6247, DOI 10.1523/JNEUROSCI.0627-10.2010; Colbert HA, 1997, J NEUROSCI, V17, P8259; Dethier V., 1976, THE HUNGRY FLY; Dus M, 2015, NEURON, V87, P139, DOI 10.1016/j.neuron.2015.05.032; Gohl DM, 2011, NAT METHODS, V8, P231, DOI 10.1038/NMETH.1561; Gong ZF, 2004, J NEUROSCI, V24, P9059, DOI 10.1523/JNEUROSCI.1645-04.2004; GUTMAN Y, 1969, PHYSIOL BEHAV, V4, P311, DOI 10.1016/0031-9384(69)90181-4; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; Harris DT, 2015, NEURON, V86, P1449, DOI 10.1016/j.neuron.2015.05.026; Hergarden AC, 2012, P NATL ACAD SCI USA, V109, P3967, DOI 10.1073/pnas.1200778109; Inagaki HK, 2014, NEURON, V84, P806, DOI 10.1016/j.neuron.2014.09.032; Inagaki HK, 2012, CELL, V148, P583, DOI 10.1016/j.cell.2011.12.022; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Lee GH, 2004, GENETICS, V167, P311, DOI 10.1534/genetics.167.1.311; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P13698, DOI 10.1073/pnas.1735416100; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Limmer S, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00365; Lin SW, 2014, NAT NEUROSCI, V17, P1536, DOI 10.1038/nn.3827; Liu C, 2012, NATURE, V488, P512, DOI 10.1038/nature11304; Liu L, 2007, NATURE, V450, P294, DOI 10.1038/nature06223; Liu YT, 2015, J COMP NEUROL, V523, P1840, DOI 10.1002/cne.23768; Marella S, 2012, NEURON, V73, P941, DOI 10.1016/j.neuron.2011.12.032; Mietlicki EG, 2009, PHYSIOL BEHAV, V96, P37, DOI 10.1016/j.physbeh.2008.08.004; Miyamoto T, 2012, CELL, V151, P1113, DOI 10.1016/j.cell.2012.10.024; Na JB, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003175; Paluzzi JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086386; Pool AH, 2014, NEURON, V83, P164, DOI 10.1016/j.neuron.2014.05.006; Sellami A, 2011, GEN COMP ENDOCR, V170, P582, DOI 10.1016/j.ygcen.2010.11.015; Sternson SM, 2013, NEURON, V77, P810, DOI 10.1016/j.neuron.2013.02.018; Zhang W, 2013, P NATL ACAD SCI USA, V110, P13612, DOI 10.1073/pnas.1312477110	43	77	77	3	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					855	866		10.1016/j.cell.2016.06.046	http://dx.doi.org/10.1016/j.cell.2016.06.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27477513	Green Accepted, Bronze			2022-12-28	WOS:000382258700010
J	Zhao, HY; Fernandez, E; Dowd, KA; Speer, SD; Platt, DJ; Gorman, MJ; Govero, J; Nelson, CA; Pierson, TC; Diamond, MS; Fremont, DH				Zhao, Haiyan; Fernandez, Estefania; Dowd, Kimberly A.; Speer, Scott D.; Platt, Derek J.; Gorman, Matthew J.; Govero, Jennifer; Nelson, Christopher A.; Pierson, Theodore C.; Diamond, Michael S.; Fremont, Daved H.			Structural Basis of Zika Virus-Specific Antibody Protection	CELL			English	Article							WEST-NILE-VIRUS; CROSS-REACTIVE ANTIBODIES; DENGUE VIRUS; DOMAIN-III; MONOCLONAL-ANTIBODY; FUSION-LOOP; NEUTRALIZATION; RECOGNITION; INFECTION; MOUSE	Zika virus (ZIKV) infection during pregnancy has emerged as a global public health problem because of its ability to cause severe congenital disease. Here, we developed six mouse monoclonal antibodies (mAbs) against ZIKV including four (ZV-48, ZV-54, ZV-64, and ZV-67) that were ZIKV specific and neutralized infection of African, Asian, and American strains to varying degrees. X-ray crystallographic and competition binding analyses of Fab fragments and scFvs defined three spatially distinct epitopes in DIII of the envelope protein corresponding to the lateral ridge (ZV-54 and ZV-67), C-C' loop (ZV-48 and ZV-64), and ABDE sheet (ZV-2) regions. In vivo passive transfer studies revealed protective activity of DIII-lateral ridge specific neutralizing mAbs in a mouse model of ZIKV infection. Our results suggest that DIII is targeted by multiple type-specific antibodies with distinct neutralizing activity, which provides a path for developing prophylactic antibodies for use in pregnancy or designing epitope-specific vaccines against ZIKV.	[Zhao, Haiyan; Gorman, Matthew J.; Nelson, Christopher A.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Fernandez, Estefania; Platt, Derek J.; Govero, Jennifer; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Diamond, Michael S.; Fremont, Daved H.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Fremont, Daved H.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Nelson, Christopher A.; Diamond, Michael S.; Fremont, Daved H.] Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA; [Dowd, Kimberly A.; Speer, Scott D.; Pierson, Theodore C.] NIAID, Viral Pathogenesis Sect, NIH, Bethesda, MD 20892 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Diamond, MS; Fremont, DH (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Fremont, DH (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.; Diamond, MS; Fremont, DH (corresponding author), Washington Univ, Sch Med, Ctr Human Immunol & Immunotherapy Programs, St Louis, MO 63110 USA.	diamond@borcim.wustl.edu; fremont@wustl.edu	Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165; Fremont, Daved/0000-0002-8544-2689; Platt, Derek/0000-0003-0766-4590; Dowd, Kimberly/0000-0003-3641-6852	NIH [R01 AI073755, R01 AI104972, T32 AI007163]; NIAID [HHSN272201400018C, HHSN272201200026C]; NIH Research Education Program [R25 HG006687]; NIAID; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R25HG006687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073755, ZIAAI001209, T32AI007163, R01AI104972] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH Research Education Program; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grants R01 AI073755 (to M.S.D. and D.H.F) and R01 AI104972 (to M.S.D.), and NIAID contracts HHSN272201400018C (to D.H.F. and M.S.D) and HHSN272201200026C (CSGID; to D.H.F.). E.F. and D.J.P. were supported by an NIH Pre-doctoral training grant award (T32 AI007163) and the NIH Research Education Program (R25 HG006687), respectively. K.A.D., S.D.S., and T.C.P. were funded by the intramural program of NIAID. We acknowledge Jay Nix (MBC 4.2.2 beamline at ALS Berkeley) for aid in remote data collection. M.S.D. consults for Inbios, Visterra, Sanofi, and Takeda Pharmaceuticals, is on the Scientific Advisory Boards of Moderna and OraGene, and has received research grants from Moderna, Sanofi, and Visterra.	Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930; Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002; Belmusto-Worn VE, 2005, AM J TROP MED HYG, V72, P189, DOI 10.4269/ajtmh.2005.72.189; Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Brien James D, 2013, Curr Protoc Microbiol, V31, DOI 10.1002/9780471729259.mc15d03s31; Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964; Cherrier MV, 2009, EMBO J, V28, P3269, DOI 10.1038/emboj.2009.245; Cockburn JJB, 2012, STRUCTURE, V20, P303, DOI 10.1016/j.str.2012.01.001; Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013; de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Dowd KA, 2015, MBIO, V6, DOI 10.1128/mBio.01559-15; Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111; Edeling MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004072; Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005; Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024; Jarmer J, 2014, J VIROL, V88, P13845, DOI 10.1128/JVI.02086-14; Kaufmann B, 2010, P NATL ACAD SCI USA, V107, P18950, DOI 10.1073/pnas.1011036107; Kaufmann B, 2006, P NATL ACAD SCI USA, V103, P12400, DOI 10.1073/pnas.0603488103; Kim J, 2009, J IMMUNOL, V182, P2583, DOI 10.4049/jimmunol.0803247; Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010; Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382; Martina BE, 2008, VACCINE, V26, P153, DOI 10.1016/j.vaccine.2007.10.055; Midgey CM, 2012, J IMMUNOL, V188, P4971, DOI 10.4049/jimmunol.1200227; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956; Oehler E, 2014, Euro Surveill, V19; Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240; Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06; Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312; Pentsuk N, 2009, BIRTH DEFECTS RES B, V86, P328, DOI 10.1002/bdrb.20201; Pierson TC., 2013, FIELDS VIROLOGY, V6th ed., P747; Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002; Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111; Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130; Schneeweiss A, 2011, VACCINE, V29, P6352, DOI 10.1016/j.vaccine.2011.04.116; Shi B, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-30; Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Smith S.A., 2013, MBIO, V4, pe13; Sukupolvi-Petty S, 2010, J VIROL, V84, P9227, DOI 10.1128/JVI.01087-10; Thompson BS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000453; Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11	53	261	283	3	61	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					1016	1027		10.1016/j.cell.2016.07.020	http://dx.doi.org/10.1016/j.cell.2016.07.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27475895	Green Accepted, Bronze			2022-12-28	WOS:000382258700022
J	Afkarian, M; Zelnick, LR; Hall, YN; Heagerty, PJ; Tuttle, K; Weiss, NS; de Boer, IH				Afkarian, Maryam; Zelnick, Leila R.; Hall, Yoshio N.; Heagerty, Patrick J.; Tuttle, Katherine; Weiss, Noel S.; de Boer, Ian H.			Clinical Manifestations of Kidney Disease Among US Adults With Diabetes, 1988-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLOMERULAR-FILTRATION-RATE; UNITED-STATES; COMPLICATIONS TRIAL; RENAL-INSUFFICIENCY; SERUM CREATININE; GLUCOSE CONTROL; BLOOD-PRESSURE; FOLLOW-UP; ALBUMINURIA; PROGRESSION	IMPORTANCE Diabetic kidney disease is the leading cause of chronic and end-stage kidney disease in the United States and worldwide. Changes in demographics and treatments may affect the prevalence and clinical manifestations of diabetic kidney disease. OBJECTIVE To characterize the clinical manifestations of kidney disease among US adults with diabetes over time. DESIGN, SETTING, AND PARTICIPANTS Serial cross-sectional studies of adults aged 20 years or older with diabetes mellitus participating in National Health and Nutrition Examination Surveys from 1988 through 2014. EXPOSURES Diabetes was defined as hemoglobin A(1c) greater than 6.5% or use of glucose-lowering medications. MAIN OUTCOMES AND MEASURES Albuminuria (urine albumin-to-creatinine ratio >= 30 mg/g), macroalbuminuria (urine albumin-to-creatinine ratio >= 300 mg/g), reduced estimated glomerular filtration rate (eGFR<60 mL/min/1.73 m(2)), and severely reduced eGFR (<30 mL/min/1.73 m(2)), incorporating data on biological variability to estimate the prevalence of persistent abnormalities. RESULTS There were 6251 adults with diabetes included (1431 from 1988-1994, 1443 from 1999-2004, 1280 from 2005-2008, and 2097 from 2009-2014). The prevalence of any diabetic kidney disease, defined as persistent albuminuria, persistent reduced eGFR, or both, did not significantly change over time from 28.4%(95% CI, 23.8%-32.9%) in 1988-1994 to 26.2%(95% CI, 22.6%-29.9%) in 2009-2014 (prevalence ratio, 0.95 [95% CI, 0.86-1.06] adjusting for age, sex, and race/ethnicity; P=.39 for trend). However, the prevalence of albuminuria decreased progressively over time from 20.8%(95% CI, 16.3%-25.3%) in 1988-1994 to 15.9%(95% CI, 12.7%-19.0%) in 2009-2014 (adjusted prevalence ratio, 0.76 [95% CI, 0.65-0.89]; P<.001 for trend). In contrast, the prevalence of reduced eGFR increased from 9.2%(95% CI, 6.2%-12.2%) in 1988-1994 to 14.1%(95% CI, 11.3%-17.0%) in 2009-2014 (adjusted prevalence ratio, 1.61 [95% CI, 1.33-1.95] comparing 2009-2014 with 1988-1994; P<.001 for trend), with a similar pattern for severely reduced eGFR (adjusted prevalence ratio, 2.86 [95% CI, 1.38-5.91]; P=.004 for trend). Significant heterogeneity in the temporal trend for albuminuria was noted by age (P=.049 for interaction) and race/ethnicity (P=.007 for interaction), with a decreasing prevalence of albuminuria observed only among adults younger than 65 years and non-Hispanic whites, whereas the prevalence of reduced GFR increased without significant differences by age or race/ethnicity. In 2009-2014, approximately 8.2 million adults with diabetes (95% CI, 6.5-9.9 million adults) had albuminuria, reduced eGFR, or both. CONCLUSIONS AND RELEVANCE Among US adults with diabetes from 1988 to 2014, the overall prevalence of diabetic kidney disease did not change significantly, whereas the prevalence of albuminuria declined and the prevalence of reduced eGFR increased.	[Afkarian, Maryam; Zelnick, Leila R.; Hall, Yoshio N.; Tuttle, Katherine; de Boer, Ian H.] Univ Washington, Kidney Res Inst, Seattle, WA 98195 USA; [Afkarian, Maryam; Zelnick, Leila R.; Hall, Yoshio N.; Tuttle, Katherine; de Boer, Ian H.] Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98195 USA; [Heagerty, Patrick J.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Tuttle, Katherine] Providence Hlth Care, Spokane, WA USA; [Tuttle, Katherine] Univ Washington, Sch Med, Inst Translat Hlth Sci, Seattle, WA USA; [Weiss, Noel S.; de Boer, Ian H.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	de Boer, IH (corresponding author), 325 Ninth Ave,Box 359606, Seattle, WA 98104 USA.	deboer@u.washington.edu	Hall, Yoshio/AAP-5723-2021; de Boer, Ian/GYJ-3282-2022	Tuttle, Katherine/0000-0002-2235-0103; Zelnick, Leila/0000-0002-8461-5111	National Institute of Diabetes and Digestive and Kidney Diseases [R01DK087726, R01DK088762, R01DK099199, K23DK089017, R01DK104706]; National Institute of Clinical and Translational Sciences of the National Institutes of Health [UL1TR000423]; American Diabetes Association [4-15-CKD-20]; Northwest Kidney Centers; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000423, UL1TR002319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087726, K23DK089017, R01DK104706, R01DK099199, R01DK088762] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institute of Clinical and Translational Sciences of the National Institutes of Health; American Diabetes Association(American Diabetes Association); Northwest Kidney Centers; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funding by grants R01DK087726, R01DK088762, R01DK099199, K23DK089017, and R01DK104706 from the National Institute of Diabetes and Digestive and Kidney Diseases, grant UL1TR000423 from the National Institute of Clinical and Translational Sciences, components of the National Institutes of Health, grant 4-15-CKD-20 from the American Diabetes Association, and unrestricted funding from Northwest Kidney Centers.	[Anonymous], LANG ENV STAT COMP; Bojestig M, 1996, DIABETES CARE, V19, P313, DOI 10.2337/diacare.19.4.313; Casagrande SS, 2013, DIABETES CARE, V36, P2271, DOI 10.2337/dc12-2258; Centers for Disease Control and Prevention (U.S.), NAT HLTH NUTR EX SUR; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Costacou T, 2007, AM J KIDNEY DIS, V50, P721, DOI 10.1053/j.ajkd.2007.08.005; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; de Boer IH, 2014, LANCET DIABETES ENDO, V2, P793, DOI 10.1016/S2213-8587(14)70155-X; de Boer IH, 2014, J AM SOC NEPHROL, V25, P2342, DOI 10.1681/ASN.2013091004; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; de Boer IH, 2011, ARCH INTERN MED, V171, P412, DOI 10.1001/archinternmed.2011.16; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; KLAHR S, 1994, NEW ENGL J MED, V330, P877, DOI 10.1056/NEJM199403313301301; Kramer HJ, 2003, JAMA-J AM MED ASSOC, V289, P3273, DOI 10.1001/jama.289.24.3273; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Molitch ME, 2015, KIDNEY INT, V87, P20, DOI 10.1038/ki.2014.128; Molitch ME, 2010, DIABETES CARE, V33, P1536, DOI 10.2337/dc09-1098; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Perkins BA, 2003, NEW ENGL J MED, V348, P2285, DOI 10.1056/NEJMoa021835; Perkins BA, 2010, KIDNEY INT, V77, P57, DOI 10.1038/ki.2009.399; Rossing P, 2005, KIDNEY INT, V68, P1446, DOI 10.1111/j.1523-1755.2005.00556.x; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Selvin E, 2007, AM J KIDNEY DIS, V50, P918, DOI 10.1053/j.ajkd.2007.08.020; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Thomas MC, 2009, DIABETES CARE, V32, P1497, DOI 10.2337/dc08-2186; TSALAMANDRIS C, 1994, DIABETES, V43, P649, DOI 10.2337/diabetes.43.5.649; Tuttle KR, 2014, DIABETES CARE, V37, P2864, DOI 10.2337/dc14-1296; TUTTLE KR, 1990, SEMIN NEPHROL, V10, P184	31	568	601	3	49	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2016	316	6					602	610		10.1001/jama.2016.10924	http://dx.doi.org/10.1001/jama.2016.10924			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7TK	27532915	Green Accepted, Bronze			2022-12-28	WOS:000380985600013
J	Cole, TB				Cole, Thomas B.			A Lady at the Virginal With a Gentleman	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2016	316	6					570	571		10.1001/jama.2015.14421	http://dx.doi.org/10.1001/jama.2015.14421			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7TK	27532904				2022-12-28	WOS:000380985600001
J	Mayor, S				Mayor, Susan			Oestrogen-containing contraceptive pills increase vitamin D levels, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Harmon QE, 2016, J CLIN ENDOCR METAB, DOI [10.1210/jc.2016-1658, DOI 10.1210/JC.2016-1658.]; Mayor S, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4061	2	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 8	2016	354								i4345	10.1136/bmj.i4345	http://dx.doi.org/10.1136/bmj.i4345			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4TP	27503612				2022-12-28	WOS:000381474300001
J	Siriwardena, S				Siriwardena, Seeta			Iris Krass OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																		KRASS I, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 5	2016	354								i4263	10.1136/bmj.i4263	http://dx.doi.org/10.1136/bmj.i4263			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9DD	27496182				2022-12-28	WOS:000381081800007
J	Wallbank, JR; Ghazaryan, D; Misra, A; Cao, Y; Tu, JS; Piot, BA; Potemski, M; Pezzini, S; Wiedmann, S; Zeitler, U; Lane, TLM; Morozov, SV; Greenaway, MT; Eaves, L; Geim, AK; Fal'ko, VI; Novoselov, KS; Mishchenko, A				Wallbank, J. R.; Ghazaryan, D.; Misra, A.; Cao, Y.; Tu, J. S.; Piot, B. A.; Potemski, M.; Pezzini, S.; Wiedmann, S.; Zeitler, U.; Lane, T. L. M.; Morozov, S. V.; Greenaway, M. T.; Eaves, L.; Geim, A. K.; Fal'ko, V. I.; Novoselov, K. S.; Mishchenko, A.			Tuning the valley and chiral quantum state of Dirac electrons in van der Waals heterostructures	SCIENCE			English	Article							GRAPHENE HETEROSTRUCTURES; TOPOLOGICAL INSULATORS; SPECTROSCOPY; FERMIONS	Chirality is a fundamental property of electrons with the relativistic spectrum found in graphene and topological insulators. It plays a crucial role in relativistic phenomena, such as Klein tunneling, but it is difficult to visualize directly. Here, we report the direct observation and manipulation of chirality and pseudospin polarization in the tunneling of electrons between two almost perfectly aligned graphene crystals. We use a strong in-plane magnetic field as a tool to resolve the contributions of the chiral electronic states that have a phase difference between the two components of their vector wave function. Our experiments not only shed light on chirality, but also demonstrate a technique for preparing graphene's Dirac electrons in a particular quantum chiral state in a selected valley.	[Wallbank, J. R.; Lane, T. L. M.; Fal'ko, V. I.; Novoselov, K. S.; Mishchenko, A.] Univ Manchester, Natl Graphene Inst, Manchester M13 9PL, Lancs, England; [Wallbank, J. R.; Ghazaryan, D.; Misra, A.; Lane, T. L. M.; Morozov, S. V.; Eaves, L.; Fal'ko, V. I.; Novoselov, K. S.; Mishchenko, A.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Cao, Y.; Tu, J. S.] Univ Manchester, Ctr Mesosci & Nanotechnol, Manchester M13 9PL, Lancs, England; [Piot, B. A.; Potemski, M.] LNCMI CNRS UGA UPS INSA EMFL, Lab Natl Champs Magnet Intenses, 25 Ave Martyrs, F-38042 Grenoble, France; [Pezzini, S.; Wiedmann, S.; Zeitler, U.] Radboud Univ Nijmegen, EMFL, High Field Magnet Lab, NL-6525 ED Nijmegen, Netherlands; [Pezzini, S.; Wiedmann, S.; Zeitler, U.] Radboud Univ Nijmegen, Inst Mol & Mat, NL-6525 ED Nijmegen, Netherlands; [Morozov, S. V.] RAS, Inst Microelect Technol & High Pur Mat, Chernogolovka 142432, Russia; [Morozov, S. V.] Natl Univ Sci & Technol MISiS, Leninsky Pr 4, Moscow 119049, Russia; [Greenaway, M. T.; Eaves, L.] Univ Nottingham, Sch Phys & Astron, Nottingham NG7 2RD, England	University of Manchester; University of Manchester; University of Manchester; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Radboud University Nijmegen; Radboud University Nijmegen; Russian Academy of Sciences; Institute of Microelectronics Technology & High-Purity Materials, RAS; National University of Science & Technology (MISIS); University of Nottingham	Fal'ko, VI; Novoselov, KS; Mishchenko, A (corresponding author), Univ Manchester, Natl Graphene Inst, Manchester M13 9PL, Lancs, England.; Fal'ko, VI; Novoselov, KS; Mishchenko, A (corresponding author), Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England.	vladimir.falko@manchester.ac.uk; kostya@manchester.ac.uk; artem.mishchenko@manchester.ac.uk	Greenaway, Mark/V-3143-2019; Greenaway, Mark/U-6287-2017; Lane, Thomas/E-5821-2018; Ghazaryan, Davit A./AAF-6235-2019; Novoselov, Kostya S/G-9581-2014; Morozov, Sergey V/H-3171-2014; Zeitler, Uli/D-4344-2012; Zeitler, Uli/P-5607-2019; Wiedmann, Steffen/F-9701-2015; Geim, Andre K/J-7888-2012; Wiedmann, Steffen/N-3298-2019; Mishchenko, Artem/C-7561-2011	Greenaway, Mark/0000-0003-3243-3794; Greenaway, Mark/0000-0003-3243-3794; Lane, Thomas/0000-0003-4787-7929; Ghazaryan, Davit A./0000-0002-8620-8560; Novoselov, Kostya S/0000-0003-4972-5371; Morozov, Sergey V/0000-0003-3075-7787; Zeitler, Uli/0000-0002-5293-2673; Wiedmann, Steffen/0000-0002-9122-7117; Geim, Andre K/0000-0003-2861-8331; Mishchenko, Artem/0000-0002-0427-5664; Potemski, Marek/0000-0001-8881-6618; Fal'ko, Vladimir/0000-0003-0828-0310; hai yan, he/0000-0003-0366-6185; Pezzini, Sergio/0000-0003-4289-907X	European Union FP7 Graphene Flagship Project [604391]; European Research Council; Hetero2D; Engineering and Physical Sciences Research Council (EPSRC); Royal Society; U.S. Army Research Office; U.S. Navy Research Office; U.S. Air Force Office of Scientific Research; Leverhulme Trust; EPSRC [EP/N007131/1]; NUST "MISiS" [K1-2015-046]; Russian Foundation for Basic Research [RFBR15-02-01221, RFBR14-02-00792]; EPSRC (UK) [EP/N01085X/1]; EPSRC [EP/N01085X/1, EP/K005014/1, EP/N010345/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/N01085X/1, EP/K005014/1, EP/N010345/1, EP/N007131/1] Funding Source: researchfish	European Union FP7 Graphene Flagship Project; European Research Council(European Research Council (ERC)European Commission); Hetero2D; Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Royal Society(Royal Society of London); U.S. Army Research Office; U.S. Navy Research Office; U.S. Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Leverhulme Trust(Leverhulme Trust); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NUST "MISiS"; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); EPSRC (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the European Union FP7 Graphene Flagship Project 604391, European Research Council Synergy Grant, Hetero2D, Engineering and Physical Sciences Research Council (EPSRC) (Toward Engineering Grand Challenges and Fellowship programs), the Royal Society, U.S. Army Research Office, U.S. Navy Research Office, and U.S. Air Force Office of Scientific Research. M.T.G acknowledges support from the Leverhulme Trust. A.M. acknowledges support of EPSRC Early Career Fellowship EP/N007131/1. S.V.M. was supported by NUST "MISiS" (grant K1-2015-046) and Russian Foundation for Basic Research (RFBR15-02-01221 and RFBR14-02-00792). Measurements in high magnetic field were supported by High Field Magnet Laboratory-Radboud University/Foundation for Fundamental Research on Matter (HFML-RU/FOM) and Laboratoire National des Champs Magnetiques Intenses-Centre National de la Recherche Scientifique (LNCMI-CNRS), members of the European Magnetic Field Laboratory (EMFL), and by EPSRC (UK) via its membership to the EMFL (grant no. EP/N01085X/1).	Amet F, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.073405; Bostwick A, 2007, NAT PHYS, V3, P36, DOI 10.1038/nphys477; Britnell L, 2012, SCIENCE, V335, P947, DOI 10.1126/science.1218461; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Culcer D, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.155457; FALKO VI, 1991, SEMICOND SCI TECH, V6, P196, DOI 10.1088/0268-1242/6/3/010; Fallahazad B, 2015, NANO LETT, V15, P428, DOI 10.1021/nl503756y; Geim AK, 2013, NATURE, V499, P419, DOI 10.1038/nature12385; HAYDEN RK, 1991, PHYS REV LETT, V66, P1749, DOI 10.1103/PhysRevLett.66.1749; Jung S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16642; Katsnelson MI, 2006, NAT PHYS, V2, P620, DOI 10.1038/nphys384; Katsnelson MI, 2006, EUR PHYS J B, V51, P157, DOI [10.1140/epjb/e2006-00203-1, 10.1140/epjb/e200S-00203-1]; Kretinin AV, 2014, NANO LETT, V14, P3270, DOI 10.1021/nl5006542; Lane TLM, 2015, APPL PHYS LETT, V107, DOI 10.1063/1.4935988; Lee GH, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3662043; Li CH, 2014, NAT NANOTECHNOL, V9, P218, DOI [10.1038/NNANO.2014.16, 10.1038/nnano.2014.16]; McCann E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.146805; Mishchenko A, 2014, NAT NANOTECHNOL, V9, P808, DOI [10.1038/NNANO.2014.187, 10.1038/nnano.2014.187]; Mucha-Kruczynski M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.195403; Novoselov KS, 2005, NATURE, V438, P197, DOI 10.1038/nature04233; Pesin D, 2012, NAT MATER, V11, P409, DOI [10.1038/nmat3305, 10.1038/NMAT3305]; Pratley L, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.245412; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Sadowski ML, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.266405; Tikhonenko FV, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.056802; Vdovin EE, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.186603; Yazyev OV, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.266806; Young AF, 2009, NAT PHYS, V5, P222, DOI 10.1038/NPHYS1198; Zhang YB, 2005, NATURE, V438, P201, DOI 10.1038/nature04235; Zhou SY, 2006, NAT PHYS, V2, P595, DOI 10.1038/nphys393	30	53	54	2	200	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					575	579		10.1126/science.aaf4621	http://dx.doi.org/10.1126/science.aaf4621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27493182	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000381560900038
J	Cho, J; Yu, NK; Kim, VN; Kaang, BK				Cho, Jun; Yu, Nam-Kyung; Kim, V. Narry; Kaang, Bong-Kiun			Response to Comment on "Multiple repressive mechanisms in the hippocampus during memory formation"	SCIENCE			English	Editorial Material									[Cho, Jun; Kim, V. Narry] Inst for Basic Sci Korea, Ctr RNA Res, Seoul 08826, South Korea; [Cho, Jun; Yu, Nam-Kyung; Kim, V. Narry; Kaang, Bong-Kiun] Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Seoul 08826, South Korea	Institute for Basic Science - Korea (IBS); Seoul National University (SNU)	Kim, VN (corresponding author), Inst for Basic Sci Korea, Ctr RNA Res, Seoul 08826, South Korea.; Kim, VN; Kaang, BK (corresponding author), Seoul Natl Univ, Coll Nat Sci, Dept Biol Sci, Seoul 08826, South Korea.	narry@snu.ac.kr; kaang@snu.ac.kr						Cho J, 2015, SCIENCE, V350, P82, DOI 10.1126/science.aac7368; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Lun MP, 2015, J NEUROSCI, V35, P4903, DOI 10.1523/JNEUROSCI.3081-14.2015; Mathew RS, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1288; Sirri A, 2010, BRAIN RES, V1308, P14, DOI 10.1016/j.brainres.2009.10.049; Stankiewicz AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142195	6	4	6	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298								10.1126/science.aaf2081	http://dx.doi.org/10.1126/science.aaf2081			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27482553				2022-12-28	WOS:000380583600030
J	Jackson, KJL; Boyd, SD				Jackson, Katherine J. L.; Boyd, Scott D.			Broadening Horizons: New Antibodies Against Influenza	CELL			English	Editorial Material							VIRUS	Seasonal influenza vaccine formulation efforts struggle to keep up with viral antigenic variation. Two studies now report engineered or naturally occurring human antibodies targeting the influenza hemagglutinin (HA) stem, with exceptional neutralizing breadth (Joyce et al., 2016; Kallewaard et al., 2016). Antibodies with similar structural features are elicited in multiple subjects, suggesting that modified vaccine regimens could provide broad protection.	[Jackson, Katherine J. L.; Boyd, Scott D.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Stanford University	Boyd, SD (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	sboyd1@stanford.edu	Jackson, Katherine/AAE-4326-2019	Jackson, Katherine/0000-0002-9952-7069				Andrews SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0522; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Jackson KJL, 2014, CELL HOST MICROBE, V16, P105, DOI 10.1016/j.chom.2014.05.013; Krammer F, 2013, CURR OPIN VIROL, V3, P521, DOI 10.1016/j.coviro.2013.07.007; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Wine Y, 2013, P NATL ACAD SCI USA, V110, P2993, DOI 10.1073/pnas.1213737110	6	4	4	1	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					532	533		10.1016/j.cell.2016.07.023	http://dx.doi.org/10.1016/j.cell.2016.07.023			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27471961	Bronze			2022-12-28	WOS:000380546500005
J	Vivaldelli, E; Sansone, S; Maier, A; Wiedermann, CJ				Vivaldelli, Ester; Sansone, Stefano; Maier, Armin; Wiedermann, Christian J.			Puffy hand syndrome	LANCET			English	Editorial Material									[Vivaldelli, Ester; Sansone, Stefano; Maier, Armin; Wiedermann, Christian J.] Med Univ Innsbruck, Teaching Hosp, Cent Hosp Bolzano, Dept Internal Med, Innsbruck, Austria	Medical University of Innsbruck	Wiedermann, CJ (corresponding author), Cent Hosp Bolzano, Dept Internal Med, I-39100 Bolzano, Italy.	christian.wiedermann@sabes.it	Wiedermann, Christian J./ABG-9521-2020						0	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 21	2017	389	10066					298	298		10.1016/S0140-6736(16)31011-X	http://dx.doi.org/10.1016/S0140-6736(16)31011-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EI9BC	27524395				2022-12-28	WOS:000392801200031
J	Ciccocioppo, R; Corazza, GR				Ciccocioppo, Rachele; Corazza, Gino Roberto			Mesenchymal stem cells for fistulising Crohn's disease	LANCET			English	Editorial Material							COLITIS		[Ciccocioppo, Rachele; Corazza, Gino Roberto] Univ Pavia, Clin Med 1, Dept Internal Med, IRCCS San Matteo Hosp Fdn, Piazzale Golgi 19, I-27100 Pavia, Italy	IRCCS Fondazione San Matteo; University of Pavia	Ciccocioppo, R (corresponding author), Univ Pavia, Clin Med 1, Dept Internal Med, IRCCS San Matteo Hosp Fdn, Piazzale Golgi 19, I-27100 Pavia, Italy.	rachele.ciccocioppo@unipv.it						Anderson P, 2013, GUT, V62, P1131, DOI 10.1136/gutjnl-2012-302152; Bouguen G, 2013, CLIN GASTROENTEROL H, V11, P975, DOI 10.1016/j.cgh.2012.12.042; Ciccocioppo R, 2015, MAYO CLIN PROC, V90, P747, DOI 10.1016/j.mayocp.2015.03.023; Ciccocioppo R, 2011, GUT, V60, P788, DOI 10.1136/gut.2010.214841; D'Haens GR, 2011, AM J GASTROENTEROL, V106, P199, DOI 10.1038/ajg.2010.392; Duijvestein M, 2011, CYTOTHERAPY, V13, P1066, DOI 10.3109/14653249.2011.597379; Garcia-Olmo D, 2009, DIS COLON RECTUM, V52, P79, DOI 10.1007/DCR.0b013e3181973487; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Liang XT, 2014, CELL TRANSPLANT, V23, P1045, DOI 10.3727/096368913X667709; Molendijk I, 2015, GASTROENTEROLOGY, V149, P918, DOI 10.1053/j.gastro.2015.06.014; Panes J, 2016, LANCET; Wang Y, 2014, NAT IMMUNOL, V15, P1009, DOI 10.1038/ni.3002	13	11	11	1	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2016	388	10051					1251	1252		10.1016/S0140-6736(16)31209-0	http://dx.doi.org/10.1016/S0140-6736(16)31209-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW5RH	27477895				2022-12-28	WOS:000383704000005
J	Mirelman, A; Rochester, L; Maidan, I; Del Din, S; Alcock, L; Nieuwhof, F; Rikkert, MO; Bloem, BR; Pelosin, E; Avanzino, L; Abbruzzese, G; Dockx, K; Bekkers, E; Giladi, N; Nieuwboer, A; Hausdorff, JM				Mirelman, Anat; Rochester, Lynn; Maidan, Inbal; Del Din, Silvia; Alcock, Lisa; Nieuwhof, Freek; Rikkert, Marcel Olde; Bloem, Bastiaan R.; Pelosin, Elisa; Avanzino, Laura; Abbruzzese, Giovanni; Dockx, Kim; Bekkers, Esther; Giladi, Nir; Nieuwboer, Alice; Hausdorff, Jeffrey M.			Addition of a non-immersive virtual reality component to treadmill training to reduce fall risk in older adults (V-TIME): a randomised controlled trial	LANCET			English	Article							PARKINSONS-DISEASE; ELDERLY-PEOPLE; GAIT; EXERCISE; COGNITION; CIRCUMSTANCES; PREVENTION; PROGRAM; WALKING; SCALE	Background Age-associated motor and cognitive deficits increase the risk of falls, a major cause of morbidity and mortality. Because of the significant ramifications of falls, many interventions have been proposed, but few have aimed to prevent falls via an integrated approach targeting both motor and cognitive function. We aimed to test the hypothesis that an intervention combining treadmill training with non-immersive virtual reality (VR) to target both cognitive aspects of safe ambulation and mobility would lead to fewer falls than would treadmill training alone. Methods We carried out this randomised controlled trial at five clinical centres across five countries (Belgium, Israel, Italy, the Netherlands, and the UK). Adults aged 60-90 years with a high risk of falls based on a history of two or more falls in the 6 months before the study and with varied motor and cognitive deficits were randomly assigned by use of computer-based allocation to receive 6 weeks of either treadmill training plus VR or treadmill training alone. Randomisation was stratified by subgroups of patients (those with a history of idiopathic falls, those with mild cognitive impairment, and those with Parkinson's disease) and sex, with stratification per clinical site. Group allocation was done by a third party not involved in onsite study procedures. Both groups aimed to train three times per week for 6 weeks, with each session lasting about 45 min and structured training progression individualised to the participant's level of performance. The VR system consisted of a motion-capture camera and a computer-generated simulation projected on to a large screen, which was specifically designed to reduce fall risk in older adults by including real-life challenges such as obstacles, multiple pathways, and distracters that required continual adjustment of steps. The primary outcome was the incident rate of falls during the 6 months after the end of training, which was assessed in a modified intention-to-treat population. Safety was assessed in all patients who were assigned a treatment. This study is registered with ClinicalTrials.gov, NCT01732653. Findings Between Jan 6, 2013, and April 3, 2015, 302 adults were randomly assigned to either the treadmill training plus VR group (n=154) or treadmill training alone group (n=148). Data from 282 (93%) participants were included in the prespecified, modified intention-to-treat analysis. Before training, the incident rate of falls was similar in both groups (10.7 [SD 35.6] falls per 6 months for treadmill training alone vs 11.9 [39.5] falls per 6 months for treadmill training plus VR). In the 6 months after training, the incident rate was significantly lower in the treadmill training plus VR group than it had been before training (6.00 [95% CI 4.36-8.25] falls per 6 months; p<0.0001 vs before training), whereas the incident rate did not decrease significantly in the treadmill training alone group (8.27 [5.55-12.31] falls per 6 months; p=0.49). 6 months after the end of training, the incident rate of falls was also significantly lower in the treadmill training plus VR group than in the treadmill training group (incident rate ratio 0.58, 95% CI 0.36-0.96; p=0.033). No serious training-related adverse events occurred. Interpretation In a diverse group of older adults at high risk for falls, treadmill training plus VR led to reduced fall rates compared with treadmill training alone.	[Mirelman, Anat; Maidan, Inbal; Giladi, Nir; Hausdorff, Jeffrey M.] Tel Aviv Sourasky Med Ctr, Neurol Inst, Ctr Study Movement Cognit & Mobil, Tel Aviv, Israel; [Mirelman, Anat; Giladi, Nir] Tel Aviv Univ, Sackler Fac Med, Dept Neurol, Tel Aviv, Israel; [Hausdorff, Jeffrey M.] Tel Aviv Univ, Sackler Fac Med, Dept Phys Therapy, Tel Aviv, Israel; [Giladi, Nir; Hausdorff, Jeffrey M.] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel; [Rochester, Lynn; Del Din, Silvia; Alcock, Lisa] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England; [Nieuwhof, Freek; Rikkert, Marcel Olde] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Geriatr Med, Nijmegen, Netherlands; [Nieuwhof, Freek; Rikkert, Marcel Olde] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Radboud Alzheimers Ctr, Nijmegen, Netherlands; [Nieuwhof, Freek; Bloem, Bastiaan R.] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Neurol, Nijmegen, Netherlands; [Pelosin, Elisa; Avanzino, Laura; Abbruzzese, Giovanni] Univ Genoa, Dept Neurosci, Genoa, Italy; [Avanzino, Laura] Univ Genoa, Dept Expt Med, Genoa, Italy; [Dockx, Kim; Bekkers, Esther; Nieuwboer, Alice] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Newcastle University - UK; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; University of Genoa; University of Genoa; KU Leuven	Mirelman, A (corresponding author), Tel Aviv Sourasky Med Ctr, Neurol Inst, Ctr Study Movement Cognit & Mobil CMCM, IL-64239 Tel Aviv, Israel.	anatmi@tlvmc.gov.il	Pelosin, Elisa/AAA-9637-2019; Bloem, Bastiaan/H-8013-2014; Rikkert, M.G.M. Olde/H-8078-2014; Giladi, Nir/AAU-8660-2020; Maidan, Inbal/AAW-7408-2021; Del Din, Silvia/H-2863-2019; Avanzino, Laura/K-6623-2016; Nieuwboer, Alice/F-5643-2013; Nieuwhof, Freek/P-6396-2015	Bloem, Bastiaan/0000-0002-6371-3337; Rikkert, M.G.M. Olde/0000-0003-1397-1677; Giladi, Nir/0000-0003-1482-8522; Del Din, Silvia/0000-0003-1154-4751; Nieuwboer, Alice/0000-0003-1193-6229; Rochester, Lynn/0000-0001-5774-9272; Nieuwhof, Freek/0000-0001-5440-7533; AVANZINO, LAURA/0000-0001-6286-1509; Alcock, Lisa/0000-0002-8364-9803; Pelosin, Elisa/0000-0002-9880-2241	European Commission [V-TIME-278169]	European Commission(European CommissionEuropean Commission Joint Research Centre)	European Commission.; This work was funded by the European Commission (FP7 project V-TIME-278169). We thank all of the V-TIME participants and staff for their time and commitment to the study. We also thank the V-TIME technical partners who allowed for the success of this study, specifically, Stuart Cupit from Inition 3D technologies, Yoram Bar Zeev from Beacon Tech Limited, our colleagues from the University of Sassari in Sardinia, and the CRO Advanced Drug Development Services. All authors take responsibility for the accuracy and completeness of the reported data and vouch for the fidelity of the trial to the protocol.	Ashburn A, 2008, DISABIL REHABIL, V30, P1205, DOI 10.1080/09638280701828930; Boyle N, 2010, CLIN GERIATR MED, V26, P583, DOI 10.1016/j.cger.2010.06.007; Brown LA, 2005, J GERONTOL A-BIOL, V60, P924, DOI 10.1093/gerona/60.7.924; Canning CG, 2015, NEUROLOGY, V84, P304, DOI 10.1212/WNL.0000000000001155; Dos Anjos RED, 2016, J AM GERIATR SOC, V64, P891, DOI 10.1111/jgs.14058; de Bruin ED, 2010, Z GERONTOL GERIATR, V43, P229, DOI 10.1007/s00391-010-0124-7; Doniger GM, 2009, ALZHEIMERS DEMENT, V5, P439, DOI 10.1016/j.jalz.2009.03.003; Eggenberger P, 2015, CLIN INTERV AGING, V10, P1711, DOI 10.2147/CIA.S91997; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fu AS, 2015, ARCH PHYS MED REHAB, V96, P2096, DOI 10.1016/j.apmr.2015.08.427; Galna B, 2010, HUM MOVEMENT SCI, V29, P843, DOI 10.1016/j.humov.2009.09.006; Ganz DA, 2005, J AM GERIATR SOC, V53, P2190, DOI 10.1111/j.1532-5415.2005.00509.x; Gillespie L. D., 2003, COCHRANE DB SYST REV, V2003; Goetz CG, 2004, MOVEMENT DISORD, V19, P1020, DOI 10.1002/mds.20213; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Heasley K, 2004, INVEST OPHTH VIS SCI, V45, P2122; Heinrich S, 2010, OSTEOPOROSIS INT, V21, P891, DOI 10.1007/s00198-009-1100-1; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Mak MK, 2014, ARCH PHYS MED REHAB, V95, P2390, DOI 10.1016/j.apmr.2014.08.006; Mehrholz J, 2016, EUR J PHYS REHABIL M; Mirelman A, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-15; Mirelman A, 2011, J GERONTOL A-BIOL, V66, P234, DOI 10.1093/gerona/glq201; Montero-Odasso M, 2012, J AM GERIATR SOC, V60, P2127, DOI 10.1111/j.1532-5415.2012.04209.x; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris ME, 2015, NEUROREHAB NEURAL RE, V29, P777, DOI 10.1177/1545968314565511; Nieuwboer A, 2009, GAIT POSTURE, V30, P459, DOI 10.1016/j.gaitpost.2009.07.108; Ohman H, 2016, J AM GERIATR SOC, V64, P731, DOI 10.1111/jgs.14059; Pai YC, 2014, J GERONTOL A-BIOL, V69, P1586, DOI 10.1093/gerona/glu087; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; Rosso AL, 2013, J GERONTOL A-BIOL, V68, P1379, DOI 10.1093/gerona/glt089; Rubenstein LZ, 2006, MED CLIN N AM, V90, P807, DOI 10.1016/j.mcna.2006.05.013; Sartini M, 2010, EUR J PUBLIC HEALTH, V20, P604, DOI 10.1093/eurpub/ckp165; Segev-Jacubovski O, 2011, EXPERT REV NEUROTHER, V11, P1057, DOI [10.1586/ern.11.69, 10.1586/ERN.11.69]; Shema SR, 2014, PHYS THER, V94, P1319, DOI 10.2522/ptj.20130305; Shen X, 2016, NEUROREHAB NEURAL RE, V30, P512, DOI 10.1177/1545968315613447; TINETTI ME, 1988, NEW ENGL J MED, V319, P1701, DOI 10.1056/NEJM198812293192604; Trojaniello D, 2015, IEEE ENG MED BIO, P5505, DOI 10.1109/EMBC.2015.7319638; van Iersel MB, 2008, J GERONTOL A-BIOL, V63, P1344; Varma VR, 2016, J GERONTOL A-BIOL, V71, P1451, DOI 10.1093/gerona/glw080; Verghese J, 2010, J GERONTOL A-BIOL, V65, P1338, DOI 10.1093/gerona/glq127; Wood BH, 2002, J NEUROL NEUROSUR PS, V72, P721, DOI 10.1136/jnnp.72.6.721; Yamada M, 2012, GERIATR GERONTOL INT, V12, P461, DOI 10.1111/j.1447-0594.2011.00794.x	43	216	225	11	121	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2016	388	10050					1170	1182		10.1016/S0140-6736(16)31325-3	http://dx.doi.org/10.1016/S0140-6736(16)31325-3			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DW5RA	27524393	Green Published			2022-12-28	WOS:000383703100031
J	Meng, FK; Li, XB; Torker, S; Shi, Y; Shen, X; Hoveyda, AH				Meng, Fanke; Li, Xiben; Torker, Sebastian; Shi, Ying; Shen, Xiao; Hoveyda, Amir H.			Catalytic enantioselective 1,6-conjugate additions of propargyl and allyl groups	NATURE			English	Article							CONJUGATE ALLYLATION; ASYMMETRIC 1,6-ADDITION; ORGANIC-SYNTHESIS; ALDEHYDES; REAGENTS; LIGANDS; IRIDIUM	Conjugate (or 1,4-) additions of carbanionic species to alpha,beta-unsaturated carbonyl compounds are vital to research in organic and medicinal chemistry, and there are several chiral catalysts that facilitate the catalytic enantioselective additions of nucleophiles to enoates(1). Nonetheless, catalytic enantioselective 1,6-conjugate additions are uncommon, and ones that incorporate readily functionalizable moieties, such as propargyl or allyl groups, into acyclic alpha,beta,gamma,delta-doubly unsaturated acceptors are unknown(2). Chemical transformations that could generate a new bond at the C6 position of a dienoate are particularly desirable because the resulting products could then be subjected to further modifications. However, such reactions, especially when dienoates contain two equally substituted olefins, are scarce(3) and are confined to reactions promoted by a phosphine-copper catalyst (with an alkyl Grignard reagent(4,5), dialkylzinc or trialkylaluminium compounds(6,7)), a diene-iridium catalyst (with arylboroxines)(8,9), or a bisphosphine-cobalt catalyst (with monosilyl-acetylenes)(10). 1,6-Conjugate additions are otherwise limited to substrates where there is full substitution at the C4 position(11). It is unclear why certain catalysts favour bond formation at C6, and-although there are a small number of catalytic enantioselective conjugate allyl additions(12-15)-related 1,6-additions and processes involving a propargyl unit are non-existent. Here we show that an easily accessible organocopper catalyst can promote 1,6-conjugate additions of propargyl and 2-boryl-substituted allyl groups to acyclic dienoates with high selectivity. A commercially available allenyl-boron compound or a monosubstituted allene may be used. Products can be obtained in up to 83 per cent yield, >98:2 diastereomeric ratio (for allyl additions) and 99:1 enantiomeric ratio. We elucidate the mechanistic details, including the origins of high site selectivity (1,6-versus 1,4-) and enantioselectivity as a function of the catalyst structure and reaction type, by means of density functional theory calculations. The utility of the approach is highlighted by an application towards enantioselective synthesis of the anti-HIV agent (-)-equisetin.	[Meng, Fanke; Li, Xiben; Torker, Sebastian; Shi, Ying; Shen, Xiao; Hoveyda, Amir H.] Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA	Boston College	Hoveyda, AH (corresponding author), Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA.	amir.hoveyda@bc.edu	shi, ying/R-4974-2019	Shen, Xiao/0000-0002-8675-1213; Shi, Ying/0000-0002-9263-4320	United States National Institutes of Health, Institute of General Medical Sciences [GM-47480]; National Science Foundation [CHE-1362763]; Division Of Chemistry [1362763] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047480, R01GM057212, R37GM047480] Funding Source: NIH RePORTER	United States National Institutes of Health, Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the United States National Institutes of Health, Institute of General Medical Sciences (GM-47480) and the National Science Foundation (CHE-1362763). We are grateful to A. Iimuro for experimental assistance.	Alexakis A, 2014, COPPER-CATALYZED ASYMMETRIC SYNTHESIS, P33; Ardolino MJ, 2014, J AM CHEM SOC, V136, P7092, DOI 10.1021/ja502280w; Becker J, 2013, ORG LETT, V15, P5982, DOI 10.1021/ol4028418; de Maria PD, 2007, SYNTHESIS-STUTTGART, P1439, DOI 10.1055/s-2007-966024; den Hartog T, 2008, ANGEW CHEM INT EDIT, V47, P398, DOI 10.1002/anie.200703702; den Hartog T, 2010, TETRAHEDRON-ASYMMETR, V21, P1574, DOI 10.1016/j.tetasy.2010.04.057; Denmark SE, 2008, ANGEW CHEM INT EDIT, V47, P1560, DOI 10.1002/anie.200604943; Henon H, 2008, ANGEW CHEM INT EDIT, V47, P9122, DOI 10.1002/anie.200803735; Hornillos V, 2013, J AM CHEM SOC, V135, P2140, DOI 10.1021/ja312487r; Jang H, 2011, J AM CHEM SOC, V133, P7859, DOI 10.1021/ja2007643; Keith JA, 2007, J AM CHEM SOC, V129, P11876, DOI 10.1021/ja070516j; Krautwald S, 2014, J AM CHEM SOC, V136, P3020, DOI 10.1021/ja5003247; Kuang YL, 2011, ORG LETT, V13, P3814, DOI 10.1021/ol201312y; Magrez-Chiquet M, 2013, CHEM-EUR J, V19, P13663, DOI 10.1002/chem.201302649; Meng FK, 2014, NATURE, V513, P367, DOI 10.1038/nature13735; Nishimura T, 2012, CHEM COMMUN, V48, P973, DOI 10.1039/c2cc16973h; Nishimura T, 2010, J AM CHEM SOC, V132, P7872, DOI 10.1021/ja1034842; Pelz NF, 2004, J AM CHEM SOC, V126, P16328, DOI 10.1021/ja044167u; Quasdorf KW, 2014, NATURE, V516, P181, DOI 10.1038/nature14007; Sawano T, 2012, J AM CHEM SOC, V134, P18936, DOI 10.1021/ja309756k; Seechurn CCCJ, 2012, ANGEW CHEM INT EDIT, V51, P5062, DOI 10.1002/anie.201107017; Shizuka M, 2008, ANGEW CHEM INT EDIT, V47, P5049, DOI 10.1002/anie.200800628; Sieber JD, 2008, J AM CHEM SOC, V130, P4978, DOI 10.1021/ja710922h; Silva EMP, 2012, SYNTHESIS-STUTTGART, V44, P3109, DOI 10.1055/s-0032-1316778; TAKAI K, 1995, SYNLETT, P963; Tissot M, 2014, COPPER-CATALYZED ASYMMETRIC SYNTHESIS, P69; Tissot M, 2013, CHEM-EUR J, V19, P11352, DOI 10.1002/chem.201300538; Yanagida Y, 2011, ANGEW CHEM INT EDIT, V50, P7910, DOI 10.1002/anie.201102467; Yoshikai N, 2012, CHEM REV, V112, P2339, DOI 10.1021/cr200241f; Yuki K, 2001, TETRAHEDRON LETT, V42, P2517, DOI 10.1016/S0040-4039(01)00217-9	30	89	90	2	143	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2016	537	7620					387	393		10.1038/nature19063	http://dx.doi.org/10.1038/nature19063			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV7EC	27479320	Green Accepted			2022-12-28	WOS:000383098000051
J	Abbink, P; Larocca, RA; De La Barrera, RA; Bricault, CA; Moseley, ET; Boyd, M; Kirilova, M; Li, ZF; Ng'ang'a, D; Nanayakkara, O; Nityanandam, R; Mercado, NB; Borducchi, EN; Agarwal, A; Brinkman, AL; Cabral, C; Chandrashekar, A; Giglio, PB; Jetton, D; Jimenez, J; Lee, BC; Mojta, S; Molloy, K; Shetty, M; Neubauer, GH; Stephenson, KE; Peron, JPS; Zanotto, PMD; Misamore, J; Finneyfrock, B; Lewis, MG; Alter, G; Modjarrad, K; Jarman, RG; Eckels, KH; Michael, NL; Thomas, SJ; Barouch, DH				Abbink, Peter; Larocca, Rafael A.; De La Barrera, Rafael A.; Bricault, Christine A.; Moseley, Edward T.; Boyd, Michael; Kirilova, Marinela; Li, Zhenfeng; Ng'ang'a, David; Nanayakkara, Ovini; Nityanandam, Ramya; Mercado, Noe B.; Borducchi, Erica N.; Agarwal, Arshi; Brinkman, Amanda L.; Cabral, Crystal; Chandrashekar, Abishek; Giglio, Patricia B.; Jetton, David; Jimenez, Jessica; Lee, Benjamin C.; Mojta, Shanell; Molloy, Katherine; Shetty, Mayuri; Neubauer, George H.; Stephenson, Kathryn E.; Peron, Jean Pierre S.; Zanotto, Paolo M. de A.; Misamore, Johnathan; Finneyfrock, Brad; Lewis, Mark G.; Alter, Galit; Modjarrad, Kayvon; Jarman, Richard G.; Eckels, Kenneth H.; Michael, Nelson L.; Thomas, Stephen J.; Barouch, Dan H.			Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys	SCIENCE			English	Article							INFECTION; ANTIBODIES; MICE	Zika virus (ZIKV) is responsible for a major ongoing epidemic in the Americas and has been causally associated with fetal microcephaly. The development of a safe and effective ZIKV vaccine is therefore an urgent global health priority. Here we demonstrate that three different vaccine platforms protect against ZIKV challenge in rhesus monkeys. A purified inactivated virus vaccine induced ZIKV-specific neutralizing antibodies and completely protected monkeys against ZIKV strains from both Brazil and Puerto Rico. Purified immunoglobulin from vaccinated monkeys also conferred passive protection in adoptive transfer studies. A plasmid DNA vaccine and a single-shot recombinant rhesus adenovirus serotype 52 vector vaccine, both expressing ZIKV premembrane and envelope, also elicited neutralizing antibodies and completely protected monkeys against ZIKV challenge. These data support the rapid clinical development of ZIKV vaccines for humans.	[Abbink, Peter; Larocca, Rafael A.; Bricault, Christine A.; Moseley, Edward T.; Boyd, Michael; Kirilova, Marinela; Li, Zhenfeng; Ng'ang'a, David; Nanayakkara, Ovini; Nityanandam, Ramya; Mercado, Noe B.; Borducchi, Erica N.; Agarwal, Arshi; Brinkman, Amanda L.; Cabral, Crystal; Chandrashekar, Abishek; Giglio, Patricia B.; Jetton, David; Jimenez, Jessica; Lee, Benjamin C.; Mojta, Shanell; Molloy, Katherine; Shetty, Mayuri; Neubauer, George H.; Stephenson, Kathryn E.; Barouch, Dan H.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [De La Barrera, Rafael A.; Modjarrad, Kayvon; Jarman, Richard G.; Eckels, Kenneth H.; Michael, Nelson L.; Thomas, Stephen J.] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA; [Peron, Jean Pierre S.; Zanotto, Paolo M. de A.] Univ Sao Paulo, BR-05508000 Sao Paulo, Brazil; [Misamore, Johnathan; Finneyfrock, Brad; Lewis, Mark G.] Bioqual, Rockville, MD 20852 USA; [Alter, Galit; Barouch, Dan H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Modjarrad, Kayvon] Henry M Jackson Fdn, Bethesda, MD 20817 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Universidade de Sao Paulo; BIOQUAL Inc.; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc	Barouch, DH (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.; Barouch, DH (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.	dbarouch@bidmc.harvard.edu	Chandrashekar, Abishek/P-2610-2019; Barouch, Dan/Y-3918-2019; de A. Zanotto, Paolo M./B-9286-2019; Peron, Jean Pierre S/F-9248-2012; Mercado, Noe/ABE-8247-2020	Chandrashekar, Abishek/0000-0001-7821-5552; de A. Zanotto, Paolo M./0000-0002-8167-0625; Brinkman, Amanda/0000-0002-2845-6494; Peron, Jean Pierre/0000-0003-1638-8866; Jetton, David/0000-0002-1615-9986; Mercado, Noe/0000-0001-7769-7326; Stephenson, Kathryn/0000-0002-3440-4105; Thomas, Stephen/0000-0002-8368-7682	U.S. Military Research and Materiel Command; U.S. Military HIV Research Program; Henry M. Jackson Foundation [W81XWH-11-2-0174]; National Institutes of Health [AI095985, AI096040, AI100663, AI124377]; Ragon Institute of MGH; MIT; Harvard; Sao Paulo Research Foundation (FAPESP) [2011/18703-2, 2014/17766-9]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI096040, UM1AI124377, U19AI095985, UM1AI100663] Funding Source: NIH RePORTER	U.S. Military Research and Materiel Command; U.S. Military HIV Research Program; Henry M. Jackson Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute of MGH; MIT; Harvard; Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Mascola, B. Graham, H. Marston, P. Vasconcelos, N. Collins, R. Olson, K. Kabra, C. Springer, G. Ballarini, N. Botero, K. Chandrika, G. Donofrio, M. Robb, D. Weiss, A. Cook, J. Campbell, S. Hetzel, U. Reimer, H. Wenschuh, T. Suscovich, C. Linde, R. Lu, L. Peter, J. Le Suer, P. Gandhi, M. Iampietro, K. Visitsunthorn, A. Badamchi-Zadeh, L. Maxfield, and F. Stephens for generous advice, assistance, and reagents. The data from this study are tabulated in the main paper and in the supplementary materials. P. A., R. A. L., D. H. B., R. G. J., K.H.E., and S. J. T. are co-inventors on pending patent applications related to ZIKV vaccines, antigens, and vectors, and licensure discussions with industry partners are currently ongoing. P. A. and D. H. B. are cofounders and equity holders in AVVI Biotech. ZIKV challenge stocks and vaccine constructs are available with appropriate material transfer agreements. We acknowledge support from the U.S. Military Research and Materiel Command and the U.S. Military HIV Research Program through its cooperative agreement with the Henry M. Jackson Foundation (W81XWH-11-2-0174); the National Institutes of Health (grants AI095985, AI096040, AI100663, and AI124377); the Ragon Institute of MGH, MIT, and Harvard; and the Sao Paulo Research Foundation (FAPESP; grants 2011/18703-2 and 2014/17766-9). The views expressed in this manuscript are those of the authors and do not represent the official views of the Department of the Army or the Department of Defense.	Abbink P, 2015, J VIROL, V89, P1512, DOI 10.1128/JVI.02950-14; Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Demicheli V., 2000, COCHRANE DB SYST REV, V2000; Demicheli V., 2009, COCHRANE DB SYST REV, V2009; Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824; Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204; Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005; Erra EO, 2015, EXPERT REV VACCINES, V14, P1167, DOI 10.1586/14760584.2015.1061939; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Fernandez S, 2015, AM J TROP MED HYG, V92, P698, DOI 10.4269/ajtmh.14-0268; Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116; Hombach J, 2005, VACCINE, V23, P5205, DOI 10.1016/j.vaccine.2004.11.040; Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367; Kreil TR, 1997, CLIN EXP IMMUNOL, V110, P358, DOI 10.1046/j.1365-2249.1997.4311446.x; Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952; Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017; Libraty DH, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000171; Martinez LJ, 2015, AM J TROP MED HYG, V93, P454, DOI 10.4269/ajtmh.14-0819; MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973; Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Stephenson KE, 2015, J IMMUNOL METHODS, V416, P105, DOI 10.1016/j.jim.2014.11.006; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505	30	362	387	0	147	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2016	353	6304					1129	1132		10.1126/science.aah6157	http://dx.doi.org/10.1126/science.aah6157			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0RN	27492477	Green Accepted			2022-12-28	WOS:000382626800047
J	Schneider, LS				Schneider, Lon S.			Reduce vascular risk to prevent dementia?	LANCET			English	Editorial Material							ALZHEIMERS-DISEASE; CLINICAL-TRIALS		[Schneider, Lon S.] Univ Southern Calif, Keck Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA 90033 USA; [Schneider, Lon S.] Univ Southern Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Schneider, LS (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA 90033 USA.; Schneider, LS (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA.	lschneid@usc.edu						Akoudad S, 2016, JAMA NEUROL, V73, P934, DOI 10.1001/jamaneurol.2016.1017; Andrieu S, 2015, LANCET NEUROL, V14, P926, DOI 10.1016/S1474-4422(15)00153-2; Boyle PA, 2013, ANN NEUROL, V74, P478, DOI 10.1002/ana.23964; Fargo KN, 2014, ALZHEIMERS DEMENT, V10, pS430, DOI 10.1016/j.jalz.2014.08.103; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Schneider JA, 2009, ANN NEUROL, V66, P200, DOI 10.1002/ana.21706; Schneider LS, 2014, J INTERN MED, V275, P251, DOI 10.1111/joim.12191; Solomon A, 2014, J INTERN MED, V275, P229, DOI 10.1111/joim.12178; van Charante E.P.M., 2016, LANCET; Williamson JD, 2016, JAMA-J AM MED ASSOC, V315, P2673, DOI 10.1001/jama.2016.7050; Winblad B, 2016, LANCET NEUROL, V15, P455, DOI 10.1016/S1474-4422(16)00062-4; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR	13	9	10	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2016	388	10046					738	740		10.1016/S0140-6736(16)31129-1	http://dx.doi.org/10.1016/S0140-6736(16)31129-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT6UH	27475274				2022-12-28	WOS:000381619200007
J	Bozovic, I; He, X; Wu, J; Bollinger, AT				Bozovic, I.; He, X.; Wu, J.; Bollinger, A. T.			Dependence of the critical temperature in overdoped copper oxides on superfluid density	NATURE			English	Article							MAGNETIC PENETRATION DEPTH; MUON-SPIN-ROTATION; MUTUAL INDUCTANCE; INTERFACE SUPERCONDUCTIVITY; FIELD PENETRATION; 2-COIL APPARATUS; LA2-XSRXCUO4; TRANSITION; INSULATOR; FILMS	The physics of underdoped copper oxide superconductors, including the pseudogap, spin and charge ordering and their relation to superconductivity(1-3), is intensely debated. The overdoped copper oxides are perceived as simpler, with strongly correlated fermion physics evolving smoothly into the conventional Bardeen-Cooper-Schrieffer behaviour. Pioneering studies on a few overdoped samples(4-11) indicated that the superfluid density was much lower than expected, but this was attributed to pair-breaking, disorder and phase separation. Here we report the way in which the magnetic penetration depth and the phase stiffness depend on temperature and doping by investigating the entire overdoped side of the La2-xSrxCuO4 phase diagram. We measured the absolute values of the magnetic penetration depth and the phase stiffness to an accuracy of one per cent in thousands of samples; the large statistics reveal clear trends and intrinsic properties. The films are homogeneous; variations in the critical superconducting temperature within a film are very small (less than one kelvin). At every level of doping the phase stiffness decreases linearly with temperature. The dependence of the zero-temperature phase stiffness on the critical superconducting temperature is generally linear, but with an offset; however, close to the origin this dependence becomes parabolic. This scaling law is incompatible with the standard Bardeen-Cooper-Schrieffer description.	[Bozovic, I.; He, X.; Wu, J.; Bollinger, A. T.] Brookhaven Natl Lab, Upton, NY 11973 USA; [Bozovic, I.; He, X.] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA	United States Department of Energy (DOE); Brookhaven National Laboratory; Yale University	Bozovic, I (corresponding author), Brookhaven Natl Lab, Upton, NY 11973 USA.; Bozovic, I (corresponding author), Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA.	bozovic@bnl.gov		Wu, Jie/0000-0001-7314-8856	US Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division; Gordon and Betty Moore Foundation's EPiQS Initiative [GBMF4410]	US Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division(United States Department of Energy (DOE)); Gordon and Betty Moore Foundation's EPiQS Initiative	A. Gozar, J. Zhang and J. Yoon contributed to developing the characterization techniques during the early stages of this work. R. Sundling developed the software for the inversion of the inductance data. We also benefited from the electrolyte-gating experiments and X-ray diffraction studies by X. Leng, and from numerical simulations by N. Bozovic. The research was done at BNL and was supported by the US Department of Energy, Basic Energy Sciences, Materials Sciences and Engineering Division. X.H. is supported by the Gordon and Betty Moore Foundation's EPiQS Initiative through grant GBMF4410. I.B. acknowledges discussions with J. Zaanen, G. Deutscher, A. Leggett, P. Littlewood, C.-B. Eom, J. Mannhart, P. Coleman, R. Prozorov, D. van der Marel, A. McKenzie, V. Kogan, P. Armitage, J.-M. Triscone, P. Canfield, A. Chubukov, B. Halperin, P. Kim, T. Lemberger, M. V. Sadovskii, D. Pavuna, Z. Radovic and M. Vanevic.	Alldredge JW, 2008, NAT PHYS, V4, P319, DOI 10.1038/nphys917; Bangura AF, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.140501; BERNHARD C, 1995, PHYS REV B, V52, P10488, DOI 10.1103/PhysRevB.52.10488; Bilbro LS, 2011, NAT PHYS, V7, P298, DOI [10.1038/nphys1912, 10.1038/NPHYS1912]; Bollinger AT, 2011, NATURE, V472, P458, DOI 10.1038/nature09998; Bonn D.A., 1996, PHYS PROPERTIES HIGH; Bozovic I, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.107001; Bozovic I, 2001, IEEE T APPL SUPERCON, V11, P2686, DOI 10.1109/77.919617; Broun DM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.237003; Claassen JH, 1997, J APPL PHYS, V82, P3028, DOI 10.1063/1.366287; CLAASSEN JH, 1991, REV SCI INSTRUM, V62, P996, DOI 10.1063/1.1141991; CLEM JR, 1992, PHYS REV B, V46, P14662, DOI 10.1103/PhysRevB.46.14662; Coffey MW, 2000, J APPL PHYS, V87, P4344, DOI 10.1063/1.373076; Coffey MW, 2001, J APPL PHYS, V89, P5570, DOI 10.1063/1.1363687; Cooper RA, 2009, SCIENCE, V323, P603, DOI 10.1126/science.1165015; Deepwell D, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.214509; Donnelly R. J., 1981, PHYSICA VADE MECUM, P121; Doslic M, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4890557; Dubuis G, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4896049; Fuchs A, 1996, PHYS REV B, V53, P14745, DOI 10.1103/PhysRevB.53.R14745; Gasparov VA, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.094523; Gauzzi A, 2000, REV SCI INSTRUM, V71, P2147, DOI 10.1063/1.1150597; Gilchrist J, 1996, PHYS REV B, V54, P3530, DOI 10.1103/PhysRevB.54.3530; Gozar A, 2008, NATURE, V455, P782, DOI 10.1038/nature07293; HEBARD AF, 1980, PHYS REV LETT, V44, P291, DOI 10.1103/PhysRevLett.44.291; HIRSCHFELD PJ, 1993, PHYS REV B, V48, P4219, DOI 10.1103/PhysRevB.48.4219; Homes CC, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.134517; Homes CC, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.024514; Homes CC, 2004, NATURE, V430, P539, DOI 10.1038/nature02673; Hosseini A, 1999, PHYS REV B, V60, P1349, DOI 10.1103/PhysRevB.60.1349; Keimer B, 2015, NATURE, V518, P179, DOI 10.1038/nature14165; Lee JY, 1996, APPL PHYS LETT, V69, P1637, DOI 10.1063/1.117056; LEE JY, 1993, APPL PHYS LETT, V62, P2419, DOI 10.1063/1.109383; Lee PA, 2006, REV MOD PHYS, V78, P17, DOI 10.1103/RevModPhys.78.17; Leggett A. J., 2006, QUANTUM LIQUIDS; Leggett AJ, 1998, J STAT PHYS, V93, P927, DOI 10.1023/B:JOSS.0000033170.38619.6c; Lemberger TR, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.140507; Lemberger TR, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.214513; Locquet JP, 1996, PHYS REV B, V54, P7481, DOI 10.1103/PhysRevB.54.7481; Logvenov G, 2009, SCIENCE, V326, P699, DOI 10.1126/science.1178863; Morenzoni E, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1273; NIEDERMAYER C, 1993, PHYS REV LETT, V71, P1764, DOI 10.1103/PhysRevLett.71.1764; Paget KM, 1999, PHYS REV B, V59, P641, DOI 10.1103/PhysRevB.59.641; Panagopoulos C, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.220502; PIPPARD AB, 1994, SUPERCOND SCI TECH, V7, P696, DOI 10.1088/0953-2048/7/9/013; Prozorov R, 2011, REP PROG PHYS, V74, DOI 10.1088/0034-4885/74/12/124505; Rourke PMC, 2011, NAT PHYS, V7, P455, DOI [10.1038/nphys1945, 10.1038/NPHYS1945]; Rufenacht A, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.227002; Tallon JL, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.180504; Turneaure SJ, 1998, J APPL PHYS, V83, P4334, DOI 10.1063/1.367193; Turneaure SJ, 1996, J APPL PHYS, V79, P4221, DOI 10.1063/1.362657; UEMURA YJ, 1993, NATURE, V364, P605, DOI 10.1038/364605a0; UEMURA YJ, 1989, PHYS REV LETT, V62, P2317, DOI 10.1103/PhysRevLett.62.2317; Vignolle B, 2008, NATURE, V455, P952, DOI 10.1038/nature07323; Wang RF, 1999, APPL PHYS LETT, V75, P3865, DOI 10.1063/1.125482; Wu J, 2013, NAT MATER, V12, P877, DOI [10.1038/nmat3719, 10.1038/NMAT3719]; Zaanen J, 2006, NAT PHYS, V2, P138; Zaanen J, 2004, NATURE, V430, P512, DOI 10.1038/430512a	60	202	207	8	234	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					309	+		10.1038/nature19061	http://dx.doi.org/10.1038/nature19061			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27535534	Green Submitted			2022-12-28	WOS:000381804900030
J	Dale, CR; Myint, M; Compton-Phillips, AL				Dale, Christopher R.; Myint, Michael; Compton-Phillips, Amy L.			Counting Better - The Limits and Future of Quality-Based Compensation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE		[Dale, Christopher R.; Myint, Michael] Swedish Hlth Serv, Seattle, WA USA; [Compton-Phillips, Amy L.] Providence Hlth & Serv, Renton, WA USA	Swedish Medical Center	Dale, CR (corresponding author), Swedish Hlth Serv, Seattle, WA USA.							[Anonymous], 2014, WASH STAT COMM MEAS; Cameron WB., 1963, INFORMAL SOCIOLOGY C; Meeker D, 2016, JAMA-J AM MED ASSOC, V315, P562, DOI 10.1001/jama.2016.0275; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024	4	3	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2016	375	7					609	611		10.1056/NEJMp1604897	http://dx.doi.org/10.1056/NEJMp1604897			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT4VF	27532826				2022-12-28	WOS:000381478600001
J	Streich, FC; Lima, CD				Streich, Frederick C., Jr.; Lima, Christopher D.			Capturing a substrate in an activated RING E3/E2-SUMO complex	NATURE			English	Article							E3 LIGASE; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; SUMO MODIFICATION; UBIQUITIN; PCNA; UBC9; MECHANISM; CONJUGATION; INSIGHTS	Post-translational protein modification by ubiquitin (Ub) and ubiquitin-like (Ubl) proteins such as small ubiquitinlike modifier (SUMO) regulates processes including protein homeostasis, the DNA damage response, and the cell cycle. Proliferating cell nuclear antigen (PCNA) is modified by Ub or poly-Ub at lysine (Lys) 164 after DNA damage to recruit repair factors. Yeast PCNA is modified by SUMO on Lys164 and Lys127 during S-phase to recruit the anti-recombinogenic helicase Srs2. Lys164 modification requires specialized E2/E3 enzyme pairs for SUMO or Ub conjugation. For SUMO, Lys164 modification is strictly dependent on the E3 ligase Siz1, suggesting the E3 alters E2 specificity to promote Lys164 modification. The structural basis for substrate interactions in activated E3/E2-Ub/Ubl complexes remains unclear. Here we report an engineered E2 protein and cross-linking strategies that trap an E3/E2-Ubl/substrate complex for structure determination, illustrating how an E3 can bypass E2 specificity to force-feed a substrate lysine into the E2 active site.	[Streich, Frederick C., Jr.; Lima, Christopher D.] Sloan Kettering Inst, Struct Biol Program, 1275 York Ave, New York, NY 10065 USA; [Lima, Christopher D.] Howard Hughes Med Inst, 1275 York Ave, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute	Lima, CD (corresponding author), Sloan Kettering Inst, Struct Biol Program, 1275 York Ave, New York, NY 10065 USA.; Lima, CD (corresponding author), Howard Hughes Med Inst, 1275 York Ave, New York, NY 10065 USA.	limac@mskcc.org		Streich Jr, Frederick/0000-0002-7549-424X; Lima, Christopher/0000-0002-9163-6092	National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS) [P41 GM103403]; NIH-ORIP (Office of Research Infrastructure Programs) High-End Shared Instrument grant) at the Advanced Photon Source [S10 RR029205]; DOE Office of Science [DE-AC02-06CH11357]; NIH/NIGMS [GM065872, GM118080]; NIH/National Cancer Institute [P30CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118080, P41GM103403, R01GM065872] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH-ORIP (Office of Research Infrastructure Programs) High-End Shared Instrument grant) at the Advanced Photon Source; DOE Office of Science(United States Department of Energy (DOE)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research at NE-CAT beamlines was funded by P41 GM103403 (National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)), S10 RR029205 (NIH-ORIP (Office of Research Infrastructure Programs) High-End Shared Instrument grant) at the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory (DE-AC02-06CH11357). Research was supported in part by GM065872 and GM118080 (NIH/NIGMS, C.D.L.) and P30CA008748 (NIH/National Cancer Institute). The content is the authors' responsibility and does not represent the official views of the NIH. C.D.L. is a Howard Hughes Medical Institute Investigator.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Armstrong AA, 2012, NATURE, V483, P59, DOI 10.1038/nature10883; Bernier-Villamor V, 2002, CELL, V108, P345, DOI 10.1016/S0092-8674(02)00630-X; Bosanac I, 2011, J MOL BIOL, V408, P420, DOI 10.1016/j.jmb.2011.03.011; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Buetow L, 2015, MOL CELL, V58, P297, DOI 10.1016/j.molcel.2015.02.017; Capili AD, 2007, J MOL BIOL, V369, P608, DOI 10.1016/j.jmb.2007.04.006; Cappadocia L, 2015, NAT STRUCT MOL BIOL, V22, P968, DOI 10.1038/nsmb.3116; Chang LF, 2015, NATURE, V522, P450, DOI 10.1038/nature14471; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dou H, 2013, NAT STRUCT MOL BIOL, V20, P982, DOI 10.1038/nsmb.2621; Dou H, 2012, NAT STRUCT MOL BIOL, V19, P876, DOI 10.1038/nsmb.2379; Duda DM, 2007, J MOL BIOL, V369, P619, DOI 10.1016/j.jmb.2007.04.007; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Jentsch S, 2013, ANNU REV GENET, V47, P167, DOI 10.1146/annurev-genet-111212-133453; Johnson ES, 2001, CELL, V106, P735, DOI 10.1016/S0092-8674(01)00491-3; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Knipscheer P, 2008, MOL CELL, V31, P371, DOI 10.1016/j.molcel.2008.05.022; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Mascle XH, 2013, J BIOL CHEM, V288, P36312, DOI 10.1074/jbc.M113.486845; Mattiroli F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4291; McGinty RK, 2014, NATURE, V514, P591, DOI 10.1038/nature13890; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page RC, 2012, BIOCHEMISTRY-US, V51, P4175, DOI 10.1021/bi300058m; Papouli E, 2005, MOL CELL, V19, P123, DOI 10.1016/j.molcel.2005.06.001; Parker JL, 2008, EMBO J, V27, P2422, DOI 10.1038/emboj.2008.162; Parker JL, 2012, NUCLEIC ACIDS RES, V40, P11380, DOI 10.1093/nar/gks892; Parker JL, 2009, EMBO J, V28, P3657, DOI 10.1038/emboj.2009.303; Pfander B, 2005, NATURE, V436, P428, DOI 10.1038/nature03665; Plechanovova A, 2012, NATURE, V489, P115, DOI 10.1038/nature11376; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Rodrigo-Brenni MC, 2010, MOL CELL, V39, P548, DOI 10.1016/j.molcel.2010.07.027; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Sampson DA, 2001, J BIOL CHEM, V276, P21664, DOI 10.1074/jbc.M100006200; Scott DC, 2014, CELL, V157, P1671, DOI 10.1016/j.cell.2014.04.037; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Streich FC, 2014, ANNU REV BIOPHYS, V43, P357, DOI 10.1146/annurev-biophys-051013-022958; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wright JD, 2016, NAT STRUCT MOL BIOL, V23, P45, DOI 10.1038/nsmb.3142; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104; Yunus AA, 2009, MOL CELL, V35, P669, DOI 10.1016/j.molcel.2009.07.013; Yunus Ali A., 2009, V497, P167, DOI 10.1007/978-1-59745-566-4_11	53	58	60	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					304	+		10.1038/nature19071	http://dx.doi.org/10.1038/nature19071			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27509863	Green Accepted			2022-12-28	WOS:000381804900029
J	Levinson, W; Yeung, JS; Ginsburg, S				Levinson, Wendy; Yeung, Jensen; Ginsburg, Shiphra			Disclosure of Medical Error	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Levinson, Wendy] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada; [Yeung, Jensen] Womens Coll Hosp, Dept Dermatol, Toronto, ON, Canada; [Yeung, Jensen] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [Ginsburg, Shiphra] Univ Toronto, Dept Med, Toronto, ON, Canada; [Ginsburg, Shiphra] Wilson Ctr Res Educ, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Levinson, W (corresponding author), Univ Toronto, St Michaels Hosp, Dept Med, 30 Bond St,LKSKI 339, Toronto, ON M5B 1W8, Canada.	wendy.levinson@utoronto.ca	Ginsburg, Shiphra R/C-1695-2008	Ginsburg, Shiphra R/0000-0002-4595-6650				Canadian Patient Safety Institute, 2011, DISCL GUID BEING OP; Gallagher TH, 2003, JAMA-J AM MED ASSOC, V289, P1001, DOI 10.1001/jama.289.8.1001; Gallagher TH, 2013, NEW ENGL J MED, V369, P1752, DOI 10.1056/NEJMsb1303119; Institute of Medicine, 2000, ERR IS HUMAN BUILDIN; Levinson WS., 2014, UNDERSTANDING MED PR; Massachusetts Coalition for the Prevention of Medical Er-rors, 2006, THINGS GO WRONG RESP; National Quality Forum, 2010, SAF PRACT BETT HEALT; Wu AW, 2000, BRIT MED J, V320, P726, DOI 10.1136/bmj.320.7237.726	8	11	11	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2016	316	7					764	765		10.1001/jama.2016.9136	http://dx.doi.org/10.1001/jama.2016.9136			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT5IA	27533161				2022-12-28	WOS:000381514800022
J	Livingston, EH; Ginsburg, S; Levinson, W				Livingston, Edward H.; Ginsburg, Shiphra; Levinson, Wendy			Introducing JAMA Professionalism	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							SELF		[Livingston, Edward H.] JAMA, 330 N Wabash Ave, Chicago, IL 60611 USA; [Livingston, Edward H.] Univ Texas Southwestern Med Sch, Houston, TX USA; [Livingston, Edward H.] Northwestern Univ, Evanston, IL USA; [Ginsburg, Shiphra] Univ Toronto, Wilson Ctr Res Educ, Toronto, ON, Canada; [Levinson, Wendy] Univ Toronto, St Michaels Hosp, Toronto, ON, Canada	Northwestern University; University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Livingston, EH (corresponding author), JAMA, 330 N Wabash Ave, Chicago, IL 60611 USA.	edward.livingston@jamanetwork.org	Ginsburg, Shiphra R/C-1695-2008	Ginsburg, Shiphra R/0000-0002-4595-6650				Brotherton S, 2016, JAMA-J AM MED ASSOC, V316, P1041, DOI 10.1001/jama.2016.9752; Chassin MR, 2015, JAMA-J AM MED ASSOC, V313, P1795, DOI 10.1001/jama.2015.3818; Cohen JJ, 2015, JAMA-J AM MED ASSOC, V313, P1839, DOI 10.1001/jama.2015.3736; DeAngelis CD, 2015, JAMA-J AM MED ASSOC, V313, P1837, DOI 10.1001/jama.2015.3597; Kirch DG, 2015, JAMA-J AM MED ASSOC, V313, P1797, DOI 10.1001/jama.2015.4019; Levinson W, 2015, UNDERSTANDING MED PR; Madara JL, 2015, JAMA-J AM MED ASSOC, V313, P1793, DOI 10.1001/jama.2015.4045; Naylor CD, 2015, JAMA-J AM MED ASSOC, V313, P1825, DOI 10.1001/jama.2015.3705	8	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2016	316	7					720	721		10.1001/jama.2016.9854	http://dx.doi.org/10.1001/jama.2016.9854			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT5IA	27533156				2022-12-28	WOS:000381514800017
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Racism, immigration, and the NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Blavatnik School of Government University of Oxford, 2015, BSGWP2015005; Department of Health, 2015, NHS CONST ENGL; Mason R., 2014, GUARDIAN; NHS Employers, VIOL STAFF; NHS England, 2016, EQ AN NHS WORKF RAC; Siddique H., 2014, GUARDIAN; Snow S, 2011, IMMIGRATION NATL HLT	7	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 15	2016	354								i4477	10.1136/bmj.i4477	http://dx.doi.org/10.1136/bmj.i4477			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GR	27527903	Green Published, Bronze			2022-12-28	WOS:000381805400016
J	Agua-Agum, J; Allegranzi, B; Ariyarajah, A; Aylward, RB; Blake, IM; Barboza, P; Bausch, D; Brennan, RJ; Clement, P; Coffey, P; Cori, A; Donnelly, CA; Dorigatti, I; Drury, P; Durski, K; Dye, C; Eckmanns, T; Ferguson, NM; Fraser, C; Garcia, E; Garske, T; Gasasira, A; Gurry, C; Gutierrez, GJ; Hamblion, E; Hinsley, W; Holden, R; Holmes, D; Hugonnet, S; Jombart, T; Kelley, E; Santhana, R; Mahmoud, N; Mills, HL; Mohamed, Y; Musa, E; Naidoo, D; Nedjati-Gilani, G; Newton, E; Norton, I; Nouvellet, P; Perkins, D; Perkins, M; Riley, S; Schumacher, D; Shah, A; Tang, M; Varsaneux, O; Van Kerkhove, MD				Agua-Agum, Junerlyn; Allegranzi, Benedetta; Ariyarajah, Archchun; Aylward, R. Bruce; Blake, Isobel M.; Barboza, Philippe; Bausch, Daniel; Brennan, Richard J.; Clement, Peter; Coffey, Pasqualina; Cori, Anne; Donnelly, Christl A.; Dorigatti, Ilaria; Drury, Patrick; Durski, Kara; Dye, Christopher; Eckmanns, Tim; Ferguson, Neil M.; Fraser, Christophe; Garcia, Erika; Garske, Tini; Gasasira, Alex; Gurry, Celine; Gutierrez, Giovanna Jaramillo; Hamblion, Esther; Hinsley, Wes; Holden, Robert; Holmes, David; Hugonnet, Stephane; Jombart, Thibaut; Kelley, Edward; Santhana, Ravi; Mahmoud, Nuha; Mills, Harriet L.; Mohamed, Yasmine; Musa, Emmanuel; Naidoo, Dhamari; Nedjati-Gilani, Gemma; Newton, Emily; Norton, Ian; Nouvellet, Pierre; Perkins, Devin; Perkins, Mark; Riley, Steven; Schumacher, Dirk; Shah, Anita; Minh Tang; Varsaneux, Olivia; Van Kerkhove, Maria D.		WHO Ebola Response Team	After Ebola in West Africa - Unpredictable Risks, Preventable Epidemics	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VIRUS DISEASE OUTBREAK; SEXUAL TRANSMISSION; RAPID RESPONSE; REMOTE AREAS; LIBERIA; INTERVENTIONS; DYNAMICS; NIGERIA; COUNTY	Between December 2013 and April 2016, the largest epidemic of Ebola virus disease (EVD) to date generated more than 28,000 cases and more than 11,000 deaths in the large, mobile populations of Guinea, Liberia, and Sierra Leone. Tracking the rapid rise and slower decline of the West African epidemic has reinforced some common understandings about the epidemiology and control of EVD but has also generated new insights. Despite having more information about the geographic distribution of the disease, the risk of human infection from animals and from survivors of EVD remains unpredictable over a wide area of equatorial Africa. Until human exposure to infection can be anticipated or avoided, future outbreaks will have to be managed with the classic approach to EVD control - extensive surveillance, rapid detection and diagnosis, comprehensive tracing of contacts, prompt patient isolation, supportive clinical care, rigorous efforts to prevent and control infection, safe and dignified burial, and engagement of the community. Empirical and modeling studies conducted during the West African epidemic have shown that large epidemics of EVD are preventable - a rapid response can interrupt transmission and restrict the size of outbreaks, even in densely populated cities. The critical question now is how to ensure that populations and their health services are ready for the next outbreak, wherever it may occur. Health security across Africa and beyond depends on committing resources to both strengthen national health systems and sustain investment in the next generation of vaccines, drugs, and diagnostics.	[Agua-Agum, Junerlyn; Allegranzi, Benedetta; Ariyarajah, Archchun; Aylward, R. Bruce; Barboza, Philippe; Bausch, Daniel; Brennan, Richard J.; Clement, Peter; Coffey, Pasqualina; Drury, Patrick; Durski, Kara; Dye, Christopher; Eckmanns, Tim; Garcia, Erika; Gasasira, Alex; Gurry, Celine; Gutierrez, Giovanna Jaramillo; Hamblion, Esther; Holden, Robert; Holmes, David; Hugonnet, Stephane; Kelley, Edward; Santhana, Ravi; Mahmoud, Nuha; Mohamed, Yasmine; Musa, Emmanuel; Naidoo, Dhamari; Newton, Emily; Norton, Ian; Perkins, Devin; Schumacher, Dirk; Shah, Anita; Minh Tang; Varsaneux, Olivia] WHO, Ave Appia, CH-1211 Geneva 27, Switzerland; [Perkins, Mark] Fdn Innovat New Diagnost, Geneva, Switzerland; [Blake, Isobel M.; Cori, Anne; Donnelly, Christl A.; Dorigatti, Ilaria; Ferguson, Neil M.; Fraser, Christophe; Garske, Tini; Hinsley, Wes; Jombart, Thibaut; Mills, Harriet L.; Nedjati-Gilani, Gemma; Nouvellet, Pierre; Riley, Steven; Van Kerkhove, Maria D.] Imperial Coll London, WHO Collaborating Ctr Infect Dis Modelling, Ctr Outbreak Anal & Modelling, Dept Infect Dis Epidemiol,Med Res Council, London, England; [Eckmanns, Tim; Schumacher, Dirk] Robert Koch Inst, Dept Infect Dis Epidemiol, Berlin, Germany; [Van Kerkhove, Maria D.] Inst Pasteur, Ctr Global Hlth, Paris, France	World Health Organization; Foundation For Innovative New Diagnostics; Imperial College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Robert Koch Institute; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Dye, C (corresponding author), WHO, Ave Appia, CH-1211 Geneva 27, Switzerland.	dyec@who.int	Cori, Anne/AFL-1641-2022; Coffey, Pasqualina/AAB-7169-2019; Ferguson, Neil/B-8578-2008; Fraser, Christophe/A-8109-2008; Dye, Christopher/AIC-4659-2022	Cori, Anne/0000-0002-8443-9162; Ferguson, Neil/0000-0002-1154-8093; Fraser, Christophe/0000-0003-2399-9657; Blake, Isobel/0000-0002-3977-1318; Hamblion, Esther/0000-0003-4250-3696; nouvellet, pierre/0000-0002-6094-5722; Newton, Emily/0000-0002-9581-7085; Shah, Anita A./0000-0003-1865-2085; Dorigatti, Ilaria/0000-0001-9959-0706; varsaneux, olivia/0000-0003-3249-0721	MRC [MR/J008761/1, MR/K010174/1] Funding Source: UKRI; Medical Research Council [G0600719B, MR/K010174/1B, 1109359] Funding Source: researchfish; National Institute for Health Research [HPRU-2012-10080] Funding Source: researchfish; Medical Research Council [MR/K010174/1, MR/J008761/1] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abramowitz SA, 2015, LANCET, V385, P330, DOI 10.1016/S0140-6736(15)60119-2; Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924; [Anonymous], 2016, EB VIR DIS OUTBR RES; [Anonymous], 2016, RES RES; [Anonymous], 2010, TECHN GUID INT DIS S; Ansumana R, 2015, NEW ENGL J MED, V372, P587, DOI 10.1056/NEJMc1413685; Aylward B, 2014, NEW ENGL J MED, V371, P1481, DOI 10.1056/NEJMoa1411100; Blackley DJ, 2015, MMWR-MORBID MORTAL W, V64, P175; Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594; Christie A, 2015, MMWR-MORBID MORTAL W, V64, P479; Commission on a Global Health Risk Framework for the Future, 2016, NEGL DIM GLOB SEC FR; Deen GF, 2015, N ENGL J MED, DOI 10.1056/NEJMoa1511410; Dhillon RS, 2015, NEW ENGL J MED, V373, P787, DOI 10.1056/NEJMp1508413; Fasina FO, 2014, EUROSURVEILLANCE, V19, P11, DOI 10.2807/1560-7917.ES2014.19.40.20920; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Kateh F, 2015, MMWR-MORBID MORTAL W, V64, P188; Kerstiens B, 1999, J INFECT DIS, V179, pS263, DOI 10.1086/514320; Kucharski AJ, 2015, P NATL ACAD SCI USA, V112, P14366, DOI 10.1073/pnas.1508814112; Lewnard JA, 2014, LANCET INFECT DIS, V14, P1189, DOI [10.1016/S1473-3099(14)70995-8, 10.1016/s1473-3099(14)70995-8]; Lindblade KA, 2015, EMERG INFECT DIS, V21, P1800, DOI 10.3201/eid2110.150912; Maganga GD, 2014, NEW ENGL J MED, V371, P2083, DOI 10.1056/NEJMoa1411099; Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773; Merler S, 2015, LANCET INFECT DIS, V15, P204, DOI 10.1016/S1473-3099(14)71074-6; Nyenswah T, 2015, MMWR-MORBID MORTAL W, V64, P500; Nyenswah T, 2014, MMWR-MORBID MORTAL W, V63, P1082; Okware SI, 2015, AFR HEALTH SCI, V15, P312, DOI 10.4314/ahs.v15i1.45; Pandey A, 2014, SCIENCE, V346, P991, DOI 10.1126/science.1260612; Pigott DM, 2014, ELIFE, V3, DOI 10.7554/eLife.04395; Pigott DM, 2014, ELIFE, V3, DOI [10.7554/eLife.02851, 10.7554/eLife.04395]; Scarpino SV, 2015, CLIN INFECT DIS, V60, P1079, DOI 10.1093/cid/ciu1131; Sharma A, 2014, MMWR-MORBID MORTAL W, V63, P1067; Shuaib F, 2014, MMWR-MORBID MORTAL W, V63, P867; Simon-Loriere E, 2015, NATURE, V524, P102, DOI 10.1038/nature14612; Stadler T, 2014, PLOS CURR, P6, DOI DOI 10.1371/CURRENTS.OUTBREAKS; Thorson A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008859; Tom-Aba D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131000; Van Kerkhove MD, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.19; Vetter Pauline, 2016, Lancet Infect Dis, V16, pe82, DOI 10.1016/S1473-3099(16)00077-3; WHO, 2015, OR 2014 EB EP; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; World Health Organisation, 2016, EB SIT REP 30 MARCH; World Health Organization, 2014, HIGH LEV M BUILD RES; World Health Organization (WHO), 2014, EB RESP PACK APPR AR	43	170	171	0	87	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2016	375	6					587	596		10.1056/NEJMsr1513109	http://dx.doi.org/10.1056/NEJMsr1513109			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU4OT	27509108	Green Published, Bronze			2022-12-28	WOS:000382193100015
J	Ito, Y; Nogami, A				Ito, Yoko; Nogami, Akihiko			Aortic Calcification and Superior-Mesenteric-Artery Stenosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ito, Yoko; Nogami, Akihiko] Univ Tsukuba, Tsukuba, Ibaraki, Japan	University of Tsukuba	Nogami, A (corresponding author), Univ Tsukuba, Tsukuba, Ibaraki, Japan.	akihiko-ind@umin.ac.jp		Nogami, Akihiko/0000-0003-0359-4601					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2016	375	6					566	566		10.1056/NEJMicm1513692	http://dx.doi.org/10.1056/NEJMicm1513692			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU4OT	27509104				2022-12-28	WOS:000382193100009
J	Schibich, D; Gloge, F; Pohner, I; Bjorkholm, P; Wade, RC; von Heijne, G; Bukau, B; Kramer, G				Schibich, Daniela; Gloge, Felix; Poehner, Ina; Bjorkholm, Patrik; Wade, Rebecca C.; von Heijne, Gunnar; Bukau, Bernd; Kramer, Guenter			Global profiling of SRP interaction with nascent polypeptides	NATURE			English	Article							TRIGGER FACTOR; PROTEIN TRANSLOCATION; MEMBRANE-PROTEIN; RECOGNITION; LOCALIZATION; PATHWAY; SECA	Signal recognition particle (SRP) is a universally conserved protein-RNA complex that mediates co-translational protein translocation and membrane insertion by targeting translating ribosomes to membrane translocons(1). The existence of parallel co- and post-translational transport pathways(2), however, raises the question of the cellular substrate pool of SRP and the molecular basis of substrate selection. Here we determine the binding sites of bacterial SRP within the nascent proteome of Escherichia coli at amino acid resolution, by sequencing messenger RNA footprints of ribosome-nascent-chain complexes associated with SRP. SRP, on the basis of its strong preference for hydrophobic transmembrane domains (TMDs), constitutes a compartment-specific targeting factor for nascent inner membrane proteins (IMPs) that efficiently excludes signal-sequence-containing precursors of periplasmic and outer membrane proteins. SRP associates with hydrophobic TMDs enriched in consecutive stretches of hydrophobic and bulky aromatic amino acids immediately on their emergence from the ribosomal exit tunnel. By contrast with current models, N-terminal TMDs are frequently skipped and TMDs internal to the polypeptide sequence are selectively recognized. Furthermore, SRP binds several TMDs in many multi-spanning membrane proteins, suggesting cycles of SRP-mediated membrane targeting. SRP-mediated targeting is not accompanied by a transient slowdown of translation and is not influenced by the ribosome-associated chaperone trigger factor (TF), which has a distinct substrate pool and acts at different stages during translation. Overall, our proteome-wide data set of SRP-binding sites reveals the underlying principles of pathway decisions for nascent chains in bacteria, with SRP acting as the dominant triaging factor, sufficient to separate IMPs from substrates of the SecA-SecB post-translational translocation and TF-assisted cytosolic protein folding pathways.	[Schibich, Daniela; Gloge, Felix; Wade, Rebecca C.; Bukau, Bernd; Kramer, Guenter] Univ Heidelberg ZMBH, Ctr Mol Biol, DKFZ ZMBH Alliance, Neuenheimer Feld 282, D-69120 Heidelberg, Germany; [Schibich, Daniela; Gloge, Felix; Bukau, Bernd; Kramer, Guenter] German Canc Res Ctr, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Poehner, Ina; Wade, Rebecca C.] HITS gGmbH, Heidelberg Inst Theoret Studies, Schloss Wolfsbrunnenweg 35, D-69118 Heidelberg, Germany; [Bjorkholm, Patrik; von Heijne, Gunnar] Stockholm Univ, Ctr Biomembrane Res, Dept Biochem & Biophys, S-10691 Stockholm, Sweden; [Bjorkholm, Patrik; von Heijne, Gunnar] Stockholm Univ, Sci Life Lab, S-17121 Solna, Sweden; [Bjorkholm, Patrik] Uppsala Univ, Dept Mol Evolut Cell & Mol Biol, S-75236 Uppsala, Sweden; [Wade, Rebecca C.] Heidelberg Univ, Interdisciplinary Ctr Sci Comp IWR, Neuenheimer Feld 205, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Heidelberg Institute for Theoretical Studies; Stockholm University; Stockholm University; Uppsala University; Ruprecht Karls University Heidelberg	Bukau, B; Kramer, G (corresponding author), Univ Heidelberg ZMBH, Ctr Mol Biol, DKFZ ZMBH Alliance, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.; Bukau, B; Kramer, G (corresponding author), German Canc Res Ctr, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	bukau@zmbh.uni-heidelberg.de; g.kramer@zmbh.uni-heidelberg.de	von Heijne, Gunnar/AAH-9389-2019; Wade, Rebecca/L-1489-2019; von Heijne, Gunnar/F-5576-2011	Wade, Rebecca/0000-0001-5951-8670; von Heijne, Gunnar/0000-0002-4490-8569; Pohner, Ina/0000-0002-2801-8902; Kramer, Gunter/0000-0001-7552-8393; Bukau, Bernd/0000-0003-0521-7199	Klaus Tschira Foundation; Deutsche Forschungsgemeinschaft [SFB638, FOR1805]; Human Frontier Science Program grant; Swedish Research Council	Klaus Tschira Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Human Frontier Science Program grant(Human Frontier Science Program); Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank members of the Bukau laboratory for valuable contributions; C. Glasser for support with data analysis; and H. Bernstein for providing plasmid pHQ4. Sequencing was done at the Genomics & Proteomics Core (DKFZ) facility. I.P. and R.C.W. acknowledge support from the Klaus Tschira Foundation. This work was supported by research grants from the Deutsche Forschungsgemeinschaft (SFB638 and FOR1805) to G.K. and B.B., a Human Frontier Science Program grant to B.B. and a grant from the Swedish Research Council to G.v.H.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Ariosa A, 2015, P NATL ACAD SCI USA, V112, pE3169, DOI 10.1073/pnas.1422594112; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Becker AH, 2013, NAT PROTOC, V8, P2212, DOI 10.1038/nprot.2013.133; Bischoff L, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5103; Bornemann T, 2008, NAT STRUCT MOL BIOL, V15, P494, DOI 10.1038/nsmb.1402; Bornemann T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5180; BUKAU B, 1993, J GEN MICROBIOL, V139, P95, DOI 10.1099/00221287-139-1-95; CASADABAN MJ, 1976, J MOL BIOL, V104, P541, DOI 10.1016/0022-2836(76)90119-4; Castanie-Cornet MP, 2014, BBA-MOL CELL RES, V1843, P1442, DOI 10.1016/j.bbamcr.2013.11.007; Clarke DJ, 1996, MOL MICROBIOL, V20, P1273, DOI 10.1111/j.1365-2958.1996.tb02646.x; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Fluman N, 2014, ELIFE, V3, DOI 10.7554/eLife.03440; Fontaine F, 2011, J BIOL CHEM, V286, P32464, DOI 10.1074/jbc.M111.245696; Gamerdinger M, 2015, SCIENCE, V348, P201, DOI 10.1126/science.aaa5335; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hoffmann A, 2010, BBA-MOL CELL RES, V1803, P650, DOI 10.1016/j.bbamcr.2010.01.017; Johnson N, 2012, J CELL SCI, V125, P3612, DOI 10.1242/jcs.102608; Kadokura H, 2009, CELL, V138, P1164, DOI 10.1016/j.cell.2009.07.030; Kramer G, 2004, J BACTERIOL, V186, P3777, DOI 10.1128/JB.186.12.3777-3784.2004; Kramer G, 2015, SCIENCE, V348, P182, DOI 10.1126/science.aab1335; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuroiwa T, 1996, J BIOL CHEM, V271, P6423, DOI 10.1074/jbc.271.11.6423; Lee HC, 2001, P NATL ACAD SCI USA, V98, P3471, DOI 10.1073/pnas.051484198; Lim B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001735; Nakatogawa H, 2005, GENE DEV, V19, P436, DOI 10.1101/gad.1259505; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Rutkowska A, 2009, FEBS LETT, V583, P2407, DOI 10.1016/j.febslet.2009.06.041; SAAF A, 1995, MOL MEMBR BIOL, V12, P209, DOI 10.3109/09687689509027509; SCHLENSTEDT G, 1992, J BIOL CHEM, V267, P24328; Zhang X, 2010, SCIENCE, V328, P757, DOI 10.1126/science.1186743	35	86	86	0	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					219	+		10.1038/nature19070	http://dx.doi.org/10.1038/nature19070			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27487212				2022-12-28	WOS:000381472100038
J	Strilic, B; Yang, LD; Albarran-Juarez, J; Wachsmuth, L; Han, K; Muller, UC; Pasparakis, M; Offermanns, S				Strilic, Boris; Yang, Lida; Albarran-Juarez, Julian; Wachsmuth, Laurens; Han, Kang; Mueller, Ulrike C.; Pasparakis, Manolis; Offermanns, Stefan			Tumour-cell-induced endothelial cell necroptosis via death receptor 6 promotes metastasis	NATURE			English	Article							AMYLOID PRECURSOR PROTEIN; LUNG METASTASIS; MIGRATION; DR6; INFLAMMATION; ACTIVATION; INSIGHTS	Metastasis is the leading cause of cancer-related death in humans. It is a complex multistep process during which individual tumour cells spread primarily through the circulatory system to colonize distant organs(1-3). Once in the circulation, tumour cells remain vulnerable, and their metastatic potential largely depends on a rapid and efficient way to escape from the blood stream by passing the endothelial barrier(4-9). Evidence has been provided that tumour cell extravasation resembles leukocyte transendothelial migration(7-9). However, it remains unclear how tumour cells interact with endothelial cells during extravasation and how these processes are regulated on a molecular level. Here we show that human and murine tumour cells induce programmed necrosis (necroptosis) of endothelial cells, which promotes tumour cell extravasation and metastasis. Treatment of mice with the receptor-interacting serine/threonine-protein kinase 1 (RIPK1)-inhibitor necrostatin-1 or endothelial-cell-specific deletion of RIPK3 reduced tumour-cell-induced endothelial necroptosis, tumour cell extravasation and metastasis. In contrast, pharmacological caspase inhibition or endothelial-cell-specific loss of caspase-8 promoted these processes. We furthermore show in vitro and in vivo that tumour-cell-induced endothelial necroptosis leading to extravasation and metastasis requires amyloid precursor protein expressed by tumour cells and its receptor, death receptor 6 (DR6), on endothelial cells as the primary mediators of these effects. Our data identify a new mechanism underlying tumour cell extravasation and metastasis, and suggest endothelial DR6-mediated necroptotic signalling pathways as targets for anti-metastatic therapies.	[Strilic, Boris; Yang, Lida; Albarran-Juarez, Julian; Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, Ludwigstr 43, D-61231 Bad Nauheim, Germany; [Wachsmuth, Laurens; Pasparakis, Manolis] Univ Cologne, Ctr Mol Med CMMC, Inst Genet, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Wachsmuth, Laurens; Pasparakis, Manolis] Cologne Excellence Cluster Cellular Stress Respon, Joseph Stelzmann Str 26, D-50931 Cologne, Germany; [Han, Kang; Mueller, Ulrike C.] Heidelberg Univ, Inst Pharm & Mol Biotechnol, Dept Bioinformat & Funct Gen, Neuenheimer Feld 364, D-69120 Heidelberg, Germany; [Offermanns, Stefan] JW Goethe Univ Frankfurt, Fac Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany	Max Planck Society; University of Cologne; University of Cologne; Ruprecht Karls University Heidelberg; Goethe University Frankfurt	Strilic, B; Offermanns, S (corresponding author), Max Planck Inst Heart & Lung Res, Dept Pharmacol, Ludwigstr 43, D-61231 Bad Nauheim, Germany.; Offermanns, S (corresponding author), JW Goethe Univ Frankfurt, Fac Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	boris.strilic@mpi-bn.mpg.de; stefan.offermanns@mpi-bn.mpg.de	Han, Kang/X-1334-2019; Pasparakis, Manolis/H-9292-2017; Juarez, Julian Albarran/K-6623-2019; Pasparakis, Manolis/N-4350-2019; Offermanns, Stefan/L-3313-2017	Pasparakis, Manolis/0000-0002-9870-0966; Juarez, Julian Albarran/0000-0003-2493-1435; Pasparakis, Manolis/0000-0002-9870-0966; Offermanns, Stefan/0000-0001-8676-6805; Wachsmuth, Laurens/0000-0003-1701-9384; HAN, KANG/0000-0002-9940-7075	German Cancer Aid; Max Planck Society; China Scholarship Council; Deutsche Forschungsgemeinschaft [MU 1457/9-2, SFB670, SFB829]; European Research Council [323040]; Worldwide Cancer Research [15-0228]; Helmholtz Alliance Preclinical Comprehensive Cancer Center	German Cancer Aid(Deutsche Krebshilfe); Max Planck Society(Max Planck SocietyFoundation CELLEX); China Scholarship Council(China Scholarship Council); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); Worldwide Cancer Research; Helmholtz Alliance Preclinical Comprehensive Cancer Center	We thank S. Fulda and our friends and colleagues for comments on the manuscript. We also thank S. Hummer for secretarial help and C. Ringel, J. Hoffmann, I.-M. Gross, D. Magalei and M. Winkels for technical help. This work was supported by the German Cancer Aid and the Max Planck Society. K.H. was supported by the China Scholarship Council. U.C.M. was supported by a grant from the Deutsche Forschungsgemeinschaft (MU 1457/9-2). M.P. received funding from the European Research Council (grant agreement 323040), the Deutsche Forschungsgemeinschaft (SFB670, SFB829), Worldwide Cancer Research (grant 15-0228) and the Helmholtz Alliance Preclinical Comprehensive Cancer Center.	Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Cermak T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr218; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; Galluzzi L, 2015, CELL DEATH DIFFER, V22, P58, DOI 10.1038/cdd.2014.137; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hick M, 2015, ACTA NEUROPATHOL, V129, P21, DOI 10.1007/s00401-014-1368-x; Huang G, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.378; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Korhonen H, 2009, J EXP MED, V206, P411, DOI 10.1084/jem.20082150; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Labelle M, 2012, CANCER DISCOV, V2, P1091, DOI 10.1158/2159-8290.CD-12-0329; Lavrik I, 2005, J CELL SCI, V118, P265, DOI 10.1242/jcs.01610; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liu JQ, 2001, IMMUNITY, V15, P23, DOI 10.1016/S1074-7613(01)00162-5; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pan GH, 1998, FEBS LETT, V431, P351, DOI 10.1016/S0014-5793(98)00791-1; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Reilly LAO, 2009, NATURE, V461, P659, DOI 10.1038/nature08402; Reymond N, 2013, NAT REV CANCER, V13, P858, DOI 10.1038/nrc3628; Schumacher D, 2013, CANCER CELL, V24, P130, DOI 10.1016/j.ccr.2013.05.008; Silke J, 2015, NAT IMMUNOL, V16, P689, DOI [10.1038/ni.3206, 10.1038/ni0815-889b]; Sivaraj KK, 2013, DEV CELL, V25, P427, DOI 10.1016/j.devcel.2013.04.008; Takagi K, 2013, CANCER SCI, V104, P1532, DOI 10.1111/cas.12239; Takai E, 2012, J CELL SCI, V125, P5051, DOI 10.1242/jcs.104976; Takayama KI, 2009, CANCER RES, V69, P137, DOI 10.1158/0008-5472.CAN-08-3633; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391; Xu K, 2015, GENE DEV, V29, P785, DOI 10.1101/gad.257675.114; Yang ZL, 2012, ONCOL LETT, V3, P1227, DOI 10.3892/ol.2012.639; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Zhou W, 2014, SEMIN CELL DEV BIOL, V35, P14, DOI 10.1016/j.semcdb.2014.07.013	36	274	285	2	81	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					215	+		10.1038/nature19076	http://dx.doi.org/10.1038/nature19076			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27487218				2022-12-28	WOS:000381472100037
J	Upshur, R				Upshur, Ross			Unresolved issues in Canada's law on physician-assisted dying	LANCET			English	Editorial Material									[Upshur, Ross] Univ Toronto, Dalla Lana Sch Publ Hlth, Dept Family & Community Med, Toronto, ON M5T 3M7, Canada; [Upshur, Ross] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Clin Publ Hlth, Toronto, ON M5T 3M7, Canada; [Upshur, Ross] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute	Upshur, R (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Dept Family & Community Med, Toronto, ON M5T 3M7, Canada.; Upshur, R (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Div Clin Publ Hlth, Toronto, ON M5T 3M7, Canada.; Upshur, R (corresponding author), Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada.	ross.upshur@utoronto.ca						[Anonymous], 2016, GLOBE MAIL; Canadian Medical Association, 2015, CMA UPD ASS DYING PO; Government of Canada Department of Justice, 2015, CONS PHYS ASS DYING; Kirkey S., 2015, NATL POST; Parliament of Canada, 2016, MED ASS DYING PAT CT; Provincial Territorial Expert Advisory Group on Physician Assisted Dying, 2015, FIN REP NOV 30 PROV; Schuklenk U, 2011, BIOETHICS, V25, P1, DOI 10.1111/j.1467-8519.2011.01939.x; Stone L, 2016, GLOBE MAIL; Truth and Reconciliation Commission of Canada, 2015, HON TRUTH REC FUT SU	9	10	10	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2016	388	10044					545	547		10.1016/S0140-6736(16)31255-7	http://dx.doi.org/10.1016/S0140-6736(16)31255-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS4NA	27511772				2022-12-28	WOS:000380756600010
J	Erdemir, A; Ramirez, G; Eryilmaz, OL; Narayanan, B; Liao, YF; Kamath, G; Sankaranarayanan, SKRS				Erdemir, Ali; Ramirez, Giovanni; Eryilmaz, Osman L.; Narayanan, Badri; Liao, Yifeng; Kamath, Ganesh; Sankaranarayanan, Subramanian K. R. S.			Carbon-based tribofilms from lubricating oils	NATURE			English	Article							FUTURE; CHALLENGES; MECHANISMS; ADDITIVES; TRIBOLOGY; FULLERENE; METALS; ZDDP; WEAR	Moving mechanical interfaces are commonly lubricated and separated by a combination of fluid films and solid 'tribofilms', which together ensure easy slippage and long wear life(1). The efficacy of the fluid film is governed by the viscosity of the base oil in the lubricant; the efficacy of the solid tribofilm, which is produced as a result of sliding contact between moving parts, relies upon the effectiveness of the lubricant's anti-wear additive (typically zinc dialkyldithiophosphate)(2). Minimizing friction and wear continues to be a challenge, and recent efforts have focused on enhancing the anti-friction and anti-wear properties of lubricants by incorporating inorganic nanoparticles and ionic liquids(3,4). Here, we describe the in operando formation of carbon-based tribofilms via dissociative extraction from base-oil molecules on catalytically active, sliding nanometre-scale crystalline surfaces, enabling base oils to provide not only the fluid but also the solid tribofilm. We study nanocrystalline catalytic coatings composed of nitrides of either molybdenum or vanadium, containing either copper or nickel catalysts, respectively. Structurally, the resulting tribofilms are similar to diamond-like carbon(5). Ball-on-disk tests at contact pressures of 1.3 gigapascals reveal that these tribofilms nearly eliminate wear, and provide lower friction than tribofilms formed with zinc dialkyldithiophosphate. Reactive and ab initio molecular-dynamics simulations show that the catalytic action of the coatings facilitates dehydrogenation of linear olefins in the lubricating oil and random scission of their carbon-carbon backbones; the products recombine to nucleate and grow a compact, amorphous lubricating tribofilm.	[Erdemir, Ali; Ramirez, Giovanni; Eryilmaz, Osman L.; Liao, Yifeng] Argonne Natl Lab, Div Energy Syst, 9700 S Cass Ave, Argonne, IL 60439 USA; [Narayanan, Badri; Kamath, Ganesh; Sankaranarayanan, Subramanian K. R. S.] Argonne Natl Lab, Ctr Nanoscale Mat, 9700 S Cass Ave, Argonne, IL 60439 USA; [Liao, Yifeng] Dow Corning Corp, 2200 West Salzburg Rd, Midland, MI 48642 USA	United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; Corning Inc; Dow Chemical Company; Dow Corning	Erdemir, A (corresponding author), Argonne Natl Lab, Div Energy Syst, 9700 S Cass Ave, Argonne, IL 60439 USA.	erdemir@anl.gov	Erdemir, Ali/P-7643-2018; Erdemir, Ali/AAF-9422-2019; k, ggk/ABC-5880-2020	Erdemir, Ali/0000-0002-6489-9620; Erdemir, Ali/0000-0002-6489-9620; Narayanan, Badri/0000-0001-8147-1047; RAMIREZ, GIOVANNI/0000-0003-0985-1605	US Department of Energy (DOE), Office of Energy Efficiency and Renewable Energy, Vehicle Technologies and Advanced Manufacturing Offices [DE-AC02-06CH11357]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Office of Science of the US Department of Energy [DE-AC02-06CH11357, DE-AC02-05CH11231]	US Department of Energy (DOE), Office of Energy Efficiency and Renewable Energy, Vehicle Technologies and Advanced Manufacturing Offices; US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Office of Science of the US Department of Energy(United States Department of Energy (DOE))	Work at Argonne National Laboratory was supported by the US Department of Energy (DOE), Office of Energy Efficiency and Renewable Energy, Vehicle Technologies and Advanced Manufacturing Offices under contract DE-AC02-06CH11357. Use of the Center for Nanoscale Materials was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. This research also used resources of the Argonne Leadership Computing Facility at Argonne National Laboratory, which is supported by the Office of Science of the US Department of Energy under contract DE-AC02-06CH11357. This research used resources of the National Energy Research Scientific Computing Center, a DOE Office of Science User Facility supported by the Office of Science of the US Department of Energy under contract DE-AC02-05CH11231. XPS and TOF-SIMS measurements were carried out in the Frederick Seitz Materials Research Laboratory Central Research Facilities, University of Illinois. We thank R. Haasch for support with the XPS measurements and T. Spila for support with the TOF-SIMS measurements. We thank D. Gosztola for help with the Raman measurements at the Center of Nanoscale Materials, Argonne National Laboratory. We also thank S. Rodil, O. Depablos and R. Mirabal for help with the GIXRD measurements at Instituto de Investigaciones en Materiales, Universidad Nacional Autonoma de Mexico. We thank E. A. Bardasz of Zual Associate in Lubrication for helpful discussions, and W. Connacher and M. McKinnon for their help in setting up the experiments.	Bowden F. P., 1936, P ROY SOC LOND A MAT, V154, P640; BOWDEN FP, 1945, NATURE, V156, P97, DOI 10.1038/156097a0; Ceamanos J, 2002, J ANAL APPL PYROL, V65, P93, DOI 10.1016/S0165-2370(01)00183-8; Cha SC., 2015, COATING TECHNOLOGY V; Chu S, 2012, NATURE, V488, P294, DOI 10.1038/nature11475; David D. J., 2001, RELATING MAT PROPERT; Erdemir A, 2006, J PHYS D APPL PHYS, V39, pR311, DOI 10.1088/0022-3727/39/18/R01; Ferrari AC, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.075414; Gosvami NN, 2015, SCIENCE, V348, P102, DOI 10.1126/science.1258788; Holmberg K, 2012, TRIBOL INT, V47, P221, DOI 10.1016/j.triboint.2011.11.022; Hsu WK, 1996, CHEM PHYS LETT, V262, P161, DOI 10.1016/0009-2614(96)01041-X; Huheey J.E., 1993, INORGANIC CHEM PRINC, P513; Johnson KL, 1995, WEAR, V190, P162, DOI 10.1016/0043-1648(95)06665-9; KANG DB, 1985, J AM CHEM SOC, V107, P7858, DOI 10.1021/ja00312a009; Kazmanli MK, 2003, SURF COAT TECH, V167, P77, DOI 10.1016/S0257-8972(02)00866-6; KROTO HW, 1992, NATURE, V359, P670, DOI 10.1038/359670a0; Liao Y, 2011, SCIENCE, V334, P1687, DOI 10.1126/science.1213902; Lim SC, 1987, ACTA METALL MATER, V35, P1, DOI 10.1016/0001-6160(87)90209-4; Mitchell DRG, 2008, MICROSC RES TECHNIQ, V71, P588, DOI 10.1002/jemt.20591; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Qiao ZJ, 2006, SCRIPTA MATER, V54, P225, DOI 10.1016/j.scriptamat.2005.09.037; Qu J, 2015, ADV MATER, V27, P4767, DOI 10.1002/adma.201502037; Sattler JJHB, 2014, CHEM REV, V114, P10613, DOI 10.1021/cr5002436; Spikes H, 2004, TRIBOL LETT, V17, P469, DOI 10.1023/B:TRIL.0000044495.26882.b5; Spikes H, 2008, LUBR SCI, V20, P103, DOI 10.1002/ls.57; Tenne R, 2014, FRONT PHYS-BEIJING, V9, P370, DOI 10.1007/s11467-013-0326-8; Tung SC, 2004, TRIBOL INT, V37, P517, DOI 10.1016/j.triboint.2004.01.013; World Energy Council, 2012, GLOB TRANSP SCEN 205; Zhang J., 1993, WEAR, V162-164, P188	29	245	251	29	375	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2016	536	7614					67	+		10.1038/nature18948	http://dx.doi.org/10.1038/nature18948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS7YM	27488799				2022-12-28	WOS:000380999200031
J	Zaza, S; Kann, L; Barrios, LC				Zaza, Stephanie; Kann, Laura; Barrios, Lisa C.			Lesbian, Gay, and Bisexual Adolescents Population Estimate and Prevalence of Health Behaviors	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Zaza, Stephanie; Kann, Laura; Barrios, Lisa C.] US Ctr Dis Control & Prevent, 1600 Clifton Rd NE,Mailstop E-75, Atlanta, GA 30329 USA	Centers for Disease Control & Prevention - USA	Barrios, LC (corresponding author), US Ctr Dis Control & Prevent, Div Adolescent & Sch Hlth, 1600 Clifton Rd NE,Mailstop E-75, Atlanta, GA 30329 USA.	lbarrios@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Institute of Medicine, 2011, HLTH LESB GAY BISEX; Kann L, 2016, MMWR SURVEILL SUMM, V65, P1; Kann L, 2016, MMWR-MORBID MORTAL W, V65, P106, DOI 10.15585/mmwr.mm6505a2; Meyer I. H., 2012, HDB PSYCHOL SEXUAL O, P252, DOI DOI 10.1093/ACPROF:OSO/9780199765218.003.0018; Mustanski B, 2014, AM J PUBLIC HEALTH, V104, P218, DOI 10.2105/AJPH.2013.301625; Trust for America's Health, 2014, ADDR SOC DET HLTH IN	6	68	67	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 13	2016	316	22					2355	2356		10.1001/jama.2016.11683	http://dx.doi.org/10.1001/jama.2016.11683			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EE8OE	27532437	Green Accepted			2022-12-28	WOS:000389884600011
J	Brennan, PF				Brennan, Patricia Flatley			The National Library of Medicine: Accelerating Discovery, Delivering Information, Improving Health	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Brennan, Patricia Flatley] Natl Lib Med, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Brennan, PF (corresponding author), NIH, Natl Lib Med, Bldg 38,8600 Rockville Pike, Bethesda, MD 20894 USA.	patti.brennan@nih.gov			NATIONAL LIBRARY OF MEDICINE [ZIHLM200888] Funding Source: NIH RePORTER	NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))		Aronson AR, 2010, J AM MED INFORM ASSN, V17, P229, DOI 10.1136/jamia.2009.002733; Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Brennan PF, 2015, J NURS SCHOLARSHIP, V47, P477, DOI 10.1111/jnu.12159; Doughty E, 2011, BIOINFORMATICS, V27, P408, DOI 10.1093/bioinformatics/btq667	4	2	2	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 6	2016	165	11					808	+		10.7326/M16-1737	http://dx.doi.org/10.7326/M16-1737			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EE0KO	27537845				2022-12-28	WOS:000389263900009
J	Neumann, CN; Hooker, JM; Ritter, T				Neumann, Constanze N.; Hooker, Jacob M.; Ritter, Tobias			Concerted nucleophilic aromatic substitution with F-19(-) and F-18(-) (vol 534, pg 369, 2016)	NATURE			English	Correction													Ritter, Tobias/AAJ-8703-2021; Neumann, Constanze/AAL-3918-2020	Neumann, Constanze/0000-0003-1004-1140				Eumann CNN, 2016, NATURE, V534, P369, DOI 10.1038/nature17667	1	6	6	2	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 13	2016	538	7624								10.1038/nature19311	http://dx.doi.org/10.1038/nature19311			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA5OS	27487221	Bronze			2022-12-28	WOS:000386671000052
J	Khare, S; Nagle, AS; Biggart, A; Lai, YH; Liang, F; Davis, LC; Barnes, SW; Mathison, CJN; Myburgh, E; Gao, MY; Gillespie, JR; Liu, XZ; Tan, JL; Stinson, M; Rivera, IC; Ballard, J; Yeh, V; Groessl, T; Federe, G; Koh, HXY; Venable, JD; Bursulaya, B; Shapiro, M; Mishra, PK; Spraggon, G; Brock, A; Mottram, JC; Buckner, FS; Rao, SPS; Wen, BG; Walker, JR; Tuntland, T; Molteni, V; Glynne, RJ; Supek, F				Khare, Shilpi; Nagle, Advait S.; Biggart, Agnes; Lai, Yin H.; Liang, Fang; Davis, Lauren C.; Barnes, S. Whitney; Mathison, Casey J. N.; Myburgh, Elmarie; Gao, Mu-Yun; Gillespie, J. Robert; Liu, Xianzhong; Tan, Jocelyn L.; Stinson, Monique; Rivera, Ianne C.; Ballard, Jaime; Yeh, Vince; Groessl, Todd; Federe, Glenn; Koh, Hazel X. Y.; Venable, John D.; Bursulaya, Badry; Shapiro, Michael; Mishra, Pranab K.; Spraggon, Glen; Brock, Ansgar; Mottram, Jeremy C.; Buckner, Frederick S.; Rao, Srinivasa P. S.; Wen, Ben G.; Walker, John R.; Tuntland, Tove; Molteni, Valentina; Glynne, Richard J.; Supek, Frantisek			Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness	NATURE			English	Article							TRYPANOSOMA-CRUZI; RANDOMIZED-TRIAL; DRUG DISCOVERY; BENZNIDAZOLE; POSACONAZOLE; BORTEZOMIB; INFECTION; SYSTEM; GENE; CURE	Chagas disease, leishmaniasis and sleeping sickness affect 20 million people worldwide and lead to more than 50,000 deaths annually(1). The diseases are caused by infection with the kinetoplastid parasites Trypanosoma cruzi, Leishmania spp. and Trypanosoma brucei spp., respectively. These parasites have similar biology and genomic sequence, suggesting that all three diseases could be cured with drugs that modulate the activity of a conserved parasite target(2). However, no such molecular targets or broad spectrum drugs have been identified to date. Here we describe a selective inhibitor of the kinetoplastid proteasome (GNF6702) with unprecedented in vivo efficacy, which cleared parasites from mice in all three models of infection. GNF6702 inhibits the kinetoplastid proteasome through a non-competitive mechanism, does not inhibit the mammalian proteasome or growth of mammalian cells, and is well-tolerated in mice. Our data provide genetic and chemical validation of the parasite proteasome as a promising therapeutic target for treatment of kinetoplastid infections, and underscore the possibility of developing a single class of drugs for these neglected diseases.	[Khare, Shilpi; Nagle, Advait S.; Biggart, Agnes; Lai, Yin H.; Liang, Fang; Davis, Lauren C.; Barnes, S. Whitney; Mathison, Casey J. N.; Gao, Mu-Yun; Liu, Xianzhong; Tan, Jocelyn L.; Stinson, Monique; Rivera, Ianne C.; Ballard, Jaime; Yeh, Vince; Groessl, Todd; Federe, Glenn; Venable, John D.; Bursulaya, Badry; Shapiro, Michael; Spraggon, Glen; Brock, Ansgar; Wen, Ben G.; Walker, John R.; Tuntland, Tove; Molteni, Valentina; Glynne, Richard J.; Supek, Frantisek] Novartis Res Fdn, Genom Inst, 10675 John Jay Hopkins Dr, San Diego, CA 92121 USA; [Myburgh, Elmarie; Mottram, Jeremy C.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Infect Immun & Inflammat, Wellcome Trust Ctr Mol Parasitol, Glasgow G12 8TA, Lanark, Scotland; [Myburgh, Elmarie; Mottram, Jeremy C.] Univ York, Dept Biol, Ctr Immunol & Infect, Wentworth Way, York YO10 5DD, N Yorkshire, England; [Gillespie, J. Robert; Buckner, Frederick S.] Univ Washington, Dept Med, Seattle, WA 98109 USA; [Koh, Hazel X. Y.; Rao, Srinivasa P. S.] Novartis Inst Trop Dis, 10 Biopolis Rd, Singapore 138670, Singapore	Novartis; University of Glasgow; University of York - UK; University of Washington; University of Washington Seattle; Novartis	Supek, F (corresponding author), Novartis Res Fdn, Genom Inst, 10675 John Jay Hopkins Dr, San Diego, CA 92121 USA.	fsupek@gnf.org	Gillespie, J. Robert/AAA-2496-2019; Buckner, Frederick/AAF-3938-2020	Buckner, Frederick/0000-0001-7796-6477; Myburgh, Elmarie/0000-0002-2007-5902; Mottram, Jeremy/0000-0001-5574-3766; Mathison, Casey/0000-0002-1310-826X	Wellcome Trust [091038/Z/09/Z, 104976/Z/14/Z, 104111/15/Z]; NIH [AI106850]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097177, R01AI106850] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by grants from the Wellcome Trust (091038/Z/09/Z to R.J.G. and F.S., and 104976/Z/14/Z, 104111/15/Z to J.C.M. and E.M.) and NIH (AI106850 to F.S.B.). We thank S. Croft, R. Don, L. Gredsted, A. Hudson and J. Mendlein for discussions, R. Tarleton for T. cruzi CL strain, and G. Cross for T. brucei Lister 427 strain. We thank A. Kreusch for help with proteasome purification, and F. Luna for help with T. cruzi whole-genome sequencing. We acknowledge technical assistance of O. Faghih in generating the plasmids for ectopic expression of PSMB4 in T. cruzi, R. Ritchie for IVIS in vivo imaging, and A. Mak, J. Matzen and P. Anderson for execution of high-throughput screens. We thank J. Isbell and T. Hollenbeck for profiling GNF6702 in ADME assays.	[Anonymous], 2012, WHO TECHN REP SER; Bern C, 2015, NEW ENGL J MED, V373, P1882, DOI [10.1056/NEJMra1410150, 10.1056/NEJMc1510996]; Bern C, 2011, NEW ENGL J MED, V364, P2527, DOI 10.1056/NEJMct1014204; Bilbe G, 2015, SCIENCE, V348, P974, DOI 10.1126/science.aaa3683; Buckner FS, 1996, ANTIMICROB AGENTS CH, V40, P2592, DOI 10.1128/AAC.40.11.2592; Bustamante JM, 2008, NAT MED, V14, P542, DOI 10.1038/nm1744; Chatelain E, 2015, J BIOMOL SCREEN, V20, P22, DOI 10.1177/1087057114550585; Coura JR, 2010, ACTA TROP, V115, P5, DOI 10.1016/j.actatropica.2010.03.008; Dorlo TPC, 2008, ANTIMICROB AGENTS CH, V52, P2855, DOI 10.1128/AAC.00014-08; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; Fernandez Y, 2006, J BIOL CHEM, V281, P1107, DOI 10.1074/jbc.M511607200; HARIHARAN S, 1993, MOL BIOCHEM PARASIT, V57, P15, DOI 10.1016/0166-6851(93)90240-X; Hotez PJ, 2015, SCIENCE, V348, P296, DOI 10.1126/science.348.6232.296-b; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Kalvass JC, 2001, DRUG METAB DISPOS, V29, P1332; Kennedy PGE, 2013, LANCET NEUROL, V12, P186, DOI 10.1016/S1474-4422(12)70296-X; Khare S, 2015, ANTIMICROB AGENTS CH, V59, P6385, DOI 10.1128/AAC.00689-15; Khare S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005058; Li C, 2013, DRUG DISCOV TODAY, V18, P71, DOI 10.1016/j.drudis.2012.09.004; Li H, 2016, NATURE, V530, P233, DOI 10.1038/nature16936; Li XM, 2010, JNCI-J NATL CANCER I, V102, P1069, DOI 10.1093/jnci/djq198; Logan-Klumpler FJ, 2012, NUCLEIC ACIDS RES, V40, pD98, DOI 10.1093/nar/gkr1032; McGwire BS, 2014, QJM-INT J MED, V107, P7, DOI 10.1093/qjmed/hct116; McLatchie AP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002571; Melby PC, 2001, CURR PROTOC IMMUNOL, DOI DOI 10.1002/0471142735.IM1902S28; Melnick JS, 2006, P NATL ACAD SCI USA, V103, P3153, DOI 10.1073/pnas.0511292103; Molina I, 2014, NEW ENGL J MED, V370, P1899, DOI 10.1056/NEJMoa1313122; Morillo CA, 2015, NEW ENGL J MED, V373, P1295, DOI 10.1056/NEJMoa1507574; Myburgh E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002384; Nagle AS, 2014, CHEM REV, V114, P11305, DOI 10.1021/cr500365f; Nelson KG, 2006, ANTIMICROB AGENTS CH, V50, P1238, DOI 10.1128/AAC.50.4.1238-1244.2006; Nunes MCP, 2013, J AM COLL CARDIOL, V62, P767, DOI 10.1016/j.jacc.2013.05.046; Sacks D, 2004, IMMUNOL REV, V201, P225, DOI 10.1111/j.0105-2896.2004.00185.x; Steverding D, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-29; Sundar S, 2015, EXPERT OPIN PHARMACO, V16, P237, DOI 10.1517/14656566.2015.973850; Taylor MC, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-32; Unno M, 2002, STRUCTURE, V10, P609, DOI 10.1016/S0969-2126(02)00748-7; Viotti R, 2014, ANTIMICROB AGENTS CH, V58, P635, DOI 10.1128/AAC.01662-13; Viotti R, 2009, EXPERT REV ANTI-INFE, V7, P157, DOI 10.1586/14787210.7.2.157; Wang JL, 2009, CHEM BIODIVERS, V6, P1887, DOI 10.1002/cbdv.200900117; Waters NJ, 2008, J PHARM SCI-US, V97, P4586, DOI 10.1002/jps.21317; WHO, 2010, WHO TECH REP SER, V949, P1; Wilk S., 2001, CURR PROTOC PROTEIN; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yardley V, 2000, INT J ANTIMICROB AG, V13, P243, DOI 10.1016/S0924-8579(99)00133-8; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	46	232	234	3	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					229	+		10.1038/nature19339	http://dx.doi.org/10.1038/nature19339			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9LQ	27501246	Green Accepted			2022-12-28	WOS:000382539100047
J	Kieffer, BL				Kieffer, Brigitte L.			DRUG DISCOVERY Designing the ideal opioid	NATURE			English	Editorial Material							RECEPTOR; ANALGESIA; GENE		[Kieffer, Brigitte L.] McGill Univ, Douglas Mental Hlth Inst, Dept Psychiat, Montreal, PQ H4H 1R3, Canada	McGill University	Kieffer, BL (corresponding author), McGill Univ, Douglas Mental Hlth Inst, Dept Psychiat, Montreal, PQ H4H 1R3, Canada.	brigitte.kieffer@douglas.mcgill.ca						Audet M, 2012, CELL, V151, P14, DOI 10.1016/j.cell.2012.09.003; BROWNSTEIN MJ, 1993, P NATL ACAD SCI USA, V90, P5391, DOI 10.1073/pnas.90.12.5391; DeWire SM, 2013, J PHARMACOL EXP THER, V344, P708, DOI 10.1124/jpet.112.201616; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Kieffer BL, 2002, PROG NEUROBIOL, V66, P285, DOI 10.1016/S0301-0082(02)00008-4; Kobilka B, 2008, TRENDS PHARMACOL SCI, V29, P79, DOI 10.1016/j.tips.2007.11.009; Manglik A, 2016, NATURE, V537, P185, DOI 10.1038/nature19112; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Matthes HWD, 1996, NATURE, V383, P819, DOI 10.1038/383819a0; Raehal KM, 2011, PHARMACOL REV, V63, P1001, DOI 10.1124/pr.111.004598; Shoichet BK, 2012, TRENDS PHARMACOL SCI, V33, P268, DOI 10.1016/j.tips.2012.03.007; Trang T, 2015, J NEUROSCI, V35, P13879, DOI 10.1523/JNEUROSCI.2711-15.2015	12	15	17	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					170	171		10.1038/nature19424	http://dx.doi.org/10.1038/nature19424			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DU9LQ	27533037				2022-12-28	WOS:000382539100031
J	Manglik, A; Lin, H; Aryal, DK; McCorvy, JD; Dengler, D; Corder, G; Levit, A; Kling, RC; Bernat, V; Hubner, H; Huang, XP; Sassano, MF; Giguere, PM; Lober, S; Duan, D; Scherrer, G; Kobilka, BK; Gmeiner, P; Roth, BL; Shoichet, BK				Manglik, Aashish; Lin, Henry; Aryal, Dipendra K.; McCorvy, John D.; Dengler, Daniela; Corder, Gregory; Levit, Anat; Kling, Ralf C.; Bernat, Viachaslau; Huebner, Harald; Huang, Xi-Ping; Sassano, Maria F.; Giguere, Patrick M.; Loeber, Stefan; Duan, Da; Scherrer, Gregory; Kobilka, Brian K.; Gmeiner, Peter; Roth, Bryan L.; Shoichet, Brian K.			Structure-based discovery of opioid analgesics with reduced side effects	NATURE			English	Article							A(2A) RECEPTOR ANTAGONISTS; PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; MORPHINE ANALGESIA; LIGAND DISCOVERY; BIASED AGONISM; MICE; PAIN; IDENTIFICATION; MODEL	Morphine is an alkaloid from the opium poppy used to treat pain. The potentially lethal side effects of morphine and related opioids-which include fatal respiratory depression-are thought to be mediated by mu-opioid-receptor (mu OR) signalling through the beta-arrestin pathway or by actions at other receptors. Conversely, G-protein mu OR signalling is thought to confer analgesia. Here we computationally dock over 3 million molecules against the mu OR structure and identify new scaffolds unrelated to known opioids. Structure-based optimization yields PZM21-a potent G(i) activator with exceptional selectivity for mu OR and minimal beta-arrestin-2 recruitment. Unlike morphine, PZM21 is more efficacious for the affective component of analgesia versus the reflexive component and is devoid of both respiratory depression and morphine-like reinforcing activity in mice at equi-analgesic doses. PZM21 thus serves as both a probe to disentangle mu OR signalling and a therapeutic lead that is devoid of many of the side effects of current opioids.	[Manglik, Aashish; Scherrer, Gregory; Kobilka, Brian K.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Lin, Henry; Levit, Anat; Duan, Da; Shoichet, Brian K.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Aryal, Dipendra K.; McCorvy, John D.; Huang, Xi-Ping; Sassano, Maria F.; Giguere, Patrick M.; Roth, Bryan L.] UNC Chapel Hill Med Sch, Dept Pharmacol, Chapel Hill, NC 27514 USA; [Dengler, Daniela; Kling, Ralf C.; Bernat, Viachaslau; Huebner, Harald; Loeber, Stefan; Gmeiner, Peter] Univ Erlangen Nurnberg, Dept Chem & Pharm, Schuhstr 19, D-91052 Erlangen, Germany; [Corder, Gregory; Scherrer, Gregory] Stanford Univ, Sch Med, Stanford Neurosci Inst, Dept Anesthesiol Perioperat & Pain Med,Neurosurg, Stanford, CA 94305 USA; [Kling, Ralf C.] Paracelsus Med Univ, Inst Physiol & Pathophysiol, D-90419 Nurnberg, Germany	Stanford University; University of California System; University of California San Francisco; University of Erlangen Nuremberg; Stanford University	Kobilka, BK (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.; Shoichet, BK (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA.; Roth, BL (corresponding author), UNC Chapel Hill Med Sch, Dept Pharmacol, Chapel Hill, NC 27514 USA.; Gmeiner, P (corresponding author), Univ Erlangen Nurnberg, Dept Chem & Pharm, Schuhstr 19, D-91052 Erlangen, Germany.	kobilka@stanford.edu; peter.gmeiner@fau.de; bryan_roth@med.unc.edu; shoichet@cgl.ucsf.edu	Roth, Bryan L/F-3928-2010; Gmeiner, Peter/N-5275-2015; Roth, Bryan/ABE-7032-2020; Bernat, Viachaslau/I-7606-2015	Roth, Bryan/0000-0002-0561-6520; Bernat, Viachaslau/0000-0003-4741-7420; Scherrer, Gregory/0000-0002-1983-5126; Dengler, Daniela/0000-0002-3886-2621; Gmeiner, Peter/0000-0002-4127-197X; Kobilka, Brian/0000-0001-5958-3990	US National Institutes of Health [GM106990, DA036246, GM59957]; National Institutes of Mental Health Psychoactive Drug Screening Program; Michael Hooker Distinguished Professorship; German Research Foundation [Gm 13/10, GRK 1910]; Stanford University Medical Scientist Training Program [T32GM007365]; American Heart Association [12PRE8120001];  [DA017204];  [DA035764]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008294, R01GM059957, T32GM067547, T32GM007365, U19GM106990] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH104974] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA017204, P01DA035764, R37DA036246] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Mental Health Psychoactive Drug Screening Program; Michael Hooker Distinguished Professorship; German Research Foundation(German Research Foundation (DFG)); Stanford University Medical Scientist Training Program; American Heart Association(American Heart Association); ; ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Supported by the US National Institutes of Health grants GM106990 (B.K.K., B.K.S. and P.G.), DA036246 (B.K.K.), GM59957 (B.K.S.), and the National Institutes of Mental Health Psychoactive Drug Screening Program (B.L.R.) and DA017204 (B.L.R., D.A.), DA035764 (B.L.R.) and the Michael Hooker Distinguished Professorship (B.L.R.) and the German Research Foundation Grants Gm 13/10 and GRK 1910 (P.G). A.M. received support from the Stanford University Medical Scientist Training Program (T32GM007365) and the American Heart Association (12PRE8120001).	Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Balter RE, 2013, J PHARMACOL TOX MET, V67, P162, DOI 10.1016/j.vascn.2013.02.003; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Besnard J, 2012, NATURE, V492, P215, DOI 10.1038/nature11691; BLANCHAR.RJ, 1969, J COMP PHYSIOL PSYCH, V68, P129, DOI 10.1037/h0027676; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; Bohn LM, 2003, J NEUROSCI, V23, P10265; BOLLES RC, 1980, BEHAV BRAIN SCI, V3, P291, DOI 10.1017/S0140525X0000491X; BOLLES RC, 1970, PSYCHOL REV, V77, P32, DOI 10.1037/h0028589; Carlsson J, 2011, NAT CHEM BIOL, V7, P769, DOI 10.1038/nchembio.662; Carlsson J, 2010, J MED CHEM, V53, P3748, DOI 10.1021/jm100240h; Case DA., 2015, AMBER 2015; Clougherty JE, 2010, ENVIRON HEALTH PERSP, V118, P769, DOI 10.1289/ehp.0901631; de Graaf C, 2011, J MED CHEM, V54, P8195, DOI 10.1021/jm2011589; DeWire SM, 2013, J PHARMACOL EXP THER, V344, P708, DOI 10.1124/jpet.112.201616; Estes WK, 1941, J EXP PSYCHOL, V29, P390, DOI 10.1037/h0062283; ESTES WK, 1948, J EXP PSYCHOL, V38, P173, DOI 10.1037/h0057525; Fenalti G, 2015, NAT STRUCT MOL BIOL, V22, P265, DOI 10.1038/nsmb.2965; Gaulton A, 2012, NUCLEIC ACIDS RES, V40, pD1100, DOI 10.1093/nar/gkr777; Goetz A, 2011, J MOL BIOL, V414, P611, DOI 10.1016/j.jmb.2011.10.015; GOGAS KR, 1991, NEUROSCIENCE, V42, P617, DOI 10.1016/0306-4522(91)90031-I; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Groer CE, 2007, MOL PHARMACOL, V71, P549, DOI 10.1124/mol.106.028258; Han S, 2015, CELL, V162, P363, DOI 10.1016/j.cell.2015.05.057; Hiller C, 2013, J MED CHEM, V56, P5130, DOI 10.1021/jm400520c; Huang WJ, 2015, NATURE, V524, P315, DOI 10.1038/nature14886; Huang XP, 2015, NATURE, V527, P477, DOI 10.1038/nature15699; Huang XP, 2010, ASSAY DRUG DEV TECHN, V8, P727, DOI 10.1089/adt.2010.0331; Hubner H, 2000, J MED CHEM, V43, P756, DOI 10.1021/jm991098z; HUGHES J, 1975, NATURE, V258, P577, DOI 10.1038/258577a0; HUNSKAAR S, 1987, PAIN, V30, P103, DOI 10.1016/0304-3959(87)90088-1; Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277; Irwin JJ, 2009, J MED CHEM, V52, P5712, DOI 10.1021/jm9006966; Jiang LI, 2007, J BIOL CHEM, V282, P10576, DOI 10.1074/jbc.M609695200; Katritch V, 2010, J MED CHEM, V53, P1799, DOI 10.1021/jm901647p; Kenakin T, 2013, NAT REV DRUG DISCOV, V12, P205, DOI 10.1038/nrd3954; KISSIN I, 1991, ANESTHESIOLOGY, V74, P166, DOI 10.1097/00000542-199101000-00025; Kolb P, 2009, P NATL ACAD SCI USA, V106, P6843, DOI 10.1073/pnas.0812657106; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Lane JR, 2008, J PHARMACOL EXP THER, V325, P319, DOI 10.1124/jpet.107.134296; Langmead CJ, 2012, J MED CHEM, V55, P1904, DOI 10.1021/jm201455y; Le Bars D, 2001, PHARMACOL REV, V53, P597; Li C, 2016, NEUROPSYCHOPHARMACOL, V41, P2122, DOI 10.1038/npp.2016.12; LORD JAH, 1977, NATURE, V267, P495, DOI 10.1038/267495a0; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517; Moller D, 2014, J MED CHEM, V57, P4861, DOI 10.1021/jm5004039; Montandon G, 2016, ANESTHESIOLOGY, V124, P641, DOI 10.1097/ALN.0000000000000984; Muchmore SW, 2008, J CHEM INF MODEL, V48, P941, DOI 10.1021/ci7004498; Mysinger MM, 2012, P NATL ACAD SCI USA, V109, P5517, DOI 10.1073/pnas.1120431109; Mysinger MM, 2010, J CHEM INF MODEL, V50, P1561, DOI 10.1021/ci100214a; Nakajima K, 2015, NEUROMETHODS, V108, P29, DOI 10.1007/978-1-4939-2944-3_2; Negri A, 2013, J CHEM INF MODEL, V53, P521, DOI 10.1021/ci400019t; Nickolls SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083691; Pasternak GW, 2013, PHARMACOL REV, V65, P1257, DOI 10.1124/pr.112.007138; Powers RA, 2002, STRUCTURE, V10, P1013, DOI 10.1016/S0969-2126(02)00799-2; Raehal KM, 2005, J PHARMACOL EXP THER, V314, P1195, DOI 10.1124/jpet.105.087254; Rajagopal S, 2013, NAT REV DRUG DISCOV, V12, DOI 10.1038/nrd3954-c1; Rajagopal S, 2011, MOL PHARMACOL, V80, P367, DOI 10.1124/mol.111.072801; RESCORLA RA, 1965, J COMP PHYSIOL PSYCH, V59, P406, DOI 10.1037/h0022060; SANBERG PR, 1988, BEHAV NEUROSCI, V102, P748, DOI 10.1037/0735-7044.102.5.748; Skinner B.F, 1938, BEHAV ORGANISMS EXPT; Soergel DG, 2014, PAIN, V155, P1829, DOI 10.1016/j.pain.2014.06.011; Sorge RE, 2014, NAT METHODS, V11, P629, DOI [10.1038/nmeth.2935, 10.1038/NMETH.2935]; SPANAGEL R, 1992, P NATL ACAD SCI USA, V89, P2046, DOI 10.1073/pnas.89.6.2046; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Tzschentke TM, 1998, PROG NEUROBIOL, V56, P613, DOI 10.1016/S0301-0082(98)00060-4; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weichert D, 2014, P NATL ACAD SCI USA, V111, P10744, DOI 10.1073/pnas.1410415111; Weiss DR, 2013, ACS CHEM BIOL, V8, P1018, DOI 10.1021/cb400103f; WOOLF CJ, 1984, PAIN, V18, P325, DOI 10.1016/0304-3959(84)90045-9; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939	75	554	573	17	345	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					185	+		10.1038/nature19112	http://dx.doi.org/10.1038/nature19112			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9LQ	27533032	Green Submitted, Green Accepted			2022-12-28	WOS:000382539100038
J	Osberger, TJ; Rogness, DC; Kohrt, JT; Stepan, AF; White, MC				Osberger, Thomas J.; Rogness, Donald C.; Kohrt, Jeffrey T.; Stepan, Antonia F.; White, M. Christina			Oxidative diversification of amino acids and peptides by small-molecule iron catalysis	NATURE			English	Article							DIVERSITY-ORIENTED SYNTHESIS; NONRIBOSOMAL PEPTIDES; FUNCTIONALIZATION; SELECTIVITY; DISCOVERY; STRATEGY; ENZYMES; BONDS	Secondary metabolites synthesized by non-ribosomal peptide synthetases display diverse and complex topologies and possess a range of biological activities(1,2). Much of this diversity derives from a synthetic strategy that entails pre-3 and post-assembly(2) oxidation of both the chiral amino acid building blocks and the assembled peptide scaffolds. The vancomycin biosynthetic pathway is an excellent example of the range of oxidative transformations that can be performed by the iron-containing enzymes involved in its biosynthesis(4). However, because of the challenges associated with using such oxidative enzymes to carry out chemical transformations in vitro, chemical syntheses guided by these principles have not been fully realized in the laboratory(5). Here we report that two small-molecule iron catalysts are capable of facilitating the targeted C-H oxidative modification of amino acids and peptides with preservation of a-centre chirality. Oxidation of proline to 5-hydroxyproline furnishes a versatile intermediate that can be transformed to rigid arylated derivatives or flexible linear carboxylic acids, alcohols, olefins and amines in both monomer and peptide settings. The value of this C-H oxidation strategy is demonstrated in its capacity for generating diversity: four 'chiral pool' amino acids are transformed to twenty-one chiral unnatural amino acids representing seven distinct functional group arrays; late-stage C-H functionalizations of a single proline-containing tripeptide furnish eight tripeptides, each having different unnatural amino acids. Additionally, a macrocyclic peptide containing a proline turn element is transformed via late-stage C-H oxidation to one containing a linear unnatural amino acid.	[Osberger, Thomas J.; Rogness, Donald C.; White, M. Christina] Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA; [Kohrt, Jeffrey T.] Groton Labs, Pfizer Worldwide Res & Dev, Eastern Point Rd, Groton, CT 06340 USA; [Stepan, Antonia F.] Pfizer Worldwide Res & Dev, Worldwide Med Chem, Cambridge, MA 02139 USA	University of Illinois System; University of Illinois Urbana-Champaign; Pfizer; Pfizer	White, MC (corresponding author), Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA.	mcwhite7@illinois.edu		Osberger, Thomas/0000-0003-3737-4666	NIH/National Institute of General Medical Sciences [GM112492]; Pfizer; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112492] Funding Source: NIH RePORTER	NIH/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pfizer(Pfizer); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Financial support for this work was provided by the NIH/National Institute of General Medical Sciences (GM112492) and a grant from Pfizer to study the modification of natural products and medicinal compounds. T.J.O. is a Springborn Graduate Fellow. We thank L. Zhu for assistance with nuclear magnetic resonance spectroscopy, D. Gray and J. Bertke for X-ray crystallographic studies, A. I. Greenwood and J. Zhao for calculations on product (-)-10, W. A. van der Donk for use of his HPLC instrument, X. Yang and X. Zhao for assistance with Marfey's reagent for chiral amino acid analysis of tripeptide (-)-53, C. Jiang for preliminary studies of amino acid oxidations, and G. S. Snapper for substrate synthesis.	Beckmann HSG, 2013, NAT CHEM, V5, P861, DOI [10.1038/NCHEM.1729, 10.1038/nchem.1729]; Burke MD, 2004, ANGEW CHEM INT EDIT, V43, P46, DOI 10.1002/anie.200300626; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; Chen MS, 2010, SCIENCE, V327, P566, DOI 10.1126/science.1183602; Dangel BD, 2001, J AM CHEM SOC, V123, P8149, DOI 10.1021/ja016280f; Driggers EM, 2008, NAT REV DRUG DISCOV, V7, P608, DOI 10.1038/nrd2590; Gong W, 2014, J AM CHEM SOC, V136, P16940, DOI 10.1021/ja510233h; Gormisky PE, 2013, J AM CHEM SOC, V135, P14052, DOI 10.1021/ja407388y; Hubbard BK, 2003, ANGEW CHEM INT EDIT, V42, P730, DOI 10.1002/anie.200390202; Lau YH, 2014, CHEM SCI, V5, P1804, DOI 10.1039/c4sc00045e; Miller SJ, 1996, J AM CHEM SOC, V118, P9606, DOI 10.1021/ja961626l; Najera C, 1999, TETRAHEDRON-ASYMMETR, V10, P2245, DOI 10.1016/S0957-4166(99)00213-X; Ratnikov MO, 2013, J AM CHEM SOC, V135, P9475, DOI 10.1021/ja402479r; Rauk A, 1999, BIOCHEMISTRY-US, V38, P9089, DOI 10.1021/bi990249x; Rella MR, 2007, J ORG CHEM, V72, P525, DOI 10.1021/jo061910n; Saladino R, 1999, J ORG CHEM, V64, P8468, DOI 10.1021/jo990185w; Schafmeister CE, 2000, J AM CHEM SOC, V122, P5891, DOI 10.1021/ja000563a; Schwarzer D, 2003, NAT PROD REP, V20, P275, DOI 10.1039/b111145k; Scola PM, 2014, J MED CHEM, V57, P1730, DOI 10.1021/jm500297k; Seiple IB, 2014, ANGEW CHEM INT EDIT, V53, P4642, DOI 10.1002/anie.201400928; Shaw MH, 2016, SCIENCE, V352, P1304, DOI 10.1126/science.aaf6635; Stevenazzi A, 2014, BIOORG MED CHEM LETT, V24, P5349, DOI 10.1016/j.bmcl.2014.10.016; Turner NJ, 2011, CHEM REV, V111, P4073, DOI 10.1021/cr200111v; UCHIDA K, 1990, BIOCHEM BIOPH RES CO, V169, P265, DOI 10.1016/0006-291X(90)91463-3; Walsh CT, 2001, CURR OPIN CHEM BIOL, V5, P525, DOI 10.1016/S1367-5931(00)00235-0; Wang P, 2012, CURR OPIN CHEM BIOL, V16, P362, DOI 10.1016/j.cbpa.2012.04.008; White CJ, 2011, NAT CHEM, V3, P509, DOI 10.1038/nchem.1062; White MC, 2012, SCIENCE, V335, P807, DOI 10.1126/science.1207661; Yudin AK, 2015, CHEM SCI, V6, P30, DOI 10.1039/c4sc03089c; Zuo ZW, 2014, J AM CHEM SOC, V136, P5257, DOI 10.1021/ja501621q	30	165	167	10	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					214	219		10.1038/nature18941	http://dx.doi.org/10.1038/nature18941			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9LQ	27479323	Green Accepted			2022-12-28	WOS:000382539100044
J	Kamphorst, JJ; Gottlieb, E				Kamphorst, Jurre J.; Gottlieb, Eyal			CANCER METABOLISM Friendly neighbours feed tumour cells	NATURE			English	Editorial Material							PANCREATIC-CANCER; MICROENVIRONMENT; AUTOPHAGY		[Kamphorst, Jurre J.; Gottlieb, Eyal] Canc Res UK Beatson Inst, Canc Metab Res Unit, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute	Kamphorst, JJ (corresponding author), Canc Res UK Beatson Inst, Canc Metab Res Unit, Glasgow G61 1BD, Lanark, Scotland.	jurre.kamphorst@glasgow.ac.uk; e.gottlieb@beatson.gla.ac.uk	Gottlieb, Eyal/G-6450-2010	Gottlieb, Eyal/0000-0002-9770-0956	Cancer Research UK [17728, 18278] Funding Source: researchfish; Rosetrees Trust [M480] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Rosetrees Trust(Rosetrees Trust)		Commisso C, 2013, NATURE, V497, P633, DOI 10.1038/nature12138; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Perera R, 2015, NATURE, V524, P361, DOI 10.1038/nature14587; Sherman MH, 2012, CANCER PREV RES, V5, P3, DOI 10.1158/1940-6207.CAPR-11-0528; Sousa CM, 2016, NATURE, V536, P479, DOI 10.1038/nature19084; Tape CJ, 2016, CELL, V165, P910, DOI 10.1016/j.cell.2016.03.029; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111	10	16	18	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					401	402		10.1038/nature19420	http://dx.doi.org/10.1038/nature19420			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV0YL	27509862	Green Submitted			2022-12-28	WOS:000382646600027
J	Huskamp, HA; Iglehart, JK				Huskamp, Haiden A.; Iglehart, John K.			Mental Health and Substance-Use Reforms - Milestones Reached, Challenges Ahead	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							PRIMARY-CARE; MEDICAL-CARE; DISORDERS; ILLNESS; DEPRESSION; INSURANCE; QUALITY; PREVALENCE; MANAGEMENT; DISEASE		[Huskamp, Haiden A.] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Huskamp, HA (corresponding author), Harvard Med Sch, Dept Hlth Care Policy, Boston, MA 02115 USA.							Alakeson V, 2010, HEALTH AFFAIR, V29, P867, DOI 10.1377/hlthaff.2010.0080; American Medical Association, 2016, AMA SEEKS INCR COV A; [Anonymous], 2007, ACT PLAN BEH HLTH WO; [Anonymous], 2011, HOM PROGR RES; [Anonymous], 2012, ASS BEH HLTH WELLN; [Anonymous], 2015, C MED CHIP; [Anonymous], 2015, 2015 STAT HLTH CAR Q; [Anonymous], 2012, MED BEN PHYS SERV 20; [Anonymous], LONG ROAD AH ACH TRU; Baird M, 2014, ANN FAM MED, V12, P183, DOI 10.1370/afm.1634; Barry CL, 2003, HEALTH AFFAIR, V22, P127, DOI 10.1377/hlthaff.22.5.127; Barry CL, 2015, HEALTH AFFAIR, V34, P2077, DOI 10.1377/hlthaff.2015.0685; Bishop TF, 2014, JAMA PSYCHIAT, V71, P176, DOI 10.1001/jamapsychiatry.2013.2862; Bishop TF, 2016, HLTH AFF MILLWOOD, V35, P271; Burns ME, 2015, PSYCHIAT SERV, V66, P221, DOI 10.1176/appi.ps.201400440; Busch AB, 2016, HEALTH AFFAIR, V35, P1247, DOI 10.1377/hlthaff.2015.1669; Centers for Disease Control and Prevention, INJ PREV CONTR OP OV; Centers for Disease Control and Prevention, 2015, INJ PREV CONTR OP OV; Coleman WL, 2009, PEDIATRICS, V124, P410, DOI 10.1542/peds.2009-1061; Creedon TB, 2016, HEALTH AFFAIR, V35, P1017, DOI 10.1377/hlthaff.2016.0098; Crowley RA, 2015, ANN INTERN MED, V163, P298, DOI 10.7326/M15-0510; CUNNINGHAM PJ, 2006, 16 CTR STUD HLTH SYS; Druss BG, 2006, GEN HOSP PSYCHIAT, V28, P145, DOI 10.1016/j.genhosppsych.2005.10.006; Edlund MJ, 2004, MED CARE, V42, P1158, DOI 10.1097/00005650-200412000-00002; Frank R. G., 2006, BETTER NOT WELL MENT; Frank RG, 2003, PSYCHIAT SERV, V54, P682, DOI 10.1176/appi.ps.54.5.682; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Golberstein E, 2015, AM J PSYCHIAT, V172, P182, DOI 10.1176/appi.ajp.2014.14030375; Goldman HH, 2006, NEW ENGL J MED, V354, P1378, DOI 10.1056/NEJMsa053737; Huetteman E., 2015, NY TIMES; Kathol RG, 2010, PSYCHOSOM MED, V72, P511, DOI 10.1097/PSY.0b013e3181e2c4a0; KATON W, 1995, JAMA-J AM MED ASSOC, V273, P1026, DOI 10.1001/jama.273.13.1026; Kilbourne AM, 2008, J GEN INTERN MED, V23, P1628, DOI 10.1007/s11606-008-0720-z; McGinty EE, 2015, SCHIZOPHR RES, V165, P227, DOI 10.1016/j.schres.2015.04.010; Mechanic D., 2014, MENTAL HLTH SOCIAL P; Milbank D., 2015, WASHINGTON POST; Murphy T., 2015, WALL STREET J; Prins SJ, 2014, PSYCHIAT SERV, V65, P862, DOI 10.1176/appi.ps.201300166; Scharf D.M., 2014, EVALUATION SAMHSA PR; Stanton E., 2016, INTEGRATION 2016 BEA; Statement of Harold Kudler M.D., 2015, COMMUNICATION; Steadman HJ, 2009, PSYCHIAT SERV, V60, P761, DOI 10.1176/ps.2009.60.6.761; Substance Abuse and Mental Health Services Administration, 2014, RES 2013 NAT SURV DR; Substance Abuse and Mental Health Services Administration, CAN WE LIV LONG INT; Substance Abuse and Mental Health Services Administration, 2015, REC SERV BEH HLTH PR; Substance Abuse and Mental Health Services Administration, 2014, PROJ NAT EXP TREATM; Swanson JW, 2015, ANN EPIDEMIOL, V25, P366, DOI 10.1016/j.annepidem.2014.03.004; Thomas KC, 2009, PSYCHIAT SERV, V60, P1323, DOI 10.1176/ps.2009.60.10.1323; Whiteford HA, 2013, LANCET, V382, P1575, DOI 10.1016/S0140-6736(13)61611-6; Zezima K., 2015, WASHINGTON POST	50	14	14	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2016	375	7					688	695		10.1056/NEJMhpr1601861	http://dx.doi.org/10.1056/NEJMhpr1601861			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT4VF	27532837				2022-12-28	WOS:000381478600014
J	Baheerathan, A; Chauhan, D; Koizia, L; O'Neal, H				Baheerathan, Aravindhan; Chauhan, Devkishan; Koizia, Louis; O'Neal, Hugh			EASILY MISSED? Idiopathic normal pressure hydrocephalus	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSIS		[Baheerathan, Aravindhan] Univ Coll London Hosp, Dept Neurol, London WC1E 6AG, England; [Chauhan, Devkishan] Kingston Hosp, Dept Med, Kingston Upon Thames KT2 7QB, Surrey, England; [Koizia, Louis] Northwick Pk Hosp & Clin Res Ctr, Dept Med, Harrow HA1 3UJ, Middx, England; [O'Neal, Hugh] Worthing Dist Hosp, Care Elderly Dept, Worthing BN11 2DH, England	University College London Hospitals NHS Foundation Trust; University of London; University College London; Imperial College London	Baheerathan, A (corresponding author), Univ Coll London Hosp, Dept Neurol, London WC1E 6AG, England.	a.baheerathan89@gmail.com						Conn HO, 2007, CLIN MED, V7, P296, DOI 10.7861/clinmedicine.7-3-296; Jaraj D, 2014, NEUROLOGY, V82, P1449, DOI 10.1212/WNL.0000000000000342; Kiefer M, 2012, DTSCH ARZTEBL INT, V109, P15, DOI 10.3238/arztebl.2012.0015; Malm J., 2006, PRACT NEUROL, V6, P14, DOI DOI 10.1136/JNNP.2006.088351; Malm J, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-22; Mori E, 2012, NEUROL MED-CHIR, V52, P775, DOI 10.2176/nmc.52.775; Pradhan S, 2008, GERIATRIC MED, V10, P589; Pujari S, 2008, J NEUROL NEUROSUR PS, V79, P1282, DOI 10.1136/jnnp.2007.123620; Razay G, 2013, ALZHEIMERS DEMENT, V9, DOI [10.1016/j.jalz.2013.05.1530, DOI 10.1016/J.JALZ.2013.05.1530]; Sasaki Makoto, 2008, Brain and Nerve (Tokyo), V60, P241; Shprecher D, 2008, CURR NEUROL NEUROSCI, V8, P371, DOI 10.1007/s11910-008-0058-2; Toma AK, 2013, ACTA NEUROCHIR, V155, P1977, DOI 10.1007/s00701-013-1835-5; Williams MA, 2013, NEUROL CLIN PRACT, V3, P375, DOI DOI 10.1212/CPJ.0B013-3182A78F6B	13	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2016	354								i3974	10.1136/bmj.i3974	http://dx.doi.org/10.1136/bmj.i3974			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GZ	27534774				2022-12-28	WOS:000381806400001
J	Mussa, FF; Horton, JD; Moridzadeh, R; Nicholson, J; Trimarchi, S; Eagle, KA				Mussa, Firas F.; Horton, Joshua D.; Moridzadeh, Rameen; Nicholson, Joseph; Trimarchi, Santi; Eagle, Kim A.			Acute Aortic Dissection and Intramural Hematoma A Systematic Review	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							INTERNATIONAL REGISTRY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; D-DIMER; ENDOVASCULAR REPAIR; CLINICAL-FEATURES; DIAGNOSIS; OUTCOMES; HEMORRHAGE; ULTRASOUND; MANAGEMENT	IMPORTANCE Acute aortic syndrome (AAS), a potentially fatal pathologic process within the aortic wall, should be suspected in patients presenting with severe thoracic pain and hypertension. AAS, including aortic dissection (approximately 90% of cases) and intramural hematoma, may be complicated by poor perfusion, aneurysm, or uncontrollable pain and hypertension. AAS is uncommon (approximately 3.5-6.0 per 100 000 patient-years) but rapid diagnosis is imperative as an emergency surgical procedure is frequently necessary. OBJECTIVE To systematically review the current evidence on diagnosis and treatment of AAS. EVIDENCE REVIEW Searches of MEDLINE, EMBASE, and the Cochrane Register of Controlled Trials for articles on diagnosis and treatment of AAS from June 1994 to January 29, 2016, were performed. Only clinical trials and prospective observational studies of 10 or more patients were included. Eighty-two studies (2 randomized clinical trials and 80 observational) describing 57 311 patients were reviewed. FINDINGS Chest or back pain was the most commonly reported presenting symptom of AAS (61.6%-84.8%). Patients were typically aged 60 to 70 years, male (50%-81%), and had hypertension (45%-100%). Sensitivities of computerized tomography and magnetic resonance imaging for diagnosis of AAS were 100% and 95% to 100%, respectively. Transesophageal echocardiography was 86% to 100% sensitive, whereas D-dimer was 51.7% to 100% sensitive and 32.8% to 89.2% specific among 6 studies (n = 876). An immediate open surgical procedure is needed for dissection of the ascending aorta, given the high mortality (26%-58%) and proximity to the aortic valve and great vessels (with potential for dissection complications such as tamponade). An RCT comparing endovascular surgical procedure to medical management for uncomplicated AAS in the descending aorta (n = 61) revealed no dissection-related deaths in either group. Endovascular surgical procedure was better than medical treatment (97% vs 43%, P < .001) for the primary end point of "favorable aortic remodeling" (false lumen thrombosis and no aortic dilation or rupture). The remaining evidence on therapies was observational, introducing significant selection bias. CONCLUSIONS AND RELEVANCE Because of the high mortality rate, AAS should be considered and diagnosed promptly in patients presenting with acute chest or back pain and high blood pressure. Computerized tomography, magnetic resonance imaging, and transesophageal echocardiography are reliable tools for diagnosing AAS. Available data suggest that open surgical repair is optimal for treating type A (ascending aorta) AAS, whereas thoracic endovascular aortic repair may be optimal for treating type B (descending aorta) AAS. However, evidence is limited by the paucity of randomized trials.	[Mussa, Firas F.] Columbia Univ, Med Ctr, Dept Surg, Div Vasc Surg, 161 Ft Washington Ave,Herbert Irving Pavil, New York, NY 10032 USA; [Horton, Joshua D.; Nicholson, Joseph] NYU, Sch Med, New York, NY USA; [Moridzadeh, Rameen] Univ Calif Los Angeles, Div Vasc Surg, Los Angeles, CA USA; [Trimarchi, Santi] Univ Milan, IRCCS Policlin San Donato, Cardiovasc Surg Dept, Milan, Italy; [Eagle, Kim A.] Univ Michigan, Dept Internal Med, Med Ctr, Div Cardiol, Ann Arbor, MI 48109 USA	Columbia University; New York University; University of California System; University of California Los Angeles; IRCCS Policlinico San Donato; University of Milan; University of Michigan System; University of Michigan	Mussa, FF (corresponding author), Columbia Univ, Med Ctr, Dept Surg, Div Vasc Surg, 161 Ft Washington Ave,Herbert Irving Pavil, New York, NY 10032 USA.	ffm2110@cumc.columbia.edu	Nicholson, Joey/AAG-6421-2019; Trimarchi, Santi/J-7361-2016	Nicholson, Joey/0000-0001-8658-5879; Trimarchi, Santi/0000-0001-5996-3264	Gore; Medtronic; Terumo	Gore; Medtronic(Medtronic); Terumo	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Trimarchi reports grants and personal fees from Gore and Medtronic. Dr Eagle reports grants from Gore, Medtronic, and Terumo. No other disclosures were reported.	Akutsu K, 2005, CIRC J, V69, P397, DOI 10.1253/circj.69.397; Bavaria JE, 2015, ANN THORAC SURG, V100, P802, DOI 10.1016/j.athoracsur.2015.03.108; Booher AM, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.01.020; Bossone E, 2013, AM J MED, V126, P909, DOI 10.1016/j.amjmed.2013.04.020; Brunkwall J, 2015, EUR J VASC ENDOVASC, V50, P130, DOI 10.1016/j.ejvs.2015.04.014; Brunkwall J, 2014, EUR J VASC ENDOVASC, V48, P285, DOI 10.1016/j.ejvs.2014.05.012; Clouse WD, 2004, MAYO CLIN PROC, V79, P176, DOI 10.4065/79.2.176; Conzelmann LO, 2012, EUR J CARDIO-THORAC, V42, P557, DOI 10.1093/ejcts/ezs025; Daily P O, 1970, Ann Thorac Surg, V10, P237; Dake MD, 1999, NEW ENGL J MED, V340, P1546, DOI 10.1056/NEJM199905203402004; Dean JH, 2014, AM J MED, V127, P878, DOI 10.1016/j.amjmed.2014.05.005; DEBAKEY ME, 1965, J THORAC CARDIOV SUR, V49, P130, DOI 10.1016/S0022-5223(19)33323-9; Di Cesare E, 2000, INT J CARDIAC IMAG, V16, P135, DOI 10.1023/A:1006404824873; Erbel Raimund, 2014, Kardiol Pol, V72, P1169, DOI 10.5603/KP.2014.0225; Evangelista A, 2005, CIRCULATION, V111, P1063, DOI 10.1161/01.CIR.0000156444.26393.80; Evangelista A, 1996, J AM COLL CARDIOL, V27, P102, DOI 10.1016/0735-1097(95)00414-9; Evangelista A, 2010, EUR HEART J, V31, P472, DOI 10.1093/eurheartj/ehp505; Falconi M, 2005, ECHOCARDIOGR-J CARD, V22, P629, DOI 10.1111/j.1540-8175.2005.04012.x; Fattori R, 2013, JACC-CARDIOVASC INTE, V6, P876, DOI 10.1016/j.jcin.2013.05.003; Ganaha F, 2002, CIRCULATION, V106, P342, DOI 10.1161/01.CIR.0000022164.26075.5A; Giachino F, 2013, CRIT CARE, V17, DOI 10.1186/cc12536; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; Harris KM, 2012, CIRCULATION, V126, pS91, DOI 10.1161/CIRCULATIONAHA.111.084541; Harris KM, 2011, CIRCULATION, V124, P1911, DOI 10.1161/CIRCULATIONAHA.110.006320; Heijmen RH, 2012, J ENDOVASC THER, V19, P213, DOI 10.1583/11-3652MR.1; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hiratzka LF, 2010, J AM COLL CARDIOL, V55, pE27, DOI 10.1016/j.jacc.2010.02.015; Howard DPJ, 2013, CIRCULATION, V127, P2031, DOI 10.1161/CIRCULATIONAHA.112.000483; Huang B, 2015, AM J CARDIOL, V115, P1595, DOI 10.1016/j.amjcard.2015.02.067; Kang DH, 1998, AM J CARDIOL, V81, P202, DOI 10.1016/S0002-9149(97)00885-0; Keren A, 1996, J AM COLL CARDIOL, V28, P627, DOI 10.1016/0735-1097(96)00186-6; Kobayashi N, 2013, INT J CARDIOL, V165, P557, DOI 10.1016/j.ijcard.2012.09.001; Kuehl H, 2008, HEART, V94, P1472, DOI 10.1136/hrt.2007.127282; LAISSY JP, 1995, RADIOLOGY, V194, P331, DOI 10.1148/radiology.194.2.7824707; Landenhed M, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001513; Li DL, 2010, J ENDOVASC THER, V17, P617, DOI 10.1583/10-3125.1a; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Moore AG, 2002, AM J CARDIOL, V89, P1235, DOI 10.1016/S0002-9149(02)02316-0; Motoyoshi N, 2003, EUR J CARDIO-THORAC, V24, P237, DOI 10.1016/S1010-7940(03)00270-7; Muehle A, 2015, J CARDIOVASC SURG, V56, P11; Nazerian P, 2014, INTERN EMERG MED, V9, P665, DOI 10.1007/s11739-014-1080-9; Nienaber CA, 2004, CIRCULATION, V109, P3014, DOI 10.1161/01.CIR.0000130644.78677.2C; Nienaber CA, 2002, CIRCULATION, V106, P284, DOI 10.1161/01.CIR.0000023453.90533.82; NIENABER CA, 1995, CIRCULATION, V92, P1465, DOI 10.1161/01.CIR.92.6.1465; Nienaber CA, 2013, CIRC-CARDIOVASC INTE, V6, P407, DOI 10.1161/CIRCINTERVENTIONS.113.000463; Olsson C, 2006, CIRCULATION, V114, P2611, DOI 10.1161/CIRCULATIONAHA.106.630400; PANTING JR, 1995, CLIN RADIOL, V50, P455, DOI 10.1016/S0009-9260(05)83160-5; Pepi M, 2000, Eur J Echocardiogr, V1, P72, DOI 10.1053/euje.2000.0002; Phillips B, OXFORD CTR EVIDENCE; Sato F, 2005, INT HEART J, V46, P1083, DOI 10.1536/ihj.46.1083; Sbarouni E, 2007, INT J CARDIOL, V122, P170, DOI 10.1016/j.ijcard.2006.11.056; Schlatter T, 2011, J VASC INTERV RADIOL, V22, P533, DOI 10.1016/j.jvir.2010.10.028; Shao N, 2014, MOL BIOL REP, V41, P6397, DOI 10.1007/s11033-014-3520-z; Shinohara T, 2003, ARTERIOSCL THROM VAS, V23, P1839, DOI 10.1161/01.ATV.0000085016.02363.80; Sommer T, 1996, RADIOLOGY, V199, P347, DOI 10.1148/radiology.199.2.8668776; Song JK, 2002, AM J MED, V113, P181, DOI 10.1016/S0002-9343(02)01171-3; Suzuki T, 1996, CIRCULATION, V93, P1244, DOI 10.1161/01.CIR.93.6.1244; Suzuki T, 2009, CIRCULATION, V119, P2702, DOI 10.1161/CIRCULATIONAHA.108.833004; Tsai TT, 2009, EUR J VASC ENDOVASC, V37, P149, DOI 10.1016/j.ejvs.2008.11.032; Tsai TT, 2005, CIRCULATION, V112, P3802, DOI 10.1161/CIRCULATIONAHA.105.534198; Vagnarelli F, 2016, EUR HEART J-ACUTE CA, V5, P61, DOI 10.1177/2048872615590146; Vagnarelli F, 2015, EUR J HEART FAIL, V17, P917, DOI 10.1002/ejhf.325; Vilacosta I, 2001, HEART, V85, P365, DOI 10.1136/heart.85.4.365; von Kodolitsch Y, 2000, ARCH INTERN MED, V160, P2977, DOI 10.1001/archinte.160.19.2977; WEINTRAUB AR, 1994, J AM COLL CARDIOL, V24, P495, DOI 10.1016/0735-1097(94)90309-3; Weiss G, 2015, EUR J CARDIO-THORAC, V47, P106, DOI 10.1093/ejcts/ezu067; Wen D, 2013, HEART, V99, P1192, DOI 10.1136/heartjnl-2013-304158; Winnerkvist A, 2006, EUR J VASC ENDOVASC, V32, P349, DOI 10.1016/j.ejvs.2006.04.004; Zahn R, 2013, J ENDOVASC THER, V20, P265, DOI 10.1583/12-4107R.1; Zhang G, 2011, THORAC CARDIOV SURG, V59, P342, DOI 10.1055/s-0030-1270761	70	230	256	9	55	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2016	316	7					754	763		10.1001/jama.2016.10026	http://dx.doi.org/10.1001/jama.2016.10026			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT5IA	27533160				2022-12-28	WOS:000381514800021
J	Frank, EG; Schlenker, W				Frank, Eyal G.; Schlenker, Wolfram			Balancing economic and ecological goals What are the trade-offs between economic development and ecosystem conservation?	SCIENCE			English	Editorial Material							LAND-USE; BIODIVERSITY; DEFORESTATION		[Frank, Eyal G.; Schlenker, Wolfram] Columbia Univ, New York, NY 10027 USA; [Schlenker, Wolfram] Natl Bur Econ Res, Cambridge, MA 02138 USA	Columbia University; National Bureau of Economic Research	Frank, EG (corresponding author), Columbia Univ, New York, NY 10027 USA.	eyal.frank@columbia.edu; wolfram.schlenker@columbia.edu		Frank, Eyal/0000-0002-5876-5319				Alix-Garcia JM, 2015, AM ECON J-ECON POLIC, V7, P1, DOI 10.1257/pol.20130139; Burgess R, 2012, Q J ECON, V127, P1707, DOI 10.1093/qje/qjs034; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Costello C, 2008, SCIENCE, V321, P1678, DOI 10.1126/science.1159478; Daily GC, 2000, SCIENCE, V289, P395, DOI 10.1126/science.289.5478.395; Ferraro PJ, 2007, J ENVIRON ECON MANAG, V54, P245, DOI 10.1016/j.jeem.2007.01.002; Jayachandran S., 2016, 22378 NBER; Jayachandran S, 2013, AM ECON REV, V103, P309, DOI 10.1257/aer.103.3.309; Kling CL, 2012, J ECON PERSPECT, V26, P3, DOI 10.1257/jep.26.4.3; Lambin EF, 2011, P NATL ACAD SCI USA, V108, P3465, DOI 10.1073/pnas.1100480108; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Muller NZ, 2009, AM ECON REV, V99, P1714, DOI 10.1257/aer.99.5.1714; Newbold T, 2015, NATURE, V520, P45, DOI 10.1038/nature14324; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752	15	14	16	3	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					651	652		10.1126/science.aaf9697	http://dx.doi.org/10.1126/science.aaf9697			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5ZC	27516587				2022-12-28	WOS:000381561200022
J	Hoenen, T; Groseth, A; Safronetz, D; Wollenberg, K; Feldmann, H				Hoenen, Thomas; Groseth, Allison; Safronetz, David; Wollenberg, Kurt; Feldmann, Heinz			Response to Comment on "Mutation rate and genotype variation of Ebola virus from Mali case sequences"	SCIENCE			English	Editorial Material							SIERRA-LEONE; OUTBREAK; TRANSMISSION; MACAQUES; DISEASE; STRAIN	Rambaut et al. show that the erratum to our report on Ebola virus Makona evolution not only corrected sample dates modified by others in GenBank but also corrected an additional transcriptional error in our original analysis. We agree with their observation that both factors contributed to our revised evolutionary rate estimate but continue to stand by our revised estimate and conclusions.	[Hoenen, Thomas; Groseth, Allison; Safronetz, David; Feldmann, Heinz] NIAID, Virol Lab, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT USA; [Wollenberg, Kurt] NIAID, Bioinformat & Computat Biosci Branch, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Feldmann, H (corresponding author), NIAID, Virol Lab, Div Intramural Res, NIH,Rocky Mt Labs, Hamilton, MT USA.	feldmannh@niaid.nih.gov	Hoenen, Thomas/H-8990-2019; Groseth, Allison/AAJ-9076-2020	Hoenen, Thomas/0000-0002-5829-6305; Groseth, Allison/0000-0001-9528-5130	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001089, ZIAAI001189] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bird BH, 2016, J INFECT DIS, V213, P703, DOI 10.1093/infdis/jiv538; Carroll MW, 2015, NATURE, V524, P97, DOI 10.1038/nature14594; Dunham EC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9000; Gire SK, 2014, SCIENCE, V345, P1369, DOI 10.1126/science.1259657; Henao-Restrepo AM, 2015, LANCET, V386, P857, DOI 10.1016/S0140-6736(15)61117-5; Hoenen T, 2015, SCIENCE, V348, P117, DOI 10.1126/science.aaa5646; Hofmann-Winkler H, 2015, J INFECT DIS, V212, pS172, DOI 10.1093/infdis/jiv101; Marzi A, 2015, EMERG INFECT DIS, V21, P1777, DOI 10.3201/eid2110.150259; Marzi A, 2015, SCIENCE, V349, P739, DOI 10.1126/science.aab3920; Park DJ, 2015, CELL, V161, P1516, DOI 10.1016/j.cell.2015.06.007; Rambaut A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf3823; Sozhamannan S, 2015, VIRUSES-BASEL, V7, P3130, DOI 10.3390/v7062763; Tong YG, 2015, NATURE, V524, P93, DOI 10.1038/nature14490	13	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300								10.1126/science.aaf4561	http://dx.doi.org/10.1126/science.aaf4561			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZC	27516593				2022-12-28	WOS:000381561200030
J	Chen, CC; Fu, LJ; Maier, J				Chen, Chia-Chin; Fu, Lijun; Maier, Joachim			Synergistic, ultrafast mass storage and removal in artificial mixed conductors	NATURE			English	Article							CHEMICAL DIFFUSION-COEFFICIENT; OXYGEN NONSTOICHIOMETRY; SOLID-ELECTROLYTE; DEFECT CHEMISTRY; TRANSPORT; CONDUCTIVITY; TEMPERATURE; GRAPHITE; CHARGE; SUPERCAPACITORS	Mixed conductors-single phases that conduct electronically and ionically-enable stoichiometric variations in a material and, therefore, mass storage and redistribution, for example, in battery electrodes. We have considered how such properties may be achieved synergistically in solid two-phase systems, forming artificial mixed conductors. Previously investigated composites suffered from poor kinetics and did not allow for a clear determination of such stoichiometric variations. Here we show, using electrochemical and chemical methods, that a melt-processed composite of the 'super-ionic' conductor RbAg4I5 and the electronic conductor graphite exhibits both a remarkable silver excess and a silver deficiency, similar to those found in single-phase mixed conductors, even though such behaviour is not possible in the individual phases. Furthermore, the kinetics of silver uptake and release is very fast. Evaluating the upper limit set by interfacial ambipolar diffusion reveals chemical diffusion coefficients that are even higher than those achieved for sodium chloride in bulk liquid water. These results could potentially stimulate systematic research into powerful, even mesoscopic, artificial mixed conductors.	[Chen, Chia-Chin; Fu, Lijun; Maier, Joachim] Max Planck Inst Solid State Res, Heisenbergstr 1, D-70569 Stuttgart, Germany	Max Planck Society	Maier, J (corresponding author), Max Planck Inst Solid State Res, Heisenbergstr 1, D-70569 Stuttgart, Germany.	s.weiglein@fkf.mpg.de	Fu, Lijun/B-1937-2016; Fu, Lijun/T-9160-2018	Fu, Lijun/0000-0002-6810-6050; Fu, Lijun/0000-0001-9830-3007				Armstrong RD, 1997, SOLID STATE IONICS, V94, P181, DOI 10.1016/S0167-2738(96)00603-0; Bakken E, 2005, SOLID STATE IONICS, V176, P217, DOI 10.1016/j.ssi.2004.07.001; Barker J, 1996, ELECTROCHIM ACTA, V41, P2481, DOI 10.1016/0013-4686(96)00036-9; Beck G, 2004, SOLID STATE IONICS, V170, P129, DOI 10.1016/j.ssi.2004.02.024; BECKER KD, 1983, SOLID STATE IONICS, V11, P213, DOI 10.1016/0167-2738(83)90026-7; Bouwmeester H.J.M., 1997, CRC HDB SOLID STATE, P501, DOI [10.1201/9781420049305, DOI 10.1201/9781420049305]; BREDIKHIN S, 1994, SOLID STATE IONICS, V67, P311, DOI 10.1016/0167-2738(94)90023-X; Burgermeister A, 2001, SOLID STATE IONICS, V141, P331, DOI 10.1016/S0167-2738(01)00745-7; Chiang YM, 1996, APPL PHYS LETT, V69, P185, DOI 10.1063/1.117366; Cussler E.L., 1997, DIFFUSION MASS TRANS; de Levie R., 1967, ADV ELECTROCHEMISTRY, V6, P329; Fromling T, 2011, J APPL PHYS, V110, DOI 10.1063/1.3626054; Fu LJ, 2015, NANO LETT, V15, P4170, DOI 10.1021/acs.nanolett.5b01320; Fu LJ, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.208301; Funke K., 1976, PROG SOLID STATE CHE, V11, P345; Hagenbeck R, 1998, J APPL PHYS, V83, P2083, DOI 10.1063/1.366941; Heyne L., 1971, Proceedings of the British Ceramic Society, P229; Huang X, 2012, CHEM SOC REV, V41, P666, DOI 10.1039/c1cs15078b; HULL MN, 1971, J ELECTROCHEM SOC, V118, P72, DOI 10.1149/1.2407955; Jamnik J, 2001, PHYS CHEM CHEM PHYS, V3, P1668, DOI 10.1039/b100180i; Kanai H, 1997, J SOLID STATE CHEM, V131, P150, DOI 10.1006/jssc.1997.7377; Kim ID, 2013, ACTA MATER, V61, P974, DOI 10.1016/j.actamat.2012.10.041; Kim S, 2002, J ELECTROCHEM SOC, V149, pJ73, DOI 10.1149/1.1507597; Kim S, 2004, SURF SCI, V549, P196, DOI 10.1016/j.susc.2003.12.002; Kudo T., 1990, SOLID STATE IONICS, P47; Lupetin P, 2010, ANGEW CHEM INT EDIT, V49, P10123, DOI 10.1002/anie.201003917; Maier J, 2005, NAT MATER, V4, P805, DOI 10.1038/nmat1513; MAIER J, 1993, J AM CERAM SOC, V76, P1212, DOI 10.1111/j.1151-2916.1993.tb03743.x; MAIER J, 1991, ADV MATER, V3, P292, DOI 10.1002/adma.19910030605; MAIER J, 1989, SOLID STATE IONICS, V32-3, P727, DOI 10.1016/0167-2738(89)90351-2; Maier J., 2007, MOD ASPECT ELECTROC, V41, P1; Maier J, 2013, ANGEW CHEM INT EDIT, V52, P4998, DOI [10.1002/anie.201205569, 10.1002/anie.201302312]; MIZUSAKI J, 1982, SOLID STATE IONICS, V6, P85, DOI 10.1016/0167-2738(82)90099-6; Mueller DN, 2012, CHEM MATER, V24, P269, DOI 10.1021/cm2033004; Nilges T, 2009, NAT MATER, V8, P101, DOI [10.1038/NMAT2358, 10.1038/nmat2358]; Oxley J., 1972, 141 M EL SOC HOUST, P446; Pech D, 2010, NAT NANOTECHNOL, V5, P651, DOI [10.1038/nnano.2010.162, 10.1038/NNANO.2010.162]; PETUSKEY WT, 1986, SOLID STATE IONICS, V21, P117, DOI 10.1016/0167-2738(86)90202-X; RALEIGH DO, 1974, J ELECTROCHEM SOC, V121, P632, DOI 10.1149/1.2401875; Riess I, 2003, SOLID STATE IONICS, V157, P1, DOI 10.1016/S0167-2738(02)00182-0; Sata N, 2000, NATURE, V408, P946, DOI 10.1038/35050047; SCHMALZRIED H, 1980, PROG SOLID STATE CH, V13, P119, DOI 10.1016/0079-6786(80)90002-3; Schmalzried H., 1981, BER BUNSEN PHYS CHEM, V85, P7; SCROSATI B, 1971, J ELECTROCHEM SOC, V118, P86, DOI 10.1149/1.2407958; Sitte W, 1997, SOLID STATE IONICS, V94, P85, DOI 10.1016/S0167-2738(96)00584-X; SITTE W, 1993, SOLID STATE IONICS, V59, P117, DOI 10.1016/0167-2738(93)90237-W; Sunarso J, 2008, J MEMBRANE SCI, V320, P13, DOI 10.1016/j.memsci.2008.03.074; Taberna PL, 2003, J ELECTROCHEM SOC, V150, pA292, DOI 10.1149/1.1543948; TATAR RC, 1982, PHYS REV B, V25, P4126, DOI 10.1103/PhysRevB.25.4126; Tuller HL, 1997, SOLID STATE IONICS, V94, P63, DOI 10.1016/S0167-2738(96)00585-1; Wagner C., 1975, PROG SOLID STATE CHE, V10, P3; Waser R, 2007, NAT MATER, V6, P833, DOI 10.1038/nmat2023	52	82	83	4	247	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					159	+		10.1038/nature19078	http://dx.doi.org/10.1038/nature19078			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27510217				2022-12-28	WOS:000381472100026
J	Petsakou, A; Perrimon, N				Petsakou, Afroditi; Perrimon, Norbert			"ISN't Thirst Sweet?'' Says the Fly	CELL			English	Editorial Material							DROSOPHILA; MECHANISMS	How food and water intake is reciprocally regulated to maintain homeostasis is unclear. New findings by Jourjine and colleagues identify four neurons in the Drosophila brain that receive both water and sugar abundance signals and oppositely regulate hunger and thirst.	[Petsakou, Afroditi; Perrimon, Norbert] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Petsakou, Afroditi; Perrimon, Norbert] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Perrimon, N (corresponding author), Harvard Med Sch, Dept Genet, Boston, MA 02115 USA.; Perrimon, N (corresponding author), Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA.	perrimon@receptor.med.harvard.edu		Perrimon, Norbert/0000-0001-7542-472X				Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; Efeyan A, 2015, NATURE, V517, P302, DOI 10.1038/nature14190; Jourjine N, 2016, CELL, V166, P855, DOI 10.1016/j.cell.2016.06.046; Kim J, 2003, NATURE, V424, P81, DOI 10.1038/nature01733; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; Mietlicki EG, 2009, PHYSIOL BEHAV, V96, P37, DOI 10.1016/j.physbeh.2008.08.004; Pool AH, 2014, CURR OPIN NEUROBIOL, V29, P57, DOI 10.1016/j.conb.2014.05.008; Thornton SN, 2016, FRONT NUTR, V3, DOI 10.3389/fnut.2016.00018; Waterson MJ, 2014, P NATL ACAD SCI USA, V111, P8137, DOI 10.1073/pnas.1315461111; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378	10	1	1	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					796	U25		10.1016/j.cell.2016.07.038	http://dx.doi.org/10.1016/j.cell.2016.07.038			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27518557	Bronze			2022-12-28	WOS:000382258700004
J	Martinez-Patino, MJ; Vilain, E; Bueno-Guerra, N				Jose Martinez-Patino, Maria; Vilain, Eric; Bueno-Guerra, Nereida			The unfinished race: 30 years of gender verification in sport	LANCET			English	Editorial Material							FEMALE; HYPERANDROGENISM		[Jose Martinez-Patino, Maria] Univ Vigo, Fac Educ Sci & Sports, Vigo, Galicia, Spain; [Vilain, Eric] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA USA; [Vilain, Eric] CNRS, Int Joint Unit Epigenet Data Polit, Paris, France; [Bueno-Guerra, Nereida] Univ Barcelona, Dept Psychol & Clin Psychobiol, Barcelona 08025, Cataluna, Spain; [Bueno-Guerra, Nereida] Max Planck Inst Evolutionary Anthropol, Dept Dev Psychol, Leipzig, Saxony, Germany	Universidade de Vigo; University of California System; University of California Los Angeles; Centre National de la Recherche Scientifique (CNRS); University of Barcelona; Max Planck Society	Bueno-Guerra, N (corresponding author), Univ Barcelona, Dept Psychol & Clin Psychobiol, Barcelona 08025, Cataluna, Spain.; Bueno-Guerra, N (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Dev Psychol, Leipzig, Saxony, Germany.	nereidabuenoguerra@gmail.com	Bueno, Nereida/K-2743-2015; MARTINEZ-PATIÑO, MARIA JOSE/K-7359-2014	Bueno, Nereida/0000-0003-1442-7905; MARTINEZ-PATIÑO, MARIA JOSE/0000-0003-2721-9240				Allen DB, 2016, HORM RES PAEDIAT, V85, P278, DOI 10.1159/000444054; Arboleda VA, 2014, NAT REV ENDOCRINOL, V10, P603, DOI 10.1038/nrendo.2014.130; Bermon S, 2014, J CLIN ENDOCR METAB, V99, P4328, DOI 10.1210/jc.2014-1391; DREGER A., 2012, ATLANTIC; Elsas LJ, 2000, GENET MED, V2, P249, DOI 10.1097/00125817-200007000-00008; INTERNATIONAL ASSOCIATION OF ATHLETICS FEDERATIONS, 2011, REG GOV EL FEM HYP C; International Olympic Committee, 2015, OL CHART; International Olympic Committee, 2015, CONS M SEX REASS HYP; Karkazis K, 2012, AM J BIOETHICS, V12, P3, DOI 10.1080/15265161.2012.680533; Martinez-Patino MJ, 2005, LANCET, V366, pS38, DOI 10.1016/S0140-6736(05)67841-5; Sanchez FJ, 2013, J SEX RES, V50, P112, DOI 10.1080/00224499.2012.752429; Tucker R., 2009, S AFR J SPORTS MED, V21, P147, DOI [10.17159/2078-516X/2009/v21i4a283, DOI 10.17159/2078-516X/2009/V21I4A283]; World Anti-Doping Agency, 2015, PROH LIST 2015	13	5	5	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2016	388	10044					541	543		10.1016/S0140-6736(16)30963-1	http://dx.doi.org/10.1016/S0140-6736(16)30963-1			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS4NA	27511770				2022-12-28	WOS:000380756600008
J	[Anonymous]				[Anonymous]			The Protection of Micro-Organisms (Reprinted from JAMA, vol 67, pg 438, 1916)	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Reprint																		Elizabeth T., 1912, MANUAL IMMUNITY, P57; Rous P, 1916, J EXP MED, V23, P601, DOI 10.1084/jem.23.5.601; Zinsser Hans, 1914, INFECT RESISTANCE, P278; 1916, JAMA, V67, P438	4	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2016	316	5					548	548		10.1001/jama.2015.17096	http://dx.doi.org/10.1001/jama.2015.17096			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9AU	27483084				2022-12-28	WOS:000381075000036
J	Wallden, M; Fange, D; Lundius, EG; Baltekin, O; Elf, J				Wallden, Mats; Fange, David; Lundius, Ebba Gregorsson; Baltekin, Ozden; Elf, Johan			The Synchronization of Replication and Division Cycles in Individual E. coli Cells	CELL			English	Article							CHROMOSOME-REPLICATION; DNA-REPLICATION; INITIATION; SIZE; GROWTH; MODEL; K-12; ORGANIZATION; HOMEOSTASIS; MOVEMENT	Isogenic E. coli cells growing in a constant environment display significant variability in growth rates, division sizes, and generation times. The guiding principle appears to be that each cell, during one generation, adds a size increment that is uncorrelated to its birth size. Here, we investigate the mechanisms underlying this "adder'' behavior by mapping the chromosome replication cycle to the division cycle of individual cells using fluorescence microscopy. We have found that initiation of chromosome replication is triggered at a fixed volume per chromosome independent of a cell's birth volume and growth rate. Each initiation event is coupled to a division event after a growth-rate-dependent time. We formalize our findings in a model showing that cell-to-cell variation in division timing and cell size is mainly driven by variations in growth rate. The model also explains why fast-growing cells display adder behavior and correctly predict deviations from the adder behavior at slow growth.	[Wallden, Mats; Fange, David; Lundius, Ebba Gregorsson; Baltekin, Ozden; Elf, Johan] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Husargatan 3, S-75124 Uppsala, Sweden	Uppsala University	Elf, J (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Husargatan 3, S-75124 Uppsala, Sweden.	johan.elf@icm.uu.se			European Research Council; Vetenskapsradet; Knut and Alice Wallenberg Foundation	European Research Council(European Research Council (ERC)European Commission); Vetenskapsradet(Swedish Research Council); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	We thank Gustaf Ullman, Alexis Boucharin, Erik Marklund, and Prune Leroy for valuable support in programming, data analysis, and cloning; Sajith Kecheril and Carolina Whalby for providing image analysis code; Bill Soderstrom for providing EC442; Benedict Michelle for providing JJC5350; and Torsten Waldminghaus and Daniel Schindler for providing DS116. This work was supported by the European Research Council, Vetenskapsradet, and the Knut and Alice Wallenberg Foundation.	Adiciptaningrum A, 2015, SCI REP-UK, V5, DOI 10.1038/srep18261; Amir A, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.208102; Bates D, 2005, CELL, V121, P899, DOI 10.1016/j.cell.2005.04.013; CAMPBELL JL, 1990, CELL, V62, P967, DOI 10.1016/0092-8674(90)90271-F; Campos M, 2014, CELL, V159, P1433, DOI 10.1016/j.cell.2014.11.022; Chai Q, 2014, J BIOL CHEM, V289, P11342, DOI 10.1074/jbc.M114.557348; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DONACHIE WD, 1968, NATURE, V219, P1077, DOI 10.1038/2191077a0; Donachie WD, 2003, CURR OPIN MICROBIOL, V6, P146, DOI 10.1016/S1369-5274(03)00026-2; Edelstein Arthur D, 2014, J Biol Methods, V1; Hammar P, 2014, NAT GENET, V46, P405, DOI 10.1038/ng.2905; HANSEN FG, 1991, RES MICROBIOL, V142, P161, DOI 10.1016/0923-2508(91)90025-6; HELMSTETTER CE, 1987, J BACTERIOL, V169, P3489, DOI 10.1128/jb.169.8.3489-3494.1987; Hill NS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002549; Huh D, 2011, NAT GENET, V43, P95, DOI 10.1038/ng.729; Kasho K, 2013, P NATL ACAD SCI USA, V110, P936, DOI 10.1073/pnas.1212070110; KOSHLAND DE, 1982, SCIENCE, V217, P220, DOI 10.1126/science.7089556; Kurokawa K, 1999, EMBO J, V18, P6642, DOI 10.1093/emboj/18.23.6642; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; LU M, 1994, CELL, V77, P413, DOI 10.1016/0092-8674(94)90156-2; Magnusson KEG, 2015, IEEE T MED IMAGING, V34, P911, DOI 10.1109/TMI.2014.2370951; Michelsen O, 2003, MICROBIOL-SGM, V149, P1001, DOI 10.1099/mic.0.26058-0; Osella M, 2014, P NATL ACAD SCI USA, V111, P3431, DOI 10.1073/pnas.1313715111; Paulsson J, 2001, Q REV BIOPHYS, V34, P1, DOI 10.1017/S0033583501003663; Paulsson JP, 2000, J MOL BIOL, V297, P179, DOI 10.1006/jmbi.2000.3526; Pritchard R.H., 1968, DNA SYNTHESIS, P1; Reyes-Lamothe R, 2010, SCIENCE, V328, P498, DOI 10.1126/science.1185757; Sadanandan S., 2014, IEEE J-STSP, V10, P174; Savageau M, 1976, BIOCH SYSTEMS ANAL S; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; SEKIMIZU K, 1987, CELL, V50, P259, DOI 10.1016/0092-8674(87)90221-2; SKARSTAD K, 1986, EMBO J, V5, P1711, DOI 10.1002/j.1460-2075.1986.tb04415.x; Skarstad K, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012922; Sliusarenko O, 2011, MOL MICROBIOL, V80, P612, DOI 10.1111/j.1365-2958.2011.07579.x; Soderstrom B, 2014, MOL MICROBIOL, V92, P1, DOI 10.1111/mmi.12534; SOMPAYRAC L, 1973, NATURE-NEW BIOL, V241, P133, DOI 10.1038/newbio241133a0; Taheri-Araghi S, 2015, CURR BIOL, V25, P385, DOI 10.1016/j.cub.2014.12.009; Ullman G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0025; Voorn WJ, 1998, ARCH MICROBIOL, V169, P43; Waldminghaus T, 2012, NUCLEIC ACIDS RES, V40, P5465, DOI 10.1093/nar/gks187; Wang P, 2010, CURR BIOL, V20, P1099, DOI 10.1016/j.cub.2010.04.045; WOLD S, 1994, EMBO J, V13, P2097, DOI 10.1002/j.1460-2075.1994.tb06485.x	42	166	167	3	103	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					729	739		10.1016/j.cell.2016.06.052	http://dx.doi.org/10.1016/j.cell.2016.06.052			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27471967	Bronze			2022-12-28	WOS:000380546500022
J	Dore, GJ; Altice, F; Litwin, AH; Dalgard, O; Gane, EJ; Shibolet, O; Luetkemeyer, A; Nahass, R; Peng, CY; Conway, B; Grebely, J; Howe, AYM; Gendrano, IN; Chen, E; Huang, HC; Dutko, FJ; Nickle, DC; Nguyen, Y; Wahl, J; Barr, E; Robertson, MN; Platt, HL				Dore, Gregory J.; Altice, Frederick; Litwin, Alain H.; Dalgard, Olav; Gane, Edward J.; Shibolet, Oren; Luetkemeyer, Anne; Nahass, Ronald; Peng, Cheng-Yuan; Conway, Brian; Grebely, Jason; Howe, Anita Y. M.; Gendrano, Isaias N.; Chen, Erluo; Huang, Hsueh-Cheng; Dutko, Frank J.; Nickle, David C.; Bach-Yen Nguyen; Wahl, Janice; Barr, Eliav; Robertson, Michael N.; Platt, Heather L.		C-EDGE CO-STAR Study Grp	Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy A Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							HCV NS5A INHIBITOR; GENOTYPE 1; MK-5172; MK-8742; RIBAVIRIN; PEOPLE; EFFICACY; SAFETY; EPIDEMIOLOGY; COINFECTION	Background: Hepatitis C virus (HCV) infection is common in persons who inject drugs (PWID). Objective: To evaluate elbasvir-grazoprevir in treating HCV infection in PWID. Design: Randomized, placebo-controlled, double-blind trial. (ClinicalTrials.gov: NCT02105688) Setting: Australia, Canada, France, Germany, Israel, the Netherlands, New Zealand, Norway, Spain, Taiwan, the United Kingdom, and the United States. Patients: 301 treatment-naive patients with chronic HCV genotype 1, 4, or 6 infection who were at least 80% adherent to visits for opioid agonist therapy (OAT). Intervention: The immediate-treatment group (ITG) received elbasvir-grazoprevir for 12 weeks; the deferred-treatment group (DTG) received placebo for 12 weeks, no treatment for 4 weeks, then open-label elbasvir-grazoprevir for 12 weeks. Measurements: The primary outcome was sustained virologic response at 12 weeks (SVR12), evaluated separately in the ITG and DTG. Other outcomes included SVR24, viral recurrence or reinfection, and adverse events. Results: The SVR12 was 91.5% (95% CI, 86.8% to 95.0%) in the ITG and 89.5% (95% CI, 81.5% to 94.8%) in the active phase of the DTG. Drug use at baseline and during treatment did not affect SVR12 or adherence to HCV therapy. Among 18 patients with posttreatment viral recurrence through 24-week follow-up, 6 had probable reinfection. If the probable reinfections were assumed to be responses, SVR12 was 94.0% (CI, 89.8% to 96.9%) in the ITG. One patient in the ITG (1 of 201) and 1 in the placebo-phase DTG (1 of 100) discontinued treatment because of an adverse event. Limitation: These findings may not be generalizable to PWID who are not receiving OAT, nor do they apply to persons with genotype 3 infection, a common strain in PWID. Conclusion: Patients with HCV infection who were receiving OAT and treated with elbasvir-grazoprevir had high rates of SVR12, regardless of ongoing drug use. These results support the removal of drug use as a barrier to interferon-free HCV treatment for patients receiving OAT.	UNSW Australia, Kirby Inst, Sydney, NSW, Australia; [Altice, Frederick] Yale Sch Med, 135 Coll St,Suite 323, New Haven, CT 06510 USA; Montefiore Med Ctr, 111 East 210th St, Bronx, NY 10467 USA; Akershus Univ Hosp, Lorenskog, Norway; Auckland Clin Studies, Auckland, New Zealand; Tel Aviv Sourasky Med Ctr, Tel Aviv, Israel; Univ Calif San Francisco, San Francisco, CA USA; ID Care, Hillsborough, NJ USA; China Med Univ, Taichung, Taiwan; Vancouver Infect Dis Ctr, Vancouver, BC, Canada; Merck & Co Inc, Kenilworth, NJ USA; [Dore, Gregory J.; Grebely, Jason] UNSW, UNSW Australia, Kirby Inst, Wallace Wurth Bldg, Sydney, NSW 2052, Australia; [Litwin, Alain H.] Montefiore Med Ctr, 1510 Waters Pl, Bronx, NY 10461 USA; [Dalgard, Olav] Akershus Univ Hosp, Infeksjonsmedisinsk Poliklin, Sykehusveien 25, N-1478 Lorenskog, Norway; [Gane, Edward J.] Auckland Clin Studies, Medacs House,3 Ferncroft St,Ground Floor, Auckland 1150, New Zealand; [Shibolet, Oren] Tel Aviv Sourasky Med Ctr, Gastrointestinal & Liver Dis, 6 Waitzmann St, IL-64239 Tel Aviv, Israel; [Luetkemeyer, Anne] Univ Calif San Francisco, 995 Potrero Ave,Box 0874,Bldg 80,Fourth Floor, San Francisco, CA 94110 USA; [Nahass, Ronald] ID Care, 105 Raider Blvd,Suite 101, Hillsborough, NJ 08844 USA; [Peng, Cheng-Yuan] China Med Univ, Sch Med, 2 Yuh Der Rd, Taichung 40447, Taiwan; [Conway, Brian] Vancouver Infect Dis Ctr, 201-1200 Burrard St, Vancouver, BC V6Z 2C7, Canada; [Howe, Anita Y. M.] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, 608-1081 Burrard St, Vancouver, BC V6Z 1Y6, Canada; [Gendrano, Isaias N.] Merck & Co Inc, 126 East Lincoln Ave,POB 2000,RY34-A474, Rahway, NJ 07065 USA; [Chen, Erluo] Merck & Co Inc, 126 East Lincoln Ave,POB 2000,RY34-A316, Rahway, NJ 07065 USA; [Huang, Hsueh-Cheng] Merck & Co Inc, 2000 Galloping Hill Rd,POB 539,K-15-4-D402, Kenilworth, NJ 07033 USA; [Dutko, Frank J.] Merck & Co Inc, 351 North Sumneytown Pike,UG3C-06, N Wales, PA 19454 USA; [Nickle, David C.] Merck Sharp & Dohme Corp, 33 Ave Louis Pasteur, Boston, MA 02115 USA; [Bach-Yen Nguyen] Merck & Co Inc, 351 North Sumneytown Pike,UG4C-06, N Wales, PA 19454 USA; [Wahl, Janice] Merck & Co Merck & Co Inc, 126 East Lincoln Ave,POB 2000,RY34-A484, Rahway, NJ 07065 USA; [Barr, Eliav] Merck & Co Inc, 351 North Sumneytown Pike,UG3C-96, N Wales, PA 19454 USA; [Robertson, Michael N.] Merck & Co Inc, 351 North Sumneytown Pike,UG3C-56, N Wales, PA 19454 USA; [Platt, Heather L.] Merck & Co Inc, 351 North Sumneytown Pike, N Wales, PA 19454 USA	University of New South Wales Sydney; Kirby Institute; Yale University; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Oslo; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University of California System; University of California San Francisco; China Medical University Taiwan; Merck & Company; University of New South Wales Sydney; Kirby Institute; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Oslo; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; University of California System; University of California San Francisco; China Medical University Taiwan; B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company; Merck & Company	Dore, GJ (corresponding author), UNSW, UNSW Australia, Kirby Inst, Wallace Wurth Bldg, Sydney, NSW 2052, Australia.	gdore@kirby.unsw.edu.au	Dore, Gregory John/ABD-5665-2021; Nickle, David/ABF-2727-2020; Streinu-Cercel, Adrian/M-5835-2017	Dore, Gregory John/0000-0002-4741-2622; Streinu-Cercel, Adrian/0000-0001-6382-5067; Ustianowski, Andrew/0000-0002-6134-7855; Altice, Frederick/0000-0002-7860-693X	Merck Co.	Merck Co.(Merck & Company)	Merck & Co.	American Association for the Study of Liver Diseases Infectious Diseases Society of America International Antiviral Society-USA, 2015, REC TEST MAN TREAT H; Aspinall EJ, 2013, CLIN INFECT DIS, V57, pS80, DOI 10.1093/cid/cit306; Barua S, 2015, ANN INTERN MED, V163, P215, DOI 10.7326/M15-0406; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Coburn CA, 2013, CHEMMEDCHEM, V8, P1930, DOI 10.1002/cmdc.201300343; Fraser IP, 2013, 8 INT WORKSH CLIN PH; Grebely J, 2015, INT J DRUG POLICY, V26, P1028, DOI 10.1016/j.drugpo.2015.07.005; Grebely J, 2013, CLIN INFECT DIS, V57, pS29, DOI 10.1093/cid/cit264; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Lahser F, 2012, HEPATOLOGY, V56, p236A; Lalezari J, 2015, J HEPATOL, V63, P364, DOI 10.1016/j.jhep.2015.03.029; Lawitz E, 2015, LANCET, V385, P1075, DOI 10.1016/S0140-6736(14)61795-5; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Marshall WL, 2015, HEPATOLOGY, V62, p573A; Marshall WL, 2013, GLOBAL ANTIVIRAL S2, V9, P61; Martin B, 2014, J HEPATOL, V61, P538, DOI 10.1016/j.jhep.2014.05.043; Martin NK, 2012, HEPATOLOGY, V55, P49, DOI 10.1002/hep.24656; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; Rockstroh JK, 2015, LANCET HIV, V2, pE319, DOI 10.1016/S2352-3018(15)00114-9; Serti E, 2015, GASTROENTEROLOGY, V149, P190, DOI 10.1053/j.gastro.2015.03.004; Sulkowski M, 2015, LANCET, V385, P1087, DOI 10.1016/S0140-6736(14)61793-1; Sulkowski MS, 2014, JAMA-J AM MED ASSOC, V312, P353, DOI 10.1001/jama.2014.7734; Summa V, 2012, ANTIMICROB AGENTS CH, V56, P4161, DOI 10.1128/AAC.00324-12; U.S. Food and Drug Administration, 2016, PRESCR INF ZEP ELB G; Zeuzem S, 2015, ANN INTERN MED, V163, P1, DOI 10.7326/M15-0785	27	260	262	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2016	165	9					625	+		10.7326/M16-0816	http://dx.doi.org/10.7326/M16-0816			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8SJ	27537841				2022-12-28	WOS:000386908600005
J	Chopra, HD; Wuttig, M				Chopra, Harsh Deep; Wuttig, Manfred			Non-Joulian magnetostriction (vol 521, pg 340, 2015)	NATURE			English	Correction															Direct For Mathematical & Physical Scien [1206397] Funding Source: National Science Foundation; Division Of Materials Research [1541236] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Chopra HD, 2015, NATURE, V521, P340, DOI 10.1038/nature14459; Joule JP, 1847, PHILOS MAG, V30, P225; Joule JP, 1847, PHIL MAG 3, V30, P76, DOI DOI 10.1080/14786444708645656; SULLIVAN M, 1980, REV SCI INSTRUM, V51, P382, DOI 10.1063/1.1136225	4	8	8	6	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 20	2016	538	7625					416	416		10.1038/nature19064	http://dx.doi.org/10.1038/nature19064			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA5PJ	27487222	Bronze			2022-12-28	WOS:000386673100046
J	Andersen, LB; Mota, J; Di Pietro, L				Andersen, Lars Bo; Mota, Jorge; Di Pietro, Loretta			Update on the global pandemic of physical inactivity	LANCET			English	Editorial Material									[Andersen, Lars Bo] Sogn Fjordane Univ Coll, Fac Teacher Educ & Sport, N-6851 Sogndal, Norway; [Mota, Jorge] Univ Porto, Fac Sports, Res Ctr Phys Act Hlth & Leisure, Oporto, Portugal; [Di Pietro, Loretta] George Washington Univ, Sch Publ Hlth, Milken Inst, Washington, DC USA	Western Norway University of Applied Sciences; Universidade do Porto; George Washington University	Andersen, LB (corresponding author), Sogn Fjordane Univ Coll, Fac Teacher Educ & Sport, N-6851 Sogndal, Norway.	lars.bo.andersen@hisf.no	mota, jorge/B-2980-2013	mota, jorge/0000-0001-7571-9181				Andersen LB, 2004, AM J EPIDEMIOL, V160, P189, DOI 10.1093/aje/kwh195; Ding D, 2016, LANCET, V388, P1311, DOI 10.1016/S0140-6736(16)30383-X; Ekelund U., 2016, LANCET; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; Reis R. S., 2016, LANCET; Sallis J. F., 2016, LANCET	6	80	90	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2016	388	10051					1255	+		10.1016/S0140-6736(16)30960-6	http://dx.doi.org/10.1016/S0140-6736(16)30960-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DW5RH	27475275				2022-12-28	WOS:000383704000008
J	Liu, M; Pang, YJ; Zhang, B; De Luna, P; Voznyy, O; Xu, JX; Zheng, XL; Dinh, CT; Fan, FJ; Cao, CH; de Arquer, FPG; Safaei, TS; Mepham, A; Klinkova, A; Kumacheva, E; Filleter, T; Sinton, D; Kelley, SO; Sargent, EH				Liu, Min; Pang, Yuanjie; Zhang, Bo; De Luna, Phil; Voznyy, Oleksandr; Xu, Jixian; Zheng, Xueli; Dinh, Cao Thang; Fan, Fengjia; Cao, Changhong; de Arquer, F. Pelayo Garcia; Safaei, Tina Saberi; Mepham, Adam; Klinkova, Anna; Kumacheva, Eugenia; Filleter, Tobin; Sinton, David; Kelley, Shana O.; Sargent, Edward H.			Enhanced electrocatalytic CO2 reduction via field-induced reagent concentration	NATURE			English	Article							CARBON-DIOXIDE; SELECTIVE CONVERSION; AU NANOPARTICLES; ELECTROREDUCTION; EFFICIENCY; CATALYSTS; STEP	Electrochemical reduction of carbon dioxide (CO2) to carbon monoxide (CO) is the first step in the synthesis of more complex carbon-based fuels and feedstocks using renewable electricity(1-7). Unfortunately, the reaction suffers from slow kinetics(7,8) owing to the low local concentration of CO2 surrounding typical CO2 reduction reaction catalysts. Alkali metal cations are known to overcome this limitation through non-covalent interactions with adsorbed reagent species(9,10), but the effect is restricted by the solubility of relevant salts. Large applied electrode potentials can also enhance CO2 adsorption(11), but this comes at the cost of increased hydrogen (H-2) evolution. Here we report that nanostructured electrodes produce, at low applied overpotentials, local high electric fields that concentrate electrolyte cations, which in turn leads to a high local concentration of CO2 close to the active CO2 reduction reaction surface. Simulations reveal tenfold higher electric fields associated with metallic nanometre-sized tips compared to quasi-planar electrode regions, and measurements using gold nanoneedles confirm a field-induced reagent concentration that enables the CO2 reduction reaction to proceed with a geometric current density for CO of 22 milliamperes per square centimetre at -0.35 volts (overpotential of 0.24 volts). This performance surpasses by an order of magnitude the performance of the best gold nanorods, nanoparticles and oxide-derived noble metal catalysts. Similarly designed palladium nanoneedle electrocatalysts produce formate with a Faradaic efficiency of more than 90 per cent and an unprecedented geometric current density for formate of 10 milliamperes per square centimetre at -0.2 volts, demonstrating the wider applicability of the field-induced reagent concentration concept.	[Liu, Min; Zhang, Bo; Voznyy, Oleksandr; Xu, Jixian; Zheng, Xueli; Dinh, Cao Thang; Fan, Fengjia; de Arquer, F. Pelayo Garcia; Safaei, Tina Saberi; Sargent, Edward H.] Univ Toronto, Dept Elect & Comp Engn, 35 St George St, Toronto, ON M5S 1A4, Canada; [Pang, Yuanjie; Cao, Changhong; Filleter, Tobin; Sinton, David] Univ Toronto, Dept Mech & Ind Engn, 5 Kings Coll Rd, Toronto, ON M5S 3G8, Canada; [Zhang, Bo] East China Univ Sci & Technol, Dept Phys, 130 Meilong Rd, Shanghai 200237, Peoples R China; [De Luna, Phil] Univ Toronto, Dept Mat Sci & Engn, 184 Coll St, Toronto, ON M5S 3E4, Canada; [Zheng, Xueli] Tianjin Univ, Sch Mat Sci & Engn, Tianjin Key Lab Composite & Funct Mat, Tianjin 300072, Peoples R China; [Mepham, Adam; Kelley, Shana O.] Univ Toronto, Inst Biomat & Biomed Engn, 164 Coll St, Toronto, ON M5S 3G9, Canada; [Klinkova, Anna; Kumacheva, Eugenia] Univ Toronto, Dept Chem, 80 St George St, Toronto, ON M5S 3H6, Canada; [Kelley, Shana O.] Univ Toronto, Leslie Dan Fac Pharm, Dept Pharmaceut Sci, 144 Coll St, Toronto, ON M5S 3M2, Canada; [Kelley, Shana O.] Univ Toronto, Dept Biochem, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto; East China University of Science & Technology; University of Toronto; Tianjin University; University of Toronto; University of Toronto; University of Toronto; University of Toronto	Sargent, EH (corresponding author), Univ Toronto, Dept Elect & Comp Engn, 35 St George St, Toronto, ON M5S 1A4, Canada.	ted.sargent@utoronto.ca	Cao, Changhong/I-8590-2012; Fan, Fengjia/A-7173-2018; Liu, Min/AFZ-6452-2022; Garcia de Arquer, F. Pelayo/AAF-1803-2019; Cao, Changhong/Z-2416-2019; Liu, Min/CAA-4092-2022; De+Luna, Phil/ABD-8341-2021; Dinh, Cao Thang/AAE-7837-2019; Liu, Min/H-3699-2011; Zhang, Bo/AAX-9762-2020; Sargent, Edward H./O-9520-2014; Kumacheva, Eugenia/U-7612-2019; Liu, Min/ABI-4990-2020; Kelley, Shana/H-5856-2015; Kelley, Shana/ABA-7403-2021	Cao, Changhong/0000-0002-9707-3518; Fan, Fengjia/0000-0002-5447-6296; Liu, Min/0000-0002-9007-4817; Garcia de Arquer, F. Pelayo/0000-0003-2422-6234; Cao, Changhong/0000-0002-9707-3518; Liu, Min/0000-0002-9007-4817; De+Luna, Phil/0000-0002-7729-8816; Dinh, Cao Thang/0000-0001-9641-9815; Liu, Min/0000-0002-9007-4817; Zhang, Bo/0000-0002-7853-979X; Sargent, Edward H./0000-0003-0396-6495; Kelley, Shana/0000-0003-3360-5359; xu, jixian/0000-0001-8119-3411; Klinkova, Anna/0000-0003-0337-0579	Ontario Research Fund: Research Excellence programme; Natural Sciences and Engineering Research Council (NSERC) of Canada; CIFAR Bio-Inspired Solar Energy programme; University of Toronto Connaught grant; Shanghai Municipal Natural Science Foundation [14ZR1410200]; National Natural Science Foundation of China [21503079]; Southern Ontario Smart Computing Innovation Platform (SOSCIP)	Ontario Research Fund: Research Excellence programme; Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIFAR Bio-Inspired Solar Energy programme; University of Toronto Connaught grant; Shanghai Municipal Natural Science Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Southern Ontario Smart Computing Innovation Platform (SOSCIP)	This work was supported by the Ontario Research Fund: Research Excellence programme, the Natural Sciences and Engineering Research Council (NSERC) of Canada, the CIFAR Bio-Inspired Solar Energy programme and a University of Toronto Connaught grant. B.Z. acknowledges funding from Shanghai Municipal Natural Science Foundation (14ZR1410200) and the National Natural Science Foundation of China (21503079). We thank X. Lan, P. Kanjanaboos, G. Walters, L. Levina, R. Wolowiec, D. Kopilovic, E. Palmiano, T. Burdyny and J. Tam from the University of Toronto for Au electron beam deposition, liquid products testing, AFM testing, TEM EELS measurements, discussions and additional aids during the course of study, Y. Tian from the King Abdullah University of Science and Technology for electrode preparation assistance, and M. Bajdich, L. D. Chen and K. Chan from Stanford University for advice on DFT calculations. This work has also benefited from the Spherical Grating Monochromator beamlines at the Canadian Light Source. DFT calculations were performed on the IBM BlueGene Q supercomputer with support from the Southern Ontario Smart Computing Innovation Platform (SOSCIP).	Back S, 2015, ACS CATAL, V5, P5089, DOI 10.1021/acscatal.5b00462; Bahn SR, 2002, COMPUT SCI ENG, V4, P56, DOI 10.1109/5992.998641; Bin XM, 2010, ANAL CHEM, V82, P5928, DOI 10.1021/ac101164n; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Chen YH, 2012, J AM CHEM SOC, V134, P19969, DOI 10.1021/ja309317u; Chen YH, 2012, J AM CHEM SOC, V134, P1986, DOI 10.1021/ja2108799; Costentin C, 2012, SCIENCE, V338, P90, DOI 10.1126/science.1224581; Das J, 2013, ANAL CHEM, V85, P7333, DOI 10.1021/ac401221f; Feng XF, 2015, J AM CHEM SOC, V137, P4606, DOI 10.1021/ja5130513; FRIEDMAN AM, 1955, J AM CHEM SOC, V77, P4499, DOI 10.1021/ja01622a016; Gao S, 2016, NATURE, V529, P68, DOI 10.1038/nature16455; Ghuman KK, 2015, PHYS CHEM CHEM PHYS, V17, P14623, DOI 10.1039/c5cp02613j; Gileadi E, 1993, ELECT KINETICS CHEM, pCh 1; HEAD JD, 1985, CHEM PHYS LETT, V122, P264, DOI 10.1016/0009-2614(85)80574-1; Hori Y, 2008, MOD ASP ELECTROCHEM, P89; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson J. D, 1962, CLASSICAL ELECTRODYN, V3, P75; Kleis J, 2011, CATAL LETT, V141, P1067, DOI 10.1007/s10562-011-0632-0; Kokoszka B, 2014, ANGEW CHEM INT EDIT, V53, P3698, DOI 10.1002/anie.201310308; Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Kresse G, 1999, PHYS REV B, V59, P1758, DOI 10.1103/PhysRevB.59.1758; Lin S, 2015, SCIENCE, V349, P1208, DOI 10.1126/science.aac8343; Lu Q, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4242; Meng H, 2011, ENERG ENVIRON SCI, V4, P1522, DOI 10.1039/c0ee00702a; Mettela G, 2015, NANO RES, V8, P2925, DOI 10.1007/s12274-015-0797-8; Min XQ, 2015, J AM CHEM SOC, V137, P4701, DOI 10.1021/ja511890h; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.16.1746; Morris AJ, 2011, CHEMSUSCHEM, V4, P191, DOI 10.1002/cssc.201000379; NODA H, 1995, B CHEM SOC JPN, V68, P1889, DOI 10.1246/bcsj.68.1889; PEEBLES DE, 1983, J PHYS CHEM-US, V87, P4378, DOI 10.1021/j100245a014; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Peterson AA, 2010, ENERG ENVIRON SCI, V3, P1311, DOI 10.1039/c0ee00071j; Qiao JL, 2014, CHEM SOC REV, V43, P631, DOI 10.1039/c3cs60323g; Rosen BA, 2011, SCIENCE, V334, P643, DOI 10.1126/science.1209786; Schmeier TJ, 2011, J AM CHEM SOC, V133, P9274, DOI 10.1021/ja2035514; Serway R. A., 1998, PRINCIPLES PHYS, V1, P602; Soleymani L, 2009, NAT NANOTECHNOL, V4, P844, DOI [10.1038/nnano.2009.276, 10.1038/NNANO.2009.276]; Studt F, 2015, CHEMCATCHEM, V7, P1105, DOI 10.1002/cctc.201500123; Tang W, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/8/084204; Varela AS, 2016, CATAL TODAY, V260, P8, DOI 10.1016/j.cattod.2015.06.009; Wang HN, 2011, J PHYS CHEM C, V115, P16711, DOI 10.1021/jp204498e; Wang W, 2011, CHEM SOC REV, V40, P3703, DOI 10.1039/c1cs15008a; Zhang QF, 2014, ACS CATAL, V4, P4027, DOI 10.1021/cs501445h; Zhu WL, 2014, J AM CHEM SOC, V136, P16132, DOI 10.1021/ja5095099; Zhu WL, 2013, J AM CHEM SOC, V135, P16833, DOI 10.1021/ja409445p	45	1021	1027	129	1900	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 15	2016	537	7620					382	+		10.1038/nature19060	http://dx.doi.org/10.1038/nature19060			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV7EC	27487220				2022-12-28	WOS:000383098000050
J	Aitken, E; Jackson, A; Kearns, R; Steven, M; Kinsella, J; Clancy, M; Macfarlane, A				Aitken, Emma; Jackson, Andrew; Kearns, Rachel; Steven, Mark; Kinsella, John; Clancy, Marc; Macfarlane, Alan			Effect of regional versus local anaesthesia on outcome after arteriovenous fistula creation: a randomised controlled trial	LANCET			English	Article							BRACHIAL-PLEXUS BLOCK; VASCULAR ACCESS; FUNCTIONAL PATENCY; EARLY FAILURE; HEMODIALYSIS; RISK; STENOSIS; GRAFT; LONG	Background Arteriovenous fistulae are the optimum form of vascular access in end-stage renal failure. However, they have a high early failure rate. Regional compared with local anaesthesia results in greater vasodilatation and increases short-term blood flow. This study investigated whether regional compared with local anaesthesia improved medium-term arteriovenous fistula patency. Methods This observer-blinded, randomised controlled trial was done at three university hospitals in Glasgow, UK. Adults undergoing primary radiocephalic or brachiocephalic arteriovenous fistula creation were randomly assigned (1: 1; in blocks of eight) using a computer-generated allocation system to receive either local anaesthesia (0.5% L-bupivacaine and 1% lidocaine injected subcutaneously) or regional (brachial plexus block [BPB]) anaesthesia (0.5% L-bupivacaine and 1.5% lidocaine with epinephrine). Patients were excluded if they were coagulopathic, had no suitable vessels, or had a previous failed ipsilateral fistula. The primary endpoint was arteriovenous fistula patency at 3 months. We analysed the data on an intention-to-treat basis. This study was registered with ClinicalTrials.gov (NCT01706354) and is complete. Findings Between Feb 6, 2013, and Dec 4, 2015, 163 patients were assessed for eligibility and 126 patients were randomly assigned to local anaesthesia (n=63) or BPB (n=63). All patients completed follow-up on an intention-to-treat basis. Primary patency at 3 months was higher in the BPB group than the local anaesthesia group (53 [84%] of 63 patients vs 39 [62%] of 63; odds ratio [OR] 3.3 [95% CI 1.4-7.6], p=0.005) and was greater in radiocephalic fistulae (20 [77%] of 26 patients vs 12 [48%] of 25; OR 3.6 [1.4-3.6], p=0.03). There were no significant adverse events related to the procedure. Interpretation Compared with local anaesthesia, BPB significantly improved 3 month primary patency rates for arteriovenous fistulae.	[Aitken, Emma; Jackson, Andrew; Clancy, Marc] Queen Elizabeth Univ Hosp, Dept Renal Surg, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland; [Kearns, Rachel; Kinsella, John; Macfarlane, Alan] Glasgow Royal Infirm, Dept Anaesthesia, Glasgow, Lanark, Scotland; [Steven, Mark] Golden Jubilee Natl Hosp, Dept Anaesthesia, Clydebank, Scotland; [Kearns, Rachel; Kinsella, John; Macfarlane, Alan] Univ Glasgow, Dept Anaesthesia Crit Care & Pain Med, Glasgow, Lanark, Scotland	Queen Elizabeth University Hospital (QEUH); University of Glasgow; Golden Jubilee Hospital; University of Glasgow	Aitken, E (corresponding author), Queen Elizabeth Univ Hosp, Dept Renal Surg, 1345 Govan Rd, Glasgow G51 4TF, Lanark, Scotland.	emmaaitken@nhs.net	Aitken, Emma/AAV-8554-2021; Aitken, Emma/AAW-4473-2020	Aitken, Emma/0000-0001-8939-7478; Macfarlane, Alan/0000-0003-3858-6468; Kearns, Rachel/0000-0001-6156-6858; Clancy, Marc/0000-0002-1709-9743	Regional Anaesthesia UK; Darlinda's Charity for Renal Research	Regional Anaesthesia UK; Darlinda's Charity for Renal Research	Regional Anaesthesia UK, Darlinda's Charity for Renal Research.; We thank the patients, surgeons, and nursing staff at the Western Infirmary, Stobhill Hospital Glasgow and Queen Elizabeth University Hospital, Glasgow. We are also grateful to the Trial Steering Committee and statistician. EA's salary was funded by Darlinda's Charity for Renal Research. AM received funding from Regional Anaesthesia UK.	Agarwal AK, 2007, SEMIN DIALYSIS, V20, P53, DOI 10.1111/j.1525-139X.2007.00242.x; Aitken EL, 2014, J VASC ACCESS, V15, P481, DOI 10.5301/jva.5000238; Bakken AM, 2007, J VASC SURG, V45, P776, DOI 10.1016/j.jvs.2006.12.046; Bray BD, 2012, QJM-INT J MED, V105, P1097, DOI 10.1093/qjmed/hcs143; Chazapis M, 2014, BMJ QUAL IMPROV REPO, V3; Dember LM, 2008, JAMA-J AM MED ASSOC, V299, P2164, DOI 10.1001/jama.299.18.2164; FERNSTROM A, 1988, ACTA CHIR SCAND, V154, P257; Glover GW, 2007, ANAESTHESIA, V62, P425, DOI 10.1111/j.1365-2044.2006.04943_2.x; Golledge J, 1999, BRIT J SURG, V86, P211, DOI 10.1046/j.1365-2168.1999.01007.x; Hofstra L, 1995, J AM SOC NEPHROL, V6, P1625; Howell SJ, 1998, BRIT J ANAESTH, V80, P14, DOI 10.1093/bja/80.1.14; Konner K, 2003, J AM SOC NEPHROL, V14, P1669, DOI 10.1097/01.ASN.0000069219.88168.39; Laskowski IA, 2007, ANN VASC SURG, V21, P730, DOI 10.1016/j.avsg.2007.07.001; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Lin Peter H, 2005, Vasc Endovascular Surg, V39, P135, DOI 10.1177/153857440503900202; Lo Monte AI, 2011, J VASC ACCESS, V12, P331, DOI 10.5301/JVA.2011.8560; Lok CE, 2007, CLIN J AM SOC NEPHRO, V2, P1043, DOI 10.2215/CJN.01080307; Lok CE, 2006, J AM SOC NEPHROL, V17, P3204, DOI 10.1681/ASN.2006030190; Macfarlane AJR, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-263; Masengu A, 2016, CLIN KIDNEY J, V9, P142, DOI 10.1093/ckj/sfv131; Meena S, 2015, SOUTH AFR J ANAESTH, V21, P12, DOI 10.1080/22201181.2015.1075764; MOUQUET C, 1989, ANESTHESIOLOGY, V70, P909, DOI 10.1097/00000542-198906000-00005; National Kidney Care Audit, 2011, NAT KIDN CAR AUD VAS; Nguyen TH, 2007, J VASC ACCESS, V8, P275, DOI 10.1177/112972980700800410; Perlas A, 2009, REGION ANESTH PAIN M, V34, P171, DOI 10.1097/AAP.0b013e31819a3f81; Reynolds TS, 2011, J VASC ACCESS, V12, P336, DOI 10.5301/JVA.2011.8827; Riella MC, 2013, NAT REV NEPHROL, V9, P348, DOI 10.1038/nrneph.2013.76; Rodriguez J, 2004, REGION ANESTH PAIN M, V29, P534, DOI 10.1016/j.rapm.2004.07.223; Rodriguez JA, 2000, NEPHROL DIAL TRANSPL, V15, P402, DOI 10.1093/ndt/15.3.402; Sahin L, 2011, J VASC SURG, V54, P749, DOI 10.1016/j.jvs.2010.12.045; Sandhu NS, 2006, J ULTRAS MED, V25, P1555, DOI 10.7863/jum.2006.25.12.1555; Schenk WG, 2010, AM SURGEON, V76, P938; Schulz KF, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-32; Shemesh D, 2006, ULTRASOUND MED BIOL, V32, P817, DOI 10.1016/j.ultrasmedbio.2006.02.1420; Shemesh D, 2003, CARDIOVASC SURG, V11, P35, DOI 10.1016/S0967-2109(02)00148-5; Sites BD, 2010, REGION ANESTH PAIN M, V35, pS74, DOI 10.1097/AAP.0b013e3181d34ff5; Soares LG, 2007, REGION ANESTH PAIN M, V32, P94, DOI 10.1016/j.rapm.2006.10.007; Thomson PC, 2007, QJM-INT J MED, V100, P415, DOI 10.1093/qjmed/hcm040; Tozzi M, 2014, J VASC ACCESS, V15, P385, DOI 10.5301/jva.5000276; Vascular Access Work Group, 2006, AM J KIDNEY DIS, V48, pS248, DOI 10.1053/j.ajkd.2006.04.040; Wilmink T, 2016, EUR J VASC ENDOVASC, V51, P134, DOI 10.1016/j.ejvs.2015.10.005; Wong V, 1996, EUR J VASC ENDOVASC, V12, P207, DOI 10.1016/S1078-5884(96)80108-0; Zaliunate R, 2011, DOES REGIONAL COMP L, P584	43	66	68	0	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2016	388	10049					1067	1074		10.1016/S0140-6736(16)30948-5	http://dx.doi.org/10.1016/S0140-6736(16)30948-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV0OD	27492881				2022-12-28	WOS:000382616900028
J	Pimentel, D; Donlea, JM; Albot, CBT; Ong, SMS; Hurston, AJFT; Miesenbock, G				Pimentel, Diogo; Donlea, Jeffrey M.; Albot, Clifford B. T.; Ong, Seoho M. S.; Hurston, Alexander J. F. T.; Miesenbock, Gero			Operation of a homeostatic sleep switch	NATURE			English	Article							TARGETED GENE-EXPRESSION; POTASSIUM CHANNELS; DROSOPHILA-MELANOGASTER; DOPAMINERGIC MODULATION; REMOTE-CONTROL; REDUCED SLEEP; VOLTAGE-CLAMP; NEURONS; MEMORY; BEHAVIOR	Sleep disconnects animals from the external world, at considerable risks and costs that must be offset by a vital benefit. Insight into this mysterious benefit will come from understanding sleep homeostasis: to monitor sleep need, an internal bookkeeper must track physiological changes that are linked to the core function of sleep(1). In Drosophila, a crucial component of the machinery for sleep homeostasis is a cluster of neurons innervating the dorsal fan-shaped body (dFB) of the central complex(2,3). Artificial activation of these cells induces sleep(2), whereas reductions in excitability cause insomnia(3,4). dFB neurons in sleep-deprived flies tend to be electrically active, with high input resistances and long membrane time constants, while neurons in rested flies tend to be electrically silent(3). Correlative evidence thus supports the simple view that homeostatic sleep control works by switching sleep-promoting neurons between active and quiescent states(3). Here we demonstrate state switching by dFB neurons, identify dopamine as a neuromodulator that operates the switch, and delineate the switching mechanism. Arousing dopamine(4-8) caused transient hyperpolarization of dFB neurons within tens of milliseconds and lasting excitability suppression within minutes. Both effects were transduced by Dop1R2 receptors and mediated by potassium conductances. The switch to electrical silence involved the downregulation of voltage-gated A-type currents carried by Shaker and Shab, and the upregulation of voltage-independent leak currents through a two-pore-domain potassium channel that we term Sandman. Sandman is encoded by the CG8713 gene and translocates to the plasma membrane in response to dopamine. dFB-restricted interference with the expression of Shaker or Sandman decreased or increased sleep, respectively, by slowing the repetitive discharge of dFB neurons in the ON state or blocking their entry into the OFF state. Biophysical changes in a small population of neurons are thus linked to the control of sleep-wake state.	[Pimentel, Diogo; Donlea, Jeffrey M.; Albot, Clifford B. T.; Ong, Seoho M. S.; Hurston, Alexander J. F. T.; Miesenbock, Gero] Univ Oxford, Ctr Neural Circuits & Behav, Tinsley Bldg,Mansfield Rd, Oxford OX1 3SR, England	University of Oxford	Miesenbock, G (corresponding author), Univ Oxford, Ctr Neural Circuits & Behav, Tinsley Bldg,Mansfield Rd, Oxford OX1 3SR, England.	gero.miesenboeck@cncb.ox.ac.uk		Miesenboeck, Gero/0000-0003-2940-3228; Song, Seo Ho/0000-0003-2970-2746	Wellcome Trust; Gatsby Charitable Foundation; Oxford Martin School; National Institutes of Health; Human Frontier Science Program; MRC [G0700888] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Gatsby Charitable Foundation; Oxford Martin School; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Frontier Science Program(Human Frontier Science Program); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Birman, R. Davis, B. Dickson, V. Jayaraman, L. Luo, G. Roman, G. Rubin, the Bloomington Stock Center, and the Vienna Drosophila Resource Center for flies. This work was supported by grants (to G.M.) from the Wellcome Trust, the Gatsby Charitable Foundation, the Oxford Martin School, and the National Institutes of Health. J.M.D. was the recipient of a postdoctoral fellowship from the Human Frontier Science Program; S. M. S. is a Commonwealth Scholar.	ANDRADE R, 1987, J PHYSIOL-LONDON, V394, P99, DOI 10.1113/jphysiol.1987.sp016862; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; BAXTER DA, 1989, J NEUROPHYSIOL, V62, P665, DOI 10.1152/jn.1989.62.3.665; BOKOCH GM, 1984, J BIOL CHEM, V259, P3560; BUCHNER E, 1976, BIOL CYBERN, V24, P85, DOI 10.1007/BF00360648; Bushey D, 2007, J NEUROSCI, V27, P5384, DOI 10.1523/JNEUROSCI.0108-07.2007; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Claridge-Chang A, 2009, CELL, V139, P405, DOI 10.1016/j.cell.2009.08.034; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P31, DOI 10.1113/jphysiol.1971.sp009366; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Donlea JM, 2014, NEURON, V81, P860, DOI 10.1016/j.neuron.2013.12.013; Donlea JM, 2011, SCIENCE, V332, P1571, DOI 10.1126/science.1202249; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Ferris J, 2006, NAT NEUROSCI, V9, P1036, DOI 10.1038/nn1738; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; HARRISWARRICK RM, 1995, J NEUROSCI, V15, P342; Hendricks JC, 2000, NEURON, V25, P129, DOI 10.1016/S0896-6273(00)80877-6; HOUNSGAARD J, 1988, J PHYSIOL-LONDON, V405, P345, DOI 10.1113/jphysiol.1988.sp017336; IVERSON LE, 1988, P NATL ACAD SCI USA, V85, P5723, DOI 10.1073/pnas.85.15.5723; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Koh K, 2008, SCIENCE, V321, P372, DOI 10.1126/science.1155942; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lima SQ, 2005, CELL, V121, P141, DOI 10.1016/j.cell.2005.02.004; Littleton JT, 2000, NEURON, V26, P35, DOI 10.1016/S0896-6273(00)81135-6; Liu QL, 2012, CURR BIOL, V22, P2114, DOI 10.1016/j.cub.2012.09.008; Marder E, 2002, NEURAL NETWORKS, V15, P479, DOI 10.1016/S0893-6080(02)00043-6; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Nicola SM, 2000, ANNU REV NEUROSCI, V23, P185, DOI 10.1146/annurev.neuro.23.1.185; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Reale V, 1997, J NEUROSCI, V17, P6545; Saper CB, 2010, NEURON, V68, P1023, DOI 10.1016/j.neuron.2010.11.032; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; Seelig JD, 2010, NAT METHODS, V7, P535, DOI [10.1038/NMETH.1468, 10.1038/nmeth.1468]; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; TIMPE LC, 1988, NATURE, V331, P143, DOI 10.1038/331143a0; Ueno T, 2012, NAT NEUROSCI, V15, P1516, DOI 10.1038/nn.3238; Zemelman BV, 2002, NEURON, V33, P15, DOI 10.1016/S0896-6273(01)00574-8	42	138	139	0	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					333	+		10.1038/nature19055	http://dx.doi.org/10.1038/nature19055			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27487216	Green Accepted, Green Submitted			2022-12-28	WOS:000381804900036
J	Vaccarella, S; Franceschi, S; Bray, F; Wild, CP; Plummer, M; Dal Maso, L				Vaccarella, Salvatore; Franceschi, Silvia; Bray, Freddie; Wild, Christopher P.; Plummer, Martyn; Dal Maso, Luigino			Worldwide Thyroid-Cancer Epidemic? The Increasing Impact of Overdiagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vaccarella, Salvatore; Franceschi, Silvia; Bray, Freddie; Wild, Christopher P.; Plummer, Martyn] Int Agcy Res Canc, Lyon, France; [Dal Maso, Luigino] Aviano Natl Canc Inst, CRO Ctr Riferimento Oncol, Canc Epidemiol Unit, Aviano, Italy	World Health Organization; International Agency for Research on Cancer (IARC); IRCCS Aviano (CRO)	Vaccarella, S (corresponding author), Int Agcy Res Canc, Lyon, France.		franceschi, silvia/M-2452-2014; dal maso, luigino/J-3616-2018; Wild, Christopher/ABC-6260-2020	franceschi, silvia/0000-0003-4181-8071; dal maso, luigino/0000-0001-6163-200X; Wild, Christopher/0000-0003-0249-8669; Bray, Freddie/0000-0002-3248-7787; Plummer, Martyn/0000-0001-5130-6497; Vaccarella, Salvatore/0000-0002-2516-2167				Davies L, 2015, ENDOCR PRACT, V21, P686, DOI 10.4158/EP14466.DSCR; Ito Y, 2014, THYROID, V24, P27, DOI 10.1089/thy.2013.0367; La Vecchia C, 2015, INT J CANCER, V136, P2187, DOI 10.1002/ijc.29251; Tsuda T, 2016, EPIDEMIOLOGY, V27, P316, DOI 10.1097/EDE.0000000000000385; Vaccarella S, 2015, THYROID, V25, P1127, DOI 10.1089/thy.2015.0116	5	581	629	3	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2016	375	7					614	617		10.1056/NEJMp1604412	http://dx.doi.org/10.1056/NEJMp1604412			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT4VF	27532827				2022-12-28	WOS:000381478600003
J	O'Malley, PG				O'Malley, Patrick G.			Review: In acute depression, interpersonal psychotherapy is more effective than control but not other therapies	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[O'Malley, Patrick G.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA	Uniformed Services University of the Health Sciences - USA	O'Malley, PG (corresponding author), Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA.							Amick HR, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6019; Keller MB, 2000, NEW ENGL J MED, V342, P1462, DOI 10.1056/NEJM200005183422001	2	0	0	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					JC22	JC22		10.7326/ACPJC-2016-165-4-022	http://dx.doi.org/10.7326/ACPJC-2016-165-4-022			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT1UI	27538183				2022-12-28	WOS:000381267200009
J	Christie, B				Christie, Bryan			Stand up for the NHS: Margaret McCartney joins Phil Hammond on stage in Edinburgh	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												bryan.christie@virgin.net							0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2016	354								i4378	10.1136/bmj.i4378	http://dx.doi.org/10.1136/bmj.i4378			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4TU	27510988				2022-12-28	WOS:000381474800009
J	McCarthy, M				McCarthy, Michael			Nearly half of US pediatric trials are unfinished or unpublished, study finds	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Pica N, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0223	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 8	2016	354								i4358	10.1136/bmj.i4358	http://dx.doi.org/10.1136/bmj.i4358			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4TP	27503827				2022-12-28	WOS:000381474300004
J	Montgomery, DR				Montgomery, David R.			Emperor Yu's Great Flood	SCIENCE			English	Editorial Material																		Allan Sarah, 1991, SHAPE TURTLE MYTH AR; Frazer James George, 1918, FOLK LORE OLD TESTAM; Fritz HM, 2009, NAT GEOSCI, V2, P448, DOI 10.1038/ngeo558; Lewis Mark Edward, 2006, FLOOD MYTHS EARLY CH; Ludwin RS, 2005, SEISMOL RES LETT, V76, P140, DOI 10.1785/gssrl.76.2.140; Montgomery David R, 2012, ROCKS DONT LIE GEOLO; RYAN WBF, 1998, NOAHS FLOOD NEW SCI; Vitaliano D., 1973, LEGENDS EARTH THEIR; Wu QL, 2016, SCIENCE, V353, P579, DOI 10.1126/science.aaf0842	9	5	6	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					538	539		10.1126/science.aah4040	http://dx.doi.org/10.1126/science.aah4040			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27493166				2022-12-28	WOS:000381560900015
J	Schougaard, SB				Schougaard, Steen B.			A nanoview of battery operation	SCIENCE			English	Editorial Material									[Schougaard, Steen B.] Univ Quebec, Dept Chim, Montreal, PQ H3C 3P8, Canada; [Schougaard, Steen B.] Tech Univ Denmark, Dept Energy Convers & Storage, Lyngby, Denmark	University of Quebec; University of Quebec Montreal; Technical University of Denmark	Schougaard, SB (corresponding author), Univ Quebec, Dept Chim, Montreal, PQ H3C 3P8, Canada.; Schougaard, SB (corresponding author), Tech Univ Denmark, Dept Energy Convers & Storage, Lyngby, Denmark.	schougaard.steen@uqam.ca	Schougaard, Steen/AAD-8919-2019					Lim J, 2016, SCIENCE, V353, P566, DOI 10.1126/science.aaf4914; Liu H, 2014, SCIENCE, V344, DOI 10.1126/science.1252817; Newman J., 2004, ELECTROCHEMICAL SYST; Padhi AK, 1997, J ELECTROCHEM SOC, V144, P1188, DOI 10.1149/1.1837571; RAVET N, 1999, ELECTROCHEMICAL SOC, V99; Yu DYW, 2006, J ELECTROCHEM SOC, V153, pA835, DOI 10.1149/1.2179199; Zaghib K, 2012, J POWER SOURCES, V216, P192, DOI 10.1016/j.jpowsour.2012.05.025	7	6	6	2	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					543	544		10.1126/science.aah4124	http://dx.doi.org/10.1126/science.aah4124			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27493170				2022-12-28	WOS:000381560900019
J	Wu, QL; Zhao, ZJ; Liu, L; Granger, DE; Wang, H; Cohen, DJ; Wu, XH; Ye, ML; Bar-Yosef, O; Lu, B; Zhang, J; Zhang, PZ; Yuan, DY; Qi, WY; Cai, LH; Bai, SBA				Wu, Qinglong; Zhao, Zhijun; Liu, Li; Granger, Darryl E.; Wang, Hui; Cohen, David J.; Wu, Xiaohong; Ye, Maolin; Bar-Yosef, Ofer; Lu, Bin; Zhang, Jin; Zhang, Peizhen; Yuan, Daoyang; Qi, Wuyun; Cai, Linhai; Bai, Shibiao			Outburst flood at 1920 BCE supports historicity of China's Great Flood and the Xia dynasty	SCIENCE			English	Article								China's historiographical traditions tell of the successful control of a Great Flood leading to the establishment of the Xia dynasty and the beginning of civilization. However, the historicity of the flood and Xia remain controversial. Here, we reconstruct an earthquake-induced landslide dam outburst flood on the Yellow River about 1920 BCE that ranks as one of the largest freshwater floods of the Holocene and could account for the Great Flood. This would place the beginning of Xia at similar to 1900 BCE, several centuries later than traditionally thought. This date coincides with the major transition from the Neolithic to Bronze Age in the Yellow River valley and supports hypotheses that the primary state-level society of the Erlitou culture is an archaeological manifestation of the Xia dynasty.	[Wu, Qinglong; Wu, Xiaohong] Peking Univ, Sch Archaeol & Museol, Beijing 100871, Peoples R China; [Wu, Qinglong; Zhao, Zhijun; Bai, Shibiao] Nanjing Normal Univ, Sch Geog Sci, Nanjing 210023, Jiangsu, Peoples R China; [Wu, Qinglong; Zhang, Peizhen] China Earthquake Adm, Inst Geol, State Key Lab Earthquake Dynam, Beijing 100029, Peoples R China; [Liu, Li] Stanford Univ, Dept East Asian Languages & Cultures, Stanford, CA 94305 USA; [Granger, Darryl E.] Purdue Univ, Dept Earth Atmospher & Planetary Sci, W Lafayette, IN 47907 USA; [Wang, Hui; Ye, Maolin; Qi, Wuyun] Chinese Acad Social Sci, Inst Archaeol, Beijing 100710, Peoples R China; [Cohen, David J.] Natl Taiwan Univ, Dept Anthropol, Taipei 10617, Taiwan; [Bar-Yosef, Ofer] Harvard Univ, Dept Anthropol, Cambridge, MA 02138 USA; [Lu, Bin] CCTEG Xian Res Inst, Xian 710077, Peoples R China; [Zhang, Jin] Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China; [Yuan, Daoyang] China Earthquake Adm, Lanzhou Inst Seismol, Lanzhou 730000, Peoples R China; [Cai, Linhai] Qinghai Prov Inst Cultural Relics & Archaeol, Xining 810007, Peoples R China; [Bai, Shibiao] Jiangsu Ctr Collaborat Innovat Geog Informat Reso, Nanjing 210023, Jiangsu, Peoples R China; [Zhang, Peizhen] Sun Yat Sen Univ, Sch Earth Sci & Geol Engn, Guangzhou 510275, Guangdong, Peoples R China	Peking University; Nanjing Normal University; China Earthquake Administration; Stanford University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Chinese Academy of Social Sciences; National Taiwan University; Harvard University; Chinese Academy of Geological Sciences; China Earthquake Administration; Sun Yat Sen University	Wu, QL (corresponding author), Peking Univ, Sch Archaeol & Museol, Beijing 100871, Peoples R China.; Wu, QL (corresponding author), Nanjing Normal Univ, Sch Geog Sci, Nanjing 210023, Jiangsu, Peoples R China.; Wu, QL (corresponding author), China Earthquake Adm, Inst Geol, State Key Lab Earthquake Dynam, Beijing 100029, Peoples R China.	wuqinglong@pku.edu.cn	Cohen, David J/A-7526-2015; Wu, Xiaohong/AAH-4348-2020	Cohen, David J/0000-0002-5973-8566; Wu, Xiaohong/0000-0002-3819-0829; bai, shibiao/0000-0002-1699-0825	National Science Foundation of China [40801010, 41271017]; Fundamental Research Grant of China [F-IGCEA-0607-1-10]; Chinese Geological Survey [121201102000150009-16]; Priority Academic Program Development of Jiangsu Higher Education Institutions; National Science and Technology Support Program [2013BAK08B01]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Grant of China; Chinese Geological Survey(China Geological Survey); Priority Academic Program Development of Jiangsu Higher Education Institutions; National Science and Technology Support Program	This research was supported by the National Science Foundation of China (nos. 40801010 and 41271017), Fundamental Research Grant of China (no. F-IGCEA-0607-1-10), Chinese Geological Survey Project (no. 121201102000150009-16), the Priority Academic Program Development of Jiangsu Higher Education Institutions, and National Science and Technology Support Program (no. 2013BAK08B01). P. Dong, H. P. Zhang, and W. Qin partly contributed to the fieldwork; X. Su and P. M. Zhang provided important financial support; Y. Chen and J. Liu-Zeng provided partial financial support; and J. K. Lu gave suggestions on the discharge estimation. Three anonymous reviewers provided valuable comments on the manuscript. We especially thank and commemorate H. B. Wang, who passed away in an accident in November 2011, for his passionate and laborious work in reconstruction of the cross section in June 2010. All data are available in the main manuscript and supplementary materials.	Allan S., 1984, J R ASIAT SOC GB IRE, V116, P242; Chang K. -C, 1986, ARCHAEOLOGY ANCIENT; Costa J. E., 2004, WORLD LARGEST FLOODS; Evani S. J., 2011, NATURAL ARTIFICIAL R, P1; Han J. Y., 2008, THE ENVIRONMENT AND, P40; IA CASS, 2003, CHINESE ARCHAEOLOGY, V3, P1; Keightley DN, 1999, CAMBRIDGE HIST ANCIE, P30; Lawler Andrew, 2009, Science, V325, P934, DOI 10.1126/science.325_934; LEE YK, 2002, ASIAN PERSPECT, V41, P15, DOI DOI 10.1353/ASI.2002.0006; Lewis Mark Edward, 2006, FLOOD MYTHS EARLY CH; Li X. Q., 2002, J NATL MUSEUM CHINES, V2002, P4; Liu L, 2012, CAMB WOR ARCHAEOL, P1, DOI 10.1017/CBO9781139015301; Liu L, 2007, ANTIQUITY, V81, P886, DOI 10.1017/S0003598X00095983; Lu HY, 2005, NATURE, V437, P967, DOI 10.1038/437967a; Lyell Charles, 1853, PRINCIPLES GEOLOGY; Nivison D. S., 1990, EARLY CHINA, V15, P87; PANG KD, 1987, J HYDROL, V96, P139, DOI 10.1016/0022-1694(87)90149-1; Reimer PJ, 2013, RADIOCARBON, V55, P1869, DOI 10.2458/azu_js_rc.55.16947; Rosen AM, 2015, HOLOCENE, V25, P1640, DOI 10.1177/0959683615594241; The Xia-Shang-Zhou Chronology Project Group, 2000, XIA SHANG ZHOU CHRON; Thorp R., 1991, EARLY CHINA, V16, P1, DOI [10.1017/S0362502800003825, DOI 10.1017/S0362502800003825]; Wang M. H., 2002, KAOGU, V2002, P1081; Wang Q., 1993, CULTURAL RELICS CENT, V1993, P63; Wang YJ, 2005, SCIENCE, V308, P854, DOI 10.1126/science.1106296; [吴庆龙 Wu Q L], 2009, [中国科学. D辑, 地球科学, Science in China. Series D, Earth Sciences], V39, P1148; [吴文祥 Wu Wenxiang], 2005, [第四纪研究, Quaternary Sciences], V25, P741; Yang XY, 2003, CHINESE SCI BULL, V48, P1877, DOI 10.1360/02wd0610; Yuan X. P., 2012, HIST CHINESE CIVILIZ, V1; Zhang X. L., 2014, ARCHAEOLOGY, V11, P91; Zou H., 1978, HENAN WENBO TONGXUAN, V1, P34	30	95	131	16	255	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					579	582		10.1126/science.aaf0842	http://dx.doi.org/10.1126/science.aaf0842			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DT5YZ	27493183				2022-12-28	WOS:000381560900039
J	Ford, I; Norrie, J				Ford, Ian; Norrie, John			Pragmatic Trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RANDOMIZED CONTROLLED-TRIALS; CLINICAL-TRIALS; PREVENTION; NEED; COST; CARE; TOOL		[Ford, Ian] Univ Glasgow, Robertson Ctr Biostat, Level 11,Boyd Orr Bldg, Glasgow G12 8QQ, Lanark, Scotland; [Norrie, John] Univ Aberdeen, Ctr Healthcare Randomised Trials, Hlth Serv Res Unit, Aberdeen, Scotland	University of Glasgow; University of Aberdeen	Ford, I (corresponding author), Univ Glasgow, Robertson Ctr Biostat, Level 11,Boyd Orr Bldg, Glasgow G12 8QQ, Lanark, Scotland.	ian.ford@glasgow.ac.uk	Ford, Ian/ABE-6145-2020		Medical Research Council [MC_PC_13040, MR/K007017/1] Funding Source: Medline; MRC [MR/K007017/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anderson ML, 2015, CLIN TRIALS, V12, P511, DOI 10.1177/1740774515597700; [Anonymous], 2008, DEV EVALUATING COMPL; Barry SJE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075379; Califf RM, 2015, CLIN TRIALS, V12, P436, DOI 10.1177/1740774515598334; Califf RM, 2014, CLIN TRIALS, V11, P626, DOI 10.1177/1740774514553485; Campbell R, 2008, LANCET, V371, P1595, DOI 10.1016/S0140-6736(08)60692-3; Chalkidou K, 2012, CLIN TRIALS, V9, P436, DOI 10.1177/1740774512450097; Choudhry NK, 2011, NEW ENGL J MED, V365, P2088, DOI 10.1056/NEJMsa1107913; ClinicalTrials. gov, HIGH SENS TROP EV PA; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Devereaux PJ, 2005, BMJ-BRIT MED J, V330, P88, DOI 10.1136/bmj.330.7482.88; Eldridge S, 2010, FAM PRACT, V27, P591, DOI 10.1093/fampra/cmq099; Ernst E, 2005, POSTGRAD MED J, V81, P203, DOI 10.1136/pgmj.2004.026807; Ford I, 1995, J CLIN EPIDEMIOL, V48, P1441; Frobert O, 2013, NEW ENGL J MED, V369, P1587, DOI 10.1056/NEJMoa1308789; Godwin Marshall, 2003, BMC Med Res Methodol, V3, P28, DOI 10.1186/1471-2288-3-28; Hansson L, 1992, Blood Press, V1, P113, DOI 10.3109/08037059209077502; Hussey MA, 2007, CONTEMP CLIN TRIALS, V28, P182, DOI 10.1016/j.cct.2006.05.007; Institute of Medicine, 2007, LEARN HEALTHC SYST W; Kent DM, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-48; Kim SYH, 2014, NEW ENGL J MED, V370, P769, DOI 10.1056/NEJMhle1312508; Loudon K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2147; Luce BR, 2009, ANN INTERN MED, V151, P206, DOI 10.7326/0003-4819-151-3-200908040-00126; McConnachie A, 2014, EUR HEART J, V35, P290, DOI 10.1093/eurheartj/eht232; McFadden E, 2015, CLIN TRIALS, V12, P72, DOI 10.1177/1740774514561242; Mitka M, 2011, JAMA-J AM MED ASSOC, V306, P1851, DOI 10.1001/jama.2011.1570; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Patsopoulos Nikolaos A, 2011, Dialogues Clin Neurosci, V13, P217; Pickard R, 2012, LANCET, V380, P1927, DOI 10.1016/S0140-6736(12)61380-4; Price D, 2011, NEW ENGL J MED, V364, P1695, DOI 10.1056/NEJMoa1010846; Ratner J, 2013, AM J MANAG CARE, V19, pE158; Relton C, 2010, BMJ-BRIT MED J, V340, pc1066, DOI DOI 10.1136/BMJ.C1066; Roland M, 1998, BRIT MED J, V316, P285, DOI 10.1136/bmj.316.7127.285; Rothwell PM, 2005, LANCET, V365, P82, DOI 10.1016/S0140-6736(04)17670-8; SCHWARTZ D, 1967, J CHRON DIS, V20, P637, DOI 10.1016/0021-9681(67)90041-0; Simon GE, 1996, JAMA-J AM MED ASSOC, V275, P1897, DOI 10.1001/jama.275.24.1897; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Sugarman J, 2014, JAMA-J AM MED ASSOC, V311, P2381, DOI 10.1001/jama.2014.4164; Thorpe KE, 2009, J CLIN EPIDEMIOL, V62, P464, DOI [10.1503/cmaj.090523, 10.1016/j.jclinepi.2008.12.011]; Treweek S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002360; Treweek S, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-37; Vickers AJ, 2014, CLIN TRIALS, V11, P615, DOI 10.1177/1740774514553681; Ware JH, 2011, NEW ENGL J MED, V364, P1685, DOI 10.1056/NEJMp1103502; YUSUF S, 1984, STAT MED, V3, P409, DOI 10.1002/sim.4780030421; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	46	688	697	4	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2016	375	5					454	463		10.1056/NEJMra1510059	http://dx.doi.org/10.1056/NEJMra1510059			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7AN	27518663	Bronze, Green Accepted			2022-12-28	WOS:000380934900009
J	Roland, M; Olesen, F				Roland, Martin; Olesen, Frede			Can pay for performance improve the quality of primary care?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							INCENTIVES		[Roland, Martin] Inst Publ Hlth, Cambridge CB2 0SR, England; [Olesen, Frede] Dept Publ Hlth, DK-8000 Aarhus, Denmark	University of Cambridge; Aarhus University	Roland, M (corresponding author), Inst Publ Hlth, Cambridge CB2 0SR, England.	mr108@cam.ac.uk		Roland, Martin/0000-0002-8533-3060				Baker D, 2003, J EPIDEMIOL COMMUN H, V57, P417, DOI 10.1136/jech.57.6.417; Beyer M, 2003, FAM PRACT, V20, P443, DOI 10.1093/fampra/cmg420; Doran T, 2008, NEW ENGL J MED, V359, P274, DOI 10.1056/NEJMsa0800310; Dreischulte T, 2016, NEW ENGL J MED, V374, P1053, DOI 10.1056/NEJMsa1508955; Kristensen SR, 2014, NEW ENGL J MED, V371, P540, DOI 10.1056/NEJMoa1400962; Lester H, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1898; McDonald R, 2007, BMJ-BRIT MED J, V334, P1357, DOI 10.1136/bmj.39238.890810.BE; Roland M, 2004, NEW ENGL J MED, V351, P1448, DOI 10.1056/NEJMhpr041294; Roland M, 2016, BMJ QUAL SAF, V25, P653, DOI 10.1136/bmjqs-2015-005003; Roland M, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4060; Roland M, 2015, HEALTH SERV RES, V50, P2090, DOI 10.1111/1475-6773.12419; University of Westminster, 2016, REP ANN SOC PRESCR N	12	12	12	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 4	2016	354								i4058	10.1136/bmj.i4058	http://dx.doi.org/10.1136/bmj.i4058			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9CY	27492822	Green Published, hybrid			2022-12-28	WOS:000381081300001
J	Moore, SA; Abbara, S; Mak, GS; Mark, EJ; Stone, JR				Moore, Stephanie A.; Abbara, Suhny; Mak, Gary S.; Mark, Eugene J.; Stone, James R.			Case 22-2016: A 65-Year-Old Man with Syncope, Dyspnea, and Leg Edema	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SUBAORTIC SEPTAL MYECTOMY; HYPERTROPHIC CARDIOMYOPATHY; PULMONARY-HYPERTENSION; SURGICAL PATHOLOGY; CONVERTING ENZYME; DIAGNOSIS; CORRELATE; BIOPSY		[Moore, Stephanie A.; Mak, Gary S.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Abbara, Suhny] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Mark, Eugene J.; Stone, James R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Moore, Stephanie A.; Mak, Gary S.] Harvard Med Sch, Dept Med, Boston, MA USA; [Abbara, Suhny] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Mark, Eugene J.; Stone, James R.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Moore, SA (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Moore, SA (corresponding author), Harvard Med Sch, Dept Med, Boston, MA USA.			Abbara, Suhny/0000-0003-2552-7362	Glaxo-SmithKline; USP Labs; Alnylam Pharmaceuticals	Glaxo-SmithKline(GlaxoSmithKline); USP Labs; Alnylam Pharmaceuticals	Dr. Mark reports receiving payments from law firms for providing expert testimony on behalf of patients in asbestos-related cases; and Dr. Stone, receiving consulting fees from Glaxo-SmithKline, fees for providing expert testimony from USP Labs, and lecture fees from Alnylam Pharmaceuticals outside the submitted work. No other potential conflict of interest relevant to this article was reported.	Allen RD, 2003, CARDIOVASC PATHOL, V12, P207, DOI 10.1016/S1054-8807(03)00057-7; [Anonymous], 1996, NEW ENGL J MED, V335, P1378; Ardehali H, 2005, AM HEART J, V150, P459, DOI 10.1016/j.ahj.2004.10.006; Asimaki A, 2011, CIRC-ARRHYTHMIA ELEC, V4, P743, DOI 10.1161/CIRCEP.111.964890; AWDEH MR, 1978, SOUTHERN MED J, V71, P969, DOI 10.1097/00007611-197808000-00030; Baughman RP, 2015, CLIN CHEST MED, V36, P703, DOI 10.1016/j.ccm.2015.08.011; Dispenzieri A, 2015, AM J HEMATOL, V90, P952, DOI 10.1002/ajh.24171; Halushka MK, 2015, J CARDIOVASC TRANSL, V8, P264, DOI 10.1007/s12265-015-9628-2; Kobayashi Shu, 2007, Mod Rheumatol, V17, P418, DOI 10.1007/s10165-007-0599-2; Kusano KF, 2016, HEART, V102, P184, DOI 10.1136/heartjnl-2015-307877; Lamke GT, 2003, CARDIOVASC PATHOL, V12, P149, DOI 10.1016/S1054-8807(03)00036-X; LIEBERMAN J, 1990, CHEST, V98, P1538, DOI 10.1378/chest.98.6.1538b; Luk A, 2009, CAN J CARDIOL, V25, pE48, DOI 10.1016/S0828-282X(09)70484-2; Matsumori A, 2000, JPN CIRC J, V64, P679, DOI 10.1253/jcj.64.679; Nakamura K, 2015, CIRCULATION, V132, P59, DOI 10.1161/CIRCULATIONAHA.115.016524; Patel H, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000748; Reddy D, 2011, CURR OPIN ONCOL, V23, P475, DOI 10.1097/CCO.0b013e328349c233; Seeger W, 2013, J AM COLL CARDIOL, V62, pD109, DOI 10.1016/j.jacc.2013.10.036; Selan JC, 2014, HEART LUNG CIRC, V23, P1100, DOI 10.1016/j.hlc.2014.07.065; Shorr AF, 1997, RESP MED, V91, P399, DOI 10.1016/S0954-6111(97)90252-3; SILVERMAN KJ, 1978, CIRCULATION, V58, P1204, DOI 10.1161/01.CIR.58.6.1204; Ungar A, 2010, EUR HEART J, V31, P2021, DOI 10.1093/eurheartj/ehq017; VENDITTI FJ, 1995, NEW ENGL J MED, V332, P1432, DOI 10.1056/NEJM199505253322108; Yanardag H, 2007, CAN RESPIR J, V14, P209, DOI 10.1155/2007/218947	24	2	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2016	375	3					262	272		10.1056/NEJMcpc1601838	http://dx.doi.org/10.1056/NEJMcpc1601838			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS0ZL	27468063				2022-12-28	WOS:000380325400011
J	Lopez, D; Luque-Fernandez, MA; Steele, A; Adler, GK; Turchin, A; Vaidya, A				Lopez, Diana; Luque-Fernandez, Miguel Angel; Steele, Amy; Adler, Gail K.; Turchin, Alexander; Vaidya, Anand			"Nonfunctional" Adrenal Tumors and the Risk for Incident Diabetes and Cardiovascular Outcomes A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							SUBCLINICAL CUSHINGS-SYNDROME; PREVALENCE; CORTISOL; DIAGNOSIS; MORTALITY	Background: Benign adrenal tumors are commonly discovered on abdominal imaging. Most are classified as nonfunctional and are considered to pose no health risk, but some are considered functional because they secrete hormones that increase risk for metabolic and cardiovascular diseases. Objective: To evaluate the hypothesis that nonfunctional adrenal tumors (NFATs) increase risk for cardiometabolic outcomes compared with absence of adrenal tumors. Design: Cohort study. Setting: Integrated hospital system. Participants: Participants with benign NFATs ("exposed"; n = 166) and those with no adrenal tumor ("unexposed"; n = 740), with at least 3 years of follow-up. Measurements: Medical records were reviewed from the time of abdominal imaging for development of incident outcomes (hypertension, composite diabetes [prediabetes or type 2 diabetes], hyperlipidemia, cardiovascular events, and chronic kidney disease) (mean, 7.7 years). Primary analyses evaluated independent associations between exposure status and incident outcomes by using adjusted generalized linear models. Secondary analyses evaluated relationships between NFATs and cortisol physiology. Results: Participants with NFATs had significantly higher risk for incident composite diabetes than those without adrenal tumors (30 of 110 [27.3%] vs. 72 of 615 [11.7%] participants; absolute risk, 15.6% [95% CI, 6.9% to 24.3%]; adjusted risk ratio, 1.87 [CI, 1.17 to 2.98]). No significant associations between NFATs and other outcomes were observed. Higher "normal" postdexa-methasone cortisol levels (<= 50 nmol/L) were associated with larger NFAT size and higher prevalence of type 2 diabetes. Limitation: Potential bias in the selection of participants and ascertainment of outcomes. Conclusion: Participants with NFATs had a significantly higher risk for diabetes than those without adrenal tumors. These results should prompt a reassessment of whether the classification of benign adrenal tumors as "nonfunctional" adequately reflects the continuum of hormone secretion and metabolic risk they may harbor.	[Lopez, Diana; Adler, Gail K.; Turchin, Alexander; Vaidya, Anand] Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, 221 Longwood Ave, Boston, MA 02115 USA; Harvard Med Sch, Boston, MA USA; Harvard Sch Publ Hlth, Boston, MA USA; Harvard Clin Res Inst Boston, Boston, MA USA; [Luque-Fernandez, Miguel Angel] London Sch Hyg & Trop Med, Dept Epidemiol & Noncommunicable Dis Epidemiol, Keppel St, London WC1E 7HT, England; [Steele, Amy] Univ Calif Davis, Sch Med, 2138 Univ Pk Dr, Sacramento, CA 95817 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California Davis	Vaidya, A (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Endocrinol Diabet & Hypertens, Ctr Adrenal Disorders, 221 Longwood Ave,RFB 287, Boston, MA 02115 USA.	anandvaidya@bwh.harvard.edu	FERNANDEZ, MIGUEL ANGEL LUQUE/L-4053-2015; FERNANDEZ, MIGUEL ANGEL LUQUE/AAZ-5017-2020; FERNANDEZ, MIGUEL ANGEL LUQUE/AAK-7183-2021	FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164; FERNANDEZ, MIGUEL ANGEL LUQUE/0000-0001-6683-5164	National Heart, Lung, and Blood Institute of the National Institutes of Health [K24 HL103845, K23HL111771]; National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [R01 DK107407]; Doris Duke Charitable Foundation [2015085]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K24HL103845, K23HL111771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107407] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Adler was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under award K24 HL103845. Dr. Vaidya was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health under award R01 DK107407; by grant 2015085 from the Doris Duke Charitable Foundation; and by the National Heart, Lung, and Blood Institute of the National Institutes of Health under award K23HL111771.	Al-Thani H, 2015, N AM J MED SCI, V7, P212, DOI 10.4103/1947-2714.157482; Androulakis II, 2014, J CLIN ENDOCR METAB, V99, P2754, DOI 10.1210/jc.2013-4064; [Anonymous], 2002, NIH CONSENS STATE SC, V19, P1; Arlt W, 2011, J CLIN ENDOCR METAB, V96, P3775, DOI 10.1210/jc.2011-1565; Bovio S, 2006, J ENDOCRINOL INVEST, V29, P298, DOI 10.1007/BF03344099; Brett K M, 2001, Vital Health Stat 13, P1; Chiodini I, 2011, J CLIN ENDOCR METAB, V96, P1223, DOI 10.1210/jc.2010-2722; Debono M, 2014, J CLIN ENDOCR METAB, V99, P4462, DOI 10.1210/jc.2014-3007; Di Dalmazi G, 2014, LANCET DIABETES ENDO, V2, P396, DOI 10.1016/S2213-8587(13)70211-0; Di Dalmazi G, 2012, EUR J ENDOCRINOL, V166, P669, DOI 10.1530/EJE-11-1039; Funder JW, 2008, J CLIN ENDOCR METAB, V93, P3266, DOI 10.1210/jc.2008-0104; HEDELAND H, 1968, ACTA MED SCAND, V184, P211; Lacroix A, 2015, LANCET, V386, P913, DOI 10.1016/S0140-6736(14)61375-1; Mantero F, 2000, J CLIN ENDOCR METAB, V85, P637, DOI 10.1210/jc.85.2.637; Marczak L, 2016, JAMA-J AM MED ASSOC, V315, P241, DOI DOI 10.1001/JAMA.2015.17599; Morelli V, 2014, J CLIN ENDOCR METAB, V99, P827, DOI 10.1210/jc.2013-3527; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; Nieman LK, 2015, J CLIN ENDOCR METAB, V100, P2807, DOI 10.1210/jc.2015-1818; Nieman LK, 2010, J CLIN ENDOCR METAB, V95, P4106, DOI 10.1210/jc.2010-0457; Organisation for Economic Co-operation and Development, 2013, HLTH GLANC 2013 OECD; Patrova J, 2015, ENDOCR PRACT, V21, P870, DOI 10.4158/EP15618.OR; Peppa M, 2010, METABOLISM, V59, P1435, DOI 10.1016/j.metabol.2010.01.007; Rossi R, 2000, J CLIN ENDOCR METAB, V85, P1440, DOI 10.1210/jc.85.4.1440; Spiegelman D, 2005, AM J EPIDEMIOL, V162, P199, DOI 10.1093/aje/kwi188; Terzolo M, 2011, EUR J ENDOCRINOL, V164, P851, DOI 10.1530/EJE-10-1147; Tuna MM, 2014, J ENDOCRINOL INVEST, V37, P765, DOI 10.1007/s40618-014-0106-5; Young WF, 2000, ENDOCRIN METAB CLIN, V29, P159, DOI 10.1016/S0889-8529(05)70122-5; Young WF, 2007, NEW ENGL J MED, V356, P601, DOI 10.1056/NEJMcp065470; Zeiger MA, 2009, ENDOCR PRACT, V15, P450, DOI 10.4158/EP.15.5.450	29	69	69	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2016	165	8					533	+		10.7326/M16-0547	http://dx.doi.org/10.7326/M16-0547			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ6BM	27479926	Green Accepted			2022-12-28	WOS:000385946600013
J	Mroz, P; Udalski, A; Pietrukowicz, P; Szymanski, MK; Soszynski, I; Wyrzykowski, L; Poleski, R; Kozlowski, S; Skowron, J; Ulaczyk, K; Skowron, D; Pawlak, M				Mroz, Przemek; Udalski, Andrzej; Pietrukowicz, Pawel; Szymanski, Michal K.; Soszynski, Igor; Wyrzykowski, Lukasz; Poleski, Radoslaw; Kozlowski, Szymon; Skowron, Jan; Ulaczyk, Krzysztof; Skowron, Dorota; Pawlak, Michal			The awakening of a classical nova from hibernation	NATURE			English	Article							GRAVITATIONAL LENSING EXPERIMENT; GALACTIC DISK; LIGHT CURVES; DWARF NOVAE; OLD NOVA; OGLE; OUTBURSTS; EVOLUTION; ATLAS	Cataclysmic variable stars-novae, dwarf novae, and nova-likes-are close binary systems consisting of a white dwarf star (the primary) that is accreting matter from a low-mass companion star (the secondary)(1). From time to time such systems undergo large-amplitude brightenings. The most spectacular eruptions, with a ten-thousandfold increase in brightness, occur in classical novae and are caused by a thermonuclear runaway on the surface of the white dwarf(2). Such eruptions are thought to recur on timescales of ten thousand to a million years(3). In between, the system's properties depend primarily on the mass-transfer rate: if it is lower than a billionth of a solar mass per year, the accretion becomes unstable and the matter is dumped onto the white dwarf during quasi-periodic dwarf nova outbursts(4). The hibernation hypothesis(5) predicts that nova eruptions strongly affect the mass-transfer rate in the binary, keeping it high for centuries after the event(6). Subsequently, the mass-transfer rate should significantly decrease for a thousand to a million years, starting the hibernation phase. After that the nova awakes again-with accretion returning to the pre-eruption level and leading to a new nova explosion. The hibernation model predicts cyclical evolution of cataclysmic variables through phases of high and low mass-transfer. The theory gained some support from the discovery of ancient nova shells around the dwarf novae Z Camelopardalis(7) and AT Cancri(8), but direct evidence for considerable mass-transfer changes prior, during and after nova eruptions has not hitherto been found. Here we report long-term observations of the classical nova V1213 Cen (Nova Centauri 2009) covering its pre- and post-eruption phases and precisely documenting its evolution. Within the six years before the explosion, the system revealed dwarf nova outbursts indicative of a low mass-transfer rate. The post-nova is two orders of magnitude brighter than the pre-nova at minimum light with no trace of dwarf nova behaviour, implying that the mass-transfer rate increased considerably as a result of the nova explosion.	[Mroz, Przemek; Udalski, Andrzej; Pietrukowicz, Pawel; Szymanski, Michal K.; Soszynski, Igor; Wyrzykowski, Lukasz; Poleski, Radoslaw; Kozlowski, Szymon; Skowron, Jan; Ulaczyk, Krzysztof; Skowron, Dorota; Pawlak, Michal] Univ Warsaw Observ, Aleje Ujazdowskie 4, PL-00478 Warsaw, Poland; [Poleski, Radoslaw] Ohio State Univ, Dept Astron, 140 West 18th Ave, Columbus, OH 43210 USA; [Ulaczyk, Krzysztof] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England	University of Warsaw; Warsaw University Observatory; University System of Ohio; Ohio State University; University of Warwick	Mroz, P (corresponding author), Univ Warsaw Observ, Aleje Ujazdowskie 4, PL-00478 Warsaw, Poland.	pmroz@astrouw.edu.pl	Skowron, Jan/M-5186-2014; Kozlowski, Szymon/G-4799-2013; Szymański, Michał K/H-6951-2018; Szymański, Michał Krzysztof/X-5627-2019; Skowron, Dorota M/AAL-8373-2020; Mroz, Przemek/ABH-9105-2020; Pawlak, Michał/AGD-5351-2022; Poleski, Radoslaw/AAM-7565-2021	Skowron, Jan/0000-0002-2335-1730; Kozlowski, Szymon/0000-0003-4084-880X; Szymański, Michał K/0000-0002-0548-8995; Szymański, Michał Krzysztof/0000-0002-0548-8995; Skowron, Dorota M/0000-0001-9439-604X; Pawlak, Michał/0000-0002-5632-9433; Poleski, Radoslaw/0000-0002-9245-6368; Udalski, Andrzej/0000-0001-5207-5619; Wyrzykowski, Lukasz/0000-0002-9658-6151; Pietrukowicz, Pawel/0000-0002-2339-5899; Ulaczyk, Krzysztof/0000-0001-6364-408X; Mroz, Przemek/0000-0001-7016-1692; Soszynski, Igor/0000-0002-7777-0842	Polish Ministry of Science and Higher Education [DI2013/014743]; National Science Center, Poland [MAESTRO 2014/14/A/ST9/00121]; STFC [ST/L000733/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/L000733/1] Funding Source: researchfish	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); National Science Center, Poland(National Science Centre, Poland); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank M. Kubiak and G. Pietrzyriski, former members of the OGLE team, for their contribution to the collection of the OGLE photometric data over the past years. PM. is supported by the 'Diamond Grant' (number DI2013/014743) funded by the Polish Ministry of Science and Higher Education. The OGLE project has received funding from the National Science Center, Poland (grant number MAESTRO 2014/14/A/ST9/00121 to AU.). We acknowledge the variable star observations from the AAVSO International Database contributed by observers worldwide and used in this research.	Collazzi AC, 2009, ASTRON J, V138, P1846, DOI 10.1088/0004-6256/138/6/1846; Guver T, 2009, MON NOT R ASTRON SOC, V400, P2050, DOI 10.1111/j.1365-2966.2009.15598.x; HONEYCUTT RK, 1995, ASTROPHYS J, V446, P838, DOI 10.1086/175841; Kafka S., 2016, OBSERVATIONS AVSO IN; KOVETZ A, 1988, ASTROPHYS J, V325, P828, DOI 10.1086/166053; Mroz P, 2015, ACTA ASTRONOM, V65, P313; Mroz P, 2015, ASTROPHYS J SUPPL S, V219, DOI 10.1088/0067-0049/219/2/26; Nelemans G, 2016, ASTROPHYS J, V817, DOI 10.3847/0004-637X/817/1/69; OSAKI Y, 1974, PUBL ASTRON SOC JPN, V26, P429; Otulakowska-Hypka M, 2016, MON NOT R ASTRON SOC, V460, P2526, DOI 10.1093/mnras/stw1120; Paczynski B., 1965, ACTA ASTRON, V15, P197; Patterson J., 2011, MON NOT R ASTRON SOC, V441, P2965; Patterson J, 2013, MON NOT R ASTRON SOC, V434, P1902, DOI 10.1093/mnras/stt1085; Pigulski A., 2009, IAU CIRC, V9043, P2; Pojmanski G, 1997, ACTA ASTRONOM, V47, P467; Pojmanski G., 2009, IAU CIRC, V9043, P1; PRIALNIK D, 1995, ASTROPHYS J, V445, P789, DOI 10.1086/175741; Ritter H, 2003, ASTRON ASTROPHYS, V404, P301, DOI 10.1051/0004-6361:20030330; ROBINSON EL, 1975, ASTRON J, V80, P515, DOI 10.1086/111774; Schreiber MR, 2016, MON NOT R ASTRON SOC, V455, pL16, DOI 10.1093/mnrasl/slv144; Schwarz G.J., 2010, ASTRON TELEGR, V2904; Schwarz GJ, 2011, ASTROPHYS J SUPPL S, V197, DOI 10.1088/0067-0049/197/2/31; SEKIGUCHI K, 1992, NATURE, V358, P563, DOI 10.1038/358563a0; Shafter AW, 2013, ASTRON J, V145, DOI 10.1088/0004-6256/145/5/117; Shafter AW, 2011, ASTROPHYS J, V734, DOI 10.1088/0004-637X/734/1/12; Shara M. M., 1998, ASP C SER, P3; Shara MM, 2007, NATURE, V446, P159, DOI 10.1038/nature05576; Shara MM, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/2/121; SHARA MM, 1986, ASTROPHYS J, V311, P163, DOI 10.1086/164762; Smak J., 1989, Acta Astronomica, V39, P317; Szymanski MK, 2010, ACTA ASTRONOM, V60, P295; Thorstensen JR, 2000, MON NOT R ASTRON SOC, V312, P629, DOI 10.1046/j.1365-8711.2000.03230.x; Udalski A, 2004, ACTA ASTRONOM, V54, P313; VANDENBERGH S, 1987, ASTRON ASTROPHYS SUP, V70, P125; Walter FM, 2012, PUBL ASTRON SOC PAC, V124, P1057, DOI 10.1086/668404; WARNER B, 1987, MON NOT R ASTRON SOC, V227, P23, DOI 10.1093/mnras/227.1.23; Warner B, 2003, CATACLYSMIC VARIABLE; Wozniak PR, 2000, ACTA ASTRONOM, V50, P421	42	22	22	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 29	2016	537	7622					649	+		10.1038/nature19066	http://dx.doi.org/10.1038/nature19066			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX4DR	27533036	Green Submitted			2022-12-28	WOS:000384331700043
J	Maitre, JL; Turlier, H; Illukkumbura, R; Eismann, B; Niwayama, R; Nedelec, F; Hiiragi, T				Maitre, Jean-Leon; Turlier, Herve; Illukkumbura, Rukshala; Eismann, Bjoern; Niwayama, Ritsuya; Nedelec, Francois; Hiiragi, Takashi			Asymmetric division of contractile domains couples cell positioning and fate specification	NATURE			English	Article							POLARITY; FORCES; 16-CELL; YAP/TAZ	During pre-implantation development, the mammalian embryo self-organizes into the blastocyst, which consists of an epithelial layer encapsulating the inner-cell mass (ICM) giving rise to all embryonic tissues(1). In mice, oriented cell division, apicobasal polarity and actomyosin contractility are thought to contribute to the formation of the ICM2-5. However, how these processes work together remains unclear. Here we show that asymmetric segregation of the apical domain generates blastomeres with different contractilities, which triggers their sorting into inner and outer positions. Three-dimensional physical modelling of embryo morphogenesis reveals that cells internalize only when differences in surface contractility exceed a predictable threshold. We validate this prediction using biophysical measurements, and successfully redirect cell sorting within the developing blastocyst using maternal myosin (Myh9)-knockout chimaeric embryos. Finally, we find that loss of contractility causes blastomeres to show ICM-like markers, regardless of their position. In particular, contractility controls Yap subcellular localization(6), raising the possibility that mechanosensing occurs during blastocyst lineage specification. We conclude that contractility couples the positioning and fate specification of blastomeres. We propose that this ensures the robust self-organization of blastomeres into the blastocyst, which confers remarkable regulative capacities to mammalian embryos.	[Maitre, Jean-Leon; Turlier, Herve; Illukkumbura, Rukshala; Eismann, Bjoern; Niwayama, Ritsuya; Nedelec, Francois; Hiiragi, Takashi] European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Maitre, Jean-Leon] Inst Curie, CNRS, INSERM, U934,UMR 3215,Mech Mammalian Dev Grp, 26 Rue Ulm, Paris 05, France; [Eismann, Bjoern] Bioquant, Neuenheimer Feld 267, D-69120 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Ruprecht Karls University Heidelberg	Maitre, JL; Hiiragi, T (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.; Maitre, JL (corresponding author), Inst Curie, CNRS, INSERM, U934,UMR 3215,Mech Mammalian Dev Grp, 26 Rue Ulm, Paris 05, France.	jean-leon.maitre@curie.fr; hiiragi@embl.de	Turlier, Hervé/Y-7600-2019; Nedelec, Francois J/H-3317-2011; Nedelec, Francois/AAC-1673-2019; Maître, Jean-Léon/C-4372-2017	Turlier, Hervé/0000-0002-9332-9125; Nedelec, Francois J/0000-0002-8141-5288; Nedelec, Francois/0000-0002-8141-5288; Maître, Jean-Léon/0000-0002-3688-1474; Illukkumbura, Rukshala/0000-0002-2131-678X; Hiiragi, Takashi/0000-0003-4964-7203	Marie Curie individual fellowships; Research Executive Agency [329044, 656306, 326701]; Bettencourt-Schueller foundation; EMBL; European Research Council; VolkswagenStifftung; Joachim Herz foundation	Marie Curie individual fellowships(European Commission); Research Executive Agency; Bettencourt-Schueller foundation; EMBL; European Research Council(European Research Council (ERC)European Commission); VolkswagenStifftung(Volkswagen); Joachim Herz foundation	We are grateful to the Hiiragi laboratory members and the European Molecular Biology Laboratory (EMBL) animal facility for their support. We thank F. Da and C. Batty for discussions on the simulations. We thank Y. Bellaiche for comments on an earlier version of the manuscript. Marie Curie individual fellowships under FP7 and H2020 programs support J.-L.M., H.T. and R.N. under Research Executive Agency grant agreements 329044, 656306 and 326701, respectively. H.T. acknowledges support from the Bettencourt-Schueller and Joachim Herz foundations. The Hiiragi laboratory is supported by EMBL, the European Research Council and VolkswagenStifftung.	Anani S, 2014, DEVELOPMENT, V141, P2813, DOI 10.1242/dev.107276; Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Benham-Pyle BW, 2015, SCIENCE, V348, P1024, DOI 10.1126/science.aaa4559; Brodland GW, 2002, J BIOMECH ENG-T ASME, V124, P188, DOI 10.1115/1.1449491; Da F, 2014, ACM T GRAPHIC, V33, DOI 10.1145/2601097.2601146; Dard N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008171; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Guzowski J, 2012, SOFT MATTER, V8, P7269, DOI 10.1039/c2sm25838b; Heisenberg CP, 2013, CELL, V153, P948, DOI 10.1016/j.cell.2013.05.008; Hirate Y, 2015, DEV GROWTH DIFFER, V57, P544, DOI 10.1111/dgd.12235; Hirate Y, 2013, CURR BIOL, V23, P1181, DOI 10.1016/j.cub.2013.05.014; Jacobelli J, 2010, NAT IMMUNOL, V11, P953, DOI 10.1038/ni.1936; Johnson MH, 2009, ANNU REV CELL DEV BI, V25, P483, DOI 10.1146/annurev.cellbio.042308.113348; JOHNSON MH, 1981, CELL, V24, P71, DOI 10.1016/0092-8674(81)90502-X; JOHNSON MH, 1983, DEV BIOL, V95, P211, DOI 10.1016/0012-1606(83)90019-2; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; LEHTONEN E, 1980, J EMBRYOL EXP MORPH, V58, P231; Maitre JL, 2015, NAT CELL BIOL, V17, P849, DOI 10.1038/ncb3185; Maitre JL, 2012, SCIENCE, V338, P253, DOI 10.1126/science.1225399; Matsumoto M, 2003, J CLIN INVEST, V112, P935, DOI 10.1172/JCI200318816; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; Samarage CR, 2015, DEV CELL, V34, P435, DOI 10.1016/j.devcel.2015.07.004; Shin JW, 2014, CELL STEM CELL, V14, P81, DOI 10.1016/j.stem.2013.10.009; Wang AB, 2010, P NATL ACAD SCI USA, V107, P14645, DOI 10.1073/pnas.1004023107; Watanabe T, 2014, DEVELOPMENT, V141, P2279, DOI 10.1242/dev.103267; Wennekamp S, 2013, NAT REV MOL CELL BIO, V14, P452, DOI 10.1038/nrm3602	28	207	210	0	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					344	+		10.1038/nature18958	http://dx.doi.org/10.1038/nature18958			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27487217	Green Submitted, Green Accepted			2022-12-28	WOS:000381804900038
J	Nwulu, U				Nwulu, Ugochi			Bernard Nchewa Nwulu OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2016	354								i4398	10.1136/bmj.i4398	http://dx.doi.org/10.1136/bmj.i4398			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4UY	27521142				2022-12-28	WOS:000381477800006
J	Chio, IIC; Jafarnejad, SM; Ponz-Sarvise, M; Park, Y; Rivera, K; Palm, W; Wilson, J; Sangar, V; Hao, Y; Ohlund, D; Wright, K; Filippini, D; Lee, EJ; Da Silva, B; Schoepfer, C; Wilkinson, JE; Buscaglia, JM; DeNicola, GM; Tiriac, H; Hammell, M; Crawford, HC; Schmidt, EE; Thompson, CB; Pappin, DJ; Sonenberg, N; Tuveson, DA				Chio, Iok In Christine; Jafarnejad, Seyed Mehdi; Ponz-Sarvise, Mariano; Park, Youngkyu; Rivera, Keith; Palm, Wilhelm; Wilson, John; Sangar, Vineet; Hao, Yuan; Oehlund, Daniel; Wright, Kevin; Filippini, Dea; Lee, Eun Jung; Da Silva, Brandon; Schoepfer, Christina; Wilkinson, John Erby; Buscaglia, Jonathan M.; DeNicola, Gina M.; Tiriac, Herve; Hammell, Molly; Crawford, Howard C.; Schmidt, Edward E.; Thompson, Craig B.; Pappin, Darryl J.; Sonenberg, Nahum; Tuveson, David A.			NRF2 Promotes Tumor Maintenance by Modulating mRNA Translation in Pancreatic Cancer	CELL			English	Article							SIGNALING PATHWAYS; DUCTAL ADENOCARCINOMA; OXIDATIVE STRESS; REDOX PROTEOMICS; INITIATION; KRAS; RAS; COMPLEX; KINASE; AKT	Pancreatic cancer is a deadly malignancy that lacks effective therapeutics. We previously reported that oncogenic Kras induced the redox master regulator Nfe2l2/Nrf2 to stimulate pancreatic and lung cancer initiation. Here, we show that NRF2 is necessary to maintain pancreatic cancer proliferation by regulating mRNA translation. Specifically, loss of NRF2 led to defects in autocrine epidermal growth factor receptor (EGFR) signaling and oxidation of specific translational regulatory proteins, resulting in impaired cap-dependent and cap-independent mRNA translation in pancreatic cancer cells. Combined targeting of the EGFR effector AKT and the glutathione antioxidant pathway mimicked Nrf2 ablation to potently inhibit pancreatic cancer ex vivo and in vivo, representing a promising synthetic lethal strategy for treating the disease.	[Chio, Iok In Christine; Ponz-Sarvise, Mariano; Park, Youngkyu; Rivera, Keith; Wilson, John; Hao, Yuan; Oehlund, Daniel; Wright, Kevin; Filippini, Dea; Lee, Eun Jung; Da Silva, Brandon; Schoepfer, Christina; Tiriac, Herve; Hammell, Molly; Pappin, Darryl J.; Tuveson, David A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Chio, Iok In Christine; Ponz-Sarvise, Mariano; Park, Youngkyu; Oehlund, Daniel; Wright, Kevin; Filippini, Dea; Lee, Eun Jung; Da Silva, Brandon; Schoepfer, Christina; Tiriac, Herve; Tuveson, David A.] Lustgarten Fdn Pancreat Canc Res Lab, Cold Spring Harbor, NY 11724 USA; [Jafarnejad, Seyed Mehdi; Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Jafarnejad, Seyed Mehdi; Sonenberg, Nahum] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Palm, Wilhelm; Thompson, Craig B.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Sangar, Vineet] Inst Syst Biol, 401 Terry Ave N, Seattle, WA 98109 USA; [Wilkinson, John Erby; Crawford, Howard C.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Wilkinson, John Erby; Crawford, Howard C.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Buscaglia, Jonathan M.] SUNY Stony Brook, Sch Med, Dept Med, Div Gastroenterol, Stony Brook, NY 11794 USA; [DeNicola, Gina M.] Weill Cornell Med Coll, Meyer Canc Ctr, New York, NY 10021 USA; [Schmidt, Edward E.] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59718 USA; [Ponz-Sarvise, Mariano] Univ Navarra Clin, CIMA, IDISNA, Dept Oncol, Pamplona 31008, Spain	Cold Spring Harbor Laboratory; McGill University; McGill University; Memorial Sloan Kettering Cancer Center; Institute for Systems Biology (ISB); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Cornell University; Montana State University System; Montana State University Bozeman; University of Navarra	Tuveson, DA (corresponding author), Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.; Tuveson, DA (corresponding author), Lustgarten Fdn Pancreat Canc Res Lab, Cold Spring Harbor, NY 11724 USA.	dtuveson@cshl.edu	Ohlund, Daniel/AFR-9335-2022; Ponz-Sarvise, Mariano/H-4104-2017; Jafarnejad, Sadegh/D-2075-2018; Palm, Wilhelm/AAS-6255-2021	Ohlund, Daniel/0000-0002-5847-2778; Ponz-Sarvise, Mariano/0000-0002-3240-729X; Rivera, Keith/0000-0003-2979-9576; Hammell, Molly/0000-0003-0405-8392; Tiriac, Herve/0000-0001-5039-6750; Jafarnejad, Seyed Mehdi/0000-0002-5129-7081; DeNicola, Gina/0000-0001-6611-6696; Filippini, Dea/0000-0002-4792-613X; Hao, Yuan/0000-0002-1588-0587	Cancer Center Support grant [5P30CA045508, P30CA008748]; CSHL Association; NIH [5P30CA45508-26, 5P50CA101955-07, 1U10CA180944-01, 5U01CA168409-3, 1R01CA190092-01, AG040020, CA152559, R01 CA159222]; Carcinoid Foundation; PCUK; David Rubinstein Center for Pancreatic Cancer Research at MSKCC; Stand Up to Cancer/KWF; STARR Foundation [I7-A718]; DOD [W81XWH-13-PRCRP-IA]; Precision Medicine Research Associates; Damon Runyon Cancer Research Foundation [DRG-2165-13]; Human Frontier Science Program [LT000190/2013]; Cancer Research Society; CCSRI [702317]; Canadian Institute of Health Research; Swedish Research Council [537-2013-7277]; Sociedad Espanola de Oncologia Medica (SEOM); Hope Funds for Cancer Research Fellowship; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA159222, U01CA168409, R01CA201318, P50CA101955, U10CA180944, R21CA152559, P30CA045508, R01CA190092] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040020, R21AG055022] Funding Source: NIH RePORTER	Cancer Center Support grant; CSHL Association; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Carcinoid Foundation; PCUK; David Rubinstein Center for Pancreatic Cancer Research at MSKCC; Stand Up to Cancer/KWF; STARR Foundation; DOD(United States Department of Defense); Precision Medicine Research Associates; Damon Runyon Cancer Research Foundation; Human Frontier Science Program(Human Frontier Science Program); Cancer Research Society; CCSRI; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Swedish Research Council(Swedish Research CouncilEuropean Commission); Sociedad Espanola de Oncologia Medica (SEOM); Hope Funds for Cancer Research Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J.R. Prigge, Montana State University, for developing the anti-Nrf2 antibody and Dr. L. Baker for critical review of the manuscript. This work was performed with the CSHL Mass Spectrometry, Animal and Tissue Imaging, and Bioinformatics Shared Resources, which are supported by Cancer Center Support grant 5P30CA045508. D.A.T. is a distinguished scholar of the Lustgarten Foundation (LF) and director of the LF-designated Laboratory of Pancreatic Cancer Research. D.A.T. is supported by the CSHL Association; the NIH (5P30CA45508-26, 5P50CA101955-07, 1U10CA180944-01, 5U01CA168409-3, and 1R01CA190092-01); the Carcinoid Foundation; PCUK; the David Rubinstein Center for Pancreatic Cancer Research at MSKCC; Stand Up to Cancer/KWF; the STARR Foundation (I7-A718), the DOD (W81XWH-13-PRCRP-IA); and the Precision Medicine Research Associates. We are also grateful for support from the following: the Damon Runyon Cancer Research Foundation (Shirley Stein fellow, DRG-2165-13, to I.I.C.C.); the Human Frontier Science Program (LT000190/2013 to I.I.C.C.); the Cancer Research Society and CCSRI (702317, N.S.); the Canadian Institute of Health Research (to S.M.J.); NIH (grants AG040020 and CA152559 to E.E.S.; grant R01 CA159222 to H.C.C.); the Swedish Research Council (537-2013-7277 to D.O.), the Sociedad Espanola de Oncologia Medica (SEOM; to M.P.-S.); and the Hope Funds for Cancer Research Fellowship (to W.P). This work was performed with the MSKCC Molecular Cytology Core, which is supported by Cancer Center Support grant P30CA008748. C.B.T. is a founder of Agios Pharmaceuticals and a member of its scientific advisory board. C.B.T. also serves on the board of directors of Merck.	Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; Belalcazar Andrea D, 2014, ISRN Biochem, V2013, P637897; Bilanges B, 2007, ONCOGENE, V26, P5973, DOI 10.1038/sj.onc.1210431; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Brandes N, 2011, J BIOL CHEM, V286, P41893, DOI 10.1074/jbc.M111.296236; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Davies BR, 2007, MOL CANCER THER, V6, P2209, DOI 10.1158/1535-7163.MCT-07-0231; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Fan XM, 2014, DRUG METAB DISPOS, V42, P1532, DOI 10.1124/dmd.114.059394; Hayes JD, 2014, TRENDS BIOCHEM SCI, V39, P199, DOI 10.1016/j.tibs.2014.02.002; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; JOHNSON LF, 1975, CELL, V4, P69, DOI 10.1016/0092-8674(75)90135-X; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Ke BB, 2013, J HEPATOL, V59, P1200, DOI 10.1016/j.jhep.2013.07.016; Khansari N, 2009, RECENT PATENTS INFLA, V3, P73, DOI 10.2174/187221309787158371; Ling JQ, 2010, P NATL ACAD SCI USA, V107, P4028, DOI 10.1073/pnas.1000315107; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Malec V, 2010, FREE RADICAL BIO MED, V48, P1626, DOI 10.1016/j.freeradbiomed.2010.03.008; Mavrakis KJ, 2008, CELL CYCLE, V7, P2791, DOI 10.4161/cc.7.18.6683; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Molife LR, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-1; Molina-Arcas M, 2013, CANCER DISCOV, V3, P548, DOI 10.1158/2159-8290.CD-12-0446; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; Niture SK, 2012, J BIOL CHEM, V287, P9873, DOI 10.1074/jbc.M111.312694; Palm W, 2015, CELL, V162, P259, DOI 10.1016/j.cell.2015.06.017; Patel MR, 2013, J THORAC ONCOL, V8, P1142, DOI 10.1097/JTO.0b013e31829ce963; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Pelletier J, 2015, CANCER RES, V75, P250, DOI 10.1158/0008-5472.CAN-14-2789; Permyakov SE, 2012, AMINO ACIDS, V42, P1435, DOI 10.1007/s00726-011-0843-0; Raught B, 2000, EMBO J, V19, P434, DOI 10.1093/emboj/19.3.434; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Ruggero D, 2005, ONCOGENE, V24, P7426, DOI 10.1038/sj.onc.1209098; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Sethuraman M, 2004, J PROTEOME RES, V3, P1228, DOI 10.1021/pr049887e; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Socinski MA, 2004, CLIN CANCER RES, V10, p4210S, DOI 10.1158/1078-0432.CCR-040009; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Talalay P, 2007, P NATL ACAD SCI USA, V104, P17500, DOI 10.1073/pnas.0708710104; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Wang H, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6095; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yap TA, 2011, J CLIN ONCOL, V29, P4688, DOI 10.1200/JCO.2011.35.5263; Ying HQ, 2012, CELL, V149, P656, DOI 10.1016/j.cell.2012.01.058; Yun J, 2015, SCIENCE, V350, P1391, DOI 10.1126/science.aaa5004; ZETTERBERG A, 1995, CURR OPIN CELL BIOL, V7, P835, DOI 10.1016/0955-0674(95)80067-0; Zhao X, 2014, CANCER RES, V74, P2455, DOI 10.1158/0008-5472.CAN-13-3009	56	218	227	3	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					963	976		10.1016/j.cell.2016.06.056	http://dx.doi.org/10.1016/j.cell.2016.06.056			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27477511	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000382258700018
J	Beenakker, C				Beenakker, Carlo			Bringing order to the expanding fermion zoo	SCIENCE			English	Editorial Material									[Beenakker, Carlo] Leiden Univ, Inst Lorentz, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Beenakker, C (corresponding author), Leiden Univ, Inst Lorentz, NL-2300 RA Leiden, Netherlands.	beenakker@lorentz.leidenuniv.nl	Beenakker, Carlo W.J./B-7424-2008	Beenakker, Carlo W.J./0000-0003-4748-4412				Burkov AA, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.235126; CARAZZA B, 1995, AM J PHYS, V63, P595, DOI 10.1119/1.17848; Heikkila TT, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/9/093019; NIELSEN HB, 1983, PHYS LETT B, V130, P389, DOI 10.1016/0370-2693(83)91529-0; Orlita M, 2014, NAT PHYS, V10, P233, DOI [10.1038/NPHYS2857, 10.1038/nphys2857]; Soluyanov AA, 2015, NATURE, V527, P495, DOI 10.1038/nature15768; Wang ZJ, 2016, NATURE, V532, P189, DOI 10.1038/nature17410; Wieder BJ, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.186402	10	5	5	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					539	540		10.1126/science.aag2865	http://dx.doi.org/10.1126/science.aag2865			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27493167	Green Submitted			2022-12-28	WOS:000381560900016
J	Sedmak, P; Pilch, J; Heller, L; Kopecek, J; Wright, J; Sedlak, P; Frost, M; Sittner, P				Sedmak, P.; Pilch, J.; Heller, L.; Kopecek, J.; Wright, J.; Sedlak, P.; Frost, M.; Sittner, P.			Grain-resolved analysis of localized deformation in nickel-titanium wire under tensile load	SCIENCE			English	Article							SHAPE-MEMORY ALLOY; X-RAY-DIFFRACTION; INDUCED MARTENSITIC-TRANSFORMATION; LUDERS-LIKE DEFORMATION; PHASE-TRANSFORMATION; NITI; FATIGUE; ANISOTROPY; STRESSES; TUBES	The stress-induced martensitic transformation in tensioned nickel-titanium shape-memory alloys proceeds by propagation of macroscopic fronts of localized deformation. We used three-dimensional synchrotron x-ray diffraction to image at micrometer-scale resolution the grain-resolved elastic strains and stresses in austenite around one such front in a prestrained nickel-titanium wire. We found that the local stresses in austenite grains are modified ahead of the nose cone-shaped buried interface where the martensitic transformation begins. Elevated shear stresses at the cone interface explain why the martensitic transformation proceeds in a localized manner. We established the crossover from stresses in individual grains to a continuum macroscopic internal stress field in the wire and rationalized the experimentally observed internal stress field and the topology of the macroscopic front by means of finite element simulations of the localized deformation.	[Sedmak, P.; Pilch, J.; Heller, L.; Kopecek, J.; Sittner, P.] Acad Sci Czech Republic, Inst Phys, Slovance 1992-2, Prague 1822, Czech Republic; [Sedmak, P.] Czech Tech Univ, Fac Nucl Sci & Phys Engn, Trojanova 13, Prague 12000, Czech Republic; [Wright, J.] European Synchrotron Radiat Facil, 71 Ave Martyrs, F-38043 Grenoble, France; [Sedlak, P.; Frost, M.] Acad Sci Czech Republic, Inst Thermomech, Dolejskova 1402-5, Prague 18200, Czech Republic	Czech Academy of Sciences; Institute of Physics of the Czech Academy of Sciences; Czech Technical University Prague; European Synchrotron Radiation Facility (ESRF); Czech Academy of Sciences; Institute of Thermomechanics of the Czech Academy of Sciences	Sittner, P (corresponding author), Acad Sci Czech Republic, Inst Phys, Slovance 1992-2, Prague 1822, Czech Republic.	sittner@fzu.cz	Sedlak, Petr/G-9758-2014; Wright, Jon/A-4321-2010; Frost, Miroslav/G-7070-2014; Heller, Ludek/B-2770-2011; Kopeček, Jaromír/G-1905-2014; Sittner, Petr/G-5322-2014	Sedlak, Petr/0000-0002-0700-902X; Wright, Jon/0000-0002-8217-0884; Frost, Miroslav/0000-0001-6044-3442; Heller, Ludek/0000-0002-4901-541X; Kopeček, Jaromír/0000-0002-9337-4639; Sittner, Petr/0000-0001-5924-5393	Czech Science Foundation [P107/12/0800, P108/12/P111, GA14-15264S]; Czech Technical University [SGS16/249/OHK4/3T/14]; European Synchrotron Radiation Facility; Ministry of Education, Youth and Sports of the Czech Republic [LM2015088, LM2015048]	Czech Science Foundation(Grant Agency of the Czech Republic); Czech Technical University; European Synchrotron Radiation Facility; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	We acknowledge support from the Czech Science Foundation (research projects P107/12/0800, P108/12/P111, and GA14-15264S) and the Czech Technical University Student Grant Competition (SGS16/249/OHK4/3T/14). We thank the European Synchrotron Radiation Facility for the provision of synchrotron beam time and a Ph.D. grant to P. Sedmak; the Ministry of Education, Youth and Sports of the Czech Republic for the support of the SAFMAT (Centre for Analysis of Functional Materials) project LM2015088 and European Spallation Source project LM2015048; the company TESCAN (J. Dluhos) for assistance with the 3D EBSD analysis; and L. Kaderavek for assistance with graphical works. Data and additional visualization tools are available at http://ofm.fzu.cz/localized%20deformation%20of%20NiTi%20in%20tension.	Ball JM, 1996, Z ANGEW MATH MECH, V76, P389; Bechle NJ, 2014, INT J SOLIDS STRUCT, V51, P967, DOI 10.1016/j.ijsolstr.2013.11.023; Bhattacharya K., 2003, MICROSTRUCTURE MARTE; Chluba C, 2015, SCIENCE, V348, P1004, DOI 10.1126/science.1261164; Dong L, 2016, INT J SOLIDS STRUCT, V80, P445, DOI 10.1016/j.ijsolstr.2015.10.006; Dong L, 2012, INT J SOLIDS STRUCT, V49, P1063, DOI 10.1016/j.ijsolstr.2012.01.006; Dye D, 2015, NAT MATER, V14, P760, DOI 10.1038/nmat4362; Elibol C, 2015, MAT SCI ENG A-STRUCT, V621, P76, DOI 10.1016/j.msea.2014.10.054; Favier D, 2007, ACTA MATER, V55, P5310, DOI 10.1016/j.actamat.2007.05.027; Hane KF, 1999, ACTA MATER, V47, P2603, DOI 10.1016/S1359-6454(99)00143-3; Iadicola MA, 2004, INT J PLASTICITY, V20, P577, DOI 10.1016/S0749-6419(03)00040-8; Jakobsen B, 2006, SCIENCE, V312, P889, DOI 10.1126/science.1124141; James RD, 2015, SCIENCE, V348, P968, DOI 10.1126/science.aab3273; Jani JM, 2014, MATER DESIGN, V56, P1078, DOI 10.1016/j.matdes.2013.11.084; Jimenez-Melero E, 2007, ACTA MATER, V55, P6713, DOI 10.1016/j.actamat.2007.08.040; Khachaturyan A. G., 1983, THEORY STRUCTURAL TR; Kimiecik M, 2013, MATER LETT, V95, P25, DOI 10.1016/j.matlet.2012.12.063; Kimiecik M, 2015, ACTA MATER, V94, P214, DOI 10.1016/j.actamat.2015.04.026; Korsunsky AM, 2006, ACTA MATER, V54, P2101, DOI 10.1016/j.actamat.2006.01.003; Lionheart WRB, 2015, INVERSE PROBL, V31, DOI 10.1088/0266-5611/31/4/045005; Liu YN, 1998, ACTA MATER, V47, P199, DOI 10.1016/S1359-6454(98)00325-5; Liu Y, 2015, ACTA MATER, V95, P411, DOI 10.1016/j.actamat.2015.03.022; Malard B, 2012, ACTA MATER, V60, P1378, DOI 10.1016/j.actamat.2011.10.024; Mao SC, 2010, ACTA MATER, V58, P3357, DOI 10.1016/j.actamat.2010.02.009; Oddershede J, 2011, MATER CHARACT, V62, P651, DOI 10.1016/j.matchar.2011.04.020; Oddershede J, 2010, J APPL CRYSTALLOGR, V43, P539, DOI 10.1107/S0021889810012963; Offerman SE, 2006, NUCL INSTRUM METH B, V246, P194, DOI 10.1016/j.nimb.2005.12.058; Otsuka K, 2005, PROG MATER SCI, V50, P511, DOI 10.1016/j.pmatsci.2004.10.001; Pieczyska EA, 2006, EXP MECH, V46, P531, DOI 10.1007/s11340-006-8351-y; Poulsen H. H., 2004, 3 DIMENSIONAL XRAY D; Racek J, 2015, SHAPE MEM SUPERELAST, V1, P204, DOI 10.1007/s40830-015-0020-5; Reedlunn B, 2014, J MECH PHYS SOLIDS, V63, P506, DOI 10.1016/j.jmps.2012.12.012; Robertson SW, 2012, INT MATER REV, V57, P1, DOI 10.1179/1743280411Y.0000000009; Robertson SW, 2015, J MECH BEHAV BIOMED, V51, P119, DOI 10.1016/j.jmbbm.2015.07.003; Sedlak P, 2012, INT J PLASTICITY, V39, P132, DOI 10.1016/j.ijplas.2012.06.008; Sedmak P, 2015, ACTA MATER, V94, P257, DOI 10.1016/j.actamat.2015.04.039; Shaw J. A., INT J PLAST, V16, P541; Sittner P, 2005, J MECH PHYS SOLIDS, V53, P1719, DOI 10.1016/j.jmps.2005.03.005; Sun QP, 2002, INT J SOLIDS STRUCT, V39, P3797, DOI 10.1016/S0020-7683(02)00182-8; Tan G, 2004, SCRIPTA MATER, V50, P193, DOI 10.1016/j.scriptamat.2003.09.018; WECHSLER MS, 1953, T AM I MIN MET ENG, V197, P1503; Xiao Y, 2016, SMART MATER STRUCT, V25, DOI 10.1088/0964-1726/25/1/017002	42	116	116	11	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					559	562		10.1126/science.aad6700	http://dx.doi.org/10.1126/science.aad6700			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27493178				2022-12-28	WOS:000381560900034
J	Patel, MR; Armstrong, PW; Bhatt, DL; Braunwald, E; Camm, AJ; Fox, KAA; Harrington, RA; Hiatt, WR; James, SK; Kirtane, AJ; Leon, MB; Lincoff, AM; Mahaffey, KW; Mauri, L; Mehran, R; Mehta, SR; Montalescot, G; Nicholls, SJ; Perkovic, V; Peterson, ED; Pocock, SJ; Roe, MT; Sabatine, MS; Sekeres, M; Solomon, SD; Steg, G; Stone, GW; Van de Werf, F; Wallentin, L; White, HD; Gibson, CM				Patel, Manesh R.; Armstrong, Paul W.; Bhatt, Deepak L.; Braunwald, Eugene; Camm, A. John; Fox, Keith A. A.; Harrington, Robert A.; Hiatt, William R.; James, Stefan K.; Kirtane, Ajay J.; Leon, Martin B.; Lincoff, A. Michael; Mahaffey, Kenneth W.; Mauri, Laura; Mehran, Roxana; Mehta, Shamir R.; Montalescot, Gilles; Nicholls, Stephen J.; Perkovic, Vlado; Peterson, Eric D.; Pocock, Stuart J.; Roe, Matthew T.; Sabatine, Marc S.; Sekeres, Mikkael; Solomon, Scott D.; Steg, Gabriel; Stone, Gregg W.; Van de Werf, Frans; Wallentin, Lars; White, Harvey D.; Gibson, C. Michael		Acad Res Org Consortium Continuing	Sharing Data from Cardiovascular Clinical Trials - A Proposal	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material													Arellano-Rodrigo, Eduardo/H-4094-2015; Brugaletta, Salvatore/E-1310-2018; Ruiz-Artacho, PEDRO/I-3100-2018; Díaz, José Luis JLDD Díaz/Q-2523-2015; Peterson, Eric David/ABF-5033-2021; Mehran, Roxana/ABF-4160-2021; Sabatine, Marc/AAJ-6751-2020; Arellano-Rodrigo, Eduardo/R-7079-2019; Rafalskiy, Vladimir V/G-3172-2013; Pilgrim, Thomas/AAS-9120-2021; James, Stefan K/J-4554-2014; Fox, keith A A/I-3742-2013; Apartsin, Konstantin/ACA-8088-2022; Malynovsky, Yaroslav/T-1898-2017; Aleksandr, Legkonogov/P-8914-2015; Perkovic, Vlado/AAY-1933-2021; Apartsin, Konstantin A/B-9179-2017; Patel, Manesh/AAC-5385-2019; mauri, laura/GPS-4868-2022; Thijs, Vincent/C-3647-2009; Apartsin, Konstantin/ABC-5678-2020; Gibson, C. Michael/AAE-8212-2019; martin-loeches, Prof. Ignacio/Q-6645-2018	Arellano-Rodrigo, Eduardo/0000-0001-6236-7826; Brugaletta, Salvatore/0000-0001-5845-1435; Ruiz-Artacho, PEDRO/0000-0002-5680-9883; Sabatine, Marc/0000-0002-0691-3359; Arellano-Rodrigo, Eduardo/0000-0001-6236-7826; Rafalskiy, Vladimir V/0000-0002-2503-9580; Pilgrim, Thomas/0000-0001-8721-4068; Apartsin, Konstantin/0000-0003-0577-9001; Malynovsky, Yaroslav/0000-0002-9118-1104; Aleksandr, Legkonogov/0000-0002-5551-4872; Apartsin, Konstantin A/0000-0003-0577-9001; Thijs, Vincent/0000-0002-6614-8417; Apartsin, Konstantin/0000-0003-0577-9001; Kunecki, Marcin/0000-0003-4077-7378; Fox, Keith/0000-0002-0140-2752; Meelu, Omar/0000-0002-3481-2731; Armstrong, Paul/0000-0002-0460-3445; Van de Werf, Frans/0000-0001-9479-7767; Rincon, Luis M./0000-0003-1819-5742; Obaitan, Itegbemie/0000-0001-5002-6821; STEG, Philippe Gabriel/0000-0001-6896-2941; Sekeres, Mikkael/0000-0003-2009-6524; martin-loeches, Prof. Ignacio/0000-0002-5834-4063; Nicholls, Stephen/0000-0002-9668-4368				Institute of Medicine, 2015, SHAR CLIN TRIAL DAT; Navar AM, 2016, JAMA-J AM MED ASSOC, V315, P1283, DOI 10.1001/jama.2016.2374; Strom BL, 2014, NEW ENGL J MED, V371, P2052, DOI 10.1056/NEJMp1411794; Taichman DB, 2016, NEW ENGL J MED, V374, P384, DOI 10.1056/NEJMe1515172; [No title captured]	5	35	37	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 4	2016	375	5					407	409		10.1056/NEJMp1605260	http://dx.doi.org/10.1056/NEJMp1605260			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS7AN	27518659	Green Published, Bronze			2022-12-28	WOS:000380934900004
J	Vivas, A; Lev-Tov, H; Kirsner, RS				Vivas, Alejandra; Lev-Tov, Hadar; Kirsner, Robert S.			Venous Leg Ulcers	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							ANKLE-BRACHIAL INDEX; COMPRESSION THERAPY; HYPERBARIC-OXYGEN; RISK-FACTORS; ARTERIAL-DISEASE; MANAGEMENT; ULCERATION; NEUROPATHY; SURGERY; IMPACT											Abbade LPF, 2011, INT J DERMATOL, V50, P405, DOI 10.1111/j.1365-4632.2010.04654.x; ABUOWN A, 1994, J VASC SURG, V20, P705, DOI 10.1016/S0741-5214(94)70157-1; Alavi A, 2016, J AM ACAD DERMATOL, V74, P627, DOI 10.1016/j.jaad.2014.10.048; Alsina-Gibert M, 2012, ACTAS DERMO-SIFILOGR, V103, P608, DOI 10.1016/j.ad.2012.01.010; Amsler F, 2009, J VASC SURG, V50, P668, DOI 10.1016/j.jvs.2009.05.018; Ashby RL, 2014, LANCET, V383, P871, DOI 10.1016/S0140-6736(13)62368-5; Berard A, 2002, ANGIOLOGY, V53, P647, DOI 10.1177/000331970205300604; Brem H, 2001, DERMATOL SURG, V27, P915, DOI 10.1046/j.1524-4725.2001.01092.x; BROWSE NL, 1982, LANCET, V2, P243; CALLAM MJ, 1987, BRIT MED J, V294, P929, DOI 10.1136/bmj.294.6577.929; CALLAM MJ, 1985, BRIT MED J, V290, P1855, DOI 10.1136/bmj.290.6485.1855; Sola ML, 2012, ANN VASC SURG, V26, P620, DOI 10.1016/j.avsg.2011.02.051; DICKEY JW, 1991, SOUTHERN MED J, V84, P557; Dimitrijevich SD, 1999, WOUND REPAIR REGEN, V7, P53; Dolibog P, 2014, INT J MED SCI, V11, P34, DOI 10.7150/ijms.7548; Ebbeskog B, 2001, SCAND J CARING SCI, V15, P235, DOI 10.1046/j.1471-6712.2001.00018.x; FALANGA V, 1993, J DERMATOL SURG ONC, V19, P764, DOI 10.1111/j.1524-4725.1993.tb00422.x; Falanga V, 1999, WOUND REPAIR REGEN, V7, P201, DOI 10.1046/j.1524-475X.1999.00201.x; Falanga V J, 2000, Adv Skin Wound Care, V13, P15; Falanga V, 2006, DERMATOL THER, V19, P383, DOI 10.1111/j.1529-8019.2006.00096.x; Fletcher A, 1997, BRIT MED J, V315, P576; Gohel MS, 2007, BMJ-BRIT MED J, V335, P83, DOI 10.1136/bmj.39216.542442.BE; HAMMARLUND C, 1994, PLAST RECONSTR SURG, V93, P829, DOI 10.1097/00006534-199404000-00026; Hess CT, 2011, ADV SKIN WOUND CARE, V24, P96, DOI 10.1097/01.ASW.0000394035.87647.38; Howard DPJ, 2008, EUR J VASC ENDOVASC, V36, P458, DOI 10.1016/j.ejvs.2008.06.013; HUNT TK, 1994, PLAST RECONSTR SURG, V93, P834; Incandela L, 2001, ANGIOLOGY, V52, pS23, DOI 10.1177/0003319701052003S06; Jankunas V, 2007, WOUNDS, V19, P128; Jaschke E, 1999, INT J DERMATOL, V38, P380, DOI 10.1046/j.1365-4362.1999.00665.x; Jull AB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001733.pub3; Kairuz E, 2007, WOUND REPAIR REGEN, V15, P266, DOI 10.1111/j.1524-475X.2007.00215.x; Kelechi TJ, 2012, J AM ACAD DERMATOL, V66, pE209, DOI 10.1016/j.jaad.2011.01.031; Khan Muhammad N, 2006, Int Wound J, V3, P113, DOI 10.1111/j.1742-4801.2006.00211.x; Khilnani Neil M, 2005, Semin Intervent Radiol, V22, P178, DOI 10.1055/s-2005-921950; KIRSNER RS, 1993, J AM ACAD DERMATOL, V28, P623, DOI 10.1016/0190-9622(93)70085-8; Lane RJ, 2003, ANZ J SURG, V73, P267, DOI 10.1046/j.1445-2197.2003.02604.x; Li J, 2007, CIRC J, V71, P377, DOI 10.1253/circj.71.377; Lilly SM, 2014, ATHEROSCLEROSIS, V233, P691, DOI 10.1016/j.atherosclerosis.2014.01.029; MARGOLIS DJ, 1994, CLIN DERMATOL, V12, P19, DOI 10.1016/0738-081X(94)90253-4; Margolis DJ, 2000, AM J MED, V109, P15, DOI 10.1016/S0002-9343(00)00379-X; Marston WA, 2014, WOUND REPAIR REGEN, V22, P334, DOI 10.1111/wrr.12156; McGuckin M, 1996, Ostomy Wound Manage, V42, P50; McGuckin M, 1996, OSTOMY WOUND MANAG, V42, P54; McGuckin M, 1996, OSTOMY WOUND MANAG, V42, P50; Meagher H, 2012, J WOUND CARE, V21, P421, DOI 10.12968/jowc.2012.21.9.421; Milic DJ, 2009, J VASC SURG, V49, P1242, DOI 10.1016/j.jvs.2008.11.069; Miteva M, 2010, DERMATOL THER, V23, P375, DOI 10.1111/j.1529-8019.2010.01338.x; Moffatt CJ, 2010, BRIT J DERMATOL, V162, P51, DOI 10.1111/j.1365-2133.2009.09397.x; Moffatt C, 2009, INT WOUND J, V6, P386, DOI 10.1111/j.1742-481X.2009.00634.x; Mostow EN, 2005, J VASC SURG, V41, P837, DOI 10.1016/j.jvs.2005.01.042; Nelson EA, 2006, J VASC SURG, V44, P803, DOI 10.1016/j.jvs.2006.05.051; Newland MR, 2009, ARCH DERMATOL, V145, P485, DOI 10.1001/archdermatol.2009.14; Nole KLB, 2015, WOUND REPAIR REGEN, V23, P137, DOI 10.1111/wrr.12247; O'Brien J, 2016, INT WOUND J; O'Donnell TF, 2014, J VASC SURG, V60, p3S, DOI 10.1016/j.jvs.2014.04.049; O'Meara S, 2012, COCHRANE DATABASE SY; O'Meara S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003557.pub5; Rabe E, 2012, INT ANGIOL, V31, P105; Reinhardt F, 2000, MUSCLE NERVE, V23, P883, DOI 10.1002/(SICI)1097-4598(200006)23:6<883::AID-MUS6>3.0.CO;2-T; Rice J Bradford, 2014, J Med Econ, V17, P347, DOI 10.3111/13696998.2014.903258; Ruckley CV, 1997, ANGIOLOGY, V48, P67, DOI 10.1177/000331979704800111; Salome GM, 2014, WORLD J SURG, V38, P233, DOI 10.1007/s00268-013-2228-x; Salome GM, 2013, WORLD J SURG, V37, P1438, DOI 10.1007/s00268-013-1975-z; Scriven JM, 1997, BRIT J SURG, V84, P334, DOI 10.1002/bjs.1800840319; Serena TE, 2014, WOUND REPAIR REGEN, V22, P688, DOI 10.1111/wrr.12227; SHAMI SK, 1993, EUR J VASCULAR SURG, V7, P195, DOI 10.1016/S0950-821X(05)80762-5; Shammas NW, 2007, VASC HEALTH RISK MAN, V3, P229, DOI 10.2147/vhrm.2007.3.2.229; Sippel K, 2011, PHLEBOLOGY, V26, P361, DOI 10.1258/phleb.2010.010043; Szewczyk MT, 2009, MED SCI MONITOR, V15, pCR74; Tang JC, 2012, WOUND REPAIR REGEN, V20, P619, DOI 10.1111/j.1524-475X.2012.00815.x; TenBrook JA, 2004, J VASC SURG, V39, P583, DOI 10.1016/j.jvs.2003.09.017; Tew GA, 2015, TRIALS, V16, DOI 10.1186/s13063-015-0963-z; THOMAS PRS, 1988, BRIT MED J, V296, P1693, DOI 10.1136/bmj.296.6638.1693; Vandongen YK, 2000, PHLEBOLOGY, V15, P33, DOI 10.1007/s005230070035; Vlajinac H, 2014, ANGIOLOGY, V65, P824, DOI 10.1177/0003319713508218; WARD DJ, 1989, BRIT J PLAST SURG, V42, P463, DOI 10.1016/0007-1226(89)90015-5; Weller CD, 2016, COCHRANE DB SYST REV, V3; Wissing U, 2002, SCAND J CARING SCI, V16, P59, DOI 10.1046/j.1471-6712.2002.00051.x; Wiszniewski A, 2011, WOUND REPAIR REGEN, V19, P552, DOI 10.1111/j.1524-475X.2011.00716.x; Xu DC, 2010, VASC MED, V15, P361, DOI 10.1177/1358863X10378376; Yim E, 2014, WOUND REPAIR REGEN, V22, P492, DOI 10.1111/wrr.12186; Yim E, 2014, JAMA DERMATOL, V150, P385, DOI 10.1001/jamadermatol.2013.6723	82	19	19	2	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 2	2016	165	3					ITC17	ITC32		10.7326/AITC201608020	http://dx.doi.org/10.7326/AITC201608020			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS2HA	27479227				2022-12-28	WOS:000380583300001
J	Weir, HJ; Mair, WB				Weir, Heather J.; Mair, William B.			SnapShot: Neuronal Regulation of Aging	CELL			English	Editorial Material									[Weir, Heather J.; Mair, William B.] Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Weir, HJ (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.			Mair, William/0000-0002-0661-1342	NATIONAL INSTITUTE ON AGING [R01AG044346] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG044346] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alcedo Joy, 2013, Frontiers in Genetics, V4, P71, DOI 10.3389/fgene.2013.00071; Burkewitz K, 2015, CELL, V160, P842, DOI 10.1016/j.cell.2015.02.004; Schinzel R, 2015, CURR OPIN CELL BIOL, V33, P102, DOI 10.1016/j.ceb.2015.01.006; Ulgherait M, 2014, CELL REP, V8, P1767, DOI 10.1016/j.celrep.2014.08.006; Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143	5	5	5	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					784	+		10.1016/j.cell.2016.07.022	http://dx.doi.org/10.1016/j.cell.2016.07.022			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27471972	Bronze			2022-12-28	WOS:000380546500030
J	Crosby, AE; Lyons, B				Crosby, Alex E.; Lyons, Bridget			Assessing Homicides by and of US Law-Enforcement Officers	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DEATH REPORTING SYSTEM		[Crosby, Alex E.; Lyons, Bridget] Ctr Dis Control & Prevent, Div Violence Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Crosby, AE (corresponding author), Ctr Dis Control & Prevent, Div Violence Prevent, Atlanta, GA 30333 USA.			Lyons, Bridget/0000-0003-1152-9439	Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Barber C, 2016, AM J PUBLIC HEALTH, V106, P922, DOI 10.2105/AJPH.2016.303074; Blair JM, 2003, AM J PREV M IN PRESS, DOI [10.1056/NEJMp1609905, DOI 10.1056/NEJMP1609905]; DeGue S, AM J PREV M IN PRESS; Lyons BH, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6510a1; Miller TR, 2016, INJ PREV	5	8	8	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 20	2016	375	16					1509	1511		10.1056/NEJMp1609905	http://dx.doi.org/10.1056/NEJMp1609905			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EJ3HF	27537352	Green Accepted			2022-12-28	WOS:000393102500003
J	Macias-Konstantopoulos, W				Macias-Konstantopoulos, Wendy			Human Trafficking: The Role of Medicine in Interrupting the Cycle of Abuse and Violence	ANNALS OF INTERNAL MEDICINE			English	Article							CHILDHOOD SEXUAL-ABUSE; HIV PREVALENCE; UNITED-STATES; HEALTH; WOMEN; YOUTH; GIRLS; CARE; VICTIMIZATION; PREDICTORS	Human trafficking, a form of modern slavery, is an egregious violation of human rights with profound personal and public health implications. It includes forced labor and sexual exploitation of both U.S. and non-U.S. citizens and has been reported in all 50 states. Victims of human trafficking are currently among the most abused and disenfranchised persons in society, and they face a wide range of negative health outcomes resulting from their subjugation and exploitation. Medicine has an important role to play in mitigating the devastating effects of human trafficking on individuals and society. Victims are cared for in emergency departments, primary care offices, urgent care centers, community health clinics, and reproductive health clinics. In addition, they are unknowingly being treated in hospital inpatient units. Injuries and illnesses requiring medical attention thus represent unique windows of opportunity for trafficked persons to receive assistance from trusted health care professionals. With education and training, health care providers can recognize signs and symptoms of trafficking, provide trauma-informed care to this vulnerable population, and respond to exploited persons who are interested and ready to receive assistance. Multidisciplinary response protocols, research, and policy advocacy can enhance the impact of antitrafficking health care efforts to interrupt the cycle of abuse and violence for these victims.	[Macias-Konstantopoulos, Wendy] Massachusetts Gen Hosp, Freedom Clin, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Macias-Konstantopoulos, W (corresponding author), Massachusetts Gen Hosp, Dept Emergency Med, Div Global Hlth & Human Rights, 125 Nashua St,Suite 910, Boston, MA 02114 USA.	wmacias@mgh.harvard.edu		Macias-Konstantopoulos, Wendy/0000-0002-5752-2104	Freedom Reimagine Opportunity Innovations Challenge Award	Freedom Reimagine Opportunity Innovations Challenge Award	By the Partnership for Freedom 2014 Reimagine Opportunity Innovations Challenge Award (for Dr. Macias-Konstantopoulos' work with the MGH Freedom Clinic and the MGH Human Trafficking Initiative [Boston, Massachusetts]). Led by Humanity United (San Francisco, California) and the U.S. Departments of Justice, Health and Human Services, Housing and Urban Development, State, and Labor (Washington, DC), the Partnership for Freedom is a public-private partnership dedicated to promoting innovative solutions to end modern-day slavery.	Ahn R, 2013, AM J PREV MED, V44, P283, DOI 10.1016/j.amepre.2012.10.025; Ahrens KR, 2012, CHILD ABUSE NEGLECT, V36, P75, DOI 10.1016/j.chiabu.2011.07.009; Baldwin SB, 2011, HEALTH HUM RIGHTS, V13, P36; Banks D., 2011, SPECIAL REPORT CHARA; Barrows J, 2008, SOUTH MED J, V101, P521, DOI 10.1097/SMJ.0b013e31816c017d; Center for Substance Abuse Treatment (US), 2014, 144816 SMA; Chettiar J, 2010, J PUBLIC HEALTH-UK, V32, P322, DOI 10.1093/pubmed/fdp126; Chisolm-Straker M, 2012, J HEALTH CARE POOR U, V23, P980, DOI 10.1353/hpu.2012.0091; Clawson H. J., 2003, NEEDS ASSESSMENT SER; Dank Meredith, 2015, SURVIVING STREETS NE; Dharmadhikari AS, 2009, INT J INFECT DIS, V13, P543, DOI 10.1016/j.ijid.2008.11.010; Early TJ, 2000, SOC WORK, V45, P118, DOI 10.1093/sw/45.2.118; Elliott DE, 2005, J COMMUNITY PSYCHOL, V33, P461, DOI 10.1002/jcop.20063; Estes R. J., 2001, COMMERCIAL SEXUAL EX; Flores T, 2010, SLAVE STREET TRUE ST; Grace AM, 2014, JAMA PEDIATR, V168, P793, DOI 10.1001/jamapediatrics.2014.999; Greenbaum VJ, 2014, CURR PROB PEDIATR AD, V44, P245, DOI 10.1016/j.cppeds.2014.07.001; Gwadz MV, 2009, J ADOLESCENCE, V32, P357, DOI 10.1016/j.adolescence.2008.01.004; Harrison SL, 2014, AM MED WOMENS ASS PO; Hossain M, 2010, AM J PUBLIC HEALTH, V100, P2442, DOI 10.2105/AJPH.2009.173229; ILO, 2014, PROF POV EC FORC LAB; International Labour Organization, 2012, ILO GLOB EST FORC LA; International Organisation for Migration, 2009, CAR TRAFF PERS GUID; Isaac R, 2011, J APPL RES CHILDREN, V2, P8; Kiss L, 2015, LANCET GLOB HEALTH, V3, pE154, DOI 10.1016/S2214-109X(15)70016-1; Konstantopoulos WM, 2013, J URBAN HEALTH, V90, P1194, DOI 10.1007/s11524-013-9837-4; Lederer L, 2014, ANN HLTH L, V23, P61; Macias-Konstantopoulos Munroe D, 2015, J APPL RES CHILD, V6, P4; Macias-Konstantopoulos W, 2016, STIGMA PREJUDICE TOU, P183; Muftic LR, 2013, J INTERPERS VIOLENCE, V28, P1859, DOI 10.1177/0886260512469102; National Human Trafficking Resource Center, 2011, COMPR HUM TRAFF ASS; National Human Trafficking Resource Center, 2016, 2015 NHTRC ANN REP; Oram S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001224; Organization for Security and Co-operation in Europe, 2013, TRAFF HUM BEINGS AM; Organization for Security and Co-operation in Europe Office of the Special Representative and Co-ordinator for Combating Trafficking in Human Beings, 2010, UNPR WORK INV EXPL T; Silverman JG, 2007, JAMA-J AM MED ASSOC, V298, P536, DOI 10.1001/jama.298.5.536; Silverman JG, 2006, JAIDS-J ACQ IMM DEF, V43, P588; Tsutsumi A, 2008, SOC SCI MED, V66, P1841, DOI 10.1016/j.socscimed.2007.12.025; Turner-Moss E, 2014, J IMMIGR MINOR HEALT, V16, P473, DOI 10.1007/s10903-013-9832-6; Tyler KA, 2001, J RES ADOLESCENCE, V11, P151, DOI 10.1111/1532-7795.00008; U.S. Department of Health and Human Services, 2016, SOAR HLTH WELLN TRAI; U.S. Department of Justice; U.S. Department of Health and Human Services; Department of Homeland Security; President's Interagency Task Force to Monitor and Combat Trafficking in Persons, 2014, PRES INT TASK FORC M; Valaei E, 2014, ASSESSMENT HARMFUL F; Whitbeck LB, 2004, J SEX RES, V41, P329, DOI 10.1080/00224490409552240; Williams Timothy P, 2010, Health Hum Rights, V12, P135; Williamson E, 2009, NAT S HLTH NEEDS HUM; Willis BM, 2002, LANCET, V359, P1417, DOI 10.1016/S0140-6736(02)08355-1; Zimmerman C., 2003, HLTH RISKS CONSEQUEN	48	49	49	0	25	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 18	2016	165	8					582	+		10.7326/M16-0094	http://dx.doi.org/10.7326/M16-0094			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DZ6BM	27537695				2022-12-28	WOS:000385946600019
J	Chailangkarn, T; Trujillo, CA; Freitas, BC; Hrvoj-Mihic, B; Herai, RH; Yu, DN; Brown, TT; Marchetto, MC; Bardy, C; McHenry, L; Stefanacci, L; Jarvinen, A; Searcy, YM; DeWitt, M; Wong, W; Lai, P; Ard, MC; Hanson, KL; Romero, S; Jacobs, B; Dale, AM; Dai, L; Korenberg, JR; Gage, FH; Bellugi, U; Halgren, E; Semendeferi, K; Muotri, AR				Chailangkarn, Thanathom; Trujillo, Cleber A.; Freitas, Beatriz C.; Hrvoj-Mihic, Branka; Herai, Roberto H.; Yu, Diana N.; Brown, Timothy T.; Marchetto, Maria C.; Bardy, Cedric; McHenry, Lauren; Stefanacci, Lisa; Jarvinen, Anna; Searcy, Yvonne M.; DeWitt, Michelle; Wong, Wenny; Lai, Philip; Ard, M. Colin; Hanson, Kari L.; Romero, Sarah; Jacobs, Bob; Dale, Anders M.; Dai, Li; Korenberg, Julie R.; Gage, Fred H.; Bellugi, Ursula; Halgren, Eric; Semendeferi, Katerina; Muotri, Alysson R.			A human neurodevelopmental model for Williams syndrome	NATURE			English	Article							PLURIPOTENT STEM-CELLS; PROSPECTIVE MOTION CORRECTION; HUMAN CEREBRAL-CORTEX; SURFACE-BASED ANALYSIS; HUMAN-FETUS; GENE; BRAIN; MRI; FRIZZLED-9; NEURONS	Williams syndrome is a genetic neurodevelopmental disorder characterized by an uncommon hypersociability and a mosaic of retained and compromised linguistic and cognitive abilities. Nearly all clinically diagnosed individuals with Williams syndrome lack precisely the same set of genes, with breakpoints in chromosome band 7q11.23 (refs 1-5). The contribution of specific genes to the neuroanatomical and functional alterations, leading to behavioural pathologies in humans, remains largely unexplored. Here we investigate neural progenitor cells and cortical neurons derived from Williams syndrome and typically developing induced pluripotent stem cells. Neural progenitor cells in Williams syndrome have an increased doubling time and apoptosis compared with typically developing neural progenitor cells. Using an individual with atypical Williams syndrome(6,7), we narrowed this cellular phenotype to a single gene candidate, frizzled 9 (FZD9). At the neuronal stage, layer V/VI cortical neurons derived from Williams syndrome were characterized by longer total dendrites, increased numbers of spines and synapses, aberrant calcium oscillation and altered network connectivity. Morphometric alterations observed in neurons from Williams syndrome were validated after Golgi staining of postmortem layer V/VI cortical neurons. This model of human induced pluripotent stem cells(8) fills the current knowledge gap in the cellular biology of Williams syndrome and could lead to further insights into the molecular mechanism underlying the disorder and the human social brain.	[Chailangkarn, Thanathom; Trujillo, Cleber A.; Freitas, Beatriz C.; Herai, Roberto H.; Stefanacci, Lisa; Romero, Sarah; Muotri, Alysson R.] Univ Calif San Diego, Sch Med, UCSD Stem Cell Program, Dept Pediat,Rady Childrens Hosp San Diego, La Jolla, CA 92037 USA; [Chailangkarn, Thanathom; Trujillo, Cleber A.; Freitas, Beatriz C.; Herai, Roberto H.; Stefanacci, Lisa; Romero, Sarah; Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92037 USA; [Chailangkarn, Thanathom; Trujillo, Cleber A.; Freitas, Beatriz C.; Herai, Roberto H.; Stefanacci, Lisa; Romero, Sarah; Muotri, Alysson R.] CARTA, La Jolla, CA 92093 USA; [Chailangkarn, Thanathom] Natl Ctr Genet Engn & Biotechnol BIOTEC, Virol & Cell Technol Lab, Pathum Thani 12120, Thailand; [Hrvoj-Mihic, Branka; Stefanacci, Lisa; Hanson, Kari L.; Semendeferi, Katerina] Univ Calif San Diego, Dept Anthropol, La Jolla, CA 92093 USA; [Herai, Roberto H.] Pontificia Univ Catolica Parana PUCPR, Grad Program Hlth Sci, Sch Med, Curitiba, Parana, Brazil; [Yu, Diana N.; Marchetto, Maria C.; Bardy, Cedric; McHenry, Lauren; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Brown, Timothy T.; Dale, Anders M.; Halgren, Eric] Univ Calif San Diego, Multimodal Imaging Lab, La Jolla, CA 92093 USA; [Brown, Timothy T.; Ard, M. Colin; Halgren, Eric] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92093 USA; [Brown, Timothy T.] Univ Calif San Diego, Ctr Human Dev, La Jolla, CA 92093 USA; [Bardy, Cedric] Flinders Univ S Australia, SAHMRI Mind & Brain Theme, Sch Med, Lab Human Neurophysiol & Genet, Adelaide, SA 5000, Australia; [Jarvinen, Anna; Searcy, Yvonne M.; DeWitt, Michelle; Wong, Wenny; Lai, Philip; Bellugi, Ursula] Salk Inst Biol Studies, Lab Cognit Neurosci, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Jacobs, Bob] Colorado Coll, Dept Psychol, Colorado Springs, CO 80903 USA; [Dale, Anders M.] Univ Calif San Diego, Sch Med, Dept Radiol, La Jolla, CA 92093 USA; [Dale, Anders M.] Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; [Dai, Li; Korenberg, Julie R.] Univ Utah, Dept Pediat, Salt Lake City, UT 84108 USA; [Dai, Li; Korenberg, Julie R.] Univ Utah, Inst Brain, Salt Lake City, UT 84108 USA; [Gage, Fred H.; Halgren, Eric; Semendeferi, Katerina; Muotri, Alysson R.] Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA; [Semendeferi, Katerina; Muotri, Alysson R.] Univ Calif San Diego, Neurosci Grad Program, Sch Med, La Jolla, CA 92093 USA	Rady Childrens Hospital San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); University of California System; University of California San Diego; Pontificia Universidade Catolica do Parana; Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Flinders University South Australia; South Australian Health & Medical Research Institute (SAHMRI); Salk Institute; Colorado College; University of California System; University of California San Diego; University of California System; University of California San Diego; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of California System; University of California San Diego; University of California System; University of California San Diego	Muotri, AR (corresponding author), Univ Calif San Diego, Sch Med, UCSD Stem Cell Program, Dept Pediat,Rady Childrens Hosp San Diego, La Jolla, CA 92037 USA.; Muotri, AR (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92037 USA.; Muotri, AR (corresponding author), CARTA, La Jolla, CA 92093 USA.; Semendeferi, K (corresponding author), Univ Calif San Diego, Dept Anthropol, La Jolla, CA 92093 USA.; Semendeferi, K; Muotri, AR (corresponding author), Univ Calif San Diego, Kavli Inst Brain & Mind, La Jolla, CA 92093 USA.; Semendeferi, K; Muotri, AR (corresponding author), Univ Calif San Diego, Neurosci Grad Program, Sch Med, La Jolla, CA 92093 USA.	ksemende@ucsd.edu; muotri@ucsd.edu	Wong, Wenny/I-4411-2015; Bardy, Cedric/F-1182-2019; Herai, Roberto/HII-2648-2022	Wong, Wenny/0000-0003-4039-6882; Bardy, Cedric/0000-0001-8321-0852; Herai, Roberto/0000-0001-9885-2735; Semendeferi, Katerina/0000-0002-9867-9554; Hanson, Kari/0000-0001-7508-7751	California Institute for Regenerative Medicine (CIRM) [TR2-01814, TR4-06747]; National Institutes of Health (NIH) [P01 NICHD033113]; NIH Director's New Innovator Award Program [1-DP2-OD006495-01, R01MH094753, R01MH103134, U19MH107367, U19MH106434, R01MH095741]; National Alliance for Research on Schizophrenia and Depression (NARSAD) Independent Investigator Grant; JPB Foundation; Paul G. Allen Family Foundation; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002]; G. Harold & Leila Y. Mathers Foundation; Royal Thai Government Scholarship; CIRM postdoctoral fellowship; Rita L. Atkinson Graduate fellowship; University of California San Diego Kavli Institute for Brain and Mind; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094753, T32MH020002, R56MH109587, U19MH107367, R01MH095741, R01MH100175, R01MH103134, U19MH106434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [T32DC007361] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006495] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Director's New Innovator Award Program; National Alliance for Research on Schizophrenia and Depression (NARSAD) Independent Investigator Grant; JPB Foundation; Paul G. Allen Family Foundation; Leona M. and Harry B. Helmsley Charitable Trust; G. Harold & Leila Y. Mathers Foundation; Royal Thai Government Scholarship; CIRM postdoctoral fellowship; Rita L. Atkinson Graduate fellowship; University of California San Diego Kavli Institute for Brain and Mind; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the California Institute for Regenerative Medicine (CIRM) TR2-01814 and TR4-06747, the National Institutes of Health (NIH) through P01 NICHD033113, NIH Director's New Innovator Award Program 1-DP2-OD006495-01, R01MH094753, R01MH103134, U19MH107367, U19MH106434, R01MH095741, a National Alliance for Research on Schizophrenia and Depression (NARSAD) Independent Investigator Grant to A.R.M., grants from the Bob and Mary Jane Engman, the JPB Foundation, Paul G. Allen Family Foundation, the Leona M. and Harry B. Helmsley Charitable Trust grant 2012-PG-MED002, Annette C. Merle-Smith, the G. Harold & Leila Y. Mathers Foundation, the Royal Thai Government Scholarship to T.C., a CIRM postdoctoral fellowship to C.A.T., the Rita L. Atkinson Graduate fellowship to B. H.-M and the University of California San Diego Kavli Institute for Brain and Mind. Human tissue was obtained from the University of Maryland Brain and Tissue Bank, which is a brain and tissue repository of the NIH NeuroBioBank. We acknowledge K. Jepsen for the DNA bead arrays and members of the Willert laboratory for assistance with the Wnt pathway experiments. We thank all the participants and their families.	Adamo A, 2015, NAT GENET, V47, P132, DOI 10.1038/ng.3169; Bellugi U, 2000, J COGNITIVE NEUROSCI, V12, P7, DOI 10.1162/089892900561959; Bellugi U, 1999, TRENDS NEUROSCI, V22, P197, DOI 10.1016/S0166-2236(99)01397-1; Beltrao-Braga PCB, 2011, CELL TRANSPLANT, V20, P1707, DOI 10.3727/096368911X566235; Brown TT, 2010, NEUROIMAGE, V53, P139, DOI 10.1016/j.neuroimage.2010.06.017; Chailangkarn T, 2012, CURR OPIN NEUROBIOL, V22, P785, DOI 10.1016/j.conb.2012.04.004; Chen B, 2008, P NATL ACAD SCI USA, V105, P11382, DOI 10.1073/pnas.0804918105; Chen J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075682; Chiang MC, 2007, NEUROIMAGE, V36, P1096, DOI 10.1016/j.neuroimage.2007.04.024; Dai L, 2009, AM J MED GENET A, V149A, P302, DOI 10.1002/ajmg.a.32652; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Doyle TF, 2004, AM J MED GENET A, V124A, P263, DOI 10.1002/ajmg.a.20416; Edelmann L, 2007, J MED GENET, V44, P136, DOI 10.1136/jmg.2006.044537; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Fischl B, 2004, NEUROIMAGE, V23, pS69, DOI 10.1016/j.neuroimage.2004.07.016; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fujimoto T, 2009, INT J ONCOL, V35, P861, DOI 10.3892/ijo_00000400; Fujimura N, 2007, J BIOL CHEM, V282, P1225, DOI 10.1074/jbc.M605851200; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Hermann BP, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.125757; Hutsler JJ, 2010, BRAIN RES, V1309, P83, DOI 10.1016/j.brainres.2009.09.120; Jacobs B, 2003, ANN NEUROL, V54, P126, DOI 10.1002/ana.10620; JACOBS B, 1993, J COMP NEUROL, V327, P83, DOI 10.1002/cne.903270107; Jacobs B, 2001, CEREB CORTEX, V11, P558, DOI 10.1093/cercor/11.6.558; Jarvinen-Pasley A, 2008, DEV PSYCHOPATHOL, V20, P1, DOI 10.1017/S0954579408000011; JAY V, 1990, DEV BRAIN RES, V54, P291, DOI 10.1016/0165-3806(90)90153-P; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Jovicich J, 2006, NEUROIMAGE, V30, P436, DOI 10.1016/j.neuroimage.2005.09.046; Korenberg JR, 2000, J COGNITIVE NEUROSCI, V12, P89, DOI 10.1162/089892900562002; Kuperman JM, 2011, PEDIATR RADIOL, V41, P1578, DOI 10.1007/s00247-011-2205-1; Lawless JF, 2005, BIOMETRIKA, V92, P529, DOI 10.1093/biomet/92.3.529; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Lian XJ, 2014, STEM CELL REP, V3, P804, DOI 10.1016/j.stemcr.2014.09.005; Livak KJ, 2013, METHODS, V59, P71, DOI 10.1016/j.ymeth.2012.10.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llorens-Bobadilla E, 2015, CELL STEM CELL, V17, P329, DOI 10.1016/j.stem.2015.07.002; Marchetto MCN, 2013, NATURE, V503, P525, DOI 10.1038/nature12686; Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016; Marinho PA, 2015, SCI REP-UK, V5, DOI 10.1038/srep09834; MARINPAD.M, 1972, BRAIN RES, V44, P625, DOI 10.1016/0006-8993(72)90324-1; MARINPADILLA M, 1970, BRAIN RES, V23, P185, DOI 10.1016/0006-8993(70)90038-7; Meyer-Lindenberg A, 2004, NEURON, V43, P623, DOI 10.1016/j.neuron.2004.08.014; RILEY JN, 1979, BRAIN RES BULL, V4, P127, DOI 10.1016/0361-9230(79)90067-4; Semendeferi K, 2011, CEREB CORTEX, V21, P1485, DOI 10.1093/cercor/bhq191; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Spitzer NC, 2004, TRENDS NEUROSCI, V27, P415, DOI 10.1016/j.tins.2004.05.003; Srinivasan K, 2012, P NATL ACAD SCI USA, V109, P19071, DOI 10.1073/pnas.1216793109; TAKASHIMA S, 1981, BRAIN RES, V225, P1, DOI 10.1016/0006-8993(81)90314-0; UYLINGS HBM, 1986, J NEUROSCI METH, V18, P127, DOI 10.1016/0165-0270(86)90116-0; Van Raay TJ, 2001, DEV GENES EVOL, V211, P453, DOI 10.1007/s004270100174; Vuksic M, 2002, PEDIATR NEUROL, V27, P36, DOI 10.1016/S0887-8994(02)00380-6; White N, 2010, MAGN RESON MED, V63, P91, DOI 10.1002/mrm.22176; WILLIAMS RS, 1978, J NEUROPATH EXP NEUR, V37, P13, DOI 10.1097/00005072-197801000-00002; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zhao CJ, 2005, DEVELOPMENT, V132, P2917, DOI 10.1242/dev.01871	59	111	112	1	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					338	+		10.1038/nature19067	http://dx.doi.org/10.1038/nature19067			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27509850	Green Submitted, Green Accepted			2022-12-28	WOS:000381804900037
J	Iacobucci, G				Iacobucci, Gareth			Sharp rise in patients waiting more than 18 weeks for elective surgery	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		The Patients Association, 2016, FEEL WAIT ANN REP EL	1	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2016	354								i4518	10.1136/bmj.i4518	http://dx.doi.org/10.1136/bmj.i4518			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GX	27531842				2022-12-28	WOS:000381806200015
J	Fleck, BW; Phillips, CI; Wright, M				Fleck, Brian W.; Phillips, Calbert I.; Wright, Mark			Richard Shayle Bartholomew OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2016	354								i4394	10.1136/bmj.i4394	http://dx.doi.org/10.1136/bmj.i4394			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4UY	27519254				2022-12-28	WOS:000381477800002
J	Kim, CC; Lee, HH; Oh, KH; Sun, JY				Kim, Chong-Chan; Lee, Hyun-Hee; Oh, Kyu Hwan; Sun, Jeong-Yun			Highly stretchable, transparent ionic touch panel	SCIENCE			English	Article							FILMS; GRAPHENE; SKIN	Because human-computer interactions are increasingly important, touch panels may require stretchability and biocompatibility in order to allow integration with the human body. However, most touch panels have been developed based on stiff and brittle electrodes. We demonstrate an ionic touch panel based on a polyacrylamide hydrogel containing lithium chloride salts. The panel is soft and stretchable, so it can sustain a large deformation. The panel can freely transmit light information because the hydrogel is transparent, with 98% transmittance for visible light. A surface-capacitive touch system was adopted to sense a touched position. The panel can be operated under more than 1000% areal strain without sacrificing its functionalities. Epidermal touch panel use on skin was demonstrated by writing words, playing a piano, and playing games.	[Kim, Chong-Chan; Lee, Hyun-Hee; Oh, Kyu Hwan; Sun, Jeong-Yun] Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151742, South Korea; [Oh, Kyu Hwan; Sun, Jeong-Yun] Seoul Natl Univ, RIAM, Seoul 151742, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Sun, JY (corresponding author), Seoul Natl Univ, Dept Mat Sci & Engn, Seoul 151742, South Korea.; Sun, JY (corresponding author), Seoul Natl Univ, RIAM, Seoul 151742, South Korea.	jysun@snu.ac.kr	oh, kyuhwan/H-5265-2018; Sun, Jeong-Yun/AAR-4630-2020	Kim, Chong-Chan/0000-0003-3662-5654	National Research Foundation of Korea (NRF) - Korean Government (MSIP) [2015R1A5A1037668]; Ministry of Trade, Industry and Energy of Korea (MOTIE) [10052783]	National Research Foundation of Korea (NRF) - Korean Government (MSIP)(National Research Foundation of Korea); Ministry of Trade, Industry and Energy of Korea (MOTIE)(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean Government (MSIP) (2015R1A5A1037668). J.-Y.S. and H.-H.L. acknowledge the support of the source technology and materials funded by the Ministry of Trade, Industry and Energy of Korea (MOTIE) (10052783).	ADLER R, 1987, IEEE T ULTRASON FERR, V34, P195, DOI 10.1109/T-UFFC.1987.26932; Aguilar R. N., 2002, Proceedings of IEEE Sensors 2002. First IEEE International Conference on Sensors (Cat. No.02CH37394), P1360, DOI 10.1109/ICSENS.2002.1037318; Akhavan O, 2010, ACS NANO, V4, P5731, DOI 10.1021/nn101390x; Bae S, 2010, NAT NANOTECHNOL, V5, P574, DOI [10.1038/nnano.2010.132, 10.1038/NNANO.2010.132]; Bhalla M.R., 2010, INT J COMPUT APPL, V6, P12, DOI DOI 10.5120/1097-1433; Darnell MC, 2013, BIOMATERIALS, V34, P8042, DOI 10.1016/j.biomaterials.2013.06.061; De S, 2009, ACS NANO, V3, P1767, DOI 10.1021/nn900348c; Ding LH, 2005, NANO LETT, V5, P2448, DOI 10.1021/nl051748o; Guo CF, 2015, P NATL ACAD SCI USA, V112, P12332, DOI 10.1073/pnas.1516873112; Haga H., 2010, SID S, V41, P669; Hotelling Steve, 2010, US Patent, Patent No. [7,663,607, 7663607]; Hu LB, 2010, ACS NANO, V4, P2955, DOI 10.1021/nn1005232; Hu LB, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3114463; Keplinger C, 2013, SCIENCE, V341, P984, DOI 10.1126/science.1240228; KREIN PT, 1990, IEEE T IND APPL, V26, P529, DOI 10.1109/28.55954; Langley D, 2013, NANOTECHNOLOGY, V24, DOI 10.1088/0957-4484/24/45/452001; Larson C, 2016, SCIENCE, V351, P1071, DOI 10.1126/science.aac5082; Obara K, 2003, BIOMATERIALS, V24, P3437, DOI 10.1016/S0142-9612(03)00220-5; Pepper W., 1981, [No title captured], Patent No. [US4293734A, 4293734]; Qiu Y, 2012, ADV DRUG DELIVER REV, V64, P49, DOI 10.1016/j.addr.2012.09.024; Sun JY, 2014, ADV MATER, V26, P7608, DOI 10.1002/adma.201403441; Sun JY, 2012, NATURE, V489, P133, DOI 10.1038/nature11409; Tahar RBH, 1998, J APPL PHYS, V83, P2631, DOI 10.1063/1.367025; Vosgueritchian M, 2012, ADV FUNCT MATER, V22, P421, DOI 10.1002/adfm.201101775; Wu ZC, 2004, SCIENCE, V305, P1273, DOI 10.1126/science.1101243; Xia YJ, 2012, ADV MATER, V24, P2436, DOI 10.1002/adma.201104795; Young T., 1993, U. S.patent, Patent No. [5, 241, 308, 5241308]; Zang JF, 2013, NAT MATER, V12, P321, DOI [10.1038/NMAT3542, 10.1038/nmat3542]	28	634	643	86	1105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					682	687		10.1126/science.aaf8810	http://dx.doi.org/10.1126/science.aaf8810			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZC	27516597				2022-12-28	WOS:000381561200036
J	[Anonymous]				[Anonymous]			The management of dry eye (vol 353, e2333, 2016)	BMJ-BRITISH MEDICAL JOURNAL			English	Correction																		*DRUG THER B, 2016, BMJ-BRIT MED J, V353, DOI DOI 10.1136/BMJ.I2333	1	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2016	354								i4463	10.1136/bmj.i4463	http://dx.doi.org/10.1136/bmj.i4463			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4UY	27520831	Green Published, Bronze			2022-12-28	WOS:000381477800014
J	Freitag, A; Constanti, M; O'Flynn, N; Faust, SN				Freitag, Andreas; Constanti, Margaret; O'Flynn, Norma; Faust, Saul N.		Guideline Dev Grp	GUIDELINES Suspected sepsis: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Freitag, Andreas; Constanti, Margaret; O'Flynn, Norma] Royal Coll Physicians, Natl Guideline Ctr, London NW1 4LE, England; [Faust, Saul N.] Univ Southampton, Fac Med, NIHR Wellcome Trust Clin Res Facil, Paediat Immunol & Infect Dis, Southampton, Hants, England; [Faust, Saul N.] Univ Hosp Southampton NHS Fdn Trust, Paediat Immunol & Infect Dis, Southampton, Hants, England	Royal College of Physicians; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust	Faust, SN (corresponding author), Univ Southampton, Fac Med, NIHR Wellcome Trust Clin Res Facil, Paediat Immunol & Infect Dis, Southampton, Hants, England.; Faust, SN (corresponding author), Univ Hosp Southampton NHS Fdn Trust, Paediat Immunol & Infect Dis, Southampton, Hants, England.	s.faust@soton.ac.uk	Faust, Saul/J-9779-2014	Faust, Saul/0000-0003-3410-7642				National Institute for Health and Care Excellence, 2015, MEN BACT MEN SEPT 16; National Institute for Health and Care Excellence, 2013, FEV 5S ASS IN MAN CL; National Institute for Health and Care Excellence, 2016, SEPS REC DIAGN EARL, pNG51; National Institute for Health and Care Excellence, 2014, NEUTR SEPS PREV MAN; Parliamentary and Health Service Ombudsman, 2013, TIM ACT SEV SEPS RAP; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287	6	14	15	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2016	354								i4030	10.1136/bmj.i4030	http://dx.doi.org/10.1136/bmj.i4030			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4UB	27514867	Green Accepted, Green Published			2022-12-28	WOS:000381475500001
J	Goncalves, KA; Silberstein, L; Li, SP; Severe, N; Hu, MFG; Yang, HL; Scadden, DT; Hu, GF				Goncalves, Kevin A.; Silberstein, Lev; Li, Shuping; Severe, Nicolas; Hu, Miaofen G.; Yang, Hailing; Scadden, David T.; Hu, Guo-fu			Angiogenin Promotes Hematopoietic Regeneration by Dichotomously Regulating Quiescence of Stem and Progenitor Cells	CELL			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSFER-RNA HALVES; SELF-RENEWAL; GENE-EXPRESSION; CORD BLOOD; PROLIFERATION; MAINTENANCE; STRESS; IDENTIFICATION; EXPANSION	Regulation of stem and progenitor cell populations is critical in the development, maintenance, and regeneration of tissues. Here, we define a novelmechanism by which a niche-secreted RNase, angiogenin (ANG), distinctively alters the functional characteristics of primitive hematopoietic stem/progenitor cells (HSPCs) compared with lineage-committed myeloid-restricted progenitor (MyePro) cells. Specifically, ANG reduces the proliferative capacity of HSPC while simultaneously increasing proliferation of MyePro cells. Mechanistically, ANG induces cell-type-specific RNA-processing events: tRNAderived stress-induced small RNA (tiRNA) generation in HSPCs and rRNA induction in MyePro cells, leading to respective reduction andincrease inprotein synthesis. Recombinant ANG protein improves survival of irradiated animals and enhances hematopoietic regeneration of mouse and human HSPCs in transplantation. Thus, ANG plays a non-cell-autonomous role in regulation of hematopoiesis by simultaneously preserving HSPC stemness and promoting MyePro proliferation. These cell-type-specific functions of ANG suggest considerable therapeutic potential.	[Goncalves, Kevin A.; Li, Shuping; Hu, Miaofen G.; Yang, Hailing; Hu, Guo-fu] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Goncalves, Kevin A.; Yang, Hailing; Hu, Guo-fu] Tufts Univ, Sackler Sch Grad Biomed Sci, Grad Program Cellular & Mol Physiol, Boston, MA 02111 USA; [Silberstein, Lev; Severe, Nicolas; Scadden, David T.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02445 USA; [Silberstein, Lev; Severe, Nicolas; Scadden, David T.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Silberstein, Lev; Severe, Nicolas; Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Tufts Medical Center; Tufts University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Hu, GF (corresponding author), Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA.; Hu, GF (corresponding author), Tufts Univ, Sackler Sch Grad Biomed Sci, Grad Program Cellular & Mol Physiol, Boston, MA 02111 USA.; Scadden, DT (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02445 USA.; Scadden, DT (corresponding author), Harvard Stem Cell Inst, Cambridge, MA 02138 USA.; Scadden, DT (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	david_scadden@harvard.edu; guo-fu.hu@tufts.edu	Gonçalves, Ana Katherine/AAO-4019-2020; GONÇALVES, ANA/K-2300-2017	Gonçalves, Ana Katherine/0000-0002-8351-5119; GONÇALVES, ANA/0000-0002-8351-5119	NIH [F31HL128127, R01DK107784, R01HL096372, R01CA105241, R01NS065237]; Sackler Dean's Fellow award; Sackler Families Collaborative Cancer Biology award; Leukemia & Lymphoma Research UK/Leukemia & Lymphoma Society fellowships; NSFC [81272674]; DoD [W81XWH-15-1-0207]; NATIONAL CANCER INSTITUTE [R01CA105241] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F31HL128127, R03HL096372, R01HL097794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB014703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107784, R01DK050234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065237] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sackler Dean's Fellow award; Sackler Families Collaborative Cancer Biology award; Leukemia & Lymphoma Research UK/Leukemia & Lymphoma Society fellowships; NSFC(National Natural Science Foundation of China (NSFC)); DoD(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Kathryn Folz-Donahue, Steven Kwok, Allen Parmalee, Laura Prickett-Rice, and Meredith Weglarz for assistance with cell sorting and Dr. Alenka Lovy for assistance with microscopy. Aged WT mice were kindly provided by NIH/NIA, and Osx and Ocn cDNA were gifts kindly provided by Dr. Deepak Balani and Dr. Henry Kronenberg. This work was supported by NIH fellowship F31HL128127 (to K.A.G.), a Sackler Dean's Fellow award (to K.A.G.), a Sackler Families Collaborative Cancer Biology award (to K.A.G. and G.H.), Leukemia & Lymphoma Research UK/Leukemia & Lymphoma Society fellowships (to L.S.), NSFC grant #81272674 (to S.L.), NIH grants R01DK107784 and R01HL096372 (to D.T.S.), DoD Award W81XWH-15-1-0207 (to G.H.), and NIH grants R01CA105241 and R01NS065237 (to G.H.). D.T.S. is a consultant and stockholder for Magenta Therapeutics and Fate Therapeutics and a consultant for Bone Therapeutics, Teva Pharmaceutical Industries, Dr. Reddy's Laboratories, and Apotex. G.H. is a consultant and stockholder of Fuyuan Biopharmaceuticals and Karma Pharmaceuticals.	Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Dhahbi JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-298; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; FETT JW, 1985, BIOCHEMISTRY-US, V24, P5480, DOI 10.1021/bi00341a030; Frelin C, 2013, NAT IMMUNOL, V14, P1037, DOI 10.1038/ni.2692; HALLAHAN TW, 1991, P NATL ACAD SCI USA, V88, P2222, DOI 10.1073/pnas.88.6.2222; Himburg HA, 2014, J CLIN INVEST, V124, P4753, DOI 10.1172/JCI76838; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Hooper LV, 2003, NAT IMMUNOL, V4, P269, DOI 10.1038/ni888; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kieran D, 2008, J NEUROSCI, V28, P14056, DOI 10.1523/JNEUROSCI.3399-08.2008; Kishimoto K, 2005, ONCOGENE, V24, P445, DOI 10.1038/sj.onc.1208223; LEE FS, 1989, BIOCHEMISTRY-US, V28, P225, DOI 10.1021/bi00427a031; Li PL, 2015, NATURE, V523, P468, DOI 10.1038/nature14569; Li Shuping, 2010, Int J Biochem Mol Biol, V1, P26; Mantel CR, 2015, CELL, V161, P1553, DOI 10.1016/j.cell.2015.04.054; Matsumoto A, 2011, CELL STEM CELL, V9, P262, DOI 10.1016/j.stem.2011.06.014; Mendelson A, 2014, NAT MED, V20, P833, DOI 10.1038/nm.3647; MOROIANU J, 1994, BIOCHEM BIOPH RES CO, V203, P1765, DOI 10.1006/bbrc.1994.2391; Morrison SJ, 2014, NATURE, V505, P327, DOI 10.1038/nature12984; Nakamura-Ishizu A, 2014, DEVELOPMENT, V141, P4656, DOI 10.1242/dev.106575; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pizzo E, 2013, J CELL SCI, V126, P4308, DOI 10.1242/jcs.134551; Saikia M, 2014, MOL CELL BIOL, V34, P2450, DOI 10.1128/MCB.00136-14; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Silberstein L., 2016, CELL STEM CELL; Singh VK, 2015, CYTOKINE, V71, P22, DOI 10.1016/j.cyto.2014.08.003; Smith AR, 2009, BRIT J HAEMATOL, V147, P246, DOI 10.1111/j.1365-2141.2009.07828.x; Subramanian V, 2008, HUM MOL GENET, V17, P130, DOI 10.1093/hmg/ddm290; Subramanian V, 2007, HUM MOL GENET, V16, P1445, DOI 10.1093/hmg/ddm095; Tsuji T, 2005, CANCER RES, V65, P1352, DOI 10.1158/0008-5472.CAN-04-2058; Xu ZP, 2003, BIOCHEMISTRY-US, V42, P121, DOI 10.1021/bi020465x; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Yoshioka N, 2006, P NATL ACAD SCI USA, V103, P14519, DOI 10.1073/pnas.0606708103	45	109	114	4	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					894	906		10.1016/j.cell.2016.06.042	http://dx.doi.org/10.1016/j.cell.2016.06.042			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27518564	Green Accepted, Bronze			2022-12-28	WOS:000382258700013
J	Webb, JLA				Webb, James L. A., Jr.			The art of medicine Aedes aegypti suppression in the Americas: historical perspectives	LANCET			English	Editorial Material									[Webb, James L. A., Jr.] Colby Coll, Dept Hist, Waterville, ME 04901 USA	Colby College	Webb, JLA (corresponding author), Colby Coll, Dept Hist, Waterville, ME 04901 USA.	jlwebb@colby.edu	Webb, James L.A./C-2789-2009						0	8	8	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 6	2016	388	10044					556	557		10.1016/S0140-6736(16)31225-9	http://dx.doi.org/10.1016/S0140-6736(16)31225-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	DS4NA	27529102				2022-12-28	WOS:000380756600016
J	Wang, ZH; Zhang, B; Guan, DB				Wang, Zhaohua; Zhang, Bin; Guan, Dabo			Take responsibility for electronic-waste disposal	NATURE			English	Editorial Material							GENERATION		[Wang, Zhaohua; Zhang, Bin] Beijing Inst Technol, Sch Management & Econ, Beijing, Peoples R China; [Wang, Zhaohua; Zhang, Bin] Beijing Inst Technol, Ctr Energy & Environm Policy Res, Beijing, Peoples R China; [Guan, Dabo] Univ East Anglia, Sch Int Dev, Climate Change Econ, Norwich, Norfolk, England	Beijing Institute of Technology; Beijing Institute of Technology; University of East Anglia	Guan, DB (corresponding author), Univ East Anglia, Sch Int Dev, Climate Change Econ, Norwich, Norfolk, England.	dabo.guan@uea.ac.uk	Wang, Zhaohua/AAP-5489-2021; Guan, Dabo/Y-2406-2019; Guan, Dabo/K-5534-2017	Guan, Dabo/0000-0003-3773-3403; Guan, Dabo/0000-0003-3773-3403	Economic and Social Research Council [ES/L016028/1] Funding Source: researchfish; Natural Environment Research Council [NE/N00714X/1] Funding Source: researchfish; ESRC [ES/L016028/1] Funding Source: UKRI; NERC [NE/N00714X/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Agoramoorthy G, 2012, NATURE, V485, P309, DOI 10.1038/485309b; Bald? CP., 2014, E WASTE STAT GUIDELI; Balde C.P., 2015, GLOBAL E WASTE MONIT; Breivik K, 2014, ENVIRON SCI TECHNOL, V48, P8735, DOI 10.1021/es5021313; Liu XB, 2006, WASTE MANAGE RES, V24, P434, DOI 10.1177/0734242X06067449; Ogunseitan OA, 2009, SCIENCE, V326, P670, DOI 10.1126/science.1176929; Robinson BH, 2009, SCI TOTAL ENVIRON, V408, P183, DOI 10.1016/j.scitotenv.2009.09.044; Wang ZH, 2011, J CLEAN PROD, V19, P977, DOI 10.1016/j.jclepro.2010.09.016; Zhang K, 2012, ENVIRON SCI TECHNOL, V46, P10861, DOI 10.1021/es303166s	9	92	97	16	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2016	536	7614					23	25		10.1038/536023a	http://dx.doi.org/10.1038/536023a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS7YM	27488785	Bronze			2022-12-28	WOS:000380999200011
J	Popkin, G				Popkin, Gabriel			Partners in knowledge	NATURE			English	Editorial Material																		Rasmussen M, 2015, NATURE, V523, P455, DOI 10.1038/nature14625; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177	2	3	3	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 28	2016	535	7613					581	582		10.1038/nj7613-581a	http://dx.doi.org/10.1038/nj7613-581a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS5XP	27471766	Bronze			2022-12-28	WOS:000380856600038
J	Gornall, J; Hoey, A; Ozieranski, P				Gornall, Jonathan; Hoey, Amanda; Ozieranski, Piotr			INVESTIGATION A pill too hard to swallow: how the NHS is limiting access to high priced drugs	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Cambridge, Dept Sociol, Cambridge, England; [Ozieranski, Piotr] Univ Bath, Dept Social & Policy Sci, Bath, Avon, England	University of Cambridge; University of Bath	Ozieranski, P (corresponding author), Univ Bath, Dept Social & Policy Sci, Bath, Avon, England.	ah839@cam.ac.uk		Ozieranski, Piotr/0000-0002-2023-3288				NHS England, 2016, 1615 NHS ENGL; NHS England, 2014, INT CLIN COMM POL ST; NICE, 2015, LED SOF TREAT CHRON; NICE, 2015, SOF TREAT CHRON HEP; NICE, 2015, OMB PAR RIT DAS TREA; Public Health England, 2015, HEP IN THE UK; Taylor P., 2014, PMLIVE          1121; US Senate Committee on Finance, 2015, PRIC SOV ITS IMP US	8	19	19	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2016	354								i4117	10.1136/bmj.i4117	http://dx.doi.org/10.1136/bmj.i4117			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS6ZH	27469086	Green Published			2022-12-28	WOS:000380931600006
J	Pollard, JW				Pollard, Jeffrey W.			Defining Metastatic Cell Latency	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TUMOR-METASTASIS; MONOCYTES		[Pollard, Jeffrey W.] Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland	University of Edinburgh	Pollard, JW (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Queens Med Res Inst, Edinburgh, Midlothian, Scotland.				NCI NIH HHS [P01 CA100324, R01 CA172451] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA172451, P01CA100324] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ames E, 2014, CANCER IMMUNOL IMMUN, V63, P21, DOI 10.1007/s00262-013-1469-8; Hanna RN, 2015, SCIENCE, V350, P985, DOI 10.1126/science.aac9407; Kitamura T, 2015, NAT REV IMMUNOL, V15, P73, DOI 10.1038/nri3789; Malladi S, 2016, CELL, V165, P45, DOI 10.1016/j.cell.2016.02.025; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138	5	11	11	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2016	375	3					280	282		10.1056/NEJMcibr1606716	http://dx.doi.org/10.1056/NEJMcibr1606716			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS0ZL	27468066	Green Accepted, Green Published			2022-12-28	WOS:000380325400015
J	Kroidl, I; Saathoff, E; Maganga, L; Makunde, WH; Hoerauf, A; Geldmacher, C; Clowes, P; Maboko, L; Hoelscher, M				Kroidl, Inge; Saathoff, Elmar; Maganga, Lucas; Makunde, Williams H.; Hoerauf, Achim; Geldmacher, Christof; Clowes, Petra; Maboko, Leonard; Hoelscher, Michael			Effect of Wuchereria bancrofti infection on HIV incidence in southwest Tanzania: a prospective cohort study	LANCET			English	Article							BLOOD MONONUCLEAR-CELLS; ETHIOPIAN IMMIGRANTS; LYMPHATIC FILARIASIS; IMMUNE ACTIVATION; T-CELLS; RESPONSES; AFRICA; SCHISTOSOMIASIS; SUSCEPTIBILITY; ALBENDAZOLE	Background The past decades have seen an ongoing controversial debate about whether the immune activation induced by helminths has an effect on the susceptibility of individuals to HIV. In view of this, we assessed the effect of lymphatic filariasis, a chronic helminth disease elicited by Wuchereria bancrofti, on HIV incidence in southwest Tanzania. Methods In this population-based cohort study, we enrolled a geographically stratified randomly chosen sample of about 10% of the households in nine distinct sites in southwest Tanzania. All household members present were followed up and tested for HIV and circulating filarial antigen, an indicator of W bancrofti adult worm burden. Our main outcome of interest was HIV incidence in participants with or without lymphatic filariasis. Findings Between May 29, 2006, and June 16, 2011, we enrolled 4283 households with roughly 18 000 participants. Of these, 2699 individuals from Kyela district participated in at least one round of the EMINI study. In the 1055 initially HIV-negative adolescents and adults with clearly defined lymphatic filariasis status, 32 new HIV infections were observed in 2626 person-years. HIV incidence in lymphatic filariasis-positive participants (1.91 cases per 100 person-years) was significantly higher than the incidence in lymphatic filariasis-negative participants (0.80 cases per 100 person-years). The age-adjusted and sex-adjusted incidence rate ratio was 2.17 (95% CI 1.08-4.37, p= 0.0300). Lymphatic filariasis status remained an independent and significantly relevant risk factor for HIV infection when controlled for other known risk factors such as sexual behaviour and socioeconomic factors. Interpretation To our knowledge, this is the first prospective study demonstrating a significantly increased risk of acquiring HIV for lymphatic filariasis-infected individuals. Immunological studies and interventional treatment studies that eliminate the adult worms and not only the microfilariae are needed to follow up on the results presented.	[Kroidl, Inge; Saathoff, Elmar; Geldmacher, Christof; Hoelscher, Michael] Univ Munich, Div Infect Dis & Trop Med, Med Ctr, D-80802 Munich, Germany; [Kroidl, Inge; Maganga, Lucas; Clowes, Petra; Maboko, Leonard; Hoelscher, Michael] Mbeya Med Res Ctr, Natl Inst Med Res, Mbeya, Tanzania; [Kroidl, Inge; Saathoff, Elmar; Geldmacher, Christof; Hoelscher, Michael] German Ctr Infect Res, Partner Site Munich, Munich, Germany; [Makunde, Williams H.] Natl Inst Med Res, Tanga, Tanzania; [Hoerauf, Achim] Univ Hosp Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany; [Hoerauf, Achim] German Ctr Infect Res DZIF, Partner Site Bonn Cologne, Bonn, Germany	University of Munich; National Institute of Medical Research; German Center for Infection Research; University of Bonn; German Center for Infection Research	Kroidl, I (corresponding author), Univ Munich, Div Infect Dis & Trop Med, Med Ctr, D-80802 Munich, Germany.	ikroidl@lrz.uni-muenchen.de	Hoelscher, Michael/D-3436-2012		European Union as part of EuropAid; German Federal Ministry of Education and Research; German Center for Infection Research	European Union as part of EuropAid; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Center for Infection Research	European Union as part of EuropAid; German Federal Ministry of Education and Research; German Center for Infection Research.	Arndts K, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001611; Babu S, 2009, J INFECT DIS, V199, P1827, DOI 10.1086/599090; Babu S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000420; BarYehuda S, 1997, AIDS, V11, P117, DOI 10.1097/00002030-199715000-00001; Bentwich Z, 1996, CLIN EXP IMMUNOL, V103, P239, DOI 10.1046/j.1365-2249.1996.d01-612.x; Fauci AS, 1996, ANN INTERN MED, V124, P654, DOI 10.7326/0003-4819-124-7-199604010-00006; Gopinath R, 2000, J INFECT DIS, V182, P1804, DOI 10.1086/317623; Grant A D, 1997, AIDS, V11 Suppl B, pS43; Hoerauf A, 2008, CURR OPIN INFECT DIS, V21, P673, DOI 10.1097/QCO.0b013e328315cde7; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000412; Kalinkovich A, 1999, J HUMAN VIROL, V2, P283; Kjetland EF, 2006, AIDS, V20, P593, DOI 10.1097/01.aids.0000210614.45212.0a; Kroidl I, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004618; Kroidl I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039529; Lawn SD, 2001, CLIN MICROBIOL REV, V14, P753, DOI 10.1128/CMR.14.4.753-777.2001; Mbabazi PS, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001396; Nielsen NO, 2007, T ROY SOC TROP MED H, V101, P602, DOI 10.1016/j.trstmh.2007.02.009; Nielsen NO, 2006, T ROY SOC TROP MED H, V100, P543, DOI 10.1016/j.trstmh.2005.08.016; Shapira-Nahor O, 1998, AIDS, V12, P1731; Simonsen PE, 2004, T ROY SOC TROP MED H, V98, P462, DOI 10.1016/j.trstmh.2003.12.005; Tafatatha T, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003825; Talaat KR, 2008, AM J TROP MED HYG, V79, P558, DOI 10.4269/ajtmh.2008.79.558; Talaat KR, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003622; Tanzania NIMR, 2011, TANZ HIV AIDS MAL IN; Taylor MJ, 2005, LANCET, V365, P2116, DOI 10.1016/S0140-6736(05)66591-9; Thomsen EK, 2016, CLIN INFECT DIS, V62, P334, DOI 10.1093/cid/civ882; VANDEPERRE P, 1995, TRENDS MICROBIOL, V3, P217, DOI 10.1016/S0966-842X(00)88928-3; Weissman D, 1996, J EXP MED, V183, P687, DOI 10.1084/jem.183.2.687	28	28	28	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 15	2016	388	10054					1912	1920		10.1016/S0140-6736(16)31252-1	http://dx.doi.org/10.1016/S0140-6736(16)31252-1			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ0AM	27495354				2022-12-28	WOS:000385499000035
J	Kotzin, JJ; Spencer, SP; McCright, SJ; Kumar, DBU; Collet, MA; Mowel, WK; Elliott, EN; Uyar, A; Makiya, MA; Dunagin, MC; Harman, CCD; Virtue, AT; Zhu, S; Bailis, W; Stein, J; Hughes, C; Raj, A; Wherry, EJ; Goff, LA; Klion, AD; Rinn, JL; Williams, A; Flavell, RA; Henao-Mejia, J				Kotzin, Jonathan J.; Spencer, Sean P.; McCright, Sam J.; Kumar, Dinesh B. Uthaya; Collet, Magalie A.; Mowel, Walter K.; Elliott, Ellen N.; Uyar, Asli; Makiya, Michelle A.; Dunagin, Margaret C.; Harman, Christian C. D.; Virtue, Anthony T.; Zhu, Stella; Bailis, Will; Stein, Judith; Hughes, Cynthia; Raj, Arjun; Wherry, E. John; Goff, Loyal A.; Klion, Amy D.; Rinn, John L.; Williams, Adam; Flavell, Richard A.; Henao-Mejia, Jorge			The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan	NATURE			English	Article							CHROMATIN; MACROPHAGES; HOMEOSTASIS; MONOCYTES; BCL-2; DIFFERENTIATION; VERNALIZATION; EXPRESSION; SURVIVAL; PRC2	Neutrophils, eosinophils and 'classical' monocytes collectively account for about 70% of human blood leukocytes and are among the shortest-lived cells in the body(1,2). Precise regulation of the lifespan of these myeloid cells is critical to maintain protective immune responses and minimize the deleterious consequences of prolonged inflammation(1,2). However, how the lifespan of these cells is strictly controlled remains largely unknown. Here we identify a long non-coding RNA that we termed Morrbid, which tightly controls the survival of neutrophils, eosinophils and classical monocytes in response to pro-survival cytokines in mice. To control the lifespan of these cells, Morrbid regulates the transcription of the neighbouring pro-apoptotic gene, Bcl2l11 (also known as Bim), by promoting the enrichment of the PRC2 complex at the Bcl2l11 promoter to maintain this gene in a poised state. Notably, Morrbid regulates this process in cis, enabling allele-specific control of Bcl2l11 transcription. Thus, in these highly inflammatory cells, changes in Morrbid levels provide a locus-specific regulatory mechanism that allows rapid control of apoptosis in response to extracellular pro-survival signals. As MORRBID is present in humans and dysregulated in individuals with hypereosinophilic syndrome, this long non-coding RNA may represent a potential therapeutic target for inflammatory disorders characterized by aberrant short-lived myeloid cell lifespan.	[Kotzin, Jonathan J.; Spencer, Sean P.; McCright, Sam J.; Mowel, Walter K.; Virtue, Anthony T.; Henao-Mejia, Jorge] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Kotzin, Jonathan J.; Spencer, Sean P.; McCright, Sam J.; Mowel, Walter K.; Virtue, Anthony T.; Wherry, E. John; Henao-Mejia, Jorge] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Kumar, Dinesh B. Uthaya; Collet, Magalie A.; Elliott, Ellen N.; Uyar, Asli; Zhu, Stella; Williams, Adam] Jackson Lab Genom Med, Farmington, CT 06032 USA; [Kumar, Dinesh B. Uthaya; Williams, Adam] Univ Connecticut, Ctr Hlth, Dept Genet & Genom Sci, Farmington, CT 06032 USA; [Makiya, Michelle A.; Klion, Amy D.] NIAID, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Dunagin, Margaret C.; Raj, Arjun] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Harman, Christian C. D.; Bailis, Will; Stein, Judith; Hughes, Cynthia; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA; [Harman, Christian C. D.; Stein, Judith; Hughes, Cynthia; Flavell, Richard A.] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Wherry, E. John] Univ Penn, Perelman Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Goff, Loyal A.] Johns Hopkins Univ, McKusick Nathans Inst Genet Med, Baltimore, MD 21205 USA; [Goff, Loyal A.] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD 21205 USA; [Rinn, John L.] Harvard Med Sch, Biol & Biomed Sci, Boston, MA 02115 USA; [Rinn, John L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Henao-Mejia, Jorge] Childrens Hosp Philadelphia, Div Transplant Immunol, Philadelphia, PA 19104 USA; [Spencer, Sean P.] Massachusetts Gen Hosp, Dept Med, 55 Fruit St, Boston, MA 02114 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Jackson Laboratory; University of Connecticut; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; Yale University; Howard Hughes Medical Institute; Yale University; University of Pennsylvania; Pennsylvania Medicine; Johns Hopkins University; Johns Hopkins University; Harvard University; Harvard Medical School; Harvard University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Harvard University; Massachusetts General Hospital	Henao-Mejia, J (corresponding author), Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.; Henao-Mejia, J (corresponding author), Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA.; Williams, A (corresponding author), Jackson Lab Genom Med, Farmington, CT 06032 USA.; Williams, A (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Genom Sci, Farmington, CT 06032 USA.; Flavell, RA (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.; Flavell, RA (corresponding author), Yale Univ, Howard Hughes Med Inst, New Haven, CT 06510 USA.; Henao-Mejia, J (corresponding author), Childrens Hosp Philadelphia, Div Transplant Immunol, Philadelphia, PA 19104 USA.	adam.williams@jax.org; richard.flavell@yale.edu; jhena@mail.med.upenn.edu	Wherry, John/ABI-1280-2020; Zhu, Shu/P-6163-2018	Zhu, Shu/0000-0002-8163-0869; Mowel, Walter/0000-0003-2393-4300; Raj, Arjun/0000-0002-2915-6960; McCright, Sam/0000-0002-4295-9290; Uthaya Kumar, Dinesh Babu/0000-0001-7210-5811; Goff, Loyal/0000-0003-2875-451X; Spencer, Sean/0000-0002-7328-5399; Makiya, Michelle/0000-0002-5673-3815	Children's Hospital of Philadelphia; IFI; IDOM; COE at the University of Pennsylvania; NIH NIAID [1R21AI110776-01]; Howard Hughes Medical Institute; NIH NIDDK [T32-DK00778017]; NIH NRSA [F30-DK094708]; NSF [1350601]; Division of Intramural Research, NIAID, NIH;  [T32-AI05542803];  [1DP2OD008514];  [1R33EB019767]; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055428, R21AI110776, F31AI124538, ZIAAI001130] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R33EB019767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007780, F30DK094708] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008514] Funding Source: NIH RePORTER	Children's Hospital of Philadelphia; IFI; IDOM; COE at the University of Pennsylvania; NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Division of Intramural Research, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank several of our colleagues for critically reading our manuscript and their suggestions. J.H.-M. was supported by the Children's Hospital of Philadelphia, the IFI and IDOM pilot projects, and the COE at the University of Pennsylvania (J.H.-M.); A.W. and R.A.F. by NIH NIAID 1R21AI110776-01; C.C.D.H. and R.A.F by Howard Hughes Medical Institute; J.J.K. by NIH NIDDK T32-DK00778017; S.P.S. by NIH NRSA F30-DK094708; W.K.M. by T32-AI05542803; A.R. and M.C.D. by New Innovator 1DP2OD008514, 1R33EB019767, NSF CAREER 1350601. This work was funded in part by the Division of Intramural Research, NIAID, NIH (M.A.M. and A.D.K.)	Bouffi C, 2015, J IMMUNOL, V195, P2683, DOI 10.4049/jimmunol.1500510; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Csorba T, 2014, P NATL ACAD SCI USA, V111, P16160, DOI 10.1073/pnas.1419030111; Dyer KD, 2008, J IMMUNOL, V181, P4004, DOI 10.4049/jimmunol.181.6.4004; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Henao-Mejia J., 2016, COLD SPRING HARB PRO; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Luo M, 2015, CELL STEM CELL, V16, P426, DOI 10.1016/j.stem.2015.02.002; Maass PG, 2012, J CLIN INVEST, V122, P3990, DOI 10.1172/JCI65508; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Paschos K, 2012, NUCLEIC ACIDS RES, V40, P7233, DOI 10.1093/nar/gks391; Ranzani V, 2015, NAT IMMUNOL, V16, P318, DOI 10.1038/ni.3093; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sarma K, 2014, CELL, V159, P869, DOI 10.1016/j.cell.2014.10.019; Shinjyo T, 2001, MOL CELL BIOL, V21, P854, DOI 10.1128/MCB.21.3.854-864.2001; Simon HU, 2010, J ALLERGY CLIN IMMUN, V126, P45, DOI 10.1016/j.jaci.2010.03.042; Villunger A, 2003, BLOOD, V101, P2393, DOI 10.1182/blood-2002-07-2132; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang LJ, 2015, CELL RES, V25, P335, DOI 10.1038/cr.2015.21; Xing Z, 2014, CELL, V159, P1110, DOI 10.1016/j.cell.2014.10.013; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhang H, 2014, J CELL BIOL, V204, P61, DOI 10.1083/jcb.201304152; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	26	170	177	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 8	2016	537	7619					239	+		10.1038/nature19346	http://dx.doi.org/10.1038/nature19346			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9LQ	27525555	Green Accepted			2022-12-28	WOS:000382539100049
J	Snowden, KC; Janssen, BJ				Snowden, Kimberley C.; Janssen, Bart J.			STRUCTURAL BIOLOGY Signal locked in	NATURE			English	Editorial Material							STRIGOLACTONE; DWARF14; PERCEPTION; RECEPTOR; HORMONE		[Snowden, Kimberley C.; Janssen, Bart J.] New Zealand Inst Plant & Food Res, Breeding & Genom Grp, Auckland 1025, New Zealand	New Zealand Institute for Plant & Food Research Ltd	Snowden, KC (corresponding author), New Zealand Inst Plant & Food Res, Breeding & Genom Grp, Auckland 1025, New Zealand.	kimberley.snowden@plantandfood.co.nz; bart.janssen@plantandfood.co.nz	Snowden, Kimberley C/J-8270-2012; Janssen, Bart J/J-4880-2014	Snowden, Kimberley C/0000-0001-9640-4015; Janssen, Bart J/0000-0002-5871-2831				Al-Babili S, 2015, ANNU REV PLANT BIOL, V66, P161, DOI 10.1146/annurev-arplant-043014-114759; Chevalier F, 2014, PLANT CELL, V26, P1134, DOI 10.1105/tpc.114.122903; de Saint Germain A., 2016, NATURE CHEM BIOL; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Kagiyama M, 2013, GENES CELLS, V18, P147, DOI 10.1111/gtc.12025; Khosla A, 2016, CURR OPIN PLANT BIOL, V33, P57, DOI 10.1016/j.pbi.2016.06.001; Nakamura H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3613; Ueguchi-Tanaka M, 2005, NATURE, V437, P693, DOI 10.1038/nature04028; Yao RF, 2016, NATURE, V536, P469, DOI 10.1038/nature19073; Zhao LH, 2015, CELL RES, V25, P1219, DOI 10.1038/cr.2015.122; Zhao LH, 2013, CELL RES, V23, P436, DOI 10.1038/cr.2013.19	12	12	13	2	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 25	2016	536	7617					402	404		10.1038/nature19418	http://dx.doi.org/10.1038/nature19418			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV0YL	27479322				2022-12-28	WOS:000382646600028
J	Gnann, JW; Whitley, RJ				Gnann, John W., Jr.; Whitley, Richard J.			Genital Herpes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SIMPLEX-VIRUS TYPE-2; RANDOMIZED CLINICAL-TRIAL; FOCUS ELISA TESTS; UNITED-STATES; DOUBLE-BLIND; ORAL ACYCLOVIR; IMMUNOSORBENT ASSAYS; HSV-2 ANTIBODIES; CONDOM USE; INFECTION	A 25-year-old woman visits her physician and reports three brief episodes of small, tender, labial ulcerations over the past year. The physical examination is unremarkable. Type-specific herpes simplex virus ( HSV) serologic tests are positive for HSV type 1 ( HSV-1) and type 2 ( HSV-2). The patient is distressed to learn that she has genital herpes, particularly since she has been contemplating pregnancy. Her husband of 2 years reports no history of HSV infection; subsequent testing reveals that he is seropositive for HSV-1 and seronegative for HSV-2. How would you advise this couple?	[Gnann, John W., Jr.] Med Univ South Carolina, Dept Med, Div Infect Dis, 135 Rutledge Ave,MSC 752, Charleston, SC 29425 USA; [Whitley, Richard J.] Univ Alabama Birmingham, Dept Pediat, Div Infect Dis, Birmingham, AL USA	Medical University of South Carolina; University of Alabama System; University of Alabama Birmingham	Gnann, JW (corresponding author), Med Univ South Carolina, Dept Med, Div Infect Dis, 135 Rutledge Ave,MSC 752, Charleston, SC 29425 USA.	gnann@musc.edu			Watermark Research Partners; GlaxoSmithKline; BioCryst; Merck	Watermark Research Partners; GlaxoSmithKline(GlaxoSmithKline); BioCryst; Merck(Merck & Company)	Dr. Gnann reports receiving fees for serving on data and safety monitoring boards from Watermark Research Partners (a contract research organization paid by GlaxoSmithKline) and BioCryst, and fees for serving on a clinical adjudication committee from Merck; and Dr. Whitley, serving on advisory boards and receiving compensation, travel support, and stock options for his role on the board of directors from Gilead Sciences and receiving fees for serving on data and safety monitoring committees from GlaxoSmithKline and Merck. No other potential conflict of interest relevant to this article was reported.	Abu-Raddad LJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002230; ACOG Committee on Practice Bulletins, 2007, Obstet Gynecol, V109, P1489; Ashley-Morrow R, 2004, CLIN MICROBIOL INFEC, V10, P530, DOI 10.1111/j.1469-0691.2004.00836.x; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Bernstein DI, 2013, CLIN INFECT DIS, V56, P344, DOI 10.1093/cid/cis891; Bradley H, 2014, J INFECT DIS, V209, P325, DOI 10.1093/infdis/jit458; Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203; BRYSON YJ, 1983, NEW ENGL J MED, V308, P916, DOI 10.1056/NEJM198304213081602; Corey L, 2004, NEW ENGL J MED, V350, P11, DOI 10.1056/NEJMoa035144; Delaney S, 2012, J INFECT DIS, V206, P486, DOI 10.1093/infdis/jis403; Dhankani V, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003922; Diaz-Mitoma F, 1998, JAMA-J AM MED ASSOC, V280, P887, DOI 10.1001/jama.280.10.887; DOUGLAS JM, 1984, NEW ENGL J MED, V310, P1551, DOI 10.1056/NEJM198406143102402; Engelberg R, 2003, SEX TRANSM DIS, V30, P174, DOI 10.1097/00007435-200302000-00015; Fanfair RN, 2013, SEX TRANSM DIS, V40, P860, DOI 10.1097/OLQ.0000000000000043; Fife KH, 2007, SEX TRANSM DIS, V34, P297, DOI 10.1097/01.olq.0000237853.69443.71; Fife KH, 1997, SEX TRANSM DIS, V24, P481, DOI 10.1097/00007435-199709000-00007; Geretti AM, 2006, SEX TRANSM INFECT, V82, P31, DOI 10.1136/sti.2006.023200; Gupta R, 2004, J INFECT DIS, V190, P1374, DOI 10.1086/424519; James SH, 2015, CLIN PERINATOL, V42, P47, DOI 10.1016/j.clp.2014.10.005; Johnston C, 2014, VACCINE, V32, P1553, DOI 10.1016/j.vaccine.2013.08.066; Leone P, 2004, SEX TRANSM DIS, V31, P311, DOI 10.1097/01.OLQ.0000123651.84697.D6; Magaret AS, 2016, CLIN INFECT DIS, V62, P456, DOI 10.1093/cid/civ908; Mark HD, 2007, SEX TRANSM DIS, V34, P681, DOI 10.1097/01.olq.0000258307.18831.f0; Mark HD, 2013, JAMA PEDIATR, V167, P691, DOI 10.1001/jamapediatrics.2013.462; Martin ET, 2009, ARCH INTERN MED, V169, P1233, DOI 10.1001/archinternmed.2009.177; Money D, 2009, INT J GYNECOL OBSTET, V104, P167, DOI 10.1016/j.ijgo.2008.10.028; Money D, 2009, INT J GYNECOL OBSTET, V104, P162, DOI 10.1016/j.ijgo.2008.10.027; Morrow RA, 2003, J CLIN MICROBIOL, V41, P5212, DOI 10.1128/JCM.41.11.5212-5214.2003; Okafor N, 2015, INT J STD AIDS, V26, P740, DOI 10.1177/0956462414552814; Patel R, 2011, INT J STD AIDS, V22, P1, DOI 10.1258/ijsa.2010.010278; Ramaswamy M, 2004, SEX TRANSM INFECT, V80, P406, DOI 10.1136/sti.2003.008201; REICHMAN RC, 1984, JAMA-J AM MED ASSOC, V251, P2103, DOI 10.1001/jama.251.16.2103; Ross K, 2011, SEX TRANSM INFECT, V87, P594, DOI 10.1136/sextrans-2011-050099; Ryder N, 2009, SEX TRANSM INFECT, V85, P416, DOI 10.1136/sti.2008.033902; Sacks SL, 1996, JAMA-J AM MED ASSOC, V276, P44, DOI 10.1001/jama.276.1.44; Schiffer JT, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0160; Schulte JM, 2014, SOUTH MED J, V107, P79, DOI 10.1097/SMJ.0000000000000062; Sheffield JS, 2006, OBSTET GYNECOL, V108, P141, DOI 10.1097/01.AOG.0000219749.96274.15; Stanberry LR, 2004, CLIN INFECT DIS, V39, P1433, DOI 10.1086/425307; Stone KM, 2004, BIRTH DEFECTS RES A, V70, P201, DOI 10.1002/bdra.20013; Summerton J, 2007, CLIN VACCINE IMMUNOL, V14, P1545, DOI 10.1128/CVI.00120-07; Tronstein E, 2011, JAMA-J AM MED ASSOC, V305, P1441, DOI 10.1001/jama.2011.420; Tyring SK, 1998, ARCH DERMATOL, V134, P185, DOI 10.1001/archderm.134.2.185; Wald A, 2006, J INFECT DIS, V194, P42, DOI 10.1086/504717; Wald A, 2005, ANN INTERN MED, V143, P707, DOI 10.7326/0003-4819-143-10-200511150-00007; Wald A, 2006, SEX TRANSM DIS, V33, P529, DOI 10.1097/01.olq.0000204723.15765.91; Wald A, 2013, JAMA PEDIATR, V167, P689, DOI 10.1001/jamapediatrics.2013.459; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1; Xu FJ, 2007, J PEDIATR-US, V151, P374, DOI 10.1016/j.jpeds.2007.04.065	50	37	38	1	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2016	375	7					666	674		10.1056/NEJMcp1603178	http://dx.doi.org/10.1056/NEJMcp1603178			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4VF	27532832				2022-12-28	WOS:000381478600008
J	Gulland, A				Gulland, Anne			BRIEFING NHS sustainability and transformation plans: proposals for savings lack scrutiny	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												agulland@bmj.com						Leys C, 2016, CAN S STEVENS SUSTAI; McKenna H, 2016, WHAT PLANNING GUIDAN; NHS England, 2015, DEL FORW VIEW NHS PL; NHS North West London Collaboration of Clinical Commissioning Groups, 2016, NW LOND SUST TRANSF	4	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 17	2016	354								i4449	10.1136/bmj.i4449	http://dx.doi.org/10.1136/bmj.i4449			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GZ	27535083				2022-12-28	WOS:000381806400006
J	Evrony, GD				Evrony, Gilad D.			A Wild Rotation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CANCER; DISEASE; HUMANS; DAMAGE; VIRUS; HEART		[Evrony, Gilad D.] Harvard Med Sch, Boston, MA 02115 USA; [Evrony, Gilad D.] Mt Sinai Hosp, New York, NY 10029 USA	Harvard University; Harvard Medical School; Icahn School of Medicine at Mount Sinai	Evrony, GD (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Evrony, GD (corresponding author), Mt Sinai Hosp, New York, NY 10029 USA.	g.evrony@gmail.com		Evrony, Gilad/0000-0001-7621-2630	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NIGMS NIH HHS [T32GM007753, T32 GM007753] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abegglen LM, 2015, JAMA-J AM MED ASSOC, V314, P1850, DOI 10.1001/jama.2015.13134; Davis BW, 2014, ILAR J, V55, P59, DOI 10.1093/ilar/ilu017; RACE GJ, 1959, CIRCULATION, V19, P928, DOI 10.1161/01.CIR.19.6.928; Stenvinkel P, 2013, KIDNEY INT, V83, P207, DOI 10.1038/ki.2012.396; SUMMERS J, 1978, P NATL ACAD SCI USA, V75, P4533, DOI 10.1073/pnas.75.9.4533; Susic D, 2011, CARDIORENAL MED, V1, P139, DOI 10.1159/000329334; Varki N, 2009, EVOL APPL, V2, P101, DOI 10.1111/j.1752-4571.2008.00064.x; Weiss RA, 2011, J EXP MED, V208, P2351, DOI 10.1084/jem.20112160; Wood JD, 1998, DIGEST DIS SCI, V43, P1443, DOI 10.1023/A:1018842210330	9	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2016	316	7					713	714		10.1001/jama.2016.4994	http://dx.doi.org/10.1001/jama.2016.4994			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT5IA	27533153	Green Accepted			2022-12-28	WOS:000381514800014
J	Mitchell, SL; Mor, V; Gozalo, PL; Servadio, JL; Teno, JM				Mitchell, Susan L.; Mor, Vincent; Gozalo, Pedro L.; Servadio, Joseph L.; Teno, Joan M.			Tube Feeding in US Nursing Home Residents With Advanced Dementia, 2000-2014	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Mitchell, Susan L.] Harvard Med Sch, Hebrew SeniorLife Inst Aging Res, Boston, MA USA; [Mor, Vincent; Gozalo, Pedro L.; Servadio, Joseph L.] Brown Univ, Ctr Gerontol & Hlth Care Res, Providence, RI 02912 USA; [Teno, Joan M.] Univ Washington, Cambia Palliat Care Ctr Excellence, Seattle, WA 98195 USA	Harvard University; Harvard Medical School; Hebrew SeniorLife; Brown University; University of Washington; University of Washington Seattle	Mitchell, SL (corresponding author), Hebrew SeniorLife Inst Aging Res, 1200 Ctr St, Boston, MA 02131 USA.	smitchell@hsl.harvard.edu		Servadio, Joseph/0000-0002-9988-5712	NATIONAL INSTITUTE ON AGING [K24AG033640, P01AG027296] Funding Source: NIH RePORTER; NIA NIH HHS [P01 AG027296, K24AG033640, K24 AG033640, P01AG02729] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Cegelka A, 2014, J AM GERIATR SOC, V62, P1590, DOI 10.1111/jgs.12924; Mitchell SL, 2003, JAMA-J AM MED ASSOC, V290, P73, DOI 10.1001/jama.290.1.73; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Sampson EL, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007209.pub2; Teno JM, 2012, J AM GERIATR SOC, V60, P1918, DOI 10.1111/j.1532-5415.2012.04148.x; Thomas KS, 2014, J AGING HEALTH, V26, P250, DOI 10.1177/0898264313513611	6	75	76	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2016	316	7					769	770		10.1001/jama.2016.9374	http://dx.doi.org/10.1001/jama.2016.9374			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT5IA	27533163	Bronze, Green Accepted			2022-12-28	WOS:000381514800024
J	Chatterjee, M				Chatterjee, Mausumi			Samir Kumar Chatterjee OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item																			0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 12	2016	354								i4395	10.1136/bmj.i4395	http://dx.doi.org/10.1136/bmj.i4395			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4UY	27519424				2022-12-28	WOS:000381477800003
J	Chen, ZJ; Shi, YH; Sun, Y; Zhang, B; Liang, XY; Cao, YX; Yang, J; Liu, JY; Wei, DM; Weng, N; Tian, LF; Hao, CF; Yang, DZ; Zhou, F; Shi, JZ; Xu, YL; Li, J; Yan, JH; Qin, YY; Zhao, H; Zhang, HP; Legro, RS				Chen, Zi-Jiang; Shi, Yuhua; Sun, Yun; Zhang, Bo; Liang, Xiaoyan; Cao, Yunxia; Yang, Jing; Liu, Jiayin; Wei, Daimin; Weng, Ning; Tian, Lifeng; Hao, Cuifang; Yang, Dongzi; Zhou, Feng; Shi, Juanzi; Xu, Yongle; Li, Jing; Yan, Junhao; Qin, Yingying; Zhao, Han; Zhang, Heping; Legro, Richard S.			Fresh versus Frozen Embryos for Infertility in the Polycystic Ovary Syndrome	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-VITRO FERTILIZATION; ASSISTED REPRODUCTIVE TECHNOLOGY; IMPAIRED ENDOMETRIAL RECEPTIVITY; TRIAL COMPARING FRESH; PERINATAL OUTCOMES; CHILDREN BORN; IVF; HYPERSTIMULATION; STIMULATION; SINGLETONS	BACKGROUND The transfer of fresh embryos is generally preferred over the transfer of frozen embryos for in vitro fertilization (IVF), but some evidence suggests that frozen-embryo transfer may improve the live-birth rate and lower the rates of the ovarian hyperstimulation syndrome and pregnancy complications in women with the polycystic ovary syndrome. METHODS In this multicenter trial, we randomly assigned 1508 infertile women with the polycystic ovary syndrome who were undergoing their first IVF cycle to undergo either fresh-embryo transfer or embryo cryopreservation followed by frozen-embryo transfer. After 3 days of embryo development, women underwent the transfer of up to two fresh or frozen embryos. The primary outcome was a live birth after the first embryo transfer. RESULTS Frozen-embryo transfer resulted in a higher frequency of live birth after the first transfer than did fresh-embryo transfer (49.3% vs. 42.0%), for a rate ratio of 1.17 (95% confidence interval [CI], 1.05 to 1.31; P = 0.004). Women who underwent frozen-embryo transfer also had a lower frequency of pregnancy loss (22.0% vs. 32.7%), for a rate ratio of 0.67 (95% CI, 0.54 to 0.83; P < 0.001), and of the ovarian hyperstimulation syndrome (1.3% vs. 7.1%), for a rate ratio of 0.19 (95% CI, 0.10 to 0.37; P < 0.001), but a higher frequency of preeclampsia (4.4% vs. 1.4%), for a rate ratio of 3.12 (95% CI, 1.26 to 7.73; P = 0.009). There were no significant between-group differences in rates of other pregnancy and neonatal complications. There were five neonatal deaths in the frozen-embryo group and none in the freshembryo group (P = 0.06). CONCLUSIONS Among infertile women with the polycystic ovary syndrome, frozen-embryo transfer was associated with a higher rate of live birth, a lower risk of the ovarian hyperstimulation syndrome, and a higher risk of preeclampsia after the first transfer than was fresh-embryo transfer. (Funded by the National Basic Research Program of China and others; ClinicalTrials.gov number, NCT01841528.)	[Chen, Zi-Jiang; Shi, Yuhua; Wei, Daimin; Li, Jing; Yan, Junhao; Qin, Yingying; Zhao, Han] Shandong Univ, Shandong Prov Hosp, Key Lab Reprod Endocrinol, Ctr Reprod Med,Minist Educ, Jinan, Peoples R China; [Chen, Zi-Jiang; Shi, Yuhua; Wei, Daimin; Li, Jing; Yan, Junhao; Qin, Yingying; Zhao, Han] Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan, Peoples R China; [Chen, Zi-Jiang; Sun, Yun] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Ctr Reprod Med, Shanghai, Peoples R China; [Chen, Zi-Jiang; Sun, Yun] Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai, Peoples R China; [Zhang, Bo] Maternal & Child Hlth Hosp Guangxi, Ctr Reprod Med, Guangxi, Peoples R China; [Liang, Xiaoyan] Sun Yat Sen Univ, Affiliated Hosp 6, Reprod Med Ctr, Guangzhou, Guangdong, Peoples R China; [Yang, Dongzi] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Ctr Reprod Med, Guangzhou, Guangdong, Peoples R China; [Cao, Yunxia] Anhui Med Univ, Affiliated Hosp 1, Ctr Reprod Med, Hefei, Peoples R China; [Yang, Jing] Wuhan Univ, Ctr Reprod Med, Wuhan, Peoples R China; [Liu, Jiayin] Nanjing Med Univ, Affiliated Hosp 1, Dept Obstet & Gynecol, Nanjing, Jiangsu, Peoples R China; [Weng, Ning] Jinghua Hosp, Reprod Med Ctr, Shenyang, Peoples R China; [Tian, Lifeng] Jiangxi Prov Maternal & Child Hlth Hosp, Ctr Reprod Med, Nanchang, Peoples R China; [Hao, Cuifang] Yantai Yuhuangding Hosp, Ctr Reprod Med, Yantai, Peoples R China; [Zhou, Feng] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Ctr Reprod Med,Dept Obstet & Gynecol, Hangzhou, Zhejiang, Peoples R China; [Shi, Juanzi] Maternal & Child Hlth Care Hosp Shanxi Prov, Assisted Reprod Ctr, Xian, Peoples R China; [Xu, Yongle] Suzhou Municipal Hosp, Ctr Reprod & Genet, Suzhou, Peoples R China; [Zhang, Heping] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Legro, Richard S.] Penn State Coll Med, Dept Obstet & Gynecol, Hershey, PA USA	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shanghai Jiao Tong University; Sun Yat Sen University; Sun Yat Sen University; Anhui Medical University; Wuhan University; Nanjing Medical University; Zhejiang University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Chen, ZJ (corresponding author), Shandong Univ, Shandong Prov Hosp, Ctr Reprod Med, 324 Jingwu Rd, Jinan 250021, Peoples R China.	chenzijiang@hotmail.com	Li, Yuan/GXV-1310-2022; Yan, Junhao/AAH-8310-2019; Zhang, He/GXN-0028-2022; liang, xiaoyan/GYJ-5006-2022; Chen, Zi-Jiang/GOE-6119-2022	Chen, Zi-Jiang/0000-0001-6637-6631; Legro, Richard/0000-0001-9927-7584; Shi, Juanzi/0000-0002-9040-7829; Tian, Lifeng/0000-0002-7135-2172	National Basic Research Program of China	National Basic Research Program of China(National Basic Research Program of China)	Funded by the National Basic Research Program of China and others; ClinicalTrials.gov number, NCT01841528.	Abdalla HI, 2010, HUM REPROD, V25, P9, DOI 10.1093/humrep/dep357; Amer Soc Reprod Med, 2013, FERTIL STERIL, V99, P44, DOI 10.1016/j.fertnstert.2012.09.038; Balen AH, 2003, HUM REPROD UPDATE, V9, P505, DOI 10.1093/humupd/dmg044; Bourgain C, 2003, HUM REPROD UPDATE, V9, P515, DOI 10.1093/humupd/dmg045; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chen ZJ, 2012, ZHONGHUA FU CHAN KE, V47, P74, DOI DOI 10.3760/CMA.J.ISSN.0529-567X.2012.01.022; Choux C, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0120-2; Davies MJ, 2012, NEW ENGL J MED, V366, P1803, DOI 10.1056/NEJMoa1008095; Delvigne A, 2002, HUM REPROD UPDATE, V8, P559, DOI 10.1093/humupd/8.6.559; Devroey P, 2004, TRENDS ENDOCRIN MET, V15, P84, DOI 10.1016/j.tem.2004.01.009; Golan A, 1989, Obstet Gynecol Surv, V44, P430, DOI 10.1097/00006254-198906000-00004; HANING RV, 1983, FERTIL STERIL, V40, P31; Hansen M, 2002, NEW ENGL J MED, V346, P725, DOI 10.1056/NEJMoa010035; HATCH R, 1981, AM J OBSTET GYNECOL, V140, P815, DOI 10.1016/0002-9378(81)90746-8; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; Horcajadas JA, 2005, MOL HUM REPROD, V11, P195, DOI 10.1093/molehr/gah150; Ishihara O, 2014, FERTIL STERIL, V101, P128, DOI 10.1016/j.fertnstert.2013.09.025; Jackson RA, 2004, OBSTET GYNECOL, V103, P551, DOI 10.1097/01.AOG.0000114989.84822.51; Kalra SK, 2011, FERTIL STERIL, V95, P548, DOI 10.1016/j.fertnstert.2010.05.049; Kawwass JF, 2015, JAMA-J AM MED ASSOC, V313, P88, DOI 10.1001/jama.2014.14488; Kissin DM, 2014, NEW ENGL J MED, V371, P91, DOI 10.1056/NEJMc1404371; Legro RS, 2007, NEW ENGL J MED, V356, P551, DOI 10.1056/NEJMoa063971; Legro RS, 2014, HUM REPROD, V29, P2075, DOI 10.1093/humrep/deu218; Legro RS, 2014, NEW ENGL J MED, V371, P119, DOI 10.1056/NEJMoa1313517; Maheshwari A, 2013, HUM REPROD, V28, P6, DOI 10.1093/humrep/des386; Maheshwari A, 2012, FERTIL STERIL, V98, P368, DOI 10.1016/j.fertnstert.2012.05.019; Opdahl S, 2015, HUM REPROD, V30, P1724, DOI 10.1093/humrep/dev090; Pandey S, 2012, HUM REPROD UPDATE, V18, P485, DOI 10.1093/humupd/dms018; Pinborg A, 2010, FERTIL STERIL, V94, P1320, DOI 10.1016/j.fertnstert.2009.05.091; PUISSANT F, 1987, HUM REPROD, V2, P705, DOI 10.1093/oxfordjournals.humrep.a136618; Sazonova A, 2012, HUM REPROD, V27, P1343, DOI 10.1093/humrep/des036; Shapiro BS, 2011, FERTIL STERIL, V96, P516, DOI 10.1016/j.fertnstert.2011.02.059; Shapiro BS, 2011, FERTIL STERIL, V96, P344, DOI 10.1016/j.fertnstert.2011.05.050; Shi YH, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-154; Tang T, 2006, HUM REPROD, V21, P80, DOI 10.1093/humrep/dei311; Wang JX, 2004, HUM REPROD, V19, P272, DOI 10.1093/humrep/deh078; Wennerholm UB, 2009, HUM REPROD, V24, P2158, DOI 10.1093/humrep/dep125; Wennerholm UB, 2013, HUM REPROD, V28, P2545, DOI 10.1093/humrep/det272	38	395	442	9	123	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2016	375	6					523	533		10.1056/NEJMoa1513873	http://dx.doi.org/10.1056/NEJMoa1513873			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU4OT	27509101	Bronze			2022-12-28	WOS:000382193100005
J	Kyu, HH; Bachman, VF; Alexander, LT; Mumford, JE; Afshin, A; Estep, K; Veerman, JL; Delwiche, K; Iannarone, ML; Moyer, ML; Cercy, K; Vos, T; Murray, CJL; Forouzanfar, MH				Kyu, Hmwe H.; Bachman, Victoria F.; Alexander, Lily T.; Mumford, John Everett; Afshin, Ashkan; Estep, Kara; Veerman, J. Lennert; Delwiche, Kristen; Iannarone, Marissa L.; Moyer, Madeline L.; Cercy, Kelly; Vos, Theo; Murray, Christopher J. L.; Forouzanfar, Mohammad H.			Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BIAS	OBJECTIVE To quantify the dose-response associations between total physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events. DESIGN Systematic review and Bayesian dose-response meta-analysis. DATA SOURCES PubMed and Embase from 1980 to 27 February 2016, and references from relevant systematic reviews. Data from the Study on Global AGEing and Adult Health conducted in China, Ghana, India, Mexico, Russia, and South Africa from 2007 to 2010 and the US National Health and Nutrition Examination Surveys from 1999 to 2011 were used to map domain specific physical activity (reported in included studies) to total activity. ELIGIBILITY CRITERIA FOR SELECTING STUDIES Prospective cohort studies examining the associations between physical activity (any domain) and at least one of the five diseases studied. RESULTS 174 articles were identified: 35 for breast cancer, 19 for colon cancer, 55 for diabetes, 43 for ischemic heart disease, and 26 for ischemic stroke (some articles included multiple outcomes). Although higher levels of total physical activity were significantly associated with lower risk for all outcomes, major gains occurred at lower levels of activity (up to 3000-4000 metabolic equivalent (MET) minutes/week). For example, individuals with a total activity level of 600 MET minutes/week (the minimum recommended level) had a 2% lower risk of diabetes compared with those reporting no physical activity. An increase from 600 to 3600 MET minutes/week reduced the risk by an additional 19%. The same amount of increase yielded much smaller returns at higher levels of activity: an increase of total activity from 9000 to 12 000 MET minutes/week reduced the risk of diabetes by only 0.6%. Compared with insufficiently active individuals (total activity < 600 MET minutes/week), the risk reduction for those in the highly active category (>= 8000 MET minutes/week) was 14% (relative risk 0.863, 95% uncertainty interval 0.829 to 0.900) for breast cancer; 21% (0.789, 0.735 to 0.850) for colon cancer; 28% (0.722, 0.678 to 0.768) for diabetes; 25% (0.754, 0.704 to 0.809) for ischemic heart disease; and 26% (0.736, 0.659 to 0.811) for ischemic stroke. CONCLUSIONS People who achieve total physical activity levels several times higher than the current recommended minimum level have a significant reduction in the risk of the five diseases studied. More studies with detailed quantification of total physical activity will help to find more precise relative risk estimates for different levels of activity.	[Kyu, Hmwe H.; Alexander, Lily T.; Mumford, John Everett; Afshin, Ashkan; Estep, Kara; Iannarone, Marissa L.; Moyer, Madeline L.; Cercy, Kelly; Vos, Theo; Murray, Christopher J. L.; Forouzanfar, Mohammad H.] Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA; [Bachman, Victoria F.] Univ Washington, Sch Med, Seattle, WA 98105 USA; [Veerman, J. Lennert] Univ Queensland, Sch Publ Hlth, Fac Med & Biomed Sci, Herston, Qld 4006, Australia; [Delwiche, Kristen] Dartmouth Coll, Geisel Sch Med, Hanover, NH 03755 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Queensland; Dartmouth College	Forouzanfar, MH (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.	forouzan@uw.edu	Veerman, Lennert/A-9973-2011	Veerman, Lennert/0000-0002-3206-8232	Bill and Melinda Gates Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was funded by the Bill and Melinda Gates Foundation. The funder of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report.	Aune D, 2015, EUR J EPIDEMIOL, V30, P529, DOI 10.1007/s10654-015-0056-z; Bramer WM, 2016, SYST REV, V5, DOI 10.1186/s13643-016-0215-7; Bull FC, 2004, COMPARATIVE QUANTIFI, P847; Csizmadi I, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-110; Department of Health (South Africa), SOUTH AFRICA WHO STU; Dong Linda, 2004, Int J Behav Nutr Phys Act, V1, P4, DOI 10.1186/1479-5868-1-4; Duval S, 2000, J AM STAT ASSOC, V95, P89, DOI 10.2307/2669529; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Forouzanfar MH, 2015, LANCET, V386, P2287, DOI 10.1016/S0140-6736(15)00128-2; Ghana Health Service Ministry of Health (Ghana) University of Ghana World Health Organization (WHO), GHANA WHO STUDY ON G; Global Burden of Disease Study 2013 Collaborators, 2015, LANCET, V386, P743, DOI [10.1016/S0140-6736(15)60692-4, DOI 10.1016/S0140-6736(15)60692-4]; International Institute for Population Sciences (India) World Health Organization (WHO), 2007, INDIA WHO STUDY ON G; JETTE M, 1990, CLIN CARDIOL, V13, P555, DOI 10.1002/clc.4960130809; Katzmarzyk PT, 2007, APPL PHYSIOL NUTR ME, V32, pS185, DOI 10.1139/H07-113; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu L, 2015, BRIT J SPORT MED, V50, P372; MEDLINE, HOW ARE THEY DIFFERE; Ministry of Health (China) National Center for Chronic and Noncommunicable Disease Control and Prevention (China) World Health Organization (WHO), CHINA WHO STUDY ON G; Moher D, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000097, 10.1136/bmj.b4037]; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; National Center for Health Statistics (NCHS) Centers for Disease Control and Prevention (CDC), 2005, UNITED STATES NATION; National Center for Health Statistics (NCHS) Centers for Disease Control and Prevention (CDC), 2013, UNITED STATES NATION; National Center for Health Statistics (NCHS) Centers for Disease Control and Prevention (CDC), 2007, UNITED STATES NATION; National Center for Health Statistics (NCHS) Centers for Disease Control and Prevention (CDC), UNITED STATES NATION; National Center for Health Statistics (NCHS) Centers for Disease Control and Prevention (CDC), 2011, UNITED STATES NATION; National Center for Health Statistics (NCHS) Centers for Disease Control and Prevention (CDC), 2009, UNITED STATES NATION; National Institute of Public Health (Mexico) World Health Organization (WHO), 2011, MEXICO WHO STUDY ON; Russian Academy of Medical Science World Health Organization (WHO), RUSSIA WHO STUDY ON; Sattelmair J, 2011, CIRCULATION, V124, P789, DOI 10.1161/CIRCULATIONAHA.110.010710; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tremblay MS, 2007, APPL PHYSIOL NUTR ME, V32, pS208, DOI 10.1139/H07-130; Wells GA, 2011, THE NEWCASTLE OTTAWA; World Health Organization, 2016, GLOBAL RECOMMENDATIO; World Health Organization, GLOBAL PHYSICAL ACTI; Wu YL, 2013, BREAST CANCER RES TR, V137, P869, DOI 10.1007/s10549-012-2396-7	35	591	610	8	79	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 9	2016	354								i3857	10.1136/bmj.i3857	http://dx.doi.org/10.1136/bmj.i3857			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4TU	27510511	Green Published, hybrid			2022-12-28	WOS:000381474800001
J	Brady, P; Gilerson, A; Kattawar, G; Sullivan, J; Twardowski, M; Dierssen, H; Cummings, M				Brady, Parrish; Gilerson, Alex; Kattawar, George; Sullivan, Jim; Twardowski, Mike; Dierssen, Heidi; Cummings, Molly			Response to Comment on "Open-ocean fish reveal an omnidirectional solution to camouflage in polarized environments"	SCIENCE			English	Editorial Material							MIRROR	Cronin et al. take issue with our evidence for polarocryptic carangid fish based on concerns of pseudoreplication, our contrast metric, and habitat. We clarify (i) the importance of camouflage in near-surface open ocean environments and (ii) the use of a Stokes contrast metric and further (iii) conduct individual-based statistics on our data set to confirm the reported polarocrypsis patterns.	[Brady, Parrish; Cummings, Molly] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA; [Gilerson, Alex] CUNY City Coll, Opt Remote Sensing Lab, New York, NY 10031 USA; [Kattawar, George] Texas A&M Univ, Dept Phys & Astron, College Stn, TX 77843 USA; [Kattawar, George] Texas A&M Univ, Inst Quantum Sci & Engn, College Stn, TX 77843 USA; [Sullivan, Jim; Twardowski, Mike] Florida Atlantic Univ, Harbor Branch Oceanog Inst, Ft Pierce, FL 34946 USA; [Dierssen, Heidi] Univ Connecticut, Dept Marine Sci, 1080 Shennecossett Rd, Groton, CT 06340 USA	University of Texas System; University of Texas Austin; City University of New York (CUNY) System; City College of New York (CUNY); Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Harbor Branch Oceanographic Institute Foundation; State University System of Florida; Florida Atlantic University; University of Connecticut	Cummings, M (corresponding author), Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA.	mcummings@austin.utexas.edu			Directorate For Geosciences [1130793] Funding Source: National Science Foundation	Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		Brady PC, 2015, SCIENCE, V350, P965, DOI 10.1126/science.aad5284; Brady PC, 2013, P NATL ACAD SCI USA, V110, P9764, DOI 10.1073/pnas.1222125110; Calabrese GM, 2014, P NATL ACAD SCI USA, V111, P13397, DOI 10.1073/pnas.1321368111; Cronin TW, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4481; DENTEN EJ, 1970, PHILOS T ROY SOC B, V258, P285, DOI 10.1098/rstb.1970.0037; Johnsen S, 2014, LIMNOL OCEANOGR, V59, P1839, DOI 10.4319/lo.2014.59.6.1839; Kamermans M, 2011, PHILOS T R SOC B, V366, P742, DOI 10.1098/rstb.2010.0211; Maan ME, 2012, AM NAT, V179, pE1, DOI 10.1086/663197; PANKHURST NW, 1982, J FISH BIOL, V21, P279, DOI 10.1111/j.1095-8649.1982.tb02833.x; PARRISH JK, 1992, ENVIRON BIOL FISH, V34, P257, DOI 10.1007/BF00004771	10	1	1	2	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299							aaf5018	10.1126/science.aaf5018	http://dx.doi.org/10.1126/science.aaf5018			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27493177				2022-12-28	WOS:000381560900030
J	Sarewitz, D				Sarewitz, Daniel			Donald Trump's appeal should be a call to arms	NATURE			English	Editorial Material									[Sarewitz, Daniel] Arizona State Univ, Consortium Sci Policy & Outcomes, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Tempe, AZ 85287 USA.	daniel.sarewitz@asu.edu							0	3	3	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 4	2016	536	7614					7	7		10.1038/536007a	http://dx.doi.org/10.1038/536007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DS7YM	27488767	Bronze			2022-12-28	WOS:000380999200003
J	McCarthy, M				McCarthy, Michael			US officials issue travel alert for Miami area as Zika cases rise to 15	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		US Centers for Disease Control and Prevention, 2016, ADV PEOPL LIV TRAV W	1	4	4	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2016	354								i4298	10.1136/bmj.i4298	http://dx.doi.org/10.1136/bmj.i4298			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9CS	27488825	Bronze, Green Published			2022-12-28	WOS:000381080600006
J	Buse, K; Hawkes, S				Buse, Kent; Hawkes, Sarah			Sitting on the FENSA: WHO engagement with industry	LANCET			English	Editorial Material									[Buse, Kent] UNAIDS, Geneva, Switzerland; [Hawkes, Sarah] UCL, Inst Global Hlth, London WC1N 1EH, England	UNAIDS; University of London; University College London	Hawkes, S (corresponding author), UCL, Inst Global Hlth, London WC1N 1EH, England.	s.hawkes@ucl.ac.uk	Hawkes, Sarah/AAK-7375-2020; Buse, Kent/AAK-6688-2020	Buse, Kent/0000-0002-5485-0110				Abbott K, 2013, REGUL GOV, V7, P96; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bexell M, 2010, GLOBAL GOV, V16, P81; Drager N, 2009, MAKING SENSE GLOBAL, P187; Faculty of Public Health UK, 2013, FPH WITHDR RESP DEAL; Gupta, 2016, WHOSE HLTH CRUCIAL N; Stuckler D, 2012, PLOS MED, V9; Stuckler D, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001020; Third World Network, 2015, WHO UN SEC PHIL FDN; WHO, 2016, FRAM ENG NONST ACT 6; Wilson D., 2012, SPECIAL REPORT FOOD; World Health Organization, 2013, GLOB ACT PLAN PREV C	12	26	26	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 30	2016	388	10043					446	447						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DS2EK	27507745	Green Submitted			2022-12-28	WOS:000380559400008
J	Boke, E; Ruer, M; Wuhr, M; Coughlin, M; Lemaitre, R; Gygi, SP; Alberti, S; Drechsel, D; Hyman, AA; Mitchison, TJ				Boke, Elvan; Ruer, Martine; Wuehr, Martin; Coughlin, Margaret; Lemaitre, Regis; Gygi, Steven P.; Alberti, Simon; Drechsel, David; Hyman, Anthony A.; Mitchison, Timothy J.			Amyloid-like Self-Assembly of a Cellular Compartment	CELL			English	Article							XENOPUS-LAEVIS; GERM PLASM; MITOCHONDRIAL CLOUD; FIBRIL FORMATION; BALBIANI BODY; MOUSE OOCYTES; NEURODEGENERATION; LOCALIZATION; DETERMINANTS; AGGREGATION	Most vertebrate oocytes contain a Balbiani body, a large, non-membrane-bound compartment packed with RNA, mitochondria, and other organelles. Little is known about this compartment, though it specifies germline identity in many non-mammalian vertebrates. We show Xvelo, a disordered protein with an N-terminal prion-like domain, is an abundant constituent of Xenopus Balbiani bodies. Disruption of the prion-like domain of Xvelo, or substitution with a prion-like domain from an unrelated protein, interferes with its incorporation into Balbiani bodies in vivo. Recombinant Xvelo forms amyloid-like networks in vitro. Amyloid-like assemblies of Xvelo recruit both RNA and mitochondria in binding assays. We propose that Xenopus Balbiani bodies form by amyloid-like assembly of Xvelo, accompanied by co-recruitment of mitochondria and RNA. Prion-like domains are found in germ plasm organizing proteins in other species, suggesting that Balbiani body formation by amyloid-like assembly could be a conserved mechanism that helps oocytes function as long-lived germ cells.	[Boke, Elvan; Wuehr, Martin; Coughlin, Margaret; Mitchison, Timothy J.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Ruer, Martine; Lemaitre, Regis; Alberti, Simon; Drechsel, David; Hyman, Anthony A.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Wuehr, Martin; Gygi, Steven P.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Max Planck Society; Harvard University; Harvard Medical School	Boke, E (corresponding author), Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA.	elvan_boke@hms.harvard.edu	Wühr, Martin/A-2447-2009; Boke, Elvan/O-6725-2017; Hyman, Tony/F-1923-2011; Hyman, Anthony A/B-3917-2017; Alberti, Simon/ABB-8277-2021; Alberti, Simon/B-2822-2017	Wühr, Martin/0000-0002-0244-8947; Hyman, Anthony A/0000-0003-3664-154X; Alberti, Simon/0000-0003-4017-6505	Protein Expression facility of the MPI-CBG; Electron Microscopy facility of the MPI-CBG; Image Processing facility of the MPI-CBG; NIH [R01-GM103785, GM39565]; Charles A. King Trust Postdoctoral Fellowship; MaxSynBio consortium - Federal Ministry of Education and Research of Germany; MaxSynBio consortium - Max Planck Society; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM039565, R01GM103785, R01GM039565] Funding Source: NIH RePORTER	Protein Expression facility of the MPI-CBG; Electron Microscopy facility of the MPI-CBG; Image Processing facility of the MPI-CBG; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles A. King Trust Postdoctoral Fellowship; MaxSynBio consortium - Federal Ministry of Education and Research of Germany; MaxSynBio consortium - Max Planck Society(Max Planck Society); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the T.J.M. and A.A.H. labs, especially Avinash Patel for helpful discussions, Andrei Pozniakovski for cloning, and Christine Field for help in making extracts. We would like to thank Doris Richter and Sonja Kroschwald for technical assistance. We are grateful to the Protein Expression, Electron Microscopy and Image Processing facilities of the MPI-CBG for their support. We would also like to thank the Nikon Imaging Center at Harvard Medical School for microscopy support. Proteomic analysis was supported by NIH grant R01-GM103785 (PI Marc W. Kirschner). M.W. was supported by the Charles A. King Trust Postdoctoral Fellowship. This work was supported by the MaxSynBio consortium, which is jointly funded by the Federal Ministry of Education and Research of Germany and the Max Planck Society (to A.A.H.) and NIH grant GM39565 (to T.J.M.).	Alberti S, 2010, METHOD ENZYMOL, V470, P709, DOI 10.1016/S0076-6879(10)70030-6; Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044; ALMUKHTAR KA, 1971, J EMBRYOL EXP MORPH, V26, P195; Bagriantsev SN, 2006, METHOD ENZYMOL, V412, P33, DOI 10.1016/S0076-6879(06)12003-0; BALINSKY B. I., 1963, ACTA EMBRYOL ET MORPHOL EXPTL, V6, P55; Berchowitz LE, 2015, CELL, V163, P406, DOI 10.1016/j.cell.2015.08.060; BILLETT FS, 1976, J EMBRYOL EXP MORPH, V36, P697; Bontems F, 2009, CURR BIOL, V19, P414, DOI 10.1016/j.cub.2009.01.038; de la Paz ML, 2004, P NATL ACAD SCI USA, V101, P87, DOI 10.1073/pnas.2634884100; Dixon DA, 2003, J EXP MED, V198, P475, DOI 10.1084/jem.20030616; Dosch R, 2004, DEV CELL, V6, P771, DOI 10.1016/j.devcel.2004.05.002; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; England JL, 2011, ANNU REV PHYS CHEM, V62, P257, DOI 10.1146/annurev-physchem-032210-103531; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; Field CM, 2014, METHOD ENZYMOL, V540, P399, DOI 10.1016/B978-0-12-397924-7.00022-4; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Gupta T, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001073; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Halfmann R, 2012, NATURE, V482, P363, DOI 10.1038/nature10875; Heim AE, 2014, DEVELOPMENT, V141, P842, DOI 10.1242/dev.090449; HERTIG AT, 1968, AM J ANAT, V122, P107, DOI 10.1002/aja.1001220107; HERTIG AT, 1967, J CELL BIOL, V34, P647, DOI 10.1083/jcb.34.2.647; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Houston DW, 2000, CURR TOP DEV BIOL, V50, P155, DOI 10.1016/S0070-2153(00)50008-8; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; KLOC M, 1995, DEVELOPMENT, V121, P287; Kogo N, 2011, DEV BIOL, V349, P462, DOI 10.1016/j.ydbio.2010.11.021; Koo EH, 1999, P NATL ACAD SCI USA, V96, P9989, DOI 10.1073/pnas.96.18.9989; Lancaster AK, 2014, BIOINFORMATICS, V30, P2501, DOI 10.1093/bioinformatics/btu310; Lei L, 2016, SCIENCE, V352, P95, DOI 10.1126/science.aad2156; Lesch BJ, 2012, NAT REV GENET, V13, P781, DOI 10.1038/nrg3294; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Li R, 2013, NAT REV MOL CELL BIO, V14, P141, DOI 10.1038/nrm3531; Marlow FL, 2008, DEV BIOL, V321, P40, DOI 10.1016/j.ydbio.2008.05.557; McAlister GC, 2014, ANAL CHEM, V86, P7150, DOI 10.1021/ac502040v; Nilsson MR, 2004, METHODS, V34, P151, DOI 10.1016/j.ymeth.2004.03.012; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Pepling ME, 2007, P NATL ACAD SCI USA, V104, P187, DOI 10.1073/pnas.0609923104; Polymenidou M, 2011, CELL, V147, P498, DOI 10.1016/j.cell.2011.10.011; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Steger K, 2001, ANAT EMBRYOL, V203, P323, DOI 10.1007/s004290100176; Toombs JA, 2012, P NATL ACAD SCI USA, V109, P6519, DOI 10.1073/pnas.1119366109; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; Wickner RB, 2013, BIOCHEMISTRY-US, V52, P1514, DOI 10.1021/bi301686a; Wuehr M, 2014, CURR BIOL, V24, P1467, DOI 10.1016/j.cub.2014.05.044; Zhou Y, 1996, DEVELOPMENT, V122, P2947	48	201	206	6	72	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					637	650		10.1016/j.cell.2016.06.051	http://dx.doi.org/10.1016/j.cell.2016.06.051			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27471966	Bronze, Green Accepted			2022-12-28	WOS:000380546500015
J	Huang, YH; Vakoc, CR				Huang, Yu-Han; Vakoc, Christopher R.			A Biomarker Harvest from One Thousand Cancer Cell Lines	CELL			English	Editorial Material							SENSITIVITY; THERAPY; GENOME	Identifying molecular biomarkers that predict cancer drug efficacy is crucial for the advancement of precision medicine. In this issue of Cell, Iorio et al. nominate hundreds of potential genetic and epigenetic biomarkers through high-throughput drug screening in similar to 1,000 molecularly annotated cancer cell lines.	[Huang, Yu-Han; Vakoc, Christopher R.] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Vakoc, CR (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.	vakoc@cshl.edu			NCI NIH HHS [P30 CA045508] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA045508] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Chabner BA, 2016, JNCI-J NATL CANCER I, V108, P108; Garraway LA, 2013, CELL, V153, P17, DOI 10.1016/j.cell.2013.03.002; Haibe-Kains B, 2013, NATURE, V504, P389, DOI 10.1038/nature12831; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Seashore-Ludlow B, 2015, CANCER DISCOV, V5, P1210, DOI 10.1158/2159-8290.CD-15-0235; Sharma SV, 2010, NAT REV CANCER, V10, P241, DOI 10.1038/nrc2820; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943	10	8	9	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					536	537		10.1016/j.cell.2016.07.010	http://dx.doi.org/10.1016/j.cell.2016.07.010			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27471963	Bronze			2022-12-28	WOS:000380546500007
J	Vyas, S; Zaganjor, E; Haigis, MC				Vyas, Sejal; Zaganjor, Elma; Haigis, Marcia C.			Mitochondria and Cancer	CELL			English	Review							GLUTAMINE-METABOLISM; CELL-SURVIVAL; OXIDATIVE-PHOSPHORYLATION; REDOX HOMEOSTASIS; PROTEIN-KINASE; TCA CYCLE; MYC; HYPOXIA; GLUTATHIONE; BIOGENESIS	Mitochondria are bioenergetic, biosynthetic, and signaling organelles that are integral in stress sensing to allow for cellular adaptation to the environment. Therefore, it is not surprising that mitochondria are important mediators of tumorigenesis, as this process requires flexibility to adapt to cellular and environmental alterations in addition to cancer treatments. Multiple aspects of mitochondrial biology beyond bioenergetics support transformation, including mitochondrial biogenesis and turnover, fission and fusion dynamics, cell death susceptibility, oxidative stress regulation, metabolism, and signaling. Thus, understanding mechanisms of mitochondrial function during tumorigenesis will be critical for the next generation of cancer therapeutics.	[Vyas, Sejal; Zaganjor, Elma; Haigis, Marcia C.] Harvard Med Sch, Dept Cell Biol, Ludwig Ctr Harvard, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Haigis, MC (corresponding author), Harvard Med Sch, Dept Cell Biol, Ludwig Ctr Harvard, Boston, MA 02115 USA.	marcia_haigis@hms.harvard.edu			American Cancer Society [127097-PF-14-255-01-TBE]; American Heart Association [15POST25560077]; Ludwig Center at Harvard; Paul F. Glenn Foundation; National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK103295-01A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103295] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); American Heart Association(American Heart Association); Ludwig Center at Harvard; Paul F. Glenn Foundation; National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We apologize for all the primary literature and work we could not cite due to space limitations. This review is not meant to be a comprehensive summary of all the work done in the field of mitochondrial functions in cancer. We thank Jonathan Coloff, Lydia Finley, Karina Gonzalez, Jessica Spinelli, and Alison Ringel for discussion on the manuscript. S.V. is supported by a postdoctoral fellowship from the American Cancer Society (127097-PF-14-255-01-TBE). E.Z. is supported by a postdoctoral fellowship from the American Heart Association (15POST25560077). M.C.H. is supported by the Ludwig Center at Harvard, the Paul F. Glenn Foundation, and the National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK103295-01A1).	Adam J, 2011, CANCER CELL, V20, P524, DOI 10.1016/j.ccr.2011.09.006; Bause AS, 2013, EXP GERONTOL, V48, P634, DOI 10.1016/j.exger.2012.08.007; Bell EL, 2011, ONCOGENE, V30, P2986, DOI 10.1038/onc.2011.37; Ben-Sahra I, 2016, SCIENCE, V351, P728, DOI 10.1126/science.aad0489; Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019; Carracedo A, 2013, NAT REV CANCER, V13, P227, DOI 10.1038/nrc3483; Chourasia AH, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0130-8; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Coloff JL, 2016, CELL METAB, V23, P867, DOI 10.1016/j.cmet.2016.03.016; Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Dang CV, 2008, NAT REV CANCER, V8, P51, DOI 10.1038/nrc2274; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Davidson SM, 2016, CELL METAB, V23, P517, DOI 10.1016/j.cmet.2016.01.007; De Luca A, 2015, ONCOTARGET, V6, P14777, DOI 10.18632/oncotarget.4401; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Dibble CC, 2015, TRENDS CELL BIOL, V25, P545, DOI 10.1016/j.tcb.2015.06.002; Ducker GS, 2016, CELL METAB, V23, P1140, DOI 10.1016/j.cmet.2016.04.016; ERNSTER L, 1981, J CELL BIOL, V91, pS227, DOI 10.1083/jcb.91.3.227s; Faubert B, 2015, CANCER LETT, V356, P165, DOI 10.1016/j.canlet.2014.01.018; Finley LWS, 2011, CANCER CELL, V19, P416, DOI 10.1016/j.ccr.2011.02.014; German NJ, 2015, CURR BIOL, V25, pR569, DOI 10.1016/j.cub.2015.05.012; Ghosh JC, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju502; Gopal YNV, 2014, CANCER RES, V74, P7037, DOI 10.1158/0008-5472.CAN-14-1392; Graves JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037699; Guo JY, 2013, GENE DEV, V27, P1447, DOI 10.1101/gad.219642.113; Guo JY, 2011, GENE DEV, V25, P460, DOI 10.1101/gad.2016311; Haq R, 2013, CANCER CELL, V23, P302, DOI 10.1016/j.ccr.2013.02.003; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; Hu YL, 2012, CANCER RES, V72, P1773, DOI 10.1158/0008-5472.CAN-11-3831; Jain M, 2012, SCIENCE, V336, P1040, DOI 10.1126/science.1218595; Jeong SM, 2014, J BIOL CHEM, V289, P4135, DOI 10.1074/jbc.M113.525949; Jiang D, 2015, CELL REP, V10, P1096, DOI 10.1016/j.celrep.2015.01.043; Jiang L, 2016, NATURE, V532, P255, DOI 10.1038/nature17393; Jin LT, 2015, CANCER CELL, V27, P257, DOI 10.1016/j.ccell.2014.12.006; Kasahara A, 2014, TRENDS CELL BIOL, V24, P761, DOI 10.1016/j.tcb.2014.08.005; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Kim D, 2015, NATURE, V520, P363, DOI 10.1038/nature14363; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; LaGory EL, 2015, CELL REP, V12, P116, DOI 10.1016/j.celrep.2015.06.006; Lamb R, 2014, ONCOTARGET, V5, P11029, DOI 10.18632/oncotarget.2789; Le A, 2012, CELL METAB, V15, P110, DOI 10.1016/j.cmet.2011.12.009; Le Gal K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad3740; LeBleu VS, 2014, NAT CELL BIOL, V16, P992, DOI 10.1038/ncb3039; LeBleu VS, 2014, NAT CELL BIOL, P1001, DOI DOI 10.1038/NCB3039; Lee JV, 2014, CELL METAB, V20, P306, DOI 10.1016/j.cmet.2014.06.004; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Li XJ, 2016, MOL CELL, V61, P705, DOI 10.1016/j.molcel.2016.02.009; Lopez J, 2015, BRIT J CANCER, V112, P957, DOI 10.1038/bjc.2015.85; Losman JA, 2013, SCIENCE, V339, P1621, DOI 10.1126/science.1231677; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Mancias JD, 2016, J MOL BIOL, V428, P1659, DOI 10.1016/j.jmb.2016.02.027; Matsuda S, 2015, FRONT BIOSCI-LANDMRK, V20, P491, DOI 10.2741/4321; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Morita M, 2015, CELL CYCLE, V14, P473, DOI 10.4161/15384101.2014.991572; Mucaj V, 2012, INT J HEMATOL, V95, P464, DOI 10.1007/s12185-012-1070-5; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Nikiforov MA, 2002, MOL CELL BIOL, V22, P5793, DOI 10.1128/MCB.22.16.5793-5800.2002; Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128; Nowicki S, 2015, FEBS J, V282, P2796, DOI 10.1111/febs.13295; Papa A, 2014, CELL, V157, P595, DOI 10.1016/j.cell.2014.03.027; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Piskounova E, 2015, NATURE, V527, P186, DOI 10.1038/nature15726; Porporato PE, 2014, CELL REP, V8, P754, DOI 10.1016/j.celrep.2014.06.043; Pyakurel A, 2015, MOL CELL, V58, P244, DOI 10.1016/j.molcel.2015.02.021; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Renault TT, 2015, MOL CELL, V57, P69, DOI 10.1016/j.molcel.2014.10.028; Reznik E, 2016, ELIFE, V5, DOI 10.7554/eLife.10769; Sancho P, 2015, CELL METAB, V22, P590, DOI 10.1016/j.cmet.2015.08.015; Sarosiek KA, 2013, MOL CELL, V51, P751, DOI 10.1016/j.molcel.2013.08.048; Schell JC, 2014, MOL CELL, V56, P400, DOI 10.1016/j.molcel.2014.09.026; Senft D, 2016, CURR OPIN CELL BIOL, V39, P43, DOI 10.1016/j.ceb.2016.02.001; Serasinghe MN, 2015, MOL CELL, V57, P521, DOI 10.1016/j.molcel.2015.01.003; Son J, 2013, NATURE, V496, P101, DOI 10.1038/nature12040; Stine ZE, 2015, CANCER DISCOV, V5, P1024, DOI 10.1158/2159-8290.CD-15-0507; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Sullivan LB, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-17; Sullivan LB, 2013, MOL CELL, V51, P236, DOI 10.1016/j.molcel.2013.05.003; Tan ZQ, 2016, MOL CANCER THER, V15, P774, DOI 10.1158/1535-7163.MCT-15-0621; Tardito S, 2015, NAT CELL BIOL, V17, P1556, DOI 10.1038/ncb3272; Toyama EQ, 2016, SCIENCE, V351, P275, DOI 10.1126/science.aab4138; Vacanti NM, 2014, MOL CELL, V56, P425, DOI 10.1016/j.molcel.2014.09.024; van Gisbergen MW, 2015, MUTAT RES-REV MUTAT, V764, P16, DOI 10.1016/j.mrrev.2015.01.001; Vaseva AV, 2009, BBA-BIOENERGETICS, V1787, P414, DOI 10.1016/j.bbabio.2008.10.005; Viale A, 2014, NATURE, V514, P628, DOI 10.1038/nature13611; von Eyss B, 2015, CANCER CELL, V28, P743, DOI 10.1016/j.ccell.2015.10.013; Vyas S, 2014, NAT REV CANCER, V14, P502, DOI 10.1038/nrc3748; Wang P, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/767136; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; WEINHOUSE S, 1956, SCIENCE, V124, P267, DOI 10.1126/science.124.3215.267; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yang CD, 2014, MOL CELL, V56, P414, DOI 10.1016/j.molcel.2014.09.025; Ye JB, 2014, CANCER DISCOV, V4, P1406, DOI 10.1158/2159-8290.CD-14-0250; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	97	863	890	18	303	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					555	566		10.1016/j.cell.2016.07.002	http://dx.doi.org/10.1016/j.cell.2016.07.002			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27471965	Green Accepted, Bronze			2022-12-28	WOS:000380546500009
J	Raman, G; Adam, GP; Halladay, CW; Langberg, VN; Ijeoma, IA; Balk, EM				Raman, Gowri; Adam, Gaelen P.; Halladay, Christopher W.; Langberg, Valerie N.; Azodo, Ijeoma A.; Balk, Ethan M.			Comparative Effectiveness of Management Strategies for Renal Artery Stenosis An Updated Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							ATHEROSCLEROTIC RENOVASCULAR DISEASE; UNSUCCESSFUL BALLOON ANGIOPLASTY; POPULATION-BASED COHORT; BLOOD-PRESSURE CONTROL; CHRONIC KIDNEY-DISEASE; LOW-PROFILE STENT; MEDICAL THERAPY; INTRAVASCULAR ULTRASOUND; EMBOLIC PROTECTION; RANDOMIZED-TRIAL	Background: Atherosclerotic renal artery stenosis (ARAS) is associated with high blood pressure (BP), decreased kidney function, renal replacement therapy (RRT), and death. Purpose: To compare benefits and harms of percutaneous transluminal renal angioplasty with stent placement (PTRAS) versus medical therapy alone in adults with ARAS. Data Sources: MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials from 1993 to 16 March 2016; gray literature; and prior systematic reviews. Study Selection: Randomized, controlled trials (RCTs); nonrandomized, comparative studies (NRCSs); single-group studies; and selected case reports that reported all-cause and cardiovascular mortality, RRT, kidney function, BP, and adverse events. Data Extraction: Six researchers extracted data on design, interventions, outcomes, and study quality into a Web-based database. Data Synthesis: Eighty-three studies met eligibility criteria. In 5 of 7 RCTs, PTRAS and medical therapy led to similar BP control in patients with ARAS, and no RCTs showed statistically significant differences in kidney function, mortality, RRT, cardiovascular events, or pulmonary edema. Eight NRCSs had more variable results, finding mostly no significant differences in mortality, RRT, or cardiovascular events but heterogeneous effects on kidney function and BP. Procedure-related adverse events were rare, and medication-related adverse events were not reported. Two RCTs found no patient characteristics that were associated with outcomes with either PTRAS or medical therapy. Single-group studies found various but inconsistent factors that predict outcomes. Case reports provided examples of clinical improvement after PTRAS in patients with acute decompensation. Limitation: Limited clinical applicability and power in RCTs, and possible publication bias and lack of adjusted analyses in NRCSs. Conclusion: The strength of evidence regarding the relative benefits and harms of PTRAS versus medical therapy alone for patients with ARAS is low. Studies have generally focused on patients with less severe ARAS.	Tufts Med Ctr, Tufts Ctr Clin Evidence Synth, Boston, MA USA; Brown Univ, Ctr Evidencebased Med, Providence, RI 02912 USA; Univ Edinburgh, Coll Med & Vet Med, Edinburgh, Midlothian, Scotland; [Adam, Gaelen P.; Halladay, Christopher W.; Langberg, Valerie N.; Balk, Ethan M.] Brown Univ, Sch Publ Hlth, Box G-S121-8, Providence, RI 02912 USA; [Raman, Gowri] Tufts Med Ctr, Box 063,800 Washington St, Boston, MA 02111 USA; [Azodo, Ijeoma A.] Univ Edinburgh, Coll Med & Vet Med, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland	Tufts Medical Center; Brown University; University of Edinburgh; Brown University; Tufts Medical Center; University of Edinburgh	Balk, EM (corresponding author), Brown Univ, Sch Publ Hlth, Box G-S121-8, Providence, RI 02912 USA.	ethan_balk@brown.edu	Balk, Ethan/AAJ-2547-2020		Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [290-20-1500002 I]	Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Under contract 290-20-1500002 I from the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.	Goncalves JAA, 2007, ARQ BRAS CARDIOL, V88, P85, DOI 10.1590/S0066-782X2007000100014; Arthurs Z, 2007, J VASC SURG, V45, P726, DOI 10.1016/j.jvs.2006.12.026; Balk E, 2006, 07EHC004EF AG HEALTH; Balk E, 2007, 0708EHC004UEF AG HEA; Balk EM, 2016, COMP EFFECTIVENESS R, V179; Balzer KM, 2009, J VASC SURG, V49, P667, DOI 10.1016/j.jvs.2008.10.006; Bax L, 2009, ANN INTERN MED, V150, P840, DOI 10.7326/0003-4819-150-12-200906160-00119; Beck AW, 2009, J VASC SURG, V49, P1387, DOI 10.1016/j.jvs.2009.02.009; Bersin RM, 2013, CATHETER CARDIO INTE, V82, P266, DOI 10.1002/ccd.24481; Blum U, 1997, NEW ENGL J MED, V336, P459, DOI 10.1056/NEJM199702133360702; Campbell John E, 2008, W V Med J, V104, P22; Chrysochou C, 2013, NEPHROL DIAL TRANSPL, V28, P479, DOI 10.1093/ndt/gfr745; Chrysochou C, 2009, INT J CARDIOL, V132, pE31, DOI 10.1016/j.ijcard.2007.07.121; Cianci R, 2013, EUR REV MED PHARMACO, V17, P507; Cianci R, 2011, ANGIOLOGY, V62, P92, DOI 10.1177/0003319710371615; Cooper CJ, 2008, CIRCULATION, V117, P2752, DOI 10.1161/CIRCULATIONAHA.107.730259; Cooper CJ, 2014, NEW ENGL J MED, V370, P13, DOI 10.1056/NEJMoa1310753; Crutchley TA, 2009, J VASC SURG, V49, P148, DOI 10.1016/j.jvs.2008.08.008; Dahabreh IJ, 2012, EUR HEART J, V33, P1893, DOI 10.1093/eurheartj/ehs114; Dangas G, 2001, J ENDOVASC THER, V8, P238, DOI 10.1583/1545-1550(2001)008<0238:IUGRAS>2.0.CO;2; de Donato G, 2007, J CARDIOVASC SURG, V48, P403; de Mast Q, 2009, J HYPERTENS, V27, P1333, DOI 10.1097/HJH.0b013e328329bbf4; Demming T, 2013, CLIN RES CARDIOL, V102, P615, DOI 10.1007/s00392-013-0579-9; Dichtel LE, 2010, CLIN NEPHROL, V74, P113; Dippel EJ, 2009, J INVASIVE CARDIOL, V21, P423; Dziemianko Ilona, 2009, Congest Heart Fail, V15, P96, DOI 10.1111/j.1751-7133.2009.00052.x; Fujihara M, 2015, CIRC J, V79, P351, DOI 10.1253/circj.CJ-14-0908; George Paul V, 2005, Indian Heart J, V57, P741; George T, 2011, SAUDI J KIDNEY DIS T, V22, P531; Gill KS, 2003, RADIOLOGY, V226, P821, DOI 10.1148/radiol.2263011244; Gill-Leertouwer TC, 2002, BRIT J RADIOL, V75, P879, DOI 10.1259/bjr.75.899.750879; Gross CM, 1998, CATHETER CARDIO DIAG, V45, P1, DOI 10.1002/(SICI)1097-0304(199809)45:1<1::AID-CCD1>3.0.CO;2-7; Guo HF, 2007, CIRCULATION, V115, P50, DOI 10.1161/CIRCULATIONAHA.106.637751; Hackam DG, 2008, AM HEART J, V156, P549, DOI 10.1016/j.ahj.2008.05.013; Hackam DG, 2011, EUR HEART J, V32, P598, DOI 10.1093/eurheartj/ehq452; Hansen KJ, 2002, J VASC SURG, V36, P443, DOI 10.1067/mva.2002.127351; Hanzel G, 2005, AM J CARDIOL, V96, P1322, DOI 10.1016/j.amjcard.2005.06.081; Harden PN, 1997, LANCET, V349, P1133, DOI 10.1016/S0140-6736(96)10093-3; Henry M, 2003, CATHETER CARDIO INTE, V60, P299, DOI 10.1002/ccd.10669; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Holden A, 2006, KIDNEY INT, V70, P948, DOI 10.1038/sj.ki.5001671; Iannone LA, 1996, CATHETER CARDIO DIAG, V37, P243, DOI 10.1002/(SICI)1097-0304(199603)37:3<243::AID-CCD3>3.0.CO;2-C; Ishida R, 2013, RENAL FAILURE, V35, P551, DOI 10.3109/0886022X.2013.773844; Islam MA, 2009, VASC MED, V14, P365, DOI 10.1177/1358863X09103200; Jaff MR, 2012, CATHETER CARDIO INTE, V80, P343, DOI 10.1002/ccd.24449; Jenks S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002944.pub2; Jokhi PP, 2009, CAN J CARDIOL, V25, pE273, DOI 10.1016/S0828-282X(09)70121-7; Kadziela J, 2015, BLOOD PRESSURE, V24, P30, DOI 10.3109/08037051.2014.958304; Kalra PA, 2010, CATHETER CARDIO INTE, V75, P1, DOI 10.1002/ccd.22290; Kanamori Hiroshi, 2009, J Invasive Cardiol, V21, pE171; Kane GC, 2010, NEPHROL DIAL TRANSPL, V25, P813, DOI 10.1093/ndt/gfp393; Kennedy DJ, 2003, AM J KIDNEY DIS, V42, P926, DOI 10.1016/j.ajkd.2003.06.004; Kindo M, 2011, INTERACT CARDIOV TH, V12, P323, DOI 10.1510/icvts.2010.254755; Komatsu Sei, 2014, J Cardiol Cases, V9, P18, DOI 10.1016/j.jccase.2013.08.014; Kumar S C Koduganti R, 2006, J Assoc Physicians India, V54, P651; Kuznetsov E, 2007, CLIN NEPHROL, V68, P32; Leesar MA, 2009, J AM COLL CARDIOL, V53, P2363, DOI 10.1016/j.jacc.2009.03.031; Lekston A, 2008, KARDIOL POL, V66, P1061; Li WS, 2012, QJM-INT J MED, V105, P567, DOI 10.1093/qjmed/hcr068; Liang P, 2013, J VASC SURG, V58, P1331, DOI 10.1016/j.jvs.2013.04.041; Lohr KN, 2008, METHODS GUIDE EFFECT; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Mannarino A, 2012, RENAL FAILURE, V34, P142, DOI 10.3109/0886022X.2011.646807; Marcantoni C, 2012, AM J KIDNEY DIS, V60, P39, DOI 10.1053/j.ajkd.2012.01.022; Mohan IV, 2015, EUR J VASC ENDOVASC, V49, P465, DOI 10.1016/j.ejvs.2014.12.026; Murphy TP, 2015, J AM COLL CARDIOL, V66, P2487, DOI 10.1016/j.jacc.2015.09.073; Murphy TP, 2014, J VASC INTERV RADIOL, V25, P511, DOI 10.1016/j.jvir.2013.09.018; Navaravong L, 2011, CARDIOVASC REVASCULA, V12, P399, DOI 10.1016/j.carrev.2011.05.002; Noce Annalisa, 2012, Arch Ital Urol Androl, V84, P249; Parikh SA, 2014, CATHETER CARDIO INTE, V84, P1163, DOI 10.1002/ccd.25559; Patel VI, 2009, J VASC SURG, V49, P1480, DOI 10.1016/j.jvs.2009.02.004; Ramos F, 2003, KIDNEY INT, V63, P276, DOI 10.1046/j.1523-1755.2003.00734.x; Rastan Aljoscha, 2008, EuroIntervention, V4, P208, DOI 10.4244/EIJV4I2A38; Riaz IB, 2014, AM J CARDIOL, V114, P1116, DOI 10.1016/j.amjcard.2014.06.033; RIMMER JM, 1993, ANN INTERN MED, V118, P712, DOI 10.7326/0003-4819-118-9-199305010-00010; Ritchie J, 2014, AM J KIDNEY DIS, V63, P186, DOI 10.1053/j.ajkd.2013.07.020; Rivolta R, 2005, J NEPHROL, V18, P749; Rocha-Singh K, 2005, J AM COLL CARDIOL, V46, P776, DOI 10.1016/j.jacc.2004.11.073; Rocha-Singh KJ, 1999, CATHETER CARDIO INTE, V47, P167, DOI 10.1002/(SICI)1522-726X(199906)47:2<167::AID-CCD7>3.0.CO;2-R; Rocha-Singh K, 2008, CATHETER CARDIO INTE, V72, P853, DOI 10.1002/ccd.21749; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Ruchin P E, 2007, Heart Lung Circ, V16, P79, DOI 10.1016/j.hlc.2006.12.008; Rzeznik D, 2011, J VASC SURG, V53, P692, DOI 10.1016/j.jvs.2010.09.054; Sapoval M, 2005, J VASC INTERV RADIOL, V16, P1195, DOI 10.1097/01.RVI.0000171765.67665.D3; Sapoval M, 2010, CARDIOVASC INTER RAD, V33, P475, DOI 10.1007/s00270-009-9733-1; Scarpioni R, 2005, J NEPHROL, V18, P423; Scarpioni R, 2009, WORLD C NEPHR; Schwarzwalder U, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-60; Silva VS, 2008, AM J HYPERTENS, V21, P1163, DOI 10.1038/ajh.2008.249; Sofroniadou S, 2012, INT UROL NEPHROL, V44, P1451, DOI 10.1007/s11255-011-0091-y; Staub D, 2010, EUR J VASC ENDOVASC, V40, P599, DOI 10.1016/j.ejvs.2010.07.013; Trani C, 2013, INT J CARDIOL, V167, P1006, DOI 10.1016/j.ijcard.2012.03.078; Trani C, 2010, CATHETER CARDIO INTE, V76, P26, DOI 10.1002/ccd.22525; Tsao CR, 2005, INT HEART J, V46, P1061, DOI 10.1536/ihj.46.1061; Alonso JV, 2013, AM J EMERG MED, V31, DOI 10.1016/j.ajem.2012.07.016; Valluri A, 2012, NEPHROL DIAL TRANSPL, V27, P734, DOI 10.1093/ndt/gfr356; van de Ven PJG, 1999, LANCET, V353, P282, DOI 10.1016/S0140-6736(98)04432-8; Weinberg I, 2014, CATHETER CARDIO INTE, V83, P603, DOI 10.1002/ccd.25263; Wells G., 2014, NEWCASTLE OTTAWA SCA; Wheatley K, 2009, NEW ENGL J MED, V361, P1953, DOI 10.1056/NEJMoa0905368; White CJ, 1997, J AM COLL CARDIOL, V30, P1445, DOI 10.1016/S0735-1097(97)00348-3; Williamson E, 2012, STAT METHODS MED RES, V21, P273, DOI 10.1177/0962280210394483; Wu GF, 2008, J INVASIVE CARDIOL, V20, P76; Zahringer M, 2007, J ENDOVASC THER, V14, P460, DOI 10.1177/152660280701400405; Zeller T, 2004, J ENDOVASC THER, V11, P95, DOI 10.1583/03-1062.1; Zeller T, 2005, J ENDOVASC THER, V12, P605, DOI 10.1583/05-1599MR.1; Zeller T., 2013, Z GEFASSKRAKHEITEN J, V42, P40; Zhu YF, 2015, ANN VASC SURG, V29, P1457, DOI 10.1016/j.avsg.2015.06.062; Ziakka S, 2008, RENAL FAILURE, V30, P965, DOI 10.1080/08860220802389334	109	45	50	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 1	2016	165	9					635	+		10.7326/M16-1053	http://dx.doi.org/10.7326/M16-1053			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA8SJ	27536808				2022-12-28	WOS:000386908600006
J	Healey, JS; Oldgren, J; Ezekowitz, M; Zhu, J; Pais, P; Wang, J; Commerford, P; Jansky, P; Avezum, A; Sigamani, A; Demasceno, A; Reilly, P; Grinvalds, A; Nakamya, J; Aje, A; Almahmeed, W; Moriarty, A; Wallentin, L; Yusuf, S; Connolly, SJ				Healey, Jeff S.; Oldgren, Jonas; Ezekowitz, Michael; Zhu, Jun; Pais, Prem; Wang, Jia; Commerford, Patrick; Jansky, Petr; Avezum, Alvaro; Sigamani, Alben; Demasceno, Albertino; Reilly, Paul; Grinvalds, Alex; Nakamya, Juliet; Aje, Akinyemi; Almahmeed, Wael; Moriarty, Andrew; Wallentin, Lars; Yusuf, Salim; Connolly, Stuart J.		RE-LY Atrial Fibrillation Registry; Cohort Study Investigators	Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study	LANCET			English	Article							EMERGENCY-DEPARTMENT; ORAL ANTICOAGULANTS; GULF SURVEY; FOLLOW-UP; MANAGEMENT; RISK; WARFARIN; METAANALYSIS; GUIDELINES; OUTCOMES	Background Atrial fi brillation is an important cause of morbidity and mortality worldwide, but scant data are available for long- term outcomes in individuals outside North America or Europe, especially in primary care settings. Methods We did a cohort study using a prospective registry of patients in 47 countries who presented to a hospital emergency department with atrial fi brillation or atrial fl utter as a primary or secondary diagnosis. 15 400 individuals were enrolled to determine the occurrence of death and strokes (the primary outcomes) in this cohort over eight geographical regions (North America, western Europe, and Australia; South America; eastern Europe; the Middle East and Mediterranean crescent; sub- Saharan Africa; India; China; and southeast Asia) 1 year after attending the emergency department. Patients from North America, western Europe, and Australia were used as the reference population, and compared with patients from the other seven regions Findings Between Dec 24, 2007, and Oct 21, 2011, we enrolled 15 400 individuals to the registry. Follow- up was complete for 15 361 (99.7%), of whom 1758 (11%) died within 1 year. Fewer deaths occurred among patients presenting to the emergency department with a primary diagnosis of atrial fi brillation compared with patients who had atrial fi brillation as a secondary diagnosis (377 [6%] of 6825 patients vs 1381 [16%] of 8536, p<0.0001). Twice as many patients had died by 1 year in South America (192 [17%] of 1132) and Africa (225 [20%] of 1137) compared with North America, western Europe, and Australia (366 [10%] of 3800, p< 0 0001). Heart failure was the most common cause of death (519 [30%] of 1758); stroke caused 148 (8%) deaths. 604 (4%) of 15361 patients had had a stroke by 1 year; 170 (3%) of 6825 for whom atrial fi brillation was a primary diagnosis and 434 (5%) of 8536 for whom it was a secondary diagnosis (p<0.001). The highest number of strokes occurred in patients in Africa (89 [8%] of 1137), China (143 [7%] of 2023), and southeast Asia (88 [7%] of 1331) and the lowest occurred in India (20 [< 1%] of 2536). 94 (3%) of 3800 patients in North America, western Europe, and Australia had a stroke. Interpretation Marked unexplained inter- regional variations in the occurrence of stroke and mortality suggest that factors other than clinical variables might be important. Prevention of death from heart failure should be a major priority in the treatment of atrial fi brillation.	[Healey, Jeff S.; Wang, Jia; Grinvalds, Alex; Nakamya, Juliet; Yusuf, Salim; Connolly, Stuart J.] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada; [Oldgren, Jonas; Wallentin, Lars] Uppsala Clin Res, Uppsala, Sweden; [Ezekowitz, Michael] Lankenau Inst Med Res, Wynnewood, PA USA; [Zhu, Jun] Fuwai Hosp CAMS, Beijing, Peoples R China; [Zhu, Jun] PUMC, Beijing, Peoples R China; [Pais, Prem; Sigamani, Alben] St Johns Med Coll & Bangalore Res Inst, Bangalore, Karnataka, India; [Commerford, Patrick] Univ Cape Town, Dept Med, Cape Town, South Africa; [Jansky, Petr] Univ Hosp Motol, Prague, Czech Republic; [Avezum, Alvaro] Inst Dante Pazzanesse Cardiol, Sao Paulo, Brazil; [Demasceno, Albertino] Eduardo Mondlane Univ, Maputo, Mozambique; [Reilly, Paul] Boehringer Ingelheim GmbH & Co KG, Bieberach, Germany; [Aje, Akinyemi] Univ Coll Hosp, Ibadan, Nigeria; [Almahmeed, Wael] Sheikh Khalifa Med City, Abu Dhabi, U Arab Emirates; [Almahmeed, Wael] Cleveland Clin, Abu Dhabi, U Arab Emirates; [Moriarty, Andrew] Craigavon Area Hosp, Craigavon, County Armagh, North Ireland	McMaster University; Population Health Research Institute; Lankenau Medical Center; Lankenau Institute for Medical Research; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; St. John's National Academy of Health Sciences; St. John's Medical College; University of Cape Town; Motol University Hospital; Instituto Dante Pazzanese de Cardiologia; Eduardo Mondlane University; Boehringer Ingelheim; University of Ibadan; University College Hospital, Ibadan; Cleveland Clinic Foundation	Healey, JS (corresponding author), McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada.; Healey, JS (corresponding author), McMaster Univ, Populat Hlth Res Inst, David Braley Cardiovasc & Stroke Res Inst, Hamilton, ON L8L 2X2, Canada.	Jeff.Healey@phri.ca	Sigamani, Alben/GQH-0406-2022; Avezum, Alvaro/AAP-7687-2020; Ezekowitz, Michael/AAJ-2543-2021	Yusuf, Salim/0000-0003-4776-5601; SIGAMANI, ALBEN/0000-0002-6927-1947; AVEZUM, ALVARO/0000-0002-3073-6890	Boehringer Ingelheim	Boehringer Ingelheim(Boehringer Ingelheim)	This cohort study was funded by Boehringer Ingelheim. All data collection, management, and analyses were undertaken exclusively by the Population Health Research Institute in Hamilton (ON, Canada).	Atzema CL, 2013, ACAD EMERG MED, V20, P193, DOI 10.1111/acem.12078; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Boriani G, 2016, EUROPACE, V18, P648, DOI 10.1093/europace/euv390; Bungard TJ, 2000, ARCH INTERN MED, V160, P41, DOI 10.1001/archinte.160.1.41; Chow CK, 2013, JAMA-J AM MED ASSOC, V310, P959, DOI 10.1001/jama.2013.184182; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Dentali F, 2012, CIRCULATION, V126, P2381, DOI 10.1161/CIRCULATIONAHA.112.115410; Diker E, 1996, AM J CARDIOL, V77, P96, DOI 10.1016/S0002-9149(97)89145-X; Ezekowitz JA, 2005, CAN MED ASSOC J, V172, P189, DOI 10.1503/cmaj.1032017; Friberg L, 2015, EUR HEART J, V36, P297, DOI 10.1093/eurheartj/ehu139; Fuster V, 2006, J AM COLL CARDIOL, V48, P854, DOI 10.1016/j.jacc.2006.07.009; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hannan EL, 2005, MED CARE, V43, P726, DOI 10.1097/01.mlr.0000167802.27044.44; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Healey JS, 2006, CAN J CARDIOL, V22, P485, DOI 10.1016/S0828-282X(06)70265-3; Jones WJ, 2001, STROKE, V32, P2232, DOI 10.1161/hs1001.096191; Kaczorowski J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d442; Kakkar AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063479; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; Larsen TB, 2012, CIRC-CARDIOVASC QUAL, V5, P335, DOI 10.1161/CIRCOUTCOMES.111.964023; Le Heuzey JY, 2010, AM J CARDIOL, V105, P687, DOI 10.1016/j.amjcard.2009.10.012; Marijon E, 2007, NEW ENGL J MED, V357, P470, DOI 10.1056/NEJMoa065085; Marijon E, 2012, LANCET, V379, P953, DOI 10.1016/S0140-6736(11)61171-9; McDonald AJ, 2008, ANN EMERG MED, V51, P58, DOI 10.1016/j.annemergmed.2007.03.007; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Neal B, 2000, LANCET, V356, P1955; Nieuwlaat R, 2005, EUR HEART J, V26, P2422, DOI 10.1093/eurheartj/ehi505; Ntep-Gweth M, 2010, EUROPACE, V12, P482, DOI 10.1093/europace/euq006; Oldgren J, 2014, CIRCULATION, V129, P1568, DOI 10.1161/CIRCULATIONAHA.113.005451; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pilote L, 2013, CAN J CARDIOL, V29, P1241, DOI 10.1016/j.cjca.2012.09.021; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Skanes AC, 2012, CAN J CARDIOL, V28, P125, DOI 10.1016/j.cjca.2012.01.021; The World Bank, WORLD BANK LIST EC 2; Wann LS, 2011, HEART RHYTHM, V8, P157, DOI 10.1016/j.hrthm.2010.11.047; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; WOLF PA, 1978, NEUROLOGY, V28, P973, DOI 10.1212/WNL.28.10.973; World Bank, 2014, GDP PER CAP CONST 20; Zubaid M, 2015, ANGIOLOGY, V66, P464, DOI 10.1177/0003319714536980; Zubaid M, 2011, CIRC-CARDIOVASC QUAL, V4, P477, DOI 10.1161/CIRCOUTCOMES.110.959700	42	163	170	0	12	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2016	388	10050					1161	1169		10.1016/S0140-6736(16)30968-0	http://dx.doi.org/10.1016/S0140-6736(16)30968-0			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW5RA	27515684				2022-12-28	WOS:000383703100030
J	Lord, SR				Lord, Stephen R.			Virtual reality and the prevention of falls in the real world	LANCET			English	Editorial Material							GAIT ADAPTABILITY; DISEASE; PEOPLE; TRIAL; RISK		[Lord, Stephen R.] Univ New South Wales, NeuRA, Randwick, NSW 2031, Australia	Neuroscience Research Australia; University of New South Wales Sydney	Lord, SR (corresponding author), Univ New South Wales, NeuRA, Randwick, NSW 2031, Australia.	s.lord@neura.edu.au		Lord, Stephen R/0000-0002-7111-8802				Alamgir H, 2012, INJURY, V43, P2065, DOI 10.1016/j.injury.2011.12.001; Caetano MJD, 2016, GAIT POSTURE, V46, P35, DOI 10.1016/j.gaitpost.2016.02.003; Canning CG, 2014, NEURODEGENER DIS MAN, V4, P203, DOI [10.2217/nmt.14.22, 10.2217/NMT.14.22]; Henderson EJ, 2016, LANCET NEUROL, V15, P249, DOI 10.1016/S1474-4422(15)00389-0; Houdijk H, 2012, PHYS THER, V92, P1452, DOI 10.2522/ptj.20110362; Mirelman A, 2016, LANCET; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Okubo Y, 2017, BRIT J SPORT MED, V51, P586, DOI 10.1136/bjsports-2015-095452; Pai YC, 2014, J GERONTOL A-BIOL, V69, P1586, DOI 10.1093/gerona/glu087; Rubenstein LZ, 2006, AGE AGEING, V35, P37, DOI 10.1093/ageing/afl084; Schoene D, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-107; Sherrington C, 2008, J AM GERIATR SOC, V56, P2234, DOI 10.1111/j.1532-5415.2008.02014.x	12	2	2	0	17	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 17	2016	388	10050					1132	1134		10.1016/S0140-6736(16)31347-2	http://dx.doi.org/10.1016/S0140-6736(16)31347-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW5RA	27524394				2022-12-28	WOS:000383703100006
J	Kalladka, D; Sinden, J; Pollock, K; Haig, C; McLean, J; Smith, W; McConnachie, A; Santosh, C; Bath, PM; Dunn, L; Muir, KW				Kalladka, Dheeraj; Sinden, John; Pollock, Kenneth; Haig, Caroline; McLean, John; Smith, Wilma; McConnachie, Alex; Santosh, Celestine; Bath, Philip M.; Dunn, Laurence; Muir, Keith W.			Human neural stem cells in patients with chronic ischaemic stroke (PISCES): a phase 1, first-in-man study	LANCET			English	Article							THERAPY; LINE; NEUROTRANSPLANTATION; TRANSPLANTATION; CTX0E03; SCALE	Background CTX0E03 is an immortalised human neural stem-cell line from which a drug product (CTX-DP) was developed for allogeneic therapy. Dose-dependent improvement in sensorimotor function in rats implanted with CTX-DP 4 weeks after middle cerebral artery occlusion stroke prompted investigation of the safety and tolerability of this treatment in stroke patients. Methods We did an open-label, single-site, dose-escalation study. Men aged 60 years or older with stable disability (National Institutes of Health Stroke Scale [NIHSS] score >= 6 and modified Rankin Scale score 2-4) 6-60 months after ischaemic stroke were implanted with single doses of 2 million, 5 million, 10 million, or 20 million cells by stereotactic ipsilateral putamen injection. Clinical and brain imaging data were collected over 2 years. The primary endpoint was safety (adverse events and neurological change). This trial is registered with ClinicalTrials.gov, number NCT01151124. Findings 13 men were recruited between September, 2010, and January, 2013, of whom 11 (mean age 69 years, range 60-82) received CTX-DP. Median NIHSS score before implantation was 7 (IQR 6-8) and the mean time from stroke was 29 (SD 14) months. Three men had subcortical infarcts only and seven had right-hemisphere infarcts. No immunological or cell-related adverse events were seen. Other adverse events were related to the procedure or comorbidities. Hyperintensity around the injection tracts on T2-weighted fluid-attenuation inversion recovery MRI was seen in five patients. At 2 years, improvement in NIHSS score ranged from 0 to 5 (median 2) points. Interpretation Single intracerebral doses of CTX-DP up to 20 million cells induced no adverse events and were associated with improved neurological function. Our observations support further investigation of CTX-DP in stroke patients.	[Kalladka, Dheeraj; Smith, Wilma; Muir, Keith W.] Univ Glasgow, Queen Elizabeth Univ Hosp, Inst Neurosci & Psychol, Govan Rd, Glasgow G51 4TF, Lanark, Scotland; [Dunn, Laurence] Univ Glasgow, Queen Elizabeth Univ Hosp, Neurosurg, Inst Neurol Sci, Glasgow G51 4TF, Lanark, Scotland; [McLean, John; Santosh, Celestine] Univ Glasgow, Queen Elizabeth Univ Hosp, Dept Neuroradiol, Glasgow G51 4TF, Lanark, Scotland; [Sinden, John; Pollock, Kenneth] ReNeuron Ltd, Surrey Res Pk, Guildford, Surrey, England; [Haig, Caroline; McConnachie, Alex] Univ Glasgow, Robertson Ctr Biostat, Glasgow G51 4TF, Lanark, Scotland; [Bath, Philip M.] Univ Nottingham, Stroke Trials Unit, Div Clin Neurosci, Nottingham, England	Queen Elizabeth University Hospital (QEUH); University of Glasgow; Queen Elizabeth University Hospital (QEUH); University of Glasgow; Queen Elizabeth University Hospital (QEUH); University of Glasgow; University of Glasgow; University of Nottingham	Muir, KW (corresponding author), Univ Glasgow, Queen Elizabeth Univ Hosp, Inst Neurosci & Psychol, Govan Rd, Glasgow G51 4TF, Lanark, Scotland.	keith.muir@glasgow.ac.uk	Muir, Keith W/A-7670-2011; Bath, Philip/F-9020-2011	Muir, Keith W/0000-0001-9535-022X; Kalladka, Dheeraj/0000-0002-0484-1494; Bath, Philip/0000-0003-2734-5132	ReNeuron Limited.; MRC [MR/N003403/1] Funding Source: UKRI; National Institute for Health Research [NF-SI-0611-10003, NF-SI-0515-10044] Funding Source: researchfish	ReNeuron Limited.; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR))	ReNeuron Limited.	Acosta SA, 2015, STROKE, V46, P2616, DOI 10.1161/STROKEAHA.115.009854; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864; Chollet F, 2014, J NEUROL, V261, P1461, DOI 10.1007/s00415-013-7172-z; Cohen PD, 2012, LANCET NEUROL, V11, P1022, DOI 10.1016/S1474-4422(12)70277-6; Favre J, 2002, NEUROSURGERY, V50, P48; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garbe C, 2002, CANCER, V94, P2305, DOI 10.1002/cncr.10468; Gupta N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004373; Hassani Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050444; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Hicks C, 2013, CELL TRANSPLANT, V22, P1541, DOI 10.3727/096368912X657936; Jones DR, 2013, BRIT J CLIN PHARMACO, V76, P203, DOI 10.1111/bcp.12057; Kalladka D, 2014, STEM CELLS CLONING, V7, P31, DOI 10.2147/SCCAA.S38003; Kondziolka D, 2004, CELL TRANSPLANT, V13, P749, DOI 10.3727/000000004783983350; Kondziolka D, 2000, NEUROLOGY, V55, P565, DOI 10.1212/WNL.55.4.565; Kondziolka D, 2005, J NEUROSURG, V103, P38, DOI 10.3171/jns.2005.103.1.0038; Kwakkel G, 2004, STROKE, V35, P2529, DOI 10.1161/01.STR.0000143153.76460.7d; Magalhaes R, 2014, CEREBROVASC DIS, V38, P46, DOI 10.1159/000364938; MAHONEY F I, 1965, Md State Med J, V14, P61; Menotti A, 2001, J CLIN EPIDEMIOL, V54, P680, DOI 10.1016/S0895-4356(00)00368-1; Pendharkar AV, 2010, STROKE, V41, P2064, DOI 10.1161/STROKEAHA.109.575993; Pollock A, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001920.pub3; Pollock K, 2006, EXP NEUROL, V199, P143, DOI 10.1016/j.expneurol.2005.12.011; Quinn TJ, 2007, STROKE, V38, P2257, DOI 10.1161/STROKEAHA.106.480723; Saka O, 2009, AGE AGEING, V38, P27, DOI 10.1093/ageing/afn281; Savitz SI, 2005, CEREBROVASC DIS, V20, P101, DOI 10.1159/000086518; Smith EJ, 2012, STEM CELLS, V30, P785, DOI 10.1002/stem.1024; Stevanato L, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-86; Stroemer P, 2009, NEUROREHAB NEURAL RE, V23, P895, DOI 10.1177/1545968309335978; Thomas RJ, 2009, BIOTECHNOL LETT, V31, P1167, DOI 10.1007/s10529-009-9989-1; Uchida N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004371; Ullberg T, 2015, STROKE, V46, P389, DOI 10.1161/STROKEAHA.114.006538	34	235	251	1	55	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2016	388	10046					787	796		10.1016/S0140-6736(16)30513-X	http://dx.doi.org/10.1016/S0140-6736(16)30513-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT6UH	27497862	Green Accepted			2022-12-28	WOS:000381619200027
J	Lek, M; Karczewski, KJ; Minikel, EV; Samocha, KE; Banks, E; Fennell, T; O'Donnell-Luria, AH; Ware, JS; Hill, AJ; Cummings, BB; Tukiainen, T; Birnbaum, DP; Kosmicki, JA; Duncan, LE; Estrada, K; Zhao, FM; Zou, J; Pierce-Hollman, E; Berghout, J; Cooper, DN; Deflaux, N; DePristo, M; Do, R; Flannick, J; Fromer, M; Gauthier, L; Goldstein, J; Gupta, N; Howrigan, D; Kiezun, A; Kurki, MI; Moonshine, AL; Natarajan, P; Orozeo, L; Peloso, GM; Poplin, R; Rivas, MA; Ruano-Rubio, V; Rose, SA; Ruderfer, DM; Shakir, K; Stenson, PD; Stevens, C; Thomas, BP; Tiao, G; Tusie-Luna, MT; Weisburd, B; Won, HH; Yu, DM; Altshuler, DM; Ardissino, D; Boehnke, M; Danesh, J; Donnelly, S; Elosua, R; Florez, JC; Gabriel, SB; Getz, G; Glatt, SJ; Hultman, CM; Kathiresan, S; Laakso, M; NcCarroll, S; McCarthy, MI; McGovern, D; McPherson, R; Neale, BM; Palotie, A; Purcell, SM; Saleheen, D; Scharf, JM; Sklar, P; Sullivan, PF; Tuomilehto, J; Tsuang, MT; Watkins, HC; Wilson, JG; Daly, MJ; MacArthur, DG				Lek, Monkol; Karczewski, Konrad J.; Minikel, Eric V.; Samocha, Kaitlin E.; Banks, Eric; Fennell, Timothy; O'Donnell-Luria, Anne H.; Ware, James S.; Hill, Andrew J.; Cummings, Beryl B.; Tukiainen, Taru; Birnbaum, Daniel P.; Kosmicki, Jack A.; Duncan, Laramie E.; Estrada, Karol; Zhao, Fengmei; Zou, James; Pierce-Hollman, Emma; Berghout, Joanne; Cooper, David N.; Deflaux, Nicole; DePristo, Mark; Do, Ron; Flannick, Jason; Fromer, Menachem; Gauthier, Laura; Goldstein, Jackie; Gupta, Namrata; Howrigan, Daniel; Kiezun, Adam; Kurki, Mitja I.; Moonshine, Ami Levy; Natarajan, Pradeep; Orozeo, Lorena; Peloso, Gina M.; Poplin, Ryan; Rivas, Manuel A.; Ruano-Rubio, Valentin; Rose, Samuel A.; Ruderfer, Douglas M.; Shakir, Khalid; Stenson, Peter D.; Stevens, Christine; Thomas, Brett P.; Tiao, Grace; Tusie-Luna, Maria T.; Weisburd, Ben; Won, Hong-Hee; Yu, Dongmei; Altshuler, David M.; Ardissino, Diego; Boehnke, Michael; Danesh, John; Donnelly, Stacey; Elosua, Roberto; Florez, Jose C.; Gabriel, Stacey B.; Getz, Gad; Glatt, Stephen J.; Hultman, Christina M.; Kathiresan, Sekar; Laakso, Markku; NcCarroll, Steven; McCarthy, Mark I.; McGovern, Dermot; McPherson, Ruth; Neale, Benjamin M.; Palotie, Aarno; Purcell, Shaun M.; Saleheen, Danish; Scharf, Jeremiah M.; Sklar, Pamela; Sullivan, Patrick F.; Tuomilehto, Jaakko; Tsuang, Ming T.; Watkins, Hugh C.; Wilson, James G.; Daly, Mark J.; MacArthur, Daniel G.		Exome Aggregation Consortium	Analysis of protein-coding genetic variation in 60,706 humans	NATURE			English	Article							HUMAN-POPULATION HISTORY; HUMAN-DISEASE; SEQUENCE VARIANTS; MUTATION; GUIDELINES; EVOLUTION; DISCOVERY; FRAMEWORK; NETWORKS	Large-scale reference data sets of human genetic variation are critical for the medical and functional interpretation of DNA sequence changes. Here we describe the aggregation and analysis of high-quality exome (protein-coding region) DNA sequence data for 60,706 individuals of diverse ancestries generated as part of the Exome Aggregation Consortium (ExAC). This catalogue of human genetic diversity contains an average of one variant every eight bases of the exome, and provides direct evidence for the presence of widespread mutational recurrence. We have used this catalogue to calculate objective metrics of pathogenicity for sequence variants, and to identify genes subject to strong selection against various classes of mutation; identifying 3,230 genes with near-complete depletion of predicted protein-truncating variants, with 72% of these genes having no currently established human disease phenotype. Finally, we demonstrate that these data can be used for the efficient filtering of candidate disease-causing variants, and for the discovery of human 'knockout' variants in protein-coding genes.	[Lek, Monkol; Karczewski, Konrad J.; Minikel, Eric V.; Samocha, Kaitlin E.; O'Donnell-Luria, Anne H.; Hill, Andrew J.; Cummings, Beryl B.; Tukiainen, Taru; Kosmicki, Jack A.; Duncan, Laramie E.; Estrada, Karol; Pierce-Hollman, Emma; Fromer, Menachem; Goldstein, Jackie; Howrigan, Daniel; Thomas, Brett P.; Neale, Benjamin M.; Palotie, Aarno; Daly, Mark J.; MacArthur, Daniel G.] Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA; [Lek, Monkol; Karczewski, Konrad J.; Minikel, Eric V.; Samocha, Kaitlin E.; Banks, Eric; O'Donnell-Luria, Anne H.; Ware, James S.; Hill, Andrew J.; Cummings, Beryl B.; Tukiainen, Taru; Birnbaum, Daniel P.; Kosmicki, Jack A.; Duncan, Laramie E.; Estrada, Karol; Zou, James; Pierce-Hollman, Emma; Flannick, Jason; Goldstein, Jackie; Gupta, Namrata; Howrigan, Daniel; Kurki, Mitja I.; Natarajan, Pradeep; Peloso, Gina M.; Rivas, Manuel A.; Stevens, Christine; Thomas, Brett P.; Weisburd, Ben; Altshuler, David M.; Donnelly, Stacey; Florez, Jose C.; Gabriel, Stacey B.; Kathiresan, Sekar; Neale, Benjamin M.; Palotie, Aarno; Scharf, Jeremiah M.; Daly, Mark J.; MacArthur, Daniel G.] Broad Inst MIT & Harvard, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Lek, Monkol] Univ Sydney, Sch Paediat & Child Hlth, Sydney, NSW 2145, Australia; [Lek, Monkol] Childrens Hosp VVestmead, Inst Neurosci & Muscle Res, Sydney, NSW 2145, Australia; [Minikel, Eric V.; Samocha, Kaitlin E.; Cummings, Beryl B.; Palotie, Aarno] Harvard Med Sch, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Samocha, Kaitlin E.; Kosmicki, Jack A.; Duncan, Laramie E.; Fromer, Menachem; Goldstein, Jackie; Howrigan, Daniel; Rose, Samuel A.; Yu, Dongmei; NcCarroll, Steven; Neale, Benjamin M.; Scharf, Jeremiah M.; Daly, Mark J.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [O'Donnell-Luria, Anne H.] Boston Childrens Hosp, Div Genet & Genom, Boston, MA 02115 USA; [Ware, James S.; NcCarroll, Steven] Harvard Med Sch, Dept Genet, Boston, MA 02115 USA; [Ware, James S.] Imperial Coll London, Natl Heart & Lung Inst, London SW7 2AZ, England; [Ware, James S.] Royal Brompton Hosp, NIHR Royal Brompton Cardiovasc Biomed Res Unit, London SW3 6NP, England; [Ware, James S.] Imperial Coll London, MRC Clin Sci Ctr, London SW7 2AZ, England; [Hill, Andrew J.; Zhao, Fengmei] Univ Washington, Genome Sci, Seattle, WA 98195 USA; [Kosmicki, Jack A.] Harvard Med Sch, Program Bioinformat & Integrat Genom, Boston, MA 02115 USA; [Berghout, Joanne] Jackson Lab, Mouse Genome Informat, 600 Main St, Bar Harbor, ME 04609 USA; [Berghout, Joanne] Univ Arizona, Ctr Biomed Informat & Biostat, Tucson, AZ 85721 USA; [Cooper, David N.; Stenson, Peter D.] Cardiff Univ, Inst Med Genet, Cardiff CF10 3XQ, S Glam, Wales; [Deflaux, Nicole] Google, Mountain View, CA 94043 USA; [DePristo, Mark; Gauthier, Laura; Kiezun, Adam; Moonshine, Ami Levy; Poplin, Ryan; Ruano-Rubio, Valentin; Shakir, Khalid; Tiao, Grace; Getz, Gad] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Do, Ron; Fromer, Menachem; Ruderfer, Douglas M.; Purcell, Shaun M.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Fennell, Timothy; Do, Ron; Fromer, Menachem; Ruderfer, Douglas M.; Purcell, Shaun M.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Inst Genom & Multiscale Biol, New York, NY 10029 USA; [Do, Ron] Icahn Sch Med Mt Sinai, Charles Bronfman Inst Personalized Med, New York, NY 10029 USA; [Do, Ron] Icahn Sch Med Mt Sinai, Ctr Stat Genet, New York, NY 10029 USA; [Flannick, Jason] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Fromer, Menachem; Ruderfer, Douglas M.; Purcell, Shaun M.; Sklar, Pamela] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Kurki, Mitja I.; Yu, Dongmei; Scharf, Jeremiah M.] Massachusetts Gen Hosp, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Natarajan, Pradeep; Florez, Jose C.; Getz, Gad; Kathiresan, Sekar] Harvard Med Sch, Boston, MA 02115 USA; [Natarajan, Pradeep; Peloso, Gina M.; Yu, Dongmei; Florez, Jose C.; Kathiresan, Sekar; Scharf, Jeremiah M.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Natarajan, Pradeep; Peloso, Gina M.; Kathiresan, Sekar] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Orozeo, Lorena] Inst Nacl Med Genom, Immunogen & Metab Dis Lab, Mexico City 14610, DF, Mexico; [Tusie-Luna, Maria T.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mol Biol & Genom Med Unit, Mexico City 14080, DF, Mexico; [Won, Hong-Hee] Sungkyunkwan Univ, Samsung Med Ctr, Samsung Adv Inst Hlth Sci & Technol SAIHST, Seoul, South Korea; [Yu, Dongmei; Scharf, Jeremiah M.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Altshuler, David M.] Vertex Pharmaceut, Boston, MA 02210 USA; [Ardissino, Diego] Univ Hosp, Dept Cardiol, I-43100 Parma, Italy; [Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Boehnke, Michael] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Danesh, John] Strangeways Res Lab, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Elosua, Roberto] Hosp Mar Med Res Inst, Cardiovasc Epidemiol & Genet, Barcelona 08003, Spain; [Getz, Gad] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Getz, Gad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Glatt, Stephen J.] SUNY Upstate Med Univ, Psychiat Genet Epidemiol & Neurobiol Lab, Syracuse, NY 13210 USA; [Glatt, Stephen J.] SUNY Upstate Med Univ, Dept Psychiat & Behav Sci, Syracuse, NY 13210 USA; [Glatt, Stephen J.] SUNY Upstate Med Univ, Dept Neurobiol & Physiol, Syracuse, NY 13210 USA; [Hultman, Christina M.] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio 70211, Finland; [Laakso, Markku] Kuopio Univ Hosp, Kuopio 70211, Finland; [McCarthy, Mark I.; Watkins, Hugh C.] Univ Oxford, Wellcome Trust Ctr Human Genet, S Parks Rd, Oxford OX1 2JD, England; [McCarthy, Mark I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, S Parks Rd, Oxford OX1 2JD, England; [McCarthy, Mark I.] Oxford Univ Hosp Fdn Trust, Oxford NIHR Biomed Res Ctr, Oxford OX1 2JD, England; [McGovern, Dermot] Cedars Sinai Med Ctr, Inflammatory Bowel Dis & Immunobiol Res Inst, Los Angeles, CA 90048 USA; [McPherson, Ruth] Univ Ottawa, Atherogen Lab, Inst Heart, Ottawa, ON K1Y 4W7, Canada; [Palotie, Aarno] Univ Helsinki, Inst Mol Med Finland FIMM, SF-00100 Helsinki, Finland; [Saleheen, Danish] Univ Penn, Dept Biostat & Epidemiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Saleheen, Danish] Univ Penn, Dept Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Saleheen, Danish] Ctr Noncommunicable Dis, Karachi, Pakistan; [Sklar, Pamela] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Sklar, Pamela] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Sullivan, Patrick F.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Sullivan, Patrick F.] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Tuomilehto, Jaakko] Univ Helsinki, Dept Publ Hlth, SF-00100 Helsinki, Finland; [Tsuang, Ming T.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Watkins, Hugh C.] Univ Oxford, Racicliffe Dept Med, S Parks Rd, Oxford OX1 2JD, England; [Wilson, James G.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Sydney; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Imperial College London; Royal Brompton Hospital; Imperial College London; University of Washington; University of Washington Seattle; Harvard University; Harvard Medical School; Jackson Laboratory; University of Arizona; Cardiff University; Google Incorporated; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Icahn School of Medicine at Mount Sinai; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Instituto Nacional de Medicina Genomica; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Samsung; Sungkyunkwan University (SKKU); Samsung Medical Center; Harvard University; Massachusetts General Hospital; Vertex Pharmaceuticals; University of Parma; University Hospital of Parma; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Karolinska Institutet; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Cedars Sinai Medical Center; University of Ottawa; University of Ottawa Heart Institute; University of Helsinki; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of North Carolina; University of North Carolina Chapel Hill; Karolinska Institutet; University of Helsinki; University of California System; University of California San Diego; University of Oxford; University of Mississippi; University of Mississippi Medical Center	MacArthur, DG (corresponding author), Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02114 USA.	danmac@broadinstitute.org	Bergen, Sarah/I-8313-2012; Rivas, Manuel/ABE-8173-2020; Duncan, Laramie/AAG-6605-2019; Ware, James S/G-5139-2012; Bjørkhaug, Lise/AAA-4356-2021; Cooper, David N/H-4384-2011; Won, Hong-Hee/D-2672-2011; Ardissino, Diego/AAC-4041-2022; Altshuler, David M/A-4476-2009; Pinheiro, Maísa/E-7424-2012; Kurki, Mitja/GWM-5671-2022; Ruderfer, Douglas M/M-5795-2016; Daly, Mark J/B-2453-2017; Natarajan, Pradeep/H-9764-2019; Duncan, Laramie/AAW-5306-2021; Berghout, Joanne/M-5493-2017; Magnusson, Patrik/C-4458-2017; McCarthy, Mark/M-3763-2015	Bergen, Sarah/0000-0002-5888-0034; Rivas, Manuel/0000-0003-1457-9925; Ware, James S/0000-0002-6110-5880; Bjørkhaug, Lise/0000-0002-9695-4559; Cooper, David N/0000-0002-8943-8484; Won, Hong-Hee/0000-0001-5719-0552; Altshuler, David M/0000-0002-7250-4107; Ruderfer, Douglas M/0000-0002-2365-386X; Daly, Mark J/0000-0002-0949-8752; Natarajan, Pradeep/0000-0001-8402-7435; Berghout, Joanne/0000-0002-9250-9159; solinas, emilia/0000-0003-3532-1317; Huerta-Chagoya, Alicia/0000-0001-6218-3904; Minikel, Eric Vallabh/0000-0003-2206-1608; Marrugat, Jaume/0000-0003-3320-554X; MacArthur, Daniel/0000-0002-5771-2290; Duncan, Laramie/0000-0003-1131-661X; Palotie, Aarno/0000-0002-2527-5874; ELOSUA, ROBERTO/0000-0001-8235-0095; Magnusson, Patrik/0000-0002-7315-7899; Hopewell, Jemma/0000-0002-3870-8018; Hattersley, Andrew/0000-0001-5620-473X; Rose, Samuel/0000-0001-9701-0050; Fuchsberger, Christian/0000-0002-5918-8947; Revilla Monsalve, Maria Cristina/0000-0002-6202-1160; Yu, Dongmei/0000-0001-7901-4365; Tukiainen, Taru/0000-0002-5404-8398; Watkins, Hugh/0000-0002-5287-9016; Goel, Anuj/0000-0003-2307-4021; Samocha, Kaitlin/0000-0002-1704-3352; O'Donnell-Luria, Anne/0000-0001-6418-9592; Barr, Cathy/0000-0003-0361-0106; Blangero, John/0000-0001-6250-5723; Orozco, Lorena/0000-0002-5801-9180; Mercader, Josep M/0000-0001-8494-3660; Grados, Marco/0000-0002-6189-6264; Garcia-Ortiz, Humberto/0000-0002-0453-980X; Kyriakou, Theodosios/0000-0001-7794-8789; Cummings, Beryl/0000-0001-6346-1646; McCarthy, Mark/0000-0002-4393-0510; Moran, Jennifer/0000-0002-5664-4716; Deflaux, Nicole/0000-0002-9421-8048; Posthuma, Danielle/0000-0001-7582-2365; Meitinger, Thomas/0000-0002-8838-8403	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107816, R01HL024799, K01HL125751, T32HL007208] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067, U41HG000330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK085584, U01DK085501, U01DK062370, U01DK085545, U01DK085526, R01DK062370, P30DK020572, P30DK043351, RC2DK088389, R01DK098032, U54DK105566, U01DK085524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM104371, F32GM115208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [RC2MH089905, U01MH094432, R01MH085521, P50MH066392, R01MH085560, R01MH095034, U01MH094421, R01MH077139] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS040024, U01NS040024, K02NS085048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG038072] Funding Source: NIH RePORTER; Medical Research Council [MR/L010305/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10087, NF-SI-0611-10219, NF-SI-0611-10099, NF-SI-0507-10228, NF-SI-0514-10027] Funding Source: researchfish; Wellcome Trust [107469/Z/15/Z] Funding Source: researchfish; MRC [G0801418, MC_UP_1102/20, G0601261, MR/L003120/1, G0800509] Funding Source: UKRI; British Heart Foundation [FS/14/55/30806] Funding Source: Medline; CIHR [MOP136936, MOP77682, MOP82810] Funding Source: Medline; Medical Research Council [G0601261, G0800509, MR/L003120/1, G0801418, MC_UP_1102/20] Funding Source: Medline; NHGRI NIH HHS [5 U54 HG003067-13, 5U54HG003067-11, U41 HG000330, U54HG003067] Funding Source: Medline; NHLBI NIH HHS [R01HL24799, HHSN268201300046C, K01HL125751, HHSN268201300049C, HHSN268201300047C, HHSN268201300050C, T32 HL007208, HHSN268201300048C, K01 HL125751, R01HL107816] Funding Source: Medline; NIA NIH HHS [P30 AG038072] Funding Source: Medline; NIDDK NIH HHS [U01 DK085545, 1RC2DK088389, U01 DK085501, P30 DK043351, U01 DK085526, DK085545, RC2DK088389, R01 DK098032, U01DK085526, R01DK062370, R01DK098032, U01 DK085584, U01 DK085524, P30 DK020572, RC2F DK088389, U54 DK105566, RC2-DK088389, U01-DK085545, U01 DK062370, DK098032, DK088389] Funding Source: Medline; NIGMS NIH HHS [R01 GM104371, F32GM115208] Funding Source: Medline; NIMH NIH HHS [MH089905, R01 MH077139, MH095034, R01MH085560, R01MH085521, U01 MH094432, MH077139, 2P50MH066392-05A1, MH094421] Funding Source: Medline; NINDS NIH HHS [U01 NS040024, K02 NS085048, NS40024-09S1, U01 NS40024-09S1, NS085048] Funding Source: Medline; PHS HHS [NIMHRC2MH089905] Funding Source: Medline; Wellcome Trust [090367, 090532, 098381] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); CIHR(Canadian Institutes of Health Research (CIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); Wellcome Trust(Wellcome Trust)		Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bamshad MJ, 2011, NAT REV GENET, V12, P745, DOI 10.1038/nrg3031; Bell CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001756; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Chagnon P, 2002, AM J HUM GENET, V71, P1443, DOI 10.1086/344580; Chong JX, 2015, AM J HUM GENET, V97, P199, DOI 10.1016/j.ajhg.2015.06.009; COOPER DN, 1988, HUM GENET, V78, P151, DOI 10.1007/BF00278187; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dewey FE, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005496; Fitzgerald TW, 2015, NATURE, V519, P223, DOI 10.1038/nature14135; Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gudbjartsson DF, 2015, NAT GENET, V47, P435, DOI 10.1038/ng.3247; Itan Y, 2015, P NATL ACAD SCI USA, V112, P13615, DOI 10.1073/pnas.1518646112; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kathiresan S, 2015, J AM COLL CARDIOL, V65, P1562, DOI 10.1016/j.jacc.2015.02.049; Li H, 2011, NATURE, V475, P493, DOI 10.1038/nature10231; Lim ET, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004494; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Minikel EV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad5169; Narasimhan V. M., 2016, SCIENCE; Petrovski S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003709; Piton A, 2013, AM J HUM GENET, V93, P368, DOI 10.1016/j.ajhg.2013.06.013; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Ruderfer D. M., 2016, NATURE GENET; Saleheen D., 2015, HUMAN KNOCKOUTS COHO; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Stoneking M, 2011, NAT REV GENET, V12, P603, DOI 10.1038/nrg3029; Sulem P, 2015, NAT GENET, V47, P448, DOI 10.1038/ng.3243; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Vicoso B, 2006, NAT REV GENET, V7, P645, DOI 10.1038/nrg1914; Voight BF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002793; Xue YL, 2012, AM J HUM GENET, V91, P1022, DOI 10.1016/j.ajhg.2012.10.015; Zook JM, 2014, NAT BIOTECHNOL, V32, P246, DOI 10.1038/nbt.2835	40	6505	6588	23	412	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					285	+		10.1038/nature19057	http://dx.doi.org/10.1038/nature19057			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27535533	Green Submitted, Green Accepted, hybrid, Green Published			2022-12-28	WOS:000381804900026
J	Davis, C; Lexchin, J; Jefferson, T; Gotzsche, P; McKee, M				Davis, Courtney; Lexchin, Joel; Jefferson, Tom; Gotzsche, Peter; McKee, Martin			"Adaptive pathways" to drug authorisation: adapting to industry?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIALS; VITAMIN-E CONSUMPTION; SURROGATE END-POINTS; RISK; DISEASE; MEDICINES; SAFETY; WOMEN		[Davis, Courtney] Kings Coll London, Dept Social Sci Hlth & Med, London, England; [Lexchin, Joel] York Univ, Sch Hlth Policy & Management, Toronto, ON, Canada; [Jefferson, Tom] Ctr Evidence Based Med, Oxford, England; [Gotzsche, Peter] Rigshosp, Nord Cochrane Ctr, Copenhagen, Denmark; [McKee, Martin] London Sch Hyg & Trop Med, London, England	University of London; King's College London; York University - Canada; University of Oxford; Rigshospitalet; University of Copenhagen; University of London; London School of Hygiene & Tropical Medicine	Davis, C (corresponding author), Kings Coll London, Dept Social Sci Hlth & Med, London, England.	courtney.davis@kcl.ac.uk	Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011	Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X	Economic and Social Research Council [ES/J006610/2, ES/J006610/1] Funding Source: researchfish; ESRC [ES/J006610/2, ES/J006610/1] Funding Source: UKRI	Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; Albert RK, 2013, AM J RESP CRIT CARE, V187, P1173, DOI 10.1164/rccm.201212-2187OE; Alpha-Tocopherol Beta Carotene Cancer Prevention Study Group, 1994, N Engl J Med, V330, P1029, DOI 10.1056/NEJM199404143301501; Arlett P, 2014, NAT REV DRUG DISCOV, V13, P395, DOI 10.1038/nrd3713-c1; Arrowsmith J, 2011, NAT REV DRUG DISCOV, V10, P1, DOI 10.1038/nrd3375; Avorn J, 2013, JAMA-J AM MED ASSOC, V309, P1349, DOI 10.1001/jama.2013.623; Banzi R, 2015, EUR J INTERN MED, V26, P572, DOI 10.1016/j.ejim.2015.08.008; Booth CM, 2014, BRIT J CANCER, V110, P551, DOI 10.1038/bjc.2013.725; Chalkidou K, 2012, CLIN TRIALS, V9, P436, DOI 10.1177/1740774512450097; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; D'Agostino RB, 2011, NEW ENGL J MED, V365, DOI [10.1056/nejmp1106984, 10.1056/NEJMp1106984]; Davis C., 2013, UNHEALTHY PHARM REGU, DOI [10.1057/9781137349477, DOI 10.1057/9781137349477]; Eichler HG, 2015, CLIN PHARMACOL THER, V97, P234, DOI 10.1002/cpt.59; European Agency for the Evaluation of Medicinal Products, 2002, EMEACPMP2484402; European Medicines Agency, 2016, AD PATHW; European Medicines Agency, 2016, EMA1808152016; European Medicines Agency, EMA2543502012; European Medicines Agency, 2014, SUMM RISK MAN PLAN R; Fleming TR, 2012, STAT MED, V31, P2973, DOI 10.1002/sim.5403; Fojo T, 2014, JAMA OTOLARYNGOL, V140, P1225, DOI 10.1001/jamaoto.2014.1570; Gibson SG, 2014, MED LAW REV, V22, P200, DOI 10.1093/medlaw/fwu005; Gonsalves G, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1500; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; Health Action International International Society of Drug Bulletins Istituto di Recerche Farmacologiche Mario Negri, 2015, INT SOC DRUG B I REC; Hemkens LG, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i493; Hoekman J, 2016, BRIT J CLIN PHARMACO, V82, P213, DOI 10.1111/bcp.12940; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; IQWIG, 2016, AD PATHW EMA STILL L; Jefferson T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g2263; Keaney JF, 2016, NEW ENGL J MED, V374, P1279, DOI 10.1056/NEJMe1602846; Khaw KT, 2001, LANCET, V357, P657, DOI 10.1016/S0140-6736(00)04128-3; Klungel OH, 2016, PHARMACOEPIDEM DR S, V25, P156, DOI 10.1002/pds.3968; Lexchin J, 2015, BRIT J CLIN PHARMACO, V79, P847, DOI 10.1111/bcp.12552; Mauri L, 2012, NEW ENGL J MED, V366, P1538, DOI 10.1056/NEJMe1202866; McCabe Christopher, 2010, BMJ, V340, pc1786, DOI 10.1136/bmj.c1786; Montori VM, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1663; Moore T, 2015, DRUG SAFETY, V38, P601, DOI 10.1007/s40264-015-0305-9; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P255, DOI 10.1038/nrd3713; Mullard A, 2011, LANCET, V377, P890, DOI 10.1016/S0140-6736(11)60334-6; Naci H, 2015, ANNU REV PHARMACOL, V55, P169, DOI 10.1146/annurev-pharmtox-010814-124614; Naci H, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4261; Pereira TV, 2012, JAMA-J AM MED ASSOC, V308, P1676, DOI 10.1001/jama.2012.13444; Prasad V, 2015, JAMA INTERN MED, V175, P1389, DOI 10.1001/jamainternmed.2015.2829; Prasad V, 2012, JAMA-J AM MED ASSOC, V307, P37, DOI 10.1001/jama.2011.1960; Prasad V, 2011, ARCH INTERN MED, V171, P1675, DOI 10.1001/archinternmed.2011.295; Rawlins M, 2008, LANCET, V372, P2152, DOI 10.1016/S0140-6736(08)61930-3; Reynolds RF, 2016, PHARMACOEPIDEM DR S, V25, P5, DOI 10.1002/pds.3933; RIMM EB, 1993, NEW ENGL J MED, V328, P1450, DOI 10.1056/NEJM199305203282004; Shumaker SA, 2004, JAMA-J AM MED ASSOC, V291, P2947, DOI 10.1001/jama.291.24.2947; STAMPFER MJ, 1993, NEW ENGL J MED, V328, P1444, DOI 10.1056/NEJM199305203282003; Svensson S, 2013, JAMA INTERN MED, V173, P611, DOI 10.1001/jamainternmed.2013.3037; Tatsioni A, 2007, JAMA-J AM MED ASSOC, V298, P2517, DOI 10.1001/jama.298.21.2517; US Government Accountability Office, 2015, DRUG SAF FDA EXP MAN; Wood AJJ, 1999, JAMA-J AM MED ASSOC, V281, P1753, DOI 10.1001/jama.281.18.1753; Zuckerman DM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6122	56	27	27	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2016	354								i4437	10.1136/bmj.i4437	http://dx.doi.org/10.1136/bmj.i4437			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GX	27531201	Green Published			2022-12-28	WOS:000381806200004
J	Sen, P; Shah, PP; Nativio, R; Berger, SL				Sen, Payel; Shah, Parisha P.; Nativio, Raffaella; Berger, Shelley L.			Epigenetic Mechanisms of Longevity and Aging	CELL			English	Review							EXTENDS LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; DNA METHYLATION; SENESCENT CELLS; GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; STRESS RESISTANCE; GROWTH-HORMONE; MUTANT MICE	Aging is an inevitable outcome of life, characterized by progressive decline in tissue and organ function and increased risk of mortality. Accumulating evidence links aging to genetic and epigenetic alterations. Given the reversible nature of epigenetic mechanisms, these pathways provide promising avenues for therapeutics against age-related decline and disease. In this review, we provide a comprehensive overview of epigenetic studies from invertebrate organisms, vertebrate models, tissues, and in vitro systems. We establish links between common operative aging pathways and hallmark chromatin signatures that can be used to identify "druggable'' targets to counter human aging and age-related disease.	[Sen, Payel; Shah, Parisha P.; Nativio, Raffaella; Berger, Shelley L.] Univ Penn, Dept Cell & Dev Biol, Epigenet Program, Philadelphia, PA 19130 USA	University of Pennsylvania	Berger, SL (corresponding author), Univ Penn, Dept Cell & Dev Biol, Epigenet Program, Philadelphia, PA 19130 USA.	bergers@upenn.edu	Sen, Payel/AAY-6834-2020	Berger, Shelley/0000-0001-5398-4400	American Heart Association [15POST21230000]; National Institutes of Health/National Institute on Aging (NIH/NIA) [P01AG031862]; National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) [R01NS078283]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS078283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG031862, ZIAAG000679] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health/National Institute on Aging (NIH/NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Jiajun Zhu for contributions in conceptualizing Figure 1. We acknowledge funding sources: American Heart Association postdoctoral grant 15POST21230000 to P.S.; National Institutes of Health/National Institute on Aging (NIH/NIA) P01AG031862 and National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) R01NS078283 to S.L.B.	Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Armstrong VL, 2014, J GERONTOL A-BIOL, V69, P923, DOI 10.1093/gerona/glt133; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; Bartholomew B, 2014, ANNU REV BIOCHEM, V83, P671, DOI 10.1146/annurev-biochem-051810-093157; Bartke A, 2004, CURR TOP DEV BIOL, V63, P189, DOI 10.1016/S0070-2153(04)63006-7; Bartke A, 2000, RES PRO CEL, V29, P181; Baumgart M, 2014, AGING CELL, V13, P965, DOI 10.1111/acel.12257; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Benayoun BA, 2015, NAT REV MOL CELL BIO, V16, P593, DOI 10.1038/nrm4048; Bergo MO, 2002, P NATL ACAD SCI USA, V99, P13049, DOI 10.1073/pnas.192460799; Booth LN, 2016, MOL CELL, V62, P728, DOI 10.1016/j.molcel.2016.05.013; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Brandt A, 2013, ADV BIOCHEM ENG BIOT, V135, P63, DOI 10.1007/10_2013_193; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Burtner CR, 2010, NAT REV MOL CELL BIO, V11, P567, DOI 10.1038/nrm2944; Capell BC, 2016, GENE DEV, V30, P321, DOI 10.1101/gad.271882.115; Capuano F, 2014, ANAL CHEM, V86, P3697, DOI 10.1021/ac500447w; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chandra T, 2012, MOL CELL, V47, P203, DOI 10.1016/j.molcel.2012.06.010; Chen D, 2013, CELL REP, V5, P1600, DOI 10.1016/j.celrep.2013.11.018; Chen HF, 2012, NUCLEIC ACIDS RES, V40, P6534, DOI 10.1093/nar/gks345; Chen Y, 2012, MOL CELL PROTEOMICS, V11, P1048, DOI 10.1074/mcp.M112.019547; Clancy DJ, 2001, SCIENCE, V292, P104, DOI 10.1126/science.1057991; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Corrigan DP, 2005, BIOCHEM J, V387, P129, DOI 10.1042/BJ20041359; Cournil A, 2001, TRENDS GENET, V17, P233, DOI 10.1016/S0168-9525(01)02306-X; Crawford D, 2007, AGING CELL, V6, P715, DOI 10.1111/j.1474-9726.2007.00327.x; Cruickshanks HA, 2013, NAT CELL BIOL, V15, P1495, DOI 10.1038/ncb2879; Dai J, 2008, CELL, V134, P1066, DOI 10.1016/j.cell.2008.07.019; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Damelin M, 2002, MOL CELL, V9, P563, DOI 10.1016/S1097-2765(02)00475-6; Dang W, 2014, CELL METAB, V19, P952, DOI 10.1016/j.cmet.2014.04.004; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; De Cecco M, 2013, AGING-US, V5, P867, DOI 10.18632/aging.100621; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dhahbi JM, 2004, P NATL ACAD SCI USA, V101, P5524, DOI 10.1073/pnas.0305300101; Di Micco R, 2011, NAT CELL BIOL, V13, P292, DOI 10.1038/ncb2170; Dou ZX, 2015, NATURE, V527, P105, DOI 10.1038/nature15548; Driscoll R, 2007, SCIENCE, V315, P649, DOI 10.1126/science.1135862; EICHER EM, 1976, J HERED, V67, P87, DOI 10.1093/oxfordjournals.jhered.a108682; Eriksson M, 2003, NATURE, V423, P293, DOI 10.1038/nature01629; Fabrizio P, 2003, GENETICS, V163, P35; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Feser J, 2010, MOL CELL, V39, P724, DOI 10.1016/j.molcel.2010.08.015; Flurkey K, 2001, P NATL ACAD SCI USA, V98, P6736, DOI 10.1073/pnas.111158898; Frankel S, 2005, AGING CELL, V4, P53, DOI 10.1111/j.1474-9726.2005.00143.x; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; FRIEDMAN DB, 1988, GENETICS, V118, P75; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Greer EL, 2007, CURR BIOL, V17, P1646, DOI 10.1016/j.cub.2007.08.047; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; Greer EL, 2015, CELL, V161, P868, DOI 10.1016/j.cell.2015.04.005; Grillari J, 2010, ADV EXP MED BIOL, V694, P172; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Han JH, 2007, SCIENCE, V315, P653, DOI 10.1126/science.1133234; Han S, 2012, TRENDS CELL BIOL, V22, P42, DOI 10.1016/j.tcb.2011.11.001; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Harel I, 2015, CELL, V160, P1013, DOI 10.1016/j.cell.2015.01.038; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hartman TK, 2007, NEUROBIOL AGING, V28, P921, DOI 10.1016/j.neurobiolaging.2006.05.012; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Hirth F, 2010, CNS NEUROL DISORD-DR, V9, P504, DOI 10.2174/187152710791556104; Horvath S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0649-6; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Hu Z, 2014, GENE DEV, V28, P396, DOI 10.1101/gad.233221.113; Ivanov A, 2013, J CELL BIOL, V202, P129, DOI 10.1083/jcb.201212110; Ivanschitz L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00171; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jin CY, 2011, CELL METAB, V14, P161, DOI 10.1016/j.cmet.2011.07.001; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059; KENNEDY BK, 1995, CELL, V80, P485, DOI 10.1016/0092-8674(95)90499-9; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kim S, 1999, MOL BIOL CELL, V10, P3125, DOI 10.1091/mbc.10.10.3125; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kozak ML, 2010, EMBO J, V29, P158, DOI 10.1038/emboj.2009.314; Kreiling JA, 2011, AGING CELL, V10, P292, DOI 10.1111/j.1474-9726.2010.00666.x; Kudlow BA, 2007, NAT REV MOL CELL BIO, V8, P394, DOI 10.1038/nrm2161; Kvam E, 2007, AUTOPHAGY, V3, P85, DOI 10.4161/auto.3586; Li L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001221; Li WS, 2007, DEV CELL, V12, P235, DOI 10.1016/j.devcel.2006.12.002; Libert S, 2013, ANNU REV PHYSIOL, V75, P669, DOI 10.1146/annurev-physiol-030212-183800; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lin MJ, 2005, J BIOL CHEM, V280, P861, DOI 10.1074/jbc.C400477200; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Longo VD, 1999, NEUROBIOL AGING, V20, P479, DOI 10.1016/S0197-4580(99)00089-5; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Matsumoto T, 2007, STROKE, V38, P1050, DOI 10.1161/01.STR.0000257967.86132.01; Maures TJ, 2011, AGING CELL, V10, P980, DOI 10.1111/j.1474-9726.2011.00738.x; MCCAY CM, 1989, NUTRITION, V5, P155; McColl G, 2008, J BIOL CHEM, V283, P350, DOI 10.1074/jbc.M705028200; McCord RP, 2013, GENOME RES, V23, P260, DOI 10.1101/gr.138032.112; McCormick MA, 2015, CELL METAB, V22, P895, DOI 10.1016/j.cmet.2015.09.008; McCormick MA, 2014, CELL REP, V8, P476, DOI 10.1016/j.celrep.2014.06.037; McCormick MA, 2011, PHILOS T R SOC B, V366, P17, DOI 10.1098/rstb.2010.0198; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Mitchell SJ, 2014, CELL REP, V6, P836, DOI 10.1016/j.celrep.2014.01.031; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nawy T, 2014, NAT METHODS, V11, P18, DOI 10.1038/nmeth.2771; Ni ZY, 2012, AGING CELL, V11, P315, DOI 10.1111/j.1474-9726.2011.00785.x; North BJ, 2014, EMBO J, V33, P1438, DOI 10.15252/embj.201386907; Norton L, 2011, DIABETOLOGIA, V54, P3132, DOI 10.1007/s00125-011-2289-z; O'Sullivan RJ, 2010, NAT STRUCT MOL BIOL, V17, P1218, DOI 10.1038/nsmb.1897; Oakes CC, 2003, P NATL ACAD SCI USA, V100, P1775, DOI 10.1073/pnas.0437971100; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Osorio FG, 2010, AGING CELL, V9, P947, DOI 10.1111/j.1474-9726.2010.00621.x; Partridge L, 2011, EXP GERONTOL, V46, P376, DOI 10.1016/j.exger.2010.09.003; Pedruzzi I, 2000, EMBO J, V19, P2569, DOI 10.1093/emboj/19.11.2569; Pegoraro G, 2009, NAT CELL BIOL, V11, P1261, DOI 10.1038/ncb1971; Peleg S, 2016, EMBO REP, V17, P455, DOI 10.15252/embr.201541132; Pendas AM, 2002, NAT GENET, V31, P94, DOI 10.1038/ng871; Platt JM, 2013, GENE DEV, V27, P1406, DOI 10.1101/gad.218776.113; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Prokocimer M, 2013, AGING CELL, V12, P533, DOI 10.1111/acel.12070; Quarrie Jason K, 2004, Sci Aging Knowledge Environ, V2004, pre5, DOI 10.1126/sageke.2004.31.re5; Rai TS, 2014, GENE DEV, V28, P2712, DOI 10.1101/gad.247528.114; Ricketts MD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8711; Riedel CG, 2013, NAT CELL BIOL, V15, P491, DOI 10.1038/ncb2720; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rogina B, 2002, SCIENCE, V298, P1745, DOI 10.1126/science.1078986; Rohde JR, 2003, MOL CELL BIOL, V23, P629, DOI 10.1128/MCB.23.2.629-635.2003; Ruggiero C, 2008, J GERONTOL A-BIOL, V63, P698, DOI 10.1093/gerona/63.7.698; Rytinki MM, 2011, CELL MOL LIFE SCI, V68, P3219, DOI 10.1007/s00018-011-0627-4; Sarg B, 2002, J BIOL CHEM, V277, P39195, DOI 10.1074/jbc.M205166200; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2005, NAT MED, V11, P440, DOI 10.1038/nm1204; Schroeder EA, 2013, CELL METAB, V17, P954, DOI 10.1016/j.cmet.2013.04.003; Sen P, 2015, GENE DEV, V29, P1362, DOI 10.1101/gad.263707.115; Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113; Shankaranarayanan P, 2011, NAT METHODS, V8, P565, DOI [10.1038/NMETH.1626, 10.1038/nmeth.1626]; Sherman HC, 1935, P NATL ACAD SCI USA, V21, P235, DOI 10.1073/pnas.21.5.235; Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111; Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103; Siebold AP, 2010, P NATL ACAD SCI USA, V107, P169, DOI 10.1073/pnas.0907739107; Simola DF, 2016, SCIENCE, V351, DOI 10.1126/science.aac6633; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; SINGHAL RP, 1987, MECH AGEING DEV, V41, P199, DOI 10.1016/0047-6374(87)90040-6; Slack C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000881; Smeal T, 1996, CELL, V84, P633, DOI 10.1016/S0092-8674(00)81038-7; Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tissenbaum HA, 2012, J GERONTOL A-BIOL, V67, P503, DOI 10.1093/gerona/gls088; van Deursen JM, 2014, NATURE, V509, P439, DOI 10.1038/nature13193; Vaquero A, 2009, GENE DEV, V23, P1849, DOI 10.1101/gad.1807009; Viollet B, 2012, CLIN SCI, V122, P253, DOI 10.1042/CS20110386; Warren LA, 2007, AGING CELL, V6, P775, DOI 10.1111/j.1474-9726.2007.00337.x; WEINDRUCH R, 1982, SCIENCE, V215, P1415, DOI 10.1126/science.7063854; Westendorp RGJ, 1998, NATURE, V396, P743, DOI 10.1038/25519; Wood JG, 2010, AGING CELL, V9, P971, DOI 10.1111/j.1474-9726.2010.00624.x; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang GQ, 2015, CELL, V161, P893, DOI 10.1016/j.cell.2015.04.018; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06; Zhou YH, 1997, P NATL ACAD SCI USA, V94, P13215, DOI 10.1073/pnas.94.24.13215	176	396	405	30	195	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					822	839		10.1016/j.cell.2016.07.050	http://dx.doi.org/10.1016/j.cell.2016.07.050			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27518561	Green Accepted, Bronze			2022-12-28	WOS:000382258700008
J	Isayama, T; Iwami, H; McDonald, S; Beyene, J				Isayama, Tetsuya; Iwami, Hiroko; McDonald, Sarah; Beyene, Joseph			Association of Noninvasive Ventilation Strategies With Mortality and Bronchopulmonary Dysplasia Among Preterm Infants A Systematic Review and Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							POSITIVE AIRWAY PRESSURE; RESPIRATORY-DISTRESS-SYNDROME; INTERMITTENT MANDATORY VENTILATION; BIRTH-WEIGHT INFANTS; SURFACTANT THERAPY; NASAL-CPAP; ENDOTRACHEAL INTUBATION; PREMATURE-INFANTS; RANDOMIZED-TRIAL; QUALITY	IMPORTANCE Various noninvasive ventilation strategies are used to prevent bronchopulmonary dysplasia (BPD) of preterm infants; however, the best mode is uncertain. OBJECTIVE To compare 7 ventilation strategies for preterm infants including nasal continuous positive airway pressure (CPAP) alone, intubation and surfactant administration followed by immediate extubation (INSURE), less invasive surfactant administration (LISA), noninvasive intermittent positive pressure ventilation, nebulized surfactant administration, surfactant administration via laryngeal mask airway, and mechanical ventilation. DATA SOURCES MEDLINE, EMBASE, CINAHL, and Cochrane CENTRAL from their inceptions to June 2016. STUDY SELECTION Randomized clinical trials comparing ventilation strategies for infants younger than 33 weeks' gestational age within 24 hours of birth who had not been intubated. DATA EXTRACTION AND SYNTHESIS Data were independently extracted by 2 reviewers and synthesized with Bayesian random-effects network meta-analyses. MAIN OUTCOMES AND MEASURES A composite of death or BPD at 36 weeks' postmenstrual age was the primary outcome. Death, BPD, severe intraventricular hemorrhage, and air leak by discharge were the main secondary outcomes. RESULTS Among 5598 infants involved in 30 trials, the incidence of the primary outcome was 33%(1665 of 4987; including 505 deaths and 1160 cases of BPD). The secondary outcomes ranged from 6%(314 of 5587) for air leak to 26%(1160 of 4455) for BPD. Compared with mechanical ventilation, LISA had a lower odds of the primary outcome (odds ratio [OR], 0.49; 95% credible interval [CrI], 0.30-0.79; absolute risk difference [RD], 164 fewer per 1000 infants; 57-253 fewer per 1000 infants; moderate quality of evidence), BPD(OR, 0.53; 95% CrI, 0.27-0.96; absolute RD, 133 fewer per 1000 infants; 95% CrI, 9-234 fewer per 1000 infants; moderate-quality), and severe intraventricular hemorrhage (OR, 0.44; 95% CrI, 0.19-0.99; absolute RD, 58 fewer per 1000 births; 95% CrI, 1-86 fewer per 1000 births; moderate-quality). Compared with nasal CPAP alone, LISA had a lower odds of the primary outcome (OR, 0.58; 95% CrI, 0.35-0.93; absolute RD, 112 fewer per 1000 births; 95% CrI, 16-190 fewer per 1000 births; moderate quality), and air leak (OR, 0.24; 95% CrI, 0.05-0.96; absolute RD, 47 fewer per 1000 births; 95% CrI, 2-59 fewer per 1000 births; very low quality). Ranking probabilities indicated that LISA was the best strategy with a surface under the cumulative ranking curve of 0.85 to 0.94, but this finding was not robust for death when limited to higher-quality evidence. CONCLUSIONS AND RELEVANCE Among preterm infants, the use of LISA was associated with the lowest likelihood of the composite outcome of death or BPD at 36 weeks' postmenstrual age. These findings were limited by the overall low quality of evidence and lack of robustness in higher-quality trials.	[Isayama, Tetsuya; McDonald, Sarah; Beyene, Joseph] McMaster Univ, Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Isayama, Tetsuya] Sunnybrook Hlth Sci Ctr, Dept Newborn & Dev Paediat, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada; [Iwami, Hiroko] Osaka City Gen Hosp, Dept Neonatol, Osaka, Japan; [McDonald, Sarah] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON, Canada; [McDonald, Sarah] McMaster Univ, Dept Radiol, Hamilton, ON, Canada	McMaster University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Osaka City General Hospital; McMaster University; McMaster University	Isayama, T (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Newborn & Dev Paediat, 2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	isayamt@mcmaster.ca	Isayama, Tetsuya/H-7290-2019	Isayama, Tetsuya/0000-0002-3669-883X				Aguar M, 2014, NEOREVIEWS, V15, pe275, DOI DOI 10.1542/neo.15-7-e275; Aguiar T., 2015, J CLIN TRIALS, V5, P221; Armanian AM, 2014, INT J PREVENTIVE MED, V5, P1543; Bao YY, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0342-7; BELL MJ, 1978, ANN SURG, V187, P1, DOI 10.1097/00000658-197801000-00001; Berggren E, 2000, ACTA PAEDIATR, V89, P460, DOI 10.1080/080352500750028195; Brix N, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-155; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Carlo WA, 2014, PEDIATRICS, V133, P171, DOI 10.1542/peds.2013-3442; Dani C, 2004, PEDIATRICS, V113, pE560, DOI 10.1542/peds.113.6.e560; Dargaville PA, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-213; Dargaville PA, 2013, NEONATOLOGY, V104, P8, DOI 10.1159/000346460; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dilmen U, 2014, J MATERN-FETAL NEO M, V27, P411, DOI 10.3109/14767058.2013.818120; Doyle LW, 2009, SEMIN FETAL NEONAT M, V14, P391, DOI 10.1016/j.siny.2009.08.004; Dunn MS, 2011, PEDIATRICS, V128, pE1069, DOI 10.1542/peds.2010-3848; DUPONT WD, 1990, CONTROL CLIN TRIALS, V11, P116, DOI 10.1016/0197-2456(90)90005-M; Finer NN, 2010, NEW ENGL J MED, V362, P1970, DOI 10.1056/NEJMoa0911783; Fischer HS, 2013, PEDIATRICS, V132, pE1351, DOI 10.1542/peds.2013-1880; Gopel W, 2015, ACTA PAEDIATR, V104, P241, DOI 10.1111/apa.12883; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1283, DOI 10.1016/j.jclinepi.2011.01.012; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P395, DOI 10.1016/j.jclinepi.2010.09.012; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Horbar JD, 2012, PEDIATRICS, V129, P1019, DOI 10.1542/peds.2011-3028; Huang Xi-Lin, 2013, Zhongguo Dang Dai Er Ke Za Zhi, V15, P9; Isayama T, 2016, EARLY RESP MANAGEMEN; Isayama T, 2015, JAMA PEDIATR, V169, P731, DOI 10.1001/jamapediatrics.2015.0510; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kandraju H, 2013, NEONATOLOGY, V103, P148, DOI 10.1159/000345198; Kanmaz HG, 2013, PEDIATRICS, V131, pE502, DOI 10.1542/peds.2012-0603; Kirpalani H, 2013, NEW ENGL J MED, V369, P611, DOI 10.1056/NEJMoa1214533; Kishore MSS, 2009, ACTA PAEDIATR, V98, P1412, DOI 10.1111/j.1651-2227.2009.01348.x; Kong Ling-Kai, 2012, Zhongguo Dang Dai Er Ke Za Zhi, V14, P888; Kribs A, 2015, JAMA PEDIATR, V169, P723, DOI 10.1001/jamapediatrics.2015.0504; Kugelman A, 2007, PEDIATRICS, V120, pE788, DOI 10.1542/peds.2006-3765; Kugelman A, 2007, J PEDIATR-US, V150, P521, DOI 10.1016/j.jpeds.2007.01.032; Kumar P, 2010, PEDIATRICS, V125, P608, DOI 10.1542/peds.2009-2863; Lista G, 2010, ARCH DIS CHILD-FETAL, V95, pF85, DOI 10.1136/adc.2009.169219; Lu G, 2004, STAT MED, V23, P3105, DOI 10.1002/sim.1875; Meneses J, 2012, ARCH PEDIAT ADOL MED, V166, P372, DOI 10.1001/archpediatrics.2011.1142; Meneses J, 2011, PEDIATRICS, V127, P300, DOI 10.1542/peds.2010-0922; Mills EJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2914; Mills EJ, 2012, JAMA-J AM MED ASSOC, V308, P1246, DOI 10.1001/2012.jama.11228; Mirnia K., 2013, MED J ISLAM WORLD SC, V21, P143, DOI DOI 10.12816/0002647; More K, 2014, JAMA PEDIATR, V168, P901, DOI 10.1001/jamapediatrics.2014.1148; Morley CJ, 2008, NEW ENGL J MED, V358, P700, DOI 10.1056/NEJMoa072788; Murray CJL, 2013, JAMA-J AM MED ASSOC, V310, P591, DOI 10.1001/jama.2013.13805; Nakhshab M, 2015, PEDIATR NEONATOL, V56, P88, DOI 10.1016/j.pedneo.2014.05.006; Nayeri Fatemeh Sadat, 2014, Acta Med Iran, V52, P596; Oncel MY, 2016, ARCH DIS CHILD-FETAL, V101, pF323, DOI 10.1136/archdischild-2015-308204; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Pinheiro JMB, 2016, J PERINATOL, V36, P196, DOI 10.1038/jp.2015.177; Puhan MA, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5630; Reininger Ann, 2005, J Perinatol, V25, P703, DOI 10.1038/sj.jp.7211381; Rojas MA, 2009, PEDIATRICS, V123, P137, DOI 10.1542/peds.2007-3501; Salama GSA, 2015, RAWAL MED J, V40, P197; Salanti G, 2011, J CLIN EPIDEMIOL, V64, P163, DOI 10.1016/j.jclinepi.2010.03.016; Sandri F, 2010, PEDIATRICS, V125, pE1402, DOI 10.1542/peds.2009-2131; Schmidt B, 2006, NEW ENGL J MED, V354, P2112, DOI 10.1056/NEJMoa054065; Schmidt B, 2003, JAMA-J AM MED ASSOC, V289, P1124, DOI 10.1001/jama.289.9.1124; Schmolzer GM, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5980; Stevens TP, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003063.pub3; Stoll BJ, 2015, JAMA-J AM MED ASSOC, V314, P1039, DOI 10.1001/jama.2015.10244; Sweet DG, 2013, NEONATOLOGY, V103, P353, DOI 10.1159/000349928; Vaucher YE, 2012, NEW ENGL J MED, V367, P2495, DOI 10.1056/NEJMoa1208506; Verder H, 1999, PEDIATRICS, V103, DOI 10.1542/peds.103.2.e24; VERDER H, 1994, NEW ENGL J MED, V331, P1051, DOI 10.1056/NEJM199410203311603; Rojas-Reyes MX, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000510.pub2	70	162	176	0	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2016	316	6					611	624		10.1001/jama.2016.10708	http://dx.doi.org/10.1001/jama.2016.10708			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7TK	27532916	Bronze			2022-12-28	WOS:000380985600014
J	Cohen, IG; Adashi, EY				Cohen, I. Glenn; Adashi, Eli Y.			The FDA is prohibited from going germline	SCIENCE			English	Editorial Material									[Cohen, I. Glenn] Harvard Univ, Petrie Flom Ctr Hlth Law Policy Biotechnol & Bioe, Cambridge, MA 02138 USA; [Adashi, Eli Y.] Brown Univ, Warren Alpert Med Sch, Med Sci, Providence, RI 02903 USA	Harvard University; Brown University	Adashi, EY (corresponding author), Brown Univ, Warren Alpert Med Sch, Med Sci, Providence, RI 02903 USA.	eli_adashi@brown.edu						Adashi E. Y., 2012, JAMA FORUM REPROD FR; Baltimore D, 2015, SCIENCE, V348, P36, DOI 10.1126/science.aab1028; Brennan Z., 2016, FDA SHOULD ALL MIT R; National Academies of Sciences Engineering and Medicine, 2016, PROJ SCI MED ETH CON; National Academies of Sciences Engineering and Medicine, 2015, HUM GEN ED INT SUMM; National Academies of Sciences Engineering and Medicine, 2016, MIT REPL TECHN ETH S; Rodriguez S, 2011, AM J BIOETHICS, V11, P20, DOI [10.1080/15265161.2010.546472, 10.1080/15265161.2011.563162]	7	28	28	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					545	546		10.1126/science.aag2960	http://dx.doi.org/10.1126/science.aag2960			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5YZ	27493171				2022-12-28	WOS:000381560900020
J	Dyer, O				Dyer, Owen			Ontario plans to stop funding high dose opioids	BMJ-BRITISH MEDICAL JOURNAL			English	News Item																		Friesen KJ, 2016, CAN MED ASSOC J, V188, P648, DOI 10.1503/cmaj.150961; Gomes T, 2014, ADDICTION, V109, P1482, DOI 10.1111/add.12598; Ray WA, 2016, JAMA-J AM MED ASSOC, V315, P2415, DOI 10.1001/jama.2016.7789	3	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2016	354								i4300	10.1136/bmj.i4300	http://dx.doi.org/10.1136/bmj.i4300			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9CS	27488880				2022-12-28	WOS:000381080600007
J	Arendt, D; King, N; Carroll, SB; Wittkopp, P; Koonin, E; Kruglyak, L				Arendt, Detlev; King, Nicole; Carroll, Sean B.; Wittkopp, Patricia; Koonin, Eugene; Kruglyak, Leonid			Big Questions in Evolution	CELL			English	Editorial Material									[Arendt, Detlev] European Mol Biol Lab, Grenoble, France; [King, Nicole] Univ Calif Berkeley, HHMI, Berkeley, CA 94720 USA; [Carroll, Sean B.] Univ Wisconsin, HHMI, Madison, WI 53706 USA; [Wittkopp, Patricia] Univ Michigan, Ann Arbor, MI 48109 USA; [Koonin, Eugene] NIH, Bethesda, MD USA; [Kruglyak, Leonid] Univ Calif Los Angeles, HHMI, Los Angeles, CA 90024 USA	European Molecular Biology Laboratory (EMBL); Howard Hughes Medical Institute; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Arendt, D (corresponding author), European Mol Biol Lab, Grenoble, France.								0	1	1	2	46	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					528	529		10.1016/j.cell.2016.07.021	http://dx.doi.org/10.1016/j.cell.2016.07.021			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27471959	Bronze			2022-12-28	WOS:000380546500003
J	Deplancke, B; Alpern, D; Gardeux, V				Deplancke, Bart; Alpern, Daniel; Gardeux, Vincent			The Genetics of Transcription Factor DNA Binding Variation	CELL			English	Review							STEM-CELL DIFFERENTIATION; TERT PROMOTER MUTATIONS; GENOME-WIDE ANALYSIS; HEMOPHILIA-B LEYDEN; REGULATORY ELEMENTS; IN-VIVO; CHROMATIN ARCHITECTURE; HISTONE MODIFICATIONS; SEQUENCE VARIATION; COLORECTAL-CANCER	Most complex trait-associated variants are located in non-coding regulatory regions of the genome, where they have been shown to disrupt transcription factor (TF)-DNA binding motifs. Variable TF-DNA interactions are therefore increasingly considered as key drivers of phenotypic variation. However, recent genome-wide studies revealed that the majority of variable TF-DNA binding events are not driven by sequence alterations in the motif of the studied TF. This observation implies that the molecular mechanisms underlying TF-DNA binding variation and, by extrapolation, inter-individual phenotypic variation are more complex than originally anticipated. Here, we summarize the findings that led to this important paradigm shift and review proposed mechanisms for local, proximal, or distal genetic variation-driven variable TF-DNA binding. In addition, we discuss the biomedical implications of these findings for our ability to dissect the molecular role(s) of non-coding genetic variants in complex traits, including disease susceptibility.	[Deplancke, Bart; Alpern, Daniel; Gardeux, Vincent] Ecole Polytech Fed Lausanne, Inst Bioengn, Lab Syst Biol & Genet, CH-1015 Lausanne, Switzerland; [Deplancke, Bart; Alpern, Daniel; Gardeux, Vincent] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute of Bioinformatics	Deplancke, B (corresponding author), Ecole Polytech Fed Lausanne, Inst Bioengn, Lab Syst Biol & Genet, CH-1015 Lausanne, Switzerland.; Deplancke, B (corresponding author), Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland.	bart.deplancke@epfl.ch	Gardeux, Vincent/O-9653-2016	Gardeux, Vincent/0000-0001-8954-2161; Deplancke, Bart/0000-0001-9935-843X; Alpern, Daniel/0000-0002-4023-9652	Swiss National Science Foundation [CRSI33_130326]; SystemsX.ch [51RTP0_151019]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SystemsX.ch	We thank Richard Benton (University of Lausanne), Sebastian Waszak (EMBL), Alina Isakova, Antonio Meireles-Filho, Petra Schwalie, and other members of the Deplancke Laboratory, as well as the anonymous reviewers for useful comments on the manuscript. We also would like to acknowledge scientific discussions with all members of the "Effect of sequence variation on chromatin structure and transcription" Sinergia Consortium (i.e., the Reymond and Hernandez Laboratories [UNIL] and the Dermitzakis Laboratory [University of Geneva]). This work was supported by the Swiss National Science Foundation grant CRSI33_130326, by SystemsX.ch (AgingX, 51RTP0_151019), and by institutional support from the Swiss Federal Institute of Technology in Lausanne (EPFL).	Adam RC, 2015, NATURE, V521, P366, DOI 10.1038/nature14289; Al Zadjali S, 2011, EUR J HAEMATOL, V87, P457, DOI 10.1111/j.1600-0609.2011.01687.x; Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Alipanahi B, 2015, NAT BIOTECHNOL, V33, P831, DOI 10.1038/nbt.3300; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ameur A, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp381; Arnosti DN, 2005, J CELL BIOCHEM, V94, P890, DOI 10.1002/jcb.20352; Banovich NE, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004663; Barozzi I, 2014, MOL CELL, V54, P844, DOI 10.1016/j.molcel.2014.04.006; Barrera LA, 2016, SCIENCE, V351, P1450, DOI 10.1126/science.aad2257; Bauer AL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001007; Benko S, 2009, NAT GENET, V41, P359, DOI 10.1038/ng.329; Berger MF, 2006, NAT BIOTECHNOL, V24, P1429, DOI 10.1038/nbt1246; Berlivet S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004018; Biggin MD, 2011, DEV CELL, V21, P611, DOI 10.1016/j.devcel.2011.09.008; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Chorley BN, 2008, MUTAT RES-REV MUTAT, V659, P147, DOI 10.1016/j.mrrev.2008.05.001; Ciabrelli F, 2015, J MOL BIOL, V427, P608, DOI 10.1016/j.jmb.2014.09.013; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Claussnitzer M, 2015, NEW ENGL J MED, V373, P895, DOI 10.1056/NEJMoa1502214; Claussnitzer M, 2014, CELL, V156, P343, DOI 10.1016/j.cell.2013.10.058; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; CROSSLEY M, 1990, NATURE, V345, P444, DOI 10.1038/345444a0; Cusanovich DA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004226; De Gobbi M, 2006, SCIENCE, V312, P1215, DOI 10.1126/science.1126431; de Wit E, 2013, NATURE, V501, P227, DOI 10.1038/nature12420; Degner JF, 2012, NATURE, V482, P390, DOI 10.1038/nature10808; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Ding ZH, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004798; Dixon JR, 2015, NATURE, V518, P331, DOI 10.1038/nature14222; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603; Dodd AW, 2013, EUR J HUM GENET, V21, P517, DOI 10.1038/ejhg.2012.197; Dowen JM, 2014, CELL, V159, P374, DOI 10.1016/j.cell.2014.09.030; Dror I, 2015, GENOME RES, V25, P1268, DOI 10.1101/gr.184671.114; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Edwards SL, 2013, AM J HUM GENET, V93, P779, DOI 10.1016/j.ajhg.2013.10.012; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Escalante CR, 2002, MOL CELL, V10, P1097, DOI 10.1016/S1097-2765(02)00703-7; FAISST S, 1992, NUCLEIC ACIDS RES, V20, P3, DOI 10.1093/nar/20.1.3; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; French JD, 2013, AM J HUM GENET, V92, P489, DOI 10.1016/j.ajhg.2013.01.002; Funnell APW, 2013, AM J HUM GENET, V92, P460, DOI 10.1016/j.ajhg.2013.02.003; Gao Z, 2015, BMC GENOMICS, V16, DOI 10.1186/1471-2164-16-S4-S3; Gelfond JAL, 2009, BIOMETRICS, V65, P1087, DOI 10.1111/j.1541-0420.2008.01180.x; Gheldof N, 2010, NUCLEIC ACIDS RES, V38, P4325, DOI 10.1093/nar/gkq175; Giorgetti L, 2014, CELL, V157, P950, DOI 10.1016/j.cell.2014.03.025; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; Gragnoli C, 1997, DIABETES, V46, P1648, DOI 10.2337/diabetes.46.10.1648; Grant SFA, 1996, NAT GENET, V14, P203, DOI 10.1038/ng1096-203; Grubert F, 2015, CELL, V162, P1051, DOI 10.1016/j.cell.2015.07.048; Gutierrez-Arcelus M, 2013, ELIFE, V2, DOI 10.7554/eLife.00523; Hathaway NA, 2012, CELL, V149, P1447, DOI 10.1016/j.cell.2012.03.052; Heinz S, 2013, NATURE, V503, P487, DOI 10.1038/nature12615; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Helms C, 2003, NAT GENET, V35, P349, DOI 10.1038/ng1268; Heyn H, 2013, GENOME RES, V23, P1363, DOI 10.1101/gr.154187.112; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hobbs K, 1998, AM J RESP CRIT CARE, V158, P1958, DOI 10.1164/ajrccm.158.6.9804011; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Hong JW, 2008, SCIENCE, V321, P1314, DOI 10.1126/science.1160631; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Hu SH, 2013, ELIFE, V2, DOI 10.7554/eLife.00726; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Isakova A, 2016, J BIOL CHEM, V291, P10293, DOI 10.1074/jbc.M115.691154; Iwafuchi-Doi M, 2014, GENE DEV, V28, P2679, DOI 10.1101/gad.253443.114; JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7; Jeong Y, 2008, NAT GENET, V40, P1348, DOI 10.1038/ng.230; Jia L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000597; Jolma A, 2015, NATURE, V527, P384, DOI 10.1038/nature15518; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Junion G, 2012, CELL, V148, P473, DOI 10.1016/j.cell.2012.01.030; Karczewski KJ, 2011, P NATL ACAD SCI USA, V108, P13353, DOI 10.1073/pnas.1103105108; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Kilpinen H, 2013, SCIENCE, V342, P744, DOI 10.1126/science.1242463; Kulakovskiy IV, 2016, NUCLEIC ACIDS RES, V44, pD116, DOI 10.1093/nar/gkv1249; Kulzer JR, 2014, AM J HUM GENET, V94, P186, DOI 10.1016/j.ajhg.2013.12.011; Lecerf L, 2014, HUM MUTAT, V35, P303, DOI 10.1002/humu.22499; Lehner B, 2013, NAT REV GENET, V14, P168, DOI 10.1038/nrg3404; Levo M, 2014, NAT REV GENET, V15, P453, DOI 10.1038/nrg3684; Li ZY, 2012, CELL, V151, P1608, DOI 10.1016/j.cell.2012.11.018; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lowe WL, 2015, GENOME RES, V25, P1432, DOI 10.1101/gr.190603.115; Ludlow LB, 1996, J BIOL CHEM, V271, P22076, DOI 10.1074/jbc.271.36.22076; Lynch VJ, 2008, EVOLUTION, V62, P2131, DOI 10.1111/j.1558-5646.2008.00440.x; Mackay TFC, 2009, NAT REV GENET, V10, P565, DOI 10.1038/nrg2612; Maerkl SJ, 2009, P NATL ACAD SCI USA, V106, P18650, DOI 10.1073/pnas.0907688106; Mancini EJ, 2015, TRENDS BIOCHEM SCI, V40, P547, DOI 10.1016/j.tibs.2015.08.011; Manco L, 2000, BRIT J HAEMATOL, V110, P993, DOI 10.1046/j.1365-2141.2000.02283.x; Manolio TA, 2013, NAT REV GENET, V14, P549, DOI 10.1038/nrg3523; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Masotti C, 2005, GENE, V359, P44, DOI 10.1016/j.gene.2005.06.004; Massouras A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003055; MATSUDA M, 1992, BLOOD, V80, P1347; Maurano MT, 2015, NAT GENET, V47, P1393, DOI 10.1038/ng.3432; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; McClay JL, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0842-7; McVicker G, 2013, SCIENCE, V342, P747, DOI 10.1126/science.1242429; Meng XD, 2005, NAT BIOTECHNOL, V23, P988, DOI 10.1038/nbt1120; MILLER IJ, 1993, MOL CELL BIOL, V13, P2776, DOI 10.1128/MCB.13.5.2776; Mirny LA, 2010, P NATL ACAD SCI USA, V107, P22534, DOI 10.1073/pnas.0913805107; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Najafabadi HS, 2015, NAT BIOTECHNOL, V33, P555, DOI 10.1038/nbt.3128; Nica AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000895; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; Nutiu R, 2011, NAT BIOTECHNOL, V29, P659, DOI 10.1038/nbt.1882; ORKIN SH, 1982, NATURE, V296, P627, DOI 10.1038/296627a0; Pai AA, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004857; Peters T, 1999, MAMM GENOME, V10, P983, DOI 10.1007/s003359901121; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Polach KJ, 1996, J MOL BIOL, V258, P800, DOI 10.1006/jmbi.1996.0288; PONCZ M, 1982, J BIOL CHEM, V257, P5994; Ponomarenko JV, 2001, NUCLEIC ACIDS RES, V29, P312, DOI 10.1093/nar/29.1.312; PTASHNE M, 1980, CELL, V19, P1, DOI 10.1016/0092-8674(80)90383-9; Raghav SK, 2012, MOL CELL, V46, P335, DOI 10.1016/j.molcel.2012.03.017; Rahimov F, 2008, NAT GENET, V40, P1341, DOI 10.1038/ng.242; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Ravasi T, 2010, CELL, V140, P744, DOI 10.1016/j.cell.2010.01.044; Reddy TE, 2012, GENOME RES, V22, P860, DOI 10.1101/gr.131201.111; REIJNEN MJ, 1992, P NATL ACAD SCI USA, V89, P6300, DOI 10.1073/pnas.89.14.6300; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Rudan MV, 2015, CELL REP, V10, P1297, DOI 10.1016/j.celrep.2015.02.004; Saiz L, 2006, CURR OPIN STRUC BIOL, V16, P344, DOI 10.1016/j.sbi.2006.05.008; Sherwood RI, 2014, NAT BIOTECHNOL, V32, P171, DOI 10.1038/nbt.2798; Siersbaek R, 2014, CELL REP, V7, P1443, DOI 10.1016/j.celrep.2014.04.042; Simicevic J, 2013, NAT METHODS, V10, P570, DOI [10.1038/NMETH.2441, 10.1038/nmeth.2441]; Slattery M, 2014, TRENDS BIOCHEM SCI, V39, P381, DOI 10.1016/j.tibs.2014.07.002; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; Smolle M, 2013, BBA-GENE REGUL MECH, V1829, P84, DOI 10.1016/j.bbagrm.2012.08.008; Soccio RE, 2015, CELL, V162, P33, DOI 10.1016/j.cell.2015.06.025; Solis C, 2001, J CLIN INVEST, V107, P753, DOI 10.1172/JCI10642; Soufi A, 2015, CELL, V161, P555, DOI 10.1016/j.cell.2015.03.017; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Spivakov M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r49; Stefflova K, 2013, CELL, V154, P530, DOI 10.1016/j.cell.2013.07.007; Stormo GD, 2010, NAT REV GENET, V11, P751, DOI 10.1038/nrg2845; Tang ZH, 2015, CELL, V163, P1611, DOI 10.1016/j.cell.2015.11.024; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; Torres JM, 2014, AM J HUM GENET, V95, P521, DOI 10.1016/j.ajhg.2014.10.001; TOURNAMILLE C, 1995, NAT GENET, V10, P224, DOI 10.1038/ng0695-224; Tuupanen S, 2009, NAT GENET, V41, P885, DOI 10.1038/ng.406; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wang JB, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv733; Wang SZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19229; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Waszak SM, 2015, CELL, V162, P1039, DOI 10.1016/j.cell.2015.08.001; Weedon MN, 2014, NAT GENET, V46, P61, DOI 10.1038/ng.2826; Weinhold N, 2014, NAT GENET, V46, P1160, DOI 10.1038/ng.3101; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Weirauch MT, 2011, SUBCELL BIOCHEM, V52, P25, DOI 10.1007/978-90-481-9069-0_3; White MA, 2013, P NATL ACAD SCI USA, V110, P11952, DOI 10.1073/pnas.1307449110; Wienert B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8085; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063; Wu JM, 2003, J IMMUNOL, V170, P132, DOI 10.4049/jimmunol.170.1.132; Xu DK, 2008, J BIOL CHEM, V283, P23567, DOI 10.1074/jbc.M800790200; Yalcin B, 2011, NATURE, V477, P326, DOI 10.1038/nature10432; Zeron-Medina J, 2013, CELL, V155, P410, DOI 10.1016/j.cell.2013.09.017; Zhang XM, 2005, GASTROENTEROLOGY, V129, P565, DOI 10.1053/j.gastro.2005.05.003; Zhao XY, 2005, J COMPUT BIOL, V12, P894, DOI 10.1089/cmb.2005.12.894; Zheng XW, 2011, BLOOD COAGUL FIBRIN, V22, P624, DOI 10.1097/MBC.0b013e3283497699; Zhou J, 2015, NAT METHODS, V12, P931, DOI [10.1038/NMETH.3547, 10.1038/nmeth.3547]	172	189	194	2	82	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					538	554		10.1016/j.cell.2016.07.012	http://dx.doi.org/10.1016/j.cell.2016.07.012			17	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27471964	Bronze, Green Submitted			2022-12-28	WOS:000380546500008
J	Brown, WJ; Mielke, GI; Kolbe-Alexander, TL				Brown, Wendy J.; Mielke, Gregore I.; Kolbe-Alexander, Tracy L.			Gender equality in sport for improved public health	LANCET			English	Editorial Material									[Brown, Wendy J.; Mielke, Gregore I.; Kolbe-Alexander, Tracy L.] Univ Queensland, Ctr Res Exercise Phys Act & Hlth, Brisbane, Qld 4072, Australia; [Mielke, Gregore I.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil; [Kolbe-Alexander, Tracy L.] Univ Cape Town, Div Exercise Sci & Sports Med, Cape Town, South Africa	University of Queensland; Universidade Federal de Pelotas; University of Cape Town	Brown, WJ (corresponding author), Univ Queensland, Ctr Res Exercise Phys Act & Hlth, Brisbane, Qld 4072, Australia.	wbrown@uq.edu.au	Brown, Wendy J/A-1553-2016; Mielke, Gregore I/E-2141-2014; Kolbe-Alexander, Tracy/C-1333-2014	Brown, Wendy J/0000-0001-9093-4509; Mielke, Gregore I/0000-0002-3043-2715; Kolbe-Alexander, Tracy/0000-0002-5025-3204				Ding D, 2016, LANCET, V388, P1311, DOI 10.1016/S0140-6736(16)30383-X; Ekelund U., 2016, LANCET; Reis R. S., 2016, LANCET; Sallis J. F., 2016, LANCET; The Los Angeles Times, 2012, LOS ANGELES TIMES; World Health Organization, 2013, GLOB ACT PLAN PREV C	6	27	29	2	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2016	388	10051					1257	+		10.1016/S0140-6736(16)30881-9	http://dx.doi.org/10.1016/S0140-6736(16)30881-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DW5RH	27475268				2022-12-28	WOS:000383704000009
J	Thienpont, B; Steinbacher, J; Zhao, H; D'Anna, F; Kuchnio, A; Ploumakis, A; Ghesquiere, B; Van Dyck, L; Boeckx, B; Schoonjans, L; Hermans, E; Amant, F; Kristensen, VN; Koh, KP; Mazzone, M; Coleman, ML; Carell, T; Carmeliet, P; Lambrechts, D				Thienpont, Bernard; Steinbacher, Jessica; Zhao, Hui; D'Anna, Flora; Kuchnio, Anna; Ploumakis, Athanasios; Ghesquiere, Bart; Van Dyck, Laurien; Boeckx, Bram; Schoonjans, Luc; Hermans, Els; Amant, Frederic; Kristensen, Vessela N.; Koh, Kian Peng; Mazzone, Massimiliano; Coleman, Mathew L.; Carell, Thomas; Carmeliet, Peter; Lambrechts, Diether			Tumour hypoxia causes DNA hyper-methylation by reducing TET activity	NATURE			English	Article							CANCER; 5-METHYLCYTOSINE; 5-HYDROXYMETHYLCYTOSINE; HYDROXYLASES; METASTASIS; EXPRESSION; MUTATIONS; PHENOTYPE; SUCCINATE; FUMARATE	Hypermethylation of the promoters of tumour suppressor genes represses transcription of these genes, conferring growth advantages to cancer cells. How these changes arise is poorly understood. Here we show that the activity of oxygen-dependent ten-eleven translocation (TET) enzymes is reduced by tumour hypoxia in human and mouse cells. TET enzymes catalyse DNA demethylation through 5-methylcytosine oxidation. This reduction in activity occurs independently of hypoxia-associated alterations in TET expression, proliferation, metabolism, hypoxia-inducible factor activity or reactive oxygen species, and depends directly on oxygen shortage. Hypoxia-induced loss of TET activity increases hypermethylation at gene promoters in vitro. In patients, tumour suppressor gene promoters are markedly more methylated in hypoxic tumour tissue, independent of proliferation, stromal cell infiltration and tumour characteristics. Our data suggest that up to half of hypermethylation events are due to hypoxia, with these events conferring a selective advantage. Accordingly, increased hypoxia in mouse breast tumours increases hypermethylation, while restoration of tumour oxygenation abrogates this effect. Tumour hypoxia therefore acts as a novel regulator of DNA methylation.	[Thienpont, Bernard; Zhao, Hui; D'Anna, Flora; Kuchnio, Anna; Ghesquiere, Bart; Van Dyck, Laurien; Boeckx, Bram; Schoonjans, Luc; Mazzone, Massimiliano; Carmeliet, Peter; Lambrechts, Diether] VIB, Vesalius Res Ctr, B-3000 Leuven, Belgium; [Thienpont, Bernard; Zhao, Hui; D'Anna, Flora; Van Dyck, Laurien; Boeckx, Bram; Lambrechts, Diether] Katholieke Univ Leuven, Dept Oncol, Lab Translat Genet, B-3000 Leuven, Belgium; [Steinbacher, Jessica; Carell, Thomas] Univ Munich, Dept Chem & Pharm, Ctr Integrat Prot Sci, Marchioninistr 15, D-81377 Munich, Germany; [Kuchnio, Anna; Schoonjans, Luc; Carmeliet, Peter] Katholieke Univ Leuven, Dept Oncol, Lab Angiogenesis & Vasc Metab, B-3000 Leuven, Belgium; [Ploumakis, Athanasios; Coleman, Mathew L.] Univ Birmingham, Inst Canc & Genom Sci, Birmingham B15 2TT, W Midlands, England; [Hermans, Els; Amant, Frederic] Katholieke Univ Leuven, Dept Oncol, Univ Hosp Leuven, Gynecol Oncol, B-3000 Leuven, Belgium; [Kristensen, Vessela N.] Oslo Univ Hosp, Radiumhosp, Inst Canc Res, Dept Genet, N-0310 Oslo, Norway; [Kristensen, Vessela N.] Univ Oslo, Akershus Univ Hosp, Dept Clin Mol Biol EpiGen, N-0318 Oslo, Norway; [Kristensen, Vessela N.] Univ Oslo, Fac Med, Inst Clin Med, Postboks 1171, N-0318 Oslo, Norway; [Koh, Kian Peng] Katholieke Univ Leuven, Dept Dev & Regenerat, B-3000 Leuven, Belgium; [Koh, Kian Peng] Katholieke Univ Leuven, Stem Cell Inst Leuven, B-3000 Leuven, Belgium; [Mazzone, Massimiliano] Katholieke Univ Leuven, Dept Oncol, Lab Mol Oncol & Angiogenesis, B-3000 Leuven, Belgium	Flanders Institute for Biotechnology (VIB); KU Leuven; University of Munich; KU Leuven; University of Birmingham; KU Leuven; University Hospital Leuven; University of Oslo; University of Oslo; University of Oslo; KU Leuven; KU Leuven; KU Leuven	Thienpont, B; Lambrechts, D (corresponding author), VIB, Vesalius Res Ctr, B-3000 Leuven, Belgium.; Thienpont, B; Lambrechts, D (corresponding author), Katholieke Univ Leuven, Dept Oncol, Lab Translat Genet, B-3000 Leuven, Belgium.	bernard.thienpont@vib-kuleuven.be; diether.lambrechts@vib-kuleuven.be	Koh, Kian Peng/S-6279-2016; Lambrechts, Diether/AAJ-3167-2020; Carmeliet, Peter/AAQ-5140-2020; Carell, Thomas/G-4799-2012; Amant, Frédéric/W-7436-2019; Coleman, Mathew L/C-1676-2014; Van Dyck, Laurien/I-4018-2016; Ghesquiere, Bart/HGU-8736-2022; Thienpont, Bernard/AAG-5423-2019	Koh, Kian Peng/0000-0003-2523-5175; Lambrechts, Diether/0000-0002-3429-302X; Carmeliet, Peter/0000-0001-7961-1821; Carell, Thomas/0000-0001-7898-2831; Amant, Frédéric/0000-0002-5452-4905; Coleman, Mathew L/0000-0001-6020-9023; Van Dyck, Laurien/0000-0002-1373-7656; Ghesquiere, Bart/0000-0003-1547-1705; D'Anna, Flora/0000-0003-4665-6673; Mazzone, Massimiliano/0000-0001-8824-4015; Thienpont, Bernard/0000-0002-8772-6845	FWO-F; ERC [CHAMELEON 617595, EU-ERC269073, CHAMELEO 334420]; FWO-F [G065615N, G070615N]; IUAP [P7/03]; Flemish Government (Methusalem); DFG [EXC114, CA275/8-5, GRK2062/1, SPP1784]; MRC [MR/N021053/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [1734215] Funding Source: researchfish; Medical Research Council [MR/N021053/1] Funding Source: researchfish	FWO-F(FWO); ERC(European Research Council (ERC)European Commission); FWO-F(FWO); IUAP; Flemish Government (Methusalem); DFG(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank G. Peuteman, T. Van Brussel, J. Serneels and K. Kurz for assistance, C. Chang for NucPE1, G.-L Xu for Tet-triple knockout ES cells. H.Z. and B.T. hold FWO-F postdoctoral fellowships. This work was supported by funding from the ERC (CHAMELEON 617595 to D.L; EU-ERC269073 to P.C.; CHAMELEO 334420 to B.T.), from the FWO-F (G065615N, G070615N) to D.L, from the IUAP (P7/03) and the Flemish Government (Methusalem) to RC., and from the DFG (EXC114 (CiPSM), grants CA275/8-5, GRK2062/1 and SPP1784) to T.C.	Bachman M, 2014, NAT CHEM, V6, P1049, DOI [10.1038/nchem.2064, 10.1038/NCHEM.2064]; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Buffa FM, 2010, BRIT J CANCER, V102, P428, DOI 10.1038/sj.bjc.6605450; Chowdhury R, 2013, ACS CHEM BIOL, V8, P1488, DOI 10.1021/cb400088q; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feinberg AP, 2010, P NATL ACAD SCI USA, V107, P1757, DOI 10.1073/pnas.0906183107; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; Heist RS, 2015, P NATL ACAD SCI USA, V112, P1547, DOI 10.1073/pnas.1424024112; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Kuchnio A, 2015, CELL REP, V12, P992, DOI 10.1016/j.celrep.2015.07.010; Landan G, 2012, NAT GENET, V44, P1207, DOI 10.1038/ng.2442; Laukka T, 2016, J BIOL CHEM, V291, P4256, DOI 10.1074/jbc.M115.688762; Mack SC, 2014, NATURE, V506, P445, DOI 10.1038/nature13108; Mariani CJ, 2014, CELL REP, V7, P1343, DOI 10.1016/j.celrep.2014.04.040; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Ploumakis A, 2015, MOL CELL, V58, P729, DOI 10.1016/j.molcel.2015.05.026; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Struhl K, 2014, ELIFE, V3, DOI 10.7554/eLife.02475; Taberlay PC, 2014, GENOME RES, V24, P1421, DOI 10.1101/gr.163485.113; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Vaupel P, 2007, ANTIOXID REDOX SIGN, V9, P1221, DOI 10.1089/ars.2007.1628; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Williams K, 2011, NATURE, V473, P343, DOI 10.1038/nature10066; Xiao MT, 2012, GENE DEV, V26, P1326, DOI 10.1101/gad.191056.112; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Zhao BL, 2014, NUCLEIC ACIDS RES, V42, P1593, DOI 10.1093/nar/gkt1090	32	368	383	4	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					63	68		10.1038/nature19081	http://dx.doi.org/10.1038/nature19081			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU7XC	27533040	Green Submitted, Green Accepted, Green Published			2022-12-28	WOS:000382426900038
J	van Charante, EPM; Richard, E; Eurelings, LS; van Dalen, JW; Ligthart, SA; van Bussel, EF; Hoevenaar-Blom, MP; Vermeulen, M; van Gool, WA				van Charante, Eric P. Moll; Richard, Edo; Eurelings, Lisa S.; van Dalen, Jan-Willem; Ligthart, Suzanne A.; van Bussel, Emma F.; Hoevenaar-Blom, Marieke P.; Vermeulen, Marinus; van Gool, Willem A.			Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial	LANCET			English	Article							BLOOD-PRESSURE; ALZHEIMERS-DISEASE; DOUBLE-BLIND; HYPERTENSION; HEALTH; OLDER; AGE	Background Cardiovascular risk factors are associated with an increased risk of dementia. We assessed whether a multidomain intervention targeting these factors can prevent dementia in a population of community-dwelling older people. Methods In this open-label, cluster-randomised controlled trial, we recruited individuals aged 70-78 years through participating general practices in the Netherlands. General practices within each health-care centre were randomly assigned (1:1), via a computer-generated randomisation sequence, to either a 6-year nurse-led, multidomain cardiovascular intervention or control (usual care). The primary outcomes were cumulative incidence of dementia and disability score (Academic Medical Center Linear Disability Score [ALDS]) at 6 years of follow-up. The main secondary outcomes were incident cardiovascular disease and mortality. Outcome assessors were masked to group assignment. Analyses included all participants with available outcome data. This trial is registered with ISRCTN, number ISRCTN29711771. Findings Between June 7, 2006, and March 12, 2009, 116 general practices (3526 participants) within 26 health-care centres were recruited and randomly assigned: 63 (1890 participants) were assigned to the intervention group and 53 (1636 participants) to the control group. Primary outcome data were obtained for 3454 (98%) participants; median follow-up was 6.7 years (21 341 person-years). Dementia developed in 121 (7%) of 1853 participants in the intervention group and in 112 (7%) of 1601 participants in the control group (hazard ratio [HR] 0.92, 95% CI 0.71-1.19; p=0.54). Mean ALDS scores measured during follow-up did not differ between groups (85.7 [SD 6.8] in the intervention group and 85.7 [7.1] in the control group; adjusted mean difference -0.02, 95% CI -0.38 to 0.42; p= 0.93). 309 (16%) of 1885 participants died in the intervention group, compared with 269 (16%) of 1634 participants in the control group (HR 0.98, 95% CI 0.80-1.18; p=0.81). Incident cardiovascular disease did not differ between groups (273 [19%] of 1469 participants in the intervention group and 228 [17%] of 1307 participants in the control group; HR 1.06, 95% CI 0.86-1.31; p=0.57). Interpretation A nurse-led, multidomain intervention did not result in a reduced incidence of all-cause dementia in an unselected population of older people. This absence of effect might have been caused by modest baseline cardiovascular risks and high standards of usual care. Future studies should assess the efficacy of such interventions in selected populations.	[van Charante, Eric P. Moll; Ligthart, Suzanne A.; van Bussel, Emma F.] Acad Med Ctr, Dept Gen Practice, Amsterdam, Netherlands; [Richard, Edo; Eurelings, Lisa S.; van Dalen, Jan-Willem; Hoevenaar-Blom, Marieke P.; Vermeulen, Marinus; van Gool, Willem A.] Acad Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Richard, Edo] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, Nijmegen, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen	van Gool, WA (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Neurol, Meibergdreef 9, NL-1100 DD Amsterdam, Netherlands.	w.a.vangool@amc.uva.nl	Hoevenaar-Blom, Maria/AGI-1087-2022; Ligthart, Suzanne A/AAC-3954-2019; Van Gool, Willem A/G-5985-2012; van Charante, Eric Moll/L-4856-2019; van Dalen, Jan Willem/K-9169-2018; van+Bussel, Emma/ABA-9127-2020; Richard, Edo/N-8460-2016; Richard, Edo/AAT-7173-2020	van Charante, Eric Moll/0000-0002-1489-5218; van Dalen, Jan Willem/0000-0002-3439-8841; Richard, Edo/0000-0002-7250-3390; Richard, Edo/0000-0002-7250-3390; Ligthart, Suzanne A./0000-0003-3216-1928; Van Gool, Willem/0000-0003-3174-8233	Dutch Ministry of Health, Welfare and Sport; Dutch Innovation Fund of Collaborative Health Insurances; Netherlands Organisation for Health Research and Development	Dutch Ministry of Health, Welfare and Sport; Dutch Innovation Fund of Collaborative Health Insurances; Netherlands Organisation for Health Research and Development(Netherlands Organization for Health Research and Development)	Dutch Ministry of Health, Welfare and Sport; Dutch Innovation Fund of Collaborative Health Insurances; and Netherlands Organisation for Health Research and Development.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th ed., DOI DOI 10.1001/JAMA.1994.03520100096; Anderson C, 2011, LANCET NEUROL, V10, P43, DOI 10.1016/S1474-4422(10)70250-7; Andrieu S, 2015, LANCET NEUROL, V14, P926, DOI 10.1016/S1474-4422(15)00153-2; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Bejan-Angoulvant T, 2010, J HYPERTENS, V28, P1366, DOI 10.1097/HJH.0b013e328339f9c5; Daviglus ML, 2010, ANN INTERN MED, V153, P176, DOI 10.7326/0003-4819-153-3-201008030-00260; Dutch College of General Practitioners Guideline Development Group, 2012, HUISARTS WET, V55, P14; Euser SM, 2009, J AM GERIATR SOC, V57, P1232, DOI 10.1111/j.1532-5415.2009.02264.x; Forette F, 1998, LANCET, V352, P1347, DOI 10.1016/S0140-6736(98)03086-4; Gorelick PB, 2014, JAMA NEUROL, V71, P1211, DOI 10.1001/jamaneurol.2014.2014; Ligthart SA, 2012, EUR J PREV CARDIOL, V19, P1365, DOI 10.1177/1741826711422979; Lincoln P, 2014, LANCET, V383, P1805, DOI 10.1016/S0140-6736(14)60758-3; Matthews FE, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000180; Moonen JEF, 2015, JAMA INTERN MED, V175, P1622, DOI 10.1001/jamainternmed.2015.4103; Ngandu T, 2015, LANCET, V385, P2255, DOI 10.1016/S0140-6736(15)60461-5; Norton S, 2014, LANCET NEUROL, V13, P788, DOI 10.1016/S1474-4422(14)70136-X; Peters R, 2008, LANCET NEUROL, V7, P683, DOI 10.1016/S1474-4422(08)70143-1; Prince M, 2013, POLICY BRIEF HEADS G; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Richard E, 2010, J NUTR HEALTH AGING, V14, P315, DOI 10.1007/s12603-010-0072-3; Richard E, 2012, J NEUROL SCI, V322, P64, DOI 10.1016/j.jns.2012.06.012; Richard E, 2009, ALZ DIS ASSOC DIS, V23, P198, DOI 10.1097/WAD.0b013e31819783a4; Satizabal CL, 2016, NEW ENGL J MED, V374, P523, DOI 10.1056/NEJMoa1504327; Schrijvers EMC, 2012, NEUROLOGY, V78, P1456, DOI 10.1212/WNL.0b013e3182553be6; Sink KM, 2015, JAMA-J AM MED ASSOC, V314, P781, DOI 10.1001/jama.2015.9617; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Stalman WAB, 2006, DUTCH GUIDELINE CARD; World Health Organization, 2015, GLOB TECHN STRAT MAL, P29	28	310	311	5	55	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 20	2016	388	10046					797	805		10.1016/S0140-6736(16)30950-3	http://dx.doi.org/10.1016/S0140-6736(16)30950-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT6UH	27474376	Green Accepted			2022-12-28	WOS:000381619200028
J	Ding, Y; Berrocal, A; Morita, T; Longden, KD; Stern, DL				Ding, Yun; Berrocal, Augusto; Morita, Tomoko; Longden, Kit D.; Stern, David L.			Natural courtship song variation caused by an intronic retroelement in an ion channel gene	NATURE			English	Article							ACTIVATED POTASSIUM CHANNELS; TISSUE-SPECIFIC EXPRESSION; DROSOPHILA-MELANOGASTER; C. ELEGANS; BEHAVIOR; EVOLUTION; LOCUS; MICE	Animal species display enormous variation for innate behaviours, but little is known about how this diversity arose. Here, using an unbiased genetic approach, we map a courtship song difference between wild isolates of Drosophila simulans and Drosophila mauritiana to a 966 base pair region within the slowpoke (slo) locus, which encodes a calcium-activated potassium channel(1). Using the reciprocal hemizygosity test(2), we confirm that slo is the causal locus and resolve the causal mutation to the evolutionarily recent insertion of a retroelement in a slo intron within D. simulans. Targeted deletion of this retroelement reverts the song phenotype and alters slo splicing. Like many ion channel genes, slo is expressed widely in the nervous system and influences a variety of behaviours(3,4); slo-null males sing little song with severely disrupted features. By contrast, the natural variant of slo alters a specific component of courtship song, illustrating that regulatory evolution of a highly pleiotropic ion channel gene can cause modular changes in behaviour.	[Ding, Yun; Berrocal, Augusto; Morita, Tomoko; Longden, Kit D.; Stern, David L.] Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA; [Berrocal, Augusto] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA	Howard Hughes Medical Institute; University of California System; University of California Berkeley	Stern, DL (corresponding author), Howard Hughes Med Inst, Janelia Res Campus, Ashburn, VA 20147 USA.	sternd@janelia.hhmi.org		Longden, Kit/0000-0002-7686-6447; Ding, Yun/0000-0001-8915-8434				Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Arthur BJ, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-11; ATKINSON NS, 1991, SCIENCE, V253, P551, DOI 10.1126/science.1857984; Atkinson NS, 2000, J NEUROSCI, V20, P2988; Bassett AR, 2014, J GENET GENOMICS, V41, P7, DOI 10.1016/j.jgg.2013.12.004; BECKER MN, 1995, J NEUROSCI, V15, P6250; Bendesky A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003157; Bendesky A, 2011, NATURE, V472, P313, DOI 10.1038/nature09821; Brenner R, 1996, J NEUROSCI, V16, P1827; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Cande J, 2014, CELL REP, V8, P362, DOI 10.1016/j.celrep.2014.06.023; de Bono M, 1998, CELL, V94, P679, DOI 10.1016/S0092-8674(00)81609-8; EWING AW, 1968, BEHAVIOUR, V31, P288, DOI 10.1163/156853968X00298; Garrigan D, 2012, GENOME RES, V22, P1499, DOI 10.1101/gr.130922.111; Gleason JM, 2002, HEREDITY, V89, P1, DOI 10.1038/sj.hdy.6800099; GOTZ KG, 1987, J EXP BIOL, V128, P35; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Greenwood AK, 2013, CURR BIOL, V23, P1884, DOI 10.1016/j.cub.2013.07.058; Huttunen S, 2004, HEREDITY, V92, P263, DOI 10.1038/sj.hdy.6800406; McGrath PT, 2009, NEURON, V61, P692, DOI 10.1016/j.neuron.2009.02.012; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Stern D. L., 2016, PREPRINT; Stern DL, 2014, TRENDS GENET, V30, P547, DOI 10.1016/j.tig.2014.09.006; Stern DL, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-38; Turner TL, 2013, MOL BIOL EVOL, V30, P2113, DOI 10.1093/molbev/mst111; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Weber JN, 2013, NATURE, V493, P402, DOI 10.1038/nature11816; Williams MA, 2001, HEREDITY, V86, P68, DOI 10.1046/j.1365-2540.2001.00811.x; Yalcin B, 2004, NAT GENET, V36, P1197, DOI 10.1038/ng1450; Yu JY, 2006, GENES BRAIN BEHAV, V5, P329, DOI 10.1111/j.1601-183X.2005.00164.x	30	73	73	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					329	+		10.1038/nature19093	http://dx.doi.org/10.1038/nature19093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27509856				2022-12-28	WOS:000381804900035
J	Muto, V; Jaspar, M; Meyer, C; Kusse, C; Chellappa, SL; Degueldre, C; Balteau, E; Shaffii-Le Bourdiec, A; Luxen, A; Middleton, B; Archer, SN; Phillips, C; Collette, F; Vandewalle, G; Dijk, DJ; Maquet, P				Muto, Vincenzo; Jaspar, Mathieu; Meyer, Christelle; Kusse, Caroline; Chellappa, Sarah L.; Degueldre, Christian; Balteau, Evelyne; Shaffii-Le Bourdiec, Anahita; Luxen, Andre; Middleton, Benita; Archer, Simon N.; Phillips, Christophe; Collette, Fabienne; Vandewalle, Gilles; Dijk, Derk-Jan; Maquet, Pierre			Local modulation of human brain responses by circadian rhythmicity and sleep debt	SCIENCE			English	Article							CLOCK GENE-EXPRESSION; PERFORMANCE; MELATONIN; PHASE; WAKEFULNESS; NEURONS	Human performance is modulated by circadian rhythmicity and homeostatic sleep pressure. Whether and how this interaction is represented at the regional brain level has not been established. We quantified changes in brain responses to a sustained-attention task during 13 functional magnetic resonance imaging sessions scheduled across the circadian cycle, during 42 hours of wakefulness and after recovery sleep, in 33 healthy participants. Cortical responses showed significant circadian rhythmicity, the phase of which varied across brain regions. Cortical responses also significantly decreased with accrued sleep debt. Subcortical areas exhibited primarily a circadian modulation that closely followed the melatonin profile. These findings expand our understanding of the mechanisms involved in maintaining cognition during the day and its deterioration during sleep deprivation and circadian misalignment.	[Muto, Vincenzo; Jaspar, Mathieu; Meyer, Christelle; Kusse, Caroline; Chellappa, Sarah L.; Degueldre, Christian; Balteau, Evelyne; Shaffii-Le Bourdiec, Anahita; Luxen, Andre; Phillips, Christophe; Collette, Fabienne; Vandewalle, Gilles; Maquet, Pierre] Univ Liege, GIGA Cyclotron Res Ctr Vivo Imaging, Liege, Belgium; [Muto, Vincenzo; Jaspar, Mathieu; Meyer, Christelle; Kusse, Caroline; Chellappa, Sarah L.; Degueldre, Christian; Balteau, Evelyne; Shaffii-Le Bourdiec, Anahita; Luxen, Andre; Phillips, Christophe; Collette, Fabienne; Vandewalle, Gilles; Maquet, Pierre] Walloon Excellence Life Sci & Biotechnol WELBIO, Liege, Belgium; [Muto, Vincenzo; Jaspar, Mathieu; Collette, Fabienne] Univ Liege, Psychol & Cognit Neurosci Res Unit, Liege, Belgium; [Middleton, Benita] Univ Surrey, Fac Hlth & Med Sci, Guildford, Surrey, England; [Archer, Simon N.; Dijk, Derk-Jan] Univ Surrey, Fac Hlth & Med Sci, Sleep Res Ctr, Guildford, Surrey, England; [Phillips, Christophe] Univ Liege, Dept Elect Engn & Comp Sci, Liege, Belgium; [Maquet, Pierre] CHU Liege, Dept Neurol, Liege, Belgium	University of Liege; WELBIO; University of Liege; University of Surrey; University of Surrey; University of Liege; University of Liege	Maquet, P (corresponding author), Univ Liege, GIGA Cyclotron Res Ctr Vivo Imaging, Liege, Belgium.; Maquet, P (corresponding author), Walloon Excellence Life Sci & Biotechnol WELBIO, Liege, Belgium.; Maquet, P (corresponding author), CHU Liege, Dept Neurol, Liege, Belgium.	pmaquet@ulg.ac.be	Muto, Vincenzo/AAS-5220-2020; Phillips, Christophe/M-3025-2017	Muto, Vincenzo/0000-0001-5100-9927; Vandewalle, Gilles/0000-0003-2483-2752; Chellappa, Sarah L./0000-0002-6190-464X; Phillips, Christophe/0000-0002-4990-425X	Fonds National de la Recherche Scientifique (Belgium); Actions de Recherche Concertee of the Wallonia-Brussels Federation; University of Liege; Fondation Medicale Reine Elisabeth; Fondation Simone et Pierre Clerdent; Bial Foundation; FEDER-Radiomed; Royal Society Wolfson Research Merit Award	Fonds National de la Recherche Scientifique (Belgium)(Fonds de la Recherche Scientifique - FNRS); Actions de Recherche Concertee of the Wallonia-Brussels Federation; University of Liege(University of Liege); Fondation Medicale Reine Elisabeth; Fondation Simone et Pierre Clerdent; Bial Foundation(Bial Foundation); FEDER-Radiomed; Royal Society Wolfson Research Merit Award(Royal Society of London)	Supported by Fonds National de la Recherche Scientifique (Belgium), Actions de Recherche Concertee of the Wallonia-Brussels Federation, University of Liege research funds, Fondation Medicale Reine Elisabeth, Fondation Simone et Pierre Clerdent, Bial Foundation, FEDER-Radiomed, and a Royal Society Wolfson Research Merit Award (D.-J.D.). We thank B. Guillaume for help in setting up the SWE analysis, E. Lambot and A. Golabek for assistance in data collection, and C. Schmidt for valuable feedback on the manuscript. Data are archived on CRC servers and available upon request. The authors report no conflict of interest.	Achermann P, 2004, AVIAT SPACE ENVIR MD, V75, pA37; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Basner M, 2011, SLEEP, V34, P581, DOI 10.1093/sleep/34.5.581; Bixler E, 2009, SLEEP MED, V10, pS3, DOI 10.1016/j.sleep.2009.07.005; Chee MWL, 2008, CURR OPIN NEUROL, V21, P417, DOI 10.1097/WCO.0b013e3283052cf7; Chun LE, 2015, J BIOL RHYTHM, V30, P417, DOI 10.1177/0748730415598608; Czeisler CA., 2011, PRINCIPLES PRACTICE, V5th ed., P402; Dijk DJ, 1997, J PHYSIOL-LONDON, V505, P851, DOI 10.1111/j.1469-7793.1997.851ba.x; DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9; DIJK DJ, 1992, J SLEEP RES, V1, P112, DOI 10.1111/j.1365-2869.1992.tb00021.x; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Franken P, 2009, EUR J NEUROSCI, V29, P1820, DOI 10.1111/j.1460-9568.2009.06723.x; Guillaume B, 2014, NEUROIMAGE, V94, P287, DOI 10.1016/j.neuroimage.2014.03.029; Lo JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045987; Pevet P, 2011, J PHYSIOL-PARIS, V105, P170, DOI 10.1016/j.jphysparis.2011.07.001; Rajaratnam SM, 2001, LANCET, V358, P999, DOI 10.1016/S0140-6736(01)06108-6; Wang TA, 2012, SCIENCE, V337, P839, DOI 10.1126/science.1222826; Wyatt JK, 2004, SLEEP, V27, P374, DOI 10.1093/sleep/27.3.374; Wyatt JK, 1999, AM J PHYSIOL-REG I, V277, pR1152; Yu X, 2014, CURR BIOL, V24, P2838, DOI 10.1016/j.cub.2014.10.019	20	106	109	2	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					687	690		10.1126/science.aad2993	http://dx.doi.org/10.1126/science.aad2993			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZC	27516598	Green Submitted, Green Published			2022-12-28	WOS:000381561200037
J	Pohl, R; Nez, F; Fernandes, LMP; Amaro, FD; Biraben, F; Cardoso, JMR; Covita, DS; Dax, A; Dhawan, S; Diepold, M; Giesen, A; Gouvea, AL; Graf, T; Hansch, TW; Indelicato, P; Julien, L; Knowles, P; Kottmann, F; Le Bigot, EO; Liu, YW; Lopes, JAM; Ludhova, L; Monteiro, CMB; Mulhauser, F; Nebel, T; Rabinowitz, P; dos Santos, JMF; Schaller, LA; Schuhmann, K; Schwob, C; Taqqu, D; Veloso, JFCA; Antognini, A				Pohl, Randolf; Nez, Francois; Fernandes, Luis M. P.; Amaro, Fernando D.; Biraben, Francois; Cardoso, Joao M. R.; Covita, Daniel S.; Dax, Andreas; Dhawan, Satish; Diepold, Marc; Giesen, Adolf; Gouvea, Andrea L.; Graf, Thomas; Hansch, Theodor W.; Indelicato, Paul; Julien, Lucile; Knowles, Paul; Kottmann, Franz; Le Bigot, Eric-Olivier; Liu, Yi-Wei; Lopes, Jose A. M.; Ludhova, Livia; Monteiro, Cristina M. B.; Mulhauser, Francoise; Nebel, Tobias; Rabinowitz, Paul; dos Santos, Joaquim M. F.; Schaller, Lukas A.; Schuhmann, Karsten; Schwob, Catherine; Taqqu, David; Veloso, Joao F. C. A.; Antognini, Aldo		CREMA Collaboration	Laser spectroscopy of muonic deuterium	SCIENCE			English	Article							PROTON RADIUS PUZZLE; LAMB SHIFT; ELASTIC-SCATTERING; HYDROGEN	The deuteron is the simplest compound nucleus, composed of one proton and one neutron. Deuteron properties such as the root-mean-square charge radius r(d) and the polarizability serve as important benchmarks for understanding the nuclear forces and structure. Muonic deuterium mu d is the exotic atom formed by a deuteron and a negative muon mu-. We measured three 2S-2P transitions in md and obtain r(d) = 2.12562(78) fm, which is 2.7 times more accurate but 7.5 sigma smaller than the CODATA-2010 value r(d) = 2.1424(21) fm. The md value is also 3.5 sigma smaller than the rd value from electronic deuterium spectroscopy. The smaller rd, when combined with the electronic isotope shift, yields a "small" proton radius r(p), similar to the one from muonic hydrogen, amplifying the proton radius puzzle.	[Pohl, Randolf; Diepold, Marc; Hansch, Theodor W.; Mulhauser, Francoise; Nebel, Tobias; Antognini, Aldo] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Pohl, Randolf] Johannes Gutenberg Univ Mainz, QUANTUM, Inst Phys & Exzellenzcluster PRISMA, D-55099 Mainz, Germany; [Nez, Francois; Biraben, Francois; Indelicato, Paul; Julien, Lucile; Le Bigot, Eric-Olivier; Schwob, Catherine] UPMC, Univ Paris 04, Lab Kastler Brossel, CNRS,Ecole Normale Super,PSL Res Univ,Coll France, F-75005 Paris, France; [Fernandes, Luis M. P.; Amaro, Fernando D.; Cardoso, Joao M. R.; Gouvea, Andrea L.; Lopes, Jose A. M.; Monteiro, Cristina M. B.; dos Santos, Joaquim M. F.] Univ Coimbra, Dept Phys, LIBPhys, P-3004516 Coimbra, Portugal; [Covita, Daniel S.; Veloso, Joao F. C. A.] Univ Aveiro, Dept Fis, I3N, P-3810193 Aveiro, Portugal; [Dax, Andreas; Dhawan, Satish] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Giesen, Adolf; Graf, Thomas] Univ Stuttgart, Inst Strahlwerkzeuge, D-70569 Stuttgart, Germany; [Giesen, Adolf; Schuhmann, Karsten] Dausinger Giesen GmbH, Rotebuhlstr 87, D-70178 Stuttgart, Germany; [Hansch, Theodor W.] Univ Munich, Munich, Germany; [Knowles, Paul; Ludhova, Livia; Mulhauser, Francoise; Schaller, Lukas A.] Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland; [Kottmann, Franz; Schuhmann, Karsten; Antognini, Aldo] ETH, Inst Particle Phys, CH-8093 Zurich, Switzerland; [Liu, Yi-Wei] Natl Tsing Hua Univ, Dept Phys, Hsinchu 300, Taiwan; [Lopes, Jose A. M.] Inst Politecn Coimbra, ISEC, P-3030199 Coimbra, Portugal; [Rabinowitz, Paul] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Schuhmann, Karsten; Taqqu, David; Antognini, Aldo] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Giesen, Adolf] Deutsch Zentrum Luft & Raumfahrt eV Helmholtz Gem, D-70569 Stuttgart, Germany; [Knowles, Paul] LogrusData, Vienna, Austria; [Ludhova, Livia] Forschungszentrum Julich, IKP 2, D-52425 Julich, Germany; [Mulhauser, Francoise] IAEA, Vienna, Austria; [Nebel, Tobias] Honeywell Proc Solut Inc, 500 Brooksbank Ave, N Vancouver, BC V7J 3S4, Canada	Max Planck Society; Johannes Gutenberg University of Mainz; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); Universidade de Coimbra; Universidade de Aveiro; Yale University; University of Stuttgart; University of Munich; University of Fribourg; Swiss Federal Institutes of Technology Domain; ETH Zurich; National Tsing Hua University; Instituto Politecnico de Coimbra (IPC); Princeton University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Helmholtz Association; German Aerospace Centre (DLR); Helmholtz Association; Research Center Julich; International Atomic Energy Agency; Honeywell	Pohl, R (corresponding author), Max Planck Inst Quantum Opt, D-85748 Garching, Germany.; Pohl, R (corresponding author), Johannes Gutenberg Univ Mainz, QUANTUM, Inst Phys & Exzellenzcluster PRISMA, D-55099 Mainz, Germany.	pohl@uni-mainz.de	Pohl, Randolf/F-3612-2011; Monteiro, Cristina Maria/R-2097-2017; Graf, Thomas/F-2963-2012; INDELICATO, PAUL/GVT-5812-2022; matias-lopes, jose a/H-6074-2012; Amaro, Fernando/M-3250-2013; Ludhova, Livia/AAE-4487-2020; Fernandes, Luis M P/E-2372-2011; Biraben, François/AFR-7960-2022; Indelicato, Paul J/D-7636-2011; Monteiro, Cristina Maria Bernardes/ABH-3547-2020; Cardoso, Joao Manuel/J-4486-2013; Liu, Yi-wei/C-6825-2013	Pohl, Randolf/0000-0001-6435-659X; Monteiro, Cristina Maria/0000-0002-1912-2804; Graf, Thomas/0000-0002-8466-073X; matias-lopes, jose a/0000-0002-6366-2963; Amaro, Fernando/0000-0001-7315-0550; Fernandes, Luis M P/0000-0002-7061-8768; Indelicato, Paul J/0000-0003-4668-8958; Monteiro, Cristina Maria Bernardes/0000-0002-1912-2804; Cardoso, Joao Manuel/0000-0002-8832-8208; dos Santos, Joaquim Marques Ferreira/0000-0002-8841-6523; Ludhova, Livia/0000-0002-3875-0590; Liu, Yi-wei/0000-0002-1090-0665; antognini, aldo/0000-0002-1837-0419; Veloso, Joao/0000-0002-7107-7203	European Research Council (ERC) [StG. 279765]; Max Planck Society; Max Planck Foundation; Swiss National Science Foundation [200020-100632, 200021L_138175, 200020_159755, 200021_165854]; Swiss Academy of Engineering Sciences; BQR de l'UFR de physique fondamentale et appliquee de l'Universite Pierre et Marie Curie-Paris 6; program PAI Germaine de Stael du ministere des affaires etrangeres France [07819NH]; Fundacao para a Ciencia e a Tecnologia (Portugal); FEDER [PTDC/FIS/102110/2008, SFRH/BPD/46611/2008, SFRH/BPD/74775/2010, SFRH/BPD/76842/2011]; Deutsche Forschungsgemeinschaft (DFG) [GR 3172/9-1]; Ministry of Science and Technology, Taiwan [100-2112-M-007-006-MY3]; ExtreMe Matter Institute, Helmholtz Alliance [HA216/EMMI]	European Research Council (ERC)(European Research Council (ERC)European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX); Max Planck Foundation(Foundation CELLEX); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Academy of Engineering Sciences; BQR de l'UFR de physique fondamentale et appliquee de l'Universite Pierre et Marie Curie-Paris 6; program PAI Germaine de Stael du ministere des affaires etrangeres France; Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); FEDER(European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); ExtreMe Matter Institute, Helmholtz Alliance	We thank E. Borie for the calculations that made this measurement possible; I. Sick for insightful discussions; L.M. Simons and B. Leoni for setting up the cyclotron trap; R. Rosenfelder and C. Hoffman for support; H. Bruckner, K. Linner, W. Simon, O. Huot and Z. Hochman for technical support; P. Maier-Komor, K. Nacke, M. Horisberger, A. Weber, L. Meier, and J. Hehner for thin foils and windows; N. Schlumpf, U. Hartmann, and M. Gaspar for electronics; S. Spielmann-Jaeggi and L. Carroll for optical measurements; Ch. Parthey and M. Herrmann for their help; Th. Udem for insightful discussions; the MEG-collaboration for a share of valuable beamtime; and A. Voss, B. Weichelt and J. Fruechtenicht for the loan of a laser pump diode. We acknowledge the essential contributions of H. Hofer and V. W. Hughes in the initial stages of the experiment and thank K. Kirch for his continuous support. We also thank the PSI accelerator division, the Hallendienst, the workshops at PSI, MPQ, and Fribourg, and other support groups for their valuable help. We acknowledge support from the European Research Council (ERC StG. 279765), the Max Planck Society and the Max Planck Foundation, the Swiss National Science Foundation (project 200020-100632, 200021L_138175, 200020_159755, 200021_165854) and the Swiss Academy of Engineering Sciences, the BQR de l'UFR de physique fondamentale et appliquee de l'Universite Pierre et Marie Curie-Paris 6, the program PAI Germaine de Stael no. 07819NH du ministere des affaires etrangeres France, the Fundacao para a Ciencia e a Tecnologia (Portugal) and FEDER (project PTDC/FIS/102110/2008 and grants SFRH/BPD/46611/2008, SFRH/BPD/74775/2010, and SFRH/BPD/76842/2011), Deutsche Forschungsgemeinschaft (DFG) GR 3172/9-1 within the D-A-CH framework, and Ministry of Science and Technology, Taiwan, no. 100-2112-M-007-006-MY3. P.I. acknowledges support by the "ExtreMe Matter Institute, Helmholtz Alliance HA216/EMMI." Reasonable requests for sharing the data should be addressed to R.P. All authors contributed substantially to this work.	Amaro P, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.022514; Antognini A, 2005, OPT COMMUN, V253, P362, DOI 10.1016/j.optcom.2005.04.079; Antognini A, 2013, ANN PHYS-NEW YORK, V331, P127, DOI 10.1016/j.aop.2012.12.003; Antognini A, 2013, SCIENCE, V339, P417, DOI 10.1126/science.1230016; Antognini A, 2009, IEEE J QUANTUM ELECT, V45, P983, DOI 10.1109/JQE.2009.2014881; Batell B, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.011803; Belushkin MA, 2007, PHYS REV C, V75, DOI 10.1103/PhysRevC.75.035202; Bernauer JC, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.242001; Beyer A, 2013, ANN PHYS-BERLIN, V525, P671, DOI 10.1002/andp.201300075; Biraben F, 2009, EUR PHYS J-SPEC TOP, V172, P109, DOI 10.1140/epjst/e2009-01045-3; Borie E, 2012, ANN PHYS-NEW YORK, V327, P733, DOI 10.1016/j.aop.2011.11.017; Carlson CE, 2015, PROG PART NUCL PHYS, V82, P59, DOI 10.1016/j.ppnp.2015.01.002; Carlson CE, 2014, PHYS REV A, V89, DOI 10.1103/PhysRevA.89.022504; Carlson CE, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.035013; Diepold M, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.042520; Faustov RN, 2015, PHYS REV A, V92, DOI 10.1103/PhysRevA.92.052512; Faustov RN, 2014, PHYS REV A, V90, DOI 10.1103/PhysRevA.90.012520; Fernandes LMP, 2007, J INSTRUM, V2, DOI 10.1088/1748-0221/2/08/P08005; Friar JL, 2013, PHYS REV C, V88, DOI 10.1103/PhysRevC.88.034003; Friar JL, 2004, PHYS LETT B, V579, P285, DOI 10.1016/j.physletb.2003.11.018; Galtier S, 2015, J PHYS CHEM REF DATA, V44, DOI 10.1063/1.4922255; Gasparian A, 2014, EPJ WEB CONF, V73, DOI 10.1051/epjconf/20147307006; Gilman R, 2013, AIP CONF PROC, V1563, P167, DOI 10.1063/1.4829401; Hernandez OJ, 2014, PHYS LETT B, V736, P344, DOI 10.1016/j.physletb.2014.07.039; Jegerlehner F, 2009, PHYS REP, V477, P1, DOI 10.1016/j.physrep.2009.04.003; Jentschura UD, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.062514; Jentschura UD, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.042505; Krauth JJ, 2016, ANN PHYS-NEW YORK, V366, P168, DOI 10.1016/j.aop.2015.12.006; Krutov AA, 2011, PHYS REV A, V84, DOI 10.1103/PhysRevA.84.052514; Lorenz IT, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.014023; Ludhova L, 2005, NUCL INSTRUM METH A, V540, P169, DOI 10.1016/j.nima.2004.11.017; Machleidt R, 2001, PHYS REV C, V63, DOI 10.1103/PhysRevC.63.024001; Mihovilovic M, 2014, EPJ WEB CONF, V81, DOI 10.1051/epjconf/20148101009; Miller GA, 2015, PHYS REV C, V91, DOI 10.1103/PhysRevC.91.055204; Miller GA, 2013, PHYS LETT B, V718, P1078, DOI 10.1016/j.physletb.2012.11.016; Mohr PJ, 2012, REV MOD PHYS, V84, P1527, DOI 10.1103/RevModPhys.84.1527; Pachucki K, 2015, PHYS REV A, V91, DOI 10.1103/PhysRevA.91.040503; Pachucki K, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.193007; Parthey CG, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.233001; Pohl R, 2013, ANNU REV NUCL PART S, V63, P175, DOI 10.1146/annurev-nucl-102212-170627; Pohl R, 2010, NATURE, V466, P213, DOI 10.1038/nature09250; Rothman LS, 2009, J QUANT SPECTROSC RA, V110, P533, DOI 10.1016/j.jqsrt.2009.02.013; Sick I, 1998, NUCL PHYS A, V637, P559, DOI 10.1016/S0375-9474(98)00334-0; Tucker-Smith D, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.101702; Urey HC, 1932, PHYS REV, V39, P164, DOI 10.1103/PhysRev.39.164; Vogelsang J, 2014, OPT EXPRESS, V22, P13050, DOI 10.1364/OE.22.013050; Vutha A. C., 2012, B AM PHYS SOC, V57; Zhan X, 2011, PHYS LETT B, V705, P59, DOI 10.1016/j.physletb.2011.10.002	48	176	179	3	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					669	673		10.1126/science.aaf2468	http://dx.doi.org/10.1126/science.aaf2468			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZC	27516595	Green Published			2022-12-28	WOS:000381561200033
J	Jahangiri, B; Raffel, OC				Jahangiri, Bijan; Raffel, O. Christopher			Enlarged Right Atrium	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Jahangiri, Bijan; Raffel, O. Christopher] Prince Charles Hosp, Brisbane, Qld, Australia	Prince Charles Hospital	Jahangiri, B (corresponding author), Prince Charles Hosp, Brisbane, Qld, Australia.	drbijan@yahoo.com	Raffel, Owen C/Q-1158-2016	Raffel, Owen C/0000-0001-5470-7050					0	1	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 11	2016	375	6					E7	E7		10.1056/NEJMicm1513588	http://dx.doi.org/10.1056/NEJMicm1513588			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DU4OT	27509122				2022-12-28	WOS:000382193100010
J	Saxton, RA; Chantranupong, L; Knockenhauer, KE; Schwartz, TU; Sabatini, DM				Saxton, Robert A.; Chantranupong, Lynne; Knockenhauer, Kevin E.; Schwartz, Thomas U.; Sabatini, David M.			Mechanism of arginine sensing by CASTOR1 upstream of mTORC1	NATURE			English	Article							SIGNAL INTEGRATION; TUMOR-SUPPRESSOR; RAG GTPASES; ACT DOMAIN; KINASE; COMPLEX; SUFFICIENCY; EVOLUTION; PROTEINS; RAPTOR	The mechanistic Target of Rapamycin Complex 1 (mTORC1) is a major regulator of eukaryotic growth that coordinates anabolic and catabolic cellular processes with inputs such as growth factors and nutrients, including amino acids(1-3). In mammals arginine is particularly important, promoting diverse physiological effects such as immune cell activation, insulin secretion, and muscle growth, largely mediated through activation of mTORC1 (refs 4-7). Arginine activates mTORC1 upstream of the Rag family of GTPases(8), through either the lysosomal amino acid transporter SLC38A9 or the GATOR2-interacting Cellular Arginine Sensor for mTORC1 (CASTOR1)(9-12). However, the mechanism by which the mTORC1 pathway detects and transmits this arginine signal has been elusive. Here, we present the 1.8 angstrom crystal structure of arginine-bound CASTOR1. Homodimeric CASTOR1 binds arginine at the interface of two Aspartate kinase, Chorismate mutase, TyrA (ACT) domains, enabling allosteric control of the adjacent GATOR2-binding site to trigger dissociation from GATOR2 and downstream activation of mTORC1. Our data reveal that CASTOR1 shares substantial structural homology with the lysine-binding regulatory domain of prokaryotic aspartate kinases, suggesting that the mTORC1 pathway exploited an ancient, amino-acid-dependent allosteric mechanism to acquire arginine sensitivity. Together, these results establish a structural basis for arginine sensing by the mTORC1 pathway and provide insights into the evolution of a mammalian nutrient sensor.	[Saxton, Robert A.; Chantranupong, Lynne; Knockenhauer, Kevin E.; Schwartz, Thomas U.; Sabatini, David M.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Saxton, Robert A.; Chantranupong, Lynne; Sabatini, David M.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Saxton, Robert A.; Chantranupong, Lynne; Sabatini, David M.] Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Saxton, Robert A.; Chantranupong, Lynne; Sabatini, David M.] Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Saxton, Robert A.; Chantranupong, Lynne; Sabatini, David M.] Harvard & Massachusetts Inst Technol, Broad Inst, 415 Main St, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Howard Hughes Medical Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Schwartz, TU; Sabatini, DM (corresponding author), MIT, Dept Biol, Cambridge, MA 02139 USA.; Sabatini, DM (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.; Sabatini, DM (corresponding author), Howard Hughes Med Inst, Cambridge, MA 02139 USA.; Sabatini, DM (corresponding author), Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Sabatini, DM (corresponding author), Harvard & Massachusetts Inst Technol, Broad Inst, 415 Main St, Cambridge, MA 02142 USA.	tus@mit.edu; sabatini@wi.mit.edu	Schwartz, Thomas/K-9029-2017; Schwartz, Thomas/ABA-1770-2021	Schwartz, Thomas/0000-0001-8012-1512; Schwartz, Thomas/0000-0001-8012-1512; /0000-0002-1446-7256; Saxton, Robert/0000-0001-9777-8270	National Institute of General Medical Sciences from the National Institutes of Health [P41 GM103403]; NIH-ORIP HEI grant [S10 RR029205]; DOE Office of Science [DE-AC02-06CH11357]; NIH [R01CA103866, AI47389, F31 CA180271]; US Department of Defense [W81XWH-07-0448]; NATIONAL CANCER INSTITUTE [P30CA014051, R01CA103866, F31CA180271] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389, R37AI047389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007287, P41GM103403] Funding Source: NIH RePORTER	National Institute of General Medical Sciences from the National Institutes of Health(General Electric); NIH-ORIP HEI grant; DOE Office of Science(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of the Sabatini and Schwartz laboratories for helpful insights. This work is based on research conducted at the Northeastern Collaborative Access Team beamlines, which are funded by the National Institute of General Medical Sciences from the National Institutes of Health (P41 GM103403). The Pilatus 6M detector on 24-ID-C beam line is funded by a NIH-ORIP HEI grant (S10 RR029205). This research used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. This work has been supported by grants from NIH (R01CA103866 and AI47389) and the US Department of Defense (W81XWH-07-0448) to D.M.S. Fellowship support was provided by NIH to L.C. (F31 CA180271). D.M.S. is an investigator of the Howard Hughes Medical Institute.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andersen KR, 2013, PROTEINS, V81, P1857, DOI 10.1002/prot.24364; Aravind L, 1999, J MOL BIOL, V287, P1023, DOI 10.1006/jmbi.1999.2653; Ban H, 2004, INT J MOL MED, V13, P537; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Bridgham JT, 2006, SCIENCE, V312, P97, DOI 10.1126/science.1123348; Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Chantranupong L, 2016, CELL, V165, P153, DOI 10.1016/j.cell.2016.02.035; Chantranupong L, 2014, CELL REP, V9, P1, DOI 10.1016/j.celrep.2014.09.014; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Coyle SM, 2013, CELL, V154, P875, DOI 10.1016/j.cell.2013.07.019; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Dumas R, 2012, ARCH BIOCHEM BIOPHYS, V519, P186, DOI 10.1016/j.abb.2011.10.016; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FLOYD JC, 1966, J CLIN INVEST, V45, P1487, DOI 10.1172/JCI105456; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kotaka M, 2006, J BIOL CHEM, V281, P31544, DOI 10.1074/jbc.M605886200; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parmigiani A, 2014, CELL REP, V9, P1281, DOI 10.1016/j.celrep.2014.10.019; Peisajovich SG, 2010, SCIENCE, V328, P368, DOI 10.1126/science.1182376; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Robin AY, 2010, J MOL BIOL, V399, P283, DOI 10.1016/j.jmb.2010.04.014; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Schrodinger, 2010, PYMOL MOL GRAPHICS S; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Yao K, 2008, J NUTR, V138, P867, DOI 10.1093/jn/138.5.867; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	41	172	181	2	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					229	+		10.1038/nature19079	http://dx.doi.org/10.1038/nature19079			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27487210	Green Accepted, Green Published			2022-12-28	WOS:000381472100040
J	Lim, J; Li, YY; Alsem, DH; So, H; Lee, SC; Bai, P; Cogswell, DA; Liu, XZ; Jin, N; Yu, YS; Salmon, NJ; Shapiro, DA; Bazant, MZ; Tyliszczak, T; Chueh, WC				Lim, Jongwoo; Li, Yiyang; Alsem, Daan Hein; So, Hongyun; Lee, Sang Chul; Bai, Peng; Cogswell, Daniel A.; Liu, Xuzhao; Jin, Norman; Yu, Young-sang; Salmon, Norman J.; Shapiro, David A.; Bazant, Martin Z.; Tyliszczak, Tolek; Chueh, William C.			Origin and hysteresis of lithium compositional spatiodynamics within battery primary particles	SCIENCE			English	Article								The kinetics and uniformity of ion insertion reactions at the solid-liquid interface govern the rate capability and lifetime, respectively, of electrochemical devices such as Li-ion batteries. Using an operando x-ray microscopy platform that maps the dynamics of the Li composition and insertion rate in LixFePO4, we found that nanoscale spatial variations in rate and in composition control the lithiation pathway at the subparticle length scale. Specifically, spatial variations in the insertion rate constant lead to the formation of nonuniform domains, and the composition dependence of the rate constant amplifies nonuniformities during delithiation but suppresses them during lithiation, and moreover stabilizes the solid solution during lithiation. This coupling of lithium composition and surface reaction rates controls the kinetics and uniformity during electrochemical ion insertion.	[Lim, Jongwoo; Li, Yiyang; Lee, Sang Chul; Liu, Xuzhao; Jin, Norman; Bazant, Martin Z.; Chueh, William C.] Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA; [Lim, Jongwoo; Chueh, William C.] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA; [Alsem, Daan Hein; Salmon, Norman J.] Hummingbird Sci, Lacey, WA 98516 USA; [So, Hongyun] Stanford Univ, Dept Aeronaut & Astronaut, Stanford, CA 94305 USA; [Bai, Peng; Cogswell, Daniel A.; Bazant, Martin Z.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Yu, Young-sang; Shapiro, David A.; Tyliszczak, Tolek] Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Bazant, Martin Z.] MIT, Dept Math, Cambridge, MA 02139 USA; [Bazant, Martin Z.] Stanford Univ, SUNCAT Interfacial Sci & Catalysis, Stanford, CA 94305 USA	Stanford University; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Massachusetts Institute of Technology (MIT); Stanford University	Chueh, WC (corresponding author), Stanford Univ, Dept Mat Sci & Engn, Stanford, CA 94305 USA.; Chueh, WC (corresponding author), SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA.	wchueh@stanford.edu	Cogswell, Daniel A/I-1740-2012; Bai, Peng/H-1043-2011; Bazant, Martin Z./AFW-1160-2022	Cogswell, Daniel A/0000-0001-8027-9635; Bai, Peng/0000-0002-2419-3498; Bazant, Martin Z./0000-0002-8200-4501; Li, Yiyang/0000-0002-5809-6901; Jin, Norman/0000-0003-0624-1924; Yu, Young-Sang/0000-0002-0545-9019	U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Sciences and Engineering [DE-AC02-76SF00515]; Ford-Stanford Alliance; DOE Office of Basic Energy Sciences [DE-AC02-05CH11231]; DOE Office of Basic Energy Sciences SBIR program [DE-SC-0007691, DE-SC-0009573]; King Abdullah University of Science and Technology; NSF [DGE-114747]; Global Climate and Energy Project at Stanford University; DOE Office of Basic Energy Sciences through the SUNCAT Center for Interface Science and Catalysis	U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Sciences and Engineering(United States Department of Energy (DOE)); Ford-Stanford Alliance; DOE Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Basic Energy Sciences SBIR program; King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); NSF(National Science Foundation (NSF)); Global Climate and Energy Project at Stanford University(Stanford University); DOE Office of Basic Energy Sciences through the SUNCAT Center for Interface Science and Catalysis	The x-ray component of this work was supported by the U.S. Department of Energy (DOE), Office of Basic Energy Sciences, Division of Materials Sciences and Engineering (contract DE-AC02-76SF00515). The battery component of this work was supported by the Ford-Stanford Alliance. The Advanced Light Source is supported by the DOE Office of Basic Energy Sciences under contract DE-AC02-05CH11231. N.J.S. and D.H.A. acknowledge support from the DOE Office of Basic Energy Sciences SBIR program under awards DE-SC-0007691 and DE-SC-0009573. Beam line 5.3.2.1 at the Advanced Light Source was funded through a donation by the King Abdullah University of Science and Technology. Also supported by a NSF Graduate Research Fellowship under grant DGE-114747 (Y.L.) and by the Global Climate and Energy Project at Stanford University and the DOE Office of Basic Energy Sciences through the SUNCAT Center for Interface Science and Catalysis (M.Z.B.). N.J.S. and D.H.A. are employed by Hummingbird Scientific, which designed and manufactured the microfluidic liquid cell used in these experiments. Part of this work was conducted the Stanford Nano Shared Facilities and the Stanford Nanofabrication Facility. We thank J. Nelson Weker, A. Wise, H. W. Shiu, M. Farmand, D. Kilcoyne, S. Fakra, Y. S. Hsieh, and A. Kammers for insightful discussions and assistance with the experiment. The raw data for this experiment are available as part of the supplementary materials.	[Anonymous], 2002, ADV LITHIUM ION BATT; Maier J, 2008, J ELECTROCHEM SOC, V155, pA339, DOI 10.1149/1.2839626; Wang JJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5570	3	271	278	12	272	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					566	571		10.1126/science.aaf4914	http://dx.doi.org/10.1126/science.aaf4914			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27493180	Green Submitted			2022-12-28	WOS:000381560900036
J	Murphy, D; McCulloch, CE; Lin, F; Banerjee, T; Bragg-Gresham, JL; Eberhardt, MS; Morgenstern, H; Pavkov, ME; Saran, R; Powe, NR; Hsu, CY				Murphy, Daniel; McCulloch, Charles E.; Lin, Feng; Banerjee, Tanushree; Bragg-Gresham, Jennifer L.; Eberhardt, Mark S.; Morgenstern, Hal; Pavkov, Meda E.; Saran, Rajiv; Powe, Neil R.; Hsu, Chi-yuan		Ctr Dis Control Prevention	Trends in Prevalence of Chronic Kidney Disease in the United States	ANNALS OF INTERNAL MEDICINE			English	Article							STAGE RENAL-DISEASE; NUTRITION EXAMINATION SURVEY; BLOOD-PRESSURE CONTROL; NATIONAL-HEALTH; TEMPORAL TRENDS; US ADULTS; RISK; HYPERTENSION; PROGRESSION; CREATININE	Background: Trends in the prevalence of chronic kidney disease (CKD) are important for health care policy and planning. Objective: To update trends in CKD prevalence. Design: Repeated cross-sectional study. Setting: NHANES (National Health and Nutrition Examination Survey) for 1988 to 1994 and every 2 years from 1999 to 2012. Participants: Adults aged 20 years or older. Measurements: Chronic kidney disease (stages 3 and 4) was defined as an estimated glomerular filtration rate (eGFR) of 15 to 59 mL/min/1.73 m(2), estimated with the Chronic Kidney Disease Epidemiology Collaboration equation from calibrated serum creatinine measurements. An expanded definition of CKD also included persons with an eGFR of at least 60 mL/min/1.73 m(2) and a 1-time urine albumin-creatinine ratio of at least 30 mg/g. Results: The unadjusted prevalence of stage 3 and 4 CKD increased from the late 1990s to the early 2000s. Since 2003 to 2004, however, the overall prevalence has largely stabilized (for example, 6.9% prevalence in 2003 to 2004 and in 2011 to 2012). There was little difference in adjusted prevalence of stage 3 and 4 CKD overall in 2003 to 2004 versus 2011 to 2012 after age, sex, race/ethnicity, and diabetes mellitus status were controlled for (P = 0.26). Lack of increase in CKD prevalence since the early 2000s was observed in most subgroups and with an expanded definition of CKD that included persons with higher eGFRs and albuminuria. Limitation: Serum creatinine and albuminuria were measured only once in each person. Conclusion: In a reversal of prior trends, there has been no appreciable increase in the prevalence of stage 3 and 4 CKD in the U.S. population overall during the most recent decade.	[Murphy, Daniel] Univ Minnesota, Dept Med, MMC 284 Mayo,8284A Campus Delivery Code, Minneapolis, MN 55455 USA; [McCulloch, Charles E.; Lin, Feng] Univ Calif San Francisco, Epidemiol & Biostat, Sch Med, 550 16th St,Box 0560, San Francisco, CA 94158 USA; [Banerjee, Tanushree; Powe, Neil R.] Priscilla Chan & Mark Zuckerberg San Francisco Ge, 1001 Potrero Ave,ZFGH 10,Box 1364, San Francisco, CA 94110 USA; [Bragg-Gresham, Jennifer L.] Univ Michigan, Internal Med Nephrol, 1455 Washington Hts,Suite 3645, Ann Arbor, MI 48109 USA; [Eberhardt, Mark S.] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd, Hyattsville, MD 20782 USA; [Morgenstern, Hal] Univ Michigan, Sch Publ Hlth, M5164 SPH 2,1415 Washington Hts, Ann Arbor, MI 48109 USA; [Pavkov, Meda E.] Ctr Dis Control & Prevent, 1600 Clifton Rd, Atlanta, GA 30329 USA; [Saran, Rajiv] Univ Michigan, Internal Med Nephrol Kidney Epidemiol & Cost Ctr, 1415 Washington Hts,SPH 1,Suite 3645, Ann Arbor, MI 48109 USA; [Hsu, Chi-yuan] UCSF Sch Med, 533 Parnassus Ave,UC Hall 404,Box 0532, San Francisco, CA 94143 USA	University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Francisco; University of Michigan System; University of Michigan; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS); University of Michigan System; University of Michigan; Centers for Disease Control & Prevention - USA; University of Michigan System; University of Michigan; University of California System; University of California San Francisco	Hsu, CY (corresponding author), Univ Calif San Francisco, Div Nephrol, 533 Parnassus Ave,U-400,Box 0532, San Francisco, CA 94143 USA.	Neil.Powe@ucsf.edu; hsuchi@medicine.ucsf.edu		Hsu, Chi-yuan/0000-0001-8182-1238	American Society of Nephrology Foundation for Kidney Research Student Scholar Grant Program; Centers for Disease Control and Prevention, and National Institutes of Health; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U58DP003839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK092291] Funding Source: NIH RePORTER	American Society of Nephrology Foundation for Kidney Research Student Scholar Grant Program; Centers for Disease Control and Prevention, and National Institutes of Health; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	American Society of Nephrology Foundation for Kidney Research Student Scholar Grant Program, Centers for Disease Control and Prevention, and National Institutes of Health.	Aitken Grant R, 2014, BMJ Open, V4, pe005480, DOI 10.1136/bmjopen-2014-005480; Bruck K, 2016, J AM SOC NEPHROL, V27, P2135, DOI 10.1681/ASN.2015050542; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; de Boer IH, 2011, NEW ENGL J MED, V365, P2366, DOI 10.1056/NEJMoa1111732; de Boer IH, 2011, JAMA-J AM MED ASSOC, V305, P2532, DOI 10.1001/jama.2011.861; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; Finne P, 2005, JAMA-J AM MED ASSOC, V294, P1782, DOI 10.1001/jama.294.14.1782; Foley RN, 2009, CLIN J AM SOC NEPHRO, V4, P965, DOI 10.2215/CJN.05281008; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Grams ME, 2013, AM J KIDNEY DIS, V62, P253, DOI 10.1053/j.ajkd.2013.03.013; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Gu Q, 2006, CIRCULATION; Gu QP, 2012, CIRCULATION, V126, P2105, DOI 10.1161/CIRCULATIONAHA.112.096156; Healthy People 2020, 2016, CHRON KIDN DIS; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Hsu CY, 2004, ANN INTERN MED, V141, P95, DOI 10.7326/0003-4819-141-2-200407200-00007; Hsu CY, 2003, J AM SOC NEPHROL, V14, P2902, DOI 10.1097/01.ASN.0000091586.46532.B4; Hsu RK, 2013, AM J KIDNEY DIS, V62, P214, DOI 10.1053/j.ajkd.2013.05.003; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Levey AS, 2007, J AM SOC NEPHROL, V18, P374, DOI 10.1681/ASN.2006121305; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; National Center for Health Statistics, 2013, NAT HLTH NUTR EX SUR; National Center for Health Statistics, 2013, NAT HLTH NUTR EX SUR; National Center for Health Statistics, 2016, NAT HLTH NUTR EX SUR; Parsa A, 2013, NEW ENGL J MED, V369, P2183, DOI 10.1056/NEJMoa1310345; PARVING HH, 1983, LANCET, V1, P1175; Plantinga LC, 2009, HYPERTENSION, V54, P47, DOI 10.1161/HYPERTENSIONAHA.109.129841; Reule S, 2016, J AM SOC NEPHROL, V27, P1487, DOI 10.1681/ASN.2014090876; Saydah SH, 2013, CLIN CHEM, V59, P675, DOI 10.1373/clinchem.2012.195644; Selvin E, 2014, ANN INTERN MED, V160, P517, DOI 10.7326/M13-2411; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; United States Renal Data System, 2015, 2015 USRDS ANN DAT R; Vittinghoff E, 2012, REGRESSION METHODS B, P347; Yoon SS, 2015, HYPERTENSION, V65, P54, DOI 10.1161/HYPERTENSIONAHA.114.04012	41	322	331	6	57	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	OCT 4	2016	165	7					473	+		10.7326/M16-0273	http://dx.doi.org/10.7326/M16-0273			17	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DY0EY	27479614	Green Accepted			2022-12-28	WOS:000384771300005
J	Shendure, J				Shendure, Jay			A deep dive into genetic variation	NATURE			English	Editorial Material							CAPTURE; EXOMES		[Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Shendure, Jay] Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute	Shendure, J (corresponding author), Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA.; Shendure, J (corresponding author), Howard Hughes Med Inst, Seattle, WA 98195 USA.	shendure@uw.edu	Shendure, Jay/AAU-3684-2021					Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Walsh R, 2016, GENET MED	9	6	6	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					277	278		10.1038/536277a	http://dx.doi.org/10.1038/536277a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27535530				2022-12-28	WOS:000381804900021
J	Shim, TN; Ali, I; Muneer, A; Bunker, CB				Shim, Tang Ngee; Ali, Iaisha; Muneer, Asif; Bunker, Christopher B.			CLINICAL UPDATES Benign male genital dermatoses	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							LICHEN-SCLEROSUS; BRITISH ASSOCIATION; DERMATOLOGISTS GUIDELINES; CASE SERIES; MANAGEMENT; MULTICENTER; MOLLUSCUM; PLANUS; GLANS		[Shim, Tang Ngee] Univ Hosp, Coventry CV2 2DX, W Midlands, England; [Ali, Iaisha] Imperial Coll Healthcare Trust, London, England; [Muneer, Asif] Univ Coll Hosp, Dept Urol, London, England; [Muneer, Asif] Univ Coll Hosp, NIHR Biomed Res Ctr, London, England; [Bunker, Christopher B.] Univ Coll Hosp, London, England	University of Warwick; University of London; University College London; University of London; University College London; University of London; University College London	Shim, TN (corresponding author), Univ Hosp, Coventry CV2 2DX, W Midlands, England.	tangngee.shim@uhcw.nhs.uk		Bunker, Christopher/0000-0002-6693-7483				Arya M, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1149; Barbagli G, 2006, J UROLOGY, V175, P1359, DOI 10.1016/S0022-5347(05)00735-4; Barbagli G, 2004, UROL INT, V73, P1, DOI 10.1159/000078794; Bunker CB, 2011, BRIT J DERMATOL, V164, P894, DOI 10.1111/j.1365-2133.2010.10183.x; Bunker CB, 2016, ROOKS TXB DERMATOLOG; Bunker CB, 2013, ACTA DERM-VENEREOL, V93, P246, DOI 10.2340/00015555-1481; Cedeno-Laurent F, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-5; Chen W, 1997, J AM ACAD DERMATOL, V36, P630, DOI 10.1016/S0190-9622(97)70255-X; Depasquale I, 2000, BJU INT, V86, P459, DOI 10.1046/j.1464-410X.2000.00772.x; Edmonds EVJ, 2012, J EUR ACAD DERMATOL, V26, P730, DOI 10.1111/j.1468-3083.2011.04155.x; Edwards SK, 2014, INT J STD AIDS, V25, P615, DOI 10.1177/0956462414533099; Fernando I, 2015, INT J STD AIDS, V26, P687, DOI 10.1177/0956462414554435; Forman D, 2012, VACCINE, V30, pF12, DOI 10.1016/j.vaccine.2012.07.055; FRANCOEUR CJ, 1988, ARCH DERMATOL, V124, P935, DOI 10.1001/archderm.124.6.935; Garaffa G, 2011, J SEX MED, V8, P1246, DOI 10.1111/j.1743-6109.2010.02165.x; Goldstein AT, 2011, J AM ACAD DERMATOL, V64, pe99, DOI [10.1016/j.jaad.2010.06.011, DOI 10.1016/J.JAAD.2010.06.011]; Hengge UR, 2006, BRIT J DERMATOL, V155, P1021, DOI 10.1111/j.1365-2133.2006.07446.x; Izaki M, 1952, KEIO J MED, V1, P61, DOI [10.2302/kjm.1.61, DOI 10.2302/KJM.1.61]; Kantere D, 2014, ACTA DERM-VENEREOL, V94, P542, DOI 10.2340/00015555-1797; Kastarinen H, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009446.pub2; Kim Grace K, 2009, J Clin Aesthet Dermatol, V2, P14; Kirtschig G, 2015, J EUR ACAD DERMATOL, V29, pE1, DOI 10.1111/jdv.13136; Liatsikos EN, 1997, SCAND J UROL NEPHROL, V31, P453, DOI 10.3109/00365599709030641; Mallon E, 1997, GENITOURIN MED, V73, P421; Mallon E, 2000, ARCH DERMATOL, V136, P350, DOI 10.1001/archderm.136.3.350; Meeuwis KAP, 2011, ACTA DERM-VENEREOL, V91, P5, DOI 10.2340/00015555-0988; Micali G, 2001, SEX TRANSM INFECT, V77, P226, DOI 10.1136/sti.77.3.226; Nasca MR, 1999, J AM ACAD DERMATOL, V41, P911, DOI 10.1016/S0190-9622(99)70245-8; National Clinical Guideline Centre (UK), 2012, PSORIASIS ASSESSMENT; Neill SM, 2010, BRIT J DERMATOL, V163, P672, DOI 10.1111/j.1365-2133.2010.09997.x; Nelson DM, 2011, J UROLOGY, V185, P522, DOI 10.1016/j.juro.2010.09.107; O'Farrell N, 2007, SEX TRANSM DIS, V34, P408, DOI 10.1097/01.olq.0000240294.79426.a3; Pannell RS, 2005, EPIDEMIOL INFECT, V133, P985, DOI 10.1017/S0950268805004425; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Payette MJ, 2015, CLIN DERMATOL, V33, P631, DOI 10.1016/j.clindermatol.2015.09.006; Porter WM, 2001, INT J STD AIDS, V12, P216, DOI 10.1258/0956462011922922; Rao A, 2011, INT J STD AIDS, V22, P418, DOI 10.1258/ijsa.2011.011072; Rashid RS, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3299; Reich HL, 2004, J AM ACAD DERMATOL, V50, P595, DOI 10.1016/j.jaad.2003.08.011; Singh JP, 2015, UROL ANNALS, V7, P303, DOI 10.4103/0974-7796.150490; Stewart L, 2014, UROLOGY, V83, pS27, DOI 10.1016/j.urology.2013.09.013; Tilly JJ, 2004, J AM ACAD DERMATOL, V51, P606, DOI 10.1016/j.jaad.2003.12.012; van der Wouden JC, 2009, COCHRANE DB SYST REV, V7	43	6	6	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2016	354								i4337	10.1136/bmj.i4337	http://dx.doi.org/10.1136/bmj.i4337			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4UB	27514401	Green Published			2022-12-28	WOS:000381475500002
J	Schrader, J; Henneberg, F; Mata, RA; Tittmann, K; Schneider, TR; Stark, H; Bourenkov, G; Chari, A				Schrader, Jil; Henneberg, Fabian; Mata, Ricardo A.; Tittmann, Kai; Schneider, Thomas R.; Stark, Holger; Bourenkov, Gleb; Chari, Ashwin			The inhibition mechanism of human 20S proteasomes enables next-generation inhibitor design	SCIENCE			English	Article							CRYSTAL-STRUCTURE; CARFILZOMIB; BORTEZOMIB; SUBSTRATE; APPROVAL; REVEALS	The proteasome is a validated target for anticancer therapy, and proteasome inhibition is employed in the clinic for the treatment of tumors and hematological malignancies. Here, we describe crystal structures of the native human 20S proteasome and its complexes with inhibitors, which either are drugs approved for cancer treatment or are in clinical trials. The structure of the native human 20S proteasome was determined at an unprecedented resolution of 1.8 angstroms. Additionally, six inhibitor-proteasome complex structures were elucidated at resolutions between 1.9 and 2.1 angstroms. Collectively, the high-resolution structures provide new insights into the catalytic mechanisms of inhibition and necessitate a revised description of the proteasome active site. Knowledge about inhibition mechanisms provides insights into peptide hydrolysis and can guide strategies for the development of next-generation proteasome-based cancer therapeutics.	[Schrader, Jil; Henneberg, Fabian; Stark, Holger; Chari, Ashwin] Max Planck Inst Biophys Chem, Dept Struct Dynam, Fassberg 11, D-37077 Gottingen, Germany; [Mata, Ricardo A.] Univ Gottingen, Inst Phys Chem, Tamannstr 6, D-37077 Gottingen, Germany; [Tittmann, Kai] Univ Gottingen, Gottingen Zentrum Mol Biowissensch, Julia Lermontowa Weg 3, D-37077 Gottingen, Germany; [Tittmann, Kai] Univ Gottingen, Schwann Schleiden Forschungszentrum, Julia Lermontowa Weg 3, D-37077 Gottingen, Germany; [Schneider, Thomas R.; Bourenkov, Gleb] DESY, Hamburg Outstn, European Mol Biol Lab, Notkestr 85, D-22603 Hamburg, Germany	Max Planck Society; University of Gottingen; University of Gottingen; University of Gottingen; European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Chari, A (corresponding author), Max Planck Inst Biophys Chem, Dept Struct Dynam, Fassberg 11, D-37077 Gottingen, Germany.; Bourenkov, G (corresponding author), DESY, Hamburg Outstn, European Mol Biol Lab, Notkestr 85, D-22603 Hamburg, Germany.	gleb@embl-hamburg.de; ashwin.chari@mpibpc.mpg.de	Mata, Ricardo A./AAC-4850-2020; Bourenkov, Gleb P/C-7794-2017; Chari, Ashwin/ABC-5304-2020; Schneider, Thomas/B-7442-2011	Mata, Ricardo A./0000-0002-2720-3364; Bourenkov, Gleb P/0000-0002-2617-5920; Chari, Ashwin/0000-0001-6220-9828; Schneider, Thomas/0000-0001-6955-7374; Henneberg, Fabian/0000-0003-3444-0947	Deutsche Forschungsgemeinschaft (DFG) [CH1098-1/1, SFB860-TP A5]; European Strategy Forum on Research Infrastructures (ESFRI); Bundesministerium fur Bildung und Forschung (BMBF) [05K2013-624]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); European Strategy Forum on Research Infrastructures (ESFRI); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank T. Conrad and H. Kohansal for help with HeLa cell culture and extract preparation, respectively. The coordinates for the determined structures are deposited in the Protein Data Bank (PDB accession codes 5LE5, 5LEX, 5LEY, 5LEZ, 5LF0, 5LF1, 5LF3, 5LF4, 5LF6, and 5LF7; these codes are associated with the relevant structures in table S2). We thank A. N. Popov for support at beamline ID23, ESRF Grenoble, France, and M. Cianci for support at beamline P13, PETRA3@DESY, in the initial stages of this project. This work was funded by grants from the Deutsche Forschungsgemeinschaft (DFG; CH1098-1/1 to A.C., SFB860-TP A5 to H.S.). H.S. and A.C. received support from an R&D Instruct grant as part of the European Strategy Forum on Research Infrastructures (ESFRI), which is supported by national member subscriptions. The installation of the transfocator system into beamline P14 was supported by Bundesministerium fur Bildung und Forschung (BMBF) grant 05K2013-624 to EMBL. A.C., J.S., F.H., and H.S. have applied for patents regarding the purification method (EP 16 17 3037.9 and USSN 62/345,913) and the next-generation proteasome inhibitor design (EP 16 17 3057.7 and USSN 62/346,203) described in this Report.	Bennett MK, 2008, CURR OPIN DRUG DISC, V11, P616; Bochtler M, 1999, ANNU REV BIOPH BIOM, V28, P295, DOI 10.1146/annurev.biophys.28.1.295; Chari A, 2015, NAT METHODS, V12, P859, DOI [10.1038/NMETH.3493, 10.1038/nmeth.3493]; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; da Fonseca PCA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8573; Demo SD, 2007, CANCER RES, V67, P6383, DOI 10.1158/0008-5472.CAN-06-4086; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Grawert MA, 2011, ANGEW CHEM INT EDIT, V50, P542, DOI 10.1002/anie.201005488; Grigoreva TA, 2015, ONCOTARGET, V6, P24733, DOI 10.18632/oncotarget.4619; Groll M, 2000, J AM CHEM SOC, V122, P1237, DOI 10.1021/ja993588m; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Harshbarger W, 2015, STRUCTURE, V23, P418, DOI 10.1016/j.str.2014.11.017; Huber EM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10900; Huber EM, 2015, STRUCTURE, V23, P407, DOI 10.1016/j.str.2014.11.019; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; Kane RC, 2006, CLIN CANCER RES, V12, P2955, DOI 10.1158/1078-0432.CCR-06-0170; Kish-Trier E, 2013, ANNU REV BIOPHYS, V42, P29, DOI 10.1146/annurev-biophys-083012-130417; Lynas JF, 1998, BIOORG MED CHEM LETT, V8, P373, DOI 10.1016/S0960-894X(98)00030-4; Shirley M, 2016, DRUGS, V76, P405, DOI 10.1007/s40265-016-0548-5	19	122	134	3	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					594	598		10.1126/science.aaf8993	http://dx.doi.org/10.1126/science.aaf8993			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27493187				2022-12-28	WOS:000381560900043
J	Sheldon, T				Sheldon, Tony			ANTIMICROBIAL RESISTANCE Saving antibiotics for when they are really needed: the Dutch example	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							REDUCTION					tonysheldon5@cs.com						[Anonymous], 2016, TACKL DRUG RES INF G; European Ctr Dis Prevention Contro, 2015, EFSA J, V13, DOI [10.2903/j.efsa.2015.4006, 10.2903/j.efsa.20Y15.4204]; Grave K, 2010, J ANTIMICROB CHEMOTH, V65, P2037, DOI 10.1093/jac/dkq247; Mevius D, 2014, J VERBRAUCH LEBENSM, V9, P177, DOI 10.1007/s00003-014-0874-z; Sheldon T., 2010, BMJ-BRIT MED J, V341, pc5677, DOI [10.1136/bmj.c5677, DOI 10.1136/BMJ.C5677]; Speksnijder DC, 2015, ZOONOSES PUBLIC HLTH, V62, P79, DOI 10.1111/zph.12167; VANBUCHEM FL, 1981, LANCET, V2, P883; ZonMw, 2015, ANT RES PROGR	8	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2016	354								i4192	10.1136/bmj.i4192	http://dx.doi.org/10.1136/bmj.i4192			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9CS	27488916				2022-12-28	WOS:000381080600002
J	Lusk, CP				Lusk, C. Patrick			Baby Nuclear Pores Grow Up Faster All the Time	CELL			English	Editorial Material							COMPLEX; CHROMATIN; CELLS	Annulate lamellae (AL) are stacked ER-derived membranes containing nuclear pore complex-like structures whose fate and function have remained a mystery. During the short interphase of early embryonic cells, AL are rapidly delivered into the nuclear envelope through fenestrations, highlighting the remarkable dynamics of the nuclear envelope.	[Lusk, C. Patrick] Yale Sch Med, New Haven, CT 06510 USA	Yale University	Lusk, CP (corresponding author), Yale Sch Med, New Haven, CT 06510 USA.	patrick.lusk@yale.edu		Lusk, C. Patrick/0000-0003-4703-0533	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM105672] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM105672] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cordes VC, 1996, CELL TISSUE RES, V284, P177, DOI 10.1007/s004410050578; D'Angelo MA, 2006, SCIENCE, V312, P440, DOI 10.1126/science.1124196; Doucet CM, 2010, CELL, V141, P1030, DOI 10.1016/j.cell.2010.04.036; Dultz E, 2008, J CELL BIOL, V180, P857, DOI 10.1083/jcb.200707026; Dultz E, 2010, J CELL BIOL, V191, P15, DOI 10.1083/jcb.201007076; Franz C, 2007, EMBO REP, V8, P165, DOI 10.1038/sj.embor.7400889; Hampoelz B, 2016, CELL, V166, P664, DOI 10.1016/j.cell.2016.06.015; King MC, 2016, CURR OPIN CELL BIOL, V41, P9, DOI 10.1016/j.ceb.2016.03.009; Rasala BA, 2006, P NATL ACAD SCI USA, V103, P17801, DOI 10.1073/pnas.0608484103; Vollmer B, 2015, DEV CELL, V33, P717, DOI 10.1016/j.devcel.2015.04.027; Wandke C, 2013, CELL, V152, P1222, DOI 10.1016/j.cell.2013.02.046	11	2	2	3	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 28	2016	166	3					534	535		10.1016/j.cell.2016.07.011	http://dx.doi.org/10.1016/j.cell.2016.07.011			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DS2ED	27471962	Bronze			2022-12-28	WOS:000380546500006
J	Stafford, N				Stafford, Ned			Richard Selzer OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												ns@europefn.de						SELZER R, PUBLICATION LIST	1	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 27	2016	354								i4182	10.1136/bmj.i4182	http://dx.doi.org/10.1136/bmj.i4182			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS6ZH	27468865				2022-12-28	WOS:000380931600015
J	Watts, G				Watts, Geoff			Suzanne Corkin Obituary	LANCET			English	Biographical-Item																		CORKIN S, PUBLICATION LIST	1	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 23	2016	388	10042					336	336		10.1016/S0140-6736(16)31114-X	http://dx.doi.org/10.1016/S0140-6736(16)31114-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR6MV	27482591				2022-12-28	WOS:000380016900025
J	Guerrero, C; Pittelkow, MR				Guerrero, Carlo; Pittelkow, Mark R.			Thyroid Ophthalmopathy, Dermopathy, and Acropachy	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Guerrero, Carlo] Maricopa Cty Gen Hosp, Phoenix, AZ 85008 USA; [Pittelkow, Mark R.] Mayo Clin, Scottsdale, AZ USA	Maricopa County General Hospital; Mayo Clinic; Mayo Clinic Phoenix	Guerrero, C (corresponding author), Maricopa Cty Gen Hosp, Phoenix, AZ 85008 USA.	carlo_guerrero@dmgaz.org		Guerrero, Carlo/0000-0002-1663-3641					0	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 21	2016	375	3					261	261		10.1056/NEJMicm1506674	http://dx.doi.org/10.1056/NEJMicm1506674			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS0ZL	27468062				2022-12-28	WOS:000380325400009
J	Perli, SD; Cui, CH; Lu, TK				Perli, Samuel D.; Cui, Cheryl H.; Lu, Timothy K.			Continuous genetic recording with self-targeting CRISPR-Cas in human cells	SCIENCE			English	Article							TUMOR-NECROSIS-FACTOR; GENOMIC DNA; RNA; CANCER; SUPPRESSION; NETWORKS; MEMORY; RATS	The ability to record molecular events in vivo would enable monitoring of signaling dynamics within cellular niches and critical factors that orchestrate cellular behavior. We present a self-contained analog memory device for longitudinal recording of molecular stimuli into DNA mutations in human cells. This device consists of a self-targeting guide RNA (stgRNA) that repeatedly directs Streptococcus pyogenes Cas9 nuclease activity toward the DNA that encodes the stgRNA, enabling localized, continuous DNA mutagenesis as a function of stgRNA expression. We demonstrate programmable and multiplexed memory storage in human cells triggered by exogenous inducers or inflammation, both in vitro and in vivo. This tool, Mammalian Synthetic Cellular Recorder Integrating Biological Events (mSCRIBE), provides a distinct strategy for investigating cell biology in vivo and enables continuous evolution of targeted DNA sequences.	[Perli, Samuel D.; Cui, Cheryl H.; Lu, Timothy K.] MIT, MIT Synthet Biol Ctr, Synthet Biol Grp, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Perli, Samuel D.; Cui, Cheryl H.; Lu, Timothy K.] MIT, Elect Res Lab, Cambridge, MA 02139 USA; [Perli, Samuel D.; Lu, Timothy K.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Cui, Cheryl H.] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Lu, Timothy K.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT)	Lu, TK (corresponding author), MIT, MIT Synthet Biol Ctr, Synthet Biol Grp, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Lu, TK (corresponding author), MIT, Elect Res Lab, Cambridge, MA 02139 USA.; Lu, TK (corresponding author), MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA.; Lu, TK (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	timlu@mit.edu			National Institutes of Health [DP2 OD008435, P50 GM098792]; Office of Naval Research; National Science Foundation [MCB-1350625]; Defense Advanced Research Projects Agency; Center for Microbiome Informatics and Therapeutics; NSF Expeditions in Computing Program [1522074]; Natural Sciences and Engineering Research Council of Canada; Direct For Biological Sciences [1350625] Funding Source: National Science Foundation; Division of Computing and Communication Foundations [1522074] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); National Science Foundation(National Science Foundation (NSF)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Center for Microbiome Informatics and Therapeutics; NSF Expeditions in Computing Program(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	The plasmid constructs mentioned in table S2 are available from Addgene via their standard materials transfer agreement. T.K.L., S.D.P., and C.H.C. are inventors on a U.S. patent application (PCT/US2016/032348) submitted by MIT that covers the self-targeting genome editing system. We thank members of the Lu laboratory for helpful discussions. We thank the MIT MicroBioCenter for technical support with next-generation sequencing and the MIT Koch Institute flow cytometry core facility for their technical assistance in cell sorting. This work was supported by the National Institutes of Health (grants DP2 OD008435 and P50 GM098792), the Office of Naval Research (grant N00014-13-1-0424), the National Science Foundation (grant MCB-1350625), the Defense Advanced Research Projects Agency, The Center for Microbiome Informatics and Therapeutics, and NSF Expeditions in Computing Program Award 1522074. C.H.C. was supported by a Natural Sciences and Engineering Research Council of Canada postgraduate fellowship. S.P., C.H.C., and T.K.L. conceived the work. S.D.P. and C.H.C. designed and performed experiments. S.D.P. performed computational analyses on next-generation sequencing data. C.H.C. conducted in vivo animal studies. S.D.P., C.H.C., and T.K.L. designed the experiments and interpreted and analyzed the data. S.D.P., C.H.C., and T.K.L. wrote the paper. Sequences of all of the DNA constructs used in this work are listed in table S2, and their plasmid maps and C++ routines are available at www.rle.mit.edu/sbg/resources/stgRNA.	Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; ALTSCHUL SF, 1986, B MATH BIOL, V48, P603, DOI 10.1016/S0092-8240(86)90010-8; Anders C, 2014, NATURE, V513, P569, DOI 10.1038/nature13579; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; BEMELMANS MHA, 1993, J IMMUNOL, V151, P5554; Bozkurt B, 1998, CIRCULATION, V97, P1382, DOI 10.1161/01.CIR.97.14.1382; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/nmeth.1648, 10.1038/NMETH.1648]; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Copeland S, 2005, CLIN DIAGN LAB IMMUN, V12, P60, DOI 10.1128/CDLI.12.1.60-67.2005; Deriano L, 2013, ANNU REV GENET, V47, P433, DOI 10.1146/annurev-genet-110711-155540; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Farzadfard F, 2014, SCIENCE, V346, P825, DOI 10.1126/science.1256272; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Herold MJ, 2008, P NATL ACAD SCI USA, V105, P18507, DOI 10.1073/pnas.0806213105; Jinek M, 2013, ELIFE, V2, DOI 10.7554/eLife.00471; Kalhor R., 2016, BIORXIV, DOI [10.1101/055863, DOI 10.1101/055863]; Kiss K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037378; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kotula JW, 2014, P NATL ACAD SCI USA, V111, P4838, DOI 10.1073/pnas.1321321111; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Maeder ML, 2013, NAT BIOTECHNOL, V31, P1137, DOI 10.1038/nbt.2726; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Minczuk M, 2008, NUCLEIC ACIDS RES, V36, P3926, DOI 10.1093/nar/gkn313; Nissim L, 2014, MOL CELL, V54, P698, DOI 10.1016/j.molcel.2014.04.022; Perli S., 2016, BIORXIV, DOI [10.1101/053058, DOI 10.1101/053058]; Rouleau M, 2010, NAT REV CANCER, V10, P293, DOI 10.1038/nrc2812; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; VanAntwerp DJ, 1996, SCIENCE, V274, P787, DOI 10.1126/science.274.5288.787; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	38	127	143	4	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2016	353	6304							aag0511	10.1126/science.aag0511	http://dx.doi.org/10.1126/science.aag0511			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0RN	27540006	Green Submitted			2022-12-28	WOS:000382626800043
J	Ornes, S				Ornes, Stephen			LET THE STRUCTURAL SYMPHONY BEGIN	NATURE			English	Editorial Material							CRYO-EM; COMPLEX											Bartesaghi A, 2015, SCIENCE, V348, P1147, DOI 10.1126/science.aab1576; Huang R, 2016, P NATL ACAD SCI USA, V113, pE4190, DOI 10.1073/pnas.1603980113; Jiang FG, 2016, SCIENCE, V351, P867, DOI 10.1126/science.aad8282; Louder RK, 2016, NATURE, V531, P604, DOI 10.1038/nature17394; Murakami K, 2015, P NATL ACAD SCI USA, V112, P13543, DOI 10.1073/pnas.1518255112; Sali A, 2015, STRUCTURE, V23, P1156, DOI 10.1016/j.str.2015.05.013; Szymborska A, 2013, SCIENCE, V341, P655, DOI 10.1126/science.1240672; Zhao JH, 2015, NATURE, V521, P241, DOI 10.1038/nature14365	8	2	2	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					361	363		10.1038/536361a	http://dx.doi.org/10.1038/536361a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27535537				2022-12-28	WOS:000381804900045
J	Sakaue, S; Hagino, N				Sakaue, Saori; Hagino, Noboru			Takayasu's Arteritis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Sakaue, Saori] Tokyo Univ Hosp, Tokyo, Japan; [Hagino, Noboru] Teikyo Univ, Chiba Med Ctr, Chiba, Japan	University of Tokyo; Teikyo University	Sakaue, S (corresponding author), Tokyo Univ Hosp, Tokyo, Japan.	saorisakaue@gmail.com		Sakaue, Saori/0000-0003-3618-9717					0	3	3	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 18	2016	375	7					675	675		10.1056/NEJMicm1503040	http://dx.doi.org/10.1056/NEJMicm1503040			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4VF	27532833				2022-12-28	WOS:000381478600009
J	Yu, Y				Yu, Yan			Normal-Weight Central Obesity and Mortality Risk	ANNALS OF INTERNAL MEDICINE			English	Letter									[Yu, Yan] Australian Natl Univ, Canberra, ACT, Australia	Australian National University	Yu, Y (corresponding author), Australian Natl Univ, Canberra, ACT, Australia.							Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Sahakyan KR, 2015, ANN INTERN MED, V163, P827, DOI 10.7326/M14-2525	2	1	1	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 16	2016	165	4					298	298		10.7326/L16-0074	http://dx.doi.org/10.7326/L16-0074			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT1UI	27538167				2022-12-28	WOS:000381267200025
J	Weng, JK; Ye, ML; Li, B; Noel, JP				Weng, Jing-Ke; Ye, Mingli; Li, Bin; Noel, Joseph P.			Co-evolution of Hormone Metabolism and Signaling Networks Expands Plant Adaptive Plasticity	CELL			English	Article							ANTHOCYANIDIN REDUCTASE; DIHYDROPHASEIC ACID; MESSENGER-RNA; GERMINATION; RECEPTORS; FEATURES; PROTEIN	Classically, hormones elicit specific cellular responses by activating dedicated receptors. Nevertheless, the biosynthesis and turnover of many of these hormone molecules also produce chemically related metabolites. These molecules may also possess hormonal activities; therefore, one or more may contribute to the adaptive plasticity of signaling outcomes in host organisms. Here, we show that a catabolite of the plant hormone abscisic acid (ABA), namely phaseic acid (PA), likely emerged in seed plants as a signaling molecule that fine-tunes plant physiology, environmental adaptation, and development. This trait was facilitated by both the emergence- selection of a PA reductase that modulates PA concentrations and by the functional diversification of the ABA receptor family to perceive and respond to PA. Our results suggest that PA serves as a hormone in seed plants through activation of a subset of ABA receptors. This study demonstrates that the co-evolution of hormone metabolism and signaling networks can expand organismal resilience.	[Weng, Jing-Ke; Ye, Mingli; Noel, Joseph P.] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Weng, Jing-Ke; Ye, Mingli; Noel, Joseph P.] Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA; [Li, Bin] Univ Calif San Diego, San Diego Sch Med, Dept Cellular & Mol Med, San Diego, CA 92093 USA; [Weng, Jing-Ke] MIT, Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA; [Weng, Jing-Ke] MIT, Dept Biol, 9 Cambridge Ctr, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Salk Institute; Salk Institute; University of California System; University of California San Diego; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Noel, JP (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA.; Noel, JP (corresponding author), Salk Inst Biol Studies, Jack H Skirball Ctr Chem Biol & Prote, La Jolla, CA 92037 USA.	noel@salk.edu	Weng, Jing-Ke/V-5934-2019; Noel, Joseph P/A-9459-2009	Weng, Jing-Ke/0000-0003-3059-0075; 	National Science Foundation [EEC-0813570]; Pioneer Foundation	National Science Foundation(National Science Foundation (NSF)); Pioneer Foundation	We thank Sean Cutler for providing Arabidopsis mutant seeds of pyr1-1, pyl1-1, pyl2-1, and pyl4-1. This work was supported by the National Science Foundation under award number EEC-0813570 to J.P.N. J.K.W. was supported by a postdoctoral fellowship from the Pioneer Foundation. J.K.W. is a Pew Scholar in the Biomedical Sciences and a Searle Scholar. J.P.N. is an investigator with the Howard Hughes Medical Institute.	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Cai L, 2012, NAT PRODUCT BIOPROSP, V2, P150, DOI 10.1007/s13659-012-0009-0; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Dupeux F, 2011, EMBO J, V30, P4171, DOI 10.1038/emboj.2011.294; Fujita Y, 2005, PLANT CELL, V17, P3470, DOI 10.1105/tpc.105.035659; Gargouri M, 2009, ARCH BIOCHEM BIOPHYS, V491, P61, DOI 10.1016/j.abb.2009.09.010; Gonzalez-Guzman M, 2012, PLANT CELL, V24, P2483, DOI 10.1105/tpc.112.098574; Hill R. D., 1992, Seed Science Research, V2, P207, DOI 10.1017/S0960258500001392; HILL RD, 1995, PLANT PHYSIOL, V108, P573, DOI 10.1104/pp.108.2.573; Hopkins R, 2011, NATURE, V469, P411, DOI 10.1038/nature09641; Huang DQ, 2007, PLANT J, V50, P414, DOI 10.1111/j.1365-313X.2007.03056.x; Hugouvieux V, 2001, CELL, V106, P477, DOI 10.1016/S0092-8674(01)00460-3; Kepka M, 2011, PLANT PHYSIOL, V157, P2108, DOI 10.1104/pp.111.182584; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kleinboelting N, 2012, NUCLEIC ACIDS RES, V40, pD1211, DOI 10.1093/nar/gkr1047; Lee J, 2007, PLANT CELL, V19, P731, DOI 10.1105/tpc.106.047688; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; MILBORROW BV, 1982, AUST J PLANT PHYSIOL, V9, P361, DOI 10.1071/PP9820361; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Peterson FC, 2010, NAT STRUCT MOL BIOL, V17, P1109, DOI 10.1038/nsmb.1898; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Ramos MD, 2004, PHYTOCHEMISTRY, V65, P955, DOI 10.1016/j.phytochem.2003.12.007; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; Seaborn T, 2010, TRENDS ENDOCRIN MET, V21, P729, DOI 10.1016/j.tem.2010.09.001; SHARKEY TD, 1980, PLANT PHYSIOL, V65, P291, DOI 10.1104/pp.65.2.291; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Theofilopoulos S, 2013, NAT CHEM BIOL, V9, P126, DOI [10.1038/NCHEMBIO.1156, 10.1038/nchembio.1156]; WalkerSimmons MK, 1997, PHYSIOL PLANTARUM, V100, P474, DOI 10.1034/j.1399-3054.1997.1000308.x; WALTON DC, 1973, PLANTA, V112, P87, DOI 10.1007/BF00386035; Xie DY, 2003, SCIENCE, V299, P396, DOI 10.1126/science.1078540; Yin P, 2009, NAT STRUCT MOL BIOL, V16, P1230, DOI 10.1038/nsmb.1730; Zhang XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067477	36	96	100	3	85	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	AUG 11	2016	166	4					881	893		10.1016/j.cell.2016.06.027	http://dx.doi.org/10.1016/j.cell.2016.06.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU5NO	27518563	Bronze			2022-12-28	WOS:000382258700012
J	Lozano, P; Henrikson, NB; Dunn, J; Morrison, CC; Nguyen, M; Blasi, PR; Anderson, ML; Whitlock, EP				Lozano, Paula; Henrikson, Nora B.; Dunn, John; Morrison, Caitlin C.; Nguyen, Matt; Blasi, Paula R.; Anderson, Melissa L.; Whitlock, Evelyn P.			Lipid Screening in Childhood and Adolescence for Detection of Familial Hypercholesterolemia Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							STATIN TREATMENT; ROSUVASTATIN THERAPY; RISK-FACTORS; FOLLOW-UP; CHILDREN; EFFICACY; SAFETY; ATHEROSCLEROSIS; GUIDELINES; EZETIMIBE	IMPORTANCE Familial hypercholesterolemia (FH) is characterized by elevated cholesterol concentrations early in life. Untreated FH is associated with premature cardiovascular disease in adulthood. OBJECTIVE Tosystematically review the evidence on benefits and harms of screening adolescents and children for heterozygous FH for the US Preventive Services Task Force (USPSTF). DATA SOURCES MEDLINE, the Cochrane Central Register of Controlled Trials, and PubMed were searched for studies published between January 1, 2005, and June 2, 2015; studies included in a previous USPSTF report were also searched. Surveillance was conducted through April 8, 2016. STUDY SELECTION Fair-and good-quality studies in English with participants 0 to 20 years of age. DATA EXTRACTION AND SYNTHESIS Two investigators independently reviewed abstracts and full-text articles and extracted data into evidence tables. Results were qualitatively summarized. MAIN OUTCOMES AND MEASURES Myocardial infarction and ischemic stroke in adulthood; lipid concentrations and atherosclerosis in childhood; diagnostic yield of screening; any harm of screening or treatment. RESULTS Based on 2 studies (n = 83 241), the diagnostic yield of universal screening for FH in childhood is 1.3 to 4.8 cases per 1000 screened. There was no eligible evidence on the benefits or harms of FH screening in childhood. Eight placebo trials of statin drugs (n = 1071, 6-104 weeks) found low-density lipoprotein cholesterol (LDL-C) decreases of 20% to 40%; 1 trial (n = 214) showed a 2.01% decrease in carotid intima-media thickness with statins, compared with 1.02% with placebo (P=.02). Three placebo trials of bile acid-sequestering agents (n = 332, 8-52 weeks) showed LDL-C reductions of 10% to 20%. In 1 trial (n = 248), ezetimibe with simvastatin resulted in greater LDL-C reductions compared with simvastatin alone at 33 weeks (mean, -54.0%[SD, 1.4%] vs-38.1%[SD, 1.4%]). One trial of ezetimibe monotherapy (n = 138) showed mean LDL-C decreases of 28%(95% CI,-31% to-25%) from baseline and negligible change with placebo at 12 weeks. Eighteen studies found statins generally well tolerated. One observational study found lower, but still normal, dehydroepiandrosterone sulfate concentrations in statin-treated males with FH at 10-year follow-up. Bile acid-sequestering agents were commonly associated with adverse gastrointestinal symptoms and poor palatability. There was no eligible evidence on the effect of FH treatment on myocardial infarction or stroke in adulthood. CONCLUSIONS AND RELEVANCE Screening can detect FH in children, and lipid-lowering treatment in childhood can reduce lipid concentrations in the short term, with little evidence of harm. There is no evidence for the effect of screening for FH in childhood on lipid concentrations or cardiovascular outcomes in adulthood, or on the long-term benefits or harms of beginning lipid-lowering treatment in childhood.	[Lozano, Paula; Henrikson, Nora B.; Dunn, John; Morrison, Caitlin C.; Nguyen, Matt; Blasi, Paula R.; Anderson, Melissa L.] Kaiser Permanente, Res Affiliates Evidence Based Practice Ctr, Grp Hlth Res Inst, Seattle, WA USA; [Whitlock, Evelyn P.] Kaiser Permanente, Res Affiliates Evidence Based Practice Ctr, Ctr Hlth Res, Portland, OR USA	Kaiser Permanente; Kaiser Permanente	Lozano, P (corresponding author), Grp Hlth Res Inst, 1730 Minor Ave,Ste 1600, Seattle, WA 98101 USA.	lozano.p@ghc.org	Lozano, Paula Maria/GPP-4090-2022	Blasi, Paula/0000-0002-7094-706X	Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This research was funded by the Agency for Healthcare Research and Quality (AHRQ) under a contract to support the USPSTF.	[Anonymous], 2007, SCREENING LIPID DISO; Austin MA, 2004, AM J EPIDEMIOL, V160, P407, DOI 10.1093/aje/kwh236; Avis HJ, 2011, J PEDIATR-US, V158, P458, DOI 10.1016/j.jpeds.2010.08.015; Avis HJ, 2010, J AM COLL CARDIOL, V55, P1121, DOI 10.1016/j.jacc.2009.10.042; Berenson GS, 1998, NEW ENGL J MED, V338, P1650, DOI 10.1056/NEJM199806043382302; Braamskamp MJAM, 2016, J AM COLL CARDIOL, V67, P455, DOI 10.1016/j.jacc.2015.11.021; Braamskamp MJAM, 2015, J CLIN LIPIDOL, V9, P741, DOI 10.1016/j.jacl.2015.07.011; Braamskamp MJAM, 2015, J PEDIATR-US, V167, P338, DOI 10.1016/j.jpeds.2015.05.006; Braamskamp MJAM, 2015, ATHEROSCLEROSIS, V241, P427, DOI 10.1016/j.atherosclerosis.2015.05.034; Braamskamp MJAM, 2015, PEDIATR DRUGS, V17, P159, DOI 10.1007/s40272-014-0116-y; Calonge N, 2007, PEDIATRICS, V120, pE215, DOI 10.1542/peds.2006-1812; Carreau V, 2011, PEDIATR DRUGS, V13, P267, DOI 10.2165/11591650-000000000-00000; Clauss SB, 2005, PEDIATRICS, V116, P682, DOI 10.1542/peds.2004-2090; Cottrell L, 2013, J OBES, V2013, DOI 10.1155/2013/732579; Daniels SR, 2015, J CLIN LIPIDOL, V9, pS5, DOI 10.1016/j.jacl.2015.03.105; Daniels SR, 2011, J CLIN LIPIDOL, V5, pS30, DOI 10.1016/j.jacl.2011.03.453; de Ferranti SD, 2016, CIRCULATION, V133, P1067, DOI 10.1161/CIRCULATIONAHA.115.018791; de Ferranti SD, 2012, CLIN CHEM, V58, P1626, DOI 10.1373/clinchem.2012.182089; de Jongh S, 2002, J AM COLL CARDIOL, V40, P2117, DOI 10.1016/S0735-1097(02)02593-7; de Jongh S, 2002, CIRCULATION, V106, P2231, DOI 10.1161/01.CIR.0000035247.42888.82; Gandelman K, 2011, PEDIATR CARDIOL, V32, P433, DOI 10.1007/s00246-011-9885-z; Gillman MW, 2012, ARCH PEDIAT ADOL MED, V166, P1097, DOI 10.1001/archpediatrics.2012.1907; Gillman MW, 2012, JAMA-J AM MED ASSOC, V307, P259, DOI 10.1001/jama.2011.2012; Haney EM, 2007, PEDIATRICS, V120, pE189, DOI 10.1542/peds.2006-1801; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hedman M, 2003, CLIN PHARMACOL THER, V74, P178, DOI 10.1016/S0009-9236(03)00153-X; Kavey Rae-Ellen W, 2012, Am Fam Physician, V86, P1; Knipscheer HC, 1996, PEDIATR RES, V39, P867, DOI 10.1203/00006450-199605000-00021; Knowles JW, 2014, AM HEART J, V168, P807, DOI 10.1016/j.ahj.2014.09.001; Kusters DM, 2015, J PEDIATR-US, V166, P1377, DOI 10.1016/j.jpeds.2015.02.043; Kusters DM, 2014, JAMA-J AM MED ASSOC, V312, P1055, DOI 10.1001/jama.2014.8892; Lefevre Michael, 2012, Am Fam Physician, V86, P1; Lozano P, JAMA-J AM MED ASSOC, DOI [10.1001/jama.2016.6423, DOI 10.1001/JAMA.2016]; Lozano P., 2016, LIPID SCREENING CHIL; McCrindle BW, 2012, PEDIATRICS, V130, P353, DOI 10.1542/peds.2012-1137; McCrindle BW, 2003, J PEDIATR-US, V143, P74, DOI 10.1016/S0022-3476(03)00186-0; McCrindle BW, 2002, PEDIATR RES, V51, P715, DOI 10.1023/01.PDR.0000015127.99522.7F; McGill HC, 2000, ARTERIOSCL THROM VAS, V20, P1998, DOI 10.1161/01.ATV.20.8.1998; National Clinical Guideline Centre (UK), 2014, LIP MOD CARD RISK AS; Neil HAW, 1999, ATHEROSCLEROSIS, V142, P105; Neil HAW, 2000, BRIT MED J, V321, P148, DOI 10.1136/bmj.321.7254.148; Newman TB, 2012, PEDIATRICS, V130, P349, DOI 10.1542/peds.2012-0481; NEWMAN WP, 1986, NEW ENGL J MED, V314, P138, DOI 10.1056/NEJM198601163140302; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Psaty BM, 2012, JAMA-J AM MED ASSOC, V307, P257, DOI 10.1001/jama.2011.1916; Reiner Z, 2014, CIRC RES, V114, P233, DOI 10.1161/CIRCRESAHA.113.302952; Rodenburg J, 2007, CIRCULATION, V116, P664, DOI 10.1161/CIRCULATIONAHA.106.671016; Rossebo AB, 2008, NEW ENGL J MED, V359, P1343, DOI 10.1056/NEJMoa0804602; Sinzinger H, 2004, BRIT J CLIN PHARMACO, V57, P525, DOI 10.1111/j.1365-2125.2003.02044.x; SKOVBY F, 1991, ARCH DIS CHILD, V66, P844, DOI 10.1136/adc.66.7.844; Stein EA, 1999, JAMA-J AM MED ASSOC, V281, P137, DOI 10.1001/jama.281.2.137; Stein EA, 2007, CIRCULATION, V116, P594, DOI 10.1161/CIRCULATIONAHA.107.717777; Stein EA, 2010, J PEDIATR-US, V156, P231, DOI 10.1016/j.jpeds.2009.08.037; STONE NJ, 1974, CIRCULATION, V49, P476, DOI 10.1161/01.CIR.49.3.476; Talmud PJ, 2013, LANCET, V381, P1293, DOI 10.1016/S0140-6736(12)62127-8; THOROGOOD M, 1991, BRIT MED J, V303, P893; Tonstad S, 1996, ARCH DIS CHILD, V74, P157, DOI 10.1136/adc.74.2.157; Tonstad S, 1996, J PEDIATR-US, V129, P42, DOI 10.1016/S0022-3476(96)70188-9; United Nations Development Programme, 2014, HUM DEV IND 2013 RAN; US Preventive Services Task Force, 2015, US PREV SERV TASK FO; van der Graaf A, 2008, J AM COLL CARDIOL, V52, P1421, DOI 10.1016/j.jacc.2008.09.002; Vuorio A, 2013, ATHEROSCLEROSIS, V226, P315, DOI 10.1016/j.atherosclerosis.2012.10.032; Wiegman A, 2004, JAMA-J AM MED ASSOC, V292, P331, DOI 10.1001/jama.292.3.331; WILLIAMS RR, 1993, AM J CARDIOL, V72, P171, DOI 10.1016/0002-9149(93)90155-6; World Health Organization, 1999, FAM HYP REP 2 WHO CO	65	40	42	1	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2016	316	6					645	655		10.1001/jama.2016.6176	http://dx.doi.org/10.1001/jama.2016.6176			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7TK	27532919	Bronze			2022-12-28	WOS:000380985600017
J	Cao, JJ; Cohen, A; Hansen, J; Lester, R; Peterson, P; Xu, HJ				Cao, Junji; Cohen, Armond; Hansen, James; Lester, Richard; Peterson, Per; Xu, Hongjie			China-US cooperation to advance nuclear power	SCIENCE			English	Editorial Material									[Cao, Junji] SKLLQG, Inst Earth Environm, Key Lab Aerosol Chem & Phys, Xian 710061, Peoples R China; [Cohen, Armond] Clean Air Task Force, Boston, MA 02108 USA; [Hansen, James] Columbia Univ, Earth Inst, New York, NY 10025 USA; [Lester, Richard] MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Peterson, Per] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Xu, Hongjie] Shanghai Inst Appl Phys, Shanghai 21203, Peoples R China	Chinese Academy of Sciences; Institute of Earth Environment, CAS; Columbia University; Massachusetts Institute of Technology (MIT); University of California System; University of California Berkeley; Chinese Academy of Sciences; Shanghai Institute of Applied Physics, CAS	Hansen, J (corresponding author), Columbia Univ, Earth Inst, New York, NY 10025 USA.	jimehansen@gmail.com	xu, hong/GSD-8903-2022; Junji, Cao/D-3259-2014	Junji, Cao/0000-0003-1000-7241				Buongiorno J, 2016, NUCL TECHNOL, V194, P1; IDDRI, 2015, PATHWAYS DEEP DECARB; Intergovernmental Panel Climate Change Working Grp III, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P1; International Energy Agency, 2014, WORLD EN OUTL 2014, P396; Joint Global Change Research Institute Pacific Northwest National Laboratory, 2016, IMPL PAR 1 WORKSH CO; Looney B., 2020, STAT REV WORLD EN 20, V69	6	37	39	4	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					547	548		10.1126/science.aaf7131	http://dx.doi.org/10.1126/science.aaf7131			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DT5YZ	27493172	Green Published			2022-12-28	WOS:000381560900021
J	Lennen, RM				Lennen, Rebecca M.			Benefits of selective feeding	SCIENCE			English	Editorial Material									[Lennen, Rebecca M.] Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2970 Horsholm, Denmark	Technical University of Denmark	Lennen, RM (corresponding author), Tech Univ Denmark, Novo Nordisk Fdn Ctr Biosustainabil, DK-2970 Horsholm, Denmark.	rlen@biosustain.dtu.dk			Novo Nordisk Fonden [NNF10CC1016517] Funding Source: researchfish; NNF Center for Biosustainability [Platform Strain Development, iLoop] Funding Source: researchfish	Novo Nordisk Fonden(Novo Nordisk Foundation); NNF Center for Biosustainability		[Anonymous], 2010, NAT ALG BIOF TECHN R; Costa OYA, 2015, J IND MICROBIOL BIOT, V42, P73, DOI 10.1007/s10295-014-1533-1; Behrens MR, 2007, SCIENCE, V316, P1185, DOI 10.1126/science.1141596; Della-Bianca BE, 2013, APPL MICROBIOL BIOT, V97, P979, DOI 10.1007/s00253-012-4631-x; Lee JW, 2012, NAT CHEM BIOL, V8, P536, DOI [10.1038/nchembio.970, 10.1038/NCHEMBIO.970]; Shaw AJ, 2016, SCIENCE, V353, P583, DOI 10.1126/science.aaf6159; U.S. Food and Drug Administration, REP FY 2010 NAT SURV	7	1	1	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 5	2016	353	6299					542	543		10.1126/science.aah4106	http://dx.doi.org/10.1126/science.aah4106			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5YZ	27493169				2022-12-28	WOS:000381560900018
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Can junior doctors feel safe to blow the whistle?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Employment Cases Update, 2016, DAY V LEW GREENW NHS; NHS Improvement NHS England, 2016, FREED SPEAK RAIS CON	2	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 1	2016	354								i4215	10.1136/bmj.i4215	http://dx.doi.org/10.1136/bmj.i4215			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9CH	27480671	Green Published, Bronze			2022-12-28	WOS:000381079500004
J	Ceschia, A; Horton, R				Ceschia, Audrey; Horton, Richard			The Lancet Public Health: a new journal and a call for papers	LANCET			English	Editorial Material									[Ceschia, Audrey] Lancet Publ Hlth, London EC2Y 5AS, England		Ceschia, A (corresponding author), Lancet Publ Hlth, London EC2Y 5AS, England.	audrey.ceschia@lancet.com							0	0	0	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2016	388	10041					222	222		10.1016/S0140-6736(16)31071-6	http://dx.doi.org/10.1016/S0140-6736(16)31071-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR2LN	27479556	Bronze			2022-12-28	WOS:000379736100010
J	Panes, J; Garcia-Olmo, D; Van Assche, G; Colombel, JF; Reinisch, W; Baumgart, DC; Dignass, A; Nachury, M; Ferrante, M; Kazemi-Shirazi, L; Grimaud, JC; de la Portilla, F; Goldin, E; Richard, MP; Leselbaum, A; Danese, S				Panes, Julian; Garcia-Olmo, Damian; Van Assche, Gert; Colombel, Jean Frederic; Reinisch, Walter; Baumgart, Daniel C.; Dignass, Axel; Nachury, Maria; Ferrante, Marc; Kazemi-Shirazi, Lili; Grimaud, Jean C.; de la Portilla, Fernando; Goldin, Eran; Richard, Marie Paule; Leselbaum, Anne; Danese, Silvio		ADMIRE CD Study Grp Collaborators	Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial	LANCET			English	Article							ANAL FISTULAS; 6-MERCAPTOPURINE; METRONIDAZOLE; INFLIXIMAB; THERAPY; CIPROFLOXACIN; REMISSION; LONG	Background Complex perianal fistulas in Crohn's disease are challenging to treat. Allogeneic, expanded, adipose-derived stem cells (Cx601) are a promising new therapeutic approach. We aimed to assess the safety and efficacy of Cx601 for treatment-refractory complex perianal fistulas in patients with Crohn's disease. Methods We did this randomised, double-blind, parallel-group, placebo-controlled study at 49 hospitals in seven European countries and Israel from July 6, 2012, to July 27, 2015. Adult patients (>= 18 years) with Crohn's disease and treatment-refractory, draining complex perianal fistulas were randomly assigned (1: 1) using a pre-established randomisation list to a single intralesional injection of 120 million Cx601 cells or 24 mL saline solution (placebo), with stratification according to concomitant baseline treatment. Treatment was administered by an unmasked surgeon, with a masked gastroenterologist and radiologist assessing the therapeutic effect. The primary endpoint was combined remission at week 24 (ie, clinical assessment of closure of all treated external openings that were draining at baseline, and absence of collections >2 cm of the treated perianal fistulas confirmed by masked central MRI). Efficacy was assessed in the intention-to-treat (ITT) and modified ITT populations; safety was assessed in the safety population. This study is registered with ClinicalTrials.gov, number NCT01541579. Findings 212 patients were randomly assigned: 107 to Cx601 and 105 to placebo. A significantly greater proportion of patients treated with Cx601 versus placebo achieved combined remission in the ITT (53 of 107 [50%] vs 36 of 105 [34%]; difference 15.2%, 97.5% CI 0.2-30.3; p=0.024) and modified ITT populations (53 of 103 [51%] vs 36 of 101 [36%]; 15.8%, 0.5-31.2; p=0.021). 18 (17%) of 103 patients in the Cx601 group versus 30 (29%) of 103 in the placebo group experienced treatment-related adverse events, the most common of which were anal abscess (six in the Cx601 group vs nine in the placebo group) and proctalgia (five vs nine). Interpretation Cx601 is an effective and safe treatment for complex perianal fistulas in patients with Crohn's disease who did not respond to conventional or biological treatments, or both.	[Panes, Julian] Hosp Clin Barcelona, Dept Gastroenterol, IDIBAPS, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Garcia-Olmo, Damian] Fdn Jimenez Diaz, Hosp Univ, Dept Surg, Madrid, Spain; [Van Assche, Gert; Ferrante, Marc] Katholieke Univ Leuven, Univ Hosp Leuven, Dept Gastroenterol & Hepatol, Leuven, Belgium; [Colombel, Jean Frederic] Icahn Sch Med Mt Sinai, Dept Gastroenterol, New York, NY 10029 USA; [Reinisch, Walter; Kazemi-Shirazi, Lili] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria; [Reinisch, Walter] McMaster Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Hamilton, ON, Canada; [Baumgart, Daniel C.] Humboldt Univ, Charite Med Sch, Dept Gastroenterol & Hepatol, Berlin, Germany; [Dignass, Axel] Agaples Markus Krankenhaus, Dept Med, Klin 1, Frankfurt, Germany; [Nachury, Maria] Ctr Hosp Univ Lille, Dept Gastroenterol & Hepatol, Lille, France; [Grimaud, Jean C.] Hop Nord Marseille, Dept Hepatogastroenterol, Marseille, France; [de la Portilla, Fernando] Univ Seville, Ctr Super Invest, Univ Virgen del Rocio Hosp, Dept Surg,Unit Coloproctol, Seville, Spain; [Goldin, Eran] Shaare Zedek Med Ctr, Inst Digest Dis, Jerusalem, Israel; [Richard, Marie Paule; Leselbaum, Anne] Parque Tecnol Madrid, TiGenix, Madrid, Spain; [Danese, Silvio] Humanitas Univ, Inst Clin Humanitas, Dept Gastroenterol, IBD Ctr, Milan, Italy	CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Sevilla; KU Leuven; University Hospital Leuven; Icahn School of Medicine at Mount Sinai; Medical University of Vienna; McMaster University; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Universite de Lille - ISITE; CHU Lille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; University of Sevilla; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Humanitas University	Panes, J (corresponding author), Hosp Clin Barcelona, Dept Gastroenterol, Barcelona 08036, Spain.	jpanes@clinic.ub.es	Baumgart, Daniel C./AAU-2930-2021; de la Portilla, Fernando/ABD-5393-2020; Dignass, Axel/V-5400-2019; Dignass, Axel/AAW-9653-2020; Danese, Silvio/ABH-9571-2020; IBIS, COLOPROCTOLOGIA/H-9797-2016; Nachury, Maria/M-4399-2018	Baumgart, Daniel C./0000-0003-2146-507X; de la Portilla, Fernando/0000-0003-0603-2911; Dignass, Axel/0000-0002-9724-054X; Danese, Silvio/0000-0001-7341-1351; Nachury, Maria/0000-0001-9583-8946; Carpio, Daniel/0000-0001-7929-1151; Garcia Olmo, Damian/0000-0002-9369-2338; Guadalajara, Hector/0000-0001-6297-9347	TiGenix	TiGenix	TiGenix.	Baumgart DC, 2012, LANCET, V380, P1590, DOI 10.1016/S0140-6736(12)60026-9; Bell SJ, 2003, ALIMENT PHARM THER, V17, P1145, DOI 10.1046/j.1365-2036.2003.01561.x; BEST WR, 1976, GASTROENTEROLOGY, V70, P439; BRANDT LJ, 1982, GASTROENTEROLOGY, V83, P383; Cho YB, 2013, CELL TRANSPLANT, V22, P279, DOI 10.3727/096368912X656045; Colombel JF, 2009, GUT, V58, P940, DOI 10.1136/gut.2008.159251; de la Portilla F, 2013, INT J COLORECTAL DIS, V28, P313, DOI 10.1007/s00384-012-1581-9; DelaRosa O, 2012, CURR OPIN BIOTECH, V23, P978, DOI 10.1016/j.copbio.2012.05.005; Domenech E, 2005, ALIMENT PHARM THER, V22, P1107, DOI 10.1111/j.1365-2036.2005.02670.x; Eglinton TW, 2012, DIS COLON RECTUM, V55, P773, DOI 10.1097/DCR.0b013e31825228b0; Garcia-Olmo D, 2015, WORLD J GASTROENTERO, V21, P3330, DOI 10.3748/wjg.v21.i11.3330; Gecse K, 2013, UNITED EUR GASTROENT, V1, P206, DOI 10.1177/2050640613487194; Geltzeiler CB, 2014, ANN GASTROENTEROL, V27, P320; Ghannam S, 2010, J IMMUNOL, V185, P302, DOI 10.4049/jimmunol.0902007; Goldstein ES, 2004, INFLAMM BOWEL DIS, V10, P79, DOI 10.1097/00054725-200403000-00003; GUYATT G, 1989, GASTROENTEROLOGY, V96, P804, DOI 10.1016/0016-5085(89)90905-0; HELLERS G, 1980, GUT, V21, P525, DOI 10.1136/gut.21.6.525; IRVINE EJ, 1995, J CLIN GASTROENTEROL, V20, P27; Kamm MA, 2008, CLIN GASTROENTEROL H, V6, P7, DOI 10.1016/j.cgh.2007.10.010; KORELITZ BI, 1985, DIGEST DIS SCI, V30, P58, DOI 10.1007/BF01318372; Lee WY, 2013, STEM CELLS, V31, P2575, DOI 10.1002/stem.1357; Losco A, 2009, INFLAMM BOWEL DIS, V15, P742, DOI 10.1002/ibd.20826; Molendijk I, 2015, GASTROENTEROLOGY, V149, P918, DOI 10.1053/j.gastro.2015.06.014; Molendijk I, 2014, INFLAMM BOWEL DIS, V20, P2022, DOI 10.1097/MIB.0000000000000148; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; PEARSON DC, 1995, ANN INTERN MED, V123, P132, DOI 10.7326/0003-4819-123-2-199507150-00009; PRESENT DH, 1980, NEW ENGL J MED, V302, P981, DOI 10.1056/NEJM198005013021801; Present DH, 1999, NEW ENGL J MED, V340, P1398, DOI 10.1056/NEJM199905063401804; Sandborn WJ, 2003, GASTROENTEROLOGY, V125, P1508, DOI 10.1016/j.gastro.2003.08.025; Sands BE, 2004, NEW ENGL J MED, V350, P876, DOI 10.1056/NEJMoa030815; Scharl Michael, 2014, World J Gastrointest Pathophysiol, V5, P205, DOI 10.4291/wjgp.v5.i3.205; Schwartz DA, 2002, GASTROENTEROLOGY, V122, P875, DOI 10.1053/gast.2002.32362; Schwartz DA, 2004, ALIMENT PHARM THER, V19, P953, DOI 10.1111/j.1365-2036.2004.01917.x; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; SOLOMON MJ, 1993, CAN J GASTROENTEROL, V7, P571, DOI 10.1155/1993/610272; Thia KT, 2009, INFLAMM BOWEL DIS, V15, P17, DOI 10.1002/ibd.20608; Van Assche G, 2010, J CROHNS COLITIS, V4, P63, DOI 10.1016/j.crohns.2009.09.009	37	544	571	3	84	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2016	388	10051					1281	1290		10.1016/S0140-6736(16)31203-X	http://dx.doi.org/10.1016/S0140-6736(16)31203-X			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW5RH	27477896				2022-12-28	WOS:000383704000031
J	Mass, E; Ballesteros, I; Farlik, M; Halbritter, F; Gunther, P; Crozet, L; Jacome-Galarza, CE; Handler, K; Klughammer, J; Kobayashi, Y; Gomez-Perdiguero, E; Schultze, JL; Beyer, M; Bock, C; Geissmann, F				Mass, Elvira; Ballesteros, Ivan; Farlik, Matthias; Halbritter, Florian; Guenther, Patrick; Crozet, Lucile; Jacome-Galarza, Christian E.; Haendler, Kristian; Klughammer, Johanna; Kobayashi, Yasuhiro; Gomez-Perdiguero, Elisa; Schultze, Joachim L.; Beyer, Marc; Bock, Christoph; Geissmann, Frederic			Specification of tissue-resident macrophages during organogenesis	SCIENCE			English	Article							RNA-SEQ; GENE-EXPRESSION; FETAL MONOCYTES; PPAR-GAMMA; CELLS; ID3; ALIGNMENT; REVEALS; TRANSCRIPTOMES; INFLAMMATION	Tissue-resident macrophages support embryonic development and tissue homeostasis and repair. The mechanisms that control their differentiation remain unclear. We report here that erythro-myeloid progenitors in mice generate premacrophages (pMacs) that simultaneously colonize the whole embryo from embryonic day 9.5 in a chemokine-receptor-dependent manner. The core macrophage program initiated in pMacs is rapidly diversified as expression of transcriptional regulators becomes tissue-specific in early macrophages. This process appears essential for macrophage specification and maintenance, as inactivation of Id3 impairs the development of liver macrophages and results in selective Kupffer cell deficiency in adults. We propose that macrophage differentiation is an integral part of organogenesis, as colonization of organ anlagen by pMacs is followed by their specification into tissue macrophages, hereby generating the macrophage diversity observed in postnatal tissues.	[Mass, Elvira; Ballesteros, Ivan; Crozet, Lucile; Jacome-Galarza, Christian E.; Geissmann, Frederic] Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA; [Farlik, Matthias; Halbritter, Florian; Klughammer, Johanna; Bock, Christoph] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Guenther, Patrick; Haendler, Kristian; Schultze, Joachim L.; Beyer, Marc] Univ Bonn, Genom & Immunoregulat Life & Med Sci Inst, Bonn, Germany; [Crozet, Lucile; Geissmann, Frederic] Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA; [Kobayashi, Yasuhiro] Matsumoto Dent Univ, Inst Oral Sci, 1780 Hiro Oka Gobara Shiojiri, Nagano 3900781, Japan; [Gomez-Perdiguero, Elisa; Geissmann, Frederic] Kings Coll London, Ctr Mol & Cellular Biol Inflammat, London SE1 1UL, England; [Schultze, Joachim L.; Beyer, Marc] German Ctr Neurodegenerat Dis, Single Cell Genom & Epigen Unit, Bonn, Germany; [Schultze, Joachim L.; Beyer, Marc] Univ Bonn, Bonn, Germany; [Bock, Christoph] Med Univ Vienna, Dept Lab Med, A-1090 Vienna, Austria; [Bock, Christoph] Max Planck Inst Informat, D-66123 Saarbrucken, Germany; [Gomez-Perdiguero, Elisa] Inst Pasteur, Macrophages & Endothelial Cells Grp, Dept Dev & Stem Cell Biol, CNRS,UMR 3738, Paris, France	Memorial Sloan Kettering Cancer Center; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; University of Bonn; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Matsumoto Dental University; University of London; King's College London; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; Medical University of Vienna; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Geissmann, F (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA.; Geissmann, F (corresponding author), Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA.; Geissmann, F (corresponding author), Kings Coll London, Ctr Mol & Cellular Biol Inflammat, London SE1 1UL, England.	geissmaf@mskcc.org	Perdiguero, Elisa Gomez/U-2120-2018; Mass, Elvira/AAH-3805-2019; Schultze, Joachim L./ABA-8176-2020; Bock, Christoph/AAE-7618-2019; Martin, Ivan Ballesteros/G-6623-2017; Halbritter, Florian/AAI-1000-2019; KOBAYASHI, YASUHIRO/AAU-4931-2021; Beyer, Marc/ABE-1408-2021; Ballesteros, Iván/AAA-6745-2020	Perdiguero, Elisa Gomez/0000-0002-7717-7897; Mass, Elvira/0000-0003-2318-2356; Schultze, Joachim L./0000-0003-2812-9853; Bock, Christoph/0000-0001-6091-3088; Halbritter, Florian/0000-0003-2452-4784; Beyer, Marc/0000-0001-9704-148X; Ballesteros, Ivan/0000-0002-6246-2353; Gunther, Patrick/0000-0002-9135-7819; Kobayashi, Yasuhiro/0000-0002-0903-3226; Klughammer, Johanna/0000-0002-3628-9278; Handler, Kristian/0000-0001-5273-5277	National Cancer Institute of the U.S. NIH [P30CA008748]; Wellcome Trust [WT101853MA]; European Research Council [2010-StG-261299]; European Molecular Biology Organization long-term fellowship [ALTF 530-2015]; Deutsche Forschungsgemeinschaft (DFG) [HA 7723/1-1]; Doktorand/inn/enprogramm der Osterreichischen Akademie der Wissenschaften (DOC) Fellowship of the Austrian Academy of Sciences; New Frontiers Group award from the Austrian Academy of Sciences; Excellence Cluster ImmunoSensation; DFG [BE 4427/3-1, SFB 704, SFB 645, INST 217/575-1, INST 217/576-1, INST 217/577-1]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	National Cancer Institute of the U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wellcome Trust(Wellcome Trust); European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Doktorand/inn/enprogramm der Osterreichischen Akademie der Wissenschaften (DOC) Fellowship of the Austrian Academy of Sciences; New Frontiers Group award from the Austrian Academy of Sciences; Excellence Cluster ImmunoSensation; DFG(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Benezra (MSKCC, New York) for the Id3<SUP>-/-</SUP> and Id3<SUP>f/f</SUP> strains. We thank the Biomedical Sequencing Facility at CeMM and the MSKCC Integrated Genomics and Bioinformatics Cores for assistance with next-generation sequencing. The data presented in this manuscript are tabulated in the main paper and the supplementary materials. Sequencing data sets described in this work have been submitted to the Gene Expression Omnibus (GEO) repository (GEO accession number GSE81774). Additionally, a genome browser track hub and additional supplementary data are available at http://macrophage-development.computational-epigenetics.org/. This work was supported by the National Cancer Institute of the U.S. NIH (grant P30CA008748) and by investigator awards from the Wellcome Trust (WT101853MA) and the European Research Council (2010-StG-261299) to F.G. E.M. is supported by a European Molecular Biology Organization long-term fellowship (ALTF 530-2015). F.H. is supported by a Deutsche Forschungsgemeinschaft (DFG) postdoctoral fellowship (HA 7723/1-1). J.K. is supported by a Doktorand/inn/enprogramm der Osterreichischen Akademie der Wissenschaften (DOC) Fellowship of the Austrian Academy of Sciences. C.B. is supported by a New Frontiers Group award from the Austrian Academy of Sciences. M.B. and J.L.S. are members of the Excellence Cluster ImmunoSensation. M.B. is supported by a DFG grant (BE 4427/3-1). J.L.S. is supported by DFG grants SFB 704, SFB 645, INST 217/575-1, INST 217/576-1, and INST 217/577-1.	A-Gonzalez N, 2013, NAT IMMUNOL, V14, P831, DOI 10.1038/ni.2622; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; Charrad M, 2014, J STAT SOFTW, V61, P1; Chorro L, 2009, J EXP MED, V206, P3089, DOI 10.1084/jem.20091586; Davies LC, 2011, EUR J IMMUNOL, V41, P2155, DOI 10.1002/eji.201141817; Deng L, 2010, AM J PATHOL, V176, P952, DOI 10.2353/ajpath.2010.090622; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Fainaru O, 2004, EMBO J, V23, P969, DOI 10.1038/sj.emboj.7600085; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gautier EL, 2012, J IMMUNOL, V189, P2614, DOI 10.4049/jimmunol.1200495; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Glaus P, 2012, BIOINFORMATICS, V28, P1721, DOI 10.1093/bioinformatics/bts260; Gorgani NN, 2008, IMMUNOL CELL BIOL, V86, P246, DOI 10.1038/sj.icb.7100131; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Guo ZL, 2011, IMMUNOL LETT, V135, P34, DOI 10.1016/j.imlet.2010.09.009; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hoekstra M, 2003, J BIOL CHEM, V278, P25448, DOI 10.1074/jbc.M301189200; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Jen Y, 1996, DEV DYNAM, V207, P235; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jux B, 2009, J IMMUNOL, V182, P6709, DOI 10.4049/jimmunol.0713344; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Li J, 2016, EMBO REP, V17, P178, DOI 10.15252/embr.201540946; Lionakis MS, 2013, J CLIN INVEST, V123, P5035, DOI 10.1172/JCI71307; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; McGrath KE, 2015, CELL REP, V11, P1892, DOI 10.1016/j.celrep.2015.05.036; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Reimand J, 2011, NUCLEIC ACIDS RES, V39, pW307, DOI 10.1093/nar/gkr378; Rosas M, 2014, SCIENCE, V344, P645, DOI 10.1126/science.1251414; Sanchez-Castillo M, 2015, NUCLEIC ACIDS RES, V43, pD1117, DOI 10.1093/nar/gku895; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Sheffield NC, 2016, BIOINFORMATICS, V32, P587, DOI 10.1093/bioinformatics/btv612; Sheng JP, 2015, IMMUNITY, V43, P382, DOI 10.1016/j.immuni.2015.07.016; Sreeramkumar V, 2014, SCIENCE, V346, P1234, DOI 10.1126/science.1256478; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhao QS, 2011, DEV BIOL, V349, P53, DOI 10.1016/j.ydbio.2010.10.004	55	442	451	2	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 9	2016	353	6304							aaf4238	10.1126/science.aaf4238	http://dx.doi.org/10.1126/science.aaf4238			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV0RN	27492475	Green Accepted			2022-12-28	WOS:000382626800042
J	Toombes, GES; Swartz, KJ				Toombes, Gilman E. S.; Swartz, Kenton J.			Twists and turns in gating ion channels with voltage The EAG potassium channel may use an alternative voltage-dependent gating mechanism	SCIENCE			English	Editorial Material							CRYSTAL-STRUCTURE; DOMAINS		[Toombes, Gilman E. S.; Swartz, Kenton J.] NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Swartz, KJ (corresponding author), NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA.	kenton.swartz@nih.gov			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002945] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Gianulis EC, 2013, J GEN PHYSIOL, V142, P351, DOI 10.1085/jgp.201310995; Haitin Y, 2013, NATURE, V501, P444, DOI 10.1038/nature12487; KAPLAN WD, 1969, GENETICS, V61, P399; Kwan DCH, 2012, J GEN PHYSIOL, V140, P279, DOI 10.1085/jgp.201210838; Lorinczi E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7672; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Morais-Cabral JH, 2015, J MOL BIOL, V427, P67, DOI 10.1016/j.jmb.2014.08.008; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Schonherr R, 2000, EMBO J, V19, P3263, DOI 10.1093/emboj/19.13.3263; WARMKE J, 1991, SCIENCE, V252, P1560, DOI 10.1126/science.1840699; Whicher JR, 2016, SCIENCE, V353, P664, DOI 10.1126/science.aaf8070; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395	15	4	4	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					646	647		10.1126/science.aah4194	http://dx.doi.org/10.1126/science.aah4194			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZC	27516583				2022-12-28	WOS:000381561200018
J	Chartron, JW; Hunt, KCL; Frydman, J				Chartron, Justin W.; Hunt, Katherine C. L.; Frydman, Judith			Cotranslational signal-independent SRP preloading during membrane targeting	NATURE			English	Article							PROTEIN BIOGENESIS FACTORS; ENDOPLASMIC-RETICULUM; RECOGNITION PARTICLE; GLOBAL ANALYSIS; IN-VIVO; RIBOSOME; TRANSLATION; YEAST; TRANSLOCATION; LOCALIZATION	Ribosome-associated factors must properly decode the limited information available in nascent polypeptides to direct them to their correct cellular fate(1). It is unclear how the low complexity information exposed by the nascent chain suffices for accurate recognition by the many factors competing for the limited surface near the ribosomal exit site(2,3). Questions remain even for the well-studied cotranslational targeting cycle to the endoplasmic reticulum, involving recognition of linear hydrophobic signal sequences or transmembrane domains by the signal recognition particle (SRP)(4,5). Notably, the SRP has low abundance relative to the large number of ribosome-nascent-chain complexes (RNCs), yet it accurately selects those destined for the endoplasmic reticulum(6). Despite their overlapping specificities, the SRP and the cotranslationally acting Hsp70 display precise mutually exclusive selectivity in vivo for their cognate RNCs7,8. To understand cotranslational nascent chain recognition in vivo, here we investigate the cotranslational membrane-targeting cycle using ribosome profiling(9) in yeast cells coupled with biochemical fractionation of ribosome populations. We show that the SRP preferentially binds secretory RNCs before their targeting signals are translated. Non-coding mRNA elements can promote this signal-independent pre-recruitment of SRP. Our study defines the complex kinetic interaction between elongation in the cytosol and determinants in the polypeptide and mRNA that modulate SRP-substrate selection and membrane targeting.	[Chartron, Justin W.; Hunt, Katherine C. L.; Frydman, Judith] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Frydman, Judith] Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Frydman, J (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.; Frydman, J (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	jfrydman@stanford.edu	Chartron, Justin/L-9096-2019	Chartron, Justin/0000-0003-1734-3424; , judith/0000-0003-2302-6943	NIH NRSA award; NIH; HFSP; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056433, R37GM056433] Funding Source: NIH RePORTER	NIH NRSA award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HFSP(Human Frontier Science Program); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Walter, J. S. Weissman and C. Jan for discussions; R. Andino and R. Hegde for critical reading of the manuscript. We thank S. Pechmann, K. M. Dalton, E. M. Sontag, P. T. Dolan and other members of the Frydman laboratory for advice on analysis. Sequencing was performed at the UCSF Center for Advanced Technology with assistance from E. Chow, J. Lund and A. Acevedo. J.W.C. is supported by an NIH NRSA award. This work was additionally supported by grants to J.F. from the NIH and HFSP.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Becker AH, 2013, NAT PROTOC, V8, P2212, DOI 10.1038/nprot.2013.133; Beckert B, 2015, NAT STRUCT MOL BIOL, V22, P767, DOI 10.1038/nsmb.3086; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Berndt U, 2009, P NATL ACAD SCI USA, V106, P1398, DOI 10.1073/pnas.0808584106; Bornemann T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5180; Breker M, 2014, NUCLEIC ACIDS RES, V42, pD726, DOI 10.1093/nar/gkt933; del Alamo M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001100; Doerfel LK, 2013, BIOPOLYMERS, V99, P837, DOI 10.1002/bip.22341; Elvekrog MM, 2015, CURR OPIN CHEM BIOL, V29, P79, DOI 10.1016/j.cbpa.2015.09.016; FREIDLIN PJ, 1980, BIOCHEM BIOPH RES CO, V93, P521, DOI 10.1016/0006-291X(80)91108-0; Gao XW, 2015, NAT METHODS, V12, P147, DOI 10.1038/nmeth.3208; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Hainzl T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8163; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Holtkamp W, 2012, NAT STRUCT MOL BIOL, V19, P1332, DOI 10.1038/nsmb.2421; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Ingolia NT, 2011, CELL, V147, P789, DOI 10.1016/j.cell.2011.10.002; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kraut-Cohen J, 2013, MOL BIOL CELL, V24, P3069, DOI 10.1091/mbc.E13-01-0038; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; KUTAY U, 1995, EMBO J, V14, P217, DOI 10.1002/j.1460-2075.1995.tb06994.x; Lakkaraju AKK, 2008, CELL, V133, P440, DOI 10.1016/j.cell.2008.02.049; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Loya A, 2008, RNA, V14, P1352, DOI 10.1261/rna.867208; Lu JL, 2008, J MOL BIOL, V384, P73, DOI 10.1016/j.jmb.2008.08.089; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mason N, 2000, EMBO J, V19, P4164, DOI 10.1093/emboj/19.15.4164; Murtagh F, 2014, J CLASSIF, V31, P274, DOI 10.1007/s00357-014-9161-z; NARANDA T, 1994, J BIOL CHEM, V269, P32286; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Nyathi Y, 2015, J CELL BIOL, V210, P287, DOI 10.1083/jcb.201410086; OGG SC, 1995, CELL, V81, P1075, DOI 10.1016/S0092-8674(05)80012-1; Pechmann S, 2014, NAT STRUCT MOL BIOL, V21, P1100, DOI 10.1038/nsmb.2919; Pechmann S, 2013, MOL CELL, V49, P411, DOI 10.1016/j.molcel.2013.01.020; Pechmann S, 2013, NAT STRUCT MOL BIOL, V20, P237, DOI 10.1038/nsmb.2466; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Rapoport TA, 1999, BIOL CHEM, V380, P1143, DOI 10.1515/BC.1999.145; Reynolds SM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000213; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Voorhees RM, 2015, ELIFE, V4, DOI 10.7554/eLife.07975; WALTER P, 1994, ANNU REV CELL BIOL, V10, P87, DOI 10.1146/annurev.cb.10.110194.000511; Williams CC, 2014, SCIENCE, V346, P748, DOI 10.1126/science.1257522; Willmund F, 2013, CELL, V152, P196, DOI 10.1016/j.cell.2012.12.001; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Woolstenhulme CJ, 2015, CELL REP, V11, P13, DOI 10.1016/j.celrep.2015.03.014; Zhang X, 2014, ANNU REV BIOPHYS, V43, P381, DOI 10.1146/annurev-biophys-051013-022653; ZHONG T, 1993, CELL, V73, P1175, DOI 10.1016/0092-8674(93)90646-8	57	100	101	1	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 11	2016	536	7615					224	+		10.1038/nature19309	http://dx.doi.org/10.1038/nature19309			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT4SV	27487213	Green Accepted			2022-12-28	WOS:000381472100039
J	Supe, A				Supe, Avinash			PERSONAL VIEW NEET: India's single exam for admission to medical school promises transparency and quality	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PERFORMANCE		[Supe, Avinash] Seth GS Med Coll, Bombay, Maharashtra, India; [Supe, Avinash] GSMC FAIMER Reg Inst, Bombay, Maharashtra, India	Seth Gordhandas Sunderdas Medical College & King Edward Memorial Hospital	Supe, A (corresponding author), Seth GS Med Coll, Bombay, Maharashtra, India.; Supe, A (corresponding author), GSMC FAIMER Reg Inst, Bombay, Maharashtra, India.	avisupe@gmail.com	Supe, Avinash/ABA-6934-2020; Supe, Avinash/AAX-2042-2021	Supe, Avinash/0000-0002-8325-1918				Donnon T, 2007, ACAD MED, V82, P100, DOI 10.1097/01.ACM.0000249878.25186.b7; Medical Council of India, 2016, NAT EL ENTR TEST UG; Yates J, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-55	3	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 3	2016	354								i4051	10.1136/bmj.i4051	http://dx.doi.org/10.1136/bmj.i4051			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9CS	27488542				2022-12-28	WOS:000381080600001
J	Gordon, AC; Mason, AJ; Thirunavukkarasu, N; Perkins, GD; Cecconi, M; Cepkova, M; Pogson, DG; Aya, HD; Anjum, A; Frazier, GJ; Santhakumaran, S; Ashby, D; Brett, SJ				Gordon, Anthony C.; Mason, Alexina J.; Thirunavukkarasu, Neeraja; Perkins, Gavin D.; Cecconi, Maurizio; Cepkova, Magda; Pogson, David G.; Aya, Hollmann D.; Anjum, Aisha; Frazier, Gregory J.; Santhakumaran, Shalini; Ashby, Deborah; Brett, Stephen J.		VANISH Investigators	Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock The VANISH Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INFUSION; CORTICOSTEROIDS; THERAPY; INJURY; SEPSIS	IMPORTANCE Norepinephrine is currently recommended as the first-line vasopressor in septic shock; however, early vasopressin use has been proposed as an alternative. OBJECTIVE To compare the effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock. DESIGN, SETTING, AND PARTICIPANTS A factorial (2x2), double-blind, randomized clinical trial conducted in 18 general adult intensive care units in the United Kingdom between February 2013 and May 2015, enrolling adult patients who had septic shock requiring vasopressors despite fluid resuscitation within a maximum of 6 hours after the onset of shock. INTERVENTIONS Patients were randomly allocated to vasopressin (titrated up to 0.06 U/min) and hydrocortisone (n = 101), vasopressin and placebo (n = 104), norepinephrine and hydrocortisone (n = 101), or norepinephrine and placebo (n = 103). MAIN OUTCOMES AND MEASURES The primary outcomewas kidney failure-free days during the 28-day period after randomization, measured as (1) the proportion of patients who never developed kidney failure and (2) median number of days alive and free of kidney failure for patients who did not survive, who experienced kidney failure, or both. Rates of renal replacement therapy, mortality, and serious adverse events were secondary outcomes. RESULTS A total of 409 patients (median age, 66 years; men, 58.2%) were included in the study, with a median time to study drug administration of 3.5 hours after diagnosis of shock. The number of survivors who never developed kidney failure was 94 of 165 patients (57.0%) in the vasopressin group and 93 of 157 patients (59.2%) in the norepinephrine group (difference, -2.3%[95% CI, -13.0% to 8.5%]). The median number of kidney failure-free days for patients who did not survive, who experienced kidney failure, or both was 9 days (interquartile range [IQR], 1 to -24) in the vasopressin group and 13 days (IQR, 1 to -25) in the norepinephrine group (difference, -4 days [95% CI, -11 to 5]). There was less use of renal replacement therapy in the vasopressin group than in the norepinephrine group (25.4% for vasopressin vs 35.3% for norepinephrine; difference, -9.9% [95% CI, -19.3% to -0.6%]). There was no significant difference in mortality rates between groups. In total, 22 of 205 patients (10.7%) had a serious adverse event in the vasopressin group vs 17 of 204 patients (8.3%) in the norepinephrine group (difference, 2.5%[95% CI, -3.3% to 8.2%]). CONCLUSIONS AND RELEVANCE Among adults with septic shock, the early use of vasopressin compared with norepinephrine did not improve the number of kidney failure-free days. Although these findings do not support the use of vasopressin to replace norepinephrine as initial treatment in this situation, the confidence interval included a potential clinically important benefit for vasopressin, and larger trials may be warranted to assess this further.	[Gordon, Anthony C.] Imperial Coll London, Sect Anaesthet Pain Med & Intens Care Med, Dept Surg & Canc, London W6 8RF, England; [Mason, Alexina J.] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, London, England; [Thirunavukkarasu, Neeraja; Anjum, Aisha; Frazier, Gregory J.; Santhakumaran, Shalini; Ashby, Deborah] Imperial Coll London, Sch Publ Hlth, Imperial Clin Trials Unit, London W6 8RF, England; [Perkins, Gavin D.] Univ Warwick, Warwick Med Sch, Warwick Clin Trials Unit, Coventry, W Midlands, England; [Cecconi, Maurizio; Aya, Hollmann D.] St Georges Univ Hosp Natl Hlth Serv Fdn Trust, Anaesthesia & Intens Care Med, London, England; [Cepkova, Magda] Whittington Hlth Natl Hlth Serv, Intens Care Unit, London, England; [Pogson, David G.] Portsmouth Hosp Natl Hlth Serv Trust, Acad Dept Crit Care, Portsmouth, Hants, England; [Brett, Stephen J.] Imperial Coll Healthcare Natl Hlth Serv Trust, Ctr Perioperat & Crit Care Res, London, England	Imperial College London; University of London; London School of Hygiene & Tropical Medicine; Imperial College London; University of Warwick; Portsmouth Hospitals NHS Trust; Imperial College London	Gordon, AC (corresponding author), Imperial Coll London, Charing Cross Hosp, ICU 11N, Fulham Palace Rd, London W6 8RF, England.	anthony.gordon@imperial.ac.uk	Mellinghoff, Johannes/V-4844-2019; Gordon, Anthony/A-3472-2012; Prowle, John/D-5014-2009; Shankar-Hari, Manu/I-6948-2012; Perkins, Gavin/E-7613-2010; Hoste, Eric/A-6353-2008; Cecconi, Maurizio/A-6241-2012; Ostermann, Marlies/B-8777-2015	Mellinghoff, Johannes/0000-0002-5455-8953; Gordon, Anthony/0000-0002-0419-547X; Prowle, John/0000-0002-5002-2721; Shankar-Hari, Manu/0000-0002-5338-2538; Hoste, Eric/0000-0001-9301-8055; Cecconi, Maurizio/0000-0002-4376-6538; Ostermann, Marlies/0000-0001-9500-9080; Harris, Clair/0000-0002-1575-8768; Perkins, Gavin/0000-0003-3027-7548; McAuley, Daniel/0000-0002-3283-1947; Mason, Alexina/0000-0001-7319-4545; Di Tomasso, Nora/0000-0001-5706-8928; Warwick, Jane/0000-0002-7320-6603	UK National Institute for Health Research (NIHR) under its Research for Patient Benefit program [PB-PG-0610-22350]; NIHR Clinician Scientist Award; NIHR Comprehensive Biomedical Research Centre based at Imperial College Healthcare National Health System (NHS) Trust and Imperial College London; UK Intensive Care Foundation; National Institute for Health Research [PB-PG-0610-22350, NIHR/CS/009/007, NF-SI-0514-10139] Funding Source: researchfish	UK National Institute for Health Research (NIHR) under its Research for Patient Benefit program; NIHR Clinician Scientist Award; NIHR Comprehensive Biomedical Research Centre based at Imperial College Healthcare National Health System (NHS) Trust and Imperial College London; UK Intensive Care Foundation; National Institute for Health Research(National Institute for Health Research (NIHR))	This article presents independent research funded by grant PB-PG-0610-22350 from the UK National Institute for Health Research (NIHR) under its Research for Patient Benefit program and an NIHR Clinician Scientist Award (Dr Gordon). It was supported by the NIHR Comprehensive Biomedical Research Centre based at Imperial College Healthcare National Health System (NHS) Trust and Imperial College London, and also by the UK Intensive Care Foundation.	Asfar P, 2014, NEW ENGL J MED, V370, P1583, DOI 10.1056/NEJMoa1312173; Bauer SR, 2008, J CRIT CARE, V23, P500, DOI 10.1016/j.jcrc.2008.04.002; BONE RC, 1992, CRIT CARE MED, V20, P864, DOI 10.1097/00003246-199206000-00025; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Ertmer C, 2007, SHOCK, V27, P281, DOI 10.1097/01.shk.0000235140.97903.90; Gordon AC, 2014, CRIT CARE MED, V42, P1325, DOI 10.1097/CCM.0000000000000212; Gordon AC, 2010, INTENS CARE MED, V36, P83, DOI 10.1007/s00134-009-1687-x; Harvey SE, 2006, INTENS CARE MED, V32, P2020, DOI 10.1007/s00134-006-0358-4; Landry DW, 1997, CIRCULATION, V95, P1122; Lauzier F, 2006, INTENS CARE MED, V32, P1782, DOI 10.1007/s00134-006-0378-0; LENZ K, 1991, GASTROENTEROLOGY, V101, P1060, DOI 10.1016/0016-5085(91)90734-3; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; O'Callaghan DJP, 2015, INTENS CARE MED, V41, P2177, DOI 10.1007/s00134-015-3849-3; Patel BM, 2002, ANESTHESIOLOGY, V96, P576, DOI 10.1097/00000542-200203000-00011; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Russell JA, 2009, CRIT CARE MED, V37, P811, DOI 10.1097/CCM.0b013e3181961ace; Seymour CW, 2015, JAMA-J AM MED ASSOC, V314, P708, DOI 10.1001/jama.2015.7885; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; Torgersen C, 2011, INTENS CARE MED, V37, P1432, DOI 10.1007/s00134-011-2312-3; Torgersen C, 2010, INTENS CARE MED, V36, P57, DOI 10.1007/s00134-009-1630-1; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/s001340050156	22	300	322	2	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 2	2016	316	5					509	518		10.1001/jama.2016.10485	http://dx.doi.org/10.1001/jama.2016.10485			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS9AU	27483065	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000381075000017
J	Laxminarayan, R; Amabile-Cuevas, CF; Cars, O; Evans, T; Heymann, DL; Hoffman, S; Holmes, A; Mendelson, M; Sridhar, D; Woolhouse, M; Rottingen, JA				Laxminarayan, Ramanan; Amabile-Cuevas, Carlos F.; Cars, Otto; Evans, Timothy; Heymann, David L.; Hoffman, Steven; Holmes, Alison; Mendelson, Marc; Sridhar, Devi; Woolhouse, Mark; Rottingen, John-Arne			UN High-Level Meeting on antimicrobials-what do we need?	LANCET			English	Editorial Material							ACCESS; RESISTANCE		[Laxminarayan, Ramanan] Ctr Dis Dynam Econ & Policy, Washington, DC 20005 USA; [Laxminarayan, Ramanan] Princeton Univ, Princeton Environm Inst, Princeton, NJ 08544 USA; [Laxminarayan, Ramanan] Publ Hlth Fdn India, New Delhi, India; [Amabile-Cuevas, Carlos F.] Fdn Lusara Invest Cient, Mexico City, DF, Mexico; [Cars, Otto] Uppsala Univ, Dept Med Sci, ReAct, Uppsala, Sweden; [Evans, Timothy] World Bank, 1818 H St NW, Washington, DC 20433 USA; [Heymann, David L.] Ctr Global Hlth Secur, Chatham House, London, England; [Hoffman, Steven] Univ Ottawa, Ottawa, ON, Canada; [Holmes, Alison] Imperial Coll, London, England; [Mendelson, Marc] Univ Cape Town, Cape Town, South Africa; [Sridhar, Devi; Woolhouse, Mark] Univ Edinburgh, Edinburgh, Midlothian, Scotland; [Rottingen, John-Arne] Norwegian Inst Publ Hlth, Oslo, Norway; [Rottingen, John-Arne] Univ Oslo, Inst Hlth & Soc, Oslo, Norway; [Rottingen, John-Arne] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Princeton University; Public Health Foundation of India; Uppsala University; The World Bank; University of Ottawa; Imperial College London; University of Cape Town; University of Edinburgh; Norwegian Institute of Public Health (NIPH); University of Oslo; Harvard University; Harvard T.H. Chan School of Public Health	Laxminarayan, R (corresponding author), Ctr Dis Dynam Econ & Policy, Washington, DC 20005 USA.; Laxminarayan, R (corresponding author), Princeton Univ, Princeton Environm Inst, Princeton, NJ 08544 USA.; Laxminarayan, R (corresponding author), Publ Hlth Fdn India, New Delhi, India.	ramanan@cddep.org	Laxminarayan, Ramanan/ABD-5050-2021; Amábile-Cuevas, Carlos/HDO-1753-2022	Amábile-Cuevas, Carlos/0000-0001-6806-544X; Mendelson, Marc/0000-0001-6668-3893; Hoffman, Steven/0000-0002-2064-3711; Holmes, Alison/0000-0001-5554-5743				Ardal C, 2016, LANCET, V387, P296, DOI 10.1016/S0140-6736(15)00470-5; Heymann DL, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i3087; Jasovsky D, 2016, UPSALA J MED SCI, V121, P159, DOI 10.1080/03009734.2016.1195900; Laxminarayan R, 2016, LANCET, V387, P168, DOI 10.1016/S0140-6736(15)00474-2; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Mendelson M, 2016, LANCET, V387, P188, DOI 10.1016/S0140-6736(15)00547-4; ONeill J., 2016, TACKLING DRUG RESIST; WHO, 2015, GLOB ACT PLAN ANT RE, DOI DOI 10.1128/MICROBE.10.354.1; Woolhouse M, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0083	9	54	55	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2016	388	10041					218	220		10.1016/S0140-6736(16)31079-0	http://dx.doi.org/10.1016/S0140-6736(16)31079-0			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DR2LN	27479554	Green Submitted			2022-12-28	WOS:000379736100008
J	Genel, M; Simpson, JL; de la Chapelle, A				Genel, Myron; Simpson, Joe Leigh; de la Chapelle, Albert			The Olympic Games and Athletic Sex Assignment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							GENDER VERIFICATION; SPORTS		[Genel, Myron] Yale Univ, Sch Med, Dept Pediat, Yale Child Hlth Res Ctr, POB 208081, New Haven, CT 06520 USA; [Simpson, Joe Leigh] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Simpson, Joe Leigh] March Dimes Fdn, New York, NY USA; [de la Chapelle, Albert] Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA	Yale University; State University System of Florida; Florida International University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Genel, M (corresponding author), Yale Univ, Sch Med, Dept Pediat, Yale Child Hlth Res Ctr, POB 208081, New Haven, CT 06520 USA.	myron.genel@yale.edu						de Hon O, 2015, SPORTS MED, V45, P57, DOI 10.1007/s40279-014-0247-x; DELACHAPELLE A, 1986, JAMA-J AM MED ASSOC, V256, P1920, DOI 10.1001/jama.256.14.1920; DELACHAPELLE A, 1993, P NATL ACAD SCI USA, V90, P4495, DOI 10.1073/pnas.90.10.4495; Ferguson-Smith MA, 2014, SPORTS MED, V44, P1629, DOI 10.1007/s40279-014-0249-8; Genel M, 2005, LANCET, V366, pS41, DOI 10.1016/S0140-6736(05)67843-9; LJUNGQVIST A, 1992, JAMA-J AM MED ASSOC, V267, P850, DOI 10.1001/jama.267.6.850; Rupert JL, 2011, CAN BULL MED HIST, V28, P339, DOI 10.3138/cbmh.28.2.339	7	9	10	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	OCT 4	2016	316	13					1359	1360		10.1001/jama.2016.11850	http://dx.doi.org/10.1001/jama.2016.11850			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DX7TC	27490137				2022-12-28	WOS:000384591300013
J	Topothai, T; Chandrasiri, O; Liangruenrom, N; Tangcharoensathien, V				Topothai, Thitikorn; Chandrasiri, Orana; Liangruenrom, Nucharapon; Tangcharoensathien, Viroj			Renewing commitments to physical activity targets in Thailand	LANCET			English	Editorial Material									[Topothai, Thitikorn] Minist Publ Hlth, Div Phys Act & Hlth, Dept Hlth, Nonthaburi 11000, Thailand; [Chandrasiri, Orana; Liangruenrom, Nucharapon; Tangcharoensathien, Viroj] Minist Publ Hlth, Int Hlth Policy Program, Nonthaburi, Thailand; [Liangruenrom, Nucharapon] Mahidol Univ, Inst Populat & Social Res, Nakhon Pathom, Thailand	Ministry of Public Health - Thailand; Ministry of Public Health - Thailand; Mahidol University	Topothai, T (corresponding author), Minist Publ Hlth, Div Phys Act & Hlth, Dept Hlth, Nonthaburi 11000, Thailand.	thitikorn.t@anamai.mail.go.th						Bureau of Policy and Strategy, 2011, THAIL HLTH LIF STRAT; Desa U, 2016, TRANSF OUR WORLD 203; Ding D, 2016, LANCET, V388, P1311, DOI 10.1016/S0140-6736(16)30383-X; Division of Physical Activity and Health Department of Health., 2016, SIT PHYS ACT; Ekelund U., 2016, LANCET; Ketwongsa P., 2015, PHYS ACT SURV THAIL; Office of National Health Examination Survey, 2016, NAT HLTH EX SURV 201; Office of National Health Examination Survey, 2008, NAT HLTH EX SURV 200; Organization WH, 2009, GLOB HLTH RISKS MORT; Reis R. S., 2016, LANCET; Sallis J. F., 2016, LANCET; ThaiHealth Foundation, 2015, PHYS ACT PROM PLAN 2; World Health Organization, 2014, NONC DIS NCD COUNTR	13	8	8	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 24	2016	388	10051					1258	1260		10.1016/S0140-6736(16)30929-1	http://dx.doi.org/10.1016/S0140-6736(16)30929-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DW5RH	27475272				2022-12-28	WOS:000383704000010
J	Mamode, N; Calder, F				Mamode, Nizam; Calder, Francis			Improving outcomes in dialysis fistulae	LANCET			English	Editorial Material							HEMODIALYSIS		[Mamode, Nizam; Calder, Francis] Guys Hosp, Dept Transplantat Nephrol & Urol, London SE1 9RT, England	Guy's & St Thomas' NHS Foundation Trust	Mamode, N (corresponding author), Guys Hosp, Dept Transplantat Nephrol & Urol, London SE1 9RT, England.	nizam.mamode@gstt.nhs.uk						Aitken E, 2016, LANCET; Al-Jaishi AA, 2014, AM J KIDNEY DIS, V63, P464, DOI 10.1053/j.ajkd.2013.08.023; Flythe JE, 2016, CLIN J AM SOC NEPHRO, V11, P1005, DOI 10.2215/CJN.11611115; Lok CE, 2013, CLIN J AM SOC NEPHRO, V8, P1213, DOI 10.2215/CJN.01690213; Pruthi R, 2013, NEPHRON CLIN PRACT, V125, P81, DOI 10.1159/000360023; Rao A, 2016, NEPHRON, V132, P253, DOI 10.1159/000444825; Renal Association, 2015, VASC ACC HAEM	7	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 10	2016	388	10049					1029	1030		10.1016/S0140-6736(16)31230-2	http://dx.doi.org/10.1016/S0140-6736(16)31230-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DV0OD	27492882				2022-12-28	WOS:000382616900006
J	Liu, JY; Ghneim, K; Sok, D; Bosche, WJ; Li, Y; Chipriano, E; Berkemeier, B; Oswald, K; Borducchi, E; Cabral, C; Peter, L; Brinkman, A; Shetty, M; Jimenez, J; Mondesir, J; Lee, B; Giglio, P; Chandrashekar, A; Abbink, P; Colantonio, A; Gittens, C; Baker, C; Wagner, W; Lewis, MG; Li, WJ; Sekaly, RP; Lifson, JD; Burton, DR; Barouch, DH				Liu, Jinyan; Ghneim, Khader; Sok, Devin; Bosche, William J.; Li, Yuan; Chipriano, Elizabeth; Berkemeier, Brian; Oswald, Kelli; Borducchi, Erica; Cabral, Crystal; Peter, Lauren; Brinkman, Amanda; Shetty, Mayuri; Jimenez, Jessica; Mondesir, Jade; Lee, Benjamin; Giglio, Patricia; Chandrashekar, Abishek; Abbink, Peter; Colantonio, Arnaud; Gittens, Courtney; Baker, Chantelle; Wagner, Wendeline; Lewis, Mark G.; Li, Wenjun; Sekaly, Rafick-Pierre; Lifson, Jeffrey D.; Burton, Dennis R.; Barouch, Dan H.			Antibody-mediated protection against SHIV challenge includes systemic clearance of distal virus	SCIENCE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; PREDICTING GENE-FUNCTION; CD4(+) T-CELLS; RHESUS-MONKEYS; MONOCLONAL-ANTIBODIES; SIV INFECTION; NEUTRALIZING ANTIBODIES; VAGINAL TRANSMISSION; PASSIVE TRANSFER; IN-VIVO	HIV-1-specific broadly neutralizing antibodies (bNAbs) can protect rhesus monkeys against simian-human immunodeficiency virus (SHIV) challenge. However, the site of antibody interception of virus and the mechanism of antibody-mediated protection remain unclear. We administered a fully protective dose of the bNAb PGT121 to rhesus monkeys and challenged them intravaginally with SHIV-SF162P3. In PGT121-treated animals, we detected low levels of viral RNA and viral DNA in distal tissues for seven days following challenge. Viral RNA-positive tissues showed transcriptomic changes indicative of innate immune activation, and cells from these tissues initiated infection after adoptive transfer into naive hosts. These data demonstrate that bNAb-mediated protection against a mucosal virus challenge can involve clearance of infectious virus in distal tissues.	[Liu, Jinyan; Borducchi, Erica; Cabral, Crystal; Peter, Lauren; Brinkman, Amanda; Shetty, Mayuri; Jimenez, Jessica; Mondesir, Jade; Lee, Benjamin; Giglio, Patricia; Chandrashekar, Abishek; Abbink, Peter; Barouch, Dan H.] Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA; [Ghneim, Khader; Sekaly, Rafick-Pierre] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Sok, Devin; Burton, Dennis R.] Scripps Res Inst, La Jolla, CA 92037 USA; [Bosche, William J.; Li, Yuan; Chipriano, Elizabeth; Berkemeier, Brian; Oswald, Kelli; Lifson, Jeffrey D.] Frederick Natl Lab, AIDS & Canc Virus Program, Leidos Biomed Res, Frederick, MD 21702 USA; [Colantonio, Arnaud] Harvard Med Sch, Boston, MA 02115 USA; [Gittens, Courtney; Baker, Chantelle; Wagner, Wendeline; Lewis, Mark G.] Bioqual, Rockville, MD 20852 USA; [Li, Wenjun] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA; [Burton, Dennis R.; Barouch, Dan H.] Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02139 USA	Harvard University; Beth Israel Deaconess Medical Center; Case Western Reserve University; Scripps Research Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Harvard Medical School; BIOQUAL Inc.; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Barouch, DH (corresponding author), Beth Israel Deaconess Med Ctr, Ctr Virol & Vaccine Res, Boston, MA 02215 USA.; Barouch, DH (corresponding author), Ragon Inst Massachusetts Gen Hosp Massachusetts I, Cambridge, MA 02139 USA.	dbarouch@bidmc.harvard.edu	Li, Wenjun/F-5634-2015; Barouch, Dan/Y-3918-2019; Chandrashekar, Abishek/P-2610-2019	Li, Wenjun/0000-0001-5335-7386; Chandrashekar, Abishek/0000-0001-7821-5552; Brinkman, Amanda/0000-0002-2845-6494; Peter, Lauren/0000-0002-2105-7503	National Institutes of Health [AI060354, AI095985, AI096040, AI100645, AI100663, AI124377, HHSN261200800001E]; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI124377, U24AI126683, UM1AI100645, U19AI095985, P30AI060354, UM1AI100663, U19AI096040] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank A. Schultz, Q. Dang, M. Pensiero, M. Ferguson, F. Stephens, J. Nkolola, K. Smith, J. Smith, S. Blackmore, L. Parenteau, S. Mathew, S. Levin, C. Shaver, and Z. Pippin for generous advice, assistance, and reagents. The SIVmac239 peptides were obtained from the NIH AIDS Research and Reference Reagent Program. The data presented in this paper are tabulated in the main paper and in the supplementary materials. The authors declare no competing financial interests. Correspondence and requests for materials should be addressed to D.H.B. (dbarouch@bidmc.harvard.edu). We acknowledge support from the National Institutes of Health (AI060354, AI095985, AI096040, AI100645, AI100663, AI124377, HHSN261200800001E) and the Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard. Transcriptomics data can be accessed at GEO (GSE83702) and the National Center for Biotechnology Information, NIH (17948367).	Baba TW, 2000, NAT MED, V6, P200, DOI 10.1038/72309; Barouch DH, 2016, CELL, V165, P656, DOI 10.1016/j.cell.2016.03.021; Barouch DH, 2015, SCIENCE, V349, P320, DOI 10.1126/science.aab3886; Barouch DH, 2013, CELL, V155, P531, DOI 10.1016/j.cell.2013.09.061; Barouch DH, 2013, NATURE, V503, P224, DOI 10.1038/nature12744; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Burton DR, 2011, P NATL ACAD SCI USA, V108, P11181, DOI 10.1073/pnas.1103012108; Chung AW, 2015, CELL, V163, P988, DOI 10.1016/j.cell.2015.10.027; dos Santos PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019493; Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934; Hansen SG, 2013, NATURE, V502, P100, DOI 10.1038/nature12519; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2016, NAT MED, V22, P362, DOI 10.1038/nm.4063; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hu JJ, 2000, J VIROL, V74, P6087, DOI 10.1128/JVI.74.13.6087-6095.2000; Li HL, 2011, J VIROL, V85, P11007, DOI 10.1128/JVI.05346-11; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Miller CJ, 2005, J VIROL, V79, P9217, DOI 10.1128/JVI.79.14.9217-9227.2005; Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109; Mostafavi S, 2010, BIOINFORMATICS, V26, P1759, DOI 10.1093/bioinformatics/btq262; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373	31	111	111	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 2	2016	353	6303					1045	1049		10.1126/science.aag0491	http://dx.doi.org/10.1126/science.aag0491			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DU9SU	27540005	Green Accepted			2022-12-28	WOS:000382558900043
J	Pedersen, MW; Ruter, A; Schweger, C; Friebe, H; Staff, RA; Kjeldsen, KK; Mendoza, MLZ; Beaudoin, AB; Zutter, C; Larsen, NK; Potter, BA; Nielsenlo, R; Rainville, RA; Orlando, L; Meltzer, DJ; Kjaer, KH; Willerslev, E				Pedersen, Mikkel W.; Ruter, Anthony; Schweger, Charles; Friebe, Harvey; Staff, Richard A.; Kjeldsen, Kristian K.; Mendoza, Marie L. Z.; Beaudoin, Alwynne B.; Zutter, Cynthia; Larsen, Nicolaj K.; Potter, Ben A.; Nielsenlo, Rasmus; Rainville, Rebecca A.; Orlando, Ludovic; Meltzer, David J.; Kjaer, Kurt H.; Willerslev, Eske			Postglacial viability and colonization in North America's ice-free corridor	NATURE			English	Article							LAKE-SEDIMENTS; DNA; SURVIVAL; HISTORY; ALBERTA; POLLEN; CANADA; SHEET; HORSE; SITE	During the Last Glacial Maximum, continental ice sheets isolated Beringia (northeast Siberia and northwest North America) from unglaciated North America. By around 15 to 14 thousand calibrated radiocarbon years before present (cal. kyr BP), glacial retreat opened an approximately 1,500-km-long corridor between the ice sheets. It remains unclear when plants and animals colonized this corridor and it became biologically viable for human migration. We obtained radiocarbon dates, pollen, macrofossils and metagenomic DNA from lake sediment cores in a bottleneck portion of the corridor. We find evidence of steppe vegetation, bison and mammoth by approximately 12.6 cal. kyr BP, followed by open forest, with evidence of moose and elk at about 11.5 cal. kyr BP, and boreal forest approximately 10 cal. kyr BP Our findings reveal that the first Americans, whether Clovis or earlier groups in unglaciated North America before 12.6 cal. kyr BP, are unlikely to have travelled by this route into the Americas. However, later groups may have used this north south passageway.	[Pedersen, Mikkel W.; Ruter, Anthony; Kjeldsen, Kristian K.; Mendoza, Marie L. Z.; Larsen, Nicolaj K.; Nielsenlo, Rasmus; Orlando, Ludovic; Meltzer, David J.; Kjaer, Kurt H.; Willerslev, Eske] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum, DK-1350 Copenhagen, Denmark; [Schweger, Charles; Friebe, Harvey] Univ Alberta, Dept Anthropol, Edmonton, AB T6G 2H4, Canada; [Staff, Richard A.] Univ Oxford, Sch Archaeol, Oxford OX1 3QY, England; [Kjeldsen, Kristian K.] Univ Ottawa, Dept Earth Sci, Ottawa, ON K1N 6N5, Canada; [Beaudoin, Alwynne B.] Royal Alberta Museum, Edmonton, AB T5N 0M6, Canada; [Zutter, Cynthia] MacEwan Univ, Dept Anthropol, Edmonton, AB T5J 4S2, Canada; [Larsen, Nicolaj K.] Aarhus Univ, Dept Geosci, DK-8000 Aarhus, Denmark; [Potter, Ben A.] Univ Alaska Fairbanks, Dept Anthropol, Fairbanks, AK 99775 USA; [Nielsenlo, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Nielsenlo, Rasmus] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Rainville, Rebecca A.] Univ Calgary, Dept Archaeol, Calgary, AB T2N 1N4, Canada; [Meltzer, David J.] Southern Methodist Univ, Dept Anthropol, Dallas, TX 75275 USA; [Willerslev, Eske] Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England; [Willerslev, Eske] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Copenhagen; University of Alberta; University of Oxford; University of Ottawa; Aarhus University; University of Alaska System; University of Alaska Fairbanks; University of California System; University of California Berkeley; University of Copenhagen; University of Calgary; Southern Methodist University; University of Cambridge; Wellcome Trust Sanger Institute	Willerslev, E (corresponding author), Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum, DK-1350 Copenhagen, Denmark.; Willerslev, E (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.; Willerslev, E (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	ewillerslev@snm.ku.dk	Willerslev, Eske/AAA-5686-2019; Larsen, Nicolaj K./A-3509-2012; Pedersen, Mikkel Winther/GSN-8119-2022; Beaudoin, Alwynne B./H-3873-2011; Orlando, Ludovic/A-8932-2013; Willerslev, Eske/A-9619-2011; Mendoza, Marie Lisandra Zepeda/C-2001-2015; Kjeldsen, Kristian Kjellerup/A-9592-2013; Nielsen, Rasmus/D-4405-2009; Pedersen, Mikkel Winther/A-8151-2014; Kjaer, Kurt/A-4199-2013	Larsen, Nicolaj K./0000-0002-0117-1106; Beaudoin, Alwynne B./0000-0002-8895-4567; Orlando, Ludovic/0000-0003-3936-1850; Willerslev, Eske/0000-0002-7081-6748; Mendoza, Marie Lisandra Zepeda/0000-0002-1126-8219; Kjeldsen, Kristian Kjellerup/0000-0002-8557-5131; Nielsen, Rasmus/0000-0003-0513-6591; Pedersen, Mikkel Winther/0000-0002-7291-8887; Kjaer, Kurt/0000-0002-8871-5179; Meltzer, David/0000-0001-8084-9802; Staff, Richard/0000-0002-8634-014X; Potter, Ben/0000-0002-4749-0428; Zutter, Cynthia/0000-0002-9112-2358	Danish National Research Foundation [DNRF94]; Lundbeck Foundation; KU	Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); KU	We thank M. L Tobiaz, T. Murchie, G. Carroll, S. Overballe-Petersen, M. Reasoner, K. Walde, D. Wilson, F. Malekani, A. Freeman, J. Holm, St John's College in Cambridge, and the Danish National Sequencing Centre for help and support. The Fig. 1 b map contains a digital elevation model licensed under the Open Government Licence - Canada (http://open.canada.ca/en/open-government-licence-canada). This study was supported by the Danish National Research Foundation (DNRF94), the Lundbeck Foundation and KU2016.	Beaudoin AB, 1996, QUATERN INT, V32, P113; BENNETT KD, 2005, DOCUMENTATION PSIMPO, P1; Birks H.J.B., 1980, QUATERNARY PALAEOECO; Burns JA, 2010, QUATERN INT, V217, P37, DOI 10.1016/j.quaint.2009.08.003; Coissac E, 2016, MOL ECOL, V25, P1423, DOI 10.1111/mec.13549; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Dillehay TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141923; Dixon EJ, 2013, QUATERN INT, V285, P57, DOI 10.1016/j.quaint.2011.02.027; Dixon EJ, 2001, QUATERNARY SCI REV, V20, P277; Driver J. C., 2008, CANADIAN J ARCHAEOLO, V32, P239; Dyke AS, 2004, DEV QUA SCI, V2, P373, DOI 10.1016/S1571-0866(04)80209-4; Faegri K., 1990, TXB POLLEN ANAL, P1; Ferring C.R., 2007, MINDING STORE, V1st ed.; Gilbert MTP, 2008, SCIENCE, V320, P786, DOI 10.1126/science.1154116; GODWIN H., 1934, NEW PHYTOLOGIST, V33, P278, DOI 10.1111/j.1469-8137.1934.tb06815.x; Gowan EJ, 2013, QUATERNARY SCI REV, V75, P100, DOI 10.1016/j.quascirev.2013.06.001; Haile J, 2009, P NATL ACAD SCI USA, V106, P22352, DOI 10.1073/pnas.0912510106; Harington C. R., 2009, J CAVE KARST STUD, V73, P162; Hartman GMD, 2008, CAN J EARTH SCI, V45, P549, DOI 10.1139/E07-069; Hebda RJ, 2008, CAN J EARTH SCI, V45, P611, DOI 10.1139/E07-064; Heintzman PD, 2016, P NATL ACAD SCI USA, V113, P8057, DOI 10.1073/pnas.1601077113; Hickin AS, 2015, BOREAS, V44, P288, DOI 10.1111/bor.12110; Hickin AS, 2016, QUATERNARY RES, V85, P409, DOI 10.1016/j.yqres.2016.02.005; HICKMAN M, 1989, Journal of Paleolimnology, V2, P305; Ives JW., 2014, PALEOAMERICAN ODYSSE, P149; Jass CN, 2011, CAN J EARTH SCI, V48, P793, DOI 10.1139/E10-096; Jonsson H, 2013, BIOINFORMATICS, V29, P1682, DOI 10.1093/bioinformatics/btt193; Kooyman B, 2006, AM ANTIQUITY, V71, P101, DOI 10.2307/40035323; Kooyman B, 2012, AM ANTIQUITY, V77, P115, DOI 10.7183/0002-7316.77.1.115; Madsen D.B., 2015, PALEOAMERICA, V1, P217, DOI [DOI 10.1179/2055557115Y.0000000006, 10.1179/2055557115Y.0000000006]; Mandryk CAS, 2001, QUATERNARY SCI REV, V20, P301, DOI 10.1016/S0277-3791(00)00115-3; Matheus P, 2004, SCIENCE, V306, P1150, DOI 10.1126/science.1101495; Mathews W.H., 1978, QUATERNARY STRATIGRA; Meiri M, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2167; Meltzer D. J., 2009, 1 PEOPLES NEW WORLD; Munyikwa K, 2011, QUAT GEOCHRONOL, V6, P407, DOI 10.1016/j.quageo.2011.03.010; Parducci L, 2013, MOL ECOL, V22, P3511, DOI 10.1111/mec.12298; Parducci L, 2012, SCIENCE, V335, P1083, DOI 10.1126/science.1216043; Pedersen M. W., 2015, P R SOC LOND B; Pedersen MW, 2013, QUATERNARY SCI REV, V75, P161, DOI 10.1016/j.quascirev.2013.06.006; Potter BA., 2014, PALEOAMERICAN ODYSSE, P81; Raghavan M, 2015, SCIENCE, V349, DOI 10.1126/science.aab3884; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Sanchez G, 2014, P NATL ACAD SCI USA, V111, P10972, DOI 10.1073/pnas.1404546111; Stokes CR, 2016, NATURE, V530, P322, DOI 10.1038/nature16947; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011; VIERECK LA, 1966, ECOL MONOGR, V36, P181, DOI 10.2307/1942416; WHITE JM, 1985, QUATERNARY RES, V24, P173, DOI 10.1016/0033-5894(85)90004-3; WHITE JM, 1979, CAN J EARTH SCI, V16, P1870, DOI 10.1139/e79-171; Willerslev E, 2003, SCIENCE, V300, P791, DOI 10.1126/science.1084114	50	198	212	8	185	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	SEP 1	2016	537	7618					45	49		10.1038/nature19085	http://dx.doi.org/10.1038/nature19085			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	DU7XC	27509852	Green Submitted, Green Accepted			2022-12-28	WOS:000382426900035
J	Guo, F; Yu, JW; Jung, HJ; Abruzzi, KC; Luo, WF; Riffith, LCG; Rosbash, M				Guo, Fang; Yu, Junwei; Jung, Hyung Jae; Abruzzi, Katharine C.; Luo, Weifei; Riffith, Leslie C. G.; Rosbash, Michael			Circadian neuron feedback controls the Drosophila sleep-activity profile	NATURE			English	Article							CLOCK NEURONS; PACEMAKER NEURONS; RHYTHMS; GENE; LIGHT; TEMPERATURE; GLUTAMATE; CIRCUITS; MUTATION; OUTPUT	Little is known about the ability of Drosophila circadian neurons to promote sleep. Here we show, using optogenetic manipulation and video recording, that a subset of dorsal clock neurons (DN1s) are potent sleep-promoting cells that release glutamate to directly inhibit key pacemaker neurons. The pacemakers promote morning arousal by activating these DN1s, implying that a late-day feedback circuit drives midday siesta and night-time sleep. To investigate more plastic aspects of the sleep program, we used a calcium assay to monitor and compare the real-time activity of DN1 neurons in freely behaving males and females. Our results revealed that DN1 neurons were more active in males than in females, consistent with the finding that male flies sleep more during the day. DN1 activity is also enhanced by elevated temperature, consistent with the ability of higher temperatures to increase sleep. These new approaches indicate that DN1s have a major effect on the fly sleep-wake profile and integrate environmental information with the circadian molecular program.	[Guo, Fang; Jung, Hyung Jae; Abruzzi, Katharine C.; Luo, Weifei; Rosbash, Michael] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA; [Guo, Fang; Jung, Hyung Jae; Abruzzi, Katharine C.; Luo, Weifei; Rosbash, Michael] Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA; [Guo, Fang; Yu, Junwei; Jung, Hyung Jae; Abruzzi, Katharine C.; Luo, Weifei; Riffith, Leslie C. G.; Rosbash, Michael] Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02454 USA; [Guo, Fang; Yu, Junwei; Jung, Hyung Jae; Abruzzi, Katharine C.; Luo, Weifei; Riffith, Leslie C. G.; Rosbash, Michael] Brandeis Univ, Volen Natl Ctr Complex Syst, Waltham, MA 02454 USA	Brandeis University; Howard Hughes Medical Institute; Brandeis University; Brandeis University; Brandeis University	Rosbash, M (corresponding author), Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02454 USA.; Rosbash, M (corresponding author), Brandeis Univ, Natl Ctr Behav Genom, Waltham, MA 02454 USA.; Rosbash, M (corresponding author), Brandeis Univ, Dept Biol, Natl Ctr Behav Genom, Waltham, MA 02454 USA.; Rosbash, M (corresponding author), Brandeis Univ, Volen Natl Ctr Complex Syst, Waltham, MA 02454 USA.	rosbash@brandeis.edu	Yu, Junwei/ABD-8532-2021	Griffith, Leslie/0000-0003-3164-9876	NIH [R01 MH067284]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH067284] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank M. Diaz, N. Nguyen, R. Spann and K. Kerr for generous help, and X. Gao and L. Luo for sending us LexAop-LUC flies, and O. Shafer and A. Sehgal for helpful discussion and comments on early versions of this manuscript. This work was supported in part by NIH R01 MH067284 (LCG).	Abruzzi K, 2015, METHOD ENZYMOL, V551, P369, DOI 10.1016/bs.mie.2014.10.025; Agosto J, 2008, NAT NEUROSCI, V11, P354, DOI 10.1038/nn2046; Aso Y, 2014, ELIFE, V3, DOI 10.7554/eLife.04580; Benito J, 2007, COLD SPRING HARB SYM, V72, P437, DOI 10.1101/sqb.2007.72.009; Cao WH, 2015, SLEEP, V38, P41, DOI 10.5665/sleep.4322; Cavanaugh DJ, 2014, CELL, V157, P689, DOI 10.1016/j.cell.2014.02.024; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Collins B, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001959; Collins B, 2012, NEURON, V74, P706, DOI 10.1016/j.neuron.2012.02.034; Diao FQ, 2015, CELL REP, V10, P1410, DOI 10.1016/j.celrep.2015.01.059; Donelson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037250; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Flourakis M, 2015, CELL, V162, P836, DOI 10.1016/j.cell.2015.07.036; Gao XJJ, 2015, NAT NEUROSCI, V18, P917, DOI 10.1038/nn.4016; Garbe DS, 2015, BIOL OPEN, V4, P1558, DOI 10.1242/bio.013011; Gilestro GF, 2009, BIOINFORMATICS, V25, P1466, DOI 10.1093/bioinformatics/btp237; Gradinaru V, 2010, CELL, V141, P154, DOI 10.1016/j.cell.2010.02.037; Grima B, 2004, NATURE, V431, P869, DOI 10.1038/nature02935; Guo F, 2014, ELIFE, V3, DOI 10.7554/eLife.02780; Hamasaka Y, 2007, J COMP NEUROL, V505, P32, DOI 10.1002/cne.21471; HARDIN PE, 1992, P NATL ACAD SCI USA, V89, P11711, DOI 10.1073/pnas.89.24.11711; Haynes PR, 2015, ELIFE, V4, DOI 10.7554/eLife.03868; Helfrich-Forster C, 2000, J BIOL RHYTHM, V15, P135, DOI 10.1177/074873040001500208; Inagaki HK, 2014, NAT METHODS, V11, P325, DOI [10.1038/NMETH.2765, 10.1038/nmeth.2765]; Jenett A, 2012, CELL REP, V2, P991, DOI 10.1016/j.celrep.2012.09.011; Klapoetke NC, 2014, NAT METHODS, V11, P338, DOI [10.1038/NMETH.2836, 10.1038/nmeth.2836]; Kunst M, 2014, CURR BIOL, V24, P2652, DOI 10.1016/j.cub.2014.09.077; Liang XT, 2016, SCIENCE, V351, P976, DOI 10.1126/science.aad3997; Liu WW, 2013, P NATL ACAD SCI USA, V110, P10294, DOI 10.1073/pnas.1220560110; Low KH, 2008, NEURON, V60, P1054, DOI 10.1016/j.neuron.2008.10.048; Majercak J, 1999, NEURON, V24, P219, DOI 10.1016/S0896-6273(00)80834-X; Masuyama K, 2012, J NEUROGENET, V26, P89, DOI 10.3109/01677063.2011.642910; MOORE RY, 1983, FED PROC, V42, P2783; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Picot M, 2009, J NEUROSCI, V29, P8312, DOI 10.1523/JNEUROSCI.0279-08.2009; Prober DA, 2006, J NEUROSCI, V26, P13400, DOI 10.1523/JNEUROSCI.4332-06.2006; Renn SCP, 1999, CELL, V99, P791, DOI 10.1016/S0092-8674(00)81676-1; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rieger D, 2006, J NEUROSCI, V26, P2531, DOI 10.1523/JNEUROSCI.1234-05.2006; Rieger D, 2007, J BIOL RHYTHM, V22, P387, DOI 10.1177/0748730407306198; Seluzicki A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001810; Shang YH, 2008, P NATL ACAD SCI USA, V105, P19587, DOI 10.1073/pnas.0809577105; Stanewsky R, 1998, CELL, V95, P681, DOI 10.1016/S0092-8674(00)81638-4; Stanewsky Ralf, 2007, Methods Mol Biol, V362, P131; Stoleru D, 2004, NATURE, V431, P862, DOI 10.1038/nature02926; Tang CHA, 2010, NEURON, V66, P378, DOI 10.1016/j.neuron.2010.04.015; Tataroglu O, 2014, METHODS, V68, P140, DOI 10.1016/j.ymeth.2014.01.001; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Yao Z, 2014, SCIENCE, V343, P1516, DOI 10.1126/science.1251285; Yao ZP, 2012, J NEUROPHYSIOL, V108, P684, DOI 10.1152/jn.00110.2012; Zhang LY, 2010, CURR BIOL, V20, P591, DOI 10.1016/j.cub.2010.02.056; Zhang Y, 2010, CURR BIOL, V20, P600, DOI 10.1016/j.cub.2010.02.044	52	165	167	1	98	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 18	2016	536	7616					292	+		10.1038/nature19097	http://dx.doi.org/10.1038/nature19097			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT9GN	27479324	Green Accepted			2022-12-28	WOS:000381804900027
J	Caille, A; Kerry, S; Tavernier, E; Leyrat, C; Eldridge, S; Giraudeau, B				Caille, Agnes; Kerry, Sally; Tavernier, Elsa; Leyrat, Clemence; Eldridge, Sandra; Giraudeau, Bruno			Timeline cluster: a graphical tool to identify risk of bias in cluster randomised trials	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PATIENT ENGAGEMENT; REDUCING WASTE; CARE; HEALTH; INTERVENTION; TELEPHONE; PEOPLE; PEACH	Robust evidence of the effectiveness of interventions relating to policy, practice, and organisation of healthcare often comes from well conducted cluster randomised trials. Such trials are, however, prone to recruitment bias depending on whether participants are recruited before the randomisation of clusters and whether the recruiter is blinded to the allocation status. In most cases, participants and trial staff cannot be blinded to the intervention, which might lead to performance and detection bias. Unfortunately, cluster trial reports often do not provide a clear description of the timing of trial processes and blinding, and these aspects are not covered by current reporting tools. This article proposes a graphical tool depicting the time sequence of steps and blinding status in cluster randomised trials. The tool might be helpful at both the protocol and the report writing stages to clarify the process and to help identify potential bias in cluster randomised trials.	[Caille, Agnes; Giraudeau, Bruno] Univ Tours, Tours, France; [Caille, Agnes; Tavernier, Elsa; Giraudeau, Bruno] CHRU Tours, INSERM, CIC1415, Tours, France; [Caille, Agnes; Tavernier, Elsa; Giraudeau, Bruno] INSERM, U1153, Ctr Rech Epidemiol & Biostat, Paris, France; [Kerry, Sally; Eldridge, Sandra] Queen Mary Univ London, Ctr Primary Care & Publ Hlth, London, England; [Leyrat, Clemence] London Sch Hyg & Trop, Dept Med Stat, London, England	Universite de Tours; CHU Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University of London; Queen Mary University London; University of London; London School of Hygiene & Tropical Medicine	Caille, A (corresponding author), Univ Tours, Tours, France.; Caille, A (corresponding author), CHRU Tours, INSERM, CIC1415, Tours, France.; Caille, A (corresponding author), INSERM, U1153, Ctr Rech Epidemiol & Biostat, Paris, France.	agnes.caille@med.univ-tours.fr	Giraudeau, Bruno/L-9003-2015; Leyrat, Clémence/I-9413-2019	Giraudeau, Bruno/0000-0003-3031-8258; Leyrat, Clémence/0000-0002-4097-4577; Caille, Agnes/0000-0003-4715-6144; Tavernier, Elsa/0000-0003-0798-1182; Eldridge, Sandra/0000-0001-5638-2317				Blackberry ID, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5272; Campbell Marion K, 2012, BMJ, V345, pe5661, DOI 10.1136/bmj.e5661; Cheyne H, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2396; Donner A, 2000, DESIGN ANAL CLUSTER; Eldridge S, 2011, A PRACTICAL GUIDE TO; Eldridge S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4006; Feder G, 2011, LANCET, V378, P1788, DOI 10.1016/S0140-6736(11)61179-3; Giraudeau B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040436; Giraudeau B, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000065; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Griffiths C, 2004, BMJ-BRIT MED J, V328, P144, DOI 10.1136/bmj.37950.784444.EE; Hahn Seokyung, 2005, BMC Med Res Methodol, V5, P10, DOI 10.1186/1471-2288-5-10; Hooper R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6681; Ioannidis JPA, 2014, LANCET, V383, P166, DOI 10.1016/S0140-6736(13)62227-8; Ivers N M, 2011, BMJ, V343, pd5886, DOI 10.1136/bmj.d5886; Juni P, 2001, BMJ-BRIT MED J, V323, P42, DOI 10.1136/bmj.323.7303.42; Kannus P, 2000, NEW ENGL J MED, V343, P1506, DOI 10.1056/NEJM200011233432101; Murphy S, 2011, PUBLIC HEALTH NUTR, V14, P219, DOI 10.1017/S1368980010001886; Perera R, 2007, BRIT MED J, V334, P127, DOI 10.1136/bmj.39045.396817.68; Pourrat X, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-260; Puffer S, 2003, BMJ-BRIT MED J, V327, P785, DOI 10.1136/bmj.327.7418.785; Young D, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-20	22	27	27	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 16	2016	354								i4291	10.1136/bmj.i4291	http://dx.doi.org/10.1136/bmj.i4291			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT9GX	27530617	Green Published, Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000381806200003
J	Haque, IS; Lazarin, GA; Kang, HP; Evans, EA; Goldberg, JD; Wapner, RJ				Haque, Imran S.; Lazarin, Gabriel A.; Kang, H. Peter; Evans, Eric A.; Goldberg, James D.; Wapner, Ronald J.			Modeled Fetal Risk of Genetic Diseases Identified by Expanded Carrier Screening	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							FRAGILE-X-SYNDROME; MEDICAL-GENETICS; AMERICAN-COLLEGE; VARIANTS; ASSOCIATION; STATEMENT; DIAGNOSIS; GENOMICS	IMPORTANCE Screening for carrier status of a limited number of single-gene conditions is the current standard of prenatal care. Methods have become available allowing rapid expanded carrier screening for a substantial number of conditions. OBJECTIVES To quantify the modeled risk of recessive conditions identifiable by an expanded carrier screening panel in individuals of diverse racial and ethnic backgrounds and to compare the results with those from current screening recommendations. DESIGN, SETTING, AND PARTICIPANTS Retrospective modeling analysis of results between January 1, 2012, and July 15, 2015, from expanded carrier screening in reproductive-aged individuals without known indication for specific genetic testing, primarily from the United States. Tests were offered by clinicians providing reproductive care. EXPOSURES Individuals were tested for carrier status for up to 94 severe or profound conditions. MAIN OUTCOMES AND MEASURES Risk was defined as the probability that a hypothetical fetus created from a random pairing of individuals (within or across 15 self-reported racial/ethnic categories; there were 11 categories with >5000 samples) would be homozygous or compound heterozygous for 2 mutations presumed to cause severe or profound disease. Severe conditions were defined as those that if left untreated cause intellectual disability or a substantially shortened lifespan; profound conditions were those causing both. RESULTS The study included 346 790 individuals. Among major US racial/ethnic categories, the calculated frequency of fetuses potentially affected by a profound or severe condition ranged from 94.5 per 100 000 (95% CI, 82.4-108.3 per 100 000) for Hispanic couples to 392.2 per 100 000 (95% CI, 366.3-420.2 per 100 000) for Ashkenazi Jewish couples. In most racial/ethnic categories, expanded carrier screening modeled more hypothetical fetuses at risk for severe or profound conditions than did screening based on current professional guidelines (Mann-Whitney P < .001). For Northern European couples, the 2 professional guidelines-based screening panels modeled 55.2 hypothetical fetuses affected per 100 000 (95% CI, 51.3-59.3 per 100 000) and the expanded carrier screening modeled 159.2 fetuses per 100 000 (95% CI, 150.4-168.6 per 100 000). Overall, relative to expanded carrier screening, guideline-based screening ranged from identification of 6%(95% CI, 4%-8%) of hypothetical fetuses affected for East Asian couples to 87%(95% CI, 84%-90%) for African or African American couples. CONCLUSIONS AND RELEVANCE In a population of diverse races and ethnicities, expanded carrier screening may increase the detection of carrier status for a variety of potentially serious genetic conditions compared with current recommendations from professional societies. Prospective studies comparing current standard-of-care carrier screening with expanded carrier screening in at-risk populations are warranted before expanded screening is adopted.	[Haque, Imran S.; Lazarin, Gabriel A.; Kang, H. Peter; Evans, Eric A.; Goldberg, James D.] Counsyl, Dept Med Affairs, San Francisco, CA USA; [Haque, Imran S.; Lazarin, Gabriel A.; Kang, H. Peter; Evans, Eric A.; Goldberg, James D.] Counsyl, Dept Res, San Francisco, CA USA; [Wapner, Ronald J.] Columbia Univ, Med Ctr, Dept Obstet & Gynecol, Div Reprod Genet, New York, NY USA	Columbia University	Haque, IS (corresponding author), 180 Kimball Way, San Francisco, CA 94080 USA.	research@counsyl.com		Wapner, Ronald/0000-0003-0727-1244; Lazarin, Gabriel/0000-0001-5061-8595	Counsyl	Counsyl	This study was funded by Counsyl, a laboratory providing expanded carrier screening.	ACOG Committee on Obstetrics, 2007, Obstet Gynecol, V109, P229; [Anonymous], 2010, Obstet Gynecol, V116, P1008, DOI 10.1097/AOG.0b013e3181fae884; Azimi M, 2016, MOL GENET GENOM MED, V4, P292, DOI 10.1002/mgg3.204; Bailey DB, 2009, PEDIATRICS, V124, P527, DOI 10.1542/peds.2008-2992; Chan M, 2011, J MOL DIAGN, V13, P305, DOI 10.1016/j.jmoldx.2010.12.001; Chen LJ, 2010, J MOL DIAGN, V12, P589, DOI 10.2353/jmoldx.2010.090227; Dawson G, 2010, PEDIATRICS, V125, pE17, DOI 10.1542/peds.2009-0958; Edwards JG, 2015, OBSTET GYNECOL, V125, P653, DOI 10.1097/AOG.0000000000000666; Feero WG, 2016, JAMA-J AM MED ASSOC, V315, P33, DOI 10.1001/jama.2015.17702; Grody WW, 2013, GENET MED, V15, P482, DOI 10.1038/gim.2013.47; Grody WW, 2011, GENET MED, V13, P996, DOI 10.1097/GIM.0b013e31823c49a2; Hagerman RJ, 2009, PEDIATRICS, V123, P378, DOI 10.1542/peds.2008-0317; Henneman L, 2016, EUR J HUM GENET, V24, pE1, DOI 10.1038/ejhg.2015.271; Kang HP, 2016, PEERJ, V4, DOI 10.7717/peerj.2162; Lazarin GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114391; Lazarin GA, 2013, GENET MED, V15, P178, DOI 10.1038/gim.2012.114; McConkie-Rosell Allyn, 2005, J Genet Couns, V14, P249, DOI 10.1007/s10897-005-4802-x; Narasimhan VM, 2016, SCIENCE, V352, P474, DOI 10.1126/science.aac8624; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schaefer TL, 2015, APPL CLIN GENET, V8, P75, DOI 10.2147/TACG.S35673; Seymour CA, 1997, HEALTH TECHNOL ASSES, V1, pi, DOI [DOI 10.3310/hta1110, DOI 10.3310/HTA1110]; Sherman S, 2005, GENET MED, V7, P584, DOI 10.1097/01.GIM.0000182468.22666.dd; Sugarman EA, 2012, EUR J HUM GENET, V20, P27, DOI 10.1038/ejhg.2011.134; Tassone F, 2014, JAMA NEUROL, V71, P355, DOI 10.1001/jamaneurol.2013.4808; Van Driest SL, 2016, JAMA-J AM MED ASSOC, V315, P47, DOI 10.1001/jama.2015.17701; Watson MS, 2006, GENET MED, V8, p1S, DOI 10.1097/01.gim.0000223891.82390.ad	26	114	116	1	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 16	2016	316	7					734	742		10.1001/jama.2016.11139	http://dx.doi.org/10.1001/jama.2016.11139			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT5IA	27533158	Bronze			2022-12-28	WOS:000381514800019
J	Malischewski, M; Adelhardt, M; Sutter, J; Meyer, K; Seppelt, K				Malischewski, M.; Adelhardt, M.; Sutter, J.; Meyer, K.; Seppelt, K.			Isolation and structural and electronic characterization of salts of the decamethylferrocene dication	SCIENCE			English	Article							HIGH-VALENT IRON; SPECTROSCOPIC CHARACTERIZATION; MOSSBAUER; METALLOCENE; COMPLEXES; OXO; ELECTROCHEMISTRY; REACTIVITY; FERROCENE; CATION	Ferrocene and its decamethyl derivative [Cp*Fe-2] are the most common standards for nonaqueous electrochemical investigations because of their well-defined and only mildly solvent-dependent reversible Fe(II)/Fe(III) redox couple. Higher oxidation states have only rarely been studied. We report the isolation and crystallographic and spectroscopic characterization of surprisingly stable Fe(IV) salts of the [Cp*Fe-2](2+) dication, produced by oxidation of [Cp*Fe-2] with AsF5, SbF5, or ReF6 in neat sulfur dioxide as well as [XeF](Sb2F11) in neat hydrogen fluoride. The Sb2F11- salt exhibits a metallocene with the expected mutually parallel arrangements of the Cp* rings, whereas the As2F11-, AsF6-, SbF6-, and ReF6- salts manifest tilt angles ranging from 4 degrees to 17 degrees. Both Fe-57 Mossbauer spectroscopy and superconducting quantum interference device magnetization studies reveal identical d-orbital splitting with an S = 1, E-3 ground state based on the 3d electronic configuration e(2g) (3)a(1g)(1) of all [Cp*Fe-2](2+) salts.	[Malischewski, M.; Seppelt, K.] Free Univ Berlin, Inst Chem & Biochem, Inorgan Chem, D-14195 Berlin, Germany; [Adelhardt, M.; Sutter, J.; Meyer, K.] Univ Erlangen Nurnberg, Dept Chem & Pharm, Inorgan Chem, D-91058 Erlangen, Germany	Free University of Berlin; University of Erlangen Nuremberg	Malischewski, M (corresponding author), Free Univ Berlin, Inst Chem & Biochem, Inorgan Chem, D-14195 Berlin, Germany.; Meyer, K (corresponding author), Univ Erlangen Nurnberg, Dept Chem & Pharm, Inorgan Chem, D-91058 Erlangen, Germany.	moritz.malischewski@fu-berlin.de; karsten.meyer@fau.de	Malischewski, Moritz/AAO-8593-2020; Meyer, Karsten/G-2570-2012	Malischewski, Moritz/0000-0002-6756-2951; Meyer, Karsten/0000-0002-7844-2998	Free University Berlin; Fonds der Chemischen Industrie; Deutsche Forschungsgemeinschaft [GRK 1582]; Friedrich-Alexander-University of Erlangen-Nurnberg	Free University Berlin; Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-University of Erlangen-Nurnberg	Supported by Free University Berlin, Fonds der Chemischen Industrie, Deutsche Forschungsgemeinschaft (GRK 1582, Fluorine as a Key Element), and Friedrich-Alexander-University of Erlangen-Nurnberg. We thank J. Telser and E. Bill for helpful discussions and E. Zolnhofer for synthesis and magnetochemical characterization of [Cp<INF>2</INF>Cr]. Computing time was made available by High-Performance Computing at ZEDAT/Free University Berlin. All crystal structures have been deposited with the Cambridge Crystallographic Data Centre under accession numbers CCDC 1449790 [C<INF>20</INF>H<INF>30</INF>Fe(As<INF>2</INF>F<INF>11</INF>)<INF>2</INF>center dot SO<INF>2</INF>], CCDC 1449791 [C<INF>20</INF>H<INF>30</INF>Fe(AsF<INF>6</INF>)<INF>2</INF>center dot 2HF], CCDC 1449792 [C<INF>20</INF>H<INF>30</INF>F<INF>14</INF>FeRe<INF>2</INF>], CCDC 1449793 [C<INF>20</INF>H<INF>30</INF>Fe(Sb<INF>2</INF>F<INF>11</INF>)<INF>2</INF>], and CCDC 1449794 [C<INF>20</INF>H<INF>30</INF>Fe(SbF<INF>6</INF>)<INF>2</INF>center dot 2HF].	Adams RD, 2001, J ORGANOMET CHEM, V637, P1, DOI 10.1016/S0022-328X(01)00875-0; Albright T. A., 1985, ORBITAL INTERACTIONS; Berry JF, 2006, SCIENCE, V312, P1937, DOI 10.1126/science.1128506; Bouwkamp MW, 2002, J AM CHEM SOC, V124, P12956, DOI 10.1021/ja027617w; BOWER BK, 1972, J AM CHEM SOC, V94, P2512, DOI 10.1021/ja00762a056; BURKEY DJ, 1995, COMMENT INORG CHEM, V17, P41, DOI 10.1080/02603599508035781; ENGELMANN F, 1953, Z NATURFORSCH B, V8, P775; EVANS WJ, 1984, J AM CHEM SOC, V106, P4270, DOI 10.1021/ja00327a037; FISCHER EO, 1952, Z NATURFORSCH B, V7, P377; FREYBERG DP, 1979, J AM CHEM SOC, V101, P892, DOI 10.1021/ja00498a017; GALE RJ, 1980, J ORGANOMET CHEM, V199, pC44, DOI 10.1016/S0022-328X(00)83867-X; Gama V., 2000, EUR J INORG CHEM, V2000, P2101; Green JC, 1998, CHEM SOC REV, V27, P263; Groves JT, 2006, J INORG BIOCHEM, V100, P434, DOI 10.1016/j.jinorgbio.2006.01.012; Gutlich P, 2011, MOSSBAUER SPECTROSCOPY AND TRANSITION METAL CHEMISTRY: FUNDAMENTALS AND APPLICATIONS, P1; Herber RH, 1999, INORG CHIM ACTA, V291, P74, DOI 10.1016/S0020-1693(99)00022-5; Hohenberger J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1718; KONIG E, 1977, CHEM PHYS LETT, V50, P439, DOI 10.1016/0009-2614(77)80361-8; Krossing I, 2004, ANGEW CHEM INT EDIT, V43, P2066, DOI 10.1002/anie.200300620; Lewis RA, 2013, INORG CHEM, V52, P8218, DOI 10.1021/ic401096p; Long N. J., 1998, METALLOCENES INTRO S, V1st; McDonald AR, 2013, COORDIN CHEM REV, V257, P414, DOI 10.1016/j.ccr.2012.08.002; McKinnon JJ, 2004, ACTA CRYSTALLOGR B, V60, P627, DOI 10.1107/S0108768104020300; MILLER JS, 1987, INORG CHEM, V26, P600, DOI 10.1021/ic00251a022; MOOCK K, 1987, J FLUORINE CHEM, V37, P253, DOI 10.1016/S0022-1139(00)82021-7; OGINO H, 1989, J CHEM SOC CHEM COMM, P828, DOI 10.1039/c39890000828; Perucha AS, 2007, ACTA CRYSTALLOGR E, V63, pM1703, DOI 10.1107/S1600536807024919; PRINS R, 1969, J AM CHEM SOC, V91, P4929, DOI 10.1021/ja01045a063; REIFF WM, 1988, J APPL PHYS, V63, P2957, DOI 10.1063/1.340915; Rohde JU, 2003, SCIENCE, V299, P1037, DOI 10.1126/science.299.5609.1037; Ruiz J, 1998, J AM CHEM SOC, V120, P11693, DOI 10.1021/ja982342z; Scepaniak JJ, 2011, SCIENCE, V331, P1049, DOI 10.1126/science.1198315; Schloder T, 2012, ANGEW CHEM INT EDIT, V51, P12063, DOI 10.1002/anie.201206464; Shapiro PJ, 2002, COORDIN CHEM REV, V231, P67, DOI 10.1016/S0010-8545(02)00114-5; SHARP PR, 1983, INORG CHEM, V22, P2689, DOI 10.1021/ic00161a010; Spackman MA, 2002, CRYSTENGCOMM, V4, P378, DOI 10.1039/b203191b; Spackman MA, 2009, CRYSTENGCOMM, V11, P19, DOI 10.1039/b818330a; de Oliveira FT, 2007, SCIENCE, V315, P835, DOI 10.1126/science.1133417; Vertes A, 1997, FULLERENE SCI TECHN, V5, P97, DOI 10.1080/15363839708011975; Vogel C, 2008, ANGEW CHEM INT EDIT, V47, P2681, DOI 10.1002/anie.200800600; WILKINSON G, 1952, J AM CHEM SOC, V74, P2125, DOI 10.1021/ja01128a527; WILLIAMS DS, 1990, J AM CHEM SOC, V112, P6728, DOI 10.1021/ja00174a052	42	61	62	3	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 12	2016	353	6300					678	682		10.1126/science.aaf6362	http://dx.doi.org/10.1126/science.aaf6362			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT5ZC	27516596				2022-12-28	WOS:000381561200035
J	Collucci, C				Collucci, Claudia			Ivo Pitanguy OBITUARY	BMJ-BRITISH MEDICAL JOURNAL			English	Biographical-Item												claudia.collucci@gmail.com						PITANGUY I, PUBLICATION LIST	1	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 11	2016	354								i4415	10.1136/bmj.i4415	http://dx.doi.org/10.1136/bmj.i4415			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4UB	27515065				2022-12-28	WOS:000381475500005
J	Armstrong, S				Armstrong, Stephen			Social networking for patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												stephen.armstrong@me.com						Al Mamun M, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.140265; Association of the British Pharmaceutical Industry, 2015, COD PRACT PHARM IND; Bender JL, 2011, J MED INTERNET RES, V13, P165, DOI 10.2196/jmir.1560; Fathom, 2015, 6 CONS US FAC GROUPS; General Medical Council, 2013, DOCT US SOC MED; TaylorWessing, 2013, SOC MED PHARM SECT	6	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	AUG 10	2016	354								i4201	10.1136/bmj.i4201	http://dx.doi.org/10.1136/bmj.i4201			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT4TW	27510525				2022-12-28	WOS:000381475000003
J	Pokorney, SD; Simon, DN; Thomas, L; Gersh, BJ; Hylek, EM; Piccini, JP; Peterson, ED				Pokorney, Sean D.; Simon, DaJuanicia N.; Thomas, Laine; Gersh, Bernard J.; Hylek, Elaine M.; Piccini, Jonathan P.; Peterson, Eric D.			Stability of International Normalized Ratios in Patients Taking Long-term Warfarin Therapy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							ATRIAL-FIBRILLATION; ANTICOAGULATION; INTENSITY; OUTCOMES; REGISTRY; AF		[Pokorney, Sean D.; Simon, DaJuanicia N.; Thomas, Laine; Piccini, Jonathan P.; Peterson, Eric D.] Duke Univ, Med Ctr, Div Cardiol, DUMC 3236, Durham, NC 27710 USA; [Gersh, Bernard J.] Mayo Clin, Coll Med, Rochester, MN USA; [Hylek, Elaine M.] Boston Univ, Sch Med, Boston, MA 02215 USA	Duke University; Mayo Clinic; Boston University	Peterson, ED (corresponding author), Duke Univ, Med Ctr, Div Cardiol, DUMC 3236, Durham, NC 27710 USA.	eric.peterson@duke.edu	Peterson, Eric David/ABF-5033-2021					Hylek EM, 1996, NEW ENGL J MED, V335, P540, DOI 10.1056/NEJM199608223350802; Lip GYH, 2014, EUR HEART J, V35, P3365, DOI 10.1093/eurheartj/ehu374; Piccini JP, 2011, AM HEART J, V162, P606, DOI 10.1016/j.ahj.2011.07.001; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Singer DE, 2009, CIRC-CARDIOVASC QUAL, V2, P297, DOI 10.1161/CIRCOUTCOMES.108.830232; Wilke T, 2012, THROMB HAEMOSTASIS, V107, P1053, DOI 10.1160/TH11-11-0768	6	33	35	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	AUG 9	2016	316	6					661	663		10.1001/jama.2016.9356	http://dx.doi.org/10.1001/jama.2016.9356			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DS7TK	27532922				2022-12-28	WOS:000380985600020
J	Mathew, RS; Mullan, H; Blusztajn, JK; Lehtinen, MK				Mathew, Rebecca S.; Mullan, Hillary; Blusztajn, Jan Krzysztof; Lehtinen, Maria K.			Comment on "Multiple repressive mechanisms in the hippocampus during memory formation"	SCIENCE			English	Editorial Material							CHOROID-PLEXUS; EXPRESSION; BRAIN		[Mathew, Rebecca S.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Mathew, Rebecca S.] Harvard Med Sch, Howard Hughes Med Inst, Boston, MA 02115 USA; [Mullan, Hillary; Lehtinen, Maria K.] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Blusztajn, Jan Krzysztof] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Boston University	Lehtinen, MK (corresponding author), Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA.	maria.lehtinen@childrens.harvard.edu		/0000-0001-8438-3122	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS088566] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG045031] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIA NIH HHS [AG045031, R01 AG045031] Funding Source: Medline; NINDS NIH HHS [NS088566, R01 NS088566] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Baruch K, 2014, SCIENCE, V346, P89, DOI 10.1126/science.1252945; Cho J, 2015, SCIENCE, V350, P82, DOI 10.1126/science.aac7368; Eckel-Mahan KL, 2008, NAT NEUROSCI, V11, P1074, DOI 10.1038/nn.2174; Lein ES, 2004, J NEUROSCI, V24, P3879, DOI 10.1523/JNEUROSCI.4710-03.2004; Liddelow SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065629; Lun MP, 2015, NAT REV NEUROSCI, V16, P445, DOI 10.1038/nrn3921; Lun MP, 2015, J NEUROSCI, V35, P4903, DOI 10.1523/JNEUROSCI.3081-14.2015; McEwen BS, 2015, NAT NEUROSCI, V18, P1353, DOI 10.1038/nn.4086; Quintela T, 2015, BRAIN STRUCT FUNCT, V220, P1251, DOI 10.1007/s00429-014-0720-1; Quintela T, 2009, CELL MOL NEUROBIOL, V29, P475, DOI 10.1007/s10571-008-9339-1; Sarvari M, 2015, ENDOCRINOLOGY, V156, P2632, DOI 10.1210/en.2015-1109; Stankiewicz AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142195; Thompson RCA, 2012, ADV PARASIT, V78, P57, DOI 10.1016/B978-0-12-394303-3.00003-7	13	12	13	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 29	2016	353	6298								10.1126/science.aaf1288	http://dx.doi.org/10.1126/science.aaf1288			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DS2HC	27482552	Green Accepted			2022-12-28	WOS:000380583600029
J	Barnett, R				Barnett, Richard			Suicide	LANCET			English	Editorial Material												richard@richardbarnettwriter.com							0	5	5	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 16	2016	388	10041					228	228		10.1016/S0140-6736(16)31030-3	http://dx.doi.org/10.1016/S0140-6736(16)31030-3			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DR2LN	27489913				2022-12-28	WOS:000379736100014
